PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shinomoto, M; Kasai, T; Tatebe, H; Kondo, M; Ohmichi, T; Morimoto, M; Chiyonobu, T; Terada, N; Allsop, D; Yokota, I; Mizuno, T; Tokuda, T				Shinomoto, Makiko; Kasai, Takashi; Tatebe, Harutsugu; Kondo, Masaki; Ohmichi, Takuma; Morimoto, Masafumi; Chiyonobu, Tomohiro; Terada, Naoto; Allsop, David; Yokota, Isao; Mizuno, Toshiki; Tokuda, Takahiko			Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients	PLOS ONE			English	Article							ALZHEIMER-DISEASE; NEURODEGENERATION; ASSOCIATION; PREVALENCE; PATHOLOGY; BEHAVIOR; MARKER; BLOOD; AGE	People with Down syndrome (DS) are at high risk of developing Alzheimer disease (AD) with aging. The diagnosis and treatment trials are hampered by a lack of reliable blood biomarkers. Plasma neurofilament light chain (NfL) is one of the established biomarkers of AD, suggesting that it may be useful as an indicator of dementia in DS patients. The aims of this study were: 1) to examine whether plasma levels of NfL in DS patients are correlated with decreased adaptive behavior scores one year after sample collection, and 2) to compare plasma levels of NfL in adults with DS and an age-matched healthy control population. In this study, plasma levels of NfL in 24 patients with DS and 24 control participants were measured by the single-molecule immunoarray (Simoa) method. We observed significantly increased plasma NfL levels in the DS compared with the control group. There was a significant correlation between age and levels of plasma NfL in both groups. This age-dependent elevation was steeper in the DS compared with the control group. Moreover, elevated plasma NfL was associated with decreased adaptive behavior scores one year later, after age-adjustment. Previously reported blood-based biomarkers available in Simoa for DS, plasma total tau and phosphorylated tau, were not significantly correlated with the annual decrement of adaptive behavior scores after age-adjustment. These results suggest that plasma NfL has the potential to serve as an objective biomarker to predict dementia in adult DS patients.	[Shinomoto, Makiko; Kasai, Takashi; Tatebe, Harutsugu; Kondo, Masaki; Ohmichi, Takuma; Mizuno, Toshiki; Tokuda, Takahiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kyoto, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Zaitaku Homecare Med, Kyoto, Japan; [Morimoto, Masafumi; Chiyonobu, Tomohiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Chiyonobu, Tomohiro] Kyoto Prefectural Univ Med, Dept Pediat, North Med Ctr, Kyoto, Japan; [Terada, Naoto] Hananoki Med Welf Ctr, Kyoto, Japan; [Allsop, David] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England; [Yokota, Isao] Kyoto Prefectural Univ Med, Dept Biostat, Kyoto, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Lancaster University; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Kasai, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kyoto, Japan.	kasaita@koto.kpu-m.ac.jp	Yokota, Isao/AAB-2910-2021; Allsop, David/B-9725-2008; Mizuno, Toshiki/AAH-7155-2020	Yokota, Isao/0000-0001-6254-2225; Allsop, David/0000-0002-0513-5575; Chiyonobu, Tomohiro/0000-0001-6678-060X	Japan Agency for Medical Research and Development (AMED) [15K09319, 18K07506]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Japan Agency for Medical Research and Development (AMED) (to TT) and by Grants-in-Aid (Nos. 15K09319 and 18K07506) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T.K.	Adams D, 2010, J INTELL DISABIL RES, V54, P393, DOI 10.1111/j.1365-2788.2010.01271.x; Aivazidis S, 2017, BURDEN TRISOMY 21 DI, V12, DOI [10.1371/journal.pone.0176307, DOI 10.1371/JOURNAL.PONE.0176307]; Annus T, 2016, ALZHEIMERS DEMENT, V12, P538, DOI 10.1016/j.jalz.2015.07.490; Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Ballard C, 2016, LANCET NEUROL, V15, P622, DOI 10.1016/S1474-4422(16)00063-6; Carr J, 2014, J APPL RES INTELLECT, V27, P555, DOI 10.1111/jar.12093; de Graaf G, 2011, J APPL RES INTELLECT, V24, P247, DOI 10.1111/j.1468-3148.2010.00593.x; Deb S, 2007, BRIT J PSYCHIAT, V190, P440, DOI 10.1192/bjp.bp.106.024984; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Elliott-King Jordan, 2016, Alzheimers Dement (Amst), V4, P126; Fortea J, 2018, LANCET NEUROL, V17, P860, DOI 10.1016/S1474-4422(18)30285-0; Ghezzo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113111; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Kasai T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188802; Lautarescu BA, 2017, NEUROPSYCHOL REV, V27, P31, DOI 10.1007/s11065-017-9341-9; Lee NC, 2017, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00316; Lewczuk P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0404-9; Lue LF, 2017, NEUROL THER, V6, pS25, DOI 10.1007/s40120-017-0074-8; Makary AT, 2015, J INTELL DISABIL RES, V59, P689, DOI 10.1111/jir.12172; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; Margallo-Lana ML, 2007, J INTELL DISABIL RES, V51, P463, DOI 10.1111/j.1365-2788.2006.00902.x; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Nieuwenhuis-Mark RE, 2009, RES DEV DISABIL, V30, P827, DOI 10.1016/j.ridd.2009.01.010; Piehl F, 2018, MULT SCLER J, V24, P1046, DOI 10.1177/1352458517715132; Portelius E, 2014, NEURODEGENER DIS, V14, P98, DOI 10.1159/000358800; Rafii MS, 2017, J ALZHEIMERS DIS, V60, P439, DOI 10.3233/JAD-170390; Strydom A, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0367-x; Suzuki H, 1997, B SPEC ED, V21, P139; Tatebe H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0206-8; Temple V, 2001, J INTELL DISABIL RES, V45, P47, DOI 10.1046/j.1365-2788.2001.00299.x; Urv TK, 2008, AM J MENT RETARD, V113, P73, DOI 10.1352/0895-8017(2008)113[73:MBRTDS]2.0.CO;2; Vagberg M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135886; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; Wu JH, 2013, EUR J HUM GENET, V21, P1016, DOI 10.1038/ejhg.2012.294; Zeilinger EL, 2013, RES DEV DISABIL, V34, P3962, DOI 10.1016/j.ridd.2013.08.013	36	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2019	14	4							e0211575	10.1371/journal.pone.0211575	http://dx.doi.org/10.1371/journal.pone.0211575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR9NM	30951523	gold, Green Published, Green Submitted			2022-12-27	WOS:000463487500003
J	Kovalenko, AA; Brenn, T; Odland, JO; Nieboer, E; Krettek, A; Anda, EE				Kovalenko, Anton A.; Brenn, Tormod; Odland, Jon Oyvind; Nieboer, Evert; Krettek, Alexandra; Anda, Erik Eik			Risk Factors for hypospadias in Northwest Russia: A Murmansk County Birth Registry Study	PLOS ONE			English	Article							MALFORMATIONS; PREGNANCY; EXPOSURE; INFANTS; SWEDEN; AGE	Background Hypospadias is the most common congenital anomaly of the penis, but its causes are mainly unknown. Of the risk factors identified, the most plausible are hormonal and genetic. The aim of this study was to identify risk factors for hypospadias in Northwest Russia based on registry data. Methods The study population included male infants registered in the Murmansk County Birth Registry between 1 January 2006 and 31 December 2011 (n = 25 475). These infants were followed-up for 2 years using the Murmansk Regional Congenital Defects Registry to identify cases of hypospadias not diagnosed at birth. We used logistic regression analysis to examine the contributions of hypospadias risk factors. Results Out of 25 475 male infants born during the study period, 148 had isolated hypospadias. The overall prevalence rate was 54.2 (95% CI 53.6-54.8) per 10 000 male infants. Those born to mothers with preeclampsia (OR = 1.65; 95% CI 1.03-2.66) or infant birthweight < 2500 g (OR = 2.06; 95% CI 1.18-3.60) exhibited increased risk for hypospadias. Maternal age, smoking during pregnancy, folic acid intake during pregnancy or hepatitis B surface antigen positivity did not associate with increased risk of hypospadias. Conclusions Combining data from a birth registry with those from a congenital defects registry provided optimal information about the prevalence of hypospadias and its association with low infant birthweight and preeclampsia. These factors have in common changes in hormone levels during pregnancy, which in turn may have contributed to hypospadias development.	[Kovalenko, Anton A.; Brenn, Tormod; Odland, Jon Oyvind; Krettek, Alexandra; Anda, Erik Eik] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Kovalenko, Anton A.] Northern State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia; [Nieboer, Evert] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Krettek, Alexandra] Univ Skovde, Sch Hlth & Educ, Dept Biomed & Publ Hlth, Skovde, Sweden; [Krettek, Alexandra] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden	UiT The Arctic University of Tromso; Northern State Medical University; McMaster University; University of Skovde; University of Gothenburg	Kovalenko, AA (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.; Kovalenko, AA (corresponding author), Northern State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia.	drkovalenko@rambler.ru	Brenn, Tormod/AAY-5357-2021	Brenn, Tormod/0000-0003-3717-8323	Publication Fund of UiT The Arctic University of Norway	Publication Fund of UiT The Arctic University of Norway	The publication charges for this article were provided by a grant from the Publication Fund of UiT The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian AJ, 2015, HYPOSPADIAS RISK FAC, P1; Akre O, 2008, ENVIRON HEALTH PERSP, V116, P1071, DOI 10.1289/ehp.10791; Anda EE, 2008, INT J CIRCUMPOL HEAL, V67, P318, DOI 10.3402/ijch.v67i4.18339; Aschim EL, 2004, INT J ANDROL, V27, P213, DOI 10.1111/j.1365-2605.2004.00473.x; Baskin L, 2017, CLIN PEDIATR, V56, P409, DOI 10.1177/0009922816684613; Bergman JEH, 2015, WORLD J UROL, V33, P2159, DOI 10.1007/s00345-015-1507-6; Brouwers MM, 2007, EUR J PEDIATR, V166, P671, DOI 10.1007/s00431-006-0304-z; Brouwers MM, 2010, BJU INT, V105, P254, DOI 10.1111/j.1464-410X.2009.08772.x; CALZOLARI E, 1986, J MED GENET, V23, P333, DOI 10.1136/jmg.23.4.333; CANNING DA, 2014, J UROLOGY, V191, P465, DOI DOI 10.1016/J.JUR0.2013.10.106; Carlson WH, 2009, J PEDIATR UROL, V5, P283, DOI 10.1016/j.jpurol.2008.12.005; Carmichael SL, 2005, PAEDIATR PERINAT EP, V19, P406, DOI 10.1111/j.1365-3016.2005.00680.x; Carmichael SL, 2013, AM J EPIDEMIOL, V178, P434, DOI 10.1093/aje/kws591; Carmichael SL, 2012, BIRTH DEFECTS RES A, V94, P499, DOI 10.1002/bdra.23021; Carter TC, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.044; Caton AR, 2008, BIRTH DEFECTS RES A, V82, P34, DOI 10.1002/bdra.20415; Chen MJ, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-20; Cunha GR, 2015, NAT REV UROL, V12, P271, DOI 10.1038/nrurol.2015.57; Czeizel AE, 1997, TERATOLOGY, V56, P335, DOI 10.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W; Djakovic N, 2008, ADV UROL, V2008, DOI 10.1155/2008/650135; Gatti JM, 2001, BJU INT, V87, P548, DOI 10.1046/j.1464-410X.2001.00088.x; Hussain N, 2002, PEDIATRICS, V109, P473, DOI 10.1542/peds.109.3.473; Kallen Bengt, 2007, Congenital Anomalies, V47, P119, DOI 10.1111/j.1741-4520.2007.00159.x; Kallen K, 2002, TERATOLOGY, V66, P185, DOI 10.1002/tera.10092; Keays MA, 2017, CUAJ-CAN UROL ASSOC, V11, P48, DOI 10.5489/cuaj.4386; Kim KS, 2004, ENVIRON RES, V94, P267, DOI 10.1016/S0013-9351(03)00085-9; Konstantinidou A E, 2007, J Infect, V54, pe41, DOI 10.1016/j.jinf.2006.03.030; Kovalenko AA, 2017, INT J CIRCUMPOL HEAL, V76, DOI 10.1080/22423982.2017.1366785; MCINTOSH GC, 1995, EPIDEMIOLOGY, V6, P282, DOI 10.1097/00001648-199505000-00016; Morera A M, 2006, J Pediatr Urol, V2, P169, DOI 10.1016/j.jpurol.2005.09.008; Nassar N, 2010, OCCUP ENVIRON MED, V67, P585, DOI 10.1136/oem.2009.048272; Nordenvall AS, 2014, J UROLOGY, V191, P783, DOI 10.1016/j.juro.2013.09.058; Porter Michael P, 2005, Pediatrics, V115, pe495, DOI 10.1542/peds.2004-1552; Sorensen HT, 2005, EPIDEMIOLOGY, V16, P806; STOLL C, 1990, J MED GENET, V27, P559, DOI 10.1136/jmg.27.9.559; Sun G, 2009, UROLOGY, V73, P1241, DOI 10.1016/j.urology.2008.12.081; Thorup J, 2014, CURR OPIN ENDOCRINOL, V21, P227, DOI 10.1097/MED.0000000000000063; Vaktskjold A, 2006, SCAND J WORK ENV HEA, V32, P41, DOI 10.5271/sjweh.975; Weidner IS, 1999, J UROLOGY, V161, P1606, DOI 10.1016/S0022-5347(05)68992-6; Xu LF, 2014, ASIAN J ANDROL, V16, P778, DOI 10.4103/1008-682X.131704	40	2	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214213	10.1371/journal.pone.0214213	http://dx.doi.org/10.1371/journal.pone.0214213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946760	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500020
J	Ryu, H; Park, HC; Kim, H; Heo, J; Kang, E; Hwang, YH; Cho, JY; Lee, KB; Oh, YK; Oh, KH; Ahn, C				Ryu, Hyunjin; Park, Hayne Cho; Kim, Hyunsuk; Heo, Jongho; Kang, Eunjung; Hwang, Young-Hwan; Cho, Jeong Yeon; Lee, Kyu-Beck; Oh, Yun Kyu; Oh, Kook-Hwan; Ahn, Curie			Bioelectrical impedance analysis as a nutritional assessment tool in Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							PHASE-ANGLE; PERITONEAL-DIALYSIS; BODY-COMPOSITION; MUSCLE MASS; MORTALITY; MALNUTRITION; ASSOCIATIONS; FLUID; RISK; INFLAMMATION	Objective Autosomal dominant polycystic kidney disease (ADPKD) patients with massive organomegaly suffer from pressure-related complications including malnutrition. In this study, we analyzed the efficacy of segmental bioelectrical impedance analysis (BIA) for objective and quantitative nutritional assessment in ADPKD patients Design and methods We conducted a cross-sectional study, to evaluate the clinical utility of segmental BIA for assessing the nutritional status of ADPKD patients. BIA measurements was assessed according to modified subjective global assessment (SGA) scores and were compared with data from a healthy population. The association between BIA measurements and the height adjusted kidney and liver volumes (htTKLV), were analyzed. Subjects A total of 288 ADPKD patients, aged >= 18 years old, were analyzed Main outcome measures Nutritional status was evaluated with SGA and segmental BIA. The htTKLV were measured in each patients using computed tomonography images. Results Higher ratios of extracellular water to total body water (ECW/TBW) in the whole-body (ECW/TBWWB), trunk (ECW/TBWTR), and lower extremities (ECW/TBWLE) and lower phase angle of lower extremities (PhA(LE)) correlated with lower SGA scores in the ADPKD population and in both gender. The four parameters, ECW/TBWWB, ECW/TBWTR, and ECW/TBW LE of >0.38 and PhA(LE) of <5.8 0 were associated with malnutrition in ADPKD patients. These correlations were preserved in the subgroup analysis for chronic kidney disease stages 1-3A. Compared to healthy populations' data, body fluid parameters and segmental ECW/TBW values, except for the upper extremities (ECW/TBWUE), were greater in ADPKD patients. Increased htTKLV was an independent risk factor for malnutrition in ADPKD. The highest correlation with htTKLV was observed for the ECW/TBWTR (r = 0.466), followed by ECW/TBWWB (r = 0.407), ECW/TBWLE (r = 0.385), PhA(LE) (r = -0.279), and PhA(TR) (r = 0.215). Conclusions These results demonstrated that segmental BIA parameters of ECW/TBWWB, ECW/TBWTR, ECW/TBWLE and PhA(LE) provide useful information on nutritional status including the impact of organomegaly in ADPKD.	[Ryu, Hyunjin; Kang, Eunjung; Oh, Kook-Hwan; Ahn, Curie] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Park, Hayne Cho] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Hyunsuk] Chuncheon Sacred Heart Hosp, Dept Internal Med, Chunchon, South Korea; [Heo, Jongho] Natl Assembly Futures Inst, Seoul, South Korea; [Hwang, Young-Hwan] Truewords Dialysis Clin, Incheon, South Korea; [Cho, Jeong Yeon] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Lee, Kyu-Beck] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Oh, Yun Kyu] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Oh, Kook-Hwan; Ahn, Curie] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hallym University; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Oh, KH; Ahn, C (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.; Oh, KH; Ahn, C (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ohchris@hanmail.net; curie@snu.ac.kr	Oh, Yun Kyu/J-5542-2012	Oh, Kook-Hwan/0000-0001-9525-2179; Kim, Hyunsuk/0000-0003-1889-253X	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI12C0014]; Korea Centers for Disease Control and Prevention [2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea; Korea Centers for Disease Control and Prevention	This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI12C0014) and Korea Centers for Disease Control and Prevention (2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, and 2016E3300200).	Alvarez-Lara MA, 2001, NEPHROL DIAL TRANSPL, V16, P94, DOI 10.1093/ndt/16.suppl_1.94; [Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39; Beberashvilil I, 2014, EUR J CLIN NUTR, V68, P683, DOI 10.1038/ejcn.2014.67; Belarmino G, 2017, WORLD J HEPATOL, V9, P401, DOI 10.4254/wjh.v9.i7.401; Carrero JJ, 2013, J RENAL NUTR, V23, P77, DOI 10.1053/j.jrn.2013.01.001; Cederholm T, 2019, CLIN NUTR, V38, P1, DOI [10.1016/j.clnu.2018.08.002, 10.1002/jpen.1440]; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Cnossen WR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-69; de Mutsert R, 2008, NEPHROL DIAL TRANSPL, V23, P2957, DOI 10.1093/ndt/gfn167; Guo QY, 2015, PERITON DIALYSIS INT, V35, P691, DOI 10.3747/pdi.2014.00008; Gupta D, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-19; Han M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-63; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144526; Kim Y, 2017, INT J EPIDEMIOL, V46, P1350, DOI 10.1093/ije/dyx105; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2013, CLIN NUTR, V32, P294, DOI 10.1016/j.clnu.2012.08.001; Lawson JA, 2001, J RENAL NUTR, V11, P16, DOI 10.1016/S1051-2276(01)85914-8; Leavey SF, 1998, AM J KIDNEY DIS, V31, P997, DOI 10.1053/ajkd.1998.v31.pm9631845; Lee JE, 2015, CLIN INTERV AGING, V10, P1327, DOI 10.2147/CIA.S86229; Lee Yoojin, 2015, Clin Nutr Res, V4, P32, DOI 10.7762/cnr.2015.4.1.32; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Liu MH, 2012, J CARDIOVASC MED, V13, P299, DOI 10.2459/JCM.0b013e328351677f; LOWRIE EG, 1995, AM J KIDNEY DIS, V26, P220, DOI 10.1016/0272-6386(95)90177-9; Maggiore Q, 1996, KIDNEY INT, V50, P2103, DOI 10.1038/ki.1996.535; Mialich M.S., 2014, INT J CLIN NUTR, V2, P1, DOI DOI 10.12691/IJCN-2-1-1; Molnar MZ, 2011, AM J TRANSPLANT, V11, P1006, DOI 10.1111/j.1600-6143.2011.03480.x; O'Neill WC, 2005, AM J KIDNEY DIS, V46, P1058, DOI 10.1053/j.ajkd.2005.08.026; Camargo DAP, 2017, NUTR CANCER, V69, P601, DOI 10.1080/01635581.2017.1299880; Pirlich M, 2000, HEPATOLOGY, V32, P1208, DOI 10.1053/jhep.2000.20524; Pupim LB, 2004, KIDNEY INT, V66, P2054, DOI 10.1111/j.1523-1755.2004.00978.x; Ryu H, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-016-0434-0; Streja E, 2011, CLIN J AM SOC NEPHRO, V6, P1463, DOI 10.2215/CJN.09131010; Tai R, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-189; Temmerman F, 2011, ALIMENT PHARM THER, V34, P702, DOI 10.1111/j.1365-2036.2011.04783.x; Van den Ham ECH, 1999, J AM SOC NEPHROL, V10, P1067; Yang J, 2016, HEPATOL RES, V46, P183, DOI 10.1111/hepr.12560	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214912	10.1371/journal.pone.0214912	http://dx.doi.org/10.1371/journal.pone.0214912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947248	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500084
J	Subramanya, V; McKay, HS; Brusca, RM; Palella, FJ; Kingsley, LA; Witt, MD; Hodis, HN; Tracy, RP; Post, WS; Haberlen, SA				Subramanya, Vinita; McKay, Heather S.; Brusca, Rebeccah M.; Palella, Frank J.; Kingsley, Lawrence A.; Witt, Mallory D.; Hodis, Howard N.; Tracy, Russell P.; Post, Wendy S.; Haberlen, Sabina A.			Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTERCELLULAR-ADHESION MOLECULE-1; CARDIOVASCULAR-DISEASE; CORONARY ATHEROSCLEROSIS; IMMUNE ACTIVATION; RISK-FACTORS; ASSOCIATION; FIBRINOGEN; PROGRESSION	Background HIV-infected persons have an increased risk of atherosclerosis relative to uninfected individuals. Inflammatory processes may contribute to this risk. We evaluated the associations of 10 biomarkers of systemic inflammation (CRP, IL-6, sTNF-alpha R1 and 2), monocyte activation (CCL2, sCD163, sCD14), coagulation (fibrinogen, D-dimer), and endothelial dysfunction (ICAM-1) with subclinical carotid atherosclerosis among participants in the Multicenter AIDS Cohort Study (MACS). Methods Carotid plaque and intima media thickness (IMT) in the common carotid (CCA-IMT) and bifurcation region were assessed by B mode ultrasound among 452 HIV-infected and 276 HIV-uninfected men from 2010-2013. Associations between levels of each biomarker and presence of focal plaque and IMT were assessed by logistic and linear regression models, adjusting for demographics, risk behaviors, traditional cardiovascular disease (CVD) risk factors, and HIV disease characteristics. Results Compared to HIV-uninfected men, HIV-infected men had significantly higher levels of 8 of the 10 biomarkers. Overall, men with sCD163, CCL2, IL-6, and CRP levels in the highest quintile had approximately 2 times the odds of carotid plaque relative to those with levels in the lowest quintile, independent of demographic and CVD risk factors. Fibrinogen levels were positively associated with CCA-IMT while ICAM-1, CCL2, and sTNF-alpha R1 levels were positively associated with bifurcation-IMT. Among HIV-uninfected men, higher levels of sTNF-alpha R2 were positively associated with CCA-IMT, fibrinogen with bifurcation-IMT and carotid plaque, and ICAM-1 with carotid plaque. Conclusion In addition to greater levels of systemic inflammation, heightened monocyte activation (sCD163, CCL2) may contribute to the burden of atherosclerosis among HIV-infected persons.	[Subramanya, Vinita; Post, Wendy S.] Johns Hopkins Sch Med, Div Cardiol, Baltimore, MD USA; [McKay, Heather S.; Post, Wendy S.; Haberlen, Sabina A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Brusca, Rebeccah M.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Palella, Frank J.] Northwestern Univ, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA; [Kingsley, Lawrence A.] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Witt, Mallory D.] Harbor Univ Calif Los Angeles, Los Angeles Biomed Res Inst, Dept Med, Torrance, CA USA; [Hodis, Howard N.] Univ Southern Calif, Keck Sch Med, Atherosclerosis Res Unit, Los Angeles, CA 90033 USA; [Tracy, Russell P.] Univ Vermont, Larner Coll Med, Dept Pathol & Lab Med, Colchester, VT USA; [Tracy, Russell P.] Univ Vermont, Larner Coll Med, Dept Biochem, Colchester, VT USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Southern California; University of Vermont; University of Vermont	Haberlen, SA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	shaberlen@jhu.edu		Subramanya, Vinita/0000-0002-1059-0847; Haberlen, Sabina/0000-0002-9467-3454	National Heart, Lung, and Blood Institute [R01 HL095129]; Johns Hopkins University Bloomberg School of Public Health [U01-AI35042]; Northwestern University [U01-AI35039]; University of California, Los Angeles [U01-AI35040]; University of Pittsburgh [U01-AI35041]; Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health [UM1-AI35043]; National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Deafness and Communication Disorders (NIDCD); National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH) [UL1-TR001079, UL1-TR001881]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079, UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL146201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI035043, U01AI035039, U01AI035041, U01AI035042, U01AI035040] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Johns Hopkins University Bloomberg School of Public Health; Northwestern University; University of California, Los Angeles(University of California System); University of Pittsburgh(University of Pittsburgh); Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Deafness and Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Heart, Lung, and Blood Institute, R01 HL095129 (WSP). Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS): Johns Hopkins University Bloomberg School of Public Health (U01-AI35042); Northwestern University, (U01-AI35039); University of California, Los Angeles, (U01-AI35040); University of Pittsburgh, (U01-AI35041); the Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health, (UM1-AI35043). The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). Targeted supplemental funding for specific projects was also provided by the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Deafness and Communication Disorders (NIDCD). MACS data collection is also supported by UL1-TR001079 (JHU ICTR) and UL1-TR001881 (UCLA) from the National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	Alonso-Villaverde C, 2004, CIRCULATION, V110, P2204, DOI 10.1161/01.CIR.0000143835.95029.7D; Amar J, 2006, J HYPERTENS, V24, P1083, DOI 10.1097/01.hjh.0000226198.44181.0c; Bahrami H, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003371; Baker JV, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000264; Baldassarre D, 2008, ANN MED, V40, P21, DOI 10.1080/07853890701645399; Bianconi V, 2018, CURR OPIN HEMATOL, V25, P44, DOI 10.1097/MOH.0000000000000389; Bielak LF, 2000, ARTERIOSCL THROM VAS, V20, P2167, DOI 10.1161/01.ATV.20.9.2167; Bongard V, 2002, ATHEROSCLEROSIS, V164, P297, DOI 10.1016/S0021-9150(02)00071-0; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Coll B, 2006, CYTOKINE, V34, P51, DOI 10.1016/j.cyto.2006.03.013; De Luca A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-414; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Feinstein MJ, 2017, J INFECT DIS, V215, P1343, DOI 10.1093/infdis/jix085; Fitch KV, 2013, AIDS, V27, P49, DOI 10.1097/QAD.0b013e328358b29c; Floris-Moore M, 2009, AIDS, V23, P941, DOI 10.1097/QAD.0b013e328329c76b; FOLSOM AR, 1993, AM J EPIDEMIOL, V138, P1023, DOI 10.1093/oxfordjournals.aje.a116821; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Freiberg MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152588; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; GIORGI JV, 1990, CLIN IMMUNOL IMMUNOP, V55, P173, DOI 10.1016/0090-1229(90)90096-9; Gonzalez-Quesada C, 2009, CURR ATHEROSCLER REP, V11, P131, DOI 10.1007/s11883-009-0021-y; Green D, 2009, ATHEROSCLEROSIS, V202, P623, DOI 10.1016/j.atherosclerosis.2008.05.039; Gross MD, 2012, CLIN CHEM, V58, P411, DOI 10.1373/clinchem.2011.168559; Hacioglu Y, 2013, ANATOL J CARDIOL, V13, P207, DOI 10.5152/akd.2013.065; Hanna DB, 2017, J INFECT DIS, V215, P1352, DOI 10.1093/infdis/jix082; Hanna DB, 2015, CLIN INFECT DIS, V61, P640, DOI 10.1093/cid/civ325; Hsu DC, 2016, AIDS, V30, P2065, DOI 10.1097/QAD.0000000000001149; Hsue PY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000422; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Joven J, 2006, CLIN CHIM ACTA, V368, P114, DOI 10.1016/j.cca.2005.12.014; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kondo K, 2005, ATHEROSCLEROSIS, V179, P155, DOI 10.1016/j.atherosclerosis.2004.09.018; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Longenecker CT, 2016, CURR OPIN HIV AIDS, V11, P216, DOI 10.1097/COH.0000000000000227; McKibben RA, 2015, J INFECT DIS, V211, P1219, DOI 10.1093/infdis/jiu594; Moreno JA, 2010, ARTERIOSCL THROM VAS, V30, P1253, DOI 10.1161/ATVBAHA.110.203364; Papagianni A, 2003, NEPHROL DIAL TRANSPL, V18, P113, DOI 10.1093/ndt/18.1.113; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Pirro M, 2018, ATHEROSCLEROSIS, V272, P101, DOI 10.1016/j.atherosclerosis.2018.03.031; Pirro M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28741; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rohde LE, 1998, ARTERIOSCL THROM VAS, V18, P1765, DOI 10.1161/01.ATV.18.11.1765; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tabara Y, 2003, HYPERTENS RES, V26, P677, DOI 10.1291/hypres.26.677; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V219, P892, DOI 10.1016/j.atherosclerosis.2011.09.016; Vos AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169986; Vos AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147484; Wada NI, 2015, AIDS, V29, P463, DOI 10.1097/QAD.0000000000000545	60	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214735	10.1371/journal.pone.0214735	http://dx.doi.org/10.1371/journal.pone.0214735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946765	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500057
J	Alharbi, AG; Khan, MM; Horner, R; Brandt, H; Chapman, C				Alharbi, Abeer G.; Khan, M. Mahmud; Horner, Ronnie; Brandt, Heather; Chapman, Cole			Impact of Medicaid coverage expansion under the Affordable Care Act on mammography and pap tests utilization among low-income women	PLOS ONE			English	Article							BREAST-CANCER MORTALITY; 1ST 2 YEARS; HEALTH-INSURANCE; PREVENTIVE SERVICES; DISPARITIES; ACCESS	Introduction The Affordable Care Act (ACA) expanded the coverage of Medicaid to include entire population with income below 138% of federal poverty line. It remains unclear whether this policy change has improved access to and utilization of health care, particularly use of mammography and Pap tests among poor women. Methods We used a difference-in-difference (DID) design to estimate the impact of Medicaid expansion on mammography and Pap tests utilization among low-income women. Expansion states are the treatment group and non-expansion states are the control group. The years 2012-13 are the pre-expansion period and 2015-16 are the post-expansion period for the purpose of estimating the DID parameters. Results The difference-in-difference estimate show that likelihood of utilizing mammograms did not change significantly among low-income women after the implementation of Medicaid expansion (DID coefficient -0.0476 with t-statistics at -1.26), Pap test decreased (coefficient -0.0615, t-statistics -2.76), and Medicaid enrollment has increased significantly among lowincome women living in expansion states (coefficient 0.0889 with t-value of 3.68). Conclusion Expansion of Medicaid was associated with increased Medicaid enrollment but did not yield near-term improvement in use of mammography and Pap tests among low-income women. Factors beyond health insurance coverage may be important in determining the likelihood of obtaining these screenings. Policy makers should try to identify other barriers to cancer screenings among low-income women in the USA.	[Alharbi, Abeer G.; Khan, M. Mahmud; Horner, Ronnie; Chapman, Cole] Univ South Carolina, Arnold Sch Publ Hlth, Hlth Serv Policy & Management Dept, Columbia, SC 29208 USA; [Brandt, Heather] Univ South Carolina, Arnold Sch Publ Hlth, Hlth Promot Educ & Behav Dept, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Alharbi, AG (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Hlth Serv Policy & Management Dept, Columbia, SC 29208 USA.	abeer.g.alharbi@gmail.com	Brandt, Heather M./AAY-8027-2020; Alharbi, Abeer/AAJ-3245-2021	Alharbi, Abeer/0000-0001-7365-138X				Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Busch SH, 2005, J HEALTH ECON, V24, P876, DOI 10.1016/j.jhealeco.2005.03.007; Carrasquillo O, 2004, PREV MED, V39, P943, DOI 10.1016/j.ypmed.2004.03.033; Cawley J, 2018, J GEN INTERN MED, V33, P1495, DOI 10.1007/s11606-018-4537-0; Choi SK, 2015, AM J PUBLIC HEALTH, V105, pS706, DOI 10.2105/AJPH.2015.302876; Coldman A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju261; Cole MB, 2017, HEALTH AFFAIR, V36, P40, DOI 10.1377/hlthaff.2016.0804; Curry SJ, 2003, FULFILLING POTENTIAL; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Garfield R, 2014, UNINSURED STARTING L; Halpern MT, 2014, CANCER-AM CANCER SOC, V120, P3016, DOI 10.1002/cncr.28704; Hofvind S, 2013, CANCER-AM CANCER SOC, V119, P3106, DOI 10.1002/cncr.28174; Kaiser Family Foundation, 2018, CURR STAT STAT MED E; Lantz PM, 2016, MILBANK Q, V94, P51, DOI 10.1111/1468-0009.12181; Maciosek MV, 2010, HEALTH AFFAIR, V29, P1656, DOI 10.1377/hlthaff.2008.0701; Meer J, 2004, SOC SCI MED, V58, P1623, DOI 10.1016/S0277-9536(03)00394-0; Miller S, 2017, NEW ENGL J MED, V376, P947, DOI 10.1056/NEJMsa1612890; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; National Center for Health Statistics, 2017, HLTH US 2016 CHARTB; Puhani PA, 2012, ECON LETT, V115, P85, DOI 10.1016/j.econlet.2011.11.025; Rauscher GH, 2012, J WOMENS HEALTH, V21, P154, DOI 10.1089/jwh.2010.2415; Rowland D., 2011, ROAD 2014 MED CHIP E; Sabik LM, 2015, AM J PREV MED, V48, P98, DOI 10.1016/j.amepre.2014.08.015; SHAPIRO S, 1966, J AMER MED ASSOC, V195, P731, DOI 10.1001/jama.195.9.731; Shartzer A, 2016, HEALTH AFFAIR, V35, P161, DOI 10.1377/hlthaff.2015.0755; Simon K, 2016, IMPACT HLTH INSURANC; Simon K, 2017, J POLICY ANAL MANAG, V36, P390, DOI 10.1002/pam.21972; Smith JaMC, 2015, CURRENT POPULATION R; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Swan J, 2010, CANCER-AM CANCER SOC, V116, P4872, DOI 10.1002/cncr.25215; US Preventive Services Task Force, 2017, USPSTF GRAD A B REC; Viens LJ, 2016, MMWR MORB MORTAL WKL; Williams JAR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189661; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; Zhao GX, 2018, AM J PREV MED, V54, pE10, DOI 10.1016/j.amepre.2017.08.024	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214886	10.1371/journal.pone.0214886	http://dx.doi.org/10.1371/journal.pone.0214886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943249	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300070
J	Cai, Y; Zheng, WG; Zhang, X; Zhangzhong, LL; Xue, XZ				Cai, Yu; Zheng, Wengang; Zhang, Xin; Zhangzhong, Lili; Xue, Xuzhang			Research on soil moisture prediction model based on deep learning	PLOS ONE			English	Article								Soil moisture is one of the main factors in agricultural production and hydrological cycles, and its precise prediction is important for the rational use and management of water resources. However, soil moisture involves complex structural characteristics and meteorological factors, and it is difficult to establish an ideal mathematical model for soil moisture prediction. Existing prediction models have problems such as prediction accuracy, generalization, and multi-feature processing capability, and prediction performance must improve. Based on this, taking the Beijing area as the research object, the deep learning regression network (DNNR) with big data fitting capability was proposed to construct a soil moisture prediction model. By integrating the dataset, analyzing the time series of the predictive variables, and clarifying the relationship between features and predictive variables through the Taylor diagram, selected meteorological parameters can provide effective weights for moisture prediction. Test results prove that the deep learning model is feasible and effective for soil moisture prediction. It's good data fitting and generalization capability can enrich the input characteristics while ensuring high accuracy in predicting the trends and values of soil moisture data and provides an effective theoretical basis for water-saving irrigation and drought control.	[Cai, Yu; Zheng, Wengang; Zhang, Xin; Zhangzhong, Lili; Xue, Xuzhang] Natl Res Ctr Intelligent Equipment Agr, Beijing, Peoples R China; [Cai, Yu; Zheng, Wengang; Zhang, Xin; Zhangzhong, Lili; Xue, Xuzhang] Minist Agr, Key Lab Qual Testing Hardware & Software Prod Agr, Beijing, Peoples R China; [Cai, Yu] Hebei Univ Technol, Coll Elect Informat Engn, Tianjin, Peoples R China	Ministry of Agriculture & Rural Affairs; Hebei University of Technology	Zheng, WG (corresponding author), Natl Res Ctr Intelligent Equipment Agr, Beijing, Peoples R China.; Zheng, WG (corresponding author), Minist Agr, Key Lab Qual Testing Hardware & Software Prod Agr, Beijing, Peoples R China.	zhengwg@nercita.org.cn		zheng, wengang/0000-0001-8901-6284	National Key Research and Development Program of China [2016YFC0403102]; Innovation ability construction project of Beijing academy of agriculture and forestry sciences [KJCX20170204, KJCX20180704]	National Key Research and Development Program of China; Innovation ability construction project of Beijing academy of agriculture and forestry sciences	The research was supported by the National Key Research and Development Program of China (2016YFC0403102); the Innovation ability construction project of Beijing academy of agriculture and forestry sciences (KJCX20170204) (KJCX20180704).	Akita R., 2016, COMPUTER SCI, V15, P1, DOI [10.1109/ICIS.2016.7550882, DOI 10.1109/ICIS.2016.7550882]; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Caraballo MA, 2016, SCI TOTAL ENVIRON, V539, P427, DOI 10.1016/j.scitotenv.2015.08.156; Chang, 2016, WATER SAVING IRRIG, V7, P70; Chen SuYing, 2015, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V23, P535; Chukalla AD, 2015, HYDROL EARTH SYST SC, V19, P4877, DOI 10.5194/hess-19-4877-2015; Collobert R., 2008, P 25 INT C MACHINE L, P160; Dehghani M, 2010, J APPL REMOTE SENS, V4, P402; Feki M, 2018, WATER-SUI, V10, DOI 10.3390/w10070850; Gill MK, 2006, J AM WATER RESOUR AS, V42, P1033, DOI 10.1111/j.1752-1688.2006.tb04512.x; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hummel JW, 2001, COMPUT ELECTRON AGR, V32, P149, DOI 10.1016/S0168-1699(01)00163-6; Jackson SH, 2003, AGR WATER MANAGE, V58, P209, DOI 10.1016/S0378-3774(02)00078-1; Leng G, 2016, AGU FALL M ABSTR, pGC31B; Li, 2014, CHINA RURAL WATER HY, V5, P165; [李宁 Li Ning], 2018, [计算机工程与应用, Computer Engineering and Application], V54, P54; Liao RK, 2018, SOIL SCI SOC AM J, V82, P436, DOI 10.2136/sssaj2017.05.0164; Liao RK, 2018, ENVIRON SCI TECHNOL, V52, P1695, DOI 10.1021/acs.est.7b02928; Liao RK, 2018, LAND DEGRAD DEV, P1; Martinez-Fernandez J, 2016, REMOTE SENS ENVIRON, V177, P277, DOI 10.1016/j.rse.2016.02.064; Ronghua JI., 2017, T CHINESE SOC AGR EN, V33, P126, DOI DOI 10.11975/J.ISSN.1002-6819.2017.Z1; Schlesinger WH, 2014, AGR FOREST METEOROL, V189, P115, DOI 10.1016/j.agrformet.2014.01.011; Shandany SMH, 2018, AGR WATER MANAGE, V204, P234, DOI 10.1016/j.agwat.2018.04.014; [舒素芳 SHU Su-fang], 2009, [中国农业气象, Chinese Journal of Agrometeorology], V30, P180; Veres M, 2015, 2015 12TH CONFERENCE ON COMPUTER AND ROBOT VISION CRV 2015, P8, DOI 10.1109/CRV.2015.15; [王儒敬 Wang Rujing], 2017, [发光学报, Chinese Journal of Luminescence], V38, P109; Williams A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160974; Zhang XiaoYue, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P140	30	43	46	18	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214508	10.1371/journal.pone.0214508	http://dx.doi.org/10.1371/journal.pone.0214508			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943228	Green Submitted, Green Published, gold			2022-12-27	WOS:000463194300044
J	George, CRR; Enriquez, RP; Gatus, BJ; Whiley, DM; Lo, YR; Ishikawa, N; Wi, T; Lahra, MM				George, C. R. Robert; Enriquez, Rodney P.; Gatus, Barrie J.; Whiley, David M.; Lo, Ying-Ru; Ishikawa, Naoko; Wi, Teodora; Lahra, Monica M.			Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016	PLOS ONE			English	Review							GONOCOCCAL SURVEILLANCE PROGRAM; EXTENDED-SPECTRUM CEPHALOSPORINS; HIGH-LEVEL RESISTANCE; ANTIMICROBIAL RESISTANCE; DECREASED SUSCEPTIBILITY; MOLECULAR EPIDEMIOLOGY; HIGH PREVALENCE; 1 JANUARY; ANTIBIOTIC SUSCEPTIBILITY; TREATMENT FAILURE	Background Antimicrobial resistance in Neisseria gonorrhoeae is a global concern, with the ongoing emergence of ceftriaxone and azithromycin resistance threatening current treatment paradigms. To monitor the emergence of antimicrobial resistance in N. gonorrhoeae, the World Health Organization (WHO) Gonococcal Antimicrobial Surveillance Programme (GASP) has operated in the Western Pacific and South East Asian regions since 1992. The true burden of antimicrobial resistance remains unknown. In response, the objective of this study was to survey ceftriaxone and azithromycin susceptibility in N. gonorrhoeae across the western Pacific and south-east Asia, and interlink this data with systematically reviewed reports of ceftriaxone and azithromycin resistance. Methods and findings The WHO Collaborating Centre for Sexually Transmitted Infections and Antimicrobial Resistance, Sydney, coordinated annual surveys of gonococcal susceptibilities with participating laboratories, and additionally undertook a systematic review of reports detailing gonococcal ceftriaxone and azithromycin susceptibility data for locations geographically in the Asia Pacific from 2011 to 2016. It was found that surveillance of gonococcal antimicrobial resistance remains limited in the Asia Pacific, with weaker surveillance of azithromycin versus ceftriaxone. Ninety-three published reports were identified (including national reports) which documented susceptibility data for ceftriaxone and azithromycin. GASP survey data was available for 21 countries, territories or areas, and suggested MICs are increasing for ceftriaxone and azithromycin. Between 2011 and 2016, the percentage of locations reporting >5% of gonococcal isolates with MICs to ceftriaxone meeting WHO's definition of decreased susceptibility (MIC >= 0.125 mg/L) increased from 14.3% to 35.3% and the percentage of locations reporting >5% of gonococcal isolates with azithromycin resistance (MIC >= 1 mg/L) increased from 14.3% to 38.9%. Published reports were available for several countries that did not provide GASP surveillance responses for ceftriaxone (n = 5) and azithromycin (n = 3) respectively. Over the study period, there was a 183% increase in the number of countries providing surveillance data for GASP for both ceftriaxone and azithromycin, and a 30.6% increase in ceftriaxone MIC testing across the Asia Pacific facilitated by this project. Conclusion This study provides the first comprehensive illustration of increasing MICs to ceftriaxone in the Asia Pacific. The survey and literature review additionally detail increasing resistance to azithromycin. Further surveillance system strengthening is required to monitor these trends in order to address and curb gonococcal AMR in the region.	[George, C. R. Robert; Enriquez, Rodney P.; Lahra, Monica M.] Prince Wales Hosp, New South Wales Hlth Pathol, Microbiol, WHO Collaborating Ctr Sexually Transmitted Infect, Randwick, NSW, Australia; [George, C. R. Robert; Enriquez, Rodney P.; Gatus, Barrie J.; Lahra, Monica M.] Prince Wales Hosp, Microbiol, New South Wales Hlth Pathol, Randwick, NSW, Australia; [Whiley, David M.] Univ Queensland, UQ Ctr Clin Res, Fac Med, Herston, Qld, Australia; [Whiley, David M.] Pathol Queensland, Microbiol Dept, Herston, Qld, Australia; [Lo, Ying-Ru] WHO, Off Malaysia, Gadong, Brunei; [Lo, Ying-Ru] WHO, Off Malaysia, Singapore, Singapore; [Lo, Ying-Ru] WHO, Off Malaysia, Kuala Lumpur, Malaysia; [Ishikawa, Naoko] WHO, Reg Off Western Pacific, Manila, Philippines; [Wi, Teodora] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Lahra, Monica M.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia	University of Queensland; World Health Organization; World Health Organization; World Health Organization; WHO Western Pacific Regional Office; World Health Organization; World Health Organization; University of New South Wales Sydney	George, CRR (corresponding author), Prince Wales Hosp, New South Wales Hlth Pathol, Microbiol, WHO Collaborating Ctr Sexually Transmitted Infect, Randwick, NSW, Australia.; George, CRR (corresponding author), Prince Wales Hosp, Microbiol, New South Wales Hlth Pathol, Randwick, NSW, Australia.	rob.george@health.nsw.gov.au	George, Charles RR/N-1181-2018; Lahra, Monica/AAQ-6548-2020; Shoushtari, Masoud/AAQ-7317-2020	George, Charles RR/0000-0003-0505-6495; Lo, Ying-Ru/0000-0002-7527-7819				Arpornsuwan T, 2014, PEPTIDES, V53, P315, DOI 10.1016/j.peptides.2013.10.020; Bala M, 2016, ANTIMICROB AGENTS CH, V60, P7518, DOI 10.1128/AAC.01907-16; Bala M, 2015, SEX TRANSM DIS, V42, P218, DOI 10.1097/OLQ.0000000000000261; Bala M, 2013, SEX TRANSM INFECT, V89, P28, DOI 10.1136/sextrans-2012-050904; Bell SM., 2018, ANTIBIOTIC SUSCEPTIB, V9th; Bharara T, 2013, SEX TRANSM INFECT, V89, pA366, DOI 10.1136/sextrans-2013-051184.1145; Bharara T, 2015, INDIAN J MED MICROBI, V33, P39, DOI 10.4103/0255-0857.148374; Bissessor M, 2015, CLIN INFECT DIS, V60, P557, DOI 10.1093/cid/ciu873; Cao WL, 2015, SEX TRANSM DIS, V42, P27, DOI 10.1097/OLQ.0000000000000218; Chang JH, 2013, J FORMOS MED ASSOC, V112, P648, DOI 10.1016/j.jfma.2013.04.008; Chen CC, 2013, J ANTIMICROB CHEMOTH, V68, P1567, DOI 10.1093/jac/dkt059; Chen S, 2013, SEX TRANSM INFECT, V89, pA238, DOI 10.1136/sextrans-2013-051184.0743; Chen SC, 2016, J ANTIMICROB CHEMOTH, V71, P92, DOI 10.1093/jac/dkv321; Chen SC, 2014, J ANTIMICROB CHEMOTH, V69, P2959, DOI 10.1093/jac/dku245; Cheng CW, 2016, J MICROBIOL IMMUNOL, V49, P708, DOI 10.1016/j.jmii.2014.08.016; Chow EPF, 2016, J CLIN MICROBIOL, V54, P2485, DOI 10.1128/JCM.01186-16; Clinical and Laboratory Standards Institute, 2018, PERF STAND ANT SUSC, VWayne, pPA; Deguchi T, 2016, EMERG INFECT DIS, V22, P142, DOI 10.3201/eid2201.150868; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Fatema Nusrat, 2014, Bangladesh Journal of Infectious Diseases, V1, P3, DOI 10.3329/bjid.v1i1.21473; Furuya R, 2013, J INFECT CHEMOTHER, V19, P1218, DOI 10.1007/s10156-013-0597-6; Gu Wei-Ming, 2014, BMC Infect Dis, V14, P731, DOI 10.1186/s12879-014-0731-9; Hamasuna R, 2015, J INFECT CHEMOTHER, V21, P340, DOI 10.1016/j.jiac.2015.01.010; Hananta IPY, 2015, SEX TRANSM INFECT, V91, pA109, DOI 10.1136/sextrans-2015-052270.291; Hananta IPY, 2016, SEX TRANSM DIS, V43, P608, DOI 10.1097/OLQ.0000000000000510; Holt JB, 2015, MMWR RECOMM REP, V64, P1; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Institute for Environmental Science and Research Limited, 2015, SEXUALLY TRANSMITTED; Ito S, 2016, J ANTIMICROB CHEMOTH, V71, P2559, DOI 10.1093/jac/dkw180; Jahan F, 2014, MALAY J PATHOL, V36, P175; Juayang AC, 2015, BRIT MICROBIOLOGY RE, V10, P1; Kanhutu KN, 2014, SEX HEALTH, V11, P280, DOI 10.1071/SH14027; Khanam R, 2016, ANTIMICROB AGENTS CH, V60, P4418, DOI 10.1128/AAC.00223-16; Khauv Phara, 2014, BMC Res Notes, V7, P784, DOI 10.1186/1756-0500-7-784; Kim HJ, 2013, ANN CLIN MICROBIOL, V16; Kirkcaldy RD, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6507a1; Kobayashi T, 2013, INT J ANTIMICROB AG, V42, pS72; Lahra MM, 2017, GONOCOCCAL ANTIMICRO; Lahra MM, 2017, GONOCCOCAL ANTIMICRO; Lahra MM, 2018, EMERG INFECT DIS, V24, P735, DOI 10.3201/eid2404.171873; Lahra MM, 2017, J ANTIMICROB CHEMOTH, V72, P705, DOI 10.1093/jac/dkw452; Lahra MM, 2016, MICROBIOL AUST, V37, P173, DOI 10.1071/MA16058; Lahra MM, 2016, COMMUN DIS INTELL, V40, pE179; Lahra MM, 2015, COMMUN DIS INTELL, V39, pE628; Lahra MM, 2015, COMMUN DIS INTELL, V39, pE347; Lahra MM, 2015, COMMUN DIS INTELL, V39, pE294; Lahra MM, 2015, COMMUN DIS INTELL, V39, pE297; Lahra MM, 2015, COMMUN DIS INTELL, V39, pE137; Lahra MM, 2014, COMMUN DIS INTELL, V38, pE390; Lahra MM, 2014, NEW ENGL J MED, V371, P1850, DOI 10.1056/NEJMc1408109; Lahra MM, 2014, COMMUN DIS INTELL, V38, pE159; Lahra MM, 2013, COMMUN DIS INTELL, V37, pE436; Lahra MM, 2013, COMMUN DIS INTELL, V37, pE278; Lahra MM, 2013, COMMUN DIS INTELL, V37, pE280; Lahra MM, 2013, COMMUN DIS INTELL, V37, pE233; Lahra MM, 2013, COMMUN DIS INTELL, V37, pE86; Lahra MM, 2012, COMMUN DIS INTELL, V36, pE166; Lee H, 2016, YONSEI MED J, V57, P350, DOI 10.3349/ymj.2016.57.2.350; Lee H, 2015, J ANTIMICROB CHEMOTH, V70, P2536, DOI 10.1093/jac/dkv146; Li S, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0622-0; Li SY, 2012, J FORMOS MED ASSOC, V111, P463, DOI 10.1016/j.jfma.2012.03.004; Liang JY, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1469-3; Lin YH, 2016, UROL SCI, V27, P86, DOI 10.1016/j.urols.2016.03.005; Lusk M Josephine, 2013, J Sex Transm Dis, V2013, P967471, DOI 10.1155/2013/967471; Mahajan N, 2016, SEX TRANSM DIS, V43, P513, DOI 10.1097/OLQ.0000000000000471; Malla S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-269; Mir BA, 2015, RES J PHARM TECHNOLO, V8, P1217, DOI [10.5958/0974-360X.2015.00222.X, DOI 10.5958/0974-360X.2015.00222.X]; Morita-Ishihara T, 2014, J ANTIMICROB CHEMOTH, V69, P2086, DOI 10.1093/jac/dku118; Nakayama S, 2016, ANTIMICROB AGENTS CH, V60, P4339, DOI 10.1128/AAC.00504-16; Ni CS, 2016, J ANTIMICROB CHEMOTH, V71, P2355, DOI 10.1093/jac/dkw131; Nie S, 2014, EUR J CLIN MICROBIOL, V33, P23, DOI 10.1007/s10096-013-1921-x; O'Reilly LC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0988-7; Olsen B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-40; Phouangsouvanh S, 2018, J GLOB ANTIMICROB RE, V13, P91, DOI 10.1016/j.jgar.2017.12.001; Read PJ, 2013, SEX HEALTH, V10, P460, DOI 10.1071/SH13077; Seike K, 2016, J ANTIMICROB CHEMOTH, V71, P2466, DOI 10.1093/jac/dkw161; Shende T, 2016, J MED MICROBIOL, V65, P701, DOI 10.1099/jmm.0.000283; Shigemura K, 2015, ANTIMICROB AGENTS CH, V59, P2695, DOI 10.1128/AAC.04320-14; Shimuta K, 2013, ANTIMICROB AGENTS CH, V57, P5225, DOI 10.1128/AAC.01295-13; Singh V, 2014, SEX TRANSM DIS, V41, pS88; Sood S, 2015, SEX TRANSM INFECT, V91, pA110, DOI 10.1136/sextrans-2015-052270.293; Sood S, 2013, NATL MED J INDIA, V26, P26; Stevens K, 2015, J ANTIMICROB CHEMOTH, V70, P1267, DOI 10.1093/jac/dku490; Su X, 2013, SEX TRANSM INFECT, V89, pA367, DOI 10.1136/sextrans-2013-051184.1146; Su XH, 2016, ANTIMICROB AGENTS CH, V60, P621, DOI 10.1128/AAC.01211-15; Su XH, 2015, SEX TRANSM INFECT, V91, pA25, DOI 10.1136/sextrans-2015-052270.81; Suzaki A, 2011, INTERNAL MED, V50, P2039, DOI 10.2169/internalmedicine.50.5586; Suzuki T, 2013, J CLIN MICROBIOL, V51, P4246, DOI 10.1128/JCM.01946-13; Takahashi S, 2014, ANTIBIOTICS-BASEL, V3, P109, DOI 10.3390/antibiotics3020109; Takayama Y, 2014, J INFECT CHEMOTHER, V20, P339, DOI 10.1016/j.jiac.2014.01.007; Tanaka M, 2015, SEX TRANSM DIS, V42, P337, DOI 10.1097/OLQ.0000000000000279; The Institute of Environmental Science and Research Ltd, 2013, SEX TRANSM INF NZ AN; The Institute of Environmental Science and Research Ltd, 2014, SEX TRANSM INF NZ AN; Trecker MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089458; Trembizki E, 2015, SEX TRANSM INFECT, V91, pA26, DOI 10.1136/sextrans-2015-052270.83; Trembizki E, 2016, CLIN INFECT DIS, V63, P1591, DOI 10.1093/cid/ciw648; Trembizki E, 2015, SEX HEALTH, V12, P439, DOI 10.1071/SH15009; Trembizki E, 2014, ANTIMICROB AGENTS CH, V58, P4984, DOI 10.1128/AAC.02993-14; Trembizki E, 2014, J ANTIMICROB CHEMOTH, V69, P1526, DOI 10.1093/jac/dkt544; Tribuddharat C, 2017, JPN J INFECT DIS, V70, P213, DOI [10.7883/yoken.JJID.2016.209, 10.7883/yoken.jjid.2016.209]; Whiley DM, 2011, EURO SURVEILL, V16; Wi T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002344; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; World Health Organization, 2018, WHO AMR SURV QUAL AS; World Health Organization, 2012, GLOB ACT PLAN CONTR; Xue J, 2015, J ANTIMICROB CHEMOTH, V70, P3404, DOI 10.1093/jac/dkv266; Yamaguchi Keizo, 2016, Jpn J Antibiot, V69, P1; Yao HY, 2017, J MICROBIOL IMMUNOL, V50, P397, DOI 10.1016/j.jmii.2015.05.024; Yasuda M, 2013, INT J ANTIMICROB AG, V42, pS76; Yasuda M, 2016, J INFECT CHEMOTHER, V22, P841, DOI 10.1016/j.jiac.2016.07.012; Yasuda M, 2014, J ANTIMICROB CHEMOTH, V69, P3116, DOI 10.1093/jac/dku221; Zheng H, 2013, SEX TRANSM INFECT, V89, pA367, DOI 10.1136/sextrans-2013-051184.1147; Zheng HP, 2014, JPN J INFECT DIS, V67, P288, DOI 10.7883/yoken.67.288; Zhu BY, 2014, SEX TRANSM DIS, V41, P501, DOI 10.1097/OLQ.0000000000000157	114	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213312	10.1371/journal.pone.0213312	http://dx.doi.org/10.1371/journal.pone.0213312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943199	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300011
J	Hernandez-Hernandez, R; Kluge, J; Ah-Peng, C; Gonzalez-Mancebo, JM				Hernandez-Hernandez, Raquel; Kluge, Jurgen; Ah-Peng, Claudine; Maria Gonzalez-Mancebo, Juana			Natural and human-impacted diversity of bryophytes along an elevational gradient on an oceanic island (La Palma, Canarias)	PLOS ONE			English	Article							SPECIES RICHNESS; DISTRIBUTION PATTERNS; EPIPHYTIC BRYOPHYTES; COMMUNITIES; FORESTS; BIODIVERSITY; DISTURBANCE; SPECIFICITY; STRATEGIES; TENERIFE	Bryophytes have been proposed as ideal indicators of ecosystem change, because they are important components of forest integrity, and considerable research indicates that some groups are sensitive to the changes associated with specific human disturbances. Bryophyte richness and abundance have been found to vary predictably along elevational gradients, but the role of human impacts on these distribution patterns remains unclear. The aim of this study is to explore the impact of human disturbance on the elevational patterns of bryophyte diversity, along an elevational gradient. Along the gradient we collected three datasets in the following sites: preserved (P), forest track roadsides (R) and disturbed by agriculture/silviculture practices (D). Two survey plots of 100 m(2) were established at every 200 m elevational step for each sites P, R, D, and in each plot bryophytes were sampled in a stratified manner. At each plot we recorded all species on available substrates and estimated their percentage cover. Our results showed that species number did not differ among studied sites, but that species diversity pattern differs among the three gradient types and species life strategy composition along the elevational gradient showed a clear response to the disturbance of mature communities. We conclude that human impact has strongly changed the elevational pattern of diversity, and that these changes vary depending on the ecological and taxonomical group considered.	[Hernandez-Hernandez, Raquel; Kluge, Jurgen; Maria Gonzalez-Mancebo, Juana] Univ La Laguna, Dept Bot Ecol & Fisiol Vegetal, Plant Conservat & Biogeog Grp, C Astrofis Francisco Sanchez S-N, San Cristobal la Laguna, Islas Canarias, Spain; [Kluge, Jurgen] Philipps Univ Marburg, Dept Geog, Marburg, Germany; [Ah-Peng, Claudine] Univ La Reunion, UMR PVBMT, San Cristobal la Laguna, Spain	Universidad de la Laguna; Philipps University Marburg	Hernandez-Hernandez, R (corresponding author), Univ La Laguna, Dept Bot Ecol & Fisiol Vegetal, Plant Conservat & Biogeog Grp, C Astrofis Francisco Sanchez S-N, San Cristobal la Laguna, Islas Canarias, Spain.	rhernand@ull.es		Gonzalez-Mancebo, Juana Maria/0000-0002-3840-9501	Agence Nationale de la recherche; Conseil Regional de La Reunion; Conseil Regional de Guadeloupe; Government of Azores; Government of Canarias	Agence Nationale de la recherche(French National Research Agency (ANR)); Conseil Regional de La Reunion; Conseil Regional de Guadeloupe; Government of Azores; Government of Canarias	This research benefited from the support of the Agence Nationale de la recherche, Conseil Regional de La Reunion, Conseil Regional de Guadeloupe, Government of Azores, Government of Canarias, under the framework of the Net-Biome transnational first call (Moveclim project).	Ah-Peng C, 2014, ARCT ANTARCT ALP RES, V46, P841, DOI 10.1657/1938-4246-46.4.841; Ah-Peng C, 2012, ACTA OECOL, V42, P58, DOI 10.1016/j.actao.2012.04.010; Andrew NR, 2003, J BIOGEOGR, V30, P731, DOI 10.1046/j.1365-2699.2003.00849.x; [Anonymous], 2001, AM J BOT; Berges L, 2017, APPL VEG SCI, V20, P468, DOI 10.1111/avsc.12296; Carracedo J. C., 2002, GEOLOGY SPAIN, P439, DOI DOI 10.1144/GOSPP; Del Arco-Aguilar MJ, 2006, MAPA VEGETACION CANA; Delgado JD, 2007, LANDSCAPE URBAN PLAN, V81, P328, DOI 10.1016/j.landurbplan.2007.01.005; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Donohue I, 2016, ECOL LETT, V19, P1172, DOI 10.1111/ele.12648; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; During Heinjo J., 1992, P1; DURING HJ, 1979, LINDBERGIA, V5, P2; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gabriel R, 2005, PLANT ECOL, V177, P125, DOI 10.1007/s11258-005-2243-6; Gabriel R., 2014, ARQUIPEL LIFE MAR SC, V31, P45; Glenn-Lewin David C., 1992, V11, P11; Gonzalez-Mancebo JM, 2003, BRYOLOGIST, V106, P383, DOI 10.1639/04; GONZALEZMANCEBO JM, 2013, P INT C ISL BIOD 201, P1; Gradstein S.R., 1989, TROPICAL RAIN FOREST, P311; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Henriques DSG, 2016, J BRYOL, V38, P183, DOI 10.1080/03736687.2016.1156360; Hernandez-Hernandez R, 2017, J VEG SCI, V28, P1209, DOI 10.1111/jvs.12573; Kaufmann S, 2017, FOREST ECOL MANAG, V400, P58, DOI 10.1016/j.foreco.2017.05.043; Lehosmaa K, 2017, BIOL CONSERV, V215, P169, DOI 10.1016/j.biocon.2017.09.010; Lloret F, 2011, FLORA, V206, P769, DOI 10.1016/j.flora.2011.04.007; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; LONGTON RE, 1988, BOT J LINN SOC, V98, P253, DOI 10.1111/j.1095-8339.1988.tb02429.x; LOSADA-LIMA A., 2010, LISTA ESPECIES SILVE, P106; Marini L, 2011, J BIOGEOGR, V38, P78, DOI 10.1111/j.1365-2699.2010.02376.x; McCain C.M., 2010, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0022548, DOI 10.1002/9780470015902.A0022548]; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Patino J, 2011, PLANT ECOL, V212, P433, DOI 10.1007/s11258-010-9835-5; Patino J, 2010, ECOL APPL, V20, P1648, DOI 10.1890/09-1086.1; Patino J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009042; Patino J, 2009, CAN J FOREST RES, V39, P48, DOI 10.1139/X08-155; R Core Team, 2015, R LANGUAGE ENV STAT; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Roberts D.W., 2016, LABDSV ORDINATION MU; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sauvajot Raymond M., 1999, Urban Ecosystems, V2, P279, DOI 10.1023/A:1009588723665; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Steinbauer MJ, 2017, ECOL EVOL, V7, P771, DOI 10.1002/ece3.2640; Strayer DL, 2006, J N AM BENTHOL SOC, V25, P271, DOI 10.1899/0887-3593(2006)25[271:CFFIC]2.0.CO;2; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Vanderpoorten A, 2003, BIODIVERS CONSERV, V12, P545, DOI 10.1023/A:1022476902547; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Whitworth A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150520; WOLF JHD, 1993, ANN MO BOT GARD, V80, P928, DOI 10.2307/2399938; Zechmeister HG, 2001, BIODIVERS CONSERV, V10, P1609, DOI 10.1023/A:1012008828522	54	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213823	10.1371/journal.pone.0213823	http://dx.doi.org/10.1371/journal.pone.0213823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943204	Green Submitted, Green Published, gold			2022-12-27	WOS:000463194300019
J	Lerman, SB; D'Amico, V				Lerman, Susannah B.; D'Amico, Vincent			Lawn mowing frequency in suburban areas has no detectable effect on Borrelia spp. vector Ixodes scapularis (Acari: Ixodidae)	PLOS ONE			English	Article							LYME-DISEASE; HABITAT ASSOCIATIONS; DAMMINI ACARI; DEER TICK; ABUNDANCE; ECOLOGY; LANDSCAPE; BIODIVERSITY; URBANIZATION; DIVERSITY	Forests have become increasingly fragmented throughout the US, with residential development serving as the primary driver of these changes. These altered landscapes have provided suitable conditions for a broad range of wildlife, including blacklegged ticks and their hosts. Lawns dominate residential landscapes, and thus their management has the potential to reduce the likelihood of contact with ticks in residential yards. We tested the hypothesis that lawn mowing frequency influences tick occurrence in 16 suburban yards in Springfield, MA. We conducted 144 tick drags in lawns of various lawn mowing frequencies (mowed every week, every 2-weeks and every 3-weeks) and did not collect any ticks of any species. Promoting frequent mowing (i.e., shorter lawns) and the removal of grass clippings could have minimal impacts on tick microhabitats, but is consequential for beneficial wildlife and other ecosystem services associated with urban biodiversity.	[Lerman, Susannah B.] US Forest Serv, Northern Res Stn, USDA, Amherst, MA 01002 USA; [Lerman, Susannah B.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [D'Amico, Vincent] US Forest Serv, Northern Res Stn, USDA, Newark, DC USA	United States Department of Agriculture (USDA); United States Forest Service; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Agriculture (USDA); United States Forest Service	Lerman, SB (corresponding author), US Forest Serv, Northern Res Stn, USDA, Amherst, MA 01002 USA.; Lerman, SB (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	sblerman@fs.fed.us		Lerman, Susannah/0000-0002-2331-8439	SEES Fellowship Program, National Science Foundation [DEB-1215859]	SEES Fellowship Program, National Science Foundation	This work was supported by DEB-1215859, SEES Fellowship Program, National Science Foundation, https://www.nsf.gov, to SBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson SA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2623-0; Adalsteinsson SA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1317; Alig RJ, 2004, LANDSCAPE URBAN PLAN, V69, P219, DOI 10.1016/j.landurbplan.2003.07.004; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Aronson MFJ, 2017, FRONT ECOL ENVIRON, V15, P189, DOI 10.1002/fee.1480; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; CARROLL MC, 1992, J MED ENTOMOL, V29, P1052, DOI 10.1093/jmedent/29.6.1052; CDC C for DC and P, 2017, LYM DIS DAT TABL INT; Daniels TJ, 2000, J MED ENTOMOL, V37, P357, DOI 10.1603/0022-2585(2000)037[0357:EPSADS]2.0.CO;2; Del Fabbro S, 2015, J VECTOR ECOL, V40, P107, DOI 10.1111/jvec.12138; DUFFY DC, 1994, J MED ENTOMOL, V31, P875, DOI 10.1093/jmedent/31.6.875; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; Feldman KA, 2015, J VECTOR ECOL, V40, P198, DOI 10.1111/jvec.12153; Frank DH, 1998, LANDSCAPE ECOL, V13, P27, DOI 10.1023/A:1007965600166; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Hope P., 2018, CONSUMER REPORTS; Kremen C, 2005, FRONT ECOL ENVIRON, V3, P540, DOI 10.1890/1540-9295(2005)003[0540:ACTEMA]2.0.CO;2; Lerman SB, 2019, LANDSCAPE URBAN PLAN, V182, P114, DOI 10.1016/j.landurbplan.2018.10.016; Lerman SB, 2018, BIOL CONSERV, V221, P160, DOI 10.1016/j.biocon.2018.01.025; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Lubelczyk CB, 2004, ENVIRON ENTOMOL, V33, P900, DOI 10.1603/0046-225X-33.4.900; Mackenstedt U, 2015, INT J PARASITOL-PAR, V4, P71, DOI 10.1016/j.ijppaw.2015.01.006; MAUPIN GO, 1991, AM J EPIDEMIOL, V133, P1105, DOI 10.1093/oxfordjournals.aje.a115823; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; NEEDHAM GR, 1991, ANNU REV ENTOMOL, V36, P659, DOI 10.1146/annurev.en.36.010191.003303; OSTFELD RS, 1995, ECOL APPL, V5, P353, DOI 10.2307/1942027; Petry WK, 2010, EXP APPL ACAROL, V52, P427, DOI 10.1007/s10493-010-9373-9; Rizzoli A, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00251; Robbins P., 2007, LAWN PEOPLE GRASSES; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; STAFFORD KC, 1993, J MED ENTOMOL, V30, P762, DOI 10.1093/jmedent/30.4.762; WILSON ML, 1985, ANN ENTOMOL SOC AM, V78, P172, DOI 10.1093/aesa/78.2.172	32	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214615	10.1371/journal.pone.0214615	http://dx.doi.org/10.1371/journal.pone.0214615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943238	gold, Green Published, Green Submitted			2022-12-27	WOS:000463194300048
J	Haltmayer, E; Ribitsch, I; Gabner, S; Rosser, J; Gueltekin, S; Peham, J; Giese, U; Dolezal, M; Egerbacher, M; Jenner, F				Haltmayer, Eva; Ribitsch, Iris; Gabner, Simone; Rosser, Julie; Gueltekin, Sinan; Peham, Johannes; Giese, Ulrich; Dolezal, Marlies; Egerbacher, Monika; Jenner, Florien			Co-culture of osteochondral explants and synovial membrane as in vitro model for osteoarthritis	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; CARTILAGE; MACROPHAGES; CELLS; INFLAMMATION; EXPRESSION; VIVO; METALLOPROTEINASES; OSTEOBLASTS; REPAIR	The purpose of the current study was to establish an in vitro model for osteoarthritis (OA) by co-culture of osteochondral and synovial membrane explants. Osteochondral explants were cultured alone (control-1) or in co-culture with synovial membrane explants (control-2) in standard culture medium or with interleukin-1 beta (IL1 beta) and tumor necrosis factor (TNF alpha) added to the culture medium (OA-model-1 = osteochondral explant; OA-model-2 = osteo-chondroal-synovial explant). In addition, in OA-model groups a 2-mm partial-thickness defect was created in the centre of the cartilage explant. Changes in the expression of extra cellular matrix (ECM) genes (collagen type-1 (Col1), Col2, Col10 and aggrecan) as well as presence and quantity of inflammatory marker genes (IL6, matrix metalloproteinase-1 (MMP1), MMP3, MMP13, a disintegrin and metalloproteinase with-thrombospondin-motif-5 (ADAMTS5) were analysed by immunohistochemistry, qPCR and ELISA. To monitor the activity of classically-activated pro-inflammatory (M1) versus alternatively-activated anti-inflammatory/repair (M2) synovial macrophages, the nitric oxide/urea ratio in the supernatant of osteochondral-synovial explant co-cultures was determined. In both OA-model groups immunohistochemistry and qPCR showed a significantly increased expression of MMPs and IL6 compared to their respective control group. ELISA results confirmed a statistically significant increase in MMP1 and MMP3 production over the culturing period. In the osteochondral-synovial explant co-culture OA-model the nitric oxide/urea ratio was increased compared to the control group, indicating a shift toward M1 synovial macrophages. In summary, chemical damage (TNF alpha, IL1 beta) in combination with a partial-thickness cartilage defect elicits an inflammatory response similar to naturally occurring OA in osteochondral explants with and without osteochondral-synovial explant co-cultures and OA model -2 showing a closer approximation of OA due to the additional shift of synovial macrophages toward the pro-inflammatory M1 phenotype.	[Haltmayer, Eva; Ribitsch, Iris; Gueltekin, Sinan; Jenner, Florien] Univ Vet Med, Univ Equine Hosp, Equine Surg, Dept Compan Anim & Horses, Vienna, Austria; [Gabner, Simone; Egerbacher, Monika] Univ Vet Med, Dept Pathobiol Histol & Embryol, Vienna, Austria; [Rosser, Julie] Tech Univ, Inst Appl Synthet Chem, Vienna, Austria; [Peham, Johannes; Giese, Ulrich] AIT, Ctr Hlth & Bioresources, Mol Diagnost, Vienna, Austria; [Dolezal, Marlies] Univ Vet Med, Dept Biomed Sci Bioinformat & Biostat Platform, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Technische Universitat Wien; Austrian Institute of Technology (AIT); University of Veterinary Medicine Vienna	Haltmayer, E (corresponding author), Univ Vet Med, Univ Equine Hosp, Equine Surg, Dept Compan Anim & Horses, Vienna, Austria.	Eva.Haltmayer@vetmeduni.ac.at	Jenner, Florien/H-2679-2013	Jenner, Florien/0000-0002-6977-1984; Peham, Johannes/0000-0003-1381-2545	Bright Sparks program of the University of Veterinary Medicine Vienna, Austria	Bright Sparks program of the University of Veterinary Medicine Vienna, Austria	The current research was funded by the Bright Sparks program of the University of Veterinary Medicine Vienna, Austria to EH. The funding source was not involved in any part of the study, neither the study design, execution of the in vitro experiments, sample analysis, data analysis nor writing of the manuscript or publication.	Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3; Arden NK, 2013, OSTEOARTHR CARTILAGE, V21, P1409, DOI 10.1016/j.joca.2013.06.021; Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Blom AB, 2004, OSTEOARTHR CARTILAGE, V12, P627, DOI 10.1016/j.joca.2004.03.003; Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290; D'Andrea P, 1998, BIOCHEM J, V329, P681, DOI 10.1042/bj3290681; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Dimitrijevic M, 2014, AGE, V36, DOI 10.1007/s11357-014-9696-2; DINGLE JT, 1979, BIOCHEM J, V184, P177, DOI 10.1042/bj1840177; Fahy N, 2014, OSTEOARTHR CARTILAGE, V22, P1167, DOI 10.1016/j.joca.2014.05.021; Fuentes-Boquete I, 2004, WOUND REPAIR REGEN, V12, P444, DOI 10.1111/j.1067-1927.2004.012412.x; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Haq I, 2003, POSTGRAD MED J, V79, P377, DOI 10.1136/pmj.79.933.377; Hiligsmann M, 2014, SEMIN ARTHRITIS RHEU, V44, P271, DOI 10.1016/j.semarthrit.2014.06.005; Huser CAM, 2006, J ORTHOP RES, V24, P725, DOI 10.1002/jor.20111; Johnson CI, 2016, VET J, V209, P40, DOI 10.1016/j.tvjl.2015.07.011; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Kraus VB, 2007, OSTEOARTHR CARTILAGE, V15, P1217, DOI 10.1016/j.joca.2007.03.017; Kraus VB, 2016, OSTEOARTHR CARTILAGE, V24, P1613, DOI 10.1016/j.joca.2016.04.010; Laria A, 2016, J INFLAMM RES, V9, P1, DOI 10.2147/JIR.S82320; Lee CM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-54; Lee CM, 2013, AM J VET RES, V74, P40, DOI 10.2460/ajvr.74.1.40; Lee JH, 2009, ARCH BIOCHEM BIOPHYS, V489, P118, DOI 10.1016/j.abb.2009.07.006; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; LINDBLAD S, 1985, ARTHRITIS RHEUM, V28, P977, DOI 10.1002/art.1780280904; Manferdini C, 2017, OSTEOARTHR CARTILAGE, V25, P1161, DOI 10.1016/j.joca.2017.01.011; Manferdini C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0983-4; Mills CD, 2001, CRIT REV IMMUNOL, V21, P399, DOI 10.1615/critrevimmunol.v21.i5.10; Ogawa K, 2007, J BONE MINER METAB, V25, P354, DOI 10.1007/s00774-007-0761-0; Patwari P, 2009, SCAND J MED SCI SPOR, V19, P528, DOI 10.1111/j.1600-0838.2009.00911.x; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Romeis B., 1989, MIKROSKOPISCHE TECHN; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P979, DOI 10.1016/j.joca.2005.03.008; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Schmutzer M, 2017, J BIOSCI BIOENG, V123, P512, DOI 10.1016/j.jbiosc.2016.11.002; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Seol D, 2014, TISSUE ENG PT A, V20, P1807, DOI [10.1089/ten.tea.2013.0444, 10.1089/ten.TEA.2013.0444]; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Stewart HL, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00178; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; Uitterlinden EJ, 2006, OSTEOARTHR CARTILAGE, V14, P250, DOI 10.1016/j.joca.2005.10.001; Utomo L, 2016, OSTEOARTHR CARTILAGE, V24, P1629, DOI 10.1016/j.joca.2016.04.013; Williams A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4424; Wynn Thomas A, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1422s93	49	35	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214709	10.1371/journal.pone.0214709	http://dx.doi.org/10.1371/journal.pone.0214709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939166	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900037
J	Gonzalez-Escalona, N; Kase, JA				Gonzalez-Escalona, Narjol; Kase, Julie Ann			Virulence gene profiles and phylogeny of Shiga toxin-positive Escherichia coli strains isolated from FDA regulated foods during 2010-2017	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; SEQUENCE TYPING SCHEME; UNITED-STATES; ANTIMICROBIAL RESISTANCE; MULTISTATE OUTBREAK; INFECTION; NON-O157; GERMANY; EPIDEMIOLOGY; PREVALENCE	Illnesses caused by Shiga toxin-producing Escherichia coli (STECs) can be life threatening, such as hemolytic uremic syndrome (HUS). The STECs most frequently identified by USDA's Microbiological Data Program (MDP) carried toxin gene subtypes stx1a and/or stx2a. Here we described the genome sequences of 331 STECs isolated from foods regulated by the FDA 2010-2017, and determined their genomic identity, serotype, sequence type, virulence potential, and prevalence of antimicrobial resistance. Isolates were selected from the MDP archive, routine food testing by FDA field labs (ORA), and food testing by a contract company. Only 276 (83%) strains were confirmed as STECs by in silico analysis. Foods from which STECs were recovered included cilantro (6%), spinach (25%), lettuce (11%), and flour (9%). Phylogenetic analysis using core genome MLST revealed these STEC genomes were highly variable, with some clustering associated with ST types and serotypes. We detected 95 different sequence types (ST); several ST were previously associated with HUS: ST21 and ST29 (O26:H11), ST11 (O157:H7), ST33 (O91:H14), ST17 (O103:H2), and ST16 (O111:H-). in silico virulome analyses showed similar to 51% of these strains were potentially pathogenic [besides stx gene they also carried eae (25%) or 26% saa (26%)]. Virulence gene prevalence was also determined: stx1 only (19%); stx2 only (66%); and stx1/sxt2 (15%). Our data form a new WGS dataset that can be used to support food safety investigations and monitor the recurrence/emergence of E. coli in foods.	[Gonzalez-Escalona, Narjol; Kase, Julie Ann] US FDA, Div Microbiol, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Gonzalez-Escalona, N (corresponding author), US FDA, Div Microbiol, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	narjol.gonzalez-escalona@fda.hhs.gov	Gonzalez-Escalona, Narjol/H-6161-2019; Gonzalez-Escalona, Narjol/A-7598-2009	Gonzalez-Escalona, Narjol/0000-0003-4568-0022; Kase, Julie/0000-0002-5094-7492	FDA Foods Science and Research Intramural Program	FDA Foods Science and Research Intramural Program	This work was supported by the FDA Foods Science and Research Intramural Program.	Allard MW, 2018, CURR OPIN BIOTECH, V49, P224, DOI 10.1016/j.copbio.2017.11.002; Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Bergholz TM, 2014, TRENDS MICROBIOL, V22, P275, DOI 10.1016/j.tim.2014.01.006; Beutin L, 2004, J CLIN MICROBIOL, V42, P1099, DOI 10.1128/JCM.42.3.1099-1108.2004; BEUTIN L, 1988, ZBL BAKT-INT J MED M, V267, P576; Beutin L, 2014, EMERG INFECT DIS, V20, P1567, DOI 10.3201/eid2009.131373; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Bielaszewska M, 2013, CLIN INFECT DIS, V56, P1373, DOI 10.1093/cid/cit055; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Bugarel M, 2011, APPL ENVIRON MICROB, V77, P2275, DOI 10.1128/AEM.02832-10; Byrne L, 2015, EPIDEMIOL INFECT, V143, P3475, DOI 10.1017/S0950268815000746; Chen Y, 2016, APPL ENVIRON MICROB, V82, P6258, DOI 10.1128/AEM.01532-16; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; Crowe SJ, 2017, NEW ENGL J MED, V377, P2036, DOI [10.1056/NEJMoa1615910, 10.1056/nejmoa1615910]; Dallman TJ, 2015, EPIDEMIOL INFECT, V143, P1672, DOI 10.1017/S0950268814002696; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Erickson MC, 2007, J FOOD PROTECT, V70, P2426, DOI 10.4315/0362-028X-70.10.2426; Ethelberg S, 2009, CLIN INFECT DIS, V48, pE78, DOI 10.1086/597502; Feng PCH, 2014, APPL ENVIRON MICROB, V80, P4757, DOI 10.1128/AEM.01182-14; Feng PCH, 2014, J FOOD PROTECT, V77, P820, DOI 10.4315/0362-028X.JFP-13-412; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Fey PD, 2000, EMERG INFECT DIS, V6, P530, DOI 10.3201/eid0605.000513; Galia W., 2015, GENOME ANNOUNC, V3, P1568; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Ghanem M, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01145-17; Gonzalez-Escaloa N, 2017, J CLIN MICROBIOL, V55, P1682, DOI 10.1128/JCM.00227-17; Gonzalez-Escalona N, 2016, APPL ENVIRON MICROB, V82, P3900, DOI 10.1128/AEM.00498-16; Gonzalez-Escalona N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117485; Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karami N, 2007, J ANTIMICROB CHEMOTH, V60, P1142, DOI 10.1093/jac/dkm327; KARCH H, 1992, INFECT IMMUN, V60, P3464, DOI 10.1128/IAI.60.8.3464-3467.1992; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Khaitan A, 2007, J CLIN MICROBIOL, V45, P1374, DOI 10.1128/JCM.00076-07; Kuehne A, 2016, EPIDEMIOL INFECT, V144, P3305, DOI 10.1017/S0950268816001436; Li Z, 2017, BMC MICROBIOL, V17, P1, DOI 10.1186/s12866-017-1043-1; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lorenz SC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00846-16; Maiden MCJ, 2016, J CLIN MICROBIOL, V54, P1949, DOI 10.1128/JCM.00301-16; Martinez-Urtaza J, 2017, MBIO, V8, DOI 10.1128/mBio.01425-17; McAllister LJ, 2016, INFECT IMMUN, V84, P775, DOI 10.1128/IAI.01229-15; Mcwilliams BD, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0003-2013; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Melton-Chelsa A.R., 1998, ESCHERICHIA COLI O15, P121; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Okello E, 2015, TROP ANIM HEALTH PRO, V47, P117, DOI 10.1007/s11250-014-0694-2; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; Pennington H, 2011, LANCET INFECT DIS, V11, P652, DOI 10.1016/S1473-3099(11)70166-9; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Ruppitsch W, 2015, J CLIN MICROBIOL, V53, P2869, DOI 10.1128/JCM.01193-15; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Schmidt H, 1996, MICROBIOL-UK, V142, P907, DOI 10.1099/00221287-142-4-907; Shin SW, 2015, APPL ENVIRON MICROB, V81, P5560, DOI 10.1128/AEM.01511-15; Strauss L, 2017, P NATL ACAD SCI USA, V114, pE10596, DOI 10.1073/pnas.1702472114; Taylor EV, 2013, J FOOD PROTECT, V76, P939, DOI 10.4315/0362-028X.JFP-12-503; Thi KNO, 2012, INFECT IMMUN, V80, P469, DOI 10.1128/IAI.05539-11; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; U.S. Department of Agriculture Food Safety and Inspection Service (USDA-FSIS), 2012, FED REGISTER, V77, P31975; Watanabe H, 1996, LANCET, V348, P831, DOI 10.1016/S0140-6736(05)65257-9; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	76	30	31	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214620	10.1371/journal.pone.0214620	http://dx.doi.org/10.1371/journal.pone.0214620			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934002	gold, Green Published, Green Submitted			2022-12-27	WOS:000462867000027
J	Singer, N; Kreuzpointner, L; Sommer, M; Wust, S; Kudielka, BM				Singer, Nina; Kreuzpointner, Ludwig; Sommer, Monika; Wuest, Stefan; Kudielka, Brigitte M.			Decision-making in everyday moral conflict situations: Development and validation of a new measure	PLOS ONE			English	Article							GENDER-DIFFERENCES; ALTRUISM; STRESS; DILEMMAS; NEUROSCIENCE; RESPONSES; VALIDITY; ROLES; BASES; MEN	In everyday life, we are often confronted with morally conflicting social interaction situations. Therefore, the main objective of the present set of studies was the development and validation of a new measure to assess decision-making in everyday moral conflict situations. All vignettes required a decision between an altruistic versus an egoistic behavioral response alternative. In three independent surveys (N = 200), we developed a 40-items measure with preferable mean rates of altruistic decisions (Study 1), clear representation of altruistic and egoistic response classes (Study 2), unambiguousness of social closeness classifications (socially close vs. socially distant protagonists; Studies 1 and 2), and high similarity to reality ratings (Studies 1 and 2). Additionally, we developed two parallelized item sets for future use in within-subjects design studies and investigated the measurement properties of our new scale (Studies 1 and 3). Results of Rasch model analyses and classical test theory fit indices showed unidimensionality and confirmed the appropriateness of the fragmentation into two parallelized item sets. Notably, in our data, there were neither effects of social closeness nor gender on the percentage of altruistic decisions. In sum, we propose the Everyday Moral Conflict Situations (EMCS) Scale as a promising new measurement tool that may facilitate further research in different research areas due to its broad applicability.	[Singer, Nina; Kreuzpointner, Ludwig; Kudielka, Brigitte M.] Univ Regensburg, Dept Med Psychol Psychol Diagnost & Res Methodol, Regensburg, Germany; [Sommer, Monika] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Sommer, Monika] Ludwig Maximilians Univ Munchen, Dept Psychol, Munich, Germany; [Wuest, Stefan] Univ Regensburg, Inst Expt Psychol, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Munich; University of Regensburg	Singer, N (corresponding author), Univ Regensburg, Dept Med Psychol Psychol Diagnost & Res Methodol, Regensburg, Germany.	Nina.Singer@psychologie.uni-regensburg.de	; Kreuzpointner, Ludwig/K-1741-2013	Kudielka, Brigitte M/0000-0002-8349-926X; Kreuzpointner, Ludwig/0000-0003-1391-0807; Wust, Stefan/0000-0002-2315-8949; Singer, Nina/0000-0003-2725-6498	German Research Foundation (DFG) [DFG-KU 1401/10-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing and by grant number DFG-KU 1401/10-1 assigned to BMK, MS, and SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler J, ECONOMETRICA; ANDERSEN EB, 1973, PSYCHOMETRIKA, V38, P123, DOI 10.1007/BF02291180; Armstrong J, 2019, SOC PSYCHOL PERS SCI, V10, P353, DOI 10.1177/1948550618755873; Bauman CW, 2014, SOC PERSONAL PSYCHOL, V8, P536, DOI 10.1111/spc3.12131; Bostyn DH, 2018, PSYCHOL SCI, V29, P1084, DOI 10.1177/0956797617752640; Branas-Garza P, 2018, ECON LETT, V170, P19, DOI 10.1016/j.econlet.2018.05.022; Capraro V, 2019, PRIMING INTUITION DE; Capraro V, 2018, JUDGM DECIS MAK, V13, P345; Capraro V, 2017, COGN PROCESS, V18, P399, DOI 10.1007/s10339-017-0822-9; Ceccato S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199528; Charness G, 2012, J ECON BEHAV ORGAN, V81, P1, DOI 10.1016/j.jebo.2011.08.009; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; Christensen KB, 2002, PSYCHOMETRIKA, V67, P563, DOI 10.1007/BF02295131; Clifford S, 2015, BEHAV RES METHODS, V47, P1178, DOI 10.3758/s13428-014-0551-2; Embretson S.E., 2000, ITEM RESPONSE THEORY; FeldmanHall O, 2012, COGNITION, V123, P434, DOI 10.1016/j.cognition.2012.02.001; Fletcher T. D., 2010, PSYCHOMETRIC APPL PS; Friesdorf R, 2015, PERS SOC PSYCHOL B, V41, P696, DOI 10.1177/0146167215575731; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Fumagalli M, 2010, COGN PROCESS, V11, P219, DOI 10.1007/s10339-009-0335-2; Giammarco EA, 2016, PERS INDIV DIFFER, V88, P26, DOI 10.1016/j.paid.2015.08.039; GILLIGAN C, 1982, AM J ORTHOPSYCHIAT, V52, P199, DOI 10.1111/j.1939-0025.1982.tb02682.x; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2013, ADV EXP SOC PSYCHOL, V47, P55, DOI 10.1016/B978-0-12-407236-7.00002-4; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2015, COGNITION, V135, P39, DOI 10.1016/j.cognition.2014.11.018; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hofmann W, 2018, PERS SOC PSYCHOL B, V44, P1697, DOI 10.1177/0146167218775075; Hofmann W, 2014, SCIENCE, V345, P1340, DOI 10.1126/science.1251560; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; Kahane G, 2018, PSYCHOL REV, V125, P131, DOI 10.1037/rev0000093; Kahane G, 2015, SOC NEUROSCI-UK, V10, P551, DOI 10.1080/17470919.2015.1023400; Kahane G, 2015, COGNITION, V134, P193, DOI 10.1016/j.cognition.2014.10.005; Kossowska M, 2016, PERS INDIV DIFFER, V101, P249, DOI 10.1016/j.paid.2016.06.017; Kurzban R, 2012, EVOL HUM BEHAV, V33, P323, DOI 10.1016/j.evolhumbehav.2011.11.002; Linacre J., 2002, RASCH MEAS T, V16; Linke LH, 2012, CURR PSYCHOL, V31, P291, DOI 10.1007/s12144-012-9146-1; Lord F.M., 1980, APPL ITEM RESPONSE T; Mair P, 2018, EXTENDED RASCH MODEL; Margittai Z, 2015, HORM BEHAV, V73, P75, DOI 10.1016/j.yhbeh.2015.05.019; Margittai Z, 2018, PSYCHONEUROENDOCRINO, V90, P22, DOI 10.1016/j.psyneuen.2018.01.015; Oda R, 2014, PERS INDIV DIFFER, V56, P206, DOI 10.1016/j.paid.2013.09.017; Oda R, 2013, BRIT J PSYCHOL, V104, P577, DOI 10.1111/bjop.12021; R Core Team, 2018, R LANG ENV STAT COMP; R Core Team, 2018, FOR READ DAT STOR MI; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Rasch D, 2011, STAT PAP, V52, P219, DOI 10.1007/s00362-009-0224-x; Reise SP, 2000, PSYCHOL ASSESSMENT, V12, P287, DOI 10.1037//1040-3590.12.3.287; Revelle W., 2018, PSYCH PROCEDURES PER; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rosen JB, 2015, PARKINSONISM RELAT D, V21, P1191, DOI 10.1016/j.parkreldis.2015.08.016; Singer N, 2017, HORM BEHAV, V93, P72, DOI 10.1016/j.yhbeh.2017.05.002; Sinnott-Armstrong W, 2008, PHENOMENOL COGN SCI, V7, P85, DOI 10.1007/s11097-007-9065-z; Sommer M, 2014, SOC NEUROSCI-UK, V9, P452, DOI 10.1080/17470919.2014.933714; Sommer M, 2010, NEUROPSYCHOLOGIA, V48, P2018, DOI 10.1016/j.neuropsychologia.2010.03.023; Starcke K, 2012, JUDGM DECIS MAK, V7, P61; Starcke K, 2011, PSYCHONEUROENDOCRINO, V36, P210, DOI 10.1016/j.psyneuen.2010.07.010; Strombach T, 2015, P NATL ACAD SCI USA, V112, P1619, DOI 10.1073/pnas.1414715112; Strombach T, 2014, J BEHAV DECIS MAKING, V27, P235, DOI 10.1002/bdm.1802; Takahashi T, 2007, MED HYPOTHESES, V68, P184, DOI 10.1016/j.mehy.2006.05.057; Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250; Taylor SE, 2006, CURR DIR PSYCHOL SCI, V15, P273, DOI 10.1111/j.1467-8721.2006.00451.x; Urbaniak GC, 2019, RES RANDOMIZER VERSI; von Davier M, 2016, CH CRC STAT SOC BEHA, P31; WILKS SS, 1946, ANN MATH STAT, V17, P257, DOI 10.1214/aoms/1177730940; Youssef FF, 2012, PSYCHONEUROENDOCRINO, V37, P491, DOI 10.1016/j.psyneuen.2011.07.017; Zhan YL, 2018, NEUROSCI LETT, V672, P15, DOI 10.1016/j.neulet.2018.02.039	69	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214747	10.1371/journal.pone.0214747	http://dx.doi.org/10.1371/journal.pone.0214747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934016	Green Published, Green Submitted, gold			2022-12-27	WOS:000462867000039
J	Pham, TT; Park, B				Thu-Thi Pham; Park, Boyoung			Alcohol use disorder and health-related quality of life in Korean night-shift workers: A cross-sectional study using the KNHANES 2007-2015 data	PLOS ONE			English	Article							NATIONAL-HEALTH; GENDER; FAMILY; DRINKING; SLEEP	This study aimed to evaluate the prevalence of night-shift work, and the association of night-shift work with alcohol use disorders(AUDs), as well as with health-related quality of life (HRQL), in Korean adult workers. A total of 26,895 adult workers aged 20-59 years were included in the analysis. AUDs were assessed using the Alcohol Use Disorders Identification Test(AUDIT), and HRQL was measured by the EuroQol-5D questionnaire with five main dimensions. We found an interaction effect between gender and working status on AUDs (p = 0.0065), suggesting that women are more fragile than men in terms of the effects of night work but not regarding HRQL (p = 0.1729). Female night workers had higher risk of AUDs than female day workers (odds ratio(OR): 2.23, 95% confidence interval (CI): 1.48-3.38) but this effect was not noted in male night workers (OR: 0.97, 95% CI: 0.69-1.37). Lower HRQL was found in depression dimension for night workers compared to day workers (OR: 1.37, 95% CI: 1.00-1.89), whereas day-night regular shift workers were protected from depression. Risk of AUDs and lower HRQL were identified in female night workers but not in male night workers. This association suggests that women are more fragile than men in terms of the effects of night work.	[Thu-Thi Pham] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, South Korea; [Park, Boyoung] Hanyang Univ, Coll Med, Dept Med, Seoul, South Korea	National Cancer Center - Korea (NCC); Hanyang University	Park, B (corresponding author), Hanyang Univ, Coll Med, Dept Med, Seoul, South Korea.	hayejine@hanmail.net		Pham, Thu Thi/0000-0002-2129-0911	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2016R1C1B1013621]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2016R1C1B1013621 to BP). The funders had no role in study design, data collection and analysis, decision to present, or preparation of the manuscript.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1097/00000374-199706000-00008; Ames GM, 1996, SOC SCI MED, V43, P1649, DOI 10.1016/S0277-9536(96)00081-0; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Bildt C, 2002, INT ARCH OCC ENV HEA, V75, P252, DOI 10.1007/s00420-001-0299-8; Boivin DB, 2014, PATHOL BIOL, V62, P292, DOI 10.1016/j.patbio.2014.08.001; Boschloo L, 2010, J AFFECT DISORDERS, V126, P441, DOI 10.1016/j.jad.2010.04.019; Buchvold HV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2470-2; Costa G, 1997, CHRONOBIOL INT, V14, P89, DOI 10.3109/07420529709001147; Costa G, 2010, SAF HEALTH WORK, V1, P112, DOI 10.5491/SHAW.2010.1.2.112; De Sio S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7340781; Driesen K, 2011, SCAND J WORK ENV HEA, V37, P402, DOI 10.5271/sjweh.3158; Fenwick R, 2001, AM BEHAV SCI, V44, P1179, DOI 10.1177/00027640121956719; Flo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033981; Frick KD, 2008, WOMEN HEALTH ISS, V18, P4, DOI 10.1016/j.whi.2007.11.003; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040101; Hermansson U, 2003, OCCUPATIONAL MED, V53; Higgins-Biddle JC, 2018, AM J DRUG ALCOHOL AB, V44, P578, DOI 10.1080/00952990.2018.1456545; Hong JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175299; Hong S, 2015, FACTORS ASS HLTH REL; ILO, 1990, C171 NIGHT WORK CONV; Isahak M, 2017, ASIA PACIFIC J PUBLI; Kang MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188019; Kim H-JS-Y, 2011, MANAGEMENT EMPLOYEES; Kim W, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0564-x; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee EK, 2015, ASIAN NURS RES, V9, P132, DOI 10.1016/j.anr.2015.04.002; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Magnavita N, 2013, EUR J RADIOL, V82, pE502, DOI 10.1016/j.ejrad.2013.04.007; Maume DJ, 2010, GENDER SOC, V24, P746, DOI 10.1177/0891243210386949; Meyers JL, 2017, PSYCHOL MED, V47, P103, DOI 10.1017/S0033291716001975; Michalak L, 2007, DRUG ALCOHOL DEPEN, V87, P268, DOI 10.1016/j.drugalcdep.2006.07.013; Morikawa Y, 2013, ALCOHOL ALCOHOLISM, V48, P202, DOI 10.1093/alcalc/ags128; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Soric M, 2013, COLLEGIUM ANTROPOL, V37, P379; Stein Michael D, 2005, Subst Abus, V26, P1, DOI 10.1300/J465v26n01_01; Venturelli F, 2017, MED LAV, V108, P52, DOI 10.23749/mdl.v108i1.5581; Yoshioka E, 2012, SOC PSYCH PSYCH EPID, V47, P651, DOI 10.1007/s00127-011-0370-z	42	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214593	10.1371/journal.pone.0214593	http://dx.doi.org/10.1371/journal.pone.0214593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30933996	Green Submitted, gold, Green Published			2022-12-27	WOS:000462867000025
J	Ammitzboll, J; Skovgaard, AM; Holstein, BE; Andersen, A; Kreiner, S; Nielsen, T				Ammitzboll, Janni; Skovgaard, Anne Mette; Holstein, Bjorn E.; Andersen, Anette; Kreiner, Svend; Nielsen, Tine			Construct validity of a service-setting based measure to identify mental health problems in infancy	PLOS ONE			English	Article							ADOLESCENT PSYCHIATRIC-DISORDERS; SOCIAL-EMOTIONAL PROBLEMS; BEHAVIORAL-PROBLEMS; CHILD-COHORT; AUTISM SPECTRUM; PRIMARY-CARE; DIFFICULTIES QUESTIONNAIRE; PRESCHOOL PSYCHOPATHOLOGY; PSYCHOMETRIC PROPERTIES; SURVEILLANCE	Accumulating research document the needs of intervention towards mental health problems in early childhood. The general child health surveillance offers opportunities for early detection of mental health vulnerability, conditioned the availability of feasible and validated measures. The Copenhagen Infant Mental Health Questionnaire, CIMHQ, was developed to be feasible for community health nurses and comprehensive regarding the range of mental health problems seen in infancy. Previous testing of the CIMHQ has documented feasibility and face validity. The aim was to investigate the construct validity of the general population measure by using the Rasch measurement models, and to explore the differential functioning of the CIMHQ relative to a number of characteristics of the infants, local independence of items, and possible latent classes of infants. CIMHQ was tested in 2,973 infants from the general population, aged 9-10 months. The infants were assessed by community health nurses at home visits, in the period from March 2011 to December 2013. Rasch measurement models were used to investigate the construct validity of the CIMHQ. Analyses showed an overall construct valid scale of mental health problems, consisting of seven valid subscales of specific problems concerning eating, sleep, emotional reactions, attention, motor activity, communication, and language, respectively. The CIMHQ fitted a graphical loglinear Rasch model without differential item function. Analyses of local homogeneity identified two latent classes of infants. A simple model with almost no local dependency between items is proposed for infants with few problems, whereas a more complicated model characterizes infants with more problems. The measure CIMHQ differentiates between infants from the general population with few and more mental health problems, and between subgroups of problems that potentially can be targets of preventive intervention.	[Ammitzboll, Janni; Skovgaard, Anne Mette; Holstein, Bjorn E.; Andersen, Anette] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Skovgaard, Anne Mette] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Kreiner, Svend] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Nielsen, Tine] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen; University of Copenhagen; University of Copenhagen	Ammitzboll, J (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	jaam@sdu.dk	Holstein, Bjørn E/G-6383-2013; Holstein, Bjørn Evald/AAO-8528-2020	Holstein, Bjørn E/0000-0002-4348-280X; Skovgaard, Anne Mette/0000-0002-8793-8303; Nielsen, Tine/0000-0002-9087-729X	Danish Ministry of Health [20566]; Danish foundation TrygFonden [7-11-1480]; Obel Family Foundation [BG/2012-18501]	Danish Ministry of Health; Danish foundation TrygFonden; Obel Family Foundation	This research was supported by the Danish Ministry of Health [20566, 2010]; the Danish foundation TrygFonden [7-11-1480, 2012]; the Obel Family Foundation [BG/2012-18501, 2012].	Alakortes J, 2017, EUR CHILD ADOLES PSY, V26, P481, DOI 10.1007/s00787-016-0909-3; Alexander KE, 2013, AUST NZ J PSYCHIAT, V47, P538, DOI 10.1177/0004867413476756; American Academy of Pediatrics, 2006, 00314005 AM AC PED; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ammitzboll J, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0744-1; ANDERSEN EB, 1973, PSYCHOMETRIKA, V38, P123, DOI 10.1007/BF02291180; Angold A, 2004, HDB INFANT DEV, P123; Angold A, 2007, J CHILD PSYCHOL PSYC, V48, P961, DOI 10.1111/j.1469-7610.2007.01832.x; [Anonymous], 2013, RASCH MODELS HLTH; Bagner DM, 2012, CLIN CHILD FAM PSYCH, V15, P113, DOI 10.1007/s10567-012-0110-2; Basten M, 2016, J ABNORM CHILD PSYCH, V44, P393, DOI 10.1007/s10802-015-9993-y; Bedford H., 2013, MEASURES CHILD DEV R; Bellman M, 2012, ARCH DIS CHILD, V97, P73, DOI 10.1136/adc.2010.186668; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolton PF, 2012, J AM ACAD CHILD PSY, V51, P249, DOI 10.1016/j.jaac.2011.12.009; Briggs-Gowan MJ, 2006, J AM ACAD CHILD PSY, V45, P849, DOI 10.1097/01.chi.0000220849.48650.59; Briggs-Gowan MJ, 2004, J PEDIATR PSYCHOL, V29, P143, DOI 10.1093/jpepsy/jsh017; Brothers KB, 2008, CLIN PEDIATR, V47, P271, DOI 10.1177/0009922807309419; Carter AS, 2004, J CHILD PSYCHOL PSYC, V45, P109, DOI 10.1046/j.0021-9630.2003.00316.x; Costello EJ, 2005, J AM ACAD CHILD PSY, V44, P972, DOI 10.1097/01.chi.0000172552.41596.6f; Costello EJ, 2006, J AM ACAD CHILD PSY, V45, P8, DOI 10.1097/01.chi.0000184929.41423.c0; Croft S, 2015, PEDIATRICS, V135, pE1210, DOI 10.1542/peds.2014-2920; D'Souza S, 2017, J ABNORM CHILD PSYCH, V45, P345, DOI 10.1007/s10802-016-0176-2; da Rocha NS, 2013, J PSYCHIATR RES, V47, P141, DOI 10.1016/j.jpsychires.2012.09.014; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Egger HL, 2009, HDB INFANT MENTAL HL, P285; Elberling H, 2014, J CHILD PSYCHOL PSYC, V55, P1328, DOI 10.1111/jcpp.12256; Finster M, 2005, ANESTHESIOLOGY, V102, P855, DOI 10.1097/00000542-200504000-00022; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; Godoy L, 2014, J DEV BEHAV PEDIATR, V35, P334, DOI 10.1097/DBP.0000000000000060; Godoy L, 2013, AM J ORTHOPSYCHIAT, V83, P73, DOI 10.1111/ajop.12005; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Guedeney A, 2014, EUR CHILD ADOLES PSY, V23, P1181, DOI 10.1007/s00787-013-0513-8; Hamon A., 2002, STAT METHODS QUALITY, DOI [10.1007/978-1-4757-3625-0_13, DOI 10.1007/978-1-4757-3625-0_13]; Hemmi MH, 2011, ARCH DIS CHILD, V96, P622, DOI 10.1136/adc.2010.191312; Huffman LC, 2004, HDB INFANT TODDLER P, P467; Ivanova MY, 2010, J AM ACAD CHILD PSY, V49, P1215, DOI 10.1016/j.jaac.2010.08.019; Jaspers M, 2013, J ABNORM CHILD PSYCH, V41, P71, DOI 10.1007/s10802-012-9653-4; Johnson MH, 2015, J CHILD PSYCHOL PSYC, V56, P228, DOI 10.1111/jcpp.12328; Kreiner S, 2004, COMMUN STAT-THEOR M, V33, P1239, DOI 10.1081/STA-120030148; Kreiner S., 2013, ITEM ANAL DIGRAM 3 1; Kreiner S., 2013, RASCH MODELS HLTH, P5, DOI DOI 10.1002/9781118574454.CH1; Kreiner S, 2013, ITEM ANAL DI 1 UNPUB; Kreiner S., 2002, STAT METHODS QUALITY, P187, DOI DOI 10.1007/978-1-4757-3625-0_15; Kreiner S, 2007, NORD PSYCHOL, V59, P268, DOI 10.1027/1901-2276.59.3.268; Kreiner S, 2011, APPL PSYCH MEAS, V35, P557, DOI 10.1177/0146621611410227; Kreiner S, 2007, STAT SOC BEHAV SC, P131, DOI 10.1007/978-0-387-49839-3_8; Kreiner S, 2007, STAT SOC BEHAV SC, P329, DOI 10.1007/978-0-387-49839-3_21; Kruizinga I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049633; Kruizinga I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038762; Landa RJ, 2013, CHILD DEV, V84, P429, DOI 10.1111/j.1467-8624.2012.01870.x; Maughan B, 2005, BRIT J PSYCHIAT, V187, P301, DOI 10.1192/bjp.187.4.301; Micali N, 2016, J DEV BEHAV PEDIATR, V37, P314, DOI 10.1097/DBP.0000000000000268; Minnis H, 2013, BRIT J PSYCHIAT, V202, P342, DOI 10.1192/bjp.bp.112.114074; National Board of Health, 2011, NAT GUID CHILD AD PR; Olsson MB, 2013, ACTA PAEDIATR, V102, P635, DOI 10.1111/apa.12229; Rasch G., 1960, PROBABILISTIC MODELS; ROSENBAUM PR, 1989, PSYCHOMETRIKA, V54, P625, DOI 10.1007/BF02296400; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Rydz D, 2005, J CHILD NEUROL, V20, P4, DOI 10.1177/08830738050200010201; Sheldrick RC, 2015, J CHILD PSYCHOL PSYC, V56, P936, DOI 10.1111/jcpp.12442; Sheldrick RC, 2011, PEDIATRICS, V128, P356, DOI 10.1542/peds.2010-3261; Sim F, 2015, RES DEV DISABIL, V45-46, P69, DOI 10.1016/j.ridd.2015.07.017; Skovgaard AM, 2008, J CHILD PSYCHOL PSYC, V49, P553, DOI 10.1111/j.1469-7610.2007.01860.x; Skovgaard AM, 2005, INFANT MENT HEALTH J, V26, P470, DOI 10.1002/imhj.20065; Skovgaard AM, 2005, SCAND J PUBLIC HEALT, V33, P197, DOI 10.1080/14034940510005662; Skovgaard AM, 2018, UGESKRIFT LAEGER, V180, P2; Skovgaard AM, 2008, EUR CHILD ADOLES PSY, V17, P290, DOI 10.1007/s00787-007-0666-4; Skovgaard AM, 2007, J CHILD PSYCHOL PSYC, V48, P62, DOI 10.1111/j.1469-7610.2006.01659.x; Skovgaard AM, 2010, DAN MED BULL, V57; Sonuga-Barke EJS, 2010, J CHILD PSYCHOL PSYC, V51, P368, DOI 10.1111/j.1469-7610.2009.02195.x; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Squires J, 2001, EARLY CHILD RES Q, V16, P405, DOI 10.1016/S0885-2006(01)00115-6; Streiner D. L., 2015, HLTH MEASUREMENT SCA, V5<feminine, DOI [10.1093/med/9780199685219.001.0001, DOI 10.1093/MED/9780199685219.001.0001, 10.1093/MED/9780199685219.001.0001]; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Volkmar F, 2005, ANNU REV PSYCHOL, V56, P315, DOI 10.1146/annurev.psych.56.091103.070159; Weitzman CC, 2006, CURR OPIN PEDIATR, V18, P641, DOI 10.1097/MOP.0b013e3280108292; Wichstrom L, 2012, J CHILD PSYCHOL PSYC, V53, P695, DOI 10.1111/j.1469-7610.2011.02514.x; Winsper C, 2014, J ABNORM CHILD PSYCH, V42, P831, DOI 10.1007/s10802-013-9813-1; Wissow LS, 2013, J AM ACAD CHILD PSY, V52, P1134, DOI 10.1016/j.jaac.2013.08.013; World-Health-Organization, 2007, ICD 10 IDC 10 CLASS; Yirmiya N, 2010, J CHILD PSYCHOL PSYC, V51, P432, DOI 10.1111/j.1469-7610.2010.02214.x; Zeanah CH, 1997, J AM ACAD CHILD PSY, V36, P165, DOI 10.1097/00004583-199702000-00007; Zeanah CH, 1997, J CHILD PSYCHOL PSYC, V38, P81, DOI 10.1111/j.1469-7610.1997.tb01506.x; Zeanah P.D., 2009, HDB INFANT MENTAL HL, P549; ZERO TO THREE, 2005, DIAGN CLASS MENT HLT	86	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214112	10.1371/journal.pone.0214112	http://dx.doi.org/10.1371/journal.pone.0214112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921359	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000035
J	Camhi, SM; Troped, PJ; Garvey, M; Hayman, LL; Must, A; Lichtenstein, AH; Crouter, SE				Camhi, Sarah M.; Troped, Philip J.; Garvey, Meghan; Hayman, Laura L.; Must, Aviva; Lichtenstein, Alice H.; Crouter, Scott E.			Associations between Walk Score and objective measures of physical activity in urban overweight and obese women	PLOS ONE			English	Article							NEIGHBORHOOD WALKABILITY; US ADULTS; TRANSPORTATION; EPIDEMIOLOGY; VALIDATION; PATTERNS; BEHAVIOR	The purpose of this study was to examine associations between the Walk Score and physical activity in young, overweight/obese urban women. Project Health included 45 White or African American women (BMI 31.5 +/- 3.9 kg/m(2); age 26.5 +/- 4.6 years; 62% African American) living in the Boston area. An accelerometer estimated steps/day and mins/day in light physical activity (100-2019 counts-per-minute) and moderate-to-vigorous-physical activity (>= 2020 cpm). Walk Score was used to estimate the walkability of home address by analyzing proximity to nearby amenities. General linear regression models estimated associations between total Walk Score and physical activity (light physical activity, moderate-to-vigorousphysical activity, steps, total activity counts, METs), adjusting for body mass index, age, race/ethnicity, seasonality, wear time, employment and student status. For physical activity variables that had significant associations with Walk Score (steps/day and steps/min), regression models were estimated for Walk Score sub-scores (parks, grocery, errands, shopping, dining/drinking, culture/entertainment and schools). Logistic regression models estimated the odds of meeting the guidelines for steps (>= 10,000/day) and moderate-to-vigorous-physical activity (>= 150mins MVPA/week) based on Walk Score. Participants had a Walk Score of 63.9 +/- 26.4, took 14,143 +/- 3,934 steps/day, and spent 206.2 +/- 66.0 mins/day in light physical activity and 46.7 +/- 17.5 mins/day in moderate-to-vigorous- physical activity. Walk Score was significantly and positively associated with steps/day (beta = 51.4, p = 0.01) and steps/min (beta = 0.06, p = 0.009) but was not associated with mins/day of light physical activity, moderate-to-vigorous-physical activity, total activity counts or METs. Parks, grocery, errands, shopping, dining/drinking, and culture/entertainment Walk Score sub-scores were significantly associated with steps and steps/min (all p<0.05), but not significantly associated for schools. Participants who lived in higher Walk Score neighborhoods were more likely to meet the step guidelines (OR, 95% CI: 1.59, 1.04-2.99) and moderate-to-vigorous-physical activity guidelines (1.63, 1.06-3.02), respectively, per 10-unit increase in Walk Score. These results indicate that living in a more walkable neighborhood may support walking behavior in young, urban-dwelling overweight/obese women and provide further evidence for the expanded use of urban planning and transportation policies to improve the walkability of urban neighborhoods.	[Camhi, Sarah M.; Troped, Philip J.; Garvey, Meghan] Univ Massachusetts, Dept Exercise Sci, Boston, MA 02125 USA; [Hayman, Laura L.] Univ Massachusetts, Dept Nursing, Boston, MA 02125 USA; [Must, Aviva] Tufts Univ, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Lichtenstein, Alice H.] Tufts Univ, Cardiovasc Nutr Lab, Boston, MA USA; [Crouter, Scott E.] Univ Tennessee, Dept Kinesiol Recreat & Sports Studies, Knoxville, TN USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; Massachusetts Department of Public Health; Tufts University; Tufts University; University of Tennessee System; University of Tennessee Knoxville	Camhi, SM (corresponding author), Univ Massachusetts, Dept Exercise Sci, Boston, MA 02125 USA.	sarah.camhi@umb.edu		Camhi, Sarah/0000-0001-5732-1591	University of Massachusetts Boston Proposal Development Grant; Boston Nutrition Obesity Research Center [DK46200]	University of Massachusetts Boston Proposal Development Grant; Boston Nutrition Obesity Research Center	Funding and support were provided by University of Massachusetts Boston Proposal Development Grant (SMC) and Boston Nutrition Obesity Research Center DK46200 (AM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Administration FH Transportation UDo], 2008, RES GUID CREAT SAF W; Althoff T, 2017, NATURE, V547, P336, DOI 10.1038/nature23018; [Anonymous], 2008, PHYS ACT GUID AM; [Anonymous], 1998, ROLE PA HTLH AGING; Berrigan D, 2006, AM J PREV MED, V31, P210, DOI 10.1016/j.amepre.2006.04.007; Berrigan David, 2012, Morbidity and Mortality Weekly Report, V61, P595; Brown SC, 2013, AM J PREV MED, V45, P202, DOI 10.1016/j.amepre.2013.03.021; Bryan SN, 2009, CAN J PUBLIC HEALTH, V100, P294, DOI 10.1007/BF03403950; Camhi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138548; Carr LJ, 2011, BRIT J SPORT MED, V45, P1144, DOI 10.1136/bjsm.2009.069609; Carr LJ, 2010, AM J PREV MED, V39, P460, DOI 10.1016/j.amepre.2010.07.007; Caspersen CJ, 2008, MED SCI SPORT EXER, V40, pS519, DOI 10.1249/MSS.0b013e31817c6737; Cerin E, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0471-5; Chudyk AM, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0469-5; Creatore MI, 2016, JAMA-J AM MED ASSOC, V315, P2211, DOI 10.1001/jama.2016.5898; Crouter SE, 2010, MED SCI SPORT EXER, V42, P1029, DOI 10.1249/MSS.0b013e3181c37458; Dasgupta K, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-81; Duncan DT, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060611; Duncan DT, 2011, INT J ENV RES PUB HE, V8, P4160, DOI 10.3390/ijerph8114160; Ewing R, 2010, J AM PLANN ASSOC, V76, P265, DOI 10.1080/01944361003766766; Eyler AA, 2003, MED SCI SPORT EXER, V35, P1529, DOI 10.1249/01.MSS.0000084622.39122.0C; Freeland AL, 2013, AM J PUBLIC HEALTH, V103, P536, DOI 10.2105/AJPH.2012.300912; Glazier RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085295; Hajna S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3603-y; Hajna S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151544; Hajna S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2082-x; Hirsch JA, 2013, AM J PREV MED, V45, P158, DOI 10.1016/j.amepre.2013.03.018; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; Moudon Anne Vernez, 2006, J Phys Act Health, V3, pS99, DOI 10.1123/jpah.3.s1.s99; Oja P, 2018, BRIT J SPORT MED, V52, P769, DOI 10.1136/bjsports-2017-098558; Owen N, 2007, AM J PREV MED, V33, P387, DOI 10.1016/j.amepre.2007.07.025; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Rafferty AP, 2002, MED SCI SPORT EXER, V34, P1255, DOI 10.1097/00005768-200208000-00005; Reis JP, 2008, J PHYS ACT HEALTH, V5, P337, DOI 10.1123/jpah.5.3.337; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Services USDoHH, 2015, GEN OOS STEP IT CALL; Thielman Justin, 2016, CMAJ Open, V4, pE720, DOI 10.9778/cmajo.20160068; Thielman J, 2015, PREV MED, V77, P174, DOI 10.1016/j.ypmed.2015.05.011; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tuckel P, 2015, AM J HEALTH BEHAV, V39, P241, DOI 10.5993/AJHB.39.2.11; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79; Tudor-Locke C, 2008, J PHYS ACT HEALTH, V5, P633, DOI 10.1123/jpah.5.5.633; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; Watson KB, 2015, J PHYS ACT HEALTH, V12, pS3, DOI 10.1123/jpah.2013-0521; Winters M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2224-1; Yang Y, 2012, AM J PREV MED, V43, P11, DOI 10.1016/j.amepre.2012.03.015	46	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214092	10.1371/journal.pone.0214092	http://dx.doi.org/10.1371/journal.pone.0214092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921337	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000034
J	Ellaway, A; Dundas, R; Robertson, T; Shiels, PG				Ellaway, Anne; Dundas, Ruth; Robertson, Tony; Shiels, Paul G.			More miles on the clock: Neighbourhood stressors are associated with telomere length in a longitudinal study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HEALTH; DEPRESSION; WEST; ENVIRONMENT; GENDER	Background There is a substantial gap in health and longevity between more affluent and more deprived areas, and more knowledge of the determinants of this health divide is required. Experience of the local residential environment is important for health although few studies have examined this in relation to biological markers of age such as telomere length. We sought to examine if residents' perceptions of neighbourhood stressors over time were associated with telomere length in a community study. Methodology/Principal finding In a prospective cohort study of 2186 adults in the West of Scotland, we measured neighbourhood stressors at three time points over a 12-year period and telomere length at the end of the study. Using linear regression models, we found that a higher accumulation of neighbourhood stressors over time was associated with shorter telomere length, even after taking cohort, social class, health behaviours (smoking status, diet, physical activity), BMI and depression into account among females only (Beta = 0.007; 95%Cl [0.001, 0.012]; P<0.014). Conclusions/Significance Neighborhood environments are potentially modifiable, and future efforts directed towards improving deleterious local environments may be useful to lessen telomere attrition.	[Ellaway, Anne; Dundas, Ruth] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Robertson, Tony] Univ Stirling, Fac Hlth Sci & Sport, Ctr Publ Hlth & Populat Hlth Res, Stirling, Scotland; [Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Stirling; University of Glasgow	Ellaway, A (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	anne.ellaway@glasgow.ac.uk	Robertson, Tony/L-5062-2015	Robertson, Tony/0000-0002-1962-5874; Ellaway, Anne/0000-0002-2117-4451	UK Medical Research Council (MRC) [MC_A540_53462]; Medical Research Council [MC_UU_12017/10, MC_UU_12017/13]; Chief Scientist's Office [SPHSU10, SPHSU13]; MRC [MC_UU_12017/10, MC_UU_12017/13] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist's Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The West of Scotland: Twenty-07 Study is funded by the UK Medical Research Council (MRC; MC_A540_53462). A.E. and R.D. are funded by the Medical Research Council (MC_UU_12017/10; MC_UU_12017/13) and the Chief Scientist's Office (SPHSU10; SPHSU13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneshensel CS, 2010, ADVANCES IN THE CONCEPTUALIZATION OF THE STRESS PROCESS: ESSAYS IN HONOR OF LEONARD I. PEARLIN, P35, DOI 10.1007/978-1-4419-1021-9_3; Arsenis NC, 2017, ONCOTARGET, V8, P45008, DOI 10.18632/oncotarget.16726; Astuti Y, 2017, ENVIRON RES, V158, P480, DOI 10.1016/j.envres.2017.06.038; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; Cawthon R.M., 2009, NUCLEIC ACIDS RES, V37, P3, DOI [10.1093/nar/gkn1027, DOI 10.1093/NAR/GKN1027]; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Clarke P, 2014, RES AGING, V36, P115, DOI 10.1177/0164027512470702; Connelly R., 2016, METHODOLOGICAL INNOV, V9, P1, DOI [10.1177/2059799116642885, DOI 10.1177/2059799116638003, 10.1177/2059799116638001]; Crous-Bou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6674; Der G., 1998, COMP W SCOTLAND 20 0; Der G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045166; Ellaway A, 2009, J EPIDEMIOL COMMUN H, V63, P78, DOI 10.1136/jech.2007.068767; Ellaway A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012268; Ellaway A, 2009, PUBLIC HEALTH, V123, P708, DOI 10.1016/j.puhe.2009.09.019; Ellaway A, 2013, NEIGHBOURHOOD STRUCT; Ellaway A, 2001, GEOGRAPHIES WOMENS H; Ellaway A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091854; Ellaway A, 2012, HEALTH PLACE, V18, P132, DOI 10.1016/j.healthplace.2011.08.005; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Evans G, 2012, OXFORD HDB POVERTY C; Gale CR, 2011, HEALTH PLACE, V17, P867, DOI 10.1016/j.healthplace.2011.05.003; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Gebreab SY, 2016, PSYCHONEUROENDOCRINO, V69, P90, DOI 10.1016/j.psyneuen.2016.03.018; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Jones R, 2014, HEALTH PLACE, V28, P187, DOI 10.1016/j.healthplace.2014.04.006; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Lopez-Isac E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4432; Lynch SM, 2017, CANCER EPIDEM BIOMAR, V26, P553, DOI 10.1158/1055-9965.EPI-16-0554; Macintyre S, 2003, HEALTH PLACE, V9, P207, DOI 10.1016/S1353-8292(02)00040-0; McGuinness D, 2012, INT J EPIDEMIOL, V41, P151, DOI 10.1093/ije/dyr215; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Needham BL, 2014, HEALTH PLACE, V28, P167, DOI 10.1016/j.healthplace.2014.04.009; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; Office of Population Censuses and Surveys, 1991, OPCS STAND OCC CLASS; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Olsen JR, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121473; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; Park M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128460; Pasquali R, 2012, ANN NY ACAD SCI, V1264, P20, DOI 10.1111/j.1749-6632.2012.06569.x; Phillips AC, 2013, PSYCHOSOM MED, V75, P288, DOI 10.1097/PSY.0b013e318289e6b5; Ridout KK, 2016, J AFFECT DISORDERS, V191, P237, DOI 10.1016/j.jad.2015.11.052; Robertson T, 2013, EPIDEMIOL REV, V35, P98, DOI 10.1093/epirev/mxs001; Robertson T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041805; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Shareck M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-930; Shiels PG, 2017, PRACT LAB MED, V7, P49, DOI 10.1016/j.plabm.2016.04.002; Shiels PG, 2017, NAT REV NEPHROL, V13, P471, DOI 10.1038/nrneph.2017.78; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Shiels PG, 2003, MOL BIOL NEURONE, P435; Smith SJ, 2012, HOUS THEORY SOC, V29, P40, DOI 10.1080/14036096.2012.624884; Sooman A, 1995, HEALTH PLACE, V1, P15, DOI 10.1016/1353-8292(95)00003-5; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Stansfeld S, 1993, J PSYCHOSOMATIC RES, P37; Timmermans EJ, 2016, CLIN RHEUMATOL, V35, P2797, DOI 10.1007/s10067-016-3388-5; Watson J., 1972, NAT NEW BIOL, P239; Wulaningsih W, 2018, J GERONTOL A-BIOL, V73, P966, DOI 10.1093/gerona/glx151; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214380	10.1371/journal.pone.0214380	http://dx.doi.org/10.1371/journal.pone.0214380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921393	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000462594000062
J	Gutierrez, C; Lopez-Abente, J; Perez-Fernandez, V; Prieto-Sanchez, A; Correa-Rocha, R; Moreno-Guillen, S; Munoz-Fernandez, MA; Pion, M				Gutierrez, Carolina; Lopez-Abente, Jacobo; Perez-Fernandez, Veronica; Prieto-Sanchez, Adrian; Correa-Rocha, Rafael; Moreno-Guillen, Santiago; Munoz-Fernandez, Maria-Angeles; Pion, Marjorie			Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients	PLOS ONE			English	Article							DISEASE PROGRESSION; HIV-INFECTION; ANTIRETROVIRAL THERAPY; ACTIVATING FACTOR; FOXP3 EXPRESSION; IL-10 PRODUCTION; MAINTENANCE; MECHANISMS; INDUCTION; CORRELATE	This study examines the relationship between regulatory B (Breg) and T (Treg) compartments, which play crucial roles in the maintenance of immune homeostasis in the context of HIV. Using flow cytometry, the phenotypes of different Breg and Treg subsets from HIV-infected and healthy individuals were analyzed, along with the suppressive capacity of Breg. Peripheral blood samples of thirteen HIV+ treatment-naive individuals, fourteen treated-HIV+ individuals with undetectable viral load and twelve healthy individuals were analyzed. The absolute counts of Breg and Treg subsets were decreased in HIV+ treatment-naive individuals in comparison to treated-HIV+ and healthy individuals. Interestingly, correlations between Breg subsets (CD24(hi)CD27(+) and PD-L1(+) B cells) and IL-10-producing Breg observed in healthy individuals were lost in HIV+ treatment-naive individuals. However, a correlation between frequencies of CD24(hi)CD38(hi) or TIM-1(+)-Breg subsets and Treg was observed in HIV+ treatment-naive individuals and not in healthy individuals. Therefore, we hypothesized that various Breg subsets might have different functions during B and T-cell homeostasis during HIV-1 infection. In parallel, stimulated Breg from HIV-infected treatment-naive individuals presented a decreased ability to suppress CD4(+) T-cell proliferation in comparison to the stimulated Breg from treated-HIV+ or healthy individuals. We demonstrate a dysregulation between Breg and Treg subsets in HIV-infected individuals, which might participate in the hyper-activation and exhaustion of the immune system that occurs in such patients.	[Gutierrez, Carolina; Moreno-Guillen, Santiago] Ramon y Cajal Univ Hosp, Ramon y Cajal Hlth Res Inst IRYCIS, Mol Immunovirol Lab, Dept Infect Dis, Madrid, Spain; [Lopez-Abente, Jacobo; Perez-Fernandez, Veronica; Prieto-Sanchez, Adrian; Correa-Rocha, Rafael; Pion, Marjorie] Univ Gen Hosp Gregorio Maranon, Hlth Res Inst Gregorio Maranon IiSGM, Immunoregulat Lab, Med & Expt Surg Bldg, Madrid, Spain; [Munoz-Fernandez, Maria-Angeles] Univ Gen Hosp Gregorio Maranon, Mol ImmunoBiol Lab, Hlth Res Inst Gregorio Maranon IiSGM, Spanish HIV HGM BioBank, Madrid, Spain; [Munoz-Fernandez, Maria-Angeles] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain; [Lopez-Abente, Jacobo] Univ Complutense Madrid, Sch Chem, Dept Biochem & Mol Biol, Vaccines & Dendrit Cells Lab, Madrid, Spain	Hospital Universitario Ramon y Cajal; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Complutense University of Madrid	Pion, M (corresponding author), Univ Gen Hosp Gregorio Maranon, Hlth Res Inst Gregorio Maranon IiSGM, Immunoregulat Lab, Med & Expt Surg Bldg, Madrid, Spain.	marjorie.pon@iisgm.com	Pion, Marjorie/AAB-5812-2022; Correa-Rocha, Rafael/C-8213-2011; Pion, Marjorie/D-8139-2012; Pion, Marjorie/D-8139-2012	Correa-Rocha, Rafael/0000-0003-3456-9986; Pion, Marjorie/0000-0003-1828-4745; Pion, Marjorie/0000-0002-6406-747X; Munoz-Fernandez/0000-0002-0813-4500; Lopez-Abente, Jacobo/0000-0003-3640-4077	Ministry of Economy and Competitiveness ISCIII-FIS [PI12/01763, PI12/00934, PI15/00923]; ERDF (FEDER) Funds from the European Commission; Research Health Institute Gregorio Maranon (IiSGM) [II-PI-MP-2018]; IiSGM; Youth Employment Program - Madrid community; FEDER Founds [PEJ15-BIO-TL-0094, PEJ15-BIO-TL0373]; Spanish AIDS Research Network; "Miguel Servet" program [CPII13/00033]; Spanish MICINN through the Ramon y Cajal [RYC-2009-05486]	Ministry of Economy and Competitiveness ISCIII-FIS; ERDF (FEDER) Funds from the European Commission; Research Health Institute Gregorio Maranon (IiSGM); IiSGM; Youth Employment Program - Madrid community; FEDER Founds(European Commission); Spanish AIDS Research Network; "Miguel Servet" program; Spanish MICINN through the Ramon y Cajal	This work was partially supported by the Ministry of Economy and Competitiveness ISCIII-FIS grants PI12/01763, PI12/00934 and PI15/00923, co-financed by ERDF (FEDER) Funds from the European Commission, "A way of making Europe". This work was also supported by the internal grant from the Research Health Institute Gregorio Maranon (IiSGM; grant II-PI-MP-2018). J.L-A. was supported by a Grant from IiSGM. A.P-S and V. P-F were supported by the Youth Employment Program co-financed by the Madrid community and FEDER Founds (PEJ15-BIO-TL-0094, PEJ15-BIO-TL0373, respectively). C.G. was supported by the Spanish AIDS Research Network. R.C-R was supported by "Miguel Servet" program (CPII13/00033), and M.P by the Spanish MICINN through the Ramon y Cajal (RYC-2009-05486). All this work was performed in the Laboratorio de Inmuno-Biologia Molecular (HGUG and IiSGM) lead by M-A.M-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena O, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1213-9; Barsotti NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151761; Berthelot JM, 2013, JOINT BONE SPINE, V80, P18, DOI 10.1016/j.jbspin.2012.04.010; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Buisker TR, 2015, AIDS BEHAV, V19, P2108, DOI 10.1007/s10461-015-1018-x; Cagigi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005427; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Chagnon-Choquet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101949; CHIRMULE N, 1992, BLOOD, V79, P1245; Correa-Rocha R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203419; den Hartog G, 2018, EUR J IMMUNOL, V48, P283, DOI 10.1002/eji.201646861; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Figueiro F, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1082703; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Floudas A, 2016, J CLIN IMMUNOL, V36, pS25, DOI 10.1007/s10875-016-0263-8; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Gheybi MK, 2017, BREAST CANCER-TOKYO, V24, P756, DOI 10.1007/s12282-017-0775-y; Gu XL, 2017, APMIS, V125, P872, DOI 10.1111/apm.12729; Hua C, 2016, J AUTOIMMUN, V73, P64, DOI 10.1016/j.jaut.2016.06.002; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jiao YM, 2014, MICROBIOL IMMUNOL, V58, P449, DOI 10.1111/1348-0421.12171; Perise-Barrios AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039472; Khan AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6997; Lal G, 2016, IMMUNOL LETT, V170, P52, DOI 10.1016/j.imlet.2016.01.002; Li GM, 2017, J INFECT DIS, V216, P1579, DOI 10.1093/infdis/jix547; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089236; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lopez-Abente J, 2017, CELL MOL IMMUNOL; Lopez-Abente J, 2016, FRONT IMMUNOL, V7, DOI [10.3389/fimmu.2016.00192, 10.3389/fimmu.2016.00197]; Ma N, 2017, MOL IMMUNOL, V85, P18, DOI 10.1016/j.molimm.2017.02.002; Mauri C, 2017, J CLIN INVEST, V127, P772, DOI 10.1172/JCI85113; McBride JA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006624; Miller V, 1999, ANN INTERN MED, V130, P570, DOI 10.7326/0003-4819-130-7-199904060-00005; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Nikolova M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005995; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pion M, 2013, AIDS, V27, P2019, DOI 10.1097/QAD.0b013e32836253fd; Ray A, 2015, INT IMMUNOL, V27, P531, DOI 10.1093/intimm/dxv033; Rodriguez B, 2003, AIDS, V17, P1983, DOI 10.1097/00002030-200309050-00018; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Saison J, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv063; Sambleben C, 2018, APMIS, V126, P143, DOI 10.1111/apm.12795; Sauce D, 2013, CURR OPIN HIV AIDS, V8, P125, DOI 10.1097/COH.0b013e32835d08a9; Siewe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092934; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Thibult ML, 2013, INT IMMUNOL, V25, P129, DOI 10.1093/intimm/dxs098; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Walters S, 2009, J IMMUNOL, V182, P793, DOI 10.4049/jimmunol.182.2.793; Wang WW, 2015, ONCOTARGET, V6, P33486, DOI 10.18632/oncotarget.5588; Xiao S, 2015, J IMMUNOL, V194, P1602, DOI 10.4049/jimmunol.1402632; Yang M, 2010, J IMMUNOL, V184, P3321, DOI 10.4049/jimmunol.0902551; Zhang MX, 2012, CELL IMMUNOL, V274, P89, DOI 10.1016/j.cellimm.2012.01.007; Zhu GF, 2018, IMMUNOL RES, V66, P281, DOI 10.1007/s12026-017-8983-2	53	8	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213744	10.1371/journal.pone.0213744	http://dx.doi.org/10.1371/journal.pone.0213744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917149	Green Published, gold, Green Submitted			2022-12-27	WOS:000462465800039
J	Pedersen, HS; Fenger-Gron, M; Bech, BH; Erlangsen, A; Vestergaard, M				Pedersen, Henrik Schou; Fenger-Gron, Morten; Bech, Bodil Hammer; Erlangsen, Annette; Vestergaard, Mogens			Frequency of health care utilization in the year prior to completed suicide: A Danish nationwide matched comparative study	PLOS ONE			English	Article							PREVENTION STRATEGIES; PEOPLE; CONTACTS; REGISTERS; THERAPY; SYSTEM	Background Suicide accounts for more than 800,000 annual deaths worldwide. Some of these deaths may be preventable by timely identification of individuals at risk and effective intervention. General practitioners (GPs) may have the potential to play an important role in this process. Aim The present study aimed to assess the frequency of primary health care utilization in the year preceding suicide. Methods Using Danish national registers, we identified all persons who died by suicide in Denmark from 1997 through 2013 and assessed the frequency of their primary care utilization and compared it with that of an age- and sex-matched reference group sampled from the background population. Results We identified 11,191 persons who died by suicide (males: 8,095, females: 3,096). Compared with the reference group (N = 55,955), a greater proportion attended general practice in the year before index date (83% vs. 76%). In the last month before index date, these figures were 32.0% and 19.4%, respectively, corresponding to a difference of 12.0 95% CI: (11.1; 12.9) percentage points after adjustment for demographic characteristics and physical comorbidity. Suicide cases had a higher GP attendance in every week in the year before suicide, but the difference increased specifically in the last four months. Conclusion More than 30% attended the GP in the month before the suicide. This indicates that general practice could be a possible place to identify suicide cases and offer intervention. However, although this proportion represents a markedly higher GP attendance than seen in the reference group, almost 70% of those who died by suicide did not attend primary care in the month before the suicide. Our study suggests that it is important that the GPs have easy access to effective suicide prevention programs for patients at risk of suicide, and that persons with suicidal thoughts are encouraged to contact their GP.	[Pedersen, Henrik Schou; Fenger-Gron, Morten; Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark; [Bech, Bodil Hammer; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Erlangsen, Annette] Mental Hlth Ctr Copenhagen, Danish Res Inst Suicide Prevent, Copenhagen, Denmark; [Erlangsen, Annette] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [Erlangsen, Annette] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA	Aarhus University; Aarhus University; Australian National University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pedersen, HS (corresponding author), Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark.	henrikp@ph.au.dk	Bech, Bodil Hammer/B-9646-2016; Erlangsen, Annette/ABE-1547-2021	Bech, Bodil Hammer/0000-0002-0287-3687; Erlangsen, Annette/0000-0003-3475-0558; Fenger-Gron, Morten/0000-0002-6354-5871; Pedersen, Henrik Schou/0000-0003-4826-6441	Lundbeck Foundation [R155-2012-11280]; Programme for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation; Novo Nordisk Foundation	Lundbeck Foundation(Lundbeckfonden); Programme for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was supported by an unrestricted grant from the Lundbeck Foundation (grant number: R155-2012-11280) and by the Programme for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation and administered by the Danish Regions. The funder had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Ahmedani BK, 2014, J GEN INTERN MED, V29, P870, DOI 10.1007/s11606-014-2767-3; Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Andersen UA, 2000, ACTA PSYCHIAT SCAND, V102, P126, DOI 10.1034/j.1600-0447.2000.102002126.x; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; Erlangsen A, 2015, SCAND J PUBLIC HEALT, V43, P333, DOI 10.1177/1403494815575193; Erlangsen A, 2015, LANCET PSYCHIAT, V2, P49, DOI 10.1016/S2215-0366(14)00083-2; Fenger-Gron M, 2018, CLIN EPIDEMIOL, V10, P1013, DOI 10.2147/CLEP.S157996; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hawton K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012189; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hochman E, 2014, J CLIN PSYCHIAT, V75, pE817, DOI 10.4088/JCP.13m08823; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kjaersgaard MIS, 2016, CLIN EPIDEMIOL, V8, P273, DOI 10.2147/CLEP.S108307; Leavey G, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0824-7; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Milner A, 2017, J AFFECT DISORDERS, V210, P294, DOI 10.1016/j.jad.2016.12.035; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; O'Neill S, 2014, J AFFECT DISORDERS, V168, P466, DOI 10.1016/j.jad.2014.07.028; Pearson A, 2009, BRIT J GEN PRACT, V59, P825, DOI 10.3399/bjgp09X472881; Power K, 1997, BRIT J GEN PRACT, V47, P211; Prior A, 2016, AM J EPIDEMIOL, V184, P199, DOI 10.1093/aje/kwv324; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schulberg HC, 2004, GEN HOSP PSYCHIAT, V26, P337, DOI 10.1016/j.genhosppsych.2004.06.007; Stark CR, 2012, RURAL REMOTE HEALTH, V12; Unutzer J, 2006, J AM GERIATR SOC, V54, P1550, DOI 10.1111/j.1532-5415.2006.00882.x; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Zalsman G, 2016, LANCET PSYCHIAT, V3, P646, DOI 10.1016/S2215-0366(16)30030-X	31	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214605	10.1371/journal.pone.0214605	http://dx.doi.org/10.1371/journal.pone.0214605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917181	gold, Green Published, Green Submitted			2022-12-27	WOS:000462465800073
J	Buggisch, P; Wursthorn, K; Stoehr, A; Atanasov, PK; Supiot, R; Lee, J; Ting, J; Petersen, J				Buggisch, Peter; Wursthorn, Karsten; Stoehr, Albrecht; Atanasov, Petar K.; Supiot, Romain; Lee, Janet; Ting, Jie; Petersen, Joerg			Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/ sofosbuvir hepatitis C treatment in a single centre in Germany	PLOS ONE			English	Article							HCV GENOTYPE 1; VIRUS-INFECTION; COMPENSATED CIRRHOSIS; VELPATASVIR; RIBAVIRIN; EFFICACY	Background Newer direct-acting antiviral therapies are increasingly becoming the therapy of choice in patients with hepatitis C virus (HCV) infection. Here, we report the safety and effectiveness of sofosbuvir/velpatasvir (SOF/VEL) and ledipasvir/sofosbuvir (LDV/SOF) in real-world cohorts in Germany. Methods Patients initiated on SOF/VEL 12 weeks or LDV/SOF 8, 12 or 24 weeks regimens in a single German centre were included in this study. Data on treatment outcomes and adverse events (AE) were analysed in patients with available sustained virologic response 12 weeks after cessation of treatment (SVR12) information overall and by subgroups. Results This study included 115 patients who received SOF/VEL from July-2016 to July-2017, and 249 patients who received LDV/SOF from November-2014 to September-2015. Overall, SVR12 was achieved in 99% of patients on SOF/VEL +/- ribavirin 12 weeks independent of HCV genotype, treatment history, or cirrhosis status, and in 96% of patients treated with LDV/SOF 8 weeks or LDV/SOF +/- ribavirin 12 or 24 weeks. In genotype 1 treatment-naive, non-cirrhotic patients, >99% achieved SVR12 across SOF/VEL and LDV/SOF regimens. Likewise, 100% of genotype 3-cirrhotic patients on SOF/VEL +/- ribavirin regimens achieved SVR12. Grade 3/4 AE were reported in 13 (5.2%) patients on LDV/SOF and in 1 (<1%) patient on SOF/VEL. Conclusion Overall, SOF/VEL and LDV/SOF achieved high SVR rates in a broad patient population. We showed the effectiveness of SOF/VEL as a pan-genotypic regimen, and regardless of treatment history or cirrhosis status. Use of such therapies improves outcomes and contributes towards the global efforts to eradicate HCV. Background Newer direct-acting antiviral therapies are increasingly becoming the therapy of choice in patients with hepatitis C virus (HCV) infection. Here, we report the safety and effectiveness of sofosbuvir/velpatasvir (SOF/VEL) and ledipasvir/sofosbuvir (LDV/SOF) in real-world cohorts in Germany.	[Buggisch, Peter; Wursthorn, Karsten; Stoehr, Albrecht; Petersen, Joerg] Asklepios Klin St Georg Haus L, IFI Inst Interdisziplinare Med, Hamburg, Germany; [Atanasov, Petar K.; Supiot, Romain] Amaris Consulting, London, England; [Lee, Janet; Ting, Jie] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Asklepios Klinik St. Georg; Gilead Sciences	Buggisch, P (corresponding author), Asklepios Klin St Georg Haus L, IFI Inst Interdisziplinare Med, Hamburg, Germany.	buggisch@ifi-medizin.de		Supiot, Romain/0000-0002-8416-3063	Gilead; (Gilead Sciences, Inc)	Gilead(Gilead Sciences); (Gilead Sciences, Inc)(Gilead Sciences)	This study was funded by Gilead. The funder (Gilead Sciences, Inc) provided support in the form of salaries for author PB, and provided input for the following: design of data analysis, data interpretation, and manuscript review. The funder did not have any additional role in data collection, data analysis, or decision to publish. Amaris Consulting provided support in the form of data analysis and manuscript preparation. The specific roles of these authors are articulated in the 'author contributions' section below.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2018, EMPF BNG THER CHRON; [Anonymous], 2017, HARV PACK INS; Asselah T, 2018, LIVER INT, V38, P443, DOI 10.1111/liv.13534; Buggisch P, 2015, J HEPATOL, V62, pS622, DOI 10.1016/S0168-8278(15)30980-6; Buggisch P, 2018, J HEPATOL, V68, P663, DOI 10.1016/j.jhep.2017.11.009; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Christensen S., 2016, C RETR OPP INF CROI; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Dietz J, 2018, GASTROENTEROLOGY, V154, P976, DOI 10.1053/j.gastro.2017.11.007; Dietz J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134395; Epclusa E., 2018, SUMMARY PRODUCT CHAR; Everson GT, 2015, ANN INTERN MED, V163, P818, DOI 10.7326/M15-1000; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Harvoni E., 2015, SUMMARY PRODUCT CHAR; Johnson SW, 2017, INT J ANTIMICROB AG, V49, P778, DOI 10.1016/j.ijantimicag.2017.01.016; Khalili M, 2017, J HEPATOL, V66, pS716, DOI 10.1016/S0168-8278(17)31916-5; Koch-Institut R, 2017, EPIDEMIOLOGISCHES B, V30, P279; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lai JB, 2017, DRUGS, V77, P313, DOI 10.1007/s40265-016-0684-y; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; Reddy KR, 2015, HEPATOLOGY, V62, P79, DOI 10.1002/hep.27826; Terrault NA, 2016, GASTROENTEROLOGY, V151, P1131, DOI 10.1053/j.gastro.2016.08.004; von Felden J, 2018, ALIMENT PHARM THER; WHO, 2017, WHO PUBLISHES LIST B; World Health Organization, 2018, GUID CAR TREATM PERS; Wyles D, 2017, CLIN INFECT DIS, V65, P6, DOI 10.1093/cid/cix260	29	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214795	10.1371/journal.pone.0214795	http://dx.doi.org/10.1371/journal.pone.0214795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946776	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500062
J	Dabee, S; Barnabas, SL; Lennard, KS; Jaumdally, SZ; Gamieldien, H; Balle, C; Happel, AU; Murugan, BD; Williamson, AL; Mkhize, N; Dietrich, J; Lewis, DA; Chiodi, F; Hope, TJ; Shattock, R; Gray, G; Bekker, LG; Jaspan, HB; Passmore, JAS				Dabee, Smritee; Barnabas, Shaun L.; Lennard, Katie S.; Jaumdally, Shameem Z.; Gamieldien, Hoyam; Balle, Christina; Happel, Anna-Ursula; Murugan, Brandon D.; Williamson, Anna-Lise; Mkhize, Nonhlanhla; Dietrich, Janan; Lewis, David A.; Chiodi, Francesca; Hope, Thomas J.; Shattock, Robin; Gray, Glenda; Bekker, Linda-Gail; Jaspan, Heather B.; Passmore, Jo-Ann S.			Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; BACTERIAL VAGINOSIS; VAGINAL MICROBIOME; HORMONAL CONTRACEPTIVES; IMMUNE ACTIVATION; TRACT; ACQUISITION; TRANSMISSION; TARGET; AGE	The genital tract of African women has been shown to differ from what is currently accepted as 'normal', defined by a pH <= 4.5 and lactobacilli-dominated microbiota. Adolescent girls and young women (AGYW) from sub-Saharan Africa are at high risk for HIV, and we hypothesized that specific biological factors are likely to be influential. This study aimed to compare characteristics of vaginal health in HIV-negative AGYW (16-22-years-old), from two South African communities, to international norms. We measured plasma hormones, vaginal pH, presence of BV (Nugent scoring), sexually transmitted infections (multiplex PCR for Chlamydia trachomatis, Neisseria gonorrhoea, Trichomonas vaginalis, Mycoplasma genitalium) and candidiasis (Gram stain) in AGYW (n = 298) from Cape Town and Soweto. Cervicovaginal microbiota was determined by 16S pyrosequencing; 44 genital cytokines were measured by Luminex; and cervical T-cell activation/proliferation (CCR5, HLA-DR, CD38, Ki67) was measured by multiparametric flow cytometry. 90/298 (30.2%) AGYW were negative for BV, candidiasis and bacterial STIs. L. crispatus and L. iners were the dominant bacteria in cervicovaginal swabs, and the median vaginal pH was 4.7. AGYW with L. crispatus-dominant microbiota (42.4%) generally had the lowest cytokine concentrations compared to women with more diverse microbiota (34/44 significantly upregulated cytokines). Frequencies of CCR5+CD4(+) T-cells co-expressing CD38 and HLA-DR correlated positively with interleukin (IL)-6, TNF-alpha, GRO-alpha, macrophage inflammatory protein (MIP)-1 alpha, and IL-9. While endogenous oestrogen had an immune-dampening effect on IL-6, TNF-related apoptosis-inducing ligand (TRAIL) and IL-16, injectable hormone contraceptives (DMPA and Net-EN) were associated with significantly lower endogenous hormone concentrations (p<0.0001 for oestrogen and progesterone) and upregulation of 34/44 cytokines. Since genital inflammation and the presence of activated CD4+ T cells in the genital tract have been implicated in increased HIV risk in South African women, the observed high levels of genital cellular activation and cytokines from AGYW may point towards biological factors increasing HIV risk in this region.	[Dabee, Smritee; Barnabas, Shaun L.; Lennard, Katie S.; Jaumdally, Shameem Z.; Gamieldien, Hoyam; Balle, Christina; Happel, Anna-Ursula; Murugan, Brandon D.; Williamson, Anna-Lise; Bekker, Linda-Gail; Jaspan, Heather B.; Passmore, Jo-Ann S.] Univ Cape Town, Inst Infect Dis & Mol Med IDM, Cape Town, South Africa; [Dabee, Smritee; Jaumdally, Shameem Z.; Happel, Anna-Ursula; Passmore, Jo-Ann S.] DST NRF CAPRISA Ctr Excellence HIV Prevent, Durban, South Africa; [Barnabas, Shaun L.; Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Fdn DTHF, Cape Town, South Africa; [Williamson, Anna-Lise; Passmore, Jo-Ann S.] Univ Cape Town, SAMRC UCT Gynaecol Canc Res Ctr GCRC, Cape Town, South Africa; [Williamson, Anna-Lise; Passmore, Jo-Ann S.] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Mkhize, Nonhlanhla] Natl Inst Communicable Dis NICD, Natl Hlth Lab Serv, Ctr HIV & STIs, Johannesburg, South Africa; [Dietrich, Janan; Gray, Glenda] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit PHRU, Johannesburg, South Africa; [Lewis, David A.] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Parramatta, Australia; [Lewis, David A.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Lewis, David A.] Univ Sydney, Sydney Med Sch Westmead, Sydney, NSW, Australia; [Chiodi, Francesca] Karolinska Inst, Stockholm, Sweden; [Hope, Thomas J.] Northwestern Univ, Chicago, IL 60611 USA; [Shattock, Robin] Imperial Coll London, London, England; [Gray, Glenda] South African Med Res Council, Cape Town, South Africa; [Jaspan, Heather B.] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Sydney; University of Sydney; Karolinska Institutet; Northwestern University; Imperial College London; South African Medical Research Council; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Passmore, JAS (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med IDM, Cape Town, South Africa.; Passmore, JAS (corresponding author), DST NRF CAPRISA Ctr Excellence HIV Prevent, Durban, South Africa.; Passmore, JAS (corresponding author), Univ Cape Town, SAMRC UCT Gynaecol Canc Res Ctr GCRC, Cape Town, South Africa.; Passmore, JAS (corresponding author), Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa.	Jo-ann.Passmore@uct.ac.za	Bekker, Linda-Gail/AAZ-8929-2020	Happel, Anna-Ursula/0000-0003-3658-8638; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Dietrich, Janan/0000-0002-1949-3138; Chiodi, Francesca/0000-0002-1385-8343	European and Developing Countries Clinical Trials Partnership (EDCTP) Strategic Primer grant [SP.2011.41304.038]; South African Department of Science and Technology [DST/CON 0260/2012]; National Research Foundation (NRF) of South Africa; Poliomyelitis Research Foundation; HIV Vaccine Trials Network SHAPe Program; Fogarty Foundation; South African Medical Research Council (MRC); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; ViiV health care in their Youth Shield program; South African Medical Research Council; National Research Foundation of South Africa	European and Developing Countries Clinical Trials Partnership (EDCTP) Strategic Primer grant; South African Department of Science and Technology; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Poliomyelitis Research Foundation; HIV Vaccine Trials Network SHAPe Program; Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; ViiV health care in their Youth Shield program; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of South Africa(National Research Foundation - South Africa)	This study was supported by grants from the European and Developing Countries Clinical Trials Partnership (EDCTP) Strategic Primer grant [SP.2011.41304.038] and the South African Department of Science and Technology [DST/CON 0260/2012]. SD was supported by the National Research Foundation (NRF) of South Africa and the Poliomyelitis Research Foundation. SLB was supported by the HIV Vaccine Trials Network SHAPe Program, the Fogarty Foundation and the South African Medical Research Council (MRC). ALW is supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. The Desmond Tutu HIV Foundation recognizes the support from ViiV health care in their Youth Shield program. The Perinatal HIV Research Unit was supported through funding from the South African Medical Research Council. KSL was supported by the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles SL, 2016, AGE MATTERS HIV TARG; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Arnold KB, 2015, MUCOSAL IMMUNOL, V9, P1, DOI [10.1038/mi.2015.28, DOI 10.1038/MI.2015.28]; Barnabas SL, 2018, INT J STD AIDS, V29, P531, DOI 10.1177/0956462417740487; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Byrne EH, 2016, LANCET INFECT DIS, V16, P441, DOI 10.1016/S1473-3099(15)00429-6; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Columb MO, 2006, CURR ANAESTH CRIT CA, V17, P233, DOI DOI 10.1016/J.CACC.2006.03.005; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Doerflinger SY, 2014, J INFECT DIS, V209, P1989, DOI 10.1093/infdis/jiu004; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Gaujoux R, 2014, GENERATING HEATMAPS; Ghanem KG, 2005, J INFECT DIS, V191, P358, DOI 10.1086/427190; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Gray-Swain MR, 2006, CURR OPIN OBSTET GYN, V18, P503, DOI 10.1097/01.gco.0000242952.87125.69; Hearps AC, 2017, MUCOSAL IMMUNOL, P1, DOI [10.1038/mi.2016.111, DOI 10.1038/MI.2016.111]; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hickey M, 2016, JAIDS-J ACQ IMM DEF, V71, P1, DOI 10.1097/QAI.0000000000000805; Hwang LY, 2011, J REPROD IMMUNOL, V88, P66, DOI 10.1016/j.jri.2010.07.008; Ibitoye M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178884; Jaspan HB, 2011, J INFECT DIS, V204, P1550, DOI 10.1093/infdis/jir591; Jaspan HB, 2011, J ADOLESCENT HEALTH, V49, P42, DOI 10.1016/j.jadohealth.2010.10.009; Jaumdally SZ, 2017, IMMUNOLOGY, DOI [10.1111/ijlh.12426, DOI 10.1111/IJLH.12426]; Jeremias I, 1998, EUR CYTOKINE NETW, V9, P687; Kahn JA, 2002, J PEDIATR-US, V141, P718, DOI 10.1067/mpd.2002.128893; Klatt NR, 2017, SCIENCE, V356, P938, DOI 10.1126/science.aai9383; Kriek JM, 2016, VIROLOGY, V493, P247, DOI 10.1016/j.virol.2016.03.022; Lawrie TA, 1998, BRIT J OBSTET GYNAEC, V105, P1082, DOI 10.1111/j.1471-0528.1998.tb09940.x; Lee V, 2006, J FAM PLAN REPROD H, V32, P104, DOI 10.1783/147118906776276440; Lennard K, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00410-17; Lewis DA, 2012, SEX TRANSM DIS, V39, P880, DOI 10.1097/OLQ.0b013e318269cf90; Liebenberg LJ, 2011, J IMMUNOL METHODS, V367, P47, DOI 10.1016/j.jim.2011.01.013; Liebenberg LJP, 2017, JAIDS-J ACQ IMM DEF, V74, P318, DOI 10.1097/QAI.0000000000001218; Masson L, 2016, SEX TRANSM INFECT, V92, P186, DOI 10.1136/sextrans-2015-052072; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Miller L, 2000, OBSTET GYNECOL, V96, P431, DOI 10.1016/S0029-7844(00)00906-6; Mitchell C, 2015, SEX TRANSM DIS, V42, P358, DOI 10.1097/OLQ.0000000000000298; Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nunn KL, 2015, MBIO, V6, DOI 10.1128/mBio.01084-15; Olive AJ, 2011, MUCOSAL IMMUNOL, V4, P208, DOI 10.1038/mi.2010.58; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Petrova MI, 2013, FEMS MICROBIOL REV, V37, P762, DOI 10.1111/1574-6976.12029; Porter KA, 2016, AIDS RES HUM RETROV, V32, P1149, DOI 10.1089/aid.2016.0206; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rivera R, 1999, AM J OBSTET GYNECOL, V181, P1263, DOI 10.1016/S0002-9378(99)70120-1; Schindler AE, 2003, MATURITAS, V46, pS7, DOI 10.1016/j.maturitas.2003.09.014; Spear GT, 2008, AIDS RES HUM RETROV, V24, P973, DOI 10.1089/aid.2008.0004; Stockl H, 2013, AM J REPROD IMMUNOL, V69, P27, DOI 10.1111/aji.12043; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tachedjian G, 2017, RES MICROBIOL, V168, P782, DOI 10.1016/j.resmic.2017.04.001; UNAIDS, 2015, EMP YOUNG WOM AD GIR; Veazey RS, 2001, TRENDS IMMUNOL, V22, P626, DOI 10.1016/S1471-4906(01)02039-7; WHO, 2015, HIV AIDS FACT SHEET; Yamamoto T, 2009, J PEDIATR ADOL GYNEC, V22, P11, DOI 10.1016/j.jpag.2008.01.073	59	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0213975	10.1371/journal.pone.0213975	http://dx.doi.org/10.1371/journal.pone.0213975			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947260	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500014
J	Boone, DR; Weisz, HA; Willey, HE; Torres, KEO; Falduto, MT; Sinha, M; Spratt, H; Bolding, IJ; Johnson, KM; Parsley, MA; DeWitt, DS; Prough, DS; Hellmich, HL				Boone, Deborah R.; Weisz, Harris A.; Willey, Hannah E.; Torres, Karen E. O.; Falduto, Michael T.; Sinha, Mala; Spratt, Heidi; Bolding, Ian J.; Johnson, Kathea M.; Parsley, Margaret A.; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.			Traumatic brain injury induces long-lasting changes in immune and regenerative signaling	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; COMPLEMENT-SYSTEM; TERM POTENTIATION; INFLAMMATION; EXPRESSION; NEUROINFLAMMATION; BIOLOGY; VALIDATION; INDUCTION; BEHAVIOR	There are no existing treatments for the long-term degenerative effects of traumatic brain injury (TBI). This is due, in part, to our limited understanding of chronic TBI and uncertainty about which proposed mechanisms for long-term neurodegeneration are amenable to treatment with existing or novel drugs. Here, we used microarray and pathway analyses to interrogate TBI-induced gene expression in the rat hippocampus and cortex at several acute, subchronic and chronic intervals (24 hours, 2 weeks, 1, 2, 3, 6 and 12 months) after parasagittal fluid percussion injury. We used Ingenuity pathway analysis (IPA) and Gene Ontology enrichment analysis to identify significantly expressed genes and prominent cell signaling pathways that are dysregulated weeks to months after TBI and potentially amenable to therapeutic modulation. We noted long-term, coordinated changes in expression of genes belonging to canonical pathways associated with the innate immune response (i.e., NF-kappa B signaling, NFAT signaling, Complement System, Acute Phase Response, Toll-like receptor signaling, and Neuroinflammatory signaling). Bioinformatic analysis suggested that dysregulation of these immune mediators-many are key hub genes-would compromise multiple cell signaling pathways essential for homeostatic brain function, particularly those involved in cell survival and neuroplasticity. Importantly, the temporal profile of beneficial and maladaptive immunoregulatory genes in the weeks to months after the initial TBI suggests wider therapeutic windows than previously indicated.	[Boone, Deborah R.; Weisz, Harris A.; Willey, Hannah E.; Sinha, Mala; Spratt, Heidi; Bolding, Ian J.; Johnson, Kathea M.; Parsley, Margaret A.; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Torres, Karen E. O.; Falduto, Michael T.] GenUs Biosyst, Northbrook, IL USA; [Falduto, Michael T.] Paradise Genom Inc, Northbrook, IL USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu		DeWitt, Douglas/0000-0001-9810-8156; Spratt, Heidi/0000-0002-9420-5028	Moody Project for Translational Traumatic Brain Injury Research	Moody Project for Translational Traumatic Brain Injury Research	This work was funded through a private grant from the Moody Project for Translational Traumatic Brain Injury Research. Recipients are DRB, HAW, HEW, MS, HS, IJB, KMJ, MAP, DSD, DSP, HLH. The funder did not play any role in the study design, data collection and analysis, or in the preparation or decision to publish manuscript. GenUs Biosystems provided support in the form of salaries for authors [MTF, KEOT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Paradise genomics provided support in the form of salaries for [MTF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of MTF is articulated in the 'author contributions' section.	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMIMI.S20062, 10.4137/BMI.S20062]; Adzic M, 2018, CURR NEUROPHARMACOL, V16, P176, DOI 10.2174/1570159X15666170828163048; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Armstrong RJE, 2001, LANCET, V358, P1174, DOI 10.1016/S0140-6736(01)06260-2; Ashabi G, 2015, METAB BRAIN DIS, V30, P747, DOI 10.1007/s11011-014-9632-2; Bayram FEO, 2018, CURR TOP MED CHEM, V18, P1416, DOI 10.2174/1568026618666180821144704; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Bhandari R, 2018, DRUG TODAY, V54, P349, DOI 10.1358/dot.2018.54.6.2828189; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Broussard JI, 2016, CELL REP, V14, P1930, DOI 10.1016/j.celrep.2016.01.070; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chu H, 2008, J IMMUNOL, V181, P3373, DOI 10.4049/jimmunol.181.5.3373; Dai HW, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012018; Dai JX, 2018, ONCOL LETT, V15, P8245, DOI 10.3892/ol.2018.8376; Dolgin E, 2017, NATURE, V551, P427, DOI 10.1038/d41586-017-07291-9; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fang B, 2014, INT J MOL SCI, V15, P6378, DOI 10.3390/ijms15046378; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; Jalles A., 2016, MOL SCI, V2, P259; Jarosik J, 2007, EXP NEUROL, V204, P20, DOI 10.1016/j.expneurol.2006.09.008; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kang S, 2018, BMB REP, V51, P92, DOI 10.5483/BMBRep.2018.51.2.219; Kinch MS, 2015, DRUG DISCOV TODAY, V20, P920, DOI 10.1016/j.drudis.2015.02.006; Kobeissy FH, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00198; Kobeissy FH, 2010, METHODS MOL BIOL, V662, P303, DOI 10.1007/978-1-60761-800-3_15; Lai WF, 2018, INFLAMMATION, V41, P449, DOI 10.1007/s10753-017-0701-7; Lakshmikanthan S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207605; Li JR, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0959-6; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu XY, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0348-1; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maqbool A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-40; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Pandey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088889; Pettit LK, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-16; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Rubin RD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070082; Ruzafa N, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700321; Sarnico I, 2009, INT REV NEUROBIOL, V85, P351, DOI 10.1016/S0074-7742(09)85024-1; Savin C, 2009, J R SOC INTERFACE, V6, P655, DOI 10.1098/rsif.2008.0387; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Sin O, 2015, CELL MOL LIFE SCI, V72, P4027, DOI 10.1007/s00018-015-1985-0; Soares HD, 1995, J NEUROSCI, V15, P8223; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stylli SS, 2000, J CLIN NEUROSCI, V7, P137, DOI 10.1054/jocn.1999.0187; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Vizuete AFK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1109-5; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhang JH, 2011, CHIN OPT LETT, V9, DOI 10.3788/COL201109.090606; Zheng S, 2017, FUTURE ONCOL, V13, P2053, DOI 10.2217/fon-2017-0199	90	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214741	10.1371/journal.pone.0214741	http://dx.doi.org/10.1371/journal.pone.0214741			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943276	gold, Green Published, Green Submitted			2022-12-27	WOS:000463194300058
J	Duncan, K; Sinanovic, E				Duncan, Kristal; Sinanovic, Edina			A cost comparison analysis of paediatric intermediate care in a tertiary hospital and an intermediate care facility in Cape Town, South Africa	PLOS ONE			English	Article							PALLIATIVE CARE; CANCER; UNIT	Background In South Africa, 600-700 new cases of paediatric cancers have been reported every year for the past 25 years, and in the year 2000, HIV/AIDS was responsible for 42,479 deaths in children under five. These children need intermediate care but research in the field is lacking, with the few costing studies conducted in South Africa reporting a range of inpatient day costs. Methods A retrospective cost analysis for the period April 2014-March 2015 was undertaken from the provider perspective in the public sector, using a step down costing approach. Costs of paediatric intermediate care were estimated for an intermediate care facility (ICF) and a tertiary hospital in Cape Town. Costs were inflated to 2016 prices and reported in US dollars. Results Cost per inpatient day was $713.09 at the hospital and $695.17 at the ICF for any child requiring care at these institutions. The cost for a paediatric patient who is HIV/TB co-infected was $7 130.94 and $6 951.67 at the hospital and ICF respectively, assuming an average length of stay of 10 days. For a patient with terminal brain carcinoma the cost was $19 966.63 and $19 464.69 at the hospital and ICF respectively, assuming an average length of stay of 28 days. Personnel costs accounted for 60% and 17% of the total cost at the hospital and ICF respectively. Overhead costs accounted for 12.33% at the ICF and 4.48% at the hospital. Conclusions The drivers of cost are not uniform across settings. Providing intermediate care at an ICF could be less costly than providing this care at a hospital, however more in-depth analysis is needed. The costs presented in this study were considerably higher than those found in other studies, however, the paucity of cost data available in this area makes comparisons difficult.	[Duncan, Kristal; Sinanovic, Edina] Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, Cape Town, South Africa	University of Cape Town	Duncan, K (corresponding author), Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, Cape Town, South Africa.	Kristal.duncan@gmail.com	Sinanovic, Edina/AAR-2590-2020					Barr RD, 2004, EUR J CANCER, V40, P1335, DOI 10.1016/j.ejca.2004.01.033; Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Connor SR, 2014, GLOBAL ATLAS PALLIAT; Conte Tania, 2015, CMAJ Open, V3, pE68, DOI 10.9778/cmajo.20140044; Desmonde S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166466; Garcia S, 1997, INTENS CARE MED, V23, P218, DOI 10.1007/s001340050320; Gold MR, 1996, COST EFFECTIVENESS H, P82; Google, 2008, GOOGL EARTH PRO SAR; Harding R, 2013, LANCET ONCOL, V14, pE183, DOI 10.1016/S1470-2045(12)70396-0; Hongoro C, 2011, J PAIN SYMPTOM MANAG, V41, P1015, DOI 10.1016/j.jpainsymman.2010.08.014; Jeena PM, 1999, INTENS CARE MED, V25, P88, DOI 10.1007/s001340050792; King Susanne, 2004, Semin Pediatr Neurol, V11, P78, DOI 10.1016/j.spen.2004.01.009; KUMARI R, 2012, INDIAN J SCI RES, V3, P59; LANDIS SE, 1991, PEDIATRICS, V88, P705; Magrath I, 2013, LANCET ONCOL, V14, pE104, DOI 10.1016/S1470-2045(13)70008-1; Miano M, 2002, HAEMATOLOGICA, V87, P637; Miret M, 1997, AIDS CARE, V9, P461, DOI 10.1080/713613173; Morden E, 2016, W CAPE MORTALITY PRO; Olukoga A., 2007, SMJ Singapore Medical Journal, V48, P143; Roze Des Ordons A, 2016, CANADIAN MED ED J PA, V2016, P7; Sandy PT, 2013, INT NURS REV, V60, P344, DOI 10.1111/inr.12022; Statistics South Africa, 2016, P0141 STAT S AFR; Statistics South Africa, 2015, STAT REL P0302 MID P; Stefan DC, 2012, SAMJ S AFR MED J, V102, P605, DOI 10.7196/SAMJ.5719; STEIN A, 1989, ARCH DIS CHILD, V64, P697, DOI 10.1136/adc.64.5.697; Western Cape Health Department, 2012, 154 W CAP HLTH DEP; Western Cape Provincial Government, 2016, W CAP GOV BUDG 2016; Wilson LS, 2010, PEDIATRICS, V126, pE541, DOI 10.1542/peds.2009-3485; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214492	10.1371/journal.pone.0214492	http://dx.doi.org/10.1371/journal.pone.0214492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943223	gold, Green Published, Green Submitted			2022-12-27	WOS:000463194300042
J	Baatjes, KJ; Kotze, MJ; McCaul, M; Conradie, M				Baatjes, Karin J.; Kotze, Maritha J.; McCaul, Micheal; Conradie, Magda			Baseline bone health status in multi-ethnic South African postmenopausal breast cancer patients at initiation of aromatase inhibitor therapy: A descriptive study	PLOS ONE			English	Article							MINERAL DENSITY; BIG 1-98; FAT DISTRIBUTION; RISK-FACTOR; WOMEN; FRACTURES; TAMOXIFEN; MANAGEMENT; HIP; LETROZOLE	Introduction Osteoporosis (OP) risk factor assessment and bone mineral density (BMD) testing are frequently omitted at baseline in aromatase inhibitor (Al) studies, which may lead to misinterpretation of Al associated bone loss. The present study describes bone health of South African postmenopausal women of predominantly Mixed Ancestry, prior to Al treatment. Methods This descriptive baseline study, nested in a prospective Al cohort study, included postmenopausal women with endocrine sensitive breast cancer, aged 50 to 80 years. A baseline questionnaire documented demographic-, medical-, lifestyle- and fracture history. Body weight was assessed clinically, and body composition and BMD measured via dual energy absorptiometry (DXA). Data was analysed in STATA 14 using descriptive and inferential statistics. Results 101 participants were recruited, with a mean age of 61 +/- 7 years. Nearly a third (n = 32) of women at baseline fulfilled global criteria for bone protection (BMD T-score >=-2SD (n = 18); BMD T-score-1.5SD to < -2SD with risk factors (n = 14). Lower body weight, body mass index (BMI), fat mass index and lean mass index were significantly associated with the participants with a BMD measurement in keeping with a diagnosis of OP (p < 0.001). Low vitamin D was present in 93% of the cohort tested (n = 95), whilst deficient vitamin D status (<20ng/ml) was documented in 52 women (55%). Conclusions In this study, a third of postmenopausal women considered for Al therapy fulfilled international criteria for bone protective pharmacological intervention. This emphasizes the need for clinical risk and BMD assessment in postmenopausal breast cancer patients at baseline. Body composition and bone health associations highlight bone fragility associated with lower body weight.	[Baatjes, Karin J.] Stellenbosch Univ, Dept Surg Sci, Fac Med & Hlth Sci, Tygerberg, South Africa; [Kotze, Maritha J.] Stellenbosch Univ, Div Chem Pathol, Dept Pathol, Fac Med & Hlth Sci, Tygerberg, South Africa; [Kotze, Maritha J.] Tygerberg Hosp, Natl Hlth Lab Serv, Tygerberg, South Africa; [McCaul, Micheal] Stellenbosch Univ, Biostat Unit, Div Epidemiol & Biostat, Dept Global Hlth, Tygerberg, South Africa; [Conradie, Magda] Stellenbosch Univ, Div Endocrinol, Dept Med, Fac Med & Hlth Sci, Tygerberg, South Africa	Stellenbosch University; Stellenbosch University; Tygerberg Hospital; Stellenbosch University; Stellenbosch University	Baatjes, KJ (corresponding author), Stellenbosch Univ, Dept Surg Sci, Fac Med & Hlth Sci, Tygerberg, South Africa.	kbaatjes@sun.ac.za	Kotze, Maritha J/GMX-0989-2022	McCaul, Michael/0000-0002-2730-6478; Kotze, Martha/0000-0002-6050-2876; Baatjes, Karin/0000-0001-8432-8844	Cancer Association of South Africa (CANSA); Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council (MRC); South African Department of Science and Technology [S003665]	Cancer Association of South Africa (CANSA); Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council (MRC); South African Department of Science and Technology	The research was supported by the Cancer Association of South Africa (CANSA) and the Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council (MRC), with funds received from the South African Department of Science and Technology (Research grant number S003665).	Andreopoulou P, 2015, ANNU REV MED, V66, P329, DOI 10.1146/annurev-med-070313-022841; Blaauw R, 1996, S AFR MED J, V86, P1081; Body Jean-Jacques, 2012, Bonekey Rep, V1, P201, DOI 10.1038/bonekey.2012.201; Bouvard B, 2012, ANN ONCOL, V23, P1151, DOI 10.1093/annonc/mdr356; California I, 2016, CAISO FLEX RES FAST, P1; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; Christodoulou S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/396541; Conradie M, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0193-0; Da Shao H, 2015, J BONE MINER METAB, V33, P507, DOI 10.1007/s00774-014-0613-7; Edwards BJ, 2011, CLIN CANCER RES, V17, P560, DOI 10.1158/1078-0432.CCR-10-1595; Hadji P, 2011, ANN ONCOL, V22, P2546, DOI 10.1093/annonc/mdr017; Hadji P, 2017, J BONE ONCOL, V7, P1, DOI 10.1016/j.jbo.2017.03.001; Ho-Pham LT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-59; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kalder M, 2014, J CLIN DENSITOM, V17, P66, DOI 10.1016/j.jocd.2013.03.003; KALLA AA, 1994, S AFR MED J, V84, P398; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kimble RB, 1996, J BIOL CHEM, V271, P28890, DOI 10.1074/jbc.271.46.28890; Lupsa BC, 2015, ENDOCRIN METAB CLIN, V44, P517, DOI 10.1016/j.ecl.2015.05.002; Mo D, 2016, ETHN HLTH, P1; Nanes MS, 2014, SEMIN NUCL MED, V44, P439, DOI 10.1053/j.semnuclmed.2014.06.006; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Pettifor JM, 1996, S AFR MED J, V86, P1270; Pisani P, 2016, WORLD J ORTHOP, V7, P171, DOI 10.5312/wjo.v7.i3.171; Prieto-Alhambra D, 2012, BREAST CANCER RES TR, V133, P1159, DOI 10.1007/s10549-012-2013-9; Rabaglio M, 2009, ANN ONCOL, V20, P1489, DOI 10.1093/annonc/mdp033; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Roux C, 2003, BONE, V33, P847, DOI 10.1016/j.bone.2003.07.008; Servitja S, 2015, THER ADV MED ONCOL, V7, P291, DOI 10.1177/1758834015598536; Servitja S, 2012, BREAST, V21, P95, DOI 10.1016/j.breast.2011.09.001; Wardley AM, 2008, ADV THER, V25, P1257, DOI 10.1007/s12325-008-0128-5; Yang PLS, 2013, J CLIN ENDOCR METAB, V98, P4516, DOI 10.1210/jc.2013-2454; Zaman K, 2012, ANN ONCOL, V23, P1474, DOI 10.1093/annonc/mdr448	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214153	10.1371/journal.pone.0214153	http://dx.doi.org/10.1371/journal.pone.0214153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939140	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900014
J	Colonetti, K; dos Santos, BB; Nalin, T; de Souza, CFM; Triplett, EW; Dobbler, PT; Schwartz, IVD; Roesch, LFW				Colonetti, Karina; dos Santos, Bruna Bento; Nalin, Tatiele; Moura de Souza, Carolina Fischinger; Triplett, Eric W.; Dobbler, Priscila Thiago; Doederlein Schwartz, Ida Vanessa; Wurdig Roesch, Luiz Fernando			Hepatic glycogen storage diseases are associated to microbial dysbiosis	PLOS ONE			English	Article							CLINICAL-COURSE; GUT MICROBIOTA; III DIAGNOSIS; HUMAN HEALTH; MANAGEMENT; GUIDELINES; DIVERSITY; SIGNATURE; TOOL	Introduction The gut microbiome has been related to several features present in Glycogen Storage Diseases (GSD) patients including obesity, inflammatory bowel disease (IBD) and liver disease. Objectives The primary objective of this study was to investigate associations between GSD and the gut microbiota. Methods Twenty-four GSD patients on treatment with uncooked cornstarch (UCCS), and 16 healthy controls had their faecal microbiota evaluated through 16S rRNA gene sequencing. Patients and controls were >= 3 years of age and not on antibiotics. Faecal pH, calprotectin, mean daily nutrient intake and current medications were recorded and correlated with gut microbiome. Results Patients' group presented higher intake of UCCS, higher prevalence of IBD (n = 04/24) and obesity/overweight (n = 18/24) compared to controls (n = 0 and 06/16, respectively). Both groups differed regarding diet (in patients, the calories' source was mainly the UCSS, and the intake of fat, calcium, sodium, and vitamins was lower than in controls), use of angiotensin-converting enzyme inhibitors (patients = 11, controls = 0; p-value = 0.001) multivitamins (patients = 22, controls = 01; p-value = 0.001), and mean faecal pH (patients = 6.23; controls = 7.41; p = 0.001). The GSD microbiome was characterized by low diversity and distinct microbial structure. The operational taxonomic unit (OTU) abundance was significantly influenced by faecal pH (r = 0.77; p = 6.8e-09), total carbohydrate (r = -0.6; p = 4.8e-05) and sugar (r = 0.057; p = 0.00013) intakes. Conclusions GSD patients presented intestinal dysbiosis, showing low faecal microbial diversity in comparison with healthy controls. Those findings might be due to the disease per se, and/or to the different diets, use of UCSS and of medicines, and obesity rate found in patients. Although the main driver of these differences is unknown, this study might help to understand how the nutritional management affects GSD patients.	[Colonetti, Karina; dos Santos, Bruna Bento; Doederlein Schwartz, Ida Vanessa] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil; [Colonetti, Karina; dos Santos, Bruna Bento; Doederlein Schwartz, Ida Vanessa] Hosp Clin Porto Alegre, Lab Basic Res & Adv Invest Neurosci BRAIN, Porto Alegre, RS, Brazil; [Nalin, Tatiele; Moura de Souza, Carolina Fischinger; Doederlein Schwartz, Ida Vanessa] Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil; [Nalin, Tatiele] Univ Fed Rio Grande do Sul, Postgrad Program Med Med Sci, Porto Alegre, RS, Brazil; [Triplett, Eric W.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Dobbler, Priscila Thiago; Wurdig Roesch, Luiz Fernando] Univ Fed Pampa, Interdisciplinary Res Ctr Biotechnol CIP Biotec, Sao Gabriel, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; State University System of Florida; University of Florida; Universidade Federal do Pampa	Roesch, LFW (corresponding author), Univ Fed Pampa, Interdisciplinary Res Ctr Biotechnol CIP Biotec, Sao Gabriel, RS, Brazil.	luiz.roesch@gmail.com	Dobbler, Priscila Caroline Thiago/E-4387-2018; Schwartz, Ida Vanessa Doederlein/ABG-5471-2020; Roesch, Luiz F W/D-2838-2009; Roesch, Luiz/GRS-4638-2022; Nalin, Tatiele/H-6029-2016; Schwartz, Ida/M-1422-2015; Santos, Bruna Bento dos/V-4850-2019; de Souza, Carolina Fischinger Moura/V-9921-2019	Dobbler, Priscila Caroline Thiago/0000-0002-7681-5463; Schwartz, Ida Vanessa Doederlein/0000-0002-7933-6687; Roesch, Luiz F W/0000-0003-1450-8828; Schwartz, Ida/0000-0002-7933-6687; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)-EDITAL PRONEX FAPERGS/CNPq 12/2014 [16/2551-0000492-7]; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA) [150218]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)-EDITAL PRONEX FAPERGS/CNPq 12/2014; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)-EDITAL PRONEX FAPERGS/CNPq 12/2014, processo 16/2551-0000492-7; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA)- n. 150218 and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi B., 2013, WATER BIOL CHEM PROC, DOI [10.1017/CBO9781139583947, DOI 10.1017/CBO9781139583947]; Bali DS, 2006, GENEREVIEWS; Barboza ADM, 2018, SEASONAL DYNAMICS AL, P18; Bjarnason I., USE FECAL CALPROTECT; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191; Carnero-Gregorio M, 2019, PROBIOTICS ANTIMICRO, V11, P143, DOI 10.1007/s12602-017-9372-9; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Chou JY, 2010, NAT REV ENDOCRINOL, V6, P676, DOI 10.1038/nrendo.2010.189; Da Silva HE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19753-9; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; DeGruttola AK, 2016, INFLAMM BOWEL DIS, V22, P1137, DOI 10.1097/MIB.0000000000000750; Derks TGJ, 2015, J INHERIT METAB DIS, V38, P537, DOI 10.1007/s10545-015-9811-2; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Di Luccia B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134893; Friedrich MJ, 2013, JAMA-J AM MED ASSOC, V309, P1447, DOI 10.1001/jama.2013.2824; Guo HH, 2016, J IMMUNOL, V196, P2300, DOI 10.4049/jimmunol.1500130; Hall AB, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.63; Herbert M., 2019, GENEREVIEWS; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jelaska BK, 2014, ENDOCRINOL DIAB META, DOI 10.1530/EDM-13-0056; Kishnani P. S., 2014, Genetics in Medicine, V16, pe1; Kishnani PS, 2010, GENET MED, V12, P446, DOI 10.1097/GIM.0b013e3181e655b6; KOTARSKI SF, 1992, J NUTR, V122, P178, DOI 10.1093/jn/122.1.178; Lawrence NT, 2015, JIMD REP, V24, P123, DOI 10.1007/8904_2015_452; Lemos LN, 2012, FOLIA MICROBIOL, V57, P409, DOI 10.1007/s12223-012-0155-0; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Matsuoka K, 2018, J GASTROENTEROL, V53, P305, DOI 10.1007/s00535-018-1439-1; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Melis D, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0301-2; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Moses SW, 2002, EUR J PEDIATR, V161, pS2, DOI 10.1007/s00431-002-0997-6; Ozen H, 2007, WORLD J GASTROENTERO, V13, P2541; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pascal V, 2017, GUT, V66, P813, DOI 10.1136/gutjnl-2016-313235; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pylro VS, 2016, MICROB ECOL, V72, P443, DOI 10.1007/s00248-016-0785-x; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rake JP, 2002, EUR J PEDIATR, V161, pS112, DOI 10.1007/BF02680007; Rake JP, 2002, EUR J PEDIATR, V161, pS20, DOI 10.1007/s00431-002-0999-4; Santos Bruna B. dos, 2017, J. inborn errors metab. screen., V5, pe170012, DOI 10.1177/2326409817733014; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sentner CP, 2016, J INHERIT METAB DIS, V39, P697, DOI 10.1007/s10545-016-9932-2; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Sleator RD, 2010, MED HYPOTHESES, V74, P214, DOI 10.1016/j.mehy.2009.08.047; Team RC., 2022, LANG ENV STAT COMP; Visser G, 2002, EUR J PEDIATR, V161, pS120, DOI 10.1007/s00431-002-1017-6; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Weinstein DA, 2002, EUR J PEDIATR, V161, pS35, DOI 10.1007/s00431-002-1000-2; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493	53	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214582	10.1371/journal.pone.0214582	http://dx.doi.org/10.1371/journal.pone.0214582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939160	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900032
J	Shimeles, E; Enquselassie, F; Aseffa, A; Tilahun, M; Mekonen, A; Wondimagegn, G; Hailu, T				Shimeles, Ezra; Enquselassie, Fikre; Aseffa, Abraham; Tilahun, Melaku; Mekonen, Alemayehu; Wondimagegn, Getachew; Hailu, Tsegaye			Risk factors for tuberculosis: A case-control study in Addis Ababa, Ethiopia	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; CONTACT; PREVALENCE; REGION	Background Tuberculosis remains a major public-health problem in the world, despite several efforts to improve case identification and treatment compliance. It is well known cause of ill-health among millions of people each year and ranks as the second leading cause of death from infectious disease worldwide. Despite implementation of the World health organization recommended strategy, the reductions in the incidence of TB have been minimal in high burden countries. Objectives and methods A case control study was carried out to assess the risk factors of TB, where cases were newly registered bacteriologically confirmed pulmonary TB patients with age greater than 15 years who present at twenty health centres in Addis Ababa. Controls were age and sex matched attendees who presented in the same health centers for non-TB health problems. Results A total of 260 cases and 260 controls were enrolled in the study and 45.8% of cases and 46.2% of controls were in the 26-45 years age bracket. According to the multivariable logistic regression analysis, seven variables were found to be independent predictors for the occurrence of TB after controlling possible confounders. Patients who live in house with no window or one window were almost two times more likely to develop tuberculosis compared to people whose house has multiple windows (AOR = 1.81; 95% CI: 1.06, 3.07). Previous history of hospital admission was found to pose risk almost more than three times (AOR = 3.39; 95% CI: 1.64-7.03). Having a household member who had TB was shown to increase risk of developing TB by three fold (AOR = 3.00; 95% CI: 1.60, 5.62). The study showed that illiterate TB patients were found to be more than twice more likely to develop TB compared to subjects who can atleast read and write (AOR, 95% CI = 2.15, 1.05, 4.40). Patients with household income of less than 1000 birrs per month were more than two times more likely to develop TB compared to those who had higher income (AOR = 2.2; 95% CI: 1.28, 3.78). Smoking has also been identified as important risk factor for developing TB by four times (AOR = 4.43; 95% CI: 2.10, 9.3). BCG was found to be protective against TB reducing the risk by one-third (AOR = 0.34; 95% CI: 0.22, 0.54). Conclusion This study showed that TB is more common among the most agile and economically active age group, and number of windows, history of hospital admission, a household member who had TB, illiteracy, low household income and smoking and lack of BCG scar were identified as independent risk factors. Therefore it is imperative that the TB control effort need a strategy to address socio economic issues such as poverty, overcrowding, smoking, and infection control at health care facilities level is an important intervention to prevent transmission of TB within the facilities.	[Shimeles, Ezra; Aseffa, Abraham; Tilahun, Melaku; Hailu, Tsegaye] ALERT Compound, Armauer Hanson Res Inst, Addis Ababa, Ethiopia; [Shimeles, Ezra; Enquselassie, Fikre] Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Black Lion Hosp, Addis Ababa, Ethiopia; [Mekonen, Alemayehu] Ethiopian Publ Hlth Assoc, Addis Ababa, Ethiopia; [Wondimagegn, Getachew] KNCV TB Fdn, Addis Ababa, Ethiopia	Addis Ababa University; KNCV Tuberculosis Foundation	Shimeles, E (corresponding author), ALERT Compound, Armauer Hanson Res Inst, Addis Ababa, Ethiopia.; Shimeles, E (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Black Lion Hosp, Addis Ababa, Ethiopia.	ezraashi@yahoo.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150	Armauer Hanson research Institute in Addis Ababa, Ethiopia	Armauer Hanson research Institute in Addis Ababa, Ethiopia	This research was fully funded ed by Armauer Hanson research Institute in Addis Ababa, Ethiopia.	Adesokan H K, 2014, Afr J Med Med Sci, V43, P45; Ali S, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0298-5; Bam TS, 2015, BMJ-BRIT MED J, V15, P604; Berhe Gebretsadik, 2013, Ethiop Med J, V51, P227; Bhat J, 2017, INDIAN J MED RES, V146, P96, DOI 10.4103/ijmr.IJMR_1029_16; Bigwan Ei, 2014, Afr J Infect Dis, V8, P22; Central Statistical Agency (CSA) [Ethiopia] ICF, 2016, ETHIOPIA DEMOGRAPHIC; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Crampin AC, 2006, EMERG INFECT DIS, V12, P729; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gambhir HS, 2010, INT HEALTH, V2, P216, DOI 10.1016/j.inhe.2010.07.001; Hirpa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-782; Kehinde A O, 2010, Afr J Med Med Sci, V39, P105; Kirenga BJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1376-3; Kurniawati Fivy, 2012, INT J PHARM PHARM SC, V4; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Louwagie GMC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1031; Mahbubul Hoque AK, 2017, INT J MED RES REV, V5; MANGTANI P, 1995, BRIT MED J, V310, P963, DOI 10.1136/bmj.310.6985.963; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; Ministry of Health, 2012, NAT GUID CLIN PROGR; Mumpe-Mwanja D, 2015, AFR HEALTH SCI, V15, P851, DOI 10.4314/ahs.v15i3.20; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Ndishimye Pacifique, 2017, Clujul Med, V90, P54, DOI 10.15386/cjmed-652; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Ryan H, 2012, J ENV PUBLIC HLTH, V91, P83; Sethi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-137; Son M, 2018, POSTGRAD MED, V130, P637, DOI 10.1080/00325481.2018.1510709; Tulu Begna, 2014, BMC Res Notes, V7, P285, DOI 10.1186/1756-0500-7-285; Wang J, 2009, BMC PUBLIC HEALTH, V9, P1471; Webb RM, 2003, INT J TUBERC LUNG D, V7, pS353; WHO, 2016, GLOB TUB REP; Wondemagegn Mulu, 2015, AFRICAN HLTH SCI, V15; Workicho A, 2017, INFECT DRUG RESIST, V10, P91, DOI 10.2147/IDR.S126274; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2017, GLOB TB TUB REP; Xu Chen, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P693; Yallew WW, 2016, DRUG HEALTHC PATIENT, V8, P71, DOI 10.2147/DHPS.S107344; Zignol M, 2013, DRUG RESIST UPDATE, V16, P108, DOI 10.1016/j.drup.2014.02.003	41	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214235	10.1371/journal.pone.0214235	http://dx.doi.org/10.1371/journal.pone.0214235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939169	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900016
J	Stanislawska-Sachadyn, A; Borzyszkowska, J; Krzeminski, M; Janowicz, A; Dziadziuszko, R; Jassem, J; Rzyman, W; Limon, J				Stanislawska-Sachadyn, Anna; Borzyszkowska, Joanna; Krzeminski, Michal; Janowicz, Alicja; Dziadziuszko, Rafal; Jassem, Jacek; Rzyman, Witold; Limon, Janusz			Folate/homocysteine metabolism and lung cancer risk among smokers	PLOS ONE			English	Article							FOLIC-ACID; HOMOCYSTEINE CONCENTRATIONS; THYMIDYLATE SYNTHASE; METHYLENETETRAHYDROFOLATE REDUCTASE; SERINE HYDROXYMETHYLTRANSFERASE; ESTROGEN-RECEPTORS; B-VITAMINS; POLYMORPHISMS; FOLATE; GENES	Background Folate and homocysteine are involved in DNA synthesis and methylation processes, which are deregulated during carcinogenesis. Objectives The aim of this study was to assess the relationship between folate/homocysteine concentrations, the functional polymorphisms of folate/homocysteine genes and lung cancer risk among cigarette smokers. Study design The study included 132 lung cancer patients and 396 controls from northern Poland, matched by sex, age and smoking status. The median cigarette pack-years of smoking among both cases and controls was 30.0. Serum, red blood cell (RBC) folates and serum homocysteine concentrations were measured. The genotypes in selected polymorphic sites of the MTHFR, CBS, SHMT1, MTHFD1, MTRR, MTR, TYMS DHFR, TCN2, and SLC19A1 genes were determined. All study participants underwent scanning with low-dose computed tomography. Results Serum folate concentrations above the median (> 17.5 nmol/l among the healthy controls) were associated with an increased lung cancer risk (odds ratio [OR], 1.54, 95% confidence intervals [CI], 1.04-2.29, P = 0.031). An analogous trend was observed when the population was analysed after subdivision according to RBC folate concentrations, that is, above a value of 506.5 nmol/l(OR, 1.53; 95% CI, 0.95-2.47; P = 0.084). Additionally, in a subset of women, an increased risk of lung cancer development was associated with the SLC19A1 c.80AA genotype (c.80AA versus GG OR, 3.14; 95% CI, 1.32-7.46; P = P = 0.010). Conclusion These results suggest that, in the population consisting of heavy smokers, high folate levels add to the cancerogenic effect of smoking.	[Stanislawska-Sachadyn, Anna; Borzyszkowska, Joanna; Limon, Janusz] Med Univ Gdansk, Dept Biol & Genet, Gdansk, Poland; [Stanislawska-Sachadyn, Anna] Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Gdansk, Poland; [Krzeminski, Michal] Gdansk Univ Technol, Dept Probabil & Biomath, Gdansk, Poland; [Janowicz, Alicja; Rzyman, Witold] Med Univ Gdansk, Dept Thorac Surg, Gdansk, Poland; [Dziadziuszko, Rafal; Jassem, Jacek] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland; [Limon, Janusz] Polish Acad Sci, Gdansk Branch, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Polish Academy of Sciences	Stanislawska-Sachadyn, A (corresponding author), Med Univ Gdansk, Dept Biol & Genet, Gdansk, Poland.; Stanislawska-Sachadyn, A (corresponding author), Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Gdansk, Poland.	astanisl@gumed.edu.pl	Krzemiński, Michał/K-6536-2018; Krzemiński, Michał/Z-3520-2019; Dziadziuszko, Rafal/U-7036-2018	Krzemiński, Michał/0000-0002-5596-366X; Krzemiński, Michał/0000-0002-5596-366X; Jassem, Jacek/0000-0002-8875-6747; Rzyman, Witold/0000-0002-9044-7791; Stanislawska-Sachadyn, Anna/0000-0002-9490-4582; Dziadziuszko, Rafal/0000-0001-8080-9843	National Centre for Research and Development, Poland [POIG.01.01.02-22-080/09]	National Centre for Research and Development, Poland(National Centre for Research & Development, Poland)	This work was supported by the National Centre for Research and Development, Poland [grant number: POIG.01.01.02-22-080/09]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arslan S, 2011, MOL BIOL REP, V38, P991, DOI 10.1007/s11033-010-0194-z; Barbaux S, 2000, CLIN CHEM, V46, P907; Brown KS, 2004, HUM GENET, V114, P182, DOI 10.1007/s00439-003-1039-9; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dougherty SM, 2006, ENDOCR-RELAT CANCER, V13, P113, DOI 10.1677/erc.1.01118; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Hung RJ, 2007, CARCINOGENESIS, V28, P1334, DOI 10.1093/carcin/bgm067; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeng YL, 2003, ANTICANCER RES, V23, P5149; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Johnson WG, 2004, AM J MED GENET A, V124A, P339, DOI 10.1002/ajmg.a.20505; Kim YI, 2006, NUTR REV, V64, P468, DOI 10.1301/nr.2006.oct.468-475; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Kiyohara C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-459; Liu HL, 2008, LUNG CANCER, V61, P21, DOI 10.1016/j.lungcan.2007.12.001; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; McNulty H, 2012, P NUTR SOC, V71, P213, DOI 10.1017/S0029665111003387; Niikawa H, 2008, CLIN CANCER RES, V14, P4417, DOI 10.1158/1078-0432.CCR-07-1950; Ozkan Y, 2007, ANTICANCER RES, V27, P1185; Piskac-Collier AL, 2011, GENE CHROMOSOME CANC, V50, P1, DOI 10.1002/gcc.20826; Sasco AJ, 2004, LUNG CANCER, V45, pS3, DOI 10.1016/j.lungcan.2004.07.998; Shen HB, 2001, CANCER EPIDEM BIOMAR, V10, P397; Shen M, 2005, LUNG CANCER-J IASLC, V49, P299, DOI 10.1016/j.lungcan.2005.04.002; Shi QL, 2005, PHARMACOGENET GENOM, V15, P547, DOI 10.1097/01.fpc.0000170916.96650.70; Shi QL, 2005, CARCINOGENESIS, V26, P649, DOI 10.1093/carcin/bgh351; Siemianowicz K, 2003, ONCOL REP, V10, P1341; Skibola CF, 2002, BLOOD, V99, P3786, DOI 10.1182/blood.V99.10.3786; Skibola CF, 2004, BLOOD, V104, P2155, DOI 10.1182/blood-2004-02-0557; Stanislawska-Sachadyn A, 2008, MOL GENET METAB, V93, P355, DOI 10.1016/j.ymgme.2007.11.004; Stanislawska-Sachadyn A, 2009, ANN HUM GENET, V73, P484, DOI 10.1111/j.1469-1809.2009.00529.x; Summers CM, 2008, J RHEUMATOL, V35, P2179, DOI 10.3899/jrheum.080071; Summers CM, 2010, BIRTH DEFECTS RES A, V88, P679, DOI 10.1002/bdra.20683; Suzuki T, 2007, CARCINOGENESIS, V28, P1718, DOI 10.1093/carcin/bgm104; Swartz MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053475; Truong T, 2010, CARCINOGENESIS, V31, P625, DOI 10.1093/carcin/bgq001; Vineis P, 2007, ANN ONCOL, V18, P1230, DOI 10.1093/annonc/mdm109; Wang L, 2007, LUNG CANCER, V57, P143, DOI 10.1016/j.lungcan.2007.03.002; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555	40	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214462	10.1371/journal.pone.0214462	http://dx.doi.org/10.1371/journal.pone.0214462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939165	gold, Green Submitted, Green Published			2022-12-27	WOS:000462993900025
J	Arias-de la Torre, J; Puigdomenech, E; Valderas, JM; Evans, JP; Martin, V; Molina, AJ; Rodriguez, N; Espallargues, M				Arias-de la Torre, Jorge; Puigdomenech, Elisa; Valderas, Jose M.; Evans, Jonathan P.; Martin, Vicente; Molina, Antonio J.; Rodriguez, Nuria; Espallargues, Mireia			Availability of specific tools to assess patient reported outcomes in hip arthroplasty in Spain. Identifying the best candidates to incorporate in an arthroplasty register. A systematic review and standardized assessment	PLOS ONE			English	Review							QUALITY-OF-LIFE; CROSS-CULTURAL ADAPTATION; MEASURES WORKING GROUP; KNEE ARTHROPLASTY; INTERNATIONAL SOCIETY; TASK-FORCE; OSTEOARTHRITIS; VALIDATION; QUESTIONNAIRES; INSTRUMENTS	Purpose 1) To systematically review the available scientific literature regarding specific instruments developed and/or tested in a Spanish population, to assess these PROMs in hip arthroplasty; 2) to carry out a standardized assessment of their measurement properties; and 3) to identify the best tools for use in Spain in an arthroplasty registry context. Methods A systematic review of PubMed/MEDLINE and EMBASE and CINHAL was done. Furthermore, a standardized assessment of the questionnaires identified using the Evaluating the Measurement of Patient-Reported Outcomes (EMPRO) tool was performed. All developments, validation and studies aiming to assess the measurement properties of PROMs in hip arthroplasty in the Spanish population were included. Data from the questionnaires on metric properties was taken into account to identify the best candidates for inclusion in a register. Results A total of 853 documents were found. After screening title and abstract, 13 full text documents were reviewed and 8 questionnaires adapted and validated to assess some of the aspects of hip arthroplasty in the Spanish population were identified. After the EMPRO assessment, 4 questionnaires showed suitable properties (WOMAC, OAKHQOL, mini-OAKHQOL and PFH). Conclusions In Spain, there are a few suitable hip-specific questionnaires currently available to assess PROMs in hip arthroplasty surgery. Some of the more widely used questionnaires, like the OHS and HOOS, have not been validated in the Spanish population until now. Identified tools are suitable for use in a clinical context, however their use in an arthroplasty register is more questionable due to the lack of validation studies of the widely used tools in other registers.	[Arias-de la Torre, Jorge; Puigdomenech, Elisa; Rodriguez, Nuria; Espallargues, Mireia] Agcy Heath Qual & Assessment Catalonia AQuAS, Barcelona, Spain; [Arias-de la Torre, Jorge; Martin, Vicente] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Arias-de la Torre, Jorge; Martin, Vicente; Molina, Antonio J.] Univ Leon, Inst Biomed IBIOMED, Leon, Spain; [Puigdomenech, Elisa] Univ Oberta Catalunya, Sch Hlth Sci, eHlth Lab Res Grp, Catalonia, Spain; [Valderas, Jose M.; Evans, Jonathan P.] Univ Exeter, Med Sch, Hlth Serv & Policy Res Grp, Exeter, Devon, England; [Evans, Jonathan P.] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Espallargues, Mireia] Hlth Serv Res Chron Patients Network REDISSEC, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Leon; UOC Universitat Oberta de Catalunya; University of Exeter; University of Exeter	Arias-de la Torre, J (corresponding author), Agcy Heath Qual & Assessment Catalonia AQuAS, Barcelona, Spain.; Arias-de la Torre, J (corresponding author), CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.; Arias-de la Torre, J (corresponding author), Univ Leon, Inst Biomed IBIOMED, Leon, Spain.	jariasdelatorre@gencat.cat	Martin, Vicente/A-1597-2008; DE LA TORRE, ANTONIO JOSÉ MOLINA/T-8682-2019; Martin, Vicente/GRE-8306-2022; Martin, Vicente/ABF-2276-2021; Valderas, Jose M/G-7967-2014; Valderas, Jose M/Y-9814-2019	Martin, Vicente/0000-0003-0552-2804; DE LA TORRE, ANTONIO JOSÉ MOLINA/0000-0002-5948-6397; Martin, Vicente/0000-0003-0552-2804; Valderas, Jose M/0000-0002-9299-1555; , Jorge/0000-0001-6908-9611; Evans, Jonathan/0000-0003-0090-1012	CIBERESP	CIBERESP	The present study was funded by CIBERESP as part of the aid granted to Jorge Ariasde la Torre in 2017 and 2018 for short internships.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Alonso J, 2000, ORTHOPEDICS, V23, P1273; Alviar MJ, 2011, J REHABIL MED, V43, P572, DOI 10.2340/16501977-0828; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bilbao A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-75; Black N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f167; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Collins NJ, 2012, CLIN GERIATR MED, V28, P367, DOI 10.1016/j.cger.2012.05.007; Dawson J, 1996, QUAL HEALTH CARE, V5, P81, DOI 10.1136/qshc.5.2.81; Escobar A, 2002, CLIN RHEUMATOL, V21, P466, DOI 10.1007/s100670200117; Escobar A, 2012, OSTEOARTHR CARTILAGE, V20, P87, DOI 10.1016/j.joca.2011.11.007; Escobar A, 2011, GAC SANIT, V25, P513, DOI 10.1016/j.gaceta.2011.06.003; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Gagnier JJ, 2017, J ORTHOP RES, V35, P2098, DOI 10.1002/jor.23604; de Tejada MGS, 2017, CLIN RHEUMATOL, V36, P1855, DOI 10.1007/s10067-017-3611-z; de Tejada MGS, 2011, CLIN RHEUMATOL, V30, P1563, DOI 10.1007/s10067-011-1855-6; Halawi MJ, 2015, ORTHOPEDICS, V38, pE685, DOI 10.3928/01477447-20150804-55; Harris K, 2016, PATIENT-RELAT OUTCOM, V7, P101, DOI 10.2147/PROM.S97774; Herdman M, 1997, QUAL LIFE RES, V6, P237; Hofstede SN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009117; Jones CA, 2007, RHEUM DIS CLIN N AM, V33, P71, DOI 10.1016/j.rdc.2006.12.008; Klassbo M, 2003, SCAND J RHEUMATOL, V32, P46, DOI 10.1080/03009740310000409; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Alonso SR, 2009, ATEN PRIM, V41, P613, DOI 10.1016/j.aprim.2009.02.005; Lovelock TM, 2018, J ARTHROPLASTY, V33, P273, DOI 10.1016/j.arth.2017.08.024; Marti-Valls J, 2000, Med Clin (Barc), V114 Suppl 2, P34; Martin-Fernandez J, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1568-3; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Navarro Collado MJ, 2005, REHABILITACION, V39, P147, DOI [10.1016/S0048-7120(05)74337-1, DOI 10.1016/S0048-7120(05)74337-1]; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; Ornetti P, 2010, OSTEOARTHR CARTILAGE, V18, P522, DOI 10.1016/j.joca.2009.12.007; Paulsen A, 2014, DAN MED J, V61; Polkowski GG, 2012, J AM ACAD ORTHOP SUR, V20, P487, DOI 10.5435/JAAOS-20-08-487; Quintana JM, 2005, OSTEOARTHR CARTILAGE, V13, P1076, DOI 10.1016/j.joca.2005.06.012; Quintana JM, 2012, ARTHRIT CARE RES, V64, P563, DOI 10.1002/acr.21570; Rasanen P, 2007, ACTA ORTHOP, V78, P108, DOI 10.1080/17453670610013501; Reeve B, 2013, QUAL LIFE RES, V22, P1889, DOI 10.1007/s11136-012-0344-y; Rolfson O, 2011, J BONE JOINT SURG BR, V93B, P867, DOI 10.1302/0301-620X.93B7.25737; Rolfson O, 2016, ACTA ORTHOP, V87, P9, DOI 10.1080/17453674.2016.1181816; Rolfson O, 2016, ACTA ORTHOP, V87, P3, DOI 10.1080/17453674.2016.1181815; Rothman M, 2009, VALUE HEALTH, V12, P1075, DOI 10.1111/j.1524-4733.2009.00603.x; Serra-Sutton V, 2009, INT J TECHNOL ASSESS, V25, P63, DOI 10.1017/S0266462309090096; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Thorborg K, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094224; Thorborg K, 2010, BRIT J SPORT MED, V44, P1186, DOI 10.1136/bjsm.2009.060889; Valderas JM, 2008, QUAL LIFE RES, V17, P1125, DOI 10.1007/s11136-008-9396-4; Valderas JM, 2008, VALUE HEALTH, V11, P700, DOI 10.1111/j.1524-4733.2007.00309.x; Valderas JM, 2006, REV ESP CARDIOL, V59, P1244, DOI 10.1157/13096592; Valls JM, 1997, MED CLIN-BARCELONA, V108, P691; Veenhof C, 2006, ARTHRIT RHEUM-ARTHR, V55, P480, DOI 10.1002/art.22001; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	53	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214746	10.1371/journal.pone.0214746	http://dx.doi.org/10.1371/journal.pone.0214746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934024	gold, Green Submitted, Green Published			2022-12-27	WOS:000462867000038
J	Kim, J; Kim, MJ; Sol, IS; Sohn, MH; Yoon, H; Shin, HJ; Kim, KW; Lee, MJ				Kim, Jonghyeon; Kim, Myung-Joon; Sol, In Suk; Sohn, Myung Hyun; Yoon, Haesung; Shin, Hyun Joo; Kim, Kyung Won; Lee, Mi-Jung			Quantitative CT and pulmonary function in children with post-infectious bronchiolitis obliterans	PLOS ONE			English	Article							IMPULSE OSCILLOMETRY; REFERENCE VALUES; WALL THICKNESS; BRONCHIAL WALL; DISEASE; RECONSTRUCTION; EMPHYSEMA; COPD	Objective To investigate the feasibility of CT-based quantitative airway and air-trapping measurements and to assess their correlation with pulmonary function in children with post-infectious bronchiolitis obliterans (PIBO). Materials and methods This retrospective study approved by the institutional review board included chest CT scans and pulmonary function tests (PFT) completed between January 2005 and December 2016 in children diagnosed with PIBO. The quantitative analysis of segmental and subsegmental bronchi was performed on each chest CT scan, measuring the areas or diameters of lumens, walls, or the entire airway. The air-trapping volume (ATV), the volume of lung area exhibiting lower attenuation than the mean attenuation of normal and air-trapping areas, was also measured in each lobe. Comparison analyses between CT parameters and PFT results were performed with Pearson or Spearman correlation. Results In total, 23 patients were enrolled (mean age 7.0 +/- 3.3 years; range, 4-15 years). We successfully measured 89.6% of all segmental bronchi. In the airway analysis, wall area showed a negative correlation with forced expiratory volume in one second (FEV1) in the majority of the pulmonary lobes. Air-trapping analyses demonstrated that ATV was negatively correlated with FEV1 and positively correlated with reactance at 5 Hz. Conclusion Quantitative airway and air-trapping measurements from chest CT are feasible and correlate with pulmonary function in pediatric PIBO patients.	[Kim, Jonghyeon; Kim, Myung-Joon; Yoon, Haesung; Shin, Hyun Joo; Lee, Mi-Jung] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Severance Hosp, Seoul, South Korea; [Sol, In Suk; Sohn, Myung Hyun; Kim, Kyung Won] Yonsei Univ, Korea 21 PLUS Project Med Sci, Severance Childrens Hosp, Dept Pediat,Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, MJ (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Severance Hosp, Seoul, South Korea.; Kim, KW (corresponding author), Yonsei Univ, Korea 21 PLUS Project Med Sci, Severance Childrens Hosp, Dept Pediat,Coll Med, Seoul, South Korea.	kwkim@yuhs.ac; mjl1213@yuhs.ac		Kim, Kyung Won/0000-0003-4529-6135; Shin, Hyun Joo/0000-0002-7462-2609; Yoon, Haesung/0000-0003-0581-8656; Sohn, Myung Hyun/0000-0002-2478-487X; Kim, Myung-Joon/0000-0002-4608-0275; Sol, In Suk/0000-0003-2470-9682; Lee, Mi-Jung/0000-0003-3244-9171				[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Bhatt SP, 2019, AM J RESP CRIT CARE, V199, P286, DOI 10.1164/rccm.201807-1351SO; Bickel S, 2014, CHEST, V146, P841, DOI 10.1378/chest.13-1875; Boone JMSK, 2011, REPORT AM ASS PHYS M, DOI DOI 10.37206/143; Colom AJ, 2018, PEDIAT PULMONOL; Dencker M, 2006, CLIN PHYSIOL FUNCT I, V26, P247, DOI 10.1111/j.1475-097X.2006.00682.x; Dettmer S, 2012, EUR J RADIOL, V81, P3606, DOI 10.1016/j.ejrad.2012.04.026; Dournes G, 2015, AM J RESP CRIT CARE, V191, P63, DOI 10.1164/rccm.201408-1423OC; Fischer GB, 2010, PAEDIATR RESPIR REV, V11, P233, DOI 10.1016/j.prrv.2010.07.005; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hastie AT, 2017, LANCET RESP MED, V5, P956, DOI 10.1016/S2213-2600(17)30432-0; Johannessen A, 2013, AM J RESP CRIT CARE, V187, P602, DOI 10.1164/rccm.201209-1722OC; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; Kim HG, 2015, EUR RADIOL, V25, P2931, DOI 10.1007/s00330-015-3700-9; Lederlin M, 2012, AM J ROENTGENOL, V199, P1226, DOI 10.2214/AJR.11.8396; Li YN, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-238; Loeb JS, 2008, PEDIATR PULM, V43, P1020, DOI 10.1002/ppul.20908; Mattiello R, 2010, PEDIATR PULM, V45, P315, DOI 10.1002/ppul.21115; Mauad T, 2002, PEDIATR PULM, V33, P466, DOI 10.1002/ppul.10097; McCollough C, 2018, MEASUREMENT REPORTIN; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; Orlandi I, 2005, RADIOLOGY, V234, P604, DOI 10.1148/radiol.2342040013; Quanjer PH, 2013, EUR RESPIR J, V42, P1046, DOI 10.1183/09031936.00195512; Stein JM, 2016, PEDIATR RADIOL, V46, P1804, DOI 10.1007/s00247-016-3686-8; Yoon HM, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140478; Yoon H, 2015, PEDIATR RADIOL, V45, P337, DOI 10.1007/s00247-014-3176-9	26	8	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214647	10.1371/journal.pone.0214647	http://dx.doi.org/10.1371/journal.pone.0214647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934017	gold, Green Published, Green Submitted			2022-12-27	WOS:000462867000030
J	Hinson, JM; Whitney, P; Wilson, CG; Nusbaum, AT				Hinson, John M.; Whitney, Paul; Wilson, Cristina G.; Nusbaum, Amy T.			Working memory loads differentially influence frame-induced bias and normative choice in risky decision making	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; DISCRETE EMOTIONS; RATIONALITY; PREFERENCES; JUDGMENT; SYSTEMS	Risky decision making can be biased by several types of contextual factors-in particular, framing of outcomes. A popular explanation for outcome framing effects is based on presumed affective reactions that contribute to accepting sure gains and avoiding sure losses. Other theories propose that selective weighting of information about gains and losses contributes to framing bias. Prior research on framing bias has focused on preferences rather than on decisions in which choices can be classified as advantageous (correct) or disadvantageous (incorrect) by a normative criterion. The current study used a novel hypothetical risky decision making task offering choices between a sure option and a gamble option. The gamble was advantageous or disadvantageous on different trials based on the normative criterion of expected value. Results showed risk avoidance with a gain frame and risk seeking with a loss frame, comparable to findings when choices involve preferences. We also examined the impact of working memory loads of either non-affective stimuli, most likely to interfere with acquisition of choice information, or affective stimuli, which might influence affective processes contributing to framing. The results were that non-affective working memory load produced the greatest framing magnitude, while affective load produced changes in framing magnitude across trials that varied by valence. In addition, only the non-affective load decreased advantageous choices and reduced the accuracy of answers to knowledge probe questions about the choices. The findings are consistent with the notion that framing effects may arise from cognitive non-engagement with the task, rather than arising by way of affective processes. Affective loads had a limited influence on framing and no reliable impact on choice accuracy or choice knowledge, suggesting that the affective loads influenced the weighting of choice information.	[Hinson, John M.; Whitney, Paul; Nusbaum, Amy T.] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA; [Wilson, Cristina G.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA	Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Hinson, JM (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	hinson@wsu.edu	Wilson, Cristina G/T-1476-2018; Wilson, Cristina/AAM-7735-2020	Wilson, Cristina G/0000-0002-9639-2752; Wilson, Cristina/0000-0002-9639-2752; Nusbaum, Amy/0000-0003-0576-0255; Hinson, John/0000-0001-9444-307X	National Institutes of Health [R21 CA-167691]; NIH [R21CA167691]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health, Grant R21 CA-167691, www.nih.gov.; Supported by NIH grant R21CA167691, John M. Hinson, Principal Investigator. We thank Peter Rosen for assistance in data collection.	Allen RJ, 2006, J EXP PSYCHOL GEN, V135, P298, DOI 10.1037/0096-3445.135.2.298; Angie AD, 2011, COGNITION EMOTION, V25, P1393, DOI 10.1080/02699931.2010.550751; Augustine AA, 2011, EMOTION, V11, P403, DOI 10.1037/a0021777; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Birnbaum MH, 2008, PSYCHOL REV, V115, P463, DOI 10.1037/0033-295X.115.2.463; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Cassotti M, 2012, EMOTION, V12, P926, DOI 10.1037/a0026788; Cuthbert B. N, 2005, A6 U FLOR; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; de Neys W, 2006, PSYCHOL SCI, V17, P428, DOI 10.1111/j.1467-9280.2006.01723.x; Gonzalez C, 2005, J ECON PSYCHOL, V26, P1, DOI 10.1016/j.joep.2004.08.004; Habib M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00253; Hinson JM, 2006, COGN AFFECT BEHAV NE, V6, P190, DOI 10.3758/CABN.6.3.190; Hinson JM, 2002, COGN AFFECT BEHAV NE, V2, P341, DOI 10.3758/CABN.2.4.341; Holper L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0365-17.2017; Howlett JR, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00088; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D, 2007, TRENDS COGN SCI, V11, P45, DOI 10.1016/j.tics.2006.11.007; Krajbich I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8455; Kuhberger A, 2002, ORGAN BEHAV HUM DEC, V89, P1162, DOI 10.1016/S0749-5978(02)00021-3; Kusev P, 2012, J NEUROSCI PSYCHOL E, V5, P250, DOI 10.1037/a0030289; Lench HC, 2011, PSYCHOL BULL, V137, P834, DOI 10.1037/a0024244; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Li R, 2017, J NEUROSCI, V37, P3588, DOI 10.1523/JNEUROSCI.3486-16.2017; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Matusiewicz AK, 2013, BEHAV PROCESS, V100, P116, DOI 10.1016/j.beproc.2013.07.019; Morgan MJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1562, DOI 10.1038/sj.npp.1300953; Paulus MP, 2012, TRENDS COGN SCI, V16, P476, DOI 10.1016/j.tics.2012.07.009; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whitney P, 2008, PSYCHON B REV, V15, P1179, DOI 10.3758/PBR.15.6.1179; Wiseman DB, 1996, ORGAN BEHAV HUM DEC, V66, P241, DOI 10.1006/obhd.1996.0053; Wright CI, 2002, NEUROREPORT, V13, P785, DOI 10.1097/00001756-200205070-00010	38	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214571	10.1371/journal.pone.0214571	http://dx.doi.org/10.1371/journal.pone.0214571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921395	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000087
J	Isberg, HK; Hedin, K; Melander, E; Molstad, S; Beckman, A				Isberg, Helena Kornfalt; Hedin, Katarina; Melander, Eva; Molstad, Sigvard; Beckman, Anders			Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: A retrospective study	PLOS ONE			English	Article							RECOMMENDATIONS	Background Urinary tract infection (UTI) is common in primary care and leads to a high number of antibiotic prescriptions. Antimicrobial resistance is a global health problem; better antimicrobial prescribing is one way to limit antimicrobial resistance. We aimed to describe the number of consultations for patients diagnosed with lower urinary tract infection (LUTI) and pyelonephritis and changes in prescribing of antibiotics to men and women with LUTI and pyelonephritis in Swedish PHC between the years 2008 and 2013. Methods We performed a descriptive study of changes in UTI diagnosis and antibiotic prescribing in UTI for the years 2008, 2010 and 2013. The Primary Care Record of Infections in Sweden, a database regarding diagnosis linked antibiotic prescribing in primary care, was analyzed concerning data for men and women of all ages regarding UTI visits and antibiotic prescribing. The results were analyzed in relation to current national guidelines. Results There was a variability in consultation incidence for LUTI with an increase between 2008 and 2010 and a decrease between 2010 and 2013, resulting in a slight rise in consultation incidence between 2008 and 2013. The use of recommended nitrofurantoin or pivmecillinam in LUTI in women increased from 54% in 2008 to 69% in 2013. Fluoroquinolones or trimethoprim were prescribed in 24% of LUTI cases in women in 2008 and in 7% of cases in 2013. Prescriptions of pivmecillinam or nitrofurantoin in male LUTI cases increased from 13% in 2008 to 31% in 2013. Fluoroquinolones or trimethoprim were prescribed in 54% of male LUTI cases in 2008 and 32% in 2013. Conclusions Swedish GPs seem to follow national guidelines in the treatment of LUTI in women. In male LUTI cases, the prescriptions of fluoroquinolones remain high and further research is needed to follow prescription patterns and enhance more prudent prescribing to this group of patients.	[Isberg, Helena Kornfalt; Hedin, Katarina; Molstad, Sigvard; Beckman, Anders] Lund Univ, Dept Clin Sci, Family Med, Malmo, Sweden; [Hedin, Katarina] Futurum, Reg Jonkoping County, Jonkoping, Sweden; [Hedin, Katarina] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Melander, Eva] Reg Ctr Communicable Dis Control, Malmo, Sweden; [Melander, Eva] Lund Univ, Dept Translat Med, Malmo, Sweden	Lund University; Futurum; Linkoping University; Lund University	Isberg, HK (corresponding author), Lund Univ, Dept Clin Sci, Family Med, Malmo, Sweden.	Helena.Isberg@med.lu.se		Beckman, Anders/0000-0002-1676-8183				Andre M, 2004, SCAND J INFECT DIS, V36, P134, DOI 10.1080/00365540410019075; Andre Malin, 2008, Lakartidningen, V105, P1107; [Anonymous], 2010, SWEDR 2010 REP SWED; Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; Dolk FCK, 2018, J ANTIMICROB CHEMOTH, V73, P2, DOI 10.1093/jac/dkx504; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Haslund JM, 2013, SCAND J PRIM HEALTH, V31, P235, DOI 10.3109/02813432.2013.844410; Hawker JI, 2014, J ANTIMICROB CHEMOTH, V69, P3423, DOI 10.1093/jac/dku291; Hummers-Pradier E, 2004, INT J CLIN PHARM TH, V42, P360; Levi Ragnar, 2010, Lakartidningen, V107, P3134; Medical Products Agency-Sweden, 2007, LOW UR TRACT INF UTI; Molstad S, 2008, EUROSURVEILLANCE, P13; Molstad S, 2017, B WORLD HEALTH ORGAN, V95, P764, DOI 10.2471/BLT.16.184374; Nord Maria, 2013, Lakartidningen, V110, P1282; Osterlund A, 2008, LAKARTIDNINGEN, P210; Public Health Agency of Sweden and National Veterinary Institute, 2013, US ANT OCC ANT RES S; Public Health Agency of Sweden National Veterinary Institute, 2015, CONS ANT OCC ANT RES; Public Health Agency of Sweden PRIS, PRIM REG INF SVER; Strama, STRAMAS GOALS US ANT; Tyrstrup M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2018-9; van den Broek d'Obrenan J, 2014, J ANTIMICROB CHEMOTH, V69, P1701, DOI 10.1093/jac/dku005	22	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214572	10.1371/journal.pone.0214572	http://dx.doi.org/10.1371/journal.pone.0214572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921411	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000088
J	Jo, S; Jeong, T; Lee, JB; Jin, Y; Yoon, J; Park, B				Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol; Park, Boyoung			Incidence of acute cerebral infarction or space occupying lesion among patients with isolated dizziness and the role of D-dimer	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; EMERGENCY-DEPARTMENT; DIAGNOSTIC-ACCURACY; PULMONARY-EMBOLISM; ISOLATED VERTIGO; STROKE; MANAGEMENT; RULE	Background To determine the incidence of acute cerebral infarction or space occupying lesion (SOL) among patients with isolated vertigo or dizziness (IVD) and to evaluate the role of cerebellar function test (CFT) and D-dimer to discriminate ACI/SOL and non-ACI/SOL. Methods A retrospective study of consecutive emergency department (ED) patients with IVD during one year was conducted. ACI was based on the diffusion-weighted magnetic resonance imaging (DW-MRI), and SOL was based on the concurrent MRI sequences. A sensitivity analysis of CFT and D-dimer was also performed. Results Among the 468 patients enrolled, 13 patients (2.8%) had ACI, 11 at cerebellum, 1 at occipital lobe, and 1 at centrum semiovale. Twenty-five patients (5.3%) had SOL. Aneurysm is most frequent (n = 7), followed by meningioma (n = 4) and venous anomaly (n = 4). In total, ACI/ SOL was found in 8.1% (n = 38). Abnormal findings in finger-to-nose (FN), heel-to-shin (HTS), and rapid alternative movement (RAM) tests were significantly higher in ACI or ACl/ SOL group, while gait disturbance, tandem gait abnormality, and Romberg's test were not. CFT sensitivities were low for ACI as well as for ACI/SOL, but specificities were high for ACI and ACI/SOL. D-dimer level showed a sensitivity of 100% at >0.18 mg/L for ACI and >0.15 mg/L for ACI/SOL. However, specificity was low at corresponding D-dimer level. Among the subgroup (n = 411) who did not show any abnormality in CFT, 9 patients (2.2%) had ACI, and 33 patients (8.0%) had ACI/SOL. Conclusion The present study reports a clinically significant incidence of ACI/SOL among ED patients with IVD. D-dimer showed high sensitive and low specificity, while CFT showed low sensitivity and high specificity.	[Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol] Chonbuk Natl Univ, Res Inst Clin Med, Dept Emergency Med, Jeonju Si, South Korea; [Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju Si, South Korea; [Park, Boyoung] Hanyang Univ, Dept Med, Coll Med, Seoul, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University Hospital; Hanyang University	Jeong, T (corresponding author), Chonbuk Natl Univ, Res Inst Clin Med, Dept Emergency Med, Jeonju Si, South Korea.; Jeong, T (corresponding author), Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju Si, South Korea.	emmd@jbnu.ac.kr			Biomecial Research Institute, Chonbuk National University Hospital [CUH 2018-08-022]	Biomecial Research Institute, Chonbuk National University Hospital	This research was funded by the Biomecial Research Institute, Chonbuk National University Hospital (CUH 2018-08-022 to TJ). The funder play no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was supported by Fund of Biomedical Research Institute, Chonbuk National University Hospital.	[Anonymous], 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19440; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Doijiri R, 2016, J STROKE CEREBROVASC, V25, P2549, DOI 10.1016/j.jstrokecerebrovasdis.2016.06.038; Valls MJF, 2015, THROMB HAEMOSTASIS, V113, P406, DOI 10.1160/TH14-06-0488; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Hoo GWS, 2018, J AM COLL RADIOL, V15, P1673, DOI 10.1016/j.jacr.2018.04.031; Kerber KA, 2006, STROKE, V37, P2484, DOI 10.1161/01.STR.0000240329.48263.0d; Khatri P, 2010, STROKE, V41, P2581, DOI 10.1161/STROKEAHA.110.593632; Lavallee P, 2014, FRONT NEUROL NEUROSC, V33, P30, DOI 10.1159/000351890; Lee H, 2006, NEUROLOGY, V67, P1178, DOI 10.1212/01.wnl.0000238500.02302.b4; Lee H, 2014, J STROKE, V16, P124, DOI 10.5853/jos.2014.16.3.124; Luengo-Fernandez R, 2009, LANCET NEUROL, V8, P235, DOI 10.1016/S1474-4422(09)70019-5; Perloff MD, 2017, AM J EMERG MED, V35, P1724, DOI 10.1016/j.ajem.2017.06.034; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Ross MA, 2007, ANN EMERG MED, V50, P109, DOI 10.1016/j.annemergmed.2007.03.008; Sanchis J, 2014, HEART, V100, P1591, DOI 10.1136/heartjnl-2013-305440; Savitz SI, 2007, ACAD EMERG MED, V14, P63, DOI 10.1197/j.aem.2006.06.060; Schappert Susan M, 2006, Vital Health Stat 13, P1; Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3; Stead LG, 2009, NEUROCRIT CARE, V10, P204, DOI 10.1007/s12028-008-9146-z	21	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214661	10.1371/journal.pone.0214661	http://dx.doi.org/10.1371/journal.pone.0214661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921431	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000105
J	Restrepo, C; Gutierrez-Rivas, M; Pacheco, YM; Garcia, M; Blanco, J; Medrano, LM; Navarrete-Munoz, MA; Gutierrez, F; Miralles, P; Dalmau, D; Gomez, JL; Gorgolas, M; Cabello, A; Resino, S; Benito, JM; Rallon, N; Munoz-Fernandez, MA				Restrepo, Clara; Gutierrez-Rivas, Monica; Pacheco, Yolanda M.; Garcia, Marcial; Blanco, Julia; Medrano, Luz M.; Navarrete-Munoz, Maria A.; Gutierrez, Felix; Miralles, Pilar; Dalmau, David; Luis Gomez, Juan; Gorgolas, Miguel; Cabello, Alfonso; Resino, Salvador; Benito, Jose M.; Rallon, Norma; Munoz-Fernandez, M. A.		Spanish AIDS Res Network Project	Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; T-CELL RECOVERY; DISEASE PROGRESSION; COUNT RECOVERY; POLYMORPHISMS; VIRUS; GENOTYPE; HAART; EXPRESSION	Objective We investigated the association of genetic polymorphisms in chemokine and chemokine receptor genes with poor immunological recovery in HIV patients starting combined antiretroviral therapy (cART) with low CD4 T-cell counts. Methods A case-control study was conducted in 412 HIV-infected patients starting cART with CD4 T-cell count <200 cells/mu L and successful viral control for two years. CD4 count increase below 200 cells/mu L after two years on cART was used to define INR (immunological nonresponder) patients. Polymorphisms in CXCL12, CCL5 and CCR2 genes were genotyped using sequenom's MassARRAY platform. Results Thirty two percent (134/412) of patients were classified as INR. After adjusting by age, route of HIV infection, length of infection before cART and viral hepatitis coinfection, CCR2 rs1799864-AG genotype was significantly associated with INR status (OR [95% CI]: 1.80 [1.04-3.11]; p = 0.04), and CXCL1 2 rs1801157-TT genotype showed a trend (OR [95% CI]: 2.47 [0.96-6.35]; p = 0.06). Conclusions CCR2 rs1799864-AG or CXCL12 rs1801157-TT genotypes influence on the probability of poor CD4 recovery in the population of HIV patients starting cART with low CD4 counts. Genotyping of these polymorphisms could be used to estimate the risk of poor CD4 restoration, mainly in patients who are diagnosed late in the course of infection.	[Restrepo, Clara; Garcia, Marcial; Navarrete-Munoz, Maria A.; Benito, Jose M.; Rallon, Norma] UAM, FJD, IIS, HIV & Viral Hepatitis Res Lab, Madrid, Spain; [Restrepo, Clara; Garcia, Marcial; Navarrete-Munoz, Maria A.; Benito, Jose M.; Rallon, Norma] Hosp Univ Rey Juan Carlos, Mostoles, Madrid, Spain; [Gutierrez-Rivas, Monica; Medrano, Luz M.; Resino, Salvador] Inst Salud Carlos III, Madrid, Spain; [Pacheco, Yolanda M.] Hosp Univ Virgen del Rocio, UGC Clin Labs, Inst Biomed Sevilla IBiS, Immunol Lab, Seville, Spain; [Blanco, Julia] IrsiCaixa AIDS Res Inst, Badalona, Spain; [Gutierrez, Felix] Hosp Gen Univ Elche, Alicante, Spain; [Gutierrez, Felix] Univ Miguel Hernandez, Alicante, Spain; [Miralles, Pilar] Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Dalmau, David] Hosp Univ Mutua Terrasa, Terrassa, Spain; [Luis Gomez, Juan] Hosp Univ Canarias, Santa Cruz De Tenerife, Spain; [Gorgolas, Miguel; Cabello, Alfonso] Fdn Jimenez Diaz, Univ Hosp, Madrid, Spain; [Munoz-Fernandez, M. A.] Hosp Gen Univ Gregorio Maranon, Lab Mol Immunobiol, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Institut de Recerca de la Sida - IrsiCaixa; Universidad Miguel Hernandez de Elche; General University Gregorio Maranon Hospital; Hospital Universitario Mutua Terrassa; Universidad de la Laguna; Fundacion Jimenez Diaz; General University Gregorio Maranon Hospital	Benito, JM (corresponding author), UAM, FJD, IIS, HIV & Viral Hepatitis Res Lab, Madrid, Spain.; Benito, JM (corresponding author), Hosp Univ Rey Juan Carlos, Mostoles, Madrid, Spain.; Resino, S (corresponding author), Inst Salud Carlos III, Madrid, Spain.	mmunoz.hgugm@gmail.com; Sresino@isciii.es; jbenito1@hotmail.com	Rivas, Mónica Gutiérrez/G-9713-2016; Pacheco, Yolanda M/C-8457-2015; Fernández-González, Marta/U-7492-2017; Resino, Salvador/B-2430-2008; Cabello, Alfonso/ABH-3203-2021; Benito, Jose/AAC-4554-2020; Blanco, Julià/A-5347-2008; Rodero, Félix Gutiérrez/Q-7880-2018; de dios, luz maria medrano/K-1946-2016	Rivas, Mónica Gutiérrez/0000-0001-9752-7498; Pacheco, Yolanda M/0000-0002-9451-8083; Fernández-González, Marta/0000-0001-9949-8504; Resino, Salvador/0000-0001-8783-0450; Blanco, Julià/0000-0002-2225-0217; Rodero, Félix Gutiérrez/0000-0002-9485-6867; de dios, luz maria medrano/0000-0003-3717-5384; Garcia, Marcial/0000-0001-7462-1836; Benito, Jose/0000-0002-7172-049X; GARCIA GOMEZ, JOSE ALBERTO/0000-0002-1203-7260; Cabello-Ubeda, Alfonso/0000-0001-8429-8358; Rallon, Norma/0000-0002-4643-247X	Spanish AIDS Research Network as part of the Health Research and Development Strategy, State Plan for Scientific and Technical Research and Innovation [RD12/0017/0031, RD16/0025/0013, RD16CIII/0002/0002, PI14CIII/00011]; Institute of Health Carlos III, ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF); IISCIII [CD14/00002, PI08/893, PI13/02256, PI16/01740]; FISABIO [UGP-14-197, UGP-15232, RD16/0025/0038]; ISCIII, Madrid, Spain [CP14/00198]; IIS-FJD	Spanish AIDS Research Network as part of the Health Research and Development Strategy, State Plan for Scientific and Technical Research and Innovation; Institute of Health Carlos III, ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF)(European Commission); IISCIII; FISABIO; ISCIII, Madrid, Spain(Instituto de Salud Carlos III); IIS-FJD	This work has been (partially) funded by the Spanish AIDS Research Network RD12/0017/0031, RD16/0025/0013, RD16CIII/0002/0002, and PI14CIII/00011 projects as part of the Health Research and Development Strategy, State Plan for Scientific and Technical Research and Innovation (2008-2011, 2013-2016) and co-financed by Institute of Health Carlos III, ISCIII-Sub-Directorate General for Research Assessment and Promotion and European Regional Development Fund (ERDF). M Gutierrez-Rivas is funded by project RD16CIII/0002/0002. LM Medrano is supported by IISCIII, grant CD14/00002. F. Gutierrez is supported by ISCIII, grants PI08/893, PI13/02256 and PI16/01740; FISABIO, grants UGP-14-197 and UGP-15232, and RD16/0025/0038. N Rallon is a Miguel Servet investigator from the ISCIII (grant CP14/00198), Madrid, Spain. MA Navarrete-Munoz is co-funded by RD16/0025/0013 project and Intramural Research Scholarship from IIS-FJD. M Garcia is co-funded by CP14/00198 project and Intramural Research Scholarship from IIS-FJD. C Restrepo was funded by project RD12/0017/0031 and currently is funded by project RD16/0025/0013.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; An P, 2002, P NATL ACAD SCI USA, V99, P10002, DOI 10.1073/pnas.142313799; Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650; Caro-Murillo AM, 2007, ENFERM INFEC MICR CL, V25, P23, DOI 10.1157/13096749; Chan DPC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010998; Daar ES, 2005, J INFECT DIS, V192, P1597, DOI 10.1086/496893; de Oliveira KB, 2013, CLIN EXP MED, V13, P211, DOI 10.1007/s10238-012-0194-5; Fernandez S, 2006, JAIDS-J ACQ IMM DEF, V41, P1, DOI 10.1097/01.qai.0000188990.57760.e3; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Guzman-Fulgencio M, 2015, EUR J CLIN INVEST, V45, P1192, DOI 10.1111/eci.12539; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Lee B, 1998, J VIROL, V72, P7450, DOI 10.1128/JVI.72.9.7450-7458.1998; Li TS, 2011, CLIN INFECT DIS, V53, P944, DOI 10.1093/cid/cir552; Mahajan SD, 2010, BIOCHEM BIOPH RES CO, V396, P348, DOI 10.1016/j.bbrc.2010.04.095; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Passam AM, 2005, J CLIN VIROL, V34, P302, DOI 10.1016/j.jcv.2004.05.021; Philpott S, 2004, CLIN INFECT DIS, V39, P861, DOI 10.1086/423386; Puissant B, 2006, AIDS RES HUM RETROV, V22, P153, DOI 10.1089/aid.2006.22.153; Rigato PO, 2008, CURR HIV RES, V6, P466, DOI 10.2174/157016208785861131; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sobrino-Vegas P, 2011, ENFERM INFEC MICR CL, V29, P645, DOI 10.1016/j.eimc.2011.06.002; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Soria A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027349; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Zoufaly A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087160	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214421	10.1371/journal.pone.0214421	http://dx.doi.org/10.1371/journal.pone.0214421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921390	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000067
J	Thilakarathne, DS; Coppo, MJC; Hartley, CA; Diaz-Mendez, A; Quinteros, JA; Fakhri, O; Vaz, PK; Devlin, JM				Thilakarathne, Dulari S.; Coppo, Mauricio J. C.; Hartley, Carol A.; Diaz-Mendez, Andres; Quinteros, Jose A.; Fakhri, Omid; Vaz, Paola K.; Devlin, Joanne M.			Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; IN-VIVO; GLYCOPROTEIN-G; VIRAL REPLICATION; TYPE-1 MUTANT; STRAINS; VIRULENCE; EFFICACY; DELETION; VITRO	Infectious laryngotracheitis (ILT) is a respiratory disease that affects chickens. It is caused by the alphaherpesvirus, infectious laryngotracheitis virus (ILTV). This virus undergoes lytic replication in the epithelial cells of the trachea and upper respiratory tract (URT) and establishes latent infection in the trigeminal ganglia (TG) and trachea. Live attenuated vaccines are widely used to control ILT. At least one of these vaccines can establish latent infections in chickens, but this has not been demonstrated for all vaccines. The aim of the current study was to determine the capacity of three commercially available vaccines (SA2, A20 and Serva) and a glycoprotein G deletion mutant vaccine candidate (Delta gG ILTV) to establish latent infection in the TG of specific pathogen free (SPF) chickens. Five groups of 7-day-old SPF chickens were eye-drop vaccinated with either one of the vaccine strains or mock-vaccinated with sterile media and followed until 20 or 21 days post-vaccination (dpv). ILTV DNA was detected at 20-21 dpv in the TG of 23/40 (57.5%) vaccinated SPF chickens (SA2 = 10/10; A20 = 6/10; Serva = 3/10; Delta gG = 4/10) by PCR, but virus could not be reactivated from TG co-cultivated with primary chicken embryo kidney cells. In the birds from which ILTV DNA was detected in the TG, ILTV DNA could not be detected in the URT or trachea of 3 birds in each of the SA2, A20 and Serva vaccinated groups, and in 4 birds in the Delta gG vaccinated group, indicating that these birds were latently infected in the absence of active lytic replication and virus shedding. Results from this study demonstrate the capacity of commercial ILTV vaccines to establish latent infections and underline their importance in the epidemiology of this disease.	[Thilakarathne, Dulari S.; Coppo, Mauricio J. C.; Hartley, Carol A.; Diaz-Mendez, Andres; Quinteros, Jose A.; Fakhri, Omid; Vaz, Paola K.; Devlin, Joanne M.] Univ Melbourne, Melbourne Vet Sch, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia	University of Melbourne	Thilakarathne, DS (corresponding author), Univ Melbourne, Melbourne Vet Sch, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia.	dthilakarath@student.unimelb.edu.au	Fakhri, Omid/Z-4995-2019; Vaz, Paola K./D-8713-2015; Quinteros, Jose Antonio/Q-2482-2016	Fakhri, Omid/0000-0002-2448-8501; Vaz, Paola K./0000-0001-6877-7383; Coppo, Mauricio/0000-0002-4344-9532; Hartley, Carol/0000-0001-6174-7341; Diaz-Mendez, Andres/0000-0003-3004-8518; Quinteros, Jose Antonio/0000-0002-3194-9783; Devlin, Joanne/0000-0003-0400-9670	Australian Research Council [DP140100480, FT140101287]	Australian Research Council(Australian Research Council)	The work was funded by the Australian Research Council through grant DP140100480 awarded to CAH and JMD and through grant FT140101287 awarded to JMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew-Crumpton R, 2016, INFECT GENET EVOL, V43, P67, DOI 10.1016/j.meegid.2016.05.023; ALLS AA, 1969, AVIAN DIS, V13, P36, DOI 10.2307/1588412; ANDREASEN JR, 1989, AVIAN DIS, V33, P524, DOI 10.2307/1591116; BAGUST TJ, 1995, AVIAN PATHOL, V24, P373, DOI 10.1080/03079459508419079; BAGUST TJ, 1986, AVIAN PATHOL, V15, P581, DOI 10.1080/03079458608436317; Chacon JLV, 2007, BRAZ J POULTRY SCI, V9, P61, DOI 10.1590/S1516-635X2007000100009; Chacon JL, 2008, J VIROL METHODS, V151, P188, DOI 10.1016/j.jviromet.2008.05.012; Chacon JL, 2015, TROP ANIM HEALTH PRO, V47, P1101, DOI 10.1007/s11250-015-0834-3; Chin RP, 2009, AVIAN DIS, V53, P574, DOI 10.1637/8873-041309-Reg.1; CLEMENTS GB, 1989, J GEN VIROL, V70, P2501, DOI 10.1099/0022-1317-70-9-2501; COEN DM, 1989, P NATL ACAD SCI USA, V86, P4736, DOI 10.1073/pnas.86.12.4736; Coppo MJC, 2012, AVIAN PATHOL, V41, P99, DOI 10.1080/03079457.2011.643222; Coppo MJC, 2011, AVIAN PATHOL, V40, P411, DOI 10.1080/03079457.2011.588686; Davison S, 2006, AVIAN DIS, V50, P50, DOI 10.1637/7398-062105R.1; Devlin JM, 2008, AVIAN PATHOL, V37, P83, DOI 10.1080/03079450701802214; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2007, VACCINE, V25, P3561, DOI 10.1016/j.vaccine.2007.01.080; DOBSON AT, 1990, NEURON, V5, P353, DOI 10.1016/0896-6273(90)90171-B; Fuchs W, 2005, J VIROL, V79, P705, DOI 10.1128/JVI.79.2.705-716.2005; Garcia M, 2013, VIROLOGY, V440, P64, DOI 10.1016/j.virol.2013.02.007; GELENCZEI EF, 1965, AVIAN DIS, V9, P44, DOI 10.2307/1587792; GELENCZEI EF, 1964, AVIAN DIS, V8, P105, DOI 10.2307/1587827; GUY JS, 1991, AVIAN DIS, V35, P348, DOI 10.2307/1591188; Han MG, 2003, AVIAN DIS, V47, P261, DOI 10.1637/0005-2086(2003)047[0261:EOLVVA]2.0.CO;2; Helferich D, 2007, J GEN VIROL, V88, P732, DOI 10.1099/vir.0.82533-0; HUGHES CS, 1991, ARCH VIROL, V121, P213, DOI 10.1007/BF01316755; Johnson DI, 2010, AVIAN DIS, V54, P1251, DOI 10.1637/9401-052310-Reg.1; KATZ JP, 1990, J VIROL, V64, P4288, DOI 10.1128/JVI.64.9.4288-4295.1990; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkpatrick NC, 2006, AVIAN PATHOL, V35, P449, DOI 10.1080/03079450601028803; KOSZVNENCHAK M, 1990, J VIROL, V64, P5396, DOI 10.1128/JVI.64.11.5396-5402.1990; KRAMER MF, 1995, J VIROL, V69, P1389, DOI 10.1128/JVI.69.3.1389-1399.1995; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120282; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; LEIB DA, 1989, J VIROL, V63, P2893, DOI 10.1128/JVI.63.7.2893-2900.1989; LEIST TP, 1989, J VIROL, V63, P4976, DOI 10.1128/JVI.63.11.4976-4978.1989; LUKERT PD, 1965, AVIAN DIS, V9, P308, DOI 10.2307/1588016; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; MEHTA A, 1995, VIROLOGY, V206, P633, DOI 10.1016/S0042-6822(95)80080-8; MEIGNIER B, 1988, VIROLOGY, V162, P251, DOI 10.1016/0042-6822(88)90417-5; Mostafa HH, 2011, J VIROL, V85, P12631, DOI 10.1128/JVI.05661-11; Nicoll MP, 2012, FEMS MICROBIOL REV, V36, P684, DOI 10.1111/j.1574-6976.2011.00320.x; Oldoni I, 2009, AVIAN PATHOL, V38, P47, DOI 10.1080/03079450802632031; Parra SHS, 2015, BRAZ J POULTRY SCI, V17, P117, DOI 10.1590/1516-635x1701117-120; Pavlova SP, 2010, J GEN VIROL, V91, P847, DOI 10.1099/vir.0.016634-0; RAGGI LG, 1961, POULTRY SCI, V40, P134, DOI 10.3382/ps.0400134; Rodriguez-Avila A, 2007, AVIAN DIS, V51, P905, DOI 10.1637/8011-041907-REGR.1; SAWTELL NM, 1992, J VIROL, V66, P2150, DOI 10.1128/JVI.66.4.2150-2156.1992; SCHNITZLEIN WM, 1995, VIROLOGY, V209, P304, DOI 10.1006/viro.1995.1262; SPECK PG, 1991, J VIROL, V65, P4001, DOI 10.1128/JVI.65.8.4001-4005.1991; STEINER I, 1990, J VIROL, V64, P1630, DOI 10.1128/JVI.64.4.1630-1638.1990; TENSER RB, 1989, J VIROL, V63, P2861, DOI 10.1128/JVI.63.6.2861-2865.1989; Thellman NM, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030028; Vagnozzi A, 2015, AVIAN DIS, V59, P394, DOI 10.1637/11075-033115-Reg.1; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Veits J, 2003, J GEN VIROL, V84, P3343, DOI 10.1099/vir.0.19570-0; Waidner LA, 2011, VIROLOGY, V411, P25, DOI 10.1016/j.virol.2010.12.023; Waidner LA, 2009, VIROLOGY, V388, P128, DOI 10.1016/j.virol.2009.02.043; WILLIAMS RA, 1992, J GEN VIROL, V73, P2415, DOI 10.1099/0022-1317-73-9-2415	60	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213866	10.1371/journal.pone.0213866	http://dx.doi.org/10.1371/journal.pone.0213866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921344	Green Published, gold			2022-12-27	WOS:000462594000026
J	Waye, KP; Fredriksson, S; Hussain-Alkhateeb, L; Gustafsson, J; van Kamp, I				Waye, Kerstin Persson; Fredriksson, Sofie; Hussain-Alkhateeb, Laith; Gustafsson, Johanna; van Kamp, Irene			Preschool teachers' perspective on how high noise levels at preschool affect children's behavior	PLOS ONE			English	Article								Early-age exposure to noise may have long-term health implications of which we have little knowledge of today. Age-specific hearing, learning inadequate coping strategies, and alterations in biological stress regulatory responses could play a role in the long-term health impacts. In Sweden about half a million children in the age between 1-5 years attend preschool. The noise exposure at preschools is intermittent and unpredictable and levels reach up to 84 dB LAeq (time indoors) with maximum levels of 118 dB LA(F), mostly due to child activity. To increase the overall understanding of the possible implications of preschool noise environments for children, this paper describes children's behavioral and emotional reactions to and coping with their everyday sound environment from a teachers perspective. A postal questionnaire study performed in 2013-2014 with answers from 3,986 preschool teachers provided the data. Content analysis was combined with quantitative analysis. Eighty-two percent of the personnel considered that children's behavior was affected rather or very much by preschool noise. The most prevalent behaviors were categorized into: be heard, be distracted, show negative internal emotions, crowd, avoid, withdraw, be exhausted, and learning. The quantitative analyses confirmed an association between the perceived loudness and noise annoyance at preschool and affirmative reporting on noise affecting the children's behavior. Age of the personnel, with the youngest age group reporting noise related behavior less often, and age distribution of the class, with 1-5 years old seeming less affected by noise, were also indicated, while pedagogic orientation was not a significant factor. Future studies should address the long-term health effects of these behaviors.	[Waye, Kerstin Persson; Fredriksson, Sofie; Hussain-Alkhateeb, Laith] Univ Gothenburg, Sahlgrenska Acad, Occupat & Environm Med, Publ Hlth & Community Med, Gothenburg, Sweden; [Waye, Kerstin Persson; Gustafsson, Johanna] Orebro Univ, Sch Hlth Sci, SIDR, Orebro, Sweden; [van Kamp, Irene] Natl Inst Publ Hlth & Environm RIVM, Ctr Sustainabil Environm & Hlth, Bilthoven, Netherlands	University of Gothenburg; Orebro University; Netherlands National Institute for Public Health & the Environment	Waye, KP (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Occupat & Environm Med, Publ Hlth & Community Med, Gothenburg, Sweden.; Waye, KP (corresponding author), Orebro Univ, Sch Hlth Sci, SIDR, Orebro, Sweden.	kerstin.persson.waye@amm.gu.se	Gustafsson, Johanna/X-7241-2019; Hussain-Alkhateeb, Laith/K-3485-2013	Gustafsson, Johanna/0000-0003-3023-3422; Fredriksson, Sofie/0000-0003-0698-527X; Hussain-Alkhateeb, Laith/0000-0001-9607-110X	Swedish Research Council for Health, Working Life and Welfare [2016-07193]; Swedish Hearing Research Foundation [2016-528]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Hearing Research Foundation	This work was supported by the Swedish Research Council for Health, Working Life and Welfare https://forte.se/en/[Grant nr 2016-07193]; and the Swedish Hearing Research Foundation https://hrf.se/[2016-528]. The grants were received by Kerstin Persson Waye. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bistrup M L, 2003, Noise Health, V5, P59; Bistrup ML, 2006, ACTA PAEDIATR, V95, P31, DOI 10.1080/08035250600885951; Creed K, 2014, THESIS; Dellve L, 2013, QUAL RES PSYCHOL, V10, P1, DOI 10.1080/14780887.2011.586099; Evans G.W., 2007, NOISE ITS EFFECTS; Evans GW, 2006, ANNU REV PSYCHOL, V57, P423, DOI 10.1146/annurev.psych.57.102904.190057; Fels J., 2008, THESIS; Fredriksson S, 2017, 12 ICBEN C NOIS PUBL; Fredriksson S, 2018, THESIS; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Job R.F. Soames, 1999, Noise Health, V1, P57; Kihlbom M, 2009, PRESCHOOL YOUNGEST G; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; Krippendorff K. H., 2013, CONTENT ANAL INTRO I; Kristiansen J, 2014, INT ARCH OCC ENV HEA, V87, P851, DOI 10.1007/s00420-014-0927-8; Official Report of the Swedish Government, 1972, 197226 SOU OFF RE 1; Official Report of the Swedish Government, 1972, 197227 SOU OFF REP 2; Persson Waye K., 2011, 20113 GOTH U SAHLGR, P3; Stansfeld SA, 2009, J ENVIRON PSYCHOL, V29, P203, DOI 10.1016/j.jenvp.2009.01.002; Swedish National Agency for Education, 2014, 201400036 DNR SWED N; Swedish Work Environment Authority, 200516 AFS SWED WORK; Wadsworth ME, 2015, CHILD DEV PERSPECT, V9, P96, DOI 10.1111/cdep.12112; Waye KP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002408; Williams P, 2019, SCAND J EDUC RES, V63, P696, DOI 10.1080/00313831.2018.1434823	24	7	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214464	10.1371/journal.pone.0214464	http://dx.doi.org/10.1371/journal.pone.0214464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921409	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000072
J	Wu, Y; Fraser, C; Gilbert, R; Mok, Q				Wu, Yue; Fraser, Caroline; Gilbert, Ruth; Mok, Quen			Effect of impregnated central venous catheters on thrombosis in paediatric intensive care: Post-hoc analyses of the CATCH trial	PLOS ONE			English	Article							RISK-FACTORS; CHILDREN; THROMBOEMBOLISM; DIAGNOSIS	Purpose The CATheter infections in CHildren (CATCH) trial reported reduced risks of bloodstream infection with antibiotic impregnated compared with heparin-bonded or standard central venous catheters (CVC) in paediatric intensive care. CVC impregnation did not increase the risk of thrombosis which was recorded in 24% of participants. This post-hoc analysis determines the effect of CVC impregnation on the risk of thrombosis leading to CVC removal or swollen limb. Methods We analysed patients in the CATCH trial, blind to CVC allocation, to define clinically relevant thrombosis based on the clinical sign most frequently recorded in patients where the CVC was removed because of concerns regarding thrombosis. In post-hoc, three-way comparisons of antibiotic, heparin and standard CVCs, we determined the effect of CVC type on time to clinically relevant thrombosis, using Cox proportional hazards regression. Results Of 1409 participants with a successful CVC insertion, the sign most frequently resulting in CVC removal was swollen limb (37.6%; 41/109), with lower rates of removal of CVC following 2 episodes of difficulty withdrawing blood or of flushing to unblock the CVC. In intention to treat analyses (n = 1485), clinically relevant thrombosis, defined by 1 or more record of swollen limb or CVC removal due to concerns about thrombosis, was recorded in 11.9% (58/486) of antibiotic CVCs, 12.1% (60/497) of heparin CVCs, and 10.2% (51/502) of standard CVCs. We found no differences in time to clinically relevant thrombosis according to type of CVC. Conclusions We found no evidence for an increased risk of clinically relevant thrombosis in antibiotic impregnated compared to heparin-bonded or standard CVCs in children receiving intensive care.	[Wu, Yue] Univ Cambridge, Sch Clin Med, Cambridge, England; [Fraser, Caroline; Gilbert, Ruth] UCL, Populat Policy & Practice Programme, NIHR Biomed Res Ctr, Great Ormond St Inst Child Hlth, London, England; [Mok, Quen] Great Ormond St Hosp Sick Children, Paediat Intens Care Unit, London, England	University of Cambridge; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Mok, Q (corresponding author), Great Ormond St Hosp Sick Children, Paediat Intens Care Unit, London, England.	Quen.Mok@gosh.nhs.uk	Mok, Quen/AAA-2648-2019	Mok, Quen/0000-0003-4807-9275; Gilbert, Ruth/0000-0001-9347-2709	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme [08/13/47]; Health Data Research UK; NIHR Great Ormond Street Hospital Biomedical Research Centre	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme(National Institute for Health Research (NIHR)); Health Data Research UK; NIHR Great Ormond Street Hospital Biomedical Research Centre	This work was supported by funding for the CATCH trial from the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number 08/13/47). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. RG receives funding from Health Data Research UK.; The authors would like to acknowledge Carrol Gamble, Michaela Brown and Tracy Moitt at the MCRN Clinical Trials Unit, the children and parents who participated in the trial, as well as the investigators and research nurses at each of the study sites for their contribution to the CATCH trial ISRCTN34884569 http://www.catchtrial.org.uk/index.html. Research at UCL Great Ormond Street Institute of Child Health is supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre.	Baskin JL, 2009, LANCET, V374, P159, DOI 10.1016/S0140-6736(09)60220-8; Gilbert RE, 2016, LANCET, V387, P1732, DOI 10.1016/S0140-6736(16)00340-8; Gray BW, 2012, J PEDIATR SURG, V47, P1159, DOI 10.1016/j.jpedsurg.2012.03.043; Hanslik A, 2008, PEDIATRICS, V122, P1284, DOI 10.1542/peds.2007-3852; Harron K, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20180; Higgerson RA, 2011, PEDIATR CRIT CARE ME, V12, P628, DOI 10.1097/PCC.0b013e318207124a; Jaffray J, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00005; Kerlin BA, 2015, PEDIATR RES, V77, P463, DOI 10.1038/pr.2014.198; Lai NM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007878.pub3; Male C, 2005, THROMB HAEMOSTASIS, V94, P516, DOI 10.1160/TH03-02-0091; Male C, 2003, SEMIN THROMB HEMOST, V29, P377; Massicotte MP, 1998, J PEDIATR-US, V133, P770, DOI 10.1016/S0022-3476(98)70149-0; Minet C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1003-9; Revel-Vilk S, 2006, ACTA HAEMATOL-BASEL, V115, P201, DOI 10.1159/000090936; Sandoval JA, 2008, J VASC SURG, V47, P837, DOI 10.1016/j.jvs.2007.11.054; Shah PS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005983.pub3; Takemoto CM, 2014, J PEDIATR-US, V164, P332, DOI 10.1016/j.jpeds.2013.10.025; Ullman AJ, 2015, PEDIATRICS, V136, pE1331, DOI 10.1542/peds.2015-1507; Vidal E, 2014, J THROMB HAEMOST, V12, P1096, DOI 10.1111/jth.12598; Yacopetti N, 2008, J INFUS MURS, V31, P241, DOI 10.1097/01.NAN.0000326833.59655.9e	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214607	10.1371/journal.pone.0214607	http://dx.doi.org/10.1371/journal.pone.0214607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921401	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000096
J	Imboden, S; Nastic, D; Ghaderi, M; Rydberg, F; Rau, TT; Mueller, MD; Epstein, E; Carlson, JW				Imboden, Sara; Nastic, Denis; Ghaderi, Mehran; Rydberg, Filippa; Rau, Tilman T.; Mueller, Michael D.; Epstein, Elisabeth; Carlson, Joseph W.			Phenotype of POLE-mutated endometrial cancer	PLOS ONE			English	Article							EXONUCLEASE DOMAIN MUTATIONS; DNA-POLYMERASE; CARCINOMAS; CLASSIFICATION; PROGRESSION; LANDSCAPE; SURVIVAL; REVEAL; RISK; PD-1	Background and purpose Individualized therapy in endometrial cancer, the most common gynaecologic cancer in the developed world, focuses on identifying specific molecular subtypes. Mutations in the exonuclease domain of the DNA polymerase epsilon (POLE) gene define one such subtype, which causes an ultra-mutated tumour phenotype. These tumours may have an improved progression-free survival and may be receptive to specific therapies. However, the clinical phenotype of these tumours is unknown. The objective of this study was to evaluate the clinical and genetic features of POLE-mutated tumours from a large cohort of women whose cases are characterized by: (1) the availability of detailed clinical and lifestyle data; (2) mutation analysis; and (3) long-term follow-up. Methods A total of 604 patients with endometrial cancer were included in the study. Data from a detailed questionnaire, including lifestyle and family history information, provided extensive pertinent information on the patients. Sequencing of exons 9-14 of the POLE gene was performed. Follow-up data were gathered and analysed. Results Hotspot pathogenic POLE mutations were identified in N = 38/599 patients (6.3%). Patients with a POLE-mutated tumour were significantly younger, were more often nulliparous, and had a history of smoking. POLE-mutated tumours were more frequently aneuploid. Prognosis for patients with hotspot POLE-mutated tumours was significantly better in comparison with patients with non-mutated tumours; however careful selection of pathogenic mutations is essential to the definition of this prognostically favourable group. Conclusions This study demonstrates that POLE-mutated endometrial cancer is significantly associated with previously unknown clinicopathologic characteristics. Outcome in POLE-mutated tumours was excellent in cases with hotspot mutations. Our results suggest that prediction of excellent outcome in cases of POLE-mutated EMCA should be restricted to cases of EMCA with hotspot mutations until further data are available on the rising number of mutations with unknown significance.	[Imboden, Sara; Mueller, Michael D.] Univ Hosp Bern, Dept Obstet & Gynaecol, Bern, Switzerland; [Imboden, Sara; Mueller, Michael D.] Univ Bern, Bern, Switzerland; [Nastic, Denis; Ghaderi, Mehran; Rydberg, Filippa; Carlson, Joseph W.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Nastic, Denis; Ghaderi, Mehran; Rydberg, Filippa; Carlson, Joseph W.] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Rau, Tilman T.] Univ Bern, Inst Pathol, Bern, Switzerland; [Epstein, Elisabeth] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Epstein, Elisabeth] Soder Sjukhuset, Dept Obstet & Gynaecol, Stockholm, Sweden	University of Bern; University Hospital of Bern; University of Bern; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Bern; Karolinska Institutet; Sodersjukhuset Hospital	Carlson, JW (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.; Carlson, JW (corresponding author), Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden.	joseph.carlson@ki.se	epstein, elisabeth/F-4586-2014; Epstein, Elisabeth/GRO-7235-2022; Ghaderi, Mehran/AAB-7416-2021	epstein, elisabeth/0000-0003-2298-7785; Carlson, Joseph/0000-0002-3006-4107	Bernese cancer league; Swiss national science foundation [IZSE70_177073]; Swedish governmental grants; Avtal om Lakarutbildning och Forskning (ALF); ALF-Stockholm County [550411]; 'Radiumhemmet' Stockholm Sweden [154112]; Magnus Bergvalls Stiftelse [2016-01472]; Stockholms Lans Landsting [20150892]	Bernese cancer league; Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish governmental grants; Avtal om Lakarutbildning och Forskning (ALF); ALF-Stockholm County; 'Radiumhemmet' Stockholm Sweden; Magnus Bergvalls Stiftelse; Stockholms Lans Landsting	Bernese cancer league (https://bern.krebsliga.ch/), Swiss national science foundation (IZSE70_177073)http://www of chi, Swedish governmental grants; Avtal om Lakarutbildning och Forskning (ALF), ALF-Stockholm County (grant no 550411)https://ki.se, Cancer research funding from 'Radiumhemmet' Stockholm Sweden (grant no 154112)https://www.rahfo.se; Magnus Bergvalls Stiftelse (2016-01472); and Stockholms Lans Landsting (20150892). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso-Sousa R, 2017, ONCOTARGET, V8, P106169, DOI 10.18632/oncotarget.22583; Bellone S, 2017, GYNECOL ONCOL, V144, P146, DOI 10.1016/j.ygyno.2016.11.023; Billingsley CC, 2016, INT J GYNECOL CANCER, V26, P933, DOI 10.1097/IGC.0000000000000681; Billingsley CC, 2015, CANCER-AM CANCER SOC, V121, P386, DOI 10.1002/cncr.29046; Cancer Genome Atlas Research Network T, 2013, INT GEN CHAR END CAR, DOI [10.1038/NATURE12113, DOI 10.1038/NATURE12113]; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Church DN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju402; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Colombo N, 2016, ANN ONCOL, V27, P16, DOI 10.1093/annonc/mdv484; Cosgrove CM, 2018, GYNECOL ONCOL, V148, P174, DOI 10.1016/j.ygyno.2017.10.037; Epstein E, 2018, ULTRASOUND OBST GYN, V51, P818, DOI 10.1002/uog.18909; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Howitt BE, 2015, JAMA ONCOL, V1, P1319, DOI 10.1001/jamaoncol.2015.2151; Hussein YR, 2015, MODERN PATHOL, V28, P505, DOI 10.1038/modpathol.2014.143; Hussein YR, 2018, MOL INSIGHTS CLASSIF, DOI [10.1016/J.PATHOL.2017.09.010, DOI 10.1016/J.PATHOL.2017.09.010]; Jacob Louis, 2018, Oncotarget, V9, P17420, DOI 10.18632/oncotarget.24724; Lindemann K, 2008, BRIT J CANCER, V98, P1582, DOI 10.1038/sj.bjc.6604313; Mauland KK, 2014, CYTOM PART B-CLIN CY, V86, P154, DOI 10.1002/cyto.b.21164; McAlpine J, 2018, J PATHOL, V244, P538, DOI 10.1002/path.5034; McConechy MK, 2016, CLIN CANCER RES, V22, P2865, DOI 10.1158/1078-0432.CCR-15-2233; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Meng B, 2014, GYNECOL ONCOL, V134, P15, DOI 10.1016/j.ygyno.2014.05.006; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nelson BH, 2015, GYNECOL ONCOL, V138, P1, DOI 10.1016/j.ygyno.2015.06.004; Pradhan M, 2012, ANN ONCOL, V23, P1178, DOI 10.1093/annonc/mdr368; Proctor L, 2017, ASSESSMENT DNA PLOID, DOI [10.1016/J.YGYNO.2017.06.020, DOI 10.1016/J.YGYNO.2017.06.020]; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rayner E, 2016, NAT REV CANCER, V16, P71, DOI 10.1038/nrc.2015.12; Reed SD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.032; Rizvi NA, MUTATIONAL LANDSCAPE; Sauerbrei W, 2018, JNCI-J NATL CANCER I, V110, P803, DOI 10.1093/jnci/djy088; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Stelloo E, 2016, CLIN CANCER RES, V22, P4215, DOI 10.1158/1078-0432.CCR-15-2878; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Talhouk A, 2015, BRIT J CANCER, V113, P299, DOI 10.1038/bjc.2015.190; Talhouk A, 2016, GYNECOL ONCOL, V143, P46, DOI 10.1016/j.ygyno.2016.07.090; van Gool IC, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1072675; van Gool IC, 2015, CLIN CANCER RES, V21, P3347, DOI 10.1158/1078-0432.CCR-15-0057; Wise MR, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.175; Wong A, 2016, MUTATION SPECTRUM PO, DOI [10.1016/J.YGYNO.2015.12.031, DOI 10.1016/J.YGYNO.2015.12.031]; Zhou B, 2008, AM J MED, V121, P501, DOI 10.1016/j.amjmed.2008.01.044	43	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214318	10.1371/journal.pone.0214318	http://dx.doi.org/10.1371/journal.pone.0214318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917185	Green Published, gold, Green Submitted			2022-12-27	WOS:000462465800060
J	Merida-Vieyra, J; De Colsa-Ranero, A; Arzate-Barbosa, P; Arias-de la Garza, E; Mendez-Tenorio, A; Murcia-Garzon, J; Aquino-Andrade, A				Merida-Vieyra, Jocelin; De Colsa-Ranero, Agustin; Arzate-Barbosa, Patricia; Arias-de la Garza, Eduardo; Mendez-Tenorio, Alfonso; Murcia-Garzon, Jazmin; Aquino-Andrade, Alejandra			First clinical isolate of Escherichia coli harboring mcr-1 gene in Mexico	PLOS ONE			English	Article							RESISTANCE GENE; BETA-LACTAMASES; MULTIPLEX PCR; SEQUENCE; ENTEROBACTERIACEAE; VIRULENCE; IDENTIFICATION; SURVEILLANCE; PLASMIDS; DATABASE	Our aim in this report was to describe the characteristics of the first clinical isolate of Escherichia coli (EC-PAG-733) harboring the mcr-1 gene found in Mexico. This isolate was obtained from a fecal sample from a young child with an oncological condition. We obtained the whole-genome sequence using next-generation sequencing and analyzed the sequence by bioinformatics tools. EC-PAG-733 was resistant to third- and fourth-generation cephalo-sporins and was susceptible to all carbapenems and amikacin; it was also resistant to cipro-floxacin, levofloxacin, gentamicin and colistin at a minimum inhibitory concentration (MIC) of 4 mu g/mL. This isolate was classified as O11:H25-ST457. EC-PAG-733 harbored an ESBL type CTX-M-55 as well as several virulence factors that have been associated with Enter-oaggregative Escherichia coli (EAEC). The mcr-1 gene was located within an Incl2 plasmid. The results of this whole genome shotgun project were deposited in DDBJ/ENA/GenBank under the accession number QKXE00000000.	[Merida-Vieyra, Jocelin; De Colsa-Ranero, Agustin; Aquino-Andrade, Alejandra] INP, Mol Microbiol Lab, Mexico City, DF, Mexico; [De Colsa-Ranero, Agustin] INP, Pediat Infect Dis Dept, Mexico City, DF, Mexico; [Arzate-Barbosa, Patricia] INP, Clin Bacteriol Lab, Mexico City, DF, Mexico; [Arias-de la Garza, Eduardo] INP, Healthcare Associated Infect Advisory Comm, Mexico City, DF, Mexico; [Mendez-Tenorio, Alfonso; Murcia-Garzon, Jazmin] Inst Politecn Nacl, Natl Sch Biol Sci, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico	Aquino-Andrade, A (corresponding author), INP, Mol Microbiol Lab, Mexico City, DF, Mexico.	alejandra.aquino@infecto.mx	Mendez-Tenorio, Alfonso/AAS-7646-2021	Mendez-Tenorio, Alfonso/0000-0003-1871-4311; Arias de la Garza, Eduardo/0000-0002-6948-634X; AQUINO ANDRADE, ALEJANDRA/0000-0002-9155-8653	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA [FOSSIS-2017-1-289537]; Recurso Fiscal Instituto Nacional de Pediatria 2017 [2018/017]	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Recurso Fiscal Instituto Nacional de Pediatria 2017	Funded by AAA CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA FOSSIS-2017-1-289537 https://www.conacyt.gob.mx/.AAA, JMV, ADCR Recurso Fiscal Instituto Nacional de Pediatria 2017 Number 2018/017 https://www.pediatria.gob.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007261; Aquino-Andrade A, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1166-z; Barreteau H, 2012, MICROB DRUG RESIST, V18, P222, DOI 10.1089/mdr.2011.0230; Birgy A, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00127-18; Bozcal E, 2018, PEERJ, V6, DOI 10.7717/peerj.5470; Bradford PA, 2016, ANTIMICROB AGENTS CH, V60, P1385, DOI 10.1128/AAC.01870-15; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Clausen PTLC, 2016, J ANTIMICROB CHEMOTH, V71, P2484, DOI 10.1093/jac/dkw184; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; CLSI, 2018, M100 CLSI; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delgado-Blas JF, 2016, ANTIMICROB AGENTS CH, V60, P6356, DOI 10.1128/AAC.01319-16; Derakhshandeh A, 2015, LETT APPL MICROBIOL, V60, P148, DOI 10.1111/lam.12349; Fratamico PM, 2004, APPL ENVIRON MICROB, V70, P7173, DOI 10.1128/AEM.70.12.7173-7178.2004; Garza-Ramos U, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomeA.00102-18, 10.1128/genomea.00102-18]; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; He QW, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0207-z; Hooper DC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025320; Hu YY, 2017, INT J ANTIMICROB AG, V50, P593, DOI 10.1016/j.ijantimicag.2017.06.011; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson JR, 2017, J CLIN MICROBIOL, V55, P1116, DOI 10.1128/JCM.01949-16; Joo EJ, 2018, J MICROBIOL BIOTECHN, V28, P1178, DOI [10.4014/jmb.1801.12060, 10.4014/jmb.1712.12060]; Karaiskos I, 2017, EXPERT REV ANTI-INFE, V15, P1123, DOI 10.1080/14787210.2017.1410434; Kuo SC, 2016, J ANTIMICROB CHEMOTH, V71, P2327, DOI 10.1093/jac/dkw122; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Li X, 2018, INFECT DRUG RESIST, V11, P1189, DOI 10.2147/IDR.S175041; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Maluta RP, 2017, OVERLAPPED SEQUENCE, V61; Rodriguez-Martinez JM, 2016, DRUG RESIST UPDATE, V29, P13, DOI 10.1016/j.drup.2016.09.001; Matamoros S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15539-7; Matussek A, 2017, EUR J CLIN MICROBIOL, V36, P1433, DOI 10.1007/s10096-017-2950-7; Meinersmann RJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02244-16; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nolan LK, 2003, VET RES COMMUN, V27, P101, DOI 10.1023/A:1022854902700; Nuesch-Inderbinen MT, 2013, J MED MICROBIOL, V62, P1828, DOI 10.1099/jmm.0.065177-0; Oliveira FA, 2018, INT J ANTIMICROB AGE; Ortega-Paredes D, 2016, EPIDEMIOL INFECT, V144, P2967, DOI 10.1017/S0950268816001369; de la Tabla VO, 2017, INT J ANTIMICROB AG, V49, P115, DOI 10.1016/j.ijantimicag.2016.10.003; Quiroga C, 2018, REV ARGENT MICROBIOL; Rhouma M, 2017, INT J ANTIMICROB AG, V49, P269, DOI 10.1016/j.ijantimicag.2016.11.026; Ross BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141845; Sheikh J, 2006, MOL MICROBIOL, V61, P338, DOI 10.1111/j.1365-2958.2006.05234.x; Sun J, 2018, TRENDS MICROBIOL, V26, P794, DOI 10.1016/j.tim.2018.02.006; Suzuki S, 2016, LANCET INFECT DIS, V16, P284, DOI 10.1016/S1473-3099(16)00008-6; Tijet N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180347; Tonini MA, 2018, J GLOB ANTIMICROB RE, V13, P209, DOI 10.1016/j.jgar.2018.05.002; Wang QJ, 2016, ONCOTARGET, V7, P82112, DOI 10.18632/oncotarget.12621; Wang Y, 2017, LANCET INFECT DIS, V17, P390, DOI 10.1016/S1473-3099(16)30527-8; Wangchinda W, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0375-4; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yu H, 2016, ANTIMICROB AGENTS CH, V60, P5033, DOI 10.1128/AAC.00440-16; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang HM, 2016, SCI BULL, V61, P875, DOI 10.1007/s11434-016-1086-y; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	58	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214648	10.1371/journal.pone.0214648	http://dx.doi.org/10.1371/journal.pone.0214648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947268	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500049
J	Mustafa, T; Li, Q; Kelly, LE; Gibbon, A; Ryan, I; Roffey, K; Simonds, S; Cowley, MA; Sleeman, MW				Mustafa, Tomris; Li, Qun; Kelly, Lauren E.; Gibbon, Anne; Ryan, Irwin; Roffey, Keisha; Simonds, Stephanie; Cowley, Michael A.; Sleeman, Mark W.			Food hypersensitivity-induced chronic gastrointestinal inflammation in a non-human primate model of diet-induced obesity	PLOS ONE			English	Article							INSULIN-RESISTANCE; CELIAC-DISEASE; RHESUS-MONKEYS; MACAQUES; UPDATE	Experimental non-human primate models of obesity are induced through the introduction of atypically calorically rich diets. Studies in captive-bred macaques show the development of obesity and diabetes with similar complications to humans including eye and kidney diseases, nerve damage associated with pain and blood vessel damage. Diets differ in outcomes and here we document inflammation of the gastrointestinal tract that can be exacerbated through these dietary interventions. Following baseline physiological evaluation of body composition, Southern pigtail macaques were given a high-fat diet (HFD) for three months. This HFD consisted of lard, grains (including gluten), dairy and fructose that was otherwise omitted from a standard macaque diet (Chow). Physiological parameters were then reassessed before animals were reverted back to standard Chow for a further three months (remission). Consumption of the HFD resulted in food-mediated hypersensitivity marked by chronic weight loss, alopecia, malabsorption, protein-losing enteropathy and gross diffuse intestinal villi atrophy and lamina propria hypertrophy. Physiological changes were more highly pronounced in female macaques suggesting sex-specific differences but could be fully reversed through change of diet. Care should be taken in choosing nonhuman primate HFD diets for creating experimental models of obesity because they can induce severe food-driven chronic inflammation of the gastrointestinal tract that can eventuate to diet-induced chronic wasting and mortality.	[Mustafa, Tomris; Li, Qun; Kelly, Lauren E.; Simonds, Stephanie; Cowley, Michael A.; Sleeman, Mark W.] Monash Univ, Biomed Discovery Inst, Metab Diabet & Obes Program, Clayton, Vic, Australia; [Mustafa, Tomris; Li, Qun; Kelly, Lauren E.; Simonds, Stephanie; Cowley, Michael A.; Sleeman, Mark W.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Gibbon, Anne; Ryan, Irwin; Roffey, Keisha] Monash Univ, Monash Anim Res Platform, Clayton, Vic, Australia	Monash University; Monash University; Monash University	Mustafa, T (corresponding author), Monash Univ, Biomed Discovery Inst, Metab Diabet & Obes Program, Clayton, Vic, Australia.; Mustafa, T (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic, Australia.	tomris.mustafa@monash.edu			Novo Nordisk A/S, Denmark; National Health and Medical Research Council (NHMRC) of Australia	Novo Nordisk A/S, Denmark(Novo Nordisk); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Novo Nordisk A/S, Denmark (https://www.novonordisk.dk/) and National Health and Medical Research Council (NHMRC) of Australia (https://nhmrc.gov.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afify SM, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0174-z; Ardeshir A, 2013, ANAT REC, V296, P1169, DOI 10.1002/ar.22727; Bao F, 2012, ARCH PATHOL LAB MED, V136, P735, DOI 10.5858/arpa.2011-0572-RA; Bauer SA, 2011, COMPARATIVE MED, V61, P514; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001614; Blackwood RS, 2008, COMPARATIVE MED, V58, P81; Bremer AA, 2011, CTS-CLIN TRANSL SCI, V4, P243, DOI 10.1111/j.1752-8062.2011.00298.x; Chadderdon SM, 2014, CIRCULATION, V129, P471, DOI 10.1161/CIRCULATIONAHA.113.003645; Chang L, 2002, GASTROENTEROLOGY, V123, P1686, DOI 10.1053/gast.2002.36603; Clayton JB, 2016, P NATL ACAD SCI USA, V113, P10376, DOI 10.1073/pnas.1521835113; Fox JG, 2001, J MED MICROBIOL, V50, P421, DOI 10.1099/0022-1317-50-5-421; Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00754; Gibson PR, 2010, J GASTROEN HEPATOL, V25, P252, DOI 10.1111/j.1440-1746.2009.06149.x; Gore MA, 2001, J MED PRIMATOL, V30, P179, DOI 10.1111/j.1600-0684.2001.tb00007.x; Hansen Barbara C, 2012, Methods Mol Biol, V933, P177, DOI 10.1007/978-1-62703-068-7_11; Hariri N, 2010, NUTR RES, V30, P632, DOI 10.1016/j.nutres.2010.09.003; HOLMBERG CA, 1982, VET PATHOL, V19, P163, DOI 10.1177/030098588201907s12; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Mubiru JN, 2011, J MED PRIMATOL, V40, P335, DOI 10.1111/j.1600-0684.2011.00495.x; Ramesh G, 2005, CLIN DIAGN LAB IMMUN, V12, P192, DOI 10.1128/CDLI.12.1.192-197.2005; Sestak K, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070401; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; Villanacci V, 2011, DIGEST LIVER DIS, V43, pS385, DOI 10.1016/S1590-8658(11)60594-X; WALIKE BC, 1977, J MED PRIMATOL, V6, P151; Walker MM, 2011, HISTOPATHOLOGY, V59, P166, DOI 10.1111/j.1365-2559.2010.03680.x	25	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214621	10.1371/journal.pone.0214621	http://dx.doi.org/10.1371/journal.pone.0214621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947272	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500047
J	Rajbhandari, R; Rai, S; Hathi, S; Thapa, R; Rai, I; Shrestha, A				Rajbhandari, Ruma; Rai, Shovana; Hathi, Sejal; Thapa, Rita; Rai, Indra; Shrestha, Anil			The quality of skilled birth attendants in Nepal: High aspirations and ground realities	PLOS ONE			English	Article							MORTALITY; PROGRAM	Background While Nepal's maternal mortality ratio (MMR) has improved overall, the proportion of maternal deaths occurring in health facilities and attended to by skilled birth attendants (SBAs), has nearly doubled over 12 years. Although there are numerous socioeconomic, environmental and other factors at play, one possible explanation for this discrepancy between utilization of skilled maternal care services and birth outcomes lies in the quality of care being provided by SBAs. The objective of this study is to determine how competent SBAs are after training, across multiple settings and facility types in Nepal. Methods We used a quantitative cross-sectional analysis to evaluate a sample of 511 SBAs, all female, from 276 sub-health posts (SHP), health posts (HP), primary healthcare centers (PHC), and district and regional hospitals in the mountain, hill, and terai districts of Nepal. Any SBA actively employed by one of these health facilities was included. SBAs who had received less than three months of training were excluded. Outcomes were measured using SBAs' scores on a standardized knowledge assessment, clinical skills assessment, and monthly delivery volume, particularly as it compared with the WHO's recommendation for minimum monthly volume to maintain competence. Results SBAs on average exhibit a deficiency of both knowledge and clinical skills, failing to meet even the 80-percent standard that is required to pass training (knowledge: 75%, standard deviation 12%; clinical skills: 48%, standard deviation 15%). Moreover, SBAs are conducting very few deliveries, with only 7 percent (38/511) meeting the minimal volume recommended to maintain competence by the WHO, and a substantial fraction (70/511, 14%) performing an average of no monthly deliveries at all. Conclusions Taken together, our findings suggest that while countries like Nepal have made important investments in SBA programs, these healthcare workers are failing to receive either effective training or sufficient practice to stay clinically competent and knowledgeable in the field. This could in part explain why institutional deliveries have generally failed to deliver better outcomes for pregnant women and their babies.	[Rajbhandari, Ruma] Harvard Med Sch, Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Rajbhandari, Ruma; Rai, Shovana; Thapa, Rita; Rai, Indra; Shrestha, Anil] Nick Simons Inst, Kathmandu, Nepal; [Hathi, Sejal] Stanford Sch Med, Palo Alto, CA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford University	Rajbhandari, R (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA.; Rajbhandari, R (corresponding author), Nick Simons Inst, Kathmandu, Nepal.	rrajbhandari@bwh.harvard.edu		Rajbhandari, Ruma/0000-0001-8281-550X; Thapa Budhathoki, Rita/0000-0003-1942-9635	National Health Training Center (NHTC) of the Ministry of Health and Population of Nepal from the Nick Simons Institute	National Health Training Center (NHTC) of the Ministry of Health and Population of Nepal from the Nick Simons Institute	Funding for the Follow up and Enhancement Program, which carried out the data collection for the study in conjunction with the National Health Training Center (NHTC) of the Ministry of Health and Population of Nepal, came entirely from the Nick Simons Institute (http://www.nsi.edu.np/en), a charitable organization that works to train and support healthcare workers in rural Nepal (www.nsi.edu.np).The Nick Simons Institute initiated this study as part of its mission to continually improve care delivery in rural Nepal. Accordingly, it will use the study results to both raise awareness and lobby for changes in skilled birth attendant training, recruitment and follow-up in Nepal and internationally. Neither the Nick Simons Institute nor the authors stand to receive material gain from the publication of this study.	Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Amato Laura, 2013, Epidemiol Prev, V37, P1; [Anonymous], 2005, WORLD HLTH REP 2005, P79; Ariff S, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-319; Bhuiyan AB, 2005, INT J GYNECOL OBSTET, V90, P56, DOI 10.1016/j.ijgo.2005.03.031; Carlough M, 2005, INT J GYNECOL OBSTET, V89, P200, DOI 10.1016/j.ijgo.2004.12.044; Central Bureau of Statistics, 2015, NEP MULT IND CLUST S; Cha S, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1267961; Estimates by WHO UNICEF UNFPA The World Bank the United Nations population Division, 2014, TRENDS MAT MORT 1990; Goldstein R., 2012, 2492 CAPST; Goyet S, 2017, LANCET, V389, P698, DOI 10.1016/S0140-6736(17)30341-0; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kyser KL, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.010; Morgan A, 2014, TROP MED INT HEALTH, V19, P1457, DOI 10.1111/tmi.12390; Morrison J, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0021-7; National Planning Commission, 2013, NEP MILL DEV GOALS P; National Planning Commission, 2015, SUST DEV GOALS 2016; Partamin, 2012, INT J GYNECOL OBSTET, V119, P125, DOI 10.1016/j.ijgo.2012.05.030; Ronsmans C, 2001, TROP MED INT HEALTH, V6, P799, DOI 10.1046/j.1365-3156.2001.00780.x; Salazar M, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.32178; Satishchandra D M, 2013, J Obstet Gynaecol India, V63, P383, DOI 10.1007/s13224-013-0457-4; Snowden JM, 2012, AM J OBSTET GYNECOL, V207; Suvedi B. K., 2009, NEPAL MATERNAL MORTA; Thatte N, 2009, GLOB PUBLIC HEALTH, V4, P600, DOI 10.1080/17441690802472406; United Nations Inter-Agency and Expert Group on MDG Indicators, 2015, MILL DEV GOALS REP 2; United Nations Population Fund, 2009, POSTTR FOLL UP SKILL	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214577	10.1371/journal.pone.0214577	http://dx.doi.org/10.1371/journal.pone.0214577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947314	gold, Green Published, Green Submitted			2022-12-27	WOS:000463314500042
J	Santos, VS; Freire, MS; Santana, RNS; Martins, PRS; Cuevas, LE; Gurgel, RQ				Santos, Victor S.; Freire, Marina S.; Santana, Ruth N. S.; Martins-Filho, Paulo R. S.; Cuevas, Luis E.; Gurgel, Ricardo Q.			Association between histamine-2 receptor antagonists and adverse outcomes in neonates: A systematic review and meta-analysis	PLOS ONE			English	Review							STRESS-ULCER PROPHYLAXIS; NECROTIZING ENTEROCOLITIS; H2-BLOCKER THERAPY; GASTROESOPHAGEAL-REFLUX; GASTRIC-ACIDITY; PRETERM INFANTS; RANITIDINE; BLOCKERS; INFECTIONS; INHIBITORS	Background The use of histamine-2 receptor antagonists (H(2)RA) in neonates is still debated because of possible risk of infection, necrotizing enterocolitis (NEC) and increased mortality. Aim To review whether the use of H(2)RA in neonates admitted to neonatal intensive care units (NICU) is associated with infection, NEC or mortality. Materials and method We performed a systematic search in PubMed, Web of Science and SCOPUS databases using the terms "histamine-2 receptor antagonists", "infection", "necrotizing enterocolitis", "mortality", "neonates" and related terms to identify studies published up to April 30, 2017. We included studies conducted in hospitalized neonates and exposed to H(2)RA. The primary outcomes were infection, NEC and mortality. We included reports of infections with clinical signs and positive culture, and NEC according to Bell stages (stage >= II) based on standardised clinical and radiologic criteria. Among 1,144 studies identified, 10 fulfilled the selection criteria. Information extracted included study design, sample size and number of participants, along with the outcomes of interest. We conducted a meta-analysis of adjusted data and pooled estimates of infection, NEC and mortality are reported as odds ratios (OR) and 95% confidence intervals (95%CI). Results Ten studies were analysed. There were substantial associations between H(2)RA and infection (pooled OR: 2.09; 95%CI: 1.35-3.24; P = 0.001) and NEC (pooled OR: 2.81, 95%)CI: 1.19-6.64; P = 0.02) but not with the mortality risk (pooled OR: 1.76; 95%CI: 0.50-6.16; P: 0.38). Conclusion Current evidence suggests that H(2)RA is associated with an increased risk of infection and NEC, but not with mortality in neonates admitted to NICU. The use of H(2)RA in neonates must be stringently considered when necessary.	[Santos, Victor S.] Univ Fed Alagoas, Ctr Epidemiol & Publ Hlth, Arapiraca, Brazil; [Freire, Marina S.; Santana, Ruth N. S.; Gurgel, Ricardo Q.] Univ Fed Sergipe, Dept Med, Aracaju, Brazil; [Martins-Filho, Paulo R. S.; Gurgel, Ricardo Q.] Univ Fed Sergipe, Postgrad Programme Hlth Sci, Aracaju, Brazil; [Martins-Filho, Paulo R. S.] Univ Fed Sergipe, Invest Pathol Lab, Aracaju, Brazil; [Cuevas, Luis E.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	Universidade Federal de Alagoas; Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Sergipe; Liverpool School of Tropical Medicine	Gurgel, RQ (corresponding author), Univ Fed Sergipe, Dept Med, Aracaju, Brazil.; Gurgel, RQ (corresponding author), Univ Fed Sergipe, Postgrad Programme Hlth Sci, Aracaju, Brazil.	ricardoqgurgel@gmail.com	Santos, Victor Santana/B-8738-2014; Cuevas, Luis E/I-3697-2015; Martins-Filho, Paulo/AAC-4773-2019; Gurgel, RQ/N-5105-2018; Martins-Filho, Paulo Ricardo/D-1077-2011	Santos, Victor Santana/0000-0003-0194-7397; Cuevas, Luis E/0000-0002-6581-0587; Gurgel, RQ/0000-0001-9651-3713; Martins-Filho, Paulo Ricardo/0000-0001-8779-0727				Afjeh SA, 2013, ARCH PEDIATR INFECT, V1, P65, DOI 10.5812/pedinfect.9051; [Anonymous], 2012, EUR J CLIN PHARMACOL, V68, P1073, DOI [10.1007/s00228-012-1221-x, DOI 10.1007/S00228-012-1221-X]; APTE NM, 1992, CRIT CARE MED, V20, P590, DOI 10.1097/00003246-199205000-00008; Bancalari E, 2008, NEONATOLOGY, V94, P197, DOI 10.1159/000143722; Barney Cindy K, 2009, Adv Neonatal Care, V9, P129, DOI 10.1097/ANC.0b013e3181a88358; Bartels DB, 2007, ARCH DIS CHILD-FETAL, V92, P449; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bianconi S, 2007, J PERINAT MED, V35, P147, DOI 10.1515/JPM.2007.017; Bitali A, 2013, PEDIATR NEONATOL, V54, P141, DOI 10.1016/j.pedneo.2013.01.011; Canani RB, 2010, CURR OPIN GASTROEN, V26, P31, DOI 10.1097/MOG.0b013e328333d781; Casner M, 2014, PEDIATR CRIT CARE ME, V15, P42, DOI 10.1097/PCC.0b013e31829f5feb; Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; FONTANA M, 1993, J PEDIATR GASTR NUTR, V16, P406, DOI 10.1097/00005176-199305000-00011; Frei R, 2013, J ALLERGY CLIN IMMUN, V132, P194, DOI 10.1016/j.jaci.2013.01.013; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Gupta RW, 2013, J PEDIATR GASTR NUTR, V56, P397, DOI 10.1097/MPG.0b013e318282a8c2; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jutel M, 2009, CLIN EXP ALLERGY, V39, P1786, DOI 10.1111/j.1365-2222.2009.03374.x; Malcolm WF, 2012, CLIN PERINATOL, V39, P99, DOI 10.1016/j.clp.2011.12.015; Patole S, 2006, PEDIATRICS, V117, P531, DOI 10.1542/peds.2005-2230; Rojas Mario A, 2005, J Perinatol, V25, P537, DOI 10.1038/sj.jp.7211353; Romaine A, 2016, EARLY HUM DEV, V99, P27, DOI 10.1016/j.earlhumdev.2016.05.010; Rosa AC, 2013, BRIT J PHARMACOL, V170, P38, DOI 10.1111/bph.12266; Sant'Anna GM, 2012, CLIN PERINATOL, V39, P543, DOI 10.1016/j.clp.2012.06.003; Santana RNS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2482-x; Singh N, 2016, INT J PEDIAT, V2016, DOI 10.1155/2016/9649162; Sterne J. A. C., 2008, SYSTEMATIC REV HLTH, V323, P189, DOI [10.1002/9780470693926.ch11, DOI 10.1002/9780470693926.CH11]; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takagaki K, 2009, J GASTROENTEROL, V44, P285, DOI 10.1007/s00535-009-0019-9; Terrin G, 2012, J MATERN-FETAL NEO M, V25, P85, DOI 10.3109/14767058.2012.714975; Terrin G, 2012, PEDIATRICS, V129, pE40, DOI 10.1542/peds.2011-0796; Uslu S, 2010, J PERINATOL, V30, P794, DOI 10.1038/jp.2010.46; van der Pol R, 2014, JAMA PEDIATR, V168, P947, DOI 10.1001/jamapediatrics.2014.1273; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; Wells G., NEWCASTLE OTTAWA SCA; Xu XA, 2006, J EXP MED, V203, P2907, DOI 10.1084/jem.20061232; Yildizdas D, 2002, J CRIT CARE, V17, P240, DOI 10.1053/jcrc.2002.36761	38	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214135	10.1371/journal.pone.0214135	http://dx.doi.org/10.1371/journal.pone.0214135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947259	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000463314500017
J	Anderson, AM; Friis, C; Gratto-Trevor, CL; Morrison, RIG; Smith, PA; Nol, E				Anderson, Alexandra M.; Friis, Christian; Gratto-Trevor, Cheri L.; Morrison, R. I. Guy; Smith, Paul A.; Nol, Erica			Consistent declines in wing lengths of Calidridine sandpipers suggest a rapid morphometric response to environmental change	PLOS ONE			English	Article							WHITE-RUMPED SANDPIPER; SEXUAL SIZE DIMORPHISM; WESTERN SANDPIPERS; CLIMATE-CHANGE; MORPHOLOGICAL ADAPTATIONS; BODY-SIZE; POPULATION DECLINES; POTENTIAL IMPACTS; PREDATOR EVASION; STOPOVER SITE	A recent study demonstrated that semipalmated sandpiper (Calidris pusffla) wing lengths have shortened from the 1980s to the present-day. We examined alternative and untested hypotheses for this change at an important stopover site, James Bay, Ontario, Canada. We evaluated morphometric patterns in wing length and bill length by age and sex, when possible, and assessed if wing shape has also changed during this time-period. We investigated patterns of morphological change in two additional Calidridine sandpipers, white-rumped sandpipers (Calidris fuscicollis) and least sandpipers (Calidris minutilla), to determine if shorter wing lengths are a widespread pattern in small sandpipers. We also examined allometric changes in wing and bill lengths to clarify if wing length declines were consistent with historical scaling relationships and indicative of a change in body size instead of only wing length change. We found that including sex and wing shape in analyses revealed important patterns in morphometric change for semipalmated sandpipers. Wing lengths declined for both sexes, but the magnitude of decline was smaller and not significant for males. Additionally, semipalmated sandpiper wings have become more convex, a shape that increases maneuverability in flight. Wing lengths, but not bill lengths, declined for most species and age classes, a pattern that was inconsistent with historical allometric scaling relationships. For juvenile semipalmated sandpipers, however, both bill and wing lengths declined according to historical scaling relationships, which could be a consequence of nutritional stress during development or a shift in the proportion of birds from smaller-sized, western breeding populations. Except for juvenile semipalmated sandpipers, we did not find evidence for an increase in the proportion of birds from different breeding populations at the stopover site. Given the wide, hemispheric distribution of these sandpipers throughout their annual cycles, our results, paired with those from a previous study, provide evidence for wide-spread reduction in wing lengths of Calidridine sandpipers since the 1980s. The shorter wing lengths and more convex wing shapes found in this study support the hypothesis that selection has favored more maneuverable wing morphology in small sandpipers.	[Anderson, Alexandra M.] Trent Univ, Environm & Life Sci, Peterborough, ON, Canada; [Friis, Christian] Environm & Climate Change Canada, Canadian Wildlife Serv, Toronto, ON, Canada; [Gratto-Trevor, Cheri L.] Environm & Climate Change Canada, Prairie & Northern Wildlife Res Ctr, Saskatoon, SK, Canada; [Morrison, R. I. Guy; Smith, Paul A.] Environm & Climate Change Canada, Natl Wildlife Res Ctr, Ottawa, ON, Canada; [Nol, Erica] Trent Univ, Biol Dept, Peterborough, ON, Canada	Trent University; Environment & Climate Change Canada; Canadian Wildlife Service; Environment & Climate Change Canada; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Trent University	Anderson, AM (corresponding author), Trent Univ, Environm & Life Sci, Peterborough, ON, Canada.	aande763@gmail.com		Anderson, Alexandra/0000-0001-6751-1751; Friis, Christian/0000-0002-4739-580X	Environment and Climate Change Canada; Ontario Trillium Scholarship; W. Garfield Weston Fellowship for Northern Research; Ontario Ministry of Natural Resources and Forestry Species at Risk Stewardship Fund [16-19-Nol]; Neotropical Migratory Bird Conservation Act Grant [F14AP00405, F17AP00668]	Environment and Climate Change Canada; Ontario Trillium Scholarship; W. Garfield Weston Fellowship for Northern Research; Ontario Ministry of Natural Resources and Forestry Species at Risk Stewardship Fund; Neotropical Migratory Bird Conservation Act Grant	This study was funded by Environment and Climate Change Canada, the Ontario Trillium Scholarship (AMA), The W. Garfield Weston Fellowship for Northern Research (AMA), the Ontario Ministry of Natural Resources and Forestry Species at Risk Stewardship Fund (16-19-Nol, EN), and the Neotropical Migratory Bird Conservation Act Grant (Award #F14AP00405, CF, and #F17AP00668, EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Apple ME, 2000, INT J PLANT SCI, V161, P127, DOI 10.1086/314237; Austin GE, 2005, GLOBAL CHANGE BIOL, V11, P31, DOI 10.1111/j.1529-8817.2003.00876.x; Baker AJ, 1999, CONDOR, V101, P887, DOI 10.2307/1370083; Bart J, 2007, J AVIAN BIOL, V38, P73, DOI 10.1111/j.2007.0908-8857.03698.x; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blankers T, 2012, J EVOLUTION BIOL, V25, P634, DOI 10.1111/j.1420-9101.2012.02458.x; Blomqvist D, 1997, ANIM BEHAV, V54, P1291, DOI 10.1006/anbe.1997.0532; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BRADSTREET MSW, 1977, CAN FIELD NAT, V91, P225; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Brown CR, 2013, CURR BIOL, V23, pR233, DOI 10.1016/j.cub.2013.02.023; Burns JG, 2003, AUK, V120, P827, DOI 10.1642/0004-8038(2003)120[0827:ROCSWS]2.0.CO;2; Burns JG, 2002, BEHAV ECOL SOCIOBIOL, V52, P128, DOI 10.1007/s00265-002-0494-y; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; de la Hera I, 2014, IBIS, V156, P209, DOI 10.1111/ibi.12112; Dos Remedios Natalie, 2010, Wader Study Group Bulletin, V117, P109; Doswald N, 2009, J BIOGEOGR, V36, P1194, DOI 10.1111/j.1365-2699.2009.02086.x; Dunn JC, 2017, IBIS, V159, P152, DOI 10.1111/ibi.12435; ENGELMOER M, 1983, Ringing and Migration, V4, P245; Evans KL, 2009, OIKOS, V118, P251, DOI 10.1111/j.1600-0706.2008.17092.x; Fernandez G, 2007, AUK, V124, P1037, DOI 10.1642/0004-8038(2007)124[1037:VITWMO]2.0.CO;2; Flinks H, 2012, J ORNITHOL, V153, P1053, DOI 10.1007/s10336-012-0834-2; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Gratto C.L., 1981, Wader Study Group Bulletin, P33; Gratto CL., 1983, MIGRATORY REPROD STR; Gratto-Trevor, 2004, N AM BANDERS MANUAL; Gratto-Trevor C, 2012, WATERBIRDS, V35, P83, DOI 10.1675/063.035.0109; Guerin GR, 2012, BIOL LETTERS, V8, P882, DOI 10.1098/rsbl.2012.0458; Harrington B.A., 1979, Studies in Avian Biology, V2, P83; HEDENSTROM A, 1992, P ROY SOC B-BIOL SCI, V247, P183, DOI 10.1098/rspb.1992.0026; Hicklin P., 2010, BIRDS N AM, DOI [10. 2173/bna. 6, DOI 10.2173/BNA.6]; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Jehl J.R. Jr, 1986, Current Ornithology, V3, P1; Krapu GL, 2006, AUK, V123, P323, DOI 10.1642/0004-8038(2006)123[323:FDOASD]2.0.CO;2; Kullberg C, 2000, AUK, V117, P1034, DOI 10.1642/0004-8038(2000)117[1034:HMFLIP]2.0.CO;2; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; Lank DB, 2017, ECOL EVOL, V7, P3243, DOI 10.1002/ece3.2898; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; Ludecke D., 2017, SJPLOT DATA VISUALIZ; Telleria JL, 2013, IBIS, V155, P750, DOI 10.1111/ibi.12078; Maclean IMD, 2008, GLOBAL CHANGE BIOL, V14, P2489, DOI 10.1111/j.1365-2486.2008.01666.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; McNeil R., 1972, Naturalist can, V99, P589; Minias P, 2015, IBIS, V157, P528, DOI 10.1111/ibi.12262; Moller AP, 2017, J EVOLUTION BIOL, V30, P1177, DOI 10.1111/jeb.13086; Nebel S., 2008, BIRDS N AM, DOI [10. 2173/bna. 115, DOI 10.2173/BNA.115]; O'Hara PD, 2006, CONDOR, V108, P225, DOI 10.1650/0010-5422(2006)108[0225:DMIWSW]2.0.CO;2; Outomuro D, 2015, J EVOLUTION BIOL, V28, P791, DOI 10.1111/jeb.12605; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; PAGE G, 1975, CONDOR, V77, P73, DOI 10.2307/1366760; PARMELEE DF, 1968, WILSON BULL, V80, P5; Parmelee DF., 1992, BIRDS N AM, DOI [10.2173/bna.29, DOI 10.2173/BNA.29]; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pergams ORW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006452; Piersma T, 2005, ANN NY ACAD SCI, V1046, P282, DOI 10.1196/annals.1343.026; Piersma T., 2010, FLEXIBLE PHENOTYPE B; Pomeroy AC, 2006, OIKOS, V112, P629, DOI 10.1111/j.0030-1299.2006.14403.x; Pomeroy AC, 2006, BEHAV ECOL, V17, P1041, DOI 10.1093/beheco/arl043; Pulido F, 2005, ANN NY ACAD SCI, V1046, P228, DOI 10.1196/annals.1343.020; Quinn G, 2002, RES DESIGN DATA ANAL; R Development Core Team, 2009, R LANG ENV STAT COMP; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serra L, 2001, J AVIAN BIOL, V32, P377, DOI 10.1111/j.0908-8857.2001.320415.x; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Stoffel MA, 2017, METHODS ECOL EVOL, V8, P1639, DOI 10.1111/2041-210X.12797; Swaddle JP, 1998, J AVIAN BIOL, V29, P172, DOI 10.2307/3677195; Szekely T, 2000, EVOLUTION, V54, P1404, DOI 10.1111/j.0014-3820.2000.tb00572.x; Tomassini A, 2014, J BIOGEOGR, V41, P944, DOI 10.1111/jbi.12248; Tseng M, 2018, J ANIM ECOL, V87, P647, DOI 10.1111/1365-2656.12789; Vagasi CI, 2016, EVOL BIOL, V43, P48, DOI 10.1007/s11692-015-9349-0; Van Buskirk J, 2010, OIKOS, V119, P1047, DOI 10.1111/j.1600-0706.2009.18349.x; Van Den Hout PJ, 2008, IBIS, V150, P219, DOI 10.1111/j.1474-919X.2008.00785.x; van der Velde Marco, 2017, Wader Study, V124, P147, DOI 10.18194/ws.00069; van Gils JA, 2016, SCIENCE, V352, P819, DOI 10.1126/science.aad6351; Vaz S, 2013, PLOS ONE, V8, P7; Wennerberg L, 2002, OECOLOGIA, V131, P380, DOI 10.1007/s00442-002-0890-z; Whitfield DP, 2003, IBIS, V145, P432, DOI 10.1046/j.1474-919X.2003.00183.x; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4	92	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213930	10.1371/journal.pone.0213930	http://dx.doi.org/10.1371/journal.pone.0213930			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943247	Green Submitted, Green Published, gold			2022-12-27	WOS:000463194300024
J	Buglak, AA; Zherdev, AV; Lei, HT; Dzantiev, BB				Buglak, Andrey A.; Zherdev, Anatoly V.; Lei, Hong-Tao; Dzantiev, Boris B.			QSAR analysis of immune recognition for triazine herbicides based on immunoassay data for polyclonal and monoclonal antibodies	PLOS ONE			English	Article							BROAD-SPECIFICITY; PREDICTIVE ABILITY; ATRAZINE; DEALKYLATION; ENANTIOMERS; REGRESSION; MOLECULES; OFLOXACIN; RESIDUES; IMPROVE	A common task in the immunodetection of structurally close compounds is to analyze the selectivity of immune recognition; it is required to understand the regularities of immune recognition and to elucidate the basic structural elements which provide it. Triazines are compounds of particular interest for such research due to their high variability and the necessity of their monitoring to provide safety for agricultural products and foodstuffs. We evaluated the binding of 20 triazines with polyclonal (pAb) and monoclonal (mAb) antibodies obtained using atrazine as the immunogenic hapten. A total of over 3000 descriptors were used in the quantitative structure-activity relationship (QSAR) analysis of binding activities (pIC(50)). A comparison of the two enzyme immunoassay systems showed that the system with pAb is much easier to describe using 2D QSAR methodology, while the system with mAb can be described using the 3D QSAR CoMFA. Thus, for the 3D QSAR model of the polyclonal antibodies, the main statistical parameter q(2) ('leave-many-out') is equal to 0.498, and for monoclonal antibodies, q(2) is equal to 0.566. Obviously, in the case of pAb, we deal with several targets, while in the case of mAb the target is one, and therefore it is easier to describe it using specific fields of molecular interactions distributed in space.	[Buglak, Andrey A.; Zherdev, Anatoly V.; Dzantiev, Boris B.] Russian Acad Sci, AN Bach Inst Biochem, Res Ctr Biotechnol, Moscow, Russia; [Buglak, Andrey A.] St Petersburg State Univ, St Petersburg, Russia; [Lei, Hong-Tao] South China Agr Univ, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou, Guangdong, Peoples R China	Research Center of Biotechnology RAS; Russian Academy of Sciences; Saint Petersburg State University; South China Agricultural University	Buglak, AA (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Res Ctr Biotechnol, Moscow, Russia.; Buglak, AA (corresponding author), St Petersburg State Univ, St Petersburg, Russia.	andreybuglak@gmail.com	Buglak, Andrey A/J-8242-2016; Buglak, Andrey/X-7871-2019; Zherdev, Anatoly/G-2916-2013	Buglak, Andrey A/0000-0002-6405-6594; Buglak, Andrey/0000-0002-6405-6594; Zherdev, Anatoly/0000-0003-3008-2839	Russian Science Foundation [14-16-00149]	Russian Science Foundation(Russian Science Foundation (RSF))	The work was financially supported by the Russian Science Foundation (Project No. 14-16-00149).	Agopian AJ, 2013, MATERN CHILD HLTH J, V17, P1768, DOI 10.1007/s10995-012-1196-3; Alexander DLJ, 2015, J CHEM INF MODEL, V55, P1316, DOI 10.1021/acs.jcim.5b00206; BARONI M, 1992, J CHEMOMETR, V6, P347, DOI 10.1002/cem.1180060605; BARONI M, 1993, QUANT STRUCT-ACT REL, V12, P9, DOI 10.1002/qsar.19930120103; Bitencourt M, 2008, PEST MANAG SCI, V64, P800, DOI 10.1002/ps.1565; Bottoni P, 2013, MICROCHEM J, V107, P136, DOI 10.1016/j.microc.2012.06.011; Chen JH, 2017, ANAL CHEM, V89, P6740, DOI 10.1021/acs.analchem.7b00997; Chen JH, 2016, J AGR FOOD CHEM, V64, P2772, DOI 10.1021/acs.jafc.6b00039; Cheney MA, 1998, COLLOID SURFACE A, V137, P267, DOI 10.1016/S0927-7757(97)00368-3; Dankwardt A, 1996, ENVIRON SCI TECHNOL, V30, P3493, DOI 10.1021/es9601604; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Funar-Timofei S, 2017, MOL DIVERS, V21, P437, DOI 10.1007/s11030-017-9735-x; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; HALL LH, 1991, J CHEM INF COMP SCI, V31, P76, DOI 10.1021/ci00001a012; Li YF, 2017, TRAC-TREND ANAL CHEM, V88, P25, DOI 10.1016/j.trac.2016.12.010; Liu CM, 2018, ANAL CHIM ACTA, V1012, P90, DOI 10.1016/j.aca.2018.01.042; Mu HT, 2018, SPECTROCHIM ACTA A, V194, P83, DOI 10.1016/j.saa.2018.01.008; Mu HT, 2015, ANALYST, V140, P1037, DOI 10.1039/c4an02155j; Pastor M, 1997, J MED CHEM, V40, P1455, DOI 10.1021/jm9608016; Rowe AM, 2008, BASIC CLIN PHARMACOL, V102, P139, DOI 10.1111/j.1742-7843.2007.00175.x; Shin JY, 2005, ENVIRON TOXICOL CHEM, V24, P1353, DOI 10.1897/04-248R.1; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; STAHLE L, 1987, Journal of Chemometrics, V1, P185, DOI 10.1002/cem.1180010306; Tian Y, 2017, CHEM ENG J, V330, P1075, DOI 10.1016/j.cej.2017.08.048; Tosco P, 2011, J COMPUT AID MOL DES, V25, P777, DOI 10.1007/s10822-011-9462-9; Tosco P, 2011, J MOL MODEL, V17, P201, DOI 10.1007/s00894-010-0684-x; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; Wang ZH, 2007, ANAL CHEM, V79, P4471, DOI 10.1021/ac070064t; Wang ZH, 2012, INT J MOL SCI, V13, P6334, DOI 10.3390/ijms13056334; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xie Y, 2018, PEST MANAG SCI, V74, P189, DOI 10.1002/ps.4693; Xu ZL, 2010, ANAL CHEM, V82, P9314, DOI 10.1021/ac1018414; Xu ZL, 2009, ANAL CHIM ACTA, V647, P90, DOI 10.1016/j.aca.2009.05.025; Yuan M, 2012, J AGR FOOD CHEM, V60, P10486, DOI 10.1021/jf303256r; Yuan M, 2011, ANAL CHEM, V83, P4767, DOI 10.1021/ac200227v; Zuo Y, 2016, J AGR FOOD CHEM, V64, P552, DOI 10.1021/acs.jafc.5b05378	37	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214879	10.1371/journal.pone.0214879	http://dx.doi.org/10.1371/journal.pone.0214879			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943259	Green Submitted, Green Published, gold			2022-12-27	WOS:000463194300067
J	Di Giorgio, JAP; Lepage, E; Tremblay-Belzile, S; Truche, S; Loubert-Hudon, A; Brisson, N				Di Giorgio, Juliana Andrea Perez; Lepage, Etienne; Tremblay-Belzile, Samuel; Truche, Sebastien; Loubert-Hudon, Audrey; Brisson, Normand			Transcription is a major driving force for plastid genome instability in Arabidopsis	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; EARLY CHLOROPLAST DEVELOPMENT; LIGHT-INDUCED TRANSCRIPTION; SIGMA-FACTOR; R-LOOPS; GENE-EXPRESSION; RNA-POLYMERASE; DNA-REPAIR; PROTEIN; REPLICATION	Though it is an essential process, transcription can be a source of genomic instability. For instance, it may generate RNA:DNA hybrids as the nascent transcript hybridizes with the complementary DNA template. These hybrids, called R-loops, act as a major cause of replication fork stalling and DNA breaks. In this study, we show that lowering transcription and R-loop levels in plastids of Arabidopsis thaliana reduces DNA rearrangements and mitigates plastid genome instability phenotypes. This effect can be observed on a genome-wide scale, as the loss of the plastid sigma transcription factor SIG6 prevents DNA rearrangements by favoring conservative repair in the presence of ciprofloxacin-induced DNA damage or in the absence of plastid genome maintenance actors such as WHY1/WHY3, RECA1 and POLIB. Additionally, resolving R-loops by the expression of a plastid-targeted exogenous RNAse H1 produces similar results. We also show that highly-transcribed genes are more susceptible to DNA rearrangements, as increased transcription of the psbD operon by SIG5 correlates with more locus-specific rearrangements. The effect of transcription is not specific to Sigma factors, as decreased global transcription levels by mutation of heat-stress-induced factor HSP21, mutation of nuclear-encoded polymerase RPOTp, or treatment with transcription-inhibitor rifampicin all prevent the formation of plastid genome rearrangements, especially under induced DNA damage conditions.	[Di Giorgio, Juliana Andrea Perez; Lepage, Etienne; Tremblay-Belzile, Samuel; Truche, Sebastien; Loubert-Hudon, Audrey; Brisson, Normand] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada	Universite de Montreal	Di Giorgio, JAP (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada.	juliana.perez@umontreal.ca		Perez Di Giorgio, Juliana/0000-0002-8959-5500	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC) to E.L. and S.T.B., and grants from NSERC to N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2017, NAT STRUCT MOL BIOL, V24, P439, DOI 10.1038/nsmb.3395; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Amon JD, 2016, ELIFE, V5, DOI 10.7554/eLife.20533; Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; BAUMGARTNER BJ, 1993, PLANT PHYSIOL, V101, P781, DOI 10.1104/pp.101.3.781; Bock S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00667; Borner T, 2015, BBA-BIOENERGETICS, V1847, P761, DOI 10.1016/j.bbabio.2015.02.004; Bouwman BAM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120632; Callegari AJ, 2016, DNA REPAIR, V41, P1, DOI 10.1016/j.dnarep.2016.03.001; Cappadocia L, 2010, PLANT CELL, V22, P1849, DOI 10.1105/tpc.109.071399; Castandet B, 2016, G3-GENES GENOM GENET, V6, P2817, DOI 10.1534/g3.116.030783; Chakraborty A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13049; Chang EYC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010033; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Chi W, 2015, BBA-BIOENERGETICS, V1847, P770, DOI 10.1016/j.bbabio.2015.01.001; Chi W, 2010, PLANT J, V64, P14, DOI 10.1111/j.1365-313X.2010.04304.x; Costes Audrey, 2012, Biomolecules, V3, P39, DOI 10.3390/biom3010039; De Septenville AL, 2012, PLOS GENET, V8, P116, DOI 10.1371/journal.pgen.1002622; Deng SK, 2014, NAT STRUCT MOL BIOL, V21, P405, DOI 10.1038/nsmb.2786; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Evans-Roberts KM, 2016, J BIOL CHEM, V291, P3136, DOI 10.1074/jbc.M115.689554; Ferrarini M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-670; Gadaleta MC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8030098; Gaillard H, 2016, ANNU REV BIOCHEM, V85, P291, DOI 10.1146/annurev-biochem-060815-014908; Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88; Ghulam MM, 2012, PLANT MOL BIOL, V79, P259, DOI 10.1007/s11103-012-9910-5; Goldberg S, 2015, METHODS MOL BIOL, V1295, P1, DOI 10.1007/978-1-4939-2550-6_1; Gowrishankar J, 2013, TRANSCR-AUSTIN, V4, P153, DOI 10.4161/trns.25101; Hamperl S, 2016, CELL, V167, P1455, DOI 10.1016/j.cell.2016.09.053; Hartono SR, 2018, J MOL BIOL, V430, P272, DOI 10.1016/j.jmb.2017.12.016; Hricova A, 2006, PLANT PHYSIOL, V141, P942, DOI 10.1104/pp.106.080069; Huang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073092; Ishizaki Y, 2005, PLANT J, V42, P133, DOI 10.1111/j.1365-313X.2005.02362.x; Kamarthapu V, 2015, CURR OPIN MICROBIOL, V24, P15, DOI 10.1016/j.mib.2014.12.005; Kanamaru K, 2001, PLANT CELL PHYSIOL, V42, P1034, DOI 10.1093/pcp/pce155; Kantidze OL, 2016, ACTA NATURAE, V8, P75, DOI 10.32607/20758251-2016-8-2-75-78; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; KLEIN RR, 1990, J BIOL CHEM, V265, P1895; Konig F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178875; Kwon T, 2010, P NATL ACAD SCI USA, V107, P13954, DOI 10.1073/pnas.1004326107; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lee DW, 2006, PLANT PHYSIOL, V140, P466, DOI 10.1104/pp.105.074575; Lepage E, 2013, PLANT PHYSIOL, V163, P867, DOI 10.1104/pp.113.223560; Lerbs-Mache S, 2011, PLANT MOL BIOL, V76, P235, DOI 10.1007/s11103-010-9714-4; Little SE, 1997, LARGE OR SMALL SCALE, P1; Loschelder H, 2006, PLANT PHYSIOL, V142, P642, DOI 10.1104/pp.106.085878; Lysenko EA, 2007, PLANT CELL REP, V26, P845, DOI 10.1007/s00299-007-0318-7; Majeran W, 2012, PLANT PHYSIOL, V158, P156, DOI 10.1104/pp.111.188474; Marechal A, 2009, P NATL ACAD SCI USA, V106, P14693, DOI 10.1073/pnas.0901710106; McDevitt S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03483-7; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Meers C, 2016, DNA REPAIR, V44, P17, DOI 10.1016/j.dnarep.2016.05.002; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Nagashima A, 2004, PLANT CELL PHYSIOL, V45, P357, DOI 10.1093/pcp/pch050; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Nukarinen E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31697; Oh S, 2013, J EXP BOT, V64, P5457, DOI 10.1093/jxb/ert308; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Olejniczak SA, 2016, PLANTA, V244, P517, DOI 10.1007/s00425-016-2551-1; Ortelt J, 2014, METHODS MOL BIOL, V1132, P47, DOI 10.1007/978-1-62703-995-6_3; Parent JS, 2011, PLANT PHYSIOL, V156, P254, DOI 10.1104/pp.111.173849; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prikryl J, 2008, NUCLEIC ACIDS RES, V36, P5152, DOI 10.1093/nar/gkn492; Schlucking K, 2013, MOL PLANT, V6, P1814, DOI 10.1093/mp/sst065; Schweer J, 2006, FEBS LETT, V580, P6617, DOI 10.1016/j.febslet.2006.11.010; Shikanai T, 2013, FUNCTION PPR PROTEIN, P6286, DOI [10.4161/rna.25207, DOI 10.4161/RNA.25207]; Singh SK, 2011, PLANT SIGNAL BEHAV, V6, P120, DOI 10.4161/psb.6.1.14215; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Sollier J, 2015, TRENDS CELL BIOL, V25, P514, DOI 10.1016/j.tcb.2015.05.003; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Stoppel R, 2012, J EXP BOT, V63, P1663, DOI 10.1093/jxb/err401; Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260; Tsunoyama Y, 2004, P NATL ACAD SCI USA, V101, P3304, DOI 10.1073/pnas.0308362101; Tsunoyama Y, 2002, FEBS LETT, V516, P225, DOI 10.1016/S0014-5793(02)02538-3; Villarreal DD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003026; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wei LZ, 2016, DNA REPAIR, V44, P76, DOI 10.1016/j.dnarep.2016.05.009; Weigel D., 2002, ARABIDOPSIS LAB MANU; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Woodson Jesse D, 2013, Plant J, V73, P1, DOI 10.1111/tpj.12011; Wu J, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00243; Xia J, 2019, CELL, V176, P127, DOI 10.1016/j.cell.2018.12.008; Yagi Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00061; Zampini E, 2015, GENOME RES, V25, P645, DOI 10.1101/gr.188573.114; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zghidi W, 2007, NUCLEIC ACIDS RES, V35, P455, DOI 10.1093/nar/gkl1067; ZHANG Y, 2017, PLANT CELL, P1, DOI DOI 10.1105/TPC.17.00065; Zhelyazkova P, 2012, PLANT CELL, V24, P123, DOI 10.1105/tpc.111.089441; Zhong LL, 2013, PLANT CELL, V25, P2925, DOI 10.1105/tpc.113.111229; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x; Zubo YO, 2011, METHODS MOL BIOL, V774, P171, DOI 10.1007/978-1-61779-234-2_11	97	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214552	10.1371/journal.pone.0214552	http://dx.doi.org/10.1371/journal.pone.0214552			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943245	gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300046
J	Paris, AJ; Guo, L; Dai, N; Katzen, JB; Patel, PN; Worthen, S; Brenner, JS				Paris, Andrew J.; Guo, Lei; Dai, Ning; Katzen, Jeremy B.; Patel, Priyal N.; Worthen, Scott; Brenner, Jacob S.			Using selective lung injury to improve murine models of spatially heterogeneous lung diseases	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISTRESS; INFLUENZA-VIRUS; STEM-CELLS; REGENERATION; RESOLUTION	Many lung diseases, such as the acute respiratory distress syndrome (ARDS), display significant regional heterogeneity with patches of severely injured tissue adjacent to apparently healthy tissue. Current mouse models that aim to mimic ARDS generally produce diffuse injuries that cannot reproducibly generate ARDS's regional heterogeneity. This deficiency prevents the evaluation of how well therapeutic agents reach the most injured regions and precludes many regenerative medicine studies since it is not possible to know which apparently healing regions suffered severe injury initially. Finally, these diffuse injury models must be relatively mild to allow for survival, as their diffuse nature does not allow for residual healthy lung to keep an animal alive long enough for many drug and regenerative medicine studies. To solve all of these deficiencies in current animal models, we have created a simple and reproducible technique to selectively induce lung injury in specific areas of the lung. Our technique, catheter-in-catheter selective lung injury (CICSLI), involves guiding an inner catheter to a particular area of the lung and delivering an injurious agent mixed with nanoparticles (fluorescently and/or radioactively labeled) that can be used days later to track the location and extent of where the initial injury occurred. Furthermore, we demonstrate that CICSLI can produce a more severe injury than diffuse models, yet has much higher survival since CICSLI intentionally leaves lung regions undamaged. Collectively, these attributes of CICSLI will allow investigators to better study how drugs act within heterogeneous lung pathologies and how regeneration occurs in severely damaged lung tissue, thereby aiding the development of new therapies for ARDS and other heterogenous lung diseases.	[Paris, Andrew J.; Katzen, Jeremy B.; Patel, Priyal N.; Brenner, Jacob S.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Guo, Lei] Chinese Acad Med Sci, Kunming Natl High Level Biosafety Res Ctr, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Dai, Ning; Worthen, Scott] Univ Penn, Dept Pediat, Div Neonatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Patel, Priyal N.; Brenner, Jacob S.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Patel, Priyal N.; Brenner, Jacob S.] Univ Penn, Perelman Sch Med, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA; [Worthen, Scott] Univ Penn, Penn Ctr Pulm Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Brenner, JS (corresponding author), Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Brenner, JS (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Brenner, JS (corresponding author), Univ Penn, Perelman Sch Med, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA.	Jacob.Brenner@uphs.upenn.edu	Guo, Lei/AEU-0178-2022	Paris, Andrew/0000-0002-9808-071X; Guo, Lei/0000-0003-1733-1802; Patel, Priyal/0000-0003-0569-0699	Univesrty of Pennsylvania Measey Physician Scientist Fellowship Alward; Parker B. Francis Fellowship Program;  [NIH - K08 HL136698];  [K08 HL138269];  [R01 AI099479];  [UG3 TR002198]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UG3TR002198] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL136698, K08HL138269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099479] Funding Source: NIH RePORTER	Univesrty of Pennsylvania Measey Physician Scientist Fellowship Alward; Parker B. Francis Fellowship Program; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded through the generous support of the Univesrty of Pennsylvania Measey Physician Scientist Fellowship Alward (AJP), the Parker B. Francis Fellowship Program (AJP), and multiple grants form the NIH - K08 HL136698 (AJP), K08 HL138269 (JSB), R01 AI099479 (GSW) and UG3 TR002198 (GSW).	Amigoni M, 2008, ANESTHESIOLOGY, V108, P1037, DOI 10.1097/ALN.0b013e318173f64f; ASHBAUGH DG, 1967, LANCET, V2, P319; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bernard G, 2017, NEW ENGL J MED, V377, P507, DOI 10.1056/NEJMp1706595; Brenner Jacob S, 2017, Nanomedicine, V13, P1495, DOI 10.1016/j.nano.2016.12.019; Chapman HA, 2011, NEW ENGL J MED, V364, P1867, DOI 10.1056/NEJMe1101800; Cross LJM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-51; Dames C, 2014, AM J RESP CELL MOL, V51, P730, DOI 10.1165/rcmb.2014-0052MA; Das S, 2013, JOVE-J VIS EXP, DOI 10.3791/50318; Fukunaga K, 2005, J IMMUNOL, V174, P5033, DOI 10.4049/jimmunol.174.8.5033; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Jaramillo-Rocha V, 2017, NEW ENGL J MED, V377, P1903, DOI 10.1056/NEJMc1711824; Kips JC, 2003, EUR RESPIR J, V22, P374, DOI 10.1183/09031936.03.00026403; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; Matthay MA, 2016, JAMA-J AM MED ASSOC, V315, P747, DOI 10.1001/jama.2016.0661; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Morales-Nebreda L, 2014, J VIROL METHODS, V209, P116, DOI 10.1016/j.jviromet.2014.09.004; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Musher DM, 2014, NEW ENGL J MED, V371, P1619, DOI 10.1056/NEJMra1312885; Nuermberger E, 2005, PHARMACOTHERAPY, V25, p134S, DOI 10.1592/phco.2005.25.12part2.134S; Paris AJ, 2016, AM J PHYSIOL-LUNG C, V311, pL1062, DOI 10.1152/ajplung.00327.2016; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ray S, 2016, STEM CELL REP, V7, P817, DOI 10.1016/j.stemcr.2016.09.010; Standiford TJ, 2016, TRANSL RES, V167, P183, DOI 10.1016/j.trsl.2015.04.015; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Vlahos R, 2014, CLIN SCI, V126, P253, DOI 10.1042/CS20130182; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0202456	10.1371/journal.pone.0202456	http://dx.doi.org/10.1371/journal.pone.0202456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943189	gold, Green Published, Green Submitted			2022-12-27	WOS:000463194300001
J	Burns, NM; Bailey, DM; Wright, PJ				Burns, Neil M.; Bailey, David M.; Wright, Peter J.			A method to improve fishing selectivity through age targeted fishing using life stage distribution modelling	PLOS ONE			English	Article							WHITING MERLANGIUS-MERLANGUS; COD GADUS-MORHUA; HADDOCK MELANOGRAMMUS-AEGLEFINUS; FISHERIES-INDUCED EVOLUTION; NORTH-SEA; SPAWNING GROUNDS; ATLANTIC COD; MATURATION SCHEDULES; SPECIES DISTRIBUTION; HABITAT SELECTION	Understanding spatial distributions of fish species is important to those seeking to manage fisheries and advise on marine developments. Distribution patterns, habitat use, and aggregative behaviour often vary throughout the life cycle and can increase the vulnerability of certain life stages to anthropogenic impacts. Here we investigate distribution changes during the life cycle of whiting (Merlangius merlangus) to the west of the UK. Density distributions for age-0, age-1 and mature fish were modelled as functions of environmental variables using generalised additive mixed effects models. The greatest densities of age-0 whiting occurred over finer sediments where temperatures were between 12 to 13 degrees C. Age-0 whiting densities decreased with increasing depth. Higher densities of age-1 whiting were also associated with fine sediments and peaked at 60 m, but this influence was also dependent on proximity to shore. Mature fish, while showing no association with any particular sediment type, were strongly associated with depths >60 m. Geostatistical aggregation curves were used to classify space use and showed persistent aggregations of age-0 whiting occupying inshore waters while age-1 and mature fish were more dispersed and differed among years. The differences in distributions among life stages suggested a general coastal to offshore shift as cohorts developed with mature whiting mainly occupying deep offshore waters. The spatial dynamics and areas of persistent life stage aggregation identified here could enable informed targeting and avoidance of specific age-class whiting to aid bycatch reduction. Given that landing obligation legislation is counterproductive unless it encourages greater fishing selectivity, the ability to avoid this species and undersized individuals would aid conservation measures and fishermen alike.	[Burns, Neil M.; Bailey, David M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Burns, Neil M.; Wright, Peter J.] Marine Lab, Marine Scotland Sci, Aberdeen, Scotland	University of Glasgow; Marine Scotland Science (MSS)	Burns, NM (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.; Burns, NM (corresponding author), Marine Lab, Marine Scotland Sci, Aberdeen, Scotland.	neil.burns@glasgow.ac.uk	WRIGHT, PETER J/C-8536-2011; Bailey, David/A-6240-2008	Bailey, David/0000-0002-0824-8823; Burns, Neil/0000-0002-6453-0161	Scottish Government Clyde 2020 project [ST02i]	Scottish Government Clyde 2020 project	This work was funded by the Scottish Government Clyde 2020 project (ST02i). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2015, ICES J MAR SCI, V72, P436, DOI 10.1093/icesjms/fsu149; Andre Carl, 2016, BMC Research Notes, V9, P63, DOI 10.1186/s13104-016-1878-9; [Anonymous], 2016, ICES DAT PORT OC; Apostolaki P, 2002, CAN J FISH AQUAT SCI, V59, P405, DOI 10.1139/F02-018; Asjes A, 2016, MAR ECOL PROG SER, V553, P203, DOI 10.3354/meps11754; ATKINSON RJA, 1987, J FISH BIOL, V31, P639, DOI 10.1111/j.1095-8649.1987.tb05268.x; Babcock EA, 2005, ICES J MAR SCI, V62, P469, DOI 10.1016/j.icesjms.2005.01.010; Bailey N, 2011, W SCOTLAND MARINE EC; Baskett ML, 2005, ECOL APPL, V15, P882, DOI 10.1890/04-0723; Baudron AR, 2019, FISH RES, V211, P217, DOI 10.1016/j.fishres.2018.10.024; Baudron AR, 2019, P NATL ACAD SCI USA, V116, P2390, DOI 10.1073/pnas.1817295116; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; BGS, 2007, EDINA GEOL DIG SERV; Bivand, 2016, RGEOS INTERFACE GEOM; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; BOWERS AB, 1954, J MAR BIOL ASSOC UK, V33, P97, DOI 10.1017/S0025315400003507; Charrier G, 2007, MAR ECOL PROG SER, V330, P201, DOI 10.3354/meps330201; Ciannelli L, 2013, MAR ECOL PROG SER, V480, P227, DOI 10.3354/meps10067; Colloca F, 2009, MAR ECOL PROG SER, V381, P287, DOI 10.3354/meps07942; Conover DO, 2009, P ROY SOC B-BIOL SCI, V276, P2015, DOI 10.1098/rspb.2009.0003; Conover DO, 2000, MAR ECOL PROG SER, V208, P303; COOPER A, 1983, J FISH BIOL, V22, P317, DOI 10.1111/j.1095-8649.1983.tb04755.x; Coull K, 1998, FISHERIES SENSITIVIT; DAAN N, 1990, NETH J SEA RES, V26, P343, DOI 10.1016/0077-7579(90)90096-Y; Demain DK, 2011, J FISH BIOL, V79, P89, DOI 10.1111/j.1095-8649.2011.02997.x; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Dunlop ES, 2009, ECOL APPL, V19, P1815, DOI 10.1890/08-1404.1; Eigaard OR, 2017, ICES J MAR SCI, V74, P847, DOI 10.1093/icesjms/fsw194; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Enberg K, 2009, EVOL APPL, V2, P394, DOI 10.1111/j.1752-4571.2009.00077.x; Fernandes PG, 2011, ICES J MAR SCI, V68, P1734, DOI 10.1093/icesjms/fsr131; Frank KT, 2018, P NATL ACAD SCI USA, V115, P6422, DOI 10.1073/pnas.1802096115; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Garrod D, 1965, FISH INVEST-LONDON, P24, DOI 10.1371/journal.pgen.1000643; Gonzalez-Irusta JM, 2017, FISH RES, V195, P141, DOI 10.1016/j.fishres.2017.07.005; Gonzalez-Irusta JM, 2016, FISH RES, V183, P180, DOI 10.1016/j.fishres.2016.05.028; Gonzalez-Irusta JM, 2016, ICES J MAR SCI, V73, P304, DOI 10.1093/icesjms/fsv180; GORDON JDM, 1977, J FISH BIOL, V10, P587, DOI 10.1111/j.1095-8649.1977.tb04091.x; Greenstreet SPR, 1997, ICES J MAR SCI, V54, P243, DOI 10.1006/jmsc.1996.0183; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HALLIDAY RG, 1988, NAFO SCI COUN STUDIE, V12, P27; HAWKINS AD, 1978, J MAR BIOL ASSOC UK, V58, P891, DOI 10.1017/S0025315400056848; Heath MR, 2012, P ROY SOC B-BIOL SCI, V279, P543, DOI 10.1098/rspb.2011.1015; Heino M, 1998, CAN J FISH AQUAT SCI, V55, P1971, DOI 10.1139/cjfas-55-8-1971; Heino M, 2002, B MAR SCI, V70, P639; Heino M, 2015, ANNU REV ECOL EVOL S, V46, P461, DOI 10.1146/annurev-ecolsys-112414-054339; Hijmans RJ, 2014, RASTER GEOGRAPHIC DA, DOI [10.1016/j.indcrop.2009.04.001, DOI 10.1016/J.INDCROP.2009.04.001]; Hislop J. R. G., 1975, ICES J MAR SCI, V36, P119, DOI [10.1093/icesjms/36.2.119, DOI 10.1093/ICESJMS/36.2.119]; HISLOP JRG, 1976, J CONSEIL, V37, P98; HISLOP JRG, 1974, J CONSEIL, V36, P42; HISLOP JRG, 1991, ICES J MAR SCI, V48, P139, DOI 10.1093/icesjms/48.2.139; Hunter A, 2015, FISH RES, V170, P14, DOI 10.1016/j.fishres.2015.05.004; ICES, 2017, ICES CM DOC; ICES, 2010, MAN INT BOTT TRAWL S; ICES, 2016, ADV JUN 2016 CELT SE, P1; International Hydrographic Organization, 2014, INT HYDR ORG PUBL B, P331, DOI [10.1016/0198-0149(86)90015-4, DOI 10.1016/0198-0149(86)90015-4]; Keitt TH., 2010, RGDAL BINDINGS GEOSP; Kelleher K., 2005, FAO FISHERIES TECHNI; Kuparinen A, 2009, EVOL APPL, V2, P234, DOI 10.1111/j.1752-4571.2009.00070.x; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Le Pape O, 2003, J SEA RES, V50, P139, DOI 10.1016/S1385-1101(03)00059-5; Le Quesne WJF, 2007, FISH FISH, V8, P181, DOI 10.1111/j.1467-2679.2007.00246.x; Lelievre S, 2014, J SEA RES, V91, P1, DOI 10.1016/j.seares.2014.03.008; Lloret J, 2002, ICES J MAR SCI, V59, P1215, DOI 10.1006/jmsc.2002.1294; Long D., 2006, FOLK; Loots C, 2011, FISH OCEANOGR, V20, P18, DOI 10.1111/j.1365-2419.2010.00564.x; MacCall AD, 1988, DYNAMIC GEOGRAPHY MA; Marteinsdottir G, 2000, ICES J MAR SCI, V57, P824, DOI 10.1006/jmsc.2000.0568; Matthiopoulos J, 2015, ECOL MONOGR, V85, P413, DOI 10.1890/14-2244.1; Mengual B, 2016, OCEAN DYNAM, V66, P1181, DOI 10.1007/s10236-016-0974-7; Metz J, 2000, CAMBRIDGE STUDIES AD, DOI [10.1017/CBO9780511525537, DOI 10.1017/CBO9780511525537]; Millar RB, 1999, REV FISH BIOL FISHER, V9, P89, DOI 10.1023/A:1008838220001; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Myers RA, 1996, MAR ECOL PROG SER, V138, P293, DOI 10.3354/meps138293; Nychka D., 2017, FIELDS TOOLS SPATIAL, DOI [10.5065/D6W957CT, DOI 10.5065/D6W957CT.R]; Oberle FKJ, 2016, J MARINE SYST, V159, P120, DOI 10.1016/j.jmarsys.2015.12.008; Petitgas P, 1998, ICES J MAR SCI, V55, P443, DOI 10.1006/jmsc.1997.0345; Povoa I, 2011, AQUAC RES, V42, P386, DOI 10.1111/j.1365-2109.2010.02632.x; R Core Team, 2018, R LANG ENV STAT COMP; Riley K., 2007, MARINE LIFE INFORM N; ROBB AP, 1981, J FISH BIOL, V18, P183, DOI 10.1111/j.1095-8649.1981.tb02813.x; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; Schrope M, 2010, NATURE, V465, P540, DOI 10.1038/465540a; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Sheridan A.K., 1995, Reviews in Fisheries Science, V3, P91; Simmonds EJ, 2007, ICES J MAR SCI, V64, P686, DOI 10.1093/icesjms/fsm045; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stefansson G, 1996, ICES J MAR SCI, V53, P577, DOI 10.1006/jmsc.1996.0079; Tobin D, 2010, MAR BIOL, V157, P1063, DOI 10.1007/s00227-009-1387-7; Trenkel VM, 2005, MAR ECOL PROG SER, V299, P257, DOI 10.3354/meps299257; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Ummenhofer CC, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0135; USDC (U. S. Department of Commerce), 2007, MAGN STEV FISH CONS, P178; van Overzee HMJ, 2015, REV FISH BIOL FISHER, V25, P65, DOI 10.1007/s11160-014-9370-x; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Whitehead PJP, 1989, FISHES NE ATLANTIC M, VI; WINTERS GH, 1985, CAN J FISH AQUAT SCI, V42, P989, DOI 10.1139/f85-124; Wood S., 2014, GAMM4 GEN ADDITIVE M; Wright PJ, 2014, ICES J MAR SCI, V71, P1393, DOI 10.1093/icesjms/fsu100; Wright PJ, 2011, ICES J MAR SCI, V68, P1918, DOI 10.1093/icesjms/fsr111; Zuur Alain F., 2009, P1	104	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214459	10.1371/journal.pone.0214459	http://dx.doi.org/10.1371/journal.pone.0214459			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939152	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000462993900022
J	Sanada, TJ; Sakao, S; Naito, A; Ishibashi-Ueda, H; Suga, M; Shoji, H; Miwa, H; Suda, R; Iwasawa, S; Tada, Y; Ishida, K; Tanabe, N; Tatsumi, K				Sanada, Takayuki Jujo; Sakao, Seiichiro; Naito, Akira; Ishibashi-Ueda, Hatsue; Suga, Masaki; Shoji, Hiroki; Miwa, Hideki; Suda, Rika; Iwasawa, Shunichiro; Tada, Yuji; Ishida, Keiichi; Tanabe, Nobuhiro; Tatsumi, Koichiro			Characterization of pulmonary intimal sarcoma cells isolated from a surgical specimen: In vitro and in vivo study	PLOS ONE			English	Article							KINASE INHIBITOR; ARTERY SARCOMA; PAZOPANIB; RECEPTOR; GROWTH; TARGETS; CANCER	Pulmonary intimal sarcoma (PIS) constitutes a rare sarcoma originating from the intimal cells of pulmonary arteries. The pathogenesis of PIS remains to be elucidated and specific treatments have not been established; therefore, prognosis is generally poor. The purpose of our study was to isolate and characterize PIS cells from a specimen resected from a patient with PIS. The surgical specimen was minced and incubated, and spindle-shaped and small cells were successfully isolated and designated as PIS-1. PIS-1 cells at passages 8-9 were used for all in vitro and in vivo experiments. Immunocytochemistry showed that PIS-1 cells were positive for vimentin, murine double minute 2, and CD44 and negative for a-smooth muscle actin, CD31, von Willebrand factor, and desmin. PIS-1 cells exhibited the hallmarks of malignant cells including the potential for autonomous proliferation, anchorage-independent growth, invasion, genetic instability, and tumorigenicity in severe combined immunodeficiency mice. The PIS-1 cells highly expressed tyrosine kinase receptors such as platelet-derived growth factor receptor, and vascular endothelial growth factor receptor 2. Pazopanib, a multi-targeted tyrosine kinase inhibitor, suppressed the proliferation of PIS-1 cells in vitro and the growth of tumors formed from xenografted PIS-1 cells. A PIS cell line was thus successfully established. The PIS-1 cells highly expressed tyrosine kinase receptors, which may be a target for treatment of PIS.	[Sanada, Takayuki Jujo; Sakao, Seiichiro; Naito, Akira; Suga, Masaki; Shoji, Hiroki; Miwa, Hideki; Suda, Rika; Iwasawa, Shunichiro; Tada, Yuji; Tanabe, Nobuhiro; Tatsumi, Koichiro] Chiba Univ, Dept Respirol B2, Grad Sch Med, Chiba, Japan; [Sanada, Takayuki Jujo; Tanabe, Nobuhiro] Chiba Univ, Dept Adv Med Pulm Hypertens, Grad Sch Med, Chiba, Japan; [Naito, Akira; Iwasawa, Shunichiro] Chiba Univ, Dept Adv Res Treatment Strategies Resp Dis, Grad Sch Med, Chiba, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka, Japan; [Ishida, Keiichi] Chiba Univ, Grad Sch Med, Dept Cardiovasc Surg, Chiba, Japan	Chiba University; Chiba University; Chiba University; National Cerebral & Cardiovascular Center - Japan; Chiba University	Sanada, TJ (corresponding author), Chiba Univ, Dept Respirol B2, Grad Sch Med, Chiba, Japan.; Sanada, TJ (corresponding author), Chiba Univ, Dept Adv Med Pulm Hypertens, Grad Sch Med, Chiba, Japan.	naikamo_resp19184@chiba-u.jp	Jujo, Takayuki/Q-7627-2018	Jujo, Takayuki/0000-0001-5725-1810	Japan Society for the Promotion of Science from the Ministry of Culture, Sports, Science, and Technology of Japan [16K19444]; Ministry of Health, Labor, and Welfare, Japan; Japan Agency for Medical Research and Development (AMED) [27280401]; Japan Society for the Promotion of Science KAKENHI from the Ministry of Culture, Sports, Science, and Technology of Japan [15K09210]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25461148]; Japan Society for the Promotion of Science KAKENHI [17H04181]; AMED [16ek0109127h0002]	Japan Society for the Promotion of Science from the Ministry of Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science KAKENHI from the Ministry of Culture, Sports, Science, and Technology of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED	T.J.S was supported by a Grant-in-Aid for Young Scientists (Japan Society for the Promotion of Science KAKENHI Grant Number 16K19444) from the Ministry of Culture, Sports, Science, and Technology of Japan; S.S. was supported by research grants to the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group of the Ministry of Health, Labor, and Welfare, Japan, a grant to the Pulmonary Hypertension Research Group (27280401) from the Japan Agency for Medical Research and Development (AMED) and a Grant-in-Aid for Scientific Research (Japan Society for the Promotion of Science KAKENHI Grant Number 15K09210) from the Ministry of Culture, Sports, Science, and Technology of Japan; N.T. was supported by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (25461148), and a grant to The Intractable Respiratory Diseases and Pulmonary Hypertension Research Group of the Ministry of Health, Labor, and Welfare, Japan (27280401); and K.T. was supported by a Grant-in-Aid for Scientific Research (Japan Society for the Promotion of Science KAKENHI Grant Number 17H04181) and grants to the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group from the Ministry of Health, Labor, and Welfare, Japan and to the Pulmonary Hypertension Research Group from AMED (No. 16ek0109127h0002). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN NH, 1973, JOHNS HOPKINS MED J, V133, P214; Bacha EA, 1999, EUR J CARDIO-THORAC, V15, P456, DOI 10.1016/S1010-7940(99)00045-7; Blackmon SH, 2009, ANN THORAC SURG, V87, P977, DOI 10.1016/j.athoracsur.2008.08.018; Bode-Lesniewska B, 2013, WHO CLASSIFICATION T, P232; Bode-Lesniewska B, 2002, PATHOLOGY GENETICS T, P223; Dewaele B, 2010, CANCER RES, V70, P7304, DOI 10.1158/0008-5472.CAN-10-1543; Funatsu Y, 2016, INTERNAL MED, V55, P2197, DOI 10.2169/internalmedicine.55.6199; Gan HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hosaka S, 2012, J ORTHOP RES, V30, P1493, DOI 10.1002/jor.22091; Jujo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087489; Jujo T, 2012, INT J ONCOL, V41, P701, DOI 10.3892/ijo.2012.1493; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kerr KM, 2005, NAT CLIN PRACT CARD, V2, P108, DOI 10.1038/ncpcardio0118; Kim ST, 2014, MOL CANCER THER, V13, P2527, DOI 10.1158/1535-7163.MCT-14-0255; Kollar A, 2017, ACTA ONCOL, V56, P88, DOI 10.1080/0284186X.2016.1234068; Li HF, 2014, TRANSL ONCOL, V7, P665, DOI 10.1016/j.tranon.2014.09.007; Mandelstamm M, 1923, VIRCHOWS ARCH A, V245, P43, DOI 10.1007/BF01992097; Maruoka M, 2012, INT J CARDIOL, V159, P119, DOI 10.1016/j.ijcard.2011.02.037; Miura S, 2005, PATHOL RES PRACT, V201, P469, DOI 10.1016/j.prp.2005.06.001; NONOMURA A, 1988, ACTA PATHOL JAPON, V38, P883; Outani H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-455; Ozbek C, 2007, TEX HEART I J, V34, P119; Quesada Jorge, 2012, Sarcoma, V2012, P849456, DOI 10.1155/2012/849456; Sakao S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-109; Tamborini E, 2007, J PATHOL, V212, P227, DOI 10.1002/path.2177; Vasuri F, 2012, HISTOPATHOLOGY, V61, P737, DOI 10.1111/j.1365-2559.2012.04241.x; Wong HH, 2015, CLIN SARCOMA RES, V5, DOI 10.1186/s13569-014-0019-2	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214654	10.1371/journal.pone.0214654	http://dx.doi.org/10.1371/journal.pone.0214654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925179	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300025
J	Boehm, M; Bukosza, EN; Huttary, N; Herzog, R; Aufricht, C; Kratochwill, K; Gebeshuber, CA				Boehm, Michael; Bukosza, Eva Nora; Huttary, Nicole; Herzog, Rebecca; Aufricht, Christoph; Kratochwill, Klaus; Gebeshuber, Christoph A.			A systems pharmacology workflow with experimental validation to assess the potential of anakinra for treatment of focal and segmental glomerulosclerosis	PLOS ONE			English	Article							MMP-9 CONTRIBUTE; RECEPTOR; EXPRESSION; INDUCTION; PODOCYTES; DISEASE; DRUGS; MODEL; GENE	Focal and Segmental Glomerulosclerosis (FSGS) is a severe glomerulopathy that frequently leads to end stage renal disease. Only a subset of patients responds to current therapies, making it important to identify alternative therapeutic options. The interleukin (IL)-1 receptor antagonist anakinra is beneficial in several diseases with renal involvement. Here, we evaluated the potential of anakinra for FSGS treatment. Molecular process models obtained from scientific literature data were used to build FSGS pathology and anakinra mechanism of action models by exploiting information on protein interactions. These molecular models were compared by statistical interference analysis and expert based molecular signature matching. Experimental validation was performed in Adriamycin- and lipopolysaccharide (LPS)-induced nephropathy mouse models. Interference analysis (containing 225 protein coding genes and 8 molecular process segments) of the FSGS molecular pathophysiology model with the drug mechanism of action of anakinra identified a statistically significant overlap with 43 shared molecular features that were enriched in pathways relevant in FSGS, such as plasminogen activating cascade, inflammation and apoptosis. Expert adjudication of molecular signature matching, focusing on molecular process segments did not suggest a high therapeutic potential of anakinra in FSGS. In line with this, experimental validation did not result in altered proteinuria or significant changes in expression of the FSGS-relevant genes COL1A1 and NPHS1. In summary, an integrated bioinformatic and experimental workflow showed that FSGS relevant molecular processes can be significantly affected by anakinra beyond the direct drug target IL-1 receptor type 1 (IL1R1) context but might not counteract central pathophysiology processes in FSGS. Anakinra is therefore not suggested for extended preclinical trials.	[Boehm, Michael; Herzog, Rebecca; Aufricht, Christoph; Kratochwill, Klaus] Med Univ Vienna, Div Pediat Nephrol & Gastroenterol, Dept Pediat & Adolescent Med, Vienna, Austria; [Bukosza, Eva Nora] Semmelweis Univ Budapest, Inst Pathophysiol, Budapest, Hungary; [Huttary, Nicole] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Herzog, Rebecca; Kratochwill, Klaus] Med Univ Vienna, Dept Pediat & Adolescent Med, Christian Doppler Lab Mol Stress Res Peritoneal D, Vienna, Austria; [Gebeshuber, Christoph A.] Epsilon 3 Gmbh, Vienna, Austria	Medical University of Vienna; Semmelweis University; Medical University of Vienna; Medical University of Vienna	Kratochwill, K (corresponding author), Med Univ Vienna, Div Pediat Nephrol & Gastroenterol, Dept Pediat & Adolescent Med, Vienna, Austria.; Kratochwill, K (corresponding author), Med Univ Vienna, Dept Pediat & Adolescent Med, Christian Doppler Lab Mol Stress Res Peritoneal D, Vienna, Austria.; Gebeshuber, CA (corresponding author), Epsilon 3 Gmbh, Vienna, Austria.	klaus.kratochwill@meduniwien.ac.at; c.gebeshuber@epsilon3.at		Herzog, Rebecca/0000-0003-1946-7770; Gebeshuber, Christoph A/0000-0003-3293-4572; Kratochwill, Klaus/0000-0003-0803-614X	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; Austrian Science Fund [FWF -P26967-B20]	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; Austrian Science Fund(Austrian Science Fund (FWF))	The financial support by the Austrian Federal Ministry of Science, Research and Economy and the National Foundation for Research, Technology and Development is gratefully acknowledged (CDL-MSRPD; RH, KK). CAG was partially funded by the Austrian Science Fund (FWF -P26967-B20). The funder (Epsilon 3 Gmbh) provided support in the form of salary for CAG and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsar B, 2018, DRUGS, V78, P1073, DOI 10.1007/s40265-018-0942-2; Akar S, 2018, ARTHRIT CARE RES, V70, P1090, DOI 10.1002/acr.23446; [Anonymous], 2016, KINERET HIGHLIGHTS P; Aschauer C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169518; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Cheng FX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05116-5; Chu SC, 2006, J RHEUMATOL, V33, P311; Czech KA, 2011, PEDIATR NEPHROL, V26, P2179, DOI 10.1007/s00467-011-1897-7; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; Dalgic B, 2007, PEDIATR NEPHROL, V22, P1391, DOI 10.1007/s00467-007-0500-8; Heerspink HJL, 2015, NEPHROL DIAL TRANSPL, V30, P105, DOI 10.1093/ndt/gfv210; Heinzel A, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00037; Heinzel A, 2014, METHODS MOL BIOL, V1159, P109, DOI 10.1007/978-1-4939-0709-0_7; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Kemper MJ, 2018, PEDIATR NEPHROL, V33, P1641, DOI 10.1007/s00467-017-3780-7; Kratochwill K, 2012, NEPHROL DIAL TRANSPL, V27, P937, DOI 10.1093/ndt/gfr459; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Liu SY, 2006, MOL CELL BIOCHEM, V284, P9, DOI 10.1007/s11010-005-9005-6; Maas RJH, 2013, PEDIATR NEPHROL, V28, P1041, DOI 10.1007/s00467-013-2452-5; Mayer B, 2016, DIABETOLOGIA, V59, P2503, DOI 10.1007/s00125-016-4032-2; Mayer P, 2012, NEPHROL DIAL TRANSPL, V27, P3995, DOI 10.1093/ndt/gfs489; Mia MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091559; Niemir ZI, 1997, KIDNEY INT, V52, P393, DOI 10.1038/ki.1997.346; Panchapakesan U, 2018, KIDNEY INT, V94, P40, DOI 10.1016/j.kint.2017.12.026; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Pullen N, 2016, KIDNEY INT, V89, P1211, DOI 10.1016/j.kint.2015.12.058; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rosenberg AZ, 2017, CLIN J AM SOC NEPHRO, V12, P502, DOI 10.2215/CJN.05960616; Saha TC, 2006, SOUTH MED J, V99, P1264, DOI 10.1097/01.smj.0000243183.87381.c2; Saleem M. A., 2016, F1000RES, V5; Topaloglu R, 2016, PEDIATR NEPHROL, V31, P633, DOI 10.1007/s00467-015-3249-5; Trachtman H, 2017, EXPERT OPIN INV DRUG, V26, P945, DOI 10.1080/13543784.2017.1351544; Trautmann A, 2017, J AM SOC NEPHROL, V28, P3055, DOI 10.1681/ASN.2016101121; Wang CS, 2018, AM J KIDNEY DIS, V71, P392, DOI 10.1053/j.ajkd.2017.09.025; Wang XY, 2005, INT J MOL MED, V16, P1117; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214332	10.1371/journal.pone.0214332	http://dx.doi.org/10.1371/journal.pone.0214332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921378	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000056
J	Latour, K; Huang, TD; Jans, B; Berhin, C; Bogaerts, P; Noel, A; Nonhoff, C; Dodemont, M; Denis, O; Ieven, M; Loens, K; Schoevaerdts, D; Catry, B; Glupczynski, Y				Latour, Katrien; Huang, Te-Din; Jans, Beatrice; Berhin, Catherine; Bogaerts, Pierre; Noel, Audrey; Nonhoff, Claire; Dodemont, Magali; Denis, Olivier; Ieven, Margareta; Loens, Katherine; Schoevaerdts, Didier; Catry, Boudewijn; Glupczynski, Youri			Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015	PLOS ONE			English	Article							TERM-CARE FACILITIES; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE; STAPHYLOCOCCUS-AUREUS; RISK-FACTORS; COLONIZATION; RESIDENTS; CARRIAGE; BACTERIA; EPIDEMIOLOGY	Objectives Following two studies conducted in 2005 and 2011, a third prevalence survey of multidrug-resistant microorganisms (MDRO) was organised in Belgian nursing homes (NHs) using a similar methodology. The aim was to measure the prevalence of carriage of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBLE) and carbapenemase-producing Enterobacteriaceae (CPE) in NH residents. Risk factors for MDRO carriage were also explored. Methods Up to 51 randomly selected residents per NH were screened for MDRO carriage by trained local nurses between June and October 2015. Rectal swabs were cultured for ESBLE, CPE and VRE, while pooled samples of nose, throat and perineum and chronic wound swabs were obtained for culture of MRSA. Antimicrobial susceptibility testing, molecular detection of resistance genes and strain genotyping were performed. Significant risk factors for MDRO colonization MDRO was determined by univariate and multivariable analysis. Results Overall, 1447 residents from 29 NHs were enrolled. The mean weighted prevalence of ESBLE and MRSA colonization was 11.3% and 9.0%, respectively. Co-colonization occurred in 1.8% of the residents. VRE and CPE carriage were identified in only one resident each. Impaired mobility and recent treatment with fluoroquinolones or with combinations of sulphonamides and trimethoprim were identified as risk factors for ESBLE carriage, while for MRSA these were previous MRSA carriage/infection, a stay in several different hospital wards during the past year, and a recent treatment with nitrofuran derivatives. Current antacid use was a predictor for both ESBL and MRSA carriage. Conclusions In line with the evolution of MRSA and ESBL colonization/infection in hospitals, a decline in MRSA carriage and an increase in ESBLE prevalence was seen in Belgian NHs between 2005 and 2015. These results show that a systemic approach, including surveillance and enhancement of infection control and antimicrobial stewardship programs is needed in both acute and chronic care facilities.	[Latour, Katrien; Jans, Beatrice; Catry, Boudewijn] Sciensano, Operat Directorate Epidemiol & Publ Hlth, Brussels, Belgium; [Latour, Katrien] Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Huang, Te-Din; Berhin, Catherine; Bogaerts, Pierre; Noel, Audrey; Glupczynski, Youri] Catholic Univ Louvain, Natl Reference Ctr Antibiot Resistant Gram Negat, Ctr Hosp Univ Namur, Lab Clin Microbiol, Yvoir, Belgium; [Nonhoff, Claire; Dodemont, Magali] Univ Libre Bruxelles, Dept Clin Microbiol, Natl Reference Ctr Methicillin Resistant Staphylo, Hop Erasme, Brussels, Belgium; [Denis, Olivier; Catry, Boudewijn] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Ieven, Margareta; Loens, Katherine] Univ Hosp Antwerp, Dept Clin Microbiol, Natl Reference Ctr Vancomycin Resistant Enterococ, Edegem, Belgium; [Schoevaerdts, Didier] Catholic Univ Louvain, Ctr Hosp Univ Namur, Dept Geriatr Med, Mont Godinne, Belgium; [Schoevaerdts, Didier] Catholic Univ Louvain, Inst Hlth & Soc, Ecole Sante Publ, Brussels, Belgium	Sciensano; KU Leuven; Universite Catholique Louvain; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Antwerp; Universite Catholique Louvain; Universite Catholique Louvain	Latour, K (corresponding author), Sciensano, Operat Directorate Epidemiol & Publ Hlth, Brussels, Belgium.; Latour, K (corresponding author), Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium.	katrien.latour@sciensano.be		Noel, Audrey/0000-0003-4600-8529; Latour, Katrien/0000-0001-9113-7712	Belgian Antibiotic Policy Coordination Committee	Belgian Antibiotic Policy Coordination Committee	This study was organized with the support of the Belgian Antibiotic Policy Coordination Committee. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2017, J ANTIMICROB CHEMOTH, V72, P56, DOI 10.1093/jac/dkw380; Aschbacher R, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0136-1; Belgian Antibiotic Policy Coordination Committee, 2017, GUID BELG TRAIT ANT; Belgian Antibiotic Policy Coordination Committee, 2017, REC TRAIT ANT MIL HO; Belgian Infection Control Society, 2008, BICS, P1; Ben-Ami R, 2006, CLIN INFECT DIS, V42, P925, DOI 10.1086/500936; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; BenAbdelhafidh L, 2016, 2017015 IPHEPI; Benenson S, 2009, INFECT CONT HOSP EP, V30, P786, DOI 10.1086/598345; Blay N, 2017, J CLIN NURS, V26, P4822, DOI 10.1111/jocn.13838; Bogaerts P, 2013, J ANTIMICROB CHEMOTH, V68, P2414, DOI 10.1093/jac/dkt201; Bonomo RA, 2000, CLIN INFECT DIS, V31, P1414, DOI 10.1086/317489; Bradley SF, 1999, INFECT CONT HOSP EP, V20, P362, DOI 10.1086/501637; Cassone M, 2015, CURR GERIATR REP, V4, P87, DOI 10.1007/s13670-015-0120-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Conseil superieur de la Sante, 2017, REC PREV MAITR PRIS; Conseil superieur Sante, 2012, MES EM ENT PROD CARB; Cunha CB, 2016, AM J INFECT CONTROL, V44, P126, DOI 10.1016/j.ajic.2015.09.019; Denis O, 2009, J ANTIMICROB CHEMOTH, V64, P1299, DOI 10.1093/jac/dkp345; Dinkelacker AG, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00843-18, 10.1128/jcm.00843-18]; El Emam K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093285; Elizaga ML, 2002, CLIN INFECT DIS, V34, P441, DOI 10.1086/338461; EUCAST,, 2019, BREAKPOINT TABLES IN; European Centre for Disease Prevention and Control, 2013, POINT PREV SURV HEAL; Flokas ME, 2017, INT J ANTIMICROB AG, V50, P649, DOI 10.1016/j.ijantimicag.2017.08.003; Fonguh S, 2015, 201554 IPHEPI, V2015-54; Fonguh S, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0159-3; Garazi M, 2009, J AM MED DIR ASSOC, V10, P414, DOI 10.1016/j.jamda.2009.02.014; GDEPIH-GOSPIZ, 2003, BICS, P1; GDEPIH-GOSPIZ, 2005, MES PREV TRANSM STAP; Giufre M, 2017, CLIN MICROBIOL INFEC, V23, P961, DOI 10.1016/j.cmi.2017.04.006; Gruber I, 2013, INT J MED MICROBIOL, V303, P405, DOI 10.1016/j.ijmm.2013.05.002; Harrison EM, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0353-5; Hayakawa K, 2013, ANTIMICROB AGENTS CH, V57, P4010, DOI 10.1128/AAC.02516-12; Huizinga P, 2017, CLIN INFECT DIS, V64, P361, DOI 10.1093/cid/ciw743; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Jans B, 2016, 2016020 IPHEPI; Jans B, 2013, 2013037 IPHEPI; Jans B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064908; Latour K., 2012, BRUSS BELG INF CONTR; Lin MY, 2013, CLIN INFECT DIS, V57, P1246, DOI 10.1093/cid/cit500; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Ludden C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0880-5; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; McKinnell JA, 2016, INFECT CONT HOSP EP, V37, P1485, DOI 10.1017/ice.2016.215; Moro ML, 2010, INFECT CONT HOSP EP, V31, pS59, DOI 10.1086/655989; Nicolle LE, 2000, CLIN INFECT DIS, V31, P752, DOI 10.1086/314010; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; O'Fallon E, 2009, INFECT CONT HOSP EP, V30, P1172, DOI 10.1086/648453; Patel J.B., 2015, PERFORMANCE STANDARD; Prabaker K, 2012, INFECT CONT HOSP EP, V33, P1193, DOI 10.1086/668435; Reuland EA, 2016, J ANTIMICROB CHEMOTH, V71, P1076, DOI 10.1093/jac/dkv441; Rodriguez-Villalobos H, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkq388; Rooney PJ, 2009, J ANTIMICROB CHEMOTH, V64, P635, DOI 10.1093/jac/dkp220; Ruiz-Garbajosa P, 2016, J ANTIMICROB CHEMOTH, V71, P348, DOI 10.1093/jac/dkv355; Saegeman VSM, 2014, ACTA CLIN BELG, V69, P30, DOI 10.1179/0001551213Z.00000000013; Stuart RL, 2011, MED J AUSTRALIA, V195, P530, DOI 10.5694/mja11.10724; van den Dool C, 2016, INFECT CONT HOSP EP, V37, P761, DOI 10.1017/ice.2016.59; Vovko P, 2005, INFECT CONT HOSP EP, V26, P191, DOI 10.1086/502525; Zhao SY, 2016, EPIDEMIOL INFECT, V144, P695, DOI 10.1017/S0950268815001879	62	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214327	10.1371/journal.pone.0214327	http://dx.doi.org/10.1371/journal.pone.0214327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921364	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000055
J	Rodriques, SG; Marblestone, AH; Boyden, ES				Rodriques, Samuel G.; Marblestone, Adam H.; Boyden, Edward S.			A theoretical analysis of single molecule protein sequencing via weak binding spectra	PLOS ONE			English	Article							ELECTRICAL DETECTION; LABEL-FREE; SPECTROSCOPY	We propose and theoretically study an approach to massively parallel single molecule peptide sequencing, based on single molecule measurement of the kinetics of probe binding (Havranek, et al., 2013) to the N-termini of immobilized peptides. Unlike previous proposals, this method is robust to both weak and non-specific probe-target affinities, which we demonstrate by applying the method to a range of randomized affinity matrices consisting of relatively low-quality binders. This suggests a novel principle for proteomic measurement whereby highly non-optimized sets of low-affinity binders could be applicable for protein sequencing, thus shifting the burden of amino acid identification from biomolecular design to readout. Measurement of probe occupancy times, or of time-averaged fluorescence, should allow high-accuracy determination of N-terminal amino acid identity for realistic probe sets. The time-averaged fluorescence method scales well to weakly-binding probes with dissociation constants of tens or hundreds of micromolar, and bypasses photobleaching limitations associated with other fluorescence-based approaches to protein sequencing. We argue that this method could lead to an approach with single amino acid resolution and the ability to distinguish many canonical and modified amino acids, even using highly non-optimized probe sets. This readout method should expand the design space for single molecule peptide sequencing by removing constraints on the properties of the fluorescent binding probes.	[Rodriques, Samuel G.; Marblestone, Adam H.; Boyden, Edward S.] MIT, Synthet Neurobiol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rodriques, Samuel G.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, McGovern Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Boyden, ES (corresponding author), MIT, Synthet Neurobiol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, McGovern Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	esb@media.mit.edu		Rodriques, Samuel/0000-0002-2509-0861; /0000-0002-0419-3351	Hertz Fellowship; NIH [1R01MH114031, 1R01EB024261]; Open Philanthropy; U.S. Army Research Office [W911NF1510548]; NIH Director's Pioneer Award [1DP1NS087724]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB024261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH114031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS087724] Funding Source: NIH RePORTER	Hertz Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Philanthropy; U.S. Army Research Office; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	SR acknowledges the Hertz Fellowship. ESB acknowledges NIH 1R01MH114031, John Doerr, Open Philanthropy, NIH 1R01EB024261, the HHMI-Simons Faculty Scholars Program, U.S. Army Research Laboratory and the U.S. Army Research Office under contract/grant number W911NF1510548, and NIH Director's Pioneer Award 1DP1NS087724. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellin DL, 2014, BIOMED CIRC SYST C, P476, DOI 10.1109/BioCAS.2014.6981766; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Borgo B, 2014, PROTEIN SCI; Borgo B, 2014, STRATEGIES COMPUTATI; Borgo B, 2014, PROTEIN SCI, V23, P312, DOI 10.1002/pro.2417; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Chandradoss SD, 2014, JOVE-J VIS EXP, DOI 10.3791/50549; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Finkelstein IJ, 2011, METHODS MOL BIOL, V745, P447, DOI 10.1007/978-1-61779-129-1_26; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Freitas JA, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709512; Fuller CW, 2016, P NATL ACAD SCI USA, V113, P5233, DOI 10.1073/pnas.1601782113; Garalde DR, 2018, NAT METHODS, V15, P201, DOI [10.1038/NMETH.4577, 10.1038/nmeth.4577]; Groll J, 2010, METHOD ENZYMOL, V472, P1, DOI 10.1016/S0076-6879(10)72019-X; Guo N, 2014, SENSORS-BASEL, V14, P20602, DOI 10.3390/s141120602; Havranek JJ, 2013, Patent No. [US20140273004A1, 20140273004]; Joo C, 2013, TRENDS BIOCHEM SCI, V38, P30, DOI 10.1016/j.tibs.2012.10.005; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Kolmogorov M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005356; Laursen RA, 1971, FEBS J, V20, P89; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lu N, 2014, ACS APPL MATER INTER, V6, P20378, DOI 10.1021/am505915y; Lu Y, 2015, SCIENCE, V347, P1132, DOI 10.1126/science.aaa0946; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; Mitra RD, 2010, SINGLE MOL PROTEIN S; Nemoto N, 1999, FEBS LETT, V462, P43, DOI 10.1016/S0014-5793(99)01474-X; Nivala J, 2013, NAT BIOTECHNOL, V31, P247, DOI 10.1038/nbt.2503; Pan H, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/4/045006; Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101; Pennacchietti F, 2017, BIOPHYS J, V113, P2037, DOI 10.1016/j.bpj.2017.08.054; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Sampath G., 2015, BIORXIV; Schlau-Cohen GS, 2013, P NATL ACAD SCI USA, V110, P10899, DOI 10.1073/pnas.1310222110; Selvin P., 2008, SINGLE MOL TECHNIQUE; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Sorgenfrei S, 2011, NAT NANOTECHNOL, V6, P125, DOI 10.1038/nnano.2010.275; Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498; Swaminathan J, 2014, BIORXIV; Swaminathan J, 2018, NAT BIOTECHNOL, V36, P1076, DOI 10.1038/nbt.4278; Tessler LA, 2011, PROTEOMICS, V11, P4731, DOI 10.1002/pmic.201100361; Tessler LA, 2011, J R SOC INTERFACE, V8, P1400, DOI 10.1098/rsif.2010.0669; van Ginkel J, 2017, BIOPHYS J, V112, p471A, DOI 10.1016/j.bpj.2016.11.2529; van Oijen AM, 2011, CURR OPIN BIOTECH, V22, P75, DOI 10.1016/j.copbio.2010.10.002; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Xu GQ, 2011, ACS CHEM BIOL, V6, P1015, DOI 10.1021/cb200164h; Yao Y, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/5/055003	51	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0212868	10.1371/journal.pone.0212868	http://dx.doi.org/10.1371/journal.pone.0212868			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921350	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000013
J	Shin, JH; Choi, Y; Park, B; Shin, NY; Jang, J; Choi, HS; Jung, SL; Ahn, K; Kim, BS				Shin, Jae Ho; Choi, Yangsean; Park, Borim; Shin, Na-Young; Jang, Jinhee; Choi, Hyun Seok; Jung, So Lyung; Ahn, Kookjin; Kim, Bum-soo			Diagnostic accuracy and efficiency of combined acquisition of low-dose time- resolved and single-phase high-resolution contrast-enhanced magnetic resonance angiography in a single session for pre- angiographic evaluation of spinal vascular disease	PLOS ONE			English	Article							DURAL ARTERIOVENOUS-FISTULAS; MR-ANGIOGRAPHY; CORD ARTERIOGRAPHY; LOCALIZATION; CLASSIFICATION; MALFORMATIONS; ARTERIES	Background/Purpose The purpose of this study was to evaluate the utility and efficacy of combined low-dose, time-resolved (TR) and single-phase high-resolution (HR) contrast-enhanced MRA (CE-MRA) as a pre-angiographic study for spinal vascular disease. Materials and methods Seventeen consecutive patients with suspected spinal vascular disease were retrospectively reviewed. All patients underwent combined low-dose TR CE-MRA and three-dimensional single-phase HR CE-MRA at 3 Tesla, followed by conventional spinal digital subtraction angiography (DSA) within 90 days. Six patients underwent additional spinal MRA and DSA for treatment follow-up. Spinal lesions were analyzed in terms of presence, disease type, laterality, spinal level, and number of arterial feeders. Results Low-dose TR CE-MRA helped proper localization of subsequent HR CE-MRA in two patients with high or low level of the lesion. For initial detection of spinal vascular disease, sensitivity, specificity and accuracy of CE-MRA were 93.3% (n = 14/15), 100% (n = 3/3), and 94.4% (n = 17/18), respectively. In characterization of dural arteriovenous fistula (AVF), perimedullary AVF, spinal cord arteriovenous malformation (AVM), and extraspinal AVM, CE-MRA correctly characterized in 86.7% (n = 13/15) among the positive findings, and in 88.9% (n = 16/18) among the several patients including negative results. CE-MRA showed matched per-case localization of arterial feeders within 1 vertebral level in 80% (n = 12/15), and matched per-lesion localization in 78.3% (n = 18/23). Conclusion Combined low-dose TR CE-MRA and single-phase HR CE-MRA at 3 Tesla was an effective and accurate non-invasive tool for the pre-angiographic evaluation of spinal vascular diseases in a single session.	[Shin, Jae Ho; Choi, Yangsean; Park, Borim; Shin, Na-Young; Jang, Jinhee; Choi, Hyun Seok; Jung, So Lyung; Ahn, Kookjin; Kim, Bum-soo] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Kim, BS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea.	bumrad@catholic.ac.kr	Choi, Yangsean/AAR-5274-2020; KIM, Bum-soo/F-3086-2018	KIM, Bum-soo/0000-0002-3870-6813				Ali S, 2007, AM J NEURORADIOL, V28, P1806, DOI 10.3174/ajnr.A0639; Amarouche M, 2015, AM J NEURORADIOL, V36, P417, DOI 10.3174/ajnr.A4164; Backes WH, 2008, AM J NEURORADIOL, V29, P619, DOI 10.3174/ajnr.A0910; Bao YH, 1997, NEUROSURGERY, V40, P75, DOI 10.1097/00006123-199701000-00017; Binkert CA, 1999, AM J NEURORADIOL, V20, P1785; CHOI IS, 1988, RADIOL CLIN N AM, V26, P1131; Farb RI, 2002, RADIOLOGY, V222, P843, DOI 10.1148/radiol.2223010826; FORBES G, 1988, RADIOLOGY, V169, P479, DOI 10.1148/radiology.169.2.3174997; Jaspers K, 2007, J MAGN RESON IMAGING, V26, P31, DOI 10.1002/jmri.20940; Kieffer E, 2002, J VASC SURG, V35, P262, DOI 10.1067/mva.2002.120378; Kiyosue H, 2017, STROKE, V48, P3215, DOI 10.1161/STROKEAHA.117.019131; Kralik SF, 2017, NEURORADIOLOGY, V59, P997, DOI 10.1007/s00234-017-1893-0; Krings T, 2005, EUR RADIOL, V15, P267, DOI 10.1007/s00330-004-2510-2; Lee YJ, 2015, ACTA RADIOL, V56, P673, DOI 10.1177/0284185114538426; Lee YJ, 2011, J MAGN RESON IMAGING, V33, P71, DOI 10.1002/jmri.22396; Lindenholz A, 2014, EUR RADIOL, V24, P2885, DOI 10.1007/s00330-014-3307-6; Luetmer PH, 2005, AM J NEURORADIOL, V26, P711; Mull M, 2007, AM J NEURORADIOL, V28, P1249, DOI 10.3174/ajnr.A0612; Nijenhuis RJ, 2007, J VASC SURG, V45, P71, DOI 10.1016/j.jvs.2006.08.085; Nijenhuis RJ, 2007, J VASC SURG, V45, P677, DOI 10.1016/j.jvs.2006.11.046; Saraf-Lavi E, 2002, AM J NEURORADIOL, V23, P858; SAVADER SJ, 1993, RADIOLOGY, V189, P165, DOI 10.1148/radiology.189.1.8372189; Spetzler RF, 2002, J NEUROSURG, V96, P145, DOI 10.3171/spi.2002.96.2.0145; Vargas MI, 2010, EUR RADIOL, V20, P2491, DOI 10.1007/s00330-010-1815-6; Zozulya Yuri P, 2006, Neurosurg Focus, V20, pE7	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214289	10.1371/journal.pone.0214289	http://dx.doi.org/10.1371/journal.pone.0214289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921365	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000050
J	van der Linden, N; Longden, T; Richards, JR; Khursheed, M; Goddijn, WMT; van Veelen, MJ; Khan, UR; van der Linden, MC				van der Linden, Naomi; Longden, Thomas; Richards, John R.; Khursheed, Munawar; Goddijn, Wilhelmina M. T.; van Veelen, Michiel J.; Khan, Uzma Rahim; van der Linden, M. Christien			The use of an 'acclimatisation' heatwave measure to compare temperature-related demand for emergency services in Australia, Botswana, Netherlands, Pakistan, and USA	PLOS ONE			English	Article							AMBIENT-TEMPERATURE; DEPARTMENT VISITS; CLIMATE-CHANGE; MORTALITY; WAVE; HEALTH; HOSPITALIZATIONS; CALIFORNIA; IMPACTS	Background Heatwaves have been linked to increased risk of mortality and morbidity and are projected to increase in frequency and intensity due to climate change. The current study uses emergency department (ED) data from Australia, Botswana, Netherlands, Pakistan, and the United States of America to evaluate the impact of heatwaves on ED attendances, admissions and mortality. Methods Routinely collected time series data were obtained from 18 hospitals. Two separate thresholds (>= 4 and >= 7) of the acclimatisation excess heat index (EHlaccl) were used to define "hot days". Analyses included descriptive statistics, independent samples T-tests to determine differences in case mix between hot days and other days, and threshold regression to determine which temperature thresholds correspond to large increases in ED attendances. Findings In all regions, increases in temperature that did not coincide with time to acclimatise resulted in increases in ED attendances, and the EHlaccl performed in a similar manner. During hot days in California and The Netherlands, significantly more children ended up in the ED, while in Pakistan more elderly people attended. Hot days were associated with more patient admissions in the ages 5-11 in California, 65-74 in Karachi, and 75-84 in The Hague. During hot days in The Hague, patients with psychiatric symptoms were more likely to die. The current study did not identify a threshold temperature associated with particularly large increases in ED demand. Interpretation The association between heat and ED demand differs between regions. A limitation of the current study is that it does not consider delayed effects or influences of other environmental factors. Given the association between heat and ED use, hospitals and governmental authorities should recognise the demands that heat can place on local health care systems. These demands differ substantially between regions, with Pakistan being the most heavily affected within our study sample.	[van der Linden, Naomi; Longden, Thomas] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia; [Richards, John R.] UC Davis Med Ctr, Emergency Dept, Sacramento, CA USA; [Khursheed, Munawar; Khan, Uzma Rahim] Aga Khan Univ Hosp, Emergency Dept, Karachi, Pakistan; [Goddijn, Wilhelmina M. T.] Acad Med Ctr, Emergency Dept, Amsterdam, Netherlands; [van Veelen, Michiel J.] Princess Marina Hosp, Gaborone, Botswana; [van Veelen, Michiel J.] Univ Botswana, Dept Emergency Med, Fac Med, Gaborone, Botswana; [van der Linden, M. Christien] Haaglanden Med Ctr, Emergency Dept, The Hague, Netherlands; [van der Linden, Naomi] AstraZeneca Netherlands, Market Access Dept, The Hague, Netherlands; [van Veelen, Michiel J.] EURAC Res, Inst Mt Emergency Med, Bolzano, Italy	University of Technology Sydney; University of California System; University of California Davis; Aga Khan University; University of Amsterdam; Academic Medical Center Amsterdam; University of Botswana; Haaglanden Medical Center; European Academy of Bozen-Bolzano	van der Linden, N (corresponding author), Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia.; van der Linden, N (corresponding author), AstraZeneca Netherlands, Market Access Dept, The Hague, Netherlands.	Naomi.vanderLinden@astrazeneca.com	Richards, John/AAJ-2482-2020; Longden, Thomas/I-7977-2015	Richards, John/0000-0003-1251-3877; Longden, Thomas/0000-0001-7593-659X; van Veelen, Michiel/0000-0003-2325-230X; van der Linden, Naomi/0000-0003-1646-9834	University of Technology Sydney Chancellor's Postdoctoral Research Fellowship; Research Fund of Haaglanden Medical Center	University of Technology Sydney Chancellor's Postdoctoral Research Fellowship; Research Fund of Haaglanden Medical Center	Funding for this study was provided through the University of Technology Sydney Chancellor's Postdoctoral Research Fellowship. Funding for open source publication of this study was provided by the Research Fund of Haaglanden Medical Center, 2019.	Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Basu R, 2018, EXAMINING ASS APPARE; Berman JD, 2017, LANCET PLANET HEALTH, V1, pE17, DOI 10.1016/s2542-5196(17)30002-5; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Gasparrini A, 2017, LANCET PLANET HEALTH, V1, pE360, DOI 10.1016/S2542-5196(17)30156-0; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Herold N, 2018, WEATHER CLIM EXTREME, V20, P54, DOI 10.1016/j.wace.2018.01.001; Huynen M, 2016, STANDING HEAT 2013 H; Jegasothy E, 2017, INT J BIOMETEOROL, V61, P1359, DOI 10.1007/s00484-017-1313-5; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Lippmann SJ, 2013, ENVIRON RES, V124, P35, DOI 10.1016/j.envres.2013.03.009; Longden, 2018, HOT DAYS HEAT UNPUB; Longden T, 2018, CLIMATIC CHANGE, V150, P343, DOI 10.1007/s10584-018-2269-0; Organization WH, 2015, CLIM HLTH COUNTR PRO; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; Perkins-Kirkpatrick SE, 2016, CLIMATIC CHANGE, V139, P101, DOI 10.1007/s10584-016-1650-0; Saleem Syed Ghazanfar, 2017, J Ayub Med Coll Abbottabad, V29, P320; Salim A, 2015, INT J OCCUP ENV MED, V6, P249, DOI 10.15171/ijoem.2015.678; Scalley BD, 2015, AUST NZ J PUBL HEAL, V39, P582, DOI 10.1111/1753-6405.12421; Sherbakov T, 2018, ENVIRON RES, V160, P83, DOI 10.1016/j.envres.2017.08.052; Wang Y, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0167-3; Wang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099599; Watts N, 2018, LANCET, V392, P2479, DOI 10.1016/S0140-6736(18)32594-7; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]; Zhang K., 2015, Environmental Health, V14	26	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214242	10.1371/journal.pone.0214242	http://dx.doi.org/10.1371/journal.pone.0214242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921372	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000046
J	Chatterjee, S; Biswas, N; Datta, A; Maiti, PK				Chatterjee, Susmita; Biswas, Nupur; Datta, Alokmay; Maiti, Prasanta Kumar			Periodicities in the roughness and biofilm growth on glass substrate with etching time: Hydrofluoric acid etchant	PLOS ONE			English	Article							BACTERIAL ADHESION; PSEUDOMONAS-AERUGINOSA; SURFACES; ATTACHMENT	Adherence of the microorganism to submerged solid surfaces leads to biofilm formation. Biofilm formation modifies the surfaces in favor of bacteria facilitating the survival of the bacteria under different stressed conditions. On the other hand, the formation of biofilm has a direct adverse economic impact in various industries and more importantly in medical practices. This adherence is the reason for the failure of many indwelling medical devices. Surface biofilm adhesion is the key to biofilm growth and stability. Hence this adhesion needs to be substantially lowered to inhibit biofilm stability. Both chemical and physical properties of the surface influence biofilm formation and modulating these properties can control this formation. In this study, we have investigated the effect of Hydrofluoric acid (HF), at a specific concentration as an etchant, on the surface morphology of substrates and the growth of biofilms of Pseudomonas aeruginosa. and Staphylococcus aureus. We find that the bacterial counts on the etched surfaces undergo a periodic increase and decrease. This, on one hand, shows the close correlation between the biofilm growth and the particular roughness scale, and on the other hand, explains the existing contradictory results regarding the effects of etching on substrate roughness and biofilm growth. We propose a simple model of a sequence of hole formation, hole expansion and etching away of the hole walls to form a new, comparatively smooth surface, coupled with the preferential accumulation of bacteria at the hole edges, to explain these periodicities.	[Chatterjee, Susmita; Maiti, Prasanta Kumar] Inst Postgrad Med Educ & Res, Kolkata, India; [Biswas, Nupur; Datta, Alokmay] Saha Inst Nucl Phys, Surface Phys & Mat Sci Div, 1-AF Bidhannagar, Kolkata, India; [Biswas, Nupur] Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, IICB TRUE Campus, Kolkata, India; [Datta, Alokmay] Cent Glass & Ceram Res Inst, CSIR, Adv Mech & Mat Characterizat Div, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Saha Institute of Nuclear Physics; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Glass & Ceramic Research Institute (CGCRI)	Chatterjee, S (corresponding author), Inst Postgrad Med Educ & Res, Kolkata, India.	drsusmita.chatterjee@gmail.com	Datta, Alokmay/C-1252-2008	Datta, Alokmay/0000-0002-2542-1042; Biswas, Nupur/0000-0002-8468-5208; Chatterjee, Susmita/0000-0002-4296-4380	Department of Science & Technology, Govt of India; Department of Science and Technology, India; Council of Scientific and Industrial Research through Saha Institute of Nuclear Physics; Department of Atomic Energy through Saha Institute of Nuclear Physics	Department of Science & Technology, Govt of India(Department of Science & Technology (India)); Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research through Saha Institute of Nuclear Physics; Department of Atomic Energy through Saha Institute of Nuclear Physics	This research was carried out jointly at Institute of Post Graduate Medical Education and Research and at Saha Institute of Nuclear Physics, with the logistics and funding Department of Science & Technology, Govt of India. The fellowship of S.C. was funded by Department of Science and Technology, India, and that of N.B. was funded Council of Scientific and Industrial Research and Department of Atomic Energy through Saha Institute of Nuclear Physics.	Broderick AH, 2013, ADV HEALTHC MATER, V2, P993, DOI 10.1002/adhm.201200334; BROWN CA, 1991, WEAR, V141, P211, DOI 10.1016/0043-1648(91)90269-Z; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x; Chatterjee S, 2014, MICROSCOPY-JPN, V63, P269, DOI 10.1093/jmicro/dfu013; Cross SE, 2009, DENT MATER, V25, P1517, DOI 10.1016/j.dental.2009.07.012; Díaz Carolina, 2007, Mat. Res., V10, P11, DOI 10.1590/S1516-14392007000100004; Feng GP, 2015, NPJ BIOFILMS MICROBI, V1, DOI 10.1038/npjbiofilms.2015.22; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Gharechahi M., 2012, J BIOMATER NANOBIOTE, V03, P541, DOI DOI 10.4236/JBNB.2012.324056; Guo K, 2013, ENVIRON SCI TECHNOL, V47, P7563, DOI 10.1021/es400901u; Ista LK, 2010, BIOFOULING, V26, P111, DOI 10.1080/08927010903383455; Ista LK, 1999, APPL ENVIRON MICROB, V65, P1603; Kolewe KW, 2018, ACS APPL MATER INTER, V10, P2275, DOI 10.1021/acsami.7b12145; Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006; Lorenzetti M, 2015, ACS APPL MATER INTER, V7, P1644, DOI 10.1021/am507148n; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8; Nosonovsky M, 2012, SPRINGER SER MATER S, V152, P25, DOI 10.1007/978-1-4614-0926-7_2; PALIK ED, 1991, J APPL PHYS, V70, P3291, DOI 10.1063/1.349263; Qiu Y, 2007, INT J ARTIF ORGANS, V30, P828, DOI 10.1177/039139880703000913; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Singh AV, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026803, 10.1371/journal.pone.0025029]; Sinha SD, 2017, PROG BIOMATER, V6, P27, DOI 10.1007/s40204-017-0061-2; SPIERINGS GACM, 1993, J MATER SCI, V28, P6261, DOI 10.1007/BF01352182; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Tran PA, 2013, INT J NANOMED, V8, P2001, DOI 10.2147/IJN.S42970; Yu P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8901253; Zogheib Lucas Villaça, 2011, Braz. Dent. J., V22, P45, DOI 10.1590/S0103-64402011000100008	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214192	10.1371/journal.pone.0214192	http://dx.doi.org/10.1371/journal.pone.0214192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917172	gold, Green Published, Green Submitted			2022-12-27	WOS:000462465800054
J	Kikuchi, K; Shigeta, S; Ishikawa, T				Kikuchi, Kenji; Shigeta, Shunsuke; Ishikawa, Takuji			Depth measurement of molecular permeation using inclined confocal microscopy	PLOS ONE			English	Article							LASER-INDUCED FLUORESCENCE; THERMOMETRY; TEMPERATURE; CALIBRATION; DISPERSION; LIF	We report a new technique for the high time-resolved depth measurement of molecular concentration distribution in a permeable hydrogel film with micro-depth precision. We developed an inclined observation technique in a laser-induced fluorescence (LIF) system, based on confocal microscopy, which measures the concentration distribution in the depth direction at less than micrometre intervals. The focal plane of confocal microscopy was tilted to enable simultaneous depth scanning in the microscopic field of view inside the permeable substrate. Our system achieved real-time and non-contact depth measurement of concentration distribution in the permeable hydrogel film. Simultaneous depth concentration measurement was realised with < 1 mu m/pixel resolution over a maximum depth range of 570 mu m, depending on the tilt angle of the stage and optical conditions. Our system measured the concentration of fluorescence materials based on the fluorescence intensities at several depth positions with a minimum concentration resolution of 1.3 nmol/L. Applying the proposed system to real-time concentration imaging, we successfully visualised unsteady concentration transport phenomena, and estimated the mass transport coefficient through the liquid-hydrogel interface. Our findings are useful for investigating the mass transport of physical, biological, and medical phenomena in permeable substrates.	[Kikuchi, Kenji; Shigeta, Shunsuke; Ishikawa, Takuji] Tohoku Univ, Grad Sch Engn, Dept Finemech, Aoba Ku, Sendai, Miyagi, Japan; [Kikuchi, Kenji; Ishikawa, Takuji] Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Kikuchi, K (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Finemech, Aoba Ku, Sendai, Miyagi, Japan.; Kikuchi, K (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, Sendai, Miyagi, Japan.	kenji@bfsl.mech.tohoku.ac.jp		Ishikawa, Takuji/0000-0002-3573-8414	Japan Society for the Promotion of Science [16K14150, 17H00853]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grant numbers 16K14150 and 17H00853 from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIS R, 1956, PROC R SOC LON SER-A, V235, P67, DOI 10.1098/rspa.1956.0065; Bai L, 2016, CHEM ENG J, V298, P281, DOI 10.1016/j.cej.2016.04.034; Bird R.B., 2006, TRANSPORT PHENOMENA, DOI 10.1002/aic.690070245; Chaze W, 2017, EXP FLUIDS, V58, DOI 10.1007/s00348-017-2375-1; Chaze W, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2142-8; Core RW, 2011, NATURE PROTCOLS, V6, P1929; DABIRI D, 1991, EXP FLUIDS, V11, P77, DOI 10.1007/BF00190283; Deusch S, 2001, MEAS SCI TECHNOL, V12, P188, DOI 10.1088/0957-0233/12/2/310; FRANZ TJ, 1975, J INVEST DERMATOL, V64, P190, DOI 10.1111/1523-1747.ep12533356; FRIEND DR, 1992, J CONTROL RELEASE, V18, P235, DOI 10.1016/0168-3659(92)90169-R; Hoffmann M, 2006, CHEM ENG SCI, V61, P2968, DOI 10.1016/j.ces.2005.11.029; Karasso PS, 1997, EXP FLUIDS, V23, P382, DOI 10.1007/s003480050125; Kikuchi K, 2015, MEAS SCI TECHNOL, V26, DOI 10.1088/0957-0233/26/2/025301; Kikuchi K, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/6/064002; Kikuchi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144938; Kim HJ, 2003, INT J HEAT MASS TRAN, V46, P3967, DOI 10.1016/S0017-9310(03)00243-6; Kim MM, 2015, MICROELECTRON ENG, V148, P129, DOI 10.1016/j.mee.2015.11.002; Kling K, 2004, CHEM ENG SCI, V59, P1523, DOI 10.1016/j.ces.2004.01.015; Krug D, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/6/065301; Kwapiszewski R, 2014, ANAL BIOANAL CHEM, V406, P4551, DOI 10.1007/s00216-014-7844-2; Lima R, 2008, BIOMED MICRODEVICES, V10, P153, DOI 10.1007/s10544-007-9121-z; Lima R, 2008, J BIOMECH, V41, P2188, DOI 10.1016/j.jbiomech.2008.04.033; Liu CC, 2018, CHEM ENG J, V332, P695, DOI 10.1016/j.cej.2017.09.128; Model MA, 2001, CYTOMETRY, V44, P309, DOI 10.1002/1097-0320(20010801)44:4<309::AID-CYTO1122>3.0.CO;2-3; Murin C, 2018, COMPUT BIOL MED, V92, P22, DOI [10.1016/j.compbiomed.2017.10.027, DOI 10.1016/J.COMPBIOMED.2017.10.027]; Natrajan VK, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/1/015401; Park HG, 2001, EXP FLUIDS, V30, P327, DOI 10.1007/s003480000199; Park JS, 2004, EXP FLUIDS, V37, P105, DOI 10.1007/s00348-004-0790-6; Prausnitz MR, 2004, NAT REV DRUG DISCOV, V3, P115, DOI 10.1038/nrd1304; Ross D, 2001, ANAL CHEM, V73, P4117, DOI 10.1021/ac010370l; Sakakibara J, 1999, EXP FLUIDS, V26, P7, DOI 10.1007/s003480050260; Shafii MB, 2010, EXP FLUIDS, V48, P651, DOI 10.1007/s00348-009-0758-7; TAYLOR G, 1953, PROC R SOC LON SER-A, V219, P186, DOI 10.1098/rspa.1953.0139; WALKER DA, 1987, J PHYS E SCI INSTRUM, V20, P217, DOI 10.1088/0022-3735/20/2/019; Wang GR, 2016, LAB CHIP, V16, P1030, DOI 10.1039/c5lc01541c; Wu J, 2013, SCI REPORTS, V3321	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214504	10.1371/journal.pone.0214504	http://dx.doi.org/10.1371/journal.pone.0214504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917189	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800068
J	Weng, SF; Vaz, L; Qureshi, N; Kai, J				Weng, Stephen F.; Vaz, Luis; Qureshi, Nadeem; Kai, Joe			Prediction of premature all-cause mortality: A prospective general population cohort study comparing machine-learning and standard epidemiological approaches	PLOS ONE			English	Article							CLASSIFICATION; CANCER; MODELS	Background Prognostic modelling using standard methods is well-established, particularly for predicting risk of single diseases. Machine-learning may offer potential to explore outcomes of even greater complexity, such as premature death. This study aimed to develop novel prediction algorithms using machine-learning, in addition to standard survival modelling, to predict premature all-cause mortality. Methods A prospective population cohort of 502,628 participants aged 40-69 years were recruited to the UK Biobank from 2006-2010 and followed-up until 2016. Participants were assessed on a range of demographic, biometric, clinical and lifestyle factors. Mortality data by ICD-10 were obtained from linkage to Office of National Statistics. Models were developed using deep learning, random forest and Cox regression. Calibration was assessed by comparing observed to predicted risks; and discrimination by area under the 'receiver operating curve' (AUC). Findings 14,418 deaths (2.9%) occurred over a total follow-up time of 3,508,454 person-years. A simple age and gender Cox model was the least predictive (AUC 0.689, 95% CI 0.681-0.699). A multivariate Cox regression model significantly improved discrimination by 6.2% (AUC 0.751, 95% CI 0.748-0.767). The application of machine-learning algorithms further improved discrimination by 3.2% using random forest (AUC 0.783, 95% CI 0.776-0.791) and 3.9% using deep learning (AUC 0.790, 95% CI 0.783-0.797). These ML algorithms improved discrimination by 9.4% and 10.1% respectively from a simple age and gender Cox regression model. Random forest and deep learning achieved similar levels of discrimination with no significant difference. Machine-learning algorithms were well-calibrated, while Cox regression models consistently over-predicted risk. Conclusions Machine-learning significantly improved accuracy of prediction of premature all-cause mortality in this middle-aged population, compared to standard methods. This study illustrates the value of machine-learning for risk prediction within a traditional epidemiological study design, and how this approach might be reported to assist scientific verification.	[Weng, Stephen F.; Vaz, Luis; Qureshi, Nadeem; Kai, Joe] Univ Nottingham, NIHR Sch Primary Care Res, Nottingham, England; [Weng, Stephen F.; Qureshi, Nadeem; Kai, Joe] Univ Nottingham, Sch Med, Div Primary Care, Primary Care Stratified Med PRISM, Nottingham, England	University of Nottingham; University of Nottingham	Weng, SF (corresponding author), Univ Nottingham, NIHR Sch Primary Care Res, Nottingham, England.; Weng, SF (corresponding author), Univ Nottingham, Sch Med, Div Primary Care, Primary Care Stratified Med PRISM, Nottingham, England.	stephen.weng@nottingham.ac.uk		Weng, Stephen/0000-0002-5281-9590; Qureshi, Nadeem/0000-0003-4909-0644; Kai, Joe/0000-0001-9040-9384; Vaz, Luis/0000-0002-2184-1234	roadtohealth Ltd.	roadtohealth Ltd.	The costs and application for data access was funded by roadtohealth Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no research funding for their time on this work.	Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Damen JAAG, 2016, BMJ, V353; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hagan M.T., 2014, NEURAL NETWORK DESIG; Hewitt J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009161; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Li C, 2013, STATA J, V13, P795, DOI 10.1177/1536867X1301300407; MACKENBACH JP, 1988, HEALTH POLICY, V10, P207, DOI 10.1016/0168-8510(88)90006-1; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Olden JD, 2002, ECOL MODEL, V154, P135, DOI 10.1016/S0304-3800(02)00064-9; Platts LG, 2016, OCCUPATIONAL ENV MED; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Stewart QT, 2020, ETHNIC HEALTH, V25, P1018, DOI 10.1080/13557858.2018.1469735; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; UK Data Service, 2001, 2001 CENS DAT TOWNS; Voets M, 2018, ABS180304337 ARXIV; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; Westreich D, 2010, J CLIN EPIDEMIOL, V63, P826, DOI 10.1016/j.jclinepi.2009.11.020; Yin P, 2017, BMJ-BRIT MED J, P356; Young J, 2016, LANCET PSYCHIAT, V3, P908, DOI 10.1016/S2215-0366(16)30218-8; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474	31	36	37	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214365	10.1371/journal.pone.0214365	http://dx.doi.org/10.1371/journal.pone.0214365			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917171	Green Published, gold, Green Submitted			2022-12-27	WOS:000462465800062
J	Wanko, B; Tardelli, M; Jurets, A; Neuhofer, A; Prager, G; Morser, J; Leung, LL; Staffler, G; Zeyda, M; Stulnig, TM				Wanko, Bettina; Tardelli, Matteo; Juerets, Alexander; Neuhofer, Angelika; Prager, Gerhard; Morser, John; Leung, Lawrence L.; Staffler, Guenther; Zeyda, Maximilian; Stulnig, Thomas M.			Antibody-mediated targeting of cleavage-specific OPN-T cell interactions	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; THROMBIN-CLEAVAGE; MACROPHAGE INFILTRATION; INSULIN-RESISTANCE; OSTEOPONTIN; OBESITY; EXPRESSION; BINDING; PROLIFERATION; MIGRATION	T cells are crucial players in obesity-mediated adipose tissue inflammation. We hypothesized that osteopontin (OPN), an inflammatory protein with enhanced activity when proteolytically cleaved, affects the number of viable T cells in adipose tissue and assessed inhibition of the interaction between T cells and thrombin and matrix metalloproteinases-cleaved OPN using antibodies and postimmune sera. Gene expression of T cell markers in adipose tissue from wild-type (wt) and Spp1(-/-) (OPN deficient) mice was analyzed after 16 weeks of high fat diet (HFD) or low fat diet (LFD) feeding. CD3, CD8 and OPN gene expression in omental adipose tissue from individuals with obesity was measured. OPN-T cell interactions were assessed with a fluorescence-based adhesion assay and blocked with antibodies targeting OPN. Comparison of T cell gene expression in adipose tissue from wt and Spp1(-/-) mice showed that OPN affected the number of T cells while in humans, levels of OPN correlated with T cell markers in omental adipose tissue. The interaction between T cells and cleaved OPN was blocked by postimmune sera following OPN peptide vaccinations and with monoclonal antibodies. In conclusion, levels of OPN affected the number of T cells in obesity and antibodies against cleaved OPN antagonize OPN-T cell interactions.	[Wanko, Bettina; Juerets, Alexander; Neuhofer, Angelika; Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Dept Med 3, Clin Div Endocrinol & Metab, Vienna, Austria; [Wanko, Bettina; Morser, John; Leung, Lawrence L.] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Wanko, Bettina; Morser, John; Leung, Lawrence L.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Tardelli, Matteo] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Prager, Gerhard] Med Univ Vienna, Dept Surg, Vienna, Austria; [Staffler, Guenther] AFFiRiS AG, Vienna, Austria; [Juerets, Alexander] IMC Univ Appl Sci Krems, Dept Life Sci, Krems, Austria; [Neuhofer, Angelika] Med Univ Vienna, Inst Canc Res, Dept Med 1, Comprehens Canc Ctr, Vienna, Austria; [Zeyda, Maximilian] Med Univ Vienna, Dept Pediat & Adolescent Med, Clin Div Pediat Pulmonol Allergol & Endocrinol, Vienna, Austria	Medical University of Vienna; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Stulnig, TM (corresponding author), Med Univ Vienna, Dept Med 3, Clin Div Endocrinol & Metab, Vienna, Austria.	thomas.stulnig@meduniwien.ac.at	Tardelli, Matteo/U-3834-2019; Jürets, Alexander/K-3469-2019	Morser, John/0000-0003-3376-8692; Tardelli, Matteo/0000-0003-2232-7779; Zeyda, Maximilian/0000-0001-5000-1974; Neuhofer, Angelika/0000-0002-8989-6207	Department of Veterans Affairs, USA [I01BX001959]; CCHD doctoral program of the FWF [W1205-B09]; Federal Ministry of Economy, Family and Youth; National Foundation for Research, Technology and Development, Austria	Department of Veterans Affairs, USA(US Department of Veterans Affairs); CCHD doctoral program of the FWF(Austrian Science Fund (FWF)); Federal Ministry of Economy, Family and Youth; National Foundation for Research, Technology and Development, Austria	The work was funded by a grant (I01BX001959) from the Department of Veterans Affairs (https://www.va.gov/), USA (to L.L.L.), by the CCHD doctoral program of the FWF (W1205-B09) (https://www.meduniwien.ac.at/hp/phd-cchd/), and the Federal Ministry of Economy, Family and Youth and the National Foundation for Research, Technology and Development, Austria (to T. M. S.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AFFiRiS AG provided support in the form of salary for author GS, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Bachmann MF, 2013, VACCINE, V31, P1777, DOI 10.1016/j.vaccine.2013.02.001; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Boggio E, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9345495; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Clemente N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00321; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gao YA, 2004, MATRIX BIOL, V23, P457, DOI 10.1016/j.matbio.2004.09.003; Giachelli CM, 1998, AM J PATHOL, V152, P353; Grun NG, 2016, IMMUNOL LETT, V179, P85, DOI 10.1016/j.imlet.2016.09.006; Hasegawa M, 2009, J RHEUMATOL, V36, P240, DOI 10.3899/jrheum.080753; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Hui T, 2015, MATRIX BIOL, V41, P19, DOI 10.1016/j.matbio.2014.11.005; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Jurets A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148333; Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kopec AK, 2017, J CLIN INVEST, V127, P3152, DOI [10.1172/JCI92744, 10.1172/jci92744]; Lancha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098398; Leitner L, 2015, OBESITY, V23, P779, DOI 10.1002/oby.21024; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Samad F, 1998, P NATL ACAD SCI USA, V95, P7591, DOI 10.1073/pnas.95.13.7591; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; SENGER DR, 1988, CANCER RES, V48, P5770; Shao ZF, 2014, J BIOL CHEM, V289, P27146, DOI 10.1074/jbc.M114.572172; Shirakawa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186303; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Tardelli M, 2016, MOL METAB, V5, P1131, DOI 10.1016/j.molmet.2016.09.003; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yamaguchi Y, 2013, J BIOL CHEM, V288, P3097, DOI 10.1074/jbc.M112.362954; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Zeyda M, 2011, OBESITY, V19, P743, DOI 10.1038/oby.2010.123	42	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2019	14	4							e0214938	10.1371/journal.pone.0214938	http://dx.doi.org/10.1371/journal.pone.0214938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR9NM	30951532	Green Published, gold, Green Submitted			2022-12-27	WOS:000463487500022
J	Garg, BK; Loring, RH				Garg, Brijesh K.; Loring, Ralph H.			GTS-21 has cell-specific anti-inflammatory effects independent of alpha 7 nicotinic acetylcholine receptors	PLOS ONE			English	Article							VAGUS NERVE; PHARMACOLOGICAL-PROPERTIES; FUNCTIONAL-PROPERTIES; CYTOKINE PRODUCTION; IMPROVES SURVIVAL; KAPPA-B; STIMULATION; AGONIST; MACROPHAGES; MODULATION	alpha 7 Nicotinic acetylcholine receptors (nAChRs) reportedly reduce inflammation by blocking effects of the important pro-inflammatory transcription factor, nuclear factor kappa-light chain-enhancer of B cells (NF kappa B). The alpha 7 nAChR partial agonist GTS-21 reduces secretion of pro-inflammatory cytokines including interleukin-6 (IL6) and tumor-necrosis factor (TNF) in models of endotoxemia and sepsis, and its anti-inflammatory effects are widely ascribed to alpha 7 nAChR activation. However, mechanistic details of alpha 7 nAChR involvement in GTS-21 effects on inflammatory pathways remain unclear. Here, we investigate how GTS-21 acts in two cell systems including the non-immune rat pituitary cell line GH4C1 expressing an NF kappa B-driven reporter gene and cytokine secretion by ex vivo cu ltures of primary mouse macrophages activated by lipopolysaccharide (LPS). GTS-21 does not change TNF-stimulated NF kappa B signaling in GH4C1 cells expressing rat alpha 7 nAChRs, suggesting that GTS-21 requires additional unidentified factors besides alpha 7 nAChR expression to allow anti-inflammatory effects in these cells. In contrast, GTS-21 dose-dependently suppresses LPSinduced IL6 and TNF secretion in primary mouse macrophages endogenously expressing alpha 7 nAChRs. GTS-21 also blocks TNF-induced phosphorylation of NF kappa B inhibitor alpha (I kappa Ba), an important intermediary in NF kappa B signaling. However, alpha 7 antagonists methyllycaconitine and a-bungarotoxin only partially reverse GTS-21 blockade of IL6 and TNF secretion. Further, GTS-21 significantly inhibited LPS-induced IL6 and TNF secretion in macrophages isolated from knockout mice lacking alpha 7 nAChRs. These data indicate that even though a discrete component of the anti-inflammatory effects of GTS-21 requires expression of alpha 7 nAChRs in macrophages, GTS-21 also has anti-inflammatory effects independent of these receptors depending on the cellular context.	[Garg, Brijesh K.; Loring, Ralph H.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA	Northeastern University	Loring, RH (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.	r.loring@northeastern.edu		Loring, Ralph/0000-0002-9228-4981				Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Banerjee C, 2000, NEUROBIOL DIS, V7, P666, DOI 10.1006/nbdi.2000.0317; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chatterjee PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035361; Cuzzocrea S, 2002, BRIT J PHARMACOL, V135, P496, DOI 10.1038/sj.bjp.0704463; de Jong PR, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1458-3; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Dunlop J, 2009, J PHARMACOL EXP THER, V328, P766, DOI 10.1124/jpet.108.146514; Garg BK, 2017, J HISTOCHEM CYTOCHEM, V65, P499, DOI 10.1369/0022155417725304; Heap GA, 2009, HUM MOL GENET, V18, pR101, DOI [10.1093/hmg/ddp001, 10.1093/hmg/ddp473]; Hecker A, 2015, J IMMUNOL, V195, P2325, DOI 10.4049/jimmunol.1400974; Horenstein NA, 2017, ACS MED CHEM LETT, V8, P989, DOI 10.1021/acsmedchemlett.7b00368; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Ingram JR, 2004, ALIMENT PHARM THER, V20, P859, DOI 10.1111/j.1365-2036.2004.02199.x; Khan MAS, 2012, SHOCK, V38, P213, DOI 10.1097/SHK.0b013e31825d628c; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Koperniak TM, 2013, J NEUROCHEM, V124, P300, DOI 10.1111/jnc.12095; Kox M, 2009, BIOCHEM PHARMACOL, V78, P863, DOI 10.1016/j.bcp.2009.06.096; Leonard S, 1996, SCHIZOPHRENIA BULL, V22, P431, DOI 10.1093/schbul/22.3.431; Levin ED, 2012, CURR DRUG TARGETS, V13, P602, DOI 10.2174/138945012800398937; Maouche K, 2013, P NATL ACAD SCI USA, V110, P4099, DOI 10.1073/pnas.1216939110; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Meyer EM, 1998, J PHARMACOL EXP THER, V287, P918; Mikulski Z, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-133; Mishra A, 2015, INDIAN J MED PAEDIAT, V36, P24, DOI 10.4103/0971-5851.151771; Nizri E, 2013, AMINO ACIDS, V45, P73, DOI 10.1007/s00726-011-1192-8; Nullens S, 2016, SHOCK, V45, P450, DOI 10.1097/SHK.0000000000000519; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; PENG X, 1994, MOL PHARMACOL, V45, P546; Placzek AN, 2005, MOL PHARMACOL, V68, P1863, DOI 10.1124/mol.105.016402; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Quik M, 1997, MOL PHARMACOL, V51, P499; Quik M, 1996, J NEUROCHEM, V67, P145; Quik M, 2015, BIOCHEM PHARMACOL, V97, P399, DOI 10.1016/j.bcp.2015.06.014; Rimmer E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0699-2; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; SCHULZ DW, 1991, J NEUROSCI, V11, P287; SEGUELA P, 1993, J NEUROSCI, V13, P596; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Sykes AP, 2000, INFLAMM RES, V49, P311, DOI 10.1007/s000110050597; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; van der Zanden EP, 2009, GASTROENTEROLOGY, V137, P1029, DOI 10.1053/j.gastro.2009.04.057; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P114, DOI 10.1002/art.24177; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Virginio C, 2002, EUR J PHARMACOL, V445, P153, DOI 10.1016/S0014-2999(02)01750-8; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Weinblatt ME, 2011, ARTHRIT CARE RES, V63, P373, DOI 10.1002/acr.20372; Wittebole X, 2007, CLIN EXP IMMUNOL, V147, P28, DOI 10.1111/j.1365-2249.2006.03248.x; Yang X, 2017, QJM-INT J MED, V110, P437, DOI 10.1093/qjmed/hcx014; Zhang JJ, 2011, MOL HUM REPROD, V17, P175, DOI 10.1093/molehr/gaq090; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao LK, 2003, J PHARMACOL EXP THER, V305, P1132, DOI 10.1124/jpet.103.048777	55	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214942	10.1371/journal.pone.0214942	http://dx.doi.org/10.1371/journal.pone.0214942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947238	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500089
J	Wu, LM; Fang, Y; Yang, HN; Bai, LY				Wu, La-Mei; Fang, Yong; Yang, Hao-Na; Bai, Lian-Yang			Effects of drought-stress on seed germination and growth physiology of quinclorac-resistant Echinochloa crusgalli	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; CRUS-GALLI; MANAGEMENT; REPRODUCTION; SALINITY; COLONA	Echinochloa crusgalli (L.) Beauv. (barnyard grass) is considered a noxious weed worldwide, and is the most pernicious weed decreasing rice yields in China. Recently, E. crusgalli has evolved quinclorac resistance, making it among the most serious herbicide resistant weeds in China. The present study explored differences in germination and growth between quinclorac-resistant and -susceptible E. crusga//icollected in Hunan Province. The order of the seven E. crusgallibiotypes assessed, from high to low quinclorac-resistance, was: quinclorac-resistant, Chunhua, Hanshou, Shimen, Hekou, Dingcheng, and quinclorac-susceptible. With an increased in the level of quinclorac-resistance, the germination rate, length of young shoots and roots, and fresh weight of E. crusgalli were all decreased compared with that in more susceptible biotypes. However, there were no significant differences between quinclorac-resistant and susceptible E. crusgalli biotypes without polyethylene glycol 6000 treatment. Drought had a more obvious effect on glutathione S-transferases (GST) activity, determined by spectrophotometric method, in quinclorac-resistant E. crusgalli. Higher resistance level biotypes showed greater activity, and when treated with polyethylene glycol 6000 for 3 days, all E. crusgalli biotypes showed the highest GST activity. This study demonstrated that as the level of quinclorac-resistance increased, the rate of seed germination decreased, while the growth of young buds, young roots, and fresh weight decreased. Increased quinclorac-resistance may be related to the increased metabolic activity of GST in E. crusgalli.	[Wu, La-Mei; Bai, Lian-Yang] Cent S Univ, Long Ping Branch, Grad Sch, Changsha, Hunan, Peoples R China; [Wu, La-Mei; Fang, Yong; Yang, Hao-Na; Bai, Lian-Yang] Hunan Acad Agr Sci, Hunan Agr Biotechnol Res Inst, Changsha, Hunan, Peoples R China	Central South University; Hunan Academy of Agricultural Sciences	Bai, LY (corresponding author), Cent S Univ, Long Ping Branch, Grad Sch, Changsha, Hunan, Peoples R China.; Bai, LY (corresponding author), Hunan Acad Agr Sci, Hunan Agr Biotechnol Res Inst, Changsha, Hunan, Peoples R China.	115596578@qq.com		lamei, wu/0000-0003-1470-8897	China Agriculture Research System for Bast and Leaf Fiber Crops [CARS-16-E19]; National Natural Science Foundation of China [31772182, 2019CT5009]	China Agriculture Research System for Bast and Leaf Fiber Crops; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from China Agriculture Research System for Bast and Leaf Fiber Crops(No. CARS-16-E19); National Natural Science Foundation of China (No. 31772182); The Central Government Directs Local Science and Technology Development Projects (2019CT5009).	Abogadallah GM, 2010, PHYSIOL PLANTARUM, V138, P60, DOI 10.1111/j.1399-3054.2009.01297.x; Azeez JO, 2005, PLANT SOIL, V276, P61, DOI 10.1007/s11104-005-3864-1; BARRETT SCH, 1983, ECON BOT, V37, P255, DOI 10.1007/BF02858881; Beltran JC, 2012, CROP PROT, V31, P31, DOI 10.1016/j.cropro.2011.09.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busi R, 2014, PEST MANAG SCI, V70, P1378, DOI 10.1002/ps.3746; Chaudhari S, 2017, WEED TECHNOL, V31, P1; Chauhan BS, 2013, WEED SCI, V61, P244, DOI 10.1614/WS-D-12-00069.1; Chauhan BS, 2010, WEED SCI, V58, P132, DOI 10.1614/WS-D-09-00016.1; Galle A, 2009, J PLANT PHYSIOL, V166, P1878, DOI 10.1016/j.jplph.2009.05.016; Gao Y, 2017, PESTIC BIOCHEM PHYS, V143, P231, DOI 10.1016/j.pestbp.2017.08.009; Hamza A, 2012, SCI WORLD J, P1, DOI 10.1100/2012/893204; Huseyin O, 2001, WEED SCI, V65, P115; Islam F., 2017, ENVIRON INT, V111, P332; Islam F, 2018, PROTOPLASMA, V255, P785, DOI 10.1007/s00709-017-1159-z; Keshtkar E, 2017, WEED SCI, V65, P732, DOI 10.1017/wsc.2017.44; Khaliq A., 2014, AGR SCI, V96, P419; Khaliq A, 2014, PLANT PROD SCI, V17, P321, DOI 10.1626/pps.17.321; Korres NE, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0350-5; LAGERWERFF J, 1961, SCIENCE, V133, P1486, DOI 10.1126/science.133.3463.1486; [李拥兵 Li Yongbing], 2003, [农药学学报, Chinese journal of pesticide science], V5, P88; Li YongBing, 2004, Plant Protection, V30, P48; Li YongBing, 2002, Journal of South China Agricultural University, V23, P33; Lopez-Martinez N, 2015, PEST MANAG SCI, V51, P171; Lovelace ML, 2007, WEED TECHNOL, V21, P683, DOI 10.1614/WT-06-060.1; Ma Guo-lan, 2013, Chinese Journal of Rice Science, V27, P184, DOI 10.3969/j.issn.1001-7216.2013.02.011; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; McKenzie-Gopsill AG, 2016, FIELD CROP RES, V192, P144, DOI 10.1016/j.fcr.2016.04.029; Oztetik E, 2008, BOT REV, V74, P419, DOI 10.1007/s12229-008-9013-9; Pedersen BP, 2007, BASIC APPL ECOL, V8, P258, DOI 10.1016/j.baae.2006.01.002; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Prostko E., 2011, CROP PRODUCTION, P19; Rezayian M, 2018, SOIL SCI PLANT NUTR, V64, P360, DOI 10.1080/00380768.2018.1436407; SCHNALL JA, 1992, PLANT PHYSIOL, V100, P216, DOI 10.1104/pp.100.1.216; Shehzad MA, 2018, J PLANT NUTR, V41, P943, DOI 10.1080/01904167.2018.1431663; Sheppard C. S., 2014, Plant Protection Quarterly, V29, P54; Talbert RE, 2007, WEED TECHNOL, V21, P324, DOI 10.1614/WT-06-084.1; Tranel PJ, 2011, J AGR FOOD CHEM, V59, P5808, DOI 10.1021/jf103797n; Van Eerd LL, 2005, J AGR FOOD CHEM, V53, P1144, DOI 10.1021/jf048627e; VARTANIAN N, 1994, PLANT PHYSIOL, V104, P761, DOI 10.1104/pp.104.2.761; Wang J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091975; Wang J, 2016, ECOTOX ENVIRON SAFE, V133, P146, DOI 10.1016/j.ecoenv.2016.07.002; Wang LF, 2016, WEED TECHNOL, V30, P533, DOI 10.1614/WT-D-15-00043; Webster TM, 2008, WEED SCI, V56, P561, DOI 10.1614/WS-07-186.1; Xu JY, 2013, PEST MANAG SCI, V69, P1407, DOI 10.1002/ps.3524; Yasuor H, 2012, PEST MANAG SCI, V68, P108, DOI 10.1002/ps.2230; Ye CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113657; Zhang ZC, 2017, FIELD CROP RES, V203, P163, DOI 10.1016/j.fcr.2016.12.003	48	20	22	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214480	10.1371/journal.pone.0214480	http://dx.doi.org/10.1371/journal.pone.0214480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947307	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500035
J	Meier, J; Nolte, G; Schneider, TR; Engel, AK; Leicht, G; Mulert, C				Meier, Jan; Nolte, Guido; Schneider, Till R.; Engel, Andreas K.; Leicht, Gregor; Mulert, Christoph			Intrinsic 40Hz-phase asymmetries predict tACS effects during conscious auditory perception	PLOS ONE			English	Article							ALTERNATING-CURRENT STIMULATION; EVENT-RELATED POTENTIALS; SPECTRAL FINGERPRINTS; BRAIN; EEG; PHASE; COMMUNICATION; OSCILLATIONS; DYNAMICS; CORTEX	Synchronized oscillatory gamma-band activity (30-100Hz) has been suggested to constitute a key mechanism to dynamically orchestrate sensory information integration across multiple spatio-temporal scales. We here tested whether interhemispheric functional connectivity and ensuing auditory perception can selectively be modulated by high-density transcranial alternating current stimulation (HD-tACS). For this purpose, we applied multi-site HD-tACS at 40Hz bilaterally with a phase lag of 180 degrees and recorded a 64-channel EEG to study the oscillatory phase dynamics at the source-space level during a dichotic listening (DL) task in twenty-six healthy participants. In this study, we revealed an oscillatory phase signature at 40Hz which reflects different temporal profiles of the phase asymmetries during left and right ear percept. Here we report that 180 degrees-tACS did not affect the right ear advantage during DL at group level. However, a follow-up analysis revealed that the intrinsic phase asymmetries during sham-tACS determined the directionality of the behavioral modulations: While a shift to left ear percept was associated with augmented interhemispheric asymmetry (closer to 180 degrees), a shift to right ear processing was elicited in subjects with lower asymmetry (closer to 0 degrees). Crucially, the modulation of the interhemispheric network dynamics depended on the deviation of the tACS-induced phase-lag from the intrinsic phase asymmetry. Our characterization of the oscillatory network trends is giving rise to the importance of phase-specific gamma-band coupling during ambiguous auditory perception, and emphasizes the necessity to address the inter-individual variability of phase asymmetries in future studies by tailored stimulation protocols.	[Meier, Jan; Leicht, Gregor; Mulert, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany; [Nolte, Guido; Schneider, Till R.; Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Mulert, Christoph] Justus Liebig Univ Giessen, Ctr Psychiat & Psychotherapy, Giessen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Justus Liebig University Giessen	Meier, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany.	j.meier@uke.de	Mulert, Christoph/AAB-3210-2020; Leicht, Gregor/AAF-7364-2020; Schneider, Till/B-3751-2010; Leicht, Gregor/ABE-2404-2020; Engel, Andreas K./AAH-6384-2019	Leicht, Gregor/0000-0002-5104-9336; Schneider, Till/0000-0002-8889-6248; Leicht, Gregor/0000-0002-5104-9336; Engel, Andreas K./0000-0003-4899-8466	German Research Foundation [SFB936/C6, SFB936/A3/Z1, SPP1665 EN 533/13-1, SFB936/Z3, SPP1665/2 SCHN 1511/1-2]; Werner Otto Foundation	German Research Foundation(German Research Foundation (DFG)); Werner Otto Foundation	This work was supported by grants from the German Research Foundation (SFB936/C6 to G.L., C.M.; SFB936/A3/Z1 to A.K.E.; SPP1665 EN 533/13-1 to A.K.E.; SFB936/Z3 to G.N.; SPP1665/2 SCHN 1511/1-2 to T.R.S.) and the Werner Otto Foundation (J.M.). German Research Foundation: www.dfg.de.Werner Otto Foundation: http://www.werner-otto-stiftung.de/de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagapan S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002424; Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Andreou C, 2015, SCHIZOPHRENIA BULL, V41, P930, DOI 10.1093/schbul/sbu121; Bachinger M, 2017, J NEUROSCI, V37, P4766, DOI 10.1523/JNEUROSCI.1756-16.2017; Baldwin SA, 2015, PSYCHOPHYSIOLOGY, V52, P790, DOI 10.1111/psyp.12401; Bastos AM, 2015, CURR OPIN NEUROBIOL, V31, P173, DOI 10.1016/j.conb.2014.11.001; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Brittain JS, 2013, CURR BIOL, V23, P436, DOI 10.1016/j.cub.2013.01.068; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Carl C, 2012, NEUROIMAGE, V59, P1657, DOI 10.1016/j.neuroimage.2011.09.020; Clayson PE, 2017, INT J PSYCHOPHYSIOL, V111, P57, DOI 10.1016/j.ijpsycho.2016.09.005; Curcic-Blake B, 2017, PROG NEUROBIOL, V148, P1, DOI 10.1016/j.pneurobio.2016.11.002; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2015, J NEUROSCI METH, V250, P3, DOI 10.1016/j.jneumeth.2014.10.003; Dowsett J, 2016, FRONT HUM NEUROSCI, V10, P309, DOI [10.3389/fnhum.2016.00309, DOI 10.3389/FNHUM.2016.00309]; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Feher KD, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00471; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Frohlich F, 2015, EXPERT REV NEUROTHER, V15, P145, DOI 10.1586/14737175.2015.992782; GREEN MF, 1994, AM J PSYCHIAT, V151, P357; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grothe I, 2012, J NEUROSCI, V32, P16172, DOI 10.1523/JNEUROSCI.0890-12.2012; Gundlach C, 2016, BRAIN STIMUL, V9, P712, DOI 10.1016/j.brs.2016.04.014; Heimrath K, 2016, FRONT CELL NEUROSCI, V10, P261, DOI [10.3389/fncel.2016.00261, DOI 10.3389/FNCEL.2016.00261]; Helfrich RF, 2016, HUM BRAIN MAPP, V37, P4099, DOI 10.1002/hbm.23298; Helfrich RF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002031; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Huffmeijer R, 2014, PHYSIOL BEHAV, V130, P13, DOI 10.1016/j.physbeh.2014.03.008; Hugdahl K, 2003, COGNITIVE BRAIN RES, V16, P58, DOI 10.1016/S0926-6410(02)00210-0; Hugdahl K, 2016, NEUROPSYCHOLOGIA, V93, P466, DOI 10.1016/j.neuropsychologia.2015.12.011; Hugdahl K, 2011, BRAIN COGNITION, V76, P211, DOI 10.1016/j.bandc.2011.03.006; Hugdahl Kenneth, 2008, Cogn Neuropsychiatry, V13, P166, DOI 10.1080/13546800801906808; Kar K, 2017, J NEUROSCI, V37, P2325, DOI 10.1523/JNEUROSCI.2266-16.2016; Kilian-Hutten N, 2011, J NEUROSCI, V31, P1715, DOI 10.1523/JNEUROSCI.4572-10.2011; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Menon V, 2005, INT REV NEUROBIOL, V66, P291, DOI 10.1016/S0074-7742(05)66010-2; Moliadze V, 2012, BRAIN STIMUL, V5, P505, DOI 10.1016/j.brs.2011.11.004; Moseley Peter, 2015, Front Neurosci, V9, P515, DOI 10.3389/fnins.2015.00515; Neuling T, 2012, NEUROIMAGE, V63, P771, DOI 10.1016/j.neuroimage.2012.07.024; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00007, DOI 10.3389/FNHUM.2013.00007]; Neuling T, 2017, NEUROIMAGE, V147, P960, DOI 10.1016/j.neuroimage.2016.11.022; Neuling T, 2015, NEUROIMAGE, V118, P406, DOI 10.1016/j.neuroimage.2015.06.026; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Noury N, 2018, NEUROIMAGE, V167, P53, DOI 10.1016/j.neuroimage.2017.11.023; Noury N, 2017, NEUROIMAGE, V158, P406, DOI 10.1016/j.neuroimage.2017.07.010; Noury N, 2016, NEUROIMAGE, V140, P99, DOI 10.1016/j.neuroimage.2016.03.065; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4; Pascual-Marqui R. D, 2007, ARXIV07111455; Pascual-Marqui RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00448; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Philip NS, 2017, AM J PSYCHIAT, V174, P628, DOI 10.1176/appi.ajp.2017.16090996; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; Polania R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9090; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Riecke L, 2015, BRAIN STIMUL, V8, P777, DOI 10.1016/j.brs.2015.04.004; Rose M, 2005, J NEUROSCI, V25, P10101, DOI 10.1523/JNEUROSCI.2998-05.2005; Rufener KS, 2016, INT J PSYCHOPHYSIOL, V101, P18, DOI 10.1016/j.ijpsycho.2016.01.002; Ruhnau P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27138; Saenz M, 2014, HEARING RES, V307, P42, DOI 10.1016/j.heares.2013.07.016; Schilberg L, 2018, CORTEX, V103, P142, DOI 10.1016/j.cortex.2018.03.001; Shahin AJ, 2007, BRAIN TOPOGR, V20, P55, DOI 10.1007/s10548-007-0031-4; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Steinmann S, 2017, SCI REP, V7, P193, DOI [10.1038/s41598-017-00306-5, DOI 10.1038/S41598-017-00306-5]; Steinmann S, 2018, BRAIN TOPOGR, V31, P218, DOI 10.1007/s10548-017-0583-x; Steinmann S, 2014, NEUROIMAGE, V100, P435, DOI 10.1016/j.neuroimage.2014.06.012; Steinmann S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00055; Stonkus R, 2016, PROBING CAUSAL ROLE, DOI [10.1101/044636, DOI 10.1101/044636]; Struber D, 2014, BRAIN TOPOGR, V27, P158, DOI 10.1007/s10548-013-0294-x; ten Oever S, 2015, P NATL ACAD SCI USA, V112, P15833, DOI 10.1073/pnas.1517519112; Thut G, 2017, CLIN NEUROPHYSIOL, V128, P843, DOI 10.1016/j.clinph.2017.01.003; Thut G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00170; Tseng P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32138; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Voytek B, 2015, BIOL PSYCHIAT, V77, P1089, DOI 10.1016/j.biopsych.2015.04.016; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Westerhausen R, 2009, CEREB CORTEX, V19, P1322, DOI 10.1093/cercor/bhn173; Wilsch A, 2018, NEUROIMAGE, V172, P766, DOI 10.1016/j.neuroimage.2018.01.038; Witkowski M, 2016, NEUROIMAGE, V140, P89, DOI 10.1016/j.neuroimage.2015.10.024; Wostmann M, 2018, BRAIN STIMUL, V11, P752, DOI 10.1016/j.brs.2018.04.006; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	92	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213996	10.1371/journal.pone.0213996	http://dx.doi.org/10.1371/journal.pone.0213996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943251	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300028
J	Lundervold, AJ; Vik, A; Lundervold, A				Lundervold, Astri J.; Vik, Alexandra; Lundervold, Arvid			Lateral ventricle volume trajectories predict response inhibition in older age-A longitudinal brain imaging and machine learning approach	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; COGNITIVE DECLINE; GRAY-MATTER; MEMORY; SEGMENTATION; PROGRESSION; ATROPHY; GENDER; ADULTS	Objective In a three-wave 6 yrs longitudinal study we investigated if the expansion of lateral ventricle (LV) volumes (regarded as a proxy for brain tissue loss) predicts third wave performance on a test of response inhibition (RI). Participants and methods Trajectories of left and right lateral ventricle volumes across the three waves were quantified using the longitudinal stream in Freesurfer. All participants (N= 74;48 females;mean age 66.0 yrs at the third wave) performed the Color-Word Interference Test (CWIT). Response time on the third condition of CWIT, divided into fast, medium and slow, was used as outcome measure in a machine learning framework. Initially, we performed a linear mixed effect (LME) analysis to describe subject-specific trajectories of the left and right LV volumes (LVV). These features were input to a multinomial logistic regression classification procedure, predicting individual belongings to one of the three RI classes. To obtain results that might generalize, we evaluated the significance of a k-fold cross-validated f1-score with a permutation test, providing a p-value that approximates the probability that the score would be obtained by chance. We also calculated a corresponding confusion matrix. Results The LME-model showed an annual similar to 3.0% LVV increase. Evaluation of a cross-validated score using 500 permutations gave an f1-score of 0.462 that was above chance level (p = 0.014). 56% of the fast performers were successfully classified. All these were females, and typically older than 65 yrs at inclusion. For the true slow performers, those being correctly classified had higher LVVs than those being misclassified, and their ages at inclusion were also higher. Conclusion Major contributions were: (i) a longitudinal design, (ii) advanced brain imaging and segmentation procedures with longitudinal data analysis, and (iii) a data driven machine learning approach including cross-validation and permutation testing to predict behaviour, solely from the individual's brain "signatures" (LVV trajectories).	[Lundervold, Astri J.; Vik, Alexandra] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Lundervold, Arvid] Univ Bergen, Mohn Med Imaging & Visualizat Ctr, Dept Biomed, Bergen, Norway	University of Bergen; University of Bergen	Lundervold, A (corresponding author), Univ Bergen, Mohn Med Imaging & Visualizat Ctr, Dept Biomed, Bergen, Norway.	arvid.lundervold@uib.no	Lundervold, Astri/AAH-9796-2021	Lundervold, Astri/0000-0002-6819-6164	Research Council of Norway [154313/V50]; Western Norway Regional Health Authority [911397, 911687, 911995]	Research Council of Norway(Research Council of Norway); Western Norway Regional Health Authority	This work was supported by Research Council of Norway (grant 154313/V50), the second and third study-wave from the Western Norway Regional Health Authority (grants 911397 and 911687, AJL). We also acknowledge the Western Norway Regional Health Authority for funding the Freesurfer Longitudinal Stream (grant 911995, AL).	Adolfsdottir S, 2017, J INT NEUROPSYCH SOC, V23, P90, DOI 10.1017/S1355617716000898; Adolfsdottir S, 2014, NEUROPSYCHOLOGY, V28, P859, DOI 10.1037/neu0000082; Aljondi R, 2019, BRAIN IMAGING BEHAV, V13, P554, DOI 10.1007/s11682-018-9887-z; Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Beck A.T., 1987, BECK DEPRESSION INVE; Borelli WV, 2018, INT PSYCHOGERIATR, V30, P1813, DOI 10.1017/S1041610218000431; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Cabeza R, 2018, NAT REV NEUROSCI, V19, P701, DOI 10.1038/s41583-018-0068-2; Calhoun Vince D, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P230; Cardenas VA, 2011, NEUROBIOL AGING, V32, P572, DOI 10.1016/j.neurobiolaging.2009.04.011; Carmichael OT, 2007, ALZ DIS ASSOC DIS, V21, P14, DOI 10.1097/WAD.0b013e318032d2b1; Carmichael OT, 2007, NEUROBIOL AGING, V28, P389, DOI 10.1016/j.neurobiolaging.2006.01.006; Chung SC, 2006, NEUROSCI LETT, V395, P155, DOI 10.1016/j.neulet.2005.10.066; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delis DC, 2001, DELIS KAPLAN EXECUTI; Espeseth T, 2012, TWIN RES HUM GENET, V15, P442, DOI 10.1017/thg.2012.8; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Gale SA, 2018, AM J MED, V131, P1161, DOI 10.1016/j.amjmed.2018.01.022; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Goh JO, 2012, PSYCHOL AGING, V27, P707, DOI 10.1037/a0026715; Gorbach T, 2017, NEUROBIOL AGING, V51, P167, DOI 10.1016/j.neurobiolaging.2016.12.002; Gunning-Dixon FM, 2003, NEUROPSYCHOLOGIA, V41, P1929, DOI 10.1016/S0028-3932(03)00129-5; Hasan KM, 2014, MAGN RESON IMAGING, V32, P405, DOI 10.1016/j.mri.2014.01.014; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Leong RLF, 2017, NEUROIMAGE, V147, P852, DOI 10.1016/j.neuroimage.2016.10.016; Lundervold AJ, 2014, SCAND J PSYCHOL, V55, P225, DOI 10.1111/sjop.12114; Madsen SK, 2015, NEUROBIOL AGING, V36, pS32, DOI 10.1016/j.neurobiolaging.2014.03.044; McDonald CR, 2012, NEUROBIOL AGING, V33, P242, DOI 10.1016/j.neurobiolaging.2010.03.015; Nevalainen N, 2015, BRAIN RES, V1612, P83, DOI 10.1016/j.brainres.2014.09.010; Nyberg L, 2019, ANNU REV PSYCHOL, V70, P219, DOI 10.1146/annurev-psych-010418-103052; Nyberg Lars, 2017, F1000Res, V6, P1215, DOI 10.12688/f1000research.11419.1; Nyberg L, 2016, P NATL ACAD SCI USA, V113, P7918, DOI 10.1073/pnas.1606309113; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Preul C, 2006, J MAGN RESON IMAGING, V24, P513, DOI 10.1002/jmri.20665; Pudas S, 2018, CEREB CORTEX, V28, P936, DOI 10.1093/cercor/bhw418; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Reuter-Lorenz PA, 2014, NEUROPSYCHOL REV, V24, P355, DOI 10.1007/s11065-014-9270-9; Rogalski EJ, 2013, J COGNITIVE NEUROSCI, V25, P29, DOI 10.1162/jocn_a_00300; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Stern Y, 2018, NEUROIMAGE, V178, P36, DOI 10.1016/j.neuroimage.2018.05.033; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Tampubolon G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144907; Todd KL, 2018, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00445; Trimarchi F, 2013, ANAT SCI INT, V88, P61, DOI 10.1007/s12565-012-0162-x; Turner GR, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.005; Vidal-Pineiro D, 2019, CEREB CORTEX, V29, P3111, DOI 10.1093/cercor/bhy177; Walhovd KB, 2014, SCAND J PSYCHOL, V55, P244, DOI 10.1111/sjop.12120; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Yuan P, 2018, NEUROIMAGE, V172, P21, DOI 10.1016/j.neuroimage.2018.01.032	53	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0207967	10.1371/journal.pone.0207967	http://dx.doi.org/10.1371/journal.pone.0207967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939173	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900003
J	Kaltsonoudis, E; Pelechas, E; Papoudou-Bai, A; Markatseli, TE; Elisaf, M; Voulgari, PV; Drosos, AA				Kaltsonoudis, Evripidis; Pelechas, Eleftherios; Papoudou-Bai, Alexandra; Markatseli, Theodora E.; Elisaf, Moses; Voulgari, Paraskevi V.; Drosos, Alexandros A.			The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital	PLOS ONE			English	Article							ULTRASOUND; SPECTRUM; ULTRASONOGRAPHY	Background Temporal artery biopsy (TAB) is useful in assisting with giant cell arteritis (GCA) diagnosis but lacks sensitivity. The aim of our study was to assess the diagnostic impact of TAB histology in patients with suspected GCA on hospital admission. Methods A prospectively maintained database was queried for all TABs performed between 1-1-2000 until 31-12-2017 at the University Hospital of Ioannina. Thus, inclusion criteria were made on the grounds of every patient that underwent a TAB during the above-mentioned period, regardless of demographic, clinical and laboratory data. Results Two hundred forty-five TABs were included (149 females and 96 males), with a mean age of 64.5 (+/- 3.5) years. The mean symptoms duration until admission to the hospital was 8.6 (+/- 1.3) weeks and all had elevated acute phase reactants on admission. The reasons of admission were fever of unknown origin (FUO) in 114 (46.5%) patients, symptoms of polymyalgia rheumatica (PMR) in 84 (34.3%), new headache in 33 (13.5%), anemia of chronic disease (ACD) in 8 (3.32%) and eye disturbances in 6 (2.5%) patients. Positive results were found in 49 (20%) TABs. More specifically, in 14% of patients with FUO, 21% in those with PMR, while in patients with a new headache the percentage was 27%. Finally, 5 out of 6 (83.3%) of patients with ocular symptoms and only one (12.5%) of those suffering from ACD. Visual manifestations and FUO are correlated with a positive TAB. Conclusion It seems that TAB is useful in assisting with GCA diagnosis, but lacks sensitivity.	[Kaltsonoudis, Evripidis; Pelechas, Eleftherios; Markatseli, Theodora E.; Voulgari, Paraskevi V.; Drosos, Alexandros A.] Univ Ioannina, Sch Med, Dept Internal Med, Rheumatol Clin, Ioannina, Greece; [Papoudou-Bai, Alexandra] Univ Ioannina, Sch Med, Dept Pathol, Ioannina, Greece; [Elisaf, Moses] Univ Ioannina, Sch Med, Dept Internal Med, Ioannina, Greece	University of Ioannina; University of Ioannina; University of Ioannina	Drosos, AA (corresponding author), Univ Ioannina, Sch Med, Dept Internal Med, Rheumatol Clin, Ioannina, Greece.	adrosos@cc.uoi.gr	Drosos, Alexandros A./AAK-1115-2020; Pelechas, Eleftherios/O-6851-2019	Pelechas, Eleftherios/0000-0002-9383-5722				Aranda-Valera IC, 2017, CLIN EXP RHEUMATOL, V35, pS123; Arida A, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-44; Bajko Z, 2015, NEUROL NEUROCHIR POL, V49, P139, DOI 10.1016/j.pjnns.2015.03.003; Berthod PE, 2018, EUR RADIOL; Bowling K, 2017, ANN MED SURG, V20, P1, DOI 10.1016/j.amsu.2017.06.020; Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F; Dejaco C, 2018, ANN RHEUM DIS, V77, P636, DOI 10.1136/annrheumdis-2017-212649; Dejaco C, 2017, RHEUMATOLOGY, V56, P506, DOI 10.1093/rheumatology/kew273; Diamantopoulos AP, 2016, RHEUMATOLOGY, V55, P66, DOI 10.1093/rheumatology/kev289; Duhaut P, 1999, ANN RHEUM DIS, V58, P335, DOI 10.1136/ard.58.6.335; Gonzalez-Gay MA, 2005, MEDICINE, V84, P269, DOI 10.1097/01.md.0000180042.42156.d1; Gonzalez-Gay MA, 2001, SEMIN ARTHRITIS RHEU, V30, P249, DOI 10.1053/sarh.2001.16650; Hellmann DB, 2017, NEW ENGL J MED, V377, P385, DOI 10.1056/NEJMe1706439; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jese R, 2017, EUR J RADIOL, V95, P9, DOI 10.1016/j.ejrad.2017.07.007; Karassa FB, 2005, ANN INTERN MED, V142, P359, DOI 10.7326/0003-4819-142-5-200503010-00011; Luqmani R, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20900; Mari B, 2009, EUR J INTERN MED, V20, P533, DOI 10.1016/j.ejim.2009.05.002; Moiseev S, 2018, ANN RHEUM DIS, V77, P1164, DOI 10.1136/annrheumdis-2018-eular.2757; Pipitone NAM, 2018, CURR OPIN RHEUMATOL, V30, P24, DOI 10.1097/BOR.0000000000000459; Ponte C, 2015, WORLD J CLIN CASES, V3, P484, DOI 10.12998/wjcc.v3.i6.484; Rana AQ, 2014, J NEUROSCI RURAL PRA, V5, P409, DOI 10.4103/0976-3147.140005; Samson M, 2015, J NEUROL NEUROSUR PS, V86, P216, DOI 10.1136/jnnp-2014-307614; Schmidt WA, 2014, THER ADV MUSCULOSKEL, V6, P39, DOI 10.1177/1759720X13512256; Shu XM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007651; Soriano A, 2017, NAT REV RHEUMATOL, V13, P476, DOI 10.1038/nrrheum.2017.98; Soussan M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000622; Stone JH, 2017, NEW ENGL J MED, V377, P317, DOI 10.1056/NEJMoa1613849; Unger M, 2016, WIEN KLIN WOCHENSCHR, V128, P796, DOI 10.1007/s00508-016-1083-9	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0210845	10.1371/journal.pone.0210845	http://dx.doi.org/10.1371/journal.pone.0210845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925156	Green Submitted, gold, Green Published			2022-12-27	WOS:000462732300002
J	Munk, R; Martindale, JL; Yang, XL; Yang, JH; Grammatikakis, I; Di Germanio, C; Mitchell, SJ; de Cabo, R; Lehrmann, E; Zhang, YQ; Becker, KG; Raz, V; Gorospe, M; Abdelmohsen, K; Panda, AC				Munk, Rachel; Martindale, Jennifer L.; Yang, Xiaoling; Yang, Jen-Hao; Grammatikakis, Ioannis; Di Germanio, Clara; Mitchell, Sarah J.; de Cabo, Rafael; Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.; Raz, Vered; Gorospe, Myriam; Abdelmohsen, Kotb; Panda, Amaresh C.			Loss of miR-451a enhances SPARC production during myogenesis	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; IN-VITRO; PROLIFERATION; BINDING; GROWTH; DIFFERENTIATION; REGENERATION; BIOGENESIS; EXPRESSION	MicroRNAs (miRNAs) are small noncoding RNAs that critically regulate gene expression. Their abundance and function have been linked to a range of physiologic and pathologic processes. In aged monkey muscle, miR-451a and miR-144-3p were far more abundant than in young monkey muscle. This observation led us to hypothesize that miR-451a and miR-144-3p may influence muscle homeostasis. To test if these conserved microRNAs were implicated in myogenesis, we investigated their function in the mouse myoblast line C2C12. The levels of both microRNAs declined with myogenesis; however, only overexpression of miR-451a, but not miR-144-3p, robustly impeded C2C12 differentiation, suggesting an inhibitory role for miR-451a in myogenesis. Further investigation of the regulatory influence of miR-451a identified as one of the major targets Sparc mRNA, which encodes a secreted protein acidic and rich in cysteine (SPARC) that functions in wound healing and cellular differentiation. In mouse myoblasts, miR-451a suppressed Sparc mRNA translation. Together, our findings indicate that miR-451a is downregulated in differentiated myoblasts and suggest that it decreases C2C12 differentiation at least in part by suppressing SPARC biosynthesis.	[Munk, Rachel; Martindale, Jennifer L.; Yang, Xiaoling; Yang, Jen-Hao; Grammatikakis, Ioannis; Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.; Gorospe, Myriam; Abdelmohsen, Kotb; Panda, Amaresh C.] NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA; [Di Germanio, Clara; Mitchell, Sarah J.; de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Raz, Vered] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Panda, Amaresh C.] Inst Life Sci, Bhubaneswar, Odisha, India	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Gorospe, M; Panda, AC (corresponding author), NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA.; Panda, AC (corresponding author), Inst Life Sci, Bhubaneswar, Odisha, India.	gorospem@mail.nih.gov; amaresh.panda@ils.res.in	Panda, Amaresh C./H-5459-2019; Gorospe, Myriam/Y-3613-2019; Martindale, Jennifer Luethy/AAD-1963-2022; Abdelmohsen, Kotb/AAX-4191-2020; de Cabo, Rafael Carlos/J-5230-2016	Panda, Amaresh C./0000-0003-3189-8995; Martindale, Jennifer Luethy/0000-0002-3234-6861; Abdelmohsen, Kotb/0000-0001-6240-5810; de Cabo, Rafael Carlos/0000-0003-2830-5693	National Institute on Aging Intramural Research Program, National Institutes of Health; Science & Engineering Research Board, Department of Science & Technology (DST), Government of India; NATIONAL INSTITUTE ON AGING [ZIAAG000363, ZICAG000616, ZIAAG000394] Funding Source: NIH RePORTER	National Institute on Aging Intramural Research Program, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Science & Engineering Research Board, Department of Science & Technology (DST), Government of India; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging Intramural Research Program, National Institutes of Health. ACP was further supported by the Science & Engineering Research Board, Department of Science & Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carvajal JJ, 2010, EXP CELL RES, V316, P3014, DOI 10.1016/j.yexcr.2010.07.005; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cho WJ, 2000, BIOCHEM BIOPH RES CO, V271, P630, DOI 10.1006/bbrc.2000.2682; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Dumont NA, 2017, METHODS MOL BIOL, V1560, P179, DOI 10.1007/978-1-4939-6788-9_12; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Guweidhi A, 2005, ANN SURG, V242, P224, DOI 10.1097/01.sla.0000171866.45848.68; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Johnson AN, 2013, DEVELOPMENT, V140, P3645, DOI 10.1242/dev.095596; Kim M, 2015, BRIT J HAEMATOL, V168, P583, DOI 10.1111/bjh.13164; Lee KP, 2015, GENE DEV, V29, P1605, DOI 10.1101/gad.263574.115; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liu ZR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/207684; MALEY MAL, 1995, EXP CELL RES, V219, P169, DOI 10.1006/excr.1995.1217; Mercken EM, 2013, AGING-US, V5, P692, DOI 10.18632/aging.100598; Nakamura K, 2013, MUSCLE NERVE, V48, P791, DOI 10.1002/mus.23822; Nakamura K, 2012, AGING-US, V4, P40; Pan X, 2013, MOL CANCER THER, V12, P1153, DOI 10.1158/1535-7163.MCT-12-0802; Panda AC, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx297; Panda AC, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2126; Panda AC, 2016, NUCLEIC ACIDS RES, V44, P2393, DOI 10.1093/nar/gkw023; Panda AC, 2014, MOL CELL BIOL, V34, P3106, DOI 10.1128/MCB.00423-14; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015; Ullah S, 2014, MOL BIOL REP, V41, P225, DOI 10.1007/s11033-013-2855-1; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107	34	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214301	10.1371/journal.pone.0214301	http://dx.doi.org/10.1371/journal.pone.0214301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925184	Green Submitted, Green Published, gold			2022-12-27	WOS:000462732300012
J	Shestyuk, AY; Kasinathan, K; Karapoondinott, V; Knight, RT; Gurumoorthy, R				Shestyuk, Avgusta Y.; Kasinathan, Karthik; Karapoondinott, Viswajith; Knight, Robert T.; Gurumoorthy, Ram			Individual EEG measures of attention, memory, and motivation predict population level TV viewership and Twitter engagement	PLOS ONE			English	Article							SOCIAL-DESIRABILITY BIAS; FRONTAL BRAIN ASYMMETRY; TELEVISION; OSCILLATIONS; RESPONSES; VALIDITY; THETA; COMMERCIALS; ACTIVATION; COMPONENTS	Television (TV) programming attracts ever-growing audiences and dominates the cultural zeitgeist. Viewership and social media engagement have become standard indices of programming success. However, accurately predicting individual episode success or future show performance using traditional metrics remains a challenge. Here we examine whether TV viewership and Twitter activity can be predicted using electroencephalography (EEG) measures, which are less affected by reporting biases and which are commonly associated with different cognitive processes. 331 participants watched an hour-long episode from one of nine prime-time shows (similar to 36 participants per episode). Three frequency-based measures were extracted: fronto-central alpha/beta asymmetry (indexing approach motivation), fronto-central alpha/theta power (indexing attention), and fronto-central theta/gamma power (indexing memory processing). All three EEG measures and the composite EEG score significantly correlated across episode segments with the two behavioral measures of TV viewership and Twitter volume. EEG measures explained more variance than either of the behavioral metrics and mediated the relationship between the two. Attentional focus was integral for both audience retention and Twitter activity, while emotional motivation was specifically linked with social engagement and program segments with high TV viewership. These findings highlight the viability of using EEG measures to predict success of TV programming and identify cognitive processes that contribute to audience engagement with television shows.	[Shestyuk, Avgusta Y.; Kasinathan, Karthik; Karapoondinott, Viswajith; Gurumoorthy, Ram] Nielsen Consumer Neurosci, R&D Dept, Berkeley, CA USA; [Shestyuk, Avgusta Y.; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shestyuk, AY (corresponding author), Nielsen Consumer Neurosci, R&D Dept, Berkeley, CA USA.; Shestyuk, AY (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	avgusta.shestyuk@nielsen.com		Shestyuk, Avgusta/0000-0003-1734-8153	Nielsen Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021135] Funding Source: NIH RePORTER	Nielsen Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by the Nielsen Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AYS, KK, VK, and RG are employees of the Consumer Neuroscience division of the Nielsen Company, and RTK is a paid consultant. The Consumer Neuroscience division of the Nielsen Company provided support in the form of salaries for authors AYS, KK, VK and RG and consultant fees to RTK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alekseichuk I, 2016, CURR BIOL, V26, P1, DOI [10.1016/j.cub.2015.11.020, DOI 10.1016/J.CUB.2015.11.020]; Amodio DM, 2008, PSYCHOPHYSIOLOGY, V45, P11, DOI 10.1111/j.1469-8986.2007.00609.x; ARNOLD HJ, 1981, ACAD MANAGE J, V24, P377, DOI 10.2307/255848; Astolfi L, 2009, COMPUTATIONAL INTELL, V2009; Auverset LA, 2016, SOC MEDIA SOC, V2, DOI 10.1177/2056305116662170; Barnett SB, 2017, J CONSUM RES, V44, P160, DOI 10.1093/jcr/ucw083; Beal V, 2011, AUSTR NZ MARK AC ANZ, P1; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; BERRIDGE CW, 2003, BRAIN ASYMMETRY, P69; Boksem MAS, 2015, J MARKETING RES, V52, P482, DOI 10.1509/jmr.13.0572; Broach VC, 1995, J ADVERTISING, V24, P45, DOI 10.1080/00913367.1995.10673488; Brojakowski Benjamin, 2015, TELEVISION SOCIAL ME, P23; Cacioppo JT, 2004, BIOL PSYCHOL, V67, P235, DOI 10.1016/j.biopsycho.2004.03.009; Cavanagh JF, 2015, J PHYSIOL-PARIS, V109, P3, DOI 10.1016/j.jphysparis.2014.04.003; Cha J., 2016, TELEVISION USE 21 CE, P21; Christoforou C, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00072; Clayton MS, 2015, TRENDS COGN SCI, V19, P188, DOI 10.1016/j.tics.2015.02.004; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Coan JA, 2003, PSYCHOPHYSIOLOGY, V40, P106, DOI 10.1111/1469-8986.00011; Connors BL, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00312; Cunningham S., 2009, TELEVISION STUDIES T, P83; Cunningham S, 2015, INT J DIGIT TELEV, V6, P203, DOI 10.1386/jdtv.6.2.203_1; Damratoski KJ, 2011, J APPL BUS RES, V27, P69; DANAHER PJ, 1995, J ADVERTISING RES, V35, P37; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Deitz GD, 2016, J ADVERTISING RES, V56, P217, DOI 10.2501/JAR-2016-030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Denrell J, 2010, MANAGE SCI, V56, P1653, DOI 10.1287/mnsc.1100.1220; Despres O, 2017, NEUROBIOL AGING, V52, P53, DOI 10.1016/j.neurobiolaging.2016.12.019; Dmochowski JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5567; Doughty M., 2012, P 10 EUR C INT TV VI, P79, DOI [10.1145/2325616.2325635, DOI 10.1145/2325616.2325635]; Falk EB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00313; Falk EB, 2010, J NEUROSCI, V30, P8421, DOI 10.1523/JNEUROSCI.0063-10.2010; FELDMAN JM, 1988, J APPL PSYCHOL, V73, P421, DOI 10.1037/0021-9010.73.3.421; Fiebelkorn IC, 2018, NEURON, V99, P842, DOI 10.1016/j.neuron.2018.07.038; Fischer NL, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00166; Fisher RJ, 2000, PSYCHOL MARKET, V17, P105, DOI 10.1002/(SICI)1520-6793(200002)17:2<105::AID-MAR3>3.0.CO;2-9; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Fortunato V.C.R., 2014, J MANAGEMENT RES, V6, P201, DOI [DOI 10.5296/JMR.V6I2.5446, 10.5296/jmr.v6i2.5446]; Freeman WJ, 2003, CLIN NEUROPHYSIOL, V114, P1053, DOI 10.1016/S1388-2457(03)00045-2; Frey JN, 2015, BRAIN RES, V1626, P183, DOI 10.1016/j.brainres.2015.02.017; GENSCH D, 1980, J MARKETING RES, V17, P307, DOI 10.2307/3150528; Gevins A, 1999, PHILOS T R SOC B, V354, P1125, DOI 10.1098/rstb.1999.0468; Giglietto F, 2014, J COMMUN, V64, P260, DOI 10.1111/jcom.12085; Gordon R, 2018, EUR J MARKETING, V52, P92, DOI 10.1108/EJM-12-2016-0881; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Guixeres J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01808; Hagemann D, 2004, BIOL PSYCHOL, V67, P157, DOI 10.1016/j.biopsycho.2004.03.006; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Harrington S., 2013, PARTICIPATIONS J AUD, V10, P405, DOI DOI 10.1080/1369118X.2012.756053; Haufe S, 2018, NEUROIMAGE, V179, P79, DOI 10.1016/j.neuroimage.2018.06.016; Hewig J, 2006, BIOL PSYCHOL, V71, P42, DOI 10.1016/j.biopsycho.2005.01.006; Hobbs MJ, 2017, IBC360; Hoffmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003004; Hunter SD III, 2016, STUD MEDIA COMMUN, V4, P13, DOI DOI 10.11114/SMC.V4I2.1611; Ignaccolo M, 2010, J BIOL PHYS, V36, P185, DOI 10.1007/s10867-009-9171-y; JONES NA, 1992, BRAIN COGNITION, V20, P280, DOI 10.1016/0278-2626(92)90021-D; Karmarkar UR, 2019, ORGAN RES METHODS, V22, P174, DOI 10.1177/1094428117730598; Keil A, 2014, PSYCHOPHYSIOLOGY, V51, P1, DOI 10.1111/psyp.12147; Klimesch W., 1999, BRAIN RES REV, V67, P157; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kong WZ, 2013, COGN NEURODYNAMICS, V7, P531, DOI 10.1007/s11571-013-9255-z; Lau TroyM., 2012, J BEHAV BRAIN SCI, V02, P387, DOI [10.4236/jbbs.2012.23044, DOI 10.4236/JBBS.2012.23044]; Lee N, 2007, INT J PSYCHOPHYSIOL, V63, P199, DOI 10.1016/j.ijpsycho.2006.03.007; Lotz Amanda D., 2018, WE NOW DISRUPT THIS; Mandelkow H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00128; Manning S, 1999, ACAD MARK STUD J, P3; Meshulam M, 2013, J NEUROPHYSIOL, V109, P2272, DOI 10.1152/jn.00474.2012; Nielsen, 2013, NEW STUD CONF CORR T; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; O'Donnell MB, 2017, SOC COGN AFFECT NEUR, V12, P61, DOI 10.1093/scan/nsw158; Ohme R, 2012, IEEE PULSE, V3, P28, DOI 10.1109/MPUL.2012.2189169; Ohme R, 2010, J ECON PSYCHOL, V31, P785, DOI 10.1016/j.joep.2010.03.008; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pampu N. C., 2011, ACTA TECHNICA NAPOCE, V52, P26; Pittman M, 2015, YOU CONNECTED VIEWIN, P20; Pizzagalli DA, 2005, PSYCHOL SCI, V16, P805, DOI 10.1111/j.1467-9280.2005.01618.x; Poels K, 2006, J ADVERTISING RES, V46, P18, DOI 10.2501/S0021849906060041; Poggi J., 2015, ADAGE           1026; Poole BD, 2014, EXP BRAIN RES, V232, P2121, DOI 10.1007/s00221-014-3902-4; Pynta P, 2014, J ADVERTISING RES, V54, P71, DOI 10.2501/JAR-54-1-071-080; REEVES B, 1985, INT J NEUROSCI, V27, P241, DOI 10.3109/00207458509149770; REEVES B, 1989, HUM COMMUN RES, V15, P493, DOI 10.1111/j.1468-2958.1989.tb00196.x; Rodrigues J, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.12908; Rossiter JR, 2001, J ADVERTISING RES, V41, P13, DOI 10.2501/JAR-41-2-13-21; ROTHSCHILD ML, 1986, COMMUN RES, V13, P182, DOI 10.1177/009365086013002003; Roy M., 2013, INT J BUSINESS SOCIA, V4, P73; Ruef AM., 2007, HDB EMOTION ELICITAT, P286; SCHAFER EWP, 1978, INT J NEUROSCI, V8, P71, DOI 10.3109/00207457809150379; Schirra S, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P2441, DOI 10.1145/2556288.2557070; Schmitt E., 2014, THE NEXT WEB; Schone B, 2016, EXP BRAIN RES, V234, P559, DOI 10.1007/s00221-015-4483-6; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schweidel DA, 2010, J MARKETING, V17, P124; Simons RF, 2003, MEDIA PSYCHOL, V5, P283, DOI 10.1207/S1532785XMEP0503_03; Smith ME, 2004, MEDIA PSYCHOL, V6, P285, DOI 10.1207/s1532785xmep0603_3; Summerfield C, 2005, NEUROIMAGE, V24, P692, DOI 10.1016/j.neuroimage.2004.09.012; Thompson F., 1997, MULTIPLE LINEAR REGR, V24, P11; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TOMARKEN AJ, 1990, J PERS SOC PSYCHOL, V59, P791, DOI 10.1037/0022-3514.59.4.791; van Dijck J, 2015, TELEV NEW MEDIA, V16, P148, DOI 10.1177/1527476414527136; Vecchiato G, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/643489; Vecchiato G, 2012, IEEE PULSE, V3, P42, DOI 10.1109/MPUL.2012.2189171; Vecchiato Giovanni, 2010, Nonlinear Biomed Phys, V4 Suppl 1, pS3, DOI 10.1186/1753-4631-4-S1-S3; Vecchiato G, 2010, BRAIN TOPOGR, V23, P165, DOI 10.1007/s10548-009-0127-0; Venkatraman V, 2015, J MARKETING RES, V52, P436, DOI 10.1509/jmr.13.0593; Werkle-Bergner M, 2006, NEUROSCI BIOBEHAV R, V30, P839, DOI 10.1016/j.neubiorev.2006.06.009; Whittingstall K, 2010, MAGN RESON IMAGING, V28, P1135, DOI 10.1016/j.mri.2010.03.042; Wilbur KC, 2016, J MEDIA ECON, V29, P51, DOI 10.1080/08997764.2016.1170022; Williams O., 2015, GUARDIAN; Wohn DY, 2011, TWEETING TV SHARING, P16; Worden MS, 2000, J NEUROSCI, V20; Yang T, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-015-0056-4	118	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214507	10.1371/journal.pone.0214507	http://dx.doi.org/10.1371/journal.pone.0214507			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921406	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000078
J	Szczepankiewicz, F; Sjolund, J; Stahlberg, F; Latt, J; Nilsson, M				Szczepankiewicz, Filip; Sjolund, Jens; Stahlberg, Freddy; Latt, Jimmy; Nilsson, Markus			Tensor-valued diffusion encoding for diffusional variance decomposition (DIVIDE): Technical feasibility in clinical MRI systems	PLOS ONE			English	Article							PULSED-FIELD-GRADIENT; BRAIN WHITE-MATTER; IN-VIVO; RESTRICTED DIFFUSION; WATER DIFFUSION; ECHO-PLANAR; ANISOTROPY; TIME; MODEL; QUANTIFICATION	Microstructure imaging techniques based on tensor-valued diffusion encoding have gained popularity within the MRI research community. Unlike conventional diffusion encoding-applied along a single direction in each shot-tensor-valued encoding employs diffusion encoding along multiple directions within a single preparation of the signal. The benefit is that such encoding may probe tissue features that are not accessible by conventional encoding. For example, diffusional variance decomposition (DIVIDE) takes advantage of tensor-valued encoding to probe microscopic diffusion anisotropy independent of orientation coherence. The drawback is that tensor-valued encoding generally requires gradient waveforms that are more demanding on hardware; it has therefore been used primarily in MRI systems with relatively high performance. The purpose of this work was to explore tensorvalued diffusion encoding on clinical MRI systems with varying performance to test its technical feasibility within the context of DIVIDE. We performed whole-brain imaging with linear and spherical b-tensor encoding at field strengths between 1.5 and 7 T, and at maximal gradient amplitudes between 45 and 80 mT/m. Asymmetric gradient waveforms were optimized numerically to yield b-values up to 2 ms/mu m(2). Technical feasibility was assessed in terms of the repeatability, SNR, and quality of DIVIDE parameter maps. Variable system performance resulted in echo times between 83 to 115 ms and total acquisition times of 6 to 9 minutes when using 80 signal samples and resolution 2x2x4 mm(3). As expected, the repeatability, signal-to-noise ratio and parameter map quality depended on hardware performance. We conclude that tensor-valued encoding is feasible for a wide range of MRI systems-even at 1.5 T with maximal gradient waveform amplitudes of 33 mT/m-and baseline experimental design and quality parameters for all included configurations. This demonstrates that tissue features, beyond those accessible by conventional diffusion encoding, can be explored on a wide range of MRI systems.	[Szczepankiewicz, Filip; Stahlberg, Freddy] Lund Univ, Dept Clin Sci Lund, Med Radiat Phys, Lund, Sweden; [Sjolund, Jens] Elekta Instrument AB, Kungstensgatan 18, Stockholm, Sweden; [Sjolund, Jens] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden; [Sjolund, Jens] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Stahlberg, Freddy; Nilsson, Markus] Lund Univ, Dept Clin Sci Lund, Diagnost Radiol, Lund, Sweden; [Latt, Jimmy] Skane Univ Hosp, Dept Imaging & Funct, Lund, Sweden; [Nilsson, Markus] Lund Univ, Bioimaging Ctr, Lund, Sweden	Lund University; Elekta; Linkoping University; Linkoping University; Lund University; Lund University; Skane University Hospital; Lund University	Szczepankiewicz, F (corresponding author), Lund Univ, Dept Clin Sci Lund, Med Radiat Phys, Lund, Sweden.	filip.szczepankiewicz@med.lu.se	Szczepankiewicz, Filip/AAV-9958-2021; Nilsson, Markus/C-6920-2012	Szczepankiewicz, Filip/0000-0002-5251-587X; Sjolund, Jens/0000-0002-9099-3522; Nilsson, Markus/0000-0002-3140-8223	Swedish Research Council [2016-03443]; Swedish Foundation for Strategic Research [AM13-0090]; Random Walk Imaging AB [MN15]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Random Walk Imaging AB	This work was supported by: MN: Swedish Research Council. Grant no. 2016-03443, https://www.vr.se/; MN: Swedish Foundation for Strategic Research. Grant no. AM13-0090, https://strategiska.se/en/; and MN: Random Walk Imaging AB. Grant no MN15, www.rwi.se.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta E, 2018, MAGN RESON MED, V79, P663, DOI 10.1002/mrm.26709; Andersson P, 1997, J ENG DESIGN, V8, P277, DOI 10.1080/09544829708907966; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Avram AV, 2013, NEUROIMAGE, V64, P229, DOI 10.1016/j.neuroimage.2012.08.048; Baron CA, 2012, MAGN RESON MED, V68, P1190, DOI 10.1002/mrm.24120; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bernstein MA, 1998, MAGN RESON MED, V39, P300, DOI 10.1002/mrm.1910390218; Butts K, 1997, MAGNET RESON MED, V38, P741, DOI 10.1002/mrm.1910380510; Choi S, 2011, MAGN RESON IMAGING, V29, P739, DOI 10.1016/j.mri.2011.02.009; Clark CA, 2001, MAGNET RESON MED, V45, P1126, DOI 10.1002/mrm.1149; CORY DG, 1990, ABSTR PAP AM CHEM S, V199, P105; Cox EF, 2010, MAGN RESON MED, V64, P1441, DOI 10.1002/mrm.22522; Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001; Does MD, 2003, MAGN RESON MED, V49, P206, DOI 10.1002/mrm.10385; Eriksson S, 2013, J MAGN RESON, V226, P13, DOI 10.1016/j.jmr.2012.10.015; Fieremans E, 2016, NEUROIMAGE, V129, P414, DOI 10.1016/j.neuroimage.2016.01.018; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; Grussu F, 2019, MAGN RESON MED, V81, P1247, DOI 10.1002/mrm.27463; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Ham CLG, 1997, JMRI-J MAGN RESON IM, V7, P933, DOI 10.1002/jmri.1880070524; Hebrank FX, 2000, P INT SOC MAG RES ME; Henriques RN, 2019, MAGN RESON MED, V81, P3245, DOI 10.1002/mrm.27606; Hutter J, 2018, HIGHLY EFFICIENT DIF; Ianus A, 2018, MAGN RESON MED, V79, P2198, DOI 10.1002/mrm.26894; Ianus A, 2016, NMR BIOMED, V29, P672, DOI 10.1002/nbm.3496; Jensen JH, 2014, NMR BIOMED, V27, P363, DOI [10.1002/nbm.3030, 10.1002/nbm.3094]; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2019, J MAGN RESON, V300, P84, DOI 10.1016/j.jmr.2019.01.007; Jespersen SN, 2013, NMR BIOMED, V26, P1647, DOI 10.1002/nbm.2999; Jespersen SN, 2012, NMR BIOMED, V25, P813, DOI 10.1002/nbm.1808; Jeurissen B, 2018, P INT SOC MAG RESON, V26; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lampinen B, 2018, P INT SOC MAG RESON, V26; Lampinen B, 2017, NEUROIMAGE, V147, P517, DOI 10.1016/j.neuroimage.2016.11.053; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Latt J, 2009, NMR BIOMED, V22, P619, DOI 10.1002/nbm.1376; Lawrenz M, 2015, NEUROIMAGE, V109, P283, DOI 10.1016/j.neuroimage.2015.01.025; Lawrenz M, 2013, MAGN RESON MED, V69, P1072, DOI 10.1002/mrm.24347; Lawrenz M, 2010, J MAGN RESON, V202, P43, DOI 10.1016/j.jmr.2009.09.015; Lundell H., 2017, P INT SOC MAG RESON, V25; Lundell H, 2018, P INT SOC MAG RESON, V26; MITRA PP, 1995, PHYS REV B, V51, P15074, DOI 10.1103/PhysRevB.51.15074; MORI S, 1995, MAGNET RESON MED, V33, P41, DOI 10.1002/mrm.1910330107; Moser E, 2012, NMR BIOMED, V25, P695, DOI 10.1002/nbm.1794; Nery F, 2018, P INT SOC MAG RESON, V26; Nilsson M, 2018, P INT SOC MAG RESON, V26; Nilsson M, 2017, P INT SOC MAG RESON, V25; Nilsson M, 2018, NEUROIMAGE, V182, P232, DOI 10.1016/j.neuroimage.2018.04.075; Nilsson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141825; Nilsson M, 2009, MAGN RESON IMAGING, V27, P176, DOI 10.1016/j.mri.2008.06.003; Ning LP, 2017, MAGN RESON MED, V78, P763, DOI 10.1002/mrm.26403; Novikov DS, 2018, MAGN RESON MED, V79, P3172, DOI 10.1002/mrm.27101; Ozarslan E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2905765; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Qin W, 2009, MAGN RESON MED, V61, P755, DOI 10.1002/mrm.21920; Qiuyun F, 2017, P INT SOC MAG RESON, V25; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Roding M, 2012, J MAGN RESON, V222, P105, DOI 10.1016/j.jmr.2012.07.005; Ronen I, 2006, MAGN RESON IMAGING, V24, P61, DOI 10.1016/j.mri.2005.10.023; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Shemesh N, 2010, NMR BIOMED, V23, P757, DOI 10.1002/nbm.1550; Shemesh N, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454131; Siemonsen S, 2008, AM J NEURORADIOL, V29, P950, DOI 10.3174/ajnr.A0951; Sigmund EE, 2011, MAGN RESON IMAGING, V29, P752, DOI 10.1016/j.mri.2011.02.016; Sjolund J, 2018, NEUROIMAGE, V175, P272, DOI 10.1016/j.neuroimage.2018.03.059; Sjolund J, 2015, J MAGN RESON, V261, P157, DOI 10.1016/j.jmr.2015.10.012; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; STEJSKAL EO, 1965, J CHEM PHYS, V43, P3597, DOI 10.1063/1.1696526; Szczepankiewicz F, 2018, P INT SOC MAG RESON, V26; Szczepankiewicz F, 2016, ARXIV161206741; Szczepankiewicz F, 2016, NEUROIMAGE, V142, P522, DOI 10.1016/j.neuroimage.2016.07.038; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Szezepankiewicz F, 2016, P INT SOC MAG RESON, V24; Tax CM, 2017, P INT SOC MAG RESON, V25; Topgaard D., 2016, DIFFUSION NMR CONFIN; Topgaard D, 2017, J MAGN RESON, V275, P98, DOI 10.1016/j.jmr.2016.12.007; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Veraart J, 2017, P INT SOC MAG RESON, V25; Vos SB, 2017, MAGN RESON MED, V77, P285, DOI 10.1002/mrm.26124; Westin CF, 2016, NEUROIMAGE, V135, P345, DOI 10.1016/j.neuroimage.2016.02.039; Winther Andersen K, 2018, P INT SOC MAG RESON, V26; WONG EC, 1995, MAGNET RESON MED, V34, P139, DOI 10.1002/mrm.1910340202; Yablonskiy DA, 2010, NMR BIOMED, V23, P661, DOI 10.1002/nbm.1520; Yang G, 2019, MAGN RESON MED, V81, P1818, DOI 10.1002/mrm.27539; Yang G, 2018, MAGN RESON MED, V80, P507, DOI 10.1002/mrm.27043	92	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214238	10.1371/journal.pone.0214238	http://dx.doi.org/10.1371/journal.pone.0214238			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921381	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000045
J	Bernstein, DI; Cardin, RD; Pullum, DA; Bravo, FJ; Kousoulas, KG; Dixon, DA				Bernstein, David I.; Cardin, Rhonda D.; Pullum, Derek A.; Bravo, Fernando J.; Kousoulas, Konstantin G.; Dixon, David A.			Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; GLYCOPROTEIN K GK; AMINO-TERMINUS; INFECTION; VACCINATION; EXPRESSION; RESPONSES; PROTEIN	Background Although herpes simplex viruses (HSV) are a major target for vaccine development no vaccine is currently licensed. Methods A live attenuated HSV virus vaccine, VC2 was compared to a subunit HSV vaccine, glycoprotein D (gD2) administered with the adjuvant, MPL/Alum using the guinea pig model of genital herpes. Three doses of intramuscular (IM) vaccine were provided followed by intravaginal challenge with HSV-2 at either 3 weeks or six months after the last vaccination. Results Both VC2 and gD2 vaccines reduced acute genital disease. VC2 was somewhat more effective in reducing acute vaginal replication, the amount of virus in neural tissue, subsequent recurrent disease and recurrent virus shedding following challenge at 3 weeks post vaccination. Both vaccines continued to provide protection at 6 months after vaccination but the differences between the vaccines became more pronounced in favor of the live attenuated vaccine, VC2. Significant differences in acute disease, acute vaginal virus replication, recurrent disease and recurrent virus shedding (P<0.05 for each) was observed comparing the vaccines. Re-examination of protection for this study using criteria similar to those used in recent clinical trials (inclusion of recurrent disease) showed that efficacy may not be as high in this model as previously thought prompting a need to assess the best predictive outcomes for protection in humans. Conclusion While both the live attenuated vaccine, VC2, and the gD2 subunit vaccine provided protection, the duration of protection appeared to be greater for VC2. Using the same evaluation criteria as used in human trials provided unique insights into the utility of the guinea pig model.	[Bernstein, David I.; Pullum, Derek A.; Bravo, Fernando J.; Dixon, David A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Bernstein, David I.; Pullum, Derek A.; Bravo, Fernando J.; Dixon, David A.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Cardin, Rhonda D.; Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Bernstein, DI (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.; Bernstein, DI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	david.bernstein@cchmc.org		KOUSOULAS, KONSTANTIN/0000-0001-7077-9003	National Institute of Allergy and Infectious Diseases [HHSN272201000008I]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000008I to CCHMC. Kousoulas has intellectual property rights to the VC2 vaccine and is a founder of IOSBiomedical Group, INC, which owns these rights and intends to commercialize the vaccine. No other authors have a financial interest or other conflicts.	Awasthi S, 2015, J VIROL, V89, P8497, DOI 10.1128/JVI.01089-15; Awasthi S, 2014, CURR OPIN VIROL, V6, P6, DOI 10.1016/j.coviro.2014.02.006; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein David I., 2015, Antiviral Chemistry & Chemotherapy, V24, P19, DOI 10.1177/2040206614566581; Bernstein David I, 2014, Antivir Chem Chemother, V23, P189, DOI 10.3851/IMP2499; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bernstein DI, 2011, VACCINE, V29, P2071, DOI 10.1016/j.vaccine.2011.01.005; Bernstein DI, 2010, VACCINE, V28, P3748, DOI 10.1016/j.vaccine.2009.10.025; BERNSTEIN DI, 1990, J CLIN MICROBIOL, V28, P11, DOI 10.1128/JCM.28.1.11-15.1990; BERNSTEIN DI, 1993, J INFECT DIS, V167, P731, DOI 10.1093/infdis/167.3.731; Bernstein DI, EVALUATION VC2 LIVE; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Chouljenko VN, 2010, J VIROL, V84, P8596, DOI 10.1128/JVI.00298-10; Chouljenko VN, 2009, J VIROL, V83, P12301, DOI 10.1128/JVI.01329-09; David AT, 2008, CURR EYE RES, V33, P455, DOI 10.1080/02713680802130362; David AT, 2012, MBIO, V3, DOI 10.1128/mBio.00144-12; Diaz F, 2018, VIROLOGY, V513, P129, DOI 10.1016/j.virol.2017.10.011; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; Harris SA, 2015, J ALZHEIMERS DIS, V48, P319, DOI 10.3233/JAD-142853; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645; Itzhaki RF, 2018, J ALZHEIMERS DIS, V64, P363, DOI 10.3233/JAD-180266; Johnston C, 2016, VACCINE, V34, P2948, DOI 10.1016/j.vaccine.2015.12.076; Kim IJ, 2013, J VIROL, V87, P8029, DOI 10.1128/JVI.01181-13; Lee HC, 2009, J VIROL, V83, P6115, DOI 10.1128/JVI.00128-09; McNicholl JM, 2017, INT J STD AIDS, V28, P372, DOI 10.1177/0956462416650123; Musarrat F, 2018, J VIROL, V92, DOI 10.1128/JVI.01842-17; Phipps W, 2016, J INFECT DIS, V213, P439, DOI 10.1093/infdis/jiv451; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Saied AA, 2014, CURR EYE RES, V39, P596, DOI 10.3109/02713683.2013.855238; SISK WP, 1994, J VIROL, V68, P766, DOI 10.1128/JVI.68.2.766-775.1994; STANBERRY LR, 1987, J INFECT DIS, V155, P914, DOI 10.1093/infdis/155.5.914; Stanfield BA, 2017, VACCINE, V35, P536, DOI 10.1016/j.vaccine.2016.12.018; Stanfield BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109890; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003	35	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213401	10.1371/journal.pone.0213401	http://dx.doi.org/10.1371/journal.pone.0213401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917165	Green Submitted, gold, Green Published			2022-12-27	WOS:000462465800031
J	Garrett, RK				Garrett, R. Kelly			Social media's contribution to political misperceptions in US Presidential elections	PLOS ONE			English	Article							NEWS; MISINFORMATION; IDEOLOGY; EXPOSURE	There is considerable concern about the role that social media, such as Facebook and Twitter, play in promoting misperceptions during political campaigns. These technologies are widely used, and inaccurate information flowing across them has a high profile. This research uses three-wave panel surveys conducted with representative samples of Americans during both the 2012 and 2016 U.S. Presidential elections to assess whether use of social media for political information promoted endorsement of falsehoods about major party candidates or important campaign issues. Fixed effects regression helps ensure that observed effects are not due to individual differences. Results indicate that social media use had a small but significant influence on misperceptions about President Obama in the 2012 election, and that this effect was most pronounced among strong partisans. Social media had no effect on belief accuracy about the Republican candidate in that election. The 2016 survey focused on campaign issues. There is no evidence that social media use influenced belief accuracy about these topics in aggregate, but Facebook users were unique. Social media use by this group reduced issue misperceptions relative to those who only used other social media. These results demonstrate that social media can alter citizens' willingness to endorse falsehoods during an election, but that the effects are often small.	[Garrett, R. Kelly] Ohio State Univ, Sch Commun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Garrett, RK (corresponding author), Ohio State Univ, Sch Commun, Columbus, OH 43210 USA.	garrett.258@osu.edu	Garrett, R. Kelly/E-8690-2010	Garrett, R. Kelly/0000-0001-7022-7452	National Science Foundation [IIS-1149599]; School of Communication at the Ohio State University	National Science Foundation(National Science Foundation (NSF)); School of Communication at the Ohio State University	The author received funding from the National Science Foundation (IIS-1149599) and from the School of Communication at the Ohio State University for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Brenden Bishop, Rob Bond, Brad Bushman, Jason Coronel, Andrew Hayes, Michael Jensen, I-Ching Lee, Russ Neuman, anonymous reviewers, and to participants at the Ohio State University Mershon Center Conference on the 2016 Presidential Election for valuable feedback on earlier versions of this manuscript. This material is based upon work supported by the National Science Foundation under Grant No. IIS-1149599. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	Allcott Hunt, 2017, J ECON PERSPECT, V31, P211, DOI DOI 10.1257/JEP.31.2.211; Allison P.D., 2009, QUANTITATIVE APPL SO, V160; Allport G.W., 1965, PSYCHOL RUMOR; [Anonymous], THE PEOPLES CHOICE; Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Berry JeffreyM., 2013, OUTRAGE IND POLITICA; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; DiFonzo N, 2016, SOC INFLUENCE, V11, P22, DOI 10.1080/15534510.2015.1137224; Dilliplane S, 2013, AM J POLIT SCI, V57, P236, DOI 10.1111/j.1540-5907.2012.00600.x; Garrett RK, 2016, J COMPUT-MEDIAT COMM, V21, P331, DOI 10.1111/jcc4.12164; Garrett RK, 2011, HUM COMMUN RES, V37, P255, DOI 10.1111/j.1468-2958.2010.01401.x; Gastil J, 2017, INT J PUBLIC OPINION; Goldman Alvin, 2011, SOCIAL EPISTEMOLOGY; Guess A., 2018, AVOIDING ECHO CHAMBE; Guess A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4586; Halaby CN, 2004, ANNU REV SOCIOL, V30, P507, DOI 10.1146/annurev.soc.30.012703.110629; HAUSMAN JA, 1981, ECONOMETRICA, V49, P1377, DOI 10.2307/1911406; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Isaac Mike, 2017, NY TIMES; Iyengar S, 2012, PUBLIC OPIN QUART, V76, P405, DOI 10.1093/poq/nfs038; Jamieson K.H., 2018, CYBERWAR RUSSIAN HAC; Jamieson K. H., 1992, DIRTY POLITICS DECEP; Jamieson K.H., 2008, ECHO CHAMBER RUSH LI; Jun YJ, 2017, P NATL ACAD SCI USA, V114, P5976, DOI 10.1073/pnas.1700175114; Kaczynski A., 2017, CNN; Kahan DM, 2013, JUDGM DECIS MAK, V8, P407; Kuklinski JH, 2000, J POLIT, V62, P790, DOI 10.1111/0022-3816.00033; Kuklinski JH, 1998, ANN AM ACAD POLIT SS, V560, P143, DOI 10.1177/0002716298560001011; Lau RR, 2008, AM J POLIT SCI, V52, P395, DOI 10.1111/j.1540-5907.2008.00319.x; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Lodge M., 2013, RATIONALIZING VOTER; Mutz DC, 2006, HEARING THE OTHER SIDE: DELIBERATIVE VERSUS PARTICIPATORY DEMOCRACY, P1, DOI 10.2277/ 0521612284; Nelson JL, 2018, NEW MEDIA SOC, V20, P3720, DOI 10.1177/1461444818758715; Oliver JE, 2014, AM J POLIT SCI, V58, P952, DOI 10.1111/ajps.12084; Oreskes N., 2010, MERCHANTS DOUBT; Pennycook G., 2017, WHO FALLS FAKE NEWS, DOI 10.2139/ssrn.3023545; Prior M, 2007, POSTBROADCAST DEMOCR; Rainie L, 2012, SOCIAL MEDIA POLITIC; Rainie L., 2012, SOCIAL MEDIA VOTING; ROSNOW RL, 1988, J COMMUN, V38, P12, DOI 10.1111/j.1460-2466.1988.tb02033.x; Shao C, 2017, ARXIV E PRINTS; Shin J., 2016, POLITICAL RUMORING T; Silverman C., 2016, BUZZFEEDNEWS; Stroud N.J., 2011, NICHE NEWS POLITICS; Tesler M, 2017, POWER POLITICAL COMM, P69; The Editorial Board, 2016, NY TIMES; Twenge JM, 2014, PSYCHOL SCI, V25, P1914, DOI 10.1177/0956797614545133; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Zollo F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181821	50	31	32	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213500	10.1371/journal.pone.0213500	http://dx.doi.org/10.1371/journal.pone.0213500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917154	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800034
J	Rutgers, M; Bach, F; Vonk, L; van Rijen, M; Akrum, V; van Boxtel, A; Dhert, W; Creemers, L				Rutgers, Marijn; Bach, Frances; Vonk, Lucienne; van Rijen, Mattie; Akrum, Vanessa; van Boxtel, Antonette; Dhert, Wouter; Creemers, Laura			PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; PARATHYROID-HORMONE; CHONDROGENIC DIFFERENTIATION; TERMINAL DIFFERENTIATION; GROWTH-PLATE; STEM-CELLS; KINASE; REPAIR; PHOSPHORYLATION; CHONDROCYTES	Regenerated cartilage formed after Autologous Chondrocyte Implantation may be of suboptimal quality due to postulated hypertrophic changes. Parathyroid hormone-related peptide, containing the parathyroid hormone sequence (PTHrP 1-34), enhances cartilage growth during development and inhibits hypertrophic differentiation of mesenchymal stromal cells (MSCs) and growth plate chondrocytes. This study aims to determine the possible anabolic and/or hypertrophic effect of PTH on human articular chondrocytes. Healthy human articular cartilage-derived chondrocytes (n = 6 donors) were cultured on type II collagen-coated transwells with/without 0.1 or 1.0 mu M PTH from day 0, 9, or 21 until the end of culture (day 28). Extracellular matrix production, (pre)hypertrophy and PTH signaling were assessed by RT-qPCR and/or immunohistochemistry for collagen type I, II, X, RUNX2, MMP13, PTHR1 and I HH and by determining glycosaminoglycan production and DNA content. The Bern score assessed cartilage quality by histology. Regardless of the concentration and initiation of supplementation, PTH treatment significantly decreased DNA and glycosaminoglycan content and reduced the Bern score compared with controls. Type I collagen deposition was increased, whereas PTHR1 expression and type II collagen deposition were decreased by PTH supplementation. Expression of the (pre)hypertrophic markers MMP13, RUNX2, IHH and type X collagen were not affected by PTH. In conclusion, PTH supplementation to healthy human articular chondrocytes did not affect hypertrophic differentiation, but negatively influenced cartilage quality, the tissues' extracellular matrix and cell content. Although PTH may be an effective inhibitor of hypertrophic differentiation in MSC-based cartilage repair, care may be warranted in applying accessory PTH treatment due to its effects on articular chondrocytes.	[Rutgers, Marijn; Vonk, Lucienne; van Rijen, Mattie; Akrum, Vanessa; van Boxtel, Antonette; Dhert, Wouter; Creemers, Laura] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands; [Bach, Frances; Dhert, Wouter] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Bach, F (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	f.c.bach@uu.nl	Creemers, Laura B/AAS-2424-2020	Vonk, Lucienne/0000-0002-5152-9532; Dhert, Wouter/0000-0001-9150-6143	Dutch Arthritis Foundation [LLP12]; Anna Foundation for Musculoskeletal Research in the Netherlands; Netherlands Organisation for Health Research and Development (NWO)	Dutch Arthritis Foundation; Anna Foundation for Musculoskeletal Research in the Netherlands; Netherlands Organisation for Health Research and Development (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	LC and FB are supported by the funding from the Dutch Arthritis Foundation (https://reumanederland.nl; LLP12 and 22, respectively). Part of the work was also funded by the Anna Foundation for Musculoskeletal Research in the Netherlands (http://www.annafonds.nl/) and the Netherlands Organisation for Health Research and Development (NWO; https://www.nwo.nl/).There has been no significant financial support for this work that could have influenced its outcome. Funders did not play any role in study design; collection, analysis, or interpretation of data; manuscript writing; or the decision to submit the manuscript for publication.	AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Bach FC, 2014, J CELL PHYSIOL, V229, P1999, DOI 10.1002/jcp.24658; BELLOWS CG, 1992, BONE MINER, V17, P15, DOI 10.1016/0169-6009(92)90707-K; Benz K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-27; Chang LH, 2016, TOXICOLOGY, V368, P116, DOI 10.1016/j.tox.2016.09.002; Chau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103061; Chen YS, 2016, MED SCI MONIT BASIC, V22, P132, DOI 10.12659/MSMBR.900242; Collins D, 1949, PATHOLOGY ARTICULAR; Cournil-Henrionnet C, 2008, BIORHEOLOGY, V45, P513, DOI 10.3233/BIR-2008-0487; CRABB ID, 1992, CALCIFIED TISSUE INT, V50, P61, DOI 10.1007/BF00297299; Csukasi F, 2018, SCI TRANSL MED, V10, DOI [10.1126/sci-translmed.aat9356.eaat9356, DOI 10.1126/SCI-TRANSLMED.AAT9356.EAAT9356]; d'Aquino R, 2011, EUR CELLS MATER, V21, P304, DOI 10.22203/eCM.v021a23; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; de Windt TS, 2017, STEM CELLS, V35, P1984, DOI 10.1002/stem.2657; Eswaramoorthy R, 2012, ACTA BIOMATER, V8, P2254, DOI 10.1016/j.actbio.2012.03.015; Fischer J, 2016, J CELL PHYSIOL, V231, P2673, DOI 10.1002/jcp.25369; Fischer J, 2014, STEM CELLS DEV, V23, P2513, DOI 10.1089/scd.2014.0101; Gao L, 2019, AM J SPORT MED, V47, P222, DOI 10.1177/0363546517740575; Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.tea.2011.0657, 10.1089/ten.TEA.2011.0657]; Grogan SP, 2006, TISSUE ENG, V12, P2141, DOI 10.1089/ten.2006.12.2141; Harrington EK, 2010, ANAT REC, V293, P225, DOI 10.1002/ar.21072; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Im GI, 2018, BIODRUGS, V32, P183, DOI 10.1007/s40259-018-0276-3; IWAMOTO M, 1994, J BIOL CHEM, V269, P17245; Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285; KANDEL RA, 1995, ARTIF CELL BLOOD SUB, V23, P565, DOI 10.3109/10731199509117971; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kim YJ, 2008, BIOCHEM BIOPH RES CO, V373, P104, DOI 10.1016/j.bbrc.2008.05.183; Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kudo S, 2000, J BONE MINER RES, V15, P253, DOI 10.1359/jbmr.2000.15.2.253; Kudo S, 2011, OSTEOARTHR CARTILAGE, V19, P886, DOI 10.1016/j.joca.2011.04.007; Lossdorfer S, 2006, CELL TISSUE RES, V325, P469, DOI 10.1007/s00441-006-0198-0; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Mueller MB, 2013, INT ORTHOP, V37, P945, DOI 10.1007/s00264-013-1800-1; Mwale F, 2010, TISSUE ENG PT A, V16, P3449, DOI [10.1089/ten.tea.2010.0091, 10.1089/ten.TEA.2010.0091]; Panda D, 2009, AM J PHYSIOL-ENDOC M, V297, pE1125, DOI 10.1152/ajpendo.00254.2009; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Roelofs AJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15040; ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007; Rutgers M, 2013, TISSUE ENG PT A, V19, P59, DOI [10.1089/ten.tea.2011.0416, 10.1089/ten.TEA.2011.0416]; Spina A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00354; Stellavato A, 2016, J CELL BIOCHEM, V117, P2158, DOI 10.1002/jcb.25556; Tsukazaki T, 1996, J ENDOCRINOL, V150, P359, DOI 10.1677/joe.0.1500359; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; Wang DG, 2008, COMPUT BIOL CHEM, V32, P462, DOI 10.1016/j.compbiolchem.2008.07.014; Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013; Weisser A, 2002, EXP CELL RES, V279, P1, DOI 10.1006/excr.2002.5580; Welch T, 2016, SPORTS MED ARTHROSC, V24, P85, DOI 10.1097/JSA.0000000000000115; WHITEMAN P, 1973, BIOCHEM J, V131, P343, DOI 10.1042/bj1310343; Zanchetta JR, 2010, CURR MED RES OPIN, V26, P2627, DOI 10.1185/03007995.2010.524121; Zerega B, 1999, J BONE MINER RES, V14, P1281, DOI 10.1359/jbmr.1999.14.8.1281; Zhang M, 2009, J CELL SCI, V122, P1382, DOI 10.1242/jcs.040709; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294; Zhang W, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4025; Zhang Y, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0068-5	57	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0213483	10.1371/journal.pone.0213483	http://dx.doi.org/10.1371/journal.pone.0213483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947269	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500012
J	Solevag, AL; Luong, D; Lee, TF; O'Reilly, M; Cheung, PY; Schmolzer, GM				Solevag, Anne Lee; Luong, Deandra; Lee, Tze-Fun; O'Reilly, Megan; Cheung, Po-Yin; Schmolzer, Georg M.			Non-perfusing cardiac rhythms in asphyxiated newborn piglets	PLOS ONE			English	Article							PULSELESS ELECTRICAL-ACTIVITY; 2015 INTERNATIONAL CONSENSUS; CARDIOVASCULAR CARE SCIENCE; HEART-RATE; CARDIOPULMONARY-RESUSCITATION; ARREST REGISTRY; SURVIVAL; MANAGEMENT; TERM; EPIDEMIOLOGY	Aim We recently demonstrated that asphyxiated piglets commonly had bradycardia displayed on electrocardiography (ECG) while no carotid blood flow (CBF) or audible heart sounds could be detected. Such pulseless electrical activity (PEA) in newborn infants has not previously been thoroughly described. The aim of this study was to further investigate the occurrence of non-perfusing cardiac rhythms in asphyxiated piglets and the potential implications for the success of cardiopulmonary resuscitation (CPR) and short-term survival. Methods Neonatal piglets (1-4 days, 1.7-2.4kg) had their right common carotid artery exposed and enclosed with a real-time ultrasonic flow probe. Heart rate (HR) was continuously measured and recorded using ECG. This allowed simultaneous monitoring of HR via ECG and CBF. The piglets were asphyxiated until cardiac arrest, defined as no CBF and no audible beat upon precordial auscultation. CPR was performed until return of spontaneous circulation (ROSC, defined as a HR >= 100 bpm). ECG traces were retrospectively assessed. Results Nine out of 21 piglets (43%) had QRS-complexes on their ECG while no CBF and no audible heart sounds could be detected. Five (56%) of the piglets with PEA and 12/12 (100%) piglets with asystole at cardiac arrest obtained ROSC (p = 0.02). Thirty-three per cent of the piglets with PEA versus 58% with asystole survived to 4 hours post-ROSC (p = 0.39). Conclusion Cardiac arrest in the presence of a non-perfusing cardiac rhythm on ECG is common in asphyxiated piglets. Clinical arrest in the presence of a non-perfusing cardiac rhythm on ECG may reduce the success of CPR.	[Solevag, Anne Lee] Akershus Univ Hosp, Dept Paediat & Adolescent Med, Lorenskog, Norway; [Luong, Deandra; Lee, Tze-Fun; O'Reilly, Megan; Cheung, Po-Yin; Schmolzer, Georg M.] Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada; [Luong, Deandra] Univ Alberta, Fac Sci, Edmonton, AB, Canada; [Lee, Tze-Fun; O'Reilly, Megan; Cheung, Po-Yin; Schmolzer, Georg M.] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada	University of Oslo; Royal Alexandra Hospital; University of Alberta; University of Alberta	Solevag, AL (corresponding author), Akershus Univ Hosp, Dept Paediat & Adolescent Med, Lorenskog, Norway.	a.l.solevag@medisin.uio.no	Solevåg, Anne Lee/AAH-9734-2021; Schmölzer, Georg M/E-7883-2010	Solevåg, Anne Lee/0000-0002-8009-7169; Schmölzer, Georg M/0000-0001-9798-2415	Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; National New Investigator of the Heart and Stroke Foundation Canada; Alberta New Investigator of the Heart and Stroke Foundation Alberta; Stollery Children's Hospital Foundation	Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; National New Investigator of the Heart and Stroke Foundation Canada; Alberta New Investigator of the Heart and Stroke Foundation Alberta; Stollery Children's Hospital Foundation	GMS is a recipient of the Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation, a National New Investigator of the Heart and Stroke Foundation Canada and an Alberta New Investigator of the Heart and Stroke Foundation Alberta. This research has also been facilitated by the Women and Children's Health Research Institute through the generous support of the Stollery Children's Hospital Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams HC, 2013, RESUSCITATION, V84, P1093, DOI 10.1016/j.resuscitation.2013.03.030; Babaeizadeh S, 2014, J ELECTROCARDIOL, V47, P798, DOI 10.1016/j.jelectrocard.2014.07.021; Brooks SC, 2010, RESUSCITATION, V81, P175, DOI 10.1016/j.resuscitation.2009.10.021; de Caen AR, 2015, CIRCULATION, V132, pS177, DOI 10.1161/CIR.0000000000000275; Dyson A, 2017, ARCH DIS CHILD-FETAL, V102, pF116, DOI 10.1136/archdischild-2016-310669; EISENBERG M, 1983, ANN EMERG MED, V12, P672, DOI 10.1016/S0196-0644(83)80413-2; Engdahl J, 2001, RESUSCITATION, V51, P17, DOI 10.1016/S0300-9572(01)00377-X; Gaertner VD, 2017, ARCH DIS CHILD-FETAL, V102, pF370, DOI 10.1136/archdischild-2016-312316; Hauck M, 2015, AM J EMERG MED, V33, P891, DOI 10.1016/j.ajem.2015.03.050; Hostler David, 2003, Prehosp Emerg Care, V7, P286, DOI 10.1080/10903120390936969; Kamarainen A, 2007, RESUSCITATION, V75, P235, DOI 10.1016/j.resuscitation.2007.04.011; Katheria A, 2012, PEDIATRICS, V130, pE1177, DOI 10.1542/peds.2012-0784; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kuisma M, 1997, ANN EMERG MED, V30, P69, DOI 10.1016/S0196-0644(97)70114-8; Larabee TM, 2008, RESUSCITATION, V78, P196, DOI 10.1016/j.resuscitation.2008.03.011; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Lemke RP, 2011, USE NEW DOPPLER UMBI, P83; Littmann L, 2014, MED PRIN PRACT, V23, P1, DOI 10.1159/000354195; Luong D, 2019, ARCH DIS CHILD-FETAL, V104, pF572, DOI 10.1136/archdischild-2018-316087; Luong DH, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00366; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Mehta C, 2012, AM J EMERG MED, V30, P236, DOI 10.1016/j.ajem.2010.08.017; MOGAYZEL C, 1995, ANN EMERG MED, V25, P484, DOI 10.1016/S0196-0644(95)70263-6; Myerburg RJ, 2013, CIRCULATION, V128, P2532, DOI 10.1161/CIRCULATIONAHA.113.004490; Patel S, 2019, ARCH DIS CHILD-FETAL, V104, pF215, DOI 10.1136/archdischild-2018-314907; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; Phillipos E, 2016, NEONATOLOGY, V109, P130, DOI 10.1159/000441940; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Sillers L, 2019, NEONATOLOGY, V115, P95, DOI 10.1159/000493357; Sobotka KS, 2015, ARCH DIS CHILD-FETAL, V100, pF337, DOI 10.1136/archdischild-2014-307319; Solevag AL, 2010, NEONATOLOGY, V98, P64, DOI 10.1159/000275560; Solevag AL, 2016, RESUSCITATION, V106, P7, DOI 10.1016/j.resuscitation.2016.06.014; Thomas AJ, 2013, RESUSCITATION, V84, P1261, DOI 10.1016/j.resuscitation.2013.02.016; van Vonderen JJ, 2015, J PEDIATR-US, V166, P49, DOI 10.1016/j.jpeds.2014.09.015; Vayrynen T, 2008, RESUSCITATION, V76, P207, DOI 10.1016/j.resuscitation.2007.07.023; Wyckoff MH, 2015, CIRCULATION, V132, pS543, DOI 10.1161/CIR.0000000000000267; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157	37	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214506	10.1371/journal.pone.0214506	http://dx.doi.org/10.1371/journal.pone.0214506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947278	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500037
J	Eloundou, SN; Lee, J; Wu, D; Lei, J; Feller, MC; Ozen, M; Zhu, Y; Hwang, M; Jia, B; Xie, H; Clemens, JL; McLane, MW; AlSaggaf, S; Nair, N; Wills-Karp, M; Wang, XB; Graham, EM; Baschat, A; Burd, I				Eloundou, Solange N.; Lee, JiYeon; Wu, Dan; Lei, Jun; Feller, Mia C.; Ozen, Maide; Zhu, Yan; Hwang, Misun; Jia, Bei; Xie, Han; Clemens, Julia L.; McLane, Michael W.; AlSaggaf, Samar; Nair, Nita; Wills-Karp, Marsha; Wang, Xiaobin; Graham, Ernest M.; Baschat, Ahmet; Burd, Irina			Placental malperfusion in response to intrauterine inflammation and its connection to fetal sequelae	PLOS ONE			English	Article							MYOCARDIAL PERFORMANCE INDEX; DEFINING NORMAL VALUES; CEREBRAL-PALSY; PRETERM BIRTH; THROMBOTIC VASCULOPATHY; DOPPLER CHANGES; BRAIN-INJURY; MOUSE MODEL; RISK; INSUFFICIENCY	Exposure to intrauterine inflammation (IUI) is associated with short- and long-term adverse perinatal outcomes. However, little data exist on utilizing placenta to prognosticate fetal injury in this scenario. Our study aimed to utilize imaging modalities to evaluate mechanisms contributing to placental injury following IUI exposure and correlated it to concomitant fetal brain injury. CD1 pregnant dams underwent laparotomies and received intrauterine injections of either lipopolysaccharide (LPS; a model of IUI) or phosphate-buffered saline (PBS). In utero ultrasound Doppler velocimetry of uterine and umbilical arteries and magnetic resonance imaging (MRI) of placental volumes with confirmatory immunohistochemical (vimentin) and histochemistry (fibrin) analyses were performed. ELISA for thrombosis markers, fibrinogen and fibrin was performed to analyze thrombi in placenta. Fetal brain immunohistochemistry was performed to detect microglial activation (ionized calcium-binding adaptor molecule 1, lba1). On ultrasound, LPS group demonstrated elevated resistance indices, pulsatility indices and a greater occurrence of absent end-diastolic flow in the umbilical and uterine arteries. In the fetus, there was an increased cardiac Tei indices in the LPS group. MRI revealed decreased volume of placenta in the LPS group associated with placental thinning and placental endothelial damage on immunohistochemistry. Decreased fibrinogen content and more thrombi staining in placenta exposed to maternal LPS indicated the hypercoagulability. Furthermore, the expression of lba1was significantly associated with placental thickness (r = -0.7890, Pearson correlation coefficient). Our data indicate that IUI can trigger events leading to maternal placental malperfusion and fetal vessel resistance, as well as predispose the developing fetus to cardiac dysfunction and brain damage. Furthermore, our data suggest that prenatal ultrasound can be a real-time clinical tool for assessing fetal risk for adverse neurologic outcomes following the potential IUI exposure.	[Eloundou, Solange N.; Lee, JiYeon; Lei, Jun; Feller, Mia C.; Ozen, Maide; Zhu, Yan; Jia, Bei; Xie, Han; Clemens, Julia L.; McLane, Michael W.; Nair, Nita; Graham, Ernest M.; Burd, Irina] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med,Div Maternal Fetal M, Baltimore, MD 21205 USA; [Wu, Dan; Hwang, Misun] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Ozen, Maide] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Neonatol, Baltimore, MD 21205 USA; [AlSaggaf, Samar] King Abdulaziz Univ, Dept Pathol, Jeddah, Saudi Arabia; [Wills-Karp, Marsha] Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA; [Wang, Xiaobin] Johns Hopkins Univ, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Early Life Origins Dis, Baltimore, MD USA; [Baschat, Ahmet] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Fetal Therapy, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; King Abdulaziz University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Burd, I (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med,Div Maternal Fetal M, Baltimore, MD 21205 USA.	iburd@jhmi.edu		Nair, Nita/0000-0002-9186-7026	Integrated Research Center for Fetal Medicine Fund [NICHDK08HD073315, R21NS098018]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD073315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS098018] Funding Source: NIH RePORTER	Integrated Research Center for Fetal Medicine Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Integrated Research Center for Fetal Medicine Fund, NICHDK08HD073315 (I.B.), and R21NS098018 (D.W.).	Andescavage N, 2017, J PERINATOL, V37, P1278, DOI 10.1038/jp.2017.129; Bahtiyar MO, 2008, SEMIN PERINATOL, V32, P190, DOI 10.1053/j.semperi.2008.02.010; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; Breen K, 2012, REPROD SCI, V19, P839, DOI 10.1177/1933719112438439; Brosens I, 2013, PLACENTA, V34, P100, DOI 10.1016/j.placenta.2012.11.017; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; Dada T, 2014, BRAIN BEHAV IMMUN, V38, P142, DOI 10.1016/j.bbi.2014.01.014; Dikshit S, 2011, J POSTGRAD MED, V57, P138, DOI 10.4103/0022-3859.81880; Friedman D, 2003, ULTRASOUND OBST GYN, V21, P33, DOI 10.1002/uog.11; Gaillard R, 2013, AM J EPIDEMIOL, V177, P743, DOI 10.1093/aje/kws296; Ghawi H, 2013, PEDIATR CARDIOL, V34, P1808, DOI 10.1007/s00246-013-0709-1; Giles W, 2003, BJOG-INT J OBSTET GY, V110, P593, DOI 10.1016/S1470-0328(03)02966-5; Girard S, 2010, J IMMUNOL, V184, P3997, DOI 10.4049/jimmunol.0903349; Girardi G, 2015, MOL PSYCHIATR, V20, P1017, DOI 10.1038/mp.2014.110; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Kirik OV KD, 2016, NEUROSCI BEHAV PHYSL, V46, P7; Kraus FT, 1999, HUM PATHOL, V30, P759, DOI 10.1016/S0046-8177(99)90136-3; Kraus FT, 1997, HUM PATHOL, V28, P246, DOI 10.1016/S0046-8177(97)90114-3; Lax A, 2007, MAGN RESON IMAGING, V25, P87, DOI 10.1016/j.mri.2006.10.007; Lei J., 2015, AM J OBSTET GYNECOL, V212, pe631; Leitner K, 2014, AM J REPROD IMMUNOL, V71, P418, DOI 10.1111/aji.12216; Lepais L, 2014, PLACENTA, V35, P611, DOI 10.1016/j.placenta.2014.04.012; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Muller ALL, 2010, ULTRASOUND OBST GYN, V36, P26, DOI 10.1002/uog.7584; LETTIERI L, 1993, AM J OBSTET GYNECOL, V168, P1480, DOI 10.1016/S0002-9378(11)90785-6; Levine D, 1997, RADIOLOGY, V204, P635, DOI 10.1148/radiology.204.3.9280237; Liu TG, 2010, AM J PHYSIOL-CELL PH, V299, pC363, DOI 10.1152/ajpcell.00057.2010; Lo JO, 2018, REPROD SCI, V25, P64, DOI 10.1177/1933719117699704; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Mone F, 2014, J MATERN-FETAL NEO M, V27, P1633, DOI 10.3109/14767058.2013.871698; Muresan D, 2016, MED ULTRASON, V18, P103, DOI 10.11152/mu.2013.2066.181.dop; Nair A, 2016, ANN PEDIAT CARDIOL, V9, P132, DOI 10.4103/0974-2069.177516; RIZZO G, 1992, ULTRASOUND OBST GYN, V2, P434, DOI 10.1046/j.1469-0705.1992.02060434.x; Romero R, 2004, J Matern Fetal Neonatal Med, V16, P146; Spinillo A, 2012, PRENATAL DIAG, V32, P1263, DOI 10.1002/pd.3988; Stanifer JW, 2016, J MED BIOGR, V24, P89, DOI 10.1177/0967772013520101; Tei C, 1995, J Cardiol, V26, P357; Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575; Viscardi RM, 2001, EARLY HUM DEV, V62, P1, DOI 10.1016/S0378-3782(01)00114-1; WHO, 2006, NEONATAL PERINATAL M; Wu D, 2018, J MAGN RESON IMAGING, V47, P1260, DOI 10.1002/jmri.25867; Wu D, 2015, J MAGN RESON IMAGING, V42, P717, DOI 10.1002/jmri.24828; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207	46	22	21	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214951	10.1371/journal.pone.0214951	http://dx.doi.org/10.1371/journal.pone.0214951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943260	Green Submitted, Green Published, gold			2022-12-27	WOS:000463194300075
J	Lillie, TA; Persaud, NE; DiCarlo, MC; Gashobotse, D; Kamali, DR; Cheron, M; Nishimoto, L; Akolo, C; Mahler, HR; Au, MC; Wolf, RC				Lillie, Tiffany A.; Persaud, Navindra E.; DiCarlo, Meghan C.; Gashobotse, Dismas; Kamali, Didier R.; Cheron, Magda; Nishimoto, Lirica; Akolo, Christopher; Mahler, Hally R.; Au, Maria C.; Wolf, R. Cameron			Reaching the unreached: Performance of an enhanced peer outreach approach to identify new HIV cases among female sex workers and men who have sex with men in HIV programs in West and Central Africa	PLOS ONE			English	Article							SOCIAL NETWORKS; DRIVEN; INFECTION; BURDEN; MSM	Finding new HIV-positive cases remains a priority to achieve the UNAIDS goals. An enhanced peer outreach approach (EPOA) was implemented to expand the delivery of HIV services to female sex workers (FSWs) and men who have sex with men (MSM) in three countries in West and Central Africa. The aim of EPOA is to identify new HIV-positive cases. EPOA was implemented in Burundi among FSWs, and in Cote d'Ivoire and Democratic Republic of the Congo (DRC) among both FSWs and MSM. Implementation ranged from five to nine weeks and was nested within a three-month reporting period. Standard outreach was suspended for the duration of EPOA implementation but was resumed thereafter. Summary service statistics were used to compare HIV seropositivity during standard outreach and EPOA. Trends were analyzed during the quarter in which EPOA was implemented, and these were compared with the two preceding quarters. Differences in proportions of HIV seropositivity were tested using Pearson's chi-square test; p-values of less than 0.05 were considered statistically significant. Overall, EPOA resulted in a higher proportion of new HIV-positive cases being found, both within and between quarters. In Burundi, HIV seropositivity among FSWs was significantly higher during EPOA than during standard outreach (10.8% vs. 4.1%, p<0.001). In Cote d'Ivoire, HIV seropositivity was significantly higher during EPOA among both populations (FSWs: 5.6% vs. 1.81%, p<0.01; MSM: 15.4% vs. 5.9%; p<0.01). In DRC, HIV seropositivity was significantly higher during EPOA among MSM (6.9% vs. 1.6%; p<0.001), but not among FSWs (5.2% vs. 4.3%; p = 0.08). Trends in HIV seropositivity during routine outreach for both populations were constant during three successive quarters but increased with the introduction of EPOA. EPOA is a public health approach with great potential for reaching new populations and ensuring that they are aware of their HIV status.	[Lillie, Tiffany A.; Persaud, Navindra E.; DiCarlo, Meghan C.; Nishimoto, Lirica; Akolo, Christopher; Mahler, Hally R.] FHI 360 LINKAGES, Washington, DC 20009 USA; [Gashobotse, Dismas] FHI 360 LINKAGES, Bujumbura, Burundi; [Kamali, Didier R.] FHI 360 LINKAGES, Abidjan, Cote Ivoire; [Cheron, Magda] FHI 360 LINKAGES, Kinshasa, DEM REP CONGO; [Au, Maria C.; Wolf, R. Cameron] USAID, Washington, DC USA	United States Agency for International Development (USAID)	Lillie, TA (corresponding author), FHI 360 LINKAGES, Washington, DC 20009 USA.	tlillie@fhi360.org		Lillie, Tiffany/0000-0002-1960-503X	U.S. President's Emergency Plan for AIDS Relief (PEPFAR); USAID [AID-OAA-A-14-00045]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID(United States Agency for International Development (USAID))	U.S. Agency for International Development (USAID), with support from U.S. President's Emergency Plan for AIDS Relief (PEPFAR), is the funder of the LINKAGES project. LINKAGES award number with USAID is: AID-OAA-A-14-00045, https://www.usaid.gov/, https://www.pepfar. gov/. Two authors of the manuscript are employed by USAID and provided support in preparation of the manuscript (MA, CW). The other authors are employed by the FHI360 project, LINKAGES (TL, NP, MD, DG, DK, MC, LN, CA, HM).	Amirkhanian YA, 2015, AIDS, V29, P583, DOI 10.1097/QAD.0000000000000558; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; BROADHEAD RS, 1995, J DRUG ISSUES, V25, P531, DOI 10.1177/002204269502500303; Decker MR, 2013, AM J REPROD IMMUNOL, V69, P122, DOI 10.1111/aji.12063; Deering KN, 2013, SEX TRANSM DIS, V40, P168, DOI 10.1097/OLQ.0b013e31827df174; FHI 360/LINKAGES, 2016, LINKAGES SYST ASS RO; FHI 360/LINKAGES, LINK CONT HIV SERV K; FHI 360/LINKAGES, 2017, LINKAGES ENH PEER OU; Fuqua V, 2012, AIDS BEHAV, V16, P256, DOI 10.1007/s10461-011-9918-x; Girault P, 2015, AIDS BEHAV, V19, P1990, DOI 10.1007/s10461-015-1069-z; Global Commission on HIV and the Law, 2012, HIV LAW RISKS RIGHTS; Golden MR, 2006, AIDS, V20, P1961, DOI 10.1097/01.aids.0000247118.74208.6a; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Joint United Nations Programme on HIV/AIDS, 2018, MIL GO CLOS GAPS BRE; Kimbrough LW, 2009, AM J PUBLIC HEALTH, V99, P1093, DOI 10.2105/AJPH.2008.139329; Mehta SH, 2016, CROI C FEB 22 25 BOS; Mehta SH, 2015, CLIN INFECT DIS, V61, P1732, DOI 10.1093/cid/civ669; Pines HA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010388; Rosenberg NE, 2014, JAIDS-J ACQ IMM DEF, V65, pE162, DOI 10.1097/QAI.0000000000000066; Smyrnov P, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25040; Ssali S, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/815823; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2016, UNAIDS PREV GAP REP; Uuskula A, 2010, J URBAN HEALTH, V87, P304, DOI 10.1007/s11524-009-9427-7; Yeka W, 2006, J URBAN HEALTH, V83, pI60, DOI 10.1007/s11524-006-9103-0	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213743	10.1371/journal.pone.0213743	http://dx.doi.org/10.1371/journal.pone.0213743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943205	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300017
J	Poole, JR; Bajer, PG				Poole, Joshua R.; Bajer, Przemyslaw G.			A small native predator reduces reproductive success of a large invasive fish as revealed by whole-lake experiments	PLOS ONE			English	Article							COMMON CARP; PARENTAL CARE; RECRUITMENT; ABUNDANCE; SIZE; EGG	The extent to which native fish communities might control the success of invasive fish has been of interest to ecologists, but it has been rarely addressed using experiments. We conducted an experiment in six small lakes in the Upper Mississippi Region to test the effects of a small native predator, bluegill sunfish (Lepomis macrochirus) on the recruitment of a large, invasive fish, the common carp (Cyprinus carpio). Bluegills are predominant throughout the region and were previously shown to consume carp eggs and larvae. We stocked both lakes at each of our 3 sites with adult carp (spawners) and one lake at each site with bluegills. We repeated the experiment at two of the three sites for two consecutive years. In each lake we assessed the abundance of post-larval carp one month after spawning (backpack electrofishing surveys) and at the end of the season (mark-recapture). For each site/year combination, catch rate of post-larval carp was typically an order of magnitude higher in control than bluegill lakes, but it often declined quickly over time. The abundance of end-of-seasonal juveniles was significantly higher (no 95% CI overlap) in control lakes than in bluegill lakes, except for one pair of lakes during one year when both the control and bluegill lake had similar, low abundance of end-of-season carp. Overall, our results support the hypothesis that common carp recruitment is substantially reduced in habitats dominated by bluegills. We also suggest our results may be applicable to other species, and that managers should explore how predation on early life stages may control other invasive species.	[Poole, Joshua R.; Bajer, Przemyslaw G.] Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, St Paul, MN 55108 USA; [Poole, Joshua R.] Idaho Fish & Game, Mccall, ID 83638 USA	University of Minnesota System; University of Minnesota Twin Cities	Poole, JR (corresponding author), Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, St Paul, MN 55108 USA.; Poole, JR (corresponding author), Idaho Fish & Game, Mccall, ID 83638 USA.	poole066@umn.edu			Legislative Citizen Commission on Minnesota Resources, Environment and Natural Resource Trust Fund	Legislative Citizen Commission on Minnesota Resources, Environment and Natural Resource Trust Fund	This work was supported by: PB, Grant #: M.L. 2013, Chp. 52, Sec. 2, Subd. 06a Aquatic Invasive Species Research Center Sub-Project #4: Common carp management using biocontrol and toxins: Phase II. Awarded to Przemyslaw Bajer, Funder: Legislative Citizen Commission on Minnesota Resources, Environment and Natural Resource Trust Fund, https://www.lccmr.leg.mn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Bajer PG, 2015, DIVERS DISTRIB, V21, P500, DOI 10.1111/ddi.12315; Bajer PG, 2015, OIKOS, V124, P1520, DOI 10.1111/oik.01795; Bajer PG, 2012, BIOL INVASIONS, V14, P1919, DOI 10.1007/s10530-012-0203-3; Bajer PG, 2010, BIOL INVASIONS, V12, P1101, DOI 10.1007/s10530-009-9528-y; Balon EK, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00563.x; Bosch VD, 1982, INTRO BIOL CONTROL; BRANDT SB, 1987, T AM FISH SOC, V116, P641, DOI 10.1577/1548-8659(1987)116<641:PBAOLO>2.0.CO;2; Brett MT, 1996, P NATL ACAD SCI USA, V93, P7723, DOI 10.1073/pnas.93.15.7723; Brown P, 2004, ECOL MODEL, V176, P83, DOI 10.1016/j.ecolmodel.2003.11.009; CARLANDER KD, 1955, J FISH RES BOARD CAN, V12, P543, DOI 10.1139/f55-029; Chase JM, 2000, TRENDS ECOL EVOL, V15, P408, DOI 10.1016/S0169-5347(00)01942-X; Rojas DC, 2018, REV BIOL TROP, V66, P189, DOI 10.15517/rbt.v66i1.28197; Cornelius R, 2006, DESCRIPTION SUMMARY; Crawford Stephen S., 1996, Advances in the Study of Behavior, V25, P53; Dauphinais JD, 2018, BIOL INVASIONS, P1; Davies GD, 2015, J APPL ECOL, V52, P1264, DOI 10.1111/1365-2664.12488; GITTLEMAN JL, 1981, ANIM BEHAV, V29, P936, DOI 10.1016/S0003-3472(81)80031-0; Hackerott S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068259; Hansen GJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077415; Hermoso V, 2011, ECOL APPL, V21, P175, DOI 10.1890/09-2011.1; Iguchi K, 2004, ECOL RES, V19, P469, DOI 10.1111/j.1440-1703.2004.00660.x; Lechelt JD, 2016, THESIS; Lechelt JD, 2016, AQUAT INVASIONS, V11, P469, DOI 10.3391/ai.2016.11.4.11; Lechelt JD, 2016, BIOL INVASIONS, V18, P831, DOI 10.1007/s10530-016-1054-0; Lohmeyer AM, 2009, BIOL INVASIONS, V11, P905, DOI 10.1007/s10530-008-9303-5; Munoz RC, 2017, B MAR SCI, V93, P789, DOI 10.5343/bms.2016.1135; OBRIEN WJ, 1976, ECOLOGY, V57, P1304, DOI 10.2307/1935055; Ogle D.H., 2021, R PACKAGE; R Development Core Team, 2009, R LANG ENV STAT COMP; RAHEL FJ, 1984, ECOLOGY, V65, P1276, DOI 10.2307/1938333; RICKER W E, 1975, P382; Silbernagel JJ, 2013, T AM FISH SOC, V142, P1134, DOI 10.1080/00028487.2013.788889; Smejkal M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07339-w; SMITH C, 1995, REV FISH BIOL FISHER, V5, P7, DOI 10.1007/BF01103363; Thresher R, 2014, NAT BIOTECHNOL, V32, P424, DOI 10.1038/nbt.2903; TONN WM, 1992, ECOLOGY, V73, P951, DOI 10.2307/1940171; TURNER AM, 1990, ECOLOGY, V71, P2241, DOI 10.2307/1938636; Weber MJ, 2013, T AM FISH SOC, V142, P471, DOI 10.1080/00028487.2012.754791; Weber MJ, 2011, N AM J FISH MANAGE, V31, P269, DOI 10.1080/02755947.2011.574923; WERNER EE, 1974, J FISH RES BOARD CAN, V31, P1531, DOI 10.1139/f74-186	41	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214009	10.1371/journal.pone.0214009	http://dx.doi.org/10.1371/journal.pone.0214009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943222	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300029
J	Bhattacharyya, S; Sathe, AA; Bhakta, M; Xing, C; Munshi, NV				Bhattacharyya, Samadrita; Sathe, Adwait A.; Bhakta, Minoti; Xing, Chao; Munshi, Nikhil V.			PAN-INTACT enables direct isolation of lineage-specific nuclei from fibrous tissues	PLOS ONE			English	Article							TRANSLATIONAL PROFILING APPROACH; GENE-EXPRESSION; CELL-TYPES; CHROMATIN; IDENTIFICATION; PURIFICATION; DIVERSITY; ENHANCERS	Recent studies have highlighted the extraordinary cell type diversity that exists within mammalian organs, yet the molecular drivers of such heterogeneity remain elusive. To address this issue, much attention has been focused on profiling the transcriptome and epigenome of individual cell types. However, standard cell type isolation methods based on surface or fluorescent markers remain problematic for cells residing within organs with significant connective tissue. Since the nucleus contains both genomic and transcriptomic information, the isolation of nuclei tagged in specific cell types (INTACT) method provides an attractive solution. Although INTACT has been successfully applied to plants, flies, zebrafish, frogs, and mouse brain and adipose tissue, broad use across mammalian organs remains challenging. Here we describe the PAN-INTACT method, which can be used to isolate cell type specific nuclei from fibrous mouse organs, which are particularly problematic. As a proof-of-concept, we demonstrate successful isolation of cell type-specific nuclei from the mouse heart, which contains substantial connective tissue and harbors multiple cell types, including cardiomyo-cytes, fibroblasts, endothelial cells, and epicardial cells. Compared to established techniques, PAN-INTACT allows more rapid isolation of cardiac nuclei to facilitate downstream applications. We show cell type-specific isolation of nuclei from the hearts of Nkx2-5(cre/+); R26(sun1-2xsf-GFP-6xmyc/+) mice, which we confirm by expression of lineage markers. Furthermore, we perform Assay for Transposase Accessible Chromatin (ATAC)-Seq to provide high-fidelity chromatin accessibility maps of Nkx2-5(+) nuclei. To extend the applicability of PAN-INTACT, we also demonstrate successful isolation of Wt1(+) podocytes from adult kidney. Taken together, our data suggest that PAN-INTACT is broadly applicable for profiling the transcriptional and epigenetic landscape of specific cell types. Thus, we envision that our method can be used to systematically probe mechanistic details of cell type-specific functions within individual organs of intact mice.	[Bhattacharyya, Samadrita; Bhakta, Minoti; Munshi, Nikhil V.] UT Southwestern Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Sathe, Adwait A.; Xing, Chao; Munshi, Nikhil V.] UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Munshi, Nikhil V.] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; [Munshi, Nikhil V.] Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Munshi, NV (corresponding author), UT Southwestern Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.; Munshi, NV (corresponding author), UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.; Munshi, NV (corresponding author), UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.; Munshi, NV (corresponding author), Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	Nikhil.Munshi@UTSouthwestern.edu	Sathe, Adwait/P-8609-2019	Sathe, Adwait/0000-0001-7532-7305; Xing, Chao/0000-0002-1838-0502	AHA [17PRE33670730]; NIH [HL136604, HL133642, HL135217]; Burroughs Wellcome Fund [1009838]; March of Dimes Foundation [5-FY13-203]; Department of Defense [PR172060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL133642, R03HL135217, R01HL136604] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the AHA (17PRE33670730 to S.B.), NIH (HL136604, HL133642, and HL135217 to N.V.M.), the Burroughs Wellcome Fund (1009838 to N.V.M.), the March of Dimes Foundation (#5-FY13-203 to N.V.M.), and the Department of Defense (PR172060 to N.V.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2017, PEERJ, V5, DOI 10.7717/peerj.4040; Amin NM, 2014, DEVELOPMENT, V141, P962, DOI 10.1242/dev.098327; Andrews S., 2010, FASTQC QUALITY CONTR; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bergmann O, 2012, JOVE-J VIS EXP, DOI 10.3791/4205; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Deal RB, 2011, NAT PROTOC, V6, P56, DOI 10.1038/nprot.2010.175; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; DeLaughter DM, 2016, DEV CELL, V39, P480, DOI 10.1016/j.devcel.2016.10.001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Gilsbach R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02762-z; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Henry GL, 2012, NUCLEIC ACIDS RES, V40, P9691, DOI 10.1093/nar/gks671; Horsthuis T, 2009, CIRC RES, V105, P61, DOI 10.1161/CIRCRESAHA.108.192443; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li G, 2016, DEV CELL, V39, P491, DOI 10.1016/j.devcel.2016.10.014; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Nakano A, 2016, BBA-MOL CELL RES, V1863, P1937, DOI 10.1016/j.bbamcr.2016.01.022; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Preissl S, 2015, CIRC RES, V117, P413, DOI 10.1161/CIRCRESAHA.115.306337; Quillien A, 2017, CELL REP, V20, P709, DOI 10.1016/j.celrep.2017.06.070; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Serpooshan V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12869-4; Sessions AO, 2016, CIRC RES, V118, P1553, DOI 10.1161/CIRCRESAHA.116.307472; Steiner FA, 2012, GENOME RES, V22, P766, DOI 10.1101/gr.131748.111; Tryon RC, 2013, GENESIS, V51, P187, DOI 10.1002/dvg.22363; Vedantham V, 2015, CIRC RES, V116, P797, DOI 10.1161/CIRCRESAHA.116.305913; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Watson N., ISOLATION USE MAMMAL; Wingett S, 2011, FASTQ SCREEN QUALITY; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zebrowski DC, 2015, ELIFE, V4, DOI 10.7554/eLife.05563; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou P, 2017, ELIFE, V6, P777, DOI [10.1101/gr.131748.111, DOI 10.1101/GR.131748.111]; Zhou PZ, 2016, CIRC RES, V118, P368, DOI 10.1161/CIRCRESAHA.116.308139	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214677	10.1371/journal.pone.0214677	http://dx.doi.org/10.1371/journal.pone.0214677			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939177	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900035
J	Qiao, X; Sai, LH; Chen, XW; Xue, LH; Lei, JJ				Qiao, Xu; Sai, Lihan; Chen, Xingwu; Xue, Lihua; Lei, Junjie			Impact of fruit-tree shade intensity on the growth, yield, and quality of intercropped wheat	PLOS ONE			English	Article							ALLEY CROPPING SYSTEM; AGROFORESTRY SYSTEMS; SOUTHERN ONTARIO; COMPETITION; NITROGEN; MAIZE; CHINA; PHOTOSYNTHESIS; GLIRICIDIA; DENSITY	Agroforestry is a common traditional practice in China-especially in the southern Xinjiang of Northwest China. However, the productivity of many agroforestry systems has been lower than expected in recent years, highlighting the need for an actionably deep mechanistic understanding of the competition between crops and trees. Here, three different fruit tree/wheat (jujube/wheat, apricot/wheat, and walnut/wheat) intercropping agroforestry systems were chosen to investigate influence of different fruit tree shade intensity on the growth, yield and quality of intercropping wheat. Compared to the monoculture wheat system, the mean daily shade intensity of the jujube-, apricot-, and walnut-based intercropping systems were, respectively, 23.2%, 57.5%, and 80.7% shade. The photosynthetic rate of wheat in the jujube-, apricot-, and walnut-based intercropping systems decreased by, respectively, 11.3%, 31.9%, and 36.2% compared to monoculture wheat, and the mean number of fertile florets per spike decreased by 26.4%, 37.4%, and 49.5%. Moreover, the apricot- and walnut-based intercropping systems deleteriously affected grain yield (constituent components spike number, grains per spike, and thousand grain weight) and decreased the total N, P, and K content of intercropping wheat. Tree shading intensity strongly enhanced the grain protein content, wet gluten content, dough development time, and dough stability time of wheat, but significantly decreased the softening degree. Strong negative linear correlations were observed between tree shade intensity and the number of fertile florets, grain yield related traits (including spike number, grains per spike, and thousand grain weight), nutrient content (N, P and K), and softening degree of wheat. In contrast, Daily shade intensity was positively linearly correlated with grain protein content, wet gluten content, dough development time, and dough stability time. We conclude that jujube-based intercropping systems can be practical in the region, as they do not decrease the yield and quality of intercropping wheat.	[Qiao, Xu] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Qiao, Xu; Sai, Lihan; Chen, Xingwu; Xue, Lihua; Lei, Junjie] Xinjiang Acad Agr Sci, Inst Grain Grp, Urumqi, Xinjiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS	Lei, JJ (corresponding author), Xinjiang Acad Agr Sci, Inst Grain Grp, Urumqi, Xinjiang, Peoples R China.	leijunjie@sohu.com			National Natural Science Foundation of China [31560587, 31660370, 31760364]; Special Fund for Agro-scientific Research in the Public Interest [201503116]; Modern Agricultural Industry Technology System [CARS-03-49]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Modern Agricultural Industry Technology System	This work was funded by the National Natural Science Foundation of China (Grant Nos. 31560587, 31660370, 31760364), Special Fund for Agro-scientific Research in the Public Interest (201503116) and the Modern Agricultural Industry Technology System (CARS-03-49). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC-International, 2013, APPR METH AN; Alam M, 2014, AGROFOREST SYST, V88, P679, DOI 10.1007/s10457-014-9681-x; Awal MA, 2006, AGR FOREST METEOROL, V139, P74, DOI 10.1016/j.agrformet.2006.06.001; Bergeron M, 2011, AGROFOREST SYST, V83, P321, DOI 10.1007/s10457-011-9402-7; Bhatta M, 2017, J SCI FOOD AGR, V97, P5311, DOI 10.1002/jsfa.8417; Brandle J. R., 2000, North American agroforestry: an integrated science and practice., P79; Celette F, 2009, EUR J AGRON, V30, P41, DOI 10.1016/j.eja.2008.07.003; Chirko CP, 1996, FOREST ECOL MANAG, V83, P171, DOI 10.1016/0378-1127(96)03721-8; Cui Hai-yan, 2013, Yingyong Shengtai Xuebao, V24, P3099; Evers A. K., 2010, The Open Agriculture Journal, V4, P49, DOI 10.2174/1874331501004010049; Friday JB, 2002, AGROFOREST SYST, V55, P125, DOI 10.1023/A:1020598110484; Gao LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070739; Garrett H. E., 2000, North American agroforestry: an integrated science and practice., P149; Ghosh PK, 2009, EUR J AGRON, V31, P43, DOI 10.1016/j.eja.2009.03.002; Grove JH., 1990, SOIL TESTING PLANT A; Jose S, 2000, AGROFOREST SYST, V48, P61, DOI 10.1023/A:1006241406462; Kittur BH, 2016, AGROFOREST SYST, V90, P237, DOI 10.1007/s10457-015-9849-z; Lu Q, 1997, ACTA ECOLOGICA SINIC, V17, P36; Peng XB, 2009, AGROFOREST SYST, V76, P569, DOI 10.1007/s10457-009-9227-9; Price GW, 1998, AGROFOREST SYST, V44, P141, DOI 10.1023/A:1006213603150; Reynolds PE, 2007, ECOL ENG, V29, P362, DOI 10.1016/j.ecoleng.2006.09.024; Rivest D, 2013, SCI TOTAL ENVIRON, V463, P51, DOI 10.1016/j.scitotenv.2013.05.071; Rivest D, 2009, J ENVIRON MANAGE, V91, P432, DOI 10.1016/j.jenvman.2009.09.013; Rowe EC, 2001, PLANT SOIL, V235, P167, DOI 10.1023/A:1011961409353; Smethurst PJ, 2017, AGR SYST, V155, P70, DOI 10.1016/j.agsy.2017.04.008; Toyota M, 2001, PLANT PROD SCI, V4, P283, DOI 10.1626/pps.4.283; Wang BJ, 2014, AGROFOREST SYST, V88, P835, DOI 10.1007/s10457-014-9729-y; [王晶晶 Wang Jingjing], 2015, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V24, P44; WILLEY RW, 1971, J AGR SCI, V77, P453, DOI 10.1017/S0021859600064522; Yang LL, 2016, EUR J AGRON, V75, P105, DOI 10.1016/j.eja.2016.01.008; Yang T, 2019, AGROFOREST SYST, V93, P1545, DOI 10.1007/s10457-018-0267-x; Zhang W, 2017, AGROFOREST SYST, V91, P881, DOI 10.1007/s10457-016-9962-7; ZOU XM, 1990, AGROFOREST SYST, V11, P85, DOI 10.1007/BF00122813	33	16	19	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0203238	10.1371/journal.pone.0203238	http://dx.doi.org/10.1371/journal.pone.0203238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939172	Green Submitted, gold, Green Published			2022-12-27	WOS:000462993900001
J	Zietzer, A; Niepmann, ST; Camara, B; Lenart, MA; Jansen, F; Becher, MU; Andrie, R; Nickenig, G; Tiyerili, V				Zietzer, Andreas; Niepmann, Sven Thomas; Camara, Bakary; Lenart, Monika Anna; Jansen, Felix; Becher, Marc Ulrich; Andrie, Rene; Nickenig, Georg; Tiyerili, Vedat			Sodium thiocyanate treatment attenuates atherosclerotic plaque formation and improves endothelial regeneration in mice	PLOS ONE			English	Article							HYPOTHIOCYANOUS ACID HOSCN; HIGH-DENSITY-LIPOPROTEIN; C-REACTIVE PROTEIN; NEOINTIMA FORMATION; CLASS-B; MYELOPEROXIDASE; INFLAMMATION; OXIDATION; SMOKING; PLASMA	Introduction Atherosclerotic plaque formation is an inflammatory process that involves the recruitment of neutrophil granulocytes and the generation of reactive oxygen species (ROS). ROS formation by myeloperoxidase, a key enzyme in H2O2 degradation, can be modulated by addition of sodium thiocyanate (NaSCN). However, the therapeutic use of NaSCN to counteract atherogenesis has been controversial, because MPO oxidizes NaSCN to hypothiocyanous acid, which is a reactive oxygen species itself. Therefore, this study aimed to investigate the effect of NaSCN treatment on atherogenesis in vivo. Methods Apolipoprotein E knockout (ApoE(-/-)) mice on western-diet were treated with NaSCN for 8 weeks. Blood levels of total cholesterol, IL-10, and IL-6 were measured. Aortic roots from these mice were analyzed histologically to quantify plaque formation, monocyte, and neutrophil granulocyte infiltration. Oxidative damage was evaluated via an L-012 chemiluminescence assay and staining for chlorotyrosine in the aortic walls. Endothelial function was assessed by use of endothelium-dependent vasodilation in isolated aortic rings. Neointima formation was evaluated in wild-type mice following wire injury of the carotid artery. Results NaSCN treatment of ApoE(-/-) mice lead to a reduction of atherosclerotic plaque size in the aortic roots but had no effect on monocyte or granulocyte infiltration. Serum levels of the pro-inflammatory cytokine IL-6 decreased whereas anti-inflammatory IL-10 increased upon NaSCN treatment. In our experiments, we found oxidative damage to be reduced and the endothelial function to be improved in the NaSCN-treated group. Additionally, NaSCN inhibited neointima formation. Conclusion NaSCN has beneficial effects on various stages of atherosclerotic plaque development in mice.	[Zietzer, Andreas; Niepmann, Sven Thomas; Camara, Bakary; Lenart, Monika Anna; Jansen, Felix; Becher, Marc Ulrich; Andrie, Rene; Nickenig, Georg; Tiyerili, Vedat] Univ Hosp Bonn, Med Dept 2, Bonn, Germany	University of Bonn	Tiyerili, V (corresponding author), Univ Hosp Bonn, Med Dept 2, Bonn, Germany.	vedat.tiyerili@ukbonn.de	Tiyerili, Vedat/CAF-1914-2022		German Society of Cardiology [DGK16/2018]; Medical Faculty of the Rheinische Friedrich-Wilhelms-University Bonn (BONFOR Gerok-grant); Else-Kroner-Fresenius-Foundation through the Medical Faculty of the University of Bonn; German Heart Foundation (Kaltenbach Stipendium)	German Society of Cardiology; Medical Faculty of the Rheinische Friedrich-Wilhelms-University Bonn (BONFOR Gerok-grant); Else-Kroner-Fresenius-Foundation through the Medical Faculty of the University of Bonn; German Heart Foundation (Kaltenbach Stipendium)	AZ was supported by the German Society of Cardiology (DGK16/2018) and by the Medical Faculty of the Rheinische Friedrich-Wilhelms-University Bonn (BONFOR Gerok-grant). STN was supported by the Else-Kroner-Fresenius-Foundation through the Medical Faculty of the University of Bonn. MAL was supported by the German Heart Foundation (Kaltenbach Stipendium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo AI, 2017, REDOX BIOL, V13, P623, DOI 10.1016/j.redox.2017.08.004; Chandler JD, 2013, J BIOL CHEM, V288, P18421, DOI 10.1074/jbc.M113.468090; Daiber A, 2017, REDOX BIOL, V12, P35, DOI 10.1016/j.redox.2017.02.001; DEGIAMPIETRO P, 1987, J CLIN CHEM CLIN BIO, V25, P711; Exner M, 2004, FREE RADICAL BIO MED, V37, P146, DOI 10.1016/j.freeradbiomed.2004.04.039; Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210; Heslop CL, 2010, J AM COLL CARDIOL, V55, P1102, DOI 10.1016/j.jacc.2009.11.050; Ismael FO, 2015, ARCH BIOCHEM BIOPHYS, V573, P40, DOI 10.1016/j.abb.2015.03.008; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050767; Love DT, 2016, FREE RADICAL BIO MED, V94, P88, DOI 10.1016/j.freeradbiomed.2016.02.016; Marsche G, 2004, ARTERIOSCL THROM VAS, V24, P2302, DOI 10.1161/01.ATV.0000148703.43429.25; Marsche G, 2003, J BIOL CHEM, V278, P47562, DOI 10.1074/jbc.M308428200; Marsche G, 2002, J BIOL CHEM, V277, P32172, DOI 10.1074/jbc.M200503200; Morgan PE, 2015, FREE RADICAL RES, V49, P743, DOI 10.3109/10715762.2015.1019347; Nedoboy PE, 2014, FREE RADICAL RES, V48, P1256, DOI 10.3109/10715762.2014.947286; Pasceri V, 2001, CIRCULATION, V103, P2531; Ronald JA, 2009, CIRCULATION, V120, P592, DOI 10.1161/CIRCULATIONAHA.108.813998; Sokolov AV, 2014, CHEM PHYS LIPIDS, V180, P72, DOI 10.1016/j.chemphyslip.2014.02.006; Teng N, 2017, REDOX REP, V22, P51, DOI 10.1080/13510002.2016.1256119; Tiyerili V, 2016, INT J CARDIOL, V204, P29, DOI 10.1016/j.ijcard.2015.11.128; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; WATKINSON G, 1947, BRIT MED J, V1, P595, DOI 10.1136/bmj.1.4504.595; WHO, 2018, GLOB HLTH EST 2019 D; Zielonka J, 2013, FREE RADICAL BIO MED, V65, P1310, DOI 10.1016/j.freeradbiomed.2013.09.017	30	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214476	10.1371/journal.pone.0214476	http://dx.doi.org/10.1371/journal.pone.0214476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939159	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900026
J	Dhamoon, MS; Cheung, YK; Moon, YP; Wright, CB; Sacco, RL; Elkind, MSV				Dhamoon, Mandip S.; Cheung, Ying-Kuen; Moon, Yeseon P.; Wright, Clinton B.; Sacco, Ralph L.; Elkind, Mitchell S. V.			Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MOBILITY LIMITATION; VASCULAR EVENTS; ISCHEMIC-STROKE; DISABILITY; INFLAMMATION; SENSITIVITY; MORTALITY; MARKERS; TRIALS	Background/Objectives Inflammatory biomarkers have been associated with stroke and mortality, but inflammation may also have detrimental effects beyond acute events. We hypothesized that serum concentrations of interleukin-6 (IL6) and lipoprotein-associated phospholipase A2 (LpPLA2) were inversely associated with long-term functional decline independently of vascular risk factors, stroke and myocardial infarction (MI) occurring during follow-up. Design Prospective population based cohort study Setting The Northern Manhattan Study Participants (including the sample size) Race/ethnically diverse stroke-free individuals in northern Manhattan aged >= 40 years (n = 3298). Intervention None Measurements Annual functional assessments with the Barthel index (BI), for a median of 13 years. BI was analyzed as a continuous variable (range 0-100). Baseline demographics, risk factors, and laboratory studies were collected, including IL6 (n = 1679), LpPLA2 mass (n = 1912) and activity (n = 1937). Separate mixed models estimated standardized associations between each biomarker and baseline functional status and change over time, adjusting for demographics, vascular risk factors, social variables, cognition, and depression measured at baseline, and stroke and MI occurring during follow-up. Results Mean age was 69 (SD 10) years, 35% were male, 53% Hispanic, 74% hypertensive, and 16-24% diabetic. LogIL6 was associated with decline in BI over time (-0.13 points per year, 95% CI -0.24, -0.02) and marginally with baseline BI (-0.20, 95% CI -0.40, 0.01). LpPLA2 activity levels were associated with baseline BI (-0.36, 95% CI -0.68, -0.04) but not change over time, and LpPLA2 mass levels were not associated with either. Conclusion In this large population-based study, higher serum inflammatory biomarker levels were associated with disability, even when adjusting for baseline covariates and stroke and MI occurring during follow-up.	[Dhamoon, Mandip S.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Dhamoon, Mandip S.; Elkind, Mitchell S. V.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Cheung, Ying-Kuen] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Moon, Yeseon P.; Elkind, Mitchell S. V.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Wright, Clinton B.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, McKnight Brain Inst, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Publ Hlth Sci, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Human Genet, Miami, FL 33136 USA	Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; University of Miami; University of Miami; University of Miami; University of Miami	Dhamoon, MS (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Dhamoon, MS (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.	mandip.dhamoon@mssm.edu	Sacco, Ralph/Y-9278-2019	Wright, Clinton/0000-0002-9797-6215	National Institute of Neurological Disorders and Stroke [R01 NS48134, R37 29993, K23NS079422]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS079422] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (R01 NS48134, MSVE; R37 29993, RLS/MSVE; K23NS079422, MSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Bustamante A, 2014, J NEUROIMMUNOL, V274, P215, DOI 10.1016/j.jneuroim.2014.07.015; Cesari M, 2012, J GERONTOL A-BIOL, V67, P671, DOI 10.1093/gerona/glr246; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Colley KJ, 2011, EPMA J, V2, P27, DOI 10.1007/s13167-011-0063-4; Dallmeier D, 2014, BEST PRACT RES CL EN, V28, P281, DOI 10.1016/j.beem.2014.01.003; Dhamoon MS, 2017, AGE AGEING, V46, P77, DOI 10.1093/ageing/afw179; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; Economos A, 2013, NEUROEPIDEMIOLOGY, V40, P253, DOI 10.1159/000343276; Elkind MSV, 2006, ARCH INTERN MED, V166, P2073, DOI 10.1001/archinte.166.19.2073; Elkind MSV, 2006, STROKE, V37, P13, DOI 10.1161/01.STR.0000195048.86810.5b; Gentry E M, 1985, Am J Prev Med, V1, P9; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Katan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083393; Lin JX, 2015, NEUROLOGY, V85, P1585, DOI 10.1212/WNL.0000000000001938; MAHONEY F I, 1965, Md State Med J, V14, P61; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nagai K, 2011, GERIATR GERONTOL INT, V11, P328, DOI 10.1111/j.1447-0594.2010.00686.x; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P1105, DOI 10.1111/j.1532-5415.2004.52308.x; Perez-Baos S, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00409; Peterson MJ, 2015, J GERONTOL A; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Saver JL, 2011, STROKE, V42, P2356, DOI 10.1161/STROKEAHA.111.619122; SHINAR D, 1987, ARCH PHYS MED REHAB, V68, P723; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Song FJ, 2006, CLIN REHABIL, V20, P347, DOI 10.1191/0269215506cr948oa; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Trapero I, 2014, METAB BRAIN DIS, V29, P593, DOI 10.1007/s11011-014-9551-2; Wannamethee SG, 2014, J AM GERIATR SOC, V62, P2357, DOI 10.1111/jgs.13133; Willey JZ, 2010, J COMMUNITY HLTH; Wright CB, 2009, STROKE, V40, P3466, DOI 10.1161/STROKEAHA.109.559567; Zuliani G, 2007, INT J GERIATR PSYCH, V22, P305, DOI 10.1002/gps.1674	36	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214784	10.1371/journal.pone.0214784	http://dx.doi.org/10.1371/journal.pone.0214784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934019	Green Published, gold, Green Submitted			2022-12-27	WOS:000462867000041
J	Zhang, S; Wang, JX; Li, Y; Liu, Y; He, L; Xia, XB				Zhang, Shuo; Wang, Jiaxing; Li, Ying; Liu, Ye; He, Li; Xia, Xiaobo			The role of primary intraocular lens implantation in the risk of secondary glaucoma following congenital cataract surgery: A systematic review and meta-analysis	PLOS ONE			English	Review							AXIAL LENGTH; COMPLICATIONS; CHILDREN; OUTCOMES; REMOVAL; EXTRACTION; AGE	Objective This meta-analysis aims to evaluate the incidence of secondary glaucoma in patients under the age of 2 years who underwent congenital cataract surgery with or without primary intraocular lens (IOL) implantation. Methods An electronic literature search was performed in Medline, EMBASE, and Web of Science databases to retrieve studies between January 2011 and November 2018. Patients with congenital cataract who did primary IOL implantation, aphakia, or secondary IOL implantation followed by receiving extraction surgery were included in this study. Relevant studies meeting defined eligibility criteria were selected and reviewed systematically by meta-analysis. Long-term incidences of secondary glaucoma, which developed at least one year after cataract surgery, were considered and discussed as clinical outcomes in each cohort. The pooled data were analyzed according to a random effects model. Results Eight publications involving 892 eyes were included in the current meta-analysis. In the general population of eyes with congenital cataract, the long-term incidence of secondary glaucoma was lower (P = 0.06) in eyes with primary IOL (9.5%) than in eyes without primary IOL (15.1%), including aphakia and secondary IOL. The pooled risk ratio (RR) favors primary IOL implantation in all patients (RR = 0.63). For bilateral congenital cataract, the incidence was 6.7% in eyes with primary IOL implantation, which is significantly lower than the 16.7% in eyes with aphakia and secondary IOL implantation (P<0.05, RR = 0.44). However, for unilateral congenital cataract surgery, the incidence was very similar in eyes with and without primary IOL (12.4% vs 12.0%, P = 0.61, RR = 0.87). Conclusions In patients under 2 years of age, primary IOL implantation for bilateral congenital cataract surgery is associated with a lower risk of secondary glaucoma.	[Zhang, Shuo; Xia, Xiaobo] Cent S Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Zhang, Shuo; Xia, Xiaobo] Cent S Univ, Xiangya Eye Ctr, Changsha, Hunan, Peoples R China; [Wang, Jiaxing; Li, Ying] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Liu, Ye] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA; [He, Li] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	Central South University; Central South University; Emory University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Xia, XB (corresponding author), Cent S Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Hunan, Peoples R China.; Xia, XB (corresponding author), Cent S Univ, Xiangya Eye Ctr, Changsha, Hunan, Peoples R China.	xbxia21@163.com	wang, jiaxing/I-1193-2019	wang, jiaxing/0000-0001-8958-6893; Zhang, Shuo/0000-0002-7356-5104; Li, Ying/0000-0002-9615-4914; Xia, Xiaobo/0000-0002-2785-3391; Liu, Ye/0000-0003-1536-706X	National Natural Science Foundation of China [81670858]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported from Xiaobo Xia, by a grant from the National Natural Science Foundation of China, and grant number is 81670858. He play roles in study design, decision to publish and preparation of the manuscript.	Asadi R, 2008, OPHTHALMOLOGY, V115, P67, DOI 10.1016/j.ophtha.2007.02.018; Basti S, 1996, OPHTHALMOLOGY, V103, P713; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; Freedman SF, 2015, JAMA OPHTHALMOL, V133, P907, DOI 10.1001/jamaophthalmol.2015.1329; Gimbel HV, 1997, OPHTHALMOLOGY, V104, P1737, DOI 10.1016/S0161-6420(97)30033-5; KEECH RV, 1989, AM J OPHTHALMOL, V108, P136, DOI 10.1016/0002-9394(89)90007-X; Kirwan C, 2010, ACTA OPHTHALMOL, V88, P53, DOI 10.1111/j.1755-3768.2009.01633.x; Kumar P, 2016, EXPERT REV MED DEVIC, V13, P381, DOI 10.1586/17434440.2016.1153967; Lambert SR, 2016, EYE, V30, P1221, DOI 10.1038/eye.2016.164; Lawrence Mary Gilbert, 2005, Trans Am Ophthalmol Soc, V103, P46; Li Q, 2014, ACTA OPHTHALMOL, V92, pe657, DOI 10.1111/aos.12465; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077864; Lim ME, 2017, CURR OPIN OPHTHALMOL, V28, P87, DOI 10.1097/ICU.0000000000000324; Ma QQ, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00636; Magli A, 2013, GRAEF ARCH CLIN EXP, V251, P309, DOI 10.1007/s00417-012-1979-7; Magnusson G, 2000, ACTA OPHTHALMOL SCAN, V78, P65, DOI 10.1034/j.1600-0420.2000.078001065.x; MCMENAMIN PG, 1989, CURR EYE RES, V8, P727, DOI 10.3109/02713688909025808; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Qian X, 2018, BR J OPHTHALMOL; Schwarzer G, 2007, R NEWS, V7, P6; Shenoy BH, 2015, AM J OPHTHALMOL, V159, P720, DOI 10.1016/j.ajo.2015.01.002; SIMON JW, 1991, OPHTHALMOLOGY, V98, P670; Solebo AL, 2017, ARCH DIS CHILD, V102, P853, DOI 10.1136/archdischild-2016-310532; Solebo AL, 2015, BRIT J OPHTHALMOL, V99, P1471, DOI 10.1136/bjophthalmol-2014-306394; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tadros D, 2016, J AAPOS, V20, P25, DOI 10.1016/j.jaapos.2015.10.010; Nyuyen TV, 2015, EBIOMEDICINE, V2, P59, DOI 10.1016/j.ebiom.2014.10.021; Unsal E, 2017, EUR J OPHTHALMOL, V27, P31, DOI 10.5301/ejo.5000812; Vasavada AR, 2018, AM J OPHTHALMOL, V193, P33, DOI 10.1016/j.ajo.2018.06.005; Wang JX, 2018, J AUTISM DEV DISORD, V48, P1530, DOI 10.1007/s10803-017-3387-7; Whitman MC, 2014, SEMIN OPHTHALMOL, V29, P414, DOI 10.3109/08820538.2014.959192; WILSON JR, 1987, INVEST OPHTH VIS SCI, V28, P2096; Wilson ME, 2017, OPHTHALMOLOGY, V124, P730, DOI 10.1016/j.ophtha.2017.01.010; Wong BY, 2009, BRIT J OPHTHALMOL, V93, P1200, DOI 10.1136/bjo.2008.155200; Zetterstrom C, 2005, J CATARACT REFR SURG, V31, P824, DOI 10.1016/j.jcrs.2005.01.012; Zhang Hui, 2013, Zhonghua Yan Ke Za Zhi, V49, P134	37	16	18	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214684	10.1371/journal.pone.0214684	http://dx.doi.org/10.1371/journal.pone.0214684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933995	Green Submitted, Green Published, gold			2022-12-27	WOS:000462867000036
J	Cho, HW; Ouh, YT; Lee, KM; Han, SW; Lee, JK; Cho, GJ; Hong, JH				Cho, Hyun-Woong; Ouh, Yung-Taek; Lee, Kyu-Min; Han, Sung Won; Lee, Jae Kwan; Cho, Geum Jun; Hong, Jin Hwa			Long-term effect of pregnancy-related factors on the development of endometrial neoplasia: A nationwide retrospective cohort study	PLOS ONE			English	Article							REPRODUCTIVE FACTORS; GROWTH-FACTOR; BREAST-CANCER; VEGF RECEPTOR-1; FOLLOW-UP; RISK; PREECLAMPSIA; WOMEN; OBESITY; IMPACT	Objective By identifying pregnancy-related risk factors for endometrial neoplasia, women's risk of developing this disease after childbirth can be predicted and high-risk women can be screened for early detection. Methods Study data from women who gave birth in Korea in 2007 were collected from the Korea National Health Insurance (KNHI) claims database between 2007 and 2015. The adjusted hazard ratios (HRs) and 95% confidence intervals (Cis) for the development of endometrial neoplasia were estimated by multivariate Cox proportional hazards models. Results Data from 386,614 women were collected for this study. By 2015, 3,370 women from the initial cohort had been diagnosed with endometrial neoplasia secondary to delivery. Multivariate Cox proportional hazards regression revealed that preeclampsia (HR 1.55, 95% CI 1.29, 1.86), advanced maternal age (>= 35; HR 1.52, 95% CI 1.39, 1.66), multifetal pregnancy (HR 1.81, 95% CI 1.46, 2.23), multiparity (HR 1.16, 95% CI 1.08, 1.24), cesarean section (HR 1.15, 95% CI 1.07, 1.23) and delivery of a large-for-gestational-age infant (HR 1.19, 95% CI 1.02, 1.39) were independent risk factors for future endometrial neoplasia. The risk for endometrial neoplasia increased as the number of risk factors increased (risk factors >= 3: HR 2.11, 95% CI 1.86-2.40). Conclusion This study showed that six pregnancy-related factors-advanced maternal age, multiparity, multifetal pregnancy, cesarean section, delivery of a large-for-gestational-age infant, and preeclampsia-are positively correlated with future development of endometrial neoplasia, including endometrial hyperplasia or cancer. Close observation and surveillance are warranted to enable early diagnosis of endometrial diseases, including endometrial cancer after pregnancy in high-risk women. However, due to unavailability of clinical information, many clinical/epidemiological factors can become confounders. Further research is needed on factors associated with the risk of endometrial neoplasia.	[Cho, Hyun-Woong; Ouh, Yung-Taek; Lee, Jae Kwan; Cho, Geum Jun; Hong, Jin Hwa] Korea Univ, Dept Obstet & Gynecol, Guro Hosp, Coll Med, Seoul, South Korea; [Lee, Kyu-Min; Han, Sung Won] Korea Univ, Sch Ind Management Engn, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University	Cho, GJ; Hong, JH (corresponding author), Korea Univ, Dept Obstet & Gynecol, Guro Hosp, Coll Med, Seoul, South Korea.	md_cho@hanmail.net; jhhong93@korea.ac.kr	Hong, Jinhwa/AAY-9037-2020	Hong, Jinhwa/0000-0002-6905-5363; LEE, Jae Kwan/0000-0003-3101-6403; Lee, Kyu-min/0000-0002-6290-1272; Ouh, Yung-Taek/0000-0001-5887-4497; CHO, HYUN-WOONG/0000-0002-0724-9971				Ali Aus Tariq, 2013, Ceska Gynekol, V78, P448; Allen N, 2015, LANCET ONCOL, V16, P1061, DOI 10.1016/S1470-2045(15)00212-0; Baba T, 2011, J OBSTET GYNAECOL RE, V37, P245, DOI 10.1111/j.1447-0756.2010.01381.x; Ferreira RAB, 2015, REV PANAM SALUD PUBL, V37, P337; BRINTON LA, 1992, AM J OBSTET GYNECOL, V167, P1317, DOI 10.1016/S0002-9378(11)91709-8; Britt K, 2012, LANCET ONCOL, V13, P1071, DOI 10.1016/S1470-2045(12)70456-4; Burton GJ, 2017, PLACENTA, V60, P134, DOI 10.1016/j.placenta.2017.06.007; Chatzaki E, 1996, CANCER RES, V56, P2059; Coenegrachts L, 2013, ONCOL REP, V29, P413, DOI 10.3892/or.2012.2178; Devor EJ, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/678984; Emons G, 2000, ENDOCR-RELAT CANCER, V7, P227, DOI 10.1677/erc.0.0070227; Emons G, 2015, GEBURTSH FRAUENHEILK, V75, P135, DOI 10.1055/s-0034-1396256; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hajiahmadi M, 2015, MED PRIN PRACT, V24, P70, DOI 10.1159/000368358; Hallum S, 2016, BRIT J CANCER, V114, P809, DOI 10.1038/bjc.2016.55; Harry VN, 2007, OBSTET GYNECOL, V110, P469, DOI 10.1097/01.AOG.0000260393.46154.5f; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kessous R, 2016, J CANCER RES CLIN, V142, P287, DOI 10.1007/s00432-015-2035-x; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kroener L, 2017, CURR OPIN OBSTET GYN, V29, P195, DOI 10.1097/GCO.0000000000000370; KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X; KVALE G, 1991, CANCER DETECT PREV, V15, P369; Lacey JV, 2008, BRIT J CANCER, V98, P45, DOI 10.1038/sj.bjc.6604102; Lacey JV, 2010, J CLIN ONCOL, V28, P788, DOI 10.1200/JCO.2009.24.1315; LESKO SM, 1991, AM J EPIDEMIOL, V133, P554, DOI 10.1093/oxfordjournals.aje.a115926; Lochen ML, 1997, ACTA OBSTET GYN SCAN, V76, P373, DOI 10.1111/j.1600-0412.1997.tb07996.x; Macdonald EM, 2014, PLACENTA, V35, P582, DOI 10.1016/j.placenta.2014.04.019; Markopoulos C., 1996, European Journal of Gynaecological Oncology, V17, P520; McPherson CP, 1996, AM J EPIDEMIOL, V143, P1195, DOI 10.1093/oxfordjournals.aje.a008707; Mogren I, 2001, ACTA ONCOL, V40, P849; Montoya-Williams D, 2017, J WOMENS HEALTH, V26, P1285, DOI 10.1089/jwh.2016.6188; Owings RA, 2014, ARCH PATHOL LAB MED, V138, P484, DOI 10.5858/arpa.2012-0709-RA; Pacheco NLP, 2015, BREAST, V24, P613, DOI 10.1016/j.breast.2015.06.006; Paltiel O, 2004, BMJ-BRIT MED J, V328, P919, DOI 10.1136/bmj.38032.820451.7C; Piccinino LJ, 1998, FAM PLANN PERSPECT, V30, P4, DOI 10.2307/2991517; Pinar H, 1996, PEDIATR PATHOL LAB M, V16, P901, DOI 10.1080/15513819609168713; Pocobelli G, 2011, EPIDEMIOLOGY, V22, P638, DOI 10.1097/EDE.0b013e3182263018; Pollio F, 2006, AM J OBSTET GYNECOL, V194, P527, DOI 10.1016/j.ajog.2005.07.048; Reigstad MM, 2017, CANCER EPIDEM BIOMAR, V26, P953, DOI 10.1158/1055-9965.EPI-16-0809; Richardson BS, 2017, EARLY HUM DEV, V112, P42, DOI 10.1016/j.earlhumdev.2017.06.009; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Shibuya M, 2011, P JPN ACAD B-PHYS, V87, P167, DOI 10.2183/pjab.87.167; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Sovino Hugo, 2002, Reprod Biomed Online, V4, P303; Sponholtz TR, 2017, CANCER CAUSE CONTROL, V28, P579, DOI 10.1007/s10552-017-0880-4; Taylor A, 2004, BRIT MED J, V328, P909, DOI 10.1136/bmj.328.7445.909; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Terry MB, 2007, AM J EPIDEMIOL, V165, P1007, DOI 10.1093/aje/kwk105; Toi M, 2002, INT J CANCER, V98, P14, DOI 10.1002/ijc.10121; Trimble CL, 2012, OBSTET GYNECOL, V120, P1160, DOI [10.1097/AOG.0b013e31826bb121, http://10.1097/AOG.0b013e31826bb121]; Wu QJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14243; Yang F, 2011, EXPERT REV ANTICANC, V11, P541, DOI [10.1586/era.10.171, 10.1586/ERA.10.171]; Zhang L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0052-2; Zyla MM, 2016, MENOPAUSE REV, V15, P176, DOI 10.5114/pm.2016.63500; Zyla MM, 2014, MENOPAUSE REV, V13, P122, DOI 10.5114/pm.2014.42714	55	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214600	10.1371/journal.pone.0214600	http://dx.doi.org/10.1371/journal.pone.0214600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921436	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000095
J	Guezennec, C; Bourhis, D; Orlhac, F; Robin, P; Corre, JB; Delcroix, O; Gobel, Y; Schick, U; Salaun, PY; Abgral, R				Guezennec, Catherine; Bourhis, David; Orlhac, Fanny; Robin, Philippe; Corre, Jean-Baptiste; Delcroix, Olivier; Gobel, Yves; Schick, Ulrike; Salaun, Pierre-Yves; Abgral, Ronan			Inter-observer and segmentation method variability of textural analysis in pre- therapeutic FDG PET/CT in head and neck cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; METABOLIC TUMOR VOLUME; PROGNOSTIC VALUE; F-18-FDG PET/CT; HETEROGENEITY; FEATURES; SURVIVAL; IMAGES; RADIOTHERAPY; PARAMETERS	Aim Characterizing tumor heterogeneity with textural indices extracted from 18F-fluorodeoxyglucose positron emission tomography (FDG PET/CT) is of growing interest in oncology. Several series showed promising results to predict survival in patients with head and neck squamous cell carcinoma (HNSCC), analyzing various tumor segmentation methods and textural indices. This preliminary study aimed at assessing the inter-observer and inter-segmentation method variability of textural indices in HNSCC pre-therapeutic FDG PET/CT. Materials and methods Consecutive patients with HNSCC referred in our department for a pre-therapeutic FDG PET/CT from January to March 2016 were retrospectively included. Two nuclear medicine physicians separately segmented all tumors using 3 different segmentation methods: a relative standardized uptake value (SUV) threshold (40%SUVmax), a signal-to-noise adaptive SUV threshold (DAISNE) and an image gradient-based method (PET-EDGE). SUV and metabolic tumor volume were recorded. Thirty-one textural indices were calculated using LIFEx software (www.lifexsoft.org). After correlation analysis, selected indices' inter-segmentation method and inter-observer variability were calculated. Results Forty-three patients (mean age 63.8 +/- 9.3y) were analyzed. Due to a too small segmented tumor volume of interest, textural analysis could not be performed in 6, 11 and 15 cases with respectively DAISNE, 40%SUVmax and PET-EDGE segmentation methods. Five independent textural indices were selected (Homogeneity, Correlation, Entropy, Busyness and LZLGE). There was a high inter-contouring method variability for Homogeneity, Correlation, Entropy and LZLGE (p<0.0001 for each index). The inter-observer reproducibility analysis revealed an excellent agreement for 3 indices (Homogeneity, Correlation and Entropy) with an intraclass correlation coefficient higher than 0.90 for the 3 methods. Conclusions This preliminary study showed a high variability of 4 out of 5 textural indices (Homogeneity, Correlation, Entropy and LZLGE) extracted from pre-therapeutic FDG PET/CT in HNSCC using 3 different contouring methods. However, for each method, there was an excellent agreement between observers for 3 of these textural indices (Homogeneity, Correlation and Entropy).	[Guezennec, Catherine; Bourhis, David; Robin, Philippe; Corre, Jean-Baptiste; Delcroix, Olivier; Salaun, Pierre-Yves; Abgral, Ronan] Brest Univ Hosp, Dept Nucl Med, Brest, France; [Orlhac, Fanny] Univ Paris Saclay, Univ Paris Sud, CNRS, Imagerie Mol Vivo,CEA SHJF,INSERM, Orsay, France; [Gobel, Yves] Brest Univ Hosp, Dept Head & Neck Surg, Brest, France; [Schick, Ulrike] Brest Univ Hosp, Dept Radiotherapy, Brest, France	CHU Brest; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Brest; CHU Brest	Abgral, R (corresponding author), Brest Univ Hosp, Dept Nucl Med, Brest, France.	ronan.abgral@chu-brest.fr	SALAUN, Pierre-Yves/X-6701-2019; Orlhac, Fanny/AAC-6428-2019; Robin, Philippe/X-6290-2019	SALAUN, Pierre-Yves/0000-0002-3899-2135; Orlhac, Fanny/0000-0002-5588-1867; Robin, Philippe/0000-0001-5521-9454; Gobel, Yves/0000-0003-3847-9937; abgral, ronan/0000-0002-5585-2564; Bourhis, David/0000-0001-8224-2027				Abgral R, 2016, HEAD NECK-J SCI SPEC, V38, pE600, DOI 10.1002/hed.24048; Abgral R, 2014, EUR J NUCL MED MOL I, V41, P659, DOI 10.1007/s00259-013-2618-1; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Ang KK, 2001, INT J RADIAT ONCOL, V51, P571, DOI 10.1016/S0360-3016(01)01690-X; [Anonymous], [No title captured]; Brooks FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116574; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Cheng NM, 2015, EUR J NUCL MED MOL I, V42, P419, DOI 10.1007/s00259-014-2933-1; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Daisne JF, 2004, RADIOLOGY, V233, P93, DOI 10.1148/radiol.2331030660; De Cecco L, 2015, ONCOTARGET, V6, P9627, DOI 10.18632/oncotarget.3301; Dibble EH, 2012, J NUCL MED, V53, P709, DOI 10.2967/jnumed.111.099531; Edge SB, 2010, AJCC CANC STAGING MA; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Geets X, 2007, EUR J NUCL MED MOL I, V34, P1427, DOI 10.1007/s00259-006-0363-4; Guezennec C, 2019, HEAD NECK-J SCI SPEC, V41, P495, DOI 10.1002/hed.25433; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hasina R, 2008, LAB INVEST, V88, P342, DOI 10.1038/labinvest.2008.6; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Jou A, 2017, ONCOL RES TREAT, V40, P328, DOI 10.1159/000477127; Kao CH, 2012, EUR J NUCL MED MOL I, V39, P1297, DOI 10.1007/s00259-012-2127-7; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; National Comprehensive Cancer Network, 2021, NCCN CLIN PRACTICE G; Nioche C, 2018, CANCER RES, V78, P4786, DOI 10.1158/0008-5472.CAN-18-0125; Oh JS, 2015, ANN SURG ONCOL, V22, P2746, DOI 10.1245/s10434-014-4284-3; Orlhac F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145063; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Pak K, 2014, J NUCL MED, V55, P884, DOI 10.2967/jnumed.113.133801; Querellou S, 2012, HEAD NECK-J SCI SPEC, V34, P462, DOI 10.1002/hed.21765; Sittel C, 1999, ORAL ONCOL, V35, P583, DOI 10.1016/S1368-8375(99)00041-X; Sobin L, 2009, TNM CLASSIFICATION M; Vallieres M, 2018, J NUCL MED, V59, P189, DOI 10.2967/jnumed.117.200501; Worsham MJ, 2012, MOL DIAGN THER, V16, P209, DOI 10.2165/11635330-000000000-00000; Xie S, 2016, J CANCER, V7, P758, DOI 10.7150/jca.14214; Xu D-H, 2004, RESEARCHGATE	38	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214299	10.1371/journal.pone.0214299	http://dx.doi.org/10.1371/journal.pone.0214299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921388	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000051
J	Kolb, JP; Draxinger, W; Klee, J; Pfeiffer, T; Eibl, M; Klein, T; Wieser, W; Huber, R				Kolb, Jan Philip; Draxinger, Wolfgang; Klee, Julian; Pfeiffer, Tom; Eibl, Matthias; Klein, Thomas; Wieser, Wolfgang; Huber, Robert			Live video rate volumetric OCT imaging of the retina with multi-MHz A-scan rates	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; DOMAIN MODE-LOCKING; SWEPT-SOURCE; VISUALIZATION; SPEED; FDML	Surgical microscopes are vital tools for ophthalmic surgeons. The recent development of an integrated OCT system for the first time allows to look at tissue features below the surface. Hence, these systems can drastically improve the quality and reduce the risk of surgical interventions. However, current commercial OCT-enhanced ophthalmic surgical microscopes provide only one additional cross sectional view to the standard microscope image and feature a low update rate. To present volumetric data at a high update rate, much faster OCT systems than the ones applied in today's surgical microscopes need to be developed. We demonstrate live volumetric retinal OCT imaging, which may provide a sufficiently large volume size (330x330x595 Voxel) and high update frequency (24.2 Hz) such that the surgeon may even purely rely on the OCT for certain surgical maneuvers. It represents a major technological step towards the possible application of OCT-only surgical microscopes in the future which would be much more compact thus enabling many additional minimal invasive applications. We show that multi-MHz A-scan rates are essential for such a device. Additionally, advanced phase-based OCT techniques require 3D OCT volumes to be detected with a stable optical phase. These techniques can provide additional functional information of the retina. Up to now, classical OCT was to slow for this, so our system can pave the way to holographic OCT with a traditional confocal flying spot approach. For the first time, we present point scanning volumetric OCT imaging of the posterior eye with up to 191.2 Hz volume rate. We show that this volume rate is high enough to enable a sufficiently stable optical phase to a level, where remaining phase errors can be corrected. Applying advanced post processing concepts for numerical refocusing or computational adaptive optics should be possible in future with such a system.	[Kolb, Jan Philip; Draxinger, Wolfgang; Klee, Julian; Pfeiffer, Tom; Eibl, Matthias; Huber, Robert] Univ Lubeck, Inst Biomed Opt, Lubeck, Germany; [Klein, Thomas; Wieser, Wolfgang] Optores GmbH, Munich, Germany	University of Lubeck	Huber, R (corresponding author), Univ Lubeck, Inst Biomed Opt, Lubeck, Germany.	Robert.Huber@bmo.uni-luebeck.de	Eibl, Matthias/AAN-5097-2020; Huber, Robert A/B-9419-2008	Eibl, Matthias/0000-0003-0351-5707; Huber, Robert A/0000-0001-9785-6574; Draxinger, Wolfgang/0000-0002-9413-3474; Pfeiffer, Tom/0000-0001-7791-1126	European Union (ERC CoG) [646669]; German Research Foundation [HU1006/6, EXC306/2]; European Union within Interreg Deutschland-Danmark from the European Regional Development Fund in the project CELLTOM; Bundesministerium fur Bildung und Forschung (BMBF) [13GW0227B]	European Union (ERC CoG); German Research Foundation(German Research Foundation (DFG)); European Union within Interreg Deutschland-Danmark from the European Regional Development Fund in the project CELLTOM; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	Funded by European Union (ERC CoG no. 646669) https://erc.europa.eu/; German Research Foundation (HU1006/6) and (EXC306/2), http://www.dfg.de/; European Union within Interreg Deutschland-Danmark from the European Regional Development Fund in the project CELLTOM, http://www.interreg.de/INTERREG2014/DE/Home/home_ node. html; Bundesministerium fur Bildung und Forschung (BMBF) 13GW0227B project Neuro-OCT, https://www.bmbf.de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, NAT PHOTONICS, V7, P445, DOI [10.1038/nphoton.2013.71, 10.1038/NPHOTON.2013.71]; Biedermann BR, 2008, OPT LETT, V33, P2556, DOI 10.1364/OL.33.002556; Buades A, 2011, IMAGE PROCESS ON LIN, V1, P208, DOI 10.5201/ipol.2011.bcm_nlm; Carrasco-Zevallos O, 2017, SPIE BIOS; Carrasco-Zevallos OM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31689; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; De Benito-Llopis L, 2014, AM J OPHTHALMOL, V157, P334, DOI 10.1016/j.ajo.2013.10.001; Ehlers JP, 2013, RETINA-J RET VIT DIS, V33, P232, DOI 10.1097/IAE.0b013e31826e86f5; El-Haddad MT, 2015, BIOMED OPT EXPRESS, V6, P3014, DOI 10.1364/BOE.6.003014; Fechtig DJ, 2015, PROC SPIE, V9312, DOI 10.1117/12.2081924; Fechtig DJ, 2015, BIOMED OPT EXPRESS, V6, P716, DOI 10.1364/BOE.6.000716; FERCHER AF, 1993, AM J OPHTHALMOL, V116, P113, DOI 10.1016/S0002-9394(14)71762-3; Ginner L, 2014, PHOTONICS; GUAYLORD R, 2016, BIOMEDO, V21, DOI DOI 10.1117/1.JBO.21.11.116008; Hillmann D, 2016, P NATL ACAD SCI; Hillmann D, 2016, SCI REP-UK, V6, DOI 10.1038/srep35209; Hiro-Oka H., 2012, BIOMED OPT EXPRESS, V3, P3067, DOI DOI 10.1364/B0E.3.003067; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huber R, 2006, OPT EXPRESS, V14, P3225, DOI 10.1364/OE.14.003225; Huber R, 2006, OPT LETT, V31, P2975, DOI 10.1364/OL.31.002975; [Institute ANS Z136 Committee. ANSI], 2000, SAF US LAS SAF US OP; IZATT JA, 1994, OPT LETT, V19, P590, DOI 10.1364/OL.19.000590; Jian YF, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026002; Junker B, 2016, OPHTHALMOLOGE, V113, P663, DOI 10.1007/s00347-016-0321-x; Kaschke M, 2014, OPTICAL DEVICES IN OPHTHALMOLOGY AND OPTOMETRY: TECHNOLOGY, DESIGN PRINCIPLES, AND CLINICAL APPLICATIONS, P1, DOI 10.1002/9783527648962; Klein T, 2013, BIOMED OPT EXPRESS, V4, P1890, DOI 10.1364/BOE.4.001890; Kocaoglu OP, 2014, BIOMED OPT EXPRESS, V5, P4186, DOI 10.1364/BOE.5.004186; Kolb JP, 2015, BIOMED OPT EXPRESS, V6, P1534, DOI 10.1364/BOE.6.001534; Laubscher M, 2002, OPT EXPRESS, V10, P429, DOI 10.1364/OE.10.000429; Lee LB, 2011, OPHTHALMIC SURG LASE; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Miller R. B., 1968, P DEC 9 11 1968 FALL; Nemeth A., 2013, OPT COHER TOMOGRAPH, V6, P163, DOI [10.1111/j.1399-3054.1981.tb04512.x, DOI 10.1111/J.1399-3054.1981.TB04512.X]; PALMER KF, 1974, J OPT SOC AM, V64, P1107, DOI 10.1364/JOSA.64.001107; PCISIG, 2015, PCI EXPR BAS SPEC RE; Pfazffle C, 2017, BIOMED OPT EXPRESS, V8, P1499, DOI 10.1364/BOE.8.001499; Probst J, 2010, BIOMEDO, V15; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; SCHMITT JM, 1995, DERMATOLOGY, V191, P93, DOI 10.1159/000246523; Shemonski ND, 2015, NAT PHOTONICS, V9, P440, DOI [10.1038/NPHOTON.2015.102, 10.1038/nphoton.2015.102]; Shemonski ND, 2015, COMPUTATIONAL APPROA; Shen LB, 2016, BIOMED OPT EXPRESS, V7, P1711, DOI 10.1364/BOE.7.001711; Spahr H, 2015, OPT LETT, V40, P4771, DOI 10.1364/OL.40.004771; Steven P, 2014, BRIT J OPHTHALMOL, V98, P900, DOI 10.1136/bjophthalmol-2013-304585; Steven P, 2013, JAMA OPHTHALMOL, V131, P1135, DOI 10.1001/jamaophthalmol.2013.4672; SWANSON EA, 1993, OPT LETT, V18, P1864, DOI 10.1364/OL.18.001864; Tao YKK, 2010, OPT LETT, V35, P3315, DOI 10.1364/OL.35.003315; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Todorich B, 2016, INVEST OPHTH VIS SCI, V57; Tsai TH, 2013, BIOMED OPT EXPRESS, V4, P1119, DOI 10.1364/BOE.4.001119; US Food and Drug Administration, 2016, K161194510 K PREM NO; Viehland C, 2016, BIOMED OPT EXPRESS, V7, P1815, DOI 10.1364/BOE.7.001815; Wang RK, 2007, OPT EXPRESS, V15, P4083, DOI 10.1364/OE.15.004083; Wang S, 2015, OPT LETT, V40, P4791, DOI 10.1364/OL.40.004791; Wang TS, 2016, JACC-CARDIOVASC IMAG, V9, P622, DOI 10.1016/j.jcmg.2015.08.010; Wieser W, 2014, BIOMED OPT EXPRESS, V5, P2963, DOI 10.1364/BOE.5.002963; Wieser W, 2010, OPT EXPRESS, V18, P14685, DOI 10.1364/OE.18.014685; Willomitzer F, 2017, OPT EXPRESS, V25, P23451, DOI 10.1364/OE.25.023451; Yelin R, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2822904; Yun SH, 2004, OPT EXPRESS, V12, P2977, DOI 10.1364/OPEX.12.002977; Zhang K, 2010, OPT EXPRESS, V18, P11772, DOI 10.1364/OE.18.011772; Zhi ZW, 2015, OPT LETT, V40, P1779, DOI 10.1364/OL.40.001779	63	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213144	10.1371/journal.pone.0213144	http://dx.doi.org/10.1371/journal.pone.0213144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921342	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000014
J	Stapleton, G; Chapman, P; Rodgers, P; Touloumis, A; Blake, A; Delaney, A				Stapleton, Gem; Chapman, Peter; Rodgers, Peter; Touloumis, Anestis; Blake, Andrew; Delaney, Aidan			The efficacy of Euler diagrams and linear diagrams for visualizing set cardinality using proportions and numbers	PLOS ONE			English	Article								This paper presents the first empirical investigation that compares Euler and linear diagrams when they are used to represent set cardinality. A common approach is to use area-proportional Euler diagrams but linear diagrams can exploit length-proportional straight-lines for the same purpose. Another common approach is to use numerical annotations. We first conducted two empirical studies, one on Euler diagrams and the other on linear diagrams. These suggest that area-proportional Euler diagrams with numerical annotations and length-proportional linear diagrams without numerical annotations support significantly better task performance. We then conducted a third study to investigate which of these two notations should be used in practice. This suggests that area-proportional Euler diagrams with numerical annotations most effectively supports task performance and so should be used to visualize set cardinalities. However, these studies focused on data that can be visualized reasonably accurately using circles and the results should be taken as valid within that context. Future work needs to determine whether the results generalize both to when circles cannot be used and for other ways of encoding cardinality information.	[Stapleton, Gem; Touloumis, Anestis; Blake, Andrew] Univ Brighton, Sch Comp Engn & Math, Ctr Secure Intelligent & Usabl Syst, Brighton, E Sussex, England; [Chapman, Peter] Edinburgh Napier Univ, Sch Comp, Edinbugh, Scotland; [Rodgers, Peter] Univ Kent, Sch Comp, Canterbury, Kent, England; [Delaney, Aidan] Bloomberg, London, England	University of Brighton; Edinburgh Napier University; University of Kent	Stapleton, G (corresponding author), Univ Brighton, Sch Comp Engn & Math, Ctr Secure Intelligent & Usabl Syst, Brighton, E Sussex, England.	g.e.stapleton@brighton.ac.uk		Touloumis, Anestis/0000-0002-5965-1639; Blake, Andrew/0000-0001-5856-4544				Alper B, 2011, IEEE T VIS COMPUT GR, V17, P2259, DOI 10.1109/TVCG.2011.186; Alsallakh B, 2016, COMPUT GRAPH FORUM, V35, P234, DOI 10.1111/cgf.12722; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Blake A, 2016, INFORM SCIENCES, V330, P455, DOI 10.1016/j.ins.2015.05.020; Chapman P, 2014, LECT NOTES COMPUT SC, V8578, P146, DOI 10.1007/978-3-662-44043-8_18; Cheng PCH, 2011, TOP COGN SCI, V3, P475, DOI 10.1111/j.1756-8765.2009.01065.x; Chow S, 2005, ELECTRON NOTES THEOR, V134, P3, DOI 10.1016/j.entcs.2005.02.017; CLEVELAND WS, 1984, J AM STAT ASSOC, V79, P531, DOI 10.2307/2288400; Collins C, 2009, IEEE T VIS COMPUT GR, V15, P1009, DOI 10.1109/TVCG.2009.122; Couturat L., 1903, HIST LANGUE UNIVERSE; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eells WC, 1926, J AM STAT ASSOC, V21, P119, DOI 10.2307/2277140; Gottfried B, 2015, J SPAT INT SCI, P3, DOI 10.5311/JOSIS.2015.10.187; Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Heer J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P203; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kestler HA, 2005, BIOINFORMATICS, V21, P1592, DOI 10.1093/bioinformatics/bti169; Leskovec J., 2011, STANFORD LARGE NETWO; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mazza R., 2009, INTRO INFORM VISUALI; Meihoefer, 1973, CANADIAN CARTOGRAPHE, V10, P63, DOI [10.3138/2771-5577-5417-369T, DOI 10.3138/2771-5577-5417-369T]; Meulemans W, 2013, IEEE T VIS COMPUT GR, V19, P1846, DOI 10.1109/TVCG.2013.76; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Micallef L, 2012, IEEE T VIS COMPUT GR, V18, P2536, DOI 10.1109/TVCG.2012.199; North TA., 2011, INTERFACES, V5; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Ottley A, 2016, IEEE T VIS COMPUT GR, V22, P529, DOI 10.1109/TVCG.2015.2467758; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Purchase H, 2012, EXPT HUMAN COMPUTER; Riche NH, 2010, IEEE T VIS COMPUT GR, V16, P1090, DOI 10.1109/TVCG.2010.210; Rodgers P, 2015, ACM T COMPUT-HUM INT, V22, DOI 10.1145/2810012; Rodgers P, 2014, J VISUAL LANG COMPUT, V25, P134, DOI 10.1016/j.jvlc.2013.08.006; Rodgers P, 2014, IEEE T VIS COMPUT GR, V20, P56, DOI 10.1109/TVCG.2013.104; Simonetto P, 2009, COMPUT GRAPH FORUM, V28, P967, DOI 10.1111/j.1467-8659.2009.01452.x; Stapleton  G., 2014, 7 INT S VIS INF COMM; Stapleton G, 2012, J VISUAL LANG COMPUT, V23, P163, DOI 10.1016/j.jvlc.2012.02.001; Stapleton G, 2011, J VISUAL LANG COMPUT, V22, P426, DOI 10.1016/j.jvlc.2011.07.001; Stapleton G, 2011, IEEE T VIS COMPUT GR, V17, P1020, DOI 10.1109/TVCG.2010.119; Touloumis A, 2013, BIOMETRICS, V69, P633, DOI 10.1111/biom.12054; Wilkinson L, 2012, IEEE T VIS COMPUT GR, V18, P321, DOI 10.1109/TVCG.2011.56	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0211234	10.1371/journal.pone.0211234	http://dx.doi.org/10.1371/journal.pone.0211234			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921363	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000462594000010
J	Yu, Q; Liu, AL; Liu, TB; Mao, YW; Chen, W; Liu, HX				Yu, Qiong; Liu, Aili; Liu, Tiebing; Mao, Yuwei; Chen, Wei; Liu, Hongxing			ECG R-wave peaks marking with simultaneously recorded continuous blood pressure	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ROBUST-DETECTION; BEATS	Background and objectives ECG signal is relatively weak and vulnerable to various noise interferences, such as electromyography. There will be robustness problems when detecting the instantaneous heart rate independently. In some cases, multiple human physiologic parameters are monitored to help in heart rate detection. Methods In this paper, an algorithm that marks the R-wave peaks with the help of simultaneously recorded continuous blood pressure is proposed and tested on two databases. One database, called the challenge database, is provided by the PhysioNet/Computing in Cardiology Challenge 2014, and the other is the MGH/MF waveform database. Results The final scores of the proposed algorithm are 97.3% for the challenge database and 96.6% for the MGH/MF waveform database. Conclusions The experimental results show that this algorithm has high detection accuracy and a relatively strong robustness.	[Yu, Qiong; Liu, Aili; Mao, Yuwei; Chen, Wei; Liu, Hongxing] Nanjing Univ, Sch Elect Sci & Engn, Xianlin Campus, Nanjing, Jiangsu, Peoples R China; [Liu, Tiebing] Nanjing Mil Command, Nanjing Gen Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing General Hospital	Liu, HX (corresponding author), Nanjing Univ, Sch Elect Sci & Engn, Xianlin Campus, Nanjing, Jiangsu, Peoples R China.	njhxliu@nju.edu.cn			National Natural Science Foundation of China [61271079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (No. 61271079) supported this paper. The URLs of the funders' website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chin FJ, 2010, IEEE ENG MED BIO, P1922, DOI 10.1109/IEMBS.2010.5628088; Chiu CC, 2005, BIOMED ENG-APP BAS C, V17, DOI 10.4015/S1016237205000238; Cui X., 2011, NEW REAL TIME ECG R, P1252; DEBOER RW, 1984, IEEE T BIO-MED ENG, V31, P384, DOI 10.1109/TBME.1984.325351; Dosinas A., 2006, Elektronika ir Elektrotechnika, P77; Johnson AEW, 2015, PHYSIOL MEAS, V36, P1665, DOI 10.1088/0967-3334/36/8/1665; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Pangerc U, 2015, PHYSIOL MEAS, V36, P1645, DOI 10.1088/0967-3334/36/8/1645; Sameni R, 2010, OPEN SOURCE ELECTROP; Sasikala P, 2011, INT J ADV COMPUTER S; She Lihuang, 2009, IM SIGN PROC 2 INT C, P1; Silva I, 2015, PHYSIOL MEAS, V36, P1629, DOI 10.1088/0967-3334/36/8/1629; Su L, 2005, J HARBIN ENG U, V26, P513; WELCH JP, 1991, J CLIN MONIT, V0007; Winchell RJ, 1996, J SURG RES, V63, P11, DOI 10.1006/jsre.1996.0214; WO CCJ, 1993, CRIT CARE MED, V21, P218, DOI 10.1097/00003246-199302000-00012	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214443	10.1371/journal.pone.0214443	http://dx.doi.org/10.1371/journal.pone.0214443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921387	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000070
J	Hoffmann, EM; Konerding, V; Nautiyal, S; Buerkert, A				Hoffmann, Ellen M.; Konerding, Verena; Nautiyal, Sunil; Buerkert, Andreas			Is the push-pull paradigm useful to explain rural-urban migration? A case study in Uttarakhand, India	PLOS ONE			English	Article								The present study explored the motivation of rural-urban migrants who moved from the Himalaya foothills of Uttarakhand to its capital city, Dehradun. A survey of 100 migrant families reported their socio-economic profile before and after migration, personal and general reasons for migration, problems in the village and in the city, and perception of push- and pull factors. A remote sensing-based analysis of land cover and forest changes was conducted for two villages of the migrants' origin, aiming to link the reasons for migration to land cover changes. This was contextualised by reported large scale changes in forest cover. Major reasons for migration mentioned in this study were education, employment opportunities with the associated income, and facilities. These were perceived as both, push and pull factors, whereas environmental factors ranked very low. Declining environment or agriculture were never mentioned spontaneously as personal reason, and only occasionally as a presumed general reason for migration, but were frequently confirmed as a major problem in the village. Thus, although such problems existed, they seemed not a major driver of rural-urban migration. For most of the respondents their migration resulted in a profound change of livelihoods and significantly improved their socio-economic situation. Land and forest cover around the chosen villages fluctuated by up to 15% with a trend to increasing forest cover in recent years. At the district and state scales, forest cover was rather stable. These results question the narrative of deforestation and environmental degradation in the Himalayas as major push-factors for rural-urban migration in Uttarakhand. Even if environmental constraints were felt, it was rather the differences in socio-economic opportunities (education, employment, facilities) that drove people to migrate to the city. Regarding the push-pull paradigm, we conclude that scenarios of external conditions under which people migrate cannot be evaluated without taking the migrants' attitudes and choices into account.	[Hoffmann, Ellen M.; Konerding, Verena; Buerkert, Andreas] Univ Kassel, Organ Agr Sci, Organ Plant Prod & Agroecosyst Res Trop & Subtrop, Witzenhausen, Germany; [Nautiyal, Sunil] ISEC, Ctr Ecol Econ & Nat Resources, Bangalore, Karnataka, India	Universitat Kassel	Hoffmann, EM (corresponding author), Univ Kassel, Organ Agr Sci, Organ Plant Prod & Agroecosyst Res Trop & Subtrop, Witzenhausen, Germany.	ellen.hoffmann@uni-kassel.de	Nautiyal, Sunil/AAQ-5585-2020; Nautiyal, Sunil/I-7029-2012; Nautiyal, Sunil/AAJ-1554-2020	Nautiyal, Sunil/0000-0002-1481-7754; 	German Research Foundation (DFG) [FOR2432, BU 1308/14-1]; International Centre for Development and Decent Work (ICDD) - Deutscher Akademischer Austauschdienst (DAAD), under the EXCEED initiative	German Research Foundation (DFG)(German Research Foundation (DFG)); International Centre for Development and Decent Work (ICDD) - Deutscher Akademischer Austauschdienst (DAAD), under the EXCEED initiative	This study was conducted in association to the Research unit "Social-Ecological Systems in the Indian Rural-Urban Interface: Functions, Scales, and Dynamics of Transition (FOR2432)" funded by the German Research Foundation (DFG; http://www.dfg.de/), grant number BU 1308/14-1 to AB, EMH, and VK. Supplementary funding was provided to SN by the International Centre for Development and Decent Work (ICDD; https://www.uni-kassel.de/einrichtungen/international-center-for-development-and-decent-work-icdd/home.html) funded by the Deutscher Akademischer Austauschdienst (DAAD), under the EXCEED initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal J, 1995, PRESENT FUTURE; Angel S., 2005, DYNAMICS GLOBAL URBA; [Anonymous], 2005, EC HUM WELL BEING SY; Bilsborrow R.E., 2002, MIGRATION POPULATION, V8, P69, DOI DOI 10.1080/14672715.2011.537850; BILSBORROW RE, 1992, EUR J POPUL, V8, P125, DOI 10.1007/BF01797549; Black R., 1998, REFUGEES ENV DEV; Chandrasekhar S., 2014, WP2014016 I GANDH I; CRAWFORD TJ, 1973, REPRESENT R SOC PSYC, V4, P53; Cumming GS, 2014, NATURE, V515, P50, DOI 10.1038/nature13945; d'Amour CB, 2017, P NATL ACAD SCI USA, V114, P8939, DOI 10.1073/pnas.1606036114; de Weerdt J, 2013, 6429 WORLD BANK; Denis E, 2014, 124 CTR LAT DES RUR; DORIGO G, 1983, ANN ASSOC AM GEOGR, V73, P1, DOI 10.1111/j.1467-8306.1983.tb01392.x; Dutta D., 2015, REMOTE SENSING APPL, V1, P98, DOI [10.1016/j.rsase.2015.07.001, DOI 10.1016/J.RSASE.2015.07.001]; Elmqvist T, 2013, 2013 URBANISATION BI, P13, DOI [10.1007/978-94-007-7088-1_1, DOI 10.1007/978-94-007-7088-1_1]; Glaeser E, 2017, J URBAN ECON, V98, P1, DOI 10.1016/j.jue.2017.01.003; Government of India, 2014, CENS OF IND 2011; Government of India Ministry of Environment, FOR SURV IND; Guha Ramachandra, 2000, UNQUIET WOODS ECOLOG; Hagen-Zanker J., 2008, 2008WP002 MAASTR GRA; Haigh M., 2012, MANAGEMENT MOUNTAIN, P218, DOI [10.1007/978-94-007-2476-1_18, DOI 10.1007/978-94-007-2476-1_18, DOI 10.1007/978-94-007-2476-1-18]; HARRIS JR, 1970, AM ECON REV, V60, P126; Hnatkovska V, 2015, WORLD BANK ECON REV, V29, pS257, DOI 10.1093/wber/lhv025; India LEAD, 2007, VAL EC SERV FOR GOV; Jain Anmol, 2010, LABOUR MIGRATION REM; Jedwab R, 2014, WORKING PAPER; Kandpal S. D., 2018, National Journal of Community Medicine, V9, P463; Krecek J., 2012, MANAGEMENT MOUNTAIN; LEE ES, 1966, DEMOGRAPHY, V3, P47, DOI 10.2307/2060063; Lewis W.A., 1954, MANCHESTER SCH EC SO, V22, P139, DOI DOI 10.1111/J.1467-9957.1954.TB00021.X; MABOGUNJE AL, 1970, GEOGR ANAL, V2, P1, DOI 10.1111/j.1538-4632.1970.tb00140.x; Mamgain R.P., 2015, OUTMIGRATION HILL RE; MASSEY DS, 1990, POPUL INDEX, V56, P3, DOI 10.2307/3644186; Parece T., 2017, REMOTE SENSING ARCMA; Pares-Ramos IK, 2008, ECOL SOC, V13; Piore M. J., 1979, BIRDS PASSAGE MIGRAN; Rais M, 2009, J SUSTAIN AGR, V33, P319, DOI 10.1080/10440040902773152; Ravenstein E.G., 1885, J STAT SOC LONDON, V48, P167; RHODA R, 1983, INT MIGR REV, V17, P34, DOI 10.2307/2545923; Satendra A.K, 2015, UTTARAKHAND DISASTER; Sati VP, 2016, ANN NATURAL SCI, V2, P26; Seto KC, 2013, 2013 URBANISATION BI, DOI [10.1007/978-94-007-7088-1_1, DOI 10.1007/978-94-007-7088-1_1]; Singh PV, 2017, SCHOLARLY RES J INTE, V4, P8608, DOI [10.21922/Srjis.V4i37.10824, DOI 10.21922/SRJIS.V4I37.10824, 10.21922/srjis.v4i37.10824]; Sridhar Kala Seetharam, 2016, 607 ADBI; Sridhar KS, 2010, 1004 S AF NETW EC RE; Stewart JQ, 1948, SOCIOMETRY, V11, P31, DOI 10.2307/2785468; Tacoli C, 1998, ENVIRON URBAN, V10, P147, DOI 10.1177/095624789801000105; The World Bank, 2013, GLOB MON REP 2013 RU, DOI DOI 10.1596/9780821398067_CH02; van der Land V., 2015, THESIS; Vinayakam K., 2013, J HUMANITIES SOCIAL, V6, P32; Wolpert J, 1965, PAPERS REGIONAL SCI, V15, P159, DOI DOI 10.1007/BF01947871; Worldwatch Institute, 1991, STATE WORLD REP 1991; Worldwatch Institute, 1989, STAT WORLD REP 1989	53	22	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214511	10.1371/journal.pone.0214511	http://dx.doi.org/10.1371/journal.pone.0214511			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939153	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900029
J	Zhang, YS; Zhou, NN; Knoll, BM; Samra, S; Ward, MR; Weintraub, S; Fawzi, AA				Zhang, Yi Stephanie; Zhou, Nina; Knoll, Brianna Marie; Samra, Sahej; Ward, Mallory R.; Weintraub, Sandra; Fawzi, Amani A.			Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer's Disease on optical coherence tomography angiography	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; AXIAL LENGTH; RECOMMENDATIONS; DEMENTIA; AGE; THICKNESS; BATTERY; VERSION	Purpose Patients with Alzheimer's Disease (AD) exhibit decreased retinal blood flow and vessel density (VD). However, it is not known whether these changes are also present in individuals with early AD (eAD) or amnestic type mild cognitive impairment (aMCI), an enriched pre-AD population with a higher risk for progressing to dementia. We performed a prospective case control clinical study to investigate whether optical coherence tomography angiography (OCTA) parameters in the macula and disc are altered in those with aMCI and eAD. Methods This is a single center study of 32 participants. Individuals with aMCl/eAD (n = 16) were 1:1 matched to cognitively normal controls (n = 16). We evaluated OCTA images of the parafoveal superficial capillary plexus (SCP) and two vascular layers in the peripapillary region, the radial peripapillary capillary (RPC) and superficial vascular complex (SVC). Outcome vascular and structural parameters included VD, vessel length density (VLD), adjusted flow index (AFI) and structural retinal nerve fiber layer (RNFL) thickness. We compared these parameters between the two groups and examined the correlation between OCTA parameters and cognitive performance on the Montreal Cognitive Assessment (MoCA). Results Cognitively impaired participants demonstrated statistically significant decrease in parafoveal SCP VD and AFI as compared to controls, but no statistically significant difference in peripapillary parameters. Furthermore, we found a significant positive correlation between MoCA scores for the entire study cohort and both the parafoveal SCP VD and peripapillary RPC VLD. Conclusion OCTA shows significant decline in parafoveal flow and VD in individuals with early cognitive impairment related to AD, suggesting that these parameters could have potential utility as early disease biomarkers. In contrast, the presence of larger vascular channels in the peripapillary region may have obscured subtle capillary changes in that region. Overall, the correlation between vascular OCTA parameters and cognitive performance supports further OCTA studies in this population.	[Zhang, Yi Stephanie; Zhou, Nina; Knoll, Brianna Marie; Samra, Sahej; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ward, Mallory R.; Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Mesulam Ctr Cognit Neurol, Chicago, IL 60611 USA; [Ward, Mallory R.; Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Alzheimers Dis Ctr, Chicago, IL 60611 USA; [Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558; Samra, Sahej/0000-0002-6037-3795; Knoll, Brianna/0000-0002-7569-1518	Illinois Society for the Prevention of Blindness; National Institutes of Health [DP3DK108248, NIA-AG13584]	Illinois Society for the Prevention of Blindness; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Illinois Society for the Prevention of Blindness (BMK) and National Institutes of Health [grant numbers DP3DK108248 (AAF), NIA-AG13584 (CNADC)]. Optovue Inc provided research instrument support with no involvement in research design, recruitment, or manuscript production.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; BELL MA, 1990, NEUROBIOL AGING, V11, P359, DOI 10.1016/0197-4580(90)90001-G; Blanks JC, 1996, NEUROBIOL AGING, V17, P377, DOI 10.1016/0197-4580(96)00010-3; Bulut M, 2018, BRIT J OPHTHALMOL, V102, P233, DOI 10.1136/bjophthalmol-2017-310476; Campbell JP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42201; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Cheung CYL, 2014, ALZHEIMERS DEMENT, V10, P135, DOI 10.1016/j.jalz.2013.06.009; Chu ZD, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.066008; Coppola G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134750; Curcio CA, 2018, JAMA OPHTHALMOL, V136, P1249, DOI 10.1001/jamaophthalmol.2018.3569; Feke Gilbert T, 2015, Alzheimers Dement (Amst), V1, P144, DOI 10.1016/j.dadm.2015.01.004; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; Frost S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.150; Gold DA, 2012, J CLIN EXP NEUROPSYC, V34, P11, DOI 10.1080/13803395.2011.614598; Handels RLH, 2017, J ALZHEIMERS DIS, V60, P1477, DOI 10.3233/JAD-170324; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2017, INVEST OPHTH VIS SCI, V58, P5188, DOI 10.1167/iovs.17-22593; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Jiang H, 2018, J NEURO-OPHTHALMOL, V38, P292, DOI 10.1097/WNO.0000000000000580; Jiang H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192154; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Johnson N, 2004, ALZ DIS ASSOC DIS, V18, P223; Kashani AH, 2017, PROG RETIN EYE RES, V60, P66, DOI 10.1016/j.preteyeres.2017.07.002; Kim SYH, 2002, AM J GERIAT PSYCHIAT, V10, P151, DOI 10.1176/appi.ajgp.10.2.151; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; Knoll Brianna, 2016, Alzheimers Dement (Amst), V4, P85; Koronyo Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93621; Lad EM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192646; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Lim JS, 2017, J NEUROL SCI, V373, P285, DOI 10.1016/j.jns.2017.01.001; Linderman RE, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.5.20; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Monsell SE, 2016, ALZ DIS ASSOC DIS, V30, P134, DOI 10.1097/WAD.0000000000000111; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelis P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26475-5; Nesper PL, 2018, INVEST OPHTH VIS SCI, V59, P3858, DOI 10.1167/iovs.18-24710; O'Bryhim BE, 2018, JAMA OPHTHALMOL, V136, P1242, DOI 10.1001/jamaophthalmol.2018.3556; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Park JJ, 2016, RETINA-J RET VIT DIS, V36, P2039, DOI 10.1097/IAE.0000000000001077; Phansalkar N., 2011, P INT C COMMUN SIGNA, P218, DOI DOI 10.1109/ICCSP.2011.5739305; Prince M, 2011, WORLD ALZHEIMER REPO; Roberts PK, 2017, INVEST OPHTH VIS SCI, V58; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sampson DM, 2017, INVEST OPHTH VIS SCI, V58, P3065, DOI 10.1167/iovs.17-21551; Scripsema Nicole K, 2016, Invest Ophthalmol Vis Sci, V57, pOCT611, DOI 10.1167/iovs.15-18945; Sharma N, 2016, J CLIN DIAGN RES, V10, pKE1, DOI 10.7860/JCDR/2016/18828.8166; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tan CS, 2016, INVEST OPHTH VIS SCI, V57, pOCT224, DOI 10.1167/iovs.15-18869; Tang FY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02767-0; Thomson Kelsey L, 2015, Alzheimers Dement (Amst), V1, P136, DOI 10.1016/j.dadm.2015.03.001; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Wei YT, 2017, INVEST OPHTH VIS SCI, V58, P3804, DOI 10.1167/iovs.17-21460; Weintraub S, 2018, ALZ DIS ASSOC DIS, V32, P10, DOI 10.1097/WAD.0000000000000223; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Zhu L, 2018, J GLAUCOMA, V27, P322, DOI 10.1097/IJG.0000000000000900; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	63	65	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214685	10.1371/journal.pone.0214685	http://dx.doi.org/10.1371/journal.pone.0214685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939178	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900036
J	Dormann, D				Dormann, Dirk			IntensityCheck - The light measuring app for microscope performance checks and consistent fluorescence imaging	PLOS ONE			English	Article							SLIDE-BASED SYSTEMS; CONFOCAL MICROSCOPY; QUALITY ASSESSMENT	Quantitative fluorescence imaging is an essential tool in biomedical research. It requires consistent and repeatable conditions such as constant sample illumination. Even on a confocal microscope this can usually only be achieved by using an external laser power meter. By combining low-cost wireless Arduino based light sensors with an easy to use Android smartphone app we provide microscope users with a simple but powerful tool to maintain sample illumination for quantitative imaging, for tracking the intensity, stability and alignment of the light sources and for comparing microscope performance.	[Dormann, Dirk] Imperial Coll London, MRC London Inst Med Sci, Microscopy Facil, Fac Med, London, England	Imperial College London	Dormann, D (corresponding author), Imperial Coll London, MRC London Inst Med Sci, Microscopy Facil, Fac Med, London, England.	dirk.dormann@lms.mrc.ac.uk						Amos WB, 2003, BIOL CELL, V95, P335, DOI 10.1016/S0248-4900(03)00078-9; Cho EH, 2006, J MICROSC-OXFORD, V223, P15, DOI 10.1111/j.1365-2818.2006.01598.x; Deagle RC, 2017, INT J BIOCHEM CELL B, V89, P120, DOI 10.1016/j.biocel.2017.06.008; Garsha K, 2008, QUANTITATIVE FLUORES; Hng KI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079879; Jonkman J, 2014, METHOD CELL BIOL, V123, P113, DOI 10.1016/B978-0-12-420138-5.00007-0; Russ J.C., 1994, IMAGE PROCESSING HDB; Swedlow JR, 2013, METHOD CELL BIOL, V114, P407, DOI 10.1016/B978-0-12-407761-4.00017-8; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Zucker RM, 2010, EVALUATION PURCHASE; Zucker RM, 2006, CYTOM PART A, V69A, P659, DOI 10.1002/cyto.a.20314; Zucker RM, 2006, CYTOM PART A, V69A, P677, DOI 10.1002/cyto.a.20313; Zucker RM, 2014, METHODS MOL BIOL, V1075, P321, DOI 10.1007/978-1-60761-847-8_17	13	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214659	10.1371/journal.pone.0214659	http://dx.doi.org/10.1371/journal.pone.0214659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921439	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000104
J	Malinowska, M; Miroslaw, B; Sikora, E; Ogonowski, J; Wojtkiewicz, AM; Szaleniec, M; Pasikowska-Piwko, M; Eris, I				Malinowska, Magdalena; Miroslaw, Barbara; Sikora, Elzbieta; Ogonowski, Jan; Wojtkiewicz, Agnieszka M.; Szaleniec, Maciej; Pasikowska-Piwko, Monika; Eris, Irena			New lupeol esters as active substances in the treatment of skin damage	PLOS ONE			English	Article							PREDICTION; DELIVERY; FILMS	The purpose of the research was to obtain new derivatives of natural triterpene lupeol and to evaluate their potential as active substances in the treatment of skin damage. Four new lupeol esters (propionate, succinate, isonicotinate and acetylsalicylate) and lupeol acetate were obtained using an eco-friendly synthesis method. In the esterification process, the commonly used hazardous reagents in this type of synthesis were replaced by safe ones. This unconventional, eco-friendly, method is particularly important because the compounds obtained are potentially active substances in skin care formulations. Even trace amounts of hazardous reagents can have a toxic effect on damaged or irritated tissues. The molecular structure of the esters were confirmed by H-1 NMR, C-13 NMR and IR spectroscopy methods. Their crystal structures were determined using XRD method. To complete the analysis of their characteristics, physicochemical properties (melting point, lipophilicity, water solubility) and biological activity of the lupeol derivatives were studied. Results of an irritant potential test, carried out on Reconstructed Human Epidermis (RHE), confirmed that the synthesized lupeol derivatives are not cytotoxic and they stimulate a process of human cell proliferation. The safety of use for tested compounds was determined in a cell viability test (cytotoxicity detection kit based on the measurement of lactate dehydrogenase activity) for keratinocytes and fibroblasts. The results obtained showed that the modification of lupeol structure improve its bioavailability and activity. All of the esters penetrate the stratum corneum and the upper layers of the dermis better than the maternal lupeol. Lupeol isonicotinate, acetate and propionate were the most effective compounds in a stimulation of the human skin cell proliferation process. This combination resulted in an increase in the concentration of cells of more than 30% in comparison to control samples. The results indicate that the chemical modification of lupeol allows to obtain promising active substances for treatment of skin damage, including thermal, chemical and radiation burns.	[Malinowska, Magdalena; Sikora, Elzbieta; Ogonowski, Jan] Cracow Univ Technol, Inst Organ Chem & Technol, Krakow, Poland; [Miroslaw, Barbara] Marie Curie Sklodowska Univ, Dept Crystallog, Fac Chem, Lublin, Poland; [Wojtkiewicz, Agnieszka M.; Szaleniec, Maciej] Polish Acad Sci, Jerzy Haber Inst Catalysis & Surface Chem, Krakow, Poland; [Pasikowska-Piwko, Monika; Eris, Irena] Dr Irena Eris Ctr Sci & Res, Piaseczno, Poland	Cracow University of Technology; Maria Curie-Sklodowska University; Polish Academy of Sciences; Jerzy Haber Institute of Catalysis & Surface Chemistry	Malinowska, M (corresponding author), Cracow Univ Technol, Inst Organ Chem & Technol, Krakow, Poland.	mmalinowska@chemia.pk.edu.pl	Wojtkiewicz, Agnieszka M./AAC-2246-2020; Miroslaw, Barbara/AAB-2775-2022; Miroslaw, Barbara/R-3859-2018; Szaleniec, Maciej/A-1198-2013	Miroslaw, Barbara/0000-0002-5765-4641; Szaleniec, Maciej/0000-0002-7650-9263; Malinowska, Magdalena Anna/0000-0001-9172-7341; Wojtkiewicz, Agnieszka Maria/0000-0001-7521-2233	European Regional Development Fund [POPW.01.03.00-06-009/11-00]	European Regional Development Fund(European Commission)	The research was carried out with the equipment purchased thanks to the financial support of the European Regional Development Fund in the framework of the Operational Program Development of Eastern Poland 2007-2013 (Contract No. POPW.01.03.00-06-009/11-00, Equipping the laboratories of the Faculties of Biology and Biotechnology, Mathematics, Physics and Informatics, and Chemistry for studies of biologically active substances and environmental samples). The calculations in Discovery Studio (BIOVIA) were supported by PL-Grid Infrastructure (AGH CYFRONET). Calculator Plugins of Chemicalize was used for structure property prediction and calculation 01.2019 https://chemicalize.com/developed by ChemAxon (http://www.chemaxon.com) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrem-Achremowicz J, 2007, THESIS; Agilent Technologies, 2014, CRYSALISPRO; [Anonymous], 2016, DISC STUD VERS 4 1; Bhandari P, 2014, BIOORG MED CHEM LETT, V24, P3596, DOI 10.1016/j.bmcl.2014.05.032; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; Bouwstra JA, 2010, OPEN DERMATOL J, V4, P10, DOI [10.2174/1874372201004010010, DOI 10.2174/1874372201004010010]; Chemsketch, 2015, CHEMSK; Chen QH, 2009, ULTRASON SONOCHEM, V16, P599, DOI 10.1016/j.ultsonch.2008.11.009; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Choy YB, 2011, PHARM RES-DORDR, V28, P943, DOI 10.1007/s11095-010-0292-6; Copp BR, 2007, NAT PROD REP, V24, P278, DOI 10.1039/b513520f; Correa RS, 2009, ACTA CRYSTALLOGR C, V65, pO97, DOI 10.1107/S0108270109004910; Csizmadia F, 1997, J PHARM SCI-US, V86, P865, DOI 10.1021/js960177k; Martins DCD, 2016, CATAL COMMUN, V86, P104, DOI 10.1016/j.catcom.2016.08.014; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Valencia-Gomez LE, 2016, INT J BIOL MACROMOL, V93, P1217, DOI 10.1016/j.ijbiomac.2016.09.083; Fontanay S, 2008, J ETHNOPHARMACOL, V120, P272, DOI 10.1016/j.jep.2008.09.001; Fotie J, 2006, J NAT PROD, V69, P62, DOI 10.1021/np050315y; Gong YH, 2004, ANTIVIR RES, V64, P127, DOI 10.1016/j.antiviral.2004.05.006; Hernandez-Vazquez L, 2010, IND CROP PROD, V31, P476, DOI 10.1016/j.indcrop.2010.01.009; Hooft RWW, 2008, J APPL CRYSTALLOGR, V41, P96, DOI 10.1107/S0021889807059870; Jain P. S., 2010, Asian Journal of Plant Sciences, V9, P163; Kandarova Helena, 2009, J Vis Exp, DOI 10.3791/1366; Khan MF, 2014, MED CHEM RES, V23, P4156, DOI 10.1007/s00044-014-0984-2; Khan PM, 2019, CHEMOSPHERE, V224, P470, DOI 10.1016/j.chemosphere.2019.02.147; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Msika P, 2014, U.S. Patent, Patent No. [US8747815 B2, 8747815, 8,747,815]; Mukhtar H, 2013, Patent No. [US 8618082 B2, 8618082]; Nanimi D, 2008, J AM ACAD DERMATOL, V58, pAB62; Parsons S, 2013, ACTA CRYSTALLOGR B, V69, P249, DOI 10.1107/S2052519213010014; Patel S, 2018, INT J BIOL MACROMOL, V107, P1888, DOI 10.1016/j.ijbiomac.2017.10.056; PreADME, 2004, BIOASSAY SCI VERS 1; Pyka A, 2005, CHROMATOGRAPHIA, V61, P37, DOI 10.1365/s10337-004-0468-5; Saleem M, 2009, CANCER LETT, V285, P109, DOI 10.1016/j.canlet.2009.04.033; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siddique HR, 2011, LIFE SCI, V88, P285, DOI 10.1016/j.lfs.2010.11.020; VASNEV VV, 1987, MAKROMOL CHEM, V188, P683; Wang WH, 2016, BIOMED PHARMACOTHER, V79, P231, DOI 10.1016/j.biopha.2016.02.010; Wang X, 2010, CHEM-BIOL INTERACT, V184, P328, DOI 10.1016/j.cbi.2010.01.034; WERTZ PW, 1985, J INVEST DERMATOL, V84, P410, DOI 10.1111/1523-1747.ep12265510; WILLIAMS AC, 1991, PHARM RES-DORDR, V8, P17, DOI 10.1023/A:1015813803205; World Health Organization (WHO), BURNS; Xu F, 2018, BIOMED PHARMACOTHER, V103, P198, DOI 10.1016/j.biopha.2018.04.019	43	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214216	10.1371/journal.pone.0214216	http://dx.doi.org/10.1371/journal.pone.0214216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921370	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000043
J	Shaffer, JG; Schieffelin, JS; Gbakie, M; Alhasan, F; Roberts, NB; Goba, A; Randazzo, J; Momoh, M; Moon, TD; Kanneh, L; Levy, DC; Podgorski, RM; Hartnett, JN; Boisen, ML; Branco, LM; Samuels, R; Grant, DS; Garry, RF				Shaffer, Jeffrey G.; Schieffelin, John S.; Gbakie, Michael; Alhasan, Foday; Roberts, Nicole B.; Goba, Augustine; Randazzo, Jessica; Momoh, Mambu; Moon, Troy D.; Kanneh, Lansana; Levy, Danielle C.; Podgorski, Rachel M.; Hartnett, Jessica N.; Boisen, Matt L.; Branco, Luis M.; Samuels, Robert; Grant, Donald S.; Garry, Robert F.		Viral Hemorrhagic Fever Consortium	A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges	PLOS ONE			English	Article							VIRUS-DISEASE; WEST-AFRICA; EBOLA; EPIDEMIOLOGY	Situated in southeastern Sierra Leone, Kenema Government Hospital (KGH) maintains one of the world's only Lassa fever isolation wards and was a strategic Ebola virus disease (EVD) treatment facility during the 2014 EVD outbreak. Since 2006, the Viral Hemorrhagic Fever Consortium (VHFC) has carried out research activities at KGH, capturing clinical and laboratory data for suspected cases of Lassa fever. Here we describe the approach, progress, and challenges in designing and maintaining a data capture and management system (DCMS) at KGH to assist infectious disease researchers in building and sustaining DCMS in low-resource environments. Results on screening patterns and case-fatality rates are provided to illustrate the context and scope of the DCMS covered in this study. A medical records system and DCMS was designed and implemented between 2010 and 2016 linking historical and prospective Lassa fever data sources across KGH Lassa fever units and its peripheral health units. Data were captured using a case report form (CRF) system, enzyme-linked immunosorbent assay (ELISA) plate readers, polymerase chain reaction (PCR) machines, blood chemistry analyzers, and data auditing procedures. Between 2008 and 2016, blood samples for 4,229 suspected Lassa fever cases were screened at KGH, ranging from 219 samples in 2008 to a peak of 760 samples in 2011. Lassa fever case-fatality rates before and following the Ebola outbreak were 65.5% (148/226) and 89.5% (17/19), respectively, suggesting that fewer, but more seriously ill subjects with Lassa fever presented to KGH following the 2014 EVD outbreak (p = .040). DCMS challenges included weak specificity of the Lassa fever suspected case definition, limited capture of patient survival outcome data, Internet costs, lapses in Internet connectivity, low bandwidth, equipment and software maintenance, lack of computer teaching laboratories, and workload fluctuations due to variable screening activity. DCMS are the backbone of international research efforts and additional literature is needed on the topic for establishing benchmarks and driving goal-based approaches for its advancement in developing countries.	[Shaffer, Jeffrey G.; Randazzo, Jessica] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Biostat & Data, New Orleans, LA 70118 USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Sect Pediat, Dept Pediat, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Sect Pediat, Dept Internal Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Sect Adult Infect Dis, Dept Pediat, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Sect Adult Infect Dis, Dept Internal Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Gbakie, Michael; Alhasan, Foday; Goba, Augustine; Momoh, Mambu; Kanneh, Lansana; Samuels, Robert; Grant, Donald S.] Kenema Govt Hosp, Viral Hemorrhag Fever Program, Kenema, Sierra Leone; [Gbakie, Michael; Alhasan, Foday; Goba, Augustine; Momoh, Mambu; Kanneh, Lansana; Samuels, Robert; Grant, Donald S.] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Roberts, Nicole B.; Levy, Danielle C.; Podgorski, Rachel M.; Hartnett, Jessica N.; Garry, Robert F.] Tulane Univ, Dept Microbiol & Immunol, New Orleans, LA 70118 USA; [Moon, Troy D.] Vanderbilt Univ, Inst Global Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA; [Boisen, Matt L.; Branco, Luis M.; Garry, Robert F.] Zalgen Labs LLC, Germantown, MD USA	Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; Kenema Government Hospital; Ministry of Health & Sanitation Sierra Leone; Tulane University; Vanderbilt University	Shaffer, JG (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Biostat & Data, New Orleans, LA 70118 USA.	jshaffer@tulane.edu		Moon, Troy/0000-0002-1637-829X; Garry, Robert/0000-0002-5683-3250	National Institute of Allergy and Infectious Diseases [1U19AI115589, AI067188, AI082119, AI2008031, AI2009061, AI104216, AI104621, P20GM103501, HHSN272200900018C, HHSN272200900049C, HHSN272201000022C, 5U19AI115589-02]; FOGARTY INTERNATIONAL CENTER [D43TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI135995, U19AI115589] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases grants/contracts 1U19AI115589, AI067188, AI082119, AI2008031, AI2009061, AI104216, AI104621, P20GM103501, HHSN272200900018C, HHSN272200900049C, HHSN272201000022C, and 5U19AI115589-02. The funder provided support in the form of salaries for authors [JGS, JSS, MG, FA, NBR, AG, JR, MM, TDM, LK, DCL, RMP, JNH, MLB, LMB, RS, DSG, RFG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are provided in the 'author contributions' section. The authors MLB, LMB, and RFG are current employees or affiliates of Zalgen Labs, LLC.	[Anonymous], 2018, AWOKO NEWSPAPER; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; BUCKLEY SM, 1970, AM J TROP MED HYG, V19, P680, DOI 10.4269/ajtmh.1970.19.680; Centers for Disease Control and Prevention, 2018, VIR HERM FEV VHFS AR; Central Intelligence Agency, 2018, WORLD FACTBOOK; Dawson J, 2011, STUD HEALTH TECHNOL, V164, P174, DOI 10.3233/978-1-60750-709-3-174; Enria DA, 2006, TROPICAL INFECT DIS, P734; Frieden TR, 2015, EMERG INFECT DIS, V21, P1897, DOI 10.3201/eid2111.150949; Goba A, 2016, J INFECT DIS, V214, pS110, DOI 10.1093/infdis/jiw239; Guthrie S, 2017, MICROSOFT DELIVER MI; Hayden EC, 2014, NATURE, V513, P474; Jazayeri D, 2015, STUD HEALTH TECHNOL, V216, P916, DOI 10.3233/978-1-61499-564-7-916; Kahn M, 2014, AUST ACAD RES LIBR, V45, P296, DOI 10.1080/00048623.2014.951910; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Kirigia JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-135; Magbity E, 2006, REPORT ASSESSMENT SI; Mamlin Burke W, 2006, AMIA Annu Symp Proc, P529; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; MCCORMICK JB, 1987, J INFECT DIS, V155, P445, DOI 10.1093/infdis/155.3.445; MONATH TP, 1974, AM J TROP MED HYG, V23, P1140, DOI 10.4269/ajtmh.1974.23.1140; MONATH TP, 1975, B WORLD HEALTH ORGAN, V52, P577; Network HM, 2006, COUNTR HLTH INF SYST; Nwagwu W, 2010, S AFR J LIBR INF, V76, P168, DOI 10.7553/76-2-79; Omollo R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003134; Owada K, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00163; Oza S, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7881; Prokscha S., 2012, PRACTICAL GUIDE CLIN; REDCap, 2018, MOB APP; Ridley M, 2015, IT NEWS AFRICA; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748; Vital Wave Consulting HIS, 2009, HLTH INFORM SYSTEMS; Washburn F, 2015, EBOLA VIRUS DIS OUTB; World Health Organization, 2018, STAT END EB OUTBR SI; World Health Organization, SIERR LEON LONG REC	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214284	10.1371/journal.pone.0214284	http://dx.doi.org/10.1371/journal.pone.0214284			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921383	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000049
J	Ravnsborg, T; Svaneklink, S; Andersen, LLT; Larsen, MR; Jensen, DM; Overgaard, M				Ravnsborg, Tina; Svaneklink, Sarah; Andersen, Lise Lotte T.; Larsen, Martin R.; Jensen, Dorte M.; Overgaard, Martin			First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; 1ST TRIMESTER; RISK; PREGNANCY; ADIPONECTIN; BIOMARKERS; WOMEN; PHOSPHOPROTEOME; PREECLAMPSIA; MASS	Background Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse outcomes including preeclampsia, caesarean section, macrosomia, neonatal morbidity and future development of type 2 diabetes in both mother and child. Current selective screening strategies rely on clinical risk factors such as age, family history of diabetes, macrosomia or GDM in a previous pregnancy, and they possess a relatively low specificity. Here we hypothesize that novel first trimester protein predictors of GDM can contribute to the current selective screening strategies for early and accurate prediction of GDM, thus allowing for timely interventions. Methods A proteomics discovery approach was applied to first trimester sera from obese (BMI >= 27 kg/m(2)) women (n = 60) in a nested case-control study design, utilizing tandem mass tag labelling and tandem mass spectrometry. A subset of the identified protein markers was further validated in a second set of serum samples (n = 210) and evaluated for their contribution as predictors of GDM in relation to the maternal risk factors, by use of logistic regression and receiver operating characteristic analysis. Results Serum proteomic profiling identified 25 proteins with significantly different levels between cases and controls. Three proteins; afamin, serum amyloid P-component and vitronectin could be further confirmed as predictors of GDM in a validation set. Vitronectin was shown to contribute significantly to the predictive power of the maternal risk factors, indicating it as a novel independent predictor of GDM. Conclusions Current selective screening strategies can potentially be improved by addition of protein predictors.	[Ravnsborg, Tina; Svaneklink, Sarah; Overgaard, Martin] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark; [Ravnsborg, Tina; Jensen, Dorte M.] Odense Univ Hosp, Danish Diabet Acad, Odense, Denmark; [Andersen, Lise Lotte T.; Jensen, Dorte M.] Odense Univ Hosp, Dept Obstet & Gynaecol, Odense, Denmark; [Larsen, Martin R.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Jensen, Dorte M.; Overgaard, Martin] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Jensen, Dorte M.] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [Jensen, Dorte M.] Odense Univ Hosp, Steno Diabet Ctr Odense, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Overgaard, M (corresponding author), Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark.; Overgaard, M (corresponding author), Univ Southern Denmark, Inst Clin Res, Odense, Denmark.	Martin.Overgaard@rsyd.dk	Jensen, Dorte Møller/T-6656-2019; Sánchez-Margalet, Victor/AAB-9986-2021	Jensen, Dorte Møller/0000-0002-3298-9824; Sánchez-Margalet, Victor/0000-0001-8638-8680; Ravnsborg, Tina/0000-0002-6376-621X; Overgaard, Martin/0000-0003-2277-590X	Danish Diabetes Academy - Novo Nordisk Foundation [PO0113]; Odense University Hospital Research Foundation [7-A212]	Danish Diabetes Academy - Novo Nordisk Foundation; Odense University Hospital Research Foundation	This work was supported by a post doc grant (PO0113) from the Danish Diabetes Academy (https://www.danishdiabetesacademy.dk/) supported by the Novo Nordisk Foundation to TR and DMJ and by a research grant (7-A212) from Odense University Hospital Research Foundation (http://www.ouh.dk/wm379761) to MO. The Villum Center for Bioanalytical Sciences at University of Southern Denmark is acknowledged for access to advanced LC-MS/MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhalima K, 2016, EUR J OBSTET GYN R B, V201, P192, DOI 10.1016/j.ejogrb.2016.04.002; Caglar GS, 2012, J OBSTET GYNAECOL RE, V38, P1286, DOI 10.1111/j.1447-0756.2012.01870.x; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Coustan DR, 2013, CLIN CHEM, V59, P1310, DOI 10.1373/clinchem.2013.203331; Ekmekci OB, 2015, ARCH GYNECOL OBSTET, V292, P53, DOI 10.1007/s00404-014-3601-1; Georgiou HM, 2008, ACTA DIABETOL, V45, P157, DOI 10.1007/s00592-008-0037-8; Iliodromiti S, 2016, DIABETOLOGIA, V59, P692, DOI 10.1007/s00125-015-3855-6; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P1383, DOI 10.1067/S0002-9378(03)00601-X; Jensen DM, 2003, DIABETIC MED, V20, P51, DOI 10.1046/j.1464-5491.2003.00857.x; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kolialexi A, 2017, EXPERT REV PROTEOMIC, V14, P269, DOI 10.1080/14789450.2017.1291345; Lacroix M, 2013, DIABETES CARE, V36, P1577, DOI 10.2337/dc12-1731; Lamain-de Ruiter M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4338; Liao Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012232; LIND T, 1991, DIABETES, V40, P8, DOI 10.2337/diab.40.2.S8; Lindsay RS, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0925-2; Maged AM, 2014, J MATERN-FETAL NEO M, V27, P1108, DOI 10.3109/14767058.2013.850489; McIntyre HD, 2018, DIABETES CARE, V41, P1339, DOI 10.2337/dc17-2393; McNulty DE, 2008, MOL CELL PROTEOMICS, V7, P971, DOI 10.1074/mcp.M700543-MCP200; Melo-Braga MN, 2014, MOL CELL PROTEOMICS, V13, P311, DOI 10.1074/mcp.M112.026898; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Nanda S, 2011, PRENATAL DIAG, V31, P135, DOI 10.1002/pd.2636; Overgaard M, 2015, PROTEOM CLIN APPL, V9, P767, DOI 10.1002/prca.201400070; Ovesen PG, 2015, J MATERN-FETAL NEO M, V28, P1720, DOI 10.3109/14767058.2014.966677; Powe CE, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0834-y; Qiu CF, 2004, PAEDIATR PERINAT EP, V18, P377, DOI 10.1111/j.1365-3016.2004.00578.x; Ravnsborg T, 2016, DIABETOLOGIA, V59, P970, DOI 10.1007/s00125-016-3869-8; Savvidou M, 2010, DIABETES, V59, P3017, DOI 10.2337/db10-0688; Smirnakis KV, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.011; Thadhani R, 2003, AM J OBSTET GYNECOL, V189, P171, DOI 10.1067/mob.2003.343; Theriault S, 2016, CLIN CHEM LAB MED, V54, P509, DOI 10.1515/cclm-2015-0537; Tramontana A, 2018, PLACENTA, V62, P9, DOI 10.1016/j.placenta.2017.12.014; Tramontana A, 2018, CLIN CHIM ACTA, V476, P160, DOI 10.1016/j.cca.2017.11.031; WHO, 2013, DIAGN CRIT CLASS HYP; Worda C, 2004, AM J OBSTET GYNECOL, V191, P2120, DOI 10.1016/j.ajog.2004.04.038; Zhao DQ, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201600152	37	20	20	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214457	10.1371/journal.pone.0214457	http://dx.doi.org/10.1371/journal.pone.0214457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917176	Green Published, Green Submitted, gold			2022-12-27	WOS:000462465800067
J	Glei, DA; Goldman, N; Weinstein, M				Glei, Dana A.; Goldman, Noreen; Weinstein, Maxine			A growing socioeconomic divide: Effects of the Great Recession on perceived economic distress in the United States	PLOS ONE			English	Article							LIFE EXPECTANCY; MULTIPLE IMPUTATION; PROSPECT-THEORY; US COUNTIES; MORTALITY; TRENDS; INEQUALITIES; DISPARITIES; STRAIN	We demonstrate widening socioeconomic disparities in perceived economic distress among Americans, characterized by increasing distress at the bottom and improved perceptions at the top of the socioeconomic ladder. We then assess the extent to which hardships related to the Great Recession account for the growing social disparity in economic distress. Based on the concept of loss aversion, we also test whether the psychological pain associated with a financial loss is greater than the perceived benefit of an equivalent gain. Analyses are based on longitudinal survey data from the Midlife Development in the US study. Results suggest that widening social disparities in perceived economic distress between the mid-2000s and mid-2010s are explained in part by differential exposure to hardships related to the Great Recession, the effects of which have lingered even four to five years after the recession officially ended. Yet, auxiliary analyses show that the socioeconomic disparities in economic distress widened by nearly as much (if not more) during the period from 1995-96 to 2004-05 as they did during the period in which the recession occurred, which suggests that the factors driving these trends may have already been in motion prior to the recession. Consistent with the loss aversion hypothesis, perceptions of financial strain appear to be somewhat more strongly affected by losses in income/assets than by gains, but the magnitude of the differentials are small and the results are not robust. Our findings paint a dismal portrait of a growing socioeconomic divide in economic distress throughout the period from the mid-1990s to the mid-2010s, although we cannot say whether these trends afflict all regions of the US equally. Spatial analysis of aggregate-level mortality and objective economic indicators could provide indirect evidence, but ultimately economic "despair" must be measured subjectively by asking people how they perceive their financial situations.	[Glei, Dana A.; Weinstein, Maxine] Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA; [Goldman, Noreen] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA	Georgetown University; Princeton University	Glei, DA (corresponding author), Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA.	dag77@georgetown.edu		Glei, Dana/0000-0002-2865-9355; Goldman, Noreen/0000-0003-2865-9491	National Institute on Aging [P01 AG020166, U19AG051426]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P2CHD047879]; Graduate School of Arts and Sciences, Georgetown University; Russell Sage Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG051426] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Graduate School of Arts and Sciences, Georgetown University; Russell Sage Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging [https://www.nia.nih.gov/, grant numbers P01 AG020166 & U19AG051426 to Carol D. Ryff]; the Eunice Kennedy Shriver National Institute of Child Health and Human Development [https://www.nichd.nih.gov/, grant number P2CHD047879], and the Graduate School of Arts and Sciences, Georgetown University [https://grad.georgetown.edu/].Noreen Goldman would like to thank the Russell Sage Foundation for their support while she was a Visiting Scholar in 2018-2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J BEHAV STUDIES BUSI; Arias E., 2018, US SMALL AREA LIFE E; Bricker J., 2011, DROWNING WEATHERING; Brim O.G., 2016, NATL SURVEY MIDLIFE, DOI 10.3886/ICPSR02760.v11; Brim OG, 1995, ICPSR02760 V11, DOI [10.3886/ICPSR02760.v11.2016, DOI 10.3886/ICPSR02760.V11.2016]; Bureau of Labor Statistics, LAB FORC STAT CURR P; Case A., DEATHS DESPAIR ARE K; Case A, 2017, MORTALITY MORBIDITY; Cherlin AJ, 2018, P NATL ACAD SCI USA, V115, P7176, DOI 10.1073/pnas.1808753115; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Deaton A., 2017, HEARING; Duque V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192370; Dwyer-Lindgren L, 2018, JAMA-J AM MED ASSOC, V319, P1013, DOI 10.1001/jama.2018.0900; Dwyer-Lindgren L, 2017, JAMA INTERN MED, V177, P1003, DOI 10.1001/jamainternmed.2017.0918; Elo I, POPUL DEV REV; Engemann KM, 2010, FED RESERVE BANK ST, V92, P1; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Glei DA, 2018, POPUL DEV REV, V44, P695, DOI 10.1111/padr.12183; Goldman N, 2018, P NATL ACAD SCI USA, V115, P7290, DOI 10.1073/pnas.1722023115; Grusky DB, 2011, GREAT RECESSION, P1; Hipple SF, 2010, MON LABOR REV, V133, P3; Hoynes H, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.3.27; Hurd M. D., 2010, EFFECTS FINANCIAL CR; Jeanne Leininger L, 2014, J MARRIAGE FAM, V76, P998, DOI 10.1111/jomf.12140; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Khazan O., MIDDLE AGED WHITE AM; Kochanek K., 2017, 293 NCHS; Masters RK, 2018, INT J EPIDEMIOL, V47, P81, DOI 10.1093/ije/dyx127; Monnat SM, 2018, AM J PREV MED, V54, P611, DOI 10.1016/j.amepre.2018.01.040; Monnat SM, 2017, J RURAL STUD, V55, P227, DOI 10.1016/j.jrurstud.2017.08.010; Monnat Shannon. M., 2017, DEATHS DESPAIR CITIE, pApril,; Monnat SM, 2016, DEATHS DESPAIR SUPPO; Montez JK, 2016, SSM-POPUL HLTH, V2, P561, DOI 10.1016/j.ssmph.2016.07.004; Muennig PA, 2018, AM J PUBLIC HEALTH, V25, pe1; Murphy SL, 2018, MORTALITY US 2017; Ruhm C.J., 2018, DEATHS DESPAIR DRUG; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Song J, 2018, GERONTOLOGIST, V58, P448, DOI 10.1093/geront/gnw269; Taylor P., 2010, ONE RECESSION 2 AM T; Taylor Paul, 2010, BALANCE SHEET 30 MON; The World Bank, GDP GROWTH RAT; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Van Dam A, 2018, WASHINGTON POST; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; Wilkinson LR, 2016, J GERONTOL B-PSYCHOL, V71, P745, DOI 10.1093/geronb/gbw001; Wolf J. M., 2017, THESIS; Xu J.Q., 2016, MORTALITY US 2015	49	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214947	10.1371/journal.pone.0214947	http://dx.doi.org/10.1371/journal.pone.0214947			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947252	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500090
J	Ko, RE; Lee, H; Jung, JH; Lee, HO; Sohn, I; Yoo, H; Ko, JY; Suh, GY; Chung, CR				Ko, Ryoung-Eun; Lee, Hyun; Jung, Jin Hee; Lee, Hee Og; Sohn, Insuk; Yoo, Heejin; Ko, Jin Yeong; Suh, Gee Young; Chung, Chi Ryang			Simple functional assessment at hospital discharge can predict long-term outcomes of ICU survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; CRITICALLY-ILL PATIENTS; CRITICAL ILLNESS; MORTALITY; REHABILITATION; FEASIBILITY; DISABILITY	Recent studies showed that physical and/or neuropsychiatric impairments significantly affect long-term mortality of ICU survivors. We conducted this study to investigate that simplified measurement of physical function and level of consciousness at hospital discharge by attending nurses could predict long-term outcomes after hospital discharge. A retrospective analysis of prospectively and retrospectively collected data of 246 patients who received medical ICU treatment was conducted. We grouped patients according to physical function and level of consciousness measured by the simplified method at hospital discharge as follow; group A included patients with alert mental and capable of walking or moving by wheel chairs; group B included those with alert mental and bed-ridden status; and Group C included those with confused mental and bed-ridden status. The two-year survival rate after hospital discharge was compared. Of 246 patients, 157 patients were included in the analysis and there were 103 survivors after two-year follow up. Compared to non-survivors, survivors were more likely to be younger (P= 0.026) and have higher body mass index (P= 0.019) and no malignant disease (P= 0.001). There were no statistically significant differences in treatment modalities including medication, use of medical devices, and physical therapy between the survivors and non-survivors. The analysis showed significant differences in survival between the groups classified by physical function (P < 0.001) and level of consciousness (P < 0.01). Multivariate analysis showed that survival rate was significantly lower among the patients in group C than in those in group B or group A (P < 0.001). Simplified method to assess physical function and level of consciousness at hospital discharge can predict long-term outcomes of medical ICU survivors.	[Ko, Ryoung-Eun; Suh, Gee Young; Chung, Chi Ryang] Sungkyunkwan Univ, Samsung Med Ctr, Dept Crit Care Med, Sch Med, Seoul, South Korea; [Lee, Hyun] Hanyang Univ, Coll Med, Div Pulm Med & Allergy, Dept Internal Med, Seoul, South Korea; [Jung, Jin Hee; Lee, Hee Og] Samsung Med Ctr, Dept Nursing, Adv Practice Nurse, Seoul, South Korea; [Sohn, Insuk; Yoo, Heejin] Samsung Med Ctr, Stat & Data Ctr, Seoul, South Korea; [Ko, Jin Yeong] Samsung Med Ctr, Dept Pharmaceut Serv, Seoul, South Korea; [Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Div Pulmonol & Crit Care Med, Dept Med,Samsung Med Ctr, Seoul, South Korea; [Chung, Chi Ryang] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Chung, CR (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Crit Care Med, Sch Med, Seoul, South Korea.; Chung, CR (corresponding author), Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.	ccrzzang@gmail.com	; Lee, Hyun/G-1336-2018	Chung, Chi Ryang/0000-0003-1830-307X; Lee, Hyun/0000-0002-1269-0913	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C0743]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) (https://www.khidi.or.kr/eps), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C0743 to CR Chung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, Clin Pharm, V9, P601; Baldwin MR, 2014, J CRIT CARE, V29, P401, DOI 10.1016/j.jcrc.2013.12.019; Brinkman S, 2013, CRIT CARE MED, V41, P1229, DOI 10.1097/CCM.0b013e31827ca4e1; Brown SM, 2017, THORAX, V72, P1094, DOI 10.1136/thoraxjnl-2017-210337; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Du B, 2010, CRIT CARE, V14, DOI 10.1186/cc8222; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Hashem MD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1516-x; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Honselmann KC, 2015, J CRIT CARE, V30, P721, DOI 10.1016/j.jcrc.2015.03.009; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Lee H, 2015, J CRIT CARE, V30, P673, DOI 10.1016/j.jcrc.2015.04.012; Mitchell ML, 2018, AUST CRIT CARE, V31, P204, DOI 10.1016/j.aucc.2017.07.002; Neumeier A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1791-1; Parry SM, 2017, INTENS CARE MED, V43, P531, DOI 10.1007/s00134-017-4685-4; Rydingsward JE, 2016, CRIT CARE MED, V44, P869, DOI 10.1097/CCM.0000000000001627; Stevens RD, 2014, TXB POSTICU MED LEGA; Tipping CJ, 2017, INTENS CARE MED, V43, P171, DOI 10.1007/s00134-016-4612-0; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214602	10.1371/journal.pone.0214602	http://dx.doi.org/10.1371/journal.pone.0214602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947283	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500044
J	Sieg, T; Schinko, T; Vogel, K; Mechler, R; Merz, B; Kreibich, H				Sieg, Tobias; Schinko, Thomas; Vogel, Kristin; Mechler, Reinhard; Merz, Bruno; Kreibich, Heidi			Integrated assessment of short-term direct and indirect economic flood impacts including uncertainty quantification	PLOS ONE			English	Article							JUNE 2013; DAMAGE; MODEL; INOPERABILITY; DISASTERS; HAZARDS; LOSSES; COSTS	Understanding and quantifying total economic impacts of flood events is essential for flood risk management and adaptation planning. Yet, detailed estimations of joint direct and indirect flood-induced economic impacts are rare. In this study an innovative modeling procedure for the joint assessment of short-term direct and indirect economic flood impacts is introduced. The procedure is applied to 19 economic sectors in eight federal states of Germany after the flood events in 2013. The assessment of the direct economic impacts is object-based and considers uncertainties associated with the hazard, the exposed objects and their vulnerability. The direct economic impacts are then coupled to a supply-side Input-Output-Model to estimate the indirect economic impacts. The procedure provides distributions of direct and indirect economic impacts which capture the associated uncertainties. The distributions of the direct economic impacts in the federal states are plausible when compared to reported values. The ratio between indirect and direct economic impacts shows that the sectors Manufacturing, Financial and Insurance activities suffered the most from indirect economic impacts. These ratios also indicate that indirect economic impacts can be almost as high as direct economic impacts. They differ strongly between the economic sectors indicating that the application of a single factor as a proxy for the indirect impacts of all economic sectors is not appropriate.	[Sieg, Tobias; Merz, Bruno; Kreibich, Heidi] GFZ German Res Ctr Geosci, Sect Hydrol, Potsdam, Germany; [Sieg, Tobias; Vogel, Kristin; Merz, Bruno] Univ Potsdam, Inst Environm Sci & Geog, Karl Liebknecht Str 24-25, Potsdam, Germany; [Sieg, Tobias; Schinko, Thomas; Mechler, Reinhard] Int Inst Appl Syst Anal IIASA, Risk & Resilience RISK Program, Schlosspl 1, Laxenburg, Austria	Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Potsdam; International Institute for Applied Systems Analysis (IIASA)	Sieg, T (corresponding author), GFZ German Res Ctr Geosci, Sect Hydrol, Potsdam, Germany.; Sieg, T (corresponding author), Univ Potsdam, Inst Environm Sci & Geog, Karl Liebknecht Str 24-25, Potsdam, Germany.; Sieg, T (corresponding author), Int Inst Appl Syst Anal IIASA, Risk & Resilience RISK Program, Schlosspl 1, Laxenburg, Austria.	tsieg@gfz-potsdam.de	Vogel, Kristin/H-6055-2019; Kreibich, Heidi/G-9408-2012	Vogel, Kristin/0000-0002-3692-6492; Sieg, Tobias/0000-0003-3859-9082; /0000-0003-2239-1578; Kreibich, Heidi/0000-0001-6274-3625	Deutsche Forschungsgemeinschaft (DFG) [GRK 2043/1]; Potsdam-Institut fur Klimafolgenforschung PIK	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Potsdam-Institut fur Klimafolgenforschung PIK	TS and KV received funding from the Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/).The grant number is GRK 2043/1. TS received funding from the Potsdam-Institut fur Klimafolgenforschung PIK (https://www.pikpotsdam.de/) during the stay at International Institute for Applied Systems Analysis (IIASA) for the Young Scientists Summer Program (YSSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar A, 2016, J GLOB ECON ANAL, V1, P181, DOI 10.21642/JGEA.010103AF; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BULLARD CW, 1977, REV ECON STAT, V59, P75; Bundesministerium des Innern, 2013, BER FLUTK 2013 KAT E; Carrera L, 2015, ENVIRON MODELL SOFTW, V63, P109, DOI 10.1016/j.envsoft.2014.09.016; de Moel H, 2015, MITIG ADAPT STRAT GL, V20, P865, DOI 10.1007/s11027-015-9654-z; Dietzenbacher E, 1997, J REGIONAL SCI, V37, P629, DOI 10.1111/0022-4146.00073; Emschergenossenschaft Hydrotec, 2004, HOCHW AKT EMSCH KAP; Eurostat, 2008, STAT CLASS EC ACT EU, V2; Figueiredo R, 2018, NAT HAZARD EARTH SYS, V18, P1297, DOI 10.5194/nhess-18-1297-2018; Flores P., 2006, NAT HAZARDS REV, V7, P72, DOI [10.1061/(ASCE)1527-6988(2006)7:2(72), DOI 10.1061/(ASCE)1527-6988(2006)7:2(72)]; Gerl T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159791; GHOSH A, 1958, ECONOMICA, V25, P58, DOI 10.2307/2550694; Grigg N. S., 1975, WATER RESOURCES B, V11, P379, DOI [10.1111/j.1752-1688.1975.tb00689.x, DOI 10.1111/J.1752-1688.1975.TB00689.X]; Hallegatte S, 2008, RISK ANAL, V28, P779, DOI 10.1111/j.1539-6924.2008.01046.x; Haraguchi M, 2015, INT J DISAST RISK RE, V14, P256, DOI 10.1016/j.ijdrr.2014.09.005; Hiete M., 2009, P 6 INT ISCRAM C GOT; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Huttenlau M, 2010, NAT HAZARD EARTH SYS, V10, P2451, DOI 10.5194/nhess-10-2451-2010; Jongman B, 2012, NAT HAZARD EARTH SYS, V12, P3733, DOI 10.5194/nhess-12-3733-2012; Jonkman SN, 2008, ECOL ECON, V66, P77, DOI 10.1016/j.ecolecon.2007.12.022; Klijn F, 2015, MITIG ADAPT STRAT GL, V20, P845, DOI 10.1007/s11027-015-9638-z; Koks EE, 2015, RISK ANAL, V35, P882, DOI 10.1111/risa.12300; Koks E, 2018, NAT CLIM CHANGE, V8, P561, DOI 10.1038/s41558-018-0185-y; Kreibich H, 2005, FLOODS DEFENCE MANAG, P851; Kreibich H, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004691; Kreibich H, 2017, RISK ANAL, V37, P774, DOI 10.1111/risa.12650; Kreibich H, 2014, NAT CLIM CHANGE, V4, P303, DOI 10.1038/nclimate2182; Kreibich H, 2010, HYDROLOG SCI J, V55, P1302, DOI 10.1080/02626667.2010.529815; Lenzen M, 2010, ECON SYST RES, V22, P43, DOI 10.1080/09535311003661226; Leontief W, 1986, INPUT OUTPUT EC; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Merz B, 2013, NAT HAZARD EARTH SYS, V13, P53, DOI 10.5194/nhess-13-53-2013; Merz B, 2010, NAT HAZARD EARTH SYS, V10, P1697, DOI 10.5194/nhess-10-1697-2010; Merz B, 2014, HOUILLE BLANCHE, P5, DOI 10.1051/lhb/2014001; Meyer V, 2013, NAT HAZARD EARTH SYS, V13, P1351, DOI 10.5194/nhess-13-1351-2013; Miller R., 2009, INPUT OUTPUT ANAL FD; Mochizuki J, 2015, INT J DISAST RISK SC, V6, P321, DOI 10.1007/s13753-015-0069-y; MURL (Ministerium fur Umwelt Raumordnung und Landwirtschaft des Landes Nordrhein Westfalen), 2000, POT HOCHW RHEIN NRW; Nafari RH, 2016, INT J DISAST RISK RE, V17, P13, DOI 10.1016/j.ijdrr.2016.03.007; Nafari RH, 2016, WATER-SUI, V8, DOI 10.3390/w8070282; Okuyama Y, 2014, ECON SYST RES, V26, P1, DOI 10.1080/09535314.2013.871505; OOSTERHAVEN J, 1988, J REGIONAL SCI, V28, P203, DOI 10.1111/j.1467-9787.1988.tb01208.x; Oosterhaven J, 2017, ECON SYST RES, V29, P452, DOI 10.1080/09535314.2017.1301395; Penning-Rowsell E, 2005, BENEFITS LOOD COASTA; Pfurtscheller C, 2015, J FLOOD RISK MANAG, V8, P329, DOI 10.1111/jfr3.12102; Pradhan RP, 2017, REV FINANC ECON, V33, P12, DOI 10.1016/j.rfe.2017.02.002; Prahl BF, 2016, NAT HAZARD EARTH SYS, V16, P1189, DOI 10.5194/nhess-16-1189-2016; R Development Core Team, 2009, R LANG ENV STAT COMP; Rojas R, 2013, GLOBAL ENVIRON CHANG, V23, P1737, DOI 10.1016/j.gloenvcha.2013.08.006; Rose A, 2005, J REGIONAL SCI, V45, P75, DOI 10.1111/j.0022-4146.2005.00365.x; Rose A., 2004, MODELING SPATIAL EC, P119, DOI DOI 10.1007/978-3-540-24787-6_7; Saint-Geours N, 2015, J FLOOD RISK MANAG, V8, P161, DOI 10.1111/jfr3.12068; Santos JR, 2004, RISK ANAL, V24, P1437, DOI 10.1111/j.0272-4332.2004.00540.x; Schroter K, 2015, HYDROL EARTH SYST SC, V19, P309, DOI 10.5194/hess-19-309-2015; Schroter K, 2014, WATER RESOUR RES, V50, P3378, DOI 10.1002/2013WR014396; Seifert I, 2010, NAT HAZARDS, V52, P453, DOI 10.1007/s11069-009-9389-9; Sieg T, 2019, THESIS; Sieg T, 2017, WATER RESOUR RES, V53, P6050, DOI 10.1002/2017WR020784; SMITH DI, 1994, WATER SA, V20, P231; Standardi G, 2014, SUBNATIONAL VERSION, P1; Temursho U., 2017, HDB INPUT OUTPUT ANA, P407, DOI DOI 10.4337/9781783476329.00018; Thieken AH, 2008, WIT TRANS ECOL ENVIR, V118, P315, DOI 10.2495/FRIAR080301; Thieken AH, 2016, NAT HAZARD EARTH SYS, V16, P1519, DOI 10.5194/nhess-16-1519-2016; Vorogushyn S, 2018, WIRES WATER, V5, DOI 10.1002/wat2.1266; Wagenaar DJ, 2016, NAT HAZARD EARTH SYS, V16, P1, DOI 10.5194/nhess-16-1-2016; Ward PJ, 2011, NAT HAZARD EARTH SYS, V11, P3181, DOI 10.5194/nhess-11-3181-2011; Willner SN, 2018, NAT CLIM CHANGE, V8, P594, DOI 10.1038/s41558-018-0173-2; Yang LJ, 2016, NAT HAZARDS, V84, pS411, DOI 10.1007/s11069-016-2534-3	70	16	16	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0212932	10.1371/journal.pone.0212932	http://dx.doi.org/10.1371/journal.pone.0212932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947312	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000463314500010
J	Lourenco, EAJ; Shaw, L; Pratt, H; Duffy, GL; Czanner, G; Zheng, YL; Hamill, KJ; McCormick, AG				Lourenco, Elizabeth A. J.; Shaw, Liam; Pratt, Harry; Duffy, Georgia L.; Czanner, Gabriela; Zheng, Yalin; Hamill, Kevin J.; McCormick, Austin G.			Application of SPF moisturisers is inferior to sunscreens in coverage of facial and eyelid regions	PLOS ONE			English	Article							BASAL-CELL-CARCINOMA; VITAMIN-D; POPULATION	Many moisturisers contain sun protection factors (SPF) equivalent to those found in sunscreens. However, there is a lack of research into how SPF moisturiser application compares to sunscreens in terms of coverage achieved and protection afforded. Previously we demonstrated that users incompletely covered their eyelid regions during routine sunscreen application. Here, we aimed to determine if SPF moisturiser users also displayed these tendencies. A study population of 84 participants (22 males, 62 females, age 18-57) were exposed to UV radiation and photographed using a tripod mounted UV sensitive DSLR camera on two separate visits. At visit one, images were acquired before and after applying either SPF30 sunscreen or moisturiser, then at visit two the study was repeated with the other formulation. Images were processed for facial landmark identification followed by segmentation mapping of hue saturation values to identify areas of the face that were/were not covered. Analyses revealed that application of moisturiser was significantly worse than sunscreen in terms area of the whole face missed (11.1% missed with sunscreen compared to 16.6% for SPF moisturiser p<0.001 paired t-test). This difference was primarily due to decreased coverage of the eyelid regions (14.0% missed with sunscreen, 20.9% moisturiser, p<0.001). Analysis of a post-study questionnaire revealed participants to be unaware of their incomplete coverage. Secondary analyses revealed improved coverage in males (p = 0.05), and, with moisturiser only, in participants with darker skin tones (p = 0.02). Together these data indicate that, despite potential advantages in terms of increased frequency of application of moisturiser, the areas of the face that are at higher cancer risk are likely not being protected, and that participants are unaware that they are at risk. As such, alternative sun-protection strategies should be promoted.	[Lourenco, Elizabeth A. J.; Shaw, Liam; Pratt, Harry; Duffy, Georgia L.; Czanner, Gabriela; Zheng, Yalin; Hamill, Kevin J.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [Czanner, Gabriela] Liverpool John Moores Univ, Fac Engn & Technol, Dept Appl Math, Liverpool, Merseyside, England; [McCormick, Austin G.] Aintree Univ Teaching Hosp, Dept Ophthalmol, Liverpool, Merseyside, England	University of Liverpool; Liverpool John Moores University	Hamill, KJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England.	khamill@liverpool.ac.uk	Zheng, Yalin/N-6432-2017; Czanner, Gabriela/ABC-7569-2021; Hamill, Kevin/ABF-9727-2020	Zheng, Yalin/0000-0002-7873-0922; Czanner, Gabriela/0000-0002-1157-2093; Hamill, Kevin/0000-0002-7852-1944; Lourenco, Elizabeth/0000-0002-3409-301X; Duffy, Georgia/0000-0002-6272-0471				ABRAHAM JC, 1973, AM J SURG, V126, P492, DOI 10.1016/S0002-9610(73)80036-4; Cook BE, 2001, OPHTHALMOLOGY, V108, P12, DOI 10.1016/S0161-6420(00)00339-0; Cook BE, 2001, OPHTHALMOLOGY, V108, P2088, DOI 10.1016/S0161-6420(01)00796-5; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Economics R, 2016, UK MARK SHAR 2015 16; Egerton TA, 2012, INT J COSMETIC SCI, V34, P117, DOI 10.1111/j.1468-2494.2011.00689.x; Fabbrocini Gabriella, 2010, Cancers (Basel), V2, P1980, DOI 10.3390/cancers2041980; Frandsen Tenna Bloch, 2014, BMC Res Notes, V7, P528, DOI 10.1186/1756-0500-7-528; Ganesan P, 2014, HSV COLOR SPACE BASE; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Iuliano A, 2012, AM J OPHTHALMOL, V153, P238, DOI 10.1016/j.ajo.2011.08.004; Kwak MS, 2015, KOREA-AUST RHEOL J, V27, P241, DOI 10.1007/s13367-015-0024-x; MARGO CE, 1993, SURV OPHTHALMOL, V38, P169, DOI 10.1016/0039-6257(93)90100-L; Pratt H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185297; Raasch B, 1998, MUTAT RES-FUND MOL M, V422, P101, DOI 10.1016/S0027-5107(98)00194-8; Reportlinker, 2017, UK HLTH BEAUT MARK 2; Saleh GM, 2017, BRIT J OPHTHALMOL, V101, P209, DOI 10.1136/bjophthalmol-2015-308261; Samanek AJ, 2006, MED J AUSTRALIA, V184, P338, DOI 10.5694/j.1326-5377.2006.tb00267.x; Wawrzynski J, 2018, BRIT J OPHTHALMOLOGY	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212548	10.1371/journal.pone.0212548	http://dx.doi.org/10.1371/journal.pone.0212548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943192	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000463194300006
J	Li, Y; Tang, XP; Zhao, ZQ; Wang, H; Wang, X; Shang, XY; Liu, P; Kou, ZH; Jiang, YQ; Li, Y				Li, Yan; Tang, Xueping; Zhao, Zunquan; Wang, Hui; Wang, Xin; Shang, Xueyi; Liu, Peng; Kou, Zhihua; Jiang, Yongqiang; Li, Yan			Intranasal immunization with recombinant outer membrane protein A induces protective immune response against Stenotrophomonas maltophilia infection	PLOS ONE			English	Article							MUCOSAL IMMUNIZATION; VACCINE; MICE; CELLS; OMPA	Stenotrophomonas maltophilia (S. maltophilia), a multi-drug resistant opportunistic pathogen, is associated with nosocomial and community-acquired infections. Preventive and therapeutic strategies for such infections are greatly needed. In this study, sequence alignment analysis revealed that Outer membrane protein A (OmpA) was highly conserved among S. maltophilia strains but shared no significant similarity with human and mouse proteomes. In mice, intranasal immunization with S. maltophilia recombinant OmpA (rOmpA) without additional adjuvant induced sustained mucosal and systemic rOmpA-specific antibody responses. Treatment with rOmpA stimulated significantly higher levels of secretion of IFN., IL-2, and IL-17A (All P<0.05) from the primary splenocytes isolated from rOmpA-immunized mice than from the primary splenocytes isolated from PBS-immunized mice. Furthermore, mice immunized with rOmpA showed significantly reduced bacterial burden in the lung and reduced levels of pro-inflammatory cytokines (TNF-alpha and IL-6) in bronchoalveolar lavage fluid (BALF) 24 hours after intranasal S. maltophilia infection, indicating that immunization with rOmpA may have protective effects against S. maltophilia challenge in mice. Our findings suggest that intranasal immunization with rOmpA may induce mucosal and systemic immune responses in mice, trigger Th1- and Th17-mediated cellular immune responses, and thus stimulate host immune defense against S. maltophilia infection. These results also demonstrate that intranasal vaccination may offer an alternative approach to current strategies since it induces a mucosal as well as a systemic immune response.	[Li, Yan; Li, Yan] Anhui Med Univ, Hosp PLA 307, Hefei, Anhui, Peoples R China; [Li, Yan; Tang, Xueping; Wang, Xin; Shang, Xueyi; Li, Yan] 307 Hosp PLA, Dept Crit Care Med, Beijing, Peoples R China; [Li, Yan] Fengyang First Peoples Hosp, Dept Resp & Digest, Fengyang, Anhui, Peoples R China; [Zhao, Zunquan; Wang, Hui; Liu, Peng; Kou, Zhihua; Jiang, Yongqiang] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China	Anhui Medical University; Fifth Medical Center of Chinese PLA General Hospital; Academy of Military Medical Sciences - China	Li, Y (corresponding author), Anhui Med Univ, Hosp PLA 307, Hefei, Anhui, Peoples R China.; Li, Y (corresponding author), 307 Hosp PLA, Dept Crit Care Med, Beijing, Peoples R China.; Jiang, YQ (corresponding author), Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China.	liyanmdhuxi@163.com; jiangyq@nic.bmi.ac.cn	Shang, Xueyi/O-7478-2018; Zhao, Zunquan/AAA-2101-2020; Liu, Peng/V-9305-2019	Shang, XueYi/0000-0002-0818-2043	National Natural Science Foundation of China [81571959, 81071399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81571959, 81071399). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzunegui J, 2000, CLIN EXP RHEUMATOL, V18, P265; Bertot GM, 2007, INFECT IMMUN, V75, P2740, DOI 10.1128/IAI.01668-06; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Cha MK, 2016, DIAGN MICR INFEC DIS, V85, P210, DOI 10.1016/j.diagmicrobio.2016.02.020; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Chen YY, 2015, J MICROBIOL, V53, P535, DOI 10.1007/s12275-015-5202-5; Cho SY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0801-7; Correia CR, 2014, PEDIATR INT, V56, pE21, DOI 10.1111/ped.12352; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Cui ZY, 2015, APPL MICROBIOL BIOT, V99, P667, DOI 10.1007/s00253-014-6147-z; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; Dutzan N, 2017, IMMUNITY, V46, P133, DOI 10.1016/j.immuni.2016.12.010; Fan HY, 2014, CLIN VACCINE IMMUNOL, V21, P126, DOI 10.1128/CVI.00434-13; Guan QF, 2015, APPL MICROBIOL BIOT, V99, P5451, DOI 10.1007/s00253-014-6339-6; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; Iliev ID, 2017, NAT REV IMMUNOL, V17, P635, DOI 10.1038/nri.2017.55; Jahangiri A, 2017, MICROB PATHOGENESIS, V105, P201, DOI 10.1016/j.micpath.2017.02.028; Jeannin P, 2002, VACCINE, V20, pA23, DOI 10.1016/S0264-410X(02)00383-3; Khassawneh M, 2010, PEDIATR NEPHROL, V25, P1377, DOI 10.1007/s00467-010-1473-6; Kim DK, 2000, VACCINE, V19, P1274, DOI 10.1016/S0264-410X(00)00235-8; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Liu YS, 2014, INFECT IMMUN, V82, P1666, DOI 10.1128/IAI.01391-13; Liu ZZ, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0173-9; Lopez-Cardenas S, 2012, MED CLIN-BARCELONA, V138, P411, DOI 10.1016/j.medcli.2011.07.002; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052; Nicodemo AC, 2007, EUR J CLIN MICROBIOL, V26, P229, DOI 10.1007/s10096-007-0279-3; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Rousseau A, 2004, LEUKEMIA LYMPHOMA, V45, P1293, DOI 10.1080/10428190310001638850; St Leger AJ, 2017, IMMUNITY, V47, P148, DOI 10.1016/j.immuni.2017.06.014; Subhani Shaik, 2016, Indian Heart J, V68 Suppl 2, pS267, DOI 10.1016/j.ihj.2015.07.048; Takahashi I, 2009, CURR OPIN IMMUNOL, V21, P352, DOI 10.1016/j.coi.2009.04.002; Wang XL, 2016, FISH SHELLFISH IMMUN, V57, P318, DOI 10.1016/j.fsi.2016.08.054; Xu GY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3258-7; Yagnik B, 2017, J APPL MICROBIOL, V122, P493, DOI 10.1111/jam.13353; Zgair AK, 2011, J MED MICROBIOL, V60, P1032, DOI 10.1099/jmm.0.026377-0; Zhang XJ, 2016, MICROB PATHOGENESIS, V96, P20, DOI 10.1016/j.micpath.2016.04.019	39	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214596	10.1371/journal.pone.0214596	http://dx.doi.org/10.1371/journal.pone.0214596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934008	Green Submitted, Green Published, gold			2022-12-27	WOS:000462867000026
J	Tabor, A; Vollaard, N; Keogh, E; Eccleston, C				Tabor, Abby; Vollaard, Niels; Keogh, Edmund; Eccleston, Christopher			Predicting the consequences of physical activity: An investigation into the relationship between anxiety sensitivity, interoceptive accuracy and action	PLOS ONE			English	Article							FEAR-AVOIDANCE MODEL; HEART-RATE; PANIC-ATTACKS; PAIN; BELIEFS; BRAIN; PERCEPTION	The ability to predict the consequences of our actions is imperative for the everyday success of our interactions. From negotiating an uneven surface, to mounting an immune response, we continually infer the limits of our body. The current investigation considered the impact that the inferred consequences of action has on the placement of limits. We hypothesised that the performance of individuals in a novel, sprint task would reflect both their ability to accurately detect changes in bodily arousal (Interoceptive Accuracy) and the inferred consequences associated with heightened arousal signals (Anxiety Sensitivity). We found that individuals who demonstrated accuracy associated with physiological arousal changes, and who showed a heightened fear of the consequences of arousal symptoms, modified their actions by decreasing their power output (mean Watts.kg(-1)) in a sprint task (Delta R-2= 0.19; F (1,34) = 19.87); p<0.001). These findings provide a basis for understanding the varying actions taken as we encounter bodily perturbation.	[Tabor, Abby; Keogh, Edmund; Eccleston, Christopher] Univ Bath, Dept Hlth, Ctr Pain Res, Bath, Avon, England; [Vollaard, Niels] Univ Bath, Dept Hlth, Bath, Avon, England; [Eccleston, Christopher] Univ Ghent, Dept Clin & Hlth Psychol, Ghent, Belgium	University of Bath; University of Bath; Ghent University	Tabor, A (corresponding author), Univ Bath, Dept Hlth, Ctr Pain Res, Bath, Avon, England.	a.tabor@bath.ac.uk		Keogh, Edmund/0000-0002-1615-3699; Eccleston, Christopher/0000-0003-0698-1543	Reckitt Benckiser Healthcare (United Kingdom) Limited; EPSRC [EP/M023281/1] Funding Source: UKRI	Reckitt Benckiser Healthcare (United Kingdom) Limited; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an unrestricted grant for research from Reckitt Benckiser Healthcare (United Kingdom) Limited awarded to Professor Christopher Eccleston. Co-author Prof Ed Keogh has provided unrelated consultancy services to Reckitt Benckiser UK Commercial Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HDB BIOBEHAVIORAL AP; Boutelle Kerri N, 2004, Int J Behav Nutr Phys Act, V1, P13, DOI 10.1186/1479-5868-1-13; Brener J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0015; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Clark A, 2015, OPEN MIND, P1, DOI [10.15502/9783958570115, DOI 10.15502/9783958570115]; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Dunn BD, 2010, BEHAV RES THER, V48, P1133, DOI 10.1016/j.brat.2010.07.006; Eccleston C., 2016, EMBODIED PSYCHOL PHY; Farb N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00763; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Giles D, 2016, EUR J APPL PHYSIOL, V116, P563, DOI 10.1007/s00421-015-3303-9; Hayes A. F., 2012, PROCESS VERSATILE CO; Herbert BM, 2007, PSYCHOPHYSIOLOGY, V44, P194, DOI 10.1111/j.1469-8986.2007.00493.x; Keogh E, 2004, PAIN, V111, P209, DOI 10.1016/j.pain.2004.06.017; Keogh E, 2002, J PAIN, V3, P320, DOI 10.1054/jpai.2002.125182; Knapp K, 1997, PSYCHOPHYSIOLOGY, V34, P467, DOI 10.1111/j.1469-8986.1997.tb02391.x; McCormick A, 2015, SPORTS MED, V45, P997, DOI 10.1007/s40279-015-0319-6; McNally RJ, 2002, BIOL PSYCHIAT, V52, P938, DOI 10.1016/S0006-3223(02)01475-0; Meacham F, 2016, EVOL MED PUBLIC HLTH, P270, DOI 10.1093/emph/eow024; Meulders A, 2011, PAIN, V152, P2460, DOI 10.1016/j.pain.2011.05.015; Morris JS, 2002, TRENDS COGN SCI, V6, P317, DOI 10.1016/S1364-6613(02)01946-0; Moshier SJ, 2016, BEHAV MODIF, V40, P178, DOI 10.1177/0145445515603704; Nam S, 2012, J CARDIOPULM REHABIL, V32, P370, DOI 10.1097/HCR.0b013e31826be485; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Paulus MP, 2009, NEUROSCI BIOBEHAV R, V33, P1080, DOI 10.1016/j.neubiorev.2009.05.003; Pezzulo G, 2014, COGN AFFECT BEHAV NE, V14, P902, DOI 10.3758/s13415-013-0227-x; Philippe RA, 2005, PERCEPT MOTOR SKILL, V101, P440, DOI 10.2466/PMS.101.6.440-444; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V65, P167, DOI 10.1016/j.ijpsycho.2007.03.005; Pollatos O, 2012, PAIN, V153, P1680, DOI 10.1016/j.pain.2012.04.030; Porges, 1993, BODY PERCEPTION QUES; REISS S, 1991, CLIN PSYCHOL REV, V11, P141, DOI 10.1016/0272-7358(91)90092-9; Ring C, 1996, PSYCHOPHYSIOLOGY, V33, P541, DOI 10.1111/j.1469-8986.1996.tb02430.x; Ring C, 2018, PSYCHOPHYSIOLOGY, V6; Ring C, 2015, BIOL PSYCHOL, V104, P193, DOI 10.1016/j.biopsycho.2014.12.010; SALLIS JF, 1986, PREV MED, V15, P331, DOI 10.1016/0091-7435(86)90001-0; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Schmidt NB, 1997, J ABNORM PSYCHOL, V106, P355, DOI 10.1037/0021-843X.106.3.355; Schmidt NB, 2006, J PSYCHIATR RES, V40, P691, DOI 10.1016/j.jpsychires.2006.07.009; Seth AK, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0007; Smits JAJ, 2008, DEPRESS ANXIETY, V25, P689, DOI 10.1002/da.20411; Smits Jasper A. J., 2010, Cognitive Behaviour Therapy, V39, P28, DOI 10.1080/16506070902915261; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Vilares I, 2011, ANN NY ACAD SCI, V1224, P22, DOI 10.1111/j.1749-6632.2011.05965.x; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Wiese W, 2015, OPEN MIND, DOI [10.15502/9783958570108, DOI 10.15502/9783958570108]; Windmann S, 1999, PSYCHOPHYSIOLOGY, V36, P339, DOI 10.1017/S0048577299980381	51	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0210853	10.1371/journal.pone.0210853	http://dx.doi.org/10.1371/journal.pone.0210853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921331	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000006
J	Joshanloo, M; Weijers, D				Joshanloo, Mohsen; Weijers, Dan			A two-dimensional conceptual framework for understanding mental well-being	PLOS ONE			English	Article							FORM MHC-SF; PERSONAL GROWTH; HAPPINESS; HEALTH; SATISFACTION; PERSPECTIVE; COMMUNION; VALIDITY; CULTURES; PEOPLE	The complex nature of mental well-being is reflected in the great diversity of variables thought to represent aspects of mental flourishing. Discovering the underlying structure of mental well-being is important for a full understanding of this complex construct. Using data from 3 countries (the United States, Japan, and Iran), we performed multi-dimensional scaling to analyze the representation of 9 hedonic and eudaimonic well-being variables in a 2-dimensional psychological space. The analyses revealed 2 interpretable underlying dimensions across cultures and gender groups. The first dimension-eudaimonic well-being versus hedonic well-being-is well-known to well-being researchers. The second dimension-existential relatedness versus Epicurean independence-has not been recognized before. Existential relatedness is the characteristic of being meaningfully interconnected with things other than oneself, and is mainly based on the variables positive relations with others, personal growth, purpose in life, and life satisfaction. Epicurean independence is the characteristic of being relatively free of painful experiences and not feeling the need to have ones' views accepted by anyone but oneself. Epicurean independence is mainly based on the variables autonomy and absence of negative affect. We explain these dimensions in detail and discuss the implications for well-being research and policy.	[Joshanloo, Mohsen] Keimyung Univ, Dept Psychol, Daegu, South Korea; [Weijers, Dan] Univ Waikato, Philosophy Programme, Hamilton, New Zealand	Keimyung University; University of Waikato	Joshanloo, M (corresponding author), Keimyung Univ, Dept Psychol, Daegu, South Korea.	mioshanloo@hotmail.com	Joshanloo, Mohsen/E-6357-2017; Joshanloo, Mohsen/M-2816-2019	Joshanloo, Mohsen/0000-0001-9350-6219; 	Keimyung University [20180339]	Keimyung University	This research was supported by the Keimyung University Research Grant of 2018 (#20180339). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele AE, 2007, J PERS SOC PSYCHOL, V93, P751, DOI 10.1037/0022-3514.93.5.751; Ai AL, 2013, J HEALTH PSYCHOL, V18, P368, DOI 10.1177/1359105311434754; Annas Julia., 1993, MORALITY HAPPINESS; Aristotle, 1986, NICOMACHEAN ETHICS; Asparouhov T, 2015, J MANAGE, V41, P1561, DOI 10.1177/0149206315591075; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Belzak W.C.M., 2017, HAPPY MIND COGNITIVE, P117, DOI [DOI 10.1007/978-3-319-58763, 10.1007/978-3-319-58763-9_7, DOI 10.1007/978-3-319-58763-9_7]; Bentham J., 1988, PRINCIPLES MORALS LE; Bergsma A, 2008, J HAPPINESS STUD, V9, P397, DOI 10.1007/s10902-006-9036-z; Bilsky W, 2011, J CROSS CULT PSYCHOL, V42, P759, DOI 10.1177/0022022110362757; Bobowik M, 2015, SOC SCI RES, V51, P189, DOI 10.1016/j.ssresearch.2014.09.011; Borg I., 2013, APPL MULTIDIMENSIONA; Commandeur J. J. F., 1993, RR9303 LEID U DEP DA; Compton WC, 2001, J PSYCHOL, V135, P486, DOI 10.1080/00223980109603714; Costa P.T., 1985, NEO PERSONALITY INVE; Crisp R., 2013, WELL BEING STANFORD; Davins M., 2010, ALOMA, V27, P265; Davison ML., 2000, HDB APPL MULTIVARIAT, P323, DOI [10.1016/B978-012691360-6/50013-6, DOI 10.1016/B978-012691360-6/50013-6]; Deci EL, 2008, J HAPPINESS STUD, V9, P1, DOI 10.1007/s10902-006-9018-1; Delle Fave A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00030; Delle Fave A, 2011, SOC INDIC RES, V100, P185, DOI 10.1007/s11205-010-9632-5; DeWitt N. W., 1967, EPICURUS HIS PHILOS; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; Diener E, 2004, ADV CELL AGING GERON, V15, P187; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2011, J PERS SOC PSYCHOL, V101, P1278, DOI 10.1037/a0024402; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Fabrigar L. R., 2011, EXPLORATORY FACTOR A; Forgeard M.C., 2011, INT J WELLBEING, V1, P79; Gallagher MW, 2009, J PERS, V77, P1025, DOI 10.1111/j.1467-6494.2009.00573.x; Hanegraaff Wouter J, 1998, NEW AGE RELIG W CULT; HELGESON VS, 1994, PSYCHOL BULL, V116, P412, DOI 10.1037/0033-2909.116.3.412; Hicks S, 2013, SOC INDIC RES, V114, P73, DOI 10.1007/s11205-013-0384-x; Hofstede G., 2010, CULTURES ORG SOFTWAR; Hout MC, 2013, WIRES COGN SCI, V4, P93, DOI 10.1002/wcs.1203; Huta V, 2010, J HAPPINESS STUD, V11, P71, DOI 10.1007/s10902-008-9123-4; Jaccard J, 2010, THEORY CONSTRUCTION; Jaworska N, 2009, TUTOR QUANT METHODS, V5, P1, DOI 10.20982/tqmp.05.1.p001; Joshanloo M., J MENTAL HLTH; Joshanloo M, 2019, CURR PSYCHOL, V38, P128, DOI 10.1007/s12144-017-9595-7; Joshanloo M, 2017, J MENT HEALTH, V26, P510, DOI 10.1080/09638237.2016.1222058; Joshanloo M, 2017, PERS INDIV DIFFER, V105, P233, DOI 10.1016/j.paid.2016.09.060; Joshanloo M, 2016, J HAPPINESS STUD, V17, P2023, DOI 10.1007/s10902-015-9683-z; Joshanloo M, 2016, PERS INDIV DIFFER, V102, P107, DOI 10.1016/j.paid.2016.06.060; Joshanloo M, 2016, PERS INDIV DIFFER, V97, P8, DOI 10.1016/j.paid.2016.02.089; Joshanloo M, 2014, J HAPPINESS STUD, V15, P475, DOI 10.1007/s10902-013-9431-1; Kafka GJ, 2002, SOC INDIC RES, V57, P171, DOI 10.1023/A:1014451725204; Karas D, 2014, PERS INDIV DIFFER, V69, P104, DOI 10.1016/j.paid.2014.05.011; Kashdan T. B., 2008, J POSIT PSYCHOL, V3, P219, DOI [10.1080/17439760802303044, DOI 10.1080/17439760802303044]; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Kitayama S., 2007, HDB CULTURAL PSYCHOL, P136; Kline R.B., 2015, PRINCIPLES PRACTICE, V4th ed., DOI DOI 10.1038/156278A0; Kraut R., 2007, WHAT IS GOOD WHY ETH; Kruskal J.B., 1978, MULTIDIMENSIONAL SCA; Legatum Institute, 2012, 2012 LEG PROSP IND M; McMahon Darrin M., 2006, HAPPINESS HIST; Michalos AC, 2017, INT HANDB QUALITY, P31, DOI 10.1007/978-3-319-39101-4_2; Mikulincer M., 1998, ATTACHMENT THEORY CL, P143; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; OECD, 2013, OECD GUID MEASUBJ; Peiter H., 2010, CHRISTLICHE ETHIK BE; Petrillo G, 2015, SOC INDIC RES, V121, P291, DOI 10.1007/s11205-014-0629-3; Pinkley RL, 2005, INT NEGOT, V10, P79, DOI 10.1163/1571806054741056; Robitschek C, 2009, J COUNS PSYCHOL, V56, P321, DOI 10.1037/a0013954; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Ryff C., 2007, NATL SURVEY MIDLIFE, DOI [10.3886/ICPSR04652.v6, DOI 10.3886/ICPSR04652.V6]; Ryff C. D., 2012, ICPSR36427V2, DOI [10.3886/ICPSR36427.v2, DOI 10.3886/ICPSR36427.V2]; Ryff CD, 2016, INT HANDB QUALITY, P95, DOI 10.1007/978-3-319-42445-3_6; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Ryff CD, 1998, PSYCHOL INQ, V9, P1, DOI 10.1207/s15327965pli0901_1; Schleiermacher F., 1821, KRITISCHE GESAMTAUSG; Spinelli E, 2007, PRACTISING EXISTENTI; Suh E, 1998, J PERS SOC PSYCHOL, V74, P482, DOI 10.1037/0022-3514.74.2.482; Tsai JL, 2007, PERSPECT PSYCHOL SCI, V2, P242, DOI 10.1111/j.1745-6916.2007.00043.x; Uchida Y, 2009, EMOTION, V9, P441, DOI 10.1037/a0015634; Vitterso J, 2016, INT HANDB QUALITY, P1, DOI 10.1007/978-3-319-42445-3_1; Waterman A.S., 1990, THEORETICAL PHILOS P, V10, P39, DOI [10.1037/h0091489, DOI 10.1037/H0091489]	79	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214045	10.1371/journal.pone.0214045	http://dx.doi.org/10.1371/journal.pone.0214045			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917191	Green Published, gold			2022-12-27	WOS:000462465800047
J	Morales, J; Yanez, A; Fernandez-Gonzalez, L; Montesinos-Magraner, L; Marco-Ahullo, A; Solana-Tramunt, M; Calvete, E				Morales, Jose; Yanez, Alexandre; Fernandez-Gonzalez, Liria; Montesinos-Magraner, Lluisa; Marco-Ahullo, Adria; Solana-Tramunt, Monica; Calvete, Esther			Stress and autonomic response to sleep deprivation in medical residents: A comparative cross-sectional study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; DUTY HOUR RESTRICTIONS; PERFORMANCE; WORKING; BURNOUT; CONSEQUENCES; INFLAMMATION; ASSOCIATION; CORTISOL; SURGEONS	The aim of this study was to evaluate the stress suffered by medical residents as the result of being on call for 24 hours, from a multidimensional approach. Two groups of medical residents selected according to their work shift, participated in the study: one group (n = 40) was sleep-deprived after having been actively on-call for 24 hours, and another contrast group (n = 18) had performed a normal work day and were not sleep-deprived. All participants completed pre-post measures during a 24 h cycle. These were administered on both occasions at 8 am. The measures included HRV, cortisol, cognitive performance and transitory mood. The effect of the group x phase interaction was significant for all variables analysed, indicating that doctors in the 24h on-call shift group showed significant deterioration in all physiological, performance and mood indicators in comparison with the participants in the group not on call. These results suggest the need to review medical on-call systems, in order to reduce the stress load, which has a direct effect on working conditions.	[Morales, Jose; Yanez, Alexandre; Solana-Tramunt, Monica] Ramon Llull Univ, Fac Psychol Educ Sci & Sport Blanquerna, Barcelona, Spain; [Fernandez-Gonzalez, Liria; Calvete, Esther] Univ Deusto, Dept Personal & Psychol Assessment & Treatment, Bilbao, Spain; [Montesinos-Magraner, Lluisa; Marco-Ahullo, Adria] Vall dHebron Res Inst, Unidad Lesionados Medulares, Barcelona, Spain	Universitat Ramon Llull; University of Deusto; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Morales, J (corresponding author), Ramon Llull Univ, Fac Psychol Educ Sci & Sport Blanquerna, Barcelona, Spain.	josema@blanquerna.url.edu	Calvete, Esther/B-8418-2011; Fernández-González, Liria/U-1908-2019; SOLANA-TRAMUNT, MONICA/F-6181-2016; Marco-Ahulló, Adrià/AAG-6171-2019; Morales, Jose/D-4248-2014	Calvete, Esther/0000-0002-6928-9557; Morales, Jose/0000-0001-5165-5195; Marco Ahullo, Adria/0000-0002-2999-9386	Aristos Campus Mundus grant [ACM2016_09]; Basque Country Government [IT982-16]	Aristos Campus Mundus grant; Basque Country Government(Basque Government)	This study has been partially funded by an Aristos Campus Mundus grant (ref. ACM2016_09) and a grant from Basque Country Government (ref. IT982-16).	Ahmed N, 2014, ANN SURG, V259, P1041, DOI 10.1097/SLA.0000000000000595; Al Haddad H, 2011, INT J SPORTS MED, V32, P598, DOI 10.1055/s-0031-1275356; Amirian I, 2014, CAN J SURG, V57, P300, DOI 10.1503/cjs.028813; Antiel RM, 2013, JAMA SURG, V148, P448, DOI 10.1001/jamasurg.2013.1368; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Borchini R, 2015, INT J OCCUP MED ENV, V28, P42, DOI 10.2478/s13382-014-0289-1; Bosquet L, 2008, BRIT J SPORT MED, V42, P709, DOI 10.1136/bjsm.2007.042200; Brandenberger J, 2010, AM J SURG, V200, P814, DOI 10.1016/j.amjsurg.2010.06.009; Burleson MH, 2003, PSYCHOPHYSIOLOGY, V40, P358, DOI 10.1111/1469-8986.00039; Camm AJ, 1996, EUR HEART J, V17, P354; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chalmers JA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00080; Chung M., 2011, J EXP CLIN MED, V3, P121, DOI 10.1016/j.jecm.2011.04.001; de Tejada BM, 2013, EUR J OBSTET GYN R B, V171, P44, DOI 10.1016/j.ejogrb.2013.08.020; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Drolet BC, 2014, FAM MED, V46, P215; Flinn F, 2011, INT J QUAL HEALTH C, V23, P210, DOI 10.1093/intqhc/mzq088; Gander P, 2008, CHRONOBIOL INT, V25, P1077, DOI 10.1080/07420520802551428; Gohar A, 2009, J CLIN SLEEP MED, V5, P191; Guo YF, 2017, PSYCHONEUROENDOCRINO, V77, P47, DOI 10.1016/j.psyneuen.2016.11.020; Harbeck B, 2015, J OCCUP HEALTH, V57, P438, DOI 10.1539/joh.14-0276-OA; Hernando D, 2018, J STRENGTH COND RES, V32, P716, DOI 10.1519/JSC.0000000000001662; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Joo EY, 2012, J CLIN NEUROL, V8, P146, DOI 10.3988/jcn.2012.8.2.146; Legault G, 2017, APPL ERGON, V58, P144, DOI 10.1016/j.apergo.2016.06.007; Licht CMM, 2009, PSYCHOSOM MED, V71, P508, DOI 10.1097/PSY.0b013e3181a292a6; Lin YH, 2012, STRESS, V15, P21, DOI 10.3109/10253890.2011.572208; Looser RR, 2010, PSYCHOSOM MED, V72, P281, DOI 10.1097/PSY.0b013e3181d35065; Luber B, 2013, SLEEP, V36, P857, DOI 10.5665/sleep.2712; Lue BH, 2010, MED TEACH, V32, P400, DOI 10.3109/01421590903437188; Matheson A, 2014, J CLIN NURS, V23, P3309, DOI 10.1111/jocn.12524; Miu AC, 2009, AUTON NEUROSCI-BASIC, V145, P99, DOI 10.1016/j.autneu.2008.11.010; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; O'Brien MJ, 2012, J BONE JOINT SURG AM, V94A, P1975, DOI 10.2106/JBJS.K.00958; Perez-Olmos I, 2014, INT J MED EDUC, V5, P56, DOI 10.5116/ijme.531a.f2c9; Gomes AR, 2016, STRESS HEALTH, V32, P167, DOI 10.1002/smi.2583; Sanz J., 2001, ANALISIS MODIF CONDU, P27, DOI [10.1093/eurheartj/ehr007, DOI 10.1093/EURHEARTJ/EHR007]; Shen SH, 2016, NURS HEALTH SCI, V18, P223, DOI 10.1111/nhs.12257; Song HT, 2015, INT J PSYCHOPHYSIOL, V96, P169, DOI 10.1016/j.ijpsycho.2015.04.008; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Tobaldini E, 2013, EUR J INTERN MED, V24, P664, DOI 10.1016/j.ejim.2013.03.011; Tochikubo O, 1996, HYPERTENSION, V27, P1318, DOI 10.1161/01.HYP.27.6.1318; Wolkow A, 2015, INT J OCCUP MED ENV, V28, P183, DOI 10.13075/ijomeh.1896.00227	45	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214858	10.1371/journal.pone.0214858	http://dx.doi.org/10.1371/journal.pone.0214858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947295	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500076
J	Doyle, JR; Bottomley, PA				Doyle, John R.; Bottomley, Paul A.			The relative age effect in European elite soccer: A practical guide to Poisson regression modelling	PLOS ONE			English	Article							BIRTH; PLAYERS	Many disciplines of scholarship are interested in the Relative Age Effect (RAE), whereby age-banding confers advantages on older members of the cohort over younger ones. Most research does not test this relationship in a manner consistent with theory (which requires a decline in frequency across the cohort year), instead resorting to non-parametric, non-directional approaches. In this article, the authors address this disconnect, provide an overview of the benefits associated with Poisson regression modelling, and two managerially useful measures for quantifying RAE bias, namely the Indices of Discrimination and Wastage. In a tutorial-like exposition, applications and extensions of this approach are illustrated using data on professional soccer players competing in the top two tiers of the "Big Five" European football leagues in the search to identify paragon clubs, leagues, and countries from which others may learn to mitigate this form of age-discrimination in the talent identification process. As with OLS regression, Poisson regression may include more than one independent variable. In this way we test competing explanations of RAE; control for unwanted sources of covariation; model interaction effects (that different clubs and countries may not all be subject to RAE to the same degree); and test for non-monotonic versions of RAE suggested in the literature.	[Doyle, John R.; Bottomley, Paul A.] Cardiff Univ, Business Sch, Cardiff, S Glam, Wales	Cardiff University	Bottomley, PA (corresponding author), Cardiff Univ, Business Sch, Cardiff, S Glam, Wales.	bottomleypa@cardiff.ac.uk		Bottomley, Paul/0000-0001-8131-6768				Ackoff, 1989, J APPL SYSTEMS ANAL, V16, P3, DOI DOI 10.1002/9781444303179.CH3; Alioa A, 2018, PREMIER LEAGUE 11 20; Bai JJ, J FINANCIAL EC; BOISOT MH, 1986, ORGAN STUD, V7, P135, DOI 10.1177/017084068600700204; Bruner MW, 2011, J SPORT SCI, V29, P1337, DOI 10.1080/02640414.2011.597419; Brustio PR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196253; Buckles KS, 2013, REV ECON STAT, V95, P711, DOI 10.1162/REST_a_00314; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Crawford C, 2014, J R STAT SOC A STAT, V177, P829, DOI 10.1111/rssa.12071; Delorme N, 2015, INT REV SOCIOL SPORT, V50, P740, DOI 10.1177/1012690213493104; Delorme N, 2010, EUR J SPORT SCI, V10, P91, DOI 10.1080/17461390903271584; Deprez D, 2012, INT J SPORTS MED, V33, P987, DOI 10.1055/s-0032-1311654; Doyle JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192209; Fumarco L, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00058; Gibbs BG, 2012, INT REV SOCIOL SPORT, V47, P644, DOI 10.1177/1012690211414343; Gutierrez Diaz del Campo D, 2010, J SPORT SCI MED, V9, P190; Hancock DJ, 2013, EUR J SPORT SCI, V13, P630, DOI 10.1080/17461391.2013.775352; Hayat MJ, 2015, J NURS EDUC, V53, P207; Helsen WF, 2000, AM J HUM BIOL, V12, P729, DOI 10.1002/1520-6300(200011/12)12:6<729::AID-AJHB2>3.0.CO;2-7; Hjertstrand P, 2017, 1176 IFN; Lovell R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137238; Matsubayashi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135349; Page L, 2017, J ECON PSYCHOL, V63, P43, DOI 10.1016/j.joep.2017.10.002; Rada A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201795; RAMSEY F, 2013, STAT SLEUTH COURSE M; Schorer J., 2015, PSYCHOL TEST ASSESSM, V57, P126	26	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213988	10.1371/journal.pone.0213988	http://dx.doi.org/10.1371/journal.pone.0213988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943241	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000463194300027
J	Fallaize, R; Franco, RZ; Hwang, F; Lovegrove, JA				Fallaize, Rosalind; Franco, Rodrigo Zenun; Hwang, Faustina; Lovegrove, Julie A.			Evaluation of the eNutri automated personalised nutrition advice by users and nutrition professionals in the UK	PLOS ONE			English	Article							QUESTIONNAIRE	Nutrition apps have great potential to support people to improve their diets, but few apps give automated validated personalised nutrition advice. A web app capable of delivering automated personalised food-based nutrition advice (eNutri) was developed. The aims of this study were to i) evaluate and optimise the personalised nutrition report provided by the app and ii) compare the personalised food-based advice with nutrition professionals' standards to aid validation. A study with nutrition professionals (NP) compared the advice provided by the app against professional Registered Dietitians (RD) (n = 16) and Registered Nutritionists (RN) (n = 16) standards. Each NP received two pre-defined scenarios, comprising an individual's characteristics and dietary intake based on an analysis of a food frequency questionnaire, along with the nutrition food-based advice that was automatically generated by the app for that individual. NPs were asked to use their professional judgment to consider the scenario, provide their three most relevant recommendations for that individual, then consider the app's advice and rate their level of agreement via 5-star scales (with 5 as complete agreement). NPs were also asked to comment on the eNutri recommendations, scores generated and overall impression. The mean scores for the appropriateness, relevance and suitability of the eNutri diet messages were 3.5, 3.3 and 3.3 respectively.	[Fallaize, Rosalind; Lovegrove, Julie A.] Univ Reading, Hugh Sinclair Unit Human Nutr, Dept Food & Nutr Sci, Reading, Berks, England; [Fallaize, Rosalind; Lovegrove, Julie A.] Univ Reading, ICMR, Dept Food & Nutr Sci, Reading, Berks, England; [Fallaize, Rosalind] Univ Hertfordshire, Sch Life & Med Sci, Coll Lane, Hatfield, Herts, England; [Franco, Rodrigo Zenun; Hwang, Faustina] Univ Reading, Sch Biol Sci, Biomed Engn Sect, Reading, Berks, England	University of Reading; University of Reading; University of Hertfordshire; University of Reading	Lovegrove, JA (corresponding author), Univ Reading, Hugh Sinclair Unit Human Nutr, Dept Food & Nutr Sci, Reading, Berks, England.; Lovegrove, JA (corresponding author), Univ Reading, ICMR, Dept Food & Nutr Sci, Reading, Berks, England.	j.a.lovegrove@reading.ac.uk	Fallaize, Rosalind/AGF-6918-2022	Fallaize, Rosalind/0000-0003-3734-6489; Zenun Franco, Rodrigo/0000-0002-1998-4367	British Nutrition Foundation (BNF); CNPq (National Counsel of Technological and Scientific Development), from the Brazilian Government	British Nutrition Foundation (BNF); CNPq (National Counsel of Technological and Scientific Development), from the Brazilian Government(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The nutrition professional study and cost of open access publication was funded by the British Nutrition Foundation (BNF) Drummond Pump Priming Award 2017, which was won by RF. However the BNF had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results. RZF was sponsored by CNPq (National Counsel of Technological and Scientific Development), from the Brazilian Government.	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Celis-Morales C, 2017, INT J EPIDEMIOL, V46, P578, DOI 10.1093/ije/dyw186; Celis-Morales C, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0450-2; Chambliss HO, 2011, PATIENT EDUC COUNS, V85, P375, DOI 10.1016/j.pec.2010.12.024; Chen J, 2017, J HUM NUTR DIET, V30, P439, DOI 10.1111/jhn.12446; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cunningham M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015726; Fallaize R, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010049; Fallaize R, 2014, J MED INTERNET RES, V16, DOI [10.2196/jmir.3355, 10.2196/jmir.3105]; Franco RZ, 2017, PROCEEDINGS OF THE ELEVENTH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS'17), P411, DOI 10.1145/3109859.3109862; Franco RZ, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.5846; Hadianfard AM, 2015, J HLTH MAN INFO, V2, P40; Lee CS, 2015, IEEE T FUZZY SYST, V23, P1777, DOI 10.1109/TFUZZ.2014.2379256; McCullough ML, 2006, PUBLIC HEALTH NUTR, V9, P152, DOI 10.1079/PHN2005938; McDoniel SO, 2010, PATIENT EDUC COUNS, V79, P185, DOI 10.1016/j.pec.2009.07.034; Motwalli O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202006; Nielsen DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112665; POLS MA, 1995, INT J EPIDEMIOL, V24, P381, DOI 10.1093/ije/24.2.381; Scientific Advisory Committee on Nutrition (SACN), 2015, CARB HLTH REP; Scientific Advisory Committee on Nutrition (SACN), 2016, VIIT D HLTH REP; Teasdale N, 2018, AM J CLIN NUTR, V107, P247, DOI 10.1093/ajcn/nqx048; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Warner MM, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8193; Zenun Franco R, 2018, ENUTRI PERSONALISED, DOI [10.5281/zenodo.1304929, DOI 10.5281/ZENODO.1304929]	26	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214931	10.1371/journal.pone.0214931	http://dx.doi.org/10.1371/journal.pone.0214931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943252	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300072
J	Garcia, MG; Pusti, D; Wahl, S; Ohlendorf, A				Garcia, Miguel Garcia; Pusti, Dibyendu; Wahl, Siegfried; Ohlendorf, Arne			A global approach to describe retinal defocus patterns	PLOS ONE			English	Article							PERIPHERAL REFRACTION; GANGLION-CELL; MYOPIA; PROGRESSION; UNDERCORRECTION; MECHANISMS; VISION; TRENDS	The popularity of myopia treatments based on the peripheral defocus theory has risen. So far, little evidence has emerged around the questions which of these treatments are effective and why. In order to establish a framework that enables clinicians and researchers to acknowledge the possible interactions of different defocus patterns across the retina, different peripheral refractive errors (PRX) of subjects and different designs of optical treatments were evaluated. Dioptric defocus patterns on the retinal level have been obtained by merging the matrices of dioptric defocus maps of the visual field of different scenarios with individual peripheral refractive errors and different optical designs of multifocal contact lenses. The newly obtained matrices were statistically compared using a non-parametric test with familywise error algorithms and multi-comparison tests. Results show that asymmetric peripheral refractive error profiles (temporal or nasal positively skewed) appear to be less prone to be changed by the defocus imposition of multifocal contact lenses than those presenting symmetric patterns (relative peripheral myopia or hyperopia).	[Garcia, Miguel Garcia; Wahl, Siegfried; Ohlendorf, Arne] Eberhard Karls Univ Tuebingen, Inst Ophthalm Res, Tubingen, Baden Wuerttemb, Germany; [Garcia, Miguel Garcia; Wahl, Siegfried; Ohlendorf, Arne] Carl Zeiss Vis Int GmbH, Aalen, Baden Wuerttemb, Germany; [Pusti, Dibyendu] Univ Murcia, Lab Opt, Murcia, Spain	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Murcia	Garcia, MG (corresponding author), Eberhard Karls Univ Tuebingen, Inst Ophthalm Res, Tubingen, Baden Wuerttemb, Germany.; Garcia, MG (corresponding author), Carl Zeiss Vis Int GmbH, Aalen, Baden Wuerttemb, Germany.	miguel.garcia-garcia@student.uni-tuebingen.de	Pusti, Dibyendu/AAA-1483-2021; García, Miguel García/V-9225-2019; Ohlendorf, Arne/ABA-6968-2020	Pusti, Dibyendu/0000-0003-3839-7587; García, Miguel García/0000-0001-7379-0080; 	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [675137]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of the University of Tubingen	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Tubingen	MYFUN receives funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 675137. Carl Zeiss Vision International GmbH provides support in the form of salaries for authors MGG, AO & SW. The University of Murcia provides support in the form of salary for the author DP. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of the University of Tubingen. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2006, CLIN EXP OPTOM, V89, P315, DOI 10.1111/j.1444-0938.2006.00055.x; Atchison DA, 2006, VISION RES, V46, P1450, DOI 10.1016/j.visres.2005.10.023; Baden T, 2017, CURR BIOL, V27, pR139, DOI 10.1016/j.cub.2016.12.022; Chakraborty R, 2015, PROG MOL BIOL TRANSL, V134, P249, DOI 10.1016/bs.pmbts.2015.06.013; Charman WN, 2010, OPHTHAL PHYSL OPT, V30, P321, DOI 10.1111/j.1475-1313.2010.00746.x; Chung K, 2002, VISION RES, V42, P2555, DOI 10.1016/S0042-6989(02)00258-4; Conrad F, 2018, OPHTHAL PHYSL OPT, P215, DOI [10.1111/opo.12459, DOI 10.1111/OPO.12459]; Fernandez EJ, 2002, J REFRACT SURG, V18, pS634; Garcia MG, 2018, BIOMED OPT EXPRESS, V9, P347, DOI 10.1364/BOE.9.000347; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Huang JH, 2016, OPHTHALMOLOGY, V123, P697, DOI 10.1016/j.ophtha.2015.11.010; Jaeken B, 2012, INVEST OPHTH VIS SCI, V53, P3405, DOI 10.1167/iovs.11-8993; Jaeken B, 2011, OPT EXPRESS, V19, P7903, DOI 10.1364/OE.19.007903; KOTULAK JC, 1986, PERCEPTION, V15, P7, DOI 10.1068/p150007; Logan N, 2018, OPHTHAL PHYSL OPT, V38, P207, DOI 10.1111/opo.12461; Lundstrom L, 2017, HDB VISUAL OPTICS; Lundstrom L, 2007, OPT EXPRESS, V15, P12654, DOI 10.1364/OE.15.012654; Maiello G, 2018, BLUR PERCEPTION VISU, V17, P1, DOI [10.1167/17.5.3, DOI 10.1167/17.5.3]; Mani A, 2017, CURR BIOL, V27, P471, DOI 10.1016/j.cub.2016.12.033; Medina A, 2016, GRAEF ARCH CLIN EXP, V254, P409, DOI 10.1007/s00417-015-3111-2; REMPT F, 1971, OPHTHALMOLOGICA, V162, P1, DOI 10.1159/000306229; Rosen R, 2012, OPHTHAL PHYSL OPT, V32, P527, DOI 10.1111/j.1475-1313.2012.00937.x; Ruiz-Alcocer Javier, 2017, J Optom, V10, P266, DOI 10.1016/j.optom.2016.08.003; Sankaridurg P, 2010, OPTOMETRY VISION SCI, V87, P631, DOI 10.1097/OPX.0b013e3181ea19c7; Schaeffel F, 2013, OPHTHAL PHYSL OPT, V33, P362, DOI 10.1111/opo.12058; Schaeffel F, 2015, CLIN EXP OPTOM, V98, P507, DOI 10.1111/cxo.12312; Smith EL, 2013, OPTOMETRY VISION SCI, V90, P1176, DOI 10.1097/OPX.0000000000000038; Sun Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124535; Sun YY, 2017, GRAEF ARCH CLIN EXP, V255, P189, DOI 10.1007/s00417-016-3529-1; Tarutta E. P., 2015, ROS PEDIAT OPHTALMOL, V10, P33; The European Parliament and the Council of the European Union, 2016, OFF J EUR UNION, V59; Wagner S, 2015, CONTACT LENS ANTERIO, V38, P2, DOI 10.1016/j.clae.2014.07.008; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; WALLMAN J, 1994, NATURE, V371, P201, DOI 10.1038/371201a0; Wolffsohn JS, 2016, CONTACT LENS ANTERIO, V39, P106, DOI 10.1016/j.clae.2016.02.005	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213574	10.1371/journal.pone.0213574	http://dx.doi.org/10.1371/journal.pone.0213574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939130	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900006
J	Okawa, Y; Maruko, I; Kawai, M; Hasegawa, T; Arakawa, H; Iida, T				Okawa, Yuka; Maruko, Ichiro; Kawai, Moeko; Hasegawa, Taiji; Arakawa, Hisaya; Iida, Tomohiro			Foveal structure and vasculature in eyes with idiopathic epiretinal membrane	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LAYER THICKNESS	Purpose To examine the foveal structure and vasculature in eyes with an idiopathic epiretinal membrane (ERM). Methods Forty-nine eyes of 48 patients with an idiopathic ERM were studied. The superficial foveal avascular zone (FAZ) was measured by optical coherence tomography angiography (OCTA; RTVue XR Avanti, Optovue Inc., Fremont, CA), and the central foveal thickness (CFT) was measured by swept source OCT (DRI-OCT, Topcon, Japan). Twenty eyes underwent vitrectomy with internal limiting membrane (ILM) peeling, and the FAZ and CFT were evaluated pre- and postoperatively. Forty-nine eyes of 49 age-matched healthy subjects were also examined as control. Results The FAZ in eyes with an ERM was significantly smaller than that of the control eyes (0.188 +/- 0.16 mm(2) vs 0.328 +/- 0.14 mm(2), P<0.01). The CFT in eyes with an ERM was significantly thicker than that of control eyes (315 +/- 0.14 mu m vs 193 +/- 0.14 mu m, P<0.01). The size of the FAZ was strongly correlated with the CFT (ERM, R = -0.753; control, R = -0.61, both P<0.01). The postoperative size of the FAZ was not significantly different from the preoperative size (0.115 mm(2) vs 0.128 mm(2), P = 0.17) but the CFT was significantly thinner (370 mu m vs 288 mu m, P<0.01) after the vitrectomy with ILM peeling in 20 eyes. Conclusions The results indicate that an ERM might affect the morphology and vasculature of not only the inner but also the outer retina before and after vitrectomy with ILM peeling. The FAZ area might have been affected by the ILM peeling.	[Okawa, Yuka; Maruko, Ichiro; Kawai, Moeko; Hasegawa, Taiji; Arakawa, Hisaya; Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University	Maruko, I (corresponding author), Tokyo Womens Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan.	imaruko@twmu.ac.jp	Maruko, Ichiro/AFP-1311-2022; Hasegawa, Taiji/ABG-8260-2021	Maruko, Ichiro/0000-0001-5647-6372; 	JSPS KAKENHI [JP16K11274]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Okawa has nothing to disclose. Dr. Maruko reports grants from JSPS KAKENHI (Grant Number JP16K11274), grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work. Dr. Kawai has nothing to disclose. Dr. Hasegawa has nothing to disclose. Dr. Arakawa has nothing to disclose. Dr. Iida reports grants and personal fees from Novartis Pharma K. K. (Japan), personal fees from Bayer Yakuhin, Ltd. (Japan), grants and personal fees from Santen Pharmaceutical Co., Ltd. (Japan), grants from Nidek, research support from Chuosangyo (Japan), outside the submitted work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottoni F, 2011, INVEST OPHTH VIS SCI, V52, P4439, DOI 10.1167/iovs.10-6732; Chen H, 2019, EYE, V33, P619, DOI 10.1038/s41433-018-0272-3; Inoue M, 2010, AM J OPHTHALMOL, V150, P834, DOI 10.1016/j.ajo.2010.06.006; Joe SG, 2013, ACTA OPHTHALMOL, V91, pE242, DOI 10.1111/aos.12017; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim YJ, 2018, BRIT J OPHTHALMOL, V102, P1086, DOI 10.1136/bjophthalmol-2017-311188; Kitagawa Y, 2019, RETINA-J RET VIT DIS, V39, P339, DOI 10.1097/IAE.0000000000001972; Koo HC, 2012, GRAEF ARCH CLIN EXP, V250, P491, DOI 10.1007/s00417-011-1848-9; Kumagai K, 2018, RETINA-J RET VIT DIS, V38, P1786, DOI 10.1097/IAE.0000000000001778; Lee JW, 2010, JPN J OPHTHALMOL, V54, P129, DOI 10.1007/s10384-009-0778-0; Michalewski J, 2007, GRAEF ARCH CLIN EXP, V245, P1623, DOI 10.1007/s00417-007-0579-4; Nelis P, 2017, GRAEF ARCH CLIN EXP, V255, P1319, DOI 10.1007/s00417-017-3640-y; Okamoto F, 2015, RETINA-J RET VIT DIS, V35, P2107, DOI 10.1097/IAE.0000000000000602; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Samara WA, 2015, RETINA-J RET VIT DIS, V35, P2188, DOI 10.1097/IAE.0000000000000847; Spaide RF, 2017, JAMA OPHTHALMOL, V135, P259, DOI 10.1001/jamaophthalmol.2016.5327; Watanabe A, 2009, OPHTHALMOLOGY, V116, P1788, DOI 10.1016/j.ophtha.2009.04.046; Zur D, 2018, AM J OPHTHALMOL, V196, P129, DOI 10.1016/j.ajo.2018.08.037	18	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214881	10.1371/journal.pone.0214881	http://dx.doi.org/10.1371/journal.pone.0214881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939161	gold, Green Submitted, Green Published			2022-12-27	WOS:000462993900045
J	Shawki, HH; Ishikawa-Yamauchi, Y; Kawashima, A; Katoh, Y; Matsuda, M; Al-Soudy, A; Minisy, FM; Kuno, A; Gulibaikelamu, X; Hirokawa, T; Takahashi, S; Oishi, H				Shawki, Hossam H.; Ishikawa-Yamauchi, Yu; Kawashima, Akihiro; Katoh, Yuki; Matsuda, Manabu; Al-Soudy, Al-Sayed; Minisy, Fatma M.; Kuno, Akihiro; Gulibaikelamu, Xiafukaiti; Hirokawa, Takatsugu; Takahashi, Satoru; Oishi, Hisashi			EFCAB2 is a novel calcium-binding protein in mouse testis and sperm	PLOS ONE			English	Article							SIGNALING PATHWAYS; CALMODULIN; MOTILITY; INVOLVEMENT; CABS1	Calcium-binding proteins regulate ion metabolism and the necessary signaling pathways for the maturational events of sperm. Our aim is to identify the novel calcium-binding proteins in testis. The gene EFCAB2 (GenBank NM_026626.3, NP_080902.1) was not previously examined, and its properties and exact mechanisms of action are unknown. In this study, we performed phylogenetic and structure prediction analyses of EFCAB2, which displays definitive structural features. Additionally, the distribution, localization, and calcium binding ability of mouse EFCAB2 were investigated. Results revealed extensive conservation of EFCAB2 among different eukaryotic orthologs. The constructed 3D model predicted that mouse EFCAB2 contains seven a-helices and two EF-hand motifs. The first EF-hand motif is located in N-terminal, while the second is located in C-terminal. By aligning the 3D structure of Ca2+-binding loops from EFCAB2 with calmodulin, we predicted six residues that might be involved in Ca2+ binding. The distribution of the Efcab2 mRNA, as determined by northern blotting, was detected only in the testis among mouse tissues. Native and recombinant EFCAB2 protein were detected by western blotting as one band at 20 kDa. In situ hybridization and immunohistochemical analyses showed its localization specifically in spermatogenic cells from primary spermatocytes to elongate spermatids within the seminiferous epithelium, but neither spermatogonia nor somatic cells were expressed. Moreover, EFCAB2 was specifically localized to the principal piece of cauda epididymal sperm flagellum. Furthermore, the analyses of purified recombinant EFCAB2 by Stains-all, ruthenium red staining, and by applying in vitro autoradiography assay showed that the physiological function of this protein is Ca2+ binding. These results suggested that EFCAB2 might be involved in the control of sperm flagellar movement. Altogether, here we describe about EFCAB2 as a novel calcium-binding protein in mouse testis and sperm.	[Shawki, Hossam H.; Kawashima, Akihiro; Al-Soudy, Al-Sayed; Kuno, Akihiro; Gulibaikelamu, Xiafukaiti; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Shawki, Hossam H.; Al-Soudy, Al-Sayed] Natl Gene Bank, Dept Anim Genet Resources, Giza, Egypt; [Shawki, Hossam H.; Kawashima, Akihiro; Minisy, Fatma M.; Oishi, Hisashi] Nagoya City Univ, Grad Sch Med Sci, Dept Comparat & Expt Med, Nagoya, Aichi, Japan; [Ishikawa-Yamauchi, Yu] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Katoh, Yuki] Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, Tokyo, Japan; [Matsuda, Manabu] Kindai Univ, Fac Med, Dept Arts & Sci, Osaka, Japan; [Minisy, Fatma M.] Natl Res Ctr, Pathol Dept, Med Res Div, Giza, Egypt; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koutou Ku, Tokyo, Japan	University of Tsukuba; Nagoya City University; University of Tsukuba; Keio University; Kindai University (Kinki University); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); National Institute of Advanced Industrial Science & Technology (AIST)	Shawki, HH; Kawashima, A (corresponding author), Univ Tsukuba, Dept Anat & Embryol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan.; Shawki, HH (corresponding author), Natl Gene Bank, Dept Anim Genet Resources, Giza, Egypt.; Shawki, HH; Kawashima, A (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Comparat & Expt Med, Nagoya, Aichi, Japan.	shawkihh@med.nagoya-cu.ac.jp; tsukutsukukawashi@hotmail.com		Kuno, Akihiro/0000-0002-4674-6882; Minisy, Fatma/0000-0001-5089-2199; Al-Soudy, Al-Sayed/0000-0002-7830-9660	Nagoya City University, Japan [201805]	Nagoya City University, Japan	We would like to declare that our work was funded for PI: Dr. Hossam H. Shawki by Nagoya City University, Japan (Grant 201805), and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD K, 1995, ARCH ANDROLOGY, V35, P187, DOI 10.3109/01485019508987871; Al-Soudy AS, 2016, GENESIS, V54, P389, DOI 10.1002/dvg.22944; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Brown T, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1012s07; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; CADAY CG, 1985, J BIOL CHEM, V260, P5985; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Chazin WJ, 2011, ACCOUNTS CHEM RES, V44, P171, DOI 10.1021/ar100110d; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Denessiouk K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109287; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Halling DB, 2016, P NATL ACAD SCI USA, V113, pE1216, DOI 10.1073/pnas.1600385113; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Jha KN, 2003, CELL MOL BIOL, V49, P329; KAWASAKI H, 1995, PROTEIN PROFILE, V2, P305; Kawashima A, 2016, MOL REPROD DEV, V83, P912, DOI 10.1002/mrd.22639; Kawashima A, 2009, BIOL REPROD, V80, P1293, DOI 10.1095/biolreprod.108.073866; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kozlowski LP, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0159-9; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Li YF, 2007, J BIOL CHEM, V282, P34104, DOI 10.1074/jbc.M702238200; Marin-Briggiler CI, 2005, J CELL SCI, V118, P2013, DOI 10.1242/jcs.02326; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Mizuno K, 2012, P NATL ACAD SCI USA, V109, P20497, DOI 10.1073/pnas.1217018109; Nelson MR, 1998, PROTEIN SCI, V7, P270; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Rahman MS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/841615; Schlingmann K, 2007, J ANDROL, V28, P706, DOI 10.2164/jandrol.106.001669; Shawki HH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190800; Shawki HH, 2016, EXP ANIM TOKYO, V65, P253, DOI 10.1538/expanim.15-0104; Si YM, 2000, BIOL REPROD, V62, P1231, DOI 10.1095/biolreprod62.5.1231; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yanez M, 2012, ADV EXP MED BIOL, V740, P461, DOI 10.1007/978-94-007-2888-2_19; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214687	10.1371/journal.pone.0214687	http://dx.doi.org/10.1371/journal.pone.0214687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933994	gold, Green Published, Green Submitted			2022-12-27	WOS:000462867000037
J	Ackermann, D; Groessl, M; Pruijm, M; Ponte, B; Escher, G; d'Uscio, CH; Guessous, I; Ehret, G; Pechere-Bertschi, A; Martin, PY; Burnier, M; Dick, B; Vogt, B; Bochud, M; Rousson, V; Dhayat, NA				Ackermann, Daniel; Groessl, Michael; Pruijm, Menno; Ponte, Belen; Escher, Genevieve; d'Uscio, Claudia H.; Guessous, Idris; Ehret, Georg; Pechere-Bertschi, Antoinette; Martin, Pierre-Yves; Burnier, Michel; Dick, Bernhard; Vogt, Bruno; Bochud, Murielle; Rousson, Valentin; Dhayat, Nasser A.			Reference intervals for the urinary steroid metabolome: The impact of sex, age, day and night time on human adult steroidogenesis	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; CIRCADIAN-RHYTHM; CORTISOL; POPULATION; EXCRETION; HORMONES; EXPRESSION; GC/MS; FATE; TOOL	Objective Urinary steroid metabolomics by GC-MS is an established method in both clinical and research settings to describe steroidogenic disorders. However, population-based reference intervals for adults do not exist. Methods We measured daytime and night time urinary excretion of 40 steroid metabolites by GC-MS in 1128 adult participants of European ancestry, aged 18 to 90 years, within a large population-based, multicentric, cross-sectional study. Age and sex-related patterns in adjacent daytime and night time urine collections over 24 hours were modelled for each steroid metabolite by multivariable linear mixed regression. We compared our results with those obtained through a systematic literature review on reference intervals of urinary steroid excretion. Results Flexible models were created for all urinary steroid metabolites thereby estimating sex-and age-related changes of the urinary steroid metabolome. Most urinary steroid metabolites showed an age-dependence with the exception of 6 beta-OH-cortisol, 18-OH-cortisol, and beta-cortol. Reference intervals for all metabolites excreted during 24 hours were derived from the 2.5th and 97.5th percentile of modelled reference curves. The excretion rate per period of metabolites predominantly derived from the adrenals was mainly higher during the day than at night and the correlation between day and night time metabolite excretion was highly positive for most androgens and moderately positive for glucocorticoids. Conclusions This study gives unprecedented new insights into sex-and age-specificity of the human adult steroid metabolome and provides further information on the day/night variation of urinary steroid hormone excretion. The population-based reference ranges for 40 GC-MS-measured metabolites will facilitate the interpretation of steroid profiles in clinical practice.	[Ackermann, Daniel; Groessl, Michael; Escher, Genevieve; d'Uscio, Claudia H.; Dick, Bernhard; Vogt, Bruno; Dhayat, Nasser A.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Hypertens & Nephrol, Bern, Switzerland; [Ackermann, Daniel; Groessl, Michael; Escher, Genevieve; d'Uscio, Claudia H.; Dick, Bernhard; Vogt, Bruno; Dhayat, Nasser A.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Clin Res, Bern, Switzerland; [Pruijm, Menno; Burnier, Michel] Univ Hosp Lausanne, Serv Nephrol, Lausanne, Switzerland; [Ponte, Belen; Martin, Pierre-Yves] Univ Hosp Geneva, Dept Specialties Internal Med, Serv Nephrol, Geneva, Switzerland; [Guessous, Idris] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Ehret, Georg] Univ Hosp Geneva, Dept Specialties Internal Med, Serv Cardiol, Geneva, Switzerland; [Pechere-Bertschi, Antoinette] Univ Hosp Geneva, Dept Internal Med Specialties, Serv Endocrinol, Geneva, Switzerland; [Bochud, Murielle; Rousson, Valentin] Univ Hosp Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Dhayat, NA (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Hypertens & Nephrol, Bern, Switzerland.; Dhayat, NA (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Clin Res, Bern, Switzerland.	nasser.dhayat@insel.ch	Pruijm, Menno/AAA-4281-2020; EHRET, Georg B/A-9532-2009; Vogt, Bruno/AAS-2876-2020; Dhayat, Nasser A/J-1350-2016	Pruijm, Menno/0000-0003-1027-1851; EHRET, Georg B/0000-0002-5730-0675; Vogt, Bruno/0000-0002-1548-6387; Dhayat, Nasser A/0000-0001-8310-5921; Rousson, Valentin/0000-0001-8092-4446; Escher, Genevieve/0000-0002-5125-2262	Swiss National Science Foundation [33CM30-124087]; CTU Scientific Grant of the Directorate for Education and Research, Inselspital, Bern University Hospital, University of Bern, Switzerland [84801054]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CTU Scientific Grant of the Directorate for Education and Research, Inselspital, Bern University Hospital, University of Bern, Switzerland	This work was supported by the Swiss National Science Foundation (grant number 33CM30-124087 to MB, http://p3.snf.ch/Project-124087) and by the CTU Scientific Grant of the Directorate for Education and Research, Inselspital, Bern University Hospital, University of Bern, Switzerland (grant number 84801054 to NAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann D, 2016, AM J HYPERTENS, V29, P484, DOI 10.1093/ajh/hpv138; Alvarez JD, 2003, BIOL REPROD, V69, P81, DOI 10.1095/biolreprod.102.011833; Arlt W, 2011, J CLIN ENDOCR METAB, V96, P3775, DOI 10.1210/jc.2011-1565; AXELSON M, 1977, J STEROID BIOCHEM, V8, P683, DOI 10.1016/0022-4731(77)90297-7; BEVAN BR, 1986, J CLIN PATHOL, V39, P627, DOI 10.1136/jcp.39.6.627; Bileck A, 2018, J STEROID BIOCH MOL; Bileck A, 2018, ANALYST, V143, P4484, DOI 10.1039/c7an01990d; Bochud M, 2019, J CLIN ENDOCR METAB, V104, P2195, DOI 10.1210/jc.2018-01942; Chan AOK, 2008, STEROIDS, V73, P828, DOI 10.1016/j.steroids.2008.03.004; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; CZEKALA NM, 1994, AM J PRIMATOL, V34, P29, DOI 10.1002/ajp.1350340107; de Jong WHA, 2018, CLIN CHEM LAB MED, V56, P103, DOI 10.1515/cclm-2016-1072; Dhayat NA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203903; Dhayat NA, 2015, J STEROID BIOCHEM, V154, P226, DOI 10.1016/j.jsbmb.2015.07.024; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FALES HM, 1965, ANAL CHEM, V37, P955, DOI 10.1021/ac60226a052; Fang K, 2010, CHINESE J ANAL CHEM, V38, P743, DOI 10.3724/SP.J.1096.2010.00743; Farland LV, 2017, CANCER CAUSE CONTROL, V28, P1441, DOI 10.1007/s10552-017-0971-2; Finken MJJ, 1999, J CLIN ENDOCR METAB, V84, P3316, DOI 10.1210/jc.84.9.3316; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; HELLMAN L, 1956, J CLIN INVEST, V35, P1033, DOI 10.1172/JCI103349; Jerjes WK, 2006, ANN CLIN BIOCHEM, V43, P287, DOI 10.1258/000456306777695564; Krone N, 2010, J STEROID BIOCHEM, V121, P496, DOI 10.1016/j.jsbmb.2010.04.010; Kudielka BM, 2003, PSYCHONEUROENDOCRINO, V28, P35, DOI 10.1016/S0306-4530(02)00008-2; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liang X, 2013, J BIOL RHYTHM, V28, P208, DOI 10.1177/0748730413486873; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Morse D, 2003, MOL ENDOCRINOL, V17, P141, DOI 10.1210/me.2002-0184; Ogna VF, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0275-x; Parikh TP, 2018, ENDOCR CONNECT, V7, P1354, DOI 10.1530/EC-18-0417; Petrovic D, 2016, PSYCHONEUROENDOCRINO, V67, P76, DOI 10.1016/j.psyneuen.2016.02.003; R Development Core Team, 2017, R LANG ENV STAT COMP; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rousson V, 2008, J APPL STAT, V35, P659, DOI 10.1080/02664760801920960; Sellix MT, 2015, J BIOL RHYTHM, V30, P7, DOI 10.1177/0748730414554222; Shackleton C., 2008, LAB GUIDE METHODS BI, P549, DOI 10.1007/978-3-540-76698-8_26.; Shackleton C, 2018, J ENDOCR SOC, V2, P974, DOI 10.1210/js.2018-00135; Shackleton C, 2010, J STEROID BIOCHEM, V121, P481, DOI 10.1016/j.jsbmb.2010.02.017; Shackleton CHL, 2008, STEROIDS, V73, P652, DOI 10.1016/j.steroids.2008.02.001; Shackleton CHJM, ENCY MASS SPECTROMET, P82006; SHACKLETON CHL, 1986, J CHROMATOGR, V379, P91, DOI 10.1016/S0378-4347(00)80683-0; SHACKLETON CHL, 1993, J STEROID BIOCHEM, V45, P127, DOI 10.1016/0960-0760(93)90132-G; Shamim W, 2000, ANN CLIN BIOCHEM, V37, P770, DOI 10.1258/0004563001900084; Siest G, 2013, CLIN CHEM LAB MED, V51, P47, DOI 10.1515/cclm-2012-0682; SLAUNWHITE WR, 1958, J CLIN ENDOCR METAB, V18, P1056, DOI 10.1210/jcem-18-10-1056; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Taylor NF, 2013, METHODS MOL BIOL, V1065, P259, DOI 10.1007/978-1-62703-616-0_17; Van Renterghem P, 2010, STEROIDS, V75, P154, DOI 10.1016/j.steroids.2009.11.008; VANCAUTER E, 1990, HORM RES, V34, P45, DOI 10.1159/000181794; VESTERGAARD P, 1980, LIPIDS, V15, P710, DOI 10.1007/BF02534025; WEYKAMP CW, 1989, CLIN CHEM, V35, P2281; Xu X, 1999, J CLIN ENDOCR METAB, V84, P3914, DOI 10.1210/jc.84.11.3914; Zaidi SK, 2012, OPEN LONGEVITY SCI, V6, P1, DOI [10.2174/1876326X01206010001, DOI 10.2174/1876326X01206010001]	55	20	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214549	10.1371/journal.pone.0214549	http://dx.doi.org/10.1371/journal.pone.0214549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925175	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300019
J	Rostom, A; Dube, C; Bishay, K; Antonova, L; Heitman, SJ; Hilsden, R				Rostom, Alaa; Dube, Catherine; Bishay, Kirles; Antonova, Lilia; Heitman, Steven J.; Hilsden, Robert			A randomized clinical prospective trial comparing split-dose picosulfate/magnesium citrate and polyethylene glycol for colonoscopy preparation	PLOS ONE			English	Article							COLORECTAL-CANCER MORTALITY; BOWEL-PREPARATION; MAGNESIUM CITRATE; POLYP DETECTION; QUALITY; INTERVAL; TOLERABILITY; ASSOCIATION; VALIDATION; ADENOMAS	Background Colonoscopy remains the gold standard for the investigation of abnormalities within the colon. However, its success is highly dependent on the quality of bowel preparation. The objective of this study was to compare the bowel preparation efficacy of picosulfate/magnesium citrate (PMC) vs polyethylene glycol (PEG) in a one-day vs two-day split dose regimen. Methods A prospective, randomized, controlled trial was conducted at the Forzani & MacPhail Colon Cancer Screening Centre in Calgary, Canada. 171 colonoscopy outpatients were randomized to split-dose PMC or PEG lavage as well as into one-day split or two-day split regimens in blocks of eight. Bowel preparation quality was recorded in a blinded manner by the endoscopist using the Ottawa Bowel Preparation Scale (OBPS) prior to washing or suctioning. The scale results were analyzed using a two-factor analysis of variance. Results 141 patients received complete colonoscopies (PMC-71; PEG-70). PEG was found to be superior to PMC (mean OBPS: 4.14 +/- 2.64 vs 5.11 +/- 3.44, p = 0.019), when adjusted for administration regimen, leading to significantly more adequate bowel preparations (79.7% vs 59.7%, p = 0.007). A two-day split dose was superior to a one-day split dose regimen (mean OBPS: 3.68 +/- 2.82 vs 5.69 +/- 3.06, p<0.001). Two-day split dosing also resulted in a better right colon cleanliness score (right bowel OBPS 1.27 +/- 0.11 vs 2.10 +/- 0.12 for one-day split, P<0.001). Conclusions Optimal bowel preparation was achieved with the use of PEG lavage when administered in a two-day split dose regimen.	[Rostom, Alaa; Dube, Catherine; Bishay, Kirles; Antonova, Lilia] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Rostom, Alaa; Dube, Catherine; Bishay, Kirles; Antonova, Lilia] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Heitman, Steven J.; Hilsden, Robert] Univ Calgary, Dept Med & Community Hlth Sci, Calgary, AB, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Calgary	Rostom, A (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.; Rostom, A (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	arostom@toh.ca		Bishay, kirles/0000-0003-4478-089X				Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Buecher B, 2007, GASTROEN CLIN BIOL, V31, P39, DOI 10.1016/S0399-8320(07)89325-0; Byrne MF, 2002, AM J GASTROENTEROL, V97, P1587, DOI 10.1111/j.1572-0241.2002.05855.x; Clark BT, 2016, CLIN GASTROENTEROL H, V14, P1155, DOI 10.1016/j.cgh.2016.03.044; Eun CS, 2011, DIGEST DIS SCI, V56, P539, DOI 10.1007/s10620-010-1457-1; Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P3461, DOI 10.3748/wjg.14.3461; Gill P, 2013, J CLIN PATHOL, V66, P655, DOI 10.1136/jclinpath-2013-201608; Hazewinkel Y, 2013, GASTROINTEST ENDOSC, V77, P916, DOI 10.1016/j.gie.2012.12.018; Horton N, 2016, AM J GASTROENTEROL, V111, P1330, DOI 10.1038/ajg.2016.273; Hoy SM, 2009, DRUGS, V69, P123, DOI 10.2165/00003495-200969010-00009; Jin Z, 2016, EUR J CLIN PHARMACOL, V72, P523, DOI 10.1007/s00228-016-2013-5; Kherad O, 2015, CAN J GASTROENTEROL, V29, P384, DOI 10.1155/2015/350587; Kim TK, 2014, GUT LIVER, V8, P625, DOI 10.5009/gnl13228; Klare P, 2015, J GASTROEN HEPATOL, V30, P1627, DOI 10.1111/jgh.13010; Lebwohl B, 2011, GASTROINTEST ENDOSC, V73, P1207, DOI 10.1016/j.gie.2011.01.051; Martel M, 2015, GASTROENTEROLOGY, V149, P79, DOI 10.1053/j.gastro.2015.04.004; Mohamed R, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/3181459; Munsterman ID, 2015, EUR J GASTROEN HEPAT, V27, P29, DOI 10.1097/MEG.0000000000000192; Papanikolaou IS, 2015, WORLD J CLIN CASES, V3, P880, DOI 10.12998/wjcc.v3.i10.880; Puckett J, 2012, CURR OPIN CLIN NUTR, V15, P499, DOI 10.1097/MCO.0b013e328356b77b; Pyenson B, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-92; Radaelli F, 2017, GUT, V66, P270, DOI 10.1136/gutjnl-2015-310685; Rostom A, 2004, GASTROINTEST ENDOSC, V59, P482, DOI 10.1016/S0016-5107(03)02875-X; Sarre R, 2005, AUST PRESCR, V28, P16, DOI 10.18773/austprescr.2005.011; Seo EH, 2012, GASTROINTEST ENDOSC, V75, P583, DOI 10.1016/j.gie.2011.09.029; Siddiqui AA, 2009, GASTROINTEST ENDOSC, V69, P700, DOI 10.1016/j.gie.2008.09.047; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Yoo IK, 2015, DIGEST LIVER DIS, V47, P131, DOI 10.1016/j.dld.2014.10.019	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0211136	10.1371/journal.pone.0211136	http://dx.doi.org/10.1371/journal.pone.0211136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921345	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000008
J	Cransac, A; Aho, S; Chretien, ML; Giroud, M; Caillot, D; Boulin, M				Cransac, Amelie; Aho, Serge; Chretien, Marie-Lorraine; Giroud, Maurice; Caillot, Denis; Boulin, Mathieu			Adherence to immunomodulatory drugs in patients with multiple myeloma	PLOS ONE			English	Article							MEDICATION ADHERENCE; VALIDITY; SAFETY; COST; TOOL	Background Immunomodulatory drugs (thalidomide, lenalidomide and pomalidomide; IMID) are widely used in the treatment of multiple myeloma patients. To date, few data are available on IMID adherence in multiple myeloma patients. The aim of our study was to evaluate IMID adherence and to compare two indirect methods to measure IMID adherence in multiple myeloma patients: a specific questionnaire and the medication possession ratio (MPR). Another aim was to explore this specific questionnaire for the assessment of IMID adherence in multiple myeloma patients. Methods All consecutive multiple myeloma patients, with at least two consecutive dispensations of thalidomide, lenalidomide or pomalidomide in our hospital were included in this prospective study. IMID adherence was measured using a specific questionnaire and the medication possession ratio. Relationship between the questionnaire scores and variables of interest was evaluated by multiple linear regression with a robust variance estimator. Findings Sixty-three patients were included in our study. The mean questionnaire score was 8.2 +/- 1.2 and the mean medication possession ratio value was 0.97 +/- 0.06. A total of 76% of patients were considered adherent according to the questionnaire (i.e. score >= 8), 94% according to the medication possession ratio (i.e. MPR >= 0.90), and 70% according to the questionnaire and the medication possession ratio. No statistically significant linear association was observed between the questionnaire score and any variables of interest including medication possession ratio. All Cronbach's alpha were relatively low (range 0.0342-0.2443), showing a low correlation of the different questions with the questionnaire score. Conclusions Our study is the first prospective study evaluating IMID adherence in multiple myeloma patients in real life. The high adherence to IMIDs reported here, regardless of the drug, is encouraging considering the efficacy, toxicity and elevated cost of IMIDs. The specific questionnaire should be used with caution to evaluate IMID adherence.	[Cransac, Amelie; Boulin, Mathieu] Univ Burgundy & Franche Comte, Dijon Univ Hosp, Dept Pharm, Dijon, France; [Cransac, Amelie; Giroud, Maurice] Univ Burgundy & Franche Comte, LNC, UMR1231, Dijon, France; [Aho, Serge] Univ Hosp, Hosp Epidemiol, Dijon, France; [Aho, Serge] Univ Hosp, Infect Control Dept, Dijon, France; [Chretien, Marie-Lorraine] Univ Burgundy Franche Comte, Univ Hosp, Dept Clin Hematol, Dijon, France; [Chretien, Marie-Lorraine] Univ Burgundy Franche Comte, SAPHIIR, UMR 1231, Dijon, France; [Giroud, Maurice] Univ Burgundy Franche Comte, Dijon Univ Hosp, Dept Neurol, Dijon, France; [Caillot, Denis] Univ Hosp, Dept Clin Hematol, Dijon, France; [Boulin, Mathieu] Univ Burgundy Franche Comte, EPICAD, LNC, UMR1231, Dijon, France	CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Cransac, A (corresponding author), Univ Burgundy & Franche Comte, Dijon Univ Hosp, Dept Pharm, Dijon, France.; Cransac, A (corresponding author), Univ Burgundy & Franche Comte, LNC, UMR1231, Dijon, France.	amelie.cransac@chu-dijon.fr	AHO, ludwig/AAR-5753-2021; CRANSAC, Amélie/AAH-5651-2020; Serge, Aho Glele Ludwig/AAP-8863-2021	CRANSAC, Amélie/0000-0003-1836-2619; Serge, Aho Glele Ludwig/0000-0001-7590-8644				Allenet B., 2013, ANNALES PHARMACEUTIQUES FRANCAISES, V71, P135, DOI 10.1016/j.pharma.2012.10.001; Arber A, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12413; Bassan F, 2014, EUR J CANCER CARE, V23, P22, DOI 10.1111/ecc.12124; Daouphars M, 2013, PHARMACOTHERAPY, V33, P152, DOI 10.1002/phar.1174; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Girerd X, 2001, ARCH MAL COEUR VAISS, V94, P839; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Gueneau P, 2018, EUR J HAEMATOL, V100, P518, DOI 10.1111/ejh.13039; Huang WC, 2016, EXPERT REV ANTICANC, V16, P423, DOI 10.1586/14737140.2016.1159515; Huntington SF, 2015, LANCET HAEMATOL, V2, pE408, DOI 10.1016/S2352-3026(15)00151-9; Lee C, 2016, J MED ECON, V19, P397, DOI 10.3111/13696998.2015.1130710; Mateos MV, 2015, BLOOD REV, V29, P387, DOI 10.1016/j.blre.2015.06.001; Moreau P, 2017, ANN ONCOL, V28, P52, DOI 10.1093/annonc/mdx096; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Muszbek N, 2008, INT J CLIN PRACT, V62, P338, DOI 10.1111/j.1742-1241.2007.01683.x; Partridge AH, 2002, JNCI-J NATL CANCER I, V94, P652; Raab MS, 2016, BRIT J HAEMATOL, V175, P66, DOI 10.1111/bjh.14193; Ribed A, 2016, INT J CLIN PHARM-NET, V38, P280, DOI 10.1007/s11096-015-0235-8; Miguel JS, 2013, LANCET ONCOL, V14, P1055, DOI 10.1016/S1470-2045(13)70380-2; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Sperber CM, 2017, PATIENT PREFER ADHER, V11, P1469, DOI 10.2147/PPA.S136890; Thompson K, 2000, SCHIZOPHR RES, V42, P241, DOI 10.1016/S0920-9964(99)00130-9; World Health Organization, 2003, ADHERENCE LONG TERM, P199	23	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214446	10.1371/journal.pone.0214446	http://dx.doi.org/10.1371/journal.pone.0214446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917164	Green Published, gold, Green Submitted			2022-12-27	WOS:000462465800065
J	Velasquez-Tibata, J; Olaya-Rodriguez, MH; Lopez-Lozano, D; Gutierrez, C; Gonzalez, I; Londono-Murcia, MC				Velasquez-Tibata, Jorge; Olaya-Rodriguez, Maria H.; Lopez-Lozano, Daniel; Gutierrez, Cesar; Gonzalez, Ivan; Londono-Murcia, Maria C.			BioModelos: A collaborative online system to map species distributions	PLOS ONE			English	Article							SELECTING THRESHOLDS; DISTRIBUTION MODELS; OCCURRENCE RECORDS; CLIMATE-CHANGE; COMPLEXITY; PREDICTION; PRIORITIES; ABSENCES; RISK	Information on species distribution is recognized as a crucial input for biodiversity conservation and management. To that end, considerable resources have been dedicated towards increasing the quantity and availability of species occurrence data, boosting their use in species distribution modeling and online platforms for their dissemination. Currently, those platforms face the challenge of bringing biology into modeling by making informed decisions that result in meaningful models, based on limited occurrence and ecological data. Here we describe BioModelos, a modeling approach supported by an online system and a core team of modelers, whereby a network of experts contributes to the development of species distribution models by assessing the quality of occurrence data, identifying potentially limiting environmental variables, establishing species' accessible areas and validating modeling predictions qualitatively. Models developed through BioModelos become freely and publicly available once validated by experts, furthering their use in conservation applications. Our approach has been implemented in Colombia since 2013 and it currently consist of a network of nearly 500 experts that collaboratively contribute to enhance the knowledge on the distribution of a growing number of species and it has aided the development of several decision support products such as national risk assessments and biodiversity compensation manuals. BioModelos is an example of operationalization of an essential biodiversity variable at a national level through the implementation of a research infrastructure that enhances the value of open access species data.	[Velasquez-Tibata, Jorge; Olaya-Rodriguez, Maria H.; Lopez-Lozano, Daniel; Gutierrez, Cesar; Gonzalez, Ivan; Londono-Murcia, Maria C.] Alexander von Humboldt Inst Res Biol Resources, Lab Appl Biogeog, Bogota, Colombia; [Velasquez-Tibata, Jorge] NASCA Conservat Program, Nat Conservancy, Bogota, Colombia		Velasquez-Tibata, J; Londono-Murcia, MC (corresponding author), Alexander von Humboldt Inst Res Biol Resources, Lab Appl Biogeog, Bogota, Colombia.; Velasquez-Tibata, J (corresponding author), NASCA Conservat Program, Nat Conservancy, Bogota, Colombia.	jorge.velasquez@tnc.org; mlondono@humboldt.org.co	Londono Murcia, Maria Cecilia/J-1327-2017	Londono Murcia, Maria Cecilia/0000-0002-2317-5503; Lopez-Lozano, Daniel/0000-0002-8347-0782; Velasquez-Tibata, Jorge/0000-0002-7773-7348; Gutierrez Montoya, Cesar/0000-0002-0801-4904	Colombian Ministry of Environment	Colombian Ministry of Environment	The authors received no specific funding for this work, though they were all employed by Humboldt Institute, an environmental organization partly funded by the Colombian Ministry of Environment. Neither Humboldt Institute nor the Ministry of Environment had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Anderson R.P., 2016, FINAL REPORT TASK GR; Anderson RP, 2012, ANN NY ACAD SCI, V1260, P66, DOI 10.1111/j.1749-6632.2011.06440.x; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; [Anonymous], 2011, ECOLOGICAL NICHES GE; [Anonymous], 2010, MAPPING SPECIES DIST; Araujo MB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat4858; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beck J, 2013, DIVERS DISTRIB, V19, P1043, DOI 10.1111/ddi.12083; Belbin L, 2013, ZOOKEYS, P67, DOI 10.3897/zookeys.305.5438; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Bogota D. C., 2016, LIBRO ROJO AVES COLO; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; BUCKLIN DN, 2015, DIVERS DISTRIB, V21, P23, DOI DOI 10.1111/ddi.12247; Geijzendorffer IR, 2016, J APPL ECOL, V53, P1341, DOI 10.1111/1365-2664.12417; Giannini TC, 2012, ECOL MODEL, V244, P127, DOI 10.1016/j.ecolmodel.2012.06.035; Guevara L, 2018, GLOBAL CHANGE BIOL, V24, P1511, DOI 10.1111/gcb.13992; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A., 2017, APPL R; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Kass JM, 2018, METHODS ECOL EVOL, V9, P1151, DOI 10.1111/2041-210X.12945; Kissling WD, 2018, BIOL REV, V93, P600, DOI 10.1111/brv.12359; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Liu C, 2018, ECOGRAPHY; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lomolino MV, FRONTIERS BIOGEOGRAP; Lopez-Gallego C, 2019, ATLAS BIODIVERSIDAD; Merow C, 2017, GLOBAL ECOL BIOGEOGR, V26, P243, DOI 10.1111/geb.12539; Meyer C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9221; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Navarro LM, 2017, CURR OPIN ENV SUST, V29, P158, DOI 10.1016/j.cosust.2018.02.005; Ocampo-Penuela N, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601367; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Peterson AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000261; Peterson AT, 2006, AM J TROP MED HYG, V75, P9, DOI 10.4269/ajtmh.2006.75.1.0750009; Peterson AT, 2018, BIODIVERS CONSERV, V27, P1277, DOI 10.1007/s10531-017-1479-5; Peterson AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002441; Peterson AT, 2005, INTERPRETATION; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Qiao HJ, 2015, METHODS ECOL EVOL, V6, P1126, DOI 10.1111/2041-210X.12397; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Renjifo LM, 2014, LIBRO ROJO AVES COLO, VI; Renjifo LM, 2016, LIBRO ROJO AVES COLO, VII, P564; Schmeller DS, 2018, BIOL REV, V93, P55, DOI 10.1111/brv.12332; Serra-Diaz JM, 2018, FOR ECOSYST, V4, DOI 10.1186/s40663-017-0120-0; Sousa-Baena MS, 2014, DIVERS DISTRIB, V20, P369, DOI 10.1111/ddi.12136; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121	55	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214522	10.1371/journal.pone.0214522	http://dx.doi.org/10.1371/journal.pone.0214522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917178	gold, Green Published, Green Submitted			2022-12-27	WOS:000462465800070
J	Delay, ER; Socia, SH; Girardin, JL; Jewkes, BC; King, JH; Delay, RJ				Delay, Eugene R.; Socia, Sarah H.; Girardin, Jessica L.; Jewkes, Benjamin C.; King, John H.; Delay, Rona J.			Cyclophosphamide and the taste system: Effects of dose fractionation and amifostine on taste cell renewal	PLOS ONE			English	Article							PATIENTS RECEIVING CHEMOTHERAPY; RADIOPROTECTOR WR-2721; LOCOMOTOR-ACTIVITY; URINARY-BLADDER; SMELL CHANGES; BUD CELL; CANCER; RECEPTOR; MICE; RAT	Chemotherapy often causes side effects that include disturbances in taste functions. Cyclophosphamide (CYP) is a chemotherapy drug that, after a single dose, elevates murine taste thresholds at times related to drug-induced losses of taste sensory cells and disruptions of proliferating cells that renew taste sensory cells. Pretreatment with amifostine can protect the taste system from many of these effects. This study compared the effects of a single dose (75 mg/kg) of CYP with effects generated by fractionated dosing of CYP (5 doses of 15 mg/kg), a dosing approach often used during chemotherapy, on the taste system of mice using immunohistochemistry. Dose fractionation prolonged the suppressive effects of CYP on cell proliferation responsible for renewal of taste sensory cells. Fractionation also reduced the total number of cells and the proportion of Type II cells within taste buds. The post-injection time of these losses coincided with the life span of Type I and II taste cells combined with lack of replacement cells. Fractionated dosing also decreased Type III cells more than a single dose, but loss of these cells may be due to factors related to the general health and/or cell renewal of taste buds rather than the life span of Type III cells. In general, pretreatment with amifostine appeared to protect taste cell renewal and the population of cells within taste buds from the cytotoxic effects of CYP with few observable adverse effects due to repeated administration. These findings may have important implications for patients undergoing chemotherapy.	[Delay, Eugene R.; Socia, Sarah H.; Girardin, Jessica L.; Jewkes, Benjamin C.; King, John H.; Delay, Rona J.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Delay, Eugene R.; Socia, Sarah H.; Girardin, Jessica L.; Jewkes, Benjamin C.; King, John H.; Delay, Rona J.] Univ Vermont, Neurosci Program, Burlington, VT USA	University of Vermont; University of Vermont	Delay, ER (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	edelay@uvm.edu			National Institutes of Health [R01DC012829]; University of Vermont Biology Department; Honors College	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Vermont Biology Department; Honors College	This research was supported by National Institutes of Health (www.NIH.gov) Grant R01DC012829 awarded to ERD. University of Vermont Biology Department and the Honors College for additional undergraduate funding to SHS, JLG and BCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaldriks AA, 2013, J GERIATR ONCOL, V4, P218, DOI 10.1016/j.jgo.2013.04.001; ANDERSON D, 1995, MUTAT RES-FUND MOL M, V330, P115, DOI 10.1016/0027-5107(95)00039-L; Andreassen CN, 2003, SEMIN RADIAT ONCOL, V13, P62, DOI 10.1053/srao.2003.50006; BAGLEY CM, 1973, CANCER RES, V33, P226; Bernhardson BM, 2008, SUPPORT CARE CANCER, V16, P275, DOI 10.1007/s00520-007-0319-7; Bernhardson BM, 2007, J PAIN SYMPTOM MANAG, V34, P403, DOI 10.1016/j.jpainsymman.2006.12.010; Boltong A, 2012, CANCER TREAT REV, V38, P152, DOI 10.1016/j.ctrv.2011.04.008; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; CROOK TR, 1986, CANCER RES, V46, P5029; Culy CR, 2001, DRUGS, V61, P641, DOI 10.2165/00003495-200161050-00012; Davidson W, 2012, ONCOL NURS FORUM, V39, P398, DOI 10.1188/12.ONF.E340-E345; Dorr RT, 1998, SEMIN RADIAT ONCOL, V8, P10; Feng P, 2015, BRAIN BEHAV IMMUN, V49, P32, DOI 10.1016/j.bbi.2015.04.001; Feng P, 2014, J NEUROSCI, V34, P2689, DOI 10.1523/JNEUROSCI.3074-13.2014; Feng P, 2014, CHEM SENSES, V39, P3, DOI 10.1093/chemse/bjt059; Feng P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043140; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Gaillard D, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006990; Gaillard D, 2011, GENESIS, V49, P295, DOI 10.1002/dvg.20731; Gamper EM, 2012, ACTA ONCOL, V51, P490, DOI 10.3109/0284186X.2011.633554; Girard BM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00020; Girard BM, 2011, AM J PHYSIOL-RENAL, V300, pF345, DOI 10.1152/ajprenal.00515.2010; Grochov? D., 2007, J APPL BIOMED, V5, P171, DOI [10.32725/jab.2007.023, DOI 10.32725/JAB.2007.023]; Grochova D, 2008, ONCOGENE, V27, P1243, DOI 10.1038/sj.onc.1210748; Hacker K, 2008, J NEUROPHYSIOL, V99, P1503, DOI 10.1152/jn.00892.2007; HOLMES S, 1993, SUPPORT CARE CANCER, V1, P326, DOI 10.1007/BF00364971; Howell D.C., 2013, FUNDAMENTAL STAT BEH, V8th, P488; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jewkes BC, 2018, CHEM SENSES, V43, P399, DOI 10.1093/chemse/bjy026; Jezernik K, 2003, CELL BIOL INT, V27, P863, DOI 10.1016/S1065-6995(03)00175-6; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kouvaris JR, 2007, ONCOLOGIST, V12, P738, DOI 10.1634/theoncologist.12-6-738; Lamar ZS, 2016, CL LYMPH MYELOM LEUK, V16, P76, DOI 10.1016/j.clml.2015.11.012; LANDAUER MR, 1988, TOXICOLOGY, V49, P315, DOI 10.1016/0300-483X(88)90014-5; LANDAUER MR, 1988, PHARMACOL THERAPEUT, V39, P97, DOI 10.1016/0163-7258(88)90046-0; LANDAUER MR, 1987, PHARMACOL BIOCHEM BE, V27, P573, DOI 10.1016/0091-3057(87)90370-4; LEVIN L, 1987, J CLIN ONCOL, V5, P756, DOI 10.1200/JCO.1987.5.5.756; Miura H, 2010, ARCH ITAL BIOL, V148, P107; Miura H, 2001, MECH DEVELOP, V106, P143, DOI 10.1016/S0925-4773(01)00414-2; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Miura H, 2014, DEV DYNAM, V243, P1286, DOI [10.1002/DVDY.24121, 10.1002/dvdy.24121]; Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006; Mukherjee N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185473; Mukherjee N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061607, 10.1371/annotation/5487e265-8175-47cb-b9a4-d85862a4a96f]; Nakayama A, 2015, CELL TISSUE RES, V359, P743, DOI 10.1007/s00441-014-2076-5; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nguyen HM, 2012, J NEUROSCI, V32, P3474, DOI 10.1523/JNEUROSCI.4167-11.2012; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Roper SD, 2017, NAT REV NEUROSCI, V18, P485, DOI 10.1038/nrn.2017.68; Roper S, 2015, PFLUG ARCH EUR J PHY, V467, P457, DOI 10.1007/s00424-014-1683-z; Seed TM, 2014, INT J RADIAT BIOL, V90, P594, DOI 10.3109/09553002.2014.899450; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Smith A, 2015, J CANC THERAPY, V6, P182, DOI [10.4236/jct.2015.62021, DOI 10.4236/JCT.2015.62021]; Steinbach S, 2009, J CLIN ONCOL, V27, P1899, DOI 10.1200/JCO.2008.19.2690; Taniguchi R, 2005, ARCH HISTOL CYTOL, V68, P243, DOI 10.1679/aohc.68.243; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; Wang H, 2009, ANN NY ACAD SCI, V1170, P596, DOI 10.1111/j.1749-6632.2009.04480.x; Wickham R S, 1999, Oncol Nurs Forum, V26, P697; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zabernigg A, 2010, ONCOLOGIST, V15, P913, DOI 10.1634/theoncologist.2009-0333	63	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214890	10.1371/journal.pone.0214890	http://dx.doi.org/10.1371/journal.pone.0214890			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947285	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500079
J	Glas, A; Hubener, M; Bonhoeffer, T; Goltstein, PM				Glas, Annet; Huebener, Mark; Bonhoeffer, Tobias; Goltstein, Pieter M.			Benchmarking miniaturized microscopy against two-photon calcium imaging using single-cell orientation tuning in mouse visual cortex	PLOS ONE			English	Article							RECEPTIVE-FIELDS; SUBTYPES; NEURONS	Miniaturized microscopes are lightweight imaging devices that allow optical recordings from neurons in freely moving animals over the course of weeks. Despite their ubiquitous use, individual neuronal responses measured with these microscopes have not been directly compared to those obtained with established in vivo imaging techniques such as bench-top two-photon microscopes. To achieve this, we performed calcium imaging in mouse primary visual cortex while presenting animals with drifting gratings. We identified the same neurons in image stacks acquired with both microscopy methods and quantified orientation tuning of individual neurons. The response amplitude and signal-to-noise ratio of calcium transients recorded upon visual stimulation were highly correlated between both microscopy methods, although influenced by neuropil contamination in miniaturized microscopy. Tuning properties, calculated for individual orientation tuned neurons, were strongly correlated between imaging techniques. Thus, neuronal tuning features measured with a miniaturized microscope are quantitatively similar to those obtained with a two-photon microscope.	[Glas, Annet; Huebener, Mark; Bonhoeffer, Tobias; Goltstein, Pieter M.] Max Planck Inst Neurobiol, Martinsried, Germany; [Glas, Annet] Grad Sch System Neurosci, Martinsried, Germany	Max Planck Society	Goltstein, PM (corresponding author), Max Planck Inst Neurobiol, Martinsried, Germany.	goltstein@neuro.mpg.de	Goltstein, Pieter/GVU-3883-2022		Max Planck Society; German Research Foundation (DFG) [SFB870]	Max Planck Society(Max Planck Society); German Research Foundation (DFG)(German Research Foundation (DFG))	This project was funded by the Max Planck Society and the Collaborative Research Center SFB870 of the German Research Foundation (DFG) to T.B. and M.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goltstein PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118277; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grinvald A, 1996, BRAIN MAPPING METHOD, P55; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kamigaki T, 2017, NAT NEUROSCI, V20, P854, DOI 10.1038/nn.4554; Keemink S. W., 2018, SCI REPORTS, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Klaus A, 2017, NEURON, V95, P1171, DOI 10.1016/j.neuron.2017.08.015; Leinweber M, 2014, JOVE-J VIS EXP, DOI 10.3791/50885; Liberti WA, 2016, NAT NEUROSCI, V19, P1665, DOI 10.1038/nn.4405; Lu JH, 2018, CELL REP, V23, P3673, DOI 10.1016/j.celrep.2018.05.062; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mazurek M., 2014, FRONT NEURAL CIRCUIT, V8, P1, DOI DOI 10.3389/FNCIR.2014.00001; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poort J, 2015, NEURON, V86, P1478, DOI 10.1016/j.neuron.2015.05.037; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rose T, 2016, SCIENCE, V352, P1319, DOI 10.1126/science.aad3358; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuett S, 2002, J NEUROSCI, V22, P6549; Yang WJ, 2017, NAT METHODS, V14, P349, DOI 10.1038/nmeth.4230; Yu H, 2015, NEUROIMAGE, V113, P397, DOI 10.1016/j.neuroimage.2015.02.070; Zhou P, 2018, ELIFE, V7, DOI 10.7554/eLife.28728; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; Zong WJ, 2017, NAT METHODS, V14, P713, DOI 10.1038/nmeth.4305	31	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214954	10.1371/journal.pone.0214954	http://dx.doi.org/10.1371/journal.pone.0214954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947245	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500092
J	Blazquez, BO; Masluk, B; Gascon, S; Diaz, RF; Aguilar-Latorre, A; Magallon, IA; Botaya, RM				Olivan Blazquez, Barbara; Masluk, Barbara; Gascon, Santiago; Fueyo Diaz, Ricardo; Aguilar-Latorre, Alejandra; Artola Magallon, Isabel; Magallon Botaya, Rosa			The use of flipped classroom as an active learning approach improves academic performance in social work: A randomized trial in a university	PLOS ONE			English	Article							EDUCATION; IMPACT; REDESIGN	Background The flipped classroom (FC) is a pedagogical approach that means that the activities that have traditionally taken place within the classroom are carried out outside the classroom. Fundamentally it implies the way in which the student studies the subject. This change of perspective in teaching-learning has raised many questions regarding its effectiveness and student satisfaction in the university studies in the degree of Social Work. Objective The main objective of this study was to evaluate the effectiveness of a Flipped Classroom methodology in the academic performance of students of the Social Work Degree. Methods An educational study, with two parallel groups was developed. The randomization was carried out by class groups. Group 1 was assigned an active teaching methodology of Flip Teaching and it was implemented during theoretical teaching hours. The other group of students, Group 2, was assigned a traditional lecturer-based learning (LB) methodology. The participants were all the students of the morning shift who studied the subject Social Work with Groups of the Social Work Degree during the academic year 2017-2018. The sample was composed of 110 subjects, with 60 subjects who developed an active teaching methodology and 50 subjects who received a LB. Results In terms of the academic performance result variable, the FT group had a mean of 6.56 (SD: 1.58) and the LB group had a mean of 5.42 (SD: 1.97) (p-value: 0.002). The FT group also had a higher percentage of students receiving merit and outstanding scores (34.5% and 6.9% respectively) and a lower percentage of students who failed (19%) as compared to the LB group in which 20.9% and 2.3% of the students received merit or outstanding grades and 46.5% failed (p-value = 0.025). No significant differences were found with regards to satisfaction with the subject and the methodology used, long-term learning and time spent preparing for the exam. Conclusions The FC teaching methodology in comparison with the LB methodology has shown to be a more effective tool regarding academic performance evaluated in a quantitative and qualitative way with regards to Social Work education at university level.	[Olivan Blazquez, Barbara; Masluk, Barbara; Gascon, Santiago; Fueyo Diaz, Ricardo] Univ Zaragoza, Fac Labour & Social Sci, Dept Psychol & Sociol, Zaragoza, Spain; [Olivan Blazquez, Barbara; Masluk, Barbara; Gascon, Santiago; Fueyo Diaz, Ricardo; Aguilar-Latorre, Alejandra; Magallon Botaya, Rosa] Inst Hlth Res Aragon IIS, Zaragoza, Spain; [Olivan Blazquez, Barbara; Masluk, Barbara; Fueyo Diaz, Ricardo; Aguilar-Latorre, Alejandra; Magallon Botaya, Rosa] Govt Aragon, Dept Res Innovat & Univ, Res Grp B21 R17, Zaragoza, Spain; [Artola Magallon, Isabel] Autonomous Community Madrid, Educ Council Board, Madrid, Spain	University of Zaragoza	Masluk, B (corresponding author), Univ Zaragoza, Fac Labour & Social Sci, Dept Psychol & Sociol, Zaragoza, Spain.; Masluk, B (corresponding author), Inst Hlth Res Aragon IIS, Zaragoza, Spain.; Masluk, B (corresponding author), Govt Aragon, Dept Res Innovat & Univ, Res Grp B21 R17, Zaragoza, Spain.	bmasluk@unizar.es	FUEYO-DÍAZ, RICARDO/AAC-2200-2019; Aguilar-Latorre, Alejandra/AAU-2908-2021; Masluk, Barbara/AAY-4440-2021; Aguilar-Latorre, Alejandra/AAU-2074-2021; Masluk, Barbara/AAD-4499-2021; Oliván-Blázquez, Bárbara/AAS-2130-2020	FUEYO-DÍAZ, RICARDO/0000-0002-0493-1641; Aguilar-Latorre, Alejandra/0000-0003-2683-7346; Aguilar-Latorre, Alejandra/0000-0003-2683-7346; Masluk, Barbara/0000-0001-9887-2250; Oliván-Blázquez, Bárbara/0000-0001-6565-9699; Gascon, Santiago/0000-0002-3723-0673	University of Zaragoza [PIIDUZ_1_137]; University of Zaragoza; Department of Research, Innovation and University of the Government of Aragon (Spain) [B21_R17]; Feder Funds "Another way to make Europe"	University of Zaragoza; University of Zaragoza; Department of Research, Innovation and University of the Government of Aragon (Spain); Feder Funds "Another way to make Europe"	The study has been financed by the University of Zaragoza (call for teaching innovation PIIDUZ_1_137).; We wish to thank the University of Zaragoza, the Research Group B21_R17 of the Department of Research, Innovation and University of the Government of Aragon (Spain), and Feder Funds "Another way to make Europe" for their support in the development of the study.	Albert M, 2014, J EDUC BUS, V89, P419, DOI 10.1080/08832323.2014.929559; Baepler P, 2014, COMPUT EDUC, V78, P227, DOI 10.1016/j.compedu.2014.06.006; Balestrery JE, 2016, SOC WORK EDUC, V35, P615, DOI 10.1080/02615479.2016.1151490; Basso-Aránguiz Matilde, 2018, Educare, V22, P20, DOI 10.15359/ree.22-2.2; Beom JH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203114; Bergmann J., 2012, FLIP YOUR CLASSROOM; Betihavas V, 2016, NURS EDUC TODAY, V38, P15, DOI 10.1016/j.nedt.2015.12.010; Bonnes SL, 2017, ACAD MED, V92, P101, DOI 10.1097/ACM.0000000000001412; Bossaer JB, 2016, AM J PHARM EDUC, V80, DOI 10.5688/ajpe80231; Burnham KD, 2018, J CHIPROPR EDUC, V32, P90, DOI 10.7899/JCE-17-21; Chen F, 2017, MED EDUC, V51, P585, DOI 10.1111/medu.13272; Chen KS, 2018, MED EDUC, V52, P910, DOI 10.1111/medu.13616; Deprey SM., 2018, J PHYS THERAPY ED, V32, P289, DOI [10.1097/JTE.0000000000000035, DOI 10.1097/JTE.0000000000000035]; European Council, 2000, EXTR CONCL PRES; Geist MJ, 2015, NURS EDUC PERSPECT, V36, P114, DOI 10.5480/13-1292; Graeff TR., 2010, MARKET ED REV, V20, P265; Heitz C, 2015, WEST J EMERG MED, V16, P851, DOI 10.5811/westjem.2015.9.27256; Holmes MR, 2015, CLIN SOC WORK J, V43, P215, DOI 10.1007/s10615-015-0521-x; Kirkpatrick Donal L, 1959, J AM SOC TRAINING DI, V13, P3; Kober L, 2015, REACHING STUDENTS WH; Lombardini C, 2018, INT REV ECON EDUC, V29, P14, DOI 10.1016/j.iree.2018.01.003; Sein-Echaluce ML, 2018, INT J ENG EDUC, V34, P851; Manterola C, 2009, REV CHIL CIR, V61, P582; McDonald K, 2013, J CONTIN EDUC NURS, V44, P437, DOI 10.3928/00220124-20130925-19; McLaughlin JE, 2014, ACAD MED, V89, P236, DOI 10.1097/ACM.0000000000000086; Moffett J, 2014, ADV MED EDUC PRACT, V5, P415, DOI 10.2147/AMEP.S70160; Njie-Carr VPS, 2017, J PROF NURS, V33, P133, DOI 10.1016/j.profnurs.2016.07.001; Pierce R, 2012, AM J PHARM EDUC, V76, DOI 10.5688/ajpe7610196; Presti CR, 2016, J NURS EDUC, V55, P252, DOI 10.3928/01484834-20160414-03; Roach T, 2014, INT REV ECON EDUC, V17, P74, DOI 10.1016/j.iree.2014.08.003; Rotellar C, 2016, AM J PHARM EDUC, V80, DOI 10.5688/ajpe80234; Sage M, 2015, J SOC WORK EDUC, V51, P668, DOI 10.1080/10437797.2015.1076274; Sahin A, 2015, EDUC TECHNOL SOC, V18, P142; Smith JD, 2013, CHEM EDUC RES PRACT, V14, P607, DOI 10.1039/c3rp00083d; STEINBERG DM, 1993, SOC WORK GROUPS, V16, P23; Tune JD, 2013, ADV PHYSIOL EDUC, V37, P316, DOI 10.1152/advan.00091.2013; van Vliet EA, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.14-09-0141; Weinstein RD, 2015, CHEM ENG EDUC, V49, P141; Wu JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204698	39	29	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214623	10.1371/journal.pone.0214623	http://dx.doi.org/10.1371/journal.pone.0214623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947270	Green Submitted, gold, Green Published			2022-12-27	WOS:000463314500048
J	Toledano, MB; Mukherjee, SK; Howell, J; Westaby, D; Khan, SA; Bilton, D; Simmonds, NJ				Toledano, M. B.; Mukherjee, S. K.; Howell, J.; Westaby, D.; Khan, S. A.; Bilton, D.; Simmonds, N. J.			The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study	PLOS ONE			English	Article							RISK-FACTORS; DIAGNOSIS; EPIDEMIOLOGY; MANAGEMENT; SARCOPENIA; CHILDREN	Objective Cystic fibrosis associated liver disease (CFLD) is the third largest cause of mortality in CF. Our aim was to define the burden of CFLD in the UK using national registry data and identify risk factors for progressive disease. Methods A longitudinal population-based cohort study was conducted. Cases were defined as all patients with CFLD identified from the UK CF Registry, 2008-2013 (n = 3417). Denominator data were derived from the entire UK CF Registry. The burden of CFLD was characterised. Regression analysis was undertaken to identify risk factors for cirrhosis and progression. Results Prevalence of CFLD increased from 203.4 to 228.3 per 1000 patients during 2008-2013. Mortality in CF patients with CFLD was more than double those without; cirrhotic patients had higher all-cause mortality (HR 1.54, 95% CI 1.09 to 2.18, p = 0.015). Median recorded age of cirrhosis diagnosis was 19 (range 5-53) years. Male sex, Pseudomonas airway infection and CF related diabetes were independent risk factors for cirrhosis. Ursodeoxycholic acid use was associated with prolonged survival in patients without cirrhosis. Conclusions This study highlights an important changing disease burden of CFLD. The prevalence is slowly increasing and, importantly, the disease is not just being diagnosed in childhood. Although the role of ursodeoxycholic acid remains controversial, this study identified a positive association with survival.	[Toledano, M. B.] Imperial Coll London, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London, England; [Mukherjee, S. K.; Khan, S. A.] Imperial Coll London, Liver Unit, St Marys Hosp, London, England; [Howell, J.] St Vincents Hosp, Burnet Inst Ctr Publ Hlth, Melbourne, Vic, Australia; [Westaby, D.] Hammersmith Hosp, Dept Gastroenterol, London, England; [Bilton, D.; Simmonds, N. J.] Royal Brompton Hosp, Adult Cyst Fibrosis Ctr, London, England; [Bilton, D.; Simmonds, N. J.] Imperial Coll, Natl Heart & Lung Inst, London, England	Imperial College London; Imperial College London; St Vincent's Hospital Melbourne; Imperial College London; Royal Brompton Hospital; Imperial College London	Toledano, MB (corresponding author), Imperial Coll London, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London, England.	m.toledano@imperial.ac.uk		Bilton, Diana/0000-0002-1913-9171	NIHR Academic Clinical Fellowship; NHMRC (Australia) Early Career Fellowship; NIHR	NIHR Academic Clinical Fellowship; NHMRC (Australia) Early Career Fellowship; NIHR(National Institute for Health Research (NIHR))	S K Mukherjee is supported by NIHR Academic Clinical Fellowship. J Howell is supported by an NHMRC (Australia) Early Career Fellowship. D Bilton and NJ Simmonds are supported by the NIHR funded specialist Respiratory Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College. NJ Simmonds has consulted for Vertex, Gilead, Chiesi, Teva, Roche and Pulmocide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Alvaro D, 2000, GASTROENTEROLOGY, V119, P1681, DOI 10.1053/gast.2000.20184; Baraldi Olga, 2015, World J Nephrol, V4, P511, DOI 10.5527/wjn.v4.i5.511; Bartlett JR, 2009, JAMA-J AM MED ASSOC, V302, P1076, DOI 10.1001/jama.2009.1295; Boelle P.-Y., 2018, CYSTIC FIBROSIS LIVE, DOI [10.1002/hep.30148, DOI 10.1002/HEP.30148]; Borzio M, DIG LIVER DIS, V33, P41; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Chen AH, 2005, AM J CLIN NUTR, V81, P686; Cheng K, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000222.pub4; Chryssostalis A, 2011, J HEPATOL, V55, P1377, DOI 10.1016/j.jhep.2011.03.028; COLOMBO C, 1994, J PEDIATR-US, V124, P393, DOI 10.1016/S0022-3476(94)70361-2; Colombo C, 1996, HEPATOLOGY, V23, P1484; Colombo C, 2002, HEPATOLOGY, V36, P1374, DOI 10.1053/jhep.2002.37136; Corbett K, 2004, J PEDIATR-US, V145, P327, DOI 10.1016/j.jpeds.2004.05.051; Cystic Fibrosis Trust, 2011, STAND CLIN CAR CHILD; Dasarathy S, 2016, J HEPATOL, V65, P1232, DOI 10.1016/j.jhep.2016.07.040; Debray D, 2017, J PEDIATR GASTR NUTR, V65, P443, DOI 10.1097/MPG.0000000000001676; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Desmond CP, 2007, LIVER INT, V27, P1402, DOI 10.1111/j.1478-3231.2007.01570.x; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Foundation CF, 2008, PAT REG 2006 ANN REP; Jeffery A, 2017, UK CYSTIC FIBROSIS R, V80; Koh C, 2017, HEPATOLOGY, V66, P591, DOI 10.1002/hep.29217; Lamireau T, 2004, J HEPATOL, V41, P920, DOI 10.1016/j.jhep.2004.08.006; Lindblad A, 1999, HEPATOLOGY, V30, P1151, DOI 10.1002/hep.510300527; LINDBLAD A, 1995, J PEDIATR-US, V126, P155, DOI 10.1016/S0022-3476(95)70528-7; Ling SC, 1999, ARCH DIS CHILD, V81, P129, DOI 10.1136/adc.81.2.129; Lurz E, 2018, J PEDIATR GASTR NUTR, V66, P222, DOI 10.1097/MPG.0000000000001792; Parkins Michael D, 2011, Ther Adv Respir Dis, V5, P105, DOI 10.1177/1753465810386051; Quon BS, 2012, PAEDIATR RESPIR REV, V13, P206, DOI 10.1016/j.prrv.2012.03.005; Rodriguez-Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI 10.1056/NEJMra0707185; Ruiz-del-Arbol L, 2015, WORLD J GASTROENTERO, V21, P11502, DOI 10.3748/wjg.v21.i41.11502; Schaible B, 2012, ANTIMICROB AGENTS CH, V56, P2114, DOI 10.1128/AAC.05574-11; SCOTTJUPP R, 1991, ARCH DIS CHILD, V66, P698, DOI 10.1136/adc.66.6.698; Sokol RJ, 1999, J PEDIATR GASTR NUTR, V28, pS1, DOI 10.1097/00005176-199900001-00001; Stonebraker JR, 2016, CLIN GASTROENTEROL H, V14, P1207, DOI 10.1016/j.cgh.2016.03.041; Taylor-Robinson D, 2018, INT J EPIDEMIOL, V47, P9, DOI 10.1093/ije/dyx196; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Wilschanski M, 1999, PEDIATRICS, V103, P52, DOI 10.1542/peds.103.1.52; Ye W, 2018, J PEDIATR GASTR NUTR, V66, P122, DOI 10.1097/MPG.0000000000001728	41	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0212779	10.1371/journal.pone.0212779	http://dx.doi.org/10.1371/journal.pone.0212779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947265	Green Published, gold			2022-12-27	WOS:000463314500009
J	Wang, WC; Yuan, ZZ; Yang, Y; Yang, XB; Liu, YT				Wang, Wencheng; Yuan, Zhenzhou; Yang, Yang; Yang, Xiaobao; Liu, Yanting			Factors influencing traffic accident frequencies on urban roads: A spatial panel time-fixed effects error model	PLOS ONE			English	Article							MOTOR-VEHICLE CRASHES; SAFETY; HETEROGENEITY; CONGESTION; SHANGHAI	China's rapid urbanization and high traffic accident frequency have received many researchers' attention. It is important to reveal how urban infrastructures and other risk factors affects the traffic accident frequency. A growing amount of research has examined the local risk factors impact on traffic accident frequency at certain time. Some studies considered these spatial influences but overlooked the temporal correlation/heterogeneity of traffic accidents and related risk factors. This study explores risk factors' influence on urban traffic accidents frequency while considering both the spatial and temporal correlation/heterogeneity of traffic accidents. The study area is split into 100 equally sized rectangle traffic analysis zones (TAZs), and the urban traffic accident frequency and attributes in each TAZ are extracted. The linear regression model, spatial lag model (SLM), spatial error model (SEM) and time-fixed effects error model (T-FEEM) are established and compared respectively. The proposed methodologies are illustrated using ten-month traffic accident data from the urban area of Guiyang City, China. The results reveal that the time-fixed effects error model, which considers both spatial and temporal correlation/heterogeneity of traffic accidents, is superior to other models. More traffic accidents will happen in those TAZs that have more hospitals or schools. Moreover, hospitals have a greater influence on traffic accidents than schools. Because of the location in the margin of the city, those TAZs that have passenger stations have more traffic accidents. This study provides policy makers with more detailed characterization about the impact of related risk factors on traffic accident frequencies, and it is suggested that not only the spatial correlation/heterogeneity but also the temporal correlation/heterogeneity should be taken into account in guiding traffic accident control of urban area.	[Wang, Wencheng; Yuan, Zhenzhou; Yang, Yang; Yang, Xiaobao] Beijing Jiaotong Univ, Key Lab Transport Ind Big Data Applicat Technol C, Beijing, Peoples R China; [Wang, Wencheng] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA; [Yang, Yang] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Liu, Yanting] Tongji Univ, Key Lab Rd & Traff Engn, Minist Educ, Shanghai, Peoples R China	Beijing Jiaotong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle; Tongji University	Yang, Y; Yang, XB (corresponding author), Beijing Jiaotong Univ, Key Lab Transport Ind Big Data Applicat Technol C, Beijing, Peoples R China.; Yang, Y (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	14114222@bjtu.edu.cn; yangxb@bjtu.edu.cn	YANG, YANG/ABD-9242-2021	YANG, YANG/0000-0002-7132-5860	Fundamental Research Funds for the Central Universities [2018JBM023]; National Natural Science Foundation of China [91746201, 71621001]; China Scholarship Council [201707090042]; Center of Cooperative Innovation for Beijing Metropolitan Transportation	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Center of Cooperative Innovation for Beijing Metropolitan Transportation	This research was jointly supported by Fundamental Research Funds for the Central Universities (No. 2018JBM023), the National Natural Science Foundation of China (Grant Nos. 91746201 and 71621001), China Scholarship Council (201707090042), and Center of Cooperative Innovation for Beijing Metropolitan Transportation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2013, SPATIAL ECONOMETRICS; BESAG JE, 1972, J ROY STAT SOC B, V34, P75; Castro M, 2012, TRANSPORT RES B-METH, V46, P253, DOI 10.1016/j.trb.2011.09.007; Chang LY, 2005, SAFETY SCI, V43, P541, DOI 10.1016/j.ssci.2005.04.004; Clifton KJ, 2007, ACCIDENT ANAL PREV, V39, P708, DOI 10.1016/j.aap.2006.11.003; Clifton KJ, 2009, TRANSPORT RES D-TR E, V14, P425, DOI 10.1016/j.trd.2009.01.001; Elhorst JP, 2014, SPRINGERBR REG SCI, P1, DOI 10.1007/978-3-642-40340-8; Elhorst JP, 2003, INT REGIONAL SCI REV, V26, P244, DOI 10.1177/0160017603253791; Guo F, 2010, ACCIDENT ANAL PREV, V42, P84, DOI 10.1016/j.aap.2009.07.005; Guo YY, 2018, ACCIDENT ANAL PREV, V113, P38, DOI 10.1016/j.aap.2018.01.015; Guo YY, 2016, ACCIDENT ANAL PREV, V95, P438, DOI 10.1016/j.aap.2015.07.001; Guo YY, 2016, CAN J CIVIL ENG, V43, P631, DOI 10.1139/cjce-2015-0478; Huang HL, 2016, ACCIDENT ANAL PREV, V95, P305, DOI 10.1016/j.aap.2016.07.040; Huang H, 2010, ACCIDENT ANAL PREV, V42, P1556, DOI 10.1016/j.aap.2010.03.013; Huang HL, 2010, TRANSPORT RES REC, P27, DOI 10.3141/2148-04; Jovanis P. P., 1986, TRANSPORTATION RES R, P42; LeSage J, 2009, STAT TEXTB MONOGR, P1; Li XG, 2008, ACCIDENT ANAL PREV, V40, P1611, DOI 10.1016/j.aap.2008.04.010; Loo B.P.Y., 2011, GEOINF 2011 19 INT C, P1, DOI 10.1109/GeoInformatics.2011.5980938; Lord D, 2000, TRANSPORT RES REC, P102, DOI 10.3141/1717-13; Ma CX, 2018, J ADV TRANSPORT, DOI 10.1155/2018/9841498; Ma CX, 2018, IEEE ACCESS, V6, DOI 10.1109/ACCESS.2018.2869890; MIAOU SP, 1994, ACCIDENT ANAL PREV, V26, P471, DOI 10.1016/0001-4575(94)90038-8; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; NBSC NBOS, 2018, CHIN STAT YB; Oh J, 2006, ACCIDENT ANAL PREV, V38, P346, DOI 10.1016/j.aap.2005.10.004; ORD K, 1975, J AM STAT ASSOC, V70, P120, DOI 10.2307/2285387; Pirdavani A, 2012, TRANSPORT RES REC, P145, DOI 10.3141/2280-16; Ponicki WR, 2013, ACCIDENT ANAL PREV, V55, P135, DOI 10.1016/j.aap.2013.03.001; Quddus MA, 2008, ACCIDENT ANAL PREV, V40, P1486, DOI 10.1016/j.aap.2008.03.009; Sun J, 2016, ACCIDENT ANAL PREV, V95, P503, DOI 10.1016/j.aap.2015.12.011; Wang C, 2013, TRANSPORTMETRICA A, V9, P124, DOI 10.1080/18128602.2010.538871; Xie K, 2014, ANAL METHODS ACCID R, V2, P39, DOI 10.1016/j.amar.2014.06.001; Xie K, 2015, ACCIDENT ANAL PREV, V74, P77, DOI 10.1016/j.aap.2014.10.015; Xie K, 2013, ACCIDENT ANAL PREV, V50, P25, DOI 10.1016/j.aap.2012.10.003; Xie YC, 2007, ACCIDENT ANAL PREV, V39, P922, DOI 10.1016/j.aap.2006.12.014; Xu PP, 2015, ACCIDENT ANAL PREV, V75, P16, DOI 10.1016/j.aap.2014.10.020; Yang Y, 2017, ENV ENG MANAGMENT J, V16	39	16	16	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214539	10.1371/journal.pone.0214539	http://dx.doi.org/10.1371/journal.pone.0214539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947277	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500039
J	Yahav, D; Abbas, M; Nassar, L; Ghrayeb, A; Kurnik, D; Shepshelovich, D; Leibovici, L; Paul, M				Yahav, Dafna; Abbas, Maria; Nassar, Laila; Ghrayeb, Alia; Kurnik, Daniel; Shepshelovich, Daniel; Leibovici, Leonard; Paul, Mical			The association of vancomycin trough levels with outcomes among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: Retrospective cohort study	PLOS ONE			English	Article							EFFICACY	Introduction Current guidelines recommend maintaining vancomycin trough concentrations between 15-20 mg/L for serious methicillin resistant staphylococcus aureus (MRSA) infections. This recommendation is based on limited evidence. Methods A retrospective study including patients with vancomycin susceptible MRSA infections (MIC< = 2 mg/L), treated with vancomycin. We compared outcomes among patients attaining high (> = 15mg/L) vs low (<15mg/L) trough vancomycin levels. We used a propensity score to matching patients achieving low and high levels and conducted an adjusted analysis in the propensity score (PS)-matched cohort using regression analysis. Primary outcome was 30-day all-cause mortality. Results Among 285 patients included, there were no significant differences between patients achieving high and low vancomycin levels in mortality (46/131, 35.1% vs 41/154, 26.6%), clinical success, microbiological success, or nephrotoxicity. Similarly, in the PS-matched cohort (n = 162), there was no significant difference in mortality between patients with high and low vancomycin levels (2 4 / 5 3, 45.3% vs 57/109, 52.3%, respectively), adjusted odds ratio for mortality with high levels 0.63 (95% confidence interval 0.28-1.43). In both cohorts, patients with pneumonia achieving high levels had significantly higher clinical and microbiological success (PS-matched cohort: clinical success: 16/32, 50.0% vs 5/27, 18.5%, p = PLOS 0.012; microbiological success: 19/32, 59.4% vs 7/27, 25.9%, p = 0.010), without significant differences in mortality. Conclusions We found no association between vancomycin levels > =15 mg/L and clinical outcomes in patients with MRSA infections. In patients with MRSA pneumonia, vancomycin levels > = 15 mg/L were associated with higher clinical success rates. Further larger cohort studies are needed to define optimal vancomycin levels according to the site of infection.	[Yahav, Dafna] Beilinson Med Ctr, Rabin Med Ctr, Infect Dis Unit, Petah Tiqwa, Israel; [Yahav, Dafna; Abbas, Maria; Shepshelovich, Daniel; Leibovici, Leonard] Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, Israel; [Nassar, Laila; Ghrayeb, Alia; Kurnik, Daniel; Paul, Mical] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Nassar, Laila; Kurnik, Daniel] Rambam Hlth Care Campus, Clin Pharmacol Unit, Haifa, Israel; [Shepshelovich, Daniel] Beilinson Med Ctr, Rabin Med Ctr, Med A, Petah Tiqwa, Israel; [Leibovici, Leonard] Beilinson Med Ctr, Rabin Med Ctr, Med E, Petah Tiqwa, Israel; [Paul, Mical] Rambam Hlth Care Campus, Inst Infect Dis, Haifa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rabin Medical Center; Rabin Medical Center; Rambam Health Care Campus	Yahav, D (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Infect Dis Unit, Petah Tiqwa, Israel.; Yahav, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, Israel.	dafna.yahav@gmail.com	Yahav, Dafna/AAX-9961-2020; Shepshelovich, Daniel/AAB-1142-2019	Yahav, Dafna/0000-0003-3181-9791; Kurnik, Daniel/0000-0002-8462-7673	State of Israel Ministry of Science, Technology Space [3-12075]	State of Israel Ministry of Science, Technology Space	This study was funded in part by the State of Israel Ministry of Science, Technology & Space, "Optimizing diagnosis, treatment and outcome definitions in elderly patients with bacterial infections", Grant number 3-12075, author who received the grant: MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Al-Hasan MN, 2013, CLIN MICROBIOL INFEC, V19, P948, DOI 10.1111/1469-0691.12085; Bakke V, 2017, ACTA ANAESTH SCAND, V61, P627, DOI 10.1111/aas.12897; Holmes NE, 2013, ANTIMICROB AGENTS CH, V57, P1654, DOI 10.1128/AAC.01485-12; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Stein GE, 2010, CURR MED RES OPIN, V26, P571, DOI 10.1185/03007990903512057; Steinmetz T, 2015, CLIN MICROBIOL INFEC, V21, P665, DOI 10.1016/j.cmi.2015.04.003; Stulik L, 2017, CLIN INFECT DIS, V64, P1081, DOI 10.1093/cid/cix055; Tongsai Sasima, 2016, BMC Res Notes, V9, P455	10	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214309	10.1371/journal.pone.0214309	http://dx.doi.org/10.1371/journal.pone.0214309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946754	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500025
J	Heinze, T; Jappe, A; Pithan, D				Heinze, Thomas; Jappe, Arlette; Pithan, David			From North American hegemony to global competition for scientific leadership? Insights from the Nobel population	PLOS ONE			English	Article							UNITED-STATES; PRIZE; SCIENCE; PHYSICS; IMPACT; TIME	Based on the entire population of Nobel laureates in science from 1901 to 2017, we show that North America's rise as global power in science started in the 1920s. Following a transition period (1940s to 1960s), its scientific hegemony was consolidated in the 1970s. Yet since the 2000s, North America's global leadership in science has come under pressure. In that time, its share of laureates across disciplines dropped, although it has retained its attractiveness as a destination for future laureates from Europe and the Asia-Pacific region. In addition, we find that North America has become apparently less effective since 2010 in transferring capacities for conducting ground-breaking research from one generation of scientists to another. Furthermore, both Europe and the Asia-Pacific region have similarly high shares of newcomer organizations with regard to where prize-winning work is conducted, indicating that these two regions are very active in the inter-organizational competition for scientific talent. Despite this competition, however, we find no support for the rise of a new global center of science.	[Heinze, Thomas; Jappe, Arlette] Univ Wuppertal, Interdisciplinary Ctr Sci & Technol Studies IZWT, Wuppertal, Germany; [Heinze, Thomas; Pithan, David] Univ Wuppertal, Inst Sociol, Wuppertal, Germany	University of Wuppertal; University of Wuppertal	Heinze, T (corresponding author), Univ Wuppertal, Interdisciplinary Ctr Sci & Technol Studies IZWT, Wuppertal, Germany.; Heinze, T (corresponding author), Univ Wuppertal, Inst Sociol, Wuppertal, Germany.	theinze@uni-wuppertal.de		Heinze, Thomas/0000-0003-4611-4591				Adams Crawford John., 1987, OUTLINE FRACTURES; [Anonymous], 1995, PLACES INQUIRY RES A; Appelt S., 2015, GLOBAL MOBILITY RES, DOI [10.1016/B978-0-12-801396-0.00007-7, DOI 10.1787/18151965, 10.1787/18151965]; Becattini F, 14057136V1 ARXIV; Ben-David J., 1971, SCI ROLE SOC COMP ST; Bonaccorsi A, 2017, SCIENTOMETRICS, V110, P217, DOI 10.1007/s11192-016-2180-2; Chan HF, 2015, SCIENTOMETRICS, V105, P2215, DOI 10.1007/s11192-015-1738-8; Chan HF, 2015, SCIENTOMETRICS, V102, P847, DOI 10.1007/s11192-014-1367-7; Chan HF, 2014, RES EVALUAT, V23, P210, DOI 10.1093/reseval/rvu011; Chariker JH, 2017, SCIENTOMETRICS, V111, P1733, DOI 10.1007/s11192-017-2364-4; Cole JR, 2009, GREAT AM U ITS RISE, pxii; Crawford Elisabeth, 1984, BEGINNINGS NOBEL I S; Fairclough R, 2015, J INFORMETR, V9, P895, DOI 10.1016/j.joi.2015.09.005; Ferrero A, 2010, J MONETARY ECON, V57, P478, DOI 10.1016/j.jmoneco.2010.04.004; Fields C, 2015, SCIENTOMETRICS, V103, P267, DOI 10.1007/s11192-015-1526-5; Fortunato S, 2014, NATURE, V508, P186, DOI 10.1038/508186a; Franzoni C, 2015, GLOBAL MOBILITY RES, P35, DOI [DOI 10.1016/B978-0-12-801396-0.00002-8, 10.1016/B978-0-12-801396-0.00002-8]; Friedman R. M., 2001, POLITICS EXCELLENCE; FRIEDMAN RM, 1981, NATURE, V292, P793, DOI 10.1038/292793a0; Hollingsworth J. R., 2006, INNOVATION SCI I CHA, P423; Hollingsworth JR, 2011, MAJOR DISCOVERIES CR; Hollingsworth R, 2008, NATURE, V454, P412, DOI 10.1038/454412a; Hunter RS, 2009, ECON J, V119, pF231, DOI 10.1111/j.1468-0297.2009.02274.x; James L.K., 1993, NOBEL LAUREATES CHEM; Jappe A., 2016, INNOVATION SCI ORG R; Jones BF, 2011, P NATL ACAD SCI USA, V108, P18910, DOI 10.1073/pnas.1102895108; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Kragh H., 1999, QUANTUM GENERATIONS, P245; KRUGMAN PR, 1987, BROOKINGS PAP ECO AC, P1, DOI 10.2307/2534513; Kurian GT, 2002, NOBEL SCI BIOGRAPHIC; Lawson C, 2015, GLOBAL MOBILITY RES, P67; Leydesdorff L, 2014, J INFORMETR, V8, P606, DOI 10.1016/j.joi.2014.05.002; Leydesdorff L, 2009, SCIENTOMETRICS, V78, P23, DOI 10.1007/s11192-008-1830-4; Litzen A., 2008, GENIUS LOGISTICS OCC; Mazloumian A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018975; National Science Board (NSB) National Science Foundation (NSF), 2018, SCI ENG IND 2018; Oakes Elizabeth H., 2007, ENCY WORLD SCI; Parsons Talcott, 1974, AM U; Redelmeier RJ, 2016, JAMA-J AM MED ASSOC, V316, P2043, DOI 10.1001/jama.2016.15702; Rodriguez-Navarro A, 2016, J ASSOC INF SCI TECH, V67, P731, DOI 10.1002/asi.23412; Rodriguez-Navarro A, 2011, J DOC, V67, P582, DOI 10.1108/00220411111145007; Schlagberger E, 2016, SCIENTOMETRICS, V109, P723, DOI 10.1007/s11192-016-2059-2; Schlessinger B.S., 1986, WHOS WHO NOBEL PRIZE, P79; Stephan P, 2012, EC SHAPES SCI; Stock J.H., 2015, INTRO ECONOMETRICS, V3rd ed.; USCB, 2019, TRAD GOODS WORLD SEA; Veugelers R., 2015, GLOBAL MOBILITY RES, P215, DOI [10.1016/B978-0-12-801396-0.00008-9, DOI 10.1016/B978-0-12-801396-0.00008-9]; Wagner CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134164; Wasson Tyler, 1987, NOBEL PRIZE WINNERS; Zhou P, 2006, RES POLICY, V35, P83, DOI 10.1016/j.respol.2005.08.006; Zhou ZW, 2014, SCIENTOMETRICS, V100, P329, DOI 10.1007/s11192-014-1306-7; Zuckerman H., 1977, SCI ELITE NOBEL LAUR	52	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213916	10.1371/journal.pone.0213916	http://dx.doi.org/10.1371/journal.pone.0213916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943240	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300022
J	Kang, SH; Cho, KH; Do, JY				Kang, Seok Hui; Cho, Kyu Hyang; Do, Jun Young			Association between periodontitis and cardiometabolic risk: Results from the Korean National Health and Nutrition Examination Survey 2008-2014	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; METABOLIC SYNDROME; SUBCLINICAL ATHEROSCLEROSIS; STROKE; HYPERTENSION; INFLAMMATION; MANAGEMENT; MORTALITY; PROFILE	Background Periodontitis and cardiovascular disease (CVD) share inflammation as common pathogenesis. Evaluating the association between periodontitis and CVD would be helpful to better understand the pathophysiology and various complications of periodontitis. We aimed to determine whether there is an independent relationship between periodontitis and various CVD risk indicators or prevalence. Patients and methods Our study used representative data from the Korea National Health and Nutrition Examination Survey. Finally, data from 26,097 participants were used for analysis. Periodontitis was defined as a community periodontal index (CPI) >= 3. Participants were classified into 3 groups according to CPI score: Non-PO (participants without periodontitis, CPI score <3), NS-PO (participants with non-severe periodontitis, CPI score = 3), and Severe PO (participants with severe periodontitis, CPI score = 4). Cardiometabolic risk was evaluated based on metabolic syndrome, future CVD risk, and prevalent CVD. Prevalent CVD was defined as participants with cerebrovascular accidents and/or coronary artery disease. Framingham risk score (FRS) was calculated in participants without prevalent CVD. Results The numbers of participants in Non-PO, NS-PO, and Severe PO groups were 17,237, 6,738, and 2,122, respectively. The proportions of participants with high FRS and/or prevalent CVD increased as the severity of periodontitis increased. In participants without prevalent CVD, the FRS according to severity of periodontitis increased in both univariate and multivariate analyses as the severity of periodontitis increased. Logistic regression showed that the odds ratio for metabolic syndrome increased as the severity of periodontitis increased on univariate analysis and that the presence of periodontitis was associated with a higher odds ratio for metabolic syndrome on multivariate analysis. Trends for prevalent CVD were similar to those of metabolic syndrome. For participants without prevalent CVD, the odds ratio for high FRS increased as the severity of periodontitis increased in both uni-variate and multivariate analyses. Subgroup analyses according to sex and age showed similar trends. Conclusion Periodontitis was associated with CVD in the Korean population. Therefore, those with periodontitis, especially young adults with severe periodontitis, may be closely monitored for CVD.	[Kang, Seok Hui; Cho, Kyu Hyang; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.	jydo@med.yu.ac.kr			2016 Yeungnam University Research Grant	2016 Yeungnam University Research Grant	This work was supported by the 2016 Yeungnam University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YB, 2016, ATHEROSCLEROSIS, V251, P311, DOI 10.1016/j.atherosclerosis.2016.07.898; Ahn YB, 2015, J CLIN PERIODONTOL, V42, P998, DOI 10.1111/jcpe.12471; American Diabetes Association, 2018, Diabetes Care, V41, pS13, DOI 10.2337/dc18-S002; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Cardoso EM, 2018, POSTGRAD MED, V130, P98, DOI 10.1080/00325481.2018.1396876; Chistiakov DA, 2016, EXP MOL PATHOL, V100, P220, DOI 10.1016/j.yexmp.2016.01.006; Choi HM, 2015, J PERIODONTOL, V86, P866, DOI 10.1902/jop.2015.150025; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dietrich T, 2013, J CLIN PERIODONTOL, DOI [10.1016/j.amjcard.2016.05.036, DOI 10.1016/J.AMJCARD.2016.05.036]; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; Han DH, 2012, J PERIODONTOL, V83, P612, DOI 10.1902/jop.2011.110304; Han DH, 2012, J CLIN PERIODONTOL, V39, P30, DOI 10.1111/j.1600-051X.2011.01806.x; Han DH, 2010, J CLIN PERIODONTOL, V37, P609, DOI 10.1111/j.1600-051X.2010.01580.x; Hansen GM, 2016, AM J CARDIOL, V118, P489, DOI 10.1016/j.amjcard.2016.05.036; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jung YS, 2014, J CLIN PERIODONTOL, V41, P262, DOI 10.1111/jcpe.12204; Katz J, 2002, J PERIODONTOL, V73, P494, DOI 10.1902/jop.2002.73.5.494; Kelly JT, 2013, J AM DENT ASSOC, V144, P371, DOI 10.14219/jada.archive.2013.0130; Kim HD, 2010, J PERIODONTOL, V81, P658, DOI 10.1902/jop.2010.090614; Kim OS, 2018, J PERIODONTAL RES, V53, P362, DOI 10.1111/jre.12521; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Kwon YE, 2011, J CLIN PERIODONTOL, V38, P781, DOI 10.1111/j.1600-051X.2011.01756.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Saito T, 2004, J DENT RES, V83, P485, DOI 10.1177/154405910408300610; Schoenfeld SR, 2013, SEMIN ARTHRITIS RHEU, V43, P77, DOI 10.1016/j.semarthrit.2012.12.002; Sim SJ, 2008, J PERIODONTOL, V79, P1652, DOI [10.1902/jop.2008.080015, 10.1902/jop.2008.080015 ]; The Korea Centers for Disease Control and Prevention, 2018, ALC DRINK; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; WHO, 2016, GLOB REC PHYS ACT HL; WHO, 2016, TOP 10 CAUS DEATH; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214731	10.1371/journal.pone.0214731	http://dx.doi.org/10.1371/journal.pone.0214731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943271	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300057
J	Singh, A; Banerjee, T; Kumar, R; Shukla, SK				Singh, Aradhana; Banerjee, Tuhina; Kumar, Raju; Shukla, Sunit Kumar			Prevalence of cases of amebic liver abscess in a tertiary care centre in India: A study on risk factors, associated microflora and strain variation of Entamoeba histolytica	PLOS ONE			English	Article							PCR AMPLIFICATION; BACTERIA; DIVERSITY; IDENTIFICATION; INFECTION; DISEASE; ASSAY	Background Amebiasis, caused by Entamoeba histolytica (E. histolytica), is a significant cause of morbidity and mortality in developing countries. Mortality due to amebiasis is mostly by extra intestinal infections, amebic liver abscess being the most common one. This study was conducted to determine the current epidemiological status, risk factors, associated microflora and strain variation of E. histolytica causing liver abscesses. Methods/Findings A total of 115 liver abscess cases comprising of 107 (93%) males and 8 (6.9%) females were included in the study. Microscopic examination of pus samples from the abscesses and species discrimination using nested multiplex PCR showed the presence of E. histolytica in 101 (87.5%) cases. Data collected by face to face interviews using a pre tested questionnaire suggested intake of untreated drinking water (ORs: 6.4, p = 0.002), habit of alcohol consumption (ORs: 4.0, p = 0.019) and lack of urban services (ORs: 0.08, p = 0.017) to be major risk factors associated with E. histolytica infections. The study of associated bacterial flora through aerobic culture of liver aspirates and conventional PCR for detection of anaerobes revealed the presence of Fusobacterium (19, 25.5%), Peptococcus (19, 25.5%), Prevotella (18, 24.3%), Bacteroides (8, 10.8%), Staphylococcus aureus (3, 4%), Escherichia coli (2, 2.7%), Peptostreptococcus (2, 2.7%), Clostridium (2, 2.7%) and Klebsiella pneumoniae (1, 1.3%). Further to study the clonality, genotyping of E. histolytica targeting six tRNA-linked polymorphic STR loci (A-L, D-A, N-K, R-R, S-TGA -D and S-Q) was carried out which showed the presence of 89 different genotypes in the liver aspirate samples. Conclusion The findings highlight the high prevalence of genetically diverse E. histolytica from the liver abscess cases in this geographical region. Low socio-economic status and habit of alcohol consumption were important predictors of amebic liver abscess.	[Singh, Aradhana; Banerjee, Tuhina] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi, UP, India; [Kumar, Raju; Shukla, Sunit Kumar] Banaras Hindu Univ, Inst Med Sci, Dept Gastroenterol, Varanasi, UP, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Banerjee, T (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi, UP, India.	drtuhina@yahoo.com	Banerjee, Tuhina/AAP-7084-2021	Banerjee, Tuhina/0000-0003-0035-2842				Ali IKM, 2007, J CLIN MICROBIOL, V45, P285, DOI 10.1128/JCM.01335-06; Ali IKM, 2005, J CLIN MICROBIOL, V43, P5842, DOI 10.1128/JCM.43.12.5842-5847.2005; Ayeh-Kumi PF, 2001, EXP PARASITOL, V99, P80, DOI 10.1006/expr.2001.4652; Benetton MLFN, 2005, T ROY SOC TROP MED H, V99, P532, DOI 10.1016/j.trstmh.2004.11.015; Brook I, 1998, J MED MICROBIOL, V47, P1075, DOI 10.1099/00222615-47-12-1075; Bs Sri-Hidajati, 2018, Afr J Infect Dis, V12, P120, DOI 10.2101/Ajid.12v1S.18; Das SK, 2013, AM J TROP MED HYG, V89, P339, DOI 10.4269/ajtmh.12-0570; Farhana F, 2009, TROP BIOMED, V26, P262; Fotedar R, 2007, CLIN MICROBIOL REV, V20, P511, DOI 10.1128/CMR.00004-07; Haghighi A, 2003, J CLIN MICROBIOL, V41, P3748, DOI 10.1128/JCM.41.8.3748-3756.2003; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; Jaiswal Virendra, 2012, BMC Res Notes, V5, P416, DOI 10.1186/1756-0500-5-416; Khairnar K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-47; Koneman E., 2006, KONEMANS COLOR ATLAS, V6; Lodhi S, 2004, TROP MED INT HEALTH, V9, P718, DOI 10.1111/j.1365-3156.2004.01246.x; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; MIRELMAN D, 1987, MICROBIOL REV, V51, P272, DOI 10.1128/MMBR.51.2.272-284.1987; Mirelman D, 1997, J CLIN MICROBIOL, V35, P2405, DOI 10.1128/JCM.35.9.2405-2407.1997; Nagano Y, 2007, BRIT J BIOMED SCI, V64, P74, DOI 10.1080/09674845.2007.11732760; Parija SC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-41; Pimenta PEP, 2002, J EUKARYOT MICROBIOL, V49, P209, DOI 10.1111/j.1550-7408.2002.tb00525.x; Rani R, 2006, AM J TROP MED HYG, V75, P880, DOI 10.4269/ajtmh.2006.75.880; Rekha R, 2006, ELECT J BIOTECHNOL, V9; Reyna-Fabian ME, 2016, AM J TROP MED HYG, V94, P147, DOI 10.4269/ajtmh.15-0458; Shirley DAT, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy161; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WITTNER M, 1970, AM J TROP MED HYG, V19, P755, DOI 10.4269/ajtmh.1970.19.755	27	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214880	10.1371/journal.pone.0214880	http://dx.doi.org/10.1371/journal.pone.0214880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943253	Green Published, gold			2022-12-27	WOS:000463194300068
J	Wang, ZS; Gu, XJ; Thrift, AP				Wang, Zhensheng; Gu, Xiangjun; Thrift, Aaron P.			Factors associated with favorable survival outcomes for Asians with hepatocellular carcinoma: A sequential matching cohort study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; UNITED-STATES; RACIAL/ETHNIC DISPARITIES; SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; MARITAL-STATUS; IMPACT; STAGE; RACE; SORAFENIB	Background Overall 5-year survival rates for patients diagnosed with hepatocellular carcinoma (HCC) are poor, but vary by race/ethnicity. We undertook a comprehensive assessment of underlying contributing factors to the favorable survival outcomes of HCC among Asians compared with non-Hispanic whites (NHW). Methods We identified 1,284 Asian and 7,072 NHW patients newly diagnosed with HCC between 1994 and 2011 in the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database. We used a novel three-step sequential matching approach to identify demographic, presentation and treatment factors that may explain survival differences between Asians and NHWs. Hazard ratios (HRs) and corresponding 95% confidence intervals (Cis) for the association between Asian race and risk of HCC-related mortality were estimated using Cox proportional hazards models. Results The absolute difference in 5-year survival rates between Asians and NHWs was 8.4% (95% CI: 4.6%-12.0%) in the demographics match analysis. The disparity remained unchanged after additionally matching on stage, grade and comorbidities in the presentation match analysis. However, in the treatment match analysis, which accounts for differences in demographic, presentation and treatment factors, the absolute difference in 5-year survival rates was reduced to 5.8% (95% CI: 2.6%-9.3%). Treatment differences explained more of survival disparity in Asian and NHW patients with localized disease than for those with regional or distant stage HCC. Conclusions Asian patients with HCC continue to have more favorable survival outcomes than NHWs with HCC. This persistent disparity seems to be more related to treatment differences than to differences in presentation characteristics including stage.	[Wang, Zhensheng; Gu, Xiangjun; Thrift, Aaron P.] Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX 77030 USA; [Thrift, Aaron P.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Thrift, AP (corresponding author), Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX 77030 USA.; Thrift, AP (corresponding author), Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.	aaron.thrift@bcm.edu		Wang, Zhensheng/0000-0003-2383-588X; Thrift, Aaron/0000-0002-0084-5308	Research Training Grant from the Cancer Prevention and Research Institute of Texas (CPRIT) [RP160097]	Research Training Grant from the Cancer Prevention and Research Institute of Texas (CPRIT)	ZW was supported by a Research Training Grant from the Cancer Prevention and Research Institute of Texas (CPRIT; RP160097), http://www.cprit.state.tx.us/funding-opportunities/. The funding bodies played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Alavi M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3110-0; American Cancer Society, CANC FACTS FIG 2018; [Anonymous], 2014, J AM STAT ASSOC, V109, P991, DOI [10.1080/01621459.2013.823775, DOI 10.1080/01621459.2013.823775]; Artinyan A, 2010, CANCER-AM CANCER SOC, V116, P1367, DOI 10.1002/cncr.24817; Bureau UC, POV THRESH; Davila JA, 2006, CLIN GASTROENTEROL H, V4, P104, DOI 10.1016/S1542-3565(05)00745-7; Eskander MF, 2016, AM J SURG, V212, P691, DOI 10.1016/j.amjsurg.2016.07.004; Ha J, 2016, J CLIN GASTROENTEROL, V50, P423, DOI 10.1097/MCG.0000000000000448; Hoehn RS, 2015, SURGERY, V158, P1244, DOI 10.1016/j.surg.2015.03.026; Jones PD, 2018, DIGEST DIS SCI, V63, P515, DOI 10.1007/s10620-017-4869-3; Keating GM, 2009, DRUGS, V69, P223, DOI 10.2165/00003495-200969020-00006; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kwak M, 2017, J KOREAN MED SCI, V32, P1974, DOI 10.3346/jkms.2017.32.12.1974; Li J, 2017, ONCOTARGET, V8, P15193, DOI 10.18632/oncotarget.14771; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mathur AK, 2010, ARCH SURG-CHICAGO, V145, P1158, DOI 10.1001/archsurg.2010.272; Mathur AK, 2010, LIVER TRANSPLANT, V16, P1033, DOI 10.1002/lt.22108; Piscaglia F, 2016, HEPATOLOGY, V63, P827, DOI 10.1002/hep.28368; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Silber JH, 2014, ANN INTERN MED, V161, P845, DOI 10.7326/M14-0900; Silber JH, 2013, JAMA-J AM MED ASSOC, V310, P389, DOI 10.1001/jama.2013.8272; Stewart SL, 2016, WORLD J GASTROENTERO, V22, P8584, DOI 10.3748/wjg.v22.i38.8584; White DL, 2017, GASTROENTEROLOGY, V152, P812, DOI 10.1053/j.gastro.2016.11.020; Wong LL, 2012, AM J SURG, V203, P726, DOI 10.1016/j.amjsurg.2011.06.055; Xu L, 2016, HEPATOBIL SURG NUTR, V5, P43, DOI 10.3978/j.issn.2304-3881.2015.08.05; Yau T, 2014, GASTROENTEROLOGY, V146, P1691, DOI 10.1053/j.gastro.2014.02.032; Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214721	10.1371/journal.pone.0214721	http://dx.doi.org/10.1371/journal.pone.0214721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943273	gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300053
J	Ayemoba, O; Hussain, N; Umar, T; Ajemba-Life, A; Kene, T; Edom, U; Ogueri, I; Nwagbara, G; Ochai, I; Eneja, C				Ayemoba, Ojor; Hussain, Nurudeen; Umar, Tahir; Ajemba-Life, Anthony; Kene, Terfa; Edom, Uchechukwu; Ogueri, Ikechukwu; Nwagbara, Goodluck; Ochai, Inalegwu; Eneja, Chikwado			Establishment of reference values for selected haematological parameters in young adult Nigerians	PLOS ONE			English	Article							CD4	Background Haematological reference values are necessary for accurate diagnosis of diseases, clinical decision-making, treatment monitoring and clinical research. Due to unavailability of pan-Nigerian reference values, local results interpretation is based on the use of Western values. Objective This study aims to establish national reference values for some haematological parameters in apparently healthy young adult Nigerians. Methods Seven Thousand, Seven Hundred and Ninety-Seven (7,797) volunteers aged 18 to 26 years participated in the study. Participants' interviewer-administered questionnaires and blood samples were collected, analyzed and those with confounding factors (HIV infection, Hepatitis B sero-positivity, Malaria and Pregnancy) were excluded from statistical analysis. The 95-percentile reference range was determined for each haematological parameter using SPSS Version 16. The result obtained was reviewed with reference to already established reference values in two West African and Western countries. Results Blood specimens from 6153 (78.9%) participants [comprising 5915 (96.1%) males and 238 (3.9%) females] were analyzed after exclusion of 1,644 (21.1%) participants with confounding variables. Reference ranges among males and females varied and these were consistent with findings from two other West African countries. The median platelets count in this study was 218 x 10(9)/I while commonly used Western value is 280 x 10(9)/I. Other haematological parameters in the study were similar to Western values. Conclusion The findings of this study will improve clinical and research decision-making. Considering that this study is limited to young adult participants, there is a need to conduct future pan-Nigerian studies that will include all age groups.	[Ayemoba, Ojor; Hussain, Nurudeen; Umar, Tahir; Ajemba-Life, Anthony; Edom, Uchechukwu; Ogueri, Ikechukwu; Nwagbara, Goodluck; Ochai, Inalegwu; Eneja, Chikwado] Minist Def Hlth Implementat Programme, Abuja, Nigeria; [Kene, Terfa] Ave Hlth Sense Ltd, Area 2, Abuja, Nigeria		Ayemoba, O (corresponding author), Minist Def Hlth Implementat Programme, Abuja, Nigeria.	orayemoba@yahoo.com		Eneja, Chikwado/0000-0002-5743-5545; Ayemoba, Ojor/0000-0003-2443-0323	Ministry of Defence Health Implementation Programme (MODHIP), Abuja, FCT, Nigeria	Ministry of Defence Health Implementation Programme (MODHIP), Abuja, FCT, Nigeria	The work described in the article was wholly funded by Ministry of Defence Health Implementation Programme (MODHIP), No. 4B Ikole Street, Area 11, Abuja, FCT, Nigeria. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina O, 2005, CLIN DIAGN LAB IMMUN, V12, P525, DOI 10.1128/CDLI.12.4.525-530.2005; Akinbo B. D., 2015, British Journal of Medicine and Medical Research, V8, P717, DOI 10.9734/BJMMR/2015/17974; Aster T, 1999, CLIN DIAGNOSTIC LAB, V6, P410; BAIN B, 1984, J CLIN PATHOL, V37, P188, DOI 10.1136/jcp.37.2.188; Bain BJ, 2012, DACIE LEWIS PRACTICA, P14; Clement Zeh E., 2012, BLOOD CELL OVERVIEW, P303, DOI [10.5772/2979, DOI 10.5772/2979]; Crampin A C, 2011, Open AIDS J, V5, P74, DOI 10.2174/1874613601105010074; Didier M, 2003, CLIN DIAGNOSTIC LAB, V10, P443, DOI [10.1128/CDLI.10.3.443-445.2003, DOI 10.1128/CDLI.10.3.443-445.2003]; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; GARDNER FH, 1968, BRIT J HAEMATOL, V14, P611, DOI 10.1111/j.1365-2141.1968.tb00367.x; GORDON AS, 1968, ANN NY ACAD SCI, V149, P318, DOI 10.1111/j.1749-6632.1968.tb15167.x; Iftikhar R, 2017, PAK ARMED FORCES MED, V67, P1068; Isah A, 2012, JOS J MED, V6, P16; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Koram Ka, 2007, Ghana Med J, V41, P160; Kueviakoe Irenee Messanh, 2011, ISRN Hematol, V2011, P736062, DOI 10.5402/2011/736062; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; MIRAND EA, 1966, ENDOCRINOLOGY, V78, P325, DOI 10.1210/endo-78-2-325; Miri-Dashe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093919; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Ngowi BJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-1; Nubila T, 2014, NIGERIAN J EXP CLIN, V1, P33, DOI [10.4103/2348-0149.135726, DOI 10.4103/2348-0149.135726]; Oladepo DK, 2009, CLIN VACCINE IMMUNOL, V16, P1374, DOI 10.1128/CVI.00378-08; Onwurah O., 2018, J HEMATOL THROMB DIS, V6, P23; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995	27	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213925	10.1371/journal.pone.0213925	http://dx.doi.org/10.1371/journal.pone.0213925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939142	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900010
J	Elliott, RL; Jiang, XP				Elliott, Robert L.; Jiang, Xian-Peng			The adverse effect of gentamicin on cell metabolism in three cultured mammary cell lines: "Are cell culture data skewed?"	PLOS ONE			English	Article							EPITHELIAL MITOCHONDRIA; CANCER; ANTIBIOTICS	Many cells are cultured in media that contains an antibiotic to prevent bacterial contamination. Mycoplasma and other bacterial contamination is a serious problem for those involved in cell culture. Antibiotics in the media helps prevent this contamination and make life easier for the investigators; as performing cell culture experiments in antibiotic free media is difficult and requires vigorous sterile technique. There are many reports of antibiotics causing mitochondrial damage. In this study, we tested the effect of gentamicin in culture media on human mammary epithelial MCF-12A and breast cancer MCF-7 and MDA-MB-231 cell lines by real time PCR, immunofluorescent microscopy, lactate assay, DNA damage assay. We found that the addition of gentamicin in media upregulated the gene expression of hypoxia inducer factor 1 alpha (HIF1a), glycolytic enzymes and glucose transporters, compared to the cells cultured in gentamicin free media. Gentamicin also increased the lactate production and inhibited mitochondrial membrane potential of the cell lines. Furthermore, the antibiotics in media induced mitochondrial reactive oxygen species causing DNA damage. We found an increase of 8-hydroxy-2'-deoxyguanosine a product of DNA oxidative damage in the media of MCF-12A, MCF-7 and MDA-MB-231 cell lines. These results showed that normal epithelial and breast cancer cells cultured in the media with gentamicin had increased HIF1a, aerobic glycolysis and DNA oxidative damage. If we use these unhealthy cells in the experiment, all data will be different, compared to cells grown in gentamicin free media. We have studied the detrimental effects of three antibiotics on mitochondrial function in the untransformed MCF-12A human mammary cell line and two human mammary cancer cell lines, MCF-7 and MB-MDA-231. The metabolic changes in all cell lines were dramatically different between those in antibiotic free media versus antibiotic containing media. There was a marked difference in gene expression of glycolytic enzymes, reactive oxygen species production and effects on membrane potential. Ironically, our first studies were done in media containing gentamicin, and repeated studies were done in gentamicin free media. The results were very different. The purpose of this report is to emphasize that metabolic cell culture data may be inaccurate because experiments were performed in cell culture media containing antibiotics. We will present evidence to support this theory.	[Elliott, Robert L.; Jiang, Xian-Peng] Sallie A Burdine Breast Fdn, Baton Rouge, LA 70816 USA		Elliott, RL (corresponding author), Sallie A Burdine Breast Fdn, Baton Rouge, LA 70816 USA.	drrobertelliott@cox.net			Sallie A Burdine Breast Foundation; Delta State University Foundation	Sallie A Burdine Breast Foundation; Delta State University Foundation	This work was funded by the Sallie A Burdine Breast Foundation and the Delta State University Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or any preparation of the manuscript.	Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313; CURGY JJ, 1985, BIOL CELL, V54, P1; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05; Duivenvoorden WCM, 2002, CANCER RES, V62, P1588; Elliott R., 2011, MICROSC MICROANAL, V17, P194; Elliott RL, 2012, BREAST CANCER RES TR, V136, P347, DOI 10.1007/s10549-012-2283-2; Elliott RL, 2017, J CANC TREATMENT RES, V5, P62, DOI DOI 10.11648/j.jctr.20170504.11; Elliott RL, 2018, INT J CLIN MED, V9, P182; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Jiang XP, 2015, BREAST CANCER RES TR, V153, P519, DOI 10.1007/s10549-015-3583-0; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; KROON AM, 1983, PHARM WEEKBLAD, V5, P81, DOI 10.1007/BF01960982; Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174; Margulis L, 1970, ORIGIN EUKARYOTIC CE; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; RIESBECK K, 1990, ANTIMICROB AGENTS CH, V34, P167, DOI 10.1128/AAC.34.1.167; Son K, 2009, ANTICANCER RES, V29, P3995; Tan Q, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.903245; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O., 1930, METABOLISM TUMORS, P254	23	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214586	10.1371/journal.pone.0214586	http://dx.doi.org/10.1371/journal.pone.0214586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934018	gold, Green Published, Green Submitted			2022-12-27	WOS:000462867000024
J	Song, YJ; Gyarmati, P				Song, Yajing; Gyarmati, Peter			Bacterial translocation in acute lymphocytic leukemia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-THERAPY; CONTAMINATION; SENSITIVITY; PROGRESSION; EXPRESSION; IMMUNITY	Bloodstream infection (BSI) is the major cause of mortality in acute lymphocytic leukemia (ALL). Causative pathogens in BSI originate from the gut microbiota due to an increase in intestinal permeability, a process known as bacterial translocation (BT). The gut microbiota in physiological conditions is controlled by a large number of immune cells as part of the gut-associated lymphoid tissue (GALT). The aim of the current study was to investigate the mechanism of bacterial translocation in leukemia by identifying and characterizing alterations in the GALT in leukemic mouse model. Our studies revealed a severe impairment of the GALT characterized by a loss of lymphatic cells in ALL, which eventually led to BSI. We identified differentially expressed genes in the intraepithelium and the lamina propria, which may contribute to BT and to the impairment of lymphocyte migration.	[Song, Yajing; Gyarmati, Peter] Univ Illinois, Coll Med, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria	Gyarmati, P (corresponding author), Univ Illinois, Coll Med, Peoria, IL 61656 USA.	gyarmati@uic.edu	Gyarmati, Peter/F-4887-2013	Gyarmati, Peter/0000-0001-7362-316X	University of Illinois College of Medicine at Peoria	University of Illinois College of Medicine at Peoria	This work was supported by the University of Illinois College of Medicine at Peoria start up grant to PG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh Ahmad, 2015, Int J Hematol Oncol Stem Cell Res, V9, P203; Aslanzadeh J, 2004, ANN CLIN LAB SCI, V34, P389; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bischoff SC, 2012, ALLERGY, P287; Bustin SA, 2004, A Z QUANTITATIVE PCR; Chandran P, 2003, SURG-J R COLL SURG E, V1, P63, DOI 10.1016/S1479-666X(03)80118-X; Chopra A, 2014, EUR J HAEMATOL, V92, P211, DOI 10.1111/ejh.12238; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Costa-Lima Carolina, 2014, Rev. Bras. Hematol. Hemoter., V36, P390, DOI 10.1016/j.bjhh.2014.09.007; de Naurois J, 2010, ANN ONCOL, V21, pv252, DOI 10.1093/annonc/mdq196; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Gawad C, 2014, P NATL ACAD SCI USA, V111, P17947, DOI 10.1073/pnas.1420822111; Ghantoji SS, 2011, LEUKEMIA; Gyarmati P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23532; Ha YJ, 2015, INT J RADIAT ONCOL, V91, P650, DOI 10.1016/j.ijrobp.2014.11.013; Hoang P, 1997, MEDIAT INFLAMM, V6, P105, DOI 10.1080/09629359791794; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang GTJ, 2002, HUM GENE THER, V13, P2017, DOI 10.1089/10430340260395875; Hutter JJ, 2010, PEDIATR REV, V31, P234, DOI 10.1542/pir.31-6-234; Kong LB, 2000, RNA, V6, P890, DOI 10.1017/S1355838200000157; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leite JB, 2014, REV BRAS HEMATOL HEM, V36, P409, DOI [10.1016/j.bjhh.2014.07.007, DOI 10.1016/J.BJHH.2014.07.007]; Lian QS, 2017, CELL RES, V27, P784, DOI 10.1038/cr.2017.54; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Nganga VK, 2013, BLOOD, V121, P3855, DOI 10.1182/blood-2012-08-446732; Nijmeijer BA, 2001, EXP HEMATOL, V29, P322, DOI 10.1016/S0301-472X(00)00669-X; Pals ST, 2007, BLOOD, V110, P3102, DOI 10.1182/blood-2007-05-075176; Piovan E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00633; Prattes J, 2016, J CLIN MICROBIOL, V54, P798, DOI 10.1128/JCM.02972-15; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schirmer M, 2016, CELL, V167, P1897, DOI 10.1016/j.cell.2016.11.046; Sequeira IR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099256; Singh RK, 2010, CELL CYCLE, V9, P4236, DOI 10.4161/cc.9.20.13636; Smith CL, 2018, NUCLEIC ACIDS RES, V46, pD836, DOI 10.1093/nar/gkx1006; Son JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127985; Sundstrom GM, 1998, EUR J HAEMATOL, V61, P250; Tian Tian, 2014, Stem Cell Investig, V1, P12, DOI 10.3978/j.issn.2306-9759.2014.04.02; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wiest R, 2003, BEST PRACT RES CL GA, V17, P397, DOI 10.1016/S1521-6918(03)00024-6; Xu B, 2007, GENE THER, V14, P1181, DOI 10.1038/sj.gt.3302966; Yu T, 2011, DIGEST DIS SCI, V56, P1354, DOI 10.1007/s10620-010-1441-9; Zgheib NB, 2012, INT J ONCOL, V41, P179, DOI 10.3892/ijo.2012.1451	44	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214526	10.1371/journal.pone.0214526	http://dx.doi.org/10.1371/journal.pone.0214526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934014	gold, Green Submitted, Green Published			2022-12-27	WOS:000462867000020
J	Cantu, I; van de Werken, HJG; Gillemans, N; Stadhouders, R; Heshusius, S; Maas, A; Esteghamat, F; Ozgur, Z; van IJcken, WFJ; Grosveld, F; von Lindern, M; Philipsen, S; van Dijk, TB				Cantu, Ileana; van de Werken, Harmen J. G.; Gillemans, Nynke; Stadhouders, Ralph; Heshusius, Steven; Maas, Alex; Esteghamat, Fatemehsadat; Ozgur, Zeliha; van IJcken, Wilfred F. J.; Grosveld, Frank; von Lindern, Marieke; Philipsen, Sjaak; van Dijk, Thamar B.			The mouse KLF1 Nan variant impairs nuclear condensation and erythroid maturation	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; RED-BLOOD-CELLS; CHROMATIN CONDENSATION; GLOBAL ROLE; CHIP-SEQ; EKLF; EXPRESSION; EKLF/KLF1; ANEMIA; MUTATIONS	Kruppel-like factor 1 (KLF1) is an essential transcription factor for erythroid development, as demonstrated by Klf1 knockout mice which die around E14 due to severe anemia. In humans, >140 KLF1 variants, causing different erythroid phenotypes, have been described. The KLF1 Nan variant, a single amino acid substitution (p.E339D) in the DNA binding domain, causes hemolytic anemia and is dominant over wildtype KLF1. Here we describe the effects of the KLF1 Nan variant during fetal development. We show that Nan embryos have defects in erythroid maturation. RNA-sequencing of the KLF1 Nan fetal liver cells revealed that Exportin 7 (Xpo7) was among the 782 deregulated genes. This nuclear exportin is implicated in terminal erythroid differentiation; in particular it is involved in nuclear condensation. Indeed, KLF1 Nan fetal liver cells had larger nuclei and reduced chromatin condensation. Knockdown of XPO7 in wildtype erythroid cells caused a similar phenotype. We propose that reduced expression of XPO7 is partially responsible for the erythroid defects observed in KLF1 Nan erythroid cells.	[Cantu, Ileana; van de Werken, Harmen J. G.; Gillemans, Nynke; Stadhouders, Ralph; Heshusius, Steven; Maas, Alex; Esteghamat, Fatemehsadat; Grosveld, Frank; Philipsen, Sjaak; van Dijk, Thamar B.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Heshusius, Steven; von Lindern, Marieke] Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands; [Ozgur, Zeliha; van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [van de Werken, Harmen J. G.] Erasmus MC, Dept Urol, Rotterdam, Netherlands; [van de Werken, Harmen J. G.] Erasmus MC, Canc Computat Biol Ctr, Rotterdam, Netherlands; [Stadhouders, Ralph] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands; [Esteghamat, Fatemehsadat] Yale Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Yale University	Philipsen, S (corresponding author), Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands.	j.philipsen@erasmusmc.nl	von Lindern, Marieke/AAH-2350-2020; Werken, Harmen van de/G-8979-2013; van ijcken, willem/N-9805-2018; Stadhouders, Ralph/J-8663-2015	Werken, Harmen van de/0000-0002-9794-1477; van ijcken, willem/0000-0002-0421-8301; Stadhouders, Ralph/0000-0002-1060-5607; Esteghamat Hanzaei, Fatemehsadat/0000-0002-1243-8013	Netherlands Genomics Initiative [NGI Zenith 93511036]; Landsteiner Foundation for Blood Transfusion Research [LSBR 1040]; Netherlands Organization for Health Research and Development [ZonMw TOP 40-00812-98-12128]; EU fp7 Specific Cooperation Research Project THALAMOSS [306201]	Netherlands Genomics Initiative; Landsteiner Foundation for Blood Transfusion Research; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); EU fp7 Specific Cooperation Research Project THALAMOSS	TvD and HvdW were supported by the Netherlands Genomics Initiative (NGI Zenith 93511036); IC, TvD, FG and SP by the Landsteiner Foundation for Blood Transfusion Research (LSBR 1040); SH, MvL and SP by the Netherlands Organization for Health Research and Development (ZonMw TOP 40-00812-98-12128); IC, TvD, FG and SP by the EU fp7 Specific Cooperation Research Project THALAMOSS (306201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Borg J, 2011, HAEMATOL-HEMATOL J, V96, P635, DOI 10.3324/haematol.2011.043265; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; de Krom M, 2002, MOL CELL, V9, P1319, DOI 10.1016/S1097-2765(02)00558-0; de-la-Iglesia-Inigo S, 2017, CLIN CASE REP, V5, P248, DOI 10.1002/ccr3.825; Dolznig H, 2001, FASEB J, V15, P1442, DOI 10.1096/fj.00-0705fje; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Gillinder KR, 2017, NUCLEIC ACIDS RES, V45, P1130, DOI 10.1093/nar/gkw1014; Hattangadi SM, 2014, BLOOD, V124, P1931, DOI 10.1182/blood-2013-11-537761; Heruth DP, 2010, GENOMICS, V96, P303, DOI 10.1016/j.ygeno.2010.07.009; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Jaffray JA, 2013, BLOOD CELL MOL DIS, V51, P71, DOI 10.1016/j.bcmd.2013.02.006; Ji P, 2010, HAEMATOL-HEMATOL J, V95, P2013, DOI 10.3324/haematol.2010.029827; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Lyon M, 1986, MOUSE NEWS LETT, V74, P95; Lyon M. F., 1983, MOUSE NEWS LETT, V68, P68; Meinders M, 2015, BLOOD, V125, P1957, DOI 10.1182/blood-2014-08-593343; Nebor D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30839-2; Nilson DG, 2006, EXP HEMATOL, V34, P705, DOI 10.1016/j.exphem.2006.02.018; Norton LJ, 2017, BLOOD ADV, V1, P685, DOI 10.1182/bloodadvances.2016002303; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Ortolano R, 2018, J PEDIAT HEMATOL ONC, V40, pE389, DOI 10.1097/MPH.0000000000001042; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; PERKINS AC, 1995, NATURE, V375, P318; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Perseu L, 2011, BLOOD, V118, P4454, DOI 10.1182/blood-2011-04-345736; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Planutis A, 2017, DEVELOPMENT, V144, P430, DOI 10.1242/dev.145656; Popova EY, 2009, CHROMOSOME RES, V17, P47, DOI 10.1007/s10577-008-9005-y; Ravindranath Y, 2018, J PEDIAT HEMATOL ONC, V40, pE405, DOI 10.1097/MPH.0000000000001056; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Satta S, 2011, HAEMATOL-HEMATOL J, V96, P767, DOI 10.3324/haematol.2010.037333; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Siatecka M, 2010, P NATL ACAD SCI USA, V107, P15151, DOI 10.1073/pnas.1004996107; Singleton B.K., 2009, BLOOD, V114, P162, DOI [10.1182/blood.V114.22.162.162, DOI 10.1182/BLOOD.V114.22.162.162, DOI 10.1182/BL00D.V114.22.162.162]; Singleton BK, 2008, BLOOD, V112, P2081, DOI 10.1182/blood-2008-03-145672; Southwood CM, 1996, DEV DYNAM, V206, P248, DOI 10.1002/(SICI)1097-0177(199607)206:3<248::AID-AJA3>3.0.CO;2-I; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tallack MR, 2009, J BIOL CHEM, V284, P20966, DOI 10.1074/jbc.M109.006346; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; White RA, 2009, BLOOD CELL MOL DIS, V43, P141, DOI 10.1016/j.bcmd.2009.03.009; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	58	6	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0208659	10.1371/journal.pone.0208659	http://dx.doi.org/10.1371/journal.pone.0208659			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921348	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000005
J	Choi, SY; Shin, E; Choe, EK; Park, B; Lee, H; Park, HE; Lee, JE; Choi, SH				Choi, Su-Yeon; Shin, Eunsoon; Choe, Eun Kyung; Park, Boram; Lee, Heesun; Park, Hyo Eun; Lee, Jong-Eun; Choi, Seung Ho			Genome-wide association study of coronary artery calcification in asymptomatic Korean populations	PLOS ONE			English	Article							AFRICAN-AMERICANS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CHROMOSOME 9P21; CALCIUM; PREVALENCE; BURDEN; LOCUS	Epidemiologic evidence indicates that the prevalence and severity of coronary artery disease vary depending on ethnicity. In this study, a genome-wide association study for coronary artery calcification (CAC) was performed in a Korean population-based sample of 400 subjects without prior coronary artery disease and replicated in another of 1,288 subjects. CAC score, as assessed by multi-detector computed tomography, was evaluated in volunteers for screening purposes as part of a routine health examination. CAC score greater than the 90th percentile across the age in each sex group was considered severe CAC. Single nucleotide polymorphisms (SNPs) associated with severe CAC after adjusting for age, sex, hypertension, and diabetes were investigated using the additive model of logistic regression. One SNP (rs10757272 in the intronic region of the CDKN2B-AS1 gene in chromosome 9p21.3) met Bonferroni correction in the discovery set (p = 7.55E-08) and was also significant in the validation set by TaqMan assay (p = 0.036). Subjects with rs10757272 were found to have an increased odds ratio (OR) of having severe CAC in multivariate logistic regression analysis after adjusting for age, sex, hypertension, and diabetes (adjusted OR 3.24 and 95% CI 2.11-4.97). In conclusion, SNP rs10757272 in chromosome 9p21.3 was associated with severe CAC based on age and sex in an asymptomatic community-based Korean population. Therefore, it was associated with promotion of coronary artery calcification in subclinical state.	[Choi, Su-Yeon; Lee, Heesun; Park, Hyo Eun; Choi, Seung Ho] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Choi, Su-Yeon; Lee, Heesun; Park, Hyo Eun; Choi, Seung Ho] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Shin, Eunsoon; Lee, Jong-Eun] DNA Link Inc, Seoul, South Korea; [Choe, Eun Kyung] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Surg, Seoul, South Korea; [Park, Boram] Seoul Natl Univ, Dept Publ Hlth Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); DNA Link, Inc.; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Choi, SY; Choi, SH (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.; Choi, SY; Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	sychoi9@gmail.com; cshmed@snuh.org	Choi, Su-Yeon/C-4312-2013	Choi, Su-Yeon/0000-0001-9977-4740	Technology Innovation Program (Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) - Ministry of Trade, Industry & Energy (MOTIE, Korea) [10050154]	Technology Innovation Program (Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) - Ministry of Trade, Industry & Energy (MOTIE, Korea)	This work was supported by the Technology Innovation Program (10050154, Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) funded By the Ministry of Trade, Industry & Energy (MOTIE, Korea). Eunsoon Shin and Jong-Eun Lee are employed by DNA Link, Inc. DNA Link, Inc. provided support in the form of salaries for authors ES and J-EL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Chan K, 2013, J AM COLL CARDIOL, V61, P957, DOI 10.1016/j.jacc.2012.10.051; Cho I, 2018, EUR HEART J, V39, P934, DOI 10.1093/eurheartj/ehx774; Cho I, 2017, ATHEROSCLEROSIS, V262, P185, DOI 10.1016/j.atherosclerosis.2016.12.006; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Divers J, 2013, CIRC-CARDIOVASC GENE, V6, P97, DOI 10.1161/CIRCGENETICS.112.964114; Gong L, 2014, PLOS ONE, V9, pe9482; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Han D, 2016, CIRC J, V80, P2349, DOI 10.1253/circj.CJ-16-0762; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kim DS, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0089-2; Lee Ji Hyun, 2015, J Cardiovasc Ultrasound, V23, P195, DOI 10.4250/jcu.2015.23.4.195; Lee TC, 2003, J AM COLL CARDIOL, V41, P39, DOI 10.1016/S0735-1097(02)02618-9; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P445, DOI 10.1161/CIRCGENETICS.109.923508; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Park HE, 2012, INT J CARDIOVAS IMAG, V28, P1227, DOI 10.1007/s10554-011-9922-2; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Saab KR, 2015, J AM SOC NEPHROL, V26, P247, DOI 10.1681/ASN.2014040393; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wassel CL, 2009, CIRC-CARDIOVASC GENE, V2, P629, DOI 10.1161/CIRCGENETICS.109.876243; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214370	10.1371/journal.pone.0214370	http://dx.doi.org/10.1371/journal.pone.0214370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921371	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000060
J	Hubner, R; Tobel, L				Huebner, Ronald; Toebel, Lisa			Conflict resolution in the Eriksen flanker task: Similarities and differences to the Simon task	PLOS ONE			English	Article							IRRELEVANT ACTIVATION; STRATEGIC CONTROL; RESPONSE-TIMES; STIMULUS; SUPPRESSION; MODEL; INTERFERENCE; INFORMATION; OVERLAP; CONTEXT	In the Eriksen flanker task as well as in the Simon task irrelevant activation produces a response conflict that has to be resolved by mental control mechanisms. Despite these similarities, however, the tasks differ with respect to their delta functions, which express how the congruency effects develop with response time. The slope of the delta function is mostly positive for the flanker task, but negative for the Simon task. Much effort has been spent to explain this difference and to investigate whether it results from task-specific control. A prominent account is that the temporal overlap between irrelevant and relevant response activation is larger in the flanker task than in the Simon task. To test this hypothesis, we increased the temporal distance in a flanker task by presenting the flankers ahead of the target. This not only produced negatively sloped delta functions but also caused reversed congruency effects. We also conducted a Simon-task experiment in which we varied the proportion of congruent stimuli. As a result, the delta function was negatively sloped only if the proportion was low. These results demonstrate that a long temporal distance is necessary but not sufficient for observing negatively sloped delta functions. Finally, we modeled the data with drift-diffusion models. Together, our results show that differently sloped delta functions can be produced with both tasks. They further indicate that activation suppression is an important control mechanism that can be adapted rather flexibly to the control demands.	[Huebner, Ronald; Toebel, Lisa] Univ Konstanz, Dept Psychol, Constance, Germany	University of Konstanz	Hubner, R (corresponding author), Univ Konstanz, Dept Psychol, Constance, Germany.	ronald.huebner@uni-konstanz.de						Akcay C, 2007, PSYCHON B REV, V14, P742, DOI 10.3758/BF03196831; Baroni G, 2012, EXP PSYCHOL, V59, P88, DOI 10.1027/1618-3169/a000130; Brent R.P., 1973, ALGORITHMS FUNCTION; Burle B, 2005, EUR J COGN PSYCHOL, V17, P619, DOI 10.1080/09541440540000121; Burle B, 2014, PSYCHON B REV, V21, P1003, DOI 10.3758/s13423-013-0561-6; D'Angelo MC, 2016, Q J EXP PSYCHOL, V69, P1890, DOI 10.1080/17470218.2016.1173077; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Eriksen CW, 1995, VISUAL SELECTIVE ATTENTION, P101; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; FLOWERS JH, 1980, B PSYCHONOMIC SOC, V16, P443; FLOWERS JH, 1982, PERCEPT PSYCHOPHYS, V32, P581, DOI 10.3758/BF03204214; Frings C, 2015, PSYCHON B REV, V22, P1577, DOI 10.3758/s13423-015-0841-4; GEGENFURTNER KR, 1992, BEHAV RES METH INSTR, V24, P560, DOI 10.3758/BF03203605; GEHRING WJ, 1992, J EXP PSYCHOL HUMAN, V18, P198, DOI 10.1037/0096-1523.18.1.198; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Hasegawa K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081804; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P280, DOI 10.1007/BF00419688; HOMMEL B, 1994, PSYCHOL RES-PSYCH FO, V56, P261, DOI 10.1007/BF00419656; Hubner R, 2007, J EXP PSYCHOL HUMAN, V33, P103, DOI 10.1037/0096-1523.33.1.103; Hubner R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00061; Hubner R, 2013, ACTA PSYCHOL, V144, P166, DOI 10.1016/j.actpsy.2013.05.012; Hubner R, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00434; Hubner R, 2010, PSYCHOL REV, V117, P759, DOI 10.1037/a0019471; Jost K, 2017, J EXP PSYCHOL LEARN, V43, P326, DOI 10.1037/xlm0000326; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Machado L, 2013, Q J EXP PSYCHOL, V66, P138, DOI 10.1080/17470218.2012.701651; Mansfield KL, 2013, BRAIN COGNITION, V82, P353, DOI 10.1016/j.bandc.2013.06.001; Mattler U, 2003, EXP BRAIN RES, V151, P272, DOI 10.1007/s00221-003-1486-5; Neill WT, 2016, ATTEN PERCEPT PSYCHO, V78, P2411, DOI 10.3758/s13414-016-1176-6; Panis S, 2016, J COGNITIVE NEUROSCI; POWELL MJD, 1964, COMPUT J, V7, P155, DOI 10.1093/comjnl/7.2.155; Pratte MS, 2010, ATTEN PERCEPT PSYCHO, V72, P2013, DOI 10.3758/APP.72.7.2013; Proctor RW, 2011, ACTA PSYCHOL, V136, P182, DOI 10.1016/j.actpsy.2010.06.010; Proctor RW, 2011, PSYCHON B REV, V18, P242, DOI 10.3758/s13423-011-0053-5; R Development Core Team, 2015, LANG ENV STAT COMP; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; Ridderinkhof KR, 2002, ATTENTION PERFORM, V19, P494; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schwarz W, 2012, PSYCHON B REV, V19, P555, DOI 10.3758/s13423-012-0254-6; Servant M, 2014, COGNITIVE PSYCHOL, V72, P162, DOI 10.1016/j.cogpsych.2014.03.002; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; Steinhauser M, 2009, J EXP PSYCHOL HUMAN, V35, P1398, DOI 10.1037/a0016467; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Sumner Petroc, 2008, Adv Cogn Psychol, V3, P317, DOI 10.2478/v10053-008-0033-0; TAYLOR DA, 1977, J EXP PSYCHOL GEN, V106, P404, DOI 10.1037/0096-3445.106.4.404; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Tobel L, 2014, ACTA PSYCHOL, V152, P47, DOI 10.1016/j.actpsy.2014.07.007; Torres-Quesada M, 2013, ACTA PSYCHOL, V142, P203, DOI 10.1016/j.actpsy.2012.11.015; Toth JP, 1995, CONSCIOUS COGN, V4, P483, DOI 10.1006/ccog.1995.1052; Ulrich R, 2015, COGNITIVE PSYCHOL, V78, P148, DOI 10.1016/j.cogpsych.2015.02.005; van den Wildenberg WPM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00222; Vorberg D, 2003, P NATL ACAD SCI USA, V100, P6275, DOI 10.1073/pnas.0931489100; Wendt M, 2014, EXP PSYCHOL, V61, P55, DOI 10.1027/1618-3169/a000227; White CN, 2018, PSYCHON B REV, V25, P286, DOI 10.3758/s13423-017-1271-2; White CN, 2011, COGNITIVE PSYCHOL, V63, P210, DOI 10.1016/j.cogpsych.2011.08.001	63	39	40	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214203	10.1371/journal.pone.0214203	http://dx.doi.org/10.1371/journal.pone.0214203			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921368	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000041
J	Torres, DA; Freitas, MB; da Matta, SLP; Novaes, RD; Goncalves, RV				Torres, Diego A.; Freitas, Mariella B.; da Matta, Sergio L. P.; Novaes, Romulo D.; Goncalves, Reggiani Vilela			Is bone loss a physiological cost of reproduction in the Great fruit-eating bat Artibeus lituratus?	PLOS ONE			English	Article							CALCIUM HOMEOSTASIS; MINERAL DENSITY; DIETARY CALCIUM; CORTICAL BONE; LACTATION; PREGNANCY; METABOLISM; STRENGTH; HISTOMORPHOMETRY; CHIROPTERA	During mammalian pregnancy and lactation, the maternal demand for calcium is increased to satisfy fetus and newborn skeletal growth. In addition to the dietary intake, females use the calcium contained in their bones to supply this increased demand, leading to a decrease in maternal bone mineral content. In reproductive insectivorous female bats, bone loss has been described as a physiological cost of reproduction, due to the reported increased risk of bone fracture. This physiological cost may be the mechanism underlying the conflict between increasing litter size and maintaining wing skeletal integrity, which would help to explain the small litter size of most bat species. If bone loss is a linking cost between reproduction and survival in bats, and most bat species have small litter sizes, one would expect to find a loss of bone and an increasing probability of bone fracture during pregnancy and lactation in other non-insectivorous bats. In this study, we tested for the existence of this cost in the Great-fruit eating bat, Artibeus lituratus. We analyzed trabecular structure, bone strength and bone mineral content for the humerus bone, hypothesizing that bone loss during reproduction in females would increase the risk of fracture. Our results showed a decrease of 22-31% in bone trabecular area in lactating females, rapidly compensated following weaning. Bone strength did not differ among reproductive and non-reproductive groups and seems to be more influenced by bone organic components rather than mineral contents. Since we observed bone loss during reproduction yet the humerus strength seems to be unaffected, we suggest that bone loss may not represent a physiological cost during reproduction for this frugivorous bat.	[Torres, Diego A.; Freitas, Mariella B.; da Matta, Sergio L. P.; Goncalves, Reggiani Vilela] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil; [da Matta, Sergio L. P.] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Novaes, Romulo D.] Univ Fed Alfenas, Dept Biol Struct, Alfenas, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Alfenas	Goncalves, RV (corresponding author), Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil.	reggysvilela@yahoo.com.br	Novaes, Romulo D/F-1210-2015; Gonçalves, Reggiani V/J-1550-2016; Torres, Diego Alejandro/Y-7411-2019; Freitas, Mariella B/H-9512-2015	Novaes, Romulo D/0000-0002-3186-5328; Gonçalves, Reggiani V/0000-0002-5831-3590; Torres, Diego Alejandro/0000-0001-8115-2070; Freitas, Mariella/0000-0001-5132-242X	Minas Gerais State Agency for Research and Development [FAPEMIG-PPM 00687-17]; National Counsel of Technological and Scientific Development (CNPq-PQ) [305093/2017-7, MCTIC 408503/2018-1]; Coordination of Improvement of Higher Level Personnel (Capes)	Minas Gerais State Agency for Research and Development; National Counsel of Technological and Scientific Development (CNPq-PQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Level Personnel (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors acknowledge the financial support of the Minas Gerais State Agency for Research and Development (FAPEMIG-PPM 00687-17), and the National Counsel of Technological and Scientific Development (CNPq-PQ 305093/2017-7 and MCTIC 408503/2018-1) and Coordination of Improvement of Higher Level Personnel (Capes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade TY, 2013, J MAMMAL, V94, P1094, DOI 10.1644/12-MAMM-A-244.1; Ardeshirpour L, 2007, ENDOCRINOLOGY, V148, P3875, DOI 10.1210/en.2006-1467; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Barclay RMR, 2003, BAT ECOLOGY, P209; BARCLAY RMR, 1994, AM NAT, V144, P1021, DOI 10.1086/285723; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Bernard RTF, 1996, S AFR J ZOOL, V31, P218; Booher CM, 2010, J MAMMAL, V91, P952, DOI 10.1644/09-MAMM-A-186.1; Bowman B. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P347; Brunet-Rossinni Anja K., 2009, P315; Charoenphandhu N, 2010, TRENDS ENDOCRIN MET, V21, P395, DOI 10.1016/j.tem.2010.02.002; CROSS NA, 1995, AM J CLIN NUTR, V61, P514, DOI 10.1093/ajcn/61.3.514; Cupertino MC, 2013, INT J EXP PATHOL, V94, P343, DOI 10.1111/iep.12046; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Egan KP, 2012, HISTOPATHOLOGY, V61, P1168, DOI 10.1111/j.1365-2559.2012.04333.x; Erben RG, 2012, METHODS MOL BIOL, V816, P279, DOI 10.1007/978-1-61779-415-5_19; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hood WR, 2011, J COMP PHYSIOL B, V181, P423, DOI 10.1007/s00360-010-0521-7; Kalkwarf HJ, 1999, J CLIN ENDOCR METAB, V84, P464, DOI 10.1210/jc.84.2.464; Kalkwarf HJ, 2002, ENDOCRINE, V17, P49, DOI 10.1385/ENDO:17:1:49; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; KWIECINSKI GG, 1987, AM J ANAT, V178, P410, DOI 10.1002/aja.1001780410; Liu XS, 2012, J BONE MINER RES, V27, P865, DOI 10.1002/jbmr.1503; MORSE A, 1945, J DENT RES, V24, P143, DOI 10.1177/00220345450240030501; Nelson SL, 2005, J CHEM ECOL, V31, P1683, DOI 10.1007/s10886-005-5920-y; Papadimitriou HM, 1996, J ZOOL, V240, P411, DOI 10.1111/j.1469-7998.1996.tb05295.x; Reeder Deeann M., 2009, P554; Sanz-Salvador L, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0424; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sequetto PL, 2017, MICROSC MICROANAL, V23, P989, DOI 10.1017/S1431927617012363; Siu WS, 2003, J BONE MINER METAB, V21, P316, DOI 10.1007/s00774-003-0427-5; Soares EA, 2015, INT J EXP PATHOL, V96, P261, DOI 10.1111/iep.12134; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Swartz SM, 2008, CELLS TISSUES ORGANS, V187, P59, DOI 10.1159/000109964; Taylor MS, 2009, J DAIRY SCI, V92, P223, DOI 10.3168/jds.2008-1345; Torres DA, 2018, REPROD FERT DEVELOP, V30, P681, DOI 10.1071/RD17163; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Wachter NJ, 2002, BONE, V31, P90, DOI 10.1016/S8756-3282(02)00779-2; Walker RS, 2008, P ROY SOC B-BIOL SCI, V275, P827, DOI 10.1098/rspb.2007.1511; Wendeln MC, 2000, BIOTROPICA, V32, P489, DOI 10.1111/j.1744-7429.2000.tb00495.x; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142; Zeni S, 2003, CALCIFIED TISSUE INT, V73, P594, DOI 10.1007/s00223-002-1093-7; ZORTEA M, 1993, J TROP ECOL, V9, P117, DOI 10.1017/S0266467400007057	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213781	10.1371/journal.pone.0213781	http://dx.doi.org/10.1371/journal.pone.0213781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921346	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000024
J	Carnes, N; Holbein, J				Carnes, Nicholas; Holbein, John			Do public officials exhibit social class biases when they handle casework? Evidence from multiple correspondence experiments	PLOS ONE			English	Article							FIELD EXPERIMENT	Are public officials more responsive to requests from affluent or poor constituents? A growing body of evidence suggests that lawmakers are more responsive to the rich when they craft policy. However, some scholars theorize that officials also exhibit a corresponding bias in favor of the poor when they handle casework, essentially giving policy to the rich and services to the poor. In this paper, we test this casework prediction using four experiments in which confederates sent simple requests to state or local officials. In each, our confederates' reported social classes were randomly assigned and signaled with a brief introductory statement mentioning the sender's occupation or economic situation. Across our samples, we find precisely-estimated null effects of social class biases: the officials we studied were equally likely to respond regardless of the constituent's class. These findings raise doubts about whether casework is really a class-biased process.	[Carnes, Nicholas] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Holbein, John] Brigham Young Univ, Dept Polit Sci, Provo, UT 84602 USA	Duke University; Brigham Young University	Carnes, N (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.	nicholas.carnes@duke.edu			National Science Foundation [SES-1657821]	National Science Foundation(National Science Foundation (NSF))	JH received funding from the National Science Foundation (SES-1657821) for this work. https://nsf.goy/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida CL, 2010, P NATL ACAD SCI USA, V107, P22384, DOI 10.1073/pnas.1015550107; Bartels Larry M., 2016, UNEQUAL DEMOCRACY PO; Bhatti Y, 2011, WHO GETS REPRESENTED?, P223; Butler DM, 2017, AM J POLIT SCI, V61, P37, DOI 10.1111/ajps.12213; Butler DM, 2012, J POLIT, V74, P474, DOI 10.1017/S0022381611001708; Butler DM, 2011, AM J POLIT SCI, V55, P463, DOI 10.1111/j.1540-5907.2011.00515.x; Butler Daniel M., 2014, REPRESENTING ADVANTA; Druckman JN, 2011, WHO GETS REPRESENTED?, P166; Einstein KL, 2017, AM J POLIT SCI, V61, P100, DOI 10.1111/ajps.12252; Gilens M., 2012, AFFLUENCE INFLUENCE; HILL KQ, 1992, AM J POLIT SCI, V36, P351, DOI 10.2307/2111481; Hout M., 2008, SOCIAL CLASS DOES IT, P25, DOI DOI 10.1177/1368430215596075; Kalla J, 2018, J POLIT, V80, P337, DOI 10.1086/693984; Kalla JL, 2016, AM J POLIT SCI, V60, P545, DOI 10.1111/ajps.12180; Kelly NJ, 2012, J POLIT, P74; Matthews Donald R., 1954, SOCIAL BACKGROUND PO; Pfaff S, DOES RELIG BIA UNPUB, DOI [10.31235/osf.io/9khds, DOI 10.31235/OSF.IO/9KHDS]; Rigby E, 2013, AM J POLIT SCI, V57, P552, DOI 10.1111/ajps.12007; SCHUMAKER PD, 1977, AM J POLIT SCI, V21, P247, DOI 10.2307/2110494; Soroka SN, 2008, PS-POLIT SCI POLIT, V41, P319, DOI 10.1017/S1049096508080505; Togerson D, 2008, DESIGNING RANDOMISED; Weber RN, 2010, PUBLIC FINANC REV, V38, P74, DOI 10.1177/1091142109358703; White A, 2018, URBAN AFF REV, V54, P794, DOI 10.1177/1078087416673202; YINGER J, 1986, AM ECON REV, V76, P881	24	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214244	10.1371/journal.pone.0214244	http://dx.doi.org/10.1371/journal.pone.0214244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917183	Green Published, gold, Green Submitted			2022-12-27	WOS:000462465800056
J	Merali, ZG; Witiw, CD; Badhiwala, JH; Wilson, JR; Fehlings, MG				Merali, Zamir G.; Witiw, Christopher D.; Badhiwala, Jetan H.; Wilson, Jefferson R.; Fehlings, Michael G.			Using a machine learning approach to predict outcome after surgery for degenerative cervical myelopathy	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; SPINAL-CORD-INJURY; SPONDYLOTIC MYELOPATHY; SURGICAL-TREATMENT; PROSPECTIVE MULTICENTER; NATURAL-HISTORY; MANAGEMENT; DECOMPRESSION; LAMINOPLASTY; HEALTH	Degenerative cervical myelopathy (DCM) is a spinal cord condition that results in progressive non-traumatic compression of the cervical spinal cord. Spine surgeons must consider a large quantity of information relating to disease presentation, imaging features, and patient characteristics to determine if a patient will benefit from surgery for DCM. We applied a supervised machine learning approach to develop a classification model to predict individual patient outcome after surgery for DCM. Patients undergoing surgery for DCM as a part of the AOSpine CSM-NA or CSM-I prospective, multi-centre studies were included in the analysis. Out of 757 patients 605, 583, and 539 patients had complete follow-up information at 6, 12, and 24 months respectively and were included in the analysis. The primary outcome was improvement in the SF-6D quality of life indicator score by the minimum clinically important difference (MCID). The secondary outcome was improvement in the modified Japanese Orthopedic Association (mJOA) score by the MCID. Predictor variables reflected information about pre-operative disease severity, disease presentation, patient demographics, and comorbidities. A machine learning approach of feature engineering, data pre-processing, and model optimization was used to create the most accurate predictive model of outcome after surgery for DCM. Following data pre-processing 48, 108, and 101 features were chosen for model training at 6, 12, and 24 months respectively. The best performing predictive model used a random forest structure and had an average area under the curve (AUC) of 0.70, classification accuracy of 77%, and sensitivity of 78% when evaluated on a testing cohort that was not used for model training. Worse pre-operative disease severity, longer duration of DCM symptoms, older age, higher body weight, and current smoking status were associated with worse surgical outcomes. We developed a model that predicted positive surgical outcome for DCM with good accuracy at the individual patient level on an independent testing cohort. Our analysis demonstrates the applicability of machine-learning to predictive modeling in spine surgery.	[Merali, Zamir G.; Witiw, Christopher D.; Badhiwala, Jetan H.; Wilson, Jefferson R.; Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Wilson, Jefferson R.] St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada; [Fehlings, Michael G.] Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Fehlings, MG (corresponding author), Univ Toronto, Div Neurosurg, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada.	michael.fehlings@uhn.ca		Badhiwala, Jetan/0000-0002-2528-1684; Fehlings, Michael/0000-0002-5722-6364	AOSpine North America (CSM-NA); AOSpine International (CSM-I)	AOSpine North America (CSM-NA); AOSpine International (CSM-I)	The authors received no specific funding for this work. The original studies were sponsored by AOSpine North America (CSM-NA) and AOSpine International (CSM-I).	Ahn JS, 2010, CLIN ORTHOP SURG, V2, P98, DOI 10.4055/cios.2010.2.2.98; Badhiwala JH, 2018, NEUROSURG CLIN N AM, V29, P21, DOI 10.1016/j.nec.2017.09.002; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Carreon LY, 2010, SPINE J, V10, P469, DOI 10.1016/j.spinee.2010.02.007; Toledo P, 2009, IEEE T INF TECHNOL B, V13, P794, DOI 10.1109/TITB.2009.2020434; Fehlings MG, 2017, GLOB SPINE J, V7, p70S, DOI 10.1177/2192568217701914; Fehlings MG, 2017, GLOB SPINE J, V7, p84S, DOI 10.1177/2192568217703387; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Fehlings MG, 2010, NEUROSURGERY, V67, P543, DOI 10.1227/01.NEU.0000386994.66508.C5; Hamburger C, 1997, SPINE, V22, P1990, DOI 10.1097/00007632-199709010-00009; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Karadimas SK, 2013, SPINE, V38, pS21, DOI 10.1097/BRS.0b013e3182a7f2c3; Kim YJ, 2007, J KOREAN NEUROSURG S, V42, P441, DOI 10.3340/jkns.2007.42.6.441; Lee SI, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02465-5; Longadge R., 2013, INT J COMPUT SCI NET, DOI DOI 10.48550/ARXIV.1305.1707; Matsuda Y, 1999, SPINE, V24, P529, DOI 10.1097/00007632-199903150-00005; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Naderi S, 1998, NEUROSURGERY, V43, P43, DOI 10.1097/00006123-199807000-00028; Naruse T, 2009, SPINE, V34, P2634, DOI 10.1097/BRS.0b013e3181b46c00; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; NURICK S, 1972, BRAIN, V95, P87; Oermann EK, 2016, SCI REP-UK, V6, DOI 10.1038/srep21161; Rhee J, 2017, GLOB SPINE J, V7, p35S, DOI 10.1177/2192568217703083; Tetreault L, 2018, NEUROSURG CLIN N AM, V29, P115, DOI 10.1016/j.nec.2017.09.020; Tetreault L, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.3.FOCUS1665; Tetreault L, 2015, WORLD NEUROSURG, V83, P679, DOI 10.1016/j.wneu.2015.01.021; Tetreault LA, 2015, SPINE J, V15, P388, DOI 10.1016/j.spinee.2014.12.145; Tetreault LA, 2014, WORLD NEUROSURG, V81, P623, DOI 10.1016/j.wneu.2013.09.023; Tetreault LA, 2013, J BONE JOINT SURG AM, V95A, P1659, DOI 10.2106/JBJS.L.01323; Walters Stephen J, 2003, Health Qual Life Outcomes, V1, P4, DOI 10.1186/1477-7525-1-4; Wilson JR, 2017, GLOB SPINE J, V7, p95S, DOI 10.1177/2192568217701716	31	44	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0215133	10.1371/journal.pone.0215133	http://dx.doi.org/10.1371/journal.pone.0215133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947300	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500101
J	Wahab, L; Jiang, HB				Wahab, Lukuman; Jiang, Haobin			A comparative study on machine learning based algorithms for prediction of motorcycle crash severity	PLOS ONE			English	Article							INJURY SEVERITY; ACCIDENT SEVERITY; HELMET USE; ENVIRONMENTAL CHARACTERISTICS; UNOBSERVED HETEROGENEITY; STATISTICAL-ANALYSIS; TRAFFIC CRASHES; ORDERED PROBIT; VEHICLE DAMAGE; DRIVER INJURY	Motorcycle crash severity is under-researched in Ghana. Thus, the probable risk factors and association between these factors and motorcycle crash severity outcomes is not known. Traditional statistical models have intrinsic assumptions and pre-defined correlations that, if flouted, can generate inaccurate results. In this study, machine learning based algorithms were employed to predict and classify motorcycle crash severity. Machine learning based techniques are non-parametric models without the presumption of relationships between endogenous and exogenous variables. The main aim of this research is to evaluate and compare different approaches to modeling motorcycle crash severity as well as investigating the effect of risk factors on the injury outcomes of motorcycle crashes. Motorcycle crash dataset between 2011 and 2015 was extracted from the National Road Traffic Crash Database at the Building and Road Research Institute (BRRI) in Ghana. The dataset was classified into four injury severity categories: fatal, hospitalized, injured, and damage-only. Three machine learning based models were developed: J48 Decision Tree Classifier, Random Forest (RF) and Instance-Based learning with parameter k (IBk) were employed to model the severity of injury in a motorcycle crash. These machine learning algorithms were validated using 10-fold cross-validation technique. The three machine learning based algorithms were compared with one another and the statistical model: multinomial logit model (MNLM). Also, the relative importance analysis of the attribute was conducted to determine the impact of these attributes on injury severity outcomes. The results of the study reveal that the predictions of machine learning algorithms are superior to the MNLM in accuracy and effectiveness, and the RF-based algorithms show the overall best agreement with the experimental data out of the three machine learning algorithms, for its global optimization and extrapolation ability. Location type, time of the crash, settlement type, collision partner, collision type, road separation, road surface type, the day of the week, and road shoulder condition were found as the critical determinants of motorcycle crash injury severity.	[Wahab, Lukuman; Jiang, Haobin] Jiangsu Univ, Sch Automot & Traff Engn, Zhenjiang, Jiangsu, Peoples R China; [Wahab, Lukuman] Tamale Tech Univ, Sch Engn, Tamale, Ghana	Jiangsu University	Jiang, HB (corresponding author), Jiangsu Univ, Sch Automot & Traff Engn, Zhenjiang, Jiangsu, Peoples R China.	jianghb@ujs.edu.cn	Wahab, Lukuman/AAO-7774-2020	Wahab, Lukuman/0000-0002-5814-8169	Ministry of Transportation, People's Republic of China [2013-364-836-900]	Ministry of Transportation, People's Republic of China	This work was supported by Ministry of Transportation, People's Republic of China (CN), Grant Number: 2013-364-836-900 to Habin Jiang. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi L, 2015, J ANAL RES CLIN MED, V3, P149, DOI [10.15171/jarcm.2015.024, DOI 10.15171/JARCM.2015.024]; Abellan J, 2013, EXPERT SYST APPL, V40, P6047, DOI 10.1016/j.eswa.2013.05.027; Ackaah W, 2011, INT J INJ CONTROL SA, V18, P21, DOI 10.1080/17457300.2010.487157; Ackaah W, 2010, TRAFFIC INJ PREV, V11, P522, DOI 10.1080/15389588.2010.489198; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P77, DOI 10.1076/icsp.10.1.77.14113; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P69, DOI 10.1076/icsp.10.1.69.14107; AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Aidoo EN, 2018, TRAFFIC INJ PREV, V19, P856, DOI 10.1080/15389588.2018.1509072; Aidoo EN, 2013, ACCIDENT ANAL PREV, V53, P23, DOI 10.1016/j.aap.2012.12.021; Akaateba MA, 2015, TRAFFIC INJ PREV, V16, P809, DOI 10.1080/15389588.2015.1024833; Akaateba MA, 2014, ACCIDENT ANAL PREV, V64, P18, DOI 10.1016/j.aap.2013.11.008; Amoh-Gyimah R, 2017, INT J INJ CONTROL SA, V24, P459, DOI 10.1080/17457300.2016.1232274; Anvari MB, 2017, INT J CIV ENG, V15, P653, DOI 10.1007/s40999-017-0180-0; Blackman RA, 2013, ACCIDENT ANAL PREV, V57, P1, DOI 10.1016/j.aap.2013.03.026; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cafiso S, 2012, PROCD SOC BEHV, V53, P881, DOI 10.1016/j.sbspro.2012.09.937; Chang LY, 2006, ACCIDENT ANAL PREV, V38, P1019, DOI 10.1016/j.aap.2006.04.009; Chang LY, 2013, SAFETY SCI, V51, P17, DOI 10.1016/j.ssci.2012.06.017; Chang LY, 2005, J SAFETY RES, V36, P365, DOI 10.1016/j.jsr.2005.06.013; Chimba D., 2009, ADV TRANSP STUD, V19, P17; Chung Y, 2014, ACCIDENT ANAL PREV, V62, P79, DOI 10.1016/j.aap.2013.08.024; Damsere-Derry J, 2017, TRAFFIC INJ PREV, V18, P736, DOI 10.1080/15389588.2017.1302083; de Lapparent M, 2006, ACCIDENT ANAL PREV, V38, P260, DOI 10.1016/j.aap.2005.09.001; Dinye R.D., 2013, SCI J REV, V2, P256, DOI [10.14196/sjas.v2i10.1032, DOI 10.14196/SJAS.V2I10.1032]; Diwani SA., 2014, ADV COMPUTER SCI INT, V3, P10; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Frank E., 2016, WEKA WORKBENCH ONLIN, V4th; Geedipally SR, 2011, TRANSPORT RES REC, P62, DOI 10.3141/2265-07; Guo YY, 2018, J TRANSP ENG A-SYST, V144, DOI 10.1061/JTEPBS.0000190; Guo YY, 2019, J TRANSP SAF SECUR, V11, P414, DOI 10.1080/19439962.2018.1447058; Guo YY, 2018, ACCIDENT ANAL PREV, V115, P118, DOI 10.1016/j.aap.2018.03.006; Guo YY, 2017, J ADV TRANSPORT, DOI 10.1155/2017/2142659; Guo YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185100; Haleem K, 2010, J SAFETY RES, V41, P347, DOI 10.1016/j.jsr.2010.04.006; Haque MM, 2009, ACCIDENT ANAL PREV, V41, P327, DOI 10.1016/j.aap.2008.12.010; Hashmienejad SHA, 2017, INT J CRASHWORTHINES, V22, P425, DOI 10.1080/13588265.2016.1275431; Helai H, 2008, ACCIDENT ANAL PREV, V40, P45, DOI 10.1016/j.aap.2007.04.002; Iranitalab A, 2017, ACCIDENT ANAL PREV, V108, P27, DOI 10.1016/j.aap.2017.08.008; Jiang H, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/9236156; Jung S, 2013, ACCIDENT ANAL PREV, V59, P357, DOI 10.1016/j.aap.2013.06.030; Kashani AT, 2014, J SAFETY RES, V51, P93, DOI 10.1016/j.jsr.2014.09.004; Kononen DW, 2011, ACCIDENT ANAL PREV, V43, P112, DOI 10.1016/j.aap.2010.07.018; Kudebong M, 2011, Ghana Med J, V45, P135; Kumar S, 2017, EUR TRANSP RES REV, V9, DOI 10.1007/s12544-017-0242-z; Lagarde E, 2007, PLOS MED, V4, P967, DOI 10.1371/journal.pmed.0040170; Long J.S., 2006, REGRESSION MODELS CA; Mafi S, 2018, TRANSPORT RES REC, V2672, P171, DOI 10.1177/0361198118794292; Maistros A, 2014, J SAFETY RES, V49, P129, DOI 10.1016/j.jsr.2014.03.002; Malyshkina NV, 2009, ACCIDENT ANAL PREV, V41, P829, DOI 10.1016/j.aap.2009.04.006; Mannering F, 2016, ANAL METHODS ACCID R, V11, P1, DOI 10.1016/j.amar.2016.04.001; Mannering F, 2014, ANAL METHODS ACCID R, V1, P1, DOI 10.1016/j.amar.2013.09.001; Mock CN, 1999, ACCIDENT ANAL PREV, V31, P359, DOI 10.1016/S0001-4575(98)00064-5; Montella A, 2012, ACCIDENT ANAL PREV, V49, P58, DOI 10.1016/j.aap.2011.04.025; Mujalli RO, 2012, P ICE TRANSP, P1; National Road Safety Commission, 2017, ROAD TRAFF CRASH GHA; Obeng DA, 2013, INT REF J ENG SCI IS, V2, P2319; Pai CW, 2007, SAFETY SCI, V45, P832, DOI 10.1016/j.ssci.2006.08.021; Pai CW, 2013, ACCIDENT ANAL PREV, V59, P1, DOI 10.1016/j.aap.2013.04.034; Pai CW, 2009, SAFETY SCI, V47, P1097, DOI 10.1016/j.ssci.2008.12.007; Pai CW, 2009, ACCIDENT ANAL PREV, V41, P565, DOI 10.1016/j.aap.2009.02.007; Pande A, 2010, J SAFETY RES, V41, P391, DOI 10.1016/j.jsr.2010.06.004; Quddus MA, 2002, J SAFETY RES, V33, P445, DOI 10.1016/S0022-4375(02)00051-8; Quddus MA, 2010, J TRANSP ENG, V136, P424, DOI 10.1061/(ASCE)TE.1943-5436.0000044; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Ranney ML, 2010, ACCIDENT ANAL PREV, V42, P2057, DOI 10.1016/j.aap.2010.06.017; Rifaat SM, 2012, ACCIDENT ANAL PREV, V49, P44, DOI 10.1016/j.aap.2011.02.025; Savolainen P, 2007, ACCIDENT ANAL PREV, V39, P955, DOI 10.1016/j.aap.2006.12.016; Savolainen PT, 2011, ACCIDENT ANAL PREV, V43, P1666, DOI 10.1016/j.aap.2011.03.025; Shahbaz M., 2011, 31236 MPRA, P1; Shaheed MSB, 2013, ACCIDENT ANAL PREV, V61, P119, DOI 10.1016/j.aap.2013.05.028; Sharma P, 2012, INTJCOMPUTER TECHNOL, V3, P293; Sugetha C, 2017, INT CONF ADV COMPU, P365, DOI 10.1109/ICoAC.2017.8441188; Suthaharan S, 2016, INTEGR SER INFORM SY, V36, P1, DOI 10.1007/978-1-4899-7641-3; Tang JJ, 2019, ACCIDENT ANAL PREV, V122, P226, DOI 10.1016/j.aap.2018.10.016; Tang JJ, 2017, IEEE T INTELL TRANSP, V18, P2340, DOI 10.1109/TITS.2016.2643005; Theofilatos A, 2015, INT J INJ CONTROL SA, V22, P284, DOI 10.1080/17457300.2014.908224; Vlahogianni EI, 2012, ACCIDENT ANAL PREV, V49, P12, DOI 10.1016/j.aap.2012.04.009; Witten IH, 2017, DATA MINING: PRACTICAL MACHINE LEARNING TOOLS AND TECHNIQUES, 4TH EDITION, P161, DOI 10.1016/B978-0-12-804291-5.00005-2; World Health Organization [WHO], 2015, GLOB STAT REP SAF 20; Ye F, 2014, ANAL METHODS ACCID R, V1, P72, DOI 10.1016/j.amar.2013.03.001; Ye X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197338; Zhu XY, 2011, ACCIDENT ANAL PREV, V43, P49, DOI 10.1016/j.aap.2010.07.007; Zou YJ, 2018, J APPL STAT, V45, P1652, DOI 10.1080/02664763.2017.1389863	83	47	47	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214966	10.1371/journal.pone.0214966	http://dx.doi.org/10.1371/journal.pone.0214966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947250	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500094
J	Yu, ZC; Zhang, W; Li, B; Luo, XP; Wang, R; Yang, XY				Yu, Zhi-Chao; Zhang, Wei; Li, Bin; Luo, Xiao-Ping; Wang, Rui; Yang, Xiao-Ye			A survey of Onchocerca fasciata infection in camels (Camelus bactrianus) with notes on morphology	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; DROMEDARIUS; NEMATODA; GUTTUROSA; RAILLIET; CATTLE; HENRY; FILARIOIDEA; PREVALENCE; ARMILLATA	The goal of this study was to provide insight into the pathogenicity of Onchocerca fasciata in Camelus bactrianus to help control onchocerciasis. From November 2015 to January 2016, the prevalence and severity of onchocerciasis were recorded in 152 camels. Nodules containing Onchocerca were collected and observed. Adult parasites were extracted from the nodules and identified via light microscopy as well as by partial sequencing of the cytochrome oxidase subunit I (C01) gene. The sequences were examined and compared to similar sequences from other Onchocerca species. In total, 80.3% of camels were parasitized. The severity of infection varied, as camels harboured between one and fifteen nodules. The morphology and the cuticle differed in both sexes and displayed considerable variation in the thickness and structure of different body parts. Identification was further confirmed using molecular biology methods. This study provides a comprehensive morphological description of Onchocerca fasciata isolated from camels. The prevalence and intensity of infection (assessed via nodules) varied in the Bactrian camels. The structure of the cuticle was an important morphological feature for species differentiation in Onchocerca. Based on our data, the morphological assessment of O. fasciata represents a reliable method to characterize other Onchocerca species.	[Yu, Zhi-Chao; Luo, Xiao-Ping; Wang, Rui; Yang, Xiao-Ye] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Wei; Li, Bin] Xinjiang Agr Univ, Coll Vet Med, Urumqi, Sinkiang, Peoples R China; [Yu, Zhi-Chao] Technol Ctr, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Xinjiang Agricultural University	Wang, R; Yang, XY (corresponding author), Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Inner Mongolia, Peoples R China.	wr2006@163.com; xiaoyeyang122@sohu.com		Rui, Wang/0000-0002-2761-9466	National Natural Science Foundation of China [31360606]; Special Fund for Agro-scientific Research in the Public Interest, China [201303037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest, China	This work was supported by the National Natural Science Foundation of China (grant no. 31360606) and the Special Fund for Agro-scientific Research in the Public Interest, China (grant no. 201303037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch F, 2016, INT J PARASITOL-PAR, V5, P192, DOI 10.1016/j.ijppaw.2016.06.001; CHAUHAN PPS, 1978, J HELMINTHOL, V52, P343, DOI 10.1017/S0022149X00005605; CHEEMA AH, 1984, J HELMINTHOL, V58, P279, DOI 10.1017/S0022149X0002513X; Colella V, 2018, TRANSBOUND EMERG DIS, V65, P1107, DOI 10.1111/tbed.12842; Crosskey R.W., 1982, Fauna of Saudi Arabia, V4, P398; Determann A, 1997, PARASITOL RES, V83, P591, DOI 10.1007/s004360050303; EBERHARD ML, 1979, J PARASITOL, V65, P379, DOI 10.2307/3280279; El-Massry AA, 2000, VET PARASITOL, V88, P305, DOI 10.1016/S0304-4017(99)00203-4; GHANDOUR AM, 1991, VET PARASITOL, V39, P67, DOI 10.1016/0304-4017(91)90063-2; Henry A., 1933, Bulletin Acad Veter France, V6, P208; Hidalgo MR, 2015, J HELMINTHOL, V89, P326, DOI 10.1017/S0022149X1400011X; HOLDSWORTH PA, 1985, AUST VET J, V62, P26, DOI 10.1111/j.1751-0813.1985.tb06038.x; HOLDSWORTH PA, 1987, INT J PARASITOL, V17, P957, DOI 10.1016/0020-7519(87)90015-4; HUSSEIN HS, 1988, VET RES COMMUN, V12, P475, DOI 10.1007/BF01075477; Ishizawa H, 2015, PATHOL INT, V65, P271, DOI 10.1111/pin.12256; Khodakaram-Tafti A, 2010, J CAMEL PRACT RES, V17, P37; Krueger A, 2007, ACTA TROP, V101, P1, DOI 10.1016/j.actatropica.2006.11.004; Li GD, 2008, J CAMEL PRACT RES, V15, P211; Makepeace BL, 2016, TRENDS PARASITOL, V32, P966, DOI 10.1016/j.pt.2016.08.013; Marques SMT, 2004, TROP ANIM HEALTH PRO, V36, P633, DOI 10.1023/B:TROP.0000042863.83233.78; Mather Cheryl, 2012, Cardiovasc Pathol, V21, pe35, DOI 10.1016/j.carpath.2011.07.004; Moghaddar N, 2006, J CAMEL PRACT RES, V13, P31; Moya L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004829; Muller R., 1979, SYMPOSIA OF THE BRITISH SOCIETY FOR PARASITOLOGY, V17, P175; Mutafchiev Y, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-309; NASHER AK, 1986, ANN PARASIT HUM COMP, V61, P77, DOI 10.1051/parasite/198661177; Upasna Sharma, 2012, International Journal of Animal and Veterinary Advances, V4, P284; Railliet A, 1910, CR SOC BIOL, V68, P248; Slama D, 2014, PARASITOL RES, V113, P2435, DOI 10.1007/s00436-014-3873-1; Takaoka H, 2012, MED VET ENTOMOL, V26, P372, DOI 10.1111/j.1365-2915.2012.01023.x; Townson Simon, 2006, Filaria J, V5, P4, DOI 10.1186/1475-2883-5-4; Uni S, 2010, PARASITOL INT, V59, P477, DOI 10.1016/j.parint.2010.05.006; Verocai GG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-242; Zubairova M. M., 2010, Parazitologiya (St. Petersburg), V44, P525	34	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214477	10.1371/journal.pone.0214477	http://dx.doi.org/10.1371/journal.pone.0214477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946756	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500034
J	Zhang, ZH; Lin, XT; Yu, QW; Teng, GJ; Zang, FC; Wang, XM; Liu, SW; Hou, ZY				Zhang, Zhonghe; Lin, Xiangtao; Yu, Qiaowen; Teng, Gaojun; Zang, Fengchao; Wang, Ximing; Liu, Shuwei; Hou, Zhongyu			Fetal ocular development in the second trimester of pregnancy documented by 7.0 T postmortem Magnetic Resonance Imaging	PLOS ONE			English	Article							BRAIN DEVELOPMENT; GESTATIONAL-AGE; GROWTH; MRI	Few investigators have analyzed fetal ocular growth with Magnetic Resonance Imaging (MRI) of high magnetic strength. Our purpose is to obtain normative biometrics for fetal ocular development in the second trimester of pregnancy. Sixty specimens with a gestational age (GA) of 12-23 weeks were scanned using a 7.0 T MRI scanner. The linear interocular and binocular distances (IOD and BOD, respectively), globe diameter (GD) and lens diameter (LD) were measured on the transverse section of the largest diameter of the eyeballs. The three dimensional (3D) visualization model of the eyeball was reconstructed with Amira software. Then, the globe and lens volumes (GV and LV, respectively) were obtained. All the measurements were plotted as a function of GA. The fetal ocular structures in the second trimester of pregnancy could be clearly delineated on 7.0 T postmortem MRI images. All the linear measurements logarithmically increased with GA, while, the volumetric measurements linearly increased with GA. Postmortem MRI of high magnetic strength can clearly document fetal ocular growth in the second trimester of pregnancy. These quantitative data may be a valuable reference for the assessment of normal fetal eyeball development in clinical settings and may be considered a supplement to anatomical investigations.	[Zhang, Zhonghe; Lin, Xiangtao; Yu, Qiaowen; Wang, Ximing; Hou, Zhongyu] Shandong Univ, Shandong Prov Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China; [Zhang, Zhonghe; Lin, Xiangtao; Yu, Qiaowen; Wang, Ximing; Hou, Zhongyu] Shandong First Med Univ, Affiliated Hosp 1, Dept Med Imaging, Jinan, Shandong, Peoples R China; [Zhang, Zhonghe; Lin, Xiangtao; Yu, Qiaowen; Liu, Shuwei; Hou, Zhongyu] Shandong Univ, Sch Med, Res Ctr Sect & Imaging Anat, Jinan, Shandong, Peoples R China; [Teng, Gaojun; Zang, Fengchao] Southeast Univ, Sch Clin Med, Zhong Da Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Southeast University - China	Hou, ZY (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China.; Hou, ZY (corresponding author), Shandong First Med Univ, Affiliated Hosp 1, Dept Med Imaging, Jinan, Shandong, Peoples R China.; Hou, ZY (corresponding author), Shandong Univ, Sch Med, Res Ctr Sect & Imaging Anat, Jinan, Shandong, Peoples R China.	houzhongyuqq@163.com			National Natural Science Foundation of China [81300497, 31371213]; Doctoral Foundation of Shandong Province [BS2013YY025]; Medicine Health and Science Technology Development Program of Shandong Province [2106WS0435]; Key Research Development Program of Shandong Province [2017GSF218077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation of Shandong Province; Medicine Health and Science Technology Development Program of Shandong Province; Key Research Development Program of Shandong Province	This work was supported by National Natural Science Foundation of China (81300497; 31371213), Doctoral Foundation of Shandong Province (BS2013YY025); Medicine Health and Science Technology Development Program of Shandong Province (2106WS0435); Key Research Development Program of Shandong Province (2017GSF218077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bault JP, 2011, ULTRASOUND OBST GYN, V37, P570, DOI 10.1002/uog.8847; BremondGignac DS, 1997, SURG RADIOL ANAT, V19, P319, DOI 10.1007/BF01637602; Dilmen G, 2002, INT J GYNECOL OBSTET, V76, P267, DOI 10.1016/S0020-7292(01)00581-1; Lan LM, 2000, RADIOLOGY, V215, P205, DOI 10.1148/radiology.215.1.r00ap05205; Li XB, 2010, PRENATAL DIAG, V30, P1064, DOI 10.1002/pd.2612; Odeh M, 2009, PRENATAL DIAG, V29, P749, DOI 10.1002/pd.2274; Paquette LB, 2009, AM J NEURORADIOL, V30, P1787, DOI 10.3174/ajnr.A1664; Robinson AJ, 2008, PEDIATR RADIOL, V38, P971, DOI 10.1007/s00247-008-0929-3; Velasco-Annis C, 2015, PRENATAL DIAG, V35, P400, DOI 10.1002/pd.4558; Zhan JF, 2013, NEUROIMAGE, V82, P115, DOI 10.1016/j.neuroimage.2013.05.063; Zhang Z, 2013, AM J NEURORADIOL, V34, P1462, DOI 10.3174/ajnr.A3406; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075511; Zhang ZH, 2011, EUR J RADIOL, V80, pE432, DOI 10.1016/j.ejrad.2010.11.024; Zhang ZH, 2011, NEURORADIOLOGY, V53, P177, DOI 10.1007/s00234-010-0781-7; Zhang ZH, 2010, INT J DEV NEUROSCI, V28, P537, DOI 10.1016/j.ijdevneu.2010.05.001	15	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214939	10.1371/journal.pone.0214939	http://dx.doi.org/10.1371/journal.pone.0214939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947240	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500088
J	Frolov, AO; Malysheva, MN; Ganyukova, AI; Spodareva, VV; Yurchenko, V; Kostygov, AY				Frolov, Alexander O.; Malysheva, Marina N.; Ganyukova, Anna I.; Spodareva, Viktoria V.; Yurchenko, Vyacheslav; Kostygov, Alexei Y.			Development of Phytomonas lipae sp. n. (Kinetoplastea: Trypanosomatidae) in the true bug Coreus marginatus (Heteroptera: Coreidae) and insights into the evolution of life cycles in the genus Phytomonas	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SALIVARY-GLANDS; PARASITES; DIVERSITY; HISTORY; PLANTS; PHYLOGENY; HEMIPTERA; INSECTS; SERPENS	Here we described a new trypanosomatid species, Phytomonas lipae, parasitizing the dock bug Coreus marginatus based on axenic culture and in vivo material. Using light and electron microscopy we characterized the development of this flagellate in the intestine, hemolymph and salivary glands of its insect host. The intestinal promastigotes of Phytomonas lipae do not divide and occur only in the anterior part of the midgut. From there they pass into hemolymph, increasing in size, and then to salivary glands, where they actively proliferate without attachment to the host's epithelium and form infective endomastigotes. We conducted molecular phylogenetic analyses based on 18s rRNA, gGAPDH and HSP83 gene sequences, of which the third marker performed the best in terms of resolving phylogenetic relationships within the genus Phytomonas. Our inference demonstrated rather early origin of the lineage comprising the new species, right after that of P. oxycareni, which represents the earliest known branch within the Phytomonas Glade. This allowed us to compare the development of P. lipae and three other Phytomonas spp. in their insect hosts and reconstruct the vectorial part of the life cycle of their common ancestor.	[Frolov, Alexander O.; Malysheva, Marina N.; Ganyukova, Anna I.; Spodareva, Viktoria V.; Kostygov, Alexei Y.] Russian Acad Sci, Zool Inst, St Petersburg, Russia; [Spodareva, Viktoria V.; Yurchenko, Vyacheslav; Kostygov, Alexei Y.] Univ Ostrava, Fac Sci, Life Sci Res Ctr, Ostrava, Czech Republic; [Yurchenko, Vyacheslav] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia; [Yurchenko, Vyacheslav] Univ Ostrava, Fac Sci, Inst Environm Technol, Ostrava, Czech Republic	Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; University of Ostrava; Sechenov First Moscow State Medical University; University of Ostrava	Kostygov, AY (corresponding author), Russian Acad Sci, Zool Inst, St Petersburg, Russia.; Kostygov, AY (corresponding author), Univ Ostrava, Fac Sci, Life Sci Res Ctr, Ostrava, Czech Republic.	kostygov@gmail.com	Kostygov, Alexei Y/D-3931-2015; Frolov, Alexander/AAP-9475-2020; Yurchenko, Vyacheslav/E-4532-2013; Frolov, Alexander O./P-3414-2015	Kostygov, Alexei Y/0000-0002-1516-437X; Frolov, Alexander/0000-0003-1444-3104; Yurchenko, Vyacheslav/0000-0003-4765-3263; 	Russian Science Foundation [18-14-00134]; European Regional Funds [16_019/0000759]; project "Pristroje IET" [CZ.1.05/2.1.00/19.0388]; University of Ostrava	Russian Science Foundation(Russian Science Foundation (RSF)); European Regional Funds; project "Pristroje IET"; University of Ostrava	This work was supported by the Russian Science Foundation (http://rscf.ru/en/) grant 18-14-00134 to AOF, MNM, AIG, and AYK; European Regional Funds (https://ec.europa.eu/regional_policy/en/funding/erdf/) grant 16_019/0000759 to VY; the project "Pristroje IET" (http://www.ietech.eu/index.php/iet-1) grant CZ.1.05/2.1.00/19.0388 to VY; and a grant from the University of Ostrava (http://www.osu.cz) to VVS and VY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoundi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004349; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Butler CE, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01266-16, 10.1128/genomea.01266-16]; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; CAMARGO EP, 1990, PARASITOL TODAY, V6, P22, DOI 10.1016/0169-4758(90)90388-K; Camargo EP, 1994, ADV DISEASE VECTOR R, P333; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chistyakova LV, 2014, PARASITOL RES, V113, P4207, DOI 10.1007/s00436-014-4096-1; Dollet M, 2000, J EUKARYOT MICROBIOL, V47, P569, DOI 10.1111/j.1550-7408.2000.tb00091.x; DOLLET M, 1984, ANNU REV PHYTOPATHOL, V22, P115, DOI 10.1146/annurev.py.22.090184.000555; Dollet M, 2012, INFECT GENET EVOL, V12, P299, DOI 10.1016/j.meegid.2011.11.010; Donovan C, 1909, LANCET, V2, P1495; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FREYMULLER E, 1990, J PROTOZOOL, V37, P225, DOI 10.1111/j.1550-7408.1990.tb01132.x; Frolov A. O., 2015, Parazitologiya (St. Petersburg), V49, P233; Frolov A.O., 1995, Tsitologiya, V37, P539; Frolov A. O., 1993, Parazitologiya (St. Petersburg), V27, P227; Frolov AO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204467; Frolov AO, 2017, EUR J PROTISTOL, V57, P85, DOI 10.1016/j.ejop.2016.10.007; Frolov AO, 2016, EUR J PROTISTOL, V52, P1, DOI 10.1016/j.ejop.2015.08.002; Gerasimov ES, 2012, EUR J PROTISTOL, V48, P185, DOI 10.1016/j.ejop.2011.09.002; HECKER H, 1990, PARASITOL RES, V76, P311, DOI 10.1007/BF00928185; Hoare C.A., 1972, P1; Hollar L, 1997, MOL BIOCHEM PARASIT, V89, P295, DOI 10.1016/S0166-6851(97)00117-5; Hruskova M, 2005, ACTA OECOL, V28, P281, DOI 10.1016/j.actao.2005.05.004; JANKEVICIUS JV, 1989, J PROTOZOOL, V36, P265, DOI 10.1111/j.1550-7408.1989.tb05361.x; Jaskowska E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004484; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kment Petr, 2006, Klapalekiana, V42, P97; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Kostygov AY, 2016, MBIO, V7, DOI 10.1128/mBio.01985-15; Kostygov AY, 2014, PROTIST, V165, P594, DOI 10.1016/j.protis.2014.07.001; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lafont A., 1909, Compte Rendu de la Societe de Biologie Paris, V66; Lafont A, 1911, CR SOC BIOL, V70, P58; LIPA JERZY J., 1966, ACTA PROTOZOOL, V4, P19; Lukes J, 2018, TRENDS PARASITOL, V34, P466, DOI 10.1016/j.pt.2018.03.002; Maslov DA, 1996, MOL BIOCHEM PARASIT, V75, P197, DOI 10.1016/0166-6851(95)02526-X; Maslov DA, 2019, PARASITOLOGY; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; Maslov DA, 2010, J EUKARYOT MICROBIOL, V57, P177, DOI 10.1111/j.1550-7408.2009.00464.x; Nedved O, 2014, ACTA ZOOL BULGAR, V66, P203; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; PODLIPAEV SA, 1987, PARAZITOLOGIYA+, V21, P545; Podlipaev SA, 1990, CATALOGUE WORLD FAUN; Porcel BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004007; SCHAUB GA, 1994, PARASITOL TODAY, V10, P463, DOI 10.1016/0169-4758(94)90155-4; Serrano MG, 1999, EXP PARASITOL, V91, P268, DOI 10.1006/expr.1998.4379; Seward EA, 2017, PROTIST, V168, P71, DOI 10.1016/j.protis.2016.11.002; Simpson AGB, 2002, MOL BIOL EVOL, V19, P2071, DOI 10.1093/oxfordjournals.molbev.a004032; Spodareva VV, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3023-1; Stevens J R, 1999, Cad Saude Publica, V15, P673, DOI 10.1590/S0102-311X1999000400002; STURM NR, 1995, FEMS MICROBIOL LETT, V130, P177, DOI 10.1111/j.1574-6968.1995.tb07716.x; Tyc J, 2013, MOL PHYLOGENET EVOL, V69, P255, DOI 10.1016/j.ympev.2013.05.024; Votypka J, 2015, TRENDS PARASITOL, V31, P460, DOI 10.1016/j.pt.2015.06.015; Votypka J, 2014, PROTIST, V165, P825, DOI 10.1016/j.protis.2014.09.002; WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4; Yurchenko V, 2016, J EUKARYOT MICROBIOL, V63, P198, DOI 10.1111/jeu.12268; Zanetti A, 2016, EUR J PROTISTOL, V56, P232, DOI 10.1016/j.ejop.2016.09.004	60	11	13	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214484	10.1371/journal.pone.0214484	http://dx.doi.org/10.1371/journal.pone.0214484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943229	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300041
J	Zandi, S; Pfister, IB; Traine, PG; Tappeiner, C; Despont, A; Rieben, R; Skowronska, M; Garweg, JG				Zandi, Souska; Pfister, Isabel B.; Traine, Peter G.; Tappeiner, Christoph; Despont, Alain; Rieben, Robert; Skowronska, Magdalena; Garweg, Justus G.			Biomarkers for PVR in rhegmatogenous retinal detachment	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINOPATHY; EPIRETINAL MEMBRANES; SUBRETINAL FLUID; VITREOUS-HUMOR; TGF-BETA; CYTOKINES; CHEMOKINES; INTERLEUKIN-6; ASSOCIATION; EXPRESSION	Purpose Various profibrotic and proinflammatory cytokines have been found upregulated in uncomplicated primary retinal detachment (pRD), but without providing a uniform picture. Here, we compare the cyto- and chemokine profiles in pRD with and without proliferative vitreoretinopathy (PVR) in an attempt to unravel relevant differences not in single cytokines, but in the cytokine profiles at diagnosis. Methods Undiluted vitreous fluid (VF) was obtained at the beginning of surgery from 174 eyes with pRD without relevant PVR (maximally grade B; group 1; n = 81) and with moderate or advanced PVR requiring a gas tamponade (group 2; n = 49) or silicon oil filling (group 3; n = 44). VF of eyes undergoing macular hole (MH) surgery served as controls (group 4; n = 26). Forty-three cytokines were quantified in parallel using a multiplex cytokine analysis system (Bioplex). For all comparisons we applied Holm's correction to control for multiple comparisons. Results 44.9% of group 2 eyes presented grade C1 and 55.1% C2-C3, whereas 86.4% of group 3 eyes exhibited a PVR grade of C2-D. CCL19 was the only cytokine that displayed higher concentrations in the vitreous of eyes with PVR C1 compared to lower PVR grades. Eyes with PVR C2-D showed higher levels of CCL27, CXCL6, IL4, IL16, CXCL10, CCL8, CCL22, MIG/CXCL9, CCL15, CCL19, CCL 23 and CXCL12 compared to controls. Interestingly, no difference of cytokine levels was detected between C1 and C2-D PVR. Conclusions CCL19 may represent a potential biomarker for early PVR progression that holds promise for future diagnostic and therapeutic applications.	[Zandi, Souska; Pfister, Isabel B.; Traine, Peter G.; Skowronska, Magdalena; Garweg, Justus G.] Berner Augenklin Lindenhof Spital, Swiss Eye Inst, Bern, Switzerland; [Zandi, Souska; Pfister, Isabel B.; Traine, Peter G.; Skowronska, Magdalena; Garweg, Justus G.] Berner Augenklin Lindenhof Spital, Clin Vitreoretinal Dis, Bern, Switzerland; [Tappeiner, Christoph] Univ Bern, Bern Univ Hosp, Inselspital, Dept Ophthalmol, Bern, Switzerland; [Despont, Alain; Rieben, Robert] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Garweg, Justus G.] Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern	Garweg, JG (corresponding author), Berner Augenklin Lindenhof Spital, Swiss Eye Inst, Bern, Switzerland.; Garweg, JG (corresponding author), Berner Augenklin Lindenhof Spital, Clin Vitreoretinal Dis, Bern, Switzerland.; Garweg, JG (corresponding author), Univ Bern, Bern, Switzerland.	garweg@swiss-eye-institute.com	; Rieben, Robert/D-7044-2017	Zandi, Souska/0000-0001-9351-4278; Skowronska, Magdalena/0000-0002-5902-5486; Rieben, Robert/0000-0003-4179-8891	Lindenhof foundation	Lindenhof foundation	Independent unconditional funding was received from the research funds of the Lindenhof foundation for the project covering 30% of the laboratory kits, but these were not personal donations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; AHMED SA, 1985, AM J PATHOL, V121, P531; Asaria Riaz H Y, 2006, Compr Ophthalmol Update, V7, P179; Banerjee S, 2007, INVEST OPHTH VIS SCI, V48, P2203, DOI 10.1167/iovs.06-1358; Bu SC, 2015, INVEST OPHTH VIS SCI, V56, P6506, DOI 10.1167/iovs.14-15971; Candore G, 2010, REJUV RES, V13, P292, DOI 10.1089/rej.2009.0942; Pastor JC, 2016, PROG RETIN EYE RES, V51, P125, DOI 10.1016/j.preteyeres.2015.07.005; Ciprian Danielescu, 2015, Rom J Ophthalmol, V59, P88; Danielescu C, 2016, MED-SURG J, V120, P124; El-Ghrably IA, 2001, BRIT J OPHTHALMOL, V85, P461, DOI 10.1136/bjo.85.4.461; Gagliano C, 2015, CURR PHARM DESIGN, V21, P4698, DOI 10.2174/1381612821666150909100212; Garweg JG, 2019, ACTA OPHTHALMOL, V97, pE580, DOI 10.1111/aos.13998; Garweg JG, 2017, GRAEF ARCH CLIN EXP, V255, P1763, DOI 10.1007/s00417-017-3724-8; Garweg JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182571; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; Hollborn M, 2008, INVEST OPHTH VIS SCI, V49, P1262, DOI 10.1167/iovs.07-0879; Holm S., 1979, SCANDINAVIAN J STAT; KAUFFMANN DJH, 1994, INVEST OPHTH VIS SCI, V35, P900; Kiang L, 2018, INVEST OPHTH VIS SCI, V59, P3767, DOI 10.1167/iovs.18-24489; Kunikata H, 2013, AM J OPHTHALMOL, V155, P1028, DOI 10.1016/j.ajo.2013.01.013; Kwon OW, 2016, DEV OPHTHALMOL, V55, P154, DOI 10.1159/000438972; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; McGrory K, 2004, BIOCHEM BIOPH RES CO, V324, P317, DOI 10.1016/j.bbrc.2004.09.056; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Patel VP, 1997, J EXP MED, V185, P1163, DOI 10.1084/jem.185.7.1163; Pennock S, 2011, AM J PATHOL, V179, P2931, DOI 10.1016/j.ajpath.2011.08.043; Rasier R, 2010, CURR EYE RES, V35, P505, DOI 10.3109/02713681003597248; Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586; Ricker LJAG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019141; Ricker LJAG, 2010, INVEST OPHTH VIS SCI, V51, P4143, DOI 10.1167/iovs.09-5057; Roldan-Pallares M, 2008, J FR OPHTALMOL, V31, P36, DOI 10.1016/S0181-5512(08)70328-0; Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20; Sadaka A, 2012, CLIN OPHTHALMOL, V6, P1325, DOI 10.2147/OPTH.S27896; Symeonidis C, 2012, CYTOKINE, V59, P184, DOI 10.1016/j.cyto.2012.04.019; Takahashi S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4256183; Takeuchi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137358; van Beek AA, 2019, TRENDS IMMUNOL, V40, P113, DOI 10.1016/j.it.2018.12.007; Ventura Maria Teresa, 2017, Clin Mol Allergy, V15, P21, DOI 10.1186/s12948-017-0077-0; Yoshida S, 2017, CLIN OPHTHALMOL, V11, P1697, DOI 10.2147/OPTH.S141821; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158; Zaja-Milatovic S, 2008, HISTOL HISTOPATHOL, V23, P1399, DOI 10.14670/HH-23.1399; Zandi S, 2016, INVEST OPHTH VIS SCI, V57, P6320, DOI 10.1167/iovs.16-20657; Zhao QQ, 2018, MOL MED REP, V17, P7301, DOI 10.3892/mmr.2018.8787; Zhuang H, 2014, GRAEF ARCH CLIN EXP, V252, P1763, DOI 10.1007/s00417-014-2768-2	48	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214674	10.1371/journal.pone.0214674	http://dx.doi.org/10.1371/journal.pone.0214674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943234	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300050
J	Zhang, WZ; He, ZC; Du, B; Luo, MN; Zheng, QH				Zhang, Weizhan; He, Zhichao; Du, Biao; Luo, Minnan; Zheng, Qinghua			Deploying external bandwidth guaranteed media server clusters for real-time live streaming in media cloud	PLOS ONE			English	Article							VIRTUAL MACHINE PLACEMENT; VIDEO; DEMAND	The cloud-based media streaming service is a promising paradigm for multimedia applications. It is attractive to media streaming service providers, who wish to deploy their media server clusters in a media cloud at reduced cost. Since the real-time live streaming service is both a bandwidth-intensive and quality-sensitive application, how to optimize the internal bandwidth utilization of a data center network (DCN) as well as guarantee the external bandwidth of the real-time live streaming application, is a key issue of deploying virtual machine (VM)-hosted media server cluster in a media cloud. Therefore, in this study, we propose an external-bandwidth-guaranteed media server cluster deployment scheme in media cloud. The approach simultaneously considers the outside bandwidth requirement of a tree-based media server cluster for live streaming and the intra-bandwidth consumption of a DCN. The proposed scheme models the optimal problem as a new terminal-Steiner-tree-like problem and provides an approximate algorithm for placing the media servers. Our evaluation results show that the proposed scheme guarantees the external bandwidth requirement of a real-time live streaming application, at the same time, greatly reduces the intra-bandwidth utilization of a media cloud with different DCN structures.	[Zhang, Weizhan; He, Zhichao; Du, Biao; Luo, Minnan; Zheng, Qinghua] Xi An Jiao Tong Univ, Dept Comp Sci & Technol, MOEKLINNS Lab, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Zhang, WZ (corresponding author), Xi An Jiao Tong Univ, Dept Comp Sci & Technol, MOEKLINNS Lab, Xian, Shaanxi, Peoples R China.	zhangwzh@xjtu.edu.cn			Fundamental Theory and Applications of Big Data with Knowledge Engineering under the National Key Research and Development Program of China [2016YFB1000903]; National Science Foundation of China [61772414, 61532015, 61702400, 61532004, 61721002, 61472317, 61502379]; MOE Innovation Research Team [IRT17R86]; Project of China Knowledge Centre for Engineering Science and Technology; consulting research project of Chinese academy of engineering "The Online and Offline Mixed Educational Service System for 'The Belt and Road' Training in MOOC China"	Fundamental Theory and Applications of Big Data with Knowledge Engineering under the National Key Research and Development Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE Innovation Research Team; Project of China Knowledge Centre for Engineering Science and Technology; consulting research project of Chinese academy of engineering "The Online and Offline Mixed Educational Service System for 'The Belt and Road' Training in MOOC China"	This work is supported by The Fundamental Theory and Applications of Big Data with Knowledge Engineering under the National Key Research and Development Program of China with grant number 2016YFB1000903, the National Science Foundation of China under Grant Nos. 61772414, 61532015, 61702400, 61532004, 61721002, 61472317, 61502379, the MOE Innovation Research Team No. IRT17R86, the Project of China Knowledge Centre for Engineering Science and Technology, and the consulting research project of Chinese academy of engineering "The Online and Offline Mixed Educational Service System for 'The Belt and Road' Training in MOOC China." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal V, 2013, IEEE T MULTIMEDIA, V15, P789, DOI 10.1109/TMM.2013.2240287; Al-Fares M, 2008, ACM SIGCOMM COMP COM, V38, P63, DOI 10.1145/1402946.1402967; Amiri M., 2015, INT J INJ CONTROL SA, P1, DOI DOI 10.1109/ANIMMA.2015.7465552; Armbrust M, 2010, COMMUN ACM, V53, P50, DOI 10.1145/1721654.1721672; Bari MF, 2013, IEEE COMMUN SURV TUT, V15, P909, DOI 10.1109/SURV.2012.090512.00043; Calheiros RN, 2011, SOFTWARE PRACT EXPER, V41, P23, DOI 10.1002/spe.995; Clegg RG, 2019, IEEE T CLOUD COMPUT, V7, P756, DOI 10.1109/TCC.2017.2680440; Cohen R, 2013, IEEE INFOCOM SER, P355; Guo Y, 2013, IEEE INFOCOM SER, P620; He J, 2014, IEEE T CIRC SYST VID, V24, P669, DOI 10.1109/TCSVT.2013.2283430; Huang CY, 2014, ACM T MULTIM COMPUT, V10, DOI 10.1145/2537855; Jennings B, 2015, J NETW SYST MANAG, V23, P567, DOI 10.1007/s10922-014-9307-7; Jiang JW, 2012, IEEE INFOCOM SER, P2876, DOI 10.1109/INFCOM.2012.6195719; Jin YC, 2015, IEEE T CIRC SYST VID, V25, P1914, DOI 10.1109/TCSVT.2015.2402892; Kaseb AS, 2019, IEEE T CLOUD COMPUT, V7, P935, DOI 10.1109/TCC.2017.2720665; Lathey A, 2015, ACM T MULTIM COMPUT, V11, DOI 10.1145/2656205; Li X, 2014, IEEE INFOCOM SER, P1842, DOI 10.1109/INFOCOM.2014.6848123; Lin GH, 2002, INFORM PROCESS LETT, V84, P103, DOI 10.1016/S0020-0190(02)00227-2; Liu HK, 2015, IEEE T PARALL DISTR, V26, P1192, DOI 10.1109/TPDS.2014.2316152; Meng XY, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/650794; Perkins C, 2012, WEB REALTIME COMMUNI; Shu C, 2011, P SOC PHOTO-OPT INS; Song XD, 2015, IEEE T CIRC SYST VID, V25, P1926, DOI 10.1109/TCSVT.2015.2416562; Tang JH, 2014, IEEE T MULTIMEDIA, V16, P1434, DOI 10.1109/TMM.2014.2308726; Wang F, 2012, IEEE INFOCOM SER, P199, DOI 10.1109/INFCOM.2012.6195578; Wen YG, 2014, IEEE T MULTIMEDIA, V16, P885, DOI 10.1109/TMM.2014.2315596; Wu Y, 2013, IEEE T MULTIMEDIA, V15, P821, DOI 10.1109/TMM.2013.2240670; Wu Y, 2011, INT CON DISTR COMP S, P268, DOI 10.1109/ICDCS.2011.50; Zhang J, 2014, IEEE INFOCOM SER, P574, DOI 10.1109/INFOCOM.2014.6847982; Zhang WY, 2018, INT J PROD RES, V56, P4676, DOI 10.1080/00207543.2017.1402137; Zhao H.L., 2016, 2016 IEEE WIR COMM N, P1, DOI DOI 10.1109/IAS.2017.8101721; Zhao Hongshan, 2017, IEEE T ENERGY CONVER, P1; Zhao YH, 2014, IEEE INFOCOM SER, P298, DOI 10.1109/INFOCOM.2014.6847951; Zhu WW, 2011, IEEE SIGNAL PROC MAG, V28, DOI 10.1109/MSP.2011.940269	34	2	2	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214809	10.1371/journal.pone.0214809	http://dx.doi.org/10.1371/journal.pone.0214809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943263	gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300063
J	Sabino-Pinto, J; Martel, A; Pasmans, F; Steinfartz, S; Vences, M				Sabino-Pinto, Joana; Martel, An; Pasmans, Frank; Steinfartz, Sebastian; Vences, Miguel			Pooling skin swabs does not inhibit qPCR detection of amphibian chytrid infection	PLOS ONE			English	Article							BATRACHOCHYTRIUM-SALAMANDRIVORANS; SP-NOV; DENDROBATIDIS; FUNGUS	Immediate and reliable pathogen detection in large numbers of samples is essential in wildlife disease monitoring and is often realized by DNA-based techniques. Pooling samples increases processing efficiency and reduces processing costs, and has been suggested as a viable technique for quantitative PCR detection of fungal amphibian pathogens of the genus Batrachochytrium. For these fungi, this diagnostic method has been validated by in vitro set ups that provided controlled test conditions but did not take into account potential effects from amphibian skin compounds (e.g. skin secretions and Microbiota) on the approach. Some of these skin compounds are known to cause PCR inhibition in single sample applications and could lead to false negative reactions and thereby hamper pathogen detection. In this study we examined the effect of skin compounds on the pooled extraction method by swabbing individuals of seven amphibian species (one Anura and six Caudata) prior to the inoculation of the swabs with chytrid zoospores. For each species, swabs were extracted in pools of different sizes (from one to four swabs) with only one swab per pool being inoculated with zoospores. There were no significant differences regarding the ability to detect zoospores when comparing pool sizes for any species, with a tendency for more false negatives when the inoculated swab had been inoculated with a single zoospore. This study provides further in vivo evidence for the viability of the pooled extraction method for DNA-based detection of pathogens.	[Sabino-Pinto, Joana; Steinfartz, Sebastian; Vences, Miguel] Braunschweig Univ Technol, Inst Zool, Braunschweig, Germany; [Martel, An; Pasmans, Frank] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium; [Steinfartz, Sebastian] Univ Leipzig, Inst Biol Mol Evolut & Systemat Anim, Leipzig, Germany	Braunschweig University of Technology; Ghent University; Leipzig University	Sabino-Pinto, J (corresponding author), Braunschweig Univ Technol, Inst Zool, Braunschweig, Germany.	joanasabinopinto@gmail.com	Pasmans, Frank/D-3667-2014	Steinfartz, Sebastian/0000-0001-5347-3969; Sabino Pinto, Joana/0000-0002-4737-5665; Vences, Miguel/0000-0003-0747-0817	Deutsche Bundesstiftung Umwelt [Aktenzeichen 32635/01-33/2]; Ghent University [BOF16/GOA/024]	Deutsche Bundesstiftung Umwelt; Ghent University(Ghent University)	This study has been partially funded through a grant of the Deutsche Bundesstiftung Umwelt to MV, DBU (Aktenzeichen 32635/01-33/2) and partially through Ghent University to FP (BOF16/GOA/024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Belden LK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01171; Bessetti J., 2007, PROFILES DNA, V10, P9, DOI [DOI 10.1161/STROKEAHA.109.559013, DOI 10.1161/STR0KEAHA.109.559013]; Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Dalbeck L, 2018, Z FELDHERPETOL, V25, P1; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Engering A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.5; Farrer RA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003703; Fox J., 2019, R COMPANION APPL REG, V.; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lederberg J, 2001, EM INF DIS GLOB LOC, DOI [10.3354/DAO073175, DOI 10.3354/DAO073175]; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Refsnider JM, 2015, G3-GENES GENOM GENET, V5, P2291, DOI 10.1534/g3.115.021808; Sabino-Pinto J, 2019, AMPHIBIA-REPTILIA, V40, P29, DOI 10.1163/15685381-20181011; Spitzen-van der Sluijs A, 2016, EMERG INFECT DIS, V22, P1286, DOI 10.3201/eid2207.160109; Stegen G, 2017, NATURE, V544, P353, DOI 10.1038/nature22059; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9	24	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214405	10.1371/journal.pone.0214405	http://dx.doi.org/10.1371/journal.pone.0214405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939146	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900020
J	Yang, SK; Yusoff, K; Ajat, M; Thomas, W; Abushelaibi, A; Akseer, R; Lim, SHE; Lai, KS				Yang, Shun-Kai; Yusoff, Khatijah; Ajat, Mokrish; Thomas, Warren; Abushelaibi, Aisha; Akseer, Riaz; Lim, Swee-Hua Erin; Lai, Kok-Song			Disruption of KPC-producing Klebsiella pneumoniae membrane via induction of oxidative stress by cinnamon bark (Cinnamomum verum J. Presl) essential oil	PLOS ONE			English	Article							L. ESSENTIAL OIL; ESCHERICHIA-COLI; MECHANOSENSITIVE CHANNEL; ACID SYNTHESIS; MECHANISM; LIPOPOLYSACCHARIDE; ANTIOXIDANT; RESISTANCE; INHIBITION; INSIGHTS	Klebsiella pneumoniae (KP) remains the most prevalent nosocomial pathogen and carries the carbapenemase (KPC) gene which confers resistance towards carbapenem. Thus, it is necessary to discover novel antimicrobials to address the issue of antimicrobial resistance in such pathogens. Natural products such as essential oils are a promising source due to their complex composition. Essential oils have been shown to be effective against pathogens, but the overall mechanisms have yet to be fully explained. Understanding the molecular mechanisms of essential oil towards KPC-KP cells would provide a deeper understanding of their potential use in clinical settings. Therefore, we aimed to investigate the mode of action of essential oil against KPC-KP cells from a proteomic perspective by comparing the overall proteome profile of KPC-KP cells treated with cinnamon bark (Cinnamomum verum J. Presl) essential oil (CBO) at their sub-inhibitory concentration of 0.08% (v/v). A total of 384 proteins were successfully identified from the non-treated cells, whereas only 242 proteins were identified from the CBO-treated cells. Proteins were then categorized based on their biological processes, cellular components and molecular function prior to pathway analysis. Pathway analysis showed that CBO induced oxidative stress in the KPC-KP cells as indicated by the abundance of oxidative stress regulator proteins such as glycyl radical cofactor, catalase peroxidase and DNA mismatch repair protein. Oxidative stress is likely to oxidize and disrupt the bacterial membrane as shown by the loss of major membrane proteins. Several genes selected for qRT-PCR analysis validated the proteomic profile and were congruent with the proteomic abundance profiles. In conclusion, KPC-KP cells exposed to CBO undergo oxidative stress that eventually disrupts the bacterial membrane possibly via interaction with the phospholipid bilayer. Interestingly, several pathways involved in the bacterial membrane repair system were also affected by oxidative stress, contributing to the loss of cells viability.	[Yang, Shun-Kai; Lai, Kok-Song] Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Serdang, Selangor, Malaysia; [Yusoff, Khatijah] Univ Putra Malaysia, Dept Microbiol, Fac Biotechnol & Biomol Sci, Serdang, Selangor, Malaysia; [Ajat, Mokrish] Univ Putra Malaysia, Dept Vet Preclin Sci, Fac Vet Med, Serdang, Selangor, Malaysia; [Thomas, Warren; Lim, Swee-Hua Erin] Perdana Univ, Perdana Univ Royal Coll Surg Ireland, Sch Med, Serdang, Selangor, Malaysia; [Abushelaibi, Aisha; Akseer, Riaz; Lim, Swee-Hua Erin] Higher Coll Technol, Div Hlth Sci, Abu Dhabi Womens Coll, Abu Dhabi, U Arab Emirates	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Perdana University; Royal College of Surgeons - Ireland; Higher Colleges of Technology - United Arab Emirates	Lai, KS (corresponding author), Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Serdang, Selangor, Malaysia.	laikoksong@upm.edu.my	Thomas, Warren/A-5477-2010; Song, Lai Kok/ABA-2585-2020; Ajat, Mokrish/AAD-4086-2021; Lim, Erin/AAR-9060-2020; Abushelaibi, Aisha/ABA-9950-2021; Lai, Kok Song/AAR-8772-2020	Lim, Erin/0000-0001-5177-0257; Thomas, Warren/0000-0003-2706-1770; Ajat, Mokrish/0000-0002-2905-4630	UPM Internal Grant [GP-IPS/2016/9505800]; Malaysian Medical Association (MMA); Fundamental Research Grant Scheme [FRGS/1/2018/SKK11/PERDANA/02/1]	UPM Internal Grant; Malaysian Medical Association (MMA); Fundamental Research Grant Scheme	The research received funding UPM Internal Grant (GP-IPS/2016/9505800), Malaysian Medical Association (MMA), and Fundamental Research Grant Scheme (FRGS/1/2018/SKK11/PERDANA/02/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Bezerra DP, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121367; Birkner JP, 2012, P NATL ACAD SCI USA, V109, P12944, DOI 10.1073/pnas.1205270109; Blount P, 2007, CURR TOP MEMBR, V58, P201, DOI 10.1016/S1063-5823(06)58008-1; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Broussard TC, 2013, BIOCHEMISTRY-US, V52, P3346, DOI 10.1021/bi4000707; Bubols GB, 2013, MINI-REV MED CHEM, V13, P318; Bunner AE, 2010, J MOL BIOL, V398, P1, DOI 10.1016/j.jmb.2010.02.036; Carvalho RL, 2016, POSTHARVEST BIOL TEC, V113, P29, DOI 10.1016/j.postharvbio.2015.11.004; Ciftci O, 2011, TOXICOL IND HEALTH, V27, P447, DOI 10.1177/0748233710388452; Cosentino M, 2014, PHYTOTHER RES, V28, P1232, DOI 10.1002/ptr.5121; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Dahham SS, 2015, MOLECULES, V20, P11808, DOI 10.3390/molecules200711808; de Souza EL, 2010, INT J FOOD MICROBIOL, V137, P308, DOI 10.1016/j.ijfoodmicro.2009.11.025; Durdu B, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3580-8; Egan AJF, 2014, P NATL ACAD SCI USA, V111, P8197, DOI 10.1073/pnas.1400376111; Emiola A, 2016, P NATL ACAD SCI USA, V113, P3108, DOI 10.1073/pnas.1521168113; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Itri Rosangela, 2014, Biophys Rev, V6, P47, DOI 10.1007/s12551-013-0128-9; Kaskatepe B, 2016, INDIAN J PHARM SCI, V78, P541, DOI 10.4172/pharmaceutical-sciences.1000150; Kawatani M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38385; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Lee CJ, 2014, ACS CHEM BIOL, V9, P237, DOI 10.1021/cb400067g; Lorenzi V, 2009, ANTIMICROB AGENTS CH, V53, P2209, DOI 10.1128/AAC.00919-08; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Mimica-Dukic N, 2016, ACS SYM SER, V1218, P187; Moynie L, 2013, J MOL BIOL, V425, P365, DOI 10.1016/j.jmb.2012.11.017; Nord S, 2009, J MOL BIOL, V386, P742, DOI 10.1016/j.jmb.2008.12.076; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pavan B, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00018; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Rahman SU, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9519718; Rhomberg PR, 2009, DIAGN MICR INFEC DIS, V65, P414, DOI 10.1016/j.diagmicrobio.2009.08.020; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Shisler KA, 2014, ARCH BIOCHEM BIOPHYS, V546, P64, DOI 10.1016/j.abb.2014.01.020; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Silva F, 2011, J MED MICROBIOL, V60, P1479, DOI 10.1099/jmm.0.034157-0; Turgis M, 2009, FOOD CONTROL, V20, P1073, DOI 10.1016/j.foodcont.2009.02.001; Ukuku DO, 2008, J FOOD PROTECT, V71, P684, DOI 10.4315/0362-028X-71.4.684; Vogel C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009217; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Willi J, 2018, NUCLEIC ACIDS RES, V46, P1945, DOI 10.1093/nar/gkx1308; Wu YP, 2016, MOLECULES, V21, DOI 10.3390/molecules21081084; Xu H, 2015, J PROTEOME RES, V14, P2480, DOI 10.1021/acs.jproteome.5b00004; Yang SK, 2018, REC NAT PROD, V12, P295, DOI 10.25135/rnp.41.17.09.058; Yang SK, 2017, MOLECULES, V22, DOI 10.3390/molecules22111733; Yang SK, 2018, REC NAT PROD, V12, P13; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Yap P.S.X., 2017, RECENT ADV PHYSL PAT; Yap PSX, 2015, J MICROBIOL BIOTECHN, V25, P1299, DOI 10.4014/jmb.1407.07054; Yap Polly Soo Xi, 2014, Open Microbiol J, V8, P6, DOI 10.2174/1874285801408010006; Yap PSX, 2013, PHYTOMEDICINE, V20, P710, DOI 10.1016/j.phymed.2013.02.013; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Yoo CB, 2005, CANCER LETT, V225, P41, DOI 10.1016/j.canlet.2004.11.018; Zainal-Abidin Z, 2013, OPEN C P J, V4, P5; Zhang G, 2013, CURR OPIN MICROBIOL, V16, P779, DOI 10.1016/j.mib.2013.09.007	57	34	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214326	10.1371/journal.pone.0214326	http://dx.doi.org/10.1371/journal.pone.0214326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939149	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000462993900018
J	Kausar, ASMZ; Reutens, DC; Weber, E; Vegh, V				Kausar, A. S. M. Zahid; Reutens, David C.; Weber, Ewald; Vegh, Viktor			Monopole antenna array design for 3 T and 7 T magnetic resonance imaging	PLOS ONE			English	Article							HIGH-FIELD MRI; COIL ARRAY; RADIOFREQUENCY COIL; BIRDCAGE COILS; INHOMOGENEITY; LIMITS; SAR	Purpose Ultra-high field magnetic resonance imaging poses a number of challenges for robust radio frequency coil designs. A monopole antenna array can potentially overcome key limitations of birdcage coil designs and may provide a useful radio frequency coil for brain imaging. Methods Four, 8 and 12 element monopole antenna arrays were simulated using 3 T and 7T magnetic resonance imaging frequencies. For comparison, 4, 8 and 12 element birdcage coils were also simulated. Coil performance was evaluated and compared and the impact of shielding was assessed. A 4 element monopole antenna array was fabricated and bench tested. Results Comparison of the 4, 8 and 12 element designs suggest that the monopole antenna array leads to better field properties than the birdcage coil in all configurations studied: unloaded, loaded with saline and loaded using a head phantom. Improvements in field properties and homogeneity were evident at both field strengths, implying that the monopole antenna array has potential for head imaging. The monopole antenna array also appears to be more efficient than the comparable birdcage coil design. Additionally, the former is scalable via the addition of more elements whereas our results suggest that this is not the case for the latter. Bench testing results show that the monopole antenna array is well matched with the transmission line, and mutual coupling between elements is sufficiently low. Conclusion We found the monopole antenna array generated a larger field intensity than the birdcage coil design, whilst also producing a more useful magnetic resonance imaging field as measured by radio frequency field homogeneity. Our study suggests that magnetic resonance imaging of the brain can likely benefit from the use of radio frequency monopole antenna arrays.	[Kausar, A. S. M. Zahid; Reutens, David C.; Vegh, Viktor] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Weber, Ewald] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Vegh, V (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.	v.vegh@uq.edu.au	Weber, Ewald/HHN-8304-2022	Weber, Ewald/0000-0002-7323-8015	Australian Research Council [LP130100703]	Australian Research Council(Australian Research Council)	This project was funded by the Australian Research Council (LP130100703). DCR and VV received the funds.	Alagappan V, 2007, MAGN RESON MED, V57, P1148, DOI 10.1002/mrm.21247; ALBERTSEN NC, 1974, IEEE T ANTENN PROPAG, VAP22, P200, DOI 10.1109/TAP.1974.1140783; Byun JD, 2017, J MAGN, V22, P378, DOI 10.4283/JMAG.2017.22.3.378; Cassidy PJ, 2005, CONCEPT MAGN RESON B, V25B, P27, DOI 10.1002/cmr.b.20029; Cheng T, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/804586; Collins CM, 2004, J MAGN RESON IMAGING, V19, P650, DOI 10.1002/jmri.20041; Dardzinski BJ, 1998, J MAGN RESON, V131, P32, DOI 10.1006/jmre.1997.1334; Gang C, 2014, P 22 ANN M ISMRM MIL; Ghanem F, 2009, ELECTRON LETT, V45, P534, DOI 10.1049/el.2009.0935; Giovannetti G, 2002, MAGN RESON MATER PHY, V15, P36, DOI 10.1016/S1352-8661(02)00122-9; Gurler N., 2012, ELECT ELECT ENG; HAYES CE, 1985, J MAGN RESON, V63, P622, DOI 10.1016/0022-2364(85)90257-4; Hong SM, 2014, MAGN RESON MED, V71, P1944, DOI 10.1002/mrm.24844; Jianxin Liang L. G., 2005, ANT TECHN SMALL ANT; JIN JM, 1994, MAGNET RESON MED, V32, P418, DOI 10.1002/mrm.1910320319; Jin JM, 1997, MAGNET RESON MED, V38, P953, DOI 10.1002/mrm.1910380615; Kraff O, 2017, J MAGN RESON IMAGING, V46, P1573, DOI 10.1002/jmri.25723; Lakshmi C. R., 2013, IOSR J ENG, V3, P46; Leifer MC, 1997, J MAGN RESON, V124, P51, DOI 10.1006/jmre.1996.7488; Liu WC, 2005, ELECTRON LETT, V41, P390, DOI 10.1049/el:20057887; Liu WC, 2004, ELECTRON LETT, V40, P1319, DOI 10.1049/el:20045952; Mao WH, 2006, MAGN RESON MED, V56, P918, DOI 10.1002/mrm.21013; Matwiyoff NA, 1999, MAGNETIC RESONANCE I; Pang Y, 2014, QUANT IMAGING MED SU, V4, P50, DOI 10.3978/j.issn.2223-4292.2014.02.07; Raaijmakers AJE, 2011, MAGN RESON MED, V66, P1488, DOI 10.1002/mrm.22886; Rios NL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192035; Sabbah AI, 2010, PROG ELECTROMA RES M, V13, P95, DOI 10.2528/PIERM10051502; Schick F, 2005, EUR RADIOL, V15, P946, DOI 10.1007/s00330-005-2678-0; Sohn SM, 2014, IEEE T MICROW THEORY, V62, P1784, DOI 10.1109/TMTT.2014.2331621; Stutzman W., 1981, ANTENNA THEORY DESIG; Thomas Vaughan J., 2012, RF COILS MRI BIRDCAG; Welker KM, 2001, RADIOLOGY, V221, P11, DOI 10.1148/radiol.2211001537; Wiggin GC, 2012, 20 ANN M ISMRM MELB; Woo MK, 2016, MAGN RESON MED, V75, P2566, DOI 10.1002/mrm.25837; Wu TY, 2002, ELECTRON LETT, V38, P1; Yan XQ, 2016, APPL MAGN RESON, V47, P527, DOI 10.1007/s00723-016-0775-7; Yan XQ, 2015, APPL MAGN RESON, V46, P59, DOI 10.1007/s00723-014-0612-9; Yang QX, 2004, MAGN RESON MED, V52, P1016, DOI 10.1002/mrm.20245	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214637	10.1371/journal.pone.0214637	http://dx.doi.org/10.1371/journal.pone.0214637			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933999	Green Published, Green Submitted, gold			2022-12-27	WOS:000462867000028
J	Tsuiki, S; Sasaki, R; Miyaguchi, S; Kojima, S; Saito, K; Inukai, Y; Masaki, M; Otsuru, N; Onishi, H				Tsuiki, Shota; Sasaki, Ryoki; Miyaguchi, Shota; Kojima, Sho; Saito, Kei; Inukai, Yasuto; Masaki, Mitsuhiro; Otsuru, Naofumi; Onishi, Hideaki			The effect of combined transcranial direct current stimulation and peripheral nerve electrical stimulation on corticospinal excitability	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; MAGNETIC STIMULATION; CORTICOMOTOR EXCITABILITY; MODULATION; PLASTICITY; DC; VARIABILITY; MECHANISMS; PARAMETERS; TASK	Transcranial direct current stimulation (tDCS) and peripheral nerve electrical stimulation (PES) can change corticospinal excitability. tDCS can be used to non-invasively modulate the cerebral cortex's excitability by applying weak current to an electrode attached to the head, and the effect varies with the electrode's polarity. Previous studies have reported the effect of combined tDCS and PES on corticospinal excitability; when compared to single stimulation, combined stimulation increases cortical excitability. In contrast, another study reported that the effect of tDCS is attenuated by PES; hence, there is no consensus opinion on the effect on combined stimulation. Therefore, this study aimed to clarify the effect of combined tDCS and PES on corticospinal excitability. In Experiment 1, the combined stimulation of anodal tDCS and PES (anodal tDCS + PES) was performed, and in Experiment 2, a combined stimulation with PES, after cathodal tDCS (PES after cathodal tDCS), was performed using a homeostatic metaplasticity theoretical model. In Experiment 1, anodal tDCS produced a significant increase from baseline in motor-evoked potential (MEP) amplitude 10 min after stimulation, but no significant changes in MEP amplitude were observed with PES or the anodal tDCS + PES condition. Experiment 2 showed a significant decrease in MEP amplitude immediately after cathodal tDCS, and a significant increase in MEP amplitude 15 min after PES, but no significant change in MEP amplitude was observed with sequential PES following cathodal tDCS. In conclusion, our data indicate that PES with anodal tDCS suppressed the effect of tDCS. Also, PES after cathodal tDCS did not induce homeostatic metaplasticity and increase corticospinal excitability.	[Tsuiki, Shota; Sasaki, Ryoki] Niigata Univ Hlth & Welf, Grad Sch, Niigata, Japan; [Tsuiki, Shota; Sasaki, Ryoki; Miyaguchi, Shota; Kojima, Sho; Saito, Kei; Inukai, Yasuto; Masaki, Mitsuhiro; Otsuru, Naofumi; Onishi, Hideaki] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Tsuiki, Shota] Tochigi Med Assoc, Rehabil Ctr, Shiobara Hot Spring Hosp, Nasushiobara, Tochigi, Japan	Niigata University; Niigata University	Tsuiki, S (corresponding author), Niigata Univ Hlth & Welf, Grad Sch, Niigata, Japan.; Tsuiki, S (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.; Tsuiki, S (corresponding author), Tochigi Med Assoc, Rehabil Ctr, Shiobara Hot Spring Hosp, Nasushiobara, Tochigi, Japan.	hpm16007@nuhw.ac.jp		Sasaki, Ryoki/0000-0003-2758-0722	Japan Society for the Promotion of Science [16H03207]; Niigata University of Health and Welfare [H29F02]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Niigata University of Health and Welfare	This work was supported by a Grant-in-Aid for Scientific Research (B) 16H03207 from the Japan Society for the Promotion of Science and a Grant-in-Aid for Scientific Research of Graduate Students of Niigata University of Health and Welfare (H29F02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RK, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-51; Antal A, 2007, EUR J NEUROSCI, V26, P2687, DOI 10.1111/j.1460-9568.2007.05896.x; BARKER AT, 1985, LANCET, V1, P1106; Bastani A, 2013, BRAIN STIMUL, V6, P932, DOI 10.1016/j.brs.2013.04.005; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Celnik P, 2009, STROKE, V40, P1764, DOI 10.1161/STROKEAHA.108.540500; Chipchase LS, 2011, ARCH PHYS MED REHAB, V92, P1423, DOI 10.1016/j.apmr.2011.01.011; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; Kirimoto H, 2014, BRAIN STIMUL, V7, P836, DOI 10.1016/j.brs.2014.09.016; Kirimoto H, 2011, CLIN NEUROPHYSIOL, V122, P777, DOI 10.1016/j.clinph.2010.09.025; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Lefaucheur JP, 2009, NEUROPHYSIOL CLIN, V39, P1, DOI 10.1016/j.neucli.2008.11.001; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Luft AR, 2002, EXP BRAIN RES, V142, P562, DOI 10.1007/s00221-001-0952-1; Miyaguchi S, 2013, BRAIN RES, V1529, P83, DOI 10.1016/j.brainres.2013.07.026; Monai H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11100; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2007, J NEUROSCI, V27, P3807, DOI 10.1523/JNEUROSCI.5348-06.2007; Rizzo V, 2014, BRAIN STIMUL, V7, P113, DOI 10.1016/j.brs.2013.10.002; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; ROTHWELL JC, 1991, EXP PHYSIOL, V76, P159, DOI 10.1113/expphysiol.1991.sp003485; Sasaki R, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00146; Sasaki R, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00030; Schabrun SM, 2018, PAIN MED, V19, P608, DOI 10.1093/pm/pnx099; Schabrun SM, 2014, BRAIN STIMUL, V7, P451, DOI 10.1016/j.brs.2014.01.058; Schabrun SM, 2013, BRAIN STIMUL, V6, P624, DOI 10.1016/j.brs.2012.09.009; Schabrun SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051298; Siebner HR, 2010, CLIN NEUROPHYSIOL, V121, P461, DOI 10.1016/j.clinph.2009.12.009; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Uy J, 2003, J NEUROSCI METH, V127, P193, DOI 10.1016/S0165-0270(03)00142-0; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214592	10.1371/journal.pone.0214592	http://dx.doi.org/10.1371/journal.pone.0214592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925178	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300023
J	Northcott, D; Sevadjian, J; Sancho-Gallegos, DA; Wahl, C; Friederich, J; Chavez, FP				Northcott, Devon; Sevadjian, Jeff; Sancho-Gallegos, Diego A.; Wahl, Chris; Friederich, Jules; Chavez, Francisco P.			Impacts of urban carbon dioxide emissions on sea-air flux and ocean acidification in nearshore waters	PLOS ONE			English	Article							BREEZE; EXCHANGE; PACIFIC; WIND	Greatly enhanced atmospheric carbon dioxide (CO2) levels relative to well-mixed marine air are observed during periods of offshore winds at coastal sensor platforms in Monterey Bay, California, USA. The highest concentrations originate from urban and agricultural areas, are driven by diurnal winds, and peak in the early morning. These enhanced atmospheric levels can be detected across a similar to 100km wide nearshore area and represent a significant addition to total oceanic CO2 uptake. A global estimate puts the added sea-air flux of CO2 from these greatly enhanced atmospheric CO2 levels at 25 million tonnes, roughly 1% of the ocean's annual CO2 uptake. The increased uptake over the 100 km coastal swath is of order 20%, indicating a potentially large impact on ocean acidification in productive coastal waters.	[Northcott, Devon; Sevadjian, Jeff; Sancho-Gallegos, Diego A.; Wahl, Chris; Friederich, Jules; Chavez, Francisco P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Sevadjian, Jeff] Scripps Inst Oceanog, La Jolla, CA USA; [Sancho-Gallegos, Diego A.] Stanford Univ, Stanford, CA 94305 USA	Monterey Bay Aquarium Research Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography; Stanford University	Northcott, D; Chavez, FP (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	dnorthcott@mbari.org; chfr@mbari.org		Wahl, Christopher/0000-0001-9675-068X; Sancho Gallegos, Diego/0000-0001-9446-1964	David and Lucile Packard Foundation; National Science Foundation [OCE-1041075, PLR-1602946]; National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This research was supported by the David and Lucile Packard Foundation and the National Science Foundation (OCE-1041075, PLR-1602946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CarbonTracker CT2016 results provided by NOAA ESRL, Boulder, Colorado, USA from the website at http://carbontracker.noaa.gov. Elevation data is from the GTOPO30 dataset. This Data is available from the U.S. Geological Survey. Coastline data used is from the freely available Global Self-consistent, Hierarchical, High-resolution Geography Database (GSHHG). This research was supported by the David and Lucile Packard Foundation and the National Science Foundation.	Andrews A. E., 2009, CARBON DIOXIDE CARBO; BANTA RM, 1993, J ATMOS SCI, V50, P3959, DOI 10.1175/1520-0469(1993)050<3959:EOTMBS>2.0.CO;2; Bourgeois T, 2016, BIOGEOSCIENCES, V13, P4167, DOI 10.5194/bg-13-4167-2016; Chavez FP, 2018, DEEP-SEA RES PT II, V151, P137, DOI 10.1016/j.dsr2.2017.01.001; Chavez FP, 2017, OCEANOGRAPHY, V30, P128, DOI 10.5670/oceanog.2017.429; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Friederich GE, 2002, PROG OCEANOGR, V54, P185, DOI 10.1016/S0079-6611(02)00049-6; Friederich GE, 1995, DEEP SEA RES 1, V42; Gille ST, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022139; Idso CD, 2001, ATMOS ENVIRON, V35, P995, DOI 10.1016/S1352-2310(00)00412-X; Ishii M, 2014, BIOGEOSCIENCES, V11, P709, DOI 10.5194/bg-11-709-2014; Jacobson MZ, 2010, ENVIRON SCI TECHNOL, V44, P2497, DOI 10.1021/es903018m; Keeling CD, 1998, ANNU REV ENERG ENV, V23, P25, DOI 10.1146/annurev.energy.23.1.25; Kindle JC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015566; Kort EA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052738; Nakadai T, 2002, APPL SOIL ECOL, V19, P161, DOI 10.1016/S0929-1393(01)00180-9; Newman S, 2013, ATMOS CHEM PHYS, V13, P4359, DOI 10.5194/acp-13-4359-2013; Perlin N, 2004, MON WEATHER REV, V132, P2110, DOI 10.1175/1520-0493(2004)132<2110:SAMWAW>2.0.CO;2; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; VERMA SB, 1976, J GEOPHYS RES-OC ATM, V81, P399, DOI 10.1029/JC081i003p00399; Wanninkhof R, 2014, LIMNOL OCEANOGR-METH, V12, P351, DOI 10.4319/lom.2014.12.351; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2	23	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214403	10.1371/journal.pone.0214403	http://dx.doi.org/10.1371/journal.pone.0214403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917190	Green Published, gold, Green Submitted			2022-12-27	WOS:000462465800063
J	Parker, L; Bourgoin, C; Martinez-Valle, A; Laderach, P				Parker, Louis; Bourgoin, Clement; Martinez-Valle, Armando; Laderach, Peter			Vulnerability of the agricultural sector to climate change: The development of a pan-tropical Climate Risk Vulnerability Assessment to inform sub-national decision making	PLOS ONE			English	Article							ADAPTIVE CAPACITY; SOCIAL VULNERABILITY; NATURAL HAZARDS; SMALLHOLDER; ADAPTATION; INDICATORS; IMPACT; POLICY	As climate change continues to exert increasing pressure upon the livelihoods and agricultural sector of many developing and developed nations, a need exists to understand and prioritise at the sub national scale which areas and communities are most vulnerable. The purpose of this study is to develop a robust, rigorous and replicable methodology that is flexible to data limitations and spatially prioritizes the vulnerability of agriculture and rural livelihoods to climate change. We have applied the methodology in Vietnam, Uganda and Nicaragua, three contrasting developing countries that are particularly threatened by climate change. We conceptualize vulnerability to climate change following the widely adopted combination of sensitivity, exposure and adaptive capacity. We used Ecocrop and Maxent ecological models under a high emission climate scenario to assess the sensitivity of the main food security and cash crops to climate change. Using a participatory approach, we identified exposure to natural hazards and the main indicators of adaptive capacity, which were modelled and analysed using geographic information systems. We finally combined the components of vulnerability using equal-weighting to produce a crop specific vulnerability index and a final accumulative score. We have mapped the hotspots of climate change vulnerability and identified the underlying driving indicators. For example, in Vietnam we found the Mekong delta to be one of the vulnerable regions due to a decline in the climatic suitability of rice and maize, combined with high exposure to flooding, sea level rise and drought. However, the region is marked by a relatively high adaptive capacity due to developed infrastructure and comparatively high levels of education. The approach and information derived from the study informs public climate change policies and actions, as vulnerability assessments are the bases of any National Adaptation Plans (NAP), National Determined Contributions (NDC) and for accessing climate finance.	[Parker, Louis; Bourgoin, Clement; Laderach, Peter] Int Ctr Trop Agr CIAT, CGIAR Res Program Climate Change Agr & Food Secur, Hanoi, Vietnam; [Bourgoin, Clement] Ctr Cooperat Int Rech Agron Dev CIRAD UPR Forets, F-34398 Montpellier, France; [Martinez-Valle, Armando] Int Ctr Trop Agr CIAT, CGIAR Res Program Climate Change Agr & Food Secur, Managua, Nicaragua	Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; Alliance; International Center for Tropical Agriculture - CIAT; CGIAR	Parker, L (corresponding author), Int Ctr Trop Agr CIAT, CGIAR Res Program Climate Change Agr & Food Secur, Hanoi, Vietnam.	louisartparker@gmail.com		Laderach, Peter/0000-0001-8708-6318	CGIAR	CGIAR(CGIAR)	This work was implemented as part of the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors.The views expressed in this document cannot be taken to reflect the official opinions of these organizations. The authors of this paper would like to thank CIAT colleagues: Dr Julian Ramirez, Dr Godefroy Grosjean and Dr Pablo Imbach for their insightful comments and suggestions. Louis Parker would like to thank Ms Than Thi Nguyen (CIAT) for her assistance collecting, translating and analysing data for Vietnam. The authors would like to thank the government partner organisations in Vietnam, notably the Institute for Agricultural Environment (IAE) and the National Institute of Agricultural Planning and Projection (NIAPP) for their support and collaboration.; This work was implemented as part of the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors.We specifically thank the International Fund for Agricultural Development for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abracosa R, 2015, CLIMATE CHANGE VULNE; Adger W.N., 2004, NEW INDICATORS VULNE; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Aminga J, 2012, TREND ANAL FOOD NUTR; [Anonymous], 2007, UG VIS 2040; [Anonymous], 2016, NIC CIFR NIC; ASAP, 2014, STRENGTH COFF CAC VA; ASAP, 2014, IFAD OP UG PROJ REST; Auffhammer M, 2012, CLIMATIC CHANGE, V111, P411, DOI 10.1007/s10584-011-0208-4; Ayanlade A, 2017, WEATHER CLIM EXTREME, V15, P24, DOI 10.1016/j.wace.2016.12.001; Baca M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088463; Berry PM, 2006, ENVIRON SCI POLICY, V9, P189, DOI 10.1016/j.envsci.2005.11.004; Bourgoin C, 2016, SPATIALLY EXPLICIT A; Bouroncle C, 2017, CLIMATIC CHANGE, V141, P123, DOI 10.1007/s10584-016-1792-0; Bronson K, 2016, BIG DATA SOC, V3, P1, DOI 10.1177/2053951716648174; Broxton PD, 2014, J APPL METEOROL CLIM, V53, P1593, DOI 10.1175/JAMC-D-13-0270.1; Buchner B., 2017, GLOBAL LANDSCAPE CLI; Bunn C, 2015, CLIMATIC CHANGE, V129, P89, DOI 10.1007/s10584-014-1306-x; Central Intelligence Agency, 2016, WORLD FACTBOOK; Chau VN, 2014, 2014 C 58 FEBR 4 7 2; Chen J, 2015, ISPRS J PHOTOGRAMM, V103, P7, DOI 10.1016/j.isprsjprs.2014.09.002; Christoff P, 2016, ENVIRON POLIT, V25, P765, DOI 10.1080/09644016.2016.1191818; Cinner JE, 2018, NAT CLIM CHANGE, V8, P117, DOI 10.1038/s41558-017-0065-x; Climate Change and Food Security (CCAFS), 2015, GCM DOWNSC DAT PORT; Coumou D, 2012, NATURE CLIMATE CHANG, DOI [10.1038/nclimate1491, DOI 10.1038/NCLIMATE1491]; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Dang TH, 2004, MAIZE VIETNAM PRODUC; de Sherbinin A, 2014, AFRICAN LATIN AM RES; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Eriksen S.H., 2007, MITIG ADAPT STRATEG, V12, P495, DOI [10.1007/s11027-006-3460-6, DOI 10.1007/S11027-006-3460-6]; Fekete A, 2009, NAT HAZARD EARTH SYS, V9, P393, DOI 10.5194/nhess-9-393-2009; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Food and Agriculture Organization of the United Nations, 2008, INTR BAS CONC FOOD S; Fritzsche K., 2014, VULNERABILITY SOURCE; Fussel H-M, 2009, REV QUANTITATIVE ANA; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; General Statistics Office of Vietnam, 2011, PERC STUD GRAD HIGH; General Statistics Office of Vietnam, 2005, NUMB FARMS PROV; General Statistics Office of Vietnam, 2005, NUMB COOP 2005 KIND; General Statistics Office of Vietnam, 2018, AGR FOR FISH; Girvetz E., 2017, CSA COUNTRY PROFILES; Giuliani G, 2011, NAT HAZARD EARTH SYS, V11, P53, DOI 10.5194/nhess-11-53-2011; Gourdji S, 2015, AGR FOREST METEOROL, V200, P270, DOI 10.1016/j.agrformet.2014.10.002; Guha-Sapir D, 2017, ANN DISASTER STAT RE; Guzzetti F, 2016, TOXICOL ENVIRON CHEM, V98, P1043, DOI 10.1080/02772248.2015.1030664; Harvey CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0089; Hepworth N, 2008, CLIMATE CHANGE UGAND; Herrera B, 2010, NICARAGUA USO POTENC; HIJMANS RJ, 2004, DIVA GIS VSN 5 0 GEO; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; IPCC, 2018, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Jarvis A, 2008, HOLE FILLED SRTM GLO; Jarvis A., 2008, HOLE FILLED SRTM GLO; Jurgilevich A, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5508; Keil A, 2009, C INT RES FOOD SEC N, P1; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; Kreft S., 2016, GLOBAL CLIMATE RISK; Kreft S, 2014, GLOBAL CLIMATE RISK; Laderach P, 2017, CLIMATIC CHANGE, V141, P47, DOI 10.1007/s10584-016-1788-9; Lanjouw P, 2013, VIETNAMS EVOLVING PO; Li YC, 2015, CLIMATIC CHANGE, V128, P355, DOI 10.1007/s10584-014-1165-5; Lung T, 2013, GLOBAL ENVIRON CHANG, V23, P522, DOI 10.1016/j.gloenvcha.2012.11.009; Marshall N, FRAMEWORK SOCIAL ADA, P44; MESA, 2015, MONITORING ENV SECUR; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Nachtergaele F.O., 2008, HARMONIZED WORLD SOI; National Institute of Nutrition Ministry of Health, 2010, AV UND STUNT WAST TO; Nelson A., 2008, ACCESSIBILITY; Oppenheimer M, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1039; Osbahr H, 2011, EXP AGR, V47, P293, DOI 10.1017/S0014479710000785; Peduzzi P, 2009, NAT HAZARD EARTH SYS, V9, P1149, DOI 10.5194/nhess-9-1149-2009; Peduzzi P., 2015, TROPICAL CYCLONES BE; Peduzzi P., 2009, FLOOD EVENTS; Ramirez Villejas J., 2010, 1 INT CTR TROP AGR C; Redfern S. K., 2012, Building resilience for adaptation to climate change in the agriculture sector. Proceedings of a Joint FAO/OECD Workshop, Rome, Italy, 23-24 April 2012, P295; Renard KG., 1997, AGR HDB, DOI DOI 10.1201/9780203739358-5; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Rippke U, 2016, NATURE CLIMATE CHANG; Roy DP, 2008, MODIS ACTIVE FIRE BU; Schmidt-Thome P., 2006, THESIS; Schroter D., 2005, Mitigation and Adaptation Strategies for Global Change, V10, P573, DOI 10.1007/s11027-005-6135-9; Schroth G, 2017, MITIG ADAPT STRAT GL, V22, P903, DOI 10.1007/s11027-016-9707-y; Sehgal VK., 2013, VULNERABILITY AGR CL; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Statistics UBO, 2015, STAT ABSTR; Stevanovic M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501452; Takeuchi W., 2013, SATELLITE BASED DROU; The Central Agency, 2016, WORLD FACTBOOK; The Word Bank, 2017, DAT UG; Thiault L, 2018, CONSERV BIOL, V32, P447, DOI 10.1111/cobi.12989; Torresan S, 2012, NAT HAZARD EARTH SYS, V12, P2347, DOI 10.5194/nhess-12-2347-2012; Trigg MA, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094014; Tucker J, 2015, REG ENVIRON CHANGE, V15, P783, DOI 10.1007/s10113-014-0741-6; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; *UN FAO, 2017, FAOSTAT DAT; United Nations Environment Programme (UNEP), 2013, DROUGHTS EV 1980 200; United Nations Environment Programme (UNEP), 2013, GLOB DAT RISK PLATF; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Vos R, 2016, STATE FOOD AGR CLIMA; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Weis SWM, 2016, CLIMATIC CHANGE, V136, P615, DOI 10.1007/s10584-016-1642-0; Yusuf A.A., 2009, CLIMATE CHANGE VULNE; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	107	56	58	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213641	10.1371/journal.pone.0213641	http://dx.doi.org/10.1371/journal.pone.0213641			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917146	gold, Green Published, Green Submitted			2022-12-27	WOS:000462465800037
J	Schuster, KD; Mohammadi, M; Cahill, KB; Matte, SL; Maillet, AD; Vashisth, H; Cote, RH				Schuster, Kevin D.; Mohammadi, Mohammadjavad; Cahill, Karyn B.; Matte, Suzanne L.; Maillet, Alexis D.; Vashisth, Harish; Cote, Rick H.			Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; PROTEIN; PHOSPHODIESTERASES; SPECIFICITY; GENERATION; MECHANICS; INSIGHTS; DOCKING; PATHWAY; DESIGN	Novel chemical controls are needed that selectively target human, animal, and plant parasitic nematodes with reduced adverse effects on the host or the environment. We hypothesize that the phosphodiesterase (PDE) enzyme family represents a potential target for development of novel nematicides and anthelmintics. To test this, we identified six PDE families present in the nematode phylum that are orthologous to six of the eleven human PDE families. We characterized the binding interactions of family-selective PDE inhibitors with human and C. elegans PDE4 in conjunction with molecular dynamics (MD) simulations to evaluate differences in binding interactions of these inhibitors within the PDE4 catalytic domain. We observed that roflumilast (human PDE4-selective inhibitor) and zardaverine (selective for human PDE3 and PDE4) were 159- and 77-fold less potent, respectively, in inhibiting C. elegans PDE4. The pan-specific PDE inhibitor isobutyl methyl xanthine (IBMX) had similar affinity for nematode and human PDE4. Of 32 residues within 5 A of the ligand binding site, five revealed significant differences in non-bonded interaction energies (van der Waals and electrostatic interaction energies) that could account for the differential binding affinities of roflumilast and zardaverine. One site (Phe506 in the human PDE4D3 amino acid sequence corresponding to Tyr253 in C. elegans PDE4) is predicted to alter the binding conformation of roflumilast and zardaverine (but not IBMX) into a less energetically favorable state for the nematode enzyme. The pharmacological differences in sensitivity to PDE4 inhibitors in conjunction with differences in the amino acids comprising the inhibitor binding sites of human and C. elegans PDE4 catalytic domains together support the feasibility of designing the next generation of anthelmintics/nematicides that could selectively bind to nematode PDEs.	[Schuster, Kevin D.; Cahill, Karyn B.; Matte, Suzanne L.; Maillet, Alexis D.; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Mohammadi, Mohammadjavad; Vashisth, Harish] Univ New Hampshire, Dept Chem Engn, Durham, NH 03824 USA; [Cahill, Karyn B.] Envirol Inc, Portland, ME USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.; Vashisth, H (corresponding author), Univ New Hampshire, Dept Chem Engn, Durham, NH 03824 USA.	harish.vashisth@unh.edu; rick.cote@unh.edu	Mohammadi, Mohammadjavad/H-1276-2019; Cote, Rick/G-3363-2013	Mohammadi, Mohammadjavad/0000-0001-7344-0857; Cote, Rick/0000-0002-1573-6526	United State Department of Agriculture-National Institute of Food and Agriculture [2016-67013-24763]; NH Agricultural Experiment Station Hatch grant [NH-00631]; National Science Foundation (NSF) Major Research Instrumentation program [PHY-1229408]; NSF [ACI-1548562, TG-MCB160183]	United State Department of Agriculture-National Institute of Food and Agriculture; NH Agricultural Experiment Station Hatch grant; National Science Foundation (NSF) Major Research Instrumentation program; NSF(National Science Foundation (NSF))	This work was supported in part by United State Department of Agriculture-National Institute of Food and Agriculture under award number 2016-67013-24763 (to R.H.C.) and the NH Agricultural Experiment Station Hatch grant NH-00631 (to R.H.C.); this is Scientific Contribution Number 2812. Computations were performed in part on Trillian, a Cray XE6m-200 supercomputer supported by the National Science Foundation (NSF) Major Research Instrumentation program under grant PHY-1229408 (H.V.) and also using the NSF-supported (ACI-1548562) Extreme Science and Engineering Discovery Environment (XSEDE) Comet resource at San Diego Supercomputer Center (SDSC) under grant TG-MCB160183 (to H.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARKER KR, 1994, J NEMATOL, V26, P127; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bolger GB, 1997, BIOCHEM J, V328, P539; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DK, 2017, BIOINFORMATICS, V33, P2768, DOI 10.1093/bioinformatics/btx349; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Charlie NK, 2006, GENETICS, V173, P111, DOI 10.1534/genetics.105.054007; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Cho SW, 2004, BIOCHEM BIOPH RES CO, V325, P525, DOI 10.1016/j.bbrc.2004.10.060; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cote RH, 2000, METHOD ENZYMOL, V315, P646; D'Ursi P, 2016, MOL INFORM, V35, P369, DOI 10.1002/minf.201501033; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujisaki H, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00125; Gross I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00576; Haning H, 2003, PROGR MED CHEM, V41, P249, DOI 10.1016/S0079-6468(02)41007-7; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Holden-Dye Lindy, 2014, WormBook, P1, DOI 10.1895/wormbook.1.143.2; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Huai Q, 2003, BIOCHEMISTRY-US, V42, P13220, DOI 10.1021/bi034653e; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Huang YY, 2013, J CHEM INF MODEL, V53, P3044, DOI 10.1021/ci400458z; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson KR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-247; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; Kim S, 2012, GENETICS, V192, P905, DOI 10.1534/genetics.112.143271; Kiontke K, 2013, CURR BIOL, V23, pR862, DOI 10.1016/j.cub.2013.08.009; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lee ME, 2002, FEBS LETT, V530, P53, DOI 10.1016/S0014-5793(02)03396-3; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Mohammadi M, 2019, PROTEINS, V87, P146, DOI 10.1002/prot.25642; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; Papaioannou Sylvana, 2008, Invertebrate Neuroscience, V8, P91, DOI 10.1007/s10158-008-0072-8; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; SCHUDT C, 1991, BIOCHEM PHARMACOL, V42, P153, DOI 10.1016/0006-2952(91)90694-Z; Seebeck T, 2011, FUTURE MED CHEM, V3, P1289, DOI [10.4155/fmc.11.77, 10.4155/FMC.11.77]; SEKHAR KR, 1996, PHOSPHODIESTERASE IN, P135; Shoemaker BA, 2012, NUCLEIC ACIDS RES, V40, pD834, DOI 10.1093/nar/gkr997; Shoemaker BA, 2010, NUCLEIC ACIDS RES, V38, pD518, DOI 10.1093/nar/gkp842; Spurr H. W. Jr., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P269; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Usuyama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042907; Wang C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00787; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963	65	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214554	10.1371/journal.pone.0214554	http://dx.doi.org/10.1371/journal.pone.0214554			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917179	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800071
J	Das, SK; Afsana, SM; Bin Elahi, S; Chisti, MJ; Das, J; Al Mamun, A; McIntyre, HD; Ahmed, T; Faruque, AG; Salam, MA				Das, Sumon Kumar; Afsana, Syeda Momena; Bin Elahi, Shahriar; Chisti, Mohammod Jobayer; Das, Jui; Al Mamun, Abdullah; McIntyre, Harold David; Ahmed, Tahmeed; Faruque, Abu Syed Golam; Salam, Mohammed Abdus			Renal insufficiency among urban populations in Bangladesh: A decade of laboratory-based observations	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; OBESITY	Objective The objective of this study was to describe the age and sex-specific prevalence of renal insufficiency, and observe its trends over a decade at an urban Bangladesh setup. Method This was a cross-sectional study, in which we observed the Estimated Glomerular Filtration Rate (eGFR) of 218,888 adults, aged >= 19 years, who had submitted their blood specimen to the Clinical Biochemistry Laboratory of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) during the years 2006-2015. We applied CKD-EPI definition in estimating eGFR using their age-and sex-specific serum creatinine concentrations. Based on the eGFR, we classified the population into five stages of renal insufficiency (stage-1 to stage-5), at age intervals of five-years. Data were analysed using the Linear Regression and Multinomial Logistic Regression models. Results Females constituted 43% (n = 94,931) of the study population; and 34% (n = 42,576) of the males and 31% (n = 29,830) of the females had their serum creatinine concentrations above the upper limit of the laboratory reference cut-off. The overall prevalence of stage2 to stage-5 renal insufficiency were 24% (n = 52,126), 17% (n = 38,539), 8% (n = 16,504) and 6% (n = 12,665) respectively; the prevalence were 23% (n = 1,890), 19% (n = 1,579), 9% (n = 769) and 9% (n = 770) respectively in 2006, and 24% (n = 10,062), 17% (n = 6,903), 6% (n = 2,537) and 5% (n = 1,924) respectively in 2015. The prevalence was higher among the females. At least 2% of the adults, younger than <44 years, had stage4 and stage-5 in 2015. The age-adjusted eGFR was significantly lower among the postmenopausal females (aged >= 46 y) compared to the same age group males (64.08 +/- 10.83 vs. 66.83 +/- 10.41 mUmin/1.73 m(2) ; p<0.001). Compared to 2006, the number of individuals with renal insufficiency (stage 2 and above) had increased at least two times, irrespective of age, in 2015. A single year of increase in the age was significantly associated with 1.32 unit reductions in the eGFR; and the reductions were higher for females who also had higher odds of renal insufficiency stages-2 and beyond. Conclusion This study observed high prevalence of stage-2 to stage-5 renal insufficiency in Bangladeshi populations, irrespective of age, and especially among the females.	[Das, Sumon Kumar; Afsana, Syeda Momena; Bin Elahi, Shahriar; Chisti, Mohammod Jobayer; Ahmed, Tahmeed; Faruque, Abu Syed Golam; Salam, Mohammed Abdus] Icddr B, Dhaka, Bangladesh; [Das, Sumon Kumar; Al Mamun, Abdullah; McIntyre, Harold David] Univ Queensland, Social Sci Res Inst, Brisbane, Qld, Australia; [Das, Sumon Kumar] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Das, Jui] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [McIntyre, Harold David] Univ Queensland, Mater Clin Sch, Brisbane, Qld, Australia; [McIntyre, Harold David] Mater Med Res Inst, South Brisbane, Qld, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of Queensland; Charles Darwin University; Menzies School of Health Research; University of Queensland; University of Queensland; Mater Research	Das, SK; Afsana, SM (corresponding author), Icddr B, Dhaka, Bangladesh.; Das, SK (corresponding author), Univ Queensland, Social Sci Res Inst, Brisbane, Qld, Australia.; Das, SK (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia.	sumon@icddrb.org; momena@icddrb.org	Mamun, Abdullah A/A-4673-2011; Das, Sumon Kumar/AAD-1551-2019; McIntyre, Harold D/F-1888-2010; Mamun, Abdullah/HHM-9898-2022	Mamun, Abdullah A/0000-0002-1535-8086; McIntyre, Harold D/0000-0001-8819-5794; 				Abraham G, 2015, CLIN KIDNEY J; Anand S, 2014, GLOBALIZATION HLTH, V10, P1, DOI [10.1186/1744-8603-10-1, DOI 10.1186/1744-8603-10-1]; Bailey PK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-240; Caballero B, 2005, NEW ENGL J MED, V352, P1514, DOI 10.1056/NEJMp048310; Dangerous Food Additives, PEOPL ETH LIV; Das S, 2010, Mymensingh Med J, V19, P415; Das SK, 2014, TROP MED INT HEALTH, V19, P240, DOI 10.1111/tmi.12231; Das SK, 2012, ATHEROSCLEROSIS, V223, P454, DOI 10.1016/j.atherosclerosis.2012.05.002; Denic A, 2017, J AM SOC NEPHROL, V28, P313, DOI 10.1681/ASN.2016020154; Ene-Iordache B, 2016, LANCET GLOB HEALTH, V4, pE307, DOI 10.1016/S2214-109X(16)00071-1; Engelgau MM, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8724-5; Fatema Kaniz, 2013, Saudi J Kidney Dis Transpl, V24, P534; Hasan MJ, 2012, COMMUNITY BASED MED, V1, P20, DOI [10.3329/cbmj.v1i1.13825, DOI 10.3329/CBMJ.V1I1.13825]; Hommos MS, 2017, J AM SOC NEPHROL, V28, P2838, DOI 10.1681/ASN.2017040421; Hsu J, 2008, CLIN J AM SOC NEPHRO, V3, P992, DOI 10.2215/CJN.00090108; Huda MN, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/267329; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Sengupta A, 2015, SOC SCI MED, V138, P161, DOI 10.1016/j.socscimed.2015.06.004	22	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214568	10.1371/journal.pone.0214568	http://dx.doi.org/10.1371/journal.pone.0214568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947271	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500040
J	Liu, WM; Forbat, L; Anderson, K				Liu, Wai-Man; Forbat, Liz; Anderson, Katrina			Death of a close friend: Short and long-term impacts on physical, psychological and social well-being	PLOS ONE			English	Article							COMPLICATED GRIEF; BEREAVED CAREGIVERS; PERSONALITY-TRAITS; SEX-DIFFERENCES; HEALTH; RECOVERY; PREPAREDNESS; PREDICTORS; ATTACHMENT; ADJUSTMENT	This paper reports the impact of a major life event-death-on the physical, psychological and social well-being of the deceased's close friends. We utilised data from a large longitudinal survey covering a period of 14 years (2002-2015) consisting a cohort of 26,515 individuals in Australia, of whom 9,586 had experienced the death of at least one close friend. This longitudinal cohort dataset comprises responses to the SF-36 (health related quality of life measure) and allowed for analysis of the short and longer-term impacts of bereavement. In order to manage the heterogeneity of the socio-demographics of respondents who did/not experience a death event, we use a new and robust approach known as the Entropy Balancing method to construct a set of weights applied to the bereaved group and the control group (the group that did not experience death). This approach enables us to match the two groups so that the distribution of socio-demographic variables between the two groups are balanced. These variables included gender, age, marital status, ethnicity, personality traits, religion, relative socio-economic disadvantage, economic resources, and education and occupation and where they resided. The data show, for the first time, a range of negative and enduring consequences experienced by people following the death of a close friend. Significant adverse physical and psychological well-being, poorer mental health and social functioning occur up to four years following bereavement. Bereaved females experienced a sharper fall in vitality, suffered greater deterioration in mental health, impaired emotional and social functioning than the male counterparts up to four years after the death. The data show that the level of social connectedness plays an important role in bereavement outcomes. Specifically, we found that less socially active respondents experienced a longer deterioration in physical and psychological health. Finally, we found evidence that the death of a close friend lowered the respondent's satisfaction with their health. Since death of friends is a universal phenomenon, we conclude the paper by reflecting on the need to recognise the death of a close friend as a substantial experience, and to offer support and services to address this disenfranchised grief. Recognising bereaved friends as a group experiencing adverse outcomes can be used internationally to prompt health and psychological services to assist this specific group, noting that there may be substantial longevity to the negative sequelae of the death of a friend. Facilitating bereaved people's support networks may be a fruitful approach to minimising these negative outcomes.	[Liu, Wai-Man] Australian Natl Univ, Sch Finance Actuarial Studies & Stat, Acton, ACT, Australia; [Forbat, Liz] Univ Stirling, Fac Social Sci, Stirling, Scotland; [Anderson, Katrina] Canberra Hosp, ANU Med Sch, Acad Unit Gen Practice, Garran, ACT, Australia	Australian National University; University of Stirling; Australian National University; Canberra Hospital	Liu, WM (corresponding author), Australian Natl Univ, Sch Finance Actuarial Studies & Stat, Acton, ACT, Australia.	waiman.liu@anu.edu.au	Liu, Wai-Man/AFM-7297-2022	Liu, Wai-Man/0000-0002-2111-9487; Anderson, Katrina Judith/0000-0003-2300-9561				Ackerman JM, 2007, EVOL HUM BEHAV, V28, P365, DOI 10.1016/j.evolhumbehav.2007.04.004; [Anonymous], 2013, BEREAVEMENT STUDIES, DOI DOI 10.4324/9781315829753; Archer John, 2003, NATURE GRIEF EVOLUTI; BAILEY KG, 1988, PSYCHOTHERAPY, V25, P132, DOI 10.1037/h0085309; Barry LC, 2002, AM J GERIAT PSYCHIAT, V10, P447; BARTH RJ, 1988, SEX ROLES, V19, P349, DOI 10.1007/BF00289842; Baumeister R.F., 1997, WHAT DO MEN WANT GEN; Becker G, 2007, PALLIATIVE MED, V21, P207, DOI 10.1177/0269216307077327; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOWLBY J, 1982, AM J ORTHOPSYCHIAT, V52, P664, DOI 10.1111/j.1939-0025.1982.tb01456.x; Butterworth P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-44; CAREY RG, 1979, OMEGA-J DEATH DYING, V10, P163, DOI 10.2190/VP4L-94KX-491M-1WVE; CGSS, 2020, CHIN GEN SOC SURV; Chen JH, 1999, PSYCHOL MED, V29, P367, DOI 10.1017/S0033291798008137; Chiu YW, 2011, PSYCHO-ONCOLOGY, V20, P1061, DOI 10.1002/pon.1811; Cleiren M.P., 1993, BEREAVEMENT ADAPTATI; Corr CA, 1998, OMEGA-J DEATH DYING, V38, P1, DOI 10.2190/LD26-42A6-1EAV-3MDN; Cross SE, 1997, PSYCHOL BULL, V122, P5, DOI 10.1037/0033-2909.122.1.5; Currier JM, 2006, DEATH STUD, V30, P403, DOI 10.1080/07481180600614351; d'Epinay CJL, 2009, OMEGA-J DEATH DYING, V60, P301, DOI 10.2190/OM.60.4.a; De Vries B., 2002, ADV LIFE COURSE RES, V7, P299, DOI [10.1016/S1040-2608(02)80038-7, DOI 10.1016/S1040-2608(02)80038-7]; Denissen JJA, 2008, J RES PERS, V42, P1285, DOI 10.1016/j.jrp.2008.04.002; DIMOND M, 1987, GERONTOLOGIST, V27, P599, DOI 10.1093/geront/27.5.599; Doka K.J., 1989, DISENFRANCHISED GRIE; Eckenrode J., 1981, SOCIAL NETWORKS SOCI, pChapter 2; Ferrario SR, 2004, PALLIATIVE MED, V18, P129, DOI 10.1191/0269216304pm870oa; Finkel EJ, 2001, J PERS SOC PSYCHOL, V81, P263, DOI 10.1037/0022-3514.81.2.263; Fitzpatrick TR, 1998, J APPL GERONTOL, V17, P204, DOI 10.1177/073346489801700209; Folkman S, 2000, AM PSYCHOL, V55, P647, DOI 10.1037//0003-066X.55.6.647; Galatzer-Levy IR, 2012, SOC SCI MED, V74, P1987, DOI 10.1016/j.socscimed.2012.02.022; GOLDBERG EL, 1988, J GERONTOL, V43, pS206, DOI 10.1093/geronj/43.6.S206; Goldberg LR., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Hainmueller J, 2012, POLIT ANAL, V20, P25, DOI 10.1093/pan/mpr025; Hays JC, 1997, OMEGA-J DEATH DYING, V35, P25, DOI 10.2190/YE89-2GU8-C8U3-MRNX; Hays JC, 2008, HDB BEREAVEMENT RES; Hebert RS, 2006, J PALLIAT MED, V9, P683, DOI 10.1089/jpm.2006.9.683; Hobbs W., 2017, NATURE HUMAN BEHAV, V1, P1; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453; JACOBS S, 1986, BRIT J MED PSYCHOL, V59, P305, DOI 10.1111/j.2044-8341.1986.tb02698.x; John O. P., 1990, HDB PERSONALITY THEO, P66; Kellehear A, 2013, QJM-INT J MED, V106, P1071, DOI 10.1093/qjmed/hct200; Kullback S., 1959, STAT INFORM THEORY; Lobb EA, 2010, DEATH STUD, V34, P673, DOI 10.1080/07481187.2010.496686; MONTEITH MJ, 1993, J PERS SOC PSYCHOL, V65, P469, DOI 10.1037/0022-3514.65.3.469; Moskowitz JT, 2003, DEATH STUD, V27, P471, DOI 10.1080/07481180390197624; Neimeyer RA, 2006, DEATH STUD, V30, P715, DOI 10.1080/07481180600848322; Nielsen MK, 2017, J PAIN SYMPTOM MANAG, V53, P540, DOI 10.1016/j.jpainsymman.2016.09.013; Ong AD, 2005, PERS INDIV DIFFER, V38, P1057, DOI 10.1016/j.paid.2004.07.004; Ong AD, 2004, J GERONTOL B-PSYCHOL, V59, pP168, DOI 10.1093/geronb/59.4.P168; Pai M, 2010, J HEALTH SOC BEHAV, V51, P183, DOI 10.1177/0022146510368933; PARK CL, 1993, COGNITIVE THER RES, V17, P561, DOI 10.1007/BF01176079; Park JH, 2005, EVOL HUM BEHAV, V26, P158, DOI 10.1016/j.evolhumbehav.2004.08.013; Prigerson H, 2002, DEATH STUD, V26, P781, DOI 10.1080/07481180290106571; Robson P, 2012, OMEGA-J DEATH DYING, V66, P97, DOI 10.2190/OM.66.2.a; Rosenblatt PC, 2007, DEATH BEREAVEMENT CU; SABLE P, 1991, OMEGA-J DEATH DYING, V23, P129, DOI 10.2190/PU6V-H0NW-61NY-1W5G; SANDERS CM, 1980, OMEGA-J DEATH DYING, V11, P217, DOI 10.2190/AHER-PDC7-VAW1-FYPX; Sandler IN, 2008, DEATH STUD, V32, P59, DOI 10.1080/07481180701741343; SAUCIER G, 1994, J PERS ASSESS, V63, P506, DOI 10.1207/s15327752jpa6303_8; Selfhout M, 2010, J PERS, V78, P509, DOI 10.1111/j.1467-6494.2010.00625.x; Shear KM, 2006, PSYCHIAT SERV, V57, P1291, DOI 10.1176/appi.ps.57.9.1291; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Stroebe M. S., 2008, HDB BEREAVEMENT RES; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Stroebe M, 2017, LANCET, V389, P347, DOI 10.1016/S0140-6736(17)30189-7; Stroebe MS, 2006, SOC SCI MED, V63, P2440, DOI 10.1016/j.socscimed.2006.06.012; STROEBE MS, 1983, PSYCHOL BULL, V93, P279, DOI 10.1037/0033-2909.93.2.279; Stroebe MS, 1993, MORTALITY BEREAVEMEN; Stroebe MS, 2001, MODELS COPING BEREAV; STROEBE W, 1988, J SOC ISSUES, V44, P143, DOI 10.1111/j.1540-4560.1988.tb02082.x; Stylianos Stanley K., 1993, P397, DOI 10.1017/CBO9780511664076.027; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; van der Houwen K, 2010, DEATH STUD, V34, P195, DOI 10.1080/07481180903559196; Vanderwerker LC, 2004, J LOSS TRAUMA, V9, P45, DOI 10.1080/15325020490255304; Wortmann JH, 2008, DEATH STUD, V32, P703, DOI 10.1080/07481180802289507; WUTHNOW R, 1980, J SCI STUD RELIG, V19, P408, DOI 10.2307/1386134; ZISOOK S, 1985, GEN HOSP PSYCHIAT, V7, P95, DOI 10.1016/0163-8343(85)90017-9	77	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214838	10.1371/journal.pone.0214838	http://dx.doi.org/10.1371/journal.pone.0214838			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947290	Green Submitted, gold, Green Published			2022-12-27	WOS:000463314500069
J	Naik, J; Hau, CM; ten Bloemendaal, L; Mok, KS; Hajji, N; Wehman, AM; Meisner, S; Muncan, V; Paauw, NJ; de Vries, HE; Nieuwland, R; Paulusma, CC; Bosma, PJ				Naik, Jyoti; Hau, Chi M.; ten Bloemendaal, Lysbeth; Mok, Kam S.; Hajji, Najat; Wehman, Ann M.; Meisner, Sander; Muncan, Vanesa; Paauw, Nanne J.; de Vries, H. E.; Nieuwland, Rienk; Paulusma, Coen C.; Bosma, Piter J.			The P4-ATPase ATP9A is a novel determinant of exosome release	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; PHOSPHOLIPID FLIPPASE; MEMBRANE-VESICLES; PHOSPHATIDYLSERINE; MICROVESICLES; CORTACTIN; PROTEIN; CELL; SECRETION; PATHWAY	Extracellular vesicles (EVs) released by cells have a role in intercellular communication to regulate a wide range of biological processes. Two types of EVs can be recognized. Exosomes, which are released from multi-vesicular bodies upon fusion with the plasma membrane, and ectosomes, which directly bud from the plasma membrane. How cells regulate the quantity of EV release is largely unknown. One of the initiating events in vesicle biogenesis is the regulated transport of phospholipids from the exoplasmic to the cytosolic leaflet of biological membranes. This process is catalyzed by P4-ATPases. The role of these phospholipid transporters in intracellular vesicle transport has been established in lower eukaryotes and is slowly emerging in mammalian cells. In Caenorhabditis elegans (C. elegans), deficiency of the P4-ATPase member TAT-5 resulted in enhanced EV shedding, indicating a role in the regulation of EV release. In this study, we investigated whether the mammalian ortholog of TAT-5, ATP9A, has a similar function in mammalian cells. We show that knockdown of ATP9A expression in human hepatoma cells resulted in a significant increase in EV release that was independent of caspase-3 activation. Pharmacological blocking of exosome release in ATP9A knockdown cells did significantly reduce the total number of EVs. Our data support a role for ATP9A in the regulation of exosome release from human cells.	[Naik, Jyoti; ten Bloemendaal, Lysbeth; Mok, Kam S.; Meisner, Sander; Muncan, Vanesa; Paulusma, Coen C.; Bosma, Piter J.] Univ Amsterdam, Amsterdam Univ Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam Gastroenterol & Metab, Amsterdam, Netherlands; [Hau, Chi M.; Hajji, Najat; Nieuwland, Rienk] Univ Amsterdam, Amsterdam Univ Med Ctr, Acad Med Ctr, Vesicle Observat Ctr,Lab Expt Clin Chem, Amsterdam, Netherlands; [Wehman, Ann M.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany; [Paauw, Nanne J.; de Vries, H. E.] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Wurzburg; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Paulusma, CC; Bosma, PJ (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam Gastroenterol & Metab, Amsterdam, Netherlands.	c.c.paulusma@amc.uva.nl; p.j.bosma@amc.uva.nl	Paulusma, Coen/AAR-7943-2021; Nieuwland, Rienk/AAC-9591-2019; Wehman, Ann M/J-7860-2019	Wehman, Ann M/0000-0001-9826-4132; de Vries, Helga/0000-0001-7904-7124	Academisch Medisch centrum (AMC), Amsterdam	Academisch Medisch centrum (AMC), Amsterdam	Project was funded by Academisch Medisch centrum (AMC), Amsterdam.	Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Boing AN, 2013, BBA-MOL CELL RES, V1833, P1844, DOI 10.1016/j.bbamcr.2013.03.013; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Chan KT, 2011, TRENDS CELL BIOL, V21, P481, DOI 10.1016/j.tcb.2011.04.004; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; HANADA K, 1995, J CELL BIOL, V128, P793, DOI 10.1083/jcb.128.5.793; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; HOLME PA, 1994, THROMB HAEMOSTASIS, V72, P666; Hong NH, 2015, J CELL BIOL, V210, P753, DOI 10.1083/jcb.201412127; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Hussein MNA, 2007, THROMB HAEMOSTASIS, V98, P1096, DOI 10.1160/TH05-04-0231; Ifergan I, 2005, CANCER RES, V65, P10952, DOI 10.1158/0008-5472.CAN-05-2021; Menck K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1378056; Murate M, 2016, CHEM PHYS LIPIDS, V194, P58, DOI 10.1016/j.chemphyslip.2015.08.009; Naito Y, 2017, CELL MOL LIFE SCI, V74, P697, DOI 10.1007/s00018-016-2346-3; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Roland BP, 2016, CRIT REV BIOCHEM MOL, V51, P513, DOI 10.1080/10409238.2016.1237934; SCHROIT AJ, 1991, BIOCHIM BIOPHYS ACTA, V1071, P313, DOI 10.1016/0304-4157(91)90019-S; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Seppen J, 2002, J HEPATOL, V36, P459, DOI 10.1016/S0168-8278(01)00308-7; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Sinha S, 2016, J CELL BIOL, V214, P197, DOI 10.1083/jcb.201601025; STEIN JM, 1991, BIOCHEM J, V274, P381, DOI 10.1042/bj2740381; Takada N, 2015, J LIPID RES, V56, P2151, DOI 10.1194/jlr.M062547; Takar M, 2016, J BIOL CHEM, V291, P15727, DOI 10.1074/jbc.M115.686253; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tanaka Y, 2016, MOL BIOL CELL, V27, P3883, DOI 10.1091/mbc.E16-08-0586; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	41	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0213069	10.1371/journal.pone.0213069	http://dx.doi.org/10.1371/journal.pone.0213069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947313	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500011
J	Willms, A; Schittek, H; Rahn, S; Sosna, J; Mert, U; Adam, D; Trauzold, A				Willms, Anna; Schittek, Hella; Rahn, Sascha; Sosna, Justyna; Mert, Ufuk; Adam, Dieter; Trauzold, Anna			Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells	PLOS ONE			English	Article							DEATH; RECEPTORS; PROMOTES; PROLIFERATION; EXPRESSION; MATURATION; RESISTANCE; MIGRATION; INVASION; TARGET	Due to their ability to preferentially induce cell death in tumor cells, while sparing healthy cells, TNF-related apoptosis-inducing ligand (TRAIL) and agonistic anti-TRAIL-R1 or anti-TRAIL-R2-specific antibodies are under clinical investigations for cancer-treatment. However, TRAIL-Rs may also induce signaling pathways, which result in malignant progression. TRAIL receptors are transcriptionally upregulated via wild-type p53 following radio- or chemotherapy. Nevertheless, the impact of p53 status on the expression and signaling of TRAIL-Rs is not fully understood. Therefore, we analyzed side by side apoptotic and non-apoptotic signaling induced by TRAIL or the agonistic TRAIL-R-specific antibodies Mapatumumab (anti-TRAIL-R1) and Lexatumumab (anti-TRAIL-R2) in the two isogenic colon carcinoma cell lines HCT116 p53(+/+) and p53(-/-). We found that HCT116 p53(+/+) cells were significantly more sensitive to TRAIL-R-triggering than p53(-/-)cells. Similarly, A549 lung cancer cells expressing wild-type p53 were more sensitive to TRAIL-R-mediated cell death than their derivatives with knockdown of p53. Our data demonstrate that the contribution of p53 in regulating TRAIL-R-induced apoptosis does not correlate to the levels of TRAIL-Rs at the plasma membrane, but rather to p53-mediated upregulation of Bax, favouring the mitochondrial amplification loop. Consistently, stronger caspase-9 and caspase-3 activation as well as PARP-cleavage was observed following TRAIL-R-triggering in HCT116 p53(+/+) compared to HCT116 p53(-/-)- cells. Interestingly, HCT116 p53(+/+) cells showed also a more potent activation of non-canonical TRAIL-R-induced signal transduction pathways like JNK, p38 and ERK1/ERK2 than p53(-/-) cells. Likewise, these cells induced IL-8 expression in response to TRAIL, Mapatumumab or Lexatumumab significantly stronger than p53(-/-)- cells. We obtained similar results in A549 cells with or without p53-knockdown and in the two isogenic colon cancer cell lines RKO p53(+/+) and p53(-/-). In both cellular systems, we could clearly demonstrate the potentiating effects of p53 on TRAIL-R-mediated IL-8 induction. In conclusion, we found that wild-type p53 increases TRAIL-R-mediated apoptosis but simultaneously augments non-apoptotic signaling.	[Willms, Anna; Schittek, Hella; Rahn, Sascha; Mert, Ufuk; Trauzold, Anna] Univ Kiel, Inst Expt Canc Res, CCC North, Div Mol Oncol, Kiel, Germany; [Sosna, Justyna; Adam, Dieter] Univ Kiel, Inst Immunol, Kiel, Germany; [Trauzold, Anna] Univ Hosp Schleswig Holstein, Clin Gen Surg Visceral Thorac Transplantat & Pedi, Kiel, Germany; [Sosna, Justyna] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of Kiel; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of California System; University of California Irvine	Trauzold, A (corresponding author), Univ Kiel, Inst Expt Canc Res, CCC North, Div Mol Oncol, Kiel, Germany.; Trauzold, A (corresponding author), Univ Hosp Schleswig Holstein, Clin Gen Surg Visceral Thorac Transplantat & Pedi, Kiel, Germany.	atrauzold@email.uni-kiel.de	Rahn, Sascha/AAE-7777-2021; Adam, Dieter/E-9763-2010; Mert, ufuk/GSN-1477-2022	Adam, Dieter/0000-0002-5668-5032; Sosna, Justyna/0000-0002-3806-3459	Deutsche Krebshilfe [110788, 70112281]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Deutsche Krebshilfe - Project 110788: Doktoranden-Stipendium des Mildred-Scheel-Doktorandenprogrammes given to Hella Schittek and Projekt 70112281 given to Anna Trauzold. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Azijli K, 2013, CELL DEATH DIFFER, V20, P858, DOI 10.1038/cdd.2013.28; Azijli K, 2012, J CELL SCI, V125, P4651, DOI 10.1242/jcs.109587; Bertsch U, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.351; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; de Miguel D, 2016, CELL DEATH DIFFER, V23, P733, DOI 10.1038/cdd.2015.174; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Granci V, 2008, EUR J CANCER, V44, P2312, DOI 10.1016/j.ejca.2008.06.042; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Hartwig T, 2017, MOL CELL, V65, P730, DOI 10.1016/j.molcel.2017.01.021; Haselmann V, 2014, GASTROENTEROLOGY, V146, P278, DOI 10.1053/j.gastro.2013.10.009; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Kuribayashi K, 2008, CANCER BIOL THER, V7, P2034, DOI 10.4161/cbt.7.12.7460; Lalaoui N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019679; Legler K, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0478-0; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Lemke J, 2010, J MOL MED, V88, P729, DOI 10.1007/s00109-010-0619-0; Meijer A, 2013, BRIT J CANCER, V109, P2685, DOI 10.1038/bjc.2013.636; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Ozoren N, 2002, NEOPLASIA, V4, P551, DOI 10.1038/sj.neo.7900270; Sanlioglu AD, 2007, INT J RADIAT ONCOL, V69, P716, DOI 10.1016/j.ijrobp.2007.03.057; Sayan BS, 2006, J BIOL CHEM, V281, P13566, DOI 10.1074/jbc.M512467200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135; Secchiero P, 2004, BLOOD, V103, P517, DOI 10.1182/blood-2003-06-2137; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Trauzold A, 2001, ONCOGENE, V20, P4258, DOI 10.1038/sj.onc.1204559; Trauzold A, 2003, BRIT J CANCER, V89, P1714, DOI 10.1038/sj.bjc.6601330; van Roosmalen IAM, 2014, BIOCHEM PHARMACOL, V91, P447, DOI 10.1016/j.bcp.2014.08.010; von Karstedt S, 2017, NAT REV CANCER, V17, P352, DOI 10.1038/nrc.2017.28; Wachter F, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-27; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Yamada H, 1999, BIOCHEM BIOPH RES CO, V265, P130, DOI 10.1006/bbrc.1999.1641; Zauli G, 2005, J CELL PHYSIOL, V202, P900, DOI 10.1002/jcp.20202; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313; Zhao J, 2012, CANCER LETT, V314, P8, DOI 10.1016/j.canlet.2011.09.040	43	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214847	10.1371/journal.pone.0214847	http://dx.doi.org/10.1371/journal.pone.0214847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947287	Green Submitted, gold, Green Published			2022-12-27	WOS:000463314500071
J	Pimenta, RJG; Brandao-Dias, PFP; Leal, HG; do Carmo, AO; de Oliveira-Mendes, BBR; Chavez-Olortegui, C; Kalapothakis, E				Gonzaga Pimenta, Ricardo Jose; Pinto Brandao-Dias, Pedro Ferreira; Leal, Hortensia Gomes; do Carmo, Anderson Oliveira; Ribeiro de Oliveira-Mendes, Barbara Bruna; Chavez-Olortegui, Carlos; Kalapothakis, Evanguedes			Selected to survive and kill: Tityus serrulatus, the Brazilian yellow scorpion	PLOS ONE			English	Article							VENOM; DICTYOPTERA; STARVATION; RESISTANCE	Annually, more than 1.2 million scorpion stings and more than 3,000 deaths occur world-wide. Tityus serrulatus Lutz and Mello, 1922 (Scorpiones, Buthidae) is the most medically relevant species in Brazil where it is spreading rapidly and causing over 90,000 cases of envenomation yearly. We monitored T. serrulatus longevity and ability to reproduce under conditions of food and/or water deprivation. We found that T. serrulatus is highly tolerant to food deprivation, with individuals enduring up to 400 days without food. On the other hand, access to water played a pivotal role in T. serrulatus survival. Food and water deprived scorpions showed weight reduction. Reproduction occurred throughout the year for food-deprived scorpions and controls, but not in the water-deprived groups. Remarkably, food-deprived animals were able to give birth after 209 days of starvation. Tityus serrulatus resistance to food and water deprivation is likely to be an additional factor underlying this species' geographic expansion and the difficulties encountered in controlling it.	[Gonzaga Pimenta, Ricardo Jose; Pinto Brandao-Dias, Pedro Ferreira; Leal, Hortensia Gomes; do Carmo, Anderson Oliveira; Ribeiro de Oliveira-Mendes, Barbara Bruna; Kalapothakis, Evanguedes] Univ Fed Minas Gerais, Dept Biol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Chavez-Olortegui, Carlos] Univ Fed Minas Gerais, Dept Bioquim Imunol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Kalapothakis, E (corresponding author), Univ Fed Minas Gerais, Dept Biol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.	kalapothakis@gmail.com	Pinto, Pedro B. D. F./D-5628-2015; Pimenta, Ricardo José Gonzaga/AAK-7830-2020; Chavez Olortegui, Carlos Delfin/F-9227-2019	Pimenta, Ricardo José Gonzaga/0000-0003-0413-7138; Kalapothakis, Evanguedes/0000-0002-8326-249X; Chavez Olortegui, Carlos Delfin/0000-0001-9390-7207; Ferreira Pinto Brandao-Dias, Pedro/0000-0001-8583-0617; Oliveira Mendes, Barbara Bruna Ribeiro/0000-0002-2269-5750; Gomes Leal, Hortensia/0000-0003-0767-8781	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (Edital Toxinologia 63/2010); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG [APQ-02826-15]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [456505/2014-8, 14/2014]; CAPES; CNPq; FAPEMIG	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (Edital Toxinologia 63/2010); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (Edital Toxinologia 63/2010), by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Processo APQ-02826-15 (Obtained by EK) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Processo 456505/2014-8 (Edital Universal MCTI/CNPq No. 14/2014) (Obtained by CCO); CAPES: capes.gov.br, CNPq: cnpq.br, FAPEMIG: fapemig.br/pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga E.R., 2012, OJGEN, V02, P210, DOI [10.4236/ojgen.2012.24027, DOI 10.4236/OJGEN.2012.24027]; ANDERSON JF, 1974, ECOLOGY, V55, P576, DOI 10.2307/1935148; BABIN DR, 1974, ARCH BIOCHEM BIOPHYS, V164, P694, DOI 10.1016/0003-9861(74)90082-4; Bortoluzzi LR, 2007, BIOTA NEOTROP, V7, P357; Brasil J, 2013, REV BRAS GEOGR MED S, V9, P158; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Colombo Wesley Dondoni, 2015, Revista Iberica de Aracnologia, V27, P105; Cruz Elieth Floret Spirandeli, 1995, Revista da Sociedade Brasileira de Medicina Tropical, V28, P123, DOI 10.1590/S0037-86821995000200007; Cupo P, 2015, REV SOC BRAS MED TRO, V48, P642, DOI 10.1590/0037-8682-0237-2015; D'Suze G, 1999, TOXICON, V37, P173, DOI 10.1016/S0041-0101(98)00180-9; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de Roodt Adolfo Rafael, 2014, Acta toxicol. argent., V22, P5; FREIREMAIA L, 1994, TOXICON, V32, P1009, DOI 10.1016/0041-0101(94)90382-4; Gefen E, 2005, J EXP BIOL, V208, P1887, DOI 10.1242/jeb.01568; Gefen E, 2004, J EXP BIOL, V207, P1017, DOI 10.1242/jeb.00860; GOYFFON M, 1983, CELL TISSUE RES, V228, P661, DOI 10.1007/BF00211482; Holbrook GL, 2003, J ECON ENTOMOL, V96, P1548, DOI 10.1603/0022-0493-96.5.1548; Hoshino K, 2006, J VENOM ANIM TOXINS, V12, P59, DOI 10.1590/S1678-91992006000100005; Jorge Duprat Figueiredo de Seguranca e Medicina do Trabalho, 2001, PREV AC COM AN PEC; Kalra B, 2012, COMP BIOCHEM PHYS A, V162, P372, DOI 10.1016/j.cbpa.2012.04.013; Ko AE, 2016, PEST MANAG SCI, V72, P1778, DOI 10.1002/ps.4211; Lima ALM, 2011, CON SCI SAUDE, V10, P627; Lourenco W.R., 1996, Journal of Venomous Animals and Toxins, V2, P121; Lourenco W.R., 1995, Journal of Venomous Animals and Toxins, V1, P51; Lourenco WR, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0016-9; Lourenco WR, 2002, EUROPEAN ARACHNOLOGY 2000, P71; Lourenco WR, 2003, ANIMAIS PECONHENTOS, V1st, P182; MATTHIESEN FA, 1962, EVOLUTION, V16, P255, DOI 10.1111/j.1558-5646.1962.tb03217.x; McCormick SJ, 1990, BIOL SCORPIONS, P224; Millot J., 1949, TRAITE ZOOLOGIE, V6, P387; Ministerio da Saude, 2001, MAN DIAGN TRAT AC AN; Ministerio da Saude (BR), 2009, MAN CONTR ESC; Olivares B., 2018, SCI REP-UK, V8, P1, DOI DOI 10.1038/S41598-017-17765-5; Outeda-Jorge S, 2009, ZOOLOGIA-CURITIBA, V26, P43, DOI 10.1590/S1984-46702009000100008; Pucca MB, 2015, TOXICON, V108, P272, DOI 10.1016/j.toxicon.2015.10.015; Ramires EN, 2011, PESTICIDES IN THE MODERN WORLD - PESTS CONTROL AND PESTICIDES EXPOSURE AND TOXICITY ASSESSMENT, P553; SINHA RC, 1967, PHYSIOL ZOOL, V40, P386, DOI 10.1086/physzool.40.4.30158456; Skutelsky O, 1996, ANIM BEHAV, V52, P49, DOI 10.1006/anbe.1996.0151; Southcott R. V., 1955, Transactions of the Royal Society of South Australia, V78, P145; Szilagyi-Zecchin Vivian Jaskiw, 2012, Indian Journal of Arachnology, V1, P15; TANAKA K, 1982, RES POPUL ECOL, V24, P360, DOI 10.1007/BF02515582; Waterman J. A., 1939, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V33, P113, DOI 10.1016/S0035-9203(39)90168-9; WHARTON D. R. A., 1965, J INSECT PHYSIOL, V11, P391, DOI 10.1016/0022-1910(65)90046-6	43	7	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214075	10.1371/journal.pone.0214075	http://dx.doi.org/10.1371/journal.pone.0214075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943232	Green Submitted, Green Published, gold			2022-12-27	WOS:000463194300031
J	Rennerfeldt, DA; Raminhos, JS; Leff, SM; Manning, P; Van Vliet, KJ				Rennerfeldt, Deena A.; Raminhos, Joana S.; Leff, Samantha M.; Manning, Pristinavae; Van Vliet, Krystyn J.			Emergent heterogeneity in putative mesenchymal stem cell colonies: Single-cell time lapsed analysis	PLOS ONE			English	Article							STROMAL CELLS; IN-VITRO; CULTURE; TRANSPLANTATION; SENESCENCE; EXPANSION; REVEALS; IMAGE; ASSAY	Bone marrow stromal cells (BMSCs) include a subset of stem cells that are considered promising for developmental studies and therapeutic applications. While it is appreciated generally that BMSC populations can exhibit morphological and functional heterogeneity upon in vitro culture expansion, the potential for heterogeneity within a single colony forming unit-generated ostensibly from a single mother cell-is less explored but is critical to design of both fundamental studies and cell therapy production. Here we observed BMSC colony formation in real time via time lapsed optical imaging and analysis, to quantify whether and how heterogeneity emerged over multiple cell divisions spanning the duration of a typical colony formation unit assay. These analyses demonstrate that such colonies are neither homogeneous subpopulations of stem cells nor necessarily derived from single originating cells. While the mechanisms for and causes of this intracolony heterogeneity are not understood fully, we further demonstrate that extensive cell-cell contacts do not correlate with senescence, but that media exchange was concurrent with diversification in even the most uniform single-cell-derived colonies. These direct quantitative observations and visualizations of colony formation provide new insights that are motivated by significant implications for both basic research and stem cell-based therapies.	[Rennerfeldt, Deena A.; Leff, Samantha M.; Manning, Pristinavae; Van Vliet, Krystyn J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Raminhos, Joana S.] Univ Nova Lisboa, Dept Mat Sci, Fac Sci & Technol, Caparica, Portugal; [Van Vliet, Krystyn J.] MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Universidade Nova de Lisboa; Massachusetts Institute of Technology (MIT)	Van Vliet, KJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Van Vliet, KJ (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	krystyn@mit.edu	Raminhos, Joana/F-4766-2019	Raminhos, Joana/0000-0001-9658-9283; Van Vliet, Krystyn/0000-0001-5735-0560	National Research Foundation of Singapore through the Singapore-MIT Alliance for Research and Technology BioSystems and Micromechanics interdisciplinary research group; US National Science Foundation Graduate Research Fellowship [1122374]	National Research Foundation of Singapore through the Singapore-MIT Alliance for Research and Technology BioSystems and Micromechanics interdisciplinary research group; US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	Funded by National Research Foundation of Singapore through the Singapore-MIT Alliance for Research and Technology BioSystems and Micromechanics interdisciplinary research group; US National Science Foundation Graduate Research Fellowship under Grant No. 1122374 (DAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieback K, 2008, TRANSFUS MED HEMOTH, V35, P286, DOI 10.1159/000141567; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Choi JH, 2010, BIOTECHNOL PROGR, V26, P888, DOI 10.1002/btpr.374; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Lee WC, 2014, P NATL ACAD SCI USA, V111, pE4409, DOI 10.1073/pnas.1402306111; Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001; McLeod CM, 2017, EUR CELLS MATER, V34, P217, DOI 10.22203/eCM.v034a14; METS T, 1981, MECH AGEING DEV, V16, P81, DOI 10.1016/0047-6374(81)90035-X; Muraglia A, 2000, J CELL SCI, V113, P1161; Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019; Perets N, 2017, BEHAV BRAIN RES, V331, P254, DOI 10.1016/j.bbr.2017.03.047; Poon Z, 2015, STEM CELL TRANSL MED, V4, P56, DOI 10.5966/sctm.2014-0154; Rennerfeldt DA, 2019, PLOS ONE, DOI [10.5281/zenodo.2551721, DOI 10.5281/ZENODO.2551721]; Rennerfeldt DA, 2019, PROTOCOLS, DOI [10.17504/protocols.io.w2sfgee, DOI 10.17504/PROTOCOLS.IO.W2SFGEE]; Rennerfeldt DA, 2016, STEM CELLS, V34, P1135, DOI 10.1002/stem.2296; Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Song IH, 2009, J ORTHOP RES, V27, P216, DOI 10.1002/jor.20726; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Tremain N, 2001, STEM CELLS, V19, P408, DOI 10.1634/stemcells.19-5-408; Undale AH, 2009, MAYO CLIN PROC, V84, P893, DOI 10.1016/S0025-6196(11)60506-5; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; Whitfield MJ, 2013, STEM CELL RES, V11, P1365, DOI 10.1016/j.scr.2013.09.004; Wu JC, 2013, BIOTECHNOL ADV, V31, P1047, DOI 10.1016/j.biotechadv.2013.09.001; Yin ZZ, 2011, I S BIOMED IMAGING, P909, DOI 10.1109/ISBI.2011.5872551; Ylostalo J, 2008, EXP HEMATOL, V36, P1390, DOI 10.1016/j.exphem.2008.05.003; ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441	31	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213452	10.1371/journal.pone.0213452	http://dx.doi.org/10.1371/journal.pone.0213452			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943212	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300013
J	Waschke, J; Pompe, T; Rettke, D; Schmidt, S; Hlawitschka, M				Waschke, Johannes; Pompe, Tilo; Rettke, David; Schmidt, Stephan; Hlawitschka, Mario			Radial profile detection of multiple spherical particles in contact with interacting surfaces	PLOS ONE			English	Article							INTERFERENCE CONTRAST MICROSCOPY; ADHESION ENERGY; SOFT; FORCES; PROBES	Adhesive interactions of soft materials play an important role in nature and technology. Interaction energies can be quantified by determining contact areas of deformable microparticles with the help of reflection interference contrast microscopy (RICM). For high throughput screening of adhesive interactions, a method to automatically evaluate large amounts of interacting microparticles was developed. An image is taken which contains circular interference patterns with visual characteristics that depend on the probe's shape due to its surface interaction. We propose to automatically detect radial profiles in images, and to measure the contact radius and size of the spherical probe, allowing the determination of particle-surface interaction energy in a simple and fast imaging and image analysis setup. To achieve this, we analyze the image gradient and we perform template matching that utilizes the physical foundations of reflection interference contrast microscopy.	[Waschke, Johannes] Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1a, Leipzig, Germany; [Pompe, Tilo; Rettke, David] Univ Leipzig, Inst Biochem, Johannisallee 21-23, Leipzig, Germany; [Schmidt, Stephan] Heinrich Heine Univ Dusseldorf, Dept Chem, Dusseldorf, Germany; [Hlawitschka, Mario] Leipzig Univ Appl Sci, Fac Comp Sci Math & Nat Sci, Leipzig, Germany	Max Planck Society; Leipzig University; Heinrich Heine University Dusseldorf	Waschke, J (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1a, Leipzig, Germany.	jowaschke@cbs.mpg.de	Schmidt, Stephan/B-8393-2013; Hlawitschka, Mario/AAU-8942-2020	Schmidt, Stephan/0000-0002-4357-304X; Waschke, Johannes/0000-0002-2334-3511	International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (Leipzig, Germany); Federal Ministry for Education and Research (BMBF) [13N13799]	International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (Leipzig, Germany); Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	J.W. received funding from the International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (Leipzig, Germany; https://imprs-neurocom.mpg.de).T.P.and D.R. acknowledge the support by a grant from Federal Ministry for Education and Research (BMBF) within the program "Photonics in Life Sciences" (no. 13N13799). The remaining authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attili S, 2012, LANGMUIR, V28, P3206, DOI 10.1021/la204602n; Butt HJ, 2017, CURR OPIN COLLOID IN, V27, P82, DOI 10.1016/j.cocis.2016.09.007; Clack NG, 2005, LANGMUIR, V21, P6430, DOI 10.1021/la050372r; Contreras-Naranjo JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2865; Contreras-Naranjo JC, 2010, APPL OPTICS, V49, P3701, DOI 10.1364/AO.49.003701; Erath J, 2010, SOFT MATTER, V6, P1432, DOI 10.1039/b923540j; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; KIMME C, 1975, COMMUN ACM, V18, P120, DOI 10.1145/360666.360677; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; Martin S, 2016, POLYMER, V102, P342, DOI 10.1016/j.polymer.2016.02.019; Martin S, 2015, PHYS CHEM CHEM PHYS, V17, P3014, DOI 10.1039/c4cp05484a; Moy VT, 1999, BIOPHYS J, V76, P1632, DOI 10.1016/S0006-3495(99)77322-4; Pussak D, 2012, SOFT MATTER, V8, P1664, DOI 10.1039/c2sm06911c; Pussak D, 2013, ANGEW CHEM INT EDIT, V52, P6084, DOI 10.1002/anie.201300469; RADLER J, 1992, LANGMUIR, V8, P848; RADLER J, 1993, J PHYS II, V3, P727; Raut S, 2009, INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER CONTROL : ICACC 2009 - PROCEEDINGS, P420, DOI 10.1109/ICACC.2009.78; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Schilling J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021901; Schmidt S, 2015, BEILSTEIN J ORG CHEM, V11, P720, DOI 10.3762/bjoc.11.82; Strzelczyk AK, 2017, GELS-BASEL, V3, DOI 10.3390/gels3030031; Wang HQ, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201702040; Wiegand G, 1998, APPL OPTICS, V37, P6892, DOI 10.1364/AO.37.006892	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214815	10.1371/journal.pone.0214815	http://dx.doi.org/10.1371/journal.pone.0214815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939163	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900042
J	Han, KS; Kim, SJ; Lee, EJ; Park, KY; Lee, JY; Lee, SW				Han, Kap Su; Kim, Su Jin; Lee, Eui Jung; Park, Kyoung Yae; Lee, Ji Young; Lee, Sung Woo			Impact of rapid lactate clearance as an indicator of hemodynamic optimization on outcome in out-of-hospital cardiac arrest: A retrospective analysis	PLOS ONE			English	Article							MEAN ARTERIAL-PRESSURE; AMERICAN-HEART-ASSOCIATION; INTERNATIONAL LIAISON COMMITTEE; CARDIOVASCULAR CARE COMMITTEE; NEW-ZEALAND COUNCIL; CARDIOPULMONARY-RESUSCITATION; EUROPEAN RESUSCITATION; COMATOSE SURVIVORS; STROKE FOUNDATION; SOUTHERN AFRICA	Objective We analyzed the impact of rapid lactate clearance as an indicator of hemodynamic optimization on the outcome of out-of-hospital cardiac arrest (OHCA) during early post-cardiac arrest care (PCAC). Methods This retrospective analysis was based on a prospective cohort. We selected adult patients with OHCA who achieved a survival event between May 2006 and December 2017. Serum lactate levels were measured at 0 and 6 h after a survival event. The lactate clearance rate was calculated as (lactate at 0 h-lactate at 6 h)/lactate at 0 h. The threshold lactate clearance value for predicting survival to discharge was determined by receiver operating characteristic (ROC) curve analysis. Rapid lactate clearance was defined as the lactate clearance above the threshold value or normalization of serum lactate level (<2.0 mmol/L) at 6 h after a survival event. The primary outcome was survival to discharge. Multivariate logistic regression was used to predict survival to discharge. Results We enrolled 335 patients. 145 patients (43.3%) survived at discharge. The threshold value of lactate clearance was >= 34% to predict survival to discharge. After adjustment for confounders, the adjusted odds ratios for no hypotension at both 0 and 6 hours and for the presence of rapid lactate clearance for survival to discharge were 8.018 (95% confidence interval [CI] 2.802-22.947) and 2.193 (95% CI 1.263-3.808), respectively. Among patients with early recovery from initial hypotension or with no hypotension events at both 0 and 6 hours, the survival rates were significantly higher in the rapid lactate clearance group than in the non-rapid lactate clearance group. Conclusions During the early PCAC period, a rapid decrease in serum lactate level was an indicator of good outcome. Hemodynamic optimization including not only prevention and immediate correction of hypotension but also rapid lactate clearance should be considered in OHCA patients.	[Han, Kap Su; Kim, Su Jin; Lee, Eui Jung; Park, Kyoung Yae; Lee, Ji Young; Lee, Sung Woo] Korea Univ, Coll Med, Dept Emergency Med, Inchon Ro 73, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lee, SW (corresponding author), Korea Univ, Coll Med, Dept Emergency Med, Inchon Ro 73, Seoul, South Korea.	kuedlee@korea.ac.kr						Beylin ME, 2013, INTENS CARE MED, V39, P1981, DOI 10.1007/s00134-013-3075-9; Bray JE, 2014, RESUSCITATION, V85, P509, DOI 10.1016/j.resuscitation.2013.12.005; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Donnino MW, 2007, RESUSCITATION, V75, P229, DOI 10.1016/j.resuscitation.2007.03.021; Donnino MW, 2014, CRIT CARE MED, V42, P1804, DOI 10.1097/CCM.0000000000000332; Hayashida K, 2017, CRIT CARE MED, V45, pE559, DOI 10.1097/CCM.0000000000002307; Kilgannon JH, 2014, CRIT CARE MED, V42, P2083, DOI 10.1097/CCM.0000000000000406; Kiyatkin ME, 2017, CURR OPIN CRIT CARE, V23, P348, DOI 10.1097/MCC.0000000000000423; Kliegel A, 2004, MEDICINE, V83, P274, DOI 10.1097/01.md.0000141098.46118.4c; Laurikkala J, 2016, RESUSCITATION, V105, P116, DOI 10.1016/j.resuscitation.2016.05.026; Masyuk M, 2019, INTENS CARE MED, V45, P55, DOI 10.1007/s00134-018-5475-3; Riveiro DFM, 2016, J INTENSIVE CARE MED, V31, P544, DOI 10.1177/0885066615592865; Mullner M, 1997, INTENS CARE MED, V23, P1138, DOI 10.1007/s001340050470; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Russo JJ, 2017, RESUSCITATION, V113, P27, DOI 10.1016/j.resuscitation.2017.01.007; Vincent JL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1403-5; Young MN, 2015, RESUSCITATION, V88, P158, DOI 10.1016/j.resuscitation.2014.12.008	18	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214547	10.1371/journal.pone.0214547	http://dx.doi.org/10.1371/journal.pone.0214547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934011	Green Published, gold, Green Submitted			2022-12-27	WOS:000462867000021
J	Ignatov, KB; Blagodatskikh, KA; Shcherbo, DS; Kramarova, TV; Monakhova, YA; Kramarov, VM				Ignatov, Konstantin B.; Blagodatskikh, Konstantin A.; Shcherbo, Dmitry S.; Kramarova, Tatiana V.; Monakhova, Yulia A.; Kramarov, Vladimir M.			Fragmentation Through Polymerization (FTP): A new method to fragment DNA for next-generation sequencing	PLOS ONE			English	Article								Fragmentation of DNA is the very important first step in preparing nucleic acids for next-generation sequencing. Here we report a novel Fragmentation Through Polymerization (FTP) technique, which is a simple, robust, and low-cost enzymatic method of fragmentation. This method generates double-stranded DNA fragments that are suitable for direct use in NGS library construction and allows the elimination of the additional step of reparation of DNA ends.	[Ignatov, Konstantin B.; Monakhova, Yulia A.; Kramarov, Vladimir M.] Russian Acad Sci, All Russia Inst Agr Biotechnol, Moscow, Russia; [Ignatov, Konstantin B.; Kramarov, Vladimir M.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Blagodatskikh, Konstantin A.] Evrogen JSC, Moscow, Russia; [Blagodatskikh, Konstantin A.; Shcherbo, Dmitry S.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Kramarova, Tatiana V.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Monakhova, Yulia A.] Syntol JSC, Moscow, Russia	All-Russia Research Institute of Agricultural Biotechnology; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Pirogov Russian National Research Medical University; Stockholm University	Ignatov, KB (corresponding author), Russian Acad Sci, All Russia Inst Agr Biotechnol, Moscow, Russia.; Ignatov, KB (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia.	ignatovkb@bk.ru	Shcherbo, Dmitry S/B-3549-2019; Blagodatskikh, Konstantin A/A-4521-2011; Ignatov, Konstantin/D-9593-2018	Ignatov, Konstantin/0000-0001-8900-5278	Ministry of Education and Science of Russian Federation [14.579.21.0012, RFMEFI57914X0012, 0112-2016-0006]; Russian State Budget	Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Russian State Budget	The work was supported by the Ministry of Education and Science of Russian Federation, grant 14.579.21.0012 (ID #RFMEFI57914X0012) and by the grant 0112-2016-0006 from the Russian State Budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Syntol JSC provided support in the form of salary for Y.A. M. and reagents for NGS-analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Evrogen JSC provided equipment for NGS-analysis and provided support in the form of salary for author K.A.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Bioron GmbH provided enzymes and reagents (including SD DNA polymerase), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUKNER I, 1995, EMBO J, V14, P1812, DOI 10.1002/j.1460-2075.1995.tb07169.x; BRUKNER I, 1990, NUCLEIC ACIDS RES, V18, P891, DOI 10.1093/nar/18.4.891; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Grokhovsky SL, 2011, BIOPHYS J, V100, P117, DOI 10.1016/j.bpj.2010.10.052; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Ignatov KB, 2014, BIOTECHNIQUES, V57, P81, DOI 10.2144/000114198; Kasoji SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133014; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Lan JH, 2015, HUM IMMUNOL, V76, P166, DOI 10.1016/j.humimm.2014.12.016; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Marine R, 2011, APPL ENVIRON MICROB, V77, P8071, DOI 10.1128/AEM.05610-11; Mikheenko A, 2018, BIOINFORMATICS, V34, P142, DOI 10.1093/bioinformatics/bty266; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Poptsova MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04532; Richterich P, 1998, GENOME RES, V8, P251, DOI 10.1101/gr.8.3.251	18	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0210374	10.1371/journal.pone.0210374	http://dx.doi.org/10.1371/journal.pone.0210374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933980	Green Published, Green Submitted, gold			2022-12-27	WOS:000462867000002
J	Merlo, M; Ammirati, E; Gentile, P; Artico, J; Cannata, A; Finocchiaro, G; Barbati, G; Sormani, P; Varrenti, M; Perkan, A; Fabris, E; Aleksova, A; Bussani, R; Petrella, D; Cipriani, M; Raineri, C; Frigerio, M; Sinagra, G				Merlo, Marco; Ammirati, Enrico; Gentile, Piero; Artico, Jessica; Cannata, Antonio; Finocchiaro, Gherardo; Barbati, Giulia; Sormani, Paola; Varrenti, Marisa; Perkan, Andrea; Fabris, Enrico; Aleksova, Aneta; Bussani, Rossana; Petrella, Duccio; Cipriani, Manlio; Raineri, Claudia; Frigerio, Maria; Sinagra, Gianfranco			Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors	PLOS ONE			English	Article							ENDOMYOCARDIAL BIOPSY; SOCIETY; ASSOCIATION; STATEMENT; DIAGNOSIS; FULMINANT	Background Persistent left ventricular (LV) systolic dysfunction in patients with acute lymphocytic myocarditis (LM) is widely unexplored. Objectives To assess the frequency and predictors of persistent LV dysfunction in patients with LM and reduced LVEF at admission. Methods and results We retrospectively evaluated 89 consecutive patients with histologically-proven acute myocarditis enrolled at three Italian referral hospitals. A subgroup of 48 patients with LM, baseline systolic impairment and an available echocardiographic assessment at 12 months (618) from discharge constituted the study population. The primary study end-point was persistent LV dysfunction, defined as LVEF <50% at 1-year, and was observed in 27/48 patients (56.3%). Higher LV end-diastolic diameter at admission (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.04-1.43, p = 0.002), non-fulminant presentation (OR 8.46, 95% CI 1.28-55.75, p = 0.013) and presence of a poor lymphocytic infiltrate (OR 12.40, 95% CI 1.23-124.97, p = 0.010) emerged as independent predictors of persistent LV dysfunction at multivariate analysis (area under the curve 0.91, 95% CI 0.82-0.99). Pre-discharge LVEF was lower in patients with persistent LV dysfunction compared to the others (32%+/- 8 vs. 53%+/- 8, p <0.001), and this single variable showed the best accuracy in predicting the study end-point (area under the curve 0.95, 95% CI 0.89-1.00). Conclusions More than half of patients presenting with acute LM and LVEF <50% who survive the acute phase show persistent LV dysfunction after 1-year from hospital discharge. Features of subacute inflammatory process and of established myocardial damage at initial hospitalization emerged as predictors of this end-point.	[Merlo, Marco; Gentile, Piero; Artico, Jessica; Cannata, Antonio; Perkan, Andrea; Fabris, Enrico; Aleksova, Aneta; Sinagra, Gianfranco] Azienda Sanit Univ Integrata ASUITS, Cardiovasc Dept, Trieste, Italy; [Merlo, Marco; Gentile, Piero; Artico, Jessica; Cannata, Antonio; Perkan, Andrea; Fabris, Enrico; Aleksova, Aneta; Bussani, Rossana; Sinagra, Gianfranco] Univ Trieste, Trieste, Italy; [Ammirati, Enrico; Sormani, Paola; Varrenti, Marisa; Cipriani, Manlio; Frigerio, Maria] Osped Niguarda Ca Granda, De Gasperis Cardio Ctr, Milan, Italy; [Finocchiaro, Gherardo] St Georges Univ London, Cardiol Clin & Acad Grp, London, England; [Barbati, Giulia] Univ Trieste, Dept Med Sci, Biostat Unit, Trieste, Italy; [Bussani, Rossana] Azienda Sanit Univ Integrata ASUITS, Dept Pathol, Trieste, Italy; [Petrella, Duccio] Osped Niguarda Ca Granda, Pathol Labs, Milan, Italy; [Raineri, Claudia] Fdn IRCCS Policlin S Matteo, Dept Cardiol, Pavia, Italy	University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; St Georges University London; University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Fondazione San Matteo	Merlo, M (corresponding author), Azienda Sanit Univ Integrata ASUITS, Cardiovasc Dept, Trieste, Italy.; Merlo, M (corresponding author), Univ Trieste, Trieste, Italy.	marco.merlo79@gmail.com	Gentile, Piero/AHE-3297-2022; Ammirati, Enrico/AAA-9961-2020; Varrenti, Marisa/AAA-9837-2019; Fabris, Enrico/AAS-8429-2020; Barbati, Giulia/N-8418-2014; Sinagra, Gianfranco/AAE-3943-2020; VARRENTI, MARISA/GZG-1954-2022; Cannata, Antonio/O-6344-2015	Ammirati, Enrico/0000-0002-1676-5257; Fabris, Enrico/0000-0001-9458-0736; Barbati, Giulia/0000-0001-8942-5686; VARRENTI, MARISA/0000-0003-4375-5991; Cannata, Antonio/0000-0001-7609-6297; Artico, Jessica/0000-0001-7112-4607; Gentile, Piero/0000-0003-3360-3548; Raineri, Claudia/0000-0001-9653-1516; Bussani, Rossana/0000-0001-8241-9726; Cipriani, Manlio/0000-0002-0632-0561; Aleksova, Aneta/0000-0001-7711-9905				Ammirati E, 2017, CIRCULATION, V136, P529, DOI 10.1161/CIRCULATIONAHA.117.026386; Anzini M, 2013, CIRCULATION, V128, P2384, DOI 10.1161/CIRCULATIONAHA.113.003092; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Caforio ALP, 2007, EUR HEART J, V28, P1326, DOI 10.1093/eurheartj/ehm076; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; Escher F, 2014, INT J CARDIOL, V177, P76, DOI 10.1016/j.ijcard.2014.09.071; Ginsberg F, 2013, CRIT CARE CLIN, V29, P465, DOI 10.1016/j.ccc.2013.03.004; Gruen S, 2012, J AM COLL CARDIOL, V59, P1604, DOI 10.1016/j.jacc.2012.01.007; Harrell F, 2007, REGRESSION MODELING; Japp AG, 2016, J AM COLL CARDIOL, V67, P2996, DOI 10.1016/j.jacc.2016.03.590; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Leone O, 2012, CARDIOVASC PATHOL, V21, P245, DOI 10.1016/j.carpath.2011.10.001; Merken J, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004228; Merlo M, 2016, AM J CARDIOL, V118, P895, DOI 10.1016/j.amjcard.2016.05.063; Sinagra G, 2016, MAYO CLIN PROC, V91, P1256, DOI 10.1016/j.mayocp.2016.05.013; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167; Yuan Zuyi, 2003, Exp Clin Cardiol, V8, P13	19	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214616	10.1371/journal.pone.0214616	http://dx.doi.org/10.1371/journal.pone.0214616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921422	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000462594000099
J	Mwagona, PC; Yao, YL; Shan, YQ; Yu, HX				Mwagona, Patteson Chula; Yao, Yunlong; Shan Yuanqi; Yu, Hongxian			Laboratory study on nitrate removal and nitrous oxide emission in intact soil columns collected from nitrogenous loaded riparian wetland, Northeast China	PLOS ONE			English	Article							DENITRIFICATION RATES; SPATIAL VARIATION; DRINKING-WATER; N2O; GROUNDWATER; REDUCTION; DYNAMICS; FOREST; PH; DECOMPOSITION	Nitrate (NO3-) pollution of surface and groundwater systems is a major problem globally. For some time now wetlands have been considered potential systems for improving water quality. Nitrate dissolved in water moving through wetlands can be removed through different processes, such as the denitrification process, where heterotrophic facultative anaerobic bacteria use NO3- for respiration, leading to the production of nitrogen (N-2) and nitrous oxide (N2O) gases. Nitrate removal and emission of N2O in wetlands can vary spatially, depending on factors such as vegetation, hydrology and soil structure. This study intended to provide a better understanding of the spatial variability and processes involved in NO3- removal and emission of N2O in riparian wetland soils. We designed a laboratory experiment simulating surface water flow through soil columns collected from different sites dominated by different plant species within a wetland. Water and gas samples for NO3-, NH4+ and N2O analyses were collected every 5 days for a period of 30 days. The results revealed significant removal of NO3- in all the soil columns, supporting the role of riparian wetland soils in removing nitrogen from surface runoff. Nitrate removal at 0 and 10cm depths in sites dominated by Phragmites australis and Carex schnimdtii was significantly higher than in the site dominated by Calamagrostis epigeio. Nitrous oxide emissions varied spatially and temporally with negative flux observed in sites dominated by P. australis and C. schnimdtii. These results reveal that in addition to the ability of wetlands to remove NO3-, some sites within wetlands are also capable of consuming N2O, hence mitigating not only agricultural nitrate pollution but also climate change.	[Mwagona, Patteson Chula; Yao, Yunlong; Shan Yuanqi; Yu, Hongxian] Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Yao, YL; Yu, HX (corresponding author), Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Heilongjiang, Peoples R China.	yaoyunlong@nefu.edu.cn; china.yhx@163.com			Fundamental Research Funds for the Central Universities [2572017CA15]; Natural Science Foundation of Heilongjiang Province [QC201604]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This study was supported by The Fundamental Research Funds for the Central Universities (2572017CA15) and Natural Science Foundation of Heilongjiang Province (QC201604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet J, 2014, SOIL BIOL BIOCHEM, V68, P291, DOI 10.1016/j.soilbio.2013.10.011; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; BLACKMER AM, 1978, SOIL BIOL BIOCHEM, V10, P187, DOI 10.1016/0038-0717(78)90095-0; Brauer N, 2015, ECOL ENG, V81, P207, DOI 10.1016/j.ecoleng.2015.04.003; Burgin AJ, 2013, SSSA BOOK S, V10, P519, DOI 10.2136/sssabookser10.c28; Buss S, 2005, SC0301552 ENV AG SCI; Butterbach-Bahl K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0122; Carrey R, 2013, APPL GEOCHEM, V32, P142, DOI 10.1016/j.apgeochem.2012.10.009; Chapuis-Lardy L, 2007, GLOBAL CHANGE BIOL, V13, P1, DOI 10.1111/j.1365-2486.2006.01280.x; Dong LF, 2011, LIMNOL OCEANOGR, V56, P279, DOI 10.4319/lo.2011.56.1.0279; Esperschutz J, 2013, BIOGEOSCIENCES, V10, P5115, DOI 10.5194/bg-10-5115-2013; Fan AM, 1996, REGUL TOXICOL PHARM, V23, P35, DOI 10.1006/rtph.1996.0006; Federation W.E., 2005, STANDARD METHODS EXA; Gardner WS, 2009, BIOGEOCHEMISTRY, V95, P185, DOI 10.1007/s10533-009-9329-5; Giles M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00407; Hayakawa A, 2012, ECOL ENG, V47, P92, DOI 10.1016/j.ecoleng.2012.06.034; Hefting MM, 2006, ECOSYSTEMS, V9, P550, DOI 10.1007/s10021-006-0160-8; Hefting MM, 2003, J ENVIRON QUAL, V32, P1194, DOI 10.2134/jeq2003.1194; Hendzel LL, 2005, ENVIRON SCI TECHNOL, V39, P4353, DOI 10.1021/es049443j; Hoffmann CC, 2011, HYDROBIOLOGIA, V674, P5, DOI 10.1007/s10750-011-0734-0; Hoffmann CC, 2000, J ENVIRON QUAL, V29, P2020, DOI 10.2134/jeq2000.00472425002900060040x; Jacinthe PA, 2012, J ENVIRON QUAL, V41, P95, DOI 10.2134/jeq2011.0308; Jain AK, 2000, J GEOPHYS RES-ATMOS, V105, P20773, DOI 10.1029/2000JD900241; Ji GD, 2002, ECOL ENG, V18, P459, DOI 10.1016/S0925-8574(01)00106-9; KOSKINEN WC, 1982, SOIL SCI SOC AM J, V46, P1165, DOI 10.2136/sssaj1982.03615995004600060009x; Lin YF, 2007, J ENVIRON SCI HEAL A, V42, P471, DOI 10.1080/10934520601187690; Lind LPD, 2013, SOIL BIOL BIOCHEM, V60, P156, DOI 10.1016/j.soilbio.2013.01.021; MAGEE PN, 1956, BRIT J CANCER, V10, P114, DOI 10.1038/bjc.1956.15; Mayer PM, 2007, J ENVIRON QUAL, V36, P1172, DOI 10.2134/jeq2006.0462; Morse JL, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001923; Munoz-Leoz B, 2011, SCI TOTAL ENVIRON, V409, P763, DOI 10.1016/j.scitotenv.2010.10.008; Gonzalez-Alcaraz MN, 2013, J ENVIRON MANAGE, V128, P964, DOI 10.1016/j.jenvman.2013.07.002; Puckett LJ, 2008, J ENVIRON QUAL, V37, P1034, DOI 10.2134/jeq2006.0550; R Core Team, 2015, R LANGUAGE ENV STAT; Rivett MO, 2008, WATER RES, V42, P4215, DOI 10.1016/j.watres.2008.07.020; Rocca C. della, 2005, Water SA, V31, P229; Saunders DL, 2001, HYDROBIOLOGIA, V443, P205, DOI 10.1023/A:1017506914063; Simek M, 2002, EUR J SOIL SCI, V53, P345, DOI 10.1046/j.1365-2389.2002.00461.x; SKIBA U, 1993, SOIL BIOL BIOCHEM, V25, P1527, DOI 10.1016/0038-0717(93)90007-X; Smolders AJP, 2010, BIOGEOCHEMISTRY, V98, P1, DOI 10.1007/s10533-009-9387-8; Song CC, 2008, J ENVIRON MANAGE, V88, P428, DOI 10.1016/j.jenvman.2007.03.030; STANFORD G, 1975, SOIL SCI SOC AM J, V39, P284, DOI 10.2136/sssaj1975.03615995003900020019x; Van den Heuvel RN, 2011, GEOBIOLOGY, V9, P294, DOI 10.1111/j.1472-4669.2011.00276.x; Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Weslien P, 2009, EUR J SOIL SCI, V60, P311, DOI 10.1111/j.1365-2389.2009.01123.x; WIJLER J, 1954, PLANT SOIL, V5, P155, DOI 10.1007/BF01343848; Willems HPL, 1997, WATER RES, V31, P841, DOI 10.1016/S0043-1354(96)00315-6; Wu DM, 2013, SOIL BIOL BIOCHEM, V60, P165, DOI 10.1016/j.soilbio.2013.01.028; Zaman M, 2008, AUST J SOIL RES, V46, P526, DOI 10.1071/SR07218; Zhang LH, 2013, ECOL ENG, V61, P82, DOI 10.1016/j.ecoleng.2013.09.065; Zhang WL, 1996, AGR ECOSYST ENVIRON, V59, P223, DOI 10.1016/0167-8809(96)01052-3; Zhao TQ, 2009, J ENVIRON SCI-CHINA, V21, P933, DOI 10.1016/S1001-0742(08)62364-5; Zou YC, 2018, J ENVIRON MANAGE, V224, P140, DOI 10.1016/j.jenvman.2018.07.052	54	5	5	9	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214456	10.1371/journal.pone.0214456	http://dx.doi.org/10.1371/journal.pone.0214456			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921385	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000071
J	Sapkota, A; Murtugudde, R; Curriero, FC; Upperman, CR; Ziska, L; Jiang, CS				Sapkota, Amir; Murtugudde, Raghu; Curriero, Frank C.; Upperman, Crystal R.; Ziska, Lewis; Jiang, Chengsheng			Associations between alteration in plant phenology and hay fever prevalence among US adults: Implication for changing climate	PLOS ONE			English	Article							ALLERGIC RHINITIS; POLLEN SEASONS; RESPONSES; MANAGEMENT; EXPOSURE; BUDBURST; RAGWEED; HEALTH	Plant phenology (e.g. timing of spring green-up, flowering) is among the most sensitive indicator of ecological response to ongoing climate variability and change. While previous studies have documented changes in the timing of spring green-up and flowering across different parts of the world, empirical evidence regarding how such ongoing ecological changes impact allergic disease burden at population level is lacking. Because earlier spring green-up may increase season length for tree pollen, we hypothesized that early onset of spring (negative anomaly in start of season (SOS)) will be associated with increased hay fever burden. To test this, we first calculated a median cardinal date for SOS for each county within the contiguous US for the years 2001-2013 using phenology data from the National Aeronautics and Space Administration's Moderate Resolution Imaging Spectroradiometer (MODIS). We categorized yearly deviations in SOS for each county from their respective long-term averages as: very early (>3 wks early), early (1-3 wks early), average (within 1 wk), late (1-3 wks late) and very late (> 3 wks late). We linked these data to 2002-2013 National Health Interview Survey data, and investigated the association between changes in SOS and hay fever prevalence using logistic regression. We observed that adults living in counties with a very early onset of SOS had a 14% higher odds of hay fever compared to the reference group, i.e. those living in counties where onset of spring was within the normal range (Odds Ratios (OR): 1.14. 95% Confidence Interval (CI): 1.03-1.27). Likewise, adults living in counties with very late onset of SOS had a 18% higher odds hay fever compared to the reference group (OR: 1.18, CI: 1.05-1.32). Our data provides the first-ever national scale assessment of the impact of changing plant phenology-linked to ongoing climate variability and change-on hay fever prevalence. Our findings are likely tied to changes in pollen dynamics, i.e early onset of spring increases the duration of exposure to tree pollen, while very late onset of spring increases the propensity of exposure because of simultaneous blooming.	[Sapkota, Amir; Upperman, Crystal R.; Jiang, Chengsheng] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Murtugudde, Raghu] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Curriero, Frank C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ziska, Lewis] ARS, Crop Syst & Global Change Lab, USDA, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United States Department of Agriculture (USDA)	Sapkota, A (corresponding author), Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA.	amirsap@umd.edu			National Institute of Environmental Health Sciences [NIEHS 1R21ES021422-01A1]	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (NIEHS 1R21ES021422-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahas R, 2006, INT J BIOMETEOROL, V51, P17, DOI 10.1007/s00484-006-0041-z; [Anonymous], 2012, MANAGING RISKS EXTRE; [Anonymous], 2014, CLIMATE CHANGE 2014; Bernstein JA, 2010, ALLERGY ASTHMA PROC, V31, P365, DOI 10.2500/aap.2010.31.3380; Bernstein L. B. P., 2007, INTERGOVERNMENTAL PA; Blaiss MS, 2010, ALLERGY ASTHMA PROC, V31, P375, DOI 10.2500/aap.2010.31.3329; Bock A, 2014, GLOBAL CHANGE BIOL, V20, P3508, DOI 10.1111/gcb.12579; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; CANNELL MGR, 1986, J APPL ECOL, V23, P177, DOI 10.2307/2403090; Centers for Disease Control and Prevention, 2016, ALL HAY FEV; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Donnelly A, 2017, INT J BIOMETEOROL, V61, pS29, DOI 10.1007/s00484-017-1371-8; Emberlin J, 2002, INT J BIOMETEOROL, V46, P159, DOI 10.1007/s00484-002-0139-x; Emberlin J, 2007, INT J BIOMETEOROL, V51, P181, DOI 10.1007/s00484-006-0059-2; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fu Y. H, GLOBAL ECOL BIOGEOGR, V23, P1255; Fu YSH, 2015, NATURE, V526, P104, DOI 10.1038/nature15402; Galan C, 2005, INT J BIOMETEOROL, V49, P184, DOI 10.1007/s00484-004-0223-5; Garcia-Mozo H, 2010, AGR FOREST METEOROL, V150, P575, DOI 10.1016/j.agrformet.2010.01.023; Garcia-Mozo H, 2015, ANN AGR ENV MED, V22, P421, DOI 10.5604/12321966.1167706; Ingram Deborah D, 2012, Vital Health Stat 2, P1; Jackson K, 2013, BFI FILM CLASSICS, P1, DOI 10.1007/978-1-84457-702-6; Jenkerson CB, 2010, 20101055 USGS, P2010; Li XC, 2017, SCI TOTAL ENVIRON, V605, P721, DOI 10.1016/j.scitotenv.2017.06.245; Lind T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166887; Luber G., 2014, HUMAN HLTH, P220, DOI DOI 10.7930/J0PN93H5; Menzel A, 2000, INT J BIOMETEOROL, V44, P76, DOI 10.1007/s004840000054; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Portier Christopher J., 2010, HUMAN HLTH PERSPECTI; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Seidman MD, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599814561600; Soneja S, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0142-z; Swets D.L., 1999, IMAGE INFORM 1999 AS; Tran NP, 2011, ALLERGY ASTHMA IMMUN, V3, P148, DOI 10.4168/aair.2011.3.3.148; Ugolotti M, 2015, AEROBIOLOGIA, V31, P341, DOI 10.1007/s10453-015-9368-4; Upperman CR, 2016, J ALLERGY CLIN IMMUN; Upperman CR, 2017, J ALLER CL IMM-PRACT, V5, P435, DOI 10.1016/j.jaip.2016.09.016; van Cauwenberge P, 2000, ALLERGY, V55, P116, DOI 10.1034/j.1398-9995.2000.00526.x; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ziska L, 2016, IMPACTS CLIMATE CHAN, P74; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	46	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0212010	10.1371/journal.pone.0212010	http://dx.doi.org/10.1371/journal.pone.0212010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921361	Green Submitted, gold, Green Published			2022-12-27	WOS:000462594000012
J	Vlasblom, E; Boere-Boonekamp, MM; Hafkamp-de Groen, E; Dusseldorp, E; van Dommelen, P; Verkerk, PH				Vlasblom, Eline; Boere-Boonekamp, Magda M.; Hafkamp-de Groen, Esther; Dusseldorp, Elise; van Dommelen, Paula; Verkerk, Paul H.			Predictive validity of developmental milestones for detecting limited intellectual functioning	PLOS ONE			English	Article							EARLY INTERVENTION; MOTOR-PERFORMANCE; CHILDREN; INFANT; DISABILITIES; ATTAINMENT; DIAGNOSIS; DELAY; BIRTH; AGE	Developmental milestones are commonly used in child health care, although from many milestones the predictive validity has not been adequately assessed. We aimed to determine the predictive validity of 75 developmental milestones for detecting limited intellectual functioning that can be obtained before the age of 4 years. We performed a case-control study with 148 children aged 5-10 years with limited intellectual functioning (IQ 50-69), who were in special education (cases) and a random sample of 300 children aged 5-10 years who were in regular elementary education (controls). Developmental milestones scores were retrieved from Child Healthcare files. We calculated sensitivity, specificity, positive likelihood ratios (LR+) and diagnostic odds ratios (DOR) for limited intellectual functioning. The LR+ determines whether a test result changes the probability that a condition exists. Given the prevalence of intellectual disability (1-3%), we considered that an LR+ > 10 would be clinically useful, as it increases the a priori probability of limited intellectual functioning from 2% to a posteriori probability of at least 17%. Out of 75 assessed milestones, 50 were included in the analysis. We found nine milestones to have a significant adjusted (for socioeconomic status and prematurity) DOR > 1 and a significant LR+ > 10 (assessment age in months between brackets): 'says "dada-baba''' (9), 'balances head well while sitting' (9), 'sits on buttocks while legs stretched' (9), 'babbles while playing' (12), 'sits in stable position without support' (12), 'walks well alone' (24), 'says "sentences" of 3 or more words' (36), 'places 3 forms in form-box' (36) and 'copies circle' (48). Sensitivities of these 9 milestones varied from 8-54%, specificities of these 9 milestones varied from 95-100%. Combining these milestones at 9,12, and 36 months respectively resulted in sensitivities of 27-60% and specificities of 94-99%. These nine developmental milestones have substantial predictive validity for limited intellectual functioning.	[Vlasblom, Eline; van Dommelen, Paula; Verkerk, Paul H.] TNO, Dept Child Hlth, Leiden, Netherlands; [Boere-Boonekamp, Magda M.] Univ Twente, Dept Hlth Technol & Serv Res, Tech Med Ctr, Enschede, Netherlands; [Hafkamp-de Groen, Esther] Rivas Zorggrp, Gorinchem, Netherlands; [Dusseldorp, Elise] Leiden Univ, Inst Psychol, Leiden, Netherlands	Netherlands Organization Applied Science Research; University of Twente; Leiden University; Leiden University - Excl LUMC	Vlasblom, E (corresponding author), TNO, Dept Child Hlth, Leiden, Netherlands.	eline.vlasblom@tno.nl						Allely CS, 2014, J ED CHILD PSYCHOL, V31, P28; Aylward GP, 2009, J DEV BEHAV PEDIATR, V30, P169, DOI 10.1097/DBP.0b013e31819f1c3e; Bilder DA, 2013, AJIDD-AM J INTELLECT, V118, P156, DOI 10.1352/1944-7558-118.2.156; Bleichrodt N, 1987, RAKIT HANDLEIDING RE; BRESLOW N, 1982, J OCCUP ENVIRON MED, V24, P255; Calonge N, 2006, PEDIATRICS, V117, P497, DOI 10.1542/peds.2005-2766; CAPUTE AJ, 1985, CLIN PEDIATR, V24, P671, DOI 10.1177/000992288502401201; Colombo J., 1993, INDIVIDUAL DIFFERENC; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; FIRST LR, 1994, NEW ENGL J MED, V330, P478, DOI 10.1056/NEJM199402173300708; Flensborg-Madsen T, 2018, DEV PSYCHOL, V54, P1434, DOI 10.1037/dev0000545; Flensborg-Madsen T, 2015, EARLY HUM DEV, V91, P393, DOI 10.1016/j.earlhumdev.2015.04.006; FUNK JB, 1982, J DEV BEHAV PEDIATR, V3, P143, DOI 10.1097/00004703-198209000-00004; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Guralnick MJ, 2017, J APPL RES INTELLECT, V30, P211, DOI 10.1111/jar.12233; Guralnick MJ, 2005, J APPL RES INTELLECT, V18, P313, DOI 10.1111/j.1468-3148.2005.00270.x; Hamadani JD, 2013, MATERN CHILD NUTR, V9, P89, DOI 10.1111/mcn.12020; Hartman E, 2010, J INTELL DISABIL RES, V54, P468, DOI 10.1111/j.1365-2788.2010.01284.x; Jacobusse G, 2006, STAT MED, V25, P2272, DOI 10.1002/sim.2351; Jenni OG, 2013, DEV NEUROPSYCHOL, V38, P98, DOI 10.1080/87565641.2012.733785; Lagae L, 2008, PEDIATR CLIN N AM, V55, P1259, DOI 10.1016/j.pcl.2008.08.001; Laurent de Angulo MS, 2005, ONTWIKKELINGSONDERZO; Macy M, 2012, INFANT YOUNG CHILD, V25, P19, DOI 10.1097/IYC.0b013e31823d37dd; Marks K, 2008, PEDIATRICS, V122, P866, DOI 10.1542/peds.2007-3142; Mathews KD, 2010, J CHILD NEUROL, V25, P1098, DOI 10.1177/0883073810371001; McGee S, 2002, J GEN INTERN MED, V17, P646; Murray GK, 2006, J CHILD PSYCHOL PSYC, V47, P25, DOI 10.1111/j.1469-7610.2005.01450.x; Murray GK, 2007, ANN NEUROL, V62, P128, DOI 10.1002/ana.21120; NCJ, 2015, BAS JGZ; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Odd DE, 2008, ARCH DIS CHILD-FETAL, V93, pF115, DOI 10.1136/adc.2007.123745; OUDEN LD, 1991, J PEDIATR-US, V118, P399, DOI 10.1016/S0022-3476(05)82154-7; Poranen-Clark T, 2015, AGE, V37, DOI 10.1007/s11357-015-9785-x; Roberts C, 2006, J CLIN CHILD ADOLESC, V35, P180, DOI 10.1207/s15374424jccp3502_2; Roze E, 2010, PEDIATRICS, V126, pE1134, DOI 10.1542/peds.2010-0698; Sandler AD, 2001, PEDIATRICS, V107; Schalock R.L., 2021, INTELLECTUAL DISABIL; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Sices L, 2003, J DEV BEHAV PEDIATR, V24, P409, DOI 10.1097/00004703-200312000-00002; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Snijders J.T., 1976, SNIJDERS OOMEN NONVE; Statistics Netherlands, 2008, STAT YB NETH; Taanila A, 2005, DEV MED CHILD NEUROL, V47, P581, DOI 10.1017/S0012162205001155; Verkerk PH, 1993, TIJDSCHRIFT JEUGDGEZ, V25, P71; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Vuijk PJ, 2010, J INTELL DISABIL RES, V54, P955, DOI 10.1111/j.1365-2788.2010.01318.x; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 2014, WECHSLER PRESCHOOL P; Weikart DP, 1998, PREV MED, V27, P233, DOI 10.1006/pmed.1998.0280; Williams Jane, 2004, J Child Health Care, V8, P34, DOI 10.1177/1367493504041852	52	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214475	10.1371/journal.pone.0214475	http://dx.doi.org/10.1371/journal.pone.0214475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921424	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000076
J	Yang, Y; Zhou, HQ; Shu, H; Zhong, DM; Zhang, MQ; Xia, JH				Yang, Yang; Zhou, Huiqiang; Shu, Hu; Zhong, Dongming; Zhang, Mingqing; Xia, Jun Hong			Effect of fasting and subsequent refeeding on the transcriptional profiles of brain in juvenile Spinibarbus hollandi	PLOS ONE			English	Article							COMPENSATORY GROWTH; PROTEIN; METABOLISM; IDENTIFICATION; DEPRIVATION; DEPOSITION; EXPRESSION; PERIODS; MUSCLE; GENES	Starvation is a common stress in fish. The underlying molecular mechanisms associated with growth depression caused by feeding restriction and compensatory growth are not well understood. We investigated the effect of fasting and refeeding on the transcriptome profiles of brain in juvenile S. hollandi using RNA-seq. A total of 4.73 x 10(8) raw reads were obtained from nine brain samples. De novo transcriptome assembly identified 387,085 unigenes with 2.1 x 10(9) nucleotides. A total of 936 annotated unigenes showed significantly differential expression among the control, fasting, and fasting-refeeding groups. The down-regulated differentially expressed genes (DEGs) during fasting were mainly associated with cell cycle, DNA replication, and mitosis. The up-regulated DEGs were mainly related to glucose and lipid metabolism, material transportation, and transcription factors. Most decreased DEGs during fasting were restored to normal levels after refeeding. Comparing with the control group, genes associated with protein synthesis, stimulus response, and carbohydrate metabolism were significantly over-expressed and pro-opio melanocortin (POMC) was down-regulated during the refeeding period. In conclusion, fish mobilized stored energetic materials and reduced energy consumption to prolong survival during fasting. After refeeding, the down-regulation of DEGs, e.g., POMC may be associated with compensatory growth. Up-regulation of DEGs related to ribosomal protein, stimulus response, and carbohydrate metabolism may contribute to eliminate negative effect of starvation on brain. This study provided the first transcriptome data related with impact of short-time starvation and refeeding in S. hollandi brains.	[Yang, Yang; Zhou, Huiqiang; Shu, Hu; Zhong, Dongming; Zhang, Mingqing] Guangzhou Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Yang, Yang; Xia, Jun Hong] Sun Yat Sen Univ, State Key Lab Biocontrol, Inst Aquat Econ Anim, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Yang, Yang; Xia, Jun Hong] Sun Yat Sen Univ, Guangdong Prov Key Lab Aquat Econ Anim, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Guangzhou University; Sun Yat Sen University; Sun Yat Sen University	Shu, H (corresponding author), Guangzhou Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.; Xia, JH (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Inst Aquat Econ Anim, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.; Xia, JH (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Aquat Econ Anim, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	shuhu001@126.com; xiajunh3@mail.sysu.edu.cn	yang, yang/GVT-5210-2022; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022		National Public Industry Major Projects of China [201303048]; Guangdong Provincial Science and Technology Program [2014A020208145]	National Public Industry Major Projects of China; Guangdong Provincial Science and Technology Program	This work is supported by the National Public Industry Major Projects of China (No. 201303048; received by HS) and the Guangdong Provincial Science and Technology Program (Nos. 2014A020208145; received by HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Cromphout K, 2006, MOL CELL BIOL, V26, P5621, DOI 10.1128/MCB.02357-05; Dai XX, 2014, MOL CELLS, V37, P126, DOI 10.14348/molcells.2014.2259; Faherty SL, 2018, MOL ECOL, V27, P709, DOI 10.1111/mec.14483; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hasselbalch SG, 1996, AM J PHYSIOL-ENDOC M, V270, pE746, DOI 10.1152/ajpendo.1996.270.5.E746; He LB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1427-2; Johansen KA, 2006, COMP BIOCHEM PHYS B, V144, P119, DOI 10.1016/j.cbpb.2006.02.001; Johansen SJS, 2001, AQUAC RES, V32, P963, DOI 10.1046/j.1365-2109.2001.00632.x; Keogh K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2578-5; Lee H, 2018, PSYCHIAT RES, V259, P197, DOI 10.1016/j.psychres.2017.10.018; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074581; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Mendez KN, 2018, AQUACULTURE, V490, P270, DOI 10.1016/j.aquaculture.2018.02.048; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; QIAN B, 2016, PLOS ONE, V11; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reigh RC, 2006, AQUACULTURE, V254, P506, DOI 10.1016/j.aquaculture.2005.10.043; Rescan PY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3837-9; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; RUSSELL NR, 1992, ENVIRON BIOL FISH, V34, P277, DOI 10.1007/BF00004774; Sancho A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034034; Schmiesing JA, 1998, P NATL ACAD SCI USA, V95, P12906, DOI 10.1073/pnas.95.22.12906; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Seda O, 2017, PHYSIOL RES, V66, pS357, DOI 10.33549/physiolres.933730; Sun YB, 2017, ZOOL RES, V38, P110, DOI 10.24272/j.issn.2095-8137.2017.017; Takahashi LS, 2011, J ANIM PHYSIOL AN N, V95, P259, DOI 10.1111/j.1439-0396.2010.01050.x; Tian XL, 2010, AQUACULTURE, V310, P122, DOI 10.1016/j.aquaculture.2010.10.021; Tian XL, 2003, AQUACULTURE, V224, P169, DOI 10.1016/S0044-8486(03)00224-2; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; WEINSTEIN J, 1994, MOL CELL BIOL, V14, P3350, DOI 10.1128/MCB.14.5.3350; Won ET, 2013, FRONTIERS ENDOCRINOL, V4; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xie S, 2001, J FISH BIOL, V58, P999, DOI 10.1111/j.1095-8649.2001.tb00550.x; Yang XL, 2018, MAR BIOTECHNOL, V20, P20, DOI 10.1007/s10126-017-9784-2; Yang Y, 2017, FISHERIES SCI, V83, P967, DOI 10.1007/s12562-017-1125-x; Ye H, 2018, MAR BIOTECHNOL, V20, P246, DOI 10.1007/s10126-018-9801-0; Yu LY, 2018, MAR BIOTECHNOL, V20, P467, DOI 10.1007/s10126-018-9809-5; Yue CY, 2018, MAR BIOTECHNOL, V20, P206, DOI 10.1007/s10126-018-9798-4; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	50	5	5	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214589	10.1371/journal.pone.0214589	http://dx.doi.org/10.1371/journal.pone.0214589			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921420	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000091
J	Bowles, KR; Julia, TCW; Qian, L; Jadow, BM; Goate, AM				Bowles, Kathryn R.; Julia, T. C. W.; Qian, Lu; Jadow, Benjamin M.; Goate, Alison M.			Reduced variability of neural progenitor cells and improved purity of neuronal cultures using magnetic activated cell sorting	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DIFFERENTIATION; INDUCTION; LINEAGE; DIVERSE; DISEASE; MARKER; CREST; CD271	Genetic and epigenetic variability between iPSC-derived neural progenitor cells (NPCs) combined with differences in investigator technique and selection protocols contributes to variability between NPC lines, which subsequently impacts the quality of differentiated neuronal cultures. We therefore sought to develop an efficient method to reduce this variability in order to improve the purity of NPC and neuronal cultures. Here, we describe a magnetic activated cell sorting (MACS) method for enriching NPC cultures for CD271-/CD133+ cells at both early (< 2-3) and late (> 10) passage. MACS results in a similar sorting efficiency to fluorescence activated cell sorting (FACS), while achieving an increased yield of live cells and reduced cellular stress. Furthermore, neurons derived from MACS NPCs showed greater homogeneity between cell lines compared to those derived from unsorted NPCs. We conclude that MACS is a cheap technique for incorporation into standard NPC differentiation and maintenance protocols in order to improve culture homogeneity and consistency.	[Bowles, Kathryn R.; Julia, T. C. W.; Qian, Lu; Jadow, Benjamin M.; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Bowles, Kathryn R.; Julia, T. C. W.; Qian, Lu; Jadow, Benjamin M.; Goate, Alison M.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Bowles, Kathryn R.; Julia, T. C. W.; Qian, Lu; Jadow, Benjamin M.; Goate, Alison M.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Goate, Alison M.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA.	alison.goate@mssm.edu		Goate, Alison/0000-0002-0576-2472	New York Stem Cell Foundation; BrightFocus [A2017144F]; CurePSP [648-2017-04]; Association for Frontotemporal Degeneration; JPB Foundation; Rainwater Charitable Foundation; Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai; NATIONAL INSTITUTE ON AGING [K01AG062683] Funding Source: NIH RePORTER	New York Stem Cell Foundation; BrightFocus(BrightFocus Foundation); CurePSP; Association for Frontotemporal Degeneration; JPB Foundation; Rainwater Charitable Foundation; Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the New York Stem Cell Foundation (https://nyscf.org) (J.TCW.), BrightFocus #A2017144F (www.brightfocus.org)(K.R.B), CurePSP #648-2017-04 (www.psp.org)(K.R.B), Association for Frontotemporal Degeneration (www.theaftd.org)(K.R.B), the JPB Foundation (www.jpbfoundation.org) (A.M.G.), and the Rainwater Charitable Foundation (https://rainwatercharitablefoundation.org) (A.M.G.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The iPSC lines were generated by the Pluripotent Stem Cell Core at Icahn School of Medicine at Mount Sinai (http://labs.icahn.mssm.edu/dsouza-lab/about-us/), New York Stem Cell Foundation (https://nyscf.org/) and the Genome Engineering and iPSC Center at Washington University (http://geic.wustl.edu/services/ipsc-core-facility/). We thank Dr. Celeste Karch for providing lines generated by the Washington University facility. We are grateful for the continuous support of the Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai (http://icahn.mssm.edu/research/portal/resources/deans-cores/flow-cytometry).	Alvarez R, 2015, INT J ORAL SCI, V7, P205, DOI 10.1038/ijos.2015.29; Alvarez-Viejo M, 2015, WORLD J STEM CELLS, V7, P470, DOI 10.4252/wjsc.v7.i2.470; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE3312, DOI 10.1073/pnas.1509741112; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheng Chialin, 2017, Curr Protoc Hum Genet, V92, DOI 10.1002/cphg.33; Doi D, 2014, STEM CELL REP, V2, P337, DOI 10.1016/j.stemcr.2014.01.013; Ghaffari LT, 2018, FRONT NEUROSCI, V12, P1, DOI [10.3389/fnins.2018.00001, DOI 10.3389/FNINS.2018.00001]; Haggarty SJ, 2016, MOL CELL NEUROSCI, V73, P104, DOI 10.1016/j.mcn.2016.01.011; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Julia TCW, 2017, STEM CELL REP, V9, P600, DOI 10.1016/j.stemcr.2017.06.018; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mattis VB, 2017, BRAIN RES, V1656, P76, DOI 10.1016/j.brainres.2015.10.001; McKinney CE, 2017, NEURAL REGEN RES, V12, P1062, DOI 10.4103/1673-5374.211180; Muratore CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105807; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Paavilainen T, 2018, STEM CELL RES, V27, P151, DOI 10.1016/j.scr.2018.01.018; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Schwartz PH, 2008, METHODS, V45, P142, DOI 10.1016/j.ymeth.2008.03.007; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Topol A, 2015, JOVE-J VIS EXP, DOI 10.3791/52495; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wilson PG, 2006, STEM CELL REV, V2, P67, DOI 10.1385/SCR:2:1:67; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Xie YY, 2018, STEM CELL RES, V26, P84, DOI 10.1016/j.scr.2017.12.003; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	31	18	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213374	10.1371/journal.pone.0213374	http://dx.doi.org/10.1371/journal.pone.0213374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917153	gold, Green Submitted, Green Published			2022-12-27	WOS:000462465800029
J	Ashraf, A; Rehman, OU; Muzammil, S; Leon, J; Naz, AA; Rasool, F; Ali, GM; Zafar, Y; Khan, MR				Ashraf, Almas; Rehman, Obaid Ur; Muzammil, Shumaila; Leon, Jens; Naz, Ali Ahmed; Rasool, Fatima; Ali, Ghulam Muhammad; Zafar, Yusuf; Khan, Muhammad Ramzan			Evolution of Deeper Rooting 1-like homoeologs in wheat entails the C-terminus mutations as well as gain and loss of auxin response elements	PLOS ONE			English	Article							ROOT-SYSTEM ARCHITECTURE; TRANSCRIPTION FACTOR; PROTEIN INTERACTIONS; GENETIC-IMPROVEMENT; ARABIDOPSIS LAZY1; ANGLE CONTROL; GROWTH ANGLE; RICE; REPRESSION; GRAVITY	Root growth angle (RGA) in response to gravity controlled by auxin is a pertinent target trait for obtainment of higher yield in cereals. But molecular basis of this root architecture trait remain obscure in wheat and barley. We selected four cultivars two each for wheat and barley to unveil the molecular genetic mechanism of Deeper Rooting 1-like gene which controls RGA in rice leading to higher yield under drought imposition. Morphological analyses revealed a deeper and vertically oriented root growth in "NARC 2009" variety of wheat than "Galaxy" and two other barley cultivars "Scarlet" and "ISR42-8". Three new homoeologs designated as TaANDRO1-like, TaBNDRO1-like and TaDNDRO1-like corresponding to A, B and D genomes of wheat could be isolated from "NARC 2009". Due to frameshift and intronization/ exonization events the gene structures of these paralogs exhibit variations in size. DRO1-like genes with five distinct domains prevail in diverse plant phyla from mosses to angiosperms but in lower plants their differentiation from LAZY, NGR and TAC1 (root and shoot angle genes) is enigmatic. Instead of IGT as denominator motif of this family, a new C-terminus motif WxxTD in the V-domain is proposed as family specific motif. The EAR-like motif IVLEM at the C-terminus of the TaADRO1-like and TaDDRO1-like that diverged to KLHTLIPNK in TaBDRO1-like and HyDRO1-like is the hallmark of these proteins. Split-YFP and yeast two hybrid assays complemented the interaction of TaDRO1-like with TOPLESS-a repressor of auxin regulated root promoting genes in plants-through IVLEM/KLHTLIPNK motif. Quantitative RT-PCR revealed abundance of DRO1-like RNA in root tips and spikelets while transcript signals were barely detectable in shoot and leaf tissues. Interestingly, wheat exhibited stronger expression of TaBDRO1-like than barley (MORO1-like), but TaBDRO1-like was the least expressing among three paralogs. The underlying cause of this expression divergence seems to be the presence of AuxRE motif TGTCTC and core TGTC with a coupling AuxRE- like motif ATTTTCTT proximal to the transcriptional start site in TaBDRO1-like and HvDRO1like promoters. This is evident from binding of ARF1 to TGTCTC and TGTC motifs of TaBDRO1-like as revealed by yeast one-hybrid assay. Thus, evolution of DRO1-like wheat homoeologs might incorporate the C-terminus mutations as well as gain and loss of AuxREs and other cis-regulatory elements during expression divergence. Since root architecture is an important target trait for wheat crop improvement, therefore DRO1-like genes have potential applications in plant breeding for enhancement of plant productivity by the use of modern genome editing approaches.	[Ashraf, Almas; Ali, Ghulam Muhammad; Khan, Muhammad Ramzan] NARC, PARC Inst Adv Studies Agr, Natl Inst Genom & Adv Biotechnol NIGAB, Islamabad, Pakistan; [Rehman, Obaid Ur; Rasool, Fatima; Khan, Muhammad Ramzan] Quaid I Azam Univ, Natl Ctr Bioinformat NCB, Islamabad, Pakistan; [Muzammil, Shumaila; Leon, Jens; Naz, Ali Ahmed] Rheinische FriedrichWilhelms Univ Bonn, Dept Crop Genet & Biotechnol, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany; [Ali, Ghulam Muhammad; Khan, Muhammad Ramzan] Natl Agr Res Ctr, Natl Inst Genom & Adv Biotechnol, Pk Rd, Islamabad, Pakistan; [Zafar, Yusuf] Pakistan Agr Res Council, Islamabad, Pakistan	National Agricultural Research Council - Pakistan; Quaid I Azam University; University of Bonn; National Agricultural Research Council - Pakistan; National Agricultural Research Council - Pakistan	Khan, MR (corresponding author), NARC, PARC Inst Adv Studies Agr, Natl Inst Genom & Adv Biotechnol NIGAB, Islamabad, Pakistan.; Khan, MR (corresponding author), Quaid I Azam Univ, Natl Ctr Bioinformat NCB, Islamabad, Pakistan.; Naz, AA (corresponding author), Rheinische FriedrichWilhelms Univ Bonn, Dept Crop Genet & Biotechnol, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany.; Khan, MR (corresponding author), Natl Agr Res Ctr, Natl Inst Genom & Adv Biotechnol, Pk Rd, Islamabad, Pakistan.	a.naz@uni-bonn.de; mrkhan@qau.edu.pk	Khan, Muhammad Ramzan/AAD-9958-2022; Ur Rehman, Obaid/GRS-7096-2022	Khan, Muhammad Ramzan/0000-0001-9167-6556	German Academic Exchange Program (DAAD)	German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	We are thankful to Bio-Resources Conservation Institute (BCI) and Crop Sciences Institute, National Agricultural Research Centre (NARC), Islamabad for providing the research material. German Academic Exchange Program (DAAD) is acknowledged for providing DAAD-Alumni fellowship-2017 to MRK for completion of this research work.	Araki H, 2002, PLANT PROD SCI, V5, P286, DOI 10.1626/pps.5.286; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Comas LH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00442; Dardick C, 2013, PLANT J, V75, P618, DOI 10.1111/tpj.12234; De Smet I, 2012, NEW PHYTOL, V193, P867, DOI 10.1111/j.1469-8137.2011.03996.x; Dong ZB, 2013, PLANT PHYSIOL, V163, P1306, DOI 10.1104/pp.113.227314; FUKAI S, 1995, FIELD CROP RES, V40, P67, DOI 10.1016/0378-4290(94)00096-U; Gallavotti A, 2010, DEVELOPMENT, V137, P2849, DOI 10.1242/dev.051748; Ge LF, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.155, 10.1038/nplants.2016.155]; Godbole R, 1999, PLANT BIOLOGY, V1, P379, DOI 10.1055/s-2007-978530; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Guseman JM, 2017, PLANT J, V89, P1093, DOI 10.1111/tpj.13470; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hill DP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S2; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hochholdinger F, 2008, PLANT J, V54, P888, DOI 10.1111/j.1365-313X.2008.03459.x; Hollender CA, 2015, NEW PHYTOL, V206, P541, DOI 10.1111/nph.13204; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ihsan H, 2015, PLANTA, V241, P1173, DOI 10.1007/s00425-015-2247-y; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kagale S, 2011, EPIGENETICS-US, V6, P141, DOI 10.4161/epi.6.2.13627; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Khan MR, 2013, MOL BIOTECHNOL, V54, P25, DOI 10.1007/s12033-012-9540-9; Kieffer M, 2006, PLANT CELL, V18, P560, DOI 10.1105/tpc.105.039107; Kong XP, 2014, TRENDS BIOTECHNOL, V32, P597, DOI 10.1016/j.tibtech.2014.09.008; Ku L, 2011, PLOS ONE, V6, P1, DOI 10.1371/journal.pone.0020621; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li P, 2017, CELL RES, V17, P402; Li X, 2017, PLOS GENET, V17; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Lopez-Arredondo Damar, 2015, F1000Res, V4, P651, DOI 10.12688/f1000research.6538.1; Lynch JP, 2015, J EXP BOT, V66, P2199, DOI 10.1093/jxb/eru508; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Mc Steen P., 2010, COLD SPRING HARBOR P; Mironova VV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S12-S4; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Puig J, 2012, MOL PLANT, V5, P974, DOI 10.1093/mp/sss047; Rich SM, 2013, J EXP BOT, V64, P1193, DOI 10.1093/jxb/ert043; Rosquete MR, 2013, CURR BIOL, V23, P817, DOI 10.1016/j.cub.2013.03.064; Roychoudhry S, 2015, CURR OPIN PLANT BIOL, V23, P124, DOI 10.1016/j.pbi.2014.12.004; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasaki S, 2015, PLANT BIOTECHNOL-NAR, V32, P103, DOI 10.5511/plantbiotechnology.15.0106a; Satbhai SB, 2015, J EXP BOT, V66, P1099, DOI 10.1093/jxb/eru529; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Sun YF, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0324-1; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Taniguchi M, 2017, PLANT CELL, V29, P1984, DOI 10.1105/tpc.16.00575; Tian HY, 2014, TRENDS PLANT SCI, V19, P426, DOI 10.1016/j.tplants.2014.01.007; Uga Y, 2015, BREEDING SCI, V65, P111, DOI 10.1270/jsbbs.65.111; Uga Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03040; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Uga Y, 2012, THEOR APPL GENET, V124, P75, DOI 10.1007/s00122-011-1688-3; Uga Y, 2011, J EXP BOT, V62, P2485, DOI 10.1093/jxb/erq429; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Vermeer Joop E M, 2015, F1000Prime Rep, V7, P32, DOI 10.12703/P7-32; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wachsman G, 2015, NEW PHYTOL, V208, P26, DOI 10.1111/nph.13469; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wasson AP, 2012, J EXP BOT, V63, P3485, DOI 10.1093/jxb/ers111; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yoshihara T, 2017, PLANT PHYSIOL, V175, P959, DOI 10.1104/pp.17.00942; Yoshihara T, 2013, PLANT J, V74, P267, DOI 10.1111/tpj.12118; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Yu LH, 2014, MOL PLANT, V7, P1653, DOI 10.1093/mp/ssu088; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	69	22	25	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214145	10.1371/journal.pone.0214145	http://dx.doi.org/10.1371/journal.pone.0214145			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947257	gold, Green Published, Green Submitted			2022-12-27	WOS:000463314500018
J	Baptista, I; Johansen, D; Figueiredo, P; Rebelo, A; Pettersen, SA				Baptista, Ivan; Johansen, Dag; Figueiredo, Pedro; Rebelo, Antonio; Pettersen, Svein Arne			A comparison of match-physical demands between different tactical systems: 1-4-5-1 vs 1-3-5-2	PLOS ONE			English	Article							SOCCER PLAYERS; ELITE SOCCER; POSSESSION STRATEGIES; PHYSIOLOGICAL DEMANDS; MOTION ANALYSIS; PERFORMANCE; FOOTBALL; TEAM; VARIABILITY; OPPOSITION	The team tactical system and distribution of the football players on the pitch is considered fundamental in team performance. The present study used time-motion analysis and triaxial-accelerometers to obtain new insights about the impact of different tactical systems (1-4-5-1 and 1-3-5-2) on physical performance, across different playing positions, in a professional football team. Player performance data in fifteen official home matches was collected for analysis. The sample included twenty-two players from five playing positions (centre backs: n = 4; full-back/wide midfielder/ wing-back: n = 9; centre midfielder: n = 6 and centre forward: n = 3), making a total of 108 match observations. A novel finding was that general match physical demands do not differ considerably between these tactical formations, probably because match-to-match variability (variation of players' running profile from match-tomatch) might be higher than the differences in physical performance between tactical systems. However, change of formation had a different impact across playing positions, with centre backs playing in 1-4-5-1 performing significant more HIRcounts than in 1-3-5-2 (p = 0.031). Furthermore, a medium effect size (r = 0.33) was observed in HIRdist, with wide players covering higher distances when playing in 1-3-5-2 than in 1-4-5-1. These findings may help coaches to develop individualised training programs to meet the demands of each playing position according to the tactical system adopted.	[Baptista, Ivan; Pettersen, Svein Arne] Arctic Univ Norway, Univ Tromso, Sch Sport Sci, Tromso, Norway; [Johansen, Dag] Arctic Univ Norway, Univ Tromso, Comp Sci Dept, Tromso, Norway; [Figueiredo, Pedro] Portuguese Football Federat, Portugal Football Sch, Lisbon, Portugal; [Figueiredo, Pedro] Univ Inst Maia, ISMAI, CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Maia, Portugal; [Rebelo, Antonio] Univ Porto, Fac Sport, Porto, Portugal	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Instituto Universitario da Maia (ISMAI); Universidade do Porto	Baptista, I (corresponding author), Arctic Univ Norway, Univ Tromso, Sch Sport Sci, Tromso, Norway.	ivan.a.baptista@uit.no	Pettersen, Svein Arne/R-4615-2019; Figueiredo, Pedro/J-4178-2013	Pettersen, Svein Arne/0000-0003-4700-0529; Figueiredo, Pedro/0000-0001-5515-3694; Baptista, Ivan/0000-0002-0330-7636				Aquino R, 2020, J STRENGTH COND RES, V34, P808, DOI 10.1519/JSC.0000000000002725; Bangsbo J., 2000, SOCCER SYSTEMS STRAT; Baptista I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198115; Baptista J, 2020, J STRENGTH COND RES, V34, P2024, DOI 10.1519/JSC.0000000000002445; Bartlett R, 2017, INT J PERF ANAL SPOR, V12, P398; Bendiksen M, 2013, HUM MOVEMENT SCI, V32, P1430, DOI 10.1016/j.humov.2013.07.011; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Bradley PS, 2011, J SPORT SCI, V29, P821, DOI 10.1080/02640414.2011.561868; Bradley PS, 2009, J SPORT SCI, V27, P159, DOI 10.1080/02640410802512775; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Carling C, 2016, J SPORT SCI, V34, P2215, DOI 10.1080/02640414.2016.1176228; Carling C, 2012, J SPORT SCI, V30, P1683, DOI 10.1080/02640414.2011.637950; Carling C, 2011, EUR J SPORT SCI, V11, P155, DOI 10.1080/17461391.2010.499972; Castellano J, 2011, INT J SPORTS MED, V32, P415, DOI 10.1055/s-0031-1271771; Clemente FM, 2016, RES SPORTS MED, V24, P352, DOI 10.1080/15438627.2016.1222277; Clemente FM, 2013, J HUM KINET, V38, P201, DOI 10.2478/hukin-2013-0060; Dalen T, 2016, J STRENGTH COND RES, V30, P351, DOI 10.1519/JSC.0000000000001063; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Drust B, 2007, SPORTS MED, V37, P783, DOI 10.2165/00007256-200737090-00003; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; Gregson W, 2010, INT J SPORTS MED, V31, P237, DOI 10.1055/s-0030-1247546; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Ingebrigtsen J, 2015, EUR J SPORT SCI, V15, P101, DOI 10.1080/17461391.2014.933879; Kannekens R, 2011, SCAND J MED SCI SPOR, V21, P846, DOI 10.1111/j.1600-0838.2010.01104.x; Krustrup P, 2001, J SPORT SCI, V19, P881, DOI 10.1080/026404101753113831; Lacome M, 2018, INT J SPORT PHYSIOL, V13, P568, DOI 10.1123/ijspp.2017-0214; Lago C, 2009, J SPORT SCI, V27, P1463, DOI 10.1080/02640410903131681; Lago-Penas C, 2010, J HUM KINET, V25, P93, DOI 10.2478/v10078-010-0036-z; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Mohr M, 2008, J STRENGTH COND RES, V22, P341, DOI 10.1519/JSC.0b013e318165fef6; Moura FA, 2013, J SPORT SCI, V31, P1568, DOI 10.1080/02640414.2013.789920; Moura FA, 2012, SPORT BIOMECH, V11, P85, DOI 10.1080/14763141.2011.637123; Vieira LHP, 2018, J STRENGTH COND RES, V32, P313, DOI 10.1519/JSC.0000000000002342; Paul DJ, 2015, INT J SPORT PHYSIOL, V10, P516, DOI 10.1123/IJSPP.2015-0029; Pettersen SA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00866; Redwood-Brown AJ, 2018, SCAND J MED SCI SPOR, V28, P2515, DOI 10.1111/sms.13271; Rein R, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3108-2; Rosnow RL, 2000, PSYCHOL SCI, V11, P446, DOI 10.1111/1467-9280.00287; Sampaio J, 2012, INT J SPORTS MED, V33, P395, DOI 10.1055/s-0031-1301320; Sarmento H, 2018, SPORTS MED, V48, P799, DOI 10.1007/s40279-017-0836-6; Sarmento H, 2014, J SPORT SCI, V32, P1831, DOI 10.1080/02640414.2014.898852; Schuth G, 2016, J SPORT SCI, V34, P501, DOI 10.1080/02640414.2015.1127402; Silva JR, 2013, J STRENGTH COND RES, V27, P20, DOI 10.1519/JSC.0b013e31824e1946; Silva P, 2016, HUM MOVEMENT SCI, V46, P39, DOI 10.1016/j.humov.2015.11.017; Trewin J, 2018, J SCI MED SPORT, V21, P196, DOI 10.1016/j.jsams.2017.05.009	45	15	15	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214952	10.1371/journal.pone.0214952	http://dx.doi.org/10.1371/journal.pone.0214952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947242	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500091
J	Tambawal, AB; Noor, RM; Salleh, R; Chembe, C; Oche, M				Tambawal, Abubakar Bello; Noor, Rafidah Md; Salleh, Rosli; Chembe, Christopher; Oche, Michael			Enhanced weight-based clustering algorithm to provide reliable delivery for VANET safety applications	PLOS ONE			English	Article							ACCESS; SCHEME	A vehicular ad hoc network (VANET) is an emerging and promising wireless technology aimed to improve traffic safety and provide comfort to road users. However, the high mobility of vehicles and frequent topology changes pose a considerable challenge to the reliable delivery of safety applications. Clustering is one of the control techniques used in VANET to make the frequent topology changes less dynamic. Nevertheless, research has shown that most of the existing clustering algorithms focus on cluster head (CH) election with very few addressing other critical issues such as cluster formation and maintenance. This has led to unstable clusters which could affect the timely delivery of safety applications. In this study, enhanced weight-based clustering algorithm (EWCA) was developed to address these challenges. We considered any vehicle moving on the same road segment with the same road ID and within the transmission range of its neighbour to be suitable for the cluster formation process. This was attributed to the fact that all safety messages are expected to be shared among the vehicles within the vicinity irrespective of their relative speedto avoid any hazardous situation. To elect a CH, we identified some metrics on the basis of the vehicle mobility information. Each vehicle was associated with a predefined weight value based on its relevance. A vehicle with the highest weight value was elected as the primary cluster head (PCH). We also introduced a secondary cluster head (SeCH) as a backup to the PCH to improve the cluster stability. SeCH took over the leadership whenever the PCH was not suitable for continuing with the leadership. The simulation results of the proposed approach showed a better performance with an increase of approximately40%- 45% in the cluster stability when compared with the existing approaches. Similarly, cluster formation messages were significantly minimized, hence reducing the communication overhead to the system and improving the reliable delivery of the safety applications.	[Tambawal, Abubakar Bello; Noor, Rafidah Md; Salleh, Rosli] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Tambawal, Abubakar Bello] Umaru Ali Shinkafi Polytech, Coll Sci & Technol, Dept Comp Sci, Sokoto, Nigeria; [Noor, Rafidah Md] Univ Malaya, Fac Comp Sci & Informat Technol, Ctr Mobile Cloud Comp Res C4MCCR, Kuala Lumpur, Malaysia; [Chembe, Christopher] Mulungushi Univ, Sch Sci Engn & Technol, Dept Comp & Informat Technol, Kabwe, Zambia; [Oche, Michael] Kampala Int Univ, Fac Sci & Technol, Dept Comp, Kampala, Uganda	Universiti Malaya; Universiti Malaya	Noor, RM (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.; Noor, RM (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Ctr Mobile Cloud Comp Res C4MCCR, Kuala Lumpur, Malaysia.	fidah@um.edu.my	SALLEH, ROSLI/B-9611-2010; Noor, Rafidah Md/B-5445-2010; Chembe, Christopher/AAZ-5841-2020; Michael, Oche/N-7942-2013; Chembe, Christopher/AGG-8163-2022	SALLEH, ROSLI/0000-0002-7379-8397; Noor, Rafidah Md/0000-0001-6266-2390; Chembe, Christopher/0000-0003-2405-7952; Michael, Oche/0000-0002-8690-1672; Chembe, Christopher/0000-0003-2405-7952				Ahizoune A, 2012, PROCEEDINGS OF THE 37TH ANNUAL IEEE CONFERENCE ON LOCAL COMPUTER NETWORKS WORKSHOPS (LCN 2012), P843, DOI 10.1109/LCNW.2012.6424072; Aissa M, 2015, PROCEDIA COMPUT SCI, V52, P294, DOI 10.1016/j.procs.2015.05.088; Al-Sultan S, 2014, J NETW COMPUT APPL, V37, P380, DOI 10.1016/j.jnca.2013.02.036; Almalag MS, 2013, INT CONF CONNECT VEH, P832, DOI [10.1109/ICCVE.2013.6799909, 10.1109/ICCVE.2013.132]; Almalag MS, 2010, C LOCAL COMPUT NETW, P631, DOI 10.1109/LCN.2010.5735785; Arkian HR, 2015, J INF SCI ENG, V31, P361; Babu S, 2016, WIREL NETW, V22, P1365, DOI 10.1007/s11276-015-1018-9; Bali RS, 2014, VEH COMMUN, V1, P134, DOI 10.1016/j.vehcom.2014.05.004; Bastani S., 2016, P 6 ACM S DEV AN INT, P75; Bazzi A., 2013, INT J ADV TELECOMMUN, V6, P2013; Bettisworth C., 2015, STATUS DEDICATED SHO; Bianchi G, 2000, IEEE J SEL AREA COMM, V18, P535, DOI 10.1109/49.840210; Booysen MJ, 2012, IET NETW, V1, P10, DOI 10.1049/iet-net.2011.0044; Caballero-Gil C, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/384869; Calhan A, 2015, SADHANA-ACAD P ENG S, V40, P351, DOI 10.1007/s12046-014-0315-9; Chatterjee M., 2002, Cluster Computing, V5, P193, DOI 10.1023/A:1013941929408; Cooper C, 2017, IEEE COMMUN SURV TUT, V19, P657, DOI 10.1109/COMST.2016.2611524; Gillani S. A., 2015, VEHICULAR AD HOC NET, V306, P3; Group I. W, 2010, IEEE STD, V802; Gupta N, 2015, VEH COMMUN, V2, P223, DOI 10.1016/j.vehcom.2015.10.001; Hadded M., 2014, JMMC, V1, P175, DOI DOI 10.13052/JMMC2246-137X.126; Hadded M, 2015, IEEE COMMUN SURV TUT, V17, P2461, DOI 10.1109/COMST.2015.2440374; Hafeez K. A., 2012, IEEE International Conference on Communications (ICC 2012), P203, DOI 10.1109/ICC.2012.6363839; Hassanabadi B, 2014, AD HOC NETW, V13, P535, DOI 10.1016/j.adhoc.2013.10.005; Katsikas L., 2015, P WORKSH NS, V3, P25; Kenney JB, 2011, P IEEE, V99, P1162, DOI 10.1109/JPROC.2011.2132790; Kwon JH, 2016, J SUPERCOMPUT, V72, P161, DOI 10.1007/s11227-015-1517-6; Lai YC, 2011, IEEE J SEL AREA COMM, V29, P83, DOI 10.1109/JSAC.2011.110109; Mammu ASK, 2015, IEEE CONF WIREL MOB, P549, DOI 10.1109/WiMOB.2015.7348010; Omar HA, 2013, IEEE T MOBILE COMPUT, V12, P1724, DOI 10.1109/TMC.2012.142; Rawashdeh ZY, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-15; Sheu TL, 2014, J INF SCI ENG, V30, P213; Sidhik A, 2013, 2013 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1424, DOI 10.1109/ICACCI.2013.6637388; Tang ZN, 2015, 2015 IEEE 9TH INTERNATIONAL CONFERENCE ON ANTI-COUNTERFEITING, SECURITY, AND IDENTIFICATION (ASID), P19, DOI 10.1109/ICASID.2015.7405653; Torabi N, 2017, COMPUT ELECTR ENG, V64, P450, DOI 10.1016/j.compeleceng.2017.02.022; Vodopivec S, 2012, 2012 35TH INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS AND SIGNAL PROCESSING (TSP), P52, DOI 10.1109/TSP.2012.6256251; Xie JL, 2016, AUTOMATIKA, V57, P252, DOI 10.7305/automatika.2016.07.885; Yan GJ, 2017, AD HOC NETW, V58, P25, DOI 10.1016/j.adhoc.2016.11.017; Yang PZ, 2015, 2015 IEEE 9TH INTERNATIONAL CONFERENCE ON ANTI-COUNTERFEITING, SECURITY, AND IDENTIFICATION (ASID), P166, DOI 10.1109/ICASID.2015.7405685; Zarei M, 2017, WIREL NETW, V23, P843, DOI 10.1007/s11276-015-1189-4; Zhang ZJ, 2014, IEEE T INTELL TRANSP, V15, P122, DOI 10.1109/TITS.2013.2274274	41	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214664	10.1371/journal.pone.0214664	http://dx.doi.org/10.1371/journal.pone.0214664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946766	gold, Green Published, Green Submitted			2022-12-27	WOS:000463314500051
J	Tsujioka, M; Uyeda, TQP; Iwadate, Y; Patel, H; Shibata, K; Yumoto, T; Yonemura, S				Tsujioka, Masatsune; Uyeda, Taro Q. P.; Iwadate, Yoshiaki; Patel, Hitesh; Shibata, Keitaro; Yumoto, Tenji; Yonemura, Shigenobu			Actin-binding domains mediate the distinct distribution of two Dictyostelium Talins through different affinities to specific subsets of actin filaments during directed cell migration	PLOS ONE			English	Article							HEAVY-CHAIN GENE; FORCE TRANSMISSION; PLASMA-MEMBRANE; TENSION SENSOR; I/LWEQ MODULE; LEADING-EDGE; IN-VIVO; MYOSIN; PROTEIN; ADHESION	Although the distinct distribution of certain molecules along the anterior or posterior edge is essential for directed cell migration, the mechanisms to maintain asymmetric protein localization have not yet been fully elucidated. Here, we studied a mechanism for the distinct localizations of two Dictyostelium talin homologues, talin A and talin B, both of which play important roles in cell migration and adhesion. Using GFP fusion, we found that talin B, as well as its C-terminal actin-binding region, which consists of an I/LWEQ domain and a villin headpiece domain, was restricted to the leading edge of migrating cells. This is in sharp contrast to talin A and its C-terminal actin-binding domain, which co-localized with myosin II along the cell posterior cortex, as reported previously. Intriguingly, even in myosin II-null cells, talin A and its actin-binding domain displayed a specific distribution, co-localizing with stretched actin filaments. In contrast, talin B was excluded from regions rich in stretched actin filaments, although a certain amount of its actin-binding region alone was present in those areas. When cells were sucked by a micro-pipette, talin B was not detected in the retracting aspirated lobe where acto-myosin, talin A, and the actin-binding regions of talin A and talin B accumulated. Based on these results, we suggest that talin A predominantly interacts with actin filaments stretched by myosin II through its C-terminal actin-binding region, while the actin-binding region of talin B does not make such distinctions. Furthermore, talin B appears to have an additional, unidentified mechanism that excludes it from the region rich in stretched actin filaments. We propose that these actin-binding properties play important roles in the anterior and posterior enrichment of talin B and talin A, respectively, during directed cell migration.	[Tsujioka, Masatsune; Yonemura, Shigenobu] RIKEN, Ctr Dev Biol, Electron Microscope Lab, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo, Japan; [Uyeda, Taro Q. P.; Yumoto, Tenji] Waseda Univ, Fac Sci & Technol, Dept Phys, Tokyo, Japan; [Iwadate, Yoshiaki] Yamaguchi Univ, Fac Sci, Yamaguchi, Japan; [Patel, Hitesh] Univ Edinburgh, Edinburgh Canc Res Ctr, Crewe Rd South, Edinburgh, Midlothian, Scotland; [Shibata, Keitaro] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Amagasaki, Hyogo, Japan; [Tsujioka, Masatsune] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Tokyo, Japan; [Shibata, Keitaro] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo, Japan; [Yonemura, Shigenobu] Tokushima Univ, Grad Sch Med Sci, Dept Cell Biol, Tokushima, Japan; [Yonemura, Shigenobu] RIKEN, Ctr Biosyst Dynam Res, Lab Ultrastruct Res, Kobe, Hyogo, Japan	RIKEN; Waseda University; Yamaguchi University; University of Edinburgh; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Medical & Dental University (TMDU); National Institute of Information & Communications Technology (NICT) - Japan; Tokushima University; RIKEN	Tsujioka, M (corresponding author), RIKEN, Ctr Dev Biol, Electron Microscope Lab, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo, Japan.; Tsujioka, M (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Tokyo, Japan.	tsumpcb@tmd.ac.jp		Iwadate, Yoshiaki/0000-0002-5300-4393				ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; Aizawa H, 1997, J CELL SCI, V110, P2333; Aizawa H, 2001, GENES CELLS, V6, P913, DOI 10.1046/j.1365-2443.2001.00470.x; Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Austen K, 2015, NAT CELL BIOL, V17, P1597, DOI 10.1038/ncb3268; BAILEY GB, 1992, J PROTOZOOL, V39, P267, DOI 10.1111/j.1550-7408.1992.tb01313.x; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; GLENNEY JR, 1981, J BIOL CHEM, V256, P8156; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Hibi M, 2004, J MUSCLE RES CELL M, V25, P127, DOI 10.1023/B:JURE.0000035842.71415.f3; Jorrisch MH, 2013, BIOL OPEN, V2, P368, DOI 10.1242/bio.20133707; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kitayama C, 2003, J CELL SCI, V116, P711, DOI 10.1242/jcs.00265; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kumar A, 2016, J CELL BIOL, V213, P371, DOI 10.1083/jcb.201510012; Lemieux MG, 2014, CYTOSKELETON, V71, P157, DOI 10.1002/cm.21160; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Manso AM, 2017, P NATL ACAD SCI USA, V114, pE6250, DOI 10.1073/pnas.1701416114; Manso AM, 2013, J BIOL CHEM, V288, P4252, DOI 10.1074/jbc.M112.427484; Matsuoka S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002862; Matsushita S, 2011, J BIOMECH, V44, P1776, DOI 10.1016/j.jbiomech.2011.04.012; Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6; Nakano K, 2001, MOL BIOL CELL, V12, P3515, DOI 10.1091/mbc.12.11.3515; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Plak K, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-015-0078-0; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Praekelt U, 2012, EUR J CELL BIOL, V91, P180, DOI 10.1016/j.ejcb.2011.12.003; Pramanik MK, 2009, GENES CELLS, V14, P821, DOI 10.1111/j.1365-2443.2009.01312.x; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Saitoh T, 2001, FEBS LETT, V509, P365, DOI 10.1016/S0014-5793(01)03186-6; Senetar MA, 2005, GENE, V362, P141, DOI 10.1016/j.gene.2005.08.012; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Shimozawa T, 2009, BIOPHYS J, V96, P1036, DOI 10.1016/j.bpj.2008.09.056; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; SPUDICH JA, 1989, CELL REGUL, V1, P1; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tsujioka M, 2004, EMBO J, V23, P2216, DOI 10.1038/sj.emboj.7600238; Tsujioka M, 1999, CURR BIOL, V9, P389, DOI 10.1016/S0960-9822(99)80169-9; Tsujioka M, 2008, EUKARYOT CELL, V7, P906, DOI 10.1128/EC.00464-07; Tsujioka M, 2012, P NATL ACAD SCI USA, V109, P12992, DOI 10.1073/pnas.1208296109; Uyeda TQP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026200; Uyeda TQP, 2000, CELL STRUCT FUNCT, V25, P1; Vorotnikov AV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1528, DOI 10.1134/S0006297911130104; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Weber I, 2002, CELL MOTIL CYTOSKEL, V53, P136, DOI 10.1002/cm.10065; Yumura S, 2003, INT REV CYTOL, V224, P173, DOI 10.1016/S0074-7696(05)24005-6; Yumura S, 2013, BIOL OPEN, V2, P200, DOI 10.1242/bio.20122899; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368	60	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214736	10.1371/journal.pone.0214736	http://dx.doi.org/10.1371/journal.pone.0214736			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946777	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500058
J	Verros, S; Lucassen, K; Hekman, EEG; Bergsma, A; Verkerke, GJ; Koopman, BFJM				Verros, Stergios; Lucassen, Koen; Hekman, Edsko E. G.; Bergsma, Arjen; Verkerke, Gijsbertus J.; Koopman, Bart F. J. M.			Evaluation of intuitive trunk and non-intuitive leg sEMG control interfaces as command input for a 2-D Fitts's law style task	PLOS ONE			English	Article							INDIVIDUALS	Duchenne muscular dystrophy (DMD) is a muscular condition that leads to muscle loss. Orthotic devices may present a solution for people with DMD to perform activities of daily living (ADL). One such device is the active trunk support but it needs a control interface to identify the user's intention. Myoelectric control interfaces can be used to detect the user's intention and consequently control an active trunk support. Current research on the control of orthotic devices that use surface electromyography (sEMG) signals as control inputs, focuses mainly on muscles that are directly linked to the movement being performed (intuitive control). However in some cases, it is hard to detect a proper sEMG signal (e.g., when there is significant amount of fat), which can result in poor control performance. A way to overcome this problem might be the introduction of other, non-intuitive forms of control. This paper presents an explorative study on the comparison and learning behavior of two different control interfaces, one using sEMG of trunk muscles (intuitive) and one using sEMG of leg muscles that can be potentially used for an active trunk support (non-intuitive). Six healthy subjects undertook a 2-D Fitts's law style task. They were asked to steer a cursor into targets that were radially distributed symmetrically in five directions. The results show that the subjects were generally able to learn to control the tasks using either of the control interfaces and improve their performance over time. Comparison of both control interfaces demonstrated that the subjects were able to learn the leg control interface task faster than the trunk control interface task. Moreover, the performance on the diagonal-targets was significantly lower compared to the one directional-targets for both control interfaces. Overall, the results show that the subjects were able to control a non-intuitive control interface with high performance. Moreover, the results indicate that the non-intuitive control may be a viable solution for controlling an active trunk support.	[Verros, Stergios; Lucassen, Koen; Hekman, Edsko E. G.; Bergsma, Arjen; Verkerke, Gijsbertus J.; Koopman, Bart F. J. M.] Univ Twente, Dept Biomech Engn, Enschede, Netherlands; [Verkerke, Gijsbertus J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	University of Twente; University of Groningen	Verros, S (corresponding author), Univ Twente, Dept Biomech Engn, Enschede, Netherlands.	s.verros@utwente.nl		Koopman, Bart/0000-0001-5091-1724; Verkerke, Bart/0000-0003-3533-2446; Verros, Stergios/0000-0002-8050-7885	Netherlands Organisation for Scientific Research (NWO) [13526]; Federation to Eradicate Duchenne; Parent Project MD; Duchenne Parent Project; Stichting FSHD; Focal Meditech; BAAT Medical; Intespring; Hankamp	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Federation to Eradicate Duchenne; Parent Project MD; Duchenne Parent Project; Stichting FSHD; Focal Meditech; BAAT Medical; Intespring; Hankamp	This work is part of the research programme Perspectief with project number 13526 (Symbionics), which is financed by the Netherlands Organisation for Scientific Research (NWO), Federation to Eradicate Duchenne, Parent Project MD, Duchenne Parent Project, Stichting FSHD, Focal Meditech, BAAT Medical, Intespring and Hankamp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antuvan CW, 2014, IEEE T NEUR SYS REH, V22, P820, DOI 10.1109/TNSRE.2014.2302212; Artemiadis PK, 2010, IEEE T ROBOT, V26, P393, DOI 10.1109/TRO.2009.2039378; BRINKMAN C, 1983, SCIENCE, V220, P438, DOI 10.1126/science.6836289; Cavallaro EE, 2006, IEEE T BIO-MED ENG, V53, P2387, DOI 10.1109/TBME.2006.880883; Cipriani C, 2011, IEEE T NEUR SYS REH, V19, P260, DOI 10.1109/TNSRE.2011.2108667; Dunning AG, 2016, J MED DEVICES, V10, DOI 10.1115/1.4034298; Dyson M, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aacbfe; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Grootenhuis MA, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-31; Lobo-Prat J, 2016, IEEE T NEUR SYS REH, P1; Lobo-Prat J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-168; MacKenzie I. S., 1992, Human-Computer Interaction, V7, P91, DOI 10.1207/s15327051hci0701_3; Mahmood MN, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0353-3; Mendell JR, 2013, MUSCLE NERVE, V48, P21, DOI 10.1002/mus.23810; Peeters L, 2018, EXP BRAIN RES, V236, P2023, DOI 10.1007/s00221-018-5279-2; Radhakrishnan SM, 2008, J NEUROPHYSIOL, V100, P2397, DOI 10.1152/jn.90614.2008; Rahman T, 2007, IEEE T NEUR SYS REH, V15, P244, DOI 10.1109/TNSRE.2007.897026; Thorp EB, 2016, IEEE T NEUR SYS REH, V24, P249, DOI 10.1109/TNSRE.2015.2439240; Williams MR, 2008, IEEE T NEUR SYS REH, V16, P485, DOI 10.1109/TNSRE.2008.2006216	19	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214645	10.1371/journal.pone.0214645	http://dx.doi.org/10.1371/journal.pone.0214645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943235	gold, Green Published, Green Submitted			2022-12-27	WOS:000463194300049
J	Hsu, NW; Liu, KS; Chang, SC				Hsu, Nai-Wei; Liu, Kai-Shuo; Chang, Shun-Chuan			Choking under the pressure of competition: A complete statistical investigation of pressure kicks in the NFL, 2000-2017	PLOS ONE			English	Article							SELF-CONSCIOUSNESS; FIELD GOAL; PERFORMANCE	In the NFL, kickers play a special role in determining the outcome of a match. There is a significant body of literature attributing the success of kicks to observed environmental and situational factors. However, the significance of these is not subject to agreement. In this study, we synthesize the deterministic and stochastic models based on data from the 2000-2017 NFL seasons to identify significant conditions associated with "choking." This study's empirical findings focus on integrating the statistical evidence on causality of skill and performance, and the interpretation of observed and unobserved heterogeneity of kicks, on the intervention effect of the new extra-point rule in the NFL since 2015, and on providing an in-depth evaluation of the impact of competition pressure.	[Hsu, Nai-Wei; Liu, Kai-Shuo] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Chang, Shun-Chuan] Mackay Med Coll, Holist Educ Ctr, New Taipei, Taiwan	Mackay Medical College; Mackay Medical College	Chang, SC (corresponding author), Mackay Med Coll, Holist Educ Ctr, New Taipei, Taiwan.	zhang@mmc.edu.tw		Chang, Shun-Chuan/0000-0003-0830-9806	Ministry of Science and Technology (Taiwan) [MOST 105-2633-H-715-001, 105-2410-H-715-001-MY2, 107-2410-H-715-003]; Mackay Medical College [1012A04, 1051B02, 1061B13, 1071B20]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Mackay Medical College	This study was supported by the Ministry of Science and Technology (Taiwan), (MOST 105-2633-H-715-001, 105-2410-H-715-001-MY2, 107-2410-H-715-003), and funds from Mackay Medical College (1012A04, 1051B02, 1061B13, 1071B20).	Abramowitz M., 1974, HDB MATH FUNCTIONS F; Aiken L.S., 1991, MULTIPLE REGRESSION; Albert J., 2017, HDB STAT METHODS ANA; Ariely D, 2009, REV ECON STUD, V76, P451, DOI 10.1111/j.1467-937X.2009.00534.x; BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610; BERRY DA, 1985, AM STAT, V39, P152, DOI 10.2307/2682830; Berry S., 2004, CHANCE, V17, P47, DOI DOI 10.1080/09332480.2004.1.0554926; Bilder Christopher R., 1998, CHANCE, V11, P20; Bottai M, 2010, STAT MED, V29, P309, DOI 10.1002/sim.3781; Butler JL, 1998, J PERS SOC PSYCHOL, V75, P1213, DOI 10.1037/0022-3514.75.5.1213; Cao Z, 2011, J SPORT ECON, V12, P231, DOI 10.1177/1527002511404785; Clark RD, 2007, PERCEPT MOTOR SKILL, V105, P827, DOI 10.2466/PMS.105.3.827-837; Clark T, 2013, 7 ANN MIT SLOAN SPOR; Dandy J, 2001, J SOC PSYCHOL, V141, P150, DOI 10.1080/00224540109600540; Dohmen TJ, 2008, J ECON BEHAV ORGAN, V65, P636, DOI 10.1016/j.jebo.2005.12.004; Drucker Peter., 2017, AGE DISCONTINUITY GU, V2nd; EHRENBERG RG, 1990, J POLIT ECON, V98, P1307, DOI 10.1086/261736; Feizi A, 2012, COMPUTATIONAL MATH M, V2012; Freeman N, 2010, MOTIV EMOTION, V34, P230, DOI 10.1007/s11031-010-9169-6; Goldschmied N, 2010, SPORT PSYCHOL, V24, P300, DOI 10.1123/tsp.24.3.300; Hill D., 2010, INT REV SPORT EXER P, V3, P24, DOI [DOI 10.1080/17509840903301199, 10.1080/17509840903301199]; Hill DM, 2009, EUR J SPORT SCI, V9, P203, DOI 10.1080/17461390902818278; Jones G, 2002, J APPL SPORT PSYCHOL, V14, P205, DOI 10.1080/10413200290103509; Jordet G, 2012, J APPL SPORT PSYCHOL, V24, P73, DOI 10.1080/10413200.2011.619000; Lazear EP, 2000, AM ECON REV, V90, P410, DOI 10.1257/aer.90.2.410; Lewis BP, 1997, PERS SOC PSYCHOL B, V23, P937, DOI 10.1177/0146167297239003; Filho ES, 2008, J APPL SPORT PSYCHOL, V20, P441, DOI 10.1080/10413200802245221; Mesagno C, 2013, J APPL SPORT PSYCHOL, V25, P72, DOI 10.1080/10413200.2012.664605; Morrison DG, 1993, CHANCE, V6, P30; Neter J., 1996, APPL LINEAR STAT MOD; Nideffer R.M., 1992, PSYCHED TO WIN; Nideffer RM, 1993, APPL SPORT PSYCHOL P, V2, P243; Otten M, 2009, J SPORT EXERCISE PSY, V31, P583, DOI 10.1123/jsep.31.5.583; Parlak O, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2904; Pasteur RD, 2014, J QUANT ANAL SPORTS, V10, P49, DOI 10.1515/jqas-2013-0039; Simas AB, 2010, COMPUT STAT DATA AN, V54, P348, DOI 10.1016/j.csda.2009.08.017; Toma M, 2017, J SPORT ECON, V18, P539, DOI 10.1177/1527002515593779; Vickers JN, 2007, J MOTOR BEHAV, V39, P381, DOI 10.3200/JMBR.39.5.381-394; Wells BM, 2012, BASIC APPL SOC PSYCH, V34, P175, DOI 10.1080/01973533.2012.655629; Worthy Darrell A., 2009, The International Journal of Creativity & Problem Solving, V19, P53	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214096	10.1371/journal.pone.0214096	http://dx.doi.org/10.1371/journal.pone.0214096			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939137	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900013
J	Zhang, W; Li, WC; Zhang, JM; Wang, N				Zhang, Wei; Li, Wenchao; Zhang, Jianming; Wang, Ning			Optimal parameter identification of synthetic gene networks using harmony search algorithm	PLOS ONE			English	Article							OPTIMAL EXPERIMENTAL-DESIGN; CIRCUITS; MODELS; EXPRESSION; SELECTION	Computational modeling of engineered gene circuits is an important while challenged task in systems biology. In order to describe and predict the response behaviors of genetic circuits using reliable model parameters, this paper applies an optimal experimental design(OED) method to obtain input signals. In order to obtain informative observations, this study focuses on maximizing Fisher information matrix(FIM)-based optimal criteria and to provide optimal inputs. Furthermore, this paper designs a two-stage optimization with the modified E-optimal criteria and applies harmony search(HS)-based OED algorithm to minimize estimation errors. The proposed optimal identification methodology involves estimation errors and the sample size to pursue a trade-off between estimation accuracy and measurement cost in modeling gene networks. The designed cost function takes two major factors into account, in which experimental costs are proportional to the number of time points. Experiments select two types of synthetic genetic networks to validate the effectiveness of the proposed HS-OED approach. Identification outcomes and analysis indicate the proposed HS-OED method outperforms two candidate OED approaches, with reduced computational effort.	[Zhang, Wei; Li, Wenchao; Zhang, Jianming; Wang, Ning] Zhejiang Univ, Dept Control & Engn, Inst Cyber Syst & Control, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, JM (corresponding author), Zhejiang Univ, Dept Control & Engn, Inst Cyber Syst & Control, Hangzhou, Zhejiang, Peoples R China.	jmzhang@iipc.zju.edu.cn		Li, Wenchao/0000-0002-7956-0742	National Natural Science Foundation of China (CN) [61573311]	National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC))	Author Wei Zhang is partly supported by National Natural Science Foundation of China (CN) 61573311.	Adoteye K, 2015, APPL MATH LETT, V40, P84, DOI 10.1016/j.aml.2014.09.013; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bandara S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000558; Banga JR, 2008, ESSAYS BIOCHEM, V45, P195, DOI 10.1042/BSE0450195; Bouffier AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110234; Busetto AG, 2013, BIOINFORMATICS, V29, P2625, DOI 10.1093/bioinformatics/btt436; Carbonell-Ballestero M, 2016, NUCLEIC ACIDS RES, V44, P496, DOI 10.1093/nar/gkv1280; Dehghannasiri R, 2015, IEEE ACM T COMPUT BI, V12, P938, DOI 10.1109/TCBB.2014.2377733; Faller D, 2003, SIMUL-T SOC MOD SIM, V79, P717, DOI 10.1177/0037549703040937; Firman T, 2017, BIOPHYS J, V113, P2121, DOI 10.1016/j.bpj.2017.08.057; FUTCHER AB, 1984, J BACTERIOL, V157, P283, DOI 10.1128/JB.157.1.283-290.1984; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Huang B, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0594-6; Huynh L, 2014, ACS SYNTH BIOL, V3, P556, DOI 10.1021/sb400139h; Le Novere N, 2015, NAT REV GENET, V16, P146, DOI 10.1038/nrg3885; Liao C, 2017, NAT MICROBIOL, V2, P1658, DOI 10.1038/s41564-017-0022-5; Lin CD, 2015, QUAL RELIAB ENG INT, V31, P155, DOI 10.1002/qre.1591; Liu Z, 2015, STRUCT MULTIDISCIP O, V52, P813, DOI 10.1007/s00158-015-1271-7; Llamosi A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004706; Mangan N. M., 2016, IEEE T MOL BIO MULT, V2, P52, DOI [10.1109/TMBMC.2016.2633265, DOI 10.1109/TMBMC.2016.2633265]; Melykuti B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-38; Meyer P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-13; Mishra D, 2014, NAT BIOTECHNOL, V32, P1268, DOI 10.1038/nbt.3044; Mohammadi P, 2017, CELL SYST, V4, P207, DOI 10.1016/j.cels.2017.01.003; Nimmegeers P, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0328-6; O'Brien EL, 2012, MATH BIOSCI, V236, P1, DOI 10.1016/j.mbs.2012.01.001; Pirgazi J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200094; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Segall-Shapiro TH, 2018, NAT BIOTECHNOL, V36, P352, DOI 10.1038/nbt.4111; Srinivas N, 2017, SCIENCE, V358, DOI 10.1126/science.aal2052; Steinke F, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-51; Stigter Johannes D, 2012, BMC Res Notes, V5, P518, DOI 10.1186/1756-0500-5-518; Ud-Dean SMM, 2016, BIOINFORMATICS, V32, P875, DOI 10.1093/bioinformatics/btv672; Vanlier J, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-20; WALTER E, 1990, AUTOMATICA, V26, P195, DOI 10.1016/0005-1098(90)90116-Y; Wilson AD, 2014, P AMER CONTR CONF, P443, DOI 10.1109/ACC.2014.6858649; Xie MQ, 2018, NAT REV MOL CELL BIO, V19, P507, DOI 10.1038/s41580-018-0024-z; Yamazaki K, 2017, SYN BIOL, V2, DOI 10.1093/synbio/ysx003; Zhu F, 2015, BIOINFORMATICS, V31, P2537, DOI 10.1093/bioinformatics/btv186	40	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0213977	10.1371/journal.pone.0213977	http://dx.doi.org/10.1371/journal.pone.0213977			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925150	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300008
J	Ma, LY; Hu, K; Li, PD; Liu, JQ; Yuan, XQ				Ma, Luyao; Hu, Kai; Li, Pengde; Liu, Jiaqi; Yuan, Xiangqun			Ultrastructure of the proboscis sensilla of ten species of butterflies (Insecta: Lepidoptera)	PLOS ONE			English	Article							FRUIT-FEEDING BUTTERFLIES; ANTENNAL SENSILLA; COMPARATIVE MORPHOLOGY; SPRUCE BUDWORM; PAPILIONOIDEA; NYMPHALIDAE; OVIPOSITION; PREFERENCES; FLIES; MOTH	The ultrastructure of the sensilla on the proboscis of ten species of butterflies, Iphiclides podalirius, Parara guttata, Colias fieldii, Celastrina oreas, Sasakia charonda, Tirumala lim-niece, Acraea issoria, Stichophthalma neumogeni, Callerebia suroia, and Libythea celtis, among five families were investigated using scanning electron microscopy. They were compared to reveal the morphological differences in the proboscis sensilla among these butterflies. Four distinct types of sensilla were found on the proboscis among these species. The types of proboscis sensilla of I. podalirius and T. limniace were sensilla chaetica, sensilla coeloconica, and sensilla basiconica. The types in the other eight species were sensilla chaetica, sensilla styloconica, and sensilla basiconica. The number of sensilla styloconica on the proboscis of non-flower-visiting species was greater than that of flower-visiting species.	[Ma, Luyao; Hu, Kai; Li, Pengde; Liu, Jiaqi; Yuan, Xiangqun] Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Yuan, XQ (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China.	Yuanxq@nwsuaf.edu.cn			National Key R & D Program of China [2017YFD0200900, 2017YFD0201800]; National Natural Science Foundation of China [31772503, 31272345, 31871971]	National Key R & D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key R & D Program of China (2017YFD0200900, 2017YFD0201800) and the National Natural Science Foundation of China (No. 31772503, No. 31272345 and No. 31871971). Xiangqun Yuan received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER P H, 1982, Journal of the Lepidopterists' Society, V36, P161; ALTNER H, 1983, FORTS ZOOL, V28, P17; ALTNER H, 1986, ZOOL ANZ, V216, P129; ALTNER H, 1985, ANNU REV ENTOMOL, V30, P273, DOI 10.1146/annurev.en.30.010185.001421; Bauder J A-S, 2014, J Res Lepid, V47, P65; Bauder JAS, 2011, ARTHROPOD STRUCT DEV, V40, P122, DOI 10.1016/j.asd.2010.11.002; Bauder JAS, 2013, BIOL J LINN SOC, V110, P291, DOI 10.1111/bij.12134; Baur R, 1998, PHYSIOL ENTOMOL, V23, P7, DOI 10.1046/j.1365-3032.1998.2310007.x; Blaney WM, 2011, ENTOMOLOGIA EXPT APP, V49, P111; Castro-Gerardino DJ, 2019, ZOOTAXA, V4559, P445, DOI 10.11646/zootaxa.4559.3.2; Corbet SA, 2010, ENTOMOLOGIA EXPT APP, V96, P289; Espeland M, 2018, CURR BIOL, V28, P770, DOI 10.1016/j.cub.2018.01.061; Faucheux MJ, 2017, ZOOL ANZ, V266, P105, DOI 10.1016/j.jcz.2016.11.002; Faucheux MJ, 2013, ANN SOC ENTOMOL FR, V49, P73, DOI 10.1080/00379271.2013.767514; GILBERT LE, 1972, P NATL ACAD SCI USA, V69, P1403, DOI 10.1073/pnas.69.6.1403; Guo MB, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00970; HALLBERG E, 1994, TISSUE CELL, V26, P489, DOI 10.1016/0040-8166(94)90002-7; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Hu Xiao-Wen, 2010, Acta Zootaxonomica Sinica, V35, P790; Inoue T, 2009, NATURWISSENSCHAFTEN, V96, P355, DOI 10.1007/s00114-008-0483-8; Karolyi F, 2012, BIOL J LINN SOC, V107, P414, DOI 10.1111/j.1095-8312.2012.01945.x; Krenn HW, 2010, ANNU REV ENTOMOL, V55, P307, DOI 10.1146/annurev-ento-112408-085338; Krenn HW, 1998, ZOOMORPHOLOGY, V118, P23, DOI 10.1007/s004350050053; Krenn HW, 2002, ZOOL ANZ, V241, P369, DOI 10.1078/0044-5231-00078; Krenn HW, 2001, J ZOOL, V254, P17, DOI 10.1017/S0952836901000528; Kunte K, 2007, FUNCT ECOL, V21, P982, DOI 10.1111/j.1365-2435.2007.01299.x; Kvello P, 2006, ARTHROPOD STRUCT DEV, V35, P35, DOI 10.1016/j.asd.2005.10.003; Lehnert MS, 2016, J MORPHOL, V277, P167, DOI 10.1002/jmor.20487; Li YP, 2018, PLOS ONE, V13; Liu HX, 2014, ANN SOC ENTOMOL FR, V50, P350, DOI 10.1080/00379271.2014.981405; Molleman F, 2005, BIOTROPICA, V37, P657, DOI 10.1111/j.1744-7429.2005.00083.x; Molleman F, 2005, BIOL J LINN SOC, V86, P333, DOI 10.1111/j.1095-8312.2005.00533.x; Monaenkova D, 2012, J R SOC INTERFACE, V9, P720, DOI 10.1098/rsif.2011.0392; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Omura H, 2009, CHEMOECOLOGY, V19, P227, DOI 10.1007/s00049-009-0024-8; Paulus HF, 1996, J ZOOL SYST EVOL RES, V34, P203; Pauw A, 2009, EVOLUTION, V63, P268, DOI 10.1111/j.1558-5646.2008.00547.x; Petr D, 2004, T AM ENTOMOL SOC, V130, P293; Pophof B, 1997, PHYSIOL ENTOMOL, V22, P239, DOI 10.1111/j.1365-3032.1997.tb01164.x; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SMEDLEY SR, 1995, SCIENCE, V270, P1816, DOI 10.1126/science.270.5243.1816; STADLER E, 1975, ENTOMOL EXP APPL, V18, P153, DOI 10.1007/BF00299983; STADLER E, 1995, PHYSIOL ENTOMOL, V20, P175, DOI 10.1111/j.1365-3032.1995.tb00814.x; Stefanescu C, 2009, OIKOS, V118, P1109, DOI 10.1111/j.1600-0706.2009.17274.x; Walters BD, 1998, CAN J ZOOL, V76, P466, DOI 10.1139/cjz-76-3-466; Wang Na, 2012, Acta Entomologica Sinica, V55, P877; Wang R, 2015, NEOTROP ENTOMOL, V44, P68, DOI 10.1007/s13744-014-0258-1; Xu ML, 2017, CAN J ZOOL, V95; Xue S, 2016, ZOOL ANZ, V263, P75, DOI 10.1016/j.jcz.2016.05.002; Xue S, 2014, J ASIA-PAC ENTOMOL, V17, P295, DOI 10.1016/j.aspen.2014.01.014; Yang ZX, 2009, ZOOTAXA, P48, DOI 10.11646/zootaxa.2204.1.4; Yuan XQ, 2014, ZOOKEYS, P17, DOI 10.3897/zookeys.399.7063; Yuvaraj JK, 2018, MICRON, V111, P9, DOI 10.1016/j.micron.2018.05.006; Zaspel JM, 2013, ZOOL ANZ, V253, P6, DOI 10.1016/j.jcz.2013.06.001	54	6	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214658	10.1371/journal.pone.0214658	http://dx.doi.org/10.1371/journal.pone.0214658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921417	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000103
J	Navarro, CM; Brolund, A; Ekholm, C; Heintz, E; Ekstrom, EH; Josefsson, PO; Leander, L; Nordstrom, P; Ziden, L; Stenstrom, K				Navarro, Cecilia Mellstrand; Brolund, Agneta; Ekholm, Carl; Heintz, Emelie; Ekstrom, Emin Hoxha; Josefsson, Per Olof; Leander, Lina; Nordstrom, Peter; Ziden, Lena; Stenstrom, Karin			Treatment of radius or ulna fractures in the elderly: A systematic review covering effectiveness, safety, economic aspects and current practice	PLOS ONE			English	Review							VOLAR LOCKING-PLATE; DORSALLY DISPLACED FRACTURE; BRIDGING EXTERNAL FIXATION; FLEXOR POLLICIS LONGUS; CLINICALLY IMPORTANT DIFFERENCE; REDISPLACED UNSTABLE FRACTURES; PERCUTANEOUS KIRSCHNER WIRES; DISTAL RADIUS; INTERNAL-FIXATION; BONE-CEMENT	Background The objective of the present study was to evaluate effectiveness, complications and cost-effectiveness of any surgical or non-surgical treatment for radius or ulna fractures in elderly patients. Secondary objectives were to analyze present treatment traditions of distal radius fractures (DRF) in Sweden and to calculate resource usage for its treatment. Methods and findings The assessment contains a systematic review of clinical and health economic studies comparing treatment options for radius or ulna fractures. The results regarding the effectiveness of the treatments are summarized in meta-analyses. In addition, the assessment contains a cost analysis for different treatment options commonly used for DRF care, and an analysis of registry data on the incidence and treatment of DRF. In total 31 randomized controlled trials were included in meta-analyses. When comparing functional outcome for plate fixation versus non-surgical treatment for DRF, there were no clinically important differences at one-year follow-up (mean difference [MD], -3.29, 95% CI, -7.03; 0.44). Similar results were found when comparing plating and percutaneous methods with respect to functional outcome (standardized mean difference [SMD], -0.07, 95% CI, -0.21; 0.07) and grip strength (MD, -3.47, 95% CI, -11.21; 4.28). There were no differences for minor complications, (risk difference [RD], -0.01, 95% CI, -0.07; 0.05) whereas major complications were less common for the percutaneous group, (RD, 0.02, 95% CI, 0.02; 0.03). Given the low number of studies, the evidence above was rated as moderate certainty. The cost for plate fixation versus plaster cast was estimated to 1698 compared to 137 US dollars. For DRF, plate fixation increased in Sweden between 2005 and 2013, and was the most common surgical method in 2013. Conclusions Surgical treatment of moderately displaced distal radius fractures in elderly patients offers no clear benefit compared to non-surgical treatment. Plating procedures have become more common during the second millennium and involve higher costs and higher risk of major complications than percutaneous options.	[Navarro, Cecilia Mellstrand] Sodersjukhuset Hosp, Inst Clin Res & Educ, Karolinska Inst, Dept Hand Surg, Stockholm, Sweden; [Brolund, Agneta; Heintz, Emelie; Ekstrom, Emin Hoxha; Leander, Lina; Stenstrom, Karin] Swedish Agcy Hlth Technol Assessment & Assessment, Stockholm, Sweden; [Ekholm, Carl] Sahlgrens Univ Hosp, Dept Orthopaed, Molndal, Sweden; [Heintz, Emelie] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Josefsson, Per Olof] Skane Univ Hosp, Dept Orthopaed, Malmo, Sweden; [Nordstrom, Peter] Dept Community Med & Rehabil, Geriatr, Umea, Sweden; [Ziden, Lena] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Hlth & Rehabil, Gothenburg, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Sahlgrenska University Hospital; Karolinska Institutet; Lund University; Skane University Hospital; University of Gothenburg	Navarro, CM (corresponding author), Sodersjukhuset Hosp, Inst Clin Res & Educ, Karolinska Inst, Dept Hand Surg, Stockholm, Sweden.	cecilia.mellstrand-navarro@sll.se	Navarro, Cecilia Mellstrand/AAU-8991-2020; Heintz, Emelie/GYD-4031-2022	Navarro, Cecilia Mellstrand/0000-0002-3312-9375; Heintz, Emelie/0000-0002-0715-7591	Swedish Agency for Health Technology Assessment and Assessment of Social Services, SBU	Swedish Agency for Health Technology Assessment and Assessment of Social Services, SBU	This study was funded by and conducted within the framework of the Swedish Agency for Health Technology Assessment and Assessment of Social Services, SBU (www.sbu.se/en), a public Agency conducting health technology assessments. The study design, data Collection and analysis were completed within this framework.	ABBASZADEGAN H, 1990, ACTA ORTHOP SCAND, V61, P528, DOI 10.3109/17453679008993575; Al-Rashid M, 2006, J BONE JOINT SURG BR, V88B, P1610, DOI 10.1302/0301-620X.88B12.17696; Angst F, 2011, ARTHRIT CARE RES, V63, pS174, DOI 10.1002/acr.20630; Arora R, 2011, J BONE JOINT SURG AM, V93A, P2146, DOI 10.2106/JBJS.J.01597; Atroshi I, 2006, ACTA ORTHOP, V77, P445, DOI 10.1080/17453670610046389; Azzopardi T, 2005, J BONE JOINT SURG BR, V87B, P837, DOI 10.1302/0301-620X.87B6.15608; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bartl C, 2014, DTSCH ARZTEBL INT, V111, P779, DOI 10.3238/arztebl.2014.0779; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Belloti JC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206895; Beumer A, 2003, ACTA ORTHOP SCAND, V74, P98, DOI 10.1080/00016470310013743; Board T, 1999, INJURY, V30, P663, DOI 10.1016/S0020-1383(99)00167-9; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cassidy C, 2003, J BONE JOINT SURG AM, V85A, P2127, DOI 10.2106/00004623-200311000-00010; Cha SM, 2012, J HAND SURG-AM, V37A, P2481, DOI 10.1016/j.jhsa.2012.07.031; Chang H C, 2001, Hand Surg, V6, P137, DOI 10.1142/S0218810401000606; Chen YH, 2016, J HAND SURG-AM, V41, P404, DOI 10.1016/j.jhsa.2015.12.008; Cho CH, 2012, CLIN ORTHOP SURG, V4, P325, DOI 10.4055/cios.2012.4.4.325; Chung KC, 2011, J BONE JOINT SURG AM, V93A, P2154, DOI 10.2106/JBJS.J.012802; Coretti S, 2014, EXPERT REV PHARM OUT, V14, P221, DOI 10.1586/14737167.2014.894462; Costa ML, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19170; Costa ML, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4807; Diaz-Garcia RJ, 2011, J HAND SURG-AM, V36A, P824, DOI 10.1016/j.jhsa.2011.02.005; Egol KA, 2010, J BONE JOINT SURG AM, V92A, P1851, DOI 10.2106/JBJS.I.00968; Elmagarmid A, 2014, OPP CHALL 22 COCHR C; Esposito J, 2013, INJURY, V44, P409, DOI 10.1016/j.injury.2012.12.003; Farner S, 2014, ORTHOPEDICS, V37, pE866, DOI 10.3928/01477447-20140924-52; Foldhazy Z, 2010, CURR ORTHOP PRACT, V21, P288, DOI 10.1097/BCO.0b013e3181cd6513; Goehre F, 2014, J HAND SURG-EUR VOL, V39, P249, DOI 10.1177/1753193413489057; Gradl G, 2013, ARCH ORTHOP TRAUM SU, V133, P595, DOI 10.1007/s00402-013-1698-5; Gradl G, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2013.10.045; Grewal R, 2007, J HAND SURG-AM, V32A, P962, DOI 10.1016/j.jhsa.2007.05.009; Hegeman JH., 2004, AKTUELLE TRAUMATOL; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Jakubietz MG, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-8; Jakubietz MG, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-24; Jeudy J, 2012, INJURY, V43, P174, DOI 10.1016/j.injury.2011.05.021; Kim JK, 2014, CLIN ORTHOP RELAT R, V472, P2536, DOI 10.1007/s11999-014-3666-y; Kim JK, 2013, CLIN ORTHOP RELAT R, V471, P1406, DOI 10.1007/s11999-013-2843-8; Kim JK, 2011, J BONE JOINT SURG AM, V93A, P609, DOI 10.2106/JBJS.J.00613; Klug RA, 2007, J HAND SURG-AM, V32A, P984, DOI 10.1016/j.jhsa.2007.05.006; Koenig KM, 2009, J BONE JOINT SURG AM, V91A, P2086, DOI 10.2106/JBJS.H.01111; Koo SC, 2006, J HAND SURG-ASIAN-PA, V11, P67, DOI 10.1142/S0218810406003048; Lattmann T, 2008, J HAND SURG-AM, V33A, P1135, DOI 10.1016/j.jhsa.2008.03.016; Leung KF, 2005, QUAL LIFE RES, V14, P1413, DOI 10.1007/s11136-004-4772-1; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MacDermid J C, 1996, J Hand Ther, V9, P178; Marcheix PS, 2010, J HAND SURG-EUR VOL, V35E, P646, DOI 10.1177/1753193410364179; Martinez-Mendez D, 2018, J HAND SURG-EUR VOL, V43, P142, DOI 10.1177/1753193417727139; Mattila VM, 2011, J TRAUMA, V71, P939, DOI 10.1097/TA.0b013e3182231af9; McFadyen I, 2011, INJURY, V42, P162, DOI 10.1016/j.injury.2010.07.236; McQueen MM, 1996, J BONE JOINT SURG BR, V78B, P404, DOI 10.1302/0301-620X.78B3.0780404; McQueen MM, 1998, J BONE JOINT SURG BR, V80B, P665, DOI 10.1302/0301-620X.80B4.8150; Mellstrand-Navarro C, 2014, BONE JOINT J, V96B, P963, DOI 10.1302/0301-620X.96B7.33149; Navarro CM, 2016, J ORTHOP TRAUMA, V30, P217, DOI 10.1097/BOT.0000000000000519; Navarro CM, 2015, J ORTHOP TRAUMA, V29, pE36, DOI 10.1097/BOT.0000000000000199; Negrini D, 2004, J Health Organ Manag, V18, P195, DOI 10.1108/14777260410548437; Omokawa S, 2018, J HAND SURG-EUR VOL, V43, P148, DOI 10.1177/1753193417748300; Oshige T, 2007, J HAND SURG-AM, V32A, P1385, DOI 10.1016/j.jhsa.2007.07.005; PRITCHETT JW, 1995, J BONE JOINT SURG BR, V77B, P267, DOI 10.1302/0301-620X.77B2.7706344; Rozental TD, 2009, J BONE JOINT SURG AM, V91A, P1837, DOI 10.2106/JBJS.H.01478; Sanchez-Sotelo J, 2000, J BONE JOINT SURG BR, V82B, P856, DOI 10.1302/0301-620X.82B6.10317; SBU Swedish Agency for Health Technology Assessment and Assesment of Social Services, 2017, CHECKL ASS RISK BIAS; SBU Swedish Agency for Health Technology Assessment and Assesment of Social Services, 2017, CHECKL ASS QUAL HLTH; SCHMALHOLZ A, 1990, CLIN ORTHOP RELAT R, P236; Schmelzer-Schmied N, 2009, INT ORTHOP, V33, P773, DOI 10.1007/s00264-007-0504-9; Schonnemann JO, 2011, J PLAST SURG HAND SU, V45, P232, DOI 10.3109/2000656X.2011.613243; Shauver MJ, 2011, J HAND SURG-AM, V36A, P1912, DOI 10.1016/j.jhsa.2011.09.039; Sintonen H, 1994, 41 NAT CTR HLTH PROG; St-Pierre C, 2016, DISABIL REHABIL, V38, P103, DOI 10.3109/09638288.2015.1027004; Strohm PC, 2004, J BONE JOINT SURG AM, V86A, P2621, DOI 10.2106/00004623-200412000-00006; Tubeuf S, 2015, BONE JOINT J, V97B, P1082, DOI 10.1302/0301-620X.97B8.35234; Wadsten MA, 2014, BONE JOINT J, V96B, P978, DOI 10.1302/0301-620X.96B7.32728; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilcke MKT, 2013, ACTA ORTHOP, V84, P292, DOI 10.3109/17453674.2013.792035; Wong TC, 2010, J HAND SURG-EUR VOL, V35E, P202, DOI 10.1177/1753193409339941; Yamashita Kazuta, 2015, Journal of UOEH, V37, P111, DOI 10.7888/juoeh.37.111; Young BT, 2000, J HAND SURG-AM, V25A, P19; Zenke Y, 2011, J ORTHOP TRAUMA, V25, P425, DOI 10.1097/BOT.0b013e3182008c83; Zimmermann R, 2003, ARCH ORTHOP TRAUM SU, V123, P22, DOI 10.1007/s00402-002-0458-8	81	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214362	10.1371/journal.pone.0214362	http://dx.doi.org/10.1371/journal.pone.0214362			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921377	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000058
J	Rupji, M; Dwivedi, B; Kowalski, J				Rupji, Manali; Dwivedi, Bhakti; Kowalski, Jeanne			NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis	PLOS ONE			English	Article							CLASS DISCOVERY; EXPRESSION; CLASSIFICATION; SIGNATURES; TOOL	Since their inception, several tools have been developed for cluster analysis and heatmap construction. The application of such tools to the number and types of genome-wide data available from next generation sequencing (NGS) technologies requires the adaptation of statistical concepts, such as in defining a most variable gene set, and more intricate cluster analyses method to address multiple omic data types. Additionally, the growing number of publicly available datasets has created the desire to estimate the statistical significance of a gene signature derived from one dataset to similarly group samples based on another dataset. The currently available number of tools and their combined use for generating heat-maps, along with the several adaptations of statistical concepts for addressing the higher dimensionality of genome-wide NGS-derived data, has created a further challenge in the ability to replicate heatmap results. We introduce NOJAH (NOt Just Another Heatmap), an interactive tool that defines and implements a workflow for genome-wide cluster analysis and heatmap construction by creating and combining several tools into a single user interface. NOJAH includes several newly developed scripts for techniques that though frequently applied are not sufficiently documented to allow for replicability of results. These techniques include: defining a most variable gene set (a.k.a., 'core genes'), estimating the statistical significance of a gene signature to separate samples into clusters, and performing a result merging integrated cluster analysis. With only a user uploaded dataset, NOJAH provides as output, among other things, the minimum documentation required for replicating heatmap results. Additionally, NOJAH contains five different existing R packages that are connected in the interface by their functionality as part of a defined workflow for genome-wide cluster analysis. The NOJAH application tool is available at http://bbisr.shinyapps.winship.emory.edu/NOJAH/ http://shinygispa.winship.emory.edu/shinyGISPA/ with corresponding source code available at https://github.com/bbisr-shinyapps/NOJAH/.	[Rupji, Manali; Dwivedi, Bhakti; Kowalski, Jeanne] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Kowalski, Jeanne] Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Kowalski, Jeanne] Dell Med Sch, Dept Oncol, Austin, TX 78701 USA	Emory University; Emory University; Rollins School Public Health	Kowalski, J (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.; Kowalski, J (corresponding author), Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.; Kowalski, J (corresponding author), Dell Med Sch, Dept Oncol, Austin, TX 78701 USA.	jeanne.kowalski@emory.edu	Rupji, Manali/K-1977-2019	Rupji, Manali/0000-0002-0520-1624; Kowalski, Jeanne/0000-0003-3458-3024	Winship Glenn Family Breast Cancer award; Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University; National Institutes of Health /National Cancer Institute [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER	Winship Glenn Family Breast Cancer award; Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University; National Institutes of Health /National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported in part by a Winship Glenn Family Breast Cancer award (Kowalski) and the Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University and National Institutes of Health /National Cancer Institute under award number P30CA138292.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Chang W., 2017, SHINY WEB APPL FRAME; Chermak E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166460; Chibon F, 2013, EUR J CANCER, V49, P2000, DOI 10.1016/j.ejca.2013.02.021; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Joshi VK, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-3; Khomtchouk BB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176334; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Rupji Manali, 2017, F1000Res, V6, P919, DOI 10.12688/f1000research.11830.1; Wang C, 2017, CLIN CANCER RES, V23, P4077, DOI 10.1158/1078-0432.CCR-17-0246; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0204542	10.1371/journal.pone.0204542	http://dx.doi.org/10.1371/journal.pone.0204542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921318	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000002
J	Yoshida, Y; Matsubara, H; Fang, X; Hayashi, K; Nomura, I; Ugaji, S; Hamada, T; Tsuchiya, H				Yoshida, Yasuhisa; Matsubara, Hidenori; Fang, Xiang; Hayashi, Katsuhiro; Nomura, Issei; Ugaji, Shuhei; Hamada, Tomo; Tsuchiya, Hiroyuki			Adipose-derived stem cell sheets accelerate bone healing in rat femoral defects	PLOS ONE			English	Article							SUPERIOR OSTEOGENIC CAPACITY; MARROW STROMAL CELLS; IN-VITRO; TISSUE; DIFFERENTIATION; REGENERATION; PHENOTYPE; PHOSPHATE; CARTILAGE	In the present study, we investigated whether both adipose-derived stem cell (ADSC) and osteogenic-induced ADSC sheets could promote bone healing in a rat distal femoral metaphysis bone defect model. A through-hole defect of 1 mm diameter was drilled into each distal femur of 12 week old rats. Forty-five rats were randomly assigned to three groups: (1) control group; (2) ADSC sheet group; or (3) osteogenic-induced ADSC sheet group. We evaluated each group by analysis of computerized tomography scans every week after the surgery, histological analysis, and Dil labeling (a method of membrane staining for post implant cell tracing). Radiological and histological evaluations showed that a part of the hole persisted in the control group at four weeks after surgery, whereas the hole was restored almost completely by new bone formation in both sheet groups. The mean value of bone density (in Houndsfield units) for the bone defect area was significantly higher in both sheet groups than that in the control group (p = 0.05) at four weeks postoperative. A large number of osteocalcin positive osteoblasts were observed at the area of bone defect, especially in the osteogenic-induced ADCS sheet group. Dil labeling in the newly formed bone showed that each sheet had differentiated into bone tissue at four weeks after surgery. The ADSC and the osteogenic-induced ADSC sheets promoted significantly quicker bone healing in the bone defect. Moreover, the osteogenic-induced ADSC sheet may be more advantageous for bone healing than the ADSC sheet because of the higher number of osteocalcin positive osteoblasts via the transplantation.	[Yoshida, Yasuhisa; Matsubara, Hidenori; Fang, Xiang; Hayashi, Katsuhiro; Nomura, Issei; Ugaji, Shuhei; Hamada, Tomo; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan	Kanazawa University	Matsubara, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.	ortho331@yahoo.co.jp	Hayashi, K/C-4685-2015	Hayashi, K/0000-0001-8665-2154; Yoshida, Yasuhisa/0000-0002-4472-7127	Japan Society for the Promotion of Science;  [2689309]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This study was supported by a Grant-in-Aid for Young Scientists to Y.Y. Grant number: 2689309; KAKENHI, Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, https://www.jsps.go.jp/j-grantsinaid/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030; ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Barba M, 2017, EXPERT OPIN BIOL TH, V17, P677, DOI 10.1080/14712598.2017.1315403; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Dawson JI, 2014, STEM CELLS, V32, P35, DOI 10.1002/stem.1559; de Girolamo L, 2011, J ORTHOP RES, V29, P100, DOI 10.1002/jor.21184; De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465; Dixit M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144541; Doorn J, 2011, BIOMATERIALS, V32, P6089, DOI 10.1016/j.biomaterials.2011.05.010; Fang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088874; Feng W, 2015, MAT SCI ENG C-MATER, V54, P133, DOI 10.1016/j.msec.2015.05.037; Lambert APF, 2009, DIFFERENTIATION, V77, P221, DOI 10.1016/j.diff.2008.10.016; Frasca S, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-016-5839-6; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Harada N, 2014, BIOMATERIALS, V35, P7800, DOI 10.1016/j.biomaterials.2014.05.052; Higuchi T, 2018, ANTICANCER RES, V38, P3031, DOI 10.21873/anticanres.12558; Houdek MT, 2017, BONE JOINT J, V99B, P134, DOI 10.1302/0301-620X.99B1.BJJ-2016-0160.R1; Katsuno T, 2013, CELL TRANSPLANT, V22, P287, DOI 10.3727/096368912X655019; Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7; Kim DH, 2009, SPINE J, V9, P886, DOI 10.1016/j.spinee.2009.05.006; Kim D, 2010, CELL TISSUE RES, V341, P359, DOI 10.1007/s00441-010-1015-3; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee JH, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/5/055002; Liu S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060982; Matthews Brya G, 2014, Bonekey Rep, V3, P560, DOI 10.1038/bonekey.2014.55; Myeroff C, 2011, J BONE JOINT SURG AM, V93A, P2227, DOI 10.2106/JBJS.J.01513; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Ning L, 2015, J ORAL IMPLANTOL, V41, P45, DOI 10.1563/AAID-JOI-D-12-00298; Nomura I, 2014, CLIN ORTHOP RELAT R, V472, P3798, DOI 10.1007/s11999-014-3608-8; Omata K, 2014, J TISSUE ENG REGEN M, V8, P604, DOI 10.1002/term.1553; Paino F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.308; Pereira AC, 2007, ARQ BRAS CARDIOL, V88, P104, DOI 10.1590/S0066-782X2007000100017; Qomi RT, 2017, WORLD J STEM CELLS, V9, P107, DOI 10.4252/wjsc.v9.i8.107; Spina A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00354; Stellavato A, 2017, CELL PHYSIOL BIOCHEM, V44, P1078, DOI 10.1159/000485414; Suganuma S, 2013, J ORTHOP SCI, V18, P145, DOI 10.1007/s00776-012-0306-9; Terai S, 2003, J BIOCHEM, V134, P551, DOI 10.1093/jb/mvg173; Tsuchiya H, 2002, J BONE JOINT SURG BR, V84B, P1162, DOI 10.1302/0301-620X.84B8.13330; Uchihara Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/629168; Ueha T, 2015, WORLD J STEM CELLS, V7, P873, DOI 10.4252/wjsc.v7.i5.873; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065685; Wang YH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195337; Wang ZL, 2018, CURR MED SCI, V38, P277, DOI 10.1007/s11596-018-1876-3; Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012; Wen Y, 2013, OR SURG OR MED OR PA, V116, pE324, DOI 10.1016/j.oooo.2012.02.024; Yamada T, 2013, BONE, V57, P343, DOI 10.1016/j.bone.2013.08.028; Yu JS, 2014, BIOMATERIALS, V35, P3516, DOI 10.1016/j.biomaterials.2014.01.015; Zhang DW, 2018, BIOACT MATER, V3, P129, DOI 10.1016/j.bioactmat.2017.08.004; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	55	21	22	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214488	10.1371/journal.pone.0214488	http://dx.doi.org/10.1371/journal.pone.0214488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921414	Green Submitted, gold, Green Published			2022-12-27	WOS:000462594000077
J	Zhang, CY; Xia, L; Rainey, JJ; Li, Y; Chen, C; Rao, ZY; Duan, JC; Sun, HY; Cao, J; Liu, P; Cheng, J; Zhang, H; Wu, JL; Wang, LX				Zhang, Canyou; Xia, Lan; Rainey, Jeanette J.; Li, Yuan; Chen, Chuang; Rao, Zhengyuan; Duan, Jinchao; Sun, Hongying; Cao, Jie; Liu, Ping; Cheng, Jun; Zhang, Hui; Wu, Jianlin; Wang, Lixia			Findings from a pilot project to assess the feasibility of active tuberculosis case finding among seniors in rural Sichuan Province, China, 2017	PLOS ONE			English	Article							NATIONAL-SURVEY; PREVALENCE; HOUSEHOLD	Background China has a substantial tuberculosis (TB) disease burden and an aging population. Seniors have a higher risk of developing TB disease compared to younger age groups. Active case finding (ACF) could help identify seniors with TB disease. Methods From March to June 2017, we included ACF during annual physical check-ups for persons aged >= 65 years in Bayi, Sichuan Province. Seniors with clinical TB symptoms (i.e., cough lasting >= 2 weeks and/or hemoptysis) or one or more risk factors (e.g., previous TB disease, diabetes, and heavy alcohol consumption) were offered chest x-rays. We used acid-Fast Bacilli smear and solid culture laboratory testing for TB confirmation. We calculated the yield (i.e., cases identified among seniors screened) and cost per new each TB case detected. Focus group-interviews were conducted with health care workers and seniors to evaluate project acceptability. Participation rates and acceptability were used to assess feasibility. Results Of the 2,393 seniors residing in Bayi, 2,049 (85.6%) were enrolled in the pilot project. Of these seniors, 794 (38.7%) presented with at least one TB risk factor and 74 (3.6%) had symptoms consistent with active TB disease. Three seniors (0.2%)-each presenting with at least one risk factor-were diagnosed with active TB. The project yielded 146 TB cases per 100,000 seniors screened; the cost per case detected was $4,897. Most workers supported ACF if additional resources and staff could be provided. Seniors appreciated the convenience of this integrated health service approach. Conclusions Although the yield was lower than expected, ACF appeared feasible in Bayi. Targeting seniors with at least one known TB risk factor could help detect previously unidentified TB cases. However, similar projects in communities with a higher TB prevalence are needed to further evaluate the yield and required resources prior to implementation on a larger scale. Findings from our pilot project should be combined with data from these future ACF projects to improve TB screening criteria.	[Zhang, Canyou; Cheng, Jun; Zhang, Hui; Wang, Lixia] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Xia, Lan; Chen, Chuang; Rao, Zhengyuan; Wu, Jianlin] Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China; [Rainey, Jeanette J.; Li, Yuan] US Ctr Dis Control & Prevent, Div Global Hlth Protect, Beijing, Peoples R China; [Duan, Jinchao; Sun, Hongying] Mianyang Ctr Dis Control & Prevent, Mianyang, Sichuan, Peoples R China; [Cao, Jie; Liu, Ping] Jiangyou Ctr Dis Control & Prevent, Mianyang, Sichuan, Peoples R China	Chinese Center for Disease Control & Prevention	Cheng, J; Zhang, H (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.; Wu, JL (corresponding author), Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China.	chengjun@chinacdc.cn; zhanghui@chinacdc.cn; scwjl888@163.com		Zhang, Canyou/0000-0003-1819-5347	China-U.S. Collaborative Program on Tuberculosis Control and Prevention [5U2GGH000018]	China-U.S. Collaborative Program on Tuberculosis Control and Prevention	The study was funded through the China-U.S. Collaborative Program on Tuberculosis Control and Prevention, covered by U.S.-China Emerging Infectious Diseases Cooperative Agreement 5U2GGH000018. LXW, HZ, and JC are recipients of the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adane K, 2019, LANCET GLOB HEALTH, V7, pE482, DOI 10.1016/S2214-109X(18)30477-7; Diel R, 2016, EUR RESPIR J, V47, P575, DOI 10.1183/13993003.01333-2015; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fox GJ, 2018, NEW ENGL J MED, V378, P221, DOI 10.1056/NEJMoa1700209; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Huynh GH, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0341-4; Jiangyou Bureau of Statistics, 2017, JIANG STAT YB 2016; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; National Bureau of Standards (U.S.A), 1957, HDB H, V28, P5; National Bureau of Statistics of the People's Republic of China, 2017, CHIN STAT YB 2017; National Center for Tuberculosis Control and Prevention China CDC, 2018, NAT TUB SURV D UNPUB; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Owiti P, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6334-4; Pande T, 2015, EUR RESPIR J, V46, P1816, DOI 10.1183/13993003.01064-2015; Pratt RH, 2011, J AM GERIATR SOC, V59, P851, DOI 10.1111/j.1532-5415.2011.03369.x; Rajagopalan S, 2016, CLIN GERIATR MED, V32, P479, DOI 10.1016/j.cger.2016.02.006; Sekandi JN, 2014, INT J TUBERC LUNG D, V18, P13, DOI 10.5588/ijtld.13.0129; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Xiao D, 2009, GUIDELINES IMPLEMENT; Yadav RP, 2014, AM J TROP MED HYG, V90, P866, DOI 10.4269/ajtmh.13-0419; Zenner D, 2013, INT J TUBERC LUNG D, V17, P573, DOI 10.5588/ijtld.12.0920; Zhang CY, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0515-y; Zhang CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176581; Zhang H, 2017, HDB GLOBAL TUBERCULO, P471, DOI [10.1007/978-1-4939-6667-7_29, DOI 10.1007/978-1-4939-6667-7_29]	29	0	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214761	10.1371/journal.pone.0214761	http://dx.doi.org/10.1371/journal.pone.0214761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921451	Green Submitted, gold, Green Published			2022-12-27	WOS:000462594000111
J	Polanco, C; de Miera, LES; Gonzalez, AI; Garcia, P; Fratini, R; Vaquero, F; Vences, FJ; de la Vega, MP				Polanco, Carlos; Enrique Saenz de Miera, Luis; Isabel Gonzalez, Ana; Garcia, Pedro; Fratini, Richard; Vaquero, Francisca; Javier Vences, Francisco; Perez de la Vega, Marcelino			Construction of a high-density interspecific (Lens culinaris x L. odemensis) genetic map based on functional markers for mapping morphological and agronomical traits, and QTLs affecting resistance to Ascochyta in lentil	PLOS ONE			English	Article							WILD RELATIVES; WIDE CROSSES; LINKAGE MAP; IDENTIFICATION; HYBRIDIZATION; DIVERSITY; BLIGHT; WHEAT; LOCI; INTROGRESSION	Usage of high-throughput sequencing approaches allow for the generation and characterization of reference transcriptome datasets that support gene-based marker discovery, which in turn can be used to build genetic maps among other purposes. We have obtained a transcriptome assembly including 49,453 genes for the lentil (Lens culinaris Medik.) cultivar Alpo using RNAseq methodology. This transcriptome was used as reference to obtain 6,306 quality polymorphic markers (SNPs and short indels) analyzing genotype data from a RIL population at F-7 generation derived from the interspecific cross between L. culinaris cv. Alpo and L. odemensis accession ILWL235. L. odemensis is a wild species included in the secondary gene pool and can be used as a source for gene introgression in lentil breeding programs. Marker data were used to construct the first genetic interspecific map between these two species. This linkage map has been used to precisely identify regions of the CDC-Redberry lentil draft genome in which the candidate genes for some qualitative traits (seed coat spotting pattern, flower color, and stem pigmentation) could be located. The genome regions corresponding to a significant single quantitative trait locus (QTL) controlling "time to flowering" located in chromosome 6 and three QTLs regulating seed size and positioned in chromosomes 1 and 5 (two QTLs) were also identified. Significant QTLs for Ascochyta blight resistance in lentil were mapped to chromosome 6 in the genome region or close to it where QTLs for Ascochyta blight resistance have previously been reported.	[Polanco, Carlos; Enrique Saenz de Miera, Luis; Isabel Gonzalez, Ana; Garcia, Pedro; Fratini, Richard; Vaquero, Francisca; Javier Vences, Francisco; Perez de la Vega, Marcelino] Univ Leon, Dept Biol Mol, Area Genet, Leon, Spain	Universidad de Leon	Polanco, C (corresponding author), Univ Leon, Dept Biol Mol, Area Genet, Leon, Spain.	carlos.polanco@unileon.es	Sáenz de Miera, Luis/ABA-4573-2021; de Miera, Luis E Sáenz/D-6864-2018; De La Vega, Marcelino Perez/B-7988-2008; Polanco, Carlos/K-7793-2017; Garcia Garcia, Pedro/D-7281-2018	Sáenz de Miera, Luis/0000-0003-1871-7379; de Miera, Luis E Sáenz/0000-0003-1871-7379; De La Vega, Marcelino Perez/0000-0002-1744-7437; Polanco, Carlos/0000-0003-1175-306X; Garcia Garcia, Pedro/0000-0002-3800-7326	Consejeria de Educacion, Junta de Castilla y Leon, Spain [LE005G18]; Spanish Ministerio de Economia y Competitividad - (FEDER funds) [AGL2013-44714-R]	Consejeria de Educacion, Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Spanish Ministerio de Economia y Competitividad - (FEDER funds)	This project was financed by the Consejeria de Educacion, Junta de Castilla y Leon, Spain (grant LE005G18) and the Spanish Ministerio de Economia y Competitividad (grant AGL2013-44714-R, co-financed with FEDER funds).	Abberton MT, 2007, PLANT BREEDING, V126, P337, DOI 10.1111/j.1439-0523.2007.01374.x; Alhakami H, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1213-3; Andrews S., 2010, FASTQC QUALITY CONTR; Ates D, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.e0149210, DOI 10.1371/JOURNAL.PONE.E0149210]; Ates D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191375; Balyan HS, 2002, CARYOLOGIA, V55, P121, DOI 10.1080/00087114.2002.10589267; Bett K, 2016, PLANT AN GEN 25 C SA; Bhadauria V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03463-9; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Dadu RHR, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01038; de la Puente R, 2013, SPAN J AGRIC RES, V11, P132, DOI 10.5424/sjar/2013111-3283; Dempewolf H, 2017, CROP SCI, V57, P1070, DOI 10.2135/cropsci2016.10.0885; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duran Y, 2004, THEOR APPL GENET, V108, P1265, DOI 10.1007/s00122-003-1542-3; Emami MK, 1999, PLANT BREEDING, V118, P579, DOI 10.1046/j.1439-0523.1999.00416.x; ERSKINE W, 1994, THEOR APPL GENET, V88, P423, DOI 10.1007/BF00223655; Eujayl I, 1998, THEOR APPL GENET, V97, P83, DOI 10.1007/s001220050869; Fedoruk MJ, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.05.0012; Fernandez M, 2005, GENOME, V48, P937, DOI 10.1139/g05-052; Fiala JV, 2009, CROP SCI, V49, P825, DOI 10.2135/cropsci2008.05.0260; Ford R, 1999, THEOR APPL GENET, V98, P93, DOI 10.1007/s001220051044; Fratini R, 2007, SPAN J AGRIC RES, V5, P348; Fratini R, 2011, GRAIN LEGUMES, V57, P18; Fratini R, 2006, EUPHYTICA, V150, P271, DOI 10.1007/s10681-006-9118-3; Fratini R, 2011, METHODS MOL BIOL, V710, P131, DOI 10.1007/978-1-61737-988-8_11; Galasso I, 2003, GENOME, V46, P1118, DOI [10.1139/g03-077, 10.1139/G03-077]; Gorim LY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01129; Gujaria-Verma N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00676; Gupta D, 2012, MOL BREEDING, V30, P429, DOI 10.1007/s11032-011-9634-2; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HAVEY MJ, 1989, THEOR APPL GENET, V77, P395, DOI 10.1007/BF00305835; Hoque M. E., 2002, Indian Journal of Genetics and Plant Breeding, V62, P5; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Khazaei H, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.06.0051; Khorramdelazad M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4488-1; Kumar J, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2155-x; Kumar J, 2014, PHYSIOL MOL BIOL PLA, V20, P125, DOI 10.1007/s12298-013-0214-2; Kumar Y, 2005, J LENTIL RES, V2, P22; LADIZINSKY G, 1993, CRIT REV PLANT SCI, V12, P169, DOI 10.1080/713608047; LADIZINSKY G, 1979, J HERED, V70, P135, DOI 10.1093/oxfordjournals.jhered.a109209; Ladizinsky G, 2015, SPRINGERBR PLANT SCI, P1, DOI 10.1007/978-3-319-14505-1_1; LAL S, 1975, INDIAN J GENET PL BR, V35, P29; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu TY, 2012, PLANT CELL, V24, P2168, DOI 10.1105/tpc.112.096636; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; MUEHLBAUER FJ, 1994, EUPHYTICA, V73, P109, DOI 10.1007/BF00027187; Mujeeb-Kazi A, 2013, ADV AGRON, V122, P179, DOI 10.1016/B978-0-12-417187-9.00004-8; Nelson R, 2018, NAT REV GENET, V19, P21, DOI 10.1038/nrg.2017.82; Ocampo B, 2000, CURR PLANT SCI BIOT, V34, P411; Ogutcen E, 2018, APPL PLANT SCI, V6, DOI 10.1002/aps3.1165; Outchkourov NS, 2018, PLANT PHYSIOL, V176, P1862, DOI 10.1104/pp.17.01662; Perez de la Vega M., 2011, Genetics, genomics and breeding of cool season grain legumes, P98; Piaskowski J, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1961-x; Poirier Yves, 2002, Arabidopsis Book, V1, pe0024, DOI 10.1199/tab.0024; R Core Team, 2015, R LANGUAGE ENV STAT; Rodda MS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01136; Rubeena, 2006, PLANT BREEDING, V125, P506, DOI 10.1111/j.1439-0523.2006.01259.x; Sari E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204124; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma DR, 1996, EUPHYTICA, V89, P325; SHARMA HC, 1995, EUPHYTICA, V82, P43, DOI 10.1007/BF00028709; Sharma S, 2017, CROP SCI, V57, P1132, DOI 10.2135/cropsci2017.01.0033; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Singh D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3596-7; Singh M, 2018, PLANT BREEDING, V137, P470, DOI 10.1111/pbr.12615; Singh M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01162; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107781; Singh M, 2013, PLANT BREEDING, V132, P667, DOI 10.1111/pbr.12089; Sudheesh S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01604; Suvorova G. N., 2014, Russian Agricultural Sciences, V40, P22, DOI 10.3103/S1068367414010182; TADMOR Y, 1987, THEOR APPL GENET, V73, P883, DOI 10.1007/BF00289394; VANDENBERG A, 1990, J HERED, V81, P484, DOI 10.1093/oxfordjournals.jhered.a111030; Verma P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139666; Voss-Fels K, 2016, PLANT BIOTECHNOL J, V14, P1086, DOI 10.1111/pbi.12456; Warschefsky E, 2014, AM J BOT, V101, P1791, DOI 10.3732/ajb.1400116; Wong MML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122025; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Wulff BBH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00692; Yu YM, 2018, BIOINFORMATICS, V34, P1229, DOI 10.1093/bioinformatics/btx763; Zaim M, 2017, FIELD CROP RES, V214, P219, DOI 10.1016/j.fcr.2017.09.007; Zeng HQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00877; Zhang HY, 2017, EVOL APPL, V10, P5, DOI 10.1111/eva.12434; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z	89	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214409	10.1371/journal.pone.0214409	http://dx.doi.org/10.1371/journal.pone.0214409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917174	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800064
J	Nagoshi, RN				Nagoshi, Rodney N.			Evidence that a major subpopulation of fall armyworm found in the Western Hemisphere is rare or absent in Africa, which may limit the range of crops at risk of infestation	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; NOCTUIDAE HOST STRAINS; FIELD COLLECTIONS; CENTRAL COLOMBIA; UNITED-STATES; RICE STRAINS; PUERTO-RICO; POPULATIONS; CORN; TEXAS	The introduction and establishment of fall armyworm (Spodoptera frugiperda) in Africa presents a major threat to agriculture in that continent and potentially to the entire Eastern Hemisphere. The species is subdivided into two subpopulations called the R-strain and C-strain that differ in their distribution on different plant hosts. This means that the scope of the economic risk posed by invasive fall armyworm is influenced by whether one or both strains are present. Multiple studies have found mitochondrial markers diagnostic of the two strains throughout Africa but there is substantial disagreement with a nuclear strain marker that makes conclusions about strain composition uncertain. In this study the issue of whether both strains are present in Africa was tested by an assay that can detect strain-biased mating behaviors. Western Hemisphere fall armyworm consistently showed evidence of strain-specific assortative mating in the field that was not found in surveys from multiple locations in Africa. The absence of strain mating biases and the disagreements between the strain diagnostic genetic markers indicates that the R-strain is rare (<1% of the population) or absent in Africa. Instead, it appears that the African fall armyworm populations are dominated by two groups, the C-strain and the descendants of interstrain hybrids. These results suggest that plant hosts associated with the R-strain may not be at high risk of fall armyworm infestation in Africa.	[Nagoshi, Rodney N.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32611 USA	United States Department of Agriculture (USDA)	Nagoshi, RN (corresponding author), ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32611 USA.	Rodney.nagoshi@ARS.USDA.GOV			United States Department of Agriculture-Agricultural Research Service [6036-22000-030-00D, 6615-22000-016-00D]; United States Agency for International Development [8044-22000-046-06R]	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United States Agency for International Development(United States Agency for International Development (USAID))	R.N.N. received funding from United States Department of Agriculture-Agricultural Research Service (6036-22000-030-00D and 6615-22000-016-00D) and the United States Agency for International Development (8044-22000-046-06R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk J. J. Jr., 1997, Journal of Cotton Science, V1, P21; Canas-Hoyos N, 2016, NEOTROP ENTOMOL, V45, P411, DOI 10.1007/s13744-016-0393-y; Canas-Hoyos N, 2014, ANN ENTOMOL SOC AM, V107, P575, DOI 10.1603/AN12154; Cock MJW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04238-y; Day R., 2017, Outlooks on Pest Management, V28, P196, DOI 10.1564/v28_oct_02; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Murua MG, 2015, J ECON ENTOMOL, V108, P2305, DOI 10.1093/jee/tov203; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; Ingber DA, 2018, J ECON ENTOMOL, V111, P361, DOI 10.1093/jee/tox311; Kost S, 2016, EVOLUTION, V70, P1418, DOI 10.1111/evo.12940; Juarez ML, 2012, J ECON ENTOMOL, V105, P573, DOI 10.1603/EC11184; Lima ER, 2009, CHEMOECOLOGY, V19, P29, DOI 10.1007/s00049-009-0005-y; Lu Y.-J., 1994, Insect Molecular Biology, V3, P123, DOI 10.1111/j.1365-2583.1994.tb00159.x; Lu YJ, 1996, FLA ENTOMOL, V79, P48, DOI 10.2307/3495753; LUGINBILL PHILIP, 1928, U S DEPT AGRIC TECH BULL, V34, P1; Nagoshi RN, 2016, INSECT MOL BIOL, V25, P324, DOI 10.1111/imb.12223; Nagoshi RN, 2006, J ECON ENTOMOL, V99, P671, DOI 10.1603/0022-0493-99.3.671; Nagoshi RN, 2004, ENVIRON ENTOMOL, V33, P881, DOI 10.1603/0046-225X-33.4.881; Nagoshi RN, 2003, INSECT MOL BIOL, V12, P453, DOI 10.1046/j.1365-2583.2003.00429.x; Nagoshi RN, 2003, ANN ENTOMOL SOC AM, V96, P329, DOI 10.1603/0013-8746(2003)096[0329:FTSIFA]2.0.CO;2; Nagoshi RN, 2017, PLOS ONE, V12; Nagoshi RN, 2007, ANN ENTOMOL SOC AM, V100, P394, DOI 10.1603/0013-8746(2007)100[394:IACOFA]2.0.CO;2; Nagoshi RN, 2008, J ECON ENTOMOL, V101, P742, DOI 10.1603/0022-0493(2008)101[742:UHTMTM]2.0.CO;2; Nagoshi RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21954-1; Nagoshi RN, 2017, J ECON ENTOMOL, V110, P2568, DOI 10.1093/jee/tox229; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171743; Nagoshi RN, 2016, J ECON ENTOMOL, V109, P2115, DOI 10.1093/jee/tow177; Nagoshi RN, 2015, J ECON ENTOMOL, V108, P135, DOI 10.1093/jee/tou044; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Nagoshi RN, 2012, J ECON ENTOMOL, V105, P418, DOI 10.1603/EC11332; Nagoshi RN, 2012, ANN ENTOMOL SOC AM, V105, P351, DOI 10.1603/AN11138; Nagoshi RN, 2010, J ECON ENTOMOL, V103, P360, DOI 10.1603/EC09253; Nagoshi RN, 2010, ANN ENTOMOL SOC AM, V103, P283, DOI 10.1603/AN09046; Nagoshi RN, 2009, ENVIRON ENTOMOL, V38, P1546, DOI 10.1603/022.038.0605; Otim MH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194571; Pashley D.P., 1989, Systematics Association Special Volume Series, P103; PASHLEY DP, 1987, ANN ENTOMOL SOC AM, V80, P731, DOI 10.1093/aesa/80.6.731; PASHLEY DP, 1988, FLA ENTOMOL, V71, P227, DOI 10.2307/3495425; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; PASHLEY DP, 1992, ANN ENTOMOL SOC AM, V85, P400, DOI 10.1093/aesa/85.4.400; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; Rios-Diez JD, 2011, J ECON ENTOMOL, V104, P1698, DOI 10.1603/EC11079; Schofl G, 2009, J EVOLUTION BIOL, V22, P1447, DOI 10.1111/j.1420-9101.2009.01759.x; Schofl G, 2011, AM NAT, V177, P470, DOI 10.1086/658904; Stokstad E, 2017, SCIENCE, V356, P473, DOI 10.1126/science.356.6337.473; Unbehend M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089255; Unbehend M, 2013, J CHEM ECOL, V39, P364, DOI 10.1007/s10886-013-0263-6	49	24	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0208966	10.1371/journal.pone.0208966	http://dx.doi.org/10.1371/journal.pone.0208966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947263	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500005
J	Maenetje, P; Lindan, C; Makkan, H; Chetty-Makkan, CM; Latka, MH; Charalambous, S; Mlotshwa, M; Malefo, M; Brumskine, W; Hills, NK; Price, MA; Edward, V				Maenetje, Pholo; Lindan, Christina; Makkan, Heeran; Chetty-Makkan, Candice M.; Latka, Mary H.; Charalambous, Salome; Mlotshwa, Mandla; Malefo, Matshidiso; Brumskine, William; Hills, Nancy K.; Price, Matthew A.; Edward, Vinodh			HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; RISK; ADOLESCENTS; POPULATION; PREVALENCE; INFECTION; COMMUNITY; COHORT	Introduction Understanding HIV incidence and risk behaviour among populations being considered for HIV vaccine studies is necessary for the appropriate design of trials. Methods Between May 2012 and June 2015, we recruited men aged 18-49 years from urban and peri-urban areas of Rustenburg, a mining town in the North West Province, South Africa. Men who reported HIV-risk behaviour were followed for nine to 12 months to determine HIV incidence and factors associated with condom use. Results A total of 400 HIV uninfected men were enrolled; 366 (91.5%) had at least one follow-up visit and were included in the analysis; 47.6% were under 25 years of age. HIV incidence was 1.9 per 100 person-years (95% CI: 0.79-4.56). Among heterosexual men (N = 339), 80.8% reported having vaginal intercourse with multiple partners in the past three months, among whom 74.1% reported inconsistent condom use. Sixty-eight percent reported vaginal intercourse with new female partners, of whom 40.6% reported inconsistent condom use. Over half (55.6%) of men who had sex with men (N = 27) reported anal intercourse with multiple male partners in the past three months, of whom 68.2% reported using condoms inconsistently. Men who had more than two female partners in the last three months (n = 121) were more likely to use condoms inconsistently (aOR 4.31, 95% CI: 1.34-13.8); in contrast, those with more than one new female sex partner (aOR 0.13, 94% CI 0.04-0.44), and whose sexual debut was after 19 years of age (aOR 0.39, 95% CI: 0.15-1.01) were less likely to use condoms inconsistently. Conclusion HIV incidence was low and similar to other studies of heterosexual men in South Africa. To identify men at high risk for HIV for enrolment in prevention trials, future researchers may need to focus on those who report early sexual debut and who report having multiple sexual partners. Men in newer relationships appear to use condoms more frequently.	[Maenetje, Pholo; Makkan, Heeran; Chetty-Makkan, Candice M.; Latka, Mary H.; Charalambous, Salome; Mlotshwa, Mandla; Malefo, Matshidiso; Brumskine, William; Edward, Vinodh] Aurum Inst, Johannesburg, South Africa; [Maenetje, Pholo; Charalambous, Salome; Mlotshwa, Mandla; Edward, Vinodh] South African Med Res Council, Collaborating Ctr, Adv Care & Treatment TB HIV, Johannesburg, South Africa; [Maenetje, Pholo; Mlotshwa, Mandla; Edward, Vinodh] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Lindan, Christina; Hills, Nancy K.; Price, Matthew A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Charalambous, Salome] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Price, Matthew A.] Int AIDS Vaccine Initiat, New York, NY USA	South African Medical Research Council; University of Witwatersrand; University of California System; University of California San Francisco; University of Witwatersrand; International AIDS Vaccine Initiative	Maenetje, P (corresponding author), Aurum Inst, Johannesburg, South Africa.; Maenetje, P (corresponding author), South African Med Res Council, Collaborating Ctr, Adv Care & Treatment TB HIV, Johannesburg, South Africa.; Maenetje, P (corresponding author), Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa.	pmaenetje@auruminstitute.org	Price, Matt/AAK-6881-2021; Makkan, Heeran/GXI-0465-2022	Price, Matt/0000-0002-2918-1373; Charalambous, Salome/0000-0001-7143-1009; Maenetje, Pholo/0000-0001-6063-4353; Brumskine, William/0000-0002-1092-9919; Makkan, Heeran/0000-0002-4737-7804	US Agency for International Development (USAID) [GPO-A-00-05-00022-00]; Contraceptive and Reproductive Health Technologies Research and Utilisation (CRTU) Program; University of California; San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS); U.S. NIMH [R25MH064712]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); Contraceptive and Reproductive Health Technologies Research and Utilisation (CRTU) Program; University of California(University of California System); San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS); U.S. NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the US Agency for International Development (USAID) under Cooperative Agreement No. GPO-A-00-05-00022-00 and the Contraceptive and Reproductive Health Technologies Research and Utilisation (CRTU) Program. The funders were involved in the study design of the protocols that were implemented at the site. The Aurum Institute conceptualized the idea for the manuscript and the funders provided technical guidance. We wish to acknowledge the support from the University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH, R25MH064712 and the International AIDS Vaccine Initiative.	Abaasa A, 2016, VACCINE, V34, P1778, DOI 10.1016/j.vaccine.2016.02.048; Baldwin Patrick, 2013, ISRN AIDS, V2013, P976035, DOI 10.1155/2013/976035; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bojanala Platinum District Municipality, 2017, FIN INT DEV PLAN 201; Cauchois, 2014, CONTRACEPTIVES PREDI, P157; Chamratrithirong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042009; Fearon E, 2017, J INT AIDS SOC, V20, DOI 10.1002/jia2.25029; Feldblum PJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000626; Hargreaves JR, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000300534.97601.d6; Justman J, 2017, LANCET HIV, V4, pE83, DOI 10.1016/S2352-3018(16)30190-4; Kamali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116100; KARIM QA, 1992, AIDS, V6, P1535, DOI 10.1097/00002030-199212000-00018; Karim QA, 2012, AIDS BEHAV, V16, P1870, DOI 10.1007/s10461-012-0209-y; KU L, 1994, FAM PLANN PERSPECT, V26, P246, DOI 10.2307/2135889; Lane T, 2016, JAIDS-J ACQ IMM DEF, V73, P609, DOI 10.1097/QAI.0000000000001162; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Metch B, 2013, AIDS BEHAV, V17, P760, DOI 10.1007/s10461-012-0351-6; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Morris L, 2014, AIDS CARE, V26, P1440, DOI 10.1080/09540121.2014.920948; Muchiri E, 2017, SOUTH AFR J INFECT D, V32, P105, DOI 10.1080/23120053.2017.1332800; National Department of health Republic of South Africa,, 2013, 2013 NAT ANT SENT HI; Ramjee G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153969; Ramjee G, 2012, AIDS BEHAV, V16, P2062, DOI 10.1007/s10461-011-0043-7; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020684; Shai NJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-462; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Shisana O, 2014, S AFRICAN NATL HIV P; UNAIDS, 2017, DATA BOOK; UNAIDS, PREV GAP REP 2016; WHO, GUID START ANT THER	30	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214786	10.1371/journal.pone.0214786	http://dx.doi.org/10.1371/journal.pone.0214786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943254	Green Published, gold			2022-12-27	WOS:000463194300061
J	Amin, S; Rattner, J; Keramati, MR; Farshidfar, F; McNamara, MG; Knox, JJ; Kopciuk, K; Vogel, HJ; Bathe, OF				Amin, Shahil; Rattner, Jodi; Keramati, Mohammad Reza; Farshidfar, Farshad; McNamara, Mairead G.; Knox, Jennifer J.; Kopciuk, Karen; Vogel, Hans J.; Bathe, Oliver F.			A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome	PLOS ONE			English	Article							BEVACIZUMAB; THERAPY; RECIST	We describe a biomarker-based approach to delivering chemotherapy that entails monitoring treatment changes in the circulating metabolome that reflect efficacy. In-vitro, multiple tumor cell lines were exposed to numerous chemotherapeutics. Supernatants were collected at baseline and 72 hours post treatment. MTT assays were used to quantify growth inhibition. Clinical samples were derived from a phase II clinical trial of second-line axitinib in patients with advanced hepatocellular carcinoma. Sera were collected at baseline and 2-4 weeks after treatment initiation. Response to therapy was estimated by CT scan at 8 weeks. Samples were analyzed by gas chromatography-mass spectrometry to identify metabolomic changes associated with response. In vitro, we found drug-specific and generalizable patterns of change in the extracellular metabolome accompany growth inhibition. A cell death signature was also identified. This approach was also applied to clinical samples. While the in vitro signatures were detectable in vivo, a more robust signal was identified clinically that appeared within 4 weeks of administering drug that distinguished individuals with a treatment response. These changes were extinguished as tumor growth resumed. Serial monitoring of the metabolome during chemotherapy is a means to follow treatment efficacy and emergence of resistance, informing the oncologist whether to modify treatment.	[Amin, Shahil; Rattner, Jodi; Keramati, Mohammad Reza; Farshidfar, Farshad; Bathe, Oliver F.] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada; [Keramati, Mohammad Reza] Univ Tehran Med Sci, Dept Surg, Tehran, Iran; [McNamara, Mairead G.] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England; [McNamara, Mairead G.] Univ Manchester, Div Canc Sci, Manchester, Lancs, England; [Knox, Jennifer J.] Princess Margaret Canc Ctr, Dept Oncol, Toronto, ON, Canada; [Knox, Jennifer J.] Univ Toronto, Toronto, ON, Canada; [Kopciuk, Karen] Univ Calgary, Dept Math & Biostat, Calgary, AB, Canada; [Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Oncol, Calgary, AB, Canada	University of Calgary; Tehran University of Medical Sciences; Christie NHS Foundation Trust; University of Manchester; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Bathe, OF (corresponding author), Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada.; Bathe, OF (corresponding author), Univ Calgary, Dept Surg, Calgary, AB, Canada.; Bathe, OF (corresponding author), Univ Calgary, Dept Oncol, Calgary, AB, Canada.	bathe@ucalgary.ca	Keramati, Mohammad Reza/B-4144-2013; Mcnamara, Mairead/J-1621-2015; Farshidfar, Farshad/B-7317-2008	Keramati, Mohammad Reza/0000-0003-0099-7114; Mcnamara, Mairead/0000-0002-2272-3678; Farshidfar, Farshad/0000-0003-3674-7336	Breast Cancer Society of Canada; Cancer Strategic Clinical Network (Alberta Health Services); Alberta Cancer Foundation	Breast Cancer Society of Canada; Cancer Strategic Clinical Network (Alberta Health Services); Alberta Cancer Foundation	OFB received funding for the study from the Breast Cancer Society of Canada (https://bcsc.ca/) and from the Cancer Strategic Clinical Network (Alberta Health Services). HJV was supported by the Alberta Cancer Foundation (https://www.albertacancer.ca/) and holds the Lance Armstrong Chair in Molecular Epidemiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No grant numbers have been provided by the granting agencies.	Alonezi S, 2017, METABOLITES, V7, DOI 10.3390/metabo7020014; [Anonymous], NON TRADITIONAL REF, DOI [10.1186/1471-2407-12-39, DOI 10.1186/1471-2407-12-39]; Borgan E, 2013, MOL ONCOL, V7, P130, DOI 10.1016/j.molonc.2012.10.005; Cao MD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-39; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Euceda LR, 2017, J PROTEOME RES, V16, P1868, DOI 10.1021/acs.jproteome.6b00918; Farshidfar F, 2012, GENOME MED, V4, DOI 10.1186/gm341; Huang G, 2014, EUR J PHARMACOL, V729, P132, DOI 10.1016/j.ejphar.2014.01.048; Jobard E, 2015, BRIT J CANCER, V113, P1148, DOI 10.1038/bjc.2015.322; Lastoria S, 2013, J NUCL MED, V54, P2062, DOI 10.2967/jnumed.113.119909; McNamara MG, 2015, CANCER-AM CANCER SOC, V121, P1620, DOI 10.1002/cncr.29227; McNamara MG, 2014, ANN M AM SOC CLIN ON, P39, DOI [10.1186/1471-2407-12-39, DOI 10.1186/1471-2407-12-39]; Morvan D, 2007, CANCER RES, V67, P2150, DOI 10.1158/0008-5472.CAN-06-2346; Pan D, 2016, INT J MOL SCI, P17; Tiziani S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1562; Weaver Z, 2012, CANCER RES, V72, P5921, DOI 10.1158/0008-5472.CAN-12-0736	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213942	10.1371/journal.pone.0213942	http://dx.doi.org/10.1371/journal.pone.0213942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939138	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900011
J	Jurga-Karwacka, A; Karwacki, GM; Schoetzau, A; Zech, CJ; Heinzelmann-Schwarz, V; Schwab, FD				Jurga-Karwacka, Agnieszka; Karwacki, Grzegorz M.; Schoetzau, Andreas; Zech, Christoph J.; Heinzelmann-Schwarz, Viola; Schwab, Fabienne D.			A forgotten disease: Pelvic congestion syndrome as a cause of chronic lower abdominal pain	PLOS ONE			English	Article							DIAGNOSIS; REFLUX; WOMEN; VEIN	Objectives Pelvic congestion syndrome is defined as chronic pelvic pain due to incompetent (dilated and refluxing) pelvic veins. The aim of this study was to investigate the prevalence of this condition by examining the prevalence of dilated ovarian and para-uterine veins in pre- and postmenopausal female patients, irrespective of their symptoms. We subsequently investigated how many women with dilated veins suffered from chronic pelvic pain. Additionally, we attempted to define diagnostic criteria that may allow for early identification of affected patients. Methods We reassessed 2384 abdomino-pelvic computed tomography scans performed on women at our institution. The maximal diameters of the ovarian and para-uterine veins were measured. Patients with a pathological process in the abdomen or pelvis affecting the veins were excluded. We considered ovarian vein dilation to be 6 mm or more in the axial plane. For patients that met these criteria, we performed a retrospective chart review to evaluate the clinical presentation and/or symptoms of these patients. Results Dilated pelvic veins were present in 293/2384 (12%) patients, 118/559 premenopausal (21%) and 175/1825 postmenopausal (10%). Chronic pelvic pain of unclear etiology had been documented prior to the CT in 54/293 (18%) women with dilated veins-2% of the whole study collective (54/2384); 8% of all premenopausal (44/559) and 0.5% of all postmenopausal (10/1825). It was often accompanied by urological symptoms such as hematuria, dysuria, and urinary frequency, in the absence of infection (p<0.05). We identified a strong correlation between the presence of dilated ovarian veins and chronic pelvic pain in premenopausal parous patients with hematuria. Conclusions Pelvic congestion syndrome appears to be an underdiagnosed and undertreated disease. In our study, 3% of all premenopausal women had documented chronic pelvic pain of unclear etiology and dilated ovarian and pelvic veins on cross-sectional imaging studies. The features we identified in this study as most relevant should enable a faster identification of patients who could benefit from a specific treatment regimen for this condition.	[Jurga-Karwacka, Agnieszka; Heinzelmann-Schwarz, Viola; Schwab, Fabienne D.] Univ Basel, Dept Gynecol & Gynecol Oncol, Univ Womens Hosp Basel, Basel, Switzerland; [Karwacki, Grzegorz M.; Zech, Christoph J.] Univ Basel, Clin Radiol & Nucl Med, Univ Basel Hosp, Basel, Switzerland; [Schoetzau, Andreas; Heinzelmann-Schwarz, Viola] Univ Basel, Dept Biomed, Ovarian Canc Res, Basel, Switzerland	University of Basel; University of Basel; University of Basel	Schwab, FD (corresponding author), Univ Basel, Dept Gynecol & Gynecol Oncol, Univ Womens Hosp Basel, Basel, Switzerland.	fabienne.schwab@usb.ch		Heinzelmann-Schwarz, Viola/0000-0002-4056-3225				Asciutto G, 2008, EUR J VASC ENDOVASC, V36, P491, DOI 10.1016/j.ejvs.2008.06.024; BEARD RW, 1988, BRIT J OBSTET GYNAEC, V95, P153, DOI 10.1111/j.1471-0528.1988.tb06845.x; BEARD RW, 1984, LANCET, V2, P946; BEINART C, 1982, RADIOLOGY, V145, P647, DOI 10.1148/radiology.145.3.7146391; Belenky A, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790625; Burak F, 2009, PHLEBOLYMPHOLOGY, V16, P290; Champaneria R, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20050; Ganeshan A, 2007, CARDIOVASC INTER RAD, V30, P1105, DOI 10.1007/s00270-007-9160-0; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Hiromura T, 2004, AM J ROENTGENOL, V183, P1411, DOI 10.2214/ajr.183.5.1831411; HOBBS JT, 1990, BRIT J HOSP MED, V43, P200; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Howard FM, 2003, OBSTET GYNECOL, V101, P594, DOI 10.1016/S0029-7844(02)02723-0; Ignacio Elizabeth A, 2008, Semin Intervent Radiol, V25, P361, DOI 10.1055/s-0028-1102998; Jaskolka JD, 2010, CAN ASSOC RADIOL J, V61, P223, DOI 10.1016/j.carj.2009.11.006; KAUFMAN JA, 1995, CARDIOVASC INTER RAD, V18, P153; Kies DD, 2012, PHLEBOLOGY, V27, P52, DOI [10.1258/phleb.2012.012S27, 10.1258/phleb.2012.012s27]; Koc Z, 2007, EUR RADIOL, V17, P1267, DOI 10.1007/s00330-006-0440-x; Labropoulos N, 1997, J VASC SURG, V26, P736, DOI 10.1016/S0741-5214(97)70084-3; Malgor RD, 2014, J VASC SURG-VENOUS L, V2, P34, DOI 10.1016/j.jvsv.2013.06.004; Motta-Ramirez Gaspar Alberto, 2013, Ginecol Obstet Mex, V81, P389; Nasser F, 2014, INT J GYNECOL OBSTET, V125, P65, DOI 10.1016/j.ijgo.2013.10.008; Nicholson T, 2006, TECH VASC INTERV RAD, V9, P19, DOI 10.1053/j.tvir.2006.08.005; Park SJ, 2004, AM J ROENTGENOL, V182, P683, DOI 10.2214/ajr.182.3.1820683; Rozenblit AM, 2001, AM J ROENTGENOL, V176, P119, DOI 10.2214/ajr.176.1.1760119; Sharma D, 2011, ARCH GYNECOL OBSTET, V283, P295, DOI 10.1007/s00404-010-1354-z; Soysal ME, 2001, HUM REPROD, V16, P931, DOI 10.1093/humrep/16.5.931; Stones RW, 2003, CLIN OBSTET GYNECOL, V46, P831, DOI 10.1097/00003081-200312000-00013; TAYLOR HC, 1959, J OBSTET GYNAECOL, V66, P781; TAYLOR HC, 1949, RES PUBL ASSOC RES N, V29, P1051; Yang DM, 2012, BRIT J RADIOL, V85, pE117, DOI 10.1259/bjr/79155839	31	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213834	10.1371/journal.pone.0213834	http://dx.doi.org/10.1371/journal.pone.0213834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939134	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900009
J	Duvivier, RJ; Boulet, J; Qu, JZ				Duvivier, Robbert J.; Boulet, John; Qu, Jason Z.			The contribution of Chinese-educated physicians to health care in the United States	PLOS ONE			English	Article							MEDICAL-EDUCATION; SYSTEM REFORM; PROFESSIONALS; DOCTORS	Background Migration of physicians has been a cause for global concern. In China, reforms of the higher education and healthcare systems have led to a shortage of postgraduate training positions relative to the number of medical graduates. Medical graduates opt for non-clinical roles or move abroad to pursue further training and practice opportunities. The impact of this physician migration is not known. This study quantifies where Chinese migrant physicians to the U.S. were educated, where they went to practice, and how these trends have changed over time. Methods We combined data on physician characteristics from the 2008 and 2017 American Medical Association Physician Masterfiles with demographic information from the Educational Commission for Foreign Medical Graduates. Using a repeated cross-sectional approach, we reviewed the available data, including citizenship at entry to medical school, medical school attended, practice specialty, and practice location. Results The number of Chinese-educated physicians (CEPs) to the United States (US) has increased over the past 10 years, from 3,878 in 2008 to 5,355 in 2017 (+38.1%). The majority held Chinese citizenship at entry to medical school (98.4% vs 97.1%) with the remainder being citizens of other East Asian nations. Of the Chinese citizens identified in 2008, 913 (19.3%) attended medical school outside of China; in 2017, 376 (6.7%) attended medical school outside of China, representing a decrease of 58.8%. Overall, in 2017, four Chinese medical schools provided 32.1% of all Chinese-educated physicians in the US. Over 50% of the CEPs were practicing in Internal Medicine, Anatomic/Clinical Pathology, Anesthesiology, Family Medicine or Neurology. Compared with all IMGs, CEPs are more likely to be Anatomic/Clinical Pathologists and Anesthesiologists. CEPs were concentrated in several states, including New York, California and Massachusetts. In 2017, a lower proportion of CEPs in the US healthcare workforce were in residency training, compared to 2008 (13.2% vs 22.8%). Conclusions Unlike trends from some other South Asian countries, the number of CEPs in the US has increased over the past 10 years. Migration trends may vary depending on citizenship and country of medical school training. The majority of Chinese-educated graduates come to the US from relatively few medical schools. Fewer CEPs currently in residency training might indicate lower success rates in securing GME training in the US.	[Duvivier, Robbert J.; Boulet, John] Fdn Adv Int Med Educ & Res, Philadelphia, PA 19104 USA; [Duvivier, Robbert J.] Parnassia Psychiat Inst, The Hague, Netherlands; [Qu, Jason Z.] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA	Parnassia Psychiatric Institute; Harvard University; Massachusetts General Hospital	Duvivier, RJ (corresponding author), Fdn Adv Int Med Educ & Res, Philadelphia, PA 19104 USA.; Duvivier, RJ (corresponding author), Parnassia Psychiat Inst, The Hague, Netherlands.	robbert.duvivier@parnassiagroep.nl	Duvivier, Robbert J/G-7479-2011	Duvivier, Robbert J/0000-0001-8282-1715; Boulet, John/0000-0003-3703-5613				*AM IMM COUNC, 2018, FOREIGN TRAINED DOCT; An JG, 2013, LANCET, V382, P936, DOI 10.1016/S0140-6736(13)61928-5; Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X; *ASS AM MED COLL, A SNAPSHOT OF THE NE; Astor A, 2005, SOC SCI MED, V61, P2492, DOI 10.1016/j.socscimed.2005.05.003; Boulet JR, 2006, HEALTH AFFAIR, V25, P469, DOI 10.1377/hlthaff.25.2.469; Duvivier R, 2013, LANCET, V381, pE10, DOI 10.1016/S0140-6736(13)60932-0; Duvivier RJ, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0217-0; Duvivier RJ, 2017, LANCET, V389, P1603, DOI 10.1016/S0140-6736(17)30944-3; Duvivier RJ, 2014, LANCET, V384, P2108, DOI 10.1016/S0140-6736(14)62369-2; Duvivier RJ, 2014, MED EDUC, V48, P860, DOI 10.1111/medu.12499; *ECFMG, ECFMG 2018 INFORMATI; HAWKINS RE, 2005, J MED LICENSURE DISC, V91, P21; Hou JL, 2014, LANCET, V384, P819, DOI 10.1016/S0140-6736(14)61307-6; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Jiang YS, 2014, LANCET, V384, P744, DOI 10.1016/S0140-6736(14)61437-9; Lam TP, 2006, MED EDUC, V40, P940, DOI 10.1111/j.1365-2929.2006.02552.x; Lixu Li, 2004, Asia Pacific Education Review, V5, P14; Mullan F, 2015, NEW ENGL J MED, V373, P2397, DOI 10.1056/NEJMp1511707; Putting Chinese doctors to the US medical test, 2014, MAIN MATCH RESULTS A; SCHOORL J, 2000, PUSH AND PULL FACTOR; van Zanten M, 2011, ACAD MED, V86, P231, DOI 10.1097/ACM.0b013e3182045efe; van Zanten M, 2008, ACAD MED, V83, pS33, DOI 10.1097/ACM.0b013e318183e649; VIZI ES, 1993, TECHNOL SOC, V15, P101, DOI 10.1016/0160-791X(93)90029-N; Wan Xuehong, 2013, J Evid Based Med, V6, P19, DOI 10.1111/jebm.12023; Wang H, 2015, POL DEVEL CONTEMP CH, P1, DOI [10.1057/9781137450609, 10.1109/IGCC.2015.7393723]; Whelan GP, 1999, MED TEACH, V21, P156, DOI 10.1080/01421599979789; Williams P T, 1996, J Am Board Fam Pract, V9, P94; Wu D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006431; Yip W, 2009, CHINA ECON REV, V20, P613, DOI 10.1016/j.chieco.2009.08.003; Zhan H.J., 2004, MARRIAGE FAM REV, V36, P175, DOI DOI 10.1300/J002V36N01_08; Zhang YT, 2006, J AGING STUD, V20, P151, DOI 10.1016/j.jaging.2005.07.002; ZHU J, 2016, LANCET; Zhu JM, 2016, LANCET, V388, P1922, DOI 10.1016/S0140-6736(16)00582-1; Zweig D, 2006, J INT MIGR INTEGR, V7, P449; 2014, SOUTH CHINA MORNING	36	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214378	10.1371/journal.pone.0214378	http://dx.doi.org/10.1371/journal.pone.0214378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30933988	Green Published, gold, Green Submitted			2022-12-27	WOS:000462867000015
J	Otoyama, I; Hamada, H; Kimura, T; Namba, H; Sekikawa, K; Kamikawa, N; Kajiwara, T; Aizawa, F; Sato, YM				Otoyama, Ippo; Hamada, Hironobu; Kimura, Tatsushi; Namba, Haruchi; Sekikawa, Kiyokazu; Kamikawa, Norimichi; Kajiwara, Teruki; Aizawa, Fumiya; Sato, Yoshinobu M.			L-cysteine improves blood fluidity impaired by acetaldehyde: In vitro evaluation	PLOS ONE			English	Article							MICROCHANNELS; FLOW	Blood fluidity is reportedly influenced by the volume and function of blood cells and plasma and is a predictor of primary cardiovascular events in patients with traditional cardiovascular risk factors. Heavy alcohol consumption was shown to be associated with a higher risk for cardiovascular diseases. Acetaldehyde (ACD), an oxidizing substance formed from ethanol, reportedly stimulates monocyte adhesion, causes abnormalities in the red blood cell (RBC) membrane, and decreases RBC deformability. In addition, it was reported that blood ACD levels are reduced in mice pretreated with L-cysteine. However, there are no studies on the effect of ACD and/or L-cysteine on blood fluidity. In the present study, we evaluated whether ACD impairs blood fluidity. In addition, the effect of L-cysteine on blood fluidity impaired by ACD was examined. Blood samples were obtained from 10 healthy, non-smoking, male volunteers (age: 23.4 +/- 1.2 years, body mass index: 21.8 +/- 2.6 kg/m(2)). ACD or ACD and L-cysteine were added to the blood samples before each experiment. We measured the passage time of 100 mu L blood and RBC suspension using Kikuchi's microchannel method. Percentage of microchannel obstruction and the number of adherent white blood cells (WBCs) on microchannel terrace were counted. The blood passage time, percentage of microchannel obstruction, and numbers of adherent WBCs on the microchannel terrace increased after adding ACD in a concentration-dependent manner, whereas they decreased after adding ACD and L-cysteine in a L-cysteine concentration-dependent manner. No significant effects were observed in passage time for 100 mu L RBC suspension after adding ACD and L-cysteine. This study suggested that blood fluidity impaired by ACD might improve after adding L-cysteine.	[Otoyama, Ippo; Hamada, Hironobu; Namba, Haruchi; Sekikawa, Kiyokazu; Kamikawa, Norimichi; Kajiwara, Teruki; Aizawa, Fumiya; Sato, Yoshinobu M.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan; [Kimura, Tatsushi] Ohkagakuen Univ, Fac Early Childhood Educ & Care, Toyoake, Aichi, Japan	Hiroshima University	Hamada, H (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan.	hirohamada@hiroshima-u.ac.jp	Hamada, Hironobu/A-6489-2018; kiyokazu, sekikawa/AAC-1498-2020	Hamada, Hironobu/0000-0002-7979-0708; Aizawa, Fumiya/0000-0003-2239-5771	Fundamental Budget for Education and Research	Fundamental Budget for Education and Research	This work was supported by Fundamental Budget for Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DEBEY HJ, 1958, J NUTR, V66, P607, DOI 10.1093/jn/66.4.607; Eileen M., 2009, ATHEROSCLEROSIS, V204, P372, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2008.10.008; Fedosov DA, 2014, BIOMECH MODEL MECHAN, V13, P239, DOI 10.1007/s10237-013-0497-9; GAINES KC, 1977, FEBS LETT, V75, P115, DOI 10.1016/0014-5793(77)80065-3; Gompper G, 2016, WIRES SYST BIOL MED, V8, P157, DOI 10.1002/wsbm.1326; Hitsumoto T, 2018, CARDIOL RES, V9, P231, DOI 10.14740/cr763w; Ishida K, 2001, MED B FUKUOKA U, V28, P203; Kensey KR, 2003, CLIN APPL THROMB-HEM, V9, P93, DOI 10.1177/107602960300900201; KIKUCHI Y, 1994, MICROVASC RES, V47, P222, DOI 10.1006/mvre.1994.1017; KIKUCHI Y, 1994, MICROVASC RES, V47, P126, DOI 10.1006/mvre.1994.1008; KIKUCHI Y, 1995, MICROVASC RES, V50, P288, DOI 10.1006/mvre.1995.1059; Kim CJ, 2009, BBA-GEN SUBJECTS, V1790, P1161, DOI 10.1016/j.bbagen.2009.05.018; Kimura T, 2016, CLIN HEMORHEOL MICRO, V61, P559, DOI 10.3233/CH-141893; Maxwell PS, 1937, J BIOL CHEM, V121, P539; Mukamal KJ, 2005, ANN INTERN MED, V142, P11, DOI 10.7326/0003-4819-142-1-200501040-00007; Mukamal KJ, 2001, CIRCULATION, V104, P1367, DOI 10.1161/hc3701.096067; Rehm J, 2017, TRENDS CARDIOVAS MED, V27, P534, DOI 10.1016/j.tcm.2017.06.002; Shiraishi Koichi, 2015, Nihon Arukoru Yakubutsu Igakkai Zasshi, V50, P13; Tsukamoto S, 1990, Arukoru Kenkyuto Yakubutsu Ison, V25, P429	19	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214585	10.1371/journal.pone.0214585	http://dx.doi.org/10.1371/journal.pone.0214585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925182	gold, Green Published, Green Submitted			2022-12-27	WOS:000462732300021
J	Costa, NA; Pansani, AP; de Castro, CH; Colugnati, DB; Xaxier, CH; Guimaraes, KC; Rabelo, LA; Nunes-Souza, V; Caixeta, LFS; Ferreira, RN				Costa, Natalia Alves; Pansani, Aline Priscila; de Castro, Carlos Henrique; Colugnati, Diego Basile; Xaxier, Carlos Henrique; Guimaraes, Katia Cylene; Rabelo, Luiza Antas; Nunes-Souza, Valeria; Souza Caixeta, Luis Fernando; Ferreira, Reginaldo Nassar			Milk restriction or oligosaccharide supplementation in calves improves compensatory gain and digestive tract development without changing hormone levels	PLOS ONE			English	Article							MANNAN OLIGOSACCHARIDE; RUMEN DEVELOPMENT; SMALL-INTESTINE; PLASMA GHRELIN; BEEF-CATTLE; FEED-INTAKE; GROWTH; HEALTH; CONSEQUENCES; ANTIBIOTICS	We estimated the effect of oligosaccharide supplementation and feed restriction on calves. The study was divided into two experimental periods of 28 days each with 20 crossbred calves that had initial body weight of 37 Kg and housed in individual pens. The animals were split in four experimental groups: animals fed 6 L milk/day (CON) in the two periods, animals fed milk restricted (3 L milk/day) in the first period and followed by CON feeding in the second period (RES), animals receiving supplementation of 5 g/day of mannanoligosaccharide (MOS) and animals receiving supplementation of 5 g/day mannan and frutoligosaccharide (MFOS). At the end of the study, all the animals were slaughtered. The average weight gain was lower in the restricted group when compared with CON and MFOS groups in the first period (P < 0.05) and there were no difference among the groups in the second period. Animals supplemented with MOS showed a significant increases in jejunal villus height and rumen papillae, which were not observed for MFOS group (P < 0.05) compared with RES and CON groups. There were no difference in ghrelin and leptin levels among treatments during periods 1 and 2 (P > 0.05). Also, the expression of ghrelin receptors in the paraventricular region of the hypothalamus did not differ among groups. We conclude that milk restriction during the first weeks of life in calves resulted in compensatory gain and did not modify the hormonal profile and expression of the ghrelin receptor in the hypothalamus. Moreover, a prebiotic supplementation changed the development of intestinal and ruminal epithelium.	[Costa, Natalia Alves; Pansani, Aline Priscila; de Castro, Carlos Henrique; Colugnati, Diego Basile; Xaxier, Carlos Henrique; Souza Caixeta, Luis Fernando; Ferreira, Reginaldo Nassar] Univ Fed Goias, Dept Physiol Sci, Inst Biol Sci, Goiania, Go, Brazil; [Guimaraes, Katia Cylene] Goiano Inst Fed, Dept Anim Sci, Anim Nutr Lab, Rio Verde, Go, Brazil; [Rabelo, Luiza Antas] Univ Fed Alagoas, Dept Physiol Sci, Inst Biol Sci, Maceio, Alagoas, Brazil; [Nunes-Souza, Valeria] Univ Fed Pernambuco, Inst Biol Sci, Dept Physiol & Pharmacol Sci, Recife, PE, Brazil	Universidade Federal de Goias; Universidade Federal de Alagoas; Universidade Federal de Pernambuco	Ferreira, RN (corresponding author), Univ Fed Goias, Dept Physiol Sci, Inst Biol Sci, Goiania, Go, Brazil.	reginaldonassar@gmail.com	Colugnati, Diego/AAD-2977-2019; da Saúde, Programa Ciências/ABF-1705-2020; Pansani, Aline Priscila/AAC-8501-2019; Xavier, Carlos H/C-8561-2013; Guimarães, Kátia C/D-3796-2014; Xavier, Carlos Henrique/AAE-8390-2022	Colugnati, Diego/0000-0002-6565-0042; Pansani, Aline Priscila/0000-0001-6898-5940; Xavier, Carlos H/0000-0003-4006-8213; Xavier, Carlos Henrique/0000-0003-4006-8213; Ferreira, Reginaldo/0000-0002-0545-1439	YES Company	YES Company	This work was supported by the YES Company (http://www.yes.ind.br). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafeez HM, 2017, ASIAN AUSTRAL J ANIM, V30, P672, DOI 10.5713/ajas.16.0535; Afsharmanesh M, 2016, ANIM NUTR, V2, P168, DOI 10.1016/j.aninu.2016.04.002; Akbarian-Tefaghi M, 2018, J ANIM PHYSIOL AN N, V102, P630, DOI 10.1111/jpn.12842; BAILE CA, 1987, J ANIM SCI, V64, P915, DOI 10.2527/jas1987.643915x; BAILE CA, 1981, J DAIRY SCI, V64, P1140, DOI 10.3168/jds.S0022-0302(81)82693-8; Baldwin R L, 2004, J DAIRY SCI, V87, pE55, DOI [10.3168/jds.2012-5970, DOI 10.3168/JDS.S0022-0302(04)70061-2]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Chen LL, 2007, COMP BIOCHEM PHYS A, V147, P893, DOI 10.1016/j.cbpa.2007.02.017; Choi YJ, 1997, J DAIRY SCI, V80, P519, DOI 10.3168/jds.S0022-0302(97)75965-4; Cox K.L., 2004, ASSAY GUIDANCE MANUA; Curtis G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191687; Donovan DC, 2002, J DAIRY SCI, V85, P947, DOI 10.3168/jds.S0022-0302(02)74153-2; Fagliari JJ, 1998, ARQ BRAS MED VET ZOO, V50, P253; Franklin ST, 2005, J DAIRY SCI, V88, P766, DOI 10.3168/jds.S0022-0302(05)72740-5; Ghosh S, 2012, TROP ANIM HEALTH PRO, V44, P617, DOI 10.1007/s11250-011-9944-8; Gorka P, 2011, J DAIRY SCI, V94, P3002, DOI 10.3168/jds.2010-3499; Gorka P, 2008, J PHYSL PHARM S3, V59, P22; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P37; Hammon HM, 2002, J ANIM SCI, V80, P337; Heinrichs AJ, 2009, LIVEST SCI, V125, P149, DOI 10.1016/j.livsci.2009.04.003; Heinrichs AJ, 2003, J DAIRY SCI, V86, P4064, DOI 10.3168/jds.S0022-0302(03)74018-1; Istasse L., 2000, Domestic Animal Endocrinology, V19, P121, DOI 10.1016/S0739-7240(00)00072-2; Jasper J, 2002, J DAIRY SCI, V85, P3054, DOI 10.3168/jds.S0022-0302(02)74391-9; Ji SQ, 1998, ANIM BIOTECHNOL, V9, P1, DOI 10.1080/10495399809525887; Kaufhold J, 2000, J VET MED A, V47, P17, DOI 10.1046/j.1439-0442.2000.00257.x; Keogh K, 2015, J ANIM SCI, V93, P3578, DOI 10.2527/jas.2014-8470; Keogh K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194445; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Kim MS, 2003, NEUROREPORT, V14, P1317, DOI [10.1097/01.wnr.0000078703.79393.d2, 10.1097/00001756-200307180-00006]; Kleessen B, 2001, BRIT J NUTR, V86, P291, DOI 10.1079/BJN2001403; Knowles TG, 2000, VET REC, V147, P593, DOI 10.1136/vr.147.21.593; Kuenzel WJ, 1999, J EXP ZOOL, V283, P348, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;348::AID-JEZ5&gt;3.0.CO;2-5; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Lesmeister KE, 2004, J DAIRY SCI, V87, P1832, DOI 10.3168/jds.S0022-0302(04)73340-8; Lesmeister KE, 2004, J DAIRY SCI, V87, P1336, DOI 10.3168/jds.S0022-0302(04)73283-X; Lesson S, 1999, POULTRY SCI, V76, P992; Miura H, 2004, J ANIM SCI, V82, P1329; Montanholi Y, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-9; Morrison SJ, 2010, LIVEST SCI, V131, P292, DOI 10.1016/j.livsci.2010.04.002; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Samanta A.K., 2012, INDIAN VET J, V89, P41; Steele MA, 2016, J DAIRY SCI, V99, P4955, DOI 10.3168/jds.2015-10351; Sugino T, 2002, BIOCHEM BIOPH RES CO, V298, P785, DOI 10.1016/S0006-291X(02)02572-X; Sweeney BC, 2010, J DAIRY SCI, V93, P148, DOI 10.3168/jds.2009-2427; Wang X, 2012, WORLD J GASTROENTERO, V18, P5719, DOI 10.3748/wjg.v18.i40.5719; Wertz-Lutz AE, 2010, J ANIM SCI, V88, P2289, DOI 10.2527/jas.2009-2447; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; WINCHESTER CF, 1957, J ANIM SCI, V16, P426, DOI 10.2527/jas1957.162426x; Xu ZR, 2000, ASIAN AUSTRAL J ANIM, V15, P1784	50	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214626	10.1371/journal.pone.0214626	http://dx.doi.org/10.1371/journal.pone.0214626			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921423	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000100
J	Paska, C; Barta, I; Drozdovszky, O; Antus, B				Paska, Csilla; Barta, Imre; Drozdovszky, Orsolya; Antus, Balazs			Elimination of bacterial DNA during RNA isolation from sputum: Bashing bead vortexing is preferable over prolonged DNase treatment	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; LOAD	Sputum often contains large amounts of contaminating bacterial DNA that, if not eliminated during RNA isolation, may interfere with gene expression studies. During RNA isolation only repeated DNase treatment can effectively remove contaminating bacterial DNA from samples, but this compromises RNA quality. In this study we tested alternative methods to facilitate the removal of DNA and improve the quality of RNA obtained. Sputum samples obtained from patients with chronic obstructive pulmonary disease were processed with dithiothreitol and subjected to various RNA isolation methods, yet with modified protocols. Modifications included prolonged DNase treatment or vortexing of sputum cells in the presence of beads prior to RNA isolation. Bacterial DNA contamination was tested by PCR using universal bacterial primers, while RNA quality was assessed by real-time PCR using GAPDH primers for amplicons of different length. We found that the RNeasy Plus Mini kit equipped with the gDNA eliminator spin column was able to completely eliminate bacterial DNA, if sputum cells were lysed in the presence of bashing beads. Notably, compared with the standard protocol, the modified procedure yielded better quality RNA as well, as indicated by improved threshold profiles of qPCR. Bead vortexing of cells was less effective when combined with other RNA isolation methods, and the repeated DNase treatment needed to completely remove contaminating DNA from the samples reduced the quality of RNA markedly. Bead vortexing in combination with certain RNA extraction methods greatly facilitates the isolation of sputum RNA that is free of contaminating bacterial DNA, and is suitable for downstream applications.	[Paska, Csilla; Barta, Imre; Drozdovszky, Orsolya; Antus, Balazs] Natl Koranyi Inst Pulmonol, Dept Pathophysiol, Budapest, Hungary; [Antus, Balazs] Natl Koranyi Inst Pulmonol, Dept Pulmonol, Budapest, Hungary		Antus, B (corresponding author), Natl Koranyi Inst Pulmonol, Dept Pathophysiol, Budapest, Hungary.; Antus, B (corresponding author), Natl Koranyi Inst Pulmonol, Dept Pulmonol, Budapest, Hungary.	antusb@hotmail.com	Drozdovszky, Orsolya/AFU-5494-2022		National Research, Development and Innovation Office [K124343]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	The study was supported by the National Research, Development and Innovation Office, Grant No: K124343 (https://nkfih.gov.hu/) to BA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro A, 2008, LETT APPL MICROBIOL, V47, P8, DOI 10.1111/j.1472-765X.2008.02372.x; Antus B, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2930434; Antus B, 2012, INFLAMM RES, V61, P1141, DOI 10.1007/s00011-012-0508-9; Baines KJ, 2011, J ALLERGY CLIN IMMUN, V127, P153, DOI 10.1016/j.jaci.2010.10.024; Brightling CE, 2006, CHEST, V129, P1344, DOI 10.1378/chest.129.5.1344; de Boer R, 2010, J MICROBIOL METH, V80, P209, DOI 10.1016/j.mimet.2009.11.009; Dragonieri S, 2009, Monaldi Arch Chest Dis, V71, P119; Drozdovszky O, 2014, RESPIRATION, V87, P408, DOI 10.1159/000358099; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; He H, 2017, SCI REP-UK, V7, DOI 10.1038/srep45199; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Kaser M, 2009, APPL ENVIRON MICROB, V75, P414, DOI 10.1128/AEM.01358-08; Korfhage C, EFFECTIVE GENOMIC DN; Louis R, 2012, Monaldi Arch Chest Dis, V77, P5; MEIER A, 1993, J CLIN MICROBIOL, V31, P646, DOI 10.1128/JCM.31.3.646-652.1993; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Paska C, 2004, DIAGN MOL PATHOL, V13, P234, DOI 10.1097/01.pdm.0000134778.37729.9f; Paska C, 2017, AM J RESP CELL MOL, V57, P626, DOI 10.1165/rcmb.2017-0198LE; Phongsisay V, 2007, J MICROBIOL METH, V68, P427, DOI 10.1016/j.mimet.2006.09.002; RAND KH, 1990, MOL CELL PROBE, V4, P445, DOI 10.1016/0890-8508(90)90003-I; Razzak R, 2016, CURR ONCOL, V23, pE86, DOI 10.3747/co.23.2830; Singh D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107381; Wagener Ariane H, 2013, Ann Am Thorac Soc, V10 Suppl, pS197, DOI 10.1513/AnnalsATS.201302-035AW	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214609	10.1371/journal.pone.0214609	http://dx.doi.org/10.1371/journal.pone.0214609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921416	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000097
J	Tegegn, HG; Erku, DA; Sebsibe, G; Gizaw, B; Seifu, D; Tigabe, M; Belachew, SA; Ayele, AA				Tegegn, Henok Getachew; Erku, Daniel Asfaw; Sebsibe, Girum; Gizaw, Biruktawit; Seifu, Dawit; Tigabe, Masho; Belachew, Sewunet Admasu; Ayele, Asnakew Achaw			Medication-related quality of life among Ethiopian elderly patients with polypharmacy: A cross-sectional study in an Ethiopia university hospital	PLOS ONE			English	Article							CONTROLLED-TRIAL; OLDER-PEOPLE; HEALTH; CARE; OUTPATIENTS; MANAGEMENT; ADHERENCE	Polypharmacy among older patients has been associated with a decline in their quality of life. We aimed to assess the medication-related quality of life (MRQOL) among older patients with polypharmacy at Gondar University Hospital, Gondar, Ethiopia. A prospective cross-sectional study was carried out among 150 elder patients who had visited the internal medicine ward and ambulatory ward of Gondar referral hospital from March 25 to May 15, 2017, using a validated scale, Medication-Related Quality of Life Scale version 1.0 (MRQoLS-v1.0). A total of 150 older patients with polypharmacy participated in the study with a mean age of 70.06 +/- 5.12, andtwo-thirds of the participants (67.3%) were female. The overall prevalence of poor quality of life due to polypharmacy in the current study was found to be three fourth (75.3%) of the participants. Regarding the severity of impairment in MRQoL, Univariate analysis revealed that frequency of hospital visits (COR = 1.34, 95% CI, 1.02-1.77) and medication number (COR = 1.94, 95% CI, 1.33, 2.8) had a statistically significant positive association with the likelihood of having a severe impairment.The multivariate analysis also showed that one unit increase in the number of hospital visits (AOR = 1.45, 95% CI, 1.040-2.024) and medications greater than 5 (AOR = 1.91, 95% CI, 1.29, 2.84) increases 1.45 and 1.91 times the likely hood of posing severe impairment of MRQoL, respectively. As far as poor MRQoL quality of life is concerned, multivariate analysis did not show any significant association between the poor MRQoL;and Sociodemographic and clinical data of patients. The poor QoL associated with medication was very high in this study. Deprescribing should be sought by the health care providers to optimize drug therapy and minimize the polypharmacy related poor quality of life.	[Tegegn, Henok Getachew; Erku, Daniel Asfaw; Sebsibe, Girum; Gizaw, Biruktawit; Seifu, Dawit; Tigabe, Masho; Belachew, Sewunet Admasu; Ayele, Asnakew Achaw] Univ Gondar, Dept Clin Pharm, Gondar, Amhara, Ethiopia	University of Gondar	Tegegn, HG (corresponding author), Univ Gondar, Dept Clin Pharm, Gondar, Amhara, Ethiopia.	heniget@gmail.com	Tegegn, Henok Getachew/C-2469-2016; Erku, Daniel/AAC-1508-2020	Tegegn, Henok Getachew/0000-0003-0644-0958; Erku, Daniel/0000-0002-8878-0317; Admasu Belachew, Sewunet/0000-0002-1050-8188; Ayele, Asnakew/0000-0001-7837-7228				Azpiazu Garrido M, 2003, ATEN PRIM, V31, P285; Bushardt RL, 2008, CLIN INTERV AGING, V3, P383, DOI 10.2147/CIA.S2468; Casado J, 2001, Aten Primaria, V28, P167; Chang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128356; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chew BH, 2015, QUAL LIFE RES, V24, P2723, DOI 10.1007/s11136-015-1006-7; Chumney Elinor C., 2006, Pharmacy Pract (Granada), V4, P103, DOI 10.4321/s1885-642x2006000300001; de Rivas B, 2008, QUAL LIFE RES, V17, P1229, DOI 10.1007/s11136-008-9397-3; Ferrer A, 2010, MED CLIN-BARCELONA, V134, P303, DOI 10.1016/j.medcli.2009.06.070; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; Henderson JA, 2006, J APPL GERONTOL, V25, p89S, DOI 10.1177/0733464805283035; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Holt EW, 2010, AGE AGEING, V39, P481, DOI 10.1093/ageing/afq040; Zamora-Sanchez JJ, 2012, ENFERM CLIN, V22, P239, DOI 10.1016/j.enfcli.2012.04.009; Jyrkka J, 2011, PHARMACOEPIDEM DR S, V20, P514, DOI 10.1002/pds.2116; Krska J, 2001, AGE AGEING, V30, P205, DOI 10.1093/ageing/30.3.205; Lalic S, 2016, EUR J CLIN PHARMACOL, V72, P1117, DOI 10.1007/s00228-016-2075-4; Machon M, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0410-3; Makai P, 2014, SOC SCI MED, V102, P83, DOI 10.1016/j.socscimed.2013.11.050; Moen J, 2009, ANN PHARMACOTHER, V43, P1978, DOI 10.1345/aph.1M354; Montiel-Luque A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171320; National Institute of Mental Health, 2018, DEPRESSION; Ong GJ, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.321; Page AT, 2016, RES SOC ADMIN PHARM, V12, P438, DOI 10.1016/j.sapharm.2015.08.011; Page AT, 2016, MATURITAS, V91, P115, DOI 10.1016/j.maturitas.2016.06.006; Parekh N, 2017, THER ADV DRUG SAF, V8, P117, DOI 10.1177/2042098616682721; Patterson SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008165.pub3, 10.1002/14651858.CD008165.pub4]; Reeve E, 2014, BRIT J CLIN PHARMACO, V78, P738, DOI 10.1111/bcp.12386; Riker Gretchen I, 2012, Home Healthc Nurse, V30, P474, DOI 10.1097/NHH.0b013e31826502dd; Rosso AL, 2013, J AM GERIATR SOC, V61, P371, DOI 10.1111/jgs.12147; Saleh F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-431; Shafie Asrul Akmal, 2013, Value Health Reg Issues, V2, P107, DOI 10.1016/j.vhri.2013.02.005; Shumaker S, 1995, INT ASSESSMENT HLTH; Taylor CT, 2003, AM J HEALTH-SYST PH, V60, P1123, DOI 10.1093/ajhp/60.11.1123; Tegegn HG, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020590; Tseng HM, 2016, QUAL LIFE RES, V25, P1295, DOI 10.1007/s11136-015-1177-2; Van der Weele GM, 2009, INT J GERIATR PSYCH, V24, P595, DOI 10.1002/gps.2162; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214191	10.1371/journal.pone.0214191	http://dx.doi.org/10.1371/journal.pone.0214191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921379	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000037
J	Scherz, MD; Hutter, CR; Rakotoarison, A; Riemann, JC; Roder, MO; Ndriantsoa, SH; Gloss, J; Roberts, SH; Crottini, A; Vences, M; Glaw, F				Scherz, Mark D.; Hutter, Carl R.; Rakotoarison, Andolalao; Riemann, Jana C.; Roeder, Mark-Oliver; Ndriantsoa, Serge H.; Gloss, Julian; Roberts, Sam Hyde; Crottini, Angelica; Vences, Miguel; Glaw, Frank			Morphological and ecological convergence at the lower size limit for vertebrates highlighted by five new miniaturised microhylid frog species from three different Madagascan genera	PLOS ONE			English	Article							ANURA MICROHYLIDAE; GENUS STUMPFFIA; BODY-SIZE; MOLECULAR PHYLOGENY; COPHYLINE FROGS; LIFE-HISTORY; AMPHIBIA; RHOMBOPHRYNE; DIVERSITY; EVOLUTION	Miniaturised frogs form a fascinating but poorly understood amphibian ecomorph and have been exceptionally prone to taxonomic underestimation. The subfamily Cophylinae (family Microhylidae), endemic to Madagascar, has a particularly large diversity of miniaturised species which have historically been attributed to the single genus Stumpffia largely based on their small size. Recent phylogenetic work has revealed that several independent lineages of cophyline microhylids evolved towards highly miniaturised body sizes, achieving adult snout- vent lengths under 16 mm. Here, we describe five new species belonging to three clades that independently miniaturised and that are all genetically highly divergent from their relatives: (i) a new genus (Mini gen.nov.) with three new species from southern Madagascar, (ii) one species of Rhombophryne, and (iii) one species of Anodonthyla. Mini mum sp. nov. from Manombo in eastern Madagascar is one of the smallest frogs in the world, reaching an adult body size of 9.7 mm in males and 11.3 mm in females. Mini scule sp.nov. from Sainte Luce in southeastern Madagascar is slightly larger and has maxillary teeth. Mini ature sp.nov. from Andohahela in southeast Madagascar is larger than its congeners but is similar in build. Rhombophryne proportionalis sp.nov. from Tsaratanana in northern Madagascar is unique among Madagascar's miniaturised frogs in being a proportional dwarf, exhibiting far less advanced signs of paedomorphism than other species of similar size. Anodonthyla eximia sp.nov. from Ranomafana in eastern Madagascar is distinctly smaller than any of its congeners and is secondarily terrestrial, providing evidence that miniaturisation and terrestriality may be evolutionarily linked. The evolution of body size in Madagascar's microhylids has been more dynamic than previously understood, and future studies will hopefully shed light on the interplay between ecology and evolution of these remarkably diverse frogs.	[Scherz, Mark D.; Glaw, Frank] ZSM, SNSB, Sekt Herpetol, Munich, Germany; [Scherz, Mark D.; Rakotoarison, Andolalao; Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Evolutionary Biol, Braunschweig, Germany; [Scherz, Mark D.] Ludwig Maximilians Univ Munchen, Dept Biol 2, Biozentrum, Systemat Zool, Planegg Martinsried, Germany; [Hutter, Carl R.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Hutter, Carl R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Rakotoarison, Andolalao; Ndriantsoa, Serge H.] Univ Antananarivo, Ment Zool & Biodiversite Anim, Antananarivo, Madagascar; [Riemann, Jana C.; Gloss, Julian] Univ Hamburg, Inst Zool, Hamburg, Germany; [Roeder, Mark-Oliver] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany; [Roberts, Sam Hyde] SEED Madagascar, London, England; [Roberts, Sam Hyde] Oxford Brookes Univ, Oxford, England; [Crottini, Angelica] Univ Porto, InBIO, Res Ctr Biodivers & Genet Resources, CIBIO, Campus Agr Vairao, Vairao, Portugal	Braunschweig University of Technology; University of Munich; University of Kansas; University of Kansas; University Antananarivo; University of Hamburg; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Oxford Brookes University; Universidade do Porto	Scherz, MD (corresponding author), ZSM, SNSB, Sekt Herpetol, Munich, Germany.; Scherz, MD (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Evolutionary Biol, Braunschweig, Germany.; Scherz, MD (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Biozentrum, Systemat Zool, Planegg Martinsried, Germany.	mark.scherz@gmail.com	Scherz, Mark D./C-9870-2019; Hutter, Carl R/A-7380-2015; Crottini, Angelica/I-7680-2013	Scherz, Mark D./0000-0002-4613-7761; Hutter, Carl/0000-0001-6381-6339; Rakotoarison, Andolalao/0000-0003-2620-440X; Vences, Miguel/0000-0003-0747-0817; Crottini, Angelica/0000-0002-8505-3050; Riemann, Jana Carina/0000-0002-5303-3354	Investigador FCT grant from the Portuguese National Funds through FCT (Foundation for Science and Technology) [IF/00209/2014]; Deutsche Forschungsgemeinschaft [GL 665/1-1, RO 3064/2-1, VE 247/13-1]; Volkswagen foundation	Investigador FCT grant from the Portuguese National Funds through FCT (Foundation for Science and Technology); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen foundation(Volkswagen)	AC is supported by an Investigador FCT grant from the Portuguese National Funds through FCT (Foundation for Science and Technology) grant IF/00209/2014. JCR, JG, M-OR and SHN were supported by the Deutsche Forschungsgemeinschaft (grant GL 665/1-1 and RO 3064/2-1). Fieldwork of FG and MV was supported by the Volkswagen foundation. MDS and MV were supported by the Deutsche Forschungsgemeinschaft (grant VE 247/13-1). No funders played any role in study design, data collection, analysis, or decision to publish.	ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Andreone F, 2005, MOL PHYLOGENET EVOL, V34, P315, DOI 10.1016/j.ympev.2004.10.013; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Blackburn David C., 2009, Breviora, V517, P1; Blackburn DC, 2008, MOL PHYLOGENET EVOL, V49, P806, DOI 10.1016/j.ympev.2008.08.015; Blommers-Schlosser R.M.A., 1991, Faune de Madagascar, V75, P1; Clarke BT, 1996, SYM ZOOL S, P201; Clemente-Carvalho RBG, 2011, MOL PHYLOGENET EVOL, V61, P79, DOI 10.1016/j.ympev.2011.05.017; Das I, 2010, ZOOTAXA, P37; Monteiro JPDC, 2018, ZOOTAXA, V4407, P483, DOI 10.11646/zootaxa.4407.4.2; de Sa RO, 2019, MOL PHYLOGENET EVOL, V130, P198, DOI 10.1016/j.ympev.2018.10.021; de Sa RO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-241; Du Preez LH, 2017, COMPLETE GUIDE FROGS; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EMERSON SB, 1979, BIOL J LINN SOC, V11, P153, DOI 10.1111/j.1095-8312.1979.tb00032.x; Fabrezi M, 1996, HERPETOLOGICA, V52, P188; Feng YJ, 2017, P NATL ACAD SCI USA, V114, pE5864, DOI 10.1073/pnas.1704632114; Garg S, 2017, PEERJ, V5, DOI 10.7717/peerj.3007; Glaw F, 2007, FIELD GUIDE AMPHIBIA; GLAW F, 1994, FIELDGUIDE AMPHIBIAN; Glaw Frank, 2010, Zoosystematics and Evolution, V86, P235, DOI 10.1002/zoos.201000006; Gould S. J., 1977, ONTOGENY PHYLOGENY; Gunther R, 2017, ZOOSYST EVOL, V93, P265, DOI 10.3897/zse.93.11576; Guibe J., 1978, BONN ZOOL MONOGR, V11, P1; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; HANKEN J, 1985, SCIENCE, V229, P871, DOI 10.1126/science.4023715; Heideman NJL, 2011, MOL PHYLOGENET EVOL, V61, P823, DOI 10.1016/j.ympev.2011.08.021; IUCN SSC Amphibian Specialist Group, 2016, IUCN RED LIST THREAT, V2016, DOI 10.2305/IUCN.UK.2016-1.RLTS.T88219153A88312479; Klages J, 2013, ZOOTAXA, V3717, P280; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Kohler F, 2008, MOL PHYLOGENET EVOL, V47, P353, DOI 10.1016/j.ympev.2007.11.032; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Kraus F, 2011, ZOOKEYS, P71, DOI 10.3897/zookeys.154.1963; Kraus F, 2010, ZOOKEYS, P39, DOI 10.3897/zookeys.48.446; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lehr E, 2008, HERPETOLOGICA, V64, P354, DOI 10.1655/07-089.1; *LEW ENV CONS, 1992, ENV IMP ASS STUD 1; Lourenco-de-Moraes R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201781; Marquez R., 2006, CALLS FROGS MADAGASC; Matsui Masafumi, 2011, Zootaxa, V2814, P33; Mott T, 2009, MOL PHYLOGENET EVOL, V51, P190, DOI 10.1016/j.ympev.2009.01.014; Oliver PM, 2017, PEERJ, V5, DOI 10.7717/peerj.3077; Padial JM, 2014, ZOOTAXA, V3825, P1, DOI 10.11646/zootaxa.3825.1.1; Parker HW, 1934, MONOGRAPH FROGS FAMI; Peloso PLV, 2017, MOL PHYLOGENET EVOL, V111, P56, DOI 10.1016/j.ympev.2017.03.016; Peloso PLV, 2016, CLADISTICS, V32, P113, DOI 10.1111/cla.12118; PELOSO PL, 2014, B AM MUS NAT HIST, V386, P1, DOI DOI 10.1206/834.1; Perl RGB, 2014, AMPHIBIA-REPTILIA, V35, P197, DOI 10.1163/15685381-00002942; Poyarkov NA, 2018, ZOOL RES, V39, P130, DOI 10.24272/j.issn.2095-8137.2018.019; Rakotoarison A, 2017, VERTEBR ZOOL, V67, P271; Ramanamanjato J-B, 2011, TSITONGAMBARIKA FORE, P34; Ramanamanjato Jean-Baptiste, 2007, P167; Ribeiro LF, 2015, PEERJ, V3, DOI 10.7717/peerj.1011; Rieppel O, 1996, SYM ZOOL S, P47; Rittmeyer EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029797; Rodriguez A, 2015, EVOL ECOL, V29, P765, DOI 10.1007/s10682-015-9774-7; Rodriguez A, 2013, MOL PHYLOGENET EVOL, V68, P541, DOI 10.1016/j.ympev.2013.04.031; Rosa GM, 2014, SALAMANDRA, V50, P201; Scherz MD, 2017, SALAMANDRA, V53, P479; Scherz MD, 2017, ZOOTAXA, V4273, P301, DOI 10.11646/zootaxa.4273.3.1; Scherz MD, 2016, SALAMANDRA, V52, P91; Scherz MD, 2016, MOL PHYLOGENET EVOL, V100, P372, DOI 10.1016/j.ympev.2016.04.019; Scherz MD, 2015, ZOOSYST EVOL, V91, P105, DOI 10.3897/zse.91.4979; Scherz MD, 2015, HERPETOLOGICA, V71, P310, DOI 10.1655/HERPETOLOGICA-D-14-00048; Tracy CR, 2010, ECOLOGY, V91, P1477, DOI 10.1890/09-0839.1; Trueb L., 1973, P65; Trueb L., 1985, FUNCTIONAL MORPHOLOG, P113; Trueb L, 1968, CRANIAL OSTEOLOGY HY, V18, P11; Trueb Linda, 1993, P255; Tu N, 2018, MOL PHYLOGENET EVOL, V126, P85, DOI 10.1016/j.ympev.2018.03.036; Vallan D, 2000, REV SUISSE ZOOL, V107, P835, DOI 10.5962/bhl.part.80150; van der Meijden A, 2007, MOL PHYLOGENET EVOL, V44, P1017, DOI 10.1016/j.ympev.2007.02.008; Vences M., 1991, Acta Biologica Benrodis, V3, P203; Vences M, 2013, ZOOTAXA, V3636, P201, DOI 10.11646/zootaxa.3636.2.1; Vences M, 2010, CONTRIB ZOOL, V79, P1; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Yeh J, 2002, EVOLUTION, V56, P628; Zimkus BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035118	81	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213314	10.1371/journal.pone.0213314	http://dx.doi.org/10.1371/journal.pone.0213314			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917162	Green Published, gold			2022-12-27	WOS:000462465800026
J	Hollingsworth, A; Soni, A; Carroll, AE; Cawley, J; Simon, K				Hollingsworth, Alex; Soni, Aparna; Carroll, Aaron E.; Cawley, John; Simon, Kosali			Gains in health insurance coverage explain variation in Democratic vote share in the 2008-2016 presidential elections	PLOS ONE			English	Article							CARE; POLITICS; REFORM; POLICY	In the last decade, health care reform has dominated U.S. public policy and political discourse. Double-digit rate increases in premiums in the Health Insurance Marketplaces established by the Affordable Care Act (ACA) in 2018 make this an ongoing issue that could affect future elections. A seminal event that changed the course of policy and politics around health care reform is the 2016 presidential election. The results of the 2016 presidential election departed considerably from polling forecasts. Given the prominence of the Affordable Care Act in the election, we test whether changes in health insurance coverage at the county-level correlate with changes in party vote share in the presidential elections from 2008 through 2016. We find that a one-percentage-point increase in county health insurance coverage was associated with a 0.25-percentage-point increase in the vote share for the Democratic presidential candidate. We further find that these gains on the part of the Democratic candidate came almost fully at the expense of the Republican (as opposed to third-party) presidential candidates. We also estimate models separately for states that did and did not expand Medicaid and find no differential effect of insurance gains on Democratic vote share for states that expanded Medicaid compared to those that did not. Our results are consistent with the hypothesis that outcomes in health insurance markets played a role in the outcome of the 2016 presidential election. The decisions made by the current administration, and how those decisions affect health insurance coverage and costs, may be important factors in future elections as well.	[Hollingsworth, Alex; Simon, Kosali] Indiana Univ, ONeill Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Soni, Aparna] Indiana Univ, Kelley Sch Business, Bloomington, IN USA; [Carroll, Aaron E.] Indiana Univ, Sch Med, Indianapolis, IN USA; [Cawley, John] Cornell Univ, Dept Policy Anal & Management, Ithaca, NY USA; [Cawley, John] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Cawley, John; Simon, Kosali] Natl Bur Econ Res, Cambridge, MA 02138 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; IU Kelley School of Business; Indiana University System; Indiana University-Purdue University Indianapolis; Cornell University; Cornell University; National Bureau of Economic Research	Simon, K (corresponding author), Indiana Univ, ONeill Sch Publ & Environm Affairs, Bloomington, IN 47405 USA.; Simon, K (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	simonkos@indiana.edu	Soni, Aparna/AAT-9417-2021; Cawley, John/E-6734-2010	Cawley, John/0000-0002-4805-9883; Soni, Aparna/0000-0003-0737-485X				[Anonymous], 2017, ELECTION 2016; Armour Stephanie, 2018, WALL STREET J; Baicker K, 2018, NBER WORKING PAPER S; Balakar B., 2017, NY TIMES; Clinton JD, 2018, AM POLIT SCI REV, V112, P167, DOI 10.1017/S0003055417000430; Cox C., ANAL 2017 PREMIUM CH; Dalen JE, 2015, AM J MED, V128, P807, DOI 10.1016/j.amjmed.2015.01.032; Eltorai AEM, 2017, JAMA-J AM MED ASSOC, V317, P1407, DOI 10.1001/jama.2017.2042; Gordon PR, 2017, ACAD MED, V92, P1241, DOI 10.1097/ACM.0000000000001725; Haselswerdt J, 2017, J HEALTH POLIT POLIC, V42, P667, DOI 10.1215/03616878-3856107; Henderson M, 2011, J HEALTH POLIT POLIC, V36, P945, DOI 10.1215/03616878-1460533; Levitt L, 2016, JAMA-J AM MED ASSOC, V316, P915, DOI 10.1001/jama.2016.11736; Mettler S., 2011, SUBMERGED STATE INVI; Morning Consult Polling, 2016, CLINT LIK WON POP VO; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; Patashnik EM, 2013, PERSPECT POLIT, V11, P1071, DOI 10.1017/S1537592713002831; Pierson Paul, 1993, WORLD POLIT, V45, P595, DOI DOI 10.2307/2950710; Rogers S., 2012, GUARDIAN	18	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214206	10.1371/journal.pone.0214206	http://dx.doi.org/10.1371/journal.pone.0214206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30946752	gold, Green Published, Green Submitted			2022-12-27	WOS:000463314500019
J	Joshi, D; Shrestha, S; Shrestha, N				Joshi, Deepak; Shrestha, Santoshi; Shrestha, Nipun			Understanding the antepartum depressive symptoms and its risk factors among the pregnant women visiting public health facilities of Nepal	PLOS ONE			English	Article							PERINATAL MENTAL-DISORDERS; MIDDLE-INCOME COUNTRIES; POSTPARTUM DEPRESSION; POSTTRAUMATIC-STRESS; POSTNATAL DEPRESSION; MATERNAL DEPRESSION; VALIDATION; ABORTION; VIOLENCE; SCALE	Introduction Antepartum depression is a contributing factor for adverse maternal and perinatal outcome. The study aimed to assess the antepartum depressive symptoms in selected public health facilities of Nepal. Methodology This is a mixed-method cross-sectional study that included 143 pregnant women attending the antenatal checkup in four public health facilities of Kathmandu. Edinburgh Postnatal Depression Scale (EPDS) tool with cut-off score > = 10 was used to assess the antepartum depressive symptoms. Bivariate and multivariable analysis was carried out to identify factors associated with the depressive symptoms. Further semi-structured interviews were conducted with 12 pregnant women identified with the depressive symptoms. Result Of the total 143 pregnant women, 26 (18%, CI at 95% 12.6-25.5) reported depressive symptoms. Multivariable analysis reported higher odds of antepartum depressive-symptoms with health problem, early gestational age, sex preference, and spousal alcohol intake. Thematic analysis of qualitative data further revealed participants' apprehension on; birth outcome, a family expectation of male child, inadequate support from the family/husband and disturbed family environment. Conclusion Notable proportion of pregnant women were reported with antepartum depressive symptoms. Women's perception on patriarchal values for childbirth was revealed to be important factor for the depressive symptoms. The study draws an attention to a need for screening for antepartum depression into primary health care system. Strengthening ongoing efforts on gender equity could contribute the psychological well-being of pregnant women.	[Joshi, Deepak] Save Children, Hlth & Nutr Dept, Kathmandu, Nepal; [Shrestha, Santoshi] Global Hlth Alliance Nepal, Kathmandu, Nepal; [Shrestha, Nipun] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia	Save the Children; Victoria University	Joshi, D (corresponding author), Save Children, Hlth & Nutr Dept, Kathmandu, Nepal.	deepak.deeps@gmail.com	Shrestha, Nipun/ABC-6127-2021	Shrestha, Nipun/0000-0003-3542-8130; Joshi, Deepak/0000-0001-8539-7411	Little Buddha College of Health Sciences	Little Buddha College of Health Sciences	Authors would like to thank all the health workers and study participants for their valuable time and cooperation. We also thank Little Buddha College of Health Sciences for their valuable cooperation and support to conduct this study.	Adewuya AO, 2006, J PSYCHOSOM OBST GYN, V27, P267, DOI 10.1080/01674820600915478; Aktas S, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.16640; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Bhusal C L, 2011, J Nepal Health Res Counc, V9, P129; Biratu A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0092-x; Branson J, 2010, STUD FAMILY PLANN, V41, P89, DOI 10.1111/j.1728-4465.2010.00229.x; Brugha TS, 2016, PSYCHOL MED, V46, P345, DOI 10.1017/S003329171500183X; Bunevicius R, 2009, ACTA OBSTET GYN SCAN, V88, P599, DOI 10.1080/00016340902846049; Central Bureau of Statistics (CBS), 2012, NAT POP HOUS CENS 20, P1; Da-Silva VA, 1998, BRAZ J MED BIOL RES, V31, P799, DOI 10.1590/S0100-879X1998000600012; Das S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-817; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; Eastwood J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169907; Enlow MB, 2010, PSYCHOL CHALLENGE, V71, P607; Fernandes MC, 2011, ARCH WOMEN MENT HLTH, V14, P209, DOI 10.1007/s00737-010-0190-2; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Gentile S, 2017, NEUROSCIENCE, V342, P154, DOI 10.1016/j.neuroscience.2015.09.001; Haghparast E, 2016, PAK J MED SCI, V32, P1097, DOI 10.12669/pjms.325.10909; Hamama L, 2010, DEPRESS ANXIETY, V27, P699, DOI 10.1002/da.20714; Ho-Yen SD, 2007, ACTA OBSTET GYN SCAN, V86, P291, DOI 10.1080/00016340601110812; Karmaliani R, 2013, NIH PUBLIC ACCESS, V55; Khatri GK, 2018, J AFFECT DISORDERS, V228, P238, DOI 10.1016/j.jad.2017.12.016; Lamichhane P, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-19; Marcinko VM, 2011, COLLEGIUM ANTROPOL, V35, P225; Matthews Z, 2016, DETERMINANTS SEX PRE, V29, P69; MOHP New ERA and ICF DHS Program, 2017, NEP DEM HLTH SURV 20, P636; Nasreen HE, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-22; National Planning Commission Nepal, 2015, SUST DEV GOALS; Participatory AR, 2012, VOICES COMMUNITY ACC; Puri M, 2010, J INTERPERS VIOLENCE, V25, P1873, DOI 10.1177/0886260509354514; Qiu C, 2007, BMC WOMENS HEALTH, V7, P1, DOI 10.1186/1472-6874-7-1; Rahman A, 2013, B WORLD HEALTH ORGAN, V91, P593, DOI 10.2471/BLT.12.109819; Regmi S, 2002, TROP MED INT HEALTH, V7, P378, DOI 10.1046/j.1365-3156.2002.00866.x; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Rondon MB, 2016, MATERNAL DEPRESSION, P1; Shakya R, 2008, J NEPAL MED ASSOC, V47, P128; Shrestha SD, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0859-2; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; Tendais I, 2014, SPAN J PSYCHOL, V17, DOI 10.1017/sjp.2014.7; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tuladhar S, 2013, WOMENS EMPOWERMENT S, P1; Varma D, 2007, J AFFECT DISORDERS, V102, P227, DOI 10.1016/j.jad.2006.09.026; Waqas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116510; Weinstock M, 2005, BRAIN BEHAV IMMUN, V19, P296, DOI 10.1016/j.bbi.2004.09.006	46	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214992	10.1371/journal.pone.0214992	http://dx.doi.org/10.1371/journal.pone.0214992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947251	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000463314500096
J	Kiffner, C; Arndt, Z; Foky, T; Gaeth, M; Gannett, A; Jackson, M; Lellman, G; Love, S; Maroldi, A; McLaughlin, S; Skenandore, B; von Euler, S; Zambrano, Z; Kissui, B				Kiffner, Christian; Arndt, Zoe; Foky, Trent; Gaeth, Megan; Gannett, Alex; Jackson, Madeline; Lellman, Georgie; Love, Sophia; Maroldi, Ana; McLaughlin, Shane; Skenandore, Bobbi; von Euler, Sarah; Zambrano, Zachary; Kissui, Bernard			Land use, REDD plus and the status of wildlife populations in Yaeda Valley, northern Tanzania	PLOS ONE			English	Article							SPECIES RICHNESS; BIODIVERSITY CONSERVATION; INTEGRATED CONSERVATION; RANGELAND DEGRADATION; PROTECTED AREAS; NATIONAL-PARK; DUNG DECAY; MANAGEMENT; LIVESTOCK; HABITAT	REDD+ projects primarily focus on reducing carbon emissions from deforestation and forest degradation in developing countries. These projects are regularly evaluated against their core objective of conserving carbon stocks, but their contribution to biodiversity conservation has rarely been assessed. To assess the conservation value of the area and the relative performance of a REDD+ land use plan in Yaeda Valley, a semi-arid savannah ecosystem in northern Tanzania, we implemented an annual wildlife monitoring scheme. Based on direct sightings and indirect signs of wildlife, obtained from stratified walking transects conducted annually from 2015-2018, we estimated annual trends of mammal species richness and wildlife densities in three REDD+ and three non-REDD+ land-use strata. Our surveys document a near complete mammal community in the area. Species accumulation curves, and subsequent statistical comparisons, indicated highest mammal species richness in the woodland habitats (both REDD+ and non REDD+ strata) as compared to more human and livestock impacted areas, and suggested constant species richness from 2015-2018. To estimate stratum- and year-specific livestock and wildlife densities (cattle, donkey, goat and sheep combined, Thomson's gazelle, Kirk's dik-dik) and wildlife sign densities (aardvark, bushbuck, bushpig, Kirk's dik dik, eland, elephant, Maasai giraffe, greater kudu, hyena, impala, lesser kudu, warthog, wildebeest, Plains zebra), we fitted species-specific detection functions in a distance sampling framework. Species-specific densities varied between 2015 and 2018 and showed substantial increases and occasional declines in other species-stratum combinations. However, population growth rates were not systematically associated with specific land-use strata. Although our results do not explicitly provide evidence that REDD+ land-use plans directly co-benefit wildlife conservation, they show that REDD+ areas have the potential to maintain intact wildlife assemblages. To ensure effective long-term conservation outcomes, we advocate for a more formal integration of wildlife conservation goals in the REDD+ scheme.	[Kiffner, Christian; Kissui, Bernard] Sch Field Studies, Ctr Wildlife Management Studies, Karatu, Tanzania; [Arndt, Zoe] Colorado State Univ, Dept Zool, Ft Collins, CO 80523 USA; [Foky, Trent; Love, Sophia] Whitman Coll, Walla Walla, WA 99362 USA; [Gaeth, Megan] Guilford Coll, Dept Biol, Greensboro, NC 27410 USA; [Gannett, Alex] Gonzaga Univ, Environm Studies, Spokane, WA 99258 USA; [Jackson, Madeline] Univ Minnesota, Ecol Evolut & Behav, St Paul, MN 55108 USA; [Lellman, Georgie] Kenyon Coll, Gambier, OH 43022 USA; [Maroldi, Ana] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [McLaughlin, Shane] Trinity Coll, Environm Sci Program, Hartford, CT 06106 USA; [Skenandore, Bobbi] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI USA; [von Euler, Sarah] Davidson Coll, Dept Biol, Davidson, NC 28036 USA; [Zambrano, Zachary] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA	Colorado State University; Whitman College; Gonzaga University; University of Minnesota System; University of Minnesota Twin Cities; Kenyon College; University of Massachusetts System; University of Massachusetts Amherst; Trinity College; University of Wisconsin System; University of Wisconsin Madison; Davidson College; Kansas State University	Kiffner, C (corresponding author), Sch Field Studies, Ctr Wildlife Management Studies, Karatu, Tanzania.	ckiffne@gwdg.de	Kiffner, Christian/F-4088-2012	Kiffner, Christian/0000-0002-7475-9023				Alkemade R, 2013, P NATL ACAD SCI USA, V110, P20900, DOI 10.1073/pnas.1011013108; Anderson J, 2015, REDUCING EMISSIONS D; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2016, ESTIMATES STAT ESTIM; [Anonymous], 2021, LANG ENV STAT COMP; Armitage DR, 1996, AMBIO, V25, P396; Barnes MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12747; Barnes RFW, 2001, AFR J ECOL, V39, P1, DOI 10.1046/j.1365-2028.2001.00266.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bart?n K, 2013, MODEL SELECTION MODE; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Bedunah DJ, 2012, RANGELAND ECOL MANAG, V65, P606, DOI 10.2111/REM-D-11-00155.1; Bello C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501105; Bluwstein J, 2016, CONSERV SOC, V14, P218, DOI 10.4103/0972-4923.191156; Bond ML, 2017, LANDSCAPE ECOL, V32, P1705, DOI 10.1007/s10980-017-0537-4; Bryan BA, 2016, NAT CLIM CHANGE, V6, P301, DOI [10.1038/NCLIMATE2874, 10.1038/nclimate2874]; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Caro T, 2009, DIVERS DISTRIB, V15, P178, DOI 10.1111/j.1472-4642.2008.00522.x; Caro T, 2016, NATURE, V537, P617, DOI 10.1038/537617d; Caro T, 2016, CONSERV BIOL, V30, P716, DOI 10.1111/cobi.12658; Caro T, 2016, TROP CONSERV SCI, V9, P1; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chase MJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2354; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Collins MB, 2011, TROP CONSERV SCI, V4, P261, DOI 10.1177/194008291100400304; Cook WM, 2002, ECOL LETT, V5, P619, DOI 10.1046/j.1461-0248.2002.00366.x; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; du Toit JT, 2017, SPRINGER SER ENV MAN, P395, DOI 10.1007/978-3-319-46709-2_12; Ducatez S, 2017, CONSERV LETT, V10, P186, DOI 10.1111/conl.12258; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Foley C., 2014, FIELD GUIDE LARGER M; Fynn RWS, 2016, J APPL ECOL, V53, P388, DOI 10.1111/1365-2664.12591; Fynn RWS, 2011, AFR J ECOL, V49, P175, DOI 10.1111/j.1365-2028.2010.01245.x; Geldmann J, 2015, BIOL CONSERV, V191, P692, DOI 10.1016/j.biocon.2015.08.029; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Githiru M, 2017, AFR J ECOL, V55, P554, DOI 10.1111/aje.12385; Greene K, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1133-2; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Jodoin S., 2017, FOREST PRESERVATION, V1st, DOI [10.1017/9781316986882, DOI 10.1017/9781316986882]; Keeping D, 2018, BIOL CONSERV, V223, P156, DOI 10.1016/j.biocon.2018.04.027; Kiffner C, 2016, J NAT CONSERV, V31, P29, DOI 10.1016/j.jnc.2016.02.006; Kiffner C, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2027; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kinnaird MF, 2012, CONSERV BIOL, V26, P1026, DOI 10.1111/j.1523-1739.2012.01942.x; Kiss A, 1990, LIVING WILDLIFE WILD; Kohler F, 2017, CONSERV BIOL, V31, P245, DOI 10.1111/cobi.12843; KREMEN C, 1994, CONSERV BIOL, V8, P388, DOI 10.1046/j.1523-1739.1994.08020388.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Marlowe F., 2002, ETHNICITY HUNTER GAT, P247; Marques FFC, 2001, J APPL ECOL, V38, P349, DOI 10.1046/j.1365-2664.2001.00584.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MILTON SJ, 1994, BIOSCIENCE, V44, P70, DOI 10.2307/1312204; Morrison TA, 2016, BIOL CONSERV, V197, P53, DOI 10.1016/j.biocon.2016.02.034; Msoffe F. U., 2011, International Journal of Biodiversity and Conservation, V3, P280; Msuha MJ, 2012, BIODIVERS CONSERV, V21, P2747, DOI 10.1007/s10531-012-0331-1; Newmark WD, 2000, BIOSCIENCE, V50, P585, DOI 10.1641/0006-3568(2000)050[0585:CWIAIC]2.0.CO;2; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Ogutu JO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169730; Ogutu JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163249; Panfil SN, 2016, CONSERV LETT, V9, P143, DOI 10.1111/conl.12188; Peterson D., 2013, HADZABE LIGHT MILLIO; Plumptre AJ, 2000, J APPL ECOL, V37, P356, DOI 10.1046/j.1365-2664.2000.00499.x; Rannestad OT, 2006, J TROP ECOL, V22, P675, DOI 10.1017/S0266467406003610; Rich LN, 2016, J APPL ECOL, V53, P1225, DOI 10.1111/1365-2664.12650; Riggio J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187407; Riggio J, 2016, P NATL ACAD SCI USA, V113, pE107, DOI 10.1073/pnas.1521506113; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ripple WJ, 2016, BIOSCIENCE, V66, P807, DOI 10.1093/biosci/biw092; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Schmeller DS, 2018, BIOL REV, V93, P55, DOI 10.1111/brv.12332; Smith LE, 2004, HUMAN BEHAV EVOLUTIO; Sollmann R, 2017, DIVERS DISTRIB, V23, P317, DOI 10.1111/ddi.12530; Stander PE, 1998, J APPL ECOL, V35, P378, DOI 10.1046/j.1365-2664.1998.00313.x; Steinbeiser CM, 2019, J MAMMAL, V100, P192, DOI 10.1093/jmammal/gyy175; Stoner C, 2007, CONSERV BIOL, V21, P635, DOI 10.1111/j.1523-1739.2007.00705.x; Thomas L, 1996, ECOLOGY, V77, P49, DOI 10.2307/2265653; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Toit D., 2010, WILD RANGELANDS CONS; UNFCCC, 2017, UNFCCC REDD WEB PLAT; van Vliet N, 2009, AFR J ECOL, V47, P40, DOI 10.1111/j.1365-2028.2007.00913.x; Viquerat S, 2013, ECOTROPICA, V19, P33; Viquerat SMA, 2012, S AFR J WILDL RES, V42, P1, DOI 10.3957/056.042.0110; Waltert M, 2008, J WILDLIFE MANAGE, V72, P603, DOI 10.2193/2006-456; Weise FJ, 2017, PEERJ, V5, DOI 10.7717/peerj.4096; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Wilfred P, 2010, TROP CONSERV SCI, V3, P103, DOI 10.1177/194008291000300102; Wood BM, 2014, HUM NATURE-INT BIOS, V25, P620, DOI 10.1007/s12110-014-9218-z; Woodroffe R., 2012, LYCAON PICTUS; Woodroffe R, 2011, J APPL ECOL, V48, P1345, DOI 10.1111/j.1365-2664.2011.02059.x; Yanda PZ, 2005, PHYS CHEM EARTH, V30, P717, DOI 10.1016/j.pce.2005.08.013; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	99	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214823	10.1371/journal.pone.0214823	http://dx.doi.org/10.1371/journal.pone.0214823			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947305	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500068
J	Nabbe, P; Le Reste, JY; Guillou-Landreat, M; Gatineau, F; Le Floch, B; Montier, T; Van Marwijk, H; Van Royen, P				Nabbe, Patrice; Le Reste, Jean Yves; Guillou-Landreat, Morgane; Gatineau, Florence; Le Floch, Bernard; Montier, Tristan; Van Marwijk, Harm; Van Royen, Paul			The French version of the HSCL-25 has now been validated for use in primary care	PLOS ONE			English	Article							PRESENT STATE EXAMINATION; SYMPTOM CHECKLIST HSCL; COEFFICIENT-ALPHA; DEPRESSION SCALE; HOSPITAL ANXIETY; VALIDITY; RELIABILITY; POPULATION; PREVALENCE; DISORDERS	Background The Hopkins Symptom Checklist in 25 items (HSCL-25) helps to assess anxiety and depression in Primary Care. Anxiety and depression show considerable overlap in primary care. This self-administrated questionnaire is valid, reliable and ergonomic in the original US version. We have translated it into French. The aim of this study was to estimate the test characteristics of the HSCL-25, in its French version (F-HSCL-25), by comparing it to the Present State Examination-9 French version (F-PSE-9) and by determining its internal validity and dimensions. Method Outpatients from three French General Practice settings (rural, semi-rural and urban) were recruited: approximately 20,000 outpatients among 17 GPs. Two groups were formed: FHSCL-25 >= 1.75 and F-HSCL-25 <1.75. A validated cut-off score of > 1.75 was considered to indicate a clinically relevant level of symptoms of depression and anxiety. In order to obtain two balanced groups, a different method of randomization was chosen for each group. The F-PSE-9 was randomly administered to 1 in 2 patients in the F-HSCL-25 >= 1.75 group, and to 1 in 16 in the (much larger) F-HSCL-25 <1.75 group. The diagnostic performance was assessed and the test results obtained from both groups were compared with their F-PSE-9 results. Results Of the 1126 patients who completed the F-HCL-25, 886 joined the F-HSCL-25 <1.75 group and 240 the F-HSCL-25 >= 1.75 group. The overall prevalence of depression, using the FHSCL-25, was 21% in these medical practices. The diagnostic performance of the F-HSCL-25 versus the F-PSE-9, the external criteria were as follows: Positive Predictive Value PPV) 69.8%, Negative Predictive Value (NPV) 87%; Sensitivity 59.1%, and Specificity 91.4%. The Principal Component Analysis showed that F-HSCL-25 is a one-dimensional tool (anxiety and depression dimensions combined) with a Cronbach Alpha of 0.93. Conclusion The F-HSCL-25 is an appropriate diagnostic tool for anxiety and depression in primary care in France due to its high specificity and high NPV. The HSCL-25 scale has a high eigenvalue. This pilot study will be extended throughout Europe; however, preliminary evidence suggests that the HSCL-25 is a reliable and suitable diagnostic tool for primary care.	[Nabbe, Patrice; Le Reste, Jean Yves; Gatineau, Florence; Le Floch, Bernard] Univ Bretagne Occidentale, Dept Gen Practice, EA SPURBO 7479, Brest, France; [Guillou-Landreat, Morgane] Univ Bretagne Occidentale, Dept Addictol, EA SPURBO 7479, Brest, France; [Montier, Tristan] Univ Bretagne Occidentale, SFR ScInBioS 148, Unite INSERM 1078, Brest, France; [Van Marwijk, Harm] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Div Populat Hlth Hlth Serv Res & Primary Care, 1 Williamson Bldg,Oxford Rd, Manchester, Lancs, England; [Van Royen, Paul] Univ Antwerp, Fac Med & Hlth Sci, Dept Primary & Interdisciplinary Care, Antwerp, Belgium	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; University of Manchester; University of Antwerp	Nabbe, P (corresponding author), Univ Bretagne Occidentale, Dept Gen Practice, EA SPURBO 7479, Brest, France.	Patrice.nabbe@univ-brest.fr	Van Marwijk, Harm/K-6306-2013	Van Marwijk, Harm/0000-0001-6206-485X; nabbe, patrice/0000-0002-2489-6476	European General Practitioners Research Network	European General Practitioners Research Network	The study had a Grant of 8000 Euros from the European General Practitioners Research Network.	Al-Turkait FA, 2011, PSYCHOPATHOLOGY, V44, P230, DOI 10.1159/000322797; [Anonymous], SANTE HOMME; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; Beck F, 2007, BAROMOTRE SANTE 2005; BERNARDI RA, 1994, EDUC PSYCHOL MEAS, V54, P766, DOI 10.1177/0013164494054003023; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brislin RW, 1970, J CROSS CULT PSYCHOL, V2; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Frojdh K, 2004, INT J GERIATR PSYCH, V19, P386, DOI 10.1002/gps.1102; Gefen D, 2005, COMMUN ASSOC INF SYS, V16, P91, DOI 10.17705/1CAIS.01605; Gliem J.A., 2003, MIDWEST RES TO PRACT, DOI [10.1016/j.encep.2016.05.011, DOI 10.1109/PROC.1975.9792]; Golden J, 2007, J AFFECT DISORDERS, V100, P265, DOI 10.1016/j.jad.2006.10.020; Grazioli R, 2000, BRIT J CLIN PSYCHOL, V39, P329, DOI 10.1348/014466500163347; Green C.D., 1997, CLASSICS HIST PSYCHO; Herique A, 2009, ENCEPHALE, V35, P73, DOI 10.1016/j.encep.2007.12.010; Hotelling H., 1933, J ED PSYCHOL; IFOP, FRANC SYST SANT; Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; Kopp-Bigault C, 2016, INT J SOC PSYCHIATR, V62, P737, DOI 10.1177/0020764016675652; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; LESAGE AD, 1991, ACTA PSYCHIAT SCAND, V83, P121, DOI 10.1111/j.1600-0447.1991.tb07376.x; LIPMAN RS, 1979, J AFFECT DISORDERS, V1, P9, DOI 10.1016/0165-0327(79)90021-1; Lundin A, 2015, J AFFECT DISORDERS, V183, P247, DOI 10.1016/j.jad.2015.05.024; Mattisson C, 2012, NORD J PSYCHIAT, P1; Nabbe P, 2018, BMC Res Notes, V11, P4, DOI 10.1186/s13104-017-3111-x; Nabbe P, 2017, EUR PSYCHIAT, V39, P99, DOI 10.1016/j.eurpsy.2016.08.004; NETTELBLADT P, 1993, SOC PSYCH PSYCH EPID, V28, P130, DOI 10.1007/BF00801743; Ponterotto JG, 2007, PERCEPT MOTOR SKILL, V105, P997, DOI 10.2466/PMS.105.3.997-1014; Roberts MV, 2016, COMP THEOL THINK, P1; Skogen JC, 2017, SCAND J PUBLIC HEALT, V45, P357, DOI 10.1177/1403494817700287; Spearman C., 1904, AM J PSYCHOL; Stowe ZN, 2005, AM J OBSTET GYNECOL, V192, P522, DOI 10.1016/j.ajog.2004.07.054; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Uher R, 2014, DEPRESS ANXIETY, V31, P459, DOI 10.1002/da.22217; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; Wing JK, 2011, MEASUREMENT CLASSIFI; World Health Organization, 2016, WORLD HLTH STAT MONI	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214804	10.1371/journal.pone.0214804	http://dx.doi.org/10.1371/journal.pone.0214804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30946774	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000463314500063
J	Waldrop, SG; Sriranganathan, N				Waldrop, Steven Grant; Sriranganathan, Nammalwar			Intracellular invasion and survival of Brucella neotomae, another possible zoonotic Brucella species	PLOS ONE			English	Article							MACROPHAGES; INFECTION; VACCINE	In 1967, Brucella neotomae was first isolated from Neotoma lepida, the dessert wood rat, in Utah. With little infection data since its discovery, the zoonotic potential of this Brucella species is largely unknown. Recent reports of isolation from human cerebrospinal fluid, along with current literature suggest that B. neotomae has the ability to infect various hosts and cell types. In this report we extend the knowledge of B. neotomae ATCC 23459's intracellular invasion and survival abilities to a variety of cell lines through gentamicin protection assays. Some of the phagocytic and epithelial cell lines from various mammalian species represent characteristics of some cell types that could be encountered by Brucella in potential hosts. It was found that B. neotomae ATCC 23459 exhibits generally lower intracellular bacterial CFUs compared to the mouse-passaged strain of B. neotomae ATCC 23459, B. suis 1330, and B. abortus 2308. Ultimately, these observations provide a small piece of the puzzle in the investigation of the breadth of B. neotomae's pathogenic potential.	[Waldrop, Steven Grant; Sriranganathan, Nammalwar] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Sriranganathan, N (corresponding author), Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med, Blacksburg, VA 24061 USA.	nathans@vt.edu			Virginia-Maryland College of Veterinary Medicine's Research and Graduate Studies department; USDA; Smithfield; Smithfield Foods Murphy Brown, LLC. (Virginia Tech Foundation, Inc.) [444115]; Virginia APHIS-USDA [422319]; Virginia Tech's Open Access Subvention Fund	Virginia-Maryland College of Veterinary Medicine's Research and Graduate Studies department; USDA(United States Department of Agriculture (USDA)); Smithfield; Smithfield Foods Murphy Brown, LLC. (Virginia Tech Foundation, Inc.); Virginia APHIS-USDA; Virginia Tech's Open Access Subvention Fund	The authors are supported by the Virginia-Maryland College of Veterinary Medicine's Research and Graduate Studies department. Support for this work was provided by the USDA and Smithfield. We thank Smithfield Foods Murphy Brown, LLC. (Virginia Tech Foundation, Inc. Fund #444115) and Virginia APHIS-USDA (Fund #422319) for their support. Additionally, the Virginia Tech's Open Access Subvention Fund covered the article processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RA, 1996, J DAIRY SCI, V79, P1021, DOI 10.3168/jds.S0022-0302(96)76454-8; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; BEAL GA, 1959, AM J VET RES, V20, P872; Bohlin J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-249; Cameron HS, METABOLIC STUDIES BR; Castaneda-Roldan EI, 2004, CELL MICROBIOL, V6, P435, DOI 10.1111/j.1462-5822.2004.00372.x; CDC, 2009, MORBIDITY MORTALITY; Covert J, 2009, EXP BIOL MED, V234, P1450, DOI 10.3181/0904-RM-124; Czibener C, 2016, VACCINE, V34, P1524, DOI 10.1016/j.vaccine.2016.02.025; Dabral N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107180; Dee TA., 1990, THESIS; Ducrotoy MJ, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0086-5; GIBBY IW, 1965, J BACTERIOL, V89, P9, DOI 10.1128/JB.89.1.9-16.1965; Kang YS, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00255-18; Kang YS, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00991-16; Kaur Gurvinder, 2012, Spermatogenesis, V2, P1; Kim S, 2015, INTERACTION BRUCELLA, DOI [10.5772/61463, DOI 10.5772/61463]; Larsen AK, 2015, BIOMED CENTRAL, V58, P9, DOI [10.1186/s13028-016-0188-5, DOI 10.1186/S13028-016-0188-5]; Larsen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084861; Lindsay DS, 2016, BOVINE MACROPHAGE BM; Lopez-Goni I, 2008, J CLIN MICROBIOL, V46, P3484, DOI 10.1128/JCM.00837-08; LSU, 2009, BRUC SPEC PRES TEST, P1; Macedo AA, 2013, VET IMMUNOL IMMUNOP, V151, P294, DOI 10.1016/j.vetimm.2012.12.001; Martin-Martin AI, 2010, MICROBES INFECT, V12, P246, DOI 10.1016/j.micinf.2009.12.008; MichauxCharachon S, 1997, J BACTERIOL, V179, P3244, DOI 10.1128/jb.179.10.3244-3249.1997; Moustafa D, 2011, VACCINE, V29, P784, DOI 10.1016/j.vaccine.2010.11.018; Moustafa DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014112; Murphy E, 2002, FEMS IMMUNOL MED MIC, V33, P191, DOI 10.1111/j.1574-695X.2002.tb00590.x; Nielsen K, 1990, ANIMAL BRUCELLOSIS; Pan L, 2017, MOL CELLS, V40, P109, DOI 10.14348/molcells.2017.2207; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Soler-Llorens PF, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00116; STOENNER HG, 1963, AM J VET RES, V24, P376; STOENNER HG, 1957, AM J VET RES, V18, P947; Suarez-Esquivel M, 2017, EMERG INFECT DIS, V23, P997, DOI 10.3201/eid2306.162018; Swearengen JR, 2012, BIODEFENSE RESEARCH METHODOLOGY AND ANIMAL MODELS, 2ND EDITION, P27; Turner K.E., 1990, THESIS TEXAS A M, P62; Verdiguel-Fernandez L, 2017, ARCH MICROBIOL, V199, P971, DOI 10.1007/s00203-017-1360-7; Villalobos-Vindas Juan M, 2017, J Med Case Rep, V11, P352, DOI 10.1186/s13256-017-1496-8; von Bargen K, 2012, FEMS MICROBIOL REV, V36, P533, DOI 10.1111/j.1574-6976.2012.00334.x; Whatmore AM, 2008, EMERG INFECT DIS, V14, P517, DOI 10.3201/eid1403.070829; ZAVIZION B, 1995, J DAIRY SCI, V78, P515, DOI 10.3168/jds.S0022-0302(95)76662-0	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213601	10.1371/journal.pone.0213601	http://dx.doi.org/10.1371/journal.pone.0213601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943213	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300016
J	Chen, XL; Xie, YF; Li, JX; Wu, W; Li, GN; Hu, HJ; Wang, XY; Meng, ZJ; Wen, YF; Huang, WH				Chen, Xiao-Long; Xie, Ya-Fen; Li, Jian-Xin; Wu, Wu; Li, Guan-Nan; Hu, Hui-Jing; Wang, Xiao-Yun; Meng, Zhao-Jian; Wen, Yue-Feng; Huang, Wen-Hua			Design and basic research on accuracy of a novel individualized three-dimensional printed navigation template in atlantoaxial pedicle screw placement	PLOS ONE			English	Article							EFFICACY; INJURY	Objective To design and evaluate the accuracy of a novel navigation template suitable for posterior cervical screw placement surgery by using 3D printing technology to improve the existing guiding template design. Methods The researchers (including spine surgeons and technicians) used CT to perform thin-slice scanning on 12 cases of normal upper cervical vertebral specimens and defined the screw channels that were completely located in the pedicle without penetrating the cortex as ideal screw channels, then designed the ideal channel of the upper cervical vertebral (atlantoaxial) pedicle screw by computer software which was regarded as the preset values, and recorded the screw entrance point, transverse angle and sagittal angle of the ideal channel. Then, researchers designed the novel navigation templates for placement pedicle screw according to the ideal screw channel preset values and manufactured them with one for every single vertebra by 3D printer. A senior spine surgeon performed the posterior surgery to implant pedicle screw on the specimens by the novel navigation templates, then performed CT thin-slice scanning on the specimens again after removing the screws, and reconstructed the actual screws channel by computer software, recorded the screw entrance point, transverse angle and sagittal angle of the actual channels which were defined as the actual values and evaluated them according to Kawaguchi's pedicle screw evaluation standard finally. The differences between the preoperative preset values of ideal screw channel and the postoperative actual values of actual screw channel were compared by a nonparametric paired rank test. Results 48 screws were placed on 12 cases of upper cervical vertebral specimens in total. It showed that the grade 0, I, II, III channels in this study were 47, 1, 0, 0, respectively. The grade 0 channels accounted for 97.92% of the total number of channels. There was no significant difference with regard to the screw entrance point, the transverse angle, and the sagittal angle between the preoperative preset values of ideal screw channels and the postoperative actual values of actual screw channels. Conclusion To implant pedicle screw assisted with the novel individually navigation template designed by 3D printed in the posterior cervical surgery can improve accuracy of pedicle screw placement and safety of the surgery.	[Chen, Xiao-Long; Xie, Ya-Fen; Li, Jian-Xin] Guangdong Prov Work Injury Rehabil Hosp, Dept Spine Surg, Guangzhou, Guangdong, Peoples R China; [Wu, Wu; Li, Guan-Nan] Guangdong Prov Work Injury Rehabil Hosp, Dept Joint Surg, Guangzhou, Guangdong, Peoples R China; [Hu, Hui-Jing; Wang, Xiao-Yun; Meng, Zhao-Jian] Guangdong Prov Work Injury Rehabil Hosp, Inst Rehabil Med, Guangzhou, Peoples R China; [Wen, Yue-Feng] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Huang, Wen-Hua] Southern Med Univ, Sch Basic Med Sci, Natl Key Discipline Human Anat, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Southern Medical University - China	Chen, XL (corresponding author), Guangdong Prov Work Injury Rehabil Hosp, Dept Spine Surg, Guangzhou, Guangdong, Peoples R China.; Huang, WH (corresponding author), Southern Med Univ, Sch Basic Med Sci, Natl Key Discipline Human Anat, Guangzhou, Guangdong, Peoples R China.	chenxiaolong_1980@126.com; 1073851445@qq.com	li, jian/GSE-0245-2022; Li, Jing/GYU-5036-2022; Li, Jin/GYQ-5363-2022; LI, JIAN/GRY-2197-2022		National Key R&D Program of China [2017YFC1103403]; Science and Technology Project of Guangdong Province [2017B090912006]	National Key R&D Program of China; Science and Technology Project of Guangdong Province	This study was supported by grants from the National Key R&D Program of China (NO. 2017YFC1103403), the Science and Technology Project of Guangdong Province (NO. 2017B090912006).	Hojo Y, 2014, EUR SPINE J, V23, P2166, DOI 10.1007/s00586-014-3470-0; Hu Y, 2014, ORTHOPEDICS, V37, pE420, DOI 10.3928/01477447-20140430-51; Jiang LH, 2016, ARCH ORTHOP TRAUM SU, V136, P1483, DOI 10.1007/s00402-016-2530-9; Kaneyama S, 2015, SPINE, V40, pE341, DOI 10.1097/BRS.0000000000000772; Kaneyama S, 2014, J NEUROSURG-SPINE, V21, P231, DOI 10.3171/2014.3.SPINE13730; Kawaguchi Y, 2012, SPINE, V37, P1983, DOI 10.1097/BRS.0b013e31825ab547; Li XC, 2015, CLIN TRANSPLANT, V29, P786, DOI 10.1111/ctr.12580; Lu S, 2011, COMPUT AIDED SURG, V16, P240, DOI 10.3109/10929088.2011.605173; Lu S, 2009, SPINE, V34, pE959, DOI 10.1097/BRS.0b013e3181c09985; Mueller CA, 2010, EUR SPINE J, V19, P809, DOI 10.1007/s00586-010-1291-3; Neo M, 2005, SPINE, V30, P2800, DOI 10.1097/01.brs.0000192297.07709.5d; Pu XW, 2018, WORLD NEUROSURG, V114, pE1, DOI 10.1016/j.wneu.2017.11.042; Ryken T, 2009, J NEUROSURG-SPINE, V10, P21, DOI 10.3171/2008.9.SPI08229; Vukicevic M, 2017, ANN BIOMED ENG, V45, P508, DOI 10.1007/s10439-016-1676-5	14	6	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214460	10.1371/journal.pone.0214460	http://dx.doi.org/10.1371/journal.pone.0214460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939170	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900023
J	Aghapour, M; Bockstahler, B; Kneissl, S; Tichy, A; Vidoni, B				Aghapour, Masoud; Bockstahler, Barbara; Kneissl, Sibylle; Tichy, Alexander; Vidoni, Britta			Femoral and tibial alignments in chihuahuas with patellar luxation by radiograph: Angular values and intra- and inter-observer agreement of measurements	PLOS ONE			English	Article							SURGICAL-CORRECTION; ANGLE MEASUREMENTS; PELVIC LIMB; DOGS; INCLINATION; VARUS; NECK; DEFORMITIES; ANTEVERSION; FREQUENCY	Measurement of fore and pelvic limb alignment in veterinary orthopedics is significant, as it is in human medicine. The establishment of reference ranges for alignments and comparing measured ranges in diseased animals to these reference values would allow veterinarians to specify the quantitative degree of an angular deformity, plan suitable treatments and evaluate treatment outcomes. Patellar luxation is a common orthopedic disease in small animal clinics. Severe grades of MPL may present with bone deformities or abnormal alignments; therefore, evaluation of the measurement methods of femoral and tibial alignment in dogs with different grades of patellar luxation to assess the accuracy and reliability of the measurements could be useful. In this retrospective study radiographs of 21 client-owned Chihuahuas that had been presented to the Small Animal Surgery of Vetmeduni Vienna from 2012-2016 with a diagnose of patellar luxation were selected. The measurements were performed on frontal, lateral and axial view radiographs to determine the femoral and tibial angles and to evaluate the intra- and inter-observer variabilities of the protocol. Radiographs of each dog were investigated by three observers. Intra-observer variability was based on measurements by each observer who repeated the protocol two times to evaluate repeatability. Inter-observer variability was based on the measurements between the three observers to evaluate the reproducibility of the protocol. The results of the study showed that 92.85% of inter-observer ICC (intra-class correlation coefficient) had high correlation, and the remaining 7.15% had good correlation. Intra-observer ICCs for measurements of the first observer were 28.57% high correlation and 50% good correlation. For the second observer, 100% high correlation was recorded, and for the third observer 71.42% high correlation and 14.28% good correlation was recorded. These results show that the selected methods have high correlation and could be used as a reliable method in veterinary orthopedics.	[Aghapour, Masoud; Vidoni, Britta] Univ Vet Med, Dept Compan Anim & Horses, Univ Clin Small Anim, Small Anim Surg, Vienna, Austria; [Bockstahler, Barbara] Univ Vet Med, Dept Compan Anim & Horses, Univ Clin Small Anim, Sect Phys Therapy,Small Anim Surg, Vienna, Austria; [Kneissl, Sibylle] Univ Vet Med, Dept Compan Anim & Horses, Univ Clin Small Anim, Diagnost Imaging, Vienna, Austria; [Tichy, Alexander] Univ Vet Med, Dept Biomed Sci Platform Bioinformat & Biostat, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Aghapour, M (corresponding author), Univ Vet Med, Dept Compan Anim & Horses, Univ Clin Small Anim, Small Anim Surg, Vienna, Austria.	masoud.aghapour@vetmeduni.ac.at	Kneissl, Sibylle Maria/ABD-8091-2021; Bockstahler, Barbara/P-3152-2019; Vidoni, Britta/AAD-4498-2021; Aghapour, Masoud/AGK-4911-2022	Kneissl, Sibylle Maria/0000-0001-9588-4715; Bockstahler, Barbara/0000-0002-1499-5753; Aghapour, Masoud/0000-0002-9654-1666				Alam MR, 2007, VET COMP ORTHOPAED, V20, P59; Arthurs GI, 2006, VET SURG, V35, P559, DOI 10.1111/j.1532-950X.2006.00189.x; BARDET JF, 1983, VET SURG, V12, P1, DOI 10.1111/j.1532-950X.1983.tb00693.x; Barnes DM, 2015, VET SURG, V44, P85, DOI 10.1111/j.1532-950X.2014.12265.x; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Dismukes DI, 2008, VET SURG, V37, P674, DOI 10.1111/j.1532-950X.2008.00434.x; Dismukes DI, 2008, VET SURG, V37, P300, DOI 10.1111/j.1532-950X.2008.00381.x; Dismukes DI, 2007, VET SURG, V36, P699, DOI 10.1111/j.1532-950X.2007.00323.x; Dudley RM, 2006, VET RADIOL ULTRASOUN, V47, P546, DOI 10.1111/j.1740-8261.2006.00184.x; Fossum, 2002, SMALL ANIMAL SURG, P1143; Franklin SP, 2012, VET SURG, V41, P86, DOI 10.1111/j.1532-950X.2011.00923.x; Fuller MC, 2014, CAN VET J, V55, P757; Gibbons SE, 2006, J SMALL ANIM PRACT, V47, P3, DOI 10.1111/j.1748-5827.2006.00067.x; Glassman M, 2011, VET SURG, V40, P830, DOI 10.1111/j.1532-950X.2011.00857.x; HAUPTMAN J, 1983, VET SURG, V12, P189, DOI 10.1111/j.1532-950X.1983.tb00740.x; Hauptman J., 1979, VET SURG, V8, P74, DOI [10.1111/j.1532-950X.1979.tb00612.x, DOI 10.1111/J.1532-950X.1979.TB00612.X]; HAYES AG, 1994, J AM VET MED ASSOC, V205, P716; HULSE DA, 1981, VET MED SM ANIM CLIN, V76, P43; Hulse DA., 1993, DIS MECH SMALL ANIMA, P808; Jackson GM, 2012, VET SURG, V41, P994, DOI 10.1111/j.1532-950X.2012.01059.x; Lambert RJ, 2010, VET SURG, V39, P181, DOI 10.1111/j.1532-950X.2009.00625.x; Macias C, 2002, J SMALL ANIM PRACT, V43, P433, DOI 10.1111/j.1748-5827.2002.tb00009.x; Miles JE, 2015, VET COMP ORTHOPAED, V28, P193, DOI 10.3415/VCOT-14-08-0127; MONTAVON PM, 1985, VET SURG, V14, P277, DOI 10.1111/j.1532-950X.1985.tb00883.x; Mortari AC, 2009, CAN VET J, V50, P1064; NUNAMAKER DM, 1973, J AM VET RADIOL SOC, V14, P45; Olimpo M, 2016, VET ITAL, P1; Osmond CS, 2006, VET RADIOL ULTRASOUN, V47, P136, DOI 10.1111/j.1740-8261.2006.00119.x; Paley D, 2002, PRINCIPLES DEFORMITY, DOI [10.1007/978-3-642-59373-4, DOI 10.1007/978-3-642-59373-4_6]; Phetkaew T, 2018, VET COMP ORTHOPAED, V31, P114, DOI [10.3415/VCOT-17-05-0067, 10.1055/s-0038-1667359]; Piermattei DL., 2006, HDB SMALL ANIMAL ORT, P562; RUMPH PF, 1990, VET SURG, V19, P328, DOI 10.1111/j.1532-950X.1990.tb01200.x; Sarierler M, 2004, ACTA VET HUNG, V52, P245, DOI 10.1556/AVet.52.2004.2.13; Schawalder P, 1981, CENTRUM COLLUM DIAPH; SINGLETO.WB, 1969, J SMALL ANIM PRACT, V10, P59, DOI 10.1111/j.1748-5827.1969.tb04021.x; Soparat C, 2012, VET COMP ORTHOPAED, V25, P197, DOI 10.3415/VCOT-11-04-0057; Swiderski JK, 2008, VET SURG, V37, P43, DOI 10.1111/j.1532-950X.2007.00347.x; Tomlinson J, 2007, VET SURG, V36, P593, DOI 10.1111/j.1532-950X.2007.00309.x; Vasseur P. B., 2003, TXB SMALL ANIMAL SUR, V3rd, P2090; Vedrine B, 2013, VET COMP ORTHOPAED, V26, P266, DOI 10.3415/VCOT-12-02-0018; WILLAUER CC, 1987, VET SURG, V16, P31, DOI 10.1111/j.1532-950X.1987.tb00910.x; Witte PG, 2015, VET COMP ORTHOPAED, V28, P331, DOI 10.3415/VCOT-14-12-0186; Yasukawa S, 2016, VET COMP ORTHOPAED, V29, P29, DOI 10.3415/VCOT-15-05-0089; Zilincik M, 2018, VET COMP ORTHOPAED, V31, P17, DOI 10.3415/VCOT-17-01-0018	44	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214579	10.1371/journal.pone.0214579	http://dx.doi.org/10.1371/journal.pone.0214579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921407	Green Submitted, gold, Green Published			2022-12-27	WOS:000462594000090
J	Decourt, C; Robert, V; Lomet, D; Anger, K; Georgelin, M; Poissenot, K; Pellicer-Rubio, MT; Aucagne, V; Beltramo, M				Decourt, Caroline; Robert, Vincent; Lomet, Didier; Anger, Karine; Georgelin, Marion; Poissenot, Kevin; Pellicer-Rubio, Maria-Teresa; Aucagne, Vincent; Beltramo, Massimiliano			The kisspeptin analog C6 is a possible alternative to PMSG (pregnant mare serum gonadotropin) for triggering synchronized and fertile ovulations in the Alpine goat	PLOS ONE			English	Article							LUTEINIZING-HORMONE SECRETION; INVESTIGATIONAL METASTIN/KISSPEPTIN ANALOG; ARTIFICIAL-INSEMINATION; PROGESTERONE; ESTRUS; LH; REPRODUCTION; PLASMA; EWES; ESTRADIOL	In temperate regions goat's reproduction is seasonal. To obtain year-round breeding, hormonal treatments are currently applied. These treatments usually combine a progesterone analog with the pregnant mare serum gonadotropin (PMSG). However, their use has significant ethical and environmental drawbacks. Therefore, alternative methods to manage reproduction are needed. The discovery that in mammals the neuropeptide kisspeptin is a major positive regulator of hypothalamo-pituitary gonadal axis offered an attractive alternative strategy to control reproduction. We have previously designed a kisspeptin analog, called C6, which offers pharmacological advantages over endogenous kisspeptin. These include a longer lasting effect and enhanced activity following intramuscular injection. In the present work, we evaluated C6 effect on LH and FSH plasma concentrations in the Alpine goat breed and tested whether C6 could replace PMSG to trigger ovulation. An intramuscular injection of C6 (15 nmol/doe) given 24 hours after the end of progestogen treatment induced a surge-like peak of both LH and FSH. This was followed by an increase of progesterone, a hallmark of ovulation induction and corpus luteus formation. These results were obtained at three different time of the year: during the breeding season, the non-breeding season and at the onset of the breeding season. Furthermore, we compared the efficacy of C6 and PMSG to induce fertile ovulations when these treatments are given at the onset of the breeding season and are followed by artificial insemination. The results of this first attempt were extremely promising with gestation rates of 45% and 64% for C6 and PMSG respectively. Pending optimization of the treatment procedure in order to improve efficacy, kisspeptin analogs could be the long sought-after alternative to PMSG.	[Decourt, Caroline; Robert, Vincent; Lomet, Didier; Anger, Karine; Georgelin, Marion; Poissenot, Kevin; Pellicer-Rubio, Maria-Teresa; Beltramo, Massimiliano] Univ Tours, UMR Physiol Reprod & Comportements INRA, CNRS, UMR85,UMR7247,IFCE, Nouzilly, France; [Aucagne, Vincent] CNRS, UPR 4301, Ctr Biophys Mol, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Beltramo, M (corresponding author), Univ Tours, UMR Physiol Reprod & Comportements INRA, CNRS, UMR85,UMR7247,IFCE, Nouzilly, France.	Massimiliano.Beltramo@inra.fr	Aucagne, Vincent/AAB-1856-2019; POISSENOT, Kévin/GMW-7942-2022; decourt, caroline/AAF-9534-2019	POISSENOT, Kevin/0000-0003-4236-1421; Ferreira, Agustin Francisco/0000-0003-0286-7524; Beltramo, Massimiliano/0000-0003-3472-2477; Aucagne, Vincent/0000-0002-2647-0188	French National Research Agency (ANR, Kiss project) [ANR-15-CE20-0015-01]; Region Centre Val de Loire (Capriss project)	French National Research Agency (ANR, Kiss project); Region Centre Val de Loire (Capriss project)	CD, VR, DL, KA, MG, KP, M-TP-R, VA and MB were supported by the French National Research Agency (ANR, Kiss project, ANR-15-CE20-0015-01) http://www.agence-nationale-recherche.fr/and Region Centre Val de Loire (Capriss project) http://www.regioncentre-valdeloire.fr/accueil.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjmand Mohammad, 2014, Vet Res Forum, V5, P247; Asami T, 2013, J MED CHEM, V56, P8298, DOI 10.1021/jm401056w; Beltramo M, 2015, J MED CHEM, V58, P3459, DOI 10.1021/jm5019675; Caillat H, 2011, RENC RECH RUMIN, V18, P418; Caraty A, 2007, ENDOCRINOLOGY, V148, P5258, DOI 10.1210/en.2007-0554; CHEMINEAU P, 1982, THERIOGENOLOGY, V17, P313, DOI 10.1016/0093-691X(82)90091-7; Chemineau P., 1994, Productions Animales (Paris), V7, P315; Dardente H, 2016, THERIOGENOLOGY, V86, P324, DOI 10.1016/j.theriogenology.2016.04.045; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Decourt C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26908; Endo N, 2015, ANIM REPROD SCI, DOI [10.1016/j.anireprosci, DOI 10.1016/J.ANIREPROSCI.]; Endo N, 2015, ANIM REPROD SCI, V159, P87, DOI 10.1016/j.anireprosci.2015.05.016; Fatet A, 2011, ANIM REPROD SCI, V124, P211, DOI 10.1016/j.anireprosci.2010.08.029; Goto Y, 2014, REPROD DOMEST ANIM, V49, P338, DOI 10.1111/rda.12283; Hashizume T, 2010, ANIM REPROD SCI, V118, P37, DOI 10.1016/j.anireprosci.2009.05.017; Knights M, 2016, ANIM SCI J, V87, P1084, DOI 10.1111/asj.12627; Leboeuf B, 2008, REPROD DOMEST ANIM, V43, P379, DOI 10.1111/j.1439-0531.2008.01188.x; Lopez-Sebastian A, 2007, THERIOGENOLOGY, V68, P1081, DOI 10.1016/j.theriogenology.2007.08.003; MONTGOMERY GW, 1985, J REPROD FERTIL, V73, P173, DOI 10.1530/jrf.0.0730173; MORI Y, 1984, J REPROD FERTIL, V72, P223, DOI 10.1530/jrf.0.0720223; Motlomelo KC, 2002, SMALL RUMINANT RES, V45, P45, DOI 10.1016/S0921-4488(02)00113-X; PANT HC, 1977, J ENDOCRINOL, V73, P247, DOI 10.1677/joe.0.0730247; PELLETIER J, 1968, CR ACAD SCI D NAT, V266, P2352; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Romano JE, 2004, SMALL RUMINANT RES, V55, P15, DOI 10.1016/j.smallrumres.2003.10.015; Roy F, 1999, BIOL REPROD, V60, P805, DOI 10.1095/biolreprod60.4.805; Sebert ME, 2010, DOMEST ANIM ENDOCRIN, V38, P289, DOI 10.1016/j.domaniend.2010.01.001; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Vilarino M, 2011, THERIOGENOLOGY, V75, P1195, DOI 10.1016/j.theriogenology.2010.11.030; WHEATLEY IS, 1969, J REPROD FERTIL, V19, P211, DOI 10.1530/jrf.0.0190211; Yotov S. A., 2016, Asian Pacific Journal of Reproduction, V5, P144	31	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214424	10.1371/journal.pone.0214424	http://dx.doi.org/10.1371/journal.pone.0214424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921391	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000068
J	Kanda, E; Kato, A; Masakane, I; Kanno, Y				Kanda, Eiichiro; Kato, Akihiko; Masakane, Ikuto; Kanno, Yoshihiko			A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; DIALYSIS PATIENTS; SERUM-ALBUMIN; DIAGNOSTIC-CRITERIA; FAT MASS; PROTEIN; MALNUTRITION; INFLAMMATION; ASSOCIATION; MUSCLE	Background Protein energy wasting (PEW) is a risk factor for death. However, the cutoff vales for PEW are not optimized for early identification of hemodialysis patients with malnutrition. We evaluated the prognosis of Japanese maintenance hemodialysis patients using nutritional indices optimized for them. Materials and methods We analyzed data from a nation-wide prospective cohort study of the Japanese Society for Dialysis Therapy Renal Data Registry to develop and validate a nutritional risk index (n = 48349, 48349, respectively). The association of nutritional factors with one-year death was tested using Cox proportional hazards models. Their cutoff levels were determined from the hazard ratios or receiver operating characteristic curves. Then, risk index was developed using scoring models. Results Male was 61.4%; average age, 65.7 +/- 12.2 years; and diabetes mellitus, 32.8%. Four clinical factors were retained in the final model: low BMI (<20kg/m(2)), yes = 3, no = 0; low serum albumin level (young <3.7g/dL; old <3.5g/dL), yes = 4, no = 0; abnormal serum total cholesterol level, low (<130mg/dL) = 1, high (220 >= mg/dL) = 2, no = 0; low serum creatinine level (young female, <9.7mg/dL; old female, <8.0mg/dL; young male, <11.6mg/dL; old male, <9.7mg/dL), yes = 4, no = 0. In the validation dataset, medium- and high-risk groups (total score 8 to 10; 11 or more) showed a higher risk of all-cause death than the low-risk group (0 to 7): medium-risk group (10.5%), hazard ratio adjusted for baseline characteristics 1.96 (95% confidence interval 1.77, 2.16); high-risk group (8.2%), 3.91 (3.57, 4.29). The medium-and high-risk groups also showed a higher risk of cardiovascular disease- and infection-caused deaths than the low-risk group. Conclusion We developed a new nutritional risk index for hemodialysis patients, which may detect patients with malnutrition with a high-risk of death.	[Kanda, Eiichiro] Kawasaki Med Sch, Med Sci, Kurashiki, Okayama, Japan; [Kato, Akihiko] Hamamatsu Univ Hosp, Blood Purificat Unit, Hamamatsu, Shizuoka, Japan; [Masakane, Ikuto] Honcho Yabuki Clin, Dept Nephrol, Yamagata, Yamagata, Japan; [Kanno, Yoshihiko] Tokyo Med Univ, Dept Nephrol, Shinjuku Ku, Tokyo, Japan	Kawasaki Medical School; Hamamatsu University School of Medicine; Tokyo Medical University	Kanda, E (corresponding author), Kawasaki Med Sch, Med Sci, Kurashiki, Okayama, Japan.	kms.cds.kanda@gmail.com		Kanda, Eiichiro/0000-0003-0676-096X				[Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; Celik G, 2011, INT J MED SCI, V8, P628, DOI 10.7150/ijms.8.628; de Mutsert R, 2009, J RENAL NUTR, V19, P127, DOI 10.1053/j.jrn.2008.08.003; Eriguchi R, 2017, CLIN J AM SOC NEPHRO, V12, P1109, DOI 10.2215/CJN.13141216; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Hoogeveen EK, 2012, CLIN J AM SOC NEPHRO, V7, P280, DOI 10.2215/CJN.05700611; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Iseki K, 2002, KIDNEY INT, V61, P1887, DOI 10.1046/j.1523-1755.2002.00324.x; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantar-Zadeh K, 2003, J RENAL NUTR, V13, P15, DOI 10.1053/jren.2003.50005; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kanda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128652; Kobayashi I, 2010, NEPHROL DIAL TRANSPL, V25, P3361, DOI 10.1093/ndt/gfq211; Kopple JD, 1997, AM J CLIN NUTR, V65, P1544, DOI 10.1093/ajcn/65.5.1544; Kyle UG, 2001, J AM GERIATR SOC, V49, P1633, DOI 10.1111/j.1532-5415.2001.49272.x; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Masakane I, 2017, REN REPLACE THER, V3, P1; Mehrotra R, 2001, ANNU REV NUTR, V21, P343, DOI 10.1146/annurev.nutr.21.1.343; Ohkawa S, 2005, NEPHROL DIAL TRANSPL, V20, P945, DOI 10.1093/ndt/gfh643; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Takahashi R, 2012, AM J NEPHROL, V36, P136, DOI 10.1159/000339940; Yasui S, 2016, ASIA PAC J CLIN NUTR, V25, P292, DOI 10.6133/apjcn.2016.25.2.10	23	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214524	10.1371/journal.pone.0214524	http://dx.doi.org/10.1371/journal.pone.0214524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921398	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000082
J	Khatri, B; Kang, S; Shouse, S; Anthony, N; Kuenzel, W; Kong, BC				Khatri, Bhuwan; Kang, Seong; Shouse, Stephanie; Anthony, Nicholas; Kuenzel, Wayne; Kong, Byungwhi C.			Copy number variation study in Japanese quail associated with stress related traits using whole genome re-sequencing data	PLOS ONE			English	Article							STRUCTURAL VARIATION; GENE; DUPLICATION; SELECTION; ALIGNMENT; DISEASE; LINES	Copy number variation (CNV) is a major driving factor for genetic variation and phenotypic diversity in animals. To detect CNVs and understand genetic components underlying stress related traits, we performed whole genome re-sequencing of pooled DNA samples of 20 birds each from High Stress (HS) and Low Stress (LS) Japanese quail lines using Illumina HiSeq 2x150 bp paired end method. Sequencing data were aligned to the quail genome and CNVnator was used to detect CNVs in the aligned data sets. The depth of coverage for the data reached to 41.4x and 42.6x for HS and LS birds, respectively. We identified 262 and 168 CNV regions affecting 1.6 and 1.9% of the reference genome that completely overlapped 454 and 493 unique genes in HS and LS birds, respectively. Ingenuity pathway analysis showed that the CNV genes were significantly enriched to phospholipase C signaling, neuregulin signaling, reelin signaling in neurons, endocrine and nervous development, humoral immune response, and carbohydrate and amino acid metabolisms in HS birds, whereas CNV genes in LS birds were enriched in cell-mediated immune response, and protein and lipid metabolisms. These findings suggest CNV genes identified in HS and LS birds could be candidate markers responsible for stress responses in birds.	[Khatri, Bhuwan; Kang, Seong; Shouse, Stephanie; Anthony, Nicholas; Kuenzel, Wayne; Kong, Byungwhi C.] Univ Arkansas, Dept Poultry Sci, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Kong, BC (corresponding author), Univ Arkansas, Dept Poultry Sci, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA.	bkong@uark.edu		Khatri, Bhuwan/0000-0001-5456-2963	USDA multistate project, NC1170, Advanced Technologies for the Genetic Improvement of Poultry; Arkansas Agricultural Experimental Station	USDA multistate project, NC1170, Advanced Technologies for the Genetic Improvement of Poultry; Arkansas Agricultural Experimental Station	This work was supported by USDA multistate project, NC1170, Advanced Technologies for the Genetic Improvement of Poultry and Arkansas Agricultural Experimental Station.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Berglund J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r73; Bickhart DM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00037; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]; Carnero A, 2012, ATLAS GENETICS CYTOG, DOI [10.4267/2042/46943, DOI 10.4267/2042/46943]; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Crooijmans RPMA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-398; Delany ME, 2009, J HERED, V100, P507, DOI 10.1093/jhered/esp044; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Elferink MG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-391; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Gill JL, 2011, NEUROBIOL DIS, V43, P184, DOI 10.1016/j.nbd.2011.03.010; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Goldstein O, 2010, MOL VIS, V16, P1549; Harr B, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.75; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Huff GR, 2013, POULTRY SCI, V92, P603, DOI 10.3382/ps.2012-02518; Hull RM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001333; Jia X, 2013, ANIM GENET, V44, P276, DOI 10.1111/age.12009; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Katju Vaishali, 2013, Frontiers in Genetics, V4, P273, DOI 10.3389/fgene.2013.00273; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu GE, 2011, MAMM GENOME, V22, P111, DOI 10.1007/s00335-010-9308-0; Locke MEO, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1713-z; Luo J, 2013, G3-GENES GENOM GENET, V3, P217, DOI 10.1534/g3.112.005132; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Meyers SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-337; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Pezer Z, 2015, GENOME RES, V25, P1114, DOI 10.1101/gr.187187.114; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Satterlee DG, 2002, POULTRY SCI, V81, P1071, DOI 10.1093/ps/81.7.1071; Satterlee DG, 2000, POULTRY SCI, V79, P1710, DOI 10.1093/ps/79.12.1710; SATTERLEE DG, 1988, POULTRY SCI, V67, P25, DOI 10.3382/ps.0670025; Schrider DR, 2010, P ROY SOC B-BIOL SCI, V277, P3213, DOI 10.1098/rspb.2010.1180; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shinomiya A, 2012, GENETICS, V190, P627, DOI 10.1534/genetics.111.136705; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Suhr CL, 2010, POULTRY SCI, V89, P633, DOI 10.3382/ps.2009-00288; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Veitia RA, 2004, GENETICS, V168, P569, DOI 10.1534/genetics.104.029785; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zhou W, 2014, GENETICA, V142, P441, DOI 10.1007/s10709-014-9788-z	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214543	10.1371/journal.pone.0214543	http://dx.doi.org/10.1371/journal.pone.0214543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921419	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000084
J	Navascues, M; Budroni, C				Navascues, Miguel; Budroni, Costantino			Theoretical research without projects	PLOS ONE			English	Article							ACADEMIC CAREERS; PERFORMANCE	We propose a funding scheme for theoretical research that does not rely on project proposals, but on recent past scientific productivity. Given a quantitative figure of merit on the latter and the total research budget, we introduce a number of policies to decide the allocation of funds in each grant call. Under some assumptions on scientific productivity, some of such policies are shown to converge, in the limit of many grant calls, to a funding configuration that is close to the maximum total productivity of the whole scientific community. We present numerical simulations showing evidence that these schemes would also perform well in the presence of statistical noise in the scientific productivity and/or its evaluation. Finally, we prove that one of our policies cannot be cheated by individual research units. Our work must be understood as a first step towards a mathematical theory of the research activity.	[Navascues, Miguel; Budroni, Costantino] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat IQOQI Vienna, Boltzmanngasse 3, A-1090 Vienna, Austria	Austrian Academy of Sciences	Navascues, M (corresponding author), Austrian Acad Sci, Inst Quantum Opt & Quantum Informat IQOQI Vienna, Boltzmanngasse 3, A-1090 Vienna, Austria.	miguel.navascues@oeaw.ac.at	Navascues, Miguel/O-6550-2015	Navascues, Miguel/0000-0003-0717-3927; Budroni, Costantino/0000-0002-6562-7862	Austrian Academy of Sciences	Austrian Academy of Sciences	MN was supported by a personal stipend from the Austrian Academy of Sciences. The sponsors did not play any role in the study design, etc.	Abramo G, 2017, VOPR OBRAZOVANIYA-ED, P112, DOI [10.17323/184-9545-2017-1-112-127, 10.17323/1814-9545-2017-1-112-127]; Afonso A., 2013, ACAD RESEMBLES DRUG; Afonso A, 2016, PS-POLIT SCI POLIT, V49, P816, DOI 10.1017/S1049096516001505; Azoulay P, 2012, NATURE, V484, P31, DOI 10.1038/484031a; Baccini A, 2016, SCIENTOMETRICS, V108, P1651, DOI 10.1007/s11192-016-1929-y; Bertsekas DP, 2003, ATHENA SCI OPTIMIZAT; Birukou A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00056; Bol T, 2018, P NATL ACAD SCI USA, V115, P4887, DOI 10.1073/pnas.1719557115; Bollen Johan, 2014, EMBO Rep, V15, P131, DOI 10.1002/embr.201338068; Bollen J, 2018, NATURE, V560, P143, DOI 10.1038/d41586-018-05887-3; Boudreau KJ, 2016, MANAGE SCI, V62, P2765, DOI 10.1287/mnsc.2015.2285; Boyd S., 2004, CONVEX OPTIMIZATION, DOI [DOI 10.1017/CBO9780511804441, 10.1017/CBO9780511804441]; Boyd S, 2003, LECT NOTES STANFORD; Campbell D, 2009, PRO INT CONF SCI INF, V1, P301; Duchi J., 2018, EE364B LECT SLIDES N; Ebadi Ashkan, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0133061; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; FWF Austrian Science Fund, 2018, START PROGR; Gillies D., 2014, ROARS T J RES POLICY, V2; Gillies D., 2008, SHOULD RES BE ORG; Hall JC, 2008, CURR BIOL, V18, pR101, DOI 10.1016/j.cub.2007.12.016; Herteliu C, 2017, PUBLICATIONS, V5, DOI 10.3390/publications5020015; Hicks D, 2012, RES POLICY, V41, P251, DOI 10.1016/j.respol.2011.09.007; Huisman J, 2002, J HIGH EDUC, V73, P141, DOI 10.1353/jhe.2002.0007; Ioannidis JPA, 2011, NATURE, V477, P529, DOI 10.1038/477529a; Jayasinghe UW, 2003, J R STAT SOC A STAT, V166, P279, DOI 10.1111/1467-985X.00278; Kwiek M, 2015, CHANG ACAD, V12, P41, DOI 10.1007/978-3-319-10720-2_3; Liao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112022; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Necker S, 2014, RES POLICY, V43, P1747, DOI 10.1016/j.respol.2014.05.002; Ruder S., 2016, ARXIV; Rzhetsky A, 2015, P NATL ACAD SCI USA, V112, P14569, DOI 10.1073/pnas.1509757112; Sandstrom U, 2018, J INFORMETR, V12, P365, DOI 10.1016/j.joi.2018.01.007; Smolin L., 2007, TROUBLE PHYS RISE ST; Steen RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068397; Traag V, 2018, SYSTEMATIC ANAL AGRE; Vandenberghe L, 1996, SIAM REV, V38, P49, DOI 10.1137/1038003; von Hippel T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118494; Waltman L, 2016, J INFORMETR, V10, P365, DOI 10.1016/j.joi.2016.02.007; Wang J, 2017, RES POLICY, V46, P1416, DOI 10.1016/j.respol.2017.06.006	40	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214026	10.1371/journal.pone.0214026	http://dx.doi.org/10.1371/journal.pone.0214026			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921374	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000031
J	Bertolani, SJ; Siegel, JB				Bertolani, Steve J.; Siegel, Justin B.			A new benchmark illustrates that integration of geometric constraints inferred from enzyme reaction chemistry can increase enzyme active site modeling accuracy	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; COMPLEX; SEQUENCE; ALIGNMENT; ROSETTA; SPECIFICITY; GLYCOSIDASE; INHIBITORS; TEMPLATES	Enzymes play a critical role in a wide array of industrial, medical, and research applications and with the recent explosion of genomic sequencing, we now have sequences for millions of enzymes for which there is no known structure. In order to utilize modern computational design tools for constructing inhibitors or engineering novel catalysts, the ability to accurately model enzymes is critical. A popular approach for modeling enzymes are comparative modeling techniques which can often accurately predict the global structural features. However, achieving atomic accuracy of an active site remains a challenge and is an issue when trying to utilize the molecular details for designing inhibitors or enhanced catalysts. Here we explore integrating knowledge about the required geometric orientation of conserved catalytic residues into the comparative modeling process in order to improve modeling accuracy. In order to investigate the utility of adding this information, we first carefully construct a benchmark set of reference structures to use. Consistent with previous findings, our benchmark demonstrates that the geometry between catalytic residues across an enzyme family is conserved and does not tend to deviate by more than 0.5 angstrom. We then find that by integrating these geometric constraints during modeling, we can double the number of atomic level accuracy models (<1 angstrom RMSD to the crystal structure ligand) within our benchmarking dataset, even for targets with templates as low as 20-30% sequence identity. Catalytic residues within an enzyme family are highly conserved and can often be readily identified through comparative sequence analysis to a known structure within the enzyme family. Therefore utilizing this readily available information has the potential to significantly improve drug design and enzyme engineering efforts for which there is no known structure for the enzyme of interest.	[Bertolani, Steve J.; Siegel, Justin B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Siegel, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.; Siegel, JB (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.; Siegel, JB (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	jbsiegel@ucdavis.edu			National Science Foundation [1827246, 1805510, 1627539]; National Institute Of Environmental Health Sciences of the National Institutes of Health (NIH) [P42ES004699]; UC Davis; Sloan Foundation [BR2014-012]; NIH [R01 GM 076324-11]; Rosetta Commons; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute Of Environmental Health Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UC Davis; Sloan Foundation(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosetta Commons; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Science Foundation Award Numbers 1827246, 1805510, 1627539, the National Institute Of Environmental Health Sciences of the National Institutes of Health (NIH) under Award Number P42ES004699, UC Davis, the Sloan Foundation BR2014-012, NIH Award Number R01 GM 076324-11 and the Rosetta Commons.	Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Bellizzi JJ, 2000, P NATL ACAD SCI USA, V97, P4573, DOI 10.1073/pnas.080508097; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Chung S Y, 1996, Pac Symp Biocomput, P126; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Dreyer MK, 1996, J MOL BIOL, V259, P458, DOI 10.1006/jmbi.1996.0332; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Finn RD, 2015, NUCLEIC ACIDS RES; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Ha NC, 2000, J BIOL CHEM, V275, P41100, DOI 10.1074/jbc.M007561200; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Ireton GC, 2003, STRUCTURE, V11, P961, DOI 10.1016/S0969-2126(03)00153-9; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; Jha RK, 2015, PROTEINS, V83, P1327, DOI 10.1002/prot.24828; Jiang Y, 2011, CHEMBIOCHEM, V12, P768, DOI 10.1002/cbic.201000693; Jogl G, 2003, P NATL ACAD SCI USA, V100, P50, DOI 10.1073/pnas.0233793100; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; KIM H, 1990, BIOCHEMISTRY-US, V29, P5546, DOI 10.1021/bi00475a019; Kim SW, 1997, BIOCHEMISTRY-US, V36, P14030, DOI 10.1021/bi971546+; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Larsen NA, 2002, NAT STRUCT BIOL, V9, P17, DOI 10.1038/nsb742; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; LII JH, 1991, J COMPUT CHEM, V12, P186, DOI 10.1002/jcc.540120208; Liu P, 2004, J MOL BIOL, V342, P551, DOI 10.1016/j.jmb.2004.06.069; Lloyd MD, 2005, BIOCHEMISTRY-US, V44, P6858, DOI 10.1021/bi047692e; Luic M, 2001, EUR J BIOCHEM, V268, P3964, DOI 10.1046/j.1432-1327.2001.02303.x; Mak WS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10005; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Nosrati GR, 2012, PROTEIN SCI, V21, P697, DOI 10.1002/pro.2055; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pillai B, 2006, P NATL ACAD SCI USA, V103, P8668, DOI 10.1073/pnas.0602537103; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rueeger H, 2012, J MED CHEM, V55, P3364, DOI 10.1021/jm300069y; Sauder JM, 2000, PROTEINS, V40, P6, DOI 10.1002/(SICI)1097-0134(20000701)40:1<6::AID-PROT30>3.0.CO;2-7; Shao Y, 2016, SPARTAN 16; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sulzenbacher G, 1999, BIOCHEMISTRY-US, V38, P4826, DOI 10.1021/bi982648i; Thompson J, 2011, PROTEINS, V79, P2380, DOI 10.1002/prot.23046; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; Varrot A, 2003, ACTA CRYSTALLOGR D, V59, P447, DOI 10.1107/S0907444902023405; Venclovas C, 2003, PROTEINS, V53, P380, DOI 10.1002/prot.10591; Yousef GM, 2004, BBA-PROTEINS PROTEOM, V1698, P77, DOI 10.1016/j.bbapap.2003.10.008; Yun YS, 2005, FEBS J, V272, P1999, DOI 10.1111/j.1742-4658.2005.04627.x; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h	55	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214126	10.1371/journal.pone.0214126	http://dx.doi.org/10.1371/journal.pone.0214126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947258	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500016
J	Lim, S; Guo, XK; Boedicker, JQ				Lim, Sean; Guo, Xiaokan; Boedicker, James Q.			Connecting single-cell properties to collective behavior in multiple wild isolates of the Enterobacter cloacae complex	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; ESCHERICHIA-COLI; CHEMOTACTIC BACTERIA; LINEAR-REGRESSION; PATTERN-FORMATION; NATURAL ASSEMBLAGES; MARINE-BACTERIA; MOTILITY; METHIONINE; GENOME	Some strains of motile bacteria self-organize to form spatial patterns of high and low cell density over length scales that can be observed by eye. One such collective behavior is the formation in semisolid agar media of a high cell density swarm band. We isolated 7 wild strains of the Enterobacter cloacae complex capable of forming this band and found its propagation speed can vary 2.5 fold across strains. To connect such variability in collective motility to strain properties, each strain's single-cell motility and exponential growth rates were measured. The band speed did not significantly correlate with any individual strain property; however, a multilinear analysis revealed that the band speed was set by a combination of the run speed and tumbling frequency. Comparison of variability in closely-related wild isolates has the potential to reveal how changes in single-cell properties influence the collective behavior of populations.	[Lim, Sean; Guo, Xiaokan; Boedicker, James Q.] Univ Southern Calif, Dept Phys & Astron, Los Angeles, CA 90007 USA; [Boedicker, James Q.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Boedicker, JQ (corresponding author), Univ Southern Calif, Dept Phys & Astron, Los Angeles, CA 90007 USA.; Boedicker, JQ (corresponding author), Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	boedicke@usc.edu		Boedicker, James/0000-0003-4107-3719; Lim, Sean/0000-0003-3190-0821	DARPA Fundamentals of Complex Collectives [W911NF1710076]; USC Provost's Undergrad Research Fellowships	DARPA Fundamentals of Complex Collectives; USC Provost's Undergrad Research Fellowships	JB received support from DARPA Fundamentals of Complex Collectives (W911NF1710076). SL received support from the USC Provost's Undergrad Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Alexopoulos EC, 2010, HIPPOKRATIA, V14, P23; Alexopoulos EC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-50; Anjuwon-Foster BR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006701; Aotani A, 2010, JPN J IND APPL MATH, V27, P5, DOI 10.1007/s13160-010-0011-z; ASWAD D, 1974, J BACTERIOL, V118, P640, DOI 10.1128/JB.118.2.640-645.1974; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barker CS, 2014, J BACTERIOL, V196, P4001, DOI 10.1128/JB.02184-14; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BLAT Y, 1995, J BACTERIOL, V177, P1683, DOI 10.1128/jb.177.7.1683-1691.1995; Borer B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03187-y; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Camdevyren H, 2005, ECOL MODEL, V181, P581, DOI 10.1016/j.ecolmodel.2004.06.043; Chan YC, 1999, ATMOS ENVIRON, V33, P3237, DOI 10.1016/S1352-2310(99)00091-6; Cotter CR, 2017, P NATL ACAD SCI USA, V114, pE4592, DOI 10.1073/pnas.1620981114; Croze OA, 2011, BIOPHYS J, V101, P525, DOI 10.1016/j.bpj.2011.06.023; Curk T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074878; Davin-Regli A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00392; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Deforet M, 2014, SOFT MATTER, V10, P2405, DOI 10.1039/c3sm53127a; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Egbert MD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001004; Fenchel T., 2001, EPPUR SI MUOVE MANY, P197; Fu X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04539-4; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; Hakim V, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa65ef; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Humann JL, 2011, STAND GENOMIC SCI, V5, P279, DOI 10.4056/sigs.2174950; Karmakar R, 2016, APPL ENVIRON MICROB, V82, P1205, DOI 10.1128/AEM.03397-15; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; KELLER EF, 1971, J THEOR BIOL, V30, P235, DOI 10.1016/0022-5193(71)90051-8; Kirkegaard JB, 2018, IMA J APPL MATH; KONDOH H, 1980, J BACTERIOL, V142, P527, DOI 10.1128/JB.142.2.527-534.1980; Kuhn MJ, 2017, P NATL ACAD SCI USA, V114, P6340, DOI 10.1073/pnas.1701644114; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li GM, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv033; Licata NA, 2016, BIOPHYS J, V110, P247, DOI 10.1016/j.bpj.2015.09.035; Liu CL, 2011, SCIENCE, V334, P238, DOI 10.1126/science.1209042; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Liu WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074487; Long W, 2007, ADV WATER RESOUR, V30, P2262, DOI 10.1016/j.advwatres.2007.05.007; Long ZC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13183-9; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Marrocco A, MODELS SELF ORGANIZI; Martinez LE, 2016, MOL MICROBIOL, V99, P88, DOI 10.1111/mmi.13218; Masson JB, 2012, P NATL ACAD SCI USA, V109, P1802, DOI 10.1073/pnas.1116772109; Mazzag BC, 2003, BIOPHYS J, V85, P3558, DOI 10.1016/S0006-3495(03)74775-4; MITCHELL JG, 1995, APPL ENVIRON MICROB, V61, P4436, DOI 10.1128/AEM.61.12.4436-4440.1995; Mitchell JG, 2006, FEMS MICROBIOL ECOL, V55, P3, DOI 10.1111/j.1574-6941.2005.00003.x; Mitchell JG, 1996, APPL ENVIRON MICROB, V62, P3716, DOI 10.1128/AEM.62.10.3716-3721.1996; MITCHELL JG, 1995, APPL ENVIRON MICROB, V61, P877, DOI 10.1128/AEM.61.3.877-882.1995; Mittal N, 2003, P NATL ACAD SCI USA, V100, P13259, DOI 10.1073/pnas.2233626100; Othmer HG, 2009, MATH MODEL NAT PHENO, V4, P3, DOI 10.1051/mmnp/20094401; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; Razo-Mejia M, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/2/026005; Sacchi CT, 2002, EMERG INFECT DIS, V8, P1117, DOI 10.3201/eid0810.020391; Saragosti J, 2011, P NATL ACAD SCI USA, V108, P16235, DOI 10.1073/pnas.1101996108; Saragosti J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000890; Shangbing A, 2015, MATH BIOSCIENCES ENG; Solon AP, 2015, EUR PHYS J-SPEC TOP, V224, P1231, DOI 10.1140/epjst/e2015-02457-0; Son K, 2016, P NATL ACAD SCI USA, V113, P8624, DOI 10.1073/pnas.1602307113; Sousa SIV, 2007, ENVIRON MODELL SOFTW, V22, P97, DOI 10.1016/j.envsoft.2005.12.002; SPRINGER MS, 1975, P NATL ACAD SCI USA, V72, P4640, DOI 10.1073/pnas.72.11.4640; Tailleur J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218103; Theves M, 2013, BIOPHYS J, V105, P1915, DOI 10.1016/j.bpj.2013.08.047; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; TSIMRING L, 1995, PHYS REV LETT, V75, P1859, DOI 10.1103/PhysRevLett.75.1859; Waite AJ, 2018, ANNU REV BIOPHYS, V47, P595, DOI 10.1146/annurev-biophys-062215-010954; WEIS RM, 1990, J BACTERIOL, V172, P1099, DOI 10.1128/jb.172.2.1099-1105.1990; WOLFE AJ, 1989, P NATL ACAD SCI USA, V86, P6973, DOI 10.1073/pnas.86.18.6973; WOODWARD DE, 1995, BIOPHYS J, V68, P2181; Wu Yilin, 2015, [Quantitative Biology, 定量生物学], V3, P199; Yan ZF, 2014, J CONTAM HYDROL, V164, P138, DOI 10.1016/j.jconhyd.2014.06.004; Yegorenkova IV, 2018, SYMBIOSIS, V74, P31, DOI 10.1007/s13199-017-0492-5; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7	81	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214719	10.1371/journal.pone.0214719	http://dx.doi.org/10.1371/journal.pone.0214719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947254	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500055
J	Lindner, M; Morresi-Hauf, A; Stowasser, A; Hapfelmeier, A; Hatz, RA; Koch, I				Lindner, Michael; Morresi-Hauf, Alicia; Stowasser, Anja; Hapfelmeier, Alexander; Hatz, Rudolf A.; Koch, Ina			Quality assessment of tissue samples stored in a specialized human lung biobank	PLOS ONE			English	Article							RNA; EXPRESSION; FROZEN; ERCC1; CISPLATIN; CANCER; DNA; CHEMOTHERAPY; STABILITY; SURVIVAL	Human sample, from patients or healthy donors, are a valuable link between basic research and clinic. Especially in translational research, they play an essential role in understanding development and progression of diseases as well as in developing new diagnostic and therapeutic tools. Stored in biobanks, fast access to appropriate material becomes possible. However, biobanking in a clinical context faces several challenges. In practice, collecting samples during clinical routine does not allow to strictly adhere to protocols of sample collection in all aspects. This may influence sample quality to variable degrees. Time from sample draw to asservation is a variable factor, and influences of prolonged storage at ambient temperature of tissues are not well understood. We investigated whether delays between 5 minutes and 3 hours, and the use of RNAlater RNA-preserving reagent would lead to a relevant drop in sample quality, measured by quantitative mRNA expression analysis. Our findings suggest that even under ambient conditions, delays up to 3 hours do not have a major impact on sample quality as long as the tissue remains intact.	[Lindner, Michael; Stowasser, Anja; Hatz, Rudolf A.; Koch, Ina] Asklepios Fachklin Munchen Gauting, Dept Thorac Surg, Asklepios Biobank Lung Dis, Gauting, Germany; [Lindner, Michael; Morresi-Hauf, Alicia; Stowasser, Anja; Hatz, Rudolf A.; Koch, Ina] German Ctr Lung Res DZL, Munich, Germany; [Morresi-Hauf, Alicia] Asklepios Fachklin Munchen Gauting, Asklepios Biobank Lung Dis, Dept Pathol, Gauting, Germany; [Hapfelmeier, Alexander] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Informat Stat & Epidemiol, Munich, Germany	Technical University of Munich	Koch, I (corresponding author), Asklepios Fachklin Munchen Gauting, Dept Thorac Surg, Asklepios Biobank Lung Dis, Gauting, Germany.; Koch, I (corresponding author), German Ctr Lung Res DZL, Munich, Germany.	Ina.Koch@asklepios.com	lindner, michael/AAO-8653-2020	lindner, michael/0000-0002-2106-0286; Koch, Ina/0000-0002-8766-017X; Hapfelmeier, Alexander/0000-0001-6765-6352	German Federal Ministry of Education and Research; Bundesministerium fur Bildung und Forschung [82DZL003A3]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The Asklepios Biobank of lung diseases is a member of the German Center of Lung Research (DZL) and as such is partly funded by the German Federal Ministry of Education and Research. Bundesministerium fur Bildung und Forschung 82DZL003A3.	ALLEWELL NM, 1974, BIOCHIM BIOPHYS ACTA, V341, P484, DOI 10.1016/0005-2744(74)90240-X; BAR W, 1988, FORENSIC SCI INT, V39, P59, DOI 10.1016/0379-0738(88)90118-1; Bennike TB, 2016, DATA BRIEF, V6, P942, DOI 10.1016/j.dib.2016.01.061; Botling J, 2009, DIAGN MOL PATHOL, V18, P44, DOI 10.1097/PDM.0b013e3181857e92; Cao CQ, 2010, J THORAC ONCOL, V5, P1692, DOI 10.1097/JTO.0b013e3181ed0489; Carstensen B., 2011, COMPARING CLIN MEASU; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Chamboredon S, 2011, MOL BIOL CELL, V22, P3366, DOI 10.1091/mbc.E10-07-0617; Chowdary D, 2006, J MOL DIAGN, V8, P31, DOI 10.2353/jmoldx.2006.050056; Gupta S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-26; Lee SM, 2012, MOL BIOTECHNOL, V24, P24; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Mutter GL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-88; Muyal JP, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-9; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Perez-Portela R, 2013, MOL ECOL RESOUR, V13, P884, DOI 10.1111/1755-0998.12122; Rosell R, 2006, CURR OPIN PHARMACOL, V6, P323, DOI 10.1016/j.coph.2006.01.011; Wang YG, 2015, BIOPRESERV BIOBANK, V13, P335, DOI 10.1089/bio.2015.0029; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0203977	10.1371/journal.pone.0203977	http://dx.doi.org/10.1371/journal.pone.0203977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947297	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500002
J	Mathis, NJ; Adaniya, EN; Smith, LM; Robling, AG; Jepsen, KJ; Schlecht, SH				Mathis, Noah J.; Adaniya, Emily N.; Smith, Lauren M.; Robling, Alexander G.; Jepsen, Karl J.; Schlecht, Stephen H.			Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growth	PLOS ONE			English	Article							MODEL; MASS; INCREASES; TRAITS	Administration of sclerostin-neutralizing antibody (Scl-Ab) treatment has been shown to elicit an anabolic bone response in growing and adult mice. Prior work characterized the response of individual mouse strains but did not establish whether the impact of Scl-Ab on whole bone strength would vary across different inbred mouse strains. Herein, we tested the hypothesis that two inbred mouse strains (A/J and C57BL/6J (B6)) will show different whole bone strength outcomes following sclerostin-neutralizing antibody (Scl-Ab) treatment during growth (4.5-8.5 weeks of age). Treated B6 femurs showed a significantly greater stiffness (S) (68.8% vs. 46.0%) and maximum load (ML) (84.7% vs. 44.8%) compared to A/J. Although treated A/J and B6 femurs showed greater cortical area (Ct.Ar) similarly relative to their controls (37.7% in A/J and 41.1% in B6), the location of new bone deposition responsible for the greater mass differed between strains and may explain the greater whole bone strength observed in treated B6 mice. A/J femurs showed periosteal expansion and endocortical infilling, while B6 femurs showed periosteal expansion. Post-yield displacement (PYD) was smaller in treated A/J femurs (-61.2%, p < 0.001) resulting in greater brittleness compared to controls; an effect not present in B6 mice. Inter-strain differences in S, ML, and PYD led to divergent changes in work-to-fracture (Work). Work was 27.2% (p = 0.366) lower in treated A/J mice and 66.2% (p < 0.001) greater in treated B6 mice relative to controls. Our data confirmed the anabolic response to Scl-Ab shown by others, and provided evidence suggesting the mechanical benefits of Scl-Ab administration may be modulated by genetic background, with intrinsic growth patterns of these mice guiding the location of new bone deposition. Whether these differential outcomes will persist in adult and elderly mice remains to be determined.	[Mathis, Noah J.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Adaniya, Emily N.; Robling, Alexander G.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Smith, Lauren M.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Jepsen, Karl J.; Schlecht, Stephen H.] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Schlecht, Stephen H.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Schlecht, SH (corresponding author), Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA.; Schlecht, SH (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	sschlech@med.umich.edu	Smith, Lauren/AAX-2022-2020; Schlecht, Stephen/AAE-2347-2020	Smith, Lauren/0000-0001-5677-2286; 	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR053237, S10RR026336, AR065424, AR069620, AR070903]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR070903] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (niams.nih.gov) (AGR: AR053237; KJJ: S10RR026336, AR065424, AR069620; SHS: AR070903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhola S, 2011, BONE, V49, P799, DOI 10.1016/j.bone.2011.07.018; ENLOW DH, 1962, AM J ANAT, V110, P79, DOI 10.1002/aja.1001100202; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jepsen KJ, 2010, J BONE MINER RES, V25, P1581, DOI 10.1002/jbmr.41; Jepsen KJ, 2001, J BONE MINER RES, V16, P1854, DOI 10.1359/jbmr.2001.16.10.1854; Kedylaya R, 2013, SCI TRANSL MED, V5, P1; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Little DG, 2017, BONE, V101, P96, DOI 10.1016/j.bone.2017.04.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marini JC, 2004, NELSON TXB PEDIAT, P2336; Morse A, 2014, J BONE MINER RES, V29, P2456, DOI 10.1002/jbmr.2278; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Pandey N, 2009, J BONE MINER RES, V24, P1969, DOI [10.1359/JBMR.090525, 10.1359/jbmr.090525]; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Price C, 2005, J BONE MINER RES, V20, P1983, DOI 10.1359/JBMR.050707; Ramcharan MA, 2017, OSTEOPOROSIS INT, V28, P1133, DOI 10.1007/s00198-016-3801-6; Recker RR, 2015, J BONE MINER RES, V30, P216, DOI 10.1002/jbmr.2351; Robling AG, 2013, BONE, V55, P256, DOI 10.1016/j.bone.2013.03.001; Roschger A, 2014, BONE, V66, P182, DOI 10.1016/j.bone.2014.06.015; Schlecht SH, 2017, J BONE MINER RES, V32, P1002, DOI 10.1002/jbmr.3093; Schlecht SH, 2015, CLIN ORTHOP RELAT R, V473, P2540, DOI 10.1007/s11999-015-4229-6; Schlecht SH, 2014, BONE, V67, P15, DOI 10.1016/j.bone.2014.06.031; Schlecht SH, 2013, BONE, V56, P127, DOI 10.1016/j.bone.2013.05.012; Sinder BP, 2014, OSTEOPOROSIS INT, V25, P2097, DOI 10.1007/s00198-014-2737-y; Sinder BP, 2015, BONE, V71, P115, DOI 10.1016/j.bone.2014.10.012; Sinder BP, 2013, J BONE MINER RES, V28, P73, DOI 10.1002/jbmr.1717; Smith LM, 2014, BONE, V67, P130, DOI 10.1016/j.bone.2014.06.035; Tian XY, 2011, BONE, V48, P197, DOI 10.1016/j.bone.2010.09.009	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214520	10.1371/journal.pone.0214520	http://dx.doi.org/10.1371/journal.pone.0214520			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947279	gold, Green Published, Green Submitted			2022-12-27	WOS:000463314500038
J	Corazza, O; Simonato, P; Demetrovics, Z; Mooney, R; van de Ven, K; Roman-Urrestarazu, A; Racmolnar, L; De Luca, I; Cinosi, E; Santacroce, R; Marini, M; Wellsted, D; Sullivan, K; Bersani, G; Martinotti, G				Corazza, Ornella; Simonato, Pierluigi; Demetrovics, Zsolt; Mooney, Roisin; van de Ven, Katinka; Roman-Urrestarazu, Andres; Racmolnar, Lili; De Luca, Ilaria; Cinosi, Eduardo; Santacroce, Rita; Marini, Massimo; Wellsted, David; Sullivan, Keith; Bersani, Giuseppe; Martinotti, Giovanni			The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study	PLOS ONE			English	Article							PERFORMANCE-ENHANCING DRUGS; ANDROGENIC STEROID USE; MEDITERRANEAN DIET; EXCESSIVE EXERCISE; MUSCLE DYSMORPHIA; PSYCHOACTIVE SUBSTANCES; APPEARANCE ANXIETY; EATING-DISORDER; CONSTRUCTION; PARTICIPANTS	Introduction In a society that perpetuates the strive for a perfect appearance, a fit body has become synonymous with success, but simultaneously hard to achieve. This represents a fertile ground for the development of Exercise Addiction (EA) alongside other disorders, such as Body Dysmorphic Disorder (BDD). This study aims to explore the diffusion of EA in fitness settings in the United Kingdom, Italy, Netherlands, Hungary and the previously unexplored association with appearance anxiety, BDD, self-esteem and the use of fitness supplements. Methods A large cross-sectional sample (N = 1711) was surveyed in fitness settings using the Exercise Addiction Inventory (EAI), Appearance Anxiety Inventory (AAI) and Rosenberg's Self Esteem Scale (RSE) in addition to questions surrounding the use of fitness supplements. Results Compulsive exercise, appearance anxiety and low self-esteem were present in this sample according to the psychometric measures used (EAI, AAI, RSE). 11.7% scored over the cut off for EA, with alarming peaks in the Netherlands (20.9%) and the United Kingdom (16.1%). 38.5% were found at risk of BDD, mainly female (47.2%). 39.8% used fitness enhancing supplements without medical consultation (95.5%). This cohort of supplement users scored higher in both EAI and AAI. The logistic regression model revealed a strong association between the consumption of sport products and the level of EA across the sample with an odds ratio (OR) of 3.03. Other co-variable factors among female were appearance anxiety (AAI; OR 1.59) and to a lesser extent self-esteem (RSE) (OR 1.08). Conclusions This study identified a high risk of EA, appearance anxiety and BDD amongst a cohort of gym users internationally. The previously-unexplored association between these disorders and the unsupervised use of a variety of fitness products, including illicit drugs, highlights the need for informed and integrated responses targeting such vulnerable individuals.	[Corazza, Ornella; Simonato, Pierluigi; Mooney, Roisin; De Luca, Ilaria; Cinosi, Eduardo; Santacroce, Rita; Wellsted, David; Sullivan, Keith; Martinotti, Giovanni] Univ Hertfordshire, Sch Life & Med Sci, Ctr Clin & Hlth Res Serv, Hatfield, Herts, England; [Corazza, Ornella; Bersani, Giuseppe] Sapienza Univ Rome, Dept Medicosurg Sci & Biotechnol, Rome, Italy; [Simonato, Pierluigi] Clin Parco Tigli, Dual Diag Unit, Padua, Italy; [Demetrovics, Zsolt; Racmolnar, Lili] Eotvos Lorand Univ, Inst Psychol, Dept Clin Psychol & Addict, Budapest, Hungary; [van de Ven, Katinka] Univ New South Wales, Social Policy Res Ctr, Sydney, NSW, Australia; [Roman-Urrestarazu, Andres] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Roman-Urrestarazu, Andres] Maastricht Univ, Dept Int Hlth, Maastricht, Netherlands; [Cinosi, Eduardo] Hertfordshire Partnership Univ NHS Fdn Trust, Hatfield, Herts, England; [Santacroce, Rita; Martinotti, Giovanni] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Marini, Massimo] Univ Padua, Dept Psychiat, Padua, Italy	University of Hertfordshire; Sapienza University Rome; Eotvos Lorand University; University of New South Wales Sydney; University of Cambridge; Maastricht University; G d'Annunzio University of Chieti-Pescara; University of Padua	Corazza, O (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Ctr Clin & Hlth Res Serv, Hatfield, Herts, England.; Corazza, O (corresponding author), Sapienza Univ Rome, Dept Medicosurg Sci & Biotechnol, Rome, Italy.	o.corazza@herts.ac.uk	Corazza, Ornella/AAJ-9363-2021; Martinotti, Giovanni/AAC-7592-2022; Roman-Urrestarazu, Andres/U-9224-2018; Demetrovics, Zsolt/F-8613-2010; van de Ven, Katinka/S-8735-2018	Corazza, Ornella/0000-0001-7371-319X; Martinotti, Giovanni/0000-0002-7292-2341; Roman-Urrestarazu, Andres/0000-0002-2405-9432; Demetrovics, Zsolt/0000-0001-5604-7551; Wellsted, David/0000-0002-2895-7838; Mooney, Roisin/0000-0001-5792-3314; van de Ven, Katinka/0000-0003-3026-9978	Hungarian National Research, Development and Innovation Office [K111938, KKP126835]; Research Design Service (East of England)	Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Research Design Service (East of England)	Zsolt Demetrovics was supported by the Hungarian National Research, Development and Innovation Office (Grant numbers: K111938, KKP126835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the Research Design Service (East of England), students from the Psychology BSc degree who assisted data collection, assessment of participants inside the gyms at the University of Hertfordshire and University of Chieti-Pescara, all the participants, and the gyms that helped to promote the study and hosted our teams. Zsolt Demetrovics' contribution was supported by the Hungarian National Research, Development and Innovation Office (Grant numbers: K111938, KKP126835).	Al-Sarraf A, 2018, RES ADV PSYCHIAT, V5, P38; Altabe M, 1996, COGNITIVE THER RES, V20, P171, DOI 10.1007/BF02228033; Altamura C, 2001, EUR ARCH PSY CLIN N, V251, P105, DOI 10.1007/s004060170042; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Asp K, 1999, AM FIT, P64; Barry CT, 2017, LET ME TAKE SELFIE A; Berczik K, 2012, SUBST USE MISUSE, V47, P403, DOI 10.3109/10826084.2011.639120; Bersani FS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/120679; Beucke JC, 2016, EUR NEUROPSYCHOPHARM, V26, P1657, DOI 10.1016/j.euroneuro.2016.04.011; Bewley A, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3208; Blaydon MJ, 2002, PSYCHOL SPORT EXERC, V3, P223, DOI 10.1016/S1469-0292(01)00021-8; Borchert J, 1996, J PSYCHOL, V130, P547, DOI 10.1080/00223980.1996.9915021; Brennan BP, 2013, AM J ADDICTION, V22, P158, DOI 10.1111/j.1521-0391.2013.00311.x; Buhlmann U, 2010, PSYCHIAT RES, V178, P171, DOI 10.1016/j.psychres.2009.05.002; Buhlmann U, 2009, J ANXIETY DISORD, V23, P694, DOI 10.1016/j.janxdis.2009.02.008; Button EJ, 1996, PROSPECTIVE STUDY SE, DOI [10.1111/j.2044-8260.1996.tb01176.x, DOI 10.1111/J.2044-8260.1996.TB01176.X]; Chandler M., 2014, STEROIDS IMAGE ENHAN; CHAPMAN CL, 1990, J SPORT MED PHYS FIT, V30, P283; Cockerill IM., 1996, COUNS PSYCHOL, V9, P119, DOI [10.1080/09515079608256358, DOI 10.1080/09515079608256358]; Corazza O, 2017, NOVEL PSYCHOACTIVE S; Corazza O, 2008, NEAR DEATH EXPERIENC; Corazza O, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/841798; Corazza O, 2013, HUM PSYCHOPHARM CLIN, V28, P317, DOI 10.1002/hup.2299; COUSINEAU D, 1977, J APPL PHYSIOL, V43, P801, DOI 10.1152/jappl.1977.43.5.801; deVries H.A., 1981, PHYSICIAN SPORTSMED, V9, P46, DOI [10.1080/00913847.1981.11711206, DOI 10.1080/00913847.1981.11711206]; Evans-Brown M., 2012, HUMAN ENHANCEMENT DR; Fernandes HM, 2018, BODY DYSMORPHIC DISO, DOI [10.5772/intechopen.76446, DOI 10.5772/INTECHOPEN.76446]; Fineberg NA, 2018, INT J NEUROPSYCHOPH, V21, P42, DOI 10.1093/ijnp/pyx088; Furnham A, 2002, J PSYCHOL INTERD DEC; GAO, 2002, GAO02985T; Glasser W., 1976, POSITIVE ADDICTION; Godier LR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00778; Graham MR, 2009, DRUG TEST ANAL, V1, P135, DOI 10.1002/dta.30; Griffiths M.D., 2005, J SUBST USE, V10, P191, DOI [DOI 10.1080/14659890500114359, 10.1080/14659890500114359]; Griffiths MD, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-014-0005-5; Griffiths MD, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.017020; Grosso G, 2013, J CRITICAL REV FOOD; Hall M, 2016, J HEALTH PSYCHOL, V21, P1939, DOI 10.1177/1359105314568579; Huang CJ, 2012, EUR J PSYCHOL ASSESS, V28, P132, DOI 10.1027/1015-5759/a000101; Kamber M, 2010, ENDOCRIN METAB CLIN, V39, P1, DOI 10.1016/j.ecl.2009.10.009; Kostrzewa E, 2013, PSYCHIAT RES, V210, P1123, DOI 10.1016/j.psychres.2013.08.050; Kuss DJ, 2011, ED HLTH, V29, P63; Leone JE, 2005, J ATHL TRAINING, V40, P352; Lichtenstein MB., 2014, SCANDINAVIAN J MED S, V24; Lichtenstein Mia Beck, 2018, Addict Behav Rep, V8, P33, DOI 10.1016/j.abrep.2018.06.001; Lichtenstein Mia Beck, 2016, Addict Behav Rep, V3, P33, DOI 10.1016/j.abrep.2016.02.002; Mabe AG, 2014, INT J EAT DISORDER, V47, P516, DOI 10.1002/eat.22254; Marzano-Parisoli MM, 2001, QUEST, V53, P216; Mastro S, 2016, J OBSESS-COMPULS REL, V8, P50, DOI 10.1016/j.jocrd.2015.12.001; Mataix J, 2012, ACTAS DERMO-SIFILOGR, V103, P655, DOI 10.1016/j.adengl.2012.09.004; Maughan RJ, 2004, J SPORT SCI, V22, P95, DOI 10.1080/0264041031000140581; Meier EP, 2014, CYBERPSYCH BEH SOC N, V17, P199, DOI 10.1089/cyber.2013.0305; Meyer C, 2011, EUR EAT DISORD REV, V19, P174, DOI 10.1002/erv.1122; Molinero O, 2009, NUTR HOSP, V24, P128; Monok K, 2012, PSYCHOL SPORT EXERC, V13, P739, DOI 10.1016/j.psychsport.2012.06.003; Monteath SA, 1997, J SOC PSYCHOL, V137, P708, DOI 10.1080/00224549709595493; Mooney R, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2619; Muller Rudhard Klaus, 2010, Handb Exp Pharmacol, P1, DOI 10.1007/978-3-540-79088-4_1; Murray SB, 2012, BODY IMAGE, V9, P193, DOI 10.1016/j.bodyim.2012.01.008; Nogueira A, 2018, REV PSICOL DEPORTE, V27, P43; O'Dea J., 2016, CHEM MODIFIED BODIES, P51, DOI DOI 10.1057/978-1-137-53535-1_4; O'Hara SE, 2014, BODY IMAGE, V11, P109, DOI 10.1016/j.bodyim.2013.12.004; Pavan C, 2006, INT J PSYCHIAT CLIN, V10, DOI [10.1007/s10899-010-9206-0, DOI 10.1007/S10899-010-9206-0]; Penas-Lledo E, 2002, INT J EAT DISORDER, V31, P370, DOI 10.1002/eat.10042; Pope HG, 2014, AM J ADDICTION, V23, P371, DOI 10.1111/j.1521-0391.2013.12118.x; POPE HG, 1988, PHYSICIAN SPORTSMED, V16, P75, DOI 10.1080/00913847.1988.11709554; Prichard I, 2005, SEX ROLES, V53, P19, DOI 10.1007/s11199-005-4270-0; Qualtrics, 2008, QUALTR ACC COD; Reuter P, 2017, ADDICTION, V112, P25, DOI 10.1111/add.13439; Ricciardelli R, 2010, SEX ROLES, V63, P64, DOI 10.1007/s11199-010-9764-8; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Sachs ML., 1992, THE EXERCISING ADULT; Sandgren SS, 2018, J LOSS TRAUMA, V23, P211, DOI 10.1080/15325024.2018.1428484; Serra-Majem L, 2006, NUTR REV, V64, pS27, DOI 10.1301/nr.2006.feb.S27-S47; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Shroff H, 2006, INT J EAT DISORDER, V39, P454, DOI 10.1002/eat.20247; Silver J, 2016, J HEALTH PSYCHOL, V21, P2647, DOI 10.1177/1359105315581516; Simon-Grima J, 2019, ADICCIONES, V31, P233, DOI 10.20882/adicciones.990; Simonato P, 2017, RES ADV PSYCHIAT, V4; Simpson CC, 2017, HEALTH COMMUN, V32, P560, DOI 10.1080/10410236.2016.1140273; Smith D, 2016, CHEM MODIFIED BODIES, P100; Snow J, 2013, QUALTRICS SURVEY SOF; Stoliaroff S, 2003, RUNNING FIT NEWS, V18, P4; Szabo, 2010, ADDICTION EXERCISE S; Szabo A, 1995, Aust J Sci Med Sport, V27, P68; Terry A, 2004, ADDICT RES THEORY, V12, P489, DOI 10.1080/16066350310001637363; Thevis M, 2008, J ANAL TOXICOL, V32, P232, DOI 10.1093/jat/32.3.232; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Underwood M, 2017, INT J DRUG POLICY, V39, P78, DOI 10.1016/j.drugpo.2016.08.012; Van de Ven K, 2018, DRUG ALCOHOL REV, V37, P837, DOI 10.1111/dar.12831; Van Hout M. C., 2014, PERFORMANCE ENHANCEM, V3, P3, DOI [10.1016/j.peh.2014.05.001, DOI 10.1016/J.PEH.2014.05.001]; Van Hout MC, 2014, INT J DRUG POLICY, V25, P444, DOI 10.1016/j.drugpo.2013.10.008; Veale D, 2001, BEHAV RES THER, V39, P1381, DOI 10.1016/S0005-7967(00)00102-9; Veale D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2278; Veale D, 2014, PSYCHOTHER PSYCHOSOM, V83, P341, DOI 10.1159/000360740; Veale D, 2014, BEHAV COGN PSYCHOTH, V42, P605, DOI 10.1017/S1352465813000556; Veale DMW., 1995, EXERCISE ADDICTION M, P1, DOI DOI 10.12691/AJSSM-1-1-1; Villella C, 2011, J GAMBL STUD, V27, P203, DOI 10.1007/s10899-010-9206-0; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Yuasa Yasuo, 1987, BODY E MINDBODY THEO; Zahnow R., 2017, CONTEMP DRUG PROBL, V44, P69, DOI DOI 10.1177/0091450917694268	101	44	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213060	10.1371/journal.pone.0213060	http://dx.doi.org/10.1371/journal.pone.0213060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943200	Green Published, gold			2022-12-27	WOS:000463194300009
J	Wang, PY; Chen, KL; Yang, SY; Lin, PH				Wang, Po-Yu; Chen, Kai-Li; Yang, Shang-Yu; Lin, Pin-Hsuan			Relationship of sleep quality, smartphone dependence, and health-related behaviors in female junior college students	PLOS ONE			English	Article							BODY-MASS INDEX; UNIVERSITY-STUDENTS; PREVALENCE; LIFE; DEPRESSION; DURATION; INSOMNIA; GENDER; DISTURBANCES; ASSOCIATION	Introduction Smartphone usage has become commonplace and impact on sleep quality among adolescents. Adolescent girls have a greater tendency toward sleep quality problems. However, relationship of sleep quality, smartphone dependence, and health-related behaviors in female junior college students has not been studied. Objectives This study had the two goals: to investigate the relationship between female college students' sleep quality, smartphone dependence, and health-related behaviors, and to identify predictors of sleep quality. Methods This study employed a cross-sectional research approach to gather 409 subjects at a junior college in southern Taiwan, and used a structured questionnaire to collect data. The questionnaire consisted of four parts: basic demographic data, the Pittsburgh Sleep Quality Index, assessment of smartphone dependence, and the Health Promoting Lifestyle Profile (HPLP). Logistic regression analysis was employed to check for any association between sleep quality and smartphone dependence or HPLP. Results Sleep quality was significantly associated with degree of smartphone dependence, total HPLP score, and scores on the four HPLP subscales of nutritional behavior, self-actualization, interpersonal support, and stress management behavior. The lower the subjects' degree of smartphone dependence was, the better their sleep quality was. Furthermore, the degree of smartphone dependence and total HPLP score were significant predictors of sleep quality. Conclusions Smartphone dependence is associated with poor sleep quality among female college students. Improving health-related behaviors (nutritional behavior, self-actualization, interpersonal support, and stress management behavior) can also promote improvement in sleep quality.	[Wang, Po-Yu] Changhua Christian Children Hosp, Dept Pediat Emergency, Changhua, Taiwan; [Chen, Kai-Li] Tajen Univ, Coll Pharm & Hlth Care, Dept Nursing, Pingtung, Taiwan; [Yang, Shang-Yu] Asia Univ, Coll Med & Hlth Sci, Dept Occupat Therapy, Taichung, Taiwan; [Lin, Pin-Hsuan] Shu Zen Jr Coll Med & Management, Dept Hlth & Beauty, Kaohsiung, Taiwan	Asia University Taiwan	Yang, SY (corresponding author), Asia Univ, Coll Med & Hlth Sci, Dept Occupat Therapy, Taichung, Taiwan.	henry879019@yahoo.com.tw						Aceijas C, 2017, PERSPECT PUBLIC HEAL, V137, P227, DOI 10.1177/1757913916666875; Almutairi KM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5999-z; Alosaimi FD, 2016, SAUDI MED J, V37, P675, DOI [10.15537/smj.2016.6.14430, 10.15537/Smj.2016.6.14430]; Baert S, 2015, SOC SCI MED, V130, P91, DOI 10.1016/j.socscimed.2015.02.011; Britton WB, 2013, MINDFULNESS RELATED, P92; Buysse D J, 1989, Psychiatry Res, V28, P193; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Chahine R, 2018, E MEDITERR HEALTH J, V24, P722, DOI 10.26719/2018.24.8.722; Chang SP, 2015, J SPORT MED PHYS FIT, V55, P1234; Chen BF, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1503-z; Chen DR, 2013, J SCHOOL HEALTH, V83, P582, DOI 10.1111/josh.12068; Chen M.Y., 1997, CHANG GUNG NURS, V8, P14; Chen TY, 2015, NEUROPSYCH DIS TREAT, V11, P741, DOI 10.2147/NDT.S77179; Cheng GHL, 2018, QUAL LIFE RES, V27, P2517, DOI 10.1007/s11136-018-1895-3; Christensen MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165331; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COREN S, 1994, INT J NEUROSCI, V79, P67, DOI 10.3109/00207459408986068; Lima TR, 2018, WORLD J PEDIATR, V14, P383, DOI 10.1007/s12519-018-0136-8; Demirci K, 2015, J BEHAV ADDICT, V4, P85, DOI 10.1556/2006.4.2015.010; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Heppner PP, 2004, COUNS PSYCHOL, V32, P344, DOI 10.1177/0011000003262793; Jaussent I, 2011, AM J GERIAT PSYCHIAT, V19, P88, DOI 10.1097/JGP.0b013e3181e049b6; Jenaro C, 2007, ADDICT RES THEORY, V15, P309, DOI 10.1080/16066350701350247; Johnson EO, 2006, PEDIATRICS, V117, pE247, DOI 10.1542/peds.2004-2629; Kazama M, 2015, TOHOKU J EXP MED, V236, P107, DOI 10.1620/tjem.236.107; Kenney SR, 2013, J STUD ALCOHOL DRUGS, V74, P841, DOI 10.15288/jsad.2013.74.841; Killgore WDS, 2008, SLEEP MED, V9, P517, DOI 10.1016/j.sleep.2007.07.003; Kim K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174619; Kim SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191713; Kuss DJ, 2011, INT J ENV RES PUB HE, V8, P3528, DOI 10.3390/ijerph8093528; Lai P P, 2013, Med J Malaysia, V68, P195; Lee SY, 2013, AM J HEALTH BEHAV, V37, P851, DOI 10.5993/AJHB.37.6.14; Lin L.-N., 2012, FORMOS J MED, V16, P72, DOI [10.6320/FJM.2012.16(1).08, DOI 10.6320/FJM.2012.16(1).08]; Lin P. H, 2018, SOC HLTH BEHAV, V1, P31, DOI [10.3389/fpsyg.2018.02316, DOI 10.3389/FPSYG.2018.02316]; Liu XC, 2017, EUR CHILD ADOLES PSY, V26, P271, DOI 10.1007/s00787-016-0885-7; Meijer AM, 2010, J CHILD PSYCHOL PSYC, V51, P1278, DOI 10.1111/j.1469-7610.2010.02261.x; Min CY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022848; Mirghani Hyder Osman, 2015, BMC Res Notes, V8, P706, DOI 10.1186/s13104-015-1712-9; Nakade Miyo, 2009, Journal of Physiological Anthropology, V28, P83, DOI 10.2114/jpa2.28.83; Nam GE, 2017, SLEEP MED, V35, P62, DOI 10.1016/j.sleep.2017.04.009; Perkinson-Gloor N, 2013, J ADOLESCENCE, V36, P311, DOI 10.1016/j.adolescence.2012.11.008; Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009; Lopez VAQ, 2018, NUTR HOSP, V35, P979, DOI 10.20960/nh.1680; REYNER A, 1995, SLEEP, V18, P127; ROSENTHAL DA, 1981, J YOUTH ADOLESCENCE, V10, P525, DOI 10.1007/BF02087944; St-Onge MP, 2016, ADV NUTR, V7, P938, DOI 10.3945/an.116.012336; Sumi K, 2012, PSYCHOL REP, V111, P929, DOI 10.2466/21.20.28.PR0.111.6.929-937; Swinkels CM, 2013, SLEEP, V36, P1019, DOI 10.5665/sleep.2800; Tanaka E, 2013, J EPIDEMIOL, V23, P132, DOI 10.2188/jea.JE20120101; Tang NKY, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw079; Tsai LL, 2004, J PSYCHOSOM RES, V56, P231, DOI 10.1016/S0022-3999(03)00507-5; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tsai S. C., 2012, FORUM ED RES, V4, P1; WALKER SN, 1987, NURS RES, V36, P76; Wallace DD, 2017, J AM COLL HEALTH, V65, P187, DOI 10.1080/07448481.2016.1269111; Wang H, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0285-8; Wang L, 2016, PSYCHIAT RES, V244, P243, DOI 10.1016/j.psychres.2016.04.011; Xie XC, 2018, J BEHAV ADDICT, V7, P466, DOI 10.1556/2006.7.2018.40; Yang SY, 2018, J AM COLL HEALTH, V66, P693, DOI 10.1080/07448481.2018.1454930; Yang SY, 2017, J COMMUN HEALTH, V42, P423, DOI 10.1007/s10900-016-0271-x	60	32	32	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214769	10.1371/journal.pone.0214769	http://dx.doi.org/10.1371/journal.pone.0214769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943270	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300060
J	Lee, PH; Chan, PC; Peng, YT; Chu, PW; Wu, MH; Jou, RW; Yu, MC; Lin, CJ; Huang, YW; Chien, ST; Lee, JJ; Chiang, CY				Lee, Pin-Hui; Chan, Pei-Chun; Peng, Yen-Ting; Chu, Po-Wei; Wu, Mei-Hua; Jou, Ruwen; Yu, Ming-Chih; Lin, Chou-Jui; Huang, Yi-Wen; Chien, Shun-Tien; Lee, Jen-Jyh; Chiang, Chen-Yuan			Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; MYCOBACTERIUM-TUBERCULOSIS; PROFICIENCY	Background The treatment outcomes of multidrug-resistant tuberculosis (MDR-TB) patients in the 1990s in Taiwan was not satisfactory. To strengthen programmatic management of drug-resistant tuberculosis (PMDT), Taiwan MDR-TB Consortium (TMTC) was established in 2007. We assess the performance and epidemiologic impact of TMTC. Methodology/Principle findings We analyzed the trends of proportion of TB cases with drug susceptibility testing, enrollment of MDR-TB patients into TMTC and outcomes of treatment of all MDR-TB patients in Taiwan from 2007-2016. We computed the trends of both incidence and prevalence of MDR-TB from 2007-2016. We assessed the trends of MDR-TB among both new and recurrent TB cases. The proportion of TB cases with drug susceptibility testing results increased from 24.2% in 2007 to 97.9% in 2016. Of the 1,452 MDR-TB patients who were eligible for TMTC care, 1,197 (82.4%) were enrolled in TMTC, in whom 82.9% had treatment success. MDR TB incidence was 9.0 cases per million in 2007, which declined to 4.6 cases per million in 2016 (p<0.0001). MDR-TB prevalence decreased from 19.4 cases per million in 2007 to 8.4 cases per million in 2016 (p<0.0001). The proportion of MDR-TB among new TB cases decreased from 1.4% in 2010 to 1.0% in 2016 (p = 0.039); and that among recurrent TB cases from 9.0% in 2010 to 1.8% in 2016 (p<0.0001). Conclusions We concluded that effective PMDT have had a significant impact on the epidemic of drug resistant TB in Taiwan.	[Lee, Pin-Hui; Chan, Pei-Chun; Peng, Yen-Ting; Chu, Po-Wei; Wu, Mei-Hua; Jou, Ruwen] Taiwan Ctr Dis Control, Taipei, Taiwan; [Chan, Pei-Chun] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Yu, Ming-Chih; Chiang, Chen-Yuan] Taipei Med Univ, Wanfang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Yu, Ming-Chih] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Yu, Ming-Chih; Chiang, Chen-Yuan] Taipei Med Univ, Coll Med, Sch Med, Div Pulm Med,Dept Internal Med, Taipei, Taiwan; [Lin, Chou-Jui] Taoyuan Gen Hosp, Minist Hlth & Welf, Pulm & Crit Care Unit, Taoyuan, Taiwan; [Huang, Yi-Wen] Changhua Hosp, Minist Hlth & Welf, Pulm & Crit Care Unit, Changhua, Taiwan; [Chien, Shun-Tien] Chest Hosp, Minist Hlth & Welf, Pulm & Crit Care Unit, Tainan, Taiwan; [Lee, Jen-Jyh] Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France	National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Chiang, CY (corresponding author), Taipei Med Univ, Wanfang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.; Chiang, CY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Div Pulm Med,Dept Internal Med, Taipei, Taiwan.; Chiang, CY (corresponding author), Int Union TB & Lung Dis, Paris, France.	cychiang@theunion.org			Taiwan Centers for Disease Control [MOHW107-CDC-C-315-112117]	Taiwan Centers for Disease Control	The study was funded by Taiwan Centers for Disease Control (author: PHL, funder website: www.cdc.gov.tw, grant number: MOHW107-CDC-C-315-112117). The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; [Anonymous], 2018, GLOB TUB REP; Bloss E, 2012, INT J TUBERC LUNG D, V16, P462, DOI 10.5588/ijtld.11.0121; Chan PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057719; Chen MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170980; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chiang CY, 2010, INT J TUBERC LUNG D, V14, P878; Chiang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044133; Chiang TY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200755; Chien JY, 2013, J ANTIMICROB CHEMOTH, V68, P1910, DOI 10.1093/jac/dkt103; Huang SH, 2012, TAIWAN EPIDEMIOL B, V28, P269; Huang SH, 2014, TAIWAN EPIDEMIOL B, V30, P64; Jou R, 2009, INT J TUBERC LUNG D, V13, P1142; Lee CY, 2015, AM J MANAG CARE, V21, pE35; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Taiwan Centers for Disease Control, TAIW TUB CONTR REP 2; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; Wu MH, 2013, INT J TUBERC LUNG D, V17, P113, DOI 10.5588/ijtld.12.0521; Wu MH, 2009, INT J TUBERC LUNG D, V13, P606; Yu MC, 2018, CLIN INFECT DIS, V67, P202, DOI 10.1093/cid/ciy066	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214792	10.1371/journal.pone.0214792	http://dx.doi.org/10.1371/journal.pone.0214792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939150	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900040
J	Dehmer, SP; Pardey, PG; Beddow, JM; Chai, Y				Dehmer, Steven P.; Pardey, Philip G.; Beddow, Jason M.; Chai, Yuan			Reshuffling the global R&D deck, 1980-2050	PLOS ONE			English	Article							LOCATION	Based on more recent science spending developments in countries such as China, Korea, India and Brazil, there is a growing sense that the world's scientific deck of cards is in the midst of a major reshuffle. But it is not clear if this reordering is limited to just the top spenders, or, indeed, how these changes have been playing out over the longer term. The new, more comprehensive research and development (R&D) spending estimates presented and discussed here reveal that we are in the midst of a possibly game-changing, albeit partial and perhaps irregular, reshuffle of the global R&D deck. These changes have potentially profound domestic and international economic development implications over the medium to long term. Notably, the fortunes of many of the world's poorer countries continue to look bleak. Using the evolving structure of past R&D spending to project forward, and absent marked changes in science policies and spending priorities, we foresee a continuing and substantial shift in the geography of R&D towards parts of Asia, along with a continuing large, and in many respects growing, gap between the world's scientific haves and have-nots.	[Dehmer, Steven P.] HealthPartners Inst, Minneapolis, MN USA; [Pardey, Philip G.; Beddow, Jason M.; Chai, Yuan] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Pardey, PG (corresponding author), Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA.	ppardey@umn.edu		Dehmer, Steven/0000-0003-3508-9239; Chai, Yuan/0000-0002-5127-9107; Pardey, Philip/0000-0002-8012-1341				Angelo C, 2016, NATURE, V539, P480, DOI 10.1038/nature.2016.21014; [Anonymous], 2018, SCI ENG IND; Beddow JM, 2015, J ECON HIST, V75, P219, DOI 10.1017/S002205071500008X; Dadush U.B., 2010, WORLD ORDER 2050; Docquier F, 2012, J ECON LIT, V50, P681, DOI 10.1257/jel.50.3.681; eurostat, EUR DAT; Fernald JG, 2014, AM ECON REV, V104, P44, DOI 10.1257/aer.104.5.44; Fogel R.W., 2007, 13184 NBER; Foure J., 2012, GREAT SHIFT MACROECO; Freeman RB, 2014, IMMIGRATION INT COLL; Goldman Sachs Global Economics Group, 2007, BRICS AND BEYOND; Hall B., 2010, HDB EC INNOVATION; Hurley TM, 2014, AM J AGR ECON, V96, P1492, DOI 10.1093/ajae/aau047; Maddison A., 2007, CONTOURS WORLD EC 1; National Science Board, 2016, SCI ENG IND; OECD, OECD STATEXTRACTS; OECD, 2008, INT BUS R D EV IMP I; OECD (Organisation for Economic Co-operation and Development), 2012, LOOK 2060 LONG TERM; PricewaterhouseCoopers, 2011, WORLD 2050 ACC SHIFT; RICYT (Red de Indicadores de Ciencia y Technologia), 2015, INDICATORS; Siedschlag I, 2013, RES POLICY, V42, P1420, DOI 10.1016/j.respol.2013.06.003; Thursby J., 2006, HERE THERE SURVEY FA; UN, WORLD POP PROSP 2012; UNESCO-UIS (United Nations Educational Scientific and Cultural Organization Institute for Statistics), 2015, UIS STAT; UNESCO-UIS (United Nations Educational Scientific and Cultural Organization-Institute for Statistics), 1999, STAT TABL 1999 UNESC; United Nations Statistics Division, 2013, UN NAT ACC MAIN AGGR; United States Department of Agriculture Economic Research Service, 2012, INT MACR DAT SET; World Bank, 2015, 2015 WORLD DEV IND D	28	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0213801	10.1371/journal.pone.0213801	http://dx.doi.org/10.1371/journal.pone.0213801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9FO	30925151	Green Submitted, gold, Green Published			2022-12-27	WOS:000462732300006
J	Zhang, GY; Langan, EA; Meier, NT; Funk, W; Siemers, F; Paus, R				Zhang, Guo-You; Langan, Ewan A.; Meier, Natalia T.; Funk, Wolfgang; Siemers, Frank; Paus, Ralf			Thyroxine (T4) may promote re-epithelialisation and angiogenesis in wounded human skin ex vivo	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; HUMAN HAIR FOLLICLE; ORGAN-CULTURE MODEL; THYROID-HORMONE; MITOCHONDRIAL-FUNCTION; ANAGEN; ULCER; MANAGEMENT; BFGF; PROLIFERATION	There is a pressing need for improved preclinical model systems in which to study human skin wound healing. Here, we report the development and application of a serum-free full thickness human skin wound healing model. Not only can re-epithelialization (epidermal repair) and angiogenesis be studied in this simple and instructive model, but the model can also be used to identify clinically relevant wound-healing promoting agents, and to dissect underlying candidate mechanisms of action in the target tissue. We present preliminary ex vivo data to suggest that Thyroxine (T4), which reportedly promotes skin wound healing in rodents in vivo, may promote key features of human skin wound healing. Namely, T4 stimulates re-epithelialisation and angiogenesis, and modulates both wound healing-associated epidermal keratin expression and energy metabolism in experimentally wound human skin. Functionally, the wound healing-promoting effects of T4 are at least partially mediated via fibroblast growth factor/fibroblast growth factor receptor-mediated signalling, since they could be significantly antagonized by bFGF-neutralizing antibody. Thus, this pragmatic, easy-to-use full-thickness human skin wound healing model provides a useful preclinical research tool in the search for clinically relevant candidate wound healing-promoting agents. These ex vivo data encourage further pre-clinical testing of topical T4 as a cost-efficient, novel agent in the management of chronic human skin wounds.	[Zhang, Guo-You] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, Shanghai, Peoples R China; [Langan, Ewan A.] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Langan, Ewan A.] Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England; [Langan, Ewan A.] NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England; [Meier, Natalia T.] Univ Lubeck, Dept Pathol, Lubeck, Germany; [Funk, Wolfgang] Klin Dr Funk, Munich, Germany; [Siemers, Frank] BG Klinikum Bergmannstrost, Dept Plast & Hand Surg, Halle, Germany; [Paus, Ralf] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Paus, Ralf] Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England; [Paus, Ralf] NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England	Shanghai Jiao Tong University; University of Lubeck; University of Manchester; University of Lubeck; University of Miami; University of Manchester	Paus, R (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.; Paus, R (corresponding author), Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England.; Paus, R (corresponding author), NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England.	rxp803@med.miami.edu			Federal Ministry of Economics, Germany (AiF/ZIM Programme); National Natural Science Foundation of China [81101430]; 2011 Chinese government award for outstanding self-financed students abroad (China Scholarship Council)	Federal Ministry of Economics, Germany (AiF/ZIM Programme); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 2011 Chinese government award for outstanding self-financed students abroad (China Scholarship Council)	This work was supported in part by a grant from the Federal Ministry of Economics, Germany (AiF/ZIM Programme) to R.P. G-Y Zhang was supported by 2011 Chinese government award for outstanding self-financed students abroad (China Scholarship Council) and National Natural Science Foundation of China (81101430).	Abramo F, 2017, VET DERMATOL, V28, P456, DOI 10.1111/vde.12456; Abramo F, 2016, ANN ANAT, V207, P109, DOI 10.1016/j.aanat.2016.03.009; Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Aoki S, 2017, WOUND REPAIR REGEN, V25, P1008, DOI 10.1111/wrr.12604; Arbiser JL, 2000, J AM ACAD DERMATOL, V42, P973, DOI 10.1016/S0190-9622(00)90288-3; Bekeschus S, 2017, EXP DERMATOL, V26, P145, DOI 10.1111/exd.13215; Bodo E, 2007, FASEB J, V21, P3346, DOI 10.1096/fj.07-8628com; Bodo E, 2007, AM J PATHOL, V171, P1153, DOI 10.2353/ajpath.2007.061164; Bodo E, 2010, ENDOCRINOLOGY, V151, P1633, DOI 10.1210/en.2009-0306; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; Cappellano G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051404; Certan D, 2013, GIORN ITAL DERMAT V, V148, P287; Cheret J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05973-0; Choi EW, 2018, EXP DERMATOL, V27, P1170, DOI 10.1111/exd.13451; Choi SM, 2018, ACTA BIOMATER, V66, P325, DOI 10.1016/j.actbio.2017.11.045; Coleman S, 2018, J ADV NURS, V74, P407, DOI 10.1111/jan.13444; Davis FB, 2004, CIRC RES, V94, P1500, DOI 10.1161/01.RES.0000130784.90237.4a; Deshayes N, 2018, EXP DERMATOL, V27, P460, DOI 10.1111/exd.13390; Eming SA, 2017, EXP DERMATOL, V26, P97, DOI 10.1111/exd.13281; Erdogan M, 1999, ACTA CHIR BELG, V99, P72; FREINKEL RK, 1972, ARCH DERMATOL, V106, P349, DOI 10.1001/archderm.106.3.349; Garcin CL, 2017, EXP DERMATOL, V26, P101, DOI 10.1111/exd.13184; Guest JF, 2018, INT WOUND J, V15, P29, DOI 10.1111/iwj.12814; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harn HIC, 2019, EXP DERMATOL, V28, P464, DOI 10.1111/exd.13460; Hawkshaw NJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003705; HOLT PJA, 1978, J INVEST DERMATOL, V71, P202, DOI 10.1111/1523-1747.ep12547158; HOLT PJA, 1977, J INVEST DERMATOL, V68, P299, DOI 10.1111/1523-1747.ep12494564; Ilonzo Nicole, 2018, Surg Technol Int, V32, P49; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jeffcoate WJ, 2018, DIABETES CARE, V41, P645, DOI 10.2337/dc17-1836; Jimenez F, 2015, EXP DERMATOL, V24, P91, DOI 10.1111/exd.12521; KAPLAN MM, 1988, J CLIN ENDOCR METAB, V66, P815, DOI 10.1210/jcem-66-4-815; Kinoda J, 2018, J RADIAT RES, V59, P27, DOI 10.1093/jrr/rrx044; Knuever J, 2012, J CLIN ENDOCR METAB, V97, P978, DOI 10.1210/jc.2011-1096; Kress E, 2009, MOL CELL ENDOCRINOL, V313, P36, DOI 10.1016/j.mce.2009.08.028; Lebonvallet N, 2018, EXP DERMATOL, V27, P950, DOI 10.1111/exd.13681; Lu ZF, 2007, EXP DERMATOL, V16, P37, DOI 10.1111/j.1600-0625.2006.00510.x; Luidens MK, 2010, VASC PHARMACOL, V52, P142, DOI 10.1016/j.vph.2009.10.007; Markova A, 2012, DERMATOL CLIN, V30, P107, DOI 10.1016/j.det.2011.08.005; Martinez ML, 2016, J AM ACAD DERMATOL, V75, P1007, DOI 10.1016/j.jaad.2016.02.1161; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Meier NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073596; Messenger AG, 2000, BRIT J DERMATOL, V142, P633, DOI 10.1046/j.1365-2133.2000.03521.x; Mizukami Y, 2017, J DERMATOL SCI, V88, P308, DOI 10.1016/j.jdermsci.2017.08.005; Moll I, 1998, J INVEST DERMATOL, V111, P251, DOI 10.1046/j.1523-1747.1998.00265.x; Nygaard B, 2015, BASIC CLIN PHARMACOL, V117, P280, DOI 10.1111/bcpt.12401; Ogino S, 2018, J SURG RES, V221, P173, DOI 10.1016/j.jss.2017.08.051; Olah A, 2016, J INVEST DERMATOL, V136, P1711, DOI 10.1016/j.jid.2016.03.033; Olivera S, 2013, METHODS MOL BIOL, V1037, P255, DOI 10.1007/978-1-62703-505-7_14; Orlandi C, 2018, EXP DERMATOL, V27, P795, DOI 10.1111/exd.13552; Pastar I, 2018, EXP DERMATOL, V27, P551, DOI 10.1111/exd.13663; Paus R, 2017, ROOKS TXB DERMATOLOG; Paus R, 2010, J INVEST DERMATOL, V130, P7, DOI 10.1038/jid.2009.359; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Poblet E, 2018, BRIT J DERMATOL, V178, P1163, DOI 10.1111/bjd.16436; Poeggeler B, 2010, FASEB J, V24, P1525, DOI 10.1096/fj.09-147728; POUMAY Y, 1994, J INVEST DERMATOL, V102, P111, DOI 10.1111/1523-1747.ep12371742; Raja, 2007, Front Biosci, V12, P2849; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547; Saijo H, 2017, WOUND REPAIR REGEN, V25, P972, DOI 10.1111/wrr.12609; Samuelov L, 2012, J INVEST DERMATOL, V132, P2332, DOI 10.1038/jid.2012.171; Shamloo A, 2018, INT J PHARMACEUT, V537, P278, DOI 10.1016/j.ijpharm.2017.12.045; Silva WN, 2018, EXP DERMATOL, V27, P630, DOI 10.1111/exd.13524; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STENN KS, 1981, P NATL ACAD SCI-BIOL, V78, P6907, DOI 10.1073/pnas.78.11.6907; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129, P726, DOI 10.1016/j.jaci.2011.11.009; Takagi N, 2017, EXP DERMATOL, V26, P137, DOI 10.1111/exd.13115; Telek A, 2007, FASEB J, V21, P3534, DOI 10.1096/fj.06-7689com; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Vidali S, 2016, J INVEST DERMATOL, V136, P2003, DOI 10.1016/j.jid.2016.05.118; Vidali S, 2014, J INVEST DERMATOL, V134, P33, DOI 10.1038/jid.2013.286; Wen J, 2017, EXP DERMATOL, V26, P433, DOI 10.1111/exd.13258; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Xie T, 2018, BURNS TRAUMA, V6, DOI 10.1186/s41038-018-0119-y	79	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0212659	10.1371/journal.pone.0212659	http://dx.doi.org/10.1371/journal.pone.0212659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925152	Green Published, Green Submitted, gold			2022-12-27	WOS:000462732300003
J	Bar, L; Hase, P; Foller, M				Baer, Ludmilla; Hase, Philipp; Foeller, Michael			PKC regulates the production of fibroblast growth factor 23 (FGF23)	PLOS ONE			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; VASCULAR CALCIFICATION; BONE; EXPRESSION; PHOSPHATE; KLOTHO; OSTEOBLAST; DIFFERENTIATION; OSTEOCYTES	Serine/threonine protein kinase C (PKC) is activated by diacylglycerol that is released from membrane lipids by phospholipase C in response to activation of G protein-coupled receptors or receptor tyrosine kinases. PKC isoforms are particularly relevant for proliferation and differentiation of cells including osteoblasts. Osteoblasts/osteocytes produce fibroblast growth factor 23 (FGF23), a hormone regulating renal phosphate and vitamin D handling. PKC activates NF kappa B, a transcription factor complex controlling FGF23 expression. Here, we analyzed the impact of PKC on FGF23 synthesis. Fgf23 expression was analyzed by qRT-PCR in UMR106 osteoblast-like cells and in IDG-SW3 osteocytes, and FGF23 protein was measured by ELISA. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate (PMA), a PKC activator, up-regulated FGF23 production. In contrast, PKC inhibitors calphostin C, Go6976, sotrastaurin and ruboxistaurin suppressed FGF23 formation. NF kappa B inhibitor withaferin A abolished the stimulatory effect of PMA on Fgf23. PKC is a powerful regulator of FGF23 synthesis, an effect which is at least partly mediated by NF kappa B.	[Baer, Ludmilla; Hase, Philipp] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Saale, Germany; [Foeller, Michael] Univ Hohenheim, Inst Physiol, Stuttgart, Germany	Martin Luther University Halle Wittenberg; University Hohenheim	Foller, M (corresponding author), Univ Hohenheim, Inst Physiol, Stuttgart, Germany.	michael.foeller@uni-hohenheim.de			Deutsche Forschungsgemeinschaft [Fo 695/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft [Fo 695/2-1].	Agoro R, 2018, FASEB J, V32, P3752, DOI 10.1096/fj.201700667R; Bar L, 2018, P NATL ACAD SCI USA, V115, P5804, DOI 10.1073/pnas.1800160115; Bar L, 2017, N-S ARCH PHARMACOL, V390, P1117, DOI 10.1007/s00210-017-1411-2; Christov M, 2014, CURR OPIN NEPHROL HY, V23, P340, DOI 10.1097/01.mnh.0000447021.51722.2f; Clinkenbeard EL, 2014, J BONE MINER RES, V29, P361, DOI 10.1002/jbmr.2049; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; Durlacher-Betzer K, 2018, KIDNEY INT, V94, P315, DOI 10.1016/j.kint.2018.02.026; Egli-Spichtig Daniela, 2018, Frontiers in Physiology, V9, P1494, DOI 10.3389/fphys.2018.01494; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Faul C, 2017, BONE, V100, P69, DOI 10.1016/j.bone.2016.10.001; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Feger M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05226-y; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Flamme I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186979; Galea GL, 2014, J BIOL CHEM, V289, P25509, DOI 10.1074/jbc.M114.580365; Glosse P, 2018, KIDNEY INT, V94, P491, DOI 10.1016/j.kint.2018.03.006; Glosse P, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0037-x; Graciolli FG, 2017, KIDNEY INT, V91, P1436, DOI 10.1016/j.kint.2016.12.029; Hanks LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122885; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Isakov N, 2018, SEMIN CANCER BIOL, V48, P36, DOI 10.1016/j.semcancer.2017.04.012; Ito N, 2015, MOL CELL ENDOCRINOL, V399, P208, DOI 10.1016/j.mce.2014.10.007; Itoh N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00247; Jeong HM, 2012, BBA-MOL CELL RES, V1823, P1225, DOI 10.1016/j.bbamcr.2012.05.018; Jimbo R, 2014, KIDNEY INT, V85, P1103, DOI 10.1038/ki.2013.332; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kuro-o M, 2019, NEPHROL DIAL TRANSPL, V34, P15, DOI 10.1093/ndt/gfy126; Kuro-o M, 2017, BONE, V100, P4, DOI 10.1016/j.bone.2016.11.013; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Leifheit-Nestler M, 2017, NEPHROL DIAL TRANSPL, V32, P1493, DOI 10.1093/ndt/gfw454; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Matsui I, 2018, KIDNEY INT, V94, P60, DOI 10.1016/j.kint.2018.02.018; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Moscat J, 2003, EMBO REP, V4, P31, DOI 10.1038/sj.embor.embor704; Orfanidou T, 2009, J CELL MOL MED, V13, P3186, DOI 10.1111/j.1582-4934.2009.00678.x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pulskens WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142510; Rodelo-Haad C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201537; Rossaint J, 2016, J CLIN INVEST, V126, P962, DOI 10.1172/JCI83470; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Schnedl C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/358086; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Tsuprykov O, 2018, J STEROID BIOCHEM, V180, P87, DOI 10.1016/j.jsbmb.2017.11.014; Voelkl J, 2013, J CLIN INVEST, V123, P812, DOI 10.1172/JCI64093; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Yamazaki M, 2015, J BONE MINER METAB, V33, P342, DOI 10.1007/s00774-014-0598-2; Zhang BB, 2016, J MOL MED, V94, P557, DOI 10.1007/s00109-015-1370-3; Zhang Q, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.11	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0211309	10.1371/journal.pone.0211309	http://dx.doi.org/10.1371/journal.pone.0211309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921339	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000011
J	Kim, DK; Kim, EK; Jung, DW; Kim, J				Kim, Do Kyeong; Kim, Eun Kyoung; Jung, Da-Woon; Kim, Jin			Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED FIBROBLASTS; ACTOMYOSIN CONTRACTILITY; GINGIVAL FIBROBLASTS; ACTIVATION PROTEIN; INDUCED SENESCENCE; TISSUE STIFFNESS; STRESS; PATHWAY; BREAST; TUMORS	Cancer-associated fibroblasts(CAFs) participate in carcinogenesis through interaction with cancer cells. This study aimed to investigate the mechanism of cytoskeletal alteration of CAFs and its role in invasion of oral squamous cell carcinoma(OSCC),Immortalized normal fibroblasts(hTERT-hNOFs) co-cultured with OSCC cells showed myofibroblastic and senescent phenotypes like CAFs. Thus, this study substituted hTERT-hNOFs for CAFs. Next, the cytoskeletal alteration and its molecular mechanism were investigated in hTERT-hNOFs co-cultured with OSCC. As results, we found that RhoA regulated cytoskeletal organization in fibroblasts surrounding OSCC cells. Furthermore, as a downstream transcriptional factor of RhoA, YAP was mainly localized in the nucleus of hTERT-hNOFs co-cultured with OSCC. Consequently, we examined whether nuclear YAP localization of fibroblasts could influence cancer progression. YAPS127A fibroblasts manifesting nuclear localization of YAP induced cytoskeletal alteration and increased gel contractility and matrix stiffness, and thereby enhances the invasiveness of OSCC cells. In conclusion, the modification of tumor microenvironment, such as cytoskeletal change and matrix remodeling via RhoA-YAP in CAFs, modulates OSCC invasion. These understandings will provide the development of novel approaches for CAFs-based cancer therapy.	[Kim, Do Kyeong; Kim, Eun Kyoung; Kim, Jin] Yonsei Univ, Oral Canc Res Inst, Dept Oral Pathol, BK21 PLUS Project,Coll Dent, Seoul, South Korea; [Kim, Do Kyeong] Jeonju Kijeon Coll, Dept Dent Hyg, Jeonju, South Korea; [Jung, Da-Woon] Gwangju Inst Sci & Technol, New Drug Targets Lab, Sch Life Sci, 1 Oryong Dong, Gwangju, South Korea	Yonsei University; Yonsei University Health System; Gwangju Institute of Science & Technology (GIST)	Kim, J (corresponding author), Yonsei Univ, Oral Canc Res Inst, Dept Oral Pathol, BK21 PLUS Project,Coll Dent, Seoul, South Korea.	jink@yuhs.ac			health fellowship foundation in Korea	health fellowship foundation in Korea	This work was supported by the health fellowship foundation in Korea (no grant number) (https://www.yuhanfoundation.or.kr) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bae JY, 2014, NEOPLASIA, V16, P928, DOI 10.1016/j.neo.2014.09.003; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Corver WE, 2011, CELL ONCOL, V34, P553, DOI 10.1007/s13402-011-0061-5; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Ferrari N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07987-0; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Haage A, 2014, FASEB J, V28, P3589, DOI 10.1096/fj.13-245613; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassona Y, 2013, CARCINOGENESIS, V34, P1286, DOI 10.1093/carcin/bgt035; Illeperuma RP, 2015, INT J CANCER, V137, P2545, DOI 10.1002/ijc.29636; Illeperuma RP, 2012, J MATER SCI-MATER M, V23, P753, DOI 10.1007/s10856-011-4473-6; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Kim EK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188847; Kumper S, 2011, CANCER CELL, V19, P695, DOI 10.1016/j.ccr.2011.05.021; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lee EJ, 2005, EXP MOL MED, V37, P379, DOI 10.1038/emm.2005.48; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P2423, DOI 10.4161/cc.9.12.12048; Naka K, 2004, J BIOL CHEM, V279, P2030, DOI 10.1074/jbc.M309457200; Narra K, 2007, CANCER BIOL THER, V6, P1691, DOI 10.4161/cbt.6.11.4874; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Prime SS, 2017, J ORAL PATHOL MED, V46, P82, DOI 10.1111/jop.12456; Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Scott AM, 2003, CLIN CANCER RES, V9, P1639; Togo Shinsaku, 2013, Cancers (Basel), V5, P149, DOI 10.3390/cancers5010149; Tommelein J, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00063; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Wheaton K, 2001, J CELL PHYSIOL, V187, P226, DOI 10.1002/jcp.1071; Zhang Y, 2018, J MOL NEUROSCI, V64, P262, DOI 10.1007/s12031-017-1018-6; Zhang YC, 2014, CELL SIGNAL, V26, P2504, DOI 10.1016/j.cellsig.2014.07.031; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214553	10.1371/journal.pone.0214553	http://dx.doi.org/10.1371/journal.pone.0214553			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921404	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000086
J	Stacey, AF; Gill, TK; Price, K; Taylor, AW				Stacey, Anne F.; Gill, Tiffany K.; Price, Kay; Taylor, Anne W.			Biomedical health profiles of unpaid family carers in an urban population in South Australia	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; QUALITY-OF-LIFE; CHRONIC STRESS; RISK-FACTOR; PSYCHOLOGICAL HEALTH; CAREGIVERS; DEMENTIA; BURDEN; DETERMINANTS	Objectives To compare the biomedical health profile and morbidity of adult carers with non-carers. Methods The North West Adelaide Health Study (NWAHS) is a representative population-based longitudinal biomedical cohort study of 4056 participants aged 18 years and over at Stage One. Informal (unpaid) carers were identified in Stage 3 of the project (2008-2010). Risk factors, chronic medical conditions and biomedical, health and demographic characteristics using self-report and blood measured variables were assessed. Data were collected through clinic visits, telephone interviews and self-completed questionnaires. Risk factors included blood pressure, cholesterol/lipids, body mass index (BMI), smoking and alcohol intake. Chronic medical conditions included cardiovascular and respiratory diseases, diabetes, and musculoskeletal conditions. Blood measured variables were routine haematology, biochemistry, Vitamin D, and the inflammatory biomarkers high sensitivity C-Reactive Protein (hs-CRP), Tumor Necrosis Factor alpha (TNF alpha) and Interleukin-6 (II-6). Results The prevalence of carers aged 40 years and over was 10.7%, n = 191. Carers aged 40 years and over were more likely to assess their health status as fair/poor and report having diabetes, arthritis, anxiety and depression. They also reported insufficient exercise and were found to have higher BMI compared with non-carers. Significant findings from blood measured variables were lower serum Vitamin D and haemoglobin. Male carers had raised diastolic blood pressure, higher blood glucose, lower haemoglobin and albumin levels and slightly elevated levels of the inflammatory biomarkers TNF alpha and hsCRP. Discussion and conclusions This study confirms informal carers had different biomedical profiles to non-carers that included some chronic physical illnesses. It identifies that both female and male carers showed a number of risk factors which need to be considered in future caregiver research, clinical guidelines and policy development regarding carer morbidity.	[Stacey, Anne F.; Taylor, Anne W.] Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Gill, Tiffany K.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Price, Kay] Univ South Australia, Sch Nursing & Midwifery, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; Flinders University South Australia; University of South Australia	Stacey, AF (corresponding author), Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia.	anne.stacey@adelaide.edu.au	Gill, Tiffany/F-9042-2010; Taylor, Anne/F-5708-2010	Gill, Tiffany/0000-0002-2822-2436; Taylor, Anne/0000-0002-4422-7974				Allen AP, 2017, NEUROSCI BIOBEHAV R, V73, P123, DOI 10.1016/j.neubiorev.2016.12.006; Allen AP, BIOL MARKERS CHRONIC; [Anonymous], 2000, AUSTR BUR STAT POP A; [Anonymous], 1999, AUSTR BUR STAT POP A; [Anonymous], 2003, USITC PUBL, V02-3659; [Anonymous], 2000, WHO TECHN REP SER; Armstrong T, 2000, PHYS ACTIVITY PATTER; Australasian Society for the Study of Obesity, 1995, HLTH WEIGHT AUSTR NA; Australian Bureau of Statistics, 2001, CENS POP HOUS SEL SO; Australian Bureau of Statistics (ABS), 2012, DIS AG CAR AUSTR SUM; Australian Institute of Health and Welfare, 2010, ARTHRITIS SERIES, V12; Australian Institute of Health and Welfare and National Heart Foundation, 1989, RISK FACT PREV STUD; Baker KL, 2008, AGING MENT HEALTH, V12, P413, DOI 10.1080/13607860802224250; Bauer ME, 2000, J NEUROIMMUNOL, V103, P84, DOI 10.1016/S0165-5728(99)00228-3; Bevans M, 2012, JAMA-J AM MED ASSOC, V307, P398, DOI 10.1001/jama.2012.29; Buyck JF, 2013, J GERONTOL A-BIOL, V68, P1316, DOI 10.1093/gerona/glt025; Cooper C, 2007, INT PSYCHOGERIATR, V19, P175, DOI 10.1017/S1041610206004297; DeFries E, CAREGIVING US CAREGI; Doran T, 2003, BRIT MED J, V327, P1388, DOI 10.1136/bmj.327.7428.1388; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gill T, 2003, SOZ PRAVENTIV MED, V48, P191, DOI 10.1007/s00038-003-2055-1; Gill TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1001; Granlund J, 2008, INT J EPIDEMIOL, P1; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Gupta S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0547-1; Hajek A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4786-6; Health Quality Ontario, 2016, REAL CAR DISTR CAR H; Hirst M, 2005, SOC SCI MED, V61, P697, DOI 10.1016/j.socscimed.2005.01.001; Ho SC, 2009, J GERONTOL A-BIOL, V64, P873, DOI 10.1093/gerona/glp034; Hori Y, 2011, NAGOYA J MED SCI, V73, P107; Johnson TV, 2013, MOL DIAGN THER, V17, P147, DOI 10.1007/s40291-013-0026-7; Kang S, 2014, SAGE OPEN MED, V2, DOI 10.1177/2050312113520152; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Laks J, 2016, INT J GERIATR PSYCH, V31, P176, DOI 10.1002/gps.4309; Lebrec J, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0264-8; Legg L, 2013, J EPIDEMIOL COMMUN H, V67, P95, DOI 10.1136/jech-2012-201652; Lovell B, 2011, NEUROSCI BIOBEHAV R, V35, P1342, DOI 10.1016/j.neubiorev.2011.02.007; Mills PJ, 2009, BRAIN BEHAV IMMUN, V23, P605, DOI 10.1016/j.bbi.2008.09.014; Moody A, 2004, THORAX, V59, P1; Neugaard B, 2008, J HAPPINESS STUD, V9, P559, DOI 10.1007/s10902-008-9089-2; Pinquart M, 2006, J GERONTOL B-PSYCHOL, V61, pP33, DOI 10.1093/geronb/61.1.P33; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Potier F, 2018, AGING CLIN EXP RES, V30, P119, DOI 10.1007/s40520-017-0765-0; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Sherwood PR, 2016, J NEURO-ONCOL, V128, P109, DOI 10.1007/s11060-016-2083-3; Sinha M., 2012, PORTRAIT CAREGIVERS; Smith L, 2014, BRIT J PSYCHIAT, V205, P197, DOI 10.1192/bjp.bp.112.125369; Stacey AF, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020173; Taylor A, 2010, AUST NZ J PUBL HEAL, V34, P394, DOI 10.1111/j.1753-6405.2010.00572.x; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; Torimoto-Sasai Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1519-6; Torres A, 2015, PSYCHIAT RES, V226, P333, DOI 10.1016/j.psychres.2014.12.066; Trivedi R, 2014, CHRONIC ILLN, V10, P167, DOI 10.1177/1742395313506947; van Ryn M, 2011, PSYCHO-ONCOLOGY, V20, P44, DOI 10.1002/pon.1703; Verbakel E, 2017, EUR J PUBLIC HEALTH, V27, P90, DOI 10.1093/eurpub/ckw229; Vitaliano PP, 2004, CURR DIR PSYCHOL SCI, V13, P13, DOI 10.1111/j.0963-7214.2004.01301004.x; Vitaliano PP, 2002, PSYCHOSOM MED, V64, P418, DOI 10.1097/00006842-200205000-00006; Vitaliano PP, 1997, ANN BEHAV MED, V19, P117, DOI 10.1007/BF02883328; von Kanel R, 2012, GERONTOLOGY, V58, P354, DOI 10.1159/000334219; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	61	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0208434	10.1371/journal.pone.0208434	http://dx.doi.org/10.1371/journal.pone.0208434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921333	gold, Green Published			2022-12-27	WOS:000462594000004
J	Tramonte, AR; Christofferson, RC				Tramonte, A. Ryan; Christofferson, Rebecca C.			Investigating the probability of establishment of Zika virus and detection through mosquito surveillance under different temperature conditions	PLOS ONE			English	Article							EXTRINSIC INCUBATION-TEMPERATURE; AEDES-AEGYPTI COMPETENCE; WEST-NILE-VIRUS; CHIKUNGUNYA VIRUS; VECTOR COMPETENCE; DENGUE INFECTION; UNITED-STATES; TRANSMISSION; TRAVELERS; OUTBREAK	Because of the increasing threat that Zika virus (ZIKV) poses to more sub-tropical area due to increased global travel, there is a need for better understanding of the effect(s) of temperature on the establishment potential of ZIKV within these subtropical, temperate, and/or seasonal Ae. aegypti populations. The first step to determining risk establishment of ZIKV in these regions is to assess ZIKV's ability to infect mosquitoes at less tropical temperatures, and thus be detected through common surveillance programs. To that end, the effect of two rearing temperatures (RT) and extrinsic incubation temperatures (EIT) on infection and dissemination rates was evaluated, as well as the interactions of such. Total, there were four combinations (RT24-EIT24, RT24-EIT28, RT28-EIT24, RT28-EIT28). Further, a stochastic SEIR framework was adapted to determine whether observed data could lead to differential success of establishment of ZIKV in naive mosquito populations. There was no consistent pattern in significant differences found across treatments for either infection or dissemination rates (p>0.05), where only a significant difference was found in infection rates between RT24-EIT24 (44%) and RT28-EIT24 (82.6%). Across all temperature conditions, the model predicted between a 76.4% and 95.4% chance of successful establishment of ZIKV in naive mosquito populations under model assumptions. We further show that excluding the maximum observed infection and dissemination rates likely overestimates the probability of local establishment of ZIKV. These results indicate that 1) there is no straightforward relationship between RT, EIT, and infection/dissemination rates, 2) in more temperate climates, ZIKV may still have the ability to establish in populations of Aedes aegypti, 3) despite an overall lack of significant differences in infection/dissemination rates, temperature may still alter the kinetics of ZIKV within the mosquito enough to affect the likelihood of infection establishment and detection within the context of mosquito surveillance programs, and 4) both the temporal and magnitude qualities of vector competence are necessary for parameterization of within-mosquito virus kinetics.	[Tramonte, A. Ryan; Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Christofferson, Rebecca C.] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.; Christofferson, RC (corresponding author), Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA.	rcarri1@lsu.edu			NIH/NIGMS [R01GM122077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122077] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NIGMS grant R01GM122077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2018, J MED ENTOMOL, V55, P217, DOI 10.1093/jme/tjx182; Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; Andreadis TG, 2001, EMERG INFECT DIS, V7, P670; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Buckner EA, 2016, J MED ENTOMOL, V53, P91, DOI 10.1093/jme/tjv145; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190; Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488; Chisenhall DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-252; Christofferson RC, 2016, J INFECT DIS, V214, pS466, DOI 10.1093/infdis/jiw283; Christofferson RC, 2016, ENVIRON HEALTH INSIG, V10, P119, DOI [10.4137/EHI.S38345, 10.4137/ehi.s38345]; Christofferson RC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-282; Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298; Costa-da-Silva Andre Luis, 2017, PLoS One, V12, pe0171951, DOI 10.1371/journal.pone.0171951; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437; Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049; Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; Lindholm DA, 2017, AM J TROP MED HYG, V96, P903, DOI 10.4269/ajtmh.16-0635; Lindsey NP, 2015, AM J TROP MED HYG, V92, P82, DOI 10.4269/ajtmh.14-0442; Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Martin E, 2019, ACTA TROP, V192, P129, DOI 10.1016/j.actatropica.2019.02.006; Mbaika S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0566-7; Moore CG, 1993, DIS DOV B DIS NCFL P; Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568; Muturi EJ, 2012, J VECTOR ECOL, V37, P154, DOI 10.1111/j.1948-7134.2012.00212.x; Muturi EJ, 2011, VECTOR-BORNE ZOONOT, V11, P1157, DOI 10.1089/vbz.2010.0209; Pires AM, 2008, REVSTAT-STAT J, V6, P165; Prevention CfDCa, 2017, PREV DFDCA ADV PEOPL; Prevention CfDCa, 2017, PREV CFDCA ZIK VIR P; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009; Rohani A, 2009, SE ASIAN J TROP MED, V40, P942; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; SMITH GC, 1993, J MED ENTOMOL, V30, P257, DOI 10.1093/jmedent/30.1.257; Teets Frank D, 2014, Virol Rep, V1-2, P2; Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795; Toro C, 2017, AM J TROP MED HYG, V96, P701, DOI 10.4269/ajtmh.16-0335; Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017; Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101; White DJ, 2001, EMERG INFECT DIS, V7, P643	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214306	10.1371/journal.pone.0214306	http://dx.doi.org/10.1371/journal.pone.0214306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921386	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000052
J	Zhang, YY; Xie, KM; Ruan, O				Zhang, Yuanyuan; Xie, Kunming; Ruan, Ou			An improved and efficient mutual authentication scheme for session initiation protocol	PLOS ONE			English	Article							KEY AGREEMENT SCHEME; USER AUTHENTICATION	Qiu et al. made a security analysis about the protocols of Chaudhry et al. and Kumari et al. in 2018, and they pointed out that there are many security weaknesses in the protocols. To improve the security, Qiu et al. proposed an advanced authentication scheme for Session Initiation Protocol on the basis of the previous protocols and claimed that their own protocol was very secure and practical. However, we demonstrate that the protocol of Qiu et al. has a serious mistake which causes their protocol cannot be executed normally. Beyond that, we also find out that their protocol cannot withstand insider attack and denial service attack. In order to remove these weaknesses, we propose an efficient provably secure mutual authentication scheme. Furthermore, our scheme provides security analysis with the help of Burrows-Abadi-Needham (BAN) logic. Compared with their protocol, ours has greater security and better performance.	[Zhang, Yuanyuan; Xie, Kunming; Ruan, Ou] Hubei Univ Technol, Sch Comp Sci, Wuhan, Hubei, Peoples R China	Hubei University of Technology	Ruan, O (corresponding author), Hubei Univ Technol, Sch Comp Sci, Wuhan, Hubei, Peoples R China.	ruanou@163.com	zhang, yuanyuan/GYA-4428-2022		National Natural Science Foundation of China [61701173, 61672010, 61702168, 61502156]; Natural Science Foundation of Hubei Province of China [2017CFB596]; Hubei Key Laboratory of Transportation Internet of Things [WHUTIOT-2017B001]; Guangxi Key Laboratory of Cryptography and Information Security [GCIS201717]; Ph.D. research startup foundation of Hubei University of Technology [BSQD2015028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Hubei Key Laboratory of Transportation Internet of Things; Guangxi Key Laboratory of Cryptography and Information Security; Ph.D. research startup foundation of Hubei University of Technology	This work is supported by the National Natural Science Foundation of China (No. 61701173, No. 61672010, No. 61702168, No. 61502156), the Natural Science Foundation of Hubei Province of China (No. 2017CFB596), the fund of Hubei Key Laboratory of Transportation Internet of Things (WHUTIOT-2017B001), Guangxi Key Laboratory of Cryptography and Information Security (GCIS201717), the Ph.D. research startup foundation of Hubei University of Technology (BSQD2015028).	Akhunzada A, 2015, J NETW COMPUT APPL, V48, P44, DOI 10.1016/j.jnca.2014.10.009; BURROWS M, 1990, ACM T COMPUT SYST, V8, P18, DOI [10.1145/77648.77649, 10.1145/74851.74852]; Chaudhry SA, 2016, SECUR COMMUN NETW, V9, P5016, DOI 10.1002/sec.1672; Chaudhry SA, 2017, PEER PEER NETW APPL, V10, P1, DOI 10.1007/s12083-015-0400-9; Farash MS, 2016, PEER PEER NETW APPL, V9, P82, DOI 10.1007/s12083-014-0315-x; Franks J, 1999, IETF RFC, V2617, P1; Guo C., 2018, IJ NETWORK SECURITY, V20, P323; Horng SJ, 2015, INFORM SCIENCES, V317, P48, DOI 10.1016/j.ins.2015.04.033; Khan MK, 2010, SENSORS-BASEL, V10, P2450, DOI 10.3390/s100302450; Kumari S, 2018, J AMB INTEL HUM COMP, V9, P643, DOI 10.1007/s12652-017-0460-1; Kumari S, 2017, PEER PEER NETW APPL, V10, P92, DOI 10.1007/s12083-015-0409-0; Kumari S, 2017, FUTURE GENER COMP SY, V68, P320, DOI 10.1016/j.future.2016.10.004; Kumari S, 2016, FUTURE GENER COMP SY, V63, P56, DOI 10.1016/j.future.2016.04.016; Kumari S, 2014, COMPUT ELECTR ENG, V40, P1997, DOI 10.1016/j.compeleceng.2014.05.007; Lu R, 2006, INT J NETWORK SECURI, V3, P35; Lu YR, 2016, PEER PEER NETW APPL, V9, P449, DOI 10.1007/s12083-015-0363-x; Ouanan, 2017, INT J NETWORK SECURI, V19, P870; Qiu SM, 2018, IEEE ACCESS, V6, P7452, DOI 10.1109/ACCESS.2017.2780124; Qiu SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194072; Tsai JL, 2009, IJ NETWORK SECURITY, V9, P12; Wu LB, 2017, KSII T INTERNET INF, V11, P4025, DOI 10.3837/tiis.2017.08.015; Xie Q, 2012, INT J COMMUN SYST, V25, P47, DOI 10.1002/dac.1286; Yang CC, 2005, COMPUT SECUR, V24, P381, DOI 10.1016/j.cose.2004.10.007; Zhang MW, 2019, IEEE SYST J, V13, P1478, DOI 10.1109/JSYST.2019.2900723; Zhang ZZ, 2015, MULTIMED TOOLS APPL, V74, P3477, DOI 10.1007/s11042-014-1885-6	25	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213688	10.1371/journal.pone.0213688	http://dx.doi.org/10.1371/journal.pone.0213688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921341	gold, Green Submitted, Green Published			2022-12-27	WOS:000462594000022
J	Krishnamurithy, G; Mohan, S; Yahya, NA; Mansor, A; Murali, MR; Raghavendran, HRB; Choudhary, R; Sasikumar, S; Kamarul, T				Krishnamurithy, Genasan; Mohan, Saktiswaren; Yahya, Noor Azlin; Mansor, Azura; Murali, Malliga Raman; Raghavendran, Hanumantha Rao Balaji; Choudhary, Rajan; Sasikumar, Swamiappan; Kamarul, Tunku			The physicochemical and biomechanical profile of forsterite and its osteogenic potential of mesenchymal stromal cells	PLOS ONE			English	Article							STEM-CELLS; BONE TISSUE; IN-VITRO; PROMOTES PROLIFERATION; DIFFERENTIATION; BIOCOMPATIBILITY; SURFACE; SCAFFOLDS; CALCIUM; SILICATES	It has been demonstrated that nanocrystalline forsterite powder synthesised using urea as a fuel in sol-gel combustion method had produced a pure forsterite (FU) and possessed superior bioactive characteristics such as bone apatite formation and antibacterial properties. In the present study, 3D-scaffold was fabricated using nanocrystalline forsterite powder in polymer sponge method. The FU scaffold was used in investigating the physicochemical, biomechanics, cell attachment, in vitro biocompatibility and osteogenic differentiation properties. For physicochemical characterisation, Fourier-transform infrared spectroscopy (FTIR), Energy dispersive X-ray (EDX), X-ray diffraction (XRD), Raman spectroscopy, Xray photoemission spectrometer (XPS) and Brunauer-Emmett-Teller (BET) were used. FTIR, EDX, XRD peaks and Raman spectroscopy demonstrated correlating to FU. The XPS confirmed the surface chemistry associating to FU. The BET revealed FU scaffold surface area of 12.67 m(2)/g and total pore size of 0.03 cm(3)/g. Compressive strength of the FU scaffold was found to be 27.18 +/- 13.4 MPa. The human bone marrow derived mesenchymal stromal cells (hBMSCs) characterisation prior to perform seeding on FU scaffold verified the stromal cell phenotypic and lineage commitments. SEM, confocal images and presto blue viability assay suggested good cell attachment and proliferation of hBMSCs on FU scaffold and comparable to a commercial bone substitutes (cBS). Osteogenic proteins and gene expression from day 7 onward indicated FU scaffold had a significant osteogenic potential (p < 0.05), when compared with day 1 as well as between FU and cBS. These findings suggest that FU scaffold has a greater potential for use in orthopaedic and/or orthodontic applications.	[Krishnamurithy, Genasan; Mohan, Saktiswaren; Mansor, Azura; Murali, Malliga Raman; Raghavendran, Hanumantha Rao Balaji; Kamarul, Tunku] Univ Malaya, Dept Orthopaed Surg NOCERAL, Fac Med, TEG, Kuala Lumpur, Malaysia; [Krishnamurithy, Genasan] Inst Translat Med, Dept Mol & Clin Canc Med, Musculoskeletal Res Grp, Liverpool, Merseyside, England; [Yahya, Noor Azlin] Univ Malaya, Fac Dent, Kuala Lumpur, Malaysia; [Choudhary, Rajan; Sasikumar, Swamiappan] Vellore Inst Technol, Sch Adv Sci, Dept Chem, Vellore, Tamil Nadu, India	Universiti Malaya; University of Liverpool; Universiti Malaya; Vellore Institute of Technology	Krishnamurithy, G; Kamarul, T (corresponding author), Univ Malaya, Dept Orthopaed Surg NOCERAL, Fac Med, TEG, Kuala Lumpur, Malaysia.; Krishnamurithy, G (corresponding author), Inst Translat Med, Dept Mol & Clin Canc Med, Musculoskeletal Res Grp, Liverpool, Merseyside, England.	veda_g82@hotmail.com; tkzrea@ummc.edu.my	Mansor, Azura/E-1250-2012; Swamiappan, Sasikumar/M-9921-2016; Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011; Choudhary, Rajan/R-7998-2018; Genasan, Krishnamurithy/AAK-1277-2020; raghavendran, hanumantha rao balaji/B-8507-2012; YAHYA, NOOR AZLIN/B-9263-2010; genasan, krishnamurithy/M-4049-2018	Swamiappan, Sasikumar/0000-0003-2533-4923; Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313; Choudhary, Rajan/0000-0001-6370-8071; YAHYA, NOOR AZLIN/0000-0002-5722-1280; 	University of Malaya Research Grant (UM RG) [RPOO5B-13HTM]; University of Malaya Postgraduate Research Grant [PPP-PG208-20146]; Fundamental Research Grant Scheme (FRGS) [FRGS-FP016]; Ministry of Higher Education [RPOO5B-13HTM, PG208-2014B]; Institute of post graduate dual PhD funding; Bright sparks scheme, University of Malaya	University of Malaya Research Grant (UM RG); University of Malaya Postgraduate Research Grant; Fundamental Research Grant Scheme (FRGS); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Institute of post graduate dual PhD funding; Bright sparks scheme, University of Malaya	This work was supported by: TK, RPOO5B-13HTM, University of Malaya Research Grant (UM RG) (https://www.um.edu.my); by TK, PPP-PG208-20146, University of Malaya Postgraduate Research Grant (https://www.um.edu.ma); and by AM, FRGS-FP016, Fundamental Research Grant Scheme (FRGS) (https://mastic.mosti.gov.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express their highest gratitude to Ministry of Higher Education for fundamental research grant scheme (FRGS) FP016-2016, University of Malaya research grant-RPOO5B-13HTM and Postgraduate Research Fund-PG208-2014B. A special thanks to Institute of post graduate dual PhD funding and Bright sparks scheme, University of Malaya for supporting the student research at University of Liverpool.	Baino F, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00202; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Choudhary R, 2017, MAT SCI ENG C-MATER, V77, P811, DOI 10.1016/j.msec.2017.03.308; Choudhary R, 2015, J ASIAN CERAM SOC, V3, P173, DOI 10.1016/j.jascer.2015.01.002; Coathup MJ, 2011, J BONE JOINT SURG AM, V93A, P2219, DOI [10.2106/JBJS.I.01623, 10.2106/JBJS.J.01623]; Cundy T., 2014, CLIN BIOCH METABOLIC, P604, DOI 10.1016/B978-0-7020-5140-1.00031-6; Diba M, 2012, COMPOS SCI TECHNOL, V72, P716, DOI 10.1016/j.compscitech.2012.01.023; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Garrido Carlos Antônio, 2010, Rev. bras. ortop., V45, P433, DOI [10.1590/S0102-36162010000400016, 10.1016/S2255-4971(15)30393-1]; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Ghomi H, 2011, J ALLOY COMPD, V509, pL63, DOI 10.1016/j.jallcom.2010.10.106; Guan M, 2012, NAT MED, V18, P456, DOI 10.1038/nm.2665; He LY, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165257; Hosseini SN, 2015, MATER LETT, V143, P16, DOI 10.1016/j.matlet.2014.12.079; Jayaswal Gaurav P, 2010, J Indian Prosthodont Soc, V10, P8, DOI 10.1007/s13191-010-0002-4; Kalinkin AM, 2003, GLASS PHYS CHEM+, V29, P410, DOI 10.1023/A:1025185229274; Karsenty G, 2000, MATRIX BIOL, V19, P85, DOI 10.1016/S0945-053X(00)00053-6; Kharaziha M, 2010, J MECH BEHAV BIOMED, V3, P530, DOI 10.1016/j.jmbbm.2010.06.003; Kihara T, 2006, BIOCHEM BIOPH RES CO, V341, P1029, DOI 10.1016/j.bbrc.2006.01.059; Kim JA, 2018, BIOMATERIALS, V157, P51, DOI 10.1016/j.biomaterials.2017.11.032; Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021; Krishnamurithy G, 2016, CERAM INT, V42, P18247, DOI 10.1016/j.ceramint.2016.08.148; Krishnamurithy G, 2015, REGEN MED, V10, P579, DOI 10.2217/rme.15.27; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Li RW, 2014, J BIOMED MATER RES A, V102, P4346, DOI 10.1002/jbm.a.35111; Lin KL, 2016, RSC ADV, V6, P13867, DOI 10.1039/c5ra26916d; Liu C, 2014, J ORTHOP TRANSL, V2, P139, DOI 10.1016/j.jot.2014.06.002; Lund A W, 2009, Open Stem Cell J, V1, P40; Martinez LM, 2017, MESENCHYMAL STROMAL CELLS AS TUMOR STROMAL MODULATORS, P369, DOI 10.1016/B978-0-12-803102-5.00015-X; Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787; Mohan S, 2017, ACS APPL MATER INTER, V9, P9291, DOI 10.1021/acsami.6b13422; Naddeo P, 2015, DENT MATER, V31, P235, DOI 10.1016/j.dental.2014.12.015; Naghieh S, 2017, MATER DESIGN, V133, P128, DOI 10.1016/j.matdes.2017.07.051; Nair MB, 2009, J BIOMED MATER RES A, V90A, P533, DOI 10.1002/jbm.a.32114; Nakamura A, 2009, TISSUE ENG PART C-ME, V15, P169, DOI 10.1089/ten.tec.2007.0334; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Raghavendran HRB, 2016, COLLOID SURFACE B, V139, P68, DOI 10.1016/j.colsurfb.2015.11.053; Raghavendran HRB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104389; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sase SP, 2012, OSTEOPONTIN NOVEL PR; Shie MY, 2017, MAT SCI ENG C-MATER, V73, P726, DOI 10.1016/j.msec.2016.12.071; Song SJ, 2007, J MICROBIOL BIOTECHN, V17, P1113; Stangarone C, 2017, J RAMAN SPECTROSC, V48, P1528, DOI 10.1002/jrs.5127; Tanabe N, 2010, OSTEOPONTIN ENHANCES; Tanabe N, 2011, J BIOL CHEM, V286, P39871, DOI 10.1074/jbc.M111.295048; Terajima M, 2014, J BIOL CHEM, V289, P22636, DOI 10.1074/jbc.M113.528513; Waked W, 2008, ORTHOPEDICS, V31, P591, DOI 10.3928/01477447-20080601-34; Wang GC., 2014, BONE SUBSTITUTE BIOM, V1st, P180, DOI [10.1533/9780857099037.2.180, DOI 10.1533/9780857099037.2.180]; Wang Liang, 2015, Chinese Medical Sciences Journal, V30, P108; Warnke PH, 2013, J CRANIO MAXILL SURG, V41, P153, DOI 10.1016/j.jcms.2012.07.003; Zanetti AS, 2015, J TISSUE ENG REGEN M, V9, P389, DOI 10.1002/term.1646; Zhao D-F, 2015, WORLD J TRADITIONAL, V1, P50	53	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214212	10.1371/journal.pone.0214212	http://dx.doi.org/10.1371/journal.pone.0214212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917166	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000462465800055
J	Infantino, V; Tutucci, E; Martin, NY; Zihlmann, A; Garcia-Molinero, V; Silvano, G; Palancade, B; Stutz, F				Infantino, Valentina; Tutucci, Evelina; Martin, Noel Yeh; Zihlmann, Audrey; Garcia-Molinero, Varinia; Silvano, Geraldine; Palancade, Benoit; Stutz, Francoise			The mRNA export adaptor Yra1 contributes to DNA double-strand break repair through its C-box domain	PLOS ONE			English	Article							HNRNP-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; SUMO WRESTLES; NUCLEAR-PORES; UBIQUITIN; RESECTION; COMPLEX; BINDING; GENE; EXO1	Yra1 is an mRNA export adaptor involved in mRNA biogenesis and export in S. cerevisiae. Yra1 overexpression was recently shown to promote accumulation of DNA: RNA hybrids favoring DNA double strand breaks (DSB), cell senescence and telomere shortening, via an unknown mechanism. Yra1 was also identified at an HO-induced DSB and Yra1 depletion causes defects in DSB repair. Previous work from our laboratory showed that Yra1 ubiquitination by Tom1 is important for mRNA export. Here, we found that Yra1 is also ubiquitinated by the SUMO-targeted ubiquitin ligases Slx5-Slx8 implicated in the interaction of irreparable DSB with nuclear pores. We further show that Yra1 binds an HO-induced irreparable DSB in a process dependent on resection. Importantly, a Yra1 mutant lacking the evolutionarily conserved C-box is not recruited to an HO-induced irreparable DSB and becomes lethal under DSB induction in a HO-cut reparable system. Together, the data provide evidence that Yra1 plays a crucial role in DSB repair via homologous recombination. While Yra1 sumoylation and/or ubiquitination are dispensable, the Yra1 C-box region is essential in this process.	[Infantino, Valentina; Zihlmann, Audrey; Garcia-Molinero, Varinia; Silvano, Geraldine; Stutz, Francoise] Univ Geneva, Dept Cell Biol, 30 Quai E Ansermet, Geneva, Switzerland; [Tutucci, Evelina] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Martin, Noel Yeh] Univ Trento, Ctr Integrat Biol CIBIO, Povo, Trento, Italy; [Palancade, Benoit] Univ Paris Diderot, Inst Jacques Monod, Sorbonne Paris Cite, CNRS,UMR 7592, Paris, France	University of Geneva; Yeshiva University; Albert Einstein College of Medicine; University of Trento; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Infantino, V; Stutz, F (corresponding author), Univ Geneva, Dept Cell Biol, 30 Quai E Ansermet, Geneva, Switzerland.	Valentina.Infantino@unige.ch; Francoise.Stutz@unige.ch	Stutz, Françoise C/N-4329-2017	PALANCADE, Benoit/0000-0002-3894-9735; Tutucci, Evelina/0000-0002-1998-7146	NCCR 'Frontiers in Genetics'; Swiss National Science Foundation [31003A 153331]; Polish Swiss Research Programme PSRP NoCore [183/2010]; Canton of Geneva; iGE3	NCCR 'Frontiers in Genetics'(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Polish Swiss Research Programme PSRP NoCore; Canton of Geneva; iGE3	This work was funded by NCCR 'Frontiers in Genetics' (fellowship to VI), the Swiss National Science Foundation (grant no 31003A 153331 to FS), Polish Swiss Research Programme PSRP NoCore (183/2010 to FS), iGE3 and the Canton of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Altmannova V, 2012, BIOMOLECULES, V2, P350, DOI 10.3390/biom2030350; Barlow JH, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-7; Bonnet A, 2015, NUCLEIC ACIDS RES, V43, P4249, DOI 10.1093/nar/gkv280; Bretes H, 2014, NUCLEIC ACIDS RES, V42, P5043, DOI 10.1093/nar/gku124; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Bystricky K, 2009, MOL CELL BIOL, V29, P835, DOI 10.1128/MCB.01009-08; Colombo CV, 2017, NUCLEIC ACIDS RES, V45, P6530, DOI 10.1093/nar/gkx347; ESPINET C, 1995, YEAST, V11, P25, DOI 10.1002/yea.320110104; Fong CM, 2013, GENETICS, V193, P483, DOI 10.1534/genetics.112.146373; Garcia-Rubio M, 2018, GENE DEV, V32, P965, DOI 10.1101/gad.311274.117; Gavalda S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005966; Horigome C, 2016, CELL CYCLE, V15, P3011, DOI 10.1080/15384101.2016.1216904; Horigome C, 2016, GENE DEV, V30, P931, DOI 10.1101/gad.277665.116; Horigome C, 2014, MOL CELL, V55, P626, DOI 10.1016/j.molcel.2014.06.027; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Iglesias N, 2010, GENE DEV, V24, P1927, DOI 10.1101/gad.583310; Jalal D, 2017, NUCLEIC ACIDS RES, V45, P2242, DOI 10.1093/nar/gkw1369; Lemaitre C, 2015, J MOL BIOL, V427, P652, DOI 10.1016/j.jmb.2014.11.014; Manfrini N, 2015, ELIFE, V4, DOI 10.7554/eLife.08942; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nixon CE, 2010, GENETICS, V185, P497, DOI 10.1534/genetics.110.115907; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Portman DS, 1997, RNA, V3, P527; Preker PJ, 2006, RNA, V12, P994, DOI 10.1261/rna.6706; Preker PJ, 2002, RNA, V8, P969, DOI 10.1017/S1355838202020046; Rodriguez-Navarro S, 2002, EMBO REP, V3, P438, DOI 10.1093/embo-reports/kvf091; Sarangi P, 2015, TRENDS BIOCHEM SCI, V40, P233, DOI 10.1016/j.tibs.2015.02.006; Schweiggert J, 2016, DEV CELL, V36, P415, DOI 10.1016/j.devcel.2016.01.011; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Su XFA, 2015, GENE DEV, V29, P1006, DOI 10.1101/gad.256404.114; Swaminathan S, 2007, MOL CELL BIOL, V27, P4674, DOI 10.1128/MCB.02052-06; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tutucci E, 2018, NAT METHODS, V15, P81, DOI 10.1038/nmeth.4502; Tutucci E, 2011, NAT REV MOL CELL BIO, V12, P376, DOI 10.1038/nrm3119; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Wang PP, 2017, NUCLEIC ACIDS RES, V45, P10923, DOI 10.1093/nar/gkx844; Westerbeck JW, 2014, MOL BIOL CELL, V25, P1, DOI 10.1091/mbc.E13-05-0291; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Xie Y, 2010, GENE DEV, V24, P893, DOI 10.1101/gad.1906510; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhao X, 2017, ACTA BIOCH BIOPH SIN, V49, P655, DOI 10.1093/abbs/gmx055; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	50	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2019	14	4							e0206336	10.1371/journal.pone.0206336	http://dx.doi.org/10.1371/journal.pone.0206336			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR9NM	30951522	Green Published, Green Submitted, gold			2022-12-27	WOS:000463487500001
J	Abebaw, Y; Berhe, S; Abebe, SM; Adefris, M; Gebeyehu, A; Gure, T; Asmare, B; Dagnu, M; Alebachew, W; Admasu, S; Abdisa, S; G Egziabher, MA				Abebaw, Yeshiwas; Berhe, Solomon; Abebe, Solomon Mekonnen; Adefris, Mulat; Gebeyehu, Abebaw; Gure, Tadesse; Asmare, Birtukan; Dagnu, Masresha; Alebachew, Wubetu; Admasu, Shumye; Abdisa, Solomon; G Egziabher, Melkamu Axumawit			Providers' knowledge on postpartum intrauterine contraceptive device (PPIUCD) service provision in Amhara region public health facility, Ethiopia	PLOS ONE			English	Article							EXPERIENCES	Introduction Postpartum intrauterine contraceptive devices (PP-IUCD) are one type of post-partum family planning method, which can be provided to a post-partum woman starting from the placental delivery time (within 10 minutes), or within the first 48 hours of postpartum period. In most developing countries, delivery time is the primary opportunity for women to access post-partum family planning methods, especially for those living in remote areas. Hence, this study assesses providers' knowledge on postpartum intrauterine contraceptive device service provision. Methods A facility-based cross-sectional study was conducted in Amhara region health center and hospitals. Health providers surveyed included obstetricians, gynecologists, general practitioners, emergency surgical officers, health officers, midwives and nurses from September 18, 2015 to December18, 2016. Simple random sampling was used to select 864 subjects. Data were collected by using a structured self-administered questionnaire and observing the facility. Multilevel analysis was done to see factors associated with outcome. Results A total of 197 health facilities and 864 providers are included in the final analysis. Of the total providers 524 (60.6%) were from a health center. The mean age (+/- SD) of participants was 27.8 years (+/- 5.4). The number of providers with good knowledge accounted for 253 of those surveyed (29.3%). The proportion of good knowledge among trained PP-IUCD providers was 35.7% (those who scored above average), and 27.9% was untrained about PP-IUCD. A considerable heterogeneity was observed between health facilities for each indicator of provider's knowledge. Gender differences were observed as the mean knowledge score deference on PP-IUCD by 0.4 points (beta= -0.41; -0.72, -0.10) when the participant was female. Having experience of regular counseling of pregnant women increases PP-IUCD knowledge score by 0.97. (beta= 0.97; 95% CI: 0.48, 1.47). Where the health facility requested clients to purchase the IUCD themselves, the mean knowledge score decreased by 0.47 points compared with free of charge at the facility level (beta = -0.47; 95%CI: -0.87, -0.07). Conclusion Our findings showed that providers' knowledge about postpartum IUCD was low in the Amhara region public health facility. The lowest knowledge score was noted among nurses, health Officers, midwives, and general practice professionals. Factors associated with providers' knowledge on PP-IUCD are the status of health facility, female sex, training on PP-IUCD, regular counseling of pregnant women, and unavailability of IUCD service.	[Abebaw, Yeshiwas; Berhe, Solomon; Adefris, Mulat; Gure, Tadesse; Asmare, Birtukan; Dagnu, Masresha; Alebachew, Wubetu; Abdisa, Solomon; G Egziabher, Melkamu Axumawit] Univ Gondar, Coll Med & Hlth Sci, Dept Obstet & Gynecol, Gondar, Ethiopia; [Abebe, Solomon Mekonnen] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Human Nutr, Gondar, Ethiopia; [Gebeyehu, Abebaw] Amhara Reg Hlth Biuro, Bahir Dar, Ethiopia; [Admasu, Shumye] Debretabor Univ, Coll Med & Hlth Sci, Dept Obstet & Gynecologyn, Debretabor, Ethiopia	University of Gondar; University of Gondar	Abebe, SM (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Human Nutr, Gondar, Ethiopia.	solomekonnen@yahoo.com		Worku, Abebaw Gebeyehu/0000-0002-1146-3399; GURE, TADESSE/0000-0003-1213-1385	Center for International Reproductive Health Training	Center for International Reproductive Health Training	This research was funded by Center for International Reproductive Health Training (CIRHT). Web site: http://cirht.med.umich.edu/.The funder had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Agha S., 2012, CLIN TRAINING ALONE; [Anonymous], 2013, TANZANIA EXPERIENCE; [Anonymous], 2015, INT J GYNECOLOGY OBS, V130, pS54; [Anonymous], 2002, FUT PUBL HLTH 21 CEN; Aruna D. V., 2015, IOSR J DENT MED SCI, V14, P56; Ayiasi RM, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.138.7026; Canning D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1160-0; Chakraborty NM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0701-y; Cleland J, 2015, STUD FAMILY PLANN, V46, P423, DOI 10.1111/j.1728-4465.2015.00041.x; Espey D., 2003, IUD RELATED KNOWLEDG, P35; ETHIOPIAN Emergency Obstetric and Newborn Care (EmONC), 2017, EHIOPIAN EM OBST NEW; Ethiopian Public Health Institute Addis Ababa E Federal Ministry of Health Addis Ababa Ethiopia ICF International Rockville Maryland USA, 2014, ETH SERV PROV ASS PL; Idowu A, 2015, Afr J Med Med Sci, V44, P43; Lisanework M. S., POSTPARTUM INTRAUTE; Marlow HM, 2014, HEALTH CARE WOMEN IN, V35, P175, DOI 10.1080/07399332.2013.815753; Mulat A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/256534; Navodani KT, 2017, CEYLON MED J, V62, P87, DOI 10.4038/cmj.v62i2.8472; NUSEIR K, 2016, PAIN RES MANAG, DOI DOI 10.1155/2016/8432973; Pasha O, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S11; Pfitzer A, 2015, INT J GYNECOL OBSTET, V130, pS54, DOI 10.1016/j.ijgo.2015.03.008; Pleah T, 2016, GLOB HEALTH-SCI PRAC, V4, pS140, DOI 10.9745/GHSP-D-16-00039; Program Learning for Postpartum Intrauterine Contraceptive Device (PPIUCD) Integration with Maternal Health Services, 2010, PROGR EXP MULT COUNT; Rupley DM, 2015, INT J GYNECOL OBSTET, V128, P137, DOI 10.1016/j.ijgo.2014.09.010; SAYEGH J, 1976, JOHNS HOPKINS MED J, V139, P31; Sujnanendra M, 2014, J OBSTET GYN INDIA, V64, P337, DOI 10.1007/s13224-014-0550-3; Zerden ML, 2013, CONTRACEPTION, V88, P624, DOI 10.1016/j.contraception.2013.05.008	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214334	10.1371/journal.pone.0214334	http://dx.doi.org/10.1371/journal.pone.0214334			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946759	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500028
J	Lenzi, H; Ben, AJ; Stein, AT				Lenzi, Henry; Ben, Angela Jornada; Stein, Airton Tetelbom			Development and validation of a patient no-show predictive model at a primary care setting in Southern Brazil	PLOS ONE			English	Article							GENERAL-PRACTICE; NON-ATTENDANCE; APPOINTMENT; ACCESS	Patient no-show is a prevalent problem in health care services leading to inefficient resources allocation and limited access to care. This study aims to develop and validate a patient no-show predictive model based on empirical data. A retrospective study was performed using scheduled appointments between 2011 and 2014 from a Brazilian public primary care setting. Fifty percent of the dataset was randomly assigned to model development, and 50% was assigned to validation. Predictive models were developed using stepwise naive and mixed-effect logistic regression along with the Akaike Information Criteria to select the best model. The area under the ROC curve (AUC) was used to assess the best model performance. Of the 57,586 scheduled appointments in the period, 70.7% (n = 40,740) were evaluated including 5,637 patients. The prevalence of no-show was 13.0% (n = 5,282). The best model presented an AUC of 80.9% (95% CI 80.1-81.7). The most important predictors were previous attendance and same-day appointments. The best model developed from data already available in the scheduling system, had a good performance to predict patient no-show. It is expected the model to be helpful to overbooking decision in the scheduling system. Further investigation is needed to explore the effectiveness of using this model in terms of improving service performance and its impact on quality of care compared to the usual practice.	[Lenzi, Henry; Stein, Airton Tetelbom] Grp Hosp Conceicao, Serv Saude Comunitaria, Porto Alegre, RS, Brazil; [Ben, Angela Jornada] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Stein, Airton Tetelbom] Univ Fed Ciencias Saude Porto Alegre, Dept Saude Colet, Porto Alegre, RS, Brazil	Vrije Universiteit Amsterdam; Universidade Federal de Ciencias da Saude de Porto Alegre	Ben, AJ (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.	a.jornadaben@vu.nl	Ben, Ângela Jornada/AAJ-2729-2020; Stein, Airton T/AAD-8391-2020; Stein, Airton/Q-2218-2015	Ben, Ângela Jornada/0000-0003-4793-9026; Stein, Airton T/0000-0002-8756-8699; Stein, Airton/0000-0002-8756-8699				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Ansell D, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2219-y; Bean A G, 1992, J Health Care Mark, V12, P14; Bender A.S., 2011, ESPAC SAUDE, V11, P56, DOI [10.22421/15177130-2010v11n2p56, DOI 10.22421/15177130-2010V11N2P56]; Berg BP, 2013, MED DECIS MAKING, V33, P976, DOI 10.1177/0272989X13478194; Bolker B., LME4 PACKAGE LINEAR; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Daggy J, 2010, HEALTH INFORM J, V16, P246, DOI 10.1177/1460458210380521; Dantas LF, 2018, HEALTH POLICY, V122, P412, DOI 10.1016/j.healthpol.2018.02.002; Ellis DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051365; George A, 2003, FAM PRACT, V20, P178, DOI 10.1093/fampra/20.2.178; Goffman RM, 2017, MIL MED, V182, pE1708, DOI 10.7205/MILMED-D-16-00345; Grafmiller J., 2017, PERMUTE VARIMP PERMU; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harris SL, 2016, EUR J OPER RES, V253, P121, DOI 10.1016/j.ejor.2016.02.017; Herland M., 2014, J BIG DATA, DOI [10.1186/2196-1115-1-2, DOI 10.1186/2196-1115-1-2]; Huang Y, 2014, Appl Clin Inform, V5, P836, DOI 10.4338/ACI-2014-04-RA-0026; Huang YL, 2016, INT J HEALTH CARE Q, V29, P475, DOI 10.1108/IJHCQA-06-2015-0077; Hwang AS, 2015, J GEN INTERN MED, V30, P1426, DOI 10.1007/s11606-015-3252-3; IBGE, ETHN RAC CHAR POP ST; Izecksohn MMV, 2014, REV BRAS MED FAM COM, V9, P235, DOI DOI 10.5712/RBMFC9(32)960; Kang H, 2013, KOREAN J ANESTHESIOL, V64, P402, DOI 10.4097/kjae.2013.64.5.402; Kaplan-Lewis E, 2013, J PRIM CARE COMMUNIT, V4, P251, DOI 10.1177/2150131913498513; Kiran T, 2015, CAN FAM PHYSICIAN, V61, P399; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lacy NL, 2004, ANN FAM MED, V2, P541, DOI 10.1370/afm.123; Ludecke D., 2019, SJSTATS COLLECTION C; Mark Reid P, 2015, AM J MANAGED CARE, V21; Nancarrow S, 2014, AUSTRALAS MED J, V7, P323, DOI 10.4066/AMJ.2014.2098; Nguyen Douglas L, 2011, J Grad Med Educ, V3, P350, DOI 10.4300/JGME-D-10-00199.1; Norris JB, 2014, DECIS SUPPORT SYST, V57, P428, DOI 10.1016/j.dss.2012.10.048; Nuti LA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-304; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Torres O, 2015, POPUL HEALTH MANAG, V18, P131, DOI 10.1089/pop.2014.0047; Tuso PJ., 1999, PERM J, V3, P68; Twisk JW, 2013, APPL LONGITUDINAL DA; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.35; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.02.11	39	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214869	10.1371/journal.pone.0214869	http://dx.doi.org/10.1371/journal.pone.0214869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947294	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500077
J	Solf, B; Schramm, S; Link, D; Klee, S				Solf, Benjamin; Schramm, Stefan; Link, Dietmar; Klee, Sascha			Objective measurement of forward-scattered light in the human eye: An electrophysiological approach	PLOS ONE			English	Article							COMPENSATION COMPARISON METHOD; STRAYLIGHT MEASUREMENT; STEADY-STATE; AGE; PERFORMANCE; PREVALENCE; RESPONSES; FLICKER; ALPHA	Purpose Psychophysical measurements are used to examine the perception of ocular stray light, for example, with C-Quant. These measurements are subjective due to their principles. This work aims to determine ocular stray light objectively; thus, a psychophysical method is transferred into an electrophysiological setup. Methods Stray light perception was measured using steady-state visual evoked potentials (VEPs) in 10 healthy subjects (7 males, 3 females, mean age +/- SD: 29.6 +/- 4.1 years). Stray light emulating filters (Tiffen Black Pro Mist 2) were used for simulating the effect of cataracts to validate the results for increased scattered light conditions. Based on the direct compensation method, the stimulus consisted of a central test field (radius = 2 degrees) with a luminance adjustable compensation light and surrounding ring-shaped stray light source (radius = 5 to 10 degrees). Both flickered in the counter phase at a frequency of 7.5 Hz. The stimuli were presented for 15 luminance levels of the compensation light. The recorded steady-state VEPs at Oz channel were transformed by means of Fourier analysis. The magnitudes at the evoked frequency were plotted against the measured brightness levels of the compensation light. By fitting two linear functions to the resulting data points, a robust minimum log(L-eq) was determined, which was correlated with the amount of stray light perception. We measured the stray light parameter log(s(c)) using C-Quant. For comparison, our results were converted into the C-Quant equivalent parameter log(s(epm)) and paired t-tests were performed for normal distributed results. Results A significant difference is observed between log(s(epm)) (without filter) and log(s(epm)) (with BPM 2 Filter) (p>0.05). No significant difference is observed between log(s(epm)) (without filter) and log(s(c)) (without filter) (p > 0.05) and between log(s(epm)) (with BPM 2 filter) and log (s(c)) (with BPM 2 filter) (p > 0.05). Conclusion The electrophysiological approach offers the ability to measure stray light perception in an objective manner.	[Solf, Benjamin; Schramm, Stefan; Link, Dietmar; Klee, Sascha] Tech Univ Ilmenau, Inst Biomed Engn & Informat, Ilmenau, Germany	Technische Universitat Ilmenau	Solf, B (corresponding author), Tech Univ Ilmenau, Inst Biomed Engn & Informat, Ilmenau, Germany.	benjamin.solf@tu-ilmenau.de		Klee, Sascha/0000-0002-0321-1255	German Federal Ministry of Education and Research [3IPT605X]; Carl-Zeiss-Foundation; German Research Foundation (DFG); Open Access Publication Fund of the Technische Universitat Ilmenau	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Carl-Zeiss-Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of the Technische Universitat Ilmenau	The authors gratefully acknowledge funding from the German Federal Ministry of Education and Research (Grant 3IPT605X, www.bmbf.de) and the Carl-Zeiss-Foundation (www.carl-zeiss-stiftung.de).We acknowledge support for the Article Processing Charge by the German Research Foundation (DFG) and the Open Access Publication Fund of the Technische Universitat Ilmenau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Uriguen JA, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/031001; Bach M, 2008, BRIT J OPHTHALMOL, V92, P396, DOI 10.1136/bjo.2007.130245; Bach M, 1999, DOC OPHTHALMOL, V99, P69, DOI 10.1023/A:1002648202420; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cervino A, 2008, BRIT J OPHTHALMOL, V92, P788, DOI 10.1136/bjo.2007.131078; Chen J, 2012, HANDBOOK OF VISUAL DISPLAY TECHNOLOGY, VOLS 1-4, P1, DOI 10.1007/978-3-540-79567-4; Coppens JE, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2209555; de Wit GC, 2006, J CATARACT REFR SURG, V32, P294, DOI 10.1016/j.jcrs.2006.01.048; DELANGEDZN H, 1958, J OPT SOC AM, V48, P777, DOI 10.1364/JOSA.48.000777; Franssen L, 2006, INVEST OPHTH VIS SCI, V47, P768, DOI 10.1167/iovs.05-0690; FRANSSEN L, 2003, INVEST OPHTH VIS S2, V44, P23852; Ginis H, 2014, BIOMED OPT EXPRESS, V5, P3036, DOI 10.1364/BOE.5.003036; Ginis H, 2012, J VISION, V12, DOI 10.1167/12.3.20; Guber I, 2011, GRAEF ARCH CLIN EXP, V249, P1367, DOI 10.1007/s00417-011-1704-y; Heinrich SP, 2016, DOC OPHTHALMOL, V133, P183, DOI 10.1007/s10633-016-9565-7; Heinrich SP, 2010, DOC OPHTHALMOL, V120, P205, DOI 10.1007/s10633-010-9212-7; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hoffmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003004; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; Klemm M, 2016, PROC SPIE, V9693, DOI 10.1117/12.2208605; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kremlacek J, 2004, VISION RES, V44, P2989, DOI 10.1016/j.visres.2004.07.002; Labecki M, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00129; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MAYER MJ, 1994, INVEST OPHTH VIS SCI, V35, P1138; Meigen T, 1999, DOC OPHTHALMOL, V98, P207, DOI 10.1023/A:1002097208337; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; Ochoa CJ, 2000, CLIN NEUROPHYSIOL, V111, P93, DOI 10.1016/S1388-2457(99)00209-6; Perz M, 2017, LEUKOS, V13, P127, DOI 10.1080/15502724.2016.1269607; PETERSEN J, 1985, GRAEF ARCH CLIN EXP, V223, P66, DOI 10.1007/BF02150947; Prokofyeva E, 2013, ACTA OPHTHALMOL, V91, P395, DOI 10.1111/j.1755-3768.2012.02444.x; REGAN D, 1966, ELECTROEN CLIN NEURO, V20, P238, DOI 10.1016/0013-4694(66)90088-5; Salchow C, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00413; Schramm S, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.7.076003; Schramm S, 2013, GRAEF ARCH CLIN EXP, V251, P1967, DOI 10.1007/s00417-013-2405-5; Schwab K, 2006, NEUROREPORT, V17, P1829, DOI 10.1097/01.wnr.0000246326.89308.ec; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Tsoneva T, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066017; Tuncel Y, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aaa78f; van den Berg TJTP, 2013, Z MED PHYS, V23, P6, DOI 10.1016/j.zemedi.2012.10.009; VANDENBERG TJTP, 1991, DOC OPHTHALMOL, V78, P177, DOI 10.1007/BF00165678; VANDENBERG TJTP, 1995, OPTOMETRY VISION SCI, V72, P52, DOI 10.1097/00006324-199502000-00003; VANDENBERG TJTP, 1986, DOC OPHTHALMOL, V61, P327, DOI 10.1007/BF00142360; VERLEGER R, 1991, ELECTROEN CLIN NEURO, V78, P240, DOI 10.1016/0013-4694(91)90039-7; Vos Johannes J, 2003, Clin Exp Optom, V86, P363; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269	47	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214850	10.1371/journal.pone.0214850	http://dx.doi.org/10.1371/journal.pone.0214850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947303	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500073
J	Lee, ARI; Ales, JM; Harris, JM				Lee, Abigail R. I.; Ales, Justin M.; Harris, Julie M.			Speed change discrimination for motion in depth using constant world and retinal speeds	PLOS ONE			English	Article							TEMPORAL INTEGRATION; VELOCITY; ACCELERATION; PERCEPTION; STEREOMOTION; TIME; THRESHOLDS; DISPARITY; MECHANISM; DIRECTION	Motion at constant speed in the world maps into retinal motion very differently for lateral motion and motion in depth. The former is close to linear, for the latter, constant speed objects accelerate on the retina as they approach. Motion in depth is frequently studied using speeds that are constant on the retina, and are thus not consistent with real-world constant motion. Our aim here was to test whether this matters: are we more sensitive to real-world motion? We measured speed change discrimination for objects undergoing accelerating retinal motion in depth (consistent with constant real-world speed), and constant retinal motion in depth (consistent with real-world deceleration). Our stimuli contained both looming and binocular disparity cues to motion in depth. We used a speed change discrimination task to obtain thresholds for conditions with and without binocular and looming motion in depth cues. We found that speed change discrimination thresholds were similar for accelerating retinal speed and constant retinal speed and were notably poor compared to classic speed discrimination thresholds. We conclude that the ecologically valid retinal acceleration in our stimuli neither helps, nor hinders, our ability to make judgements in a speed change discrimination task.	[Lee, Abigail R. I.; Ales, Justin M.; Harris, Julie M.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of St Andrews	Lee, ARI (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	aril@st-andrews.ac.uk		Lee, Abigail/0000-0002-5052-1029; Harris, Julie/0000-0002-3497-4503	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M010996/1, BB/N018516/1, BB/M001660/1]; BBSRC [BB/N018516/1, BB/M001660/1, 1645201] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; https://bbsrc.ukri.org/) [grant number BB/M010996/1 to ARIL, BB/N018516/1 to JMA and BB/M001660/1 to JMH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABLER TG, 1993, J EXP PSYCHOL HUMAN, V19, P15, DOI 10.1037/0096-1523.19.1.15; Benguigui N, 2003, J EXP PSYCHOL HUMAN, V29, P1083, DOI 10.1037/0096-1523.29.6.1083; Benguigui N, 2010, EXP BRAIN RES, V202, P327, DOI 10.1007/s00221-009-2139-0; BEVERLEY KI, 1979, VISION RES, V19, P727, DOI 10.1016/0042-6989(79)90251-7; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brenner E, 1996, VISION RES, V36, P699, DOI 10.1016/0042-6989(95)00146-8; Brenner E, 2016, I-PERCEPTION, V7, DOI 10.1177/2041669515624317; Brooks K, 2000, VISION RES, V40, P3507, DOI 10.1016/S0042-6989(00)00095-X; Brooks KR, 2006, J VISION, V6, P1214, DOI 10.1167/6.11.6; Brooks KR, 2002, J VISION, V2, DOI 10.1167/2.3.2; Brooks KR, 2004, J VISION, V4, P1061, DOI 10.1167/4.12.6; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; Burr D, 2011, VISION RES, V51, P1431, DOI 10.1016/j.visres.2011.02.008; CALDERONE JB, 1989, PERCEPT PSYCHOPHYS, V45, P391, DOI 10.3758/BF03210711; Cesqui B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119445; Cooper EA, 2016, J VISION, V16, DOI 10.1167/16.10.5; Cormack LK, 2017, ANNU REV VIS SCI, V3, P297, DOI 10.1146/annurev-vision-102016-061259; Czuba TB, 2010, J NEUROPHYSIOL, V104, P2886, DOI 10.1152/jn.00585.2009; DEBRUYN B, 1988, VISION RES, V28, P1323, DOI 10.1016/0042-6989(88)90064-8; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; GOTTSDANKER R, 1961, BRIT J PSYCHOL, V52, P31, DOI 10.1111/j.2044-8295.1961.tb00765.x; Harris JM, 2003, VISION RES, V43, P385, DOI 10.1016/S0042-6989(02)00570-9; HARRIS JM, 1995, VISION RES, V35, P885, DOI 10.1016/0042-6989(94)00194-Q; Harris JM, 1998, NAT NEUROSCI, V1, P165, DOI 10.1038/418; Harris JM, 2008, SPATIAL VISION, V21, P531, DOI 10.1163/156856808786451462; Heidenreich SM, 1996, VISION RES, V36, P1819, DOI 10.1016/0042-6989(95)00270-7; Held L, 2018, ANNU REV STAT APPL, V5, P393, DOI 10.1146/annurev-statistics-031017-100307; Jeffreys H., 1939, OXFORD CLASSIC TEXTS; KAISER MK, 1995, PERCEPT PSYCHOPHYS, V57, P817, DOI 10.3758/BF03206797; Katz LN, 2015, J NEUROSCI, V35, P10212, DOI 10.1523/JNEUROSCI.0032-15.2015; Kingdom F, 2009, PALAMEDES MATLAB ROU; Kleiner M, 2007, PERCEPTION, V36, P14; Lopez-Moliner J., 2003, PSICOLOGICA, V24, P93; Manning C, 2018, J VISION, V18, DOI 10.1167/18.6.15; MATEEFF S, 1995, VISION RES, V35, P355, DOI 10.1016/0042-6989(94)00130-E; Mateeff S, 2000, VISION RES, V40, P409, DOI 10.1016/S0042-6989(99)00185-6; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; MCKEE SP, 1981, VISION RES, V21, P491, DOI 10.1016/0042-6989(81)90095-X; MCKEE SP, 1985, J OPT SOC AM A, V2, P243, DOI 10.1364/JOSAA.2.000243; McKee SP, 1994, VISUAL DETECTION MOT, P85; MONEN J, 1994, PERCEPTION, V23, P681, DOI 10.1068/p230681; Mueller AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149413; ORBAN GA, 1984, VISION RES, V24, P33, DOI 10.1016/0042-6989(84)90141-X; Palmisano S, 2008, PERCEPTION, V37, P22, DOI 10.1068/p5806; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; Robert CP, 2009, STAT SCI, V24, P141, DOI 10.1214/09-STS284; Russo M, 2017, J NEUROPHYSIOL, V118, P2421, DOI 10.1152/jn.00025.2017; Schlack A, 2008, J VISION, V8, DOI 10.1167/8.8.9; SCHMERLER J, 1976, PERCEPTION, V5, P167, DOI 10.1068/p050167; SEKULER AB, 1992, VISION RES, V32, P2277, DOI 10.1016/0042-6989(92)90091-V; Senot P, 2005, J NEUROPHYSIOL, V94, P4471, DOI 10.1152/jn.00527.2005; SNOWDEN RJ, 1991, VISION RES, V31, P907, DOI 10.1016/0042-6989(91)90156-Y; Sumnall JH, 2000, J OPT SOC AM A, V17, P687, DOI 10.1364/JOSAA.17.000687; Trewhella J, 2003, CLIN EXP OPHTHALMOL, V31, P258, DOI 10.1046/j.1442-9071.2003.00641.x; TYLER CW, 1971, SCIENCE, V174, P958, DOI 10.1126/science.174.4012.958; TYLER CW, 1975, PERCEPT PSYCHOPHYS, V17, P225, DOI 10.3758/BF03203204; Verghese P, 2006, VISION RES, V46, P1540, DOI 10.1016/j.visres.2005.07.029; von Gruenau MW, 2007, VISION RES, V47, P2453, DOI 10.1016/j.visres.2007.06.008; Wardle SG, 2013, J VISION, V13, DOI 10.1167/13.1.17; Watamaniuk SNJ, 2003, J VISION, V3, P698, DOI 10.1167/3.11.5; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z	63	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214766	10.1371/journal.pone.0214766	http://dx.doi.org/10.1371/journal.pone.0214766			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943269	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300059
J	Sola, M; Sanchez-Quevedo, C; Martin-Piedra, MA; Carriel, V; Garzon, I; Chato-Astrain, J; Garcia-Garcia, OD; Alaminos, M; Campos, F				Sola, Miguel; Sanchez-Quevedo, Carmen; Martin-Piedra, Miguel A.; Carriel, Victor; Garzon, Ingrid; Chato-Astrain, Jesus; Garcia-Garcia, Oscar-Dario; Alaminos, Miguel; Campos, Fernando			Evaluation of the awareness of novel advanced therapies among family medicine residents in Spain	PLOS ONE			English	Article							CARE PROFESSIONALS KNOWLEDGE; UMBILICAL-CORD BLOOD; STEM-CELL THERAPIES; HEALTH; PERSPECTIVES; PERCEPTIONS; CHALLENGES; PHYSICIANS; ATTITUDES; COVERAGE	Background Advanced therapies are increasingly demanded by patients with the intent of treating some incurable conditions. Because family medicine professionals play an important role as health educators, their residency programs should incorporate new knowledge related to advanced therapies. To successfully implement these programs, how family medicine residents perceive these therapies should be investigated. The main components of perception, i.e. conceptual, procedural and attitudinal, refer to knowledge, skills and feelings, respectively. Methods and findings We designed a specific questionnaire to assess the components of perceptions of advanced therapies in 300 medical residents enrolled in the Spanish National Family Medicine Residency Program. Each component consisted of 4 or 5 topics and each topic contained 6 items. Respondents scored highest in the procedural component (average 4.12 +/- 1.00), followed by the attitudinal (3.94 +/- 1.07) and conceptual component (3.04 +/- 1.43). Differences among the three components were statistically significant (p<0.00017). Family medicine residents perceived that procedures to implement advanced therapies are well established, especially their application. However, they felt their cognitive background was insufficient to respond efficiently to the expectations generated by these new therapeutic tools, especially in the regulatory framework. High awareness of the risks and limitations of these treatments was reflected by residents' preference for clinically tested therapies. Although they appropriately situated treatment with these therapies within hospital care, they associated the biofabrication of novel products with research centers, although these therapeutic tools can be produced in different facilities. Conclusions These results are potentially useful for designing future training programs and health policies for family medicine residents, and suggest the need to implement specific training programs in advanced therapies at the conceptual, procedural and attitudinal level.	[Sola, Miguel] Univ Granada, Sch Med, Family Med Unit, Granada, Spain; [Sanchez-Quevedo, Carmen; Martin-Piedra, Miguel A.; Carriel, Victor; Garzon, Ingrid; Chato-Astrain, Jesus; Garcia-Garcia, Oscar-Dario; Alaminos, Miguel; Campos, Fernando] Inst Invest Biosanitaria Ibs GRANADA, Granada, Spain; [Sanchez-Quevedo, Carmen; Martin-Piedra, Miguel A.; Carriel, Victor; Garzon, Ingrid; Chato-Astrain, Jesus; Garcia-Garcia, Oscar-Dario; Alaminos, Miguel; Campos, Fernando] Univ Granada, Sch Med, Dept Histol, Tissue Engn Grp, Granada, Spain	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada	Alaminos, M (corresponding author), Inst Invest Biosanitaria Ibs GRANADA, Granada, Spain.; Alaminos, M (corresponding author), Univ Granada, Sch Med, Dept Histol, Tissue Engn Grp, Granada, Spain.	malaminos@ugr.es	Martin-Piedra, Miguel Angel/F-3664-2019; García García, Oscar Darío/AAR-4921-2020; Chato-Astrain, Jesus/GLS-0840-2022; ARAYA, VICTOR CARRIEL/H-9425-2018; ALAMINOS, MIGUEL/N-9960-2016	Martin-Piedra, Miguel Angel/0000-0002-4639-3175; García García, Oscar Darío/0000-0002-4710-0733; Chato-Astrain, Jesus/0000-0002-2378-2696; ARAYA, VICTOR CARRIEL/0000-0002-8114-5644; ALAMINOS, MIGUEL/0000-0003-4876-2672; Campos, Fernando/0000-0003-0034-9264	Junta de Andalucia, Spain [CTS-115]	Junta de Andalucia, Spain(Junta de Andalucia)	This work was supported by CTS-115 (Tissue Engineering Group), Junta de Andalucia, Spain, which did not play a role at any point in the research or publication process. There was no additional external funding received for this study.	Anderson L. W., 2001, TAXONOMY LEARNING TE; Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037; Anitua E, 2012, J CONTROL RELEASE, V157, P29, DOI 10.1016/j.jconrel.2011.07.004; Blumenfeld P.C., 2006, MOTIVATION COGNITIVE; Brasaite I, 2015, SCAND J CARING SCI, V29, P30, DOI 10.1111/scs.12136; Camilleri M, 2012, AM J GASTROENTEROL, V107, P336, DOI 10.1038/ajg.2011.451; Campos F, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1227-x; Campos-Sanchez A, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-46; Campos-Sanchez A, 2012, ANAT SCI EDUC, V5, P273, DOI 10.1002/ase.1291; Carek PJ, 2018, J AM BOARD FAM MED, V31, P178, DOI 10.3122/jabfm.2018.02.180022; Coutinho AJ, 2015, JAMA-J AM MED ASSOC, V314, P2364, DOI 10.1001/jama.2015.13734; Cuende N, 2013, STEM CELL TRANSL MED, V2, P243, DOI 10.5966/sctm.2013-0051; Cuende N, 2010, CELL STEM CELL, V6, P508, DOI 10.1016/j.stem.2010.05.005; Drake RL, 2014, J ANAT, V224, P256, DOI 10.1111/joa.12054; El Omar R, 2014, TISSUE ENG PART B-RE, V20, P523, DOI [10.1089/ten.teb.2013.0664, 10.1089/ten.TEB.2013.0664]; Flory E, 2013, TRANSFUS MED HEMOTH, V40, P409, DOI 10.1159/000356364; Gunter KC, 2010, CYTOTHERAPY, V12, P965, DOI 10.3109/14653249.2010.532663; Julian K, 2018, SEMIN NEUROL, V38, P176, DOI 10.1055/s-0038-1649338; Koballa TR, 2007, ATTITUDINAL MOTIVATI; Kusurkar R, 2010, ADV HEALTH SCI EDUC, V15, P303, DOI 10.1007/s10459-009-9198-7; Kvaerner KJ, 1999, BRIT MED J, V318, P91; Lennon RP, 2014, FAM MED, V46, P294; Levine AD, 2012, J LAW MED ETHICS, V40, P122, DOI 10.1111/j.1748-720X.2012.00650.x; Li DG, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017251; Martin PL, 2011, AM FAM PHYSICIAN, V84, P661; Master Z, 2014, CELL STEM CELL, V15, P267, DOI 10.1016/j.stem.2014.08.009; Nichols K, 2016, CYTOTHERAPY, V18, P127, DOI 10.1016/j.jcyt.2015.11.003; Ogbogu U, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0273-6; Ogbogu U, 2013, REGEN MED, V8, P361, DOI [10.2217/rme.13.15, 10.2217/RME.13.15]; Peberdy L, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0863-6; Peterson LE, 2018, J AM BOARD FAM MED, V31, P181, DOI 10.3122/jabfm.2018.02.170359; Phillips RL, 2014, ANN FAM MED, V12, pS1, DOI 10.1370/afm.1699; PINTRICH PR, 1993, REV EDUC RES, V63, P167, DOI 10.2307/1170472; Ratanawongsa N, 2006, J GEN INTERN MED, V21, P758, DOI 10.1111/j.1525-1497.2006.00496.x; Sakata R, 2016, TISSUE ENG PART B-RE, V22, P408, DOI 10.1089/ten.teb.2015.0534; Salinas-Miranda AA, 2014, INT J MED EDUC, V5, P87, DOI 10.5116/ijme.5334.7c8d; Santisteban-Espejo A, 2018, TISSUE ENG PT A, V24, P1504, DOI [10.1089/ten.tea.2018.0007, 10.1089/ten.TEA.2018.0007]; Senf JH, 2005, FAM MED, V37, P265; Snyder Jeremy, 2011, Open Med, V5, pe139; Sugawara Y, 2012, RISK MANAG HEALTHC P, V5, P83, DOI 10.2147/RMHP.S33661; Taylor-Weiner H, 2015, NEW ENGL J MED, V373, P985, DOI 10.1056/NEJMp1504560; Tenti E, 2018, CONT CLIN TRIAL COMM, V11, P99, DOI 10.1016/j.conctc.2018.05.014; von Tigerstrom B, 2015, FOOD DRUG LAW J, V70, P315; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935; Wolters CA, 2004, J EDUC PSYCHOL, V96, P236, DOI 10.1037/0022-0663.96.2.236; Xie Y, 1997, SOCIOL METHOD RES, V26, P233, DOI 10.1177/0049124197026002005; Zarzeczny A, 2014, STEM CELL REP, V3, P379, DOI 10.1016/j.stemcr.2014.06.016; Zhang YH, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-117; Zhao FF, 2014, OMICS, V18, P222, DOI 10.1089/omi.2013.0108	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214950	10.1371/journal.pone.0214950	http://dx.doi.org/10.1371/journal.pone.0214950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943248	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300074
J	Paton, K; Hiscock, H				Paton, Kate; Hiscock, Harriet			Strengthening care for children with complex mental health conditions: Views of Australian clinicians	PLOS ONE			English	Article							QUALITATIVE RESEARCH; PARENT EDUCATION; PEER SUPPORT; AUTISM	Objectives Improving mental health outcomes for children and young people has become a priority for policy makers in the developed world. In Australia, up to half of all children and adolescents meeting criteria for mental health disorders receive suboptimal levels of treatment (or no treatment at all) despite the availability of effective treatments. Children with complex mental health conditions are particularly at risk of inadequate treatment as optimal care requires coordination from medical, educational and social services. In Australia, clinicians including pediatricians, psychologists and child and adolescent psychiatrists deliver the bulk of mental health care for children with complex mental health conditions. We aimed to determine perspectives of these Australian clinicians on barriers and enablers within the current system and components of an optimal model of care. Methods Inductive content analysis was used to analyse 30 semi-structured interviews with key clinicians managing the care of children with complex mental health conditions across Australia. Interviews were conducted using vignettes with Attention Deficit Hyperactivity Disorder (ADHD) and Autism as exemplars. Findings Multiple barriers to optimal care exist at a systemic, clinician and family level. However, regional health systems provide an enabling environment from which metropolitan models could learn. Transitioning to adult services was highlighted as the most compromised area of care. Clinicians identified short (e.g. empowering parents to advocate for and deliver their child's care, case conferencing with schools) and long term (e.g. co-locating disciplines to deliver care, workforce training) solutions. Conclusions Whilst multiple barriers to optimal care for children with complex mental health conditions exist, clinicians identify several enablers including developing networks with other disciplines and empowering parents to advocate for and co-ordinate care. Systemic changes based on multidisciplinary, co-located and integrated care services should be developed as longer term solutions.	[Paton, Kate; Hiscock, Harriet] Murdoch Childrens Res Inst, Ctr Community Child Hlth, Hlth Serv, Melbourne, Vic, Australia; [Hiscock, Harriet] Royal Childrens Hosp, Hlth Serv Unit, Melbourne, Vic, Australia; [Hiscock, Harriet] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Hiscock, H (corresponding author), Murdoch Childrens Res Inst, Ctr Community Child Hlth, Hlth Serv, Melbourne, Vic, Australia.; Hiscock, H (corresponding author), Royal Childrens Hosp, Hlth Serv Unit, Melbourne, Vic, Australia.; Hiscock, H (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.	harriet.hiscock@rch.org.au			European Commission; National Health and Medical Research Council (NHMRC) European Union Collaborative Research Grant [1101321]; NHMRC [1136222]; Murdoch Children's Research Institute; Victorian Government's Operational Infrastructure Support Program	European Commission(European CommissionEuropean Commission Joint Research Centre); National Health and Medical Research Council (NHMRC) European Union Collaborative Research Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Children's Research Institute; Victorian Government's Operational Infrastructure Support Program	This research project was completed as part of the European Commission Horizon 2020 Framework project: Models of Child Health Appraised (MOCHA). The project's study design and conduct, data collection, management, analysis and interpretation were funded by National Health and Medical Research Council (NHMRC) European Union Collaborative Research Grant No. 1101321. HH is supported by NHMRC Clinician Fellowship Award 1136222. The Murdoch Children's Research Institute administered the grants and provided infrastructural support to its staff but played no role in the conduct or analysis of the research. The Victorian Government's Operational Infrastructure Support Program support research at the Murdoch Children's Research Institute.	Aisbett D L, 2007, Rural Remote Health, V7, P624; Association of Maternal and Child Health Programs, 2014, SEM BRAS ENF BRAS AN, P1; Boyd C, 2007, AUST J RURAL HEALTH, V15, P196, DOI 10.1111/j.1440-1584.2007.00884.x; Brenner M, 2017, INT J INTEGR CARE, V17, DOI 10.5334/ijic.2544; Cohen E, 2011, PEDIATRICS, V127, P529, DOI 10.1542/peds.2010-0910; Committee on Crossing the Quality Chasm Adaptation to Mental Health Addictive Disorders, 2006, IMPR QUAL HLTH CAR M; Dalton MA, 2002, CHILD ADOL PSYCH CL, V11, P859, DOI 10.1016/S1056-4993(02)00021-4; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Fergusson DM, 2005, ARCH GEN PSYCHIAT, V62, P66, DOI 10.1001/archpsyc.62.1.66; Grace FC, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2309-x; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Hoagwood KE, 2018, J CHILD FAM STUD, V27, P1130, DOI 10.1007/s10826-017-0961-8; Hoge MA, 2009, PSYCHIAT SERV, V60, P883, DOI 10.1176/appi.ps.60.7.883; International QSR, 1999, NVIVO QUAL DAT AN SO; Lawrence D., 2015, MENTAL HLTH CHILDREN; Marshall MN, 1996, FAM PRACT, V13, P92, DOI 10.1093/fampra/13.1.92; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Muller-Engelmann M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-260; National Academies of Sciences Engineering and Medicine, 2017, TRAIN FUT CHILD HLTH; Nicholls M.C., 2014, QUALITATIVE RES PRAC, P177, DOI DOI 10.1186/1745-6215-14-166; Niela-Vilen H, 2014, INT J NURS STUD, V51, P1524, DOI 10.1016/j.ijnurstu.2014.06.009; Oono IP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009774.pub2; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Randall M, 2016, AUST NZ J PSYCHIAT, V50, P243, DOI 10.1177/0004867415595287; Rickwood D, 2005, ADV MENT HEALTH, V4, P218, DOI 10.5172/jamh.4.3.218; Scotland Audit, 2018, CHILDR YOUNG PEOPL M; Shilling V, 2013, DEV MED CHILD NEUROL, V55, P602, DOI 10.1111/dmcn.12091; Smullen A, 2016, AUST J PUBL ADMIN, V75, P280, DOI 10.1111/1467-8500.12153; Steiner AM, 2012, J AUTISM DEV DISORD, V42, P1218, DOI 10.1007/s10803-011-1194-0; Taylor J, 2009, J CLIN NURS, V18, P1180, DOI 10.1111/j.1365-2702.2008.02661.x; Thorne S, 1997, RES NURS HEALTH, V20, P169; Thorne S, 2016, DEV QUAL INQ, V2; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tonge B, 2014, AUTISM, V18, P166, DOI 10.1177/1362361312458186; TORJESEN I, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K3253; Trainor AA, 2010, REM SPEC EDUC, V31, P34, DOI 10.1177/0741932508324401; Whiteford H, 2014, AUST NZ J PSYCHIAT, V48, P895, DOI 10.1177/0004867414541683; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Health Organization, 2008, The global burden of disease: 2004 update; World Psychiatric Association, 2005, PRES GLOB PROGR CHIL; Yin R.K., 1993, APPL CASE STUDY RES; Young S, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-174	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214821	10.1371/journal.pone.0214821	http://dx.doi.org/10.1371/journal.pone.0214821			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939168	Green Published, gold			2022-12-27	WOS:000462993900043
J	Maison, D; Marchlewska, M; Sekscinska, K; Rudzinska-Wojciechowska, J; Lozowski, F				Maison, Dominika; Marchlewska, Marta; Sekscinska, Katarzyna; Rudzinska-Wojciechowska, Joanna; Lozowski, Filip			You don't have to be rich to save money: On the relationship between objective versus subjective financial situation and having savings	PLOS ONE			English	Article							PERCEIVED INCOME ADEQUACY; SOCIAL-STATUS; PSYCHOLOGICAL-FACTORS; HEALTH-STATUS; PEOPLE SAVE; DETERMINANTS; SATISFACTION; BEHAVIOR; INEQUALITY; CAPABILITY	Saving is an important financial behavior that provides an individual with psychological security and boosts his/her overall sense of well-being. For this reason, scientists and practitioners have attempted to understand why some people save when others do not. One of the most common explanations for this phenomenon is that those individuals who earn more should be more willing to save their money. In line with this logic, people who have more money should be more likely to have savings. Considering the results of prior research, we expected objective financial situation (income) to be positively linked to having savings (i.e., propensity to have savings and the exact amount of savings). At the same time, however, we assumed that subjective financial situation (perception) should also be positively related to these variables. To test our assumptions, we conducted a nationwide representative survey (N = 1048) among Polish respondents, asking them about their objective and subjective financial situation. The results of a regression analysis showed that objective financial situation was indeed significantly positively related to having savings. However, subjective financial situation was also positively correlated with having savings (even when we controlled for objective financial situation and demographic variables). We discuss the implications of the links between objective versus subjective financial situations and having savings.	[Maison, Dominika; Sekscinska, Katarzyna; Lozowski, Filip] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Marchlewska, Marta] Polish Acad Sci, Inst Psychol, Warsaw, Poland; [Rudzinska-Wojciechowska, Joanna] SWPS Univ Social Sci & Humanities, Wroclaw Fac Psychol, Wroclaw, Poland	University of Warsaw; Polish Academy of Sciences; Institute of Psychology of the Polish Academy of Sciences; SWPS University of Social Sciences & Humanities	Maison, D (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	dominika@psych.uw.edu.pl		Sekscinska, Katarzyna/0000-0002-6641-6506; Rudzinska-Wojciechowska, Joanna/0000-0003-3995-6803	Faculty of Psychology at the University of Warsaw [BST 181421/2018]	Faculty of Psychology at the University of Warsaw	This project was supported by the Faculty of Psychology at the University of Warsaw (BST 181421/2018 awarded to Dominika Maison). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; [Anonymous], 2015, J FINANC COUNS PLAN; Bandura A, 1994, ENCY HUMAN BEHAV, DOI DOI 10.1002/9780470479216.CORPSY0836; Boehm JK, 2008, J CAREER ASSESSMENT, V16, P101, DOI 10.1177/1069072707308140; Bricker Jesse, 2014, FEDERAL RESERVE B, V100, P1; Browning M, 1996, J ECON LIT, V34, P1797; Burchardt T, 2005, SOC INDIC RES, V74, P57, DOI 10.1007/s11205-005-6519-y; Canova L, 2005, J ECON PSYCHOL, V26, P21, DOI 10.1016/j.joep.2003.08.007; Chan A, 2002, SOC INDIC RES, V57, P263, DOI 10.1023/A:1014787712820; Clark AE, 2010, ECON J, V120, P573, DOI 10.1111/j.1468-0297.2010.02359.x; Croy G, 2010, J ECON PSYCHOL, V31, P860, DOI 10.1016/j.joep.2010.06.002; Davis E.P., 1987, HOME EC RES J, V15, P247, DOI [10.1177/1077727X8701500405., DOI 10.1177/1077727X8701500405]; Diener E, 2002, SOC INDIC RES, V57, P119, DOI 10.1023/A:1014411319119; Diener E, 2002, SOC INDIC RES, V59, P229, DOI 10.1023/A:1019672513984; Diener E, 2009, SOC INDIC RES SER, V37, P201, DOI [10.1111/j.0963-7214.2004.00501001.x, 10.1007/978-90-481-2350-6_9]; Durante KM, 2016, J MARKETING RES, V53, P814, DOI 10.1509/jmr.15.0319; Dynan KE, 2004, J POLIT ECON, V112, P397, DOI 10.1086/381475; Fisher Patti, J FIN COUNSELING PLA, V23, P63; Fisher PJ, 2010, J ECON PSYCHOL, V31, P92, DOI 10.1016/j.joep.2009.11.002; Garbinsky EN, 2014, J CONSUM RES, V41, P610, DOI 10.1086/676965; Gasiorowska A., 2015, POL PSYCHOL BULL, V46, P197, DOI [10.1515/ppb-2015-0026, DOI 10.1515/PPB-2015-0026]; Gasiorowska A, 2014, J ECON PSYCHOL, V43, P64, DOI 10.1016/j.joep.2014.04.007; GoBankingRates, 2017, MOR HALF AM HAV LESS, DOI [10.1016/j.joep.2010.06.002, DOI 10.1016/J.JOEP.2010.06.002]; Grable JE, 2013, SOC INDIC RES, V114, P1109, DOI 10.1007/s11205-012-0192-8; Graham C, 2002, 28 SSRN CTR SOC EC D, DOI [10.2139/ssrn.1028319, DOI 10.2139/SSRN.1028319]; Gutter MS, 2012, FAM CONSUM SCI RES J, V41, P86, DOI 10.1111/j.1552-3934.2012.02130.x; Han C.-K, 2009, J SOCIO-ECON, V2009, P475, DOI DOI 10.1016/J.S0CEC.2008.07.002; Han CK, 2009, SOC SERV REV, V83, P221, DOI 10.1086/600861; Hansen T, 2008, SOC INDIC RES, V89, P323, DOI 10.1007/s11205-007-9234-z; Harris MN, 2002, ECON REC, V78, P207, DOI 10.1111/1475-4932.00024; Hayhoe C.R., 1998, J FINANC COUNS PLAN, V9, P21; Hershfield HE, 2011, J MARKETING RES, V48, pS23, DOI 10.1509/jmkr.48.SPL.S23; Hogarth J. M., 2003, FINANCIAL COUNSELING, V14, P1; Horioka CY, 1997, ECON J, V107, P537, DOI 10.1111/1468-0297.00176; HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5; ING, 2017, INT SURV SAV; JACKMAN MR, 1973, AM SOCIOL REV, V38, P569, DOI 10.2307/2094408; Joo S, 2004, J FAM ECON ISS, V25, P162, DOI [10.1023/B:JEEI.0000016722.37994.9f, DOI 10.1023/B:JEEI.0000016722.37994.9F]; Karademas EC, 2006, PERS INDIV DIFFER, V40, P1281, DOI 10.1016/j.paid.2005.10.019; Katona G., 1975, PSYCHOL EC; Kim Jae-Ho, 2003, [Journal of Law, 법학연구], V14, P75; Kostakis I., 2012, INT J EC PRACTICES T, V2, P253; LEA SEG, 1995, J ECON PSYCHOL, V16, P681, DOI 10.1016/0167-4870(95)00013-4; Litwin H, 2009, GERONTOLOGIST, V49, P397, DOI 10.1093/geront/gnp036; LUNT PK, 1991, J ECON PSYCHOL, V12, P621, DOI 10.1016/0167-4870(91)90003-C; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Macleod J, 2005, SOC SCI MED, V61, P1916, DOI 10.1016/j.socscimed.2005.04.009; Maison D., 2019, PSYCHOL FINANCIAL BE; Maison D., 2013, POLE WORLD FINANCE; Malone K, 2010, J FAM ECON ISS, V31, P63, DOI 10.1007/s10834-009-9176-5; Marks GN, 1999, SOC INDIC RES, V46, P301; Garcia MTM, 2011, INT REV APPL ECON, V25, P225, DOI 10.1080/02692171.2010.483467; MILLS RJ, 1992, FAM RELAT, V41, P440, DOI 10.2307/585588; Miron-Shatz T, 2014, JUDGM DECIS MAK, V9, P152; Noring, 1994, FINANCIAL COUNSELING, V5, P25; Okech D, 2013, J POLICY PRACT, V12, P107, DOI 10.1080/15588742.2013.766917; OLSON GI, 1993, SOC INDIC RES, V28, P173, DOI 10.1007/BF01079657; Plantinga A, 2019, SHAME POVERTY RELATE, DOI [10.1027/2151-2604/a000079, DOI 10.1027/2151-2604/A000079]; Porter N.M, 1993, FINANCIAL COUNSELING, V4, P135; Rabinovich A, 2007, J ECON PSYCHOL, V28, P444, DOI 10.1016/j.joep.2006.09.002; Ranta M, 2013, LONGITUD LIFE COURSE, V4, P57; Roszkiewicz M, 2014, INT J CONSUM STUD, V38, P602, DOI 10.1111/ijcs.12129; Sekscinska K, 2018, MARKETING RYNEK, P31; Shim S, 2012, J ECON PSYCHOL, V33, P155, DOI 10.1016/j.joep.2011.08.005; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Stoller MA, 2003, J APPL GERONTOL, V22, P230, DOI 10.1177/0733464803022002004; Sumarwan U., 1993, J FAM ECON ISS, V14, P343, DOI [10.1007/BF01013984, DOI 10.1007/BF01013984]; Sussman AB, 2012, PSYCHOL SCI, V23, P101, DOI 10.1177/0956797611421484; Szopinski T., 2017, ACTA SCI POLONORUM O, V16, P117, DOI [10.22630/ASPE.2017.16.2.24, DOI 10.22630/ASPE.2017.16.2.24]; Tang T.L.-P., 2004, J MANAGE PSYCHOL, V19, P111, DOI [10.1108/02683940410526091, DOI 10.1108/02683940410526091]; Tang TLP, 2005, MANAG RES, V3, P7, DOI 10.1108/15365430580001311; ter Bogt TFM, 2006, J ADOLESCENT HEALTH, V39, P27, DOI 10.1016/j.jadohealth.2005.09.007; Traut-Mattausch E, 2011, Z PSYCHOL, V219, P246, DOI 10.1027/2151-2604/a000079; Veenhoven R, 1999, SOC INDIC RES, V48, P157; Vera-Toscano E, 2006, SOC INDIC RES, V77, P211, DOI 10.1007/s11205-005-2614-3; Walson C, 1993, J FAM ECON ISS, V14, P193, DOI DOI 10.1007/BF01022177; Webbley P., 2006, HDB CONT BEHAV EC FD, P297; Webley P, 2006, J ECON PSYCHOL, V27, P140, DOI 10.1016/j.joep.2005.06.016; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilkinson RG, 1999, INT J HEALTH SERV, V29, P525, DOI 10.2190/3QXP-4N6T-N0QG-ECXP; Williams VF, 2017, J PUBLIC HEALTH MAN, V23, P487, DOI 10.1097/PHH.0000000000000468; Worneryd K.E, 1999, PSYCHOL SAVING STUDY; Xiao J.J., 1997, J FAM ECON ISS, V18, P333, DOI [DOI 10.1023/A:1024991304216, DOI 10.1023/A:1024991]; Xiao JJ, 2018, INT J CONSUM STUD, V42, P501, DOI 10.1111/ijcs.12461; Xiao JJ, 2018, INT J CONSUM STUD, V42, P448, DOI 10.1111/ijcs.12445; Xiao JJ, 2014, SOC INDIC RES, V118, P415, DOI 10.1007/s11205-013-0414-8; Yuh Y, 2010, J CONSUM AFF, V44, P70, DOI 10.1111/j.1745-6606.2010.01158.x; Zaleskiewicz T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079407	89	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214396	10.1371/journal.pone.0214396	http://dx.doi.org/10.1371/journal.pone.0214396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934007	Green Submitted, Green Published, gold			2022-12-27	WOS:000462867000016
J	Alexopoulos, AS; Jackson, GL; Edelman, D; Smith, VA; Berkowitz, TSZ; Woolson, SL; Bosworth, HB; Crowley, MJ				Alexopoulos, Anastasia-Stefania; Jackson, George L.; Edelman, David; Smith, Valerie A.; Berkowitz, Theodore S. Z.; Woolson, Sandra L.; Bosworth, Hayden B.; Crowley, Matthew J.			Clinical factors associated with persistently poor diabetes control in the Veterans Health Administration: A nationwide cohort study	PLOS ONE			English	Article							GLYCEMIC CONTROL; GLUCOSE CONTROL; CARE COSTS; TYPE-2; ADULTS; PREDICTORS; COMPLICATIONS; DEPRESSION; MANAGEMENT; ADHERENCE	Objective Patients with persistent poorly-controlled diabetes mellitus (PPDM) despite engagement in clinic-based care are at particularly high risk for diabetes complications and costs. Understanding this population's demographics, comorbidities and care utilization could guide strategies to address PPDM. We characterized factors associated with PPDM in a large sample of Veterans with type 2 diabetes. Methods We identified a cohort of Veterans with medically treated type 2 diabetes, who received Veterans Health Administration primary care during fiscal years 2012 and 2013. PPDM was defined by hemoglobin A1c levels uniformly >8.5% during fiscal year (FY) 2012, despite engagement with care during this period. We used FY 2012 demographic, comorbidity and medication data to describe PPDM in relation to better-controlled diabetes patients and created multivariable models to examine associations between clinical factors and PPDM. We also constructed multivariable models to explore the association between PPDM and FY 2013 care utilization. Results In our cohort of diabetes patients (n = 435,820), 12% met criteria for PPDM. Patients with PPDM were younger than better-controlled patients, less often married, and more often Black/African-American and Hispanic or Latino/Latina. Of included comorbidities, only retinopathy (OR 1.68, 95% confidence interval (CI): 1.63,1.73) and nephropathy (OR 1.26, 95% CI: 1.19,1.34) demonstrated clinically significant associations with PPDM. Complex insulin regimens such as premixed (OR 10.80, 95% CI: 10.11,11.54) and prandial-containing regimens (OR 18.74, 95% CI: 17.73,19.81) were strongly associated with PPDM. Patients with PPDM had higher care utilization, particularly endocrinology care (RR 3.56, 95% CI: 3.47,3.66); although only 26.4% of patients saw endocrinology overall. Conclusion PPDM is strongly associated with complex diabetes regimens, although heterogeneity in care utilization exists. While there is evidence of underutilization, inadequacy of available care may also contribute to PPDM. Our findings should inform tailored approaches to meet the needs of PPDM, who are among the highest-risk, highest-cost patients with diabetes.	[Alexopoulos, Anastasia-Stefania; Jackson, George L.; Edelman, David; Smith, Valerie A.; Berkowitz, Theodore S. Z.; Woolson, Sandra L.; Bosworth, Hayden B.; Crowley, Matthew J.] Durham Vet Affairs Hlth Care Syst, Ctr Innovat Accelerate Discovery & Practice Trans, Durham, NC 27705 USA; [Alexopoulos, Anastasia-Stefania; Crowley, Matthew J.] Duke Univ, Div Endocrinol, Durham, NC 27708 USA; [Jackson, George L.; Smith, Valerie A.; Bosworth, Hayden B.] Duke Univ, Dept Populat Hlth Sci, Durham, NC USA; [Jackson, George L.; Edelman, David; Smith, Valerie A.; Bosworth, Hayden B.] Duke Univ, Div Gen Internal Med, Durham, NC USA; [Bosworth, Hayden B.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Crowley, MJ (corresponding author), Durham Vet Affairs Hlth Care Syst, Ctr Innovat Accelerate Discovery & Practice Trans, Durham, NC 27705 USA.; Crowley, MJ (corresponding author), Duke Univ, Div Endocrinol, Durham, NC 27708 USA.	matthew.crowley@duke.edu		Smith, Valerie/0000-0001-5170-9819; Edelman, David/0000-0001-7112-6151	Veterans Health Administration (VHA) Health Services Research Development [IIR-13-063]; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Transformation [CIN 13-410]; National Institutes of Health [T32DK007012]; Health Services Research & Development Senior Career Scientist Award [RCS 08-027]; Career Development Award from VHA Health Services Research Development [CDA 13-261]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007012] Funding Source: NIH RePORTER	Veterans Health Administration (VHA) Health Services Research Development; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Transformation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Services Research & Development Senior Career Scientist Award; Career Development Award from VHA Health Services Research Development; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from Veterans Health Administration (VHA) Health Services Research & Development (IIR-13-063), URL: https://www.hsrd.research.va.gov/funding/iir.cfm, and by the Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Transformation (CIN 13-410), URL: https://www.durham.hsrd.research.va.gov/).Research reported in this publication was also supported by the National Institutes of Health under Award Number T32DK007012 (ASA), URL: https://researchtraining.nih.gov/programs/training-grants/t32.HBB is supported by a Health Services Research & Development Senior Career Scientist Award (RCS 08-027) URL: https://www.hsrd.research.va.gov/cdp/res_career_scientist.cfm.MJC is supported by a Career Development Award from VHA Health Services Research & Development (CDA 13-261), URL: https://www.hsrd.research.va.gov/cdp/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x; Baxter M, 2016, DIABETIC MED, V33, P1575, DOI 10.1111/dme.13062; Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; Centers for Disease Control and Prevention USD of H and HS, 2017, NAT DIAB STAT REP; Control CfD, 2018, PREV DEPR AD AG 20 U; Crowley MJ, 2016, TELEMED E-HEALTH, V22, P376, DOI 10.1089/tmj.2015.0145; Crowley MJ, 2014, CHRONIC ILLN, V10, P291, DOI 10.1177/1742395314523653; Department of Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Dirmaier J, 2010, PSYCHOTHER PSYCHOSOM, V79, P172, DOI 10.1159/000296135; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egede LE, 2011, DIABETES CARE, V34, P938, DOI 10.2337/dc10-1504; Egede LE, 2011, ANN PHARMACOTHER, V45, P169, DOI 10.1345/aph.1P442; Egede LE, 2010, MED CARE, V48, P527, DOI 10.1097/MLR.0b013e3181d558dc; El-Kebbi IM, 2003, ARCH INTERN MED, V163, P69, DOI 10.1001/archinte.163.1.69; Everett CM, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0823-5; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gilmer TP, 2005, DIABETES CARE, V28, P59, DOI 10.2337/diacare.28.1.59; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Hertz RP, 2005, CLIN THER, V27, P1064, DOI 10.1016/j.clinthera.2005.07.009; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jackson GL, 2018, ANN INTERN MED, V169, P825, DOI 10.7326/M17-1987; Kim S, 2007, DIABETES CARE, V30, P1281, DOI 10.2337/dc06-2070; Kim Y, 2019, J TELEMED TELECARE, V25, P587, DOI 10.1177/1357633X18782599; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Lynch CP, 2015, J GEN INTERN MED, V30, P25, DOI 10.1007/s11606-014-2990-y; McBrien KA, 2013, DIABETES CARE, V36, P1172, DOI 10.2337/dc12-0862; McMahon GT, 2012, DIABETES TECHNOL THE, V14, P1060, DOI 10.1089/dia.2012.0137; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Morgan P, 2017, INQUIRY-J HEALTH CAR, V54, DOI 10.1177/0046958017712762; Nanayakkara N, 2018, DIABETIC MED, V35, P1087, DOI 10.1111/dme.13660; Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273; Preisser JS, 2016, STAT MED, V35, P1722, DOI 10.1002/sim.6804; Reid MW, 2018, DIABETES TECHNOL THE, V20, P370, DOI 10.1089/dia.2017.0450; Richardson LK, 2008, GEN HOSP PSYCHIAT, V30, P509, DOI 10.1016/j.genhosppsych.2008.07.001; Stokes A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170219; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WEATHERSPOON LJ, 1994, DIABETES CARE, V17, P1148, DOI 10.2337/diacare.17.10.1148; Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004; Zuur Alain F., 2009, P1	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214679	10.1371/journal.pone.0214679	http://dx.doi.org/10.1371/journal.pone.0214679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9FO	30925177	Green Submitted, Green Published, gold			2022-12-27	WOS:000462732300027
J	Rancourt, A; Sato, S; Satoh, MS				Rancourt, Ann; Sato, Sachiko; Satoh, Masahiko S.			Dose-dependent spatiotemporal responses of mammalian cells to an alkylating agent	PLOS ONE			English	Article							MISMATCH-REPAIR; DNA-REPAIR; HELA-CELLS; STEM-CELLS; MUTS-ALPHA; POLY(ADP-RIBOSE); O-6-METHYLGUANINE; MECHANISMS; DAMAGE; CYCLE	Cultured cell populations are composed of heterogeneous cells, and previous single-cell lineage tracking analysis of individual HeLa cells provided empirical evidence for significant heterogeneity of the rate of cell proliferation and induction of cell death. Nevertheless, such cell lines have been used for investigations of cellular responses to various substances, resulting in incomplete characterizations. This problem caused by heterogeneity within cell lines could be overcome by investigating the spatiotemporal responses of individual cells to a substance. However, no approach to investigate the responses by analyzing spatiotemporal data is currently available. Thus, this study aimed to analyze the spatiotemporal responses of individual HeLa cells to cytotoxic, sub-cytotoxic, and non-cytotoxic doses of the well-characterized carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Although cytotoxic doses of MNNG are known to induce cell death, the single-cell tracking approach revealed that cell death occurred following at least four different cellular events, suggesting that cell death is induced via multiple processes. We also found that HeLa cells exposed to a sub-cytotoxic dose of MNNG were in a state of equilibrium between cell proliferation and cell death, with cell death again induced through different processes. However, exposure of cells to a non-cytotoxic dose of MNNG promoted growth by reducing the cell doubling time, thus promoting the growth of a sub-population of cells. A single-cell lineage tracking approach could dissect processes leading to cell death in a spatiotemporal manner and the results suggest that spatiotemporal data obtained by tracking individual cells can be used as a new type of bioinformatics data resource that enables the examination of cellular responses to various external substances.	[Rancourt, Ann; Sato, Sachiko] Laval Univ, Fac Med, Lab Glycobiol & Bioimaging, Res Ctr Infect Dis,CHUQ, Quebec City, PQ, Canada; [Rancourt, Ann; Satoh, Masahiko S.] Laval Univ, Lab DNA Damage Responses & Bioimaging, CHUQ, Fac Med, Quebec City, PQ, Canada	Laval University; Laval University	Satoh, MS (corresponding author), Laval Univ, Lab DNA Damage Responses & Bioimaging, CHUQ, Fac Med, Quebec City, PQ, Canada.	masahiko.sato@crchudequebec.ulaval.ca			Canadian Foundation for Innovation [MSS 20155, SS 20155]	Canadian Foundation for Innovation(Canada Foundation for Innovation)	Funded by MSS 20155 Canadian Foundation for Innovation https://www.innovation.ca.SS 20155 Canadian Foundation for Innovation https://www.innovation.ca.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; CHOPRA DP, 1976, J NATL CANCER I, V56, P583, DOI 10.1093/jnci/56.3.583; CHOPRA DP, 1977, J NATL CANCER I, V58, P923, DOI 10.1093/jnci/58.4.923; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; EADIE JS, 1984, NATURE, V308, P201, DOI 10.1038/308201a0; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; HAWN MT, 1995, CANCER RES, V55, P3721; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; MYRNES B, 1982, J CELL BIOCHEM, V20, P381, DOI 10.1002/jcb.240200408; Rancourt A, BIORXIV, DOI [10.1101/319525, DOI 10.1101/319525]; ROBERTS DC, 1970, INT J CANCER, V5, P238, DOI 10.1002/ijc.2910050211; Sato S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23328; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schroering AG, 2007, EXP CELL RES, V313, P292, DOI 10.1016/j.yexcr.2006.10.018; Schroering AG, 2009, CANCER RES, V69, P6307, DOI 10.1158/0008-5472.CAN-09-0899; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; SINGER B, 1968, SCIENCE, V160, P1235, DOI 10.1126/science.160.3833.1235; SMITH GJ, 1983, MUTAT RES, V111, P405, DOI 10.1016/0027-5107(83)90036-2; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Strauss B, 1975, Basic Life Sci, V5A, P13; Tominaga Y, 1997, CARCINOGENESIS, V18, P889, DOI 10.1093/carcin/18.5.889; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZHUKOVSKAYA N, 1994, CARCINOGENESIS, V15, P2189, DOI 10.1093/carcin/15.10.2189; [No title captured]	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214512	10.1371/journal.pone.0214512	http://dx.doi.org/10.1371/journal.pone.0214512			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925183	Green Submitted, Green Published, gold			2022-12-27	WOS:000462732300016
J	Chen, L; Zhao, X				Chen, Long; Zhao, Xia			Characterization of air flow and lung function in the pulmonary acinus by fluid-structure interaction in idiopathic interstitial pneumonias	PLOS ONE			English	Article							FUNCTION TESTS; CLASSIFICATION; FIBROSIS; MOTION; DIAGNOSIS; DISEASE; UPDATE; MODELS	Background and objective The idiopathic interstitial pneumonias (IIPs) are diffuse parenchymal lung disorders that are associated with substantial morbidity and mortality. Early diagnosis and disease stratification of IIP patients are important because these are related with the treatment and prognosis. Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) are two major distinctive pathologic patterns of pulmonary fibrosis. We researched the application of the fluid-structure interaction (FSI) to the respiratory system and compared the pulmonary acinus mechanics and functions in healthy and IIP models. Methods The human pulmonary alveolus is idealized by a three-dimensional honeycomb-like geometry, and a fluid-structure interaction analysis is performed to study the normal and diseased breathing mechanics. The computational domain consists of two generations of alveolar ducts within the pulmonary acinus, with alveolar geometries approximated as closely packed 14-sided polygons. Findings In a normal breathing cycle, the flow rate of the healthy model is significantly larger than that of the NSIP and IPF models. Similar trends are observed for the volume change and the maximum pressure drop. The flow rate and the volume change of the NSIP are almost the same as those of IPF. The maximum pressure drop of NSIP is 5.5% larger than that of IPF. There is a 47% decrease in the pulmonary acinus compliance for the NSIP and IPF compared with that of the healthy model. The acinus resistances of NSIP and IPF are higher than those of the healthy lung by 6.4 similar to 11.2%. In particular, the pulmonary acinus resistance of the NSIP lung is higher than that of the IPF lung by 4.5%. Conclusions Our study demonstrates the differences of air flow and lung function in the pulmonary acinus between the healthy and the IIP models. These changes in the lung are important considerations for early diagnosis and disease stratification in patients. Patient-based geometry can to be included in the computational models in future studies.	[Chen, Long] Nanjing Univ Aeronaut & Astronaut, Coll Aerosp Engn, Nanjing, Jiangsu, Peoples R China; [Zhao, Xia] Nanjing Univ Chinese Med, Dept Rheumatol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics; Nanjing University of Chinese Medicine	Zhao, X (corresponding author), Nanjing Univ Chinese Med, Dept Rheumatol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China.	zhaoxia31600906@sina.com			Cultivation Project of Jiangsu Province Hospital of Traditional Chinese Medicine [Y17006]	Cultivation Project of Jiangsu Province Hospital of Traditional Chinese Medicine	This work was supported by the Cultivation Project of Jiangsu Province Hospital of Traditional Chinese Medicine (Grant No. Y17006).	Aghasafari P, 2019, J GERONTOL A-BIOL, V74, P139, DOI 10.1093/gerona/gly097; Bavo AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154517; Benito S, 1991, PULMONARY COMPLIANCE, V13, P86; Brusasco V, 1986, CLIN TESTS RESP FUNC; Bungartz H.-J., 2006, LECT NOTES COMPUTATI, V53; CHERNIACK RM, 1995, AM J RESP CRIT CARE, V151, P1180; Cottin V, 2017, AM J RESP CRIT CARE, V196, P1162, DOI 10.1164/rccm.201612-2492OC; Dailey HL, 2007, J AEROSOL SCI, V38, P269, DOI 10.1016/j.jaerosci.2007.01.001; Dempsey TM, 2018, MAYO CLIN PROC, V93, P763, DOI 10.1016/j.mayocp.2018.04.009; Denny E, 1997, J BIOMECH ENG-T ASME, V119, P289, DOI 10.1115/1.2796093; Domino S, 2015, SANDIA NATL LAB SAND; Dutta A, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039680; Edwards HC, 2010, SANDIA NATL LAB SAND; Fernandez E, 1985, Adv Psychosom Med, V14, P149; FUNG YC, 1988, J APPL PHYSIOL, V64, P2132, DOI 10.1152/jappl.1988.64.5.2132; HAEFELIBLEUER B, 1988, ANAT RECORD, V220, P401, DOI 10.1002/ar.1092200410; Harris R Scott, 2005, Respir Care, V50, P78; HEISTRACHER T, 1995, J AEROSOL SCI, V26, P497, DOI 10.1016/0021-8502(94)00113-D; Heroux M, 2003, SANDIA NATL LAB SAND; Hofemeier P, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027328; Hutchinson JP, 2016, EUR RESPIR J, V48, P1453, DOI 10.1183/13993003.00378-2016; Katzenstein ALA, 2000, AM J SURG PATHOL, V24, P1, DOI 10.1097/00000478-200001000-00001; Kim JongWon, 2017, Med Sci (Basel), V5, DOI 10.3390/medsci5040021; Kim J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183654; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kolanjiyil AV, 2017, J AEROSOL SCI, V114, P301, DOI 10.1016/j.jaerosci.2017.10.001; Koshiyama K, 2019, CLIN BIOMECH, V66, P32, DOI 10.1016/j.clinbiomech.2018.01.001; Lai-Fook SJ, 2000, J APPL PHYSIOL, V89, P163, DOI 10.1152/jappl.2000.89.1.163; Li XYS, 2003, ACM T MATH SOFTWARE, V29, P110, DOI 10.1145/779359.779361; Montaudon M, 2007, J ANAT, V211, P579, DOI 10.1111/j.1469-7580.2007.00811.x; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006; Oakes JM, 2016, J BIOMECH, V49, P2213, DOI 10.1016/j.jbiomech.2015.11.026; Oakes JM, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000870; Ostrovski Y, 2016, INT J NANOMED, V11, P3385, DOI 10.2147/IJN.S102138; Politi AZ, 2010, J THEOR BIOL, V266, P614, DOI 10.1016/j.jtbi.2010.07.032; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rendall TCS, 2009, J COMPUT PHYS, V228, P6231, DOI 10.1016/j.jcp.2009.05.013; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Saad SMI, 2010, COLLOID SURFACE A, V354, P34, DOI 10.1016/j.colsurfa.2009.07.046; Salvatore M, 2018, CLIN IMAG, V51, P332, DOI 10.1016/j.clinimag.2018.06.013; Smith ML, 2016, ARCH PATHOL LAB MED, V140, P221, DOI 10.5858/arpa.2015-0288-SA; Sud A, 2001, CLIN RHEUMATOL, V20, P177, DOI 10.1007/s100670170060; Sverzellati N, 2015, RADIOGRAPHICS, V35, P1849, DOI 10.1148/rg.2015140334; Sznitman J, 2007, J BIOMECH ENG-T ASME, V129, P658, DOI 10.1115/1.2768109; Tehrani JN, 2015, PHYS MED BIOL, V60, P8833, DOI 10.1088/0031-9155/60/22/8833; Travis WD, 2000, AM J SURG PATHOL, V24, P19, DOI 10.1097/00000478-200001000-00003; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; West J.B., 2012, RESP PHYSL ESSENTIAL; Xia GH, 2010, ANN BIOMED ENG, V38, P1836, DOI 10.1007/s10439-010-9956-y; YEH HC, 1980, B MATH BIOL, V42, P461, DOI 10.1007/BF02460796; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	52	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214441	10.1371/journal.pone.0214441	http://dx.doi.org/10.1371/journal.pone.0214441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921412	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000069
J	Derbyshire, MC; Denton-Giles, M; Hane, JK; Chang, S; Mousavi-Derazmahalleh, M; Raffaele, S; Buchwaldt, L; Kamphuis, LG				Derbyshire, Mark Charles; Denton-Giles, Matthew; Hane, James K.; Chang, Steven; Mousavi-Derazmahalleh, Mahsa; Raffaele, Sylvain; Buchwaldt, Lone; Kamphuis, Lars G.			A whole genome scan of SNP data suggests a lack of abundant hard selective sweeps in the genome of the broad host range plant pathogenic fungus Sclerotinia sclerotiorum	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; FUNGICIDE RESISTANCE; POPULATIONS; EVOLUTION; SEQUENCE; RECOMBINATION; ADAPTATION; ALIGNMENT; PROGRAM; GENE	The pathogenic fungus Sclerotinia sclerotiorum infects over 600 species of plant. It is present in numerous environments throughout the world and causes significant damage to many agricultural crops. Fragmentation and lack of gene flow between populations may lead to population sub-structure. Within discrete recombining populations, positive selection may lead to a 'selective sweep'. This is characterised by an increase in frequency of a favourable allele leading to reduction in genotypic diversity in a localised genomic region due to the phenomenon of genetic hitchhiking. We aimed to assess whether isolates of S. sclerotiorum from around the world formed genotypic clusters associated with geographical origin and to determine whether signatures of population-specific positive selection could be detected. To do this, we sequenced the genomes of 25 isolates of S. sclerotiorum collected from four different continents-Australia, Africa (north and south), Europe and North America (Canada and the northen United States) and conducted SNP based analyses of population structure and selective sweeps. Among the 25 isolates, there was evidence for two major population clusters. One of these consisted of 11 isolates from Canada, the USA and France (population 1), and the other consisted of nine isolates from Australia and one from Morocco (population 2). The rest of the isolates were genotypic outliers. We found that there was evidence of outcrossing in these two populations based on linkage disequilibrium decay. However, only a single candidate selective sweep was observed, and it was present in population 2. This sweep was close to a Major Facilitator Superfamily transporter gene, and we speculate that this gene may have a role in nutrient uptake from the host. The low abundance of selective sweeps in the S. sclerotiorum genome contrasts the numerous examples in the genomes of other fungal pathogens. This may be a result of its slow rate of evolution and low effective recombination rate due to self-fertilisation and vegetative reproduction.	[Derbyshire, Mark Charles; Denton-Giles, Matthew; Hane, James K.; Chang, Steven; Mousavi-Derazmahalleh, Mahsa; Kamphuis, Lars G.] Curtin Univ, Ctr Crop & Dis Management, Perth, WA, Australia; [Mousavi-Derazmahalleh, Mahsa] Univ Western Australia, UWA Sch Agr & Environm, Perth, WA, Australia; [Raffaele, Sylvain] Univ Toulouse, Lab Interact Plantes Microorganismes LIPM, Toulouse, France; [Buchwaldt, Lone] Saskatoon Res & Dev Ctr, Agr & Agri Food Canada, Saskatoon, SK, Canada	Curtin University; University of Western Australia; Universite de Toulouse; Agriculture & Agri Food Canada	Derbyshire, MC (corresponding author), Curtin Univ, Ctr Crop & Dis Management, Perth, WA, Australia.	mark.derbyshire@curtin.edu.au	Kamphuis, Lars/GVU-9293-2022; Mousavi-Derazmahalleh, Mahsa/AAH-3001-2020; Kamphuis, Lars G/B-5360-2011; Kamphuis, Lars/X-3458-2019; Hane, James/A-7062-2011; Raffaele, Sylvain/K-6673-2019	Kamphuis, Lars G/0000-0002-9042-0513; Kamphuis, Lars/0000-0002-9042-0513; Hane, James/0000-0002-7651-0977; Raffaele, Sylvain/0000-0002-2442-9632; Denton-Giles, Matthew/0000-0001-8953-871X; Mousavi-Derazmahalleh, Mahsa/0000-0002-2299-2050; Derbyshire, Mark/0000-0001-5302-9868	Grains Research and Development Corporation of (GRDC) Australia [CUR00023]; Centre for Crop and Disease Management in Curtin University [CUR00023]; GRDC; European Research Council [ERC StG 336808]; French Laboratory of Excellence project TULIP [ANR 10 LABX 41, ANR 11 IDEX 0002 02]; Curtin University	Grains Research and Development Corporation of (GRDC) Australia(Grains R&D Corp); Centre for Crop and Disease Management in Curtin University; GRDC; European Research Council(European Research Council (ERC)European Commission); French Laboratory of Excellence project TULIP; Curtin University	MCD, MD-G and LGK are funded through a bilateral agreement between the Grains Research and Development Corporation of (GRDC) Australia and the Centre for Crop and Disease Management in Curtin University on grant number CUR00023. Steven Chang and James K Hane are also funded by the GRDC through a bilateral agreement with the Curtin University. The GRDC had no role in developing this study. SR is supported by a starting grant of the European Research Council (ERC StG 336808) and the French Laboratory of Excellence project TULIP (ANR 10 LABX 41; ANR 11 IDEX 0002 02). Neither of these funding bodies had any role in developing this study.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andrew M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029943; Attanayake RN, 2014, HEREDITY, V113, P353, DOI 10.1038/hdy.2014.37; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Badet T, 2017, ELIFE, V6, DOI 10.7554/eLife.22472; Badouin H, 2017, MOL ECOL, V26, P2041, DOI 10.1111/mec.13976; Bandyopadhyay B, 1999, ANN NY ACAD SCI, V894, P28, DOI 10.1111/j.1749-6632.1999.tb08040.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burdon JJ, 2016, PHYTOPATHOLOGY, V106, P1117, DOI 10.1094/PHYTO-01-16-0036-FI; Carbone I, 2001, MOL ECOL, V10, P2409, DOI 10.1046/j.0962-1083.2001.01380.x; Carbone I, 2001, MOL ECOL, V10, P947, DOI 10.1046/j.1365-294X.2001.01244.x; Carpenter MA, 1999, NEW ZEAL J CROP HORT, V27, P13, DOI 10.1080/01140671.1999.9514075; Chen WJ, 2007, APPL ENVIRON MICROB, V73, P5162, DOI 10.1128/AEM.00507-07; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clarkson JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00490; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Delmas CEL, 2017, MOL ECOL, V26, P1936, DOI 10.1111/mec.14006; Derbyshire MC, 2016, PLANT PATHOL, V65, P859, DOI 10.1111/ppa.12517; Derbyshire M, 2017, GENOME BIOL EVOL, V9, P593, DOI 10.1093/gbe/evx030; dos Santos SC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00180; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Fabre F, 2015, EVOL APPL, V8, P919, DOI 10.1111/eva.12304; Grimmer MK, 2015, PEST MANAG SCI, V71, P207, DOI 10.1002/ps.3781; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haasl RJ, 2016, MOL ECOL, V25, P5, DOI 10.1111/mec.13339; Hartmann FE, 2018, MOL ECOL, V27, P2725, DOI 10.1111/mec.14711; Haubold B, 2015, BIOINFORMATICS, V31, P1169, DOI 10.1093/bioinformatics/btu815; Hayes LE, 2016, PLANT DIS, V100, P483, DOI 10.1094/PDIS-02-15-0214-RE; Heick TM, 2017, EUR J PLANT PATHOL, V149, P669, DOI 10.1007/s10658-017-1216-7; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Kamvar ZN, 2017, PEERJ, V5, DOI 10.7717/peerj.4152; Keane TM, 2013, BIOINFORMATICS, V29, P389, DOI 10.1093/bioinformatics/bts697; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Leggett Richard M., 2013, Frontiers in Genetics, V4, P288, DOI 10.3389/fgene.2013.00288; Lehner MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173915; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long HG, 2016, GENOME BIOL EVOL, V8, P3815, DOI 10.1093/gbe/evw286; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Maude RB, 1997, PLANT PATHOGENS WORL, V34, P109; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Mohd-Assaad N, 2018, GENOME BIOL EVOL, V10, P1315, DOI 10.1093/gbe/evy087; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; Pavlidis P, 2017, J BIOL RES-THESSALON, V24, DOI 10.1186/s40709-017-0064-0; Pavlidis P, 2013, MOL BIOL EVOL, V30, P2224, DOI 10.1093/molbev/mst112; Pereira MF, 2013, J MICROBIOL, V51, P70, DOI 10.1007/s12275-013-2393-5; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pool JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003080; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Sun JM, 2005, J INTEGR PLANT BIOL, V47, P385, DOI 10.1111/j.1744-7909.2005.00077.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	67	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214201	10.1371/journal.pone.0214201	http://dx.doi.org/10.1371/journal.pone.0214201			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921376	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000040
J	Harvey, C; Hegney, D; Sobolewska, A; Chamberlain, D; Wood, E; Wirihana, L; Mclellan, S; Hendricks, J; Wake, T				Harvey, Clare; Hegney, Desley; Sobolewska, Agnieszka; Chamberlain, Diane; Wood, Elspeth; Wirihana, Lisa; Mclellan, Sandy; Hendricks, Joyce; Wake, Troy			Developing a community-based nursing and midwifery career pathway - A narrative systematic review	PLOS ONE			English	Review							PRIMARY-HEALTH-CARE; GRADUATE NURSES; AUSTRALIA VIEWS; NEW-ZEALAND; TRANSITION; TEAMS; EXPERIENCES; WORKFORCE; WORK	Introduction Community nursing and midwifery is changing in response to a shift in care from hospital to home, brought about by increasing costs to care because of an aging population and increasing chronicity. Until now, community nursing positions and scope of practice has been dependent on service focus and location, which has led to the role being unclearly defined. Lack of appeal for a career in community practice and a looming workforce shortage necessitates a review into how community nursing and midwifery transition to practice is supported. Methods This review sought to identify, assess and summarize available evidence relating to transitioning into community nursing and midwifery practice as a speciality. A systematic review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses approach. A narrative synthesis was then undertaken on papers that examined community nursing and midwifery pathway perspectives which define, and enable or inhibit a contemporary pathway. Thematic analysis used a theoretical framework developed for early career and rapid transition to nursing specialty practice. Results There is a paucity of research that identifies community nursing and midwifery as a discreet scope of practice. Twelve papers were eventually included in the review. Verbatim findings were extracted from the papers and clustered into categories based on the chosen theoretical framework. Major themes were 'the self' (professional and personal); 'transition processes'; and, a 'sense of belonging'. Sub themes included narrative identifying inhibitors and enablers in each theme. Discussion No definition of community practice or pathway was identified in nursing, although midwifery was clearly defined. Community nursing practice was described as generalist in nature although specialist knowledge is required. Being part of the community in the professional sense and personal sense was considered important. The importance of transition was identified where pre-entry exposure to community practice was seen as important. Stages in transition to practice were recognised as pre-entry; incomer; insider; and, a sense of belonging. The process of transition should be planned and individualised acknowledging past experience whilst acknowledging the specialist nature of community-based practice.	[Harvey, Clare; Wood, Elspeth] Cent Queensland Univ, Sch Nursing Midwifery & Social Sci, Townsville Campus, Townsville, Qld, Australia; [Hegney, Desley; Sobolewska, Agnieszka] Cent Queensland Univ, Res Div, Brisbane Campus, Brisbane, Qld, Australia; [Hegney, Desley] Univ Adelaide, Nursing Sch, Adelaide, SA, Australia; [Chamberlain, Diane] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia; [Wirihana, Lisa] Cent Queensland Univ, Sch Nursing Midwifery & Social Sci, Noosa Campus, Noosa, Qld, Australia; [Mclellan, Sandy] Cent Queensland Univ, Sch Nursing Midwifery & Social Sci, Mackay Campus, Mackay, Qld, Australia; [Hendricks, Joyce] Cent Queensland Univ, Sch Nursing Midwifery & Social Sci, Bundaberg Campus, Bundaberg, Qld, Australia; [Wake, Troy] Mackay Hlth Serv, Dept Hlth, Proserpine, Qld, Australia	Central Queensland University; Central Queensland University; University of Adelaide; Flinders University South Australia; Central Queensland University; Central Queensland University; Central Queensland University	Harvey, C (corresponding author), Cent Queensland Univ, Sch Nursing Midwifery & Social Sci, Townsville Campus, Townsville, Qld, Australia.	c.l.harvey@cqu.edu.au	Hegney, Desley/U-8004-2019; Harvey, Clare/N-1679-2019; Wood, Elspeth/AAE-1885-2022; Wood, Elspeth/ABD-9689-2021	Hegney, Desley/0000-0003-1267-1760; Harvey, Clare/0000-0001-9016-8840; Wood, Elspeth/0000-0002-2021-9152; Chamberlain, Diane/0000-0002-4157-9966; Sobolewska, Agnieszka/0000-0001-7712-7921	Queensland Health, Office of the Chief Nurse and Midwife, Health Innovation, Investment and Research Office through Mackay Hospital and Health Service; Queensland Health, Office of the Chief Nurse and Midwife through Mackay Hospital and Health Service	Queensland Health, Office of the Chief Nurse and Midwife, Health Innovation, Investment and Research Office through Mackay Hospital and Health Service; Queensland Health, Office of the Chief Nurse and Midwife through Mackay Hospital and Health Service	This project is funded by Queensland Health, Office of the Chief Nurse and Midwife, Health Innovation, Investment and Research Office, through the sponsor, Mackay Hospital and Health Service. This research is not subject to results-dependent funding or veto of publication by the sponsor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project is funded by Queensland Health, Office of the Chief Nurse and Midwife through the sponsor, Mackay Hospital and Health Service. This research is not subject to results-dependant funding or veto of publication by the sponsor.	Abou Elnour A, 2015, AUSTRALAS MED J, V8, P320, DOI 10.4066/AMJ.2015.2508; Aranda K, 2005, J ADV NURS, V51, P131, DOI 10.1111/j.1365-2648.2005.03476.x; Ashley C, 2018, J CLIN NURS, V27, P661, DOI 10.1111/jocn.13984; Ashley C, 2018, J CLIN NURS, V27, P355, DOI 10.1111/jocn.13930; Austin L, 2006, J ADV NURS, V54, P542, DOI 10.1111/j.1365-2648.2006.03868_1.x; Australian Health Ministers' Advisory Council, 2017, NATL STRATEGIC FRAME; Bakon S, 2018, NURSE EDUC PRACT, V28, P80, DOI 10.1016/j.nepr.2017.10.009; Barends Eric., 2018, EVIDENCE BASED MANAG; Barlow A, 2004, EVIDENCE BASED MIDWI, V2, P4; Barrett A, 2016, CONTEMP NURSE, V52, P119, DOI 10.1080/10376178.2016.1198234; Betony K, 2013, NURS EDUC TODAY, V33, P1136, DOI 10.1016/j.nedt.2012.12.007; Booker C, 2018, FRAMEWORK LIFELONG L; Coddington R, 2017, WOMEN BIRTH, V30, P70, DOI 10.1016/j.wombi.2016.08.001; Commonwealth of Australia, 2011, NAT HLTH FUND POOL; Darvill A, 2014, Compr Child Adoles N, V37, P6, DOI 10.3109/01460862.2013.855841; Fenwick J, 2012, J CLIN NURS, V21, P2054, DOI 10.1111/j.1365-2702.2012.04090.x; Fox R, 2015, FRAMEWORK LIFELONG L; Freund T, 2015, INT J NURS STUD, V52, P727, DOI 10.1016/j.ijnurstu.2014.11.014; Gao Y, 2014, MIDWIFERY, V30, P447, DOI 10.1016/j.midw.2013.04.004; Gohery P, 2013, INTENS CRIT CARE NUR, V29, P321, DOI 10.1016/j.iccn.2013.06.002; Gray M, 2016, MIDWIFERY, V42, P74, DOI 10.1016/j.midw.2016.09.018; Halcomb E, 2017, J CLIN NURS, V26, P535, DOI 10.1111/jocn.13479; Halcomb E, 2016, J CLIN NURS, V25, P1193, DOI 10.1111/jocn.13224; Harris M, 2017, COORDINATION CARE PR; Hartman SA, 2018, J NURS EDUC, V57, P630, DOI 10.3928/01484834-20180921-13; Harvey C, 2018, FACILITATING PATHWAY; Hegney D, BMC NURSING; Henderson J, 2018, HEALTH SOC CARE COMM, V26, P80, DOI 10.1111/hsc.12464; Homer CSE, 2009, MIDWIFERY, V25, P673, DOI 10.1016/j.midw.2007.11.003; Hunter B, 2004, MIDWIFERY, V20, P261, DOI 10.1016/j.midw.2003.12.004; Jacelon C, 2015, REHABIL NURS, V40, P12, DOI 10.1002/rnj.176; Jackson N, 2005, HEALTH PROMOT INT, V20, P367, DOI 10.1093/heapro/dai022; Jost Sandra G, 2010, Nurs Adm Q, V34, P208, DOI 10.1097/NAQ.0b013e3181e7032c; Keleher H, 2010, AUST J PRIM HEALTH, V16, P211, DOI 10.1071/PY09064; Kemp L, 2005, PUBLIC HEALTH NURS, V22, P254, DOI 10.1111/j.0737-1209.2005.220309.x; King N, 2003, SOC WORK HEALTH CARE, V38, P51, DOI 10.1300/J010v38n02_03; Kruske S, 2016, MIDWIFERY, V40, P1, DOI 10.1016/j.midw.2016.05.004; Lazenbatt A, 2000, NT RES, V5, P178; Lea J, 2007, Rural Remote Health, V7, P814; Lea J, 2017, J NURS MANAGE, V25, P176, DOI 10.1111/jonm.12453; Lea J, 2015, J CLIN NURS, V24, P2826, DOI 10.1111/jocn.12890; Lea J, 2015, J CLIN NURS, V24, P948, DOI 10.1111/jocn.12720; McInnes S, 2015, NURSE EDUC PRACT, V15, P443, DOI 10.1016/j.nepr.2015.04.004; McKenna H, 2004, PRIM HEALTH CARE RES, V5, P77; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Morphet J, 2017, J ADV NURS, V73, P1970, DOI 10.1111/jan.13279; Patterson E., 2005, AUSTR J PRIMARY HLTH, V11, P47, DOI DOI 10.1071/PY05007; Pesut DJ, 2004, J NURS SCHOLARSHIP, V36, P2, DOI 10.1111/j.1547-5069.2004.04002.x; Phelan A, 2018, J ADV NURS, V74, P626, DOI 10.1111/jan.13466; Popay J., 2006, PRODUCT ESRC METHODS, DOI DOI 10.13140/2.1.1018.4643; Price Kay, 2006, Collegian, V13, P16, DOI 10.1016/S1322-7696(08)60535-1; Procter N, 2011, INT J NURS PRACT, V17, P254, DOI 10.1111/j.1440-172X.2011.01932.x; PROSPERO, 2016, INT PROSP REG SYST R; Schwartz L, 2011, ARCH PSYCHIAT NURS, V25, P153, DOI 10.1016/j.apnu.2010.08.001; Sherman RO, 2013, J NURS MANAGE, V21, P899, DOI 10.1111/jonm.12188; Simons L, 2006, PRIMARY CARE MENTAL, V4, P121; Smith JC, 2017, RURAL REMOTE HEALTH, V17, DOI [10.22605/RRH4256, 10.22605/rrh4256]; Speed S, 2006, SOCIOL HEALTH ILL, V28, P883, DOI 10.1111/j.1467-9566.2006.00511.x; Spoorenberg SLW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190751; The Joanna Briggs Institute, 2014, J BRIGGS I SYST REV; Tierney O, 2018, WOMEN BIRTH, V31, pE210, DOI 10.1016/j.wombi.2017.09.009; Wenger E., 1999, COMMUNITIES PRACTICE; WHO, 2008, WORLD HLTH REPORT 20; World Health Organisation, 1974, TECHN REP SER, V558; World Health Organization, 2017, HUM RES OBS SER, V18; World Health Organization, 1978, DECL ALM AT, DOI DOI 10.1016/S0140-6736(79)90622-6	66	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0211160	10.1371/journal.pone.0211160	http://dx.doi.org/10.1371/journal.pone.0211160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921338	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000009
J	Mwangome, M; Ngari, M; Bwahere, P; Kabore, P; McGrath, M; Kerac, M; Berkley, JA				Mwangome, Martha; Ngari, Moses; Bwahere, Paluku; Kabore, Patrick; McGrath, Marie; Kerac, Marko; Berkley, James A.			Anthropometry at birth and at age of routine vaccination to predict mortality in the first year of life: A birth cohort study in BukinaFaso	PLOS ONE			English	Article							SEVERE ACUTE MALNUTRITION; INFANTS; RELIABILITY	Background The World Health Organization currently defines severe acute malnutrition (SAM) in infants aged under 6 months of age using weight-for-length Z score (WLZ). Given widespread use of mid-upper arm circumference (MUAC) for identifying SAM in older children and weight-for-age (WAZ) for growth monitoring, there is increasing debate about the optimal anthropometric criteria to best identify infants u6m at-risk of mortality. Objective To determine the discriminatory value for mortality during the first 12 months of life of anthropometry taken at birth and at age two months (approximate age of routine vaccination). Design Data were analyzed from a birth cohort recruited between April and December of 2004 at four health facilities within Bansalogho District in Burkina Faso. Infants were followed up for 12 months. Mortality risks were estimated using hazards ratios (HR). Discriminatory value was assessed using receiver operating characteristic curves. Results Of 1,103 infants, 227 (21%) were low birthweight (LBW). During 12 months, 86 (7.8%) infants died; 38 (44%) among the LBW group. At birth, MUAC<9.0cm, weight<2.5kg, length<44.2cm and incalculable WLZ were associated with mortality. Sixty (70%) deaths occurred after the age of two months; 26 (43%) among LBW infants. At age two months, any MUAC <11.5cm, weight <3.8kg (WAZ<-3) and length <52.4cm (LAZ<-3) were associated with risk of mortality. WLZ was not associated with mortality at any threshold. Birth weight did not modify the effect of the association between month two MUAC and one-year mortality (P = 0.33). Conclusion Infants at heightened risk of mortality and are better identified during early infancy by MUAC or WFA than by WLZ. LBW infants with low anthropometry at the age of routine immunizations remain at elevated risk than normal birth weight (NBW)infants and require intervention. Effectiveness, cost-effectiveness and coverage of applying proposed thresholds should be investigated as a priority to inform policy and practice.	[Mwangome, Martha; Ngari, Moses; Berkley, James A.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Mwangome, Martha; Ngari, Moses; Berkley, James A.] Childhood Acute Illness & Nutr Network, Nairobi, Kenya; [Bwahere, Paluku] Univ Libre Bruxelles, Sch Publ Hlth, Ctr Res Epidemiol Biostat & Clin Res, Brussels, Belgium; [Bwahere, Paluku] Valid Int, Oxford, England; [Kabore, Patrick] World Hlth Org, Africa Reg Off, Brazzaville, Rep Congo; [McGrath, Marie] Emergency Nutr Network, Oxford, England; [Kerac, Marko] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Berkley, James A.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England	Universite Libre de Bruxelles; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Mwangome, M (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.; Mwangome, M (corresponding author), Childhood Acute Illness & Nutr Network, Nairobi, Kenya.	mmwangome@kemri-wellcome.org	Kerac, Marko/GQR-1136-2022; Kerac, Marko/G-1777-2010; Mwangome, Martha/AFO-0988-2022	Kerac, Marko/0000-0002-3745-7317; Mwangome, Martha/0000-0003-4806-1307; McGrath, Marie/0000-0002-0660-1873; Berkley, James/0000-0002-1236-849X	Irish Aid funding [HQPU/2018/ENN]; Joint Global Health Trials grant [MR/N021940/1]; Bill & Melinda Gates Foundation [OPP1131320]; MRC [MR/M007367/1, MR/N021940/1] Funding Source: UKRI	Irish Aid funding; Joint Global Health Trials grant; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Irish Aid funding https://www.irishaid.ie/to Emergency Nutrition Network grant number HQPU/2018/ENN to M. McGrath, Joint Global Health Trials grant https://mrc.ukri.org/funding/to M. Mwangome (MR/N021940/1) and Bill & Melinda Gates Foundation grant https://www.gatesfoundation.org/number [OPP1131320] to James Berkley.	Ale FGB, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0149-5; Corbett M., 2000, SEVERE MALNUTRITION; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Elizabeth NL, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-54; Garner P, 2000, ARCH DIS CHILD, V82, P197, DOI 10.1136/adc.82.3.197; Grijalva-Eternod CS, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12345; Thi HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142420; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Kabore P, 2004, ARCH PEDIATRIE, V11, P807, DOI 10.1016/j.arcped.2004.03.034; Kabore P, 2009, J PEDIAT PUERICULTUR, V22, P121; Kerac M, 2018, PEERJ; Kerac M, 2011, ARCH DIS CHILD, V96, P1008, DOI 10.1136/adc.2010.191882; Knops Noel B B, 2005, BMC Pediatr, V5, P26, DOI 10.1186/1471-2431-5-26; Kumar RK, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00020; Lelijveld N., 2017, REV METHODS DETECT C; Marchant T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-624; Mwangome M, 2017, AM J CLIN NUTR, V105, P1415, DOI 10.3945/ajcn.116.149815; Mwangome MK, 2014, MATERN CHILD NUTR, V10, P474, DOI 10.1111/mcn.12124; Mwangome MK, 2012, B WORLD HEALTH ORGAN, V90, P887, DOI 10.2471/BLT.12.109009; Mwangome MK, 2012, TROP MED INT HEALTH, V17, P622, DOI 10.1111/j.1365-3156.2012.02959.x; Oberlin O, 2008, FIELD EXCHANGE; Otupiri E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106712; Romano C, 2018, DEV MED CHILD NEUROL, V60, P892, DOI 10.1111/dmcn.13921; Seema, 1997, J TROP PEDIATRICS, V43, P213, DOI 10.1093/tropej/43.4.213; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNT REG; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Villar J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2467; Villar J, 2015, LANCET GLOB HEALTH, V3, pE681, DOI 10.1016/S2214-109X(15)00163-1; Vygen SB, 2013, J PEDIATR-US, V162, P515, DOI 10.1016/j.jpeds.2012.09.008; WHO, 2013, GUID UPD MAN SEV AC; World Health Organization, 2006, WHO CHILD GROWTH STA	32	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213523	10.1371/journal.pone.0213523	http://dx.doi.org/10.1371/journal.pone.0213523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921335	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000462594000018
J	Sidhu, JS; Ramakrishnan, SM; Ali, S; Bernardo, A; Bai, GH; Abdullah, S; Ayana, G; Sehgal, SK				Sidhu, Jagdeep Singh; Ramakrishnan, Sai Mukund; Ali, Shaukat; Bernardo, Amy; Bai, Guihua; Abdullah, Sidrat; Ayana, Girma; Sehgal, Sunish K.			Assessing the genetic diversity and characterizing genomic regions conferring Tan Spot resistance in cultivated rye	PLOS ONE			English	Article							SECALE-CEREALE L.; WIDE ASSOCIATION; PHYLOGENETIC-RELATIONSHIPS; CORE COLLECTION; WHEAT; TRAITS; MARKER; ESTABLISHMENT; INFORMATION; COMPONENTS	Rye (Secale cereale L.) is known for its wide adaptation due to its ability to tolerate harsh environments in semiarid areas. To assess the diversity in rye we genotyped a panel of 178 geographically diverse accessions of four Secale sp. from U.S. National Small Grains Collection using 4,037 high-quality SNPs (single nucleotide polymorphisms) developed by genotyping-by-sequencing (GBS). PCA and STRUCTURE analysis revealed three major clusters that separate S. cereale L. from S. strictum and S. sylvestre, however, genetic clusters did not correlate with geographic origins and growth habit (spring/winter). The panel was evaluated for response to Pyrenophora tritici-repentis race 5 (PTR race 5) and nearly 59% accessions showed resistance or moderate resistance. Genome-wide association study (GWAS) was performed on S. cereale subsp. cereale using the 4,037 high-quality SNPs. Two QTLs (QTs.sdsu-5R and QTs.sdsu-2R) on chromosomes 5R and 2R were identified conferring resistance to PTR race 5 (p < 0.001) that explained 13.1% and 11.6% of the phenotypic variation, respectively. Comparative analysis showed a high degree of synteny between rye and wheat with known rearrangements as expected. QTs.sdsu-2R was mapped in the genomic region corresponding to wheat chromosome group 2 and QTs. sdsu-5R was mapped to a small terminal region on chromosome 4BL. Based on the genetic diversity, a set of 32 accessions was identified to represents more than 99% of the allelic diversity with polymorphic information content (PIC) of 0.25. This set can be utilized for genetic characterization of useful traits and genetic improvement of rye, triticale, and wheat.	[Sidhu, Jagdeep Singh; Ramakrishnan, Sai Mukund; Ali, Shaukat; Abdullah, Sidrat; Ayana, Girma; Sehgal, Sunish K.] South Dakota State Univ, Dept Agron Hort & Plant Sci, Brookings, SD 57007 USA; [Bernardo, Amy] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Bai, Guihua] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS USA	South Dakota State University; Kansas State University; United States Department of Agriculture (USDA)	Sehgal, SK (corresponding author), South Dakota State Univ, Dept Agron Hort & Plant Sci, Brookings, SD 57007 USA.	sunish.sehgal@sdstate.edu		SEHGAL, SUNISH/0000-0001-5644-7547	USDA hatch project [SD00H538-15]; USDA-CAP [2016-68004-24768]; South Dakota Wheat Commission [3X7262, 3X8258]	USDA hatch project; USDA-CAP; South Dakota Wheat Commission	This project was collectively funded by the USDA hatch project SD00H538-15, USDA-CAP 2016-68004-24768 and South Dakota Wheat Commission 3X7262 and 3X8258. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah S, 2017, PLANT PATHOLOGY J, V33, P229, DOI 10.5423/PPJ.OA.12.2016.0265; Ahmad I., 2017, WHEAT IMPROVEMENT MA, P39, DOI [10.5772/67242, DOI 10.5772/67242]; Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; Alheit KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-235; Alipour H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01293; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ammar K., 2004, TRITICALE IMPROVEMEN, P1; Andersson R, 2009, J AGR FOOD CHEM, V57, P2004, DOI 10.1021/jf801280f; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Arruda MP, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0028; Ayana GT, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00926; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; Bauer E, 2017, PLANT J, V89, P853, DOI 10.1111/tpj.13436; Bellucci A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173313; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; Bolibok H, 2005, EUPHYTICA, V146, P109, DOI 10.1007/s10681-005-0548-0; Bolibok-Bragoszewska H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-184; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-578; Borner A, 2000, EUPHYTICA, V116, P203, DOI 10.1023/A:1004052505692; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burger JC, 2006, MOL ECOL, V15, P2527, DOI 10.1111/j.1365-294X.2006.02938.x; Bushuk W, 2001, CEREAL FOOD WORLD, V46, P70; CARVER BF, 1994, CROP SCI, V34, P1505, DOI 10.2135/cropsci1994.0011183X003400060017x; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Chen J, 2016, G3-GENES GENOM GENET, V6, P3803, DOI 10.1534/g3.116.034561; Chikmawati T, 2005, GENOME, V48, P792, DOI 10.1139/g05-043; Crespo-Herrera LA, 2017, HEREDITAS, V154, P1, DOI 10.1186/s41065-017-0033-5; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; De Bustos A, 2002, PLANT SYST EVOL, V235, P147, DOI 10.1007/s00606-002-0215-z; Dinglasan E, 2016, EUPHYTICA, V209, P693, DOI 10.1007/s10681-016-1660-z; Dong Y.C., 2003, J PLANT GENET RESOUR, V4, P1, DOI DOI 10.13430/J.CNKI.JPGR.2003.01.001; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; El Khoury D, 2011, J NUTR METAB, V2012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fan Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00946; Farfan IDB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117737; Faris JD, 2013, THEOR APPL GENET, V126, P2197, DOI 10.1007/s00122-013-2157-y; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; FRIEBE B, 1990, THEOR APPL GENET, V79, P385, DOI 10.1007/BF01186083; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Friesen TL, 2004, THEOR APPL GENET, V109, P464, DOI 10.1007/s00122-004-1678-9; Fu SL, 2010, J GENET, V89, P489, DOI 10.1007/s12041-010-0070-6; Gawenda I, 2015, PLANT BREEDING, V134, P28, DOI 10.1111/pbr.12237; Guo Y, 2014, CROP J, V2, P38, DOI 10.1016/j.cj.2013.11.001; Gurung S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108179; Hagenblad J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0710-y; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; helmholtz Zentrum Munchen, PGSB PLANT GEN SYST; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Isik Z, 2007, GENOME, V50, P724, DOI 10.1139/G07-052; Jannink Jean-Luc, 2002, P59, DOI 10.1079/9780851996011.0059; Juliana P, 2018, THEOR APPL GENET, V131, P1405, DOI 10.1007/s00122-018-3086-6; Khush GS, 1961, AM J BOT JSTOR, P723; Kidane YG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01586; Kim W, 2004, CROP SCI, V44, P1254, DOI 10.2135/cropsci2004.1254; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Korzun V, 1998, THEOR APPL GENET, V96, P203, DOI 10.1007/s001220050728; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LAMARI L, 1989, CAN J PLANT PATHOL, V11, P49, DOI 10.1080/07060668909501146; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li Y, 2004, GENET RESOUR CROP EV, V51, P845, DOI 10.1007/s10722-005-8313-8; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu HJ, 2017, MOL PLANT, V10, P414, DOI 10.1016/j.molp.2016.06.016; Liu JD, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1167-3; Lozada DN, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2005-2; Ma R, 2004, HEREDITAS, V140, P210, DOI 10.1111/j.1601-5223.2004.01844.x; Ma XF, 2001, THEOR APPL GENET, V102, P517, DOI 10.1007/s001220051676; Mago R, 2002, THEOR APPL GENET, V104, P1317, DOI 10.1007/s00122-002-0879-3; Martis MM, 2013, PLANT CELL, V25, P3685, DOI 10.1105/tpc.113.114553; Mascher M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076925; Matos M, 2001, HEREDITAS, V134, P229, DOI 10.1111/j.1601-5223.2001.00229.x; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; McKendry AL, 1996, CROP SCI, V36, P844, DOI 10.2135/cropsci1996.0011183X003600040003x; Milczarski P, 2016, J APPL GENET, V57, P439, DOI 10.1007/s13353-016-0347-4; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Milczarski Paweland Masojc P, 2017, PLOONE PUBLIC LIB, V12, DOI [10.1371/journal.pone.0189912, DOI 10.1371/JOURNAL.PONE.0189912]; Mohler V, 2001, PLANT BREEDING, V120, P448, DOI 10.1046/j.1439-0523.2001.00622.x; Mullner D, 2013, J STAT SOFTW, V53, P1; Mwadzingeni L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171692; Niedziela A, 2016, GENETIC DIVERSITY TR, V5, P355, DOI [10.1186/s40064-016-1997-8, DOI 10.1186/S40064-016-1997-8]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2015, R LANGUAGE ENV STAT; Raboin LM, 2016, RICE, V9, DOI 10.1186/s12284-016-0131-4; Reinert S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01061; Roy JK, 2010, MOL BREEDING, V26, P243, DOI 10.1007/s11032-010-9402-8; Saulescu NN, 2011, CZECH J GENET PLANT, V47, pS56, DOI 10.17221/3255-CJGPB; SENCER HA, 1980, BIOL J LINN SOC, V13, P299, DOI 10.1111/j.1095-8312.1980.tb00089.x; Shang HY, 2006, GENET MOL BIOL, V29, P685, DOI 10.1590/S1415-47572006000400018; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Shi W, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01035; Swiecka S, 2014, J APPL GENET, V55, P469, DOI 10.1007/s13353-014-0223-z; Tadesse W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141339; Targonska M, 2016, PLANT MOL BIOL REP, V34, P37, DOI 10.1007/s11105-015-0896-4; Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; Varshney RK, 2007, THEOR APPL GENET, V114, P1105, DOI 10.1007/s00122-007-0504-6; Virdi SK, 2016, G3-GENES GENOM GENET, V6, P4139, DOI 10.1534/g3.116.036525; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang HW, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0919-9; Wojcik-Jaga M, 2018, THEOR APPL GENET, V131, P167, DOI 10.1007/s00122-017-2994-1; Xiao YJ, 2017, MOL PLANT, V10, P359, DOI 10.1016/j.molp.2016.12.008; Yao QiLun, 2008, Agricultural Sciences in China, V7, P1423, DOI 10.1016/S1671-2927(08)60398-3; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zhang HL, 2011, THEOR APPL GENET, V122, P49, DOI 10.1007/s00122-010-1421-7; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zohary D., 1971, ORGIN S W ASIATIC CE, P235	114	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214519	10.1371/journal.pone.0214519	http://dx.doi.org/10.1371/journal.pone.0214519			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921415	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000081
J	Strobl, V; Straub, L; Bruckner, S; Albrecht, M; Maitip, J; Kolari, E; Chantawannakul, P; Williams, GR; Neumann, P				Strobl, Verena; Straub, Lars; Bruckner, Selina; Albrecht, Matthias; Maitip, Jakkrawut; Kolari, Eleonora; Chantawannakul, Panuwan; Williams, Geoffrey R.; Neumann, Peter			Not every sperm counts: Male fertility in solitary bees, Osmia cornuta	PLOS ONE			English	Article							RED MASON BEE; BODY-SIZE; HONEY-BEE; REPRODUCTIVE-BEHAVIOR; LIGNARIA HYMENOPTERA; COMPETITION SUCCESS; EXTREME POLYANDRY; MATING SYSTEMS; R-SELECTION; FEMALES	Reproductive strategies can act as strong selective forces on reproductive traits of male insects, resulting in species-specific variation in sperm quantity and viability. For solitary bees, basic measures of sperm quantity and viability are scarce. Here we evaluated for the first time quantity and viability of sperm in male Osmia cornuta solitary bees at different times after emergence, and how they were affected by male body mass and environmental condition (laboratory or semi-field arena). Sperm viability immediately after adult emergence showed no significant difference compared to four day old individuals, suggesting that O. cornuta males are capable of mating immediately post emergence. However, sperm counts were significantly higher in four day old individuals from the semi-field arena when compared to newly emerged males. This might reflect a final phase of sperm maturation. Regardless of individual male age and body mass differences, O. cornuta males produced on average similar to 175'000 spermatozoa that were similar to 65% viable, which are both significantly lower compared to eusocial honeybees and bumblebees. Moreover, sperm quantity, but not viability, was positively correlated with male body mass four days after emergence, while no such relationship was detected immediately after emergence. Even though individuals maintained in semi-field conditions exhibited a significantly greater loss of body mass, experimental arena had no significant effect on male survival, sperm quality or total living sperm produced. This suggests that the proposed laboratory design provides a cost-efficient and simple experimental approach to assess sperm traits in solitary bees. In conclusion, our data suggest a reduced investment in both sperm quantity and quality by male O. cornuta, which appears to be adaptive in light of the life history of this solitary bee.	[Strobl, Verena; Straub, Lars; Bruckner, Selina; Kolari, Eleonora; Williams, Geoffrey R.; Neumann, Peter] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Strobl, Verena; Straub, Lars; Kolari, Eleonora; Williams, Geoffrey R.; Neumann, Peter] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland; [Bruckner, Selina; Williams, Geoffrey R.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Albrecht, Matthias] Agroscope, Agroecol & Environm, Zurich, Switzerland; [Maitip, Jakkrawut] King Mongkuts Univ Technol, Fac Sci Energy & Environm, Rayong Campus, Bankhai, Rayong, Thailand; [Maitip, Jakkrawut; Chantawannakul, Panuwan] Chiang Mai Univ, Dept Biol, Bee Protect Ctr, Fac Sci, Chiang Mai, Thailand; [Chantawannakul, Panuwan] Chiang Mai Univ, Environm Sci Res Ctr, Fac Sci, Chiang Mai, Thailand	University of Bern; Swiss Federal Research Station Agroscope; Auburn University System; Auburn University; Swiss Federal Research Station Agroscope; Chiang Mai University; Chiang Mai University	Strobl, V; Straub, L (corresponding author), Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland.; Strobl, V; Straub, L (corresponding author), Agroscope, Swiss Bee Res Ctr, Bern, Switzerland.	verena.strobl@vetsuisse.unibe.ch; lars.straub@vetsuisse.unibe.ch	Neumann, Peter/C-9964-2015; Maitip, Jakkrawut/AAF-7539-2019; Maitip, Jakkrawut/GRO-5473-2022; Maitip, Jakkrawut/AAE-5317-2020; Straub, Lars/AAP-2820-2020; Williams, Geoffrey/C-9637-2015	Neumann, Peter/0000-0001-5163-5215; Maitip, Jakkrawut/0000-0001-6265-1421; Straub, Lars/0000-0002-2091-1499; Williams, Geoffrey/0000-0002-0093-1126	Okotoxzentrum (EAWAG); Bundesamt fur Umwelt (BAFU); Agroscope; Vinetum Foundation; Swiss National Science Foundation (SNSF) [31003A_169751]; Foundation for Food and Agriculture Research Pollinator Health Fund [549003]; Chiang Mai University Fund; ASEM-DUO Fellowship Program	Okotoxzentrum (EAWAG); Bundesamt fur Umwelt (BAFU); Agroscope; Vinetum Foundation; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Foundation for Food and Agriculture Research Pollinator Health Fund; Chiang Mai University Fund; ASEM-DUO Fellowship Program	Financial support was provided by the Okotoxzentrum (EAWAG) to V.S. and P.N., by the Bundesamt fur Umwelt (BAFU) to L.S., G.R.W. and P.N., Agroscope to V.S., the Vinetum Foundation to P.N., the Swiss National Science Foundation (SNSF) project 31003A_169751 to G.R.W., the Foundation for Food and Agriculture Research Pollinator Health Fund grant 549003 to G.R.W., the Chiang Mai University Fund to P.N., as well as the ASEM-DUO Fellowship Program to L.S. and J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 1980, AM SCI, V68, P146; ALCOCK J, 1994, ANNU REV ENTOMOL, V39, P1, DOI 10.1146/annurev.en.39.010194.000245; ALCOCK J, 1977, BEHAV ECOL SOCIOBIOL, V2, P385, DOI 10.1007/BF00299507; [Anonymous], 1953, PCHELOVODSTVO; [Anonymous], 1984, SPERM COMPETITION EV; Armbruster L, 1913, ARCH ZELLFORSCH, V11, P243; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Ball MA, 1998, J THEOR BIOL, V194, P251, DOI 10.1006/jtbi.1998.0756; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BATRA SWT, 1984, SCI AM, V250, P120, DOI 10.1038/scientificamerican0284-120; Berg S, 1997, APIDOLOGIE, V28, P449, DOI 10.1051/apido:19970611; BIRKHEAD TR, 1990, TRENDS ECOL EVOL, V5, P48, DOI 10.1016/0169-5347(90)90047-H; Bosch J, 2005, BEHAV ECOL SOCIOBIOL, V59, P124, DOI 10.1007/s00265-005-0017-8; Bosch J, 2002, ECOL ENTOMOL, V27, P129, DOI 10.1046/j.1365-2311.2002.00406.x; Bosch J, 2000, ENVIRON ENTOMOL, V29, P8, DOI 10.1603/0046-225X-29.1.8; BOSCH J, 1994, APIDOLOGIE, V25, P265, DOI 10.1051/apido:19940301; Bosch J, 2003, ENVIRON ENTOMOL, V32, P711, DOI 10.1603/0046-225X-32.4.711; BOSCH J, 1994, APIDOLOGIE, V25, P84, DOI 10.1051/apido:19940109; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Bosch J, 2008, ANIM BEHAV, V75, P809, DOI 10.1016/j.anbehav.2007.06.018; Bresslau E., 1905, Zoologischer Anzeiger, Vxxix, P299; Brown MJF, 2003, EVOLUTION, V57, P2067, DOI 10.1111/j.0014-3820.2003.tb00386.x; Cane JH, 2016, J INSECT PHYSIOL, V95, P105, DOI 10.1016/j.jinsphys.2016.09.011; Collins AM, 1999, THERIOGENOLOGY, V51, P1513, DOI 10.1016/S0093-691X(99)00094-1; Conrad T, 2010, J EXP BIOL, V213, P4065, DOI 10.1242/jeb.038174; CURRIE RW, 1987, BEE WORLD, V68, P129, DOI 10.1080/0005772X.1987.11098922; Czekonska K, 2015, APIDOLOGIE, V46, P1, DOI 10.1007/s13592-014-0296-z; DANFORTH BN, 1992, ANN ENTOMOL SOC AM, V85, P616, DOI 10.1093/aesa/85.5.616; Danielsson I, 1998, ANN ZOOL FENN, V35, P241; DUCHATEAU MJ, 1995, INSECT SOC, V42, P255, DOI 10.1007/BF01240420; EASAC, 2015, EASAC POLICY REP, V26, P1; ELLIS L, 1988, PERS INDIV DIFFER, V9, P697, DOI 10.1016/0191-8869(88)90059-1; Fliszkiewicz M., 2009, Annals of Warsaw University of Life Sciences - SGGW, Animal Science, P51; Fliszkiewicz M, 2013, J APIC SCI, V57, P73, DOI 10.2478/JAS-2013-0018; GAGE MJG, 1994, P ROY SOC B-BIOL SCI, V258, P247, DOI 10.1098/rspb.1994.0169; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; GERBER HS, 1970, SCIENCE, V167, P82, DOI 10.1126/science.167.3914.82; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Greeff M, 2008, EUR J ENTOMOL, V105, P849, DOI 10.14411/eje.2008.112; Greene W.H., 2012, ECONOMETRIC ANAL; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Koeniger N, 2005, APIDOLOGIE, V36, P211, DOI 10.1051/apido:2005011; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; Leckie G., 2010, CTR MULTILEVEL MODEL; MAC ARTHUR ROBERT H., 1967; Madras-Majewska B., 2011, Annals of Warsaw University of Life Sciences - SGGW, Animal Science, P115; Maeta Y., 1978, B TOHOKU NATL AGR EX, V57, P1; Maeta Y., 1974, MANAGE MAMEKO BEE OS; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Mitchell M.N., 2012, INTERPRETING VISUALI; Newson R, 2002, STATA J, V2, P45, DOI 10.1177/1536867X0200200103; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; PARRY GD, 1981, OECOLOGIA, V48, P260, DOI 10.1007/BF00347974; Paxton RJ, 1999, NATURWISSENSCHAFTEN, V86, P143, DOI 10.1007/s001140050588; Paxton RJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P174, DOI 10.1007/s00265-002-0561-4; Paxton RJ, 2005, APIDOLOGIE, V36, P145, DOI 10.1051/apido:2005007; Pech-May FG, 2012, INSECT SOC, V59, P417, DOI 10.1007/s00040-012-0236-8; PHILLIPS J K, 1978, Journal of the Kansas Entomological Society, V51, P91; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Polaczek B, 2000, APIDOLOGIE, V31, P525, DOI 10.1051/apido:2000143; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Radwan J, 1996, P ROY SOC B-BIOL SCI, V263, P855, DOI 10.1098/rspb.1996.0126; RAW A, 1979, BEHAVIOUR, V70, P168, DOI 10.1163/156853979X00043; RAW A, 1972, T ROY ENT SOC LONDON, V124, P213; Retschnig G, 2015, ENVIRON MICROBIOL, V17, P4322, DOI 10.1111/1462-2920.12825; Retschnig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085261; Rhodes JW, 2011, APIDOLOGIE, V42, P29, DOI 10.1051/apido/2010026; Roman A, 2010, J APIC SCI, V54, P25; Rosenheim JA, 1996, AM NAT, V148, P501, DOI 10.1086/285937; Schiestl FP, 2000, BEHAV ECOL SOCIOBIOL, V48, P303, DOI 10.1007/s002650000241; Schluns H, 2005, ANIM BEHAV, V70, P125, DOI 10.1016/j.anbehav.2004.11.005; Schluns H, 2003, APIDOLOGIE, V34, P577, DOI 10.1051/apido:2003051; Sedivy C, 2011, FUNCT ECOL, V25, P718, DOI 10.1111/j.1365-2435.2010.01828.x; Seidelmann K, 2014, BEHAVIOUR, V151, P1687, DOI 10.1163/1568539X-00003213; Seidelmann K, 2006, BEHAV ECOL, V17, P839, DOI 10.1093/beheco/arl017; Seidelmann K, 2015, BIOL J LINN SOC, V115, P28, DOI 10.1111/bij.12472; Seidemann K, 1999, J INSECT BEHAV, V12, P13, DOI 10.1023/A:1020920929613; SELANDER ROBERT K., 1965, AMER NATUR, V99, P129, DOI 10.1086/282360; SEVERINGHAUS LL, 1981, BEHAV ECOL SOCIOBIOL, V9, P51, DOI 10.1007/BF00299853; Simmons L. W., 2001, MG BEH ECOL; SIMMONS LW, 1992, EVOLUTION, V46, P366, DOI 10.2307/2409857; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; StataCorp, 2021, STATA RELEASE 17 STA; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Straub L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0506; Sturup M, 2013, BEHAV ECOL, V24, P1192, DOI 10.1093/beheco/art049; Taniguchi S, 1956, SCI REP HYOGO U AGR, V2, P37, DOI [10.24546/81005994, DOI 10.24546/81005994]; Tasei JN, 1998, J APICULT RES, V37, P107; Thalmann U., 1991, THESIS; Thornhill R., 1983, pi; TORCHIO PF, 1989, ANN ENTOMOL SOC AM, V82, P599, DOI 10.1093/aesa/82.5.599; TORCHIO PF, 1987, ENVIRON ENTOMOL, V16, P664, DOI 10.1093/ee/16.3.664; Uekoetter Laura, 2014, Entomologie Heute, V26, P111; Vance JT, 2009, J EXP BIOL, V212, P2604, DOI 10.1242/jeb.028100; Wedell N, 2002, BEHAV ECOL, V13, P450, DOI 10.1093/beheco/13.4.450; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wegener J, 2012, CRYOBIOLOGY, V65, P126, DOI 10.1016/j.cryobiol.2012.04.010; Wiklund C, 2001, P ROY SOC B-BIOL SCI, V268, P1661, DOI 10.1098/rspb.2001.1719; Wilkaniec Zdzislaw, 2004, Journal of Apicultural Science, V48, P47; Williams GR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.04; Winston M.L., 1991, BIOL HONEY BEE; WOYKE J., 1958, BEE WORLD, V39, P3; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	105	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214597	10.1371/journal.pone.0214597	http://dx.doi.org/10.1371/journal.pone.0214597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921425	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000094
J	Erens, B; Mitchell, KR; Gibson, L; Datta, J; Lewis, R; Field, N; Wellings, K				Erens, Bob; Mitchell, Kirstin R.; Gibson, Lorna; Datta, Jessica; Lewis, Ruth; Field, Nigel; Wellings, Kaye			Health status, sexual activity and satisfaction among older people in Britain: A mixed methods study	PLOS ONE			English	Article							3RD NATIONAL-SURVEY; LIFE-STYLES; ATTITUDES; MEN; ADULTS; WOMEN	Background Men and women are increasingly likely to stay sexually active into later life, but research shows that sexual activity and satisfaction decrease with increasing age. Ill health and medical treatments may affect sexual activity but there is little research on why some older people with a health problem affecting their sexual activity are satisfied with their sex life, and others are not. Methods A mixed method study integrating data and analyses from the third British National Survey of Sexual Attitudes and Lifestyles n = 3343 aged 55-74 years) and from follow-up in-depth interviews with 23 survey participants who reported having a health condition or taking medication affecting their sex life. Results Overall, 26.9% of men and 17.1% of women aged 55-74 reported having a health condition that affected their sex life. Among this group, women were less likely than men to be sexually active in the previous 6 months 54.3% vs 62.0%) but just as likely to be satisfied with their sex life 41.9% vs 42.1%). In follow-up interviews, participants sometimes struggled to tease out the effects of ill health from those of advancing age. Where effects of ill health were identified, they tended to operate through the inclination and capacity to be sexually active, the practical possibilities for doing so and the limits placed on forms of sexual expression. In close relationships partners worked to establish compensatory mechanisms, but in less close relationships ill health provided an excuse to stop sex or deterred attempts to resolve difficulties. Most fundamentally, ill health may influence whether individuals have a partner with whom to have sex. Conclusion The data show complex interactions between health, lifestyle and relationship factors that affect sexual activity/satisfaction. When dealing with sexual problems in older people, practitioners need to take account of individual lifestyle, needs and preferences.	[Erens, Bob] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Mitchell, Kirstin R.; Lewis, Ruth] Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Mitchell, Kirstin R.; Gibson, Lorna; Datta, Jessica; Lewis, Ruth; Wellings, Kaye] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England; [Field, Nigel] UCL, Inst Global Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Wellings, K (corresponding author), London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England.	Kaye.Wellings@Ishtm.ac.uk	Field, Nigel/ABG-3948-2020; Weatherburn, Peter/AAC-2701-2019	Lewis, Ruth/0000-0002-6768-6188; Erens, Bob/0000-0002-4430-954X; Field, Nigel/0000-0002-2825-6652	Medical Research Council [G0701757]; Wellcome Trust [084840]; Economic and Social Research Council; Department of Health; United Kingdom Medical Research Council [MC_UU_12017/11]; Chief Scientist Office [SPHSU11]; MRC [G0701757, MC_UU_12017/11] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council [G0701757] and the Wellcome Trust [084840] with contributions from the Economic and Social Research Council and Department of Health. Since September 2015, Kirstin Mitchell has been supported by the United Kingdom Medical Research Council [grant MC_UU_12017/11], and Chief Scientist Office [grant SPHSU11]. Since October 2017, Ruth Lewis has been supported by the United Kingdom Medical Research Council [grant MC_UU_12017/11], and Chief Scientist Office [grant SPHSU11]. The sponsors played no role in the study design, data interpretation, data collection, data analysis or writing of the article.	[Anonymous], 2010, SEX ROMANCE RELATION; Beckman N, 2014, J SEX MED, V11, P401, DOI 10.1111/jsm.12381; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Corona G, 2013, BEST PRACT RES CL EN, V27, P581, DOI 10.1016/j.beem.2013.05.007; Corona G, 2010, J SEX MED, V7, P1362, DOI 10.1111/j.1743-6109.2009.01601.x; DeLamater J, 2012, J SEX RES, V49, P125, DOI 10.1080/00224499.2011.603168; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Field N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010521; Field N, 2013, LANCET, V382, P1830, DOI 10.1016/S0140-6736(13)62222-9; Foley S., 2015, CURR SEX HEALTH REP, V7, P70, DOI [10.1007/s11930-015-0046-x, DOI 10.1007/S11930-015-0046-X, https://doi.org/10.1007/s11930-015-0046-x]; Fortenberry JD, 2013, AIDS, V27, pS127, DOI 10.1097/QAD.0000000000000048; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; Kontula O, 2009, J SEX RES, V46, P46, DOI 10.1080/00224490802624414; Laumann EO, 2008, J SEX MED, V5, P2300, DOI 10.1111/j.1743-6109.2008.00974.x; Laumann EO, 2006, ARCH SEX BEHAV, V35, P145, DOI 10.1007/s10508-005-9005-3; Lee DM, 2016, ARCH SEX BEHAV, V45, P133, DOI 10.1007/s10508-014-0465-1; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Mitchell KR, 2013, LANCET, V382, P1817, DOI 10.1016/S0140-6736(13)62366-1; Mitchell KR, 2013, J SEX RES, V50, P17, DOI 10.1080/00224499.2011.621038; Morley JETDT, 2012, PATHYS PRINCIPLES PR, P93; Nicolosi A, 2004, J AFFECT DISORDERS, V82, P235, DOI 10.1016/j.jad.2003.12.008; Nicolosi A, 2004, UROLOGY, V64, P991, DOI 10.1016/j.urology.2004.06.055; ONS, 2016, 2016 BAS NAT POP PRO; Steptoe A, 2016, HEART, V102, P1095, DOI 10.1136/heartjnl-2015-308993; Thomas HN, 2015, ANN FAM MED, V13, P336, DOI 10.1370/afm.1820; Tiefer L, 2007, J SEX MARITAL THER, V33, P473, DOI 10.1080/00926230701480521; Trompeter SE, 2012, AM J MED, V125, P37, DOI 10.1016/j.amjmed.2011.07.036; Wellings K, 2013, LANCET, V382, P1759, DOI 10.1016/S0140-6736(13)62378-8; Wittmann D, 2015, J SEX MED, V12, P494, DOI 10.1111/jsm.12732	30	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213835	10.1371/journal.pone.0213835	http://dx.doi.org/10.1371/journal.pone.0213835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917152	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000462465800041
J	Schaafsma, AW; Limay-Rios, V; Baute, TS; Smith, JL				Schaafsma, Arthur W.; Limay-Rios, Victor; Baute, Tracey S.; Smith, Jocelyn L.			Neonicotinoid insecticide residues in subsurface drainage and open ditch water around maize fields in southwestern Ontario	PLOS ONE			English	Article							SURFACE WATERS; AQUATIC ENVIRONMENT; PARTICULATE MATTER; LEACHING BEHAVIOR; TILE DRAINS; PESTICIDE; TRANSPORT; EXPOSURE; SOIL; CONTAMINATION	Neonicotinoids are widely used class of insecticides. Most are seed treatments and during planting active ingredient may be abraded and lost in fugitive dust. Much of this active ingredient contaminates surface waters, exposing aquatic organism to potential ill effects. This study examines concentrations of neonicotinoids appearing in tile drains and open ditches around commercial maize fields around planting time where neonicotinoid seed treatments had been used. This sample set represents surface water leaving the point of origin, for which data are sparse. Clothianidin was found more often than thiamethoxam and at higher concentrations; at a median concentration of 0.35 ng/mL in tile drain water and almost twice that (0.68 ng/mL) in ditches into which the tiles are draining after applications of 19 g/ha on seed. This concentration reveals a 40 to 50 fold dilution for neonicotinoid residues between the points where they leave the field in which they were applied and when they are found in nearby streams in a similar ecosystem. Our data support that for a no-observed-effect concentration of 0.3 ng/mL for thiamethoxam there would be between a 1.6 and 100-fold margin of safety to mayflies in most streams if fugitive dust on pneumatic planters were properly mitigated.	[Schaafsma, Arthur W.; Limay-Rios, Victor; Smith, Jocelyn L.] Univ Guelph, Dept Plant Agr, Ridgetown Campus, Ridgetown, ON, Canada; [Baute, Tracey S.] Ontario Minist Agr Food & Rural Affairs, Ridgetown, ON, Canada	University of Guelph	Schaafsma, AW (corresponding author), Univ Guelph, Dept Plant Agr, Ridgetown Campus, Ridgetown, ON, Canada.	aschaafs@uoguelph.ca	Smith, Jocelyn/AAG-8545-2019	Limay-Rios, Victor/0000-0002-0866-3568; Schaafsma, Arthur W/0000-0002-5527-5664; Smith, Jocelyn/0000-0001-6747-9798	Ontario Ministry of Agriculture Food and Rural Affairs [ND2013-2110]; Agriculture and Agri-Food Canada, Canadian Agricultural Adaptation Program; Grain Farmers of Ontario [CAAP 0593, GF2 0183]; Agriculture and Agri-Food Canada; Pollinator Partnership's Corn Dust Research Consortium (CDRC 2013)	Ontario Ministry of Agriculture Food and Rural Affairs; Agriculture and Agri-Food Canada, Canadian Agricultural Adaptation Program(Agriculture & Agri Food Canada); Grain Farmers of Ontario; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Pollinator Partnership's Corn Dust Research Consortium (CDRC 2013)	Funding for this study was provided by Ontario Ministry of Agriculture Food and Rural Affairs, 2013-14 New Directions Research Program (ND2013-2110) http://www.omafra.gov.on.ca/english/research/new_directions/ndresearchprogram.html AS; Agriculture and Agri-Food Canada, Canadian Agricultural Adaptation Program, administered and jointly funded by Grain Farmers of Ontario (CAAP 0593) http://gfo.ca/, http://www.agr.gc.ca/eng/programs-and-services/canadian-agricultural-adaptation-program-2014-2019/? id=1396016168338 AS; Agriculture and Agri-Food Canada, Growing Forward 2, administered and jointly funded by Grain Farmers of Ontario (GF2 0183) http://www.agr.gc.ca/eng/about-us/key-departmental-initiatives/growing-forward-2/? id=1294780620963 AS; and the Pollinator Partnership's Corn Dust Research Consortium (CDRC 2013) http://pollinator.org/CDRC AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173836; Anderson JC, 2015, SCI TOTAL ENVIRON, V505, P409, DOI 10.1016/j.scitotenv.2014.09.090; Bajeer M., 2012, ANAL CHEM, V3, P604, DOI DOI 10.4236/AJAC.2012.38079; Bartlett AJ, 2018, ENVIRON POLLUT, V238, P63, DOI 10.1016/j.envpol.2018.03.004; Bowley S.R., 2015, HITCHHIKERS GUIDE ST; Chretien F, 2017, ENVIRON POLLUT, V224, P255, DOI 10.1016/j.envpol.2017.02.002; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; EPA, 2010, CLOTH REG PROSP T400; Finnegan MS, 2017, ENV TOXICOLOGY CHEM; Forero LG, 2017, CHEMOSPHERE, V188, P130, DOI 10.1016/j.chemosphere.2017.08.126; Girolami V, 2012, J APPL ENTOMOL, V136, P17, DOI 10.1111/j.1439-0418.2011.01648.x; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gupta S, 2002, B ENVIRON CONTAM TOX, V68, P502, DOI 10.1007/s001280283; Gupta S, 2008, B ENVIRON CONTAM TOX, V80, P431, DOI 10.1007/s00128-008-9420-y; Hladik ML, 2018, ENVIRON POLLUT, V235, P1022, DOI 10.1016/j.envpol.2018.01.013; Hladik ML, 2016, ENVIRON CHEM, V13, P12, DOI 10.1071/EN15061; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Huseth AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097081; Institute S, 2014, SAS 9 4 OUTP DEL SYS; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; KLADIVKO EJ, 1991, J ENVIRON QUAL, V20, P264, DOI 10.2134/jeq1991.00472425002000010043x; Kladivko EJ, 1999, J ENVIRON QUAL, V28, P997, DOI 10.2134/jeq1999.00472425002800030033x; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kung KJS, 2000, SOIL SCI SOC AM J, V64, P1290, DOI 10.2136/sssaj2000.6441290x; Limay-Rios V, 2016, ENVIRON TOXICOL CHEM, V35, P303, DOI 10.1002/etc.3257; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Miles JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174171; Morrissey CA, 2015, ENVIRON INT, V74, P291, DOI 10.1016/j.envint.2014.10.024; Negley T, 2014, ACS SYM SER, V1174, P337; NRA, 2001, EV NEW ACT THIAM PRO; Nuyttens D, 2013, PEST MANAG SCI, V69, P564, DOI 10.1002/ps.3485; Pickford DB, 2018, ENVIRON TOXICOL CHEM, V37, P1040, DOI 10.1002/etc.4028; PMRA, 2018, PEST LABL SEARCH HLT; Radolinski J, 2018, SCI TOTAL ENVIRON, V618, P561, DOI 10.1016/j.scitotenv.2017.11.031; Sanchez-Bayo F, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00071; Schaafsma A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118139; Schaafsma AW, 2017, PEST MANAGEMENT SCI; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Smalling KL, 2018, J ENVIRON SCI HEAL B, V53, P176, DOI 10.1080/03601234.2017.1405619; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Stewart G., 2013, NEONICOTINOIDS FIELD; Struger J, 2017, CHEMOSPHERE, V169, P516, DOI 10.1016/j.chemosphere.2016.11.036; Sur Robin, 2003, Bulletin of Insectology, V56, P35; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Vander Veen Sid, 2007, DRAINAGE GUIDE ONTAR, P29; Xue YG, 2015, ENVIRON SCI TECHNOL, V49, P13003, DOI 10.1021/acs.est.5b03753	47	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214787	10.1371/journal.pone.0214787	http://dx.doi.org/10.1371/journal.pone.0214787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947236	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500061
J	Wood, JR; Wilmshurst, JM				Wood, Jamie R.; Wilmshurst, Janet M.			Comparing the effects of asynchronous herbivores on New Zealand montane vegetation communities	PLOS ONE			English	Article							MOA AVES; PLANT; TRANSFORMATION; EXTINCTION; SYSTEMS; DIET	Large herbivores facilitate a range of important ecological processes yet globally have experienced high rates of decline and extinction over the past 50,000 years. To some extent this lost function may be replaced through the introduction of ecological surrogate taxa, either by active management or via historic introductions. However, comparing the ecological effects of herbivores that existed in the same location, but at different times, can be a challenging proposition. Here we provide an example from New Zealand that demonstrates an approach for making such comparisons. In New Zealand it has been suggested that post-19th Century mammal introductions (e.g. deer and hare) may have filled ecological niches left vacant after the 15th Century AD extinction of large avian herbivores (moa). We quantified pollen assemblages from fecal samples deposited by these two asynchronous herbivore communities to see whether they were comparable. The fecal samples were collected at the same location, and in a native-dominated vegetation community that has experience little anthropogenic disturbance and their contents reflect both the local habitat and diet preferences of the depositing herbivore. The results reveal that the current forest understory is relatively sparse and species depauperate compared to the prehistoric state, indicating that deer and moa had quite different impacts on the local vegetation community. The study provides an example of how combining coprolite and fecal analyses of prehistoric and modern herbivores may clarify the degree of ecological overlap between asynchronous herbivore communities and provide insights into the extent of ecological surrogacy provided by introduced taxa.	[Wood, Jamie R.; Wilmshurst, Janet M.] Manaaki Whenua Landcare Res, Lincoln, New Zealand; [Wilmshurst, Janet M.] Univ Auckland, Sch Environm, Auckland, New Zealand	Landcare Research - New Zealand; University of Auckland	Wood, JR (corresponding author), Manaaki Whenua Landcare Res, Lincoln, New Zealand.	woodj@landcarereserch.co.nz	Wood, Jamie/AAU-5530-2021; Wood, Jamie/A-9393-2008	Wood, Jamie/0000-0001-8008-6083	Marsden Fund; Crown Research Institute from the Ministry of Business, Innovation and Employment's Science and Innovation Group	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Crown Research Institute from the Ministry of Business, Innovation and Employment's Science and Innovation Group	This research was funded by the Marsden Fund (administered by the Royal Society of New Zealand) and Strategic Science Investment Funding from the Crown Research Institute from the Ministry of Business, Innovation and Employment's Science and Innovation Group.	[Anonymous], 2007, C2 SOFTWARE ECOLOGIC; ATKINSON IAE, 1989, NEW ZEAL J ECOL, V12, P67; Bakker ES, 2016, P NATL ACAD SCI USA, V113, P847, DOI 10.1073/pnas.1502545112; Barkla J, 2001, IMPACT CATTLE BEECH; BATCHELER CL, 1989, NEW ZEAL J ECOL, V12, P57; Burney DA, 2012, TORTOISE, V1, P104; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; CAUGHLEY G, 1989, NEW ZEAL J ECOL, V12, P3; Caughley G, 1988, SEM 2000 FUT NZ WILD, P51; Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; Department of Conservation, 2011, MOUNT ASP NAT PARK M; DUNCAN K, 1989, NEW ZEAL J ECOL, V12, P97; Forsyth DM, 2010, NEW ZEAL J ECOL, V34, P48; Forsyth DM, 2002, NEW ZEAL J ZOOL, V29, P323, DOI 10.1080/03014223.2002.9518316; Galetti M, 2018, BIOL REV, V93, P845, DOI 10.1111/brv.12374; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Hansen Dennis M., 2010, P111; Hansen DM, 2009, SCIENCE, V324, P42, DOI 10.1126/science.1172393; JANZEN DH, 1982, OIKOS, V38, P150, DOI 10.2307/3544014; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Lee WG, 2010, NEW ZEAL J ECOL, V34, P28; Mark AF, 1977, NATL PARKS SCI SERIE, V2; Moar NT, 2011, NEW ZEAL J BOT, V49, P201, DOI 10.1080/0028825X.2010.526617; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Perry GLW, 2014, QUATERNARY SCI REV, V105, P126, DOI 10.1016/j.quascirev.2014.09.025; Perry GLW, 2012, GLOBAL CHANGE BIOL, V18, P1609, DOI 10.1111/j.1365-2486.2011.02631.x; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Rogers GM, 2016, NEW ZEAL J BOT, V54, P393, DOI 10.1080/0028825X.2016.1216866; Rule S, 2012, SCIENCE, V335, P1483, DOI 10.1126/science.1214261; Saltre F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10511; Veblen KE, 2016, ECOL APPL, V26, P1610, DOI 10.1890/15-1367.1; Villavicencio NA, 2016, ECOGRAPHY, V39, P125, DOI 10.1111/ecog.01606; Vlasakker van de J., 2014, REWILDING EUROPE BIS; Wallach AD, 2018, CONSERV BIOL, V32, P962, DOI 10.1111/cobi.13116; Wardle DA, 2001, ECOL MONOGR, V71, P587, DOI 10.1890/0012-9615(2001)071[0587:IBMINZ]2.0.CO;2; Wood J., 2007, THESIS; Wood JR, 2011, NEW ZEAL J GEOL GEOP, V54, P431, DOI 10.1080/00288306.2011.590212; Wood JR, 2017, J VEG SCI, V28, P160, DOI 10.1111/jvs.12469; Wood JR, 2013, P NATL ACAD SCI USA, V110, P16910, DOI 10.1073/pnas.1307700110; Wood JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040025; Wood JR, 2008, QUATERNARY SCI REV, V27, P2593, DOI 10.1016/j.quascirev.2008.09.019	41	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214959	10.1371/journal.pone.0214959	http://dx.doi.org/10.1371/journal.pone.0214959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947249	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500093
J	Kristiawan, M; El Hassan, M; El Faye, A; Sobolik, V				Kristiawan, Magdalena; El Hassan, Mouhammad; El Faye, Alioune; Sobolik, Vaclav			Experimental investigation of Taylor-Couette-Poiseuille flow at low Taylor and Reynolds numbers	PLOS ONE			English	Article							ROTATING CYLINDERS; VELOCITY-FIELD; MASS-TRANSFER; AXIAL-FLOW; STABILITY; INSTABILITIES; PARAMETERS; REGIMES; SYSTEM	Flow patterns of a Taylor-Couette-Poiseuille flow were studied at low axial Reynolds and rotational Taylor numbers (Re <= 10.5, Ta <= 319). The radius ratio of the inner and outer cylinders was 0.804 and the ratio of the length of the annulus to the gap width was 44.5. Complete map of the studied flow regimes was elaborated. The axial and azimuthal components of the wall shear rate y were measured at the outer fixed cylinder using a three-segment electrodiffusion probe. The components of the wall shear rate of helices have never been measured in previous investigations. Spatio-temporal description of multiple flow patterns was obtained using flow visualizations and simultaneous measurements of wall shear rate components. The flow structures include Taylor vortices, helices winding in the same direction as the base flow or in the opposite direction, helices that were stagnant or moving in the axial direction, smooth or with superposed azimuthal waves, among others. The influence of different flow structures on the wall shear stress components is discussed with and without axial base flow. It was found that the wall shear stress is a function of Ta but no significant dependence on Re was observed for the studied flow regimes and that the mean wall shear stress increases with the number of azimuthal waves. It was also noted that the ED probes provide a more detailed information about flow patterns than torque measurements and visualizations described in the literature.	[Kristiawan, Magdalena] INRA, UR 1268 BIA, BP 71627, Nantes, France; [El Hassan, Mouhammad] Prince Mohammad Bin Fahd Univ, Fac Engn, Al Khobar, Saudi Arabia; [El Faye, Alioune; Sobolik, Vaclav] Univ La Rochelle, UMR 7356, LaSIE, La Rochelle, France	INRAE; Prince Mohammad Bin Fahd University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); La Rochelle Universite	El Hassan, M (corresponding author), Prince Mohammad Bin Fahd Univ, Fac Engn, Al Khobar, Saudi Arabia.	melhassan@pmu.edu.sa						Abcha N, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13020-5; Akonur A, 2003, PHYS FLUIDS, V15, P947, DOI 10.1063/1.1556615; AL-Mahasneh MA, 2017, INT J OIL GAS COAL E, V5, P19, DOI DOI 10.11648/J.0GCE.20170502.12; Altmeyer S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046308; Altmeyer S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066313; ANDERECK CD, 1986, J FLUID MECH, V164, P155, DOI 10.1017/S0022112086002513; Bouabdallah A., 1981, Symmetries and Broken Symmetries in Condensed Matter Physics. Proceedings of the Colloque Pierre Curie, P407; BUHLER K, 1984, Z ANGEW MATH MECH, V64, pT180; CHANDRASEKHAR S, 1960, P NATL ACAD SCI USA, V46, P141, DOI 10.1073/pnas.46.1.141; CHUNG KC, 1977, J FLUID MECH, V81, P641, DOI 10.1017/S0022112077002274; COGNET G, 1984, J MEC THEOR APPL, P7; Curran SJ, 2004, CHEM ENG SCI, V59, P5859, DOI 10.1016/j.ces.2004.07.044; Deguchi K, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.043017; DIPRIMA RC, 1960, J FLUID MECH, V9, P621, DOI 10.1017/S0022112060001365; DONNELLY RJ, 1960, J FLUID MECH, V7, P401, DOI 10.1017/S0022112060000177; Esser A, 1996, PHYS FLUIDS, V8, P1814, DOI 10.1063/1.868963; Fenot M, 2011, INT J THERM SCI, V50, P1138, DOI 10.1016/j.ijthermalsci.2011.02.013; GU ZH, 1986, CAN J CHEM ENG, V64, P185, DOI 10.1002/cjce.5450640203; Hanratty TJ, 1983, FLUID MECH MEASUREME, P519; Heise M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045301; Hwang JY, 2004, COMPUT FLUIDS, V33, P97, DOI 10.1016/S0045-7930(03)00033-1; KATAOKA K, 1977, INT J HEAT MASS TRAN, V20, P57, DOI 10.1016/0017-9310(77)90084-9; Leveque M. A., 1928, ANN MINES, V13, P201; LUEPTOW RM, 1992, PHYS FLUIDS A-FLUID, V4, P2446, DOI 10.1063/1.858485; Martinand D, 2017, J FLUID MECH, V824, P438, DOI 10.1017/jfm.2017.351; Martinand D, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3243976; Meseguer A, 2002, J FLUID MECH, V455, P129, DOI 10.1017/S0022112001007315; Pinter A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026318; Pinter A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.044506; Poncet S, 2011, INT J HEAT FLUID FL, V32, P128, DOI 10.1016/j.ijheatfluidflow.2010.08.003; Raguin LG, 2004, J FLUID MECH, V516, P125, DOI 10.1017/S002211200400059X; RECKTENWALD A, 1993, PHYS REV E, V48, P4444, DOI 10.1103/PhysRevE.48.4444; Resende MM, 2004, BRAZ J CHEM ENG, V21, P175, DOI 10.1590/S0104-66322004000200006; SNYDER HA, 1962, PROC R SOC LON SER-A, V265, P198, DOI 10.1098/rspa.1962.0004; Sobolik V, 2011, J APPL FLUID MECH, V4, P25; TAKEUCHI DI, 1981, J FLUID MECH, V102, P101, DOI 10.1017/S0022112081002565; TSAMERET A, 1994, PHYS REV E, V49, P1291, DOI 10.1103/PhysRevE.49.1291; Vedantam S, 2006, CHEM ENG RES DES, V84, P522, DOI 10.1205/cherd.05219; WEIN O, 1987, COLLECT CZECH CHEM C, V52, P2169, DOI 10.1135/cccc19872169; Wereley ST, 1999, PHYS FLUIDS, V11, P3637, DOI 10.1063/1.870228	40	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212728	10.1371/journal.pone.0212728	http://dx.doi.org/10.1371/journal.pone.0212728			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943190	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300007
J	Naruse, M; Koike, Y; Kamei, N; Sakamoto, R; Yambe, Y; Arimitsu, M				Naruse, Mitsuhide; Koike, Yasuhiro; Kamei, Nozomu; Sakamoto, Ryuichi; Yambe, Yuko; Arimitsu, Michinori			Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial	PLOS ONE			English	Article							BLOOD-PRESSURE; RECEPTOR BLOCKER; METAANALYSIS; OLMESARTAN	Background Based on non-clinical data, it is expected that azilsartan, an angiotensin II receptor blocker, will help improve insulin resistance in addition to its hypotensive action. The present study is aimed to explore the effect of azilsartan compared to telmisartan on insulin sensitivity in hypertensive patients in the clinical setting. Methods This multicenter, randomized, open-label, parallel-group exploratory study was conducted in Japan. We randomized adult patients (>= 20 years old) with grade I or II essential hypertension and coexisting type 2 diabetes (1:1) to receive either oral azilsartan (20 mg/day;17 patients) or telmisartan (40 mg/day;16 patients) for 12 weeks. The primary endpoint was the change in the homeostasis model assessment ratio of insulin resistance (HOMA-R) from the baseline at the end of the treatment period. We also evaluated its safety and efficacy on other diabetes-related variables and blood pressure. Findings The mean changes in HOMA-R at the end of treatment were 0.22 (95% CI, -1.09-1.52) in the azilsartan group and -0.23 (95% CI, -0.72-0.27) in the telmisartan group. We found no clinically remarkable changes between the groups in diabetes-related variables such as fasting blood glucose, fasting insulin, HbA1c (NGSP), HOMA-beta, or 1,5-anhydroglucitol. Reductions in clinic systolic and diastolic blood pressure were observed at week 4 and the reduced levels were maintained throughout the treatment period in both groups. No serious treatment-emergent adverse events (TEAEs) were observed. Only one drug-related TEAE (mild decrease in blood pressure) was reported in one patient in the azilsartan group. Conclusion Neither azilsartan nor telmisartan had any clinically remarkable effects on insulin resistance parameters when administered for 12 weeks to patients with grade I or II essential hypertension and coexisting type 2 diabetes mellitus. Azilsartan (20 mg/day) and telmisartan (40 mg/day) exerted comparable antihypertensive effects.	[Naruse, Mitsuhide] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst Endocrine & Metab Dis, Div Endocrinol Metab & Hypertens, Kyoto, Japan; [Koike, Yasuhiro] Takeda Pharmaceut Co Ltd, Japan Med Affairs, Tokyo, Japan; [Kamei, Nozomu] Hiroshima Red Cross Hosp, Dept Endocrinol & Metab, Hiroshima, Japan; [Kamei, Nozomu] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Sakamoto, Ryuichi] Natl Hosp Org Kyushu Med Ctr, Dept Endocrinol & Metab, Fukuoka, Fukuoka, Japan; [Yambe, Yuko] Natl Hosp Org Nagoya Med Ctr, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan; [Arimitsu, Michinori] A2 Healthcare Corp, Data Sci Div, Biostat Dept 1, Tokyo, Japan	Takeda Pharmaceutical Company Ltd; Nagoya Medical Center	Naruse, M (corresponding author), Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst Endocrine & Metab Dis, Div Endocrinol Metab & Hypertens, Kyoto, Japan.	mnaruse@kyotolan.hosp.go.jp		Kamei, Nozomu/0000-0002-7686-437X	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was sponsored by Takeda Pharmaceutical Company Limited (https://www.takeda.com/).The funder was involved in study design, decision to publish and preparation of the manuscript, as well as providing financial support in the forms of salaries for YK. MA is an employee of A2 Healthcare Corporation. The specific roles of the authors are articulated in the 'author contribution' section.	Arao T, 2013, ENDOCR J, V60, P563, DOI 10.1507/endocrj.EJ12-0326; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Destro M, 2011, EXPERT OPIN PHARMACO, V12, P2719, DOI 10.1517/14656566.2011.632367; Hao G, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-148; Hiramitsu K, 2013, J BLOOD PRESSURE, V20, P94; Iwai M, 2007, AM J HYPERTENS, V20, P579, DOI 10.1016/j.amjhyper.2006.12.010; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Lim S, 2014, REV ENDOCR METAB DIS, V15, P329, DOI 10.1007/s11154-014-9298-4; Mori H, 2012, ADV THER, V29, P635, DOI 10.1007/s12325-012-0032-x; Nakayama S, 2008, HYPERTENS RES, V31, P7, DOI 10.1291/hypres.31.7; Rakugi H, 2012, HYPERTENS RES, V35, P552, DOI 10.1038/hr.2012.8; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Takagi H, 2014, J AM SOC HYPERTENS, V8, P578, DOI 10.1016/j.jash.2014.05.006; Takagi H, 2014, HYPERTENS RES, V37, P432, DOI 10.1038/hr.2013.142; The Japan Diabetes Society, EV BAS PRACT GUID TR; Usui I, 2007, DIABETES RES CLIN PR, V77, P210, DOI 10.1016/j.diabres.2006.11.014; Watanabe M, 2010, INTERNAL MED, V49, P1843, DOI 10.2169/internalmedicine.49.3189; Weber MA, 2014, J CLIN HYPERTENS, V16, P14, DOI 10.1111/jch.12237; Yamana A, 2008, DIABETES RES CLIN PR, V82, P127, DOI 10.1016/j.diabres.2008.07.003; Zhao M, 2011, DIABETES OBES METAB, V13, P1123, DOI 10.1111/j.1463-1326.2011.01471.x	21	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214727	10.1371/journal.pone.0214727	http://dx.doi.org/10.1371/journal.pone.0214727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943275	Green Submitted, gold, Green Published			2022-12-27	WOS:000463194300056
J	Lee, YS; Oh, SH; Lee, YS; Her, AY; Chang, IB				Lee, Young Seok; Oh, Su Hwan; Lee, Yong Suk; Her, Ae-Young; Chang, In Bae			Development of defibrillation simulator with LC-Tank type inductance coupling position measurement system	PLOS ONE			English	Article							SENSOR	In this study, we construct a paddle positioning system for defibrillation training simulators. The system consists of a chest manikin fabricated based on the standard somatotype of Koreans and simulator paddles similar to those of commercial defibrillators. Multiple coils are arranged orthogonally in both the chest manikin and paddles; their positioning is based on electromagnetic induction, such that the positions of the paddles can be successfully detected across the chest. The calculated and actual positions are compared using the measured signals. We find a mean error of 0.0891 mm for all positions, with a standard deviation of 0.6611 mm. In addition, we connect our paddle positioning system to a graphical user interface that enables visualization of the paddles' current locations.	[Lee, Young Seok; Oh, Su Hwan; Lee, Yong Suk; Chang, In Bae] Kangwon Natl Univ, Dept Mech & Mechatron Engn, Chuncheon Si, Gangwon Do, South Korea; [Her, Ae-Young] Kangwon Natl Univ, Sch Med, Chuncheon Si, Gangwon Do, South Korea	Kangwon National University; Kangwon National University	Chang, IB (corresponding author), Kangwon Natl Univ, Dept Mech & Mechatron Engn, Chuncheon Si, Gangwon Do, South Korea.	inbae@kangwon.ac.kr			Kangwon National University [520150058]; Human Resources Development program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) [20154030200950]	Kangwon National University; Human Resources Development program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP)	This work was supported by the 2015 Research Grant from Kangwon National University, No. 520150058 (http://www.kangwon.ac.kr/) and the Human Resources Development program (No. 20154030200950) of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) http://www.ketep.re.kr/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, 2015, HIGHL CPR ECC GUID; Chen PJ, 2010, J MICROELECTROMECH S, V19, P721, DOI 10.1109/JMEMS.2010.2049825; Cho S, 2016, IEEE TECHNOL SOC MAG, V35, P75, DOI 10.1109/MTS.2016.2518253; Fonseca MA, 2006, FLEXIBLE WIRELESS PA, P37; Heames RM, 2001, BRIT MED J, V322, P1393, DOI 10.1136/bmj.322.7299.1393; Lakhotia M, 2003, J INDIAN ACAD CLIN M, V4, P200; Lee Y, 2017, THESIS; Wang Y, 2008, SENSORS-BASEL, V8, P7982, DOI 10.3390/s8127982	8	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214576	10.1371/journal.pone.0214576	http://dx.doi.org/10.1371/journal.pone.0214576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925171	Green Submitted, gold, Green Published			2022-12-27	WOS:000462732300020
J	Tillmann, FP; Quack, I; Woznowski, M; Rump, LC				Tillmann, Frank-Peter; Quack, Ivo; Woznowski, Magdalena; Rump, Lars Christian			Effect of recipient-donor sex and weight mismatch on graft survival after deceased donor renal transplantation	PLOS ONE			English	Article							KIDNEY-TRANSPLANTATION; H-Y; GLOMERULAR NUMBER; RISK-FACTORS; SIZE; IMPACT; OUTCOMES; BIRTH	This study evaluated the combined effect of recipient-to-donor weight and sex mismatch after deceased-donor renal transplantation in a German transplant cohort and the evolution of recipient-to-donor weight difference over a 13-year observation period. The association of absolute weight and sex difference with graft failure was explored in an outpatient cohort of deceased-donor transplant recipients who underwent kidney transplantation between 2000 and 2012. Graft failure was defined as repeated need for dialysis or death with a functioning graft. Recipient and donor sex pairings were classified as sex concordant (MDMR/FDFR) or discordant (MDFR/FDMR). These classes were further stratified into four groups according to recipient-to-donor weight mismatch >= 10 kg (recipient > donor) or <10 kg (recipient <donor). Multivariable Cox proportional hazards models were applied to evaluate the time to graft loss adjusting for donor, immunologic, surgical, organizational, and recipient predictors. Sex-concordant transplant pairings <10 kg weight difference served as the reference group. Among 826 transplant recipients, 154 developed graft failure (18.6%). Median graft survival time was 3.9 years; first quartile (0.2-1.2), second quartile (1.2-2.9), third quartile (2.9-5.8), and fourth quartile (5.8-12.4). After multivariable adjustment, the highest relative hazard for graft failure was observed for sex-discordant transplant pairings with a. 10 kg weight difference between recipient and donor (compared to the reference group MDMR/FDFR with weight difference <10 kg, MDMR/FDFR with weight difference. 10 kg, hazard ratio 1.86, 95% confidence interval 1.07-3.32-p = 0.029; MDFR/FDMR with weight difference <10 kg, hazard ratio 1.14, 95% confidence interval 0.78-1.68-p = 0.507, and MDFR/FDMR with weight difference >= 10 kg, hazard ratio 2.00, 95% confidence interval 1.15-3.48-p = 0.014). A recipient-to-donor weight mismatch of >= 10 kg was associated with an increased risk of graft loss or recipient death with a functioning graft. Concurrent sex discordance seemed to enhance this effect as indicated by an increase in the hazard ratio. We detected no significant tendency for increasing recipient-to-donor weight differences from 2000 to 2012.	[Tillmann, Frank-Peter; Quack, Ivo; Woznowski, Magdalena; Rump, Lars Christian] Heinrich Heine Univ Dusseldorf, Klin Nephrol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Tillmann, FP (corresponding author), Heinrich Heine Univ Dusseldorf, Klin Nephrol, Dusseldorf, Germany.	frank.tillmann@uni-duesseldorf.de	Tillmann, Frank Peter/AAE-1686-2021	Tillmann, Frank Peter/0000-0002-4610-4361				Baldelomar EJ, 2016, KIDNEY INT, V89, P498, DOI 10.1038/ki.2015.316; Bassi R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169077; Beeman SC, 2014, AM J PHYSIOL-RENAL, V306, pF1381, DOI 10.1152/ajprenal.00092.2014; Bertoni E, 2001, TRANSPLANT P, V33, P3363, DOI 10.1016/S0041-1345(01)02448-4; BRENNER BM, 1993, AM J KIDNEY DIS, V21, P66, DOI 10.1016/0272-6386(93)70097-I; Chisholm-Burns MA, 2016, PATIENT PREFER ADHER, V10, P703, DOI 10.2147/PPA.S104646; D'Addio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053797; Denhaerynck K, 2007, AM J TRANSPLANT, V7, P108, DOI 10.1111/j.1600-6143.2006.01611.x; Denic A, 2017, J AM SOC NEPHROL, V28, P313, DOI 10.1681/ASN.2016020154; Feldman HI, 1996, J AM SOC NEPHROL, V7, P151; Finger JD, 2016, DTSCH ARZTEBL INT, V113, P712, DOI 10.3238/arztebl.2016.0712; Gaston RS, 1996, TRANSPLANTATION, V61, P383, DOI 10.1097/00007890-199602150-00010; Ghafari A, 2008, TRANSPL P, V40, P135, DOI 10.1016/j.transproceed.2007.11.029; Giral M, 2010, J AM SOC NEPHROL, V21, P1022, DOI 10.1681/ASN.2009121296; Goldberg RJ, 2010, TRANSPLANTATION, V90, P867, DOI 10.1097/TP.0b013e3181f24e75; Gratwohl A, 2008, LANCET, V372, P49, DOI 10.1016/S0140-6736(08)60992-7; Heaphy ELG, 2013, AM J TRANSPLANT, V13, P1001, DOI 10.1111/ajt.12154; Hernandez-Fuentes MP, 2018, AM J TRANSPLANT, V18, P1370, DOI 10.1111/ajt.14594; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Jindal RM, 2005, AM J NEPHROL, V25, P474, DOI 10.1159/000087920; Kasiske BL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000024564.22119.3D; Kim SJ, 2009, J AM SOC NEPHROL, V20, P2025, DOI 10.1681/ASN.2008101110; Kolonko A, 2013, TRANSPL P, V45, P1639, DOI 10.1016/j.transproceed.2012.12.019; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; McGee J, 2010, J AM COLL SURGEONS, V210, P718, DOI 10.1016/j.jamcollsurg.2009.12.032; Merion RM, 2005, JAMA-J AM MED ASSOC, V294, P2726, DOI 10.1001/jama.294.21.2726; Miller AJ, 2017, CLIN J AM SOC NEPHRO, V12, P669, DOI 10.2215/CJN.07660716; Narasimhamurthy M, 2017, CLIN KIDNEY J, V10, P116, DOI 10.1093/ckj/sfw097; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; Opelz G, 2013, TRANSPLANT REV-ORLAN, V27, P43, DOI 10.1016/j.trre.2013.01.004; Popli R, 2014, IMMUNOL RES, V58, P249, DOI 10.1007/s12026-014-8514-3; Spivey CA, 2014, CLIN TRANSPLANT, V28, P96, DOI 10.1111/ctr.12283; Tan JC, 2012, GENDER MED, V9, P335, DOI 10.1016/j.genm.2012.07.004	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214048	10.1371/journal.pone.0214048	http://dx.doi.org/10.1371/journal.pone.0214048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925158	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300009
J	Chandrashekar, S; Saha, S; Varghese, B; Mohan, L; Shetty, G; Porwal, A; Hazra, A; Mondal, S; Das, R				Chandrashekar, S.; Saha, S.; Varghese, B.; Mohan, L.; Shetty, G.; Porwal, A.; Hazra, A.; Mondal, S.; Das, R.			Cost and cost-effectiveness of health behavior change interventions implemented with self-help groups in Bihar, India	PLOS ONE			English	Article							NEWBORN BABIES; MORTALITY	Introduction Health interventions implemented with self-help groups (SHGs) enhance the relevance and acceptability of the health services. The Parivartan program was implemented in eight districts of Bihar with women's self-help groups to increase adoption of maternal and newborn health behaviors through layering health behavior change communication. This study estimates the cost and cost-effectiveness of a health behavior change program with SHGs in Bihar. Methods Cost analysis was conducted from a provider's perspective. All costs have been presented in US dollars for the purpose of international comparisons and converted to constant values. The effectiveness estimate was based on the reported changes in select newborn care practices. A decision model approach was used to estimate the potential number of neonatal deaths averted based on adoption of key newborn care practices. Using India's life expectancy of 65 years, cost per life year saved was calculated. A one-way sensitivity analysis was conducted using the upper and lower estimates for various variables in the model, and functionality of SHGs. Results The cost of forming an SHG group was US$254 and that of reaching a woman within the group was US$19. The unit cost for delivering health interventions through the Parivartan program was US$148 per group and US$11 per woman reached. During an 18 months period, Parivartan program reached around 17,120 SHGs and an estimated 20,544 pregnant women resulting in an estimated prevention of 23 neonatal deaths at a cost of US $3,825 per life year saved. Conclusion SHGs can be an effective platform to increase uptake of women's health interventions and follow-up care, and also to broaden their utility beyond microfinance, particularly when they operate at a larger scale.	[Chandrashekar, S.; Mohan, L.; Shetty, G.] Karnataka Hlth Promot Trust, Bangalore, Karnataka, India; [Saha, S.; Varghese, B.] Publ Hlth Fdn India, New Delhi, India; [Saha, S.] Indian Inst Publ Hlth, Gandhinagar, India; [Porwal, A.; Hazra, A.] Populat Council, New Delhi, India; [Mondal, S.; Das, R.] Project Concern Int, New Delhi, India	Public Health Foundation of India	Chandrashekar, S (corresponding author), Karnataka Hlth Promot Trust, Bangalore, Karnataka, India.	sudhashreec@yahoo.co.in	Saha, Somen/C-6286-2012	Saha, Somen/0000-0002-8043-3388	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Support for this study was provided by the Bill & Melinda Gates Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AccessAfrica, 2011, MICR AFR STAT SECT R; [Anonymous], 2013, ANN HLTH SURV 2012 1; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Devika J, 2007, INDIAN J GEND STUD, V14, P33, DOI 10.1177/097152150601400103; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Haddix AC, 2003, PREVENTION EFFECTIVE; Harper M, 2002, SONGLINES MICHAELTRE, P25; Isern J., 2007, 12 CGAP; Lorenzetti LMJ, 2017, HEALTH POLICY PLANN, V32, P732, DOI 10.1093/heapol/czw170; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Rai RK, 2014, J EPIDEMIOL GLOB HEA, V4, P239, DOI 10.1016/j.jegh.2013.12.006; Saggurti N., 2018, EVALUATING IMPACT PA, DOI 10.7910/DVN/WPHXJK; Saggurti N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202562; Saha S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-36; Tankha A, 2002, SME TECHNICAL WORKIN; Varghese B, 1999, AIDS, V13, P1745, DOI 10.1097/00002030-199909100-00019	19	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213723	10.1371/journal.pone.0213723	http://dx.doi.org/10.1371/journal.pone.0213723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921334	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000023
J	Koch, D; Schuetz, P; Haubitz, S; Kutz, A; Mueller, B; Weber, H; Regez, K; Conca, A; Schuetz, P; Hausfater, P; Amin, D; Haubitz, S; Faessler, L; Grolimund, E; Kutz, A; Schild, U; Caldara, Z; Regez, K; Zhydkov, A; Kahles, T; Nedeltchev, K; von Felten, S; De Geest, S; Conca, A; Schaefer-Keller, P; Huber, A; Bargetzi, M; Buergi, U; Sauvin, G; Perrig-Chiello, P; Reutlinger, B; Koch, D; Weber, H; Mueller, B				Koch, Daniel; Schuetz, Philipp; Haubitz, Sebastian; Kutz, Alexander; Mueller, Beat; Weber, Helen; Regez, Katharina; Conca, Antoinette; Schuetz, Philipp; Hausfater, Pierre; Amin, Devendra; Haubitz, Sebastian; Faessler, Lukas; Grolimund, Eva; Kutz, Alexander; Schild, Ursula; Caldara, Zeljka; Regez, Katharina; Zhydkov, Andriy; Kahles, Timo; Nedeltchev, Krassen; von Felten, Stefanie; De Geest, Sabina; Conca, Antoinette; Schaefer-Keller, Petra; Huber, Andreas; Bargetzi, Mario; Buergi, Ulrich; Sauvin, Gabrielle; Perrig-Chiello, Pasqualina; Reutlinger, Barbara; Koch, Daniel; Weber, Helen; Mueller, Beat		Triage Study Grp	Improving the post-acute care discharge score (PACD) by adding patients' self-care abilities: A prospective cohort study	PLOS ONE			English	Article							PREDICTION; MODEL	Background Reducing delays in hospital discharge is important to improve transition processes and reduce health care costs. The recently proposed post-acute care discharge score focusing on the self-care abilities before hospital admission allows early identification of patients with a need for post-acute care. New limitations in self-care abilities identified during hospitalization may also indicate a risk. Our aim was to investigate whether the addition of the post-acute care discharge score and a validated self-care instrument would improve the prognostic accuracy to predict post-acute discharge needs in unselected medical inpatients. Methods We included consecutive adult medical and neurological inpatients. Logistic regression models with area under the receiver operating characteristic curve were calculated to study associations of post-acute discharge score and self-care index with post-acute discharge risk. We calculated joint regression models and reclassification statistics including the net reclassification index and integrated discrimination improvement to investigate whether merging the self-care index and the post-acute discharge score leads to better diagnostic accuracy. Results Out of 1342 medical and 402 neurological patients, 150 (11.18%) and 94 (23.38%) have reached the primary endpoint of being discharged to a post-acute care facility. Multivariate analysis showed that the self-care index is an outcome predictor (OR 0.897, 95%Cl 0.864-0.930). By combining the self-care index and the post-acute care discharge score discrimination for medical (from area under the curve 0.77 to 0.83) and neurological patients (from area under the curve 0.68 to 0.78) could be significantly improved. Reclassification statistics also showed significant improvements with regard to net reclassification index (14.2%, p<0.05) and integrated discrimination improvement (4.83%, p<0.05). Conclusions Incorporating an early assessment of patients' actual intrahospital self-care ability to the post-acute care discharge score led to an improved prognostic accuracy for identifying adult, medical and neurological patients at risk for discharge to a post-acute care facility.	[Koch, Daniel; Weber, Helen; Conca, Antoinette] Kantonsspital Aarau AG, Dept Clin Nursing Sci, Aarau, Switzerland; [Koch, Daniel; Schuetz, Philipp; Haubitz, Sebastian; Kutz, Alexander; Mueller, Beat; Regez, Katharina; Conca, Antoinette] Kantonsspital Aarau AG, Univ Dept Internal Med, Aarau, Switzerland; [Koch, Daniel; Schuetz, Philipp; Grolimund, Eva; Kutz, Alexander; Schild, Ursula; Caldara, Zeljka; Regez, Katharina; Zhydkov, Andriy; Bargetzi, Mario; Mueller, Beat] Kantonsspital Aarau, Univ Dept Internal Med, Aarau, Switzerland; [Hausfater, Pierre; Sauvin, Gabrielle] Grp Hosp Pitie Salpetriere, AP HP, Emergency Dept 1, Paris, France; [Amin, Devendra] Morton Plant Hosp, Dept Crit Care, Clearwater, FL USA; [Haubitz, Sebastian] Div Infect Dis, Aarau, Switzerland; [Haubitz, Sebastian] Kantonsspital Aarau, Hosp Epidemiol, Aarau, Switzerland; [Faessler, Lukas; Perrig-Chiello, Pasqualina] Univ Bern, Dept Psychol, Bern, Switzerland; [Kahles, Timo; Nedeltchev, Krassen] Kantonsspital Aarau, Dept Neurol, Aarau, Switzerland; [von Felten, Stefanie] Univ Hosp Basel, Clin Trial Unit, Basel, Switzerland; [De Geest, Sabina] Univ Basel, Inst Nursing Sci, Basel, Switzerland; [Conca, Antoinette; Reutlinger, Barbara; Weber, Helen] Kantonsspital Aarau, Dept Clin Nursing Sci, Aarau, Switzerland; [Schaefer-Keller, Petra] Univ Appl Sci & Arts Western Switzerland, Sch Hlth Sci Fribourg, HedS FR, HES SO, Fribourg, Switzerland; [Huber, Andreas] Kantonsspital Aarau, Dept Lab Med, Aarau, Switzerland; [Buergi, Ulrich] Kantonsspital Aarau, Emergency Dept, Aarau, Switzerland	Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Kantonsspital Aarau AG (KSA); University of Bern; Kantonsspital Aarau AG (KSA); University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); University of Applied Sciences & Arts Western Switzerland; Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA)	Conca, A (corresponding author), Kantonsspital Aarau AG, Dept Clin Nursing Sci, Aarau, Switzerland.; Conca, A (corresponding author), Kantonsspital Aarau AG, Univ Dept Internal Med, Aarau, Switzerland.	antoinette.conca@ksa.ch; beat.mueller@ksa.ch	Mueller, Beat/G-2662-2012; von Felten, Stefanie/L-3514-2019; schuetz, philipp/C-8475-2013	von Felten, Stefanie/0000-0002-5264-6394; schuetz, philipp/0000-0001-6400-4949; De Geest, Sabina/0000-0001-6596-7237; Koch, Daniel/0000-0002-4660-5924	Thermofisher; Swiss National Science Foundation (SNSF) [PP00P3_150531/1]; Swiss National Science Foundation [SNF 407440_167376]; Schweizerische Akademie der Medizinischen Wissenschaften (SAMW)	Thermofisher; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schweizerische Akademie der Medizinischen Wissenschaften (SAMW)	Thermofisher provided an unrestricted research grant for this study. PS is supported by the Swiss National Science Foundation (SNSF Professorship, PP00P3_150531/1); http://www.snf.ch/de/Seiten/default.aspx.BM is supported by the Swiss National Science Foundation (SNF 407440_167376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.snf.ch/de/Seiten/default.aspx. This study was also supported by the Schweizerische Akademie der Medizinischen Wissenschaften (SAMW).	AlHilli MM, 2013, J AM COLL SURGEONS, V217, P507, DOI 10.1016/j.jamcollsurg.2013.04.036; Bartholomeyczik S, 2006, FOCUS; Campbell SE, 2005, AGE AGEING, V34, P467, DOI 10.1093/ageing/afi141; Conca A, 2015, PFLEGEWISSENSCHAFT, V11; Conca A, 2012, PFLEGEWISSENSCHAFT, V5, DOI [10.3936/1155, DOI 10.3936/1155]; Conca A, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2897-0; Costa AP, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-172; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Grosse-Schlarmann J, 2007, CMS EPA VERSCHIEDENE; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hauck K, 2011, MED CARE, V49, P1068, DOI 10.1097/MLR.0b013e31822efb09; Hendy P, 2012, CLIN MED, V12, P320, DOI 10.7861/clinmedicine.12-4-320; Holland DE, 2006, NURS RES, V55, P62, DOI 10.1097/00006199-200601000-00008; Hunstein D., 2015, ENTWICKLUNG TESTUNG; Jette DU, 2014, PHYS THER, V94, P1252, DOI 10.2522/ptj.20130359; Jupp BJ, 2011, GERIATR GERONTOL INT, V11, P8, DOI 10.1111/j.1447-0594.2010.00626.x; Kantonsspital Aarau AG, 2017, KSA GESCH 2014 2015; Liu SK, 2016, J AM GERIATR SOC, V64, P2095, DOI 10.1111/jgs.14345; Majeed MU, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-410; Schariatzadeh R, 2011, Praxis (Bern 1994), V100, P75, DOI 10.1024/1661-8157/a000410; Schuetz P., 2012, OPTIMIERTER PATIEN 4; Schuetz P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1098-z; Schuetz P, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-12; Simonet ML, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-154; Sundstrom J, 2011, SCAND J PUBLIC HEALT, V39, P439, DOI 10.1177/1403494810396556; Tanaka M, 2008, ARCH GERONTOL GERIAT, V47, P1, DOI 10.1016/j.archger.2007.06.002	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214194	10.1371/journal.pone.0214194	http://dx.doi.org/10.1371/journal.pone.0214194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921356	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000038
J	Tong, YX; Kucukdeger, E; Halper, J; Cesewski, E; Karakozoff, E; Haring, AP; McIlvain, D; Singh, M; Khandelwal, N; Meholic, A; Laheri, S; Sharma, A; Johnson, BN				Tong, Yuxin; Kucukdeger, Ezgi; Halper, Justin; Cesewski, Ellen; Karakozoff, Elena; Haring, Alexander P.; McIlvain, David; Singh, Manjot; Khandelwal, Nikita; Meholic, Alex; Laheri, Sahil; Sharma, Akshay; Johnson, Blake N.			Low-cost sensor-integrated 3D-printed personalized prosthetic hands for children with amniotic band syndrome: A case study in sensing pressure distribution on an anatomical human-machine interface (AHMI) using 3D-printed conformal electrode arrays	PLOS ONE			English	Article							3D; DESIGN; MODEL	Interfacing anatomically conformal electronic components, such as sensors, with biology is central to the creation of next-generation wearable systems for health care and human augmentation applications. Thus, there is a need to establish computer-aided design and manufacturing methods for producing personalized anatomically conformal systems, such as wearable devices and human-machine interfaces (HMIs). Here, we show that a three-dimensional (3D) scanning and 3D printing process enabled the design and fabrication of a sensor-integrated anatomical human-machine interface (AHMI) in the form of personalized prosthetic hands that contain anatomically conformal electrode arrays for children affected by amniotic band syndrome, a common birth defect. A methodology for identifying optimal scanning parameters was identified based on local and global metrics of registered point cloud data quality. This method identified an optimal rotational angle step size between adjacent 3D scans. The sensitivity of the optimization process to variations in organic shape (i.e., geometry) was examined by testing other anatomical structures, including a foot, an ear, and a porcine kidney. We found that personalization of the prosthetic interface increased the tissue-prosthesis contact area by 408% relative to the non-personalized devices. Conformal 3D printing of carbon nanotube-based polymer inks across the personalized AHMI facilitated the integration of electronic components, specifically, conformal sensor arrays for measuring the pressure distribution across the AHMI (i.e., the tissue-prosthesis interface). We found that the pressure across the AHMI exhibited a non-uniform distribution and became redistributed upon activation of the prosthetic hand's grasping action. Overall, this work shows that the integration of 3D scanning and 3D printing processes offers the ability to design and fabricate wearable systems that contain sensor-integrated AHMIs.	[Tong, Yuxin; Kucukdeger, Ezgi; Halper, Justin; Karakozoff, Elena; McIlvain, David; Singh, Manjot; Khandelwal, Nikita; Meholic, Alex; Johnson, Blake N.] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA; [Cesewski, Ellen; Johnson, Blake N.] Virginia Tech, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA; [Haring, Alexander P.; Johnson, Blake N.] Virginia Tech, Macromol Innovat Inst, Blacksburg, VA 24061 USA; [Laheri, Sahil; Johnson, Blake N.] Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA; [Sharma, Akshay] Virginia Tech, Sch Architecture Design, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Johnson, BN (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.; Johnson, BN (corresponding author), Virginia Tech, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA.; Johnson, BN (corresponding author), Virginia Tech, Macromol Innovat Inst, Blacksburg, VA 24061 USA.; Johnson, BN (corresponding author), Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA.	bnj@vt.edu	Tong, Yuxin/CAG-8207-2022; Cesewski, Ellen/AAW-6494-2021; Chan, Simmy/AAD-9046-2021	Tong, Yuxin/0000-0002-2775-6057; Singh, Manjot/0000-0002-8165-254X; Cesewski, Ellen/0000-0002-6604-2321; Kucukdeger, Ezgi/0000-0002-6587-6850	National Science Foundation [DUE-1644138]; Virginia Tech Student Engineers' Council [SEC-2018]; Virginia Tech Institute for Creativity, Arts, and Technology (ICAT-2018)	National Science Foundation(National Science Foundation (NSF)); Virginia Tech Student Engineers' Council; Virginia Tech Institute for Creativity, Arts, and Technology (ICAT-2018)	BNJ is grateful for the generous support of the National Science Foundation (DUE-1644138) and the Virginia Tech Student Engineers' Council (SEC-2018). BNJ and AS are grateful for the generous support of the Virginia Tech Institute for Creativity, Arts, and Technology (ICAT-2018). All funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received from this study.	Ahn BY, 2011, JOVE-J VIS EXP, DOI 10.3791/3189; Apeagyei P.R., 2010, INT J DIGITAL CONTEN, V4, P58, DOI DOI 10.4156/JDCTA.V0L4.ISSUE7.6; Aszmann OC, 2015, LANCET, V385, P2183, DOI 10.1016/S0140-6736(14)61776-1; Bahari MS, 2012, INT J SOC ROBOT, V4, P59, DOI 10.1007/s12369-011-0133-8; Bhattacharya S, 2015, INDIAN J PLAST SURG, V48, P4, DOI 10.4103/0970-0358.155260; Boehnen C, 2005, 5 INT C 3D DIG IM MO; Callieri M, 2003, VCLABS TOOLS 3D RANG; Cesewski E, 2018, LAB CHIP, V18, P2087, DOI 10.1039/c8lc00427g; Chang JW, 2014, ARTIF ORGANS, V38, pE95, DOI 10.1111/aor.12310; Chua MCH, 2013, 35 ANN INT C IEEE EN; Cignoni P., 2008, 6 EUR IT CHAPT C 200, DOI 10.2312/LocalChapterEvents/ItalChap/ItalianChapConf2008/129-136; Dahiya RS, 2010, IEEE T ROBOT, V26, P1, DOI 10.1109/TRO.2009.2033627; Dastoorian R, 2018, AUTOMATED SURFACE IN; Dawood A, 2015, BRIT DENT J, V219, P521, DOI 10.1038/sj.bdj.2015.914; Dodziuk H, 2016, KARDIOCHIR TORAKOCHI, V13, P283, DOI 10.5114/kitp.2016.62625; Gough N. R., 2014, REGEN MED, V7, pec347, DOI [10.1126/scisignal.aaa4763, DOI 10.1126/SCISIGNAL.AAA4763]; Goyanes A, 2016, J CONTROL RELEASE, V234, P41, DOI 10.1016/j.jconrel.2016.05.034; Graczyk EL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26952-x; Gretsch KF, 2016, PROSTHET ORTHOT INT, V40, P400, DOI 10.1177/0309364615579317; Guo SZ, 2017, ADV MATER, V29, DOI 10.1002/adma.201701218; Gupta MK, 2015, NANO LETT, V15, P5321, DOI 10.1021/acs.nanolett.5b01688; Haring AP, 2017, ADV OPT MATER, V5, DOI 10.1002/adom.201700367; Hochman JB, 2014, OTOLARYNG HEAD NECK, V150, P448, DOI 10.1177/0194599813518008; Ibrahim D, 2009, J CRANIO MAXILL SURG, V37, P167, DOI 10.1016/j.jcms.2008.10.008; Johnson BN, 2015, ADV FUNCT MATER, V25, P6205, DOI 10.1002/adfm.201501760; Kim MK, 2015, AUTOMAT CONSTR, V49, P225, DOI 10.1016/j.autcon.2014.07.010; Kita K, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-55; Kong KTS, 2012, POLYM BULL, V69, P937, DOI 10.1007/s00289-012-0777-z; Kong YL, 2016, NANO TODAY, V11, P330, DOI 10.1016/j.nantod.2016.04.007; Kong YL, 2014, NANO LETT, V14, P7017, DOI 10.1021/nl5033292; Kuyper MA, 2001, PROSTHET ORTHOT INT, V25, P228, DOI 10.1080/03093640108726606; Kyberd PJ, 2009, BRIT J OCCUP THER, V72, P212, DOI 10.1177/030802260907200506; Laliberte T, 2010, MECH SCI, V1, P19, DOI 10.5194/ms-1-19-2010; Lee KH, 2017, ANN REHABIL MED-ARM, V41, P875, DOI 10.5535/arm.2017.41.5.875; Light C., 1999, BRIT J OCCUP THER, V62, P7, DOI [10.1177/030802269906200103, DOI 10.1177/030802269906200103]; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; Lu NS, 2012, ADV FUNCT MATER, V22, P4044, DOI 10.1002/adfm.201200498; Mannoor MS, 2013, NANO LETT, V13, P2634, DOI 10.1021/nl4007744; McAlpine MC, 2016, INVENTORS MULTIFUNCT; Morrison RJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010825; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Owens CM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045007; Pang C, 2012, NAT MATER, V11, P795, DOI 10.1038/NMAT3380; Pathak Vimal Kumar, 2018, Journal of the Institution of Engineers (India): Series C (Mechanical, Production, Aerospace and Marine Engineering), V99, P197, DOI 10.1007/s40032-016-0337-7; Patton JG, 1989, COMPREHENSIVE MANAGE, P137; Phillips B., 2015, GLOB HUM TECHN C GHT; Pulli K, 1999, 3D DIG IM MOD 1999 P; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Rushton DI, 1983, BMJ-BRIT MED J, V286, P2; Rusinkiewicz S, 2002, ACM T GRAPHIC, V21, P438, DOI 10.1145/566570.566600; Rusinkiewicz S., 2001, 3D DIG IM MOD 2001 P; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; Schrank ES, 2011, J REHABIL RES DEV, V48, P31, DOI 10.1682/JRRD.2009.12.0195; Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832; Sepulveda AT, 2013, NANOSCALE, V5, P4847, DOI 10.1039/c3nr00753g; Shanmuganathan N, 2011, J Indian Prosthodont Soc, V11, P232, DOI 10.1007/s13191-011-0074-9; Shuang-Zhuang G., 2017, ADV MATER, V29; Singh M, 2017, LAB CHIP, V17, P2561, DOI 10.1039/c7lc00468k; Smith DG, 2009, PROSTHESES CHILDREN; SMITS FM, 1958, AT&T TECH J, V37, P711, DOI 10.1002/j.1538-7305.1958.tb03883.x; Sypniewski B L, 1972, Artif Limbs, V16, P20; Tam MD, 2012, J RADIOL CASE REP, V6, P31, DOI 10.3941/jrcr.v6i1.889; Temple JP, 2014, J BIOMED MATER RES A, V102, P4317, DOI 10.1002/jbm.a.35107; ten Kate J, 2017, DISABIL REHABIL-ASSI, V12, P300, DOI 10.1080/17483107.2016.1253117; Waran V, 2014, J SURG EDUC, V71, P193, DOI 10.1016/j.jsurg.2013.08.010; Wilson AB, 1998, PRIMER LIMB PROSTHET; Wilson AB, 1976, LIMB PROSTHETICS; Yogeswaran N, 2015, PH D RES MICR EL PRI; Youssef RF, 2015, BJU INT, V116, P697, DOI 10.1111/bju.13183; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005; Zuniga JM, 2016, J PROSTHET ORTHOT, V28, P103, DOI DOI 10.1097/JPO.0000000000000097; Zuniga Jorge, 2015, BMC Res Notes, V8, P10, DOI 10.1186/s13104-015-0971-9	72	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214120	10.1371/journal.pone.0214120	http://dx.doi.org/10.1371/journal.pone.0214120			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921360	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000036
J	Le Neve, B; Derrien, M; Tap, J; Brazeilles, R; Portier, SC; Guyonnet, D; Ohman, L; Storsrud, S; Tornblom, H; Simren, M				Le Neve, Boris; Derrien, Muriel; Tap, Julien; Brazeilles, Remi; Portier, Stephanie Cools; Guyonnet, Denis; Ohman, Lena; Storsrud, Stine; Tornblom, Hans; Simren, Magnus			Fasting breath H-2 and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome	PLOS ONE			English	Article							LACTIS DN-173 010; ABDOMINAL DISTENSION; FECAL MICROBIOTA; GAS; SYMPTOMS; BIFIDOBACTERIUM; PROBIOTICS; EXCRETION; SEVERITY; PREVALENCE	Objectives Aim of this study was to assess the effect of a fermented milk product containing Bifidobacterium lactis CNCM I-2494 (FMP) on gastrointestinal (GI) symptoms and exhaled H-2 and CH4 during a nutrient and lactulose challenge in patients with irritable bowel syndrome (IBS). Methods We included 125 patients with IBS (Rome III). Fasted subjects were served a 400ml liquid test meal containing 25g lactulose. The intensity of eight GI symptoms and the amount of exhaled H-2 and CH4 were assessed before and during 4h after meal intake. The challenge was repeated after 14 days consumption of FMP or a control product in a double-blind, randomized, parallel design. The metabolic potential of fecal microbiota was profiled using 16S MiSeq analysis of samples obtained before and after the intervention. Results 106 patients with IBS were randomized. No difference between FMP or control groups was found on GI symptoms or breath H-2 and CH4 in the whole cohort. A post-hoc analysis in patients stratified according to their fasting H-2 levels showed that in high H-2 producers (fasting H-2 level >= 10ppm, n = 35), FMP consumption reduced fasting H-2 levels (p = 0.003) and H-2 production during the challenge (p = 0.002) and tended to decrease GI discomfort (p = 0.05) vs. control product. The Prevotella /Bacteroides metabolic potential at baseline was higher in high H-2 producers (p<0.05) vs. low H-2 producers and FMP consumption reduced this ratio (p<0.05) vs. control product. Conclusions The response to a fermented milk product containing Bifidobacterium lactis CNCM I-2494 (FMP) in patients with IBS seems to be associated with the metabolic potential of the gut microbiota.	[Le Neve, Boris; Derrien, Muriel; Tap, Julien; Brazeilles, Remi; Portier, Stephanie Cools] Danone Nutricia Res, Palaiseau, France; [Guyonnet, Denis] Diana Nova, Clichy La Garenne, France; [Ohman, Lena] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Immunol & Microbiol, Gothenburg, Sweden; [Ohman, Lena; Storsrud, Stine; Tornblom, Hans; Simren, Magnus] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Simren, Magnus] Univ N Carolina, Ctr Funct Gastrointestinal & Motil Disorders, Chapel Hill, NC 27515 USA	Danone Nutricia; University of Gothenburg; University of Gothenburg; University of North Carolina; University of North Carolina Chapel Hill	Le Neve, B (corresponding author), Danone Nutricia Res, Palaiseau, France.	boris.le-neve@danone.com	Derrien, Muriel/AAS-6845-2021; Guyonnet, Denis/AAE-4073-2021; Tap, Julien/E-5760-2010; guyonnet, denis/AAX-6149-2021; Guyonnet, Denis/Y-5314-2019; Störsrud, Stine/AAH-1390-2019	Derrien, Muriel/0000-0001-8841-9153; Tap, Julien/0000-0001-8998-5413; guyonnet, denis/0000-0002-7900-6880; Le Neve, Boris/0000-0003-3892-9045	Swedish Medical Research Council [13409, 21691, 21692]; Marianne and Marcus Wallenberg Foundation; AFA Forsakring; Faculty of Medicine, University of Gothenburg; Danone Nutricia Research	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Marianne and Marcus Wallenberg Foundation; AFA Forsakring; Faculty of Medicine, University of Gothenburg; Danone Nutricia Research(Danone Nutricia)	This research was supported by the Swedish Medical Research Council (grants 13409, 21691 and 21692), the Marianne and Marcus Wallenberg Foundation, AFA Forsakring, the Faculty of Medicine, University of Gothenburg, as well as by Danone Nutricia Research.	Agrawal A, 2009, ALIMENT PHARM THER, V29, P104, DOI 10.1111/j.1365-2036.2008.03853.x; Agrawal A, 2008, ALIMENT PHARM THER, V27, P2, DOI 10.1111/j.1365-2036.2007.03549.x; Azpiroz F, 2005, GASTROENTEROLOGY, V129, P1060, DOI 10.1053/j.gastro.2005.06.062; Azpiroz F, 2005, GUT, V54, P893, DOI 10.1136/gut.2004.048868; Bendezu RA, 2015, NEUROGASTROENT MOTIL, V27, P1249, DOI 10.1111/nmo.12618; Bennet SMP, 2016, AM J GASTROENTEROL, V111, P1165, DOI 10.1038/ajg.2016.223; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang L, 2001, AM J GASTROENTEROL, V96, P3341; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dimidi E, 2014, GUT, V63, pA196, DOI 10.1136/gutjnl-2014-307263.424; FLOURIE B, 1988, GASTROENTEROLOGY, V95, P356, DOI 10.1016/0016-5085(88)90491-X; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Guyonnet D, 2009, BRIT J NUTR, V102, P1654, DOI 10.1017/S0007114509990882; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Hungin APS, 2013, ALIMENT PHARM THER, V38, P864, DOI 10.1111/apt.12460; Kim HJ, 2005, NEUROGASTROENT MOTIL, V17, P687, DOI 10.1111/j.1365-2982.2005.00695.x; Le Neve B, 2013, AM J GASTROENTEROL, V108, P786, DOI 10.1038/ajg.2013.75; Le Neve B, 2016, CLIN GASTROENTEROL H, V14, P226, DOI 10.1016/j.cgh.2015.09.039; LEVITT MD, 1969, NEW ENGL J MED, V281, P122, DOI 10.1056/NEJM196907172810303; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Maier L, 2013, CELL HOST MICROBE, V14, P641, DOI 10.1016/j.chom.2013.11.002; Major G, 2017, GASTROENTEROLOGY, V152, P124, DOI 10.1053/j.gastro.2016.09.062; Malagelada JR, 2017, AM J GASTROENTEROL, V112, P1221, DOI 10.1038/ajg.2017.129; Manichanh C, 2014, GUT, V63, P401, DOI 10.1136/gutjnl-2012-303013; Marteau P, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12078; Martinez C, 2012, AM J GASTROENTEROL, V107, P736, DOI 10.1038/ajg.2011.472; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Nordin S, 2013, SCAND J PSYCHOL, V54, P112, DOI 10.1111/sjop.12029; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Ringel Y, 2009, CLIN GASTROENTEROL H, V7, P68, DOI 10.1016/j.cgh.2008.07.008; SAHOTA SS, 1982, J GEN MICROBIOL, V128, P319; Sandler RS, 2000, DIGEST DIS SCI, V45, P1166, DOI 10.1023/A:1005554103531; Simren M, 2006, GUT, V55, P297, DOI 10.1136/gut.2005.075127; STEGGERDA FR, 1968, ANN NY ACAD SCI, V150, P57, DOI 10.1111/j.1749-6632.1968.tb19031.x; STEGGERDA FR, 1966, AM J CLIN NUTR, V19, P120, DOI 10.1093/ajcn/19.2.120; STONEDORSHOW T, 1987, AM J CLIN NUTR, V46, P61, DOI 10.1093/ajcn/46.1.61; Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049; Tielemans MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069876; TOMLIN J, 1991, GUT, V32, P665, DOI 10.1136/gut.32.6.665; Tornblom H, 2012, AM J GASTROENTEROL, V107, P754, DOI 10.1038/ajg.2012.5; Veiga P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06328; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Whorwell PJ, 2006, AM J GASTROENTEROL, V101, P1581, DOI 10.1111/j.1572-0241.2006.00734.x; Yao CK, 2015, J GASTROEN HEPATOL, V30, P1731, DOI 10.1111/jgh.13015; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214273	10.1371/journal.pone.0214273	http://dx.doi.org/10.1371/journal.pone.0214273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946757	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500022
J	Raghavan, R; Aaron, GJ; Nahar, B; Knowles, J; Neufeld, LM; Rahman, S; Mondal, P; Ahmed, T				Raghavan, Ramkripa; Aaron, Grant J.; Nahar, Baitun; Knowles, Jacky; Neufeld, Lynnette M.; Rahman, Sabuktagin; Mondal, Prasenjit; Ahmed, Tahmeed			Household coverage of vitamin A fortification of edible oil in Bangladesh	PLOS ONE			English	Article							EXPENDITURES SURVEYS HCES; SCALE FOOD FORTIFICATION; FORTIFIED VEGETABLE-OIL; WHEAT-FLOUR; YOUNG-CHILDREN; RETINYL PALMITATE; MAIZE FLOUR; DEFICIENCY; CONSUMPTION; PROGRAMS	Mandatory fortification of edible oil (soybean and palm) with vitamin A was decreed in Bangladesh in 2013. Yet, there is a dearth of data on the availability and consumption of vitamin A fortifiable oil at household level across population sub-groups. To fill this gap, our study used a nationally representative survey in Bangladesh to assess the purchase of fortifiable edible oil among households and project potential vitamin A intake across population subgroups. Data is presented by strata, age range and poverty-the factors that potentially influence oil coverage. Across 1,512 households, purchase of commercially produced fortifiable edible oil was high (87.5%). Urban households were more likely to purchase fortifiable oil (94.0%) than households in rural low performing (79.7%) and rural other strata (88.1%) (p value: 0.01). Households in poverty were less likely to purchase fortifiable oil (82.1%) than households not in poverty (91.4%) (p <0.001). Projected estimates suggested that vitamin A fortified edible oil would at least partially meet daily vitamin A estimated average requirement (EAR) for the majority of the population. However, certain population sub-groups may still have vitamin A intake below the EAR and alternative strategies may be applied to address the vitamin A needs of these vulnerable sub-groups. This study concludes that a high percentage of Bangladeshi population across different sub-groups have access to fortifiable edible oil and further provides evidence to support mandatory edible oil fortification with vitamin A in Bangladesh.	[Raghavan, Ramkripa; Aaron, Grant J.; Knowles, Jacky; Neufeld, Lynnette M.; Rahman, Sabuktagin] GAIN, Geneva, Switzerland; [Raghavan, Ramkripa] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Early Life Origins Dis, Baltimore, MD USA; [Nahar, Baitun; Mondal, Prasenjit; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res Icddr B, Dhaka, Bangladesh; [Ahmed, Tahmeed] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University	Raghavan, R (corresponding author), GAIN, Geneva, Switzerland.; Raghavan, R (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Early Life Origins Dis, Baltimore, MD USA.	ramkripa@gmail.com			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Funding for this research was provided by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) to GAIN. The funding covered the costs of implementing the research only. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron GJ, 2017, J NUTR, V147, p984S, DOI 10.3945/jn.116.245753; Aaron GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163176; Aaron GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162462; Akhtar S, 2013, J HEALTH POPUL NUTR, V31, P413; Alkire S., 2014, MULTIDIMENSIONAL POV; Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; [Anonymous], 2011, BANGL MULT IND CLUST; Arsenault JE, 2013, J NUTR, V143, P197, DOI 10.3945/jn.112.169524; Bermudez OI, 2012, FOOD NUTR BULL, V33, pS208, DOI 10.1177/15648265120333S209; Choudhury R, 2012, INT J SUP CHAIN MGT, V1; Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S; Dary O, 2012, FOOD NUTR BULL, V33, pS190, DOI 10.1177/15648265120333S207; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; Fiedler JL, 2015, PUBLIC HEALTH NUTR, V18, P414, DOI 10.1017/S1368980014000640; Gain, 2016, FORT ED OILS BANGL; Hammond EG, 2005, SOYBEAN OIL; Hemery YM, 2015, FOOD CHEM, V184, P90, DOI 10.1016/j.foodchem.2015.03.096; Hotz C, 2015, MATERN CHILD NUTR, V11, P39, DOI 10.1111/mcn.12245; Imhoff-Kunsch B, 2007, J NUTR, V137, P1017, DOI 10.1093/jn/137.4.1017; Institute of Medicine, 2000, DRI DIET REF INT APP; Knowles JM, 2017, J NUTR, V147, p1004S, DOI 10.3945/jn.116.242586; Kraemer K, 2008, NUTR REV, V66, P517, DOI 10.1111/j.1753-4887.2008.00084.x; Laillou A, 2013, FOOD NUTR BULL, V34, pS72, DOI 10.1177/15648265130342S109; Leyvraz M, 2015, NUTRIENTS, V7, P9960, DOI [10.3390/nu7125511, 10.3390/nu8090541]; Luthringer CL, 2015, GLOB HEALTH-SCI PRAC, V3, P446, DOI 10.9745/GHSP-D-15-00171; Mekuria Getnet, 2017, BMC Nutr, V3, P28, DOI 10.1186/s40795-017-0148-0; Nahar B., 2015, NATL SALT IODIZATION; Pan SuWen, 2008, Journal of Agricultural and Applied Economics, V40, P821; Parisi P, 2012, MED HYPOTHESES, V79, P246, DOI 10.1016/j.mehy.2012.04.049; Pena-Rosas JP, 2008, NUTR REV, V66, P148, DOI 10.1111/j.1753-4887.2008.00019.x; Pignitter M, 2014, J AGR FOOD CHEM, V62, P7559, DOI 10.1021/jf502109j; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Rahman S, 2017, PUBLIC HEALTH NUTR, V20, P1114, DOI [10.1017/S1368980016003049, 10.1017/s1368980016003049]; Rohner F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158552; Rowe JP, 2009, J FOOD COMPOS ANAL, V22, P33, DOI 10.1016/j.jfca.2008.09.004; Simler K, URBANIZATION RURAL U; Souganidis E, 2013, NUTRIENTS, V5, P3257, DOI 10.3390/nu5083257; Spohrer R, 2013, FOOD NUTR BULL, V34, pS50, DOI 10.1177/15648265130342S107; Tazhibayev S, 2008, FOOD NUTR BULL, V29, P255, DOI 10.1177/156482650802900402; UNICEF, 2014, FACTSH VIT A SUPPL P; van den Wijngaart A, 2013, FOOD NUTR BULL, V34, pS102, DOI 10.1177/15648265130342S112; Watson R, 2010, NUTR DIETARY SUPPLEM; Weisell R, 2012, FOOD NUTR BULL, V33, pS157, DOI 10.1177/15648265120333S203; Zamora G, 2014, ANN NY ACAD SCI, V1312, P40, DOI 10.1111/nyas.12306	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212257	10.1371/journal.pone.0212257	http://dx.doi.org/10.1371/journal.pone.0212257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943194	Green Submitted, Green Published, gold			2022-12-27	WOS:000463194300005
J	Salcedo-Porras, N; Guarneri, A; Oliveira, PL; Lowenberger, C				Salcedo-Porras, Nicolas; Guarneri, Alessandra; Oliveira, Pedro L.; Lowenberger, Carl			Rhodnius prolixus: Identification of missing components of the IMD immune signaling pathway and functional characterization of its role in eliminating bacteria	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; GENE-EXPRESSION; VECTOR; TOLL; EVOLUTION; GENOMES; TRIATOMINES; REDUCTION; RESPONSES; RESOURCE	The innate immune system in insects is regulated by specific signalling pathways. Most immune related pathways were identified and characterized in holometabolous insects such as Drosophila melanogaster, and it was assumed they would be highly conserved in all insects. The hemimetabolous insect, Rhodnius prolixus, has served as a model to study basic insect physiology, but also is a major vector of the human parasite, Trypanosome cruzi, that causes 10,000 deaths annually. The publication of the R. prolixus genome revealed that one of the main immune pathways, the Immune-deficiency pathway (IMD), was incomplete and probably non-functional, an observation shared with other hemimetabolous insects including the pea aphid (Acyrthosiphon pisum) and the bedbug (Cimex lectularius). It was proposed that the IMD pathway is inactive in R. prolixus as an adaptation to prevent eliminating beneficial symbiont gut bacteria. We used bioinformatic analyses based on reciprocal BLAST and HMM-profile searches to find orthologs for most of the "missing" elements of the IMD pathway and provide data that these are regulated in response to infection with Gram-negative bacteria. We used RNAi strategies to demonstrate the role of the IMD pathway in regulating the expression of specific antimicrobial peptides (AMPs) in the fat body of R. prolixus. The data indicate that the IMD pathway is present and active in R. prolixus, which opens up new avenues of research on R. prolixus-T. cruzi interactions.	[Salcedo-Porras, Nicolas; Lowenberger, Carl] Simon Fraser Univ, Dept Biol Sci, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada; [Guarneri, Alessandra] Inst Rene Rachou, Ave Augusto de Lima, Belo Horizonte, MG, Brazil; [Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, CCS, Rio De Janeiro, RJ, Brazil	Simon Fraser University; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Salcedo-Porras, N (corresponding author), Simon Fraser Univ, Dept Biol Sci, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada.	nicolas_salcedo@sfu.ca	guarneri, Alessandra A/I-4124-2012; L. Oliveira, Pedro/A-9438-2010	Guarneri, Alessandra Aparecida/0000-0002-9162-2731; L. Oliveira, Pedro/0000-0003-0307-354X; Salcedo-Porras, Nicolas/0000-0002-8291-5233	NSERC Discovery grant [RGPIN261940]; MITACS Globalink Research Award [IT08650]	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS Globalink Research Award	This work was supported by NSERC Discovery grant to CL (RGPIN261940), www.nserc-crsng.gc.ca; MITACS Globalink Research Award to NSP (IT08650), https://www.mitacs.ca/en/programs/globalink/globalink-research-award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zumaya-Estrada FA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2561-2; Alves CL, 2011, J MED ENTOMOL, V48, P372, DOI 10.1603/ME10151; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Anselme C, 2006, APPL ENVIRON MICROB, V72, P6766, DOI 10.1128/AEM.00942-06; Armisen D, 2018, BIORXIV, DOI [10.1101/242230, DOI 10.1101/242230]; Armitage SAO, 2015, DEV COMP IMMUNOL, V48, P315, DOI 10.1016/j.dci.2014.03.004; Arp AP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00570; Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007; Bao YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-160; Begun DJ, 2000, GENETICS, V154, P1231; Behrman EL, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2599; Benoit JB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10165; Bottino-Rojas V, 2018, J BIOL CHEM, V293, P9053, DOI 10.1074/jbc.RA117.001589; Brucker RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045125; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Campbell Michael S, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0411s48; Castro DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036591; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Chavez ASO, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00223; Dias FD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004186; Diaz-Albiter HM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1401-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2016, NUCLEIC ACIDS RES, V44, pD793, DOI 10.1093/nar/gkv1208; Elsik CG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-106; Ferreira RC, 2016, PARASITOLOGY, V143, P434, DOI 10.1017/S0031182015001857; Flores-Villegas AL, 2015, B ENTOMOL RES, V105, P523, DOI 10.1017/S0007485315000504; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Gordon ERL, 2016, APPL ENVIRON MICROB, V82, P7123, DOI 10.1128/AEM.02114-16; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Guarneri AA, 2017, J INSECT PHYSIOL, V97, P66, DOI 10.1016/j.jinsphys.2016.07.005; Han M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-245; Ioannidis P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-738; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kersey PJ, 2018, NUCLEIC ACIDS RES, V46, pD802, DOI 10.1093/nar/gkx1011; Kim JH, 2011, INSECT BIOCHEM MOLEC, V41, P332, DOI 10.1016/j.ibmb.2011.01.011; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Kuechler SM, 2011, APPL ENVIRON MICROB, V77, P2869, DOI 10.1128/AEM.02983-10; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lai AG, 2016, BIORXIV, DOI [10.1101/091835, DOI 10.1101/091835]; Lai AG, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3769-4; Latorre-Estivalis JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40049; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindsay SA, 2014, DEV COMP IMMUNOL, V42, P16, DOI 10.1016/j.dci.2013.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; McTaggart SJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-63; MELLO CB, 1995, J INVERTEBR PATHOL, V65, P261, DOI 10.1006/jipa.1995.1040; Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112; Morin-Poulard Ismael, 2013, JAKSTAT, V2, pe25700, DOI 10.4161/jkst.25700; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; Nishide Y, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2207; Noireau F, 2009, VET RES, V40, DOI 10.1051/vetres/2009009; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Palmer WJ, 2015, MOL BIOL EVOL, V32, P2111, DOI 10.1093/molbev/msv093; Panfilio KA, 2017, BIORXIV, DOI [10. 1101/201731, DOI 10.1101/201731]; Poelchau M, 2015, NUCLEIC ACIDS RES, V43, pD714, DOI 10.1093/nar/gku983; Rao Q, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1379-6; Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Saha S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax032; Savioli L, WHO DEP CONTROL NEGL; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaw DK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14401; Sloan DB, 2014, MOL BIOL EVOL, V31, P857, DOI 10.1093/molbev/msu004; Snodgrass RE, 1939, SCIENCE, V90, P159, DOI [10.1126/science.90.2329.159-a, DOI 10.1126/SCIENCE.90.2329.159-A]; Song N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048778; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; TEJERA G. E, 1919, B SOC PATHOL EXOT, V12, P509; Toenshoff ER, 2012, ENVIRON MICROBIOL, V14, P1284, DOI 10.1111/j.1462-2920.2012.02712.x; Toubiana M, 2014, DEV COMP IMMUNOL, V45, P300, DOI 10.1016/j.dci.2014.03.021; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Ursic-Bedoya RJ, 2008, J INSECT PHYSIOL, V54, P593, DOI 10.1016/j.jinsphys.2007.12.009; Ursic-Bedoya RJ, 2007, DEV COMP IMMUNOL, V31, P109, DOI 10.1016/j.dci.2006.05.008; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vieira CS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1398-4; Vieira CS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0736-2; Vieira CS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-232; Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106; Whitten MMA, 2001, EXP PARASITOL, V98, P44, DOI 10.1006/expr.2001.4615; Yin CL, 2016, NUCLEIC ACIDS RES, V44, pD801, DOI 10.1093/nar/gkv1204; Zhang RD, 2017, FRONT CELL INFECT MI, V7, DOI [10.3382/fcimb.2017.00022, 10.3389/fcimb.2017.00022]; Zhong X, 2016, SCI REP-UK, V6, DOI 10.1038/srep20654	90	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214794	10.1371/journal.pone.0214794	http://dx.doi.org/10.1371/journal.pone.0214794			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943246	Green Submitted, Green Published, gold			2022-12-27	WOS:000463194300062
J	Serrano, RL; Yu, WF; Graham, RM; Liu-Bryan, R; Terkeltaub, R				Serrano, Ramon L.; Yu, Weifang; Graham, Robert M.; Liu-Bryan, Ru; Terkeltaub, Robert			A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INTIMAL HYPERPLASIA; TISSUE TRANSGLUTAMINASE; OXIDATIVE STRESS; APOPTOSIS; DIFFERENTIATION; SUMOYLATION; ACTIVATION	Neointimal hyperplasia, stimulated by injury and certain vascular diseases, promotes artery obstruction and tissue ischemia. In vascular smooth muscle cell (VSMCs), multiple modulators of protein handling machinery regulate intimal hyperplasia. These include elements of the VSMC unfolded protein response to endoplasmic reticulum stress (UPRER), and trans-glutaminase 2 (TG2), which catalyzes post-translational protein modification. Previous results for deficiency of UPRER -specific mediator XBP1, and of TG2, have been significant, but in multiple instances contradictory, for effects on cultured VSMC function, and, using multiple models, for neointimal hyperplasia in vivo. Here, we engineered VSMC-specific deficiency of XBP1, and studied cultured VSMCs, and neointimal hyperplasia in response to carotid artery ligation in vivo. Intimal area almost doubled in Xbp1(fl/fl) SM22 alpha-CRE+ mice 21 days post-ligation. Cultured murine Xbp1 deficient VSMCs migrated more in response to platelet derived growth factor (PDGF) than control VSMCs, and had an increased level of inositol-requiring enzyme 1 alpha (Ire1 alpha), a PDGF receptor-binding UPRER transmembrane endonuclease whose substrates include XBP1. Cultured XBP1-deficient VSMCs demonstrated decreased levels of TG2 protein, in association with increased TG2 polyubiquitination, but with increased TG transamidation catalytic activity. Moreover, IRE1 alpha, and TG2-specific transamidation cross-links were increased in carotid artery neointima in Xbp1(fl/fl) SM22 alpha-CRE+ mice. Cultured TG2-deficient VSMCs had decreased XBP1 associated with increased IRE1 alpha, and increased migration in response to PDGF. Neointimal hyperplasia also was significantly increased in Tgm2(fl/fl) SM22 alpha-CRE+ mice at 21 days after carotid ligation. In conclusion, a VSMC regulatory circuit between XBP1 and TG2 limits neointimal hyperplasia in response to carotid ligation.	[Serrano, Ramon L.; Yu, Weifang; Liu-Bryan, Ru; Terkeltaub, Robert] Univ Calif San Diego, Dept Med, Vet Affairs Healthcare Syst, La Jolla, CA 92093 USA; [Graham, Robert M.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Yu, Weifang] Univ Southern Calif, Dept Cardiovasc Res, Los Angeles, CA USA	University of California System; University of California San Diego; Victor Chang Cardiac Research Institute; University of Southern California	Terkeltaub, R (corresponding author), Univ Calif San Diego, Dept Med, Vet Affairs Healthcare Syst, La Jolla, CA 92093 USA.	rterkeltaub@ucsd.edu			Department of Veterans Affairs Merit Review [I01BX002234, I01BX001660]; NIH [P50 AR060772-6]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060772] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001660] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	The study was supported by Department of Veterans Affairs Merit Review grants I01BX002234 (RLB) and I01BX001660 (RT), and NIH grant P50 AR060772-6 Project 1 (RT).	Abdullah A, 2018, EUR J CELL BIOL, V97, P359, DOI 10.1016/j.ejcb.2018.05.002; Agnihotri N, 2017, AMINO ACIDS, V49, P425, DOI 10.1007/s00726-016-2320-2; Almanza A, 2019, FEBS J, V286, P241, DOI 10.1111/febs.14608; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Covino R, 2018, MOL CELL, V71, P458, DOI 10.1016/j.molcel.2018.07.019; Dammanahalli KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039106; de Jong RCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185820; Gao JH, 2011, CIRCULATION, V124, P830, DOI 10.1161/CIRCULATIONAHA.110.014050; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Guo FJ, 2014, CELL SIGNAL, V26, P1998, DOI 10.1016/j.cellsig.2014.05.008; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hui DY, 2008, CURR DRUG TARGETS, V9, P251, DOI 10.2174/138945008783755601; Ishimura S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06943; Johnson KA, 2008, CIRC RES, V102, P529, DOI 10.1161/CIRCRESAHA.107.154260; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lee CS, 2017, APOPTOSIS, V22, P1057, DOI 10.1007/s10495-017-1396-9; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Luciani A, 2009, J IMMUNOL, V183, P2775, DOI 10.4049/jimmunol.0900993; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mendler L, 2016, CIRC RES, V118, P132, DOI 10.1161/CIRCRESAHA.115.307730; Min SK, 2014, J KOREAN MED SCI, V29, P363, DOI 10.3346/jkms.2014.29.3.363; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nurminskaya M, 2014, J VASC RES, V51, P418, DOI 10.1159/000369461; Scott RA, 2014, BIOMACROMOLECULES, V15, P2825, DOI 10.1021/bm5007757; Shin S, 2013, J VASC SURG, V57, P1362, DOI 10.1016/j.jvs.2012.09.062; SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; van den Akker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023067; Wu J, 2016, CELL PHYSIOL BIOCHEM, V38, P847, DOI 10.1159/000443039; Yang Xiang-Jiao, 2013, F1000Prime Rep, V5, P45, DOI 10.12703/P5-45; Yu WF, 2012, ATHEROSCLEROSIS, V222, P417, DOI 10.1016/j.atherosclerosis.2012.04.001; Zeng LF, 2015, ARTERIOSCL THROM VAS, V35, P2134, DOI 10.1161/ATVBAHA.115.305420; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhao Q, 2017, FASEB J, V31, P5321, DOI 10.1096/fj.201700327R	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212235	10.1371/journal.pone.0212235	http://dx.doi.org/10.1371/journal.pone.0212235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943188	gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300004
J	Zhelezova, A; Chernov, T; Tkhakakhova, A; Xenofontova, N; Semenov, M; Kutovaya, O				Zhelezova, Alena; Chernov, Timofey; Tkhakakhova, Azida; Xenofontova, Natalya; Semenov, Mikhail; Kutovaya, Olga			Prokaryotic community shifts during soil formation on sands in the tundra zone	PLOS ONE			English	Article							BACTERIAL COMMUNITY; DENITRIFYING BACTERIA; MICROBIAL DIVERSITY; FUNGAL COMMUNITIES; EARLIEST STAGES; SUCCESSION; RESPONSES; MOUNTAIN; GENES; LAND	A chronosequence approach, i.e., a comparison of spatially distinct plots with different stages of succession, is commonly used for studying microbial community dynamics during paedogenesis. The successional traits of prokaryotic communities following sand fixation processes have previously been characterized for arid and semi-arid regions, but they have not been considered for the tundra zone, where the environmental conditions are unfavourable for the establishment of complicated biocoenoses. In this research, we characterized the prokaryotic diversity and abundance of microbial genes found in a typical tundra and wooded tundra along a gradient of increasing vegetation-unfixed aeolian sand, semi-fixed surfaces with mosses and lichens, and mature soil under fully developed plant cover. Microbial communities from typical tundra and wooded tundra plots at three stages of sand fixation were compared using quantitative polymerase chain reaction (qPCR) and high-throughput sequencing of 16S rRNA gene libraries. The abundances of ribosomal genes increased gradually in both chronosequences, and a similar trend was observed for the functional genes related to the nitrogen cycle (nifH, bacterial amoA, nirK and nirS). The relative abundance of Planctomycetes increased, while those of Thaumarchaeota, Cyanobacteria and Chloroflexi decreased from unfixed sands to mature soils. According to beta-diversity analysis, prokaryotic communities of unfixed sands were more heterogeneous compared to those of mature soils. Despite the differences in the plant cover of the two mature soils, the structural compositions of the prokaryotic communities were shaped in the same way. Thus, sand fixation in the tundra zone increases archaeal, bacterial and fungal abundances, shifts and unifies prokaryotic communities structure.	[Zhelezova, Alena; Chernov, Timofey; Tkhakakhova, Azida; Xenofontova, Natalya; Semenov, Mikhail; Kutovaya, Olga] VV Dokuchaev Soil Sci Inst, Dept Soil Biol & Biochem, Moscow, Russia; [Xenofontova, Natalya] Lomonosov Moscow State Univ, Dept Soil Sci, Moscow, Russia	Dokuchaev Soil Science Institute; Lomonosov Moscow State University	Zhelezova, A (corresponding author), VV Dokuchaev Soil Sci Inst, Dept Soil Biol & Biochem, Moscow, Russia.	zhelezova.ad@gmail.com	Chernov, Timofey/B-8985-2018; Zhelezova, Alena/GWZ-2540-2022; Semenov, Mikhail V./N-1754-2018; Tkhakakhova, Azida/U-9651-2019; Zhelezova, Alena/X-1944-2019	Semenov, Mikhail V./0000-0001-6811-5793; Zhelezova, Alena/0000-0002-2086-299X	Russian Science Foundation [17-16-01057]; RSF	Russian Science Foundation(Russian Science Foundation (RSF)); RSF(Russian Science Foundation (RSF))	This research was primarily supported by the Russian Science Foundation (project number 17-16-01057). All authors (Alena Zhelezova, Timofey Chernov, Azida Tkhakakhova, Natalya Xenofontova, Mikhail Semenov, Olga Kutovaya) received the financial support from RSF. RSF-http://www.rscf.ru/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bellezza S, 2003, J APPL PHYCOL, V15, P193, DOI 10.1023/A:1023811311686; Blaud A, 2015, RES MICROBIOL, V166, P796, DOI 10.1016/j.resmic.2015.07.013; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184; Brown SP, 2014, MOL ECOL, V23, P481, DOI 10.1111/mec.12487; Buckeridge KM, 2013, SOIL BIOL BIOCHEM, V65, P338, DOI 10.1016/j.soilbio.2013.06.012; Cao CY, 2017, APPL MICROBIOL BIOT, V101, P6217, DOI 10.1007/s00253-017-8336-z; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castle SC, 2017, OECOLOGIA, V185, P513, DOI 10.1007/s00442-017-3965-6; CHAO A, 1984, SCAND J STAT, V11, P265; Chapin F.S, 2012, PRINCIPLES TERRESTRI; Chrismas NAM, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy032; Ciccazzo S, 2016, ANN MICROBIOL, V66, P43, DOI 10.1007/s13213-015-1130-1; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Esposito A, 2013, CURR MICROBIOL, V67, P472, DOI 10.1007/s00284-013-0391-9; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Glanville HC, 2012, FUNCT ECOL, V26, P1366, DOI 10.1111/j.1365-2435.2012.02056.x; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; ISSS, 2014, WORLD REF BAS SOIL R; Jangid K, 2013, MOL ECOL, V22, P3415, DOI 10.1111/mec.12325; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Kelly LC, 2014, MICROB ECOL, V68, P504, DOI 10.1007/s00248-014-0432-3; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Levy-Booth DJ, 2014, SOIL BIOL BIOCHEM, V75, P11, DOI 10.1016/j.soilbio.2014.03.021; Li J, 2016, J ENVIRON SCI-CHINA, V39, P155, DOI 10.1016/j.jes.2015.10.009; Liu LC, 2017, SOIL BIOL BIOCHEM, V107, P125, DOI 10.1016/j.soilbio.2016.12.030; Liu XY, 2018, P NATL ACAD SCI USA, V115, P3398, DOI 10.1073/pnas.1715382115; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Ma WB, 2016, SOIL BIOL BIOCHEM, V101, P195, DOI 10.1016/j.soilbio.2016.07.023; Madsen EL, 2011, CURR OPIN BIOTECH, V22, P456, DOI 10.1016/j.copbio.2011.01.008; Makhalanyane TP, 2016, CURR OPIN BIOTECH, V38, P159, DOI 10.1016/j.copbio.2016.01.011; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Navarrete AA, 2015, MOL ECOL, V24, P2433, DOI 10.1111/mec.13172; Nemergut DR, 2007, MICROB ECOL, V53, P110, DOI 10.1007/s00248-006-9144-7; Poly F, 2001, APPL ENVIRON MICROB, V67, P2255, DOI 10.1128/AEM.67.5.2255-2262.2001; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Regan K, 2017, SOIL BIOL BIOCHEM, V109, P214, DOI 10.1016/j.soilbio.2016.11.011; Ren JS, 2018, SCI TOTAL ENVIRON, V625, P782, DOI 10.1016/j.scitotenv.2017.12.309; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rughoft S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01638; Schaub I, 2019, MICROB ECOL, V77, P217, DOI 10.1007/s00248-018-1220-2; Schmidt SK, 2008, P ROY SOC B-BIOL SCI, V275, P2793, DOI 10.1098/rspb.2008.0808; Schmidt SK, 2014, MOL ECOL, V23, P254, DOI 10.1111/mec.12589; Semenov MV, 2018, APPL SOIL ECOL, V127, P8, DOI 10.1016/j.apsoil.2018.03.002; Sengupta A, 2017, APPL SOIL ECOL, V119, P35, DOI 10.1016/j.apsoil.2017.05.031; Sengupta A, 2015, MICROB ECOL, V70, P853, DOI 10.1007/s00248-015-0609-4; Sigler WV, 2002, MICROB ECOL, V43, P397, DOI 10.1007/s00248-001-0045-5; Sun HY, 2016, J MT SCI-ENGL, V13, P1621, DOI 10.1007/s11629-015-3570-2; Tas N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03089-z; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Turner BL, 2015, ECOSYSTEMS, V18, P287, DOI 10.1007/s10021-014-9830-0; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang SK, 2018, ECOL EVOL, V8, P1693, DOI 10.1002/ece3.3746; Wu XK, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014038; Yabe S, 2017, INT J SYST EVOL MICR, V67, P2615, DOI 10.1099/ijsem.0.001985; Yang YD, 2017, EUR J SOIL BIOL, V82, P1, DOI 10.1016/j.ejsobi.2017.05.006; Yarwood SA, 2017, SOIL BIOL BIOCHEM, V114, P160, DOI 10.1016/j.soilbio.2017.07.017; Yu J, 2016, APPL SOIL ECOL, V101, P124, DOI 10.1016/j.apsoil.2016.01.022; Yu Y, 2005, WATER SCI TECHNOL, V52, P85, DOI 10.2166/wst.2005.0502; Zhan J, 2012, MICROBIOL RES, V167, P157, DOI 10.1016/j.micres.2011.05.006	63	11	14	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0206777	10.1371/journal.pone.0206777	http://dx.doi.org/10.1371/journal.pone.0206777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939175	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900002
J	Vu, HTK; Benjakul, S; Vongkamjan, K				Hue Thi Kim Vu; Benjakul, Soottawat; Vongkamjan, Kitiya			Characterization of Listeria prophages in lysogenic isolates from foods and food processing environments	PLOS ONE			English	Article							GENOME SEQUENCE; SP NOV.; MONOCYTOGENES; BACTERIOPHAGE; DIVERSITY; PHAGES; STRAINS; EVOLUTION; SPP.	Prophages are commonly found in Listeria genomes, potentially enhancing survival or fitness of Listeria spp. Currently, there is still limited information on the distribution of prophages among Listeria isolates of different allelic types and from various sources. In this study, by using mitomycin C induction, prophages were found in 23/144 isolates (16.0%), including 13 L. monocytogenes and 10 Listeria spp. isolates, resulting in 28 and 11 induced phages, respectively. These prophage-carrying isolates (lysogens) were obtained from foods and food-related environments presenting 3 common allelic types (ATs) of L. monocytogenes (lineage I, II and IV), 4 ATs of L. innocua and 1 AT of L. welshimeri. The likelihood of prophage-carrying isolates of L. monocytogenes was 14.4 (95% CI: 4.9-35.4), and 18.5 (95% CI: 4.8-50.2) for Listeria spp. The 39 induced phages were classified into 3 lysis groups by the host range test against 9 major serotypes of L. monocytogenes and 5 species of Listeria. Most phages were host-specific with higher ability to lyse L. monocytogenes serotype 4 than other serotypes. The genome size of phages ranged from 35 +/- 2 kb to 50 +/- 2 kb and belonged to two common phage families, Myoviridae and Siphoviridae. Restriction analysis classified 19 selected phages into 16 restriction profiles, suggesting highly diverse prophages with at least 16 types. This may contribute to the variation in the genomes of Listeria. Information obtained here provides basic knowledge for further study to understand the overall role of prophages in Listeria, including roles in survival or fitness in foods and food processing environments.	[Hue Thi Kim Vu; Benjakul, Soottawat; Vongkamjan, Kitiya] Prince Songkla Univ, Dept Food Technol, Hat Yai, Songkla, Thailand; [Hue Thi Kim Vu] NIVR, Dept Vet Hyg & Food Safety, Hanoi, Vietnam	Prince of Songkla University	Vongkamjan, K (corresponding author), Prince Songkla Univ, Dept Food Technol, Hat Yai, Songkla, Thailand.	kitiya.v@psu.ac.th	Benjakul, Soottawat/C-8927-2009	Benjakul, Soottawat/0000-0001-9433-3671	Higher Education Research Promotion; Thailand's Education Hub for Southern Region of ASEAN Countries Project Office of the Higher Education Commission; Prince of Songkla University [AGR600584S]; TRF Distinguished Research Professor Grant	Higher Education Research Promotion; Thailand's Education Hub for Southern Region of ASEAN Countries Project Office of the Higher Education Commission; Prince of Songkla University; TRF Distinguished Research Professor Grant	This project is financially supported by the Higher Education Research Promotion and the Thailand's Education Hub for Southern Region of ASEAN Countries Project Office of the Higher Education Commission (to HTKV). Funding from Prince of Songkla University (AGR600584S; to KV) and the TRF Distinguished Research Professor Grant (to SB) is also acknowledged.	Bertsch D, 2013, INT J SYST EVOL MICR, V63, P526, DOI 10.1099/ijs.0.036947-0; Bondy-Denomy J, 2016, ISME J, V10, P2854, DOI 10.1038/ismej.2016.79; Burgess CM, 2016, INT J FOOD MICROBIOL, V221, P37, DOI 10.1016/j.ijfoodmicro.2015.12.014; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; den Bakker HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067511; Denes T, 2014, APPL ENVIRON MICROB, V80, P4616, DOI 10.1128/AEM.00720-14; Desiere F, 2002, ANTON LEEUW INT J G, V82, P73, DOI 10.1023/A:1020676825358; Domelier AS, 2009, J BACTERIOL, V191, P4776, DOI 10.1128/JB.00426-09; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Eugster MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021500; Ferreira V, 2011, APPL ENVIRON MICROB, V77, P2701, DOI 10.1128/AEM.02553-10; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Goh S, 2007, MICROBIOL-SGM, V153, P676, DOI 10.1099/mic.0.2006/002436-0; Graves LM, 2010, INT J SYST EVOL MICR, V60, P1280, DOI 10.1099/ijs.0.014118-0; Guttman B, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P29; Hain T, 2006, J BACTERIOL, V188, P7405, DOI 10.1128/JB.00758-06; Halter EL, 2013, INT J SYST EVOL MICR, V63, P641, DOI 10.1099/ijs.0.036830-0; Jiang SC, 1996, MAR ECOL PROG SER, V142, P27, DOI 10.3354/meps142027; Kim JW, 2008, APPL ENVIRON MICROB, V74, P6623, DOI 10.1128/AEM.01282-08; Klumpp Jochen, 2013, Bacteriophage, V3, pe26861; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Kutter E., 2005, BACTERIOPHAGES BIOL; Lemaitre JP, 1997, LETT APPL MICROBIOL, V24, P51, DOI 10.1046/j.1472-765X.1997.00346.x; Liao JQ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00306-17; LOESSNER MJ, 1990, APPL ENVIRON MICROB, V56, P1912, DOI 10.1128/AEM.56.6.1912-1918.1990; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; LOESSNER MJ, 1991, LETT APPL MICROBIOL, V12, P196, DOI 10.1111/j.1472-765X.1991.tb00538.x; Lopez E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094358; Mammina C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-152; Marini E, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.17.30217; Nale JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037263; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Nightingale KK, 2005, J BACTERIOL, V187, P5537, DOI 10.1128/JB.187.16.5537-5551.2005; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; PALUMBO S A, 1991, Food Microbiology (London), V8, P63, DOI 10.1016/0740-0020(91)90017-V; Poblet-Icart M, 1998, CURR MICROBIOL, V36, P365, DOI 10.1007/s002849900324; Rabinovich L, 2012, CELL, V150, P792, DOI 10.1016/j.cell.2012.06.036; Rychli K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176857; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Switt AIM, 2013, FOOD MICROBIOL, V36, P275, DOI 10.1016/j.fm.2013.06.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tolvanen R, 2008, J FOOD PROTECT, V71, P1550, DOI 10.4315/0362-028X-71.8.1550; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Vongkamjan K, 2017, FOOD MICROBIOL, V66, P11, DOI 10.1016/j.fm.2017.03.014; Vongkamjan K, 2016, J FOOD PROTECT, V79, P239, DOI 10.4315/0362-028X.JFP-15-361; Vongkamjan K, 2015, FOOD CONTROL, V50, P265, DOI 10.1016/j.foodcont.2014.09.001; Vongkamjan K, 2012, APPL ENVIRON MICROB, V78, P8666, DOI 10.1128/AEM.01859-12; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Wright EE, 2013, J APPL MICROBIOL, V114, P1616, DOI 10.1111/jam.12192; Zimmer M, 2003, MOL MICROBIOL, V50, P303, DOI 10.1046/j.1365-2958.2003.03684.x	53	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214641	10.1371/journal.pone.0214641	http://dx.doi.org/10.1371/journal.pone.0214641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934000	Green Submitted, gold, Green Published			2022-12-27	WOS:000462867000029
J	Mastromoro, G; Calcagni, G; Versacci, P; Putotto, C; Chinali, M; Lambiase, C; Unolt, M; Pelliccione, E; Anaclerio, S; Caprio, C; Cioffi, S; Bilio, M; Baban, A; Drago, F; Digilio, MC; Marino, B; Baldini, A				Mastromoro, Gioia; Calcagni, Giulio; Versacci, Paolo; Putotto, Carolina; Chinali, Marcello; Lambiase, Caterina; Unolt, Marta; Pelliccione, Elena; Anaclerio, Silvia; Caprio, Cinzia; Cioffi, Sara; Bilio, Marchesa; Baban, Anwar; Drago, Fabrizio; Digilio, Maria Cristina; Marino, Bruno; Baldini, Antonio			Left pulmonary artery in 22q11.2 deletion syndrome. Echocardiographic evaluation in patients without cardiac defects and role of Tbx1 in mice	PLOS ONE			English	Article							AORTIC-ARCH; CHROMOSOME 22Q11; CARDIOVASCULAR DEFECTS; ANOMALOUS ORIGIN; ASCENDING AORTA; TETRALOGY; HEART; ARTERIOSUS; ATRESIA; FALLOT	Introduction and hypothesis Patients with 22q11 deletion syndrome (22q11.2DS) present, in about 75% of cases, typical patterns of cardiac defects, with a particular involvement on the ventricular outflow tract and great arteries. However, in this genetic condition the dimensions of the pulmonary arteries (PAs) never were specifically evaluated. We measured both PAs diameter in patients with 22q11.2DS without cardiac defects, comparing these data to a normal control group. Moreover, we measured the PAs diameter in Tbx1 mutant mice. Finally, a cell fate mapping in Tbx1 mutants was used to study the expression of this gene in the morphogenesis of PAs. Methods We evaluated 58 patients with 22q11.2DS without cardiac defects. The control group consisted of 54 healthy subjects, matched for age and sex. All cases underwent a complete transthoracic echocardiography. Moreover, we crossed Tbx1(+/-) mice and harvested fetuses. We examined the cardiovascular phenotype of 8 wild type (WT), 37 heterozygous (Tbx1(+/-)) and 6 null fetuses (Tbx1(-/-)). Finally, we crossed Tbx1(Cre/+) mice with R26R(mT-mG) Cre reporter mice to study Tbx1 expression in the pulmonary arteries. Results The echocardiographic study showed that the mean of the LPA/RPA ratio in 22q11.2DS was smaller (0.80 +/- 0.12) than in controls (0.97 +/- 0.08; p < 0.0001). Mouse studies resulted in similar data as the size of LPA and RPA was not significantly different in WT embryos, but in Tbx1(+/-) and Tbx1(-/-) embryos the LPA was significantly smaller than the RPA in both mutants (P = 0.0016 and 0.0043, respectively). We found that Tbx1 is expressed near the origin of the PAs and in their adventitia. Conclusions Children with 22q11.2DS without cardiac defects show smaller LPA compared with healthy subjects. Mouse studies suggest that this anomaly is due to haploinsufficiency of Tbx1. These data may be useful in the clinical management of children with 22q11.2DS and should guide further experimental studies as to the mechanisms underlying PAs development.	[Mastromoro, Gioia; Versacci, Paolo; Putotto, Carolina; Lambiase, Caterina; Unolt, Marta; Anaclerio, Silvia; Marino, Bruno] Sapienza Univ Rome, Dept Pediat, Rome, Italy; [Calcagni, Giulio; Chinali, Marcello; Pelliccione, Elena; Baban, Anwar; Drago, Fabrizio; Digilio, Maria Cristina] Bambino Gesu Pediat Hosp & Res Inst, Dept Pediat Cardiol & Cardiac Surg, Rome, Italy; [Caprio, Cinzia; Cioffi, Sara; Bilio, Marchesa; Baldini, Antonio] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy; [Baldini, Antonio] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	Sapienza University Rome; IRCCS Bambino Gesu; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II	Marino, B (corresponding author), Sapienza Univ Rome, Dept Pediat, Rome, Italy.; Baldini, A (corresponding author), CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy.; Baldini, A (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.	bruno.marino@uniroma1.it; antonio.baldini@unina.it	Drago, Fabrizio/AAA-6071-2020; Unolt, Marta/AAB-5685-2020; Digilio, Maria Cristina/AAI-2434-2019; Calcagni, Giulio/AAH-9179-2019; CIOFFI, Sara/GWZ-9079-2022; Baldini, Antonio/M-2355-2015	Drago, Fabrizio/0000-0003-1888-373X; Unolt, Marta/0000-0002-4133-714X; CIOFFI, Sara/0000-0003-3197-6578; Mastromoro, Gioia/0000-0003-0788-1683; calcagni, giulio/0000-0003-3187-0829; Baldini, Antonio/0000-0002-5330-0256; VERSACCI, PAOLO/0000-0002-4484-4729; Caprio, Cinzia/0000-0002-3476-5162; Putotto, Carolina/0000-0003-3778-3769; Chinali, Marcello/0000-0002-5813-9465; Baban, Anwar/0000-0002-9428-4934	Fondation Leducq [TNE 15CVD01]; Telethon Foundation [GGP14211]	Fondation Leducq(Leducq Foundation); Telethon Foundation(Fondazione Telethon)	This work was supported by the Baldini: Fondation Leducq (TNE 15CVD01) (https://www.fondationleducq.org/), and by the Baldini: Telethon Foundation (GGP14211) (www.telethon.it).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal V., 2017, CARDIOL YOUNG, V13, P1, DOI [10.1017/S104795111700227X, DOI 10.1017/S104795111700227X]; Babaoglu K, 2013, PEDIATR CARDIOL, V34, P1785, DOI 10.1007/s00246-013-0714-4; DODO H, 1995, AM J CARDIOL, V75, P1294, DOI 10.1016/S0002-9149(99)80788-7; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; ELZENGA NJ, 1990, J THORAC CARDIOV SUR, V100, P416; ELZENGA NJ, 1986, INT J CARDIOL, V11, P195, DOI 10.1016/0167-5273(86)90179-8; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Huynh T, 2007, GENESIS, V45, P470, DOI 10.1002/dvg.20317; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kelly RG, 2007, DEV DYNAM, V236, P821, DOI 10.1002/dvdy.21063; KUTSCHE LM, 1988, AM J CARDIOL, V61, P850, DOI 10.1016/0002-9149(88)91078-8; Lewin MB, 1997, AM J CARDIOL, V80, P493, DOI 10.1016/S0002-9149(97)00401-3; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Maldjian P, 2018, J CLIN IMAG SCI, V8, DOI 10.4103/jcis.JCIS_66_17; Marino B, 1999, GENET COUNSEL, V10, P25; Marino B, 1996, AM J CARDIOL, V77, P505, DOI 10.1016/S0002-9149(97)89345-9; Marino B, 1999, AM J CARDIOL, V84, P360, DOI 10.1016/S0002-9149(99)00297-0; Marino B., 2002, PROG PEDIATR CARDIOL, V15, P9; McElhinney DB, 2001, J AM COLL CARDIOL, V37, P2114, DOI 10.1016/S0735-1097(01)01286-4; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Momma K, 1996, AM J CARDIOL, V78, P591, DOI 10.1016/S0002-9149(96)00374-8; Momma K, 1997, J AM COLL CARDIOL, V30, P1067, DOI 10.1016/S0735-1097(97)00240-4; Momma K, 1996, J AM COLL CARDIOL, V27, P198, DOI 10.1016/0735-1097(95)00415-7; MOMMA K, 1995, AM J CARDIOL, V76, P618, DOI 10.1016/S0002-9149(99)80170-2; MOMMA K, 1986, BRIT HEART J, V55, P39; Momma K, 1999, PEDIATR CARDIOL, V20, P97, DOI 10.1007/s002469900414; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Pettersen MD, 2008, J AM SOC ECHOCARDIOG, V21, P922, DOI 10.1016/j.echo.2008.02.006; PRESBITERO P, 1984, BRIT HEART J, V52, P178; Rana MS, 2014, CIRC RES, V115, P790, DOI 10.1161/CIRCRESAHA.115.305020; Rana MS, 2014, AM J MED GENET A, V164, P1372, DOI 10.1002/ajmg.a.35881; Romano R, 2016, J INVEST ALLERG CLIN, V26, P390, DOI 10.18176/jiaci.0107; Sett SS, 2001, CARDIOL YOUNG, V11, P676, DOI 10.1017/S104795110100110X; Toscano A, 2002, EUR J PEDIATR, V161, P116, DOI 10.1007/s00431-001-0877-5; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zhang Z, 2005, DEVELOPMENT, V132, P5307, DOI 10.1242/dev.02086	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0211170	10.1371/journal.pone.0211170	http://dx.doi.org/10.1371/journal.pone.0211170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933971	gold, Green Published, Green Submitted			2022-12-27	WOS:000462867000004
J	Pietrangelo, A; Ridgway, ND				Pietrangelo, Antonietta; Ridgway, Neale D.			Phosphorylation of a serine/proline-rich motif in oxysterol binding protein-related protein 4L (ORP4L) regulates cholesterol and vimentin binding	PLOS ONE			English	Article							PLASMA-MEMBRANE	The family of oxysterol binding protein (OSBP) and OSBP-related proteins (ORPs) mediate sterol and phospholipid transfer and signaling at membrane contact sites (MCS). The activity of OSBP at MCS is regulated by phosphorylation, but whether this applies to ORPs is unknown. Here we report the functional characterization of a unique proline/serine-rich phosphorylation motif (S762SPSSPSS769) in the lipid binding OSBP-related domain of full-length ORP4L and a truncated variant ORP4S. Phosphorylation was confirmed by mass spectrometry and [P-32]PO4 incorporation, and in silico and in vitro assays using purified ORP4L identified putative proline-directed kinases that phosphorylate the site. The functional significance of the phospho-site was assessed by mutating serine 762, S763, S766 and S768 to aspartate or alanine to produce phosphomimetic (S4D) and phosphorylation-deficient (S4A) mutants, respectively. Solution binding of 25-hydroxycholesterol and cholesterol by recombinant ORP4L-S4D and -S4A was similar to wild-type but ORP4L-S4D more effectively extracted cholesterol from liposomes. ORP4L homo-dimerization was unaffected by phosphorylation but gel filtration of ORP4L-S4D indicated that the native conformation was affected. Confocal microscopy revealed that ORP4L-S4D also strongly associated with bundled vimentin filaments, a feature shared with ORP4S which lacks the PH and dimerization domains. We conclude that phosphorylation of a unique serine/proline motif in the ORD induces a conformation change in ORP4L that enhances interaction with vimentin and cholesterol extraction from membranes.	[Pietrangelo, Antonietta; Ridgway, Neale D.] Dalhousie Univ, Dept Biochem & Mol Biol, Atlantic Res Ctr, Halifax, NS, Canada; [Ridgway, Neale D.] Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS, Canada; [Pietrangelo, Antonietta] Univ Ottawa, Inst Heart, Ottawa, ON, Canada	Dalhousie University; Dalhousie University; University of Ottawa; University of Ottawa Heart Institute	Ridgway, ND (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Atlantic Res Ctr, Halifax, NS, Canada.; Ridgway, ND (corresponding author), Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS, Canada.	nridgway@dal.ca		Ridgway, Neale/0000-0002-0441-6228	Canadian Institutes of Health Research; Institute of Nutrition, Metabolism and Diabetes [MOP-15284]; Winnifred Lockwood Endowment for Research, IWK Hospital, Halifax, Nova Scotia, Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Nutrition, Metabolism and Diabetes; Winnifred Lockwood Endowment for Research, IWK Hospital, Halifax, Nova Scotia, Canada	NDR received funding for this research from the Canadian Institutes of Health Research, Institute of Nutrition, Metabolism and Diabetes (Grant #MOP-15284), http://www.cihr-irsc.gc.ca/e/193.html.NDR also received funding from the Winnifred Lockwood Endowment for Research, IWK Hospital, Halifax, Nova Scotia, Canada. This is an internal award and there is no grant number or web site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Dong JQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08791-0; Fournier MV, 1999, CANCER RES, V59, P3748; Ghai R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00861-5; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Heringa J, 1999, COMPUT CHEM, V23, P341, DOI 10.1016/S0097-8485(99)00012-1; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Li JW, 2016, ONCOTARGET, V7, P65849, DOI 10.18632/oncotarget.11671; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Moreira EF, 2001, J BIOL CHEM, V276, P18570, DOI 10.1074/jbc.M011259200; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Pietrangelo A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215335; Pietrangelo A, 2018, CELL MOL LIFE SCI, V75, P3079, DOI 10.1007/s00018-018-2795-y; Prashek J, 2017, J BIOL CHEM, V292, P14217, DOI 10.1074/jbc.M117.780007; Schittek B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-231; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vazquez-Novelle MD, 2014, CURR BIOL, V24, P638, DOI 10.1016/j.cub.2014.01.034; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001; Zhao KX, 2017, CELL REP, V19, P1807, DOI 10.1016/j.celrep.2017.05.028; Zhong WB, 2019, CELL REP, V26, P2166, DOI 10.1016/j.celrep.2019.01.082; Zhong WB, 2016, CIRC RES, V119, P1296, DOI 10.1161/CIRCRESAHA.116.309603; Zhong WB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12702; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	31	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214768	10.1371/journal.pone.0214768	http://dx.doi.org/10.1371/journal.pone.0214768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925160	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300030
J	Sugimori, F; Hirakawa, H; Tsutsui, A; Yamaji, H; Komaru, S; Takasaki, M; Iwamatsu, T; Uemura, T; Uemura, Y; Morita, K; Tsumura, T				Sugimori, Fumiaki; Hirakawa, Hiroyuki; Tsutsui, Ai; Yamaji, Hiroyuki; Komaru, Shohei; Takasaki, Mai; Iwamatsu, Tadashi; Uemura, Toshimasa; Uemura, Yo; Morita, Kenichi; Tsumura, Takashi			A novel electron emission-based cell culture device promotes cell proliferation and differentiation of pre-osteoblastic MC3T3-E1 cells	PLOS ONE			English	Article							TRABECULAR BONE MASS; MESSENGER-RNA; STIMULATION; CBFA1; OSTEOPONTIN; OSTEOCLASTS; EXPRESSION; PLASMA; MUSCLE; GENE	In this report we demonstrate the effect of a novel electron emission-based cell culture device on the proliferation and differentiation of pre-osteoblastic MC3T3-E1 cells. Our device has an electron emission element that allows, for the first time, stable emission of electrons into an atmosphere. Atmospheric electrons react with gas molecules to generate radicals and negative ions, which induce a variety of biochemical reactions in the attached cell culture system. In this study, we demonstrated the effect of this new electron emission-based cell culture device on cell proliferation and differentiation using pre-osteoblastic MC3T3-E1 cells. Electron emission stimulation (EES) was applied directly to culture medium containing plated cells, after which the number of living cells, the mRNA levels of osteogenesis-related genes, and the alkaline phosphatase (ALP) activity were evaluated. The growth rate of EES-exposed cells increased by approximately 20% in comparison with unexposed control cells. We also found the mRNA levels of osteogenic specific genes such as collagen type I alpha-1, core-binding factor alpha-1, and osteocalcin to be up-regulated following EES. ALP activity, a marker for osteogenic activity, was significantly enhanced in EES-treated cells. Furthermore, reactive oxygen species generated by EES were measured to determine their effect on MC3T3-E1 cells. These results suggest that our new electron emission-based cell culture device, while providing a relatively weak stimulus in comparison with atmospheric plasma systems, promotes cell proliferation and differentiation. This system is expected to find application in regenerative medicine, specifically in relation to bone regeneration.	[Sugimori, Fumiaki; Hirakawa, Hiroyuki; Tsutsui, Ai; Yamaji, Hiroyuki; Komaru, Shohei; Takasaki, Mai; Iwamatsu, Tadashi] Sharp Co Ltd, Business Solut Business Unit, Adv Technol Dev Unit, Yamato Koriyama, Nara, Japan; [Uemura, Toshimasa; Uemura, Yo; Morita, Kenichi; Tsumura, Takashi] JTEC COOPERAT, Cell Culture Mkt & Res Ctr, Osaka, Ibaraki, Japan; [Uemura, Toshimasa] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Hisense; Sharp Corporation; Osaka University	Sugimori, F (corresponding author), Sharp Co Ltd, Business Solut Business Unit, Adv Technol Dev Unit, Yamato Koriyama, Nara, Japan.	sugimori.fumiaki@sharp.co.jp	Iwamatsu, Tadashi/U-7826-2018	Iwamatsu, Tadashi/0000-0001-7670-1426; Sugimori, Fumiaki/0000-0002-0588-6117				Bique AM, 2016, ELECTROMAGN BIOL MED, V35, P353, DOI 10.3109/15368378.2016.1138124; Dauben TJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5178640; Diaz-Vegas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129882; Doucet Barbara M., 2012, Yale Journal of Biology and Medicine, V85, P201; Han I, 2017, ONCOTARGET, V8, P36399, DOI 10.18632/oncotarget.16821; Iwamatsu T., 2017, J IMAG SOC JPN, V56, P16; Iwamatsu T, 2019, APPL PHYS LETT, V114, DOI 10.1063/1.5077062; Jervey C, 1990, Contemp Orthop, V20, P61; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kumar A, 2016, J BIOMATER APPL, V31, P594, DOI 10.1177/0885328216658376; Kumar A, 2016, BIOMATER SCI-UK, V4, P136, DOI 10.1039/c5bm00350d; Lau YC, 2015, OSTEOPOROSIS INT, V26, P481, DOI 10.1007/s00198-014-2866-3; Lau YC, 2014, SPINE J, V14, P2472, DOI 10.1016/j.spinee.2014.04.001; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; MERRY K, 1993, J CELL SCI, V104, P1013; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Ohta T, 2005, J VAC SCI TECHNOL B, V23, P2336, DOI 10.1116/1.2102928; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Sasaki S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25728; Schellnack K, 1979, Beitr Orthop Traumatol, V26, P473; Tamaki H, 2015, J MUSCULOSKEL NEURON, V15, P270; Tominami K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180507; Wang YP, 2016, PLOS GENET, V12, DOI [10.1371/journal.pgen.1005803, 10.1371/journal.pgen.1006390]; YOKOO K, 1994, J VAC SCI TECHNOL B, V12, P801, DOI 10.1116/1.587350; Zhang JY, 2016, ACTA BIOMATER, V32, P46, DOI 10.1016/j.actbio.2015.12.024; Zhuang HM, 1997, BIOCHEM BIOPH RES CO, V237, P225, DOI 10.1006/bbrc.1997.7118	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213579	10.1371/journal.pone.0213579	http://dx.doi.org/10.1371/journal.pone.0213579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921357	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000019
J	Chakravarty, S; Mandal, RK; Duff, ML; Schmidt, NW				Chakravarty, Shubham; Mandal, Rabindra K.; Duff, Morgan L.; Schmidt, Nathan W.			Intestinal short-chain fatty acid composition does not explain gut microbiota-mediated effects on malaria severity	PLOS ONE			English	Article							INFLAMMATION; METABOLITES; PROPIONATE; BUTYRATE; IMMUNITY; GPR109A	Malaria is a devastating disease resulting in significant morbidity and mortality, especially in the developing world. Previously, we showed that the gut microbiome modulates severity of malaria in mice, though the exact mechanism was unknown. One well-studied mechanism by which the intestinal microbiota exerts an effect on host health is by synthesis of short-chain fatty acids (SCFAs). SCFAs have pleiotropic effects on the host, including modulating the immune system and altering susceptibility to pathogens. The objective of the current work was to explore if gut microbiota-mediated resistance and susceptibility to malaria in mice is through differential production of SCFAs. Of the eight detected SCFAs, only propionic acid (C3) was different between two groups of resistant and two groups of susceptible mice, with higher levels in feces of susceptible mice compared to resistant mice. Nevertheless, subsequent analysis revealed no robust correlation between malaria severity and levels of fecal propionic acid. In spite of the broad effect of SCFAs on host physiology, including host immunity, this study shows that gut microbiota-mediated modulation of malaria severity in mice is independent of fecal SCFA levels. Additionally, our data indicates that intestinal SCFAs do not function as biomarkers for prediction of malaria disease	[Chakravarty, Shubham; Mandal, Rabindra K.; Duff, Morgan L.; Schmidt, Nathan W.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville	Schmidt, NW (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	nathan.schmidt@louisville.edu		Chakravarty, Shubham/0000-0002-8123-1761	National Institutes of Health [1R01AI123486, 1P20GM113226-01, 1P50AA024337-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health, grant number 1R01AI123486 to NWS and the University of Louisville CREAM Center is partially supported by grants 1P20GM113226-01 and 1P50AA024337-01 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autino B, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.061; Azcarate IG, 2013, BRIT J PHARMACOL, V169, P645, DOI 10.1111/bph.12156; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Ciarlo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep37944; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; He LQ, 2018, J CHROMATOGR B, V1092, P359, DOI 10.1016/j.jchromb.2018.06.028; Jacobson A, 2018, CELL HOST MICROBE, V24, P296, DOI 10.1016/j.chom.2018.07.002; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kim CH, 2016, MICROB CELL, V3, P398, DOI 10.15698/mic2016.10.536; Kim M, 2017, GUT MICROBES, V8, P392, DOI 10.1080/19490976.2017.1299311; Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001; Li M, 2018, EUR J PHARMACOL, V831, P52, DOI 10.1016/j.ejphar.2018.05.003; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Rodrigues HG, 2016, EUR J PHARMACOL, V785, P50, DOI 10.1016/j.ejphar.2015.03.098; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Villarino N, 2015, ANTIMICROB AGENTS CH, V59, P3672, DOI 10.1128/AAC.02858-14; Villarino NF, 2016, P NATL ACAD SCI USA, V113, P2235, DOI 10.1073/pnas.1504887113; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858	22	6	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214449	10.1371/journal.pone.0214449	http://dx.doi.org/10.1371/journal.pone.0214449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917184	gold, Green Submitted, Green Published			2022-12-27	WOS:000462465800066
J	Blevins, TP; Yu, YY; Belshe, RB; Bellamy, AR; Morrison, LA				Blevins, Tamara P.; Yu, Yinyi; Belshe, Robert B.; Bellamy, Abbie R.; Morrison, Lynda A.			Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays	PLOS ONE			English	Article							GLYCOPROTEIN-D; FUSION; ENTRY; DOMAIN; HSV-1	Preventive viral vaccine efficacy trials require large-scale sample analysis to quantitate immune responses and their correlation with infection outcomes. Traditional plaque reduction assays measure a functionally important form of humoral immunity, neutralizing antibody titer. These assays, however, are time-consuming and laborious. We previously developed a higher throughput assay of neutralizing antibody to herpes simplex viruses 1 and 2 (Blevins et al., PLOS ONE, 10(12), e0144738) using the enzyme-linked virus inducible system (ELVIS) cell line; this cell line produces beta-galactosidase in response to HSV infection. Here, serum samples from recipients of an investigational vaccine in the Herpevac Trial for Women were used to compare the ELVIS cell assay with the lower throughput, traditional plaque reduction assay. We demonstrate that neutralizing antibody titers to HSV-1 or HSV-2 determined using ELVIS cells positively correlate with neutralizing antibody titers determined by traditional plaque reduction assay, thus validating a higher throughput alternative for large-scale sample analysis.	[Blevins, Tamara P.; Yu, Yinyi; Belshe, Robert B.; Bellamy, Abbie R.; Morrison, Lynda A.] St Louis Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63104 USA; [Bellamy, Abbie R.] Emmes Corp, Rockville, MD USA; [Morrison, Lynda A.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	Saint Louis University; Emmes Corporation; Saint Louis University	Morrison, LA (corresponding author), St Louis Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63104 USA.; Morrison, LA (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.	lynda.morrison@health.slu.edu		Blevins, Tamara/0000-0003-1955-2641	Division of Microbiology and Infectious Diseases, National Institutes of Health [HHSN27220130021I, HHSN272201500002C]	Division of Microbiology and Infectious Diseases, National Institutes of Health	This work was performed under contracts #HHSN27220130021I (to RBB and LAM, Saint Louis University) and #HHSN272201500002C (Emmes) from the Division of Microbiology and Infectious Diseases, National Institutes of Health, https://www.niaid.nih.gov/about/dmid.	Ashley RL, 1997, VIRAL IMMUNOL, V10, P213, DOI 10.1089/vim.1997.10.213; Awasthi S, 2014, J INFECT DIS, V210, P571, DOI 10.1093/infdis/jiu177; Baccari A, 2016, VACCINE, V34, P3901, DOI 10.1016/j.vaccine.2016.05.033; Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Blevins TP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144738; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Cocchi F, 2004, P NATL ACAD SCI USA, V101, P7445, DOI 10.1073/pnas.0401883101; Cooper D, 2004, VACCINE, V23, P236, DOI 10.1016/j.vaccine.2004.05.011; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Fan Q, 2014, J VIROL, V88, P6470, DOI 10.1128/JVI.00465-14; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Lazear E, 2008, J VIROL, V82, P700, DOI 10.1128/JVI.02192-07; Peng T, 1998, J VIROL, V72, P65, DOI 10.1128/JVI.72.1.65-72.1998; Sathiyamoorthy K, 2017, CURR OPIN VIROL, V24, P97, DOI 10.1016/j.coviro.2017.04.006; STABELL EC, 1992, J VIROL METHODS, V38, P195, DOI 10.1016/0166-0934(92)90110-Y; Whitbeck JC, 2014, J VIROL, V88, P7786, DOI 10.1128/JVI.00544-14	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214467	10.1371/journal.pone.0214467	http://dx.doi.org/10.1371/journal.pone.0214467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946751	Green Submitted, gold, Green Published			2022-12-27	WOS:000463314500033
J	Frolund, M; Falk, L; Ahrens, P; Jensen, JS				Frolund, Maria; Falk, Lars; Ahrens, Peter; Jensen, Jorgen Skov			Detection of ureaplasmas and bacterial vaginosis associated bacteria and their association with non-gonococcal urethritis in men	PLOS ONE			English	Article							MYCOPLASMA-GENITALIUM; CHLAMYDIA-TRACHOMATIS; UREALYTICUM; PCR; AMPLIFICATION; POPULATION; WOMEN; TIME	No aetiology is found in up to 40% of men with symptomatic urethritis. Male partners of women with bacterial vaginosis (BV) may be at higher risk of non-gonococcal urethritis (NGU). The aim of this study was to examine the role of BV associated bacteria in first-void urine (FVU) in 97 asymptomatic men without urethritis (controls) and 44 men (cases) with NGU including 20 men with idiopathic urethritis (IU) attending a Swedish STD-clinic between January and October 2010. BV-associated bacteria and ureaplasmas were detected by quantitative PCR assays. All BV associated bacteria, except Megasphaera-like type 1, were strongly positively correlated with U. urealyticum p<0.005 and even stronger with the combined U. urealyticum and U. parvum load (p<0.0005) suggesting that ureaplasma induced elevated pH may stimulate the growth of BV associated bacteria. No statistically significant differences were found between IU cases and controls in the prevalence or load of BV associated bacteria or ureaplasmas. In multiple logistic regression, Megasphaera-like type 1 was associated with IU (p = 0.03), but most positive FVU samples contained very few bacteria and the finding may not be clinically relevant.	[Frolund, Maria; Ahrens, Peter; Jensen, Jorgen Skov] Statens Serum Inst, Res Unit Reprod Microbiol, Copenhagen S, Denmark; [Falk, Lars] Linkoping Univ Hosp, Dept Dermatovenereol, Linkoping, Sweden; [Falk, Lars] Linkoping Univ, Linkoping, Sweden	Statens Serum Institut; Linkoping University; Linkoping University	Jensen, JS (corresponding author), Statens Serum Inst, Res Unit Reprod Microbiol, Copenhagen S, Denmark.	jsj@ssi.dk	Falk, Lars/AAG-8348-2020	Jensen, Jorgen Skov/0000-0002-7464-7435; Ahrens, Peter/0000-0003-3776-7929	ALF-Grant [LIO-205751]; County Council of Ostergotland, Sweden; ALF-Grant from County Council of Ostergotland, Sweden [LIO-205751, LIO-60221, LIO-60311]	ALF-Grant; County Council of Ostergotland, Sweden; ALF-Grant from County Council of Ostergotland, Sweden	This study was supported by ALF-Grant LIO-60221; ALF-Grant LIO-60311; ALF-Grant LIO-205751, to LF, all from County Council of Ostergotland, Sweden, https://www.researchweb.org/is/lio/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann LH, 2015, CLIN INFECT DIS, V61, pS763, DOI 10.1093/cid/civ755; Beamer MA, 2017, ANAEROBE, V45, P40, DOI 10.1016/j.anaerobe.2017.02.020; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; Carre H, 2008, SEX TRANSM INFECT, V84, P239, DOI 10.1136/sti.2007.028068; Cowan S, 2018, EPI NEWS, P34; Datcu R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-480; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Eriksson K, 2010, APMIS, V118, P903, DOI 10.1111/j.1600-0463.2010.02678.x; Falk L, 2004, SEX TRANSM INFECT, V80, P289, DOI 10.1136/sti.2003.006817; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Frolund M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201380; Frolund M, 2016, ACTA DERM-VENEREOL, V96, P689, DOI 10.2340/00015555-2314; Frolund M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102743; Haggerty CL, 2004, CLIN INFECT DIS, V39, P990, DOI 10.1086/423963; Horner P, 2018, J EUR ACAD DERMATOL, V32, P1845, DOI 10.1111/jdv.15146; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Jensen JS, 2003, J CLIN MICROBIOL, V41, P261, DOI 10.1128/JCM.41.1.261-266.2003; Keane FEA, 2000, INT J STD AIDS, V11, P356, DOI 10.1258/0956462001916056; Keane FEA, 1997, GENITOURIN MED, V73, P373; Liu CM, 2015, MBIO, V6, DOI 10.1128/mBio.00589-15; Manhart LE, 2013, SEX TRANSM DIS, V40, P944, DOI 10.1097/OLQ.0000000000000054; Moi H, 2017, INT J STD AIDS, V28, P773, DOI 10.1177/0956462416666482; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Paralanov V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-88; Peipert JF, 1997, AM J OBSTET GYNECOL, V177, P1184, DOI 10.1016/S0002-9378(97)70038-3; Petrina M, 2016, AM J OBSTET GYNECOL, V215, P833; Plummer EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190199; Ripa T, 2007, SEX TRANSM DIS, V34, P255, DOI 10.1097/OLQ.0b013e31805ce2b9; Shimada Y, 2014, INT J STD AIDS, V25, P294, DOI 10.1177/0956462413504556; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Tabrizi SN, 2007, SEX HEALTH, V4, P41, DOI 10.1071/SH06054; The Public Health Agency of Sweden, 2018, ANN REPORT; Thorsen P, 2006, ACTA OBSTET GYN SCAN, V85, P906, DOI 10.1080/00016340500432655; Turner AN, 2016, SEX TRANSM DIS, V43, P172, DOI 10.1097/OLQ.0000000000000414; Wetmore CM, 2011, J INFECT DIS, V204, P1274, DOI 10.1093/infdis/jir517; Zhang NW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114241	39	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214425	10.1371/journal.pone.0214425	http://dx.doi.org/10.1371/journal.pone.0214425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946763	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500031
J	Henrard, S; Corbiere, V; Schandene, L; Ducarme, M; Van Praet, A; Petit, E; Singh, M; Locht, C; Dirix, V; Mascart, F				Henrard, Sophie; Corbiere, Veronique; Schandene, Liliane; Ducarme, Martine; Van Praet, Anne; Petit, Emmanuelle; Singh, Mahavir; Locht, Camille; Dirix, Violette; Mascart, Francoise			Proportions of interferon-gamma-producing ascites lymphocytes in response to mycobacterial antigens: A help for early diagnosis of peritoneal tuberculosis in a low TB incidence country	PLOS ONE			English	Article							HEPARIN-BINDING; RELEASE ASSAY; ADENOSINE-DEAMINASE; CELL; INFECTION	Background Peritoneal tuberculosis (TB) remains difficult to diagnose because of its non-specific clinical features and the lack of efficient microbiological tests. As delayed diagnosis is associated with high mortality rates, new diagnostic tools are needed. Methods and findings We investigated for 24 patients prospectively enrolled with a possible diagnosis of peritoneal TB, the diagnostic value of the analysis of IFN-gamma production by peritoneal fluid lymphocytes in response to a short in vitro stimulation with mycobacterial antigens. The patients were classified in two groups: non-TB and confirmed or highly probable TB. Diagnosis of TB was based on microbiological and histopathological criteria and/or a favorable response to anti-TB treatment. The IFN-gamma production by peritoneal CD4(+) T lymphocytes was analyzed by flow cytometry after an overnight in vitro stimulation with three different mycobacterial antigens, purified protein derivative (PPD), heparin-binding haemagglutinin (HBHA) or earlysecreted-antigen-target-6 (ESAT-6). The percentages of PPD-, HBHA- or ESAT-6-induced IFN-gamma-producing peritoneal fluid CD4(+) T lymphocytes were higher in the TB group than in the non-TB group (p = 0.0007, p = 0.0004, and p = 0.0002 respectively). Based on cut-off values determined by ROC curve analysis of the results from TB and highly probable TB compared to those of non-TB patients, the sensitivity of these three tests was 100% with a specificity of 92%. Conclusions The analysis of mycobacterial-induced IFN-gamma production by peritoneal lymphocytes is a promising tool to reliably and rapidly diagnose peritoneal TB. Further studies should be performed on larger cohorts of patients in high-TB-incidence countries to confirm the clinical value of this new diagnostic approach for peritoneal TB.	[Henrard, Sophie] Univ Libre Bruxelles, Hop Erasme, Immunodeficiencies Treatment Unit, Brussels, Belgium; [Corbiere, Veronique; Van Praet, Anne; Dirix, Violette; Mascart, Francoise] Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Schandene, Liliane; Ducarme, Martine; Mascart, Francoise] Univ Libre Bruxelles, Hop Erasme, Immunobiol Clin, Brussels, Belgium; [Petit, Emmanuelle; Locht, Camille] INSERM, U1019, Lille, France; [Petit, Emmanuelle; Locht, Camille] CNRS, UMR8204, Lille, France; [Petit, Emmanuelle; Locht, Camille] Univ Lille, Lille, France; [Petit, Emmanuelle; Locht, Camille] Inst Pasteur, Ctr Infect & Immunite Lille, Lille, France; [Singh, Mahavir] Lionex Diagnost & Therapeut, Braunschweig, Germany	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Lionex Diagnostics & Therapeutics GmbH	Mascart, F (corresponding author), Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, Brussels, Belgium.; Mascart, F (corresponding author), Univ Libre Bruxelles, Hop Erasme, Immunobiol Clin, Brussels, Belgium.	fmascart@ulb.ac.be		Mascart, Francoise/0000-0001-7635-7944	Fonds National de la Recherche Scientifique (FNRS) [PDR T.0147.13]; European Community [643381]; "Region de Bruxelles-Capitale - Innoviris"	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Community(European Commission); "Region de Bruxelles-Capitale - Innoviris"(Innoviris)	This work was supported by: F.M., Fonds National de la Recherche Scientifique (FNRS) - PDR T.0147.13; F.M., the European Community within the Horizon2020 program TBVAC2020-grant agreement 643381; and F.M., the "Region de Bruxelles-Capitale - Innoviris". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshahrani AS, 2016, J GASTRIC CANCER, V16, P111, DOI 10.5230/jgc.2016.16.2.111; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Bourgain G, 2016, CLIN RES HEPATOL GAS, V40, pE44, DOI 10.1016/j.clinre.2015.11.006; Chow KM, 2002, CLIN INFECT DIS, V35, P409, DOI 10.1086/341898; Guirat A, 2011, CLIN RES HEPATOL GAS, V35, P60, DOI 10.1016/j.gcb.2010.07.023; Horne DJ, 2018, INT J TUBERC LUNG D, V22, P617, DOI 10.5588/ijtld.17.0721; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Lataifeh I, 2014, J OBSTET GYNAECOL, V34, P268, DOI 10.3109/01443615.2013.870140; Lee JY, 2015, J INFECTION, V70, P356, DOI 10.1016/j.jinf.2014.09.012; Lorenz R, 2010, INFECTION, V38, P69, DOI 10.1007/s15010-009-9469-5; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Muller C, 2012, SCAND J UROL NEPHROL, V46, P314, DOI 10.3109/00365599.2012.659206; Naval-Macabuhay I, 2016, J LEUKOCYTE BIOL, V99, P349, DOI 10.1189/jlb.3A1214-580RR; Place S, 2010, AM J RESP CRIT CARE, V182, P848, DOI 10.1164/rccm.201001-0083OC; Sanai FM, 2005, ALIMENT PHARM THER, V22, P685, DOI 10.1111/j.1365-2036.2005.02645.x; Tao L, 2014, DIAGN MICR INFEC DIS, V79, P102, DOI 10.1016/j.diagmicrobio.2013.12.010; Thomas MM, 2008, INT J TUBERC LUNG D, V12, P651; Vaid U, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TNMI7-0006-2016; Vaz AM, 2017, BMJ CASE REP, V2017; Weledji EP, 2017, WORLD J GASTRO SURG, V9, P174, DOI 10.4240/wjgs.v9.i8.174; Wyndham-Thomas C, 2014, CLIN VACCINE IMMUNOL, V21, P321, DOI 10.1128/CVI.00651-13	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214333	10.1371/journal.pone.0214333	http://dx.doi.org/10.1371/journal.pone.0214333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946755	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500027
J	Dong, G; Liang, FY; Sun, B; Wang, CC; Liu, YY; Guan, XP; Yang, B; Xiu, CH; Yang, N; Liu, FY; Lu, TY; Han, W				Dong, Guo; Liang, Fengying; Sun, Bo; Wang, Chengcheng; Liu, Yangyang; Guan, Xiangpeng; Yang, Bo; Xiu, Chunhong; Yang, Ning; Liu, Fengyu; Lu, Tianyi; Han, Wei			Presence and function of stress granules in atrial fibrillation	PLOS ONE			English	Article							OXIDATIVE STRESS; PHOSPHORYLATION; TACHYCARDIA; APOPTOSIS; DAMAGE	Aims Stress granules (SGs) are transient cytoplasmic mRNA and protein complexes that form in eukaryotic cells under stress. SGs are related to multiple diseases, but there are no reports of the existence of SGs in atrial fibrillation (AF). Methods and results Cell models of AF were established by field stimulation at 600 times per minute. HL-1 cells, cardiomyocytes and cardiac fibroblasts were transfected with G3BP1-cDNA plasmid by Lipofectamine 2000. The presence of SGs was detected by immunofluorescence analysis against GTPase-activating protein SH3 domain binding protein 1 (G3BP1) and poly(A)-binding protein 1 (PABP-1) and electron microscopy. Stable HL-1 cell lines transfected with lenti-virus overexpressing G3BP1 were constructed to further induce the formation of SGs in AF. Reactive oxygen species (ROS) and calcium overload in tachypaced HL-1 cells were studied by flow cytometry. The effects of G3BP1 overexpression on cardiac fibroblast proliferation and the protein expression level of collagen I/III and fibronectin-1 were also studied. Additionally, we detected protein synthesis in general and in single cells by puromycin incorporation in paced HL-1 cells. Here, we first showed that SGs are present in both tachypaced mouse cardiomyocytes and HL-1 atrial cells, although the presence is partial and at a low level. G3BP1 overexpression promoted SG formation, inhibited the rapid pacing-induced increase in ROS level, and attenuated calcium overload in HL-1 cells (all P<0.05). Furthermore, G3BP1 overexpression inhibited cardiac fibroblast proliferation (P<0.05) and decreased the protein expression level of collagen I and fibronectin-1 in cardiac fibroblasts stimulated by angiotensin II (all P<0.05). The bulk puromycin incorporation analyzed by Western blot did not show a global reduction in protein synthesis. However, puromycin incorporation in single cells detected by immunofluorescence analysis showed that protein synthesis in SG-containing cells significantly reduced (P<0.01). Conclusions SGs are rapidly induced and present parially in AF, and G3BP1 overexpression promotes SG formation and confers cytoprotection against oxidative stress, calcium overload and atrial fibrosis in AF.	[Dong, Guo; Wang, Chengcheng; Liu, Yangyang; Guan, Xiangpeng; Yang, Bo; Xiu, Chunhong; Yang, Ning; Liu, Fengyu; Lu, Tianyi; Han, Wei] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Liang, Fengying] Guangzhou Med Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Sun, Bo] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Guangzhou Medical University; Harbin Medical University	Han, W (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China.	dr.hanwei@foxmail.com			National Natural Science Foundation of China [81470461, 81270251]; Scientific fund for Outstanding People of Heilongjiang Province [JC2016018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific fund for Outstanding People of Heilongjiang Province	This work was supported primarily by the National Natural Science Foundation of China (81470461 and 81270251 to Dr Han) and the Scientific fund for Outstanding People of Heilongjiang Province (JC2016018 to Dr Han). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Aguirre L, 2017, AM J PHYSIOL-LUNG C, V313, pL1058, DOI 10.1152/ajplung.00141.2017; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; Chen LH, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1809592; DeSantiago J, 2018, HEART RHYTHM, V15, P1233, DOI 10.1016/j.hrthm.2018.03.041; Dong ZX, 2017, SCI REP-UK, V7, DOI 10.1038/srep46307; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Hu YF, 2015, NAT REV CARDIOL, V12, P230, DOI 10.1038/nrcardio.2015.2; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kwok HH, 2017, CELL MOL LIFE SCI, V74, P3613, DOI 10.1007/s00018-017-2540-y; Levy S, 1998, EUR HEART J, V19, P1294, DOI 10.1053/euhj.1998.1050; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174; Ohashi N, 2004, J CARDIOVASC PHARM, V44, P386, DOI 10.1097/01.fjc.0000138163.11612.7b; Purohit A, 2013, CIRCULATION, V128, P1748, DOI 10.1161/CIRCULATIONAHA.113.003313; Shite J, 2001, J AM COLL CARDIOL, V38, P1734, DOI 10.1016/S0735-1097(01)01596-0; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Takahashi M, 2013, BLOOD, V122, P715, DOI 10.1182/blood-2013-03-493718; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wolkowicz PE, 2007, EUR J PHARMACOL, V576, P122, DOI 10.1016/j.ejphar.2007.08.004; Yang XX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004763; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019	29	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213769	10.1371/journal.pone.0213769	http://dx.doi.org/10.1371/journal.pone.0213769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943206	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300018
J	Garnier, AS; Planchais, M; Riou, J; Jacquemin, C; Ordonez, L; Saint-Andre, JP; Croue, A; Saoudi, A; Delneste, Y; Devys, A; Boutin, I; Subra, JF; Duveau, A; Augusto, JF				Garnier, Anne-Sophie; Planchais, Martin; Riou, Jeremie; Jacquemin, Clement; Ordonez, Laurence; Saint-Andre, Jean-Paul; Croue, Anne; Saoudi, Abdelhadi; Delneste, Yves; Devys, Anne; Boutin, Isabelle; Subra, Jean-Francois; Duveau, Agnes; Augusto, Jean-Francois			Pre-transplant CD45RC expression on blood T cells differentiates patients with cancer and rejection after kidney transplantation	PLOS ONE			English	Article							LONG-TERM COMPLICATIONS; MECHANISMS; TOLERANCE; UPDATE; RISK	Background Biological biomarkers to stratify cancer risk before kidney transplantation are lacking. Several data support that tumor development and growth is associated with a tolerant immune profile. T cells expressing low levels of CD45RC preferentially secrete regulatory cytokines and contain regulatory T cell subset. In contrast, T cells expressing high levels of CD45RC have been shown to secrete proinflammatory cytokines, to drive alloreactivity and to predict acute rejection (AR) in kidney transplant patients. In the present work, we evaluated whether pre-transplant CD45RC(low) T cell subset was predictive of post-transplant cancer occurrence. Methods We performed an observational cohort study of 89 consecutive first time kidney transplant patients whose CD45RC T cell expression was determined by flow cytometry before transplantation. Post-transplant events including cancer, AR, and death were assessed retrospectively. Results After a mean follow-up of 11.1 +/- 4.1 years, cancer occurred in 25 patients (28.1%) and was associated with a decreased pre-transplant proportion of CD4(+)CD45RC(high) T cells, with a frequency below 51.9% conferring a 3.7-fold increased risk of post-transplant malignancy (HR 3.71 [1.24-11.1], p = 0.019). The sensibility, specificity, negative predictive and positive predictive values of CD4(+)CD45RC(high)<51.9% were 84.0, 54.7, 89.8 and 42.0% respectively. Confirming our previous results, frequency of CD8(+)CD45RC(high) T cells above 52.1% was associated with AR, conferring a 20-fold increased risk (HR 21.7 [2.67-176.2], p = 0.0004). The sensibility, specificity, negative predictive and positive predictive values of CD8(+)CD45RC(high)>52.1% were 94.5, 68.0, 34.7 and 98.6% respectively. Frequency of CD4(+)CD45RC(high) T cells was positively correlated with those of CD8(+)CD45RC(high) (p<0.0001), suggesting that recipients with high AR risk display a low cancer risk. Conclusion High frequency of CD45RC(high) T cells was associated with AR, while low frequency was associated with cancer. Thus, CD45RC expression on T cells appears as a double-edged sword biomarker of promising interest to assess both cancer and AR risk before kidney transplantation.	[Garnier, Anne-Sophie; Planchais, Martin; Saint-Andre, Jean-Paul; Subra, Jean-Francois; Augusto, Jean-Francois] LUNAM Univ, Angers, France; [Garnier, Anne-Sophie; Planchais, Martin; Subra, Jean-Francois; Duveau, Agnes; Augusto, Jean-Francois] CHU Angers, Serv Nephrol Dialyse Transplantat, Angers, France; [Riou, Jeremie] Univ Bretagne Loire, Univ Angers, CNRS 6021, MINT,INSERM 1066,IBS CHU, Angers, France; [Jacquemin, Clement] Univ Bordeaux, INSERM U1035, BMGIC, Immunodermatol ATIP AVENIR, Bordeaux, France; [Ordonez, Laurence; Saoudi, Abdelhadi] Univ Toulouse, Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Saint-Andre, Jean-Paul; Croue, Anne] CHU Angers, Lab Anatomopathol, Angers, France; [Delneste, Yves; Subra, Jean-Francois; Augusto, Jean-Francois] Univ Angers, Univ Nantes, INSERM, CRCINA, Angers, France; [Delneste, Yves; Subra, Jean-Francois; Augusto, Jean-Francois] LabEx IGO Immunotherapy Graft Oncol, Angers, France; [Devys, Anne] Etab Francais Sang Pays de Loire, Lab HLA, Angers, France; [Boutin, Isabelle] Etab Francais Sang Pays de Loire, Ctr Sante, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers	Augusto, JF (corresponding author), LUNAM Univ, Angers, France.; Augusto, JF (corresponding author), CHU Angers, Serv Nephrol Dialyse Transplantat, Angers, France.; Augusto, JF (corresponding author), Univ Angers, Univ Nantes, INSERM, CRCINA, Angers, France.; Augusto, JF (corresponding author), LabEx IGO Immunotherapy Graft Oncol, Angers, France.	jfaugusto@chu-angers.fr	DELNESTE, Yves/K-7367-2015; JACQUEMIN, Clement/AAA-1618-2022; Jean-François, Augusto/L-2887-2015; SAOUDI, Abdelhadi/K-6719-2014; Garnier, Anne-Sophie/ABG-5292-2021	DELNESTE, Yves/0000-0002-2142-596X; Jean-François, Augusto/0000-0003-1498-2132; SAOUDI, Abdelhadi/0000-0001-7015-8178; Riou, Jeremie/0000-0002-7056-9257				Au E, 2018, NAT REV NEPHROL, V14, P508, DOI 10.1038/s41581-018-0022-6; Augusto JF, 2013, ANN TRANSPL, V18, P368, DOI 10.12659/AOT.883979; Bottomley MJ, 2013, BRIT MED BULL, V106, P117, DOI 10.1093/bmb/ldt012; Braudeau C, 2007, TRANSPL INT, V20, P845, DOI 10.1111/j.1432-2277.2007.00537.x; Braza F, 2015, J AM SOC NEPHROL, V26, P1795, DOI 10.1681/ASN.2014050480; Carroll RP, 2010, J AM SOC NEPHROL, V21, P713, DOI 10.1681/ASN.2009060669; Clark MC, 2012, ANN NY ACAD SCI, V1253, P58, DOI 10.1111/j.1749-6632.2011.06304.x; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; Dantal J, 2016, TRANSPLANTATION, V100, P2569, DOI 10.1097/TP.0000000000001428; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gatault P, 2017, AM J TRANSPLANT, V17, P1370, DOI 10.1111/ajt.14109; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hope CM, 2014, KIDNEY INT, V86, P175, DOI 10.1038/ki.2013.538; Lam AJ, 2017, TRANSPLANTATION, V101, P2277, DOI 10.1097/TP.0000000000001757; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Moreau A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015461; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; Ordonez L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069791; Ordonez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005287; Picarda E, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90088; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; San Segundo D, 2014, TRANSPLANTATION, V98, P1213, DOI 10.1097/TP.0000000000000202; Silkensen JR, 2000, J AM SOC NEPHROL, V11, P582, DOI 10.1681/ASN.V113582; Subra JF, 2001, J IMMUNOL, V166, P2944, DOI 10.4049/jimmunol.166.5.2944; Xystrakis E, 2004, J IMMUNOL, V173, P3140, DOI 10.4049/jimmunol.173.5.3140	29	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214321	10.1371/journal.pone.0214321	http://dx.doi.org/10.1371/journal.pone.0214321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925186	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300013
J	Zhabokritsky, A; Nelson, LE; Tharao, W; Husbands, W; Sa, T; Zhang, NH; Thomas-Pavanel, J; Baidoobonso, S; Kaul, R				Zhabokritsky, Alice; Nelson, LaRon E.; Tharao, Wangari; Husbands, Winston; Sa, Ting; Zhang, Nanhua; Thomas-Pavanel, Jamie; Baidoobonso, Shamara; Kaul, Rupert			Barriers to HIV pre-exposure prophylaxis among African, Caribbean and Black men in Toronto, Canada	PLOS ONE			English	Article							TRANSGENDER WOMEN; SEX; AWARENESS; PREP; RISK; PREVENTION; WILLINGNESS; INFECTION	Introduction Single-tablet combination emtricitabine/tenofovir is highly effective as HIV pre-exposure prophylaxis (PrEP). Scale-up efforts have targeted men who have sex with men (MSM), but patterns of racial disparities in PrEP use have begun to emerge. African, Caribbean and Black (ACB) communities in Canada and USA are also disproportionately affected by HIV, and there is lack of guidance regarding PrEP implementation in this priority population. Methods ACB men from Toronto, Canada were recruited in community settings by peers. Participants completed a detailed socio-behavioural questionnaire. Biological samples were collected and tested for sexually transmitted infections. Willingness to accept PrEP was assessed in relation to actual and self-perceived risk of acquiring HIV, as well as demographic and behavioural variables. Results 424 ACB men were included in the analysis. ACB MSM were more likely to accept PrEP than ACB men only reporting sex with women (MSW; 50.0% vs. 23.6%). The most common reasons for PrEP non-acceptance were concerns regarding side-effects and low self-perceived risk. PrEP acceptance was lowest among younger men (12.5%) and those born in Canada (15.2%). Men with a high self-perceived HIV risk were more likely to accept PrEP (41.3% vs. 22.7% of men with a low self-perceived risk), but only 25.4% of men who were defined as being at high-risk, self-identified themselves as such. Conclusions Most ACB MSW were unlikely to accept PrEP, largely due to low self-perceived HIV risk, but PrEP acceptance among ACB MSM was similar to other contemporaneous Toronto MSM communities. PrEP acceptance was particularly low among younger ACB men and those born in Canada. Tailored strategies will be needed to effectively implement PrEP in Toronto ACB communities.	[Zhabokritsky, Alice] Univ Toronto, Dept Med, Toronto, ON, Canada; [Nelson, LaRon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Nelson, LaRon E.] Univ Rochester, Sch Nursing, Rochester, NY USA; [Tharao, Wangari] Womens Hlth Womens Hands, Toronto, ON, Canada; [Husbands, Winston] Ontario HIV Treatment Network, Toronto, ON, Canada; [Sa, Ting; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Thomas-Pavanel, Jamie] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Baidoobonso, Shamara] Chief Publ Hlth Off, Charlottetown, PE, Canada; [Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Rochester; Cincinnati Children's Hospital Medical Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto	Zhabokritsky, A (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	azhabokritsky@qmed.ca		Husbands, Winston/0000-0003-4742-5105; Kaul, Rupert/0000-0002-1586-4093; Zhang, Nanhua/0000-0001-5796-3404; Nelson, LaRon/0000-0002-2630-602X	Canadian Institutes of Health Research (CIHR) [HET-85518, TMI-138656]; Ontario HIV Treatment Network (OHTN) Knowledge, Translation and Exchange grant; University of Toronto - OHTN Endowed Chair in HIV Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN) Knowledge, Translation and Exchange grant; University of Toronto - OHTN Endowed Chair in HIV Research	This research was supported by grants from the Canadian Institutes of Health Research (CIHR; #HET-85518, #TMI-138656) and an Ontario HIV Treatment Network (OHTN) Knowledge, Translation and Exchange grant. RK is supported by a University of Toronto - OHTN Endowed Chair in HIV Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, STIGM DISCR IND 1 AC; [Anonymous], 2006, CAN WE MEAS HIV AIDS; Bourgeois A C, 2017, Can Commun Dis Rep, V43, P248, DOI 10.14745/ccdr.v43i12a01; Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Eaton LA, 2017, PREV SCI, V18, P505, DOI 10.1007/s11121-017-0756-6; Eaton LA, 2015, AIDS PATIENT CARE ST, V29, P423, DOI 10.1089/apc.2014.0303; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grace D, 2018, AIDS PATIENT CARE ST, V32, P24, DOI 10.1089/apc.2017.0153; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Kesler MA, 2016, AIDS CARE, V28, P1378, DOI 10.1080/09540121.2016.1178703; Kesler MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2859-6; Khanna AS, 2016, JAMA INTERN MED, V176, P136, DOI 10.1001/jamainternmed.2015.6536; Krakower DS, 2016, CURR OPIN HIV AIDS, V11, P41, DOI 10.1097/COH.0000000000000206; Leonardi M, 2011, INT J STD AIDS, V22, P738, DOI 10.1258/ijsa.2011.011057; Liu J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1439-5; MacFadden DR, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20791; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Nelson LE, BMC INFECT DIS; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Smith DK, 2012, JAIDS-J ACQ IMM DEF, V60, P421, DOI 10.1097/QAI.0b013e318256b2f6; Tan DHS, 2017, CAN MED ASSOC J, V189, pE1448, DOI 10.1503/cmaj.170494; UNAIDS, 2017, LAT STAT STAT AIDS E; Wilton J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20777; Yi S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21580	27	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0213740	10.1371/journal.pone.0213740	http://dx.doi.org/10.1371/journal.pone.0213740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9FO	30925582	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300005
J	Kumar, S; Phogat, BS; Vikas, VK; Sharma, AK; Saharan, MS; Singh, AK; Kumari, J; Singh, R; Jacob, SR; Singh, GP; Sivasamy, M; Jayaprakash, P; Meeta, M; Jaiswal, JP; Shikha, D; Honrao, BK; Kalappanavar, IK; Mishra, PC; Singh, SP; Vaish, SS; Solanki, VA				Kumar, Sundeep; Phogat, B. S.; Vikas, V. K.; Sharma, A. K.; Saharan, M. S.; Singh, Amit Kumar; Kumari, Jyoti; Singh, Rakesh; Jacob, Sherry Rachel; Singh, G. P.; Sivasamy, M.; Jayaprakash, P.; Meeta, M.; Jaiswal, J. P.; Shikha, Deep; Honrao, B. K.; Kalappanavar, I. K.; Mishra, P. C.; Singh, S. P.; Vaish, S. S.; Solanki, V. A.			Mining of Indian wheat germplasm collection for adult plant resistance to leaf rust	PLOS ONE			English	Article							STRIPE RUST; DURABLE RESISTANCE; POWDERY MILDEW; GENE; LR34; ASSOCIATION; IMPROVEMENT; PATHOGENS; FUTURE; LR46	Leaf rust (Puccinia triticina Eriks.) is a fungal disease of wheat (Triticum spp.), which causes considerable yield loss. Adult plant resistance (APR) is one of the most sustainable approaches to control leaf rust. In this study, field-testing was carried out across ten different locations, followed by molecular screening, to detect the presence of APR genes, Lr34+, Lr46+, Lr67+ and Lr68 in Indian wheat germplasm. In field screening, 190 wheat accessions were selected from 6,319 accessions based on leaf tip necrosis (LTN), disease severity and the average coefficient of infection. Molecular screening revealed that 73% of the accessions possessed known APR genes either as single or as a combination of two or three genes. The occurrence of increased LTN intensity, decreased leaf rust severity and greater expression of APR genes were more in relatively cooler locations. In 52 lines, although the presence of the APR genes was not detected, it still displayed high levels of resistance. Furthermore, 49 accessions possessing either two or three APR genes were evaluated for stability across locations for grain yield. It emerged that eight accessions had wider adaptability. Resistance based on APR genes, in the background of high yielding cultivars, is expected to provide a high level of race non-specific resistance, which is durable.	[Kumar, Sundeep; Phogat, B. S.; Singh, Amit Kumar; Kumari, Jyoti; Singh, Rakesh; Jacob, Sherry Rachel] ICAR Natl Bur Plant Genet Resources, Pusa Campus, New Delhi, India; [Vikas, V. K.; Sivasamy, M.; Jayaprakash, P.] ICAR Indian Agr Res Inst, Reg Stn, Wellington, Tamil Nadu, India; [Sharma, A. K.; Saharan, M. S.; Singh, G. P.] ICAR Indian Inst Wheat & Barley Res, Karnal, Haryana, India; [Meeta, M.] Punjab Agr Univ, Ludhiana, Punjab, India; [Jaiswal, J. P.; Shikha, Deep] Govind Ballabh Pant Univ Agr & Technol, Pantnagar, Uttarakhand, India; [Honrao, B. K.] Agharkar Res Inst, Pune, Maharashtra, India; [Kalappanavar, I. K.] Univ Agr Sci, Dharwad, Karnataka, India; [Mishra, P. C.] Zonal Agr Res Stn JNKVV, Powarkheda, Madhya Pradesh, India; [Singh, S. P.] Narendra Deva Univ Agr & Technol, Faizabad, Uttar Pradesh, India; [Vaish, S. S.] Banaras Hindu Univ, Varanasi, Uttar Pradesh, India; [Solanki, V. A.] Sardarkrushinagar Dantiwada Agr Univ, Vijapur, Gujarat, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Punjab Agricultural University; Govind Ballabh Pant University of Agriculture Technology; Department of Science & Technology (India); Agharkar Research Institute (ARI); Banaras Hindu University (BHU)	Kumar, S (corresponding author), ICAR Natl Bur Plant Genet Resources, Pusa Campus, New Delhi, India.	Sundeep.Kumar@icar.gov.in	Kumar, Saran/GWQ-9968-2022; Singh, Rakesh/AAI-6165-2020; kumari, Jyoti/GSE-6263-2022; KUMAR, SANDEEP/GZA-7182-2022; Jayaprakash*, P/ABC-7625-2020; Saharan, Mahender/AAI-9831-2020	Singh, Rakesh/0000-0001-7269-6420; Vaish, Shyam Saran/0000-0003-0283-1783; Kumar, Sundeep/0000-0002-0015-8559	CABin project, ICAR, New Delhi [16103]; Indian Council of Agricultural Research, Government of India under ICAR-NBPGR-Multi-location Evaluation Programme	CABin project, ICAR, New Delhi; Indian Council of Agricultural Research, Government of India under ICAR-NBPGR-Multi-location Evaluation Programme	The work was funded by a sponsored research component of CABin project (Scheme Code: 16103), ICAR, New Delhi.; The authors are grateful to Indian Council of Agricultural Research, Government of India for supporting this research under ICAR-NBPGR-Multi-location Evaluation Programme. The authors are thankful to Director, ICAR-NBPGR New Delhi and Director, IIWBR, Karnal for providing the facilities and guidance in germplasm evaluation. The authors are also thankful to Dr. S. C. Bhardwaj, Head, IIWBR RS, Flowerdale, Shimla for providing inoculum during the course of investigation.	Bansal UK, 2008, THEOR APPL GENET, V117, P307, DOI 10.1007/s00122-008-0775-6; Chen WQ, 2013, EUPHYTICA, V192, P339, DOI 10.1007/s10681-012-0854-2; Dakouri A, 2014, MOL BREEDING, V33, P639, DOI 10.1007/s11032-013-9981-2; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; DYCK PL, 1991, CROP SCI, V31, P309, DOI 10.2135/cropsci1991.0011183X003100020016x; DYCK PL, 1979, CAN J PLANT SCI, V59, P329, DOI 10.4141/cjps79-053; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Forrest K, 2014, MOL BREEDING, V34, P2109, DOI 10.1007/s11032-014-0166-4; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Gauch HG, 2013, CROP SCI, V53, P1860, DOI 10.2135/cropsci2013.04.0241; Gauch HG, 2011, CROP SCI, V51, P96, DOI 10.2135/cropsci2010.04.0206; Herrera-Foessel SA, 2014, THEOR APPL GENET, V127, P781, DOI 10.1007/s00122-013-2256-9; Herrera-Foessel SA, 2012, THEOR APPL GENET, V124, P1475, DOI 10.1007/s00122-012-1802-1; Hiebert CW, 2010, THEOR APPL GENET, V121, P1083, DOI 10.1007/s00122-010-1373-y; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; Johnson R., 1988, BREEDING STRATEGIES; Joshi AK, 2007, EUPHYTICA, V157, P431, DOI 10.1007/s10681-007-9385-7; Juliana P, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.01.0002; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2006, THEOR APPL GENET, V114, P21, DOI 10.1007/s00122-006-0406-z; Lagudah ES, 2011, EUPHYTICA, V179, P81, DOI 10.1007/s10681-010-0336-3; Li ZF, 2014, CROP SCI, V54, P1907, DOI 10.2135/cropsci2014.02.0162; Loegering W. Q., 1959, METHODS RECORDING CE; Ma H, 1996, PLANT DIS, V80, P66, DOI 10.1094/PD-80-0066; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; McIntosh RA, 1998, EUPHYTICA, V100, P19, DOI 10.1023/A:1018387402918; McIntosh RA, 2011, CATALOGUE GENE SYM S; Messmer MM, 2000, THEOR APPL GENET, V100, P419, DOI 10.1007/s001220050055; Moore JW, 2015, NAT GENET, V47, P1494, DOI 10.1038/ng.3439; Nagarajan S, 2005, CURR SCI INDIA, V89, P1467; Pasquini M, 2003, J GENET BREED, V57, P191; Pathan AK, 2006, EUPHYTICA, V149, P327, DOI 10.1007/s10681-005-9081-4; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Risk JM, 2012, PLANT BIOTECHNOL J, V10, P477, DOI 10.1111/j.1467-7652.2012.00683.x; Rosewarne GM, 2006, THEOR APPL GENET, V112, P500, DOI 10.1007/s00122-005-0153-6; RUBIALES D, 1995, PLANT DIS, V79, P1208, DOI 10.1094/PD-79-1208; Singh RP, 2011, EUPHYTICA, V179, P175, DOI 10.1007/s10681-010-0322-9; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; SINGH RP, 1992, GENOME, V35, P24, DOI 10.1139/g92-004; Singh RP, 1998, PHYTOPATHOLOGY, V88, P890, DOI 10.1094/PHYTO.1998.88.9.890; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; United Nations, 2015, ESAPWP241 UN; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; ZOBEL RW, 1988, AGRON J, V80, P388, DOI 10.2134/agronj1988.00021962008000030002x	45	11	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213468	10.1371/journal.pone.0213468	http://dx.doi.org/10.1371/journal.pone.0213468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921352	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000017
J	Martinez-Conde, S; McCamy, MB; Troncoso, XG; Otero-Millan, J; Macknik, SL				Martinez-Conde, Susana; McCamy, Michael B.; Troncoso, Xoana G.; Otero-Millan, Jorge; Macknik, Stephen L.			Area V1 responses to illusory corner-folds in Vasarely's nested squares and the Alternating Brightness Star illusions	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; CONTRAST-SENSITIVITY; SALIENCE VARIES; STRIATE CORTEX; MICROSACCADES; NEURONS; DYNAMICS; MONKEY; ANGLE; SHAPE	Vasarely's nested squares illusion shows that the corners of concentric squares, arranged in a gradient of increasing or decreasing luminance, generate illusory "corner-folds," which appear more salient (either brighter or darker) than the adjacent flat (non- corner) regions of each individual square. The Alternating Brightness Star (ABS) illusion, based on Vasarely's classic nested squares, further shows that the strength of these corner-folds depends on corner angle. Previous psychophysical studies showed the relationship between corner angle and perceived contrast in the ABS illusion to be linear, with sharp angles looking higher in contrast, and shallow angles lower in contrast. Center-surround difference-of-Gaussians (DOG) modeling did not replicate this linear relationship, however, suggesting that a full neural explanation of the nested squares and ABS illusions might be found in the visual cortex, rather than at subcortical stages. Here we recorded the responses from single area V1 neurons in the awake primate, during the presentation of visual stimuli containing illusory corner-folds of various angles. Our results showed stronger neural responses for illusory corner-folds made from sharper than from shallower corners, consistent with predictions from the previous psychophysical work. The relationship between corner angle and strength of the neuronal responses, albeit parametric, was apparently non-linear. This finding was in line with the previous DOG data, but not with the psychophysical data. Our combined results suggest that, whereas corner-fold illusions likely originate from center surround retinogeniculate processes, their complete neural explanation may be found in extrastriate visual cortical areas.	[Martinez-Conde, Susana; McCamy, Michael B.; Troncoso, Xoana G.; Otero-Millan, Jorge; Macknik, Stephen L.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Martinez-Conde, Susana; Macknik, Stephen L.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Troncoso, Xoana G.] CNRS, UNIC, Gif Sur Yvette, France; [Otero-Millan, Jorge] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA	Barrow Neurological Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University	Martinez-Conde, S (corresponding author), Barrow Neurol Inst, Phoenix, AZ 85013 USA.; Martinez-Conde, S (corresponding author), Suny Downstate Med Ctr, Brooklyn, NY 11203 USA.	smart@neuralcorrelate.com	Martinez-Conde, Susana/AAK-6725-2021	Martinez-Conde, Susana/0000-0003-4600-9767; Troncoso, Xoana/0000-0001-7343-1272; Otero-Millan, Jorge/0000-0002-9789-8392	Research to Prevent Blindness Inc.; Empire Innovation Program; Barrow Neurological Foundation; National Eye Institute; National Science Foundation [0643306, 0852636, 113786, 0726113, 1523614]	Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); Empire Innovation Program; Barrow Neurological Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF))	This study was supported by a challenge grant from Research to Prevent Blindness Inc. to the Department of Ophthalmology at SUNY Downstate, the Empire Innovation Program (Awards to S.L.M. and S.M.-C.), the Barrow Neurological Foundation (Awards to S.L.M. and S.M.-C.), the National Eye Institute (Award to David H. Hubel) and the National Science Foundation (Awards 0643306, 0852636 and 113786 to S.M.C. and Awards 0726113 and 1523614 to S.L.M.). X.G.T. and J.O.-M. were Fellows of the Barrie Foundation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; [Anonymous], 1984, J PHYSL, DOI [10.1113/jphysiol.1984.sp015498, DOI 10.1113/JPHYSIOL.1984.SP015498]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H, 1961, POSSIBLE PRINCIPLES; Barlow HB, 1989, NEURAL COMPUT, V1, P295, DOI 10.1162/neco.1989.1.3.295; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen MG, 2014, NEURON, V82, P682, DOI 10.1016/j.neuron.2014.03.023; Costela FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110889; Dayan P, 2001, COMPUTATIONAL NEUROS; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hurvich LM., 1981, COLOR VISION; IRVIN GE, 1993, VISUAL NEUROSCI, V10, P363, DOI 10.1017/S0952523800003758; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Levitt JB, 2001, J NEUROPHYSIOL, V85, P2111, DOI 10.1152/jn.2001.85.5.2111; Macknik SL, 2000, P NATL ACAD SCI USA, V97, P7556, DOI 10.1073/pnas.110142097; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Martinez-Conde S, 2001, SOC NEUR 31 ANN M SO; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032; REMMEL RS, 1984, IEEE T BIO-MED ENG, V31, P388, DOI 10.1109/TBME.1984.325352; ROBSON JG, 1966, J OPT SOC AM, V56, P1141, DOI 10.1364/JOSA.56.001141; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; Tadmor Y, 2000, VISION RES, V40, P3145, DOI 10.1016/S0042-6989(00)00166-8; Troncoso XG, 2005, PERCEPTION, V34, P409, DOI 10.1068/p5383; Troncoso XG, 2007, PERCEPTION, V36, P808, DOI 10.1068/p5610; Troncoso XG, 2009, SPATIAL VISION, V22, P211, DOI 10.1163/156856809788313129; van Kerkoerle T, 2014, P NATL ACAD SCI USA, V111, P14332, DOI 10.1073/pnas.1402773111; Vasarely V, 1970, VASARELY 2	38	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0210941	10.1371/journal.pone.0210941	http://dx.doi.org/10.1371/journal.pone.0210941			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921330	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000007
J	Matz, SC; Menges, JI; Stillwell, DJ; Schwartz, HA				Matz, Sandra C.; Menges, Jochen I.; Stillwell, David J.; Schwartz, H. Andrew			Predicting individual-level income from Facebook profiles	PLOS ONE			English	Article							PERSONALITY; MEDIA	Information about a person's income can be useful in several business-related contexts, such as personalized advertising or salary negotiations. However, many people consider this information private and are reluctant to share it. In this paper, we show that income is predictable from the digital footprints people leave on Facebook. Applying an established machine learning method to an income-representative sample of 2,623 U.S. Americans, we found that (i) Facebook Likes and Status Updates alone predicted a person's income with an accuracy of up to r = 0.43, and (ii) Facebook Likes and Status Updates added incremental predictive power above and beyond a range of socio-demographic variables (Delta R-2 = 6-16%, with a correlation of up to r = 0.49). Our findings highlight both opportunities for businesses and legitimate privacy concerns that such prediction models pose to individuals and society when applied without individual consent.	[Matz, Sandra C.] Columbia Univ, Columbia Business Sch, New York, NY 10027 USA; [Menges, Jochen I.] Univ Zurich, Dept Business Adm, Zurich, Switzerland; [Stillwell, David J.] Univ Cambridge, Judge Business Sch, Cambridge, England; [Schwartz, H. Andrew] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA	Columbia University; University of Zurich; University of Cambridge; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Matz, SC (corresponding author), Columbia Univ, Columbia Business Sch, New York, NY 10027 USA.	sm4409@gsb.columbia.edu	Schwartz, H. Andrew/AAE-7276-2021	Matz, Sandra C./0000-0002-0969-4403				Baeza-Yates R, 2016, PROCEEDINGS OF THE 2016 ACM WEB SCIENCE CONFERENCE (WEBSCI'16), P1, DOI 10.1145/2908131.2908135; Berg T., 2018, RISE FINTECHS CREDIT; Berthon PR, 2012, BUS HORIZONS, V55, P261, DOI 10.1016/j.bushor.2012.01.007; Blau FD, 2007, ACAD MANAGE PERSPECT, V21, P7, DOI 10.5465/AMP.2007.24286161; Caskey J.P., 1994, FRINGE BANKING CHECK; CPC Strategy, 2016, GET MOST OUT GOOGL A; Darity WA, 1998, J ECON PERSPECT, V12, P63, DOI 10.1257/jep.12.2.63; Davidson Paul, 2017, US TODAY; DeCenzo DA, 2010, HUMAN RESOURCE MANAG; Deloitte, 2018, 2018 GLOB HUM CAP TR; Eichstaedt JC, 2018, P NATL ACAD SCI USA, V115, P11203, DOI 10.1073/pnas.1802331115; Friedman J, 2001, SPRINGER SERIES STAT, V10; Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475; Golbeck J., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P149, DOI 10.1109/PASSAT/SocialCom.2011.33; GOLUB GH, 1970, NUMER MATH, V14, P403, DOI 10.1007/BF02163027; James G., 2017, INTRO STAT LEARNING; Kosinski M, 2015, AM PSYCHOL, V70, P543, DOI 10.1037/a0039210; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; Kotler P.T., 2020, PRINCIPLES MARKETING, V18th; Kraus MW, 2009, PSYCHOL SCI, V20, P99, DOI 10.1111/j.1467-9280.2008.02251.x; Lax J, 2007, LABOR LAW J, V58, P47; Magee JC, 2007, PERS SOC PSYCHOL B, V33, P200, DOI 10.1177/0146167206294413; Marcus B, 2006, J PERS SOC PSYCHOL, V90, P1014, DOI 10.1037/0022-3514.90.6.1014; Myers D., 2013, SOC PSYCHOL-GERMANY; Noyes D., 2017, TOP 20 VALUABLE FACE; Park G, 2015, J PERS SOC PSYCHOL, V108, P934, DOI 10.1037/pspp0000020; Pennebaker JW, 2003, J PERS SOC PSYCHOL, V85, P291, DOI 10.1037/0022-3514.85.2.291; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; Preotiuc-Pietro D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138717; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Salm L., 2017, 70 EMPLOYERS ARE SNO; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Segalin C, 2017, IEEE T AFFECT COMPUT, V8, P268, DOI 10.1109/TAFFC.2016.2516994; Statista, 2018, NUMB FAC US AG US JA NUMB FAC US AG US JA; Timm J., 2014, BOSS SAYS DONT TELL; Wang H, J PERS SOC PSYCHOL; Youyou W, 2014, P NATL ACAD SCI USA, V112, DOI [10.1073/pnas.1417910112, DOI 10.1073/PNAS.1417910112]; Zarsky T, 2016, SCI TECHNOL HUM VAL, V41, P118, DOI 10.1177/0162243915605575	38	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214369	10.1371/journal.pone.0214369	http://dx.doi.org/10.1371/journal.pone.0214369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921389	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000059
J	Poteet, E; Liu, DL; Liang, ZD; Van Buren, G; Chen, CY; Yao, QZ				Poteet, Ethan; Liu, Dongliang; Liang, Zhengdong; Van Buren, George; Chen, Changyi; Yao, Qizhi			Mesothelin and TGF-alpha predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR INHIBITORS; MESENCHYMAL TRANSITION; PHASE-III; ANTITUMOR-ACTIVITY; GEFITINIB ZD1839; LUNG; GEMCITABINE; IRESSA; ERLOTINIB	Clinical trials of EGFR inhibitors in combination with gemcitabine for the treatment of pancreatic ductal adenocarcinoma (PDAC) have generated mixed results partially due to the poorly defined effectiveness of EGFR inhibitors in PDAC. Here, we studied a panel of PDAC cell lines to compare the IC50s of the EGFR inhibitors gefitinib and cetuximab. We found that gefitinib induced biphasic inhibition in over 50% of PDAC cells, with the initial growth inhibition occurring at nanomolar concentrations and a second growth inhibition occurring outside the clinical range. In contrast to gefitinib, cetuximab produced a single phase growth inhibition in a subset of PDAC cells. Using this sensitivity data, we screened for correlations between cell morphology proteins and EGFR ligands to EGFR inhibitor sensitivity, and found that mesothelin and the EGFR ligand TGF-alpha have a strong correlation to gefitinib and cetuximab sensitivity. Analysis of downstream signaling pathways indicated that plc-gamma 1 and c-myc were consistently inhibited by EGFR inhibitor treatment in sensitive cell lines. While an inconsistent additive effect was observed with either cetuximab or gefitinib in combination with gemcitabine, the cell pathway data indicated consistent ERK activation, leading us to pursue EGFR inhibitors in combination with trametinib, a MEK1/2 inhibitor. Both cetuximab and gefitinib in combination with trametinib produced an additive effect in all EGFR sensitive cell lines. Our results indicate that mesothelin and TGF-alpha can predict PDAC sensitivity to EGFR inhibitors and a combination of EGFR inhibitors with trametinib could be a novel effective treatment for PDAC.	[Poteet, Ethan; Liu, Dongliang; Liang, Zhengdong; Van Buren, George; Chen, Changyi; Yao, Qizhi] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Surg Res, Houston, TX 77030 USA; [Yao, Qizhi] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Yao, QZ (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Div Surg Res, Houston, TX 77030 USA.; Yao, QZ (corresponding author), Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA.	qizhiyao@bcm.edu	Liu, Dongliang/AAP-6335-2021; Liu, Dongliang/AAM-9595-2021	Liu, Dongliang/0000-0001-5843-5451; Liu, Dongliang/0000-0001-5843-5451; Yao, Cathy/0000-0002-2267-0588	Michael E. DeBakey Department of Surgery Faculty Research Seed Grant from BCM; Dan Duncan Cancer Center Seed Fund from BCM; NIH [P30 AI036211, P30 CA125123, S10 RR024574, R01 CA183984]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NATIONAL CANCER INSTITUTE [R01CA183984, P30CA125123] Funding Source: NIH RePORTER	Michael E. DeBakey Department of Surgery Faculty Research Seed Grant from BCM; Dan Duncan Cancer Center Seed Fund from BCM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytometry and Cell Sorting Core at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was partially supported by Michael E. DeBakey Department of Surgery Faculty Research Seed Grant from BCM (PI: Poteet), Dan Duncan Cancer Center Seed Fund from BCM and NIH R01 CA183984 (PI: Yao). We gratefully acknowledge support from the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123, and S10 RR024574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2005, MOL CANCER THER, V4, P1943, DOI 10.1158/1535-7163.MCT-05-0065; Argani P, 2001, CLIN CANCER RES, V7, P3862; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bharadwaj U, 2016, ONCOTARGET, V7, P26307, DOI 10.18632/oncotarget.8368; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Chang AY, 2013, ANTI-CANCER DRUG, V24, P251, DOI 10.1097/CAD.0b013e32835ba289; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Ciardiello F, 2000, CLIN CANCER RES, V6, P2053; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; De Cesare M, 2014, CLIN CANCER RES, V20, P995, DOI 10.1158/1078-0432.CCR-13-1684; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Diep CH, 2011, CLIN CANCER RES, V17, P2744, DOI 10.1158/1078-0432.CCR-10-2214; Doody JF, 2007, MOL CANCER THER, V6, P2642, DOI 10.1158/1535-7163.MCT-06-0506; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Hayes TK, 2016, CANCER CELL, V29, P75, DOI 10.1016/j.ccell.2015.11.011; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Hotz B, 2012, GASTRIC CANCER, V15, P252, DOI 10.1007/s10120-011-0102-9; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; Ko AH, 2016, CLIN CANCER RES, V22, P61, DOI 10.1158/1078-0432.CCR-15-0979; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Liston DR, 2017, CLIN CANCER RES, V23, P3489, DOI 10.1158/1078-0432.CCR-16-3083; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Miyabayashi K, 2013, CANCER RES, V73, P2221, DOI 10.1158/0008-5472.CAN-12-1453; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Morgan MA, 2008, CLIN CANCER RES, V14, P5142, DOI 10.1158/1078-0432.CCR-07-4072; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ono M, 2004, MOL CANCER THER, V3, P465; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Pino MS, 2006, CANCER RES, V66, P3802, DOI 10.1158/0008-5472.CAN-05-3753; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; RAN W, 1986, P NATL ACAD SCI USA, V83, P8216, DOI 10.1073/pnas.83.21.8216; Rao TD, 2017, ACS CHEM BIOL, V12, P2085, DOI 10.1021/acschembio.7b00305; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sinn M, 2017, J CLIN ONCOL, V35, P3330, DOI 10.1200/JCO.2017.72.6463; Todorova MG, 2009, CELL SIGNAL, V21, P523, DOI 10.1016/j.cellsig.2008.12.005; Wakeling AE, 2002, CANCER RES, V62, P5749; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Zhang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068303	45	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213294	10.1371/journal.pone.0213294	http://dx.doi.org/10.1371/journal.pone.0213294			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921351	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000015
J	Veronese, N; Stubbs, B; Koyanagi, A; Vaona, A; Demurtas, J; Schofield, P; Maggi, S				Veronese, Nicola; Stubbs, Brendon; Koyanagi, Ai; Vaona, Alberto; Demurtas, Jacopo; Schofield, Patricia; Maggi, Stefania			Mitochondrial genetic haplogroups and cardiovascular diseases: Data from the Osteoarthritis Initiative	PLOS ONE			English	Article							MTDNA VARIATION; DNA; SUSCEPTIBILITY; LONGEVITY	Background Some case-control studies reported that mitochondrial haplogroups could be associated with the onset of cardiovascular diseases (CVD), but the literature regarding this topic is limited. We aimed to investigate whether any mitochondrial haplogroup carried a higher or lower risk of CVD in a large cohort of North American people affected by knee osteoarthritis or at high risk for this condition. Materials and methods A longitudinal cohort study including individuals from the Osteoarthritis Initiative was done. Haplogroups were assigned through a combination of sequencing and PCR-RFLP techniques. All the mitochondrial haplogroups have been named following this nomenclature: HV, JT, UK, IWX, and superHV/others. The strength of the association between mitochondrial haplogroups and incident CVD was evaluated through a Cox's regression analysis, adjusted for potential confounders, and reported as hazard ratios (HRs) with their 95% confidence intervals (CIs). Results Overall, 3,288 Caucasian participants (56.8% women) with a mean age of 61.3 +/- 9.2 years without CVD at baseline were included. During a median follow-up of 8 years, 322 individuals (= 9.8% of baseline population) developed a CVD. After adjusting for 11 potential confounders at baseline and taking those with the HV haplotype as reference (the most frequent), those with JT carried a significant lower risk of CVD (HR = 0.75; 95%CI: 0.54-0.96; p = 0.03). Participants with the J haplogroup had the lowest risk of CVD (HR = 0.71; 95%CI: 0.46-0.95; p = 0.02). Conclusions The presence of JT haplogroups (particularly J) may be associated with a reduced risk of CVD. However, this result was not based on a high level of statistical significance. Thus, future research with larger sample size is needed to assess whether our results can be corroborated.	[Veronese, Nicola; Maggi, Stefania] CNR, Neurosci Inst, Aging Branch, Padua, Italy; [Veronese, Nicola; Maggi, Stefania] S De Bellis Res Hosp, Natl Inst Gastroenterol, Castellana Grotte, Ba, Italy; [Stubbs, Brendon] South London & Maudsley NHS Fdn Trust, Denmark Hill, London, England; [Koyanagi, Ai] Fundacio St Joan de Deu, Res & Dev Unit, Parc Sanitari St Joan de Deu, CIBERSAM, Barcelona, Spain; [Vaona, Alberto] Azienda ULSS20 Verona, Primary Care Dept, Verona, Italy; [Demurtas, Jacopo] Azienda USL Toscana Sud Est, Primary Care Dept, Grosseto, Italy; [Schofield, Patricia] Anglia Ruskin Univ, Fac Hlth Social Care & Educ, Chelmsford, England	Consiglio Nazionale delle Ricerche (CNR); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Anglia Ruskin University	Veronese, N (corresponding author), CNR, Neurosci Inst, Aging Branch, Padua, Italy.; Veronese, N (corresponding author), S De Bellis Res Hosp, Natl Inst Gastroenterol, Castellana Grotte, Ba, Italy.	ilmannato@gmail.com	Stubbs, Brendon/X-1904-2018; Koyanagi, Ai/D-3833-2018; Schofield, Patricia/U-8534-2019; Veronese, Nicola/K-4343-2018; Demurtas, Jacopo/AAA-8814-2019	Stubbs, Brendon/0000-0001-7387-3791; Koyanagi, Ai/0000-0002-9565-5004; Veronese, Nicola/0000-0002-9328-289X; Demurtas, Jacopo/0000-0003-3001-8546	Miguel Servet contract [CP13/00150, PI15/00862]; ISCIII - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER); National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]; Merck Research Laboratories; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Pfizer, Inc.	Miguel Servet contract; ISCIII - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER); National Institutes of Health, a branch of the Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Novartis Pharmaceuticals Corporation(Novartis); GlaxoSmithKline(GlaxoSmithKline); Pfizer, Inc.(Pfizer)	Ai Koyanagi's work was supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII -General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER). The OAI is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J AFR; Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809; Cai XY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006423; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010; Fernandez-Caggiano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044128; Fernandez-Moreno M, 2016, ANN RHEUMATIC DIS; Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029; Gallardo ME, 2012, EUR HEART J, V33, P346, DOI 10.1093/eurheartj/ehr280; Golubenko MV, 2015, MOL BIOL+, V49, P867, DOI 10.1134/S0026893315050088; Hagen CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071904, 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201]; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Krzywanski DM, 2011, LAB INVEST, V91, P1122, DOI 10.1038/labinvest.2011.95; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Lemieux H, 2009, J BIOENERG BIOMEMBR, V41, P99, DOI 10.1007/s10863-009-9211-0; Luchini C, 2016, GENE CHROMOSOME CANC, V55, P741, DOI 10.1002/gcc.22381; Mafficini A, 2016, ONCOTARGET, V7, P1076, DOI 10.18632/oncotarget.6834; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Meschia JF, 2010, LANCET NEUROL, V9, P453, DOI 10.1016/S1474-4422(10)70092-2; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; MITOMAP, 2017, MITOMAP HUM MIT GEN; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Pant S, 2014, J CARDIOVASC PHARM T, V19, P170, DOI 10.1177/1074248413504994; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rego-Perez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Torroni A, 1996, GENETICS, V144, P1835; Tranah GJ, 2011, MITOCHONDRION, V11, P855, DOI 10.1016/j.mito.2011.04.005; Venter M, 2017, J GENET GENOMICS, V44, P139, DOI 10.1016/j.jgg.2016.12.003; Veronese N, 2018, J NUTR HEALTH AGING, V22, P371, DOI 10.1007/s12603-017-0941-0; Veronese N, 2018, REJUV RES, V21, P15, DOI 10.1089/rej.2017.1917; Veronese N, 2017, J AFFECT DISORDERS, V217, P55, DOI 10.1016/j.jad.2017.03.069; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wang YW, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00232; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9	38	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213656	10.1371/journal.pone.0213656	http://dx.doi.org/10.1371/journal.pone.0213656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921349	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000462594000021
J	Zito, P; Labbozzetta, M; Notarbartolo, M; Sajeva, M; Poma, P				Zito, Pietro; Labbozzetta, Manuela; Notarbartolo, Monica; Sajeva, Maurizio; Poma, Paola			Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells	PLOS ONE			English	Article							DRUG EFFLUX TRANSPORTERS; CASSETTE ABC FAMILY; MULTIDRUG-RESISTANCE; MEDICINAL-PLANTS; CURCUMIN	The genus Cyphostemma (Planch.) Alston (Vitaceae) includes about 150 species distributed in eastern and southern Africa and Madagascar. Some species are used in traditional medicine and their biological activities, including antiproliferative effects against cancer cell lines, have been demonstrated. To date no investigations on Cyphostemma essential oils have been carried out. Essential oils, which play important roles in plant defenses have been demonstrated to be active in the treatment of several human diseases and to enhance bioavability of other drugs. The aim of this paper was to identify the chemical composition of the essential oil of the leaves of Cyphostemma juttae (Dinter & Gilg) Desc. and to verify some biological activities on two triple negative breast cancer cell lines (MDA-MB-231, SUM 149), characterized by the over-expression of the transcription factor NF-kappa B. In the essential oil, obtained by hydrodistillation and analysed by gas chromatography-mass spectrometry, 39 compounds were detected and with phytol (30%) dominating the chemical composition. C. juttae essential oil reduced cell growth and showed a pro-oxidant activity in both cell lines. Moreover, C. juttae essential oil caused a substantial decrease of NF-kappa B activation and consequently a significant reduction of some NF-kappa B target genes. The present study shows for the first time the cytotoxic properties of C. juttae essential oil and highlight its availability to interfere with NF-kappa B pathway, suggesting a potential therapeutic use in triple negative breast cancers (TNBCs) of this essential oil.	[Zito, Pietro; Labbozzetta, Manuela; Notarbartolo, Monica; Sajeva, Maurizio; Poma, Paola] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy	University of Palermo	Notarbartolo, M; Sajeva, M (corresponding author), Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy.	monica.notarbartolo@unipa.it; maurizio.sajeva@unipa.it	Poma, Paola/AAE-5325-2022; Notarbartolo di Villarosa, Monica/AAE-5324-2022; Labbozzetta, Manuela/AAE-5418-2022; Sajeva, Maurizio/N-7544-2014; Zito, Pietro/N-7527-2014	Sajeva, Maurizio/0000-0003-4731-7112; Zito, Pietro/0000-0002-6188-5434	University of Palermo	University of Palermo	The research was done with the basic funds of University of Palermo (funders) devoted to independent and free research. The authors are employees of the University and their salaries are paid only by the University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Boichuk S, 2017, ONCOL LETT, V14, P5039, DOI 10.3892/ol.2017.6795; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cao SG, 2011, CHEM BIODIVERS, V8, P643, DOI 10.1002/cbdv.201000061; Chen ZL, 2016, CANCER LETT, V370, P153, DOI 10.1016/j.canlet.2015.10.010; Craven P, 2004, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2004.RLTS.T46838A11084910.EN; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; El-Sayed A. M, PHEROBASE DATABASE I; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Islam MT, 2018, FOOD CHEM TOXICOL, V121, P82, DOI 10.1016/j.fct.2018.08.032; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Labbozzetta M, 2009, ANN NY ACAD SCI, V1155, P278, DOI 10.1111/j.1749-6632.2009.03699.x; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Notarbartolo M, 2005, CANCER LETT, V224, P53, DOI 10.1016/j.canlet.2004.10.051; Ochwang'i DO, 2014, J ETHNOPHARMACOL, V151, P1040, DOI 10.1016/j.jep.2013.11.051; Opoku AR, 2000, PHYTOTHER RES, V14, P534, DOI 10.1002/1099-1573(200011)14:7&lt;534::AID-PTR661&gt;3.0.CO;2-A; Poma P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196947; Poma P, 2017, OMICS, V21, P225, DOI 10.1089/omi.2017.0020; Sajeva M, 2000, SUCCULENTS; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Song Y., 2015, BIOCH ANAL BIOCH, V4, P211; Teklehaymanot T, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-12; Tholl D, 2015, ADV BIOCH ENG BIOTEC, V148; Udegbunam R. I., 2013, African Journal of Biotechnology, V12, P2288; Xie YQ, 2010, MOL PHARMACOL, V78, P310, DOI 10.1124/mol.109.061713	27	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214594	10.1371/journal.pone.0214594	http://dx.doi.org/10.1371/journal.pone.0214594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921428	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000093
J	De Bortoli, D; da Costa, N; Goulart, M; Campara, J				De Bortoli, Daiane; da Costa, Newton, Jr.; Goulart, Marco; Campara, Jssica			Personality traits and investor profile analysis: A behavioral finance study	PLOS ONE			English	Article							RISK; DECISION; TOLERANCE	This study investigates which of four paradigms best portrays the risk profile manifest by investors in their financial asset investment decisions. The paradigms used to explain this profile were: prospect theory, investor profile analysis (IPA), the Big Five Personality Test, and the Cognitive Reflection Test (CRT). The choice of proxy for the risk preferences (profile) of a typical investor was defined by simulating investments in a laboratory setting. The results are analyzed using ordered logistic regression and show that people who have greater risk tolerance according to IPA, who violate prospect theory, and who have a high degree of openness to experience have the greatest probability of taking higher levels of risk in their investment decisions. With regard to the CRT, higher numbers of correct responses in this test has an inverse relationship with risk taking.	[De Bortoli, Daiane] Univ Fed Santa Catarina, Dept Econ, Florianopolis, SC, Brazil; [da Costa, Newton, Jr.] Pontificia Univ Catolica Parana, Business Sch, Curitiba, PR, Brazil; [da Costa, Newton, Jr.; Campara, Jssica] Univ Fed Santa Catarina, Dept Business Adm, Florianopolis, SC, Brazil; [Goulart, Marco] Santa Catarina State Univ, Dept Business Adm, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Pontificia Universidade Catolica do Parana; Universidade Federal de Santa Catarina (UFSC); Universidade do Estado de Santa Catarina	da Costa, N (corresponding author), Pontificia Univ Catolica Parana, Business Sch, Curitiba, PR, Brazil.; da Costa, N (corresponding author), Univ Fed Santa Catarina, Dept Business Adm, Florianopolis, SC, Brazil.	newton.costa@pucpr.br	Goulart, Marco/HIK-2688-2022; da Costa Jr., Newton C. A./AAZ-4155-2020	Goulart, Marco/0000-0002-8705-1446; da Costa Jr., Newton C. A./0000-0001-7723-2676	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306331/2014-4]; Capes	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number 306331/2014-4 to NdC, and by Capes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Associac Brasileira das Entidades dos Mercados Financeiros e de Capitais, 2014, COD ANBIMA REG MELH; Baddeley M, 2010, CAMBRIDGE WORKING PA, V1006; Belcher LJ, 2010, J BEHAV FINANC, V11, P239, DOI 10.1080/15427560.2010.527412; Borghans L, 2008, J HUM RESOUR, V43, P972; Brasileira das Entidades dos Mercados Financeiros e de Capitais (ANBIMA), 2015, RANK; Brown S, 2011, DISCUSSION PAPER SER, P6191; Cameron C, 2005, MICROECONOMETRICS ME; Charness G, 2013, J ECON BEHAV ORGAN, V87, P43, DOI 10.1016/j.jebo.2012.12.023; Christelis D, 2010, EUR ECON REV, V54, P18, DOI 10.1016/j.euroecorev.2009.04.001; Corter JE, 2006, J BUS PSYCHOL, V20, P369, DOI 10.1007/s10869-005-9010-5; De Valores (IOSCO), 2013, PRINCFIN BENCHM; DeYoung CG, 2012, J RES PERS, V46, P63, DOI 10.1016/j.jrp.2011.12.003; Di Girolamo A, 2015, J BEHAV EXP ECON, V59, P1, DOI 10.1016/j.socec.2015.08.004; Dl Friedman Cassar A., 2004, EC LAB INTENSIVE COU; Dohmen T, 2010, AM ECON REV, V100, P1238, DOI 10.1257/aer.100.3.1238; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Filbeck G., 2005, J BEHAV FINANC, V6, P170, DOI [10.1207/s15427579jpfm0604_1, DOI 10.1207/S15427579JPFM0604_1]; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Goulart M, 2015, J ECON BEHAV ORGAN, V116, P310, DOI 10.1016/j.jebo.2015.04.014; Goulart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054542; Greene W.H., 2012, ECONOMETRIC ANAL; Jain R., 2015, IUP J MANAGEMENT RES, V14, P7; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lubinski D, 1997, INTELLIGENCE, V24, P159, DOI 10.1016/S0160-2896(97)90016-7; Mandal B, 2014, ECONOMICA, V81, P522, DOI 10.1111/ecca.12088; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mayfield C., 2008, FINANCIAL SERVICES R, V17, P219, DOI DOI 10.2307/2392984; Mooreland J., 2011, IRRATIONAL INVESTORS; Nicholson N, 2002, WORKING PAPER; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rustichini A., 2012, I STUDY LABOR, V6750, P1; Rzeszutek M, 2015, CONTEMP ECON, V9, P337, DOI 10.5709/ce.1897-9254.173; Shefrin H, 2015, RAE-REV ADMIN EMPRES, V55, P95, DOI 10.1590/S0034-759020150109; Sreedevi R, 2011, J BEHAV FINANC, V8, P47; Thaler RH., 2021, NUDGE FINAL EDITION; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Weber M, 1998, J ECON BEHAV ORGAN, V33, P167, DOI 10.1016/S0167-2681(97)00089-9	38	19	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214062	10.1371/journal.pone.0214062	http://dx.doi.org/10.1371/journal.pone.0214062			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917175	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800049
J	del Cerro, P; Megias, M; Lopez-Baena, FJ; Gil-Serrano, A; Perez-Montano, F; Ollero, FJ				del Cerro, Pablo; Megias, Manuel; Javier Lopez-Baena, Francisco; Gil-Serrano, Antonio; Perez-Montano, Francisco; Javier Ollero, Francisco			Osmotic stress activates nif and fix genes and induces the Rhizobium tropici CIAT 899 Nod factor production via NodD2 by up-regulation of the nodA2 operon and the nodA3 gene	PLOS ONE			English	Article							NODULATION FACTORS; READ ALIGNMENT; PHASEOLUS; SYMBIOSIS; INDUCTION; TREHALOSE; DISCOVERY; EFFICIENT; PROTEINS; BACTERIA	The symbiosis between rhizobia and legumes is characterized by a complex molecular dialogue in which the bacterial NodD protein plays a major role due to its capacity to activate the expression of the nodulation genes in the presence of appropiate flavonoids. These genes are involved in the synthesis of molecules, the nodulation factors (NF), responsible for launching the nodulation process. Rhizobium tropici CIAT 899, a rhizobial strain that nodulates Phaseolus vulgaris, is characterized by its tolerance to multiple environmental stresses such as high temperatures, acidity or elevated osmolarity. This strain produces nodulation factors under saline stress and the same set of CIAT 899 nodulation genes activated by inducing flavonoids are also up-regulated in a process controlled by the NodD2 protein. In this paper, we have studied the effect of osmotic stress (high mannitol concentrations) on the R. tropici CIAT 899 transcriptomic response. In the same manner as with saline stress, the osmotic stress mediated NF production and export was controlled directly by NodD2. In contrast to previous reports, the nodA2FE operon and the nodA3 and nodD1 genes were up-regulated with mannitol, which correlated with an increase in the production of biologically active NF. Interestingly, in these conditions, this regulatory protein controlled not only the expression of nodulation genes but also the expression of other genes involved in protein folding and synthesis, motility, synthesis of polysaccharides and, surprinsingly, nitrogen fixation. Moreover, the non-metabolizable sugar dulcitol was also able to induce the NF production and the activation of nod genes in CIAT 899.	[del Cerro, Pablo; Megias, Manuel; Javier Lopez-Baena, Francisco; Perez-Montano, Francisco; Javier Ollero, Francisco] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Gil-Serrano, Antonio] Univ Seville, Fac Quim, Dept Quim Organ, Seville, Spain	University of Sevilla; University of Sevilla	Ollero, FJ (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	fjom@us.es	Pérez-Montaño, Francisco/K-8971-2014; del Cerro Sánhez, Pablo PdC/H-7198-2016; del Cerro Sánchez, Pablo/ABG-1194-2020; Lopez Baena, Francisco Javier/L-4670-2014; Ollero Marquez, Francisco Javier/G-3271-2015	Pérez-Montaño, Francisco/0000-0002-6272-2063; del Cerro Sánhez, Pablo PdC/0000-0002-8030-7226; del Cerro Sánchez, Pablo/0000-0002-8030-7226; Lopez Baena, Francisco Javier/0000-0001-7799-0338; Ollero Marquez, Francisco Javier/0000-0002-3641-7946	Ministerio de Economia y Competitividad [AGL2016-77163-R]; Ministerio de Educacion, Cultura y Deporte [FPU14-00160]; Spanish Ministerio de Economia y Competitividad (MINECO) [AGL2016-77163-R]; FPU fellowship of the Ministerio de Economia y Competitividad (MINECO) [FPU14/00160]	Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Educacion, Cultura y Deporte(Spanish Government); Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); FPU fellowship of the Ministerio de Economia y Competitividad (MINECO)	PdC, MM, AMGS, FJO were supported by Ministerio de Economia y Competitividad, grant reference: AGL2016-77163-R. http://www.ciencia.gob.es/portal/site/MICINN/. PdC was supported by Ministerio de Educacion, Cultura y Deporte, grant reference: FPU14-00160. https://www.mecd.gob.es/portada-mecd/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded with project AGL2016-77163-R from the Spanish Ministerio de Economia y Competitividad (MINECO). Mr. Del Cerro is recipient of an FPU fellowship (FPU14/00160) of the Ministerio de Economia y Competitividad (MINECO). We would like to thank the Servicio de Espectrometria de Masas, Servicio de Resonancia Magnetica Nuclear and Servicio de Biologia of the Centro de Investigacion Tecnologia e Innovaccion (CITIUS) of the University of Seville for technical support.	Alexandre A, 2014, DNA RES, V21, P195, DOI 10.1093/dnares/dst050; Alexandre A, 2011, FEMS MICROBIOL ECOL, V75, P28, DOI 10.1111/j.1574-6941.2010.00993.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BALDANI VLD, 1980, SOIL BIOL BIOCHEM, V12, P433, DOI 10.1016/0038-0717(80)90021-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Boboye B, 2004, J APPL MICROBIOL, V97, P256, DOI 10.1111/j.1365-2672.2004.02194.x; BREEDVELD MW, 1991, ARCH MICROBIOL, V156, P501, DOI 10.1007/BF00245399; BUENDIACLAVERIA AM, 1986, J APPL BACTERIOL, V61, P1, DOI 10.1111/j.1365-2672.1986.tb03752.x; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; del Cerro P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46712; del Cerro P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154029; del Cerro P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2033-z; del Cerro P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1458-8; DEMAAGD RA, 1988, J BACTERIOL, V170, P4424, DOI 10.1128/jb.170.9.4424-4427.1988; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Estevez J, 2009, FEMS MICROBIOL LETT, V293, P220, DOI 10.1111/j.1574-6968.2009.01540.x; Fernandez-Aunion C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-192; Guasch-Vidal B, 2013, MOL PLANT MICROBE IN, V26, P451, DOI 10.1094/MPMI-09-12-0213-R; Hungria M, 2000, SOIL BIOL BIOCHEM, V32, P1515, DOI 10.1016/S0038-0717(00)00063-8; Hungria M, 2010, PLANT SOIL, V331, P413, DOI 10.1007/s11104-009-0262-0; Jimenez-Guerrero I, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010001; Kelly S, 2018, ENVIRON MICROBIOL, V20, P97, DOI 10.1111/1462-2920.14006; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lamrabet Y, 1999, MOL PLANT MICROBE IN, V12, P207, DOI 10.1094/MPMI.1999.12.3.207; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LopezLara IM, 1995, PLANT MOL BIOL, V29, P465, DOI 10.1007/BF00020978; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARTINEZROMERO E, 1991, INT J SYST BACTERIOL, V41, P417, DOI 10.1099/00207713-41-3-417; Moron B, 2005, CHEM BIOL, V12, P1029, DOI 10.1016/j.chembiol.2005.06.014; Nogales J, 2002, MOL PLANT MICROBE IN, V15, P225, DOI 10.1094/MPMI.2002.15.3.225; Ormeno-Orrillo E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-735; Perez-Montano F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2543-3; Picard F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-588; POUPOT R, 1993, BIOCHEMISTRY-US, V32, P10430, DOI 10.1021/bi00090a019; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SPAINK HP, 1992, MOL PLANT MICROBE IN, V5, P72, DOI 10.1094/MPMI-5-072; SPAINK HP, 1992, PLANT MOL BIOL, V20, P977, DOI 10.1007/BF00027167; TRUCHET G, 1989, PROTOPLASMA, V149, P82, DOI 10.1007/BF01322980; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; Yeh KC, 2002, J BACTERIOL, V184, P525, DOI 10.1128/JB.184.2.525-530.2002; ZAAT SAJ, 1987, J BACTERIOL, V169, P198, DOI 10.1128/jb.169.1.198-204.1987; Zahran H.H., 1999, REV MICROBIOLOGY MOL, V63, P968; Zipfel C, 2017, NATURE, V543, P328, DOI 10.1038/nature22009	48	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213298	10.1371/journal.pone.0213298	http://dx.doi.org/10.1371/journal.pone.0213298			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917160	Green Published, Green Submitted, gold			2022-12-27	WOS:000462465800025
J	Hoyt, KJ; Sarkar, S; White, L; Joseph, NM; Salgame, P; Lakshminarayanan, S; Muthaiah, M; Kumar, SV; Ellner, JJ; Roy, G; Horsburgh, CR; Hochberg, NS				Hoyt, Kacie J.; Sarkar, Sonali; White, Laura; Joseph, Noyal Mariya; Salgame, Padmini; Lakshminarayanan, Subitha; Muthaiah, Muthuraj; Kumar, Saka Vinod; Ellner, Jerrold J.; Roy, Gautam; Horsburgh, C. Robert, Jr.; Hochberg, Natasha S.			Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis	PLOS ONE			English	Article							LUNG-DISEASE; RISK-FACTORS; ADULTS; INFECTION; SEVERITY	Background The relationship between malnutrition and tuberculosis (TB) severity is understudied. We investigated the effect of malnutrition on radiographic findings and mycobacterial burden. Methods Subjects included newly diagnosed, smear-positive, culture-confirmed, pulmonary TB cases enrolled in the Regional Prospective Observational Research for TB (RePORT) cohort. Multivariate regression models were used to evaluate the relationship at start of treatment between body mass index (BMI) and chest radiograph (CXR) findings of cavitation and percentage of lung affected and mycobacterial growth indicator tube (MGIT) time to positive (TTP). Severe malnutrition was defined as BMI< 16 kg/m(2), moderate malnutrition as 16-18.4kg/m(2), and "normal"/overweight as >= 18.5 kg/m(2). Results Of 173 TB cases with chest x-ray data, 131 (76%) were male. The median age was 45 years (range 16-82); 42 (24%) had severe malnutrition and 58 (34%) moderate malnutrition. Median percentage of lung affected was 32% (range 0-95), and 132 (76%) had cavitation. Individuals with severe malnutrition had, on average, 11.1% [95% CI: 4.0-13.3] more lung affected, compared to those with normal BMI, controlling for diabetes and cavitation. In multivariable analyses, cases with severe malnutrition had a 4.6-fold [95% CI, 1.5-14.1] increased odds of cavitation compared to those with normal BMI, controlling for smoking. Median MGIT TTP was 194.5 hours. Neither severe (aRR 0.99; 95% CI, 0.9-1.2) nor moderate (aRR 0.97; 95% CI, 0.8-1.1) malnutrition was associated with MGIT TTP. Conclusion We found that malnutrition was associated with increased extent of disease and cavitation on CXR. These findings may reflect the immunomodulatory effect of malnutrition on pulmonary pathology.	[Hoyt, Kacie J.; Horsburgh, C. Robert, Jr.; Hochberg, Natasha S.] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Sarkar, Sonali; Lakshminarayanan, Subitha; Roy, Gautam] JIPMER, Dept Prevent & Social Med, Pondicherry, India; [White, Laura; Horsburgh, C. Robert, Jr.] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Joseph, Noyal Mariya] JIPMER, Dept Microbiol, Pondicherry, India; [Salgame, Padmini] Rutgers New Jersey Med Sch, Newark, NJ USA; [Muthaiah, Muthuraj] Govt Hosp Chest Dis, Intermediate Reference Lab, Pondicherry, India; [Kumar, Saka Vinod] JIPMER, Dept Pulm Med, Pondicherry, India; [Ellner, Jerrold J.; Horsburgh, C. Robert, Jr.; Hochberg, Natasha S.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA	Boston University; Jawaharlal Institute of Postgraduate Medical Education & Research; Boston University; Jawaharlal Institute of Postgraduate Medical Education & Research; Rutgers State University New Brunswick; Rutgers State University Medical Center; Jawaharlal Institute of Postgraduate Medical Education & Research; Boston University	Hoyt, KJ; Hochberg, NS (corresponding author), Boston Univ, Dept Epidemiol, Boston, MA 02215 USA.; Hochberg, NS (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.	khoyt@bu.edu; nhoch@bu.edu	Sarkar, Sonali/AAU-8993-2020; Joseph, Noyal Mariya/AAW-2061-2020; Lakshminarayanan, Subitha/AAV-3661-2020	Joseph, Noyal Mariya/0000-0001-6586-2742; Lakshminarayanan, Subitha/0000-0002-1205-5741; Hochberg, Natasha/0000-0002-5449-9973; Hoyt, Kacie/0000-0002-3841-8432; Sarkar, Sonali/0000-0003-0528-6805	US Civilian Research & Development Foundation [USB1-31150-XX-13]; National Science Foundation [OISE-9531011]; Government of India's Department of Biotechnology; Indian Council of Medical Research; United States National Institutes of Health; National Institute of Allergy and Infectious Diseases; Office of AIDS Research; US Civilian Research & Development Foundation Global	US Civilian Research & Development Foundation; National Science Foundation(National Science Foundation (NSF)); Government of India's Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Civilian Research & Development Foundation Global	This work was supported by US Civilian Research & Development Foundation [Award Number USB1-31150-XX-13]; and National Science Foundation [Cooperative Agreement No. OISE-9531011]. This project was funded in whole or in part with Federal funds from the Government of India's Department of Biotechnology; the Indian Council of Medical Research; the United States National Institutes of Health; National Institute of Allergy and Infectious Diseases; Office of AIDS Research; and distributed in part by US Civilian Research & Development Foundation Global (award to JJE and GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, NUTRITION, V19, P265, DOI 10.1016/S0899-9007(02)00854-7; Al-Tawfiq JA, 2009, INT J TUBERC LUNG D, V13, P367; [Anonymous], 2018, BMI CLASSIFICATION; Bhargava A, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5407; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dhanaraj B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124260; Dowdy DW, 2014, CLIN INFECT DIS, V59, P1123, DOI 10.1093/cid/ciu506; Gonzalez-Torres C, 2013, NUTRIENTS, V5, P579, DOI 10.3390/nu5020579; Grobler L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub4; Hochberg NS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183195; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268; Lin HH, 2018, CLIN INFECT DIS, V66, P699, DOI 10.1093/cid/cix852; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; Madebo T, 1997, SCAND J INFECT DIS, V29, P355, DOI 10.3109/00365549709011830; Najera O, 2001, CLIN EXP IMMUNOL, V126, P461, DOI 10.1046/j.1365-2249.2001.01694.x; Paton NI, 2004, AM J CLIN NUTR, V80, P460, DOI 10.1093/ajcn/80.2.460; Perez-Guzman C, 2001, INT J TUBERC LUNG D, V5, P455; Podewils LJ, 2011, EPIDEMIOL INFECT, V139, P113, DOI 10.1017/S0950268810000907; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Sarkar M, 2017, CLIN RESPIR J, V11, P285, DOI 10.1111/crj.12621; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; Villamor E, 2006, EUR J CLIN NUTR, V60, P163, DOI 10.1038/sj.ejcn.1602281; WEAVER RA, 1974, AM REV RESPIR DIS, V109, P162; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9; World Health Organization, 2018, END TB STRAT	31	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214011	10.1371/journal.pone.0214011	http://dx.doi.org/10.1371/journal.pone.0214011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917170	gold, Green Published, Green Submitted			2022-12-27	WOS:000462465800046
J	Jankovic, J; Davidovic, M; Bjegovic-Mikanovic, V; Jankovic, S				Jankovic, Janko; Davidovic, Masa; Bjegovic-Mikanovic, Vesna; Jankovic, Slavenka			Status of cardiovascular health in the Republic of Serbia: Results from the National Health Survey	PLOS ONE			English	Article							COASTAL ECUADOR; DISEASE; PREVALENCE; METRICS; METAANALYSIS; ASSOCIATION; RISK; MEN	Background Cardiovascular diseases (CVD) remain the most significant cause of death in low-and middle- income countries where the burden of CVD continues to rise due to the increasing incidence of CVD. The aim of this study was to assess the prevalence of ideal cardiovascular health (CVH) across sex and age groups and to analyze associations between demographic and socio-economic variables and ideal CVH metrics in the adult population of the Republic of Serbia. Methods Information on demographic (age, sex, marital status, and type of settlement) and socioeconomic characteristics (education, and wealth index), and the 7 ideal CVH metrics (smoking, physical activity, healthy diet, BMI, blood pressure, cholesterol, and glucose) was obtained for 13100 respondents aged 20 years and above, from the 2013 National Health Survey in the Republic of Serbia. According to the American Heart Association, the ideal CVH was defined as the simultaneous presence of 7 ideal CVH metrics. Results Out of all ideal CVH metrics, the most prevalent components were ideal glucose (92.2%), ideal cholesterol (86.4%) and ideal smoking (63%), while the least prevalent ideal CVH component was ideal healthy diet (2.4%). Only 0.1% had all 7 CVH components at the ideal level. According to the multivariable logistic regression analysis the higher number of ideal CVH metrics was observed in women (OR = 4.46), younger people (OR = 7.12), people living without partner (OR = 1.70), more educated (OR = 2.51 for middle educated and OR = 3.57 for high educated), as well as among the rich (OR = 1.43). Conclusion Our findings of existing age-specific, sex and socio-economic differences in the prevalence and number of ideal CVH metrics should serve for the development of appropriate CVD prevention policies tailored to fit specific needs of both sexes, all age groups and people with different socioeconomic status.	[Jankovic, Janko; Davidovic, Masa; Bjegovic-Mikanovic, Vesna] Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia; [Jankovic, Janko; Davidovic, Masa; Bjegovic-Mikanovic, Vesna] Univ Belgrade, Fac Med, Ctr Sch Publ Hlth & Management, Belgrade, Serbia; [Jankovic, Slavenka] Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Jankovic, J (corresponding author), Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia.; Jankovic, J (corresponding author), Univ Belgrade, Fac Med, Ctr Sch Publ Hlth & Management, Belgrade, Serbia.	drjankojankovic@yahoo.com	Bjegovic-Mikanovic, Vesna/AAD-9847-2019	Bjegovic-Mikanovic, Vesna/0000-0002-8299-6555; Jankovic, Janko/0000-0002-2387-6596; Jankovic, Slavenka/0000-0001-6791-3056	Ministry of Health of the Republic of Serbia; Institute of Public Health of Serbia; Ministry of Education, Science and Technological Development of the Republic of Serbia [175025]	Ministry of Health of the Republic of Serbia; Institute of Public Health of Serbia; Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	The 2013 National Health Survey (without data on Kosovo and Metohia) was supported by the Ministry of Health of the Republic of Serbia and the Institute of Public Health of Serbia "Dr. Milan Jovanovic Batut." Funding for this work was obtained by the Ministry of Education, Science and Technological Development of the Republic of Serbia (project No 175025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneni EC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006904; Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Bi YF, 2015, J AM COLL CARDIOL, V65, P1013, DOI 10.1016/j.jacc.2014.12.044; Chang Y, 2016, HEART LUNG CIRC, V25, P982, DOI 10.1016/j.hlc.2016.02.007; Clark H, 2013, LANCET, V381, P510, DOI 10.1016/S0140-6736(13)60058-6; Crichton GE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-253; Del Brutto OH, 2013, ENVIRON HEALTH PREV, V18, P422, DOI 10.1007/s12199-013-0344-8; Del Brutto OH, 2013, J COMMUN HEALTH, V38, P634, DOI 10.1007/s10900-013-9658-0; European Commission Eurostat, 2013, EUR HLTH INT SURV EH; Fang J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005371; Fang N, 2016, INT J CARDIOL, V214, P280, DOI 10.1016/j.ijcard.2016.03.210; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Graciani A, 2013, CIRC-CARDIOVASC QUAL, V6, P90, DOI 10.1161/CIRCOUTCOMES.112.967893; Guo LL, 2017, CLIN CARDIOL, V40, P1339, DOI 10.1002/clc.22836; Gupta B, 2017, GLOB HEART, V12, P219, DOI 10.1016/j.gheart.2014.09.004; Huffman MD, 2014, CURR PROB CARDIOLOGY, V39, P399, DOI 10.1016/j.cpcardiol.2014.05.005; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Institute of Medicine, 2010, PROMOTING CARDIOVASC; Jankovic J, 2010, EUR J PUBLIC HEALTH, V20, P389, DOI 10.1093/eurpub/ckp189; Jankovic S, 2014, INT J PUBLIC HEALTH, V59, P769, DOI 10.1007/s00038-014-0579-1; Johansson J, 1999, AM J PREV MED, V16, P322, DOI 10.1016/S0749-3797(99)00019-7; Kim Ji Young, 2013, J Prev Med Public Health, V46, P319, DOI 10.3961/jpmph.2013.46.6.319; Lee HJ, 2013, KOREAN J FAM MED, V34, P403, DOI 10.4082/kjfm.2013.34.6.403; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Moghaddam MM, 2014, ANN SAUDI MED, V34, P134, DOI 10.5144/0256-4947.2014.134; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Ren J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3632-6; Rutstein S.O., 2004, DHS COMP REPORTS; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; The Indonesian National Health Research Council, 2013, IND BAS HLTH SURV 20; Townsend N, 2015, EUR HEART J, V36, P2696, DOI 10.1093/eurheartj/ehv428; Velasquez-Melendez Gustavo, 2015, Rev. bras. epidemiol., V18, P97, DOI 10.1590/1980-5497201500060009; WHO, 2014, SERB NONC DIS NCD CO; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; World Health Organization, 2017, CARDIOVASCULAR DIS; Wu HY, 2013, INT J CARDIOL, V168, P760, DOI 10.1016/j.ijcard.2012.09.235; Younus A, 2016, MAYO CLIN PROC, V91, P649, DOI 10.1016/j.mayocp.2016.01.019; Zeng Q, 2013, INT J CARDIOL, V167, P2311, DOI 10.1016/j.ijcard.2012.06.022	39	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214505	10.1371/journal.pone.0214505	http://dx.doi.org/10.1371/journal.pone.0214505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917180	Green Published, Green Submitted, gold			2022-12-27	WOS:000462465800069
J	Dong, CJ; Xie, K; Sun, XB; Lyu, MM; Yue, H				Dong, Chunjiao; Xie, Kun; Sun, Xubin; Lyu, Miaomiao; Yue, Hao			Roadway traffic crash prediction using a state-space model based support vector regression approach	PLOS ONE			English	Article							NEGATIVE BINOMIAL REGRESSION; DRIVER INJURY SEVERITY; OPTIMIZED NEURAL-NETWORK; PARAMETERS TOBIT-MODEL; MIXED LOGIT MODEL; FREQUENCY; VEHICLE; MACHINE; SAFETY; TIME	Conventional traffic crash analyzing methods focus on identifying the relationship between traffic crash outcomes and impact risk factors and explaining the effects of risk factors, which ignore the changes of roadway systems and can lead to inaccurate results in traffic crash predictions. To address this issue, an innovative two-step method is proposed and a support vector regression (SVR) model is formulated into state-space model (SSM) framework for traffic crash prediction. The SSM was developed in the first step to identify the dynamic evolution process of the roadway systems that are caused by the changes of traffic flow and predict the changes of impact factors in roadway systems. Using the predicted impact factors, the SVR model was incorporated in the second step to perform the traffic crash prediction. A five-year dataset that obtained from 1152 roadway segments in Tennessee was employed to validate the model effectiveness. The proposed models result in an average prediction MAPE of 7.59%, a MAE of 0.11, and a RMSD of 0.32. For the performance comparison, a SVR model and a multivariate negative binomial (MVNB) model were developed to do the same task. The results show that the proposed model has superior performances in terms of prediction accuracy compared to the SVR and MVNB models. Compared to the SVR and MVNB models, the benefit of incorporating a state-space model to identify the changes of roadway systems is significant evident in the proposed models for all crash types, and the prediction accuracy that measured by MAPE can be improved by 4.360% and 6.445% on average, respectively. Apart from accuracy improvement, the proposed models are more robust and the predictions can retain a smoother pattern. Furthermore, the results show that the proposed model has a more precise and synchronized response behavior to the high variations of the observed data, especially for the phenomenon of extra zeros.	[Dong, Chunjiao; Yue, Hao] Beijing Jiaotong Univ, Minist Transport, Key Lab Transport Ind Big Data Applicat Technol C, Beijing, Peoples R China; [Xie, Kun] Beijing Jiaotong Univ, Sch Traff & Transportat, Natl Demonstrat Ctr Expt Traff & Transportat Educ, Beijing, Peoples R China; [Sun, Xubin] Beijing Jiaotong Univ, Sch Elect & Informat Engn, Beijing, Peoples R China; [Lyu, Miaomiao] Southwest Jiaotong Univ, Sch Transportat & Logist, Chengdu, Sichuan, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; Beijing Jiaotong University; Southwest Jiaotong University	Xie, K (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Natl Demonstrat Ctr Expt Traff & Transportat Educ, Beijing, Peoples R China.	XIEKUN@BJTU.EDU.CN		Dong, Cheng-Di/0000-0002-4758-3739	National Natural Science Foundation of China [71621001, 71210001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The funding was provided by the National Natural Science Foundation of China (No. 71621001 and 71210001). The funders provided the funding to support the research.	Abdel-Aty M, 2011, ACCIDENT ANAL PREV, V43, P461, DOI 10.1016/j.aap.2010.10.002; Abdelwahab HT, 2002, TRANSPORT RES REC, P115, DOI 10.3141/1784-15; Akin D, 2010, SCI RES ESSAYS, V5, P2837; Anastasopoulos PC, 2009, ACCIDENT ANAL PREV, V41, P153, DOI 10.1016/j.aap.2008.10.005; Campbell C, 2002, NEUROCOMPUTING, V48, P63, DOI 10.1016/S0925-2312(01)00643-9; Chang LY, 2013, SAFETY SCI, V51, P17, DOI 10.1016/j.ssci.2012.06.017; Chang LY, 2005, SAFETY SCI, V43, P541, DOI 10.1016/j.ssci.2005.04.004; Chen C, 2016, ACCIDENT ANAL PREV, V90, P128, DOI 10.1016/j.aap.2016.02.011; Chen K, 2014, APPL ENERG, V113, P690, DOI 10.1016/j.apenergy.2013.08.025; Chiou YC, 2013, ACCIDENT ANAL PREV, V50, P73, DOI 10.1016/j.aap.2012.03.030; Cristianini N., 2000, INTRO SUPPORT VECTOR; Daniels S, 2010, ACCIDENT ANAL PREV, V42, P393, DOI 10.1016/j.aap.2009.08.019; Dong C, 2014, J TRANSPORTATION ENG, V140, P1; Dong CJ, 2014, SAFETY SCI, V70, P63, DOI 10.1016/j.ssci.2014.05.006; Dong CJ, 2014, TRANSPORT RES C-EMER, V43, P20, DOI 10.1016/j.trc.2014.02.014; Dong CJ, 2014, ACCIDENT ANAL PREV, V70, P320, DOI 10.1016/j.aap.2014.04.018; Dong CJ, 2014, ACCIDENT ANAL PREV, V62, P87, DOI 10.1016/j.aap.2013.09.011; Dong N., 2015, ACCIDENT ANAL PREV, V90, P128; El-Basyouny K, 2006, TRANSPORT RES REC, P9, DOI 10.3141/1950-02; El-Basyouny K, 2009, ACCIDENT ANAL PREV, V41, P820, DOI 10.1016/j.aap.2009.04.005; Eluru N, 2007, ACCIDENT ANAL PREV, V39, P1037, DOI 10.1016/j.aap.2007.02.001; Huang HL, 2016, TRANSPORTMETRICA A, V12, P330, DOI 10.1080/23249935.2015.1136008; Huang WH, 2014, IEEE T INTELL TRANSP, V15, P2191, DOI 10.1109/TITS.2014.2311123; Khair S.J., 2014, J TRAFFIC LOGISTICS, V2, P92, DOI [10.12720/jtle.2.2.92-94, DOI 10.12720/JTLE.2.2.92-94]; Kim DG, 2006, ACCIDENT ANAL PREV, V38, P1094, DOI 10.1016/j.aap.2006.04.017; Kunt MM, 2011, TRANSPORT-VILNIUS, V26, P353, DOI 10.3846/16484142.2011.635465; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee J., 2002, ACCIDENT ANAL PREV, V34, P73; Li XG, 2008, ACCIDENT ANAL PREV, V40, P1611, DOI 10.1016/j.aap.2008.04.010; Lord D, 2005, TRANSPORT RES REC, P88; Lord D, 2006, ACCIDENT ANAL PREV, V38, P751, DOI 10.1016/j.aap.2006.02.001; Lord D, 2010, TRANSPORT RES A-POL, V44, P291, DOI 10.1016/j.tra.2010.02.001; Lv YS, 2015, IEEE T INTELL TRANSP, V16, P865, DOI 10.1109/TITS.2014.2345663; Ma JM, 2006, TRANSPORT RES REC, P24, DOI 10.3141/1950-04; Malyshkina NV, 2010, ACCIDENT ANAL PREV, V42, P131, DOI 10.1016/j.aap.2009.07.013; Mbalawata IS, 2015, COMPUT STAT DATA AN, V83, P101, DOI 10.1016/j.csda.2014.10.006; Miaou SP, 2003, TRANSPORT RES REC, P31; Milton JC, 2008, ACCIDENT ANAL PREV, V40, P260, DOI 10.1016/j.aap.2007.06.006; Pahukula J, 2015, ACCIDENT ANAL PREV, V75, P155, DOI 10.1016/j.aap.2014.11.021; Park ES, 2007, TRANSPORT RES REC, P1, DOI 10.3141/2019-01; Polson NG, 2017, TRANSPORT RES C-EMER, V79, P1, DOI 10.1016/j.trc.2017.02.024; Ren G, 2011, EXPERT SYST APPL, V38, P10420, DOI 10.1016/j.eswa.2011.02.066; Sarkka S., 2013, P IEEE INT WORKSH MA, P1, DOI DOI 10.1109/INDCON.2013.6726131; Sarkka S, 2009, IEEE T AUTOMAT CONTR, V54, P596, DOI 10.1109/TAC.2008.2008348; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Wang XK, 2005, TRANSPORT RES REC, P195; Wu Q, 2014, ACCIDENT ANAL PREV, V72, P105, DOI 10.1016/j.aap.2014.06.014; Xie YC, 2007, ACCIDENT ANAL PREV, V39, P922, DOI 10.1016/j.aap.2006.12.014; Yu RJ, 2013, ACCIDENT ANAL PREV, V51, P252, DOI 10.1016/j.aap.2012.11.027; Zeng Q, 2018, TRANSPORTMETRICA A, V14, P177, DOI 10.1080/23249935.2017.1353556; Zeng Q, 2017, ACCIDENT ANAL PREV, V100, P37, DOI 10.1016/j.aap.2016.12.023; Zeng Q, 2016, ACCIDENT ANAL PREV, V97, P87, DOI 10.1016/j.aap.2016.08.017; Zeng Q, 2016, ANAL METHODS ACCID R, V10, P12, DOI 10.1016/j.amar.2016.03.002; Zeng Q, 2014, ACCIDENT ANAL PREV, V73, P351, DOI 10.1016/j.aap.2014.09.006; Zeng Q, 2014, ACCIDENT ANAL PREV, V67, P105, DOI 10.1016/j.aap.2014.02.018; Zhang YL, 2007, TRANSPORT RES REC, P92, DOI 10.3141/2024-11	57	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2019	14	4							e0214866	10.1371/journal.pone.0214866	http://dx.doi.org/10.1371/journal.pone.0214866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR9NM	30951535	Green Published, gold, Green Submitted			2022-12-27	WOS:000463487500017
J	Abdelhameed, AS; Kadi, AA; Attwa, MW; AlRabiah, H				Abdelhameed, Ali S.; Kadi, Adnan A.; Attwa, Mohamed W.; AlRabiah, Haitham			Validated LC-MS/MS assay for quantification of the newly approved tyrosine kinase inhibitor, dacomitinib, and application to investigating its metabolic stability	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGFR-MUTATION; LUNG; RESISTANCE; DISCOVERY; AZD9291; PLASMA	Dacomitinib (DMB) is a second-generation irreversible tyrosine kinase inhibitor (TKI) that is claimed to overcome the disadvantages of the resistance reported for first-line epidermal growth factor receptor (EGFR) TKIs. Towards the end of 2018, the US Food and Drug Administration approved DMB in the form of VIZIMPRO tablets. In the current study, a validated LC-MS/MS assay was established for DMB quantification in rat liver microsomes (RLMs) with application to the drug metabolic stability assessment. Chromatographic resolution of DMB and lapatinib (internal standard) was achieved using an isocratic mobile phase and a reversed-phase C-18 column. The linearity of the established LC-MS/MS assay ranged from 2 to 500 ng/mL with r(2) >= 0.9999. The limit of detection (LOD) and limit of quantification (LOQ) were 0.35 and 1.1 ng/mL, respectively. The precision and accuracy (both intra-day and inter-day) were 0.84-3.58% and 92.2-100.32%, respectively. The metabolic stability of DMB in the RLM matrix was estimated by calculating two parameters, in vitro t(1/2) (0.97 mUmin/kg) and intrinsic clearance (157.5 min). Such values infer that DMB would be excreted very slowly from the human body, which might lead to possible bioaccumulation. To the best of our knowledge, this is the first method for DMB analysis in RLMs with metabolic stability estimation.	[Abdelhameed, Ali S.; Kadi, Adnan A.; Attwa, Mohamed W.; AlRabiah, Haitham] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh, Saudi Arabia; [Attwa, Mohamed W.] Mansoura Univ, Students Univ Hosp, Mansoura, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Mansoura University	Abdelhameed, AS; Attwa, MW (corresponding author), King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh, Saudi Arabia.; Attwa, MW (corresponding author), Mansoura Univ, Students Univ Hosp, Mansoura, Egypt.	asaber@ksu.edu.sa; mzeidan@ksu.edu.sa	KADI, ADNAN Ahmed/U-3384-2019; Attwa, Mohamed Wagih/E-6201-2016; AlRabiah, Haitham/S-6017-2018; Attwa, Mohamed/AAB-2304-2022; Abdelhameed, Ali/A-1333-2012	KADI, ADNAN Ahmed/0000-0001-8115-4228; Attwa, Mohamed/0000-0002-1147-4960; Abdelhameed, Ali/0000-0002-5910-2832	Deanship of Scientific Research at the King Saud University [RG-1435-025]	Deanship of Scientific Research at the King Saud University	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at the King Saud University for funding this work through the Research Group Project No. RG-1435-025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhameed AS, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3793; Alrabiah H, 2019, RSC ADV, V9, P4862, DOI 10.1039/c8ra09812c; Attwa MW, 2018, RSC ADV, V8, P40387, DOI 10.1039/c8ra08161a; Baranczewski P, 2006, PHARMACOL REP, V58, P453; Barron F, 2018, J THORAC DIS, V10, P1265, DOI 10.21037/jtd.2018.03.28; Caldwell G, 2014, OPTIMIZATION DRUG DI; Costa DB, 2015, TRANSL LUNG CANCER R, V4, P809, DOI 10.3978/j.issn.2218-6751.2015.05.05; Denis MG, 2015, CLIN CHIM ACTA, V444, P81, DOI 10.1016/j.cca.2015.01.039; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Finlay MRV, 2014, J MED CHEM, V57, P8249, DOI 10.1021/jm500973a; Gridelli C, 2015, NAT REV DIS PRIMERS, V1, DOI [10.1038/nrdp.2015.9, 10.1038/nrdp.2015.48]; Haghgoo SM, 2015, EUR J PHARMACOL, V754, P88, DOI 10.1016/j.ejphar.2015.02.029; ICH F, 1996, GUID IND Q2B VAL AN; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Jorge SEDC, 2014, BRAZ J MED BIOL RES, V47, P929, DOI 10.1590/1414-431X20144099; Kadi AA, 2016, BIOMED CHROMATOGR, V30, P1248, DOI 10.1002/bmc.3674; Larsen JE, 2011, CANCER J, V17, P512, DOI 10.1097/PPO.0b013e31823e701a; Liao BC, 2015, CURR OPIN ONCOL, V27, P94, DOI 10.1097/CCO.0000000000000164; Metro G, 2012, TRANSL LUNG CANCER R, V1, P5, DOI 10.3978/j.issn.2218-6751.2011.12.01; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Peters S, 2014, CANCER TREAT REV, V40, P917, DOI 10.1016/j.ctrv.2014.06.010; Qiu XJ, 2019, J PHARMACEUT BIOMED, V166, P66, DOI 10.1016/j.jpba.2018.12.041; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tan CS, 2015, LANCET ONCOL, V16, pE447, DOI 10.1016/S1470-2045(15)00246-6; U. S. Food and Drug Administration (FDA), 2000, GUID IND AN PROC MET; U. S. Food and Drug Administration (FDA), 2018, VIZ DAC TABL; Wu YL, 2017, LANCET ONCOL, V18, P1454, DOI 10.1016/S1470-2045(17)30608-3	27	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214598	10.1371/journal.pone.0214598	http://dx.doi.org/10.1371/journal.pone.0214598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947315	Green Submitted, gold, Green Published			2022-12-27	WOS:000463314500043
J	Castaneda, SF; Garcia, ML; Lopez-Gurrola, M; Stoutenberg, M; Emory, K; Daviglus, ML; Kaplan, R; Giachello, AL; Molina, KM; Perreira, KM; Youngblood, ME; Vidot, DC; Talavera, GA				Castaneda, Sheila F.; Garcia, Melawhy L.; Lopez-Gurrola, Maria; Stoutenberg, Mark; Emory, Kristen; Daviglus, Martha L.; Kaplan, Robert; Giachello, Aida L.; Molina, Kristine M.; Perreira, Krista M.; Youngblood, Marston E.; Vidot, Denise C.; Talavera, Gregory A.			Alcohol use, acculturation and socioeconomic status among Hispanic/Latino men and women: The Hispanic Community Health Study/Study of Latinos	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES; GENDER-DIFFERENCES; CONSUMPTION; DRINKING; RISK; AMERICAN; ADULTS; METAANALYSIS; DESIGN	The objective of this study was to examine the prevalence and patterns of alcohol use among U.S. Hispanic/Latino adults of diverse backgrounds. The population-based Hispanic Community Health Study/Study of Latinos (HCHS/SOL) enrolled a cohort of Hispanic/ Latino adults (N= 16,415) ages 18-74 years at time of recruitment, from four US metropolitan areas between 2008-11. Drinking patterns and socio-demographics questionnaires were administered as part of the baseline examination. The relationship between age, sex, socio-demographics, acculturation, current alcohol use, and alcohol risk disorder, defined by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [no risk (i.e., never drinker), low risk (i.e., women<7 drinks/week; men<14 drinks/week), and at-risk (i.e., women>7 drinks/week; men>14 drinks/week)] were assessed in unadjusted and adjusted multinomial logistic regression analyses. Men reported a higher prevalence than women of at-risk drinking. For women, increased odds of at-risk alcohol use was associated with: a younger age, greater education, full-time employment, and acculturation after adjustment. For men, having a lower income (vs. higher income) or a higher income (vs. not reported) and being employed fulltime (vs. retired) was associated with at-risk alcohol use. For both men and women, there were variations in odds of at-risk drinking across Hispanic/Latino heritage backgrounds, after adjustment. Exact values, odds ratios and p-values are reported within the text. Common factors across sex associated with at-risk drinking included being of Mexican background and being employed full-time. Intervention strategies should consider diversity within the Hispanic/Latino community when designing alcohol abuse prevention programs.	[Castaneda, Sheila F.; Lopez-Gurrola, Maria; Talavera, Gregory A.] San Diego State Univ, Sch Publ Hlth, Southbay Latino Res Ctr, San Diego, CA 92182 USA; [Garcia, Melawhy L.] Calif State Univ Long Beach, Dept Hlth Sci, Long Beach, CA 90840 USA; [Stoutenberg, Mark] Univ Tennessee, Dept Hlth & Human Performance, Chattanooga, TN USA; [Emory, Kristen] San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA; [Daviglus, Martha L.; Molina, Kristine M.; Perreira, Krista M.] Univ Illinois, Inst Minor Hlth Res, Chicago, IL USA; [Kaplan, Robert] Einstein Coll Med, Bronx, NY USA; [Kaplan, Robert] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Giachello, Aida L.] Northwestern Univ, Chicago, IL 60611 USA; [Perreira, Krista M.; Youngblood, Marston E.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Vidot, Denise C.] Univ Miami, Miami, FL USA	California State University System; San Diego State University; California State University System; California State University Long Beach; University of Tennessee System; University of Tennessee at Chattanooga; California State University System; San Diego State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yeshiva University; Albert Einstein College of Medicine; Fred Hutchinson Cancer Center; Northwestern University; University of North Carolina; University of North Carolina Chapel Hill; University of Miami	Castaneda, SF (corresponding author), San Diego State Univ, Sch Publ Hlth, Southbay Latino Res Ctr, San Diego, CA 92182 USA.	scastaneda@sdsu.edu	Castaneda, Sheila F./AAK-3025-2020; Garcia, Melawhy/AAE-9698-2020; Castaneda, Sheila/I-4132-2014	Castaneda, Sheila/0000-0002-1975-0544; Deloukas, Panos/0000-0001-9251-070X	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233, N01-HC65234, N01-HC65235, N01-HC65236, N01-HC65237]; National Center on Minority Health and Health Disparities; National Institute of Deafness and Other Communications Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; Office of Dietary Supplements; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Deafness and Other Communications Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to acknowledge the following funding sources and individuals: The Hispanic Community Health Study/Study of Latinos is funded by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following Institutes/Centers/Offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Center on Minority Health and Health Disparities, the National Institute of Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements.	Alkerwi A, 2009, ATHEROSCLEROSIS, V204, P624, DOI 10.1016/j.atherosclerosis.2008.10.036; BLACK SA, 1993, AM J PUBLIC HEALTH, V83, P890, DOI 10.2105/AJPH.83.6.890; Caetano R, 2008, J STUD ALCOHOL DRUGS, V69, P441, DOI 10.15288/jsad.2008.69.441; Center for Disease Control and Prevention (CDC), ALC US YOUR HLTH 201; Chartier K, 2010, ALCOHOL RES HEALTH, V33, P152; Collins SE, 2016, ALCOHOL RES-CURR REV, V38, P83; Cook WK, 2014, ALCOHOL CLIN EXP RES, V38, P3043, DOI 10.1111/acer.12573; Elkind MSV, 2006, STROKE, V37, P13, DOI 10.1161/01.STR.0000195048.86810.5b; Erskine S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-99; Glass JE, 2017, SOC PSYCH PSYCH EPID, V52, P515, DOI 10.1007/s00127-017-1362-4; Ikehara S, 2013, PREV MED, V57, P505, DOI 10.1016/j.ypmed.2013.07.003; Jones L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1720-7; Klatsky AL, 2001, JAMA-J AM MED ASSOC, V285, P2004, DOI 10.1001/jama.285.15.2004; Kochhar R., 2018, KEY FINDINGS RISE IN; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Lee Christina S, 2013, J Ethn Subst Abuse, V12, P356, DOI 10.1080/15332640.2013.836730; Lopez EB, 2018, ETHNIC HEALTH, V23, P797, DOI 10.1080/13557858.2017.1294664; Marchetta Claire M., 2012, Morbidity and Mortality Weekly Report, V61, P534; MARKIDES KS, 1990, AM J PUBLIC HEALTH, V80, P42, DOI 10.2105/AJPH.80.Suppl.42; Mukamal KJ, 2006, J AM GERIATR SOC, V54, P30, DOI 10.1111/j.1532-5415.2005.00561.x; Mulia N, 2008, J STUD ALCOHOL DRUGS, V69, P824, DOI 10.15288/jsad.2008.69.824; Probst C, 2015, DRUG ALCOHOL REV, V34, P267, DOI 10.1111/dar.12184; Rehm J, 2017, ADDICTION, V112, P968, DOI 10.1111/add.13757; Rote SM, 2013, J ADDICT DIS, V32, P354, DOI 10.1080/10550887.2013.859452; Salas-Wright CP, 2015, SOC PSYCH PSYCH EPID, V50, P39, DOI 10.1007/s00127-014-0889-x; Sanchez J, 2015, DRUG ALCOHOL DEPEN, V151, P241, DOI 10.1016/j.drugalcdep.2015.03.025; Sanchez M, 2014, PSYCHOL ADDICT BEHAV, V28, P990, DOI 10.1037/a0037807; SAS Institute Inc, 2011, SAS SOFTW VERS 9 3; Schwartz SJ, 2014, AM J DRUG ALCOHOL AB, V40, P359, DOI 10.3109/00952990.2014.910521; Scott-Sheldon LAJ, 2016, AIDS BEHAV, V20, pS19, DOI 10.1007/s10461-015-1108-9; Shield KD, 2013, ALCOHOL RES-CURR REV, V35, P155; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; van Oers JAM, 1999, ALCOHOL ALCOHOLISM, V34, P78, DOI 10.1093/alcalc/34.1.78; Zemore SE, 2007, ALCOHOL CLIN EXP RES, V31, P1968, DOI 10.1111/j.1530-0277.2007.00532.x	35	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214906	10.1371/journal.pone.0214906	http://dx.doi.org/10.1371/journal.pone.0214906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947280	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500081
J	Rose, I; Yoshimizu, MH; Bonilla, DL; Fedorova, N; Lane, RS; Padgett, KA				Rose, Ian; Yoshimizu, Melissa Hardstone; Bonilla, Denise L.; Fedorova, Natalia; Lane, Robert S.; Padgett, Kerry A.			Phylogeography of Borrelia spirochetes in lxodes pacificus and lxodes spinipalpis ticks highlights differential acarological risk of tick-borne disease transmission in northern versus southern California	PLOS ONE			English	Article							IXODES-PACIFICUS; IXODIDAE NYMPHS; LYME-DISEASE; MULTIPLE ALIGNMENTS; SP-NOV; BURGDORFERI; BISSETTII; ACARI; DIVERSITY; IDENTIFICATION	The common human-biting tick, Ixodes pacificus, is the primary vector of the Lyme disease spirochete, Borrelia burgdorferisensu stricto (ss) in western North America and has been found to harbor other closely-related spirochetes in the Borrelia burgdorferisensu lato (sl) complex. Between 2008-2015, 11,066 adult and 3,815 nymphal I. pacificus and five adult and 144 nymphal Ixodes spinpalpis, a commonly collected wildlife tick, were collected from 42 California counties. Borrelia burgdorferisl was detected in 1.2% and 3.8% I. pacificus adults and nymphs, respectively. Results from this study indicate genetic diversity and geographic structure of B. burgdorferisl in California I. pacificus ticks, by sequence comparison of the 16S rRNA gene, with B. burgdorferi ss, the agent of Lyme disease, found only in I. pacificus collected from the north and central coastal and Sierra Nevada foothill regions; B. burgdorferi ss was not detected in ticks tested from southern California. In contrast, Borrelia bissettiae, a member of the B. burgdorferisl complex, was detected in both I. pacificus and I. spinipalpis, in the coastal region of both northern and southern California, but was absent from ticks in the Sierra Nevada foothills. In a similar pattern to B. bissettiae, Borrelia americana (a member of the B. burgdorferisl complex) was detected in a single adult I. pacificus from the north coast and two I. spinipalpis nymphs from south-coastal California. This study highlights that the geographic area of Lyme disease acarological risk in California is the north-central and Sierra Nevada foothill regions of the state with little to no risk in the southern regions of the state.	[Rose, Ian; Yoshimizu, Melissa Hardstone; Bonilla, Denise L.; Padgett, Kerry A.] Calif Dept Publ Hlth, Vector Borne Dis Sect, Richmond, CA 94804 USA; [Fedorova, Natalia; Lane, Robert S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Rose, Ian] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA; [Bonilla, Denise L.] USDA, Anim & Plant Hlth Inspect Serv, Ft Collins, CO USA	California Department of Public Health; University of California System; University of California Berkeley; Cornell University; United States Department of Agriculture (USDA)	Padgett, KA (corresponding author), Calif Dept Publ Hlth, Vector Borne Dis Sect, Richmond, CA 94804 USA.	Kerry.Padgett@cdph.ca.gov		Padgett, Kerry/0000-0002-9535-3401; Rose, Ian/0000-0002-0603-432X				Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Barbieri AM, 2013, VECTOR-BORNE ZOONOT, V13, P147, DOI 10.1089/vbz.2012.1102; Barbour AG, 1996, J BACTERIOL, V178, P6635, DOI 10.1128/jb.178.22.6635-6639.1996; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; BISSETT ML, 1987, J CLIN MICROBIOL, V25, P2296, DOI 10.1128/JCM.25.12.2296-2301.1987; Brown RN, 2006, J MED ENTOMOL, V43, P743, DOI 10.1603/0022-2585(2006)43[743:SMOBBS]2.0.CO;2; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clark KL, 2014, J MED MICROBIOL, V63, P674, DOI 10.1099/jmm.0.073122-0; Cook VJ, 2016, EMERG INFECT DIS, V22, P2205, DOI 10.3201/eid2212.152046; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Fedorova N, 2014, TICKS TICK-BORNE DIS, V5, P951, DOI 10.1016/j.ttbdis.2014.07.015; Furman DP., 1984, TICKS CALIFORNIA ACA; Geller J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-202; Girard YA, 2011, J CLIN MICROBIOL, V49, P945, DOI 10.1128/JCM.01689-10; Golovchenko M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1353-4; Hacker GM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195586; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kjemtrup A., 2018, VECTOR BORNE DIS SEC, P1; Krause PJ, 2015, CLIN MICROBIOL INFEC, V21, P631, DOI 10.1016/j.cmi.2015.02.006; Krause PJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191725; Lane RS, 2007, J VECTOR ECOL, V32, P342, DOI 10.3376/1081-1710(2007)32[342:HBOIPA]2.0.CO;2; Lane RS, 2013, TICKS TICK-BORNE DIS, V4, P377, DOI 10.1016/j.ttbdis.2013.02.005; LANE RS, 1994, J MED ENTOMOL, V31, P417, DOI 10.1093/jmedent/31.3.417; LANE RS, 1992, AM J EPIDEMIOL, V136, P1358, DOI 10.1093/oxfordjournals.aje.a116448; Lee X, 2014, J MED ENTOMOL, V51, P694, DOI 10.1603/ME13140; Lynn GE, 2018, J MED ENTOMOL, V55, P711, DOI 10.1093/jme/tjx258; MacDonald AJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1938-y; Maraspin V, 2016, CLIN INFECT DIS, V63, P914, DOI 10.1093/cid/ciw417; MARCONI RT, 1992, J CLIN MICROBIOL, V30, P2830, DOI 10.1128/JCM.30.11.2830-2834.1992; Margos G, 2017, INT J SYST EVOL MICR, V67, P3872, DOI 10.1099/ijsem.0.002214; Margos G, 2016, INT J SYST EVOL MICR, V66, P1447, DOI 10.1099/ijsem.0.000897; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; MEYERS HB, 1992, WESTERN J MED, V157, P455; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI [10.1093/bioinformatics/btn575, 10.1093/bioinformatics/btp666]; Newman EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118146; Oliver JH, 2003, P NATL ACAD SCI USA, V100, P11642, DOI 10.1073/pnas.1434553100; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Padgett KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005020; Padgett KA, 2011, TICKS TICK-BORNE DIS, V2, P191, DOI 10.1016/j.ttbdis.2011.07.002; PERSING DH, 1990, J CLIN MICROBIOL, V28, P566, DOI 10.1128/JCM.28.3.566-572.1990; Postic D, 1998, J CLIN MICROBIOL, V36, P3497, DOI 10.1128/JCM.36.12.3497-3504.1998; Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8; Raileanu C, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00036; Rudenko N, 2009, FEMS MICROBIOL LETT, V292, P274, DOI 10.1111/j.1574-6968.2009.01498.x; Rudenko N, 2008, J CLIN MICROBIOL, V46, P3540, DOI 10.1128/JCM.01032-08; Rudenko N, 2011, TICKS TICK-BORNE DIS, V2, P123, DOI 10.1016/j.ttbdis.2011.04.002; Rudenko N, 2009, J CLIN MICROBIOL, V47, P3875, DOI 10.1128/JCM.01050-09; Salkeld DJ, 2018, EMERG INFECT DIS, V24, P2356, DOI 10.3201/eid2412.171632; Schneider BS, 2000, J CLIN MICROBIOL, V38, P3103, DOI 10.1128/JCM.38.8.3103-3105.2000; SCHWAN TG, 1993, J CLIN MICROBIOL, V31, P3096, DOI 10.1128/JCM.31.12.3096-3108.1993; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; Swei A, 2011, J MED ENTOMOL, V48, P20, DOI 10.1603/ME10131; Talleklint-Eisen L, 1999, J PARASITOL, V85, P824, DOI 10.2307/3285817; Vredevoe LK, 2004, J MED ENTOMOL, V41, P736, DOI 10.1603/0022-2585-41.4.736; Yu PF, 2016, ACTA TROP, V158, P181, DOI 10.1016/j.actatropica.2016.02.027	57	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214726	10.1371/journal.pone.0214726	http://dx.doi.org/10.1371/journal.pone.0214726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946767	gold, Green Published, Green Submitted			2022-12-27	WOS:000463314500056
J	Platt, EL; Romero, DM				Platt, Edward L.; Romero, Daniel M.			Towards attack tolerant networks: Concurrent multipath routing and the butterfly network	PLOS ONE			English	Article							CENSORSHIP; SECURITY	It is crucial for large-scale communication networks such as the internet to be resilient against attacks such as censorship and surveillance, which pose a threat to free expression and free association. Self-organized networks such as the internet's router network typically have heavy-tailed degree distributions, making them highly vulnerable to targeted attacks against central nodes. While cryptographic solutions exist, they fail to address the underlying topological problem, and remain vulnerable to man-in-the-middle attacks and coercion. Coercion-resistant, topological approaches to attack tolerance are needed to address the current vulnerability of communications infrastructure to censorship and surveillance. We present a novel concurrent multipath routing (CMR) algorithm for the wraparound butterfly network topology, as well as a highly attack-tolerant Structured Multipath Fault Tolerance (SMFT) architecture which incorporates the butterfly CMR algorithm. We also identify a previously unexplored relationship between network topology, trust transitivity, and attack-tolerance, and provide a framework for further exploration of this relationship. Our work is the first theoretical demonstration of a point-to-point communication network architecture that can resist coercion and other non-technical attacks, without requiring infinitely transitive trust. To address cases where the network structure cannot be fully controlled, we demonstrate how a snapshot of the internet's router network can be partially rewired for greater attack-tolerance. More broadly, we hope that this work will serve as a starting point for the evelopment of additional topology-based attack-tolerant communication architectures to guard against the dangers of censorship and surveillance.	[Platt, Edward L.; Romero, Daniel M.] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Platt, EL (corresponding author), Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA.	elplatt@umich.edu		Platt, Edward/0000-0003-2148-3841	NSF [IIS-1617820]	NSF(National Science Foundation (NSF))	This work was supported by the NSF under Grant No. IIS-1617820 to DMR. There was no additional external funding received for this study.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alrajeh NA, 2013, INT J DISTRIB SENS N, V2013; Avizienis A, 2004, IEEE T DEPEND SECURE, V1, P11, DOI 10.1109/TDSC.2004.2; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Baran P, 1964, RAND CORPORATION RES, VI-XI, P637; Blakley G. R., 1979, P AFIPS 1979 NAT COM, P313, DOI [DOI 10.1109/MARK.1979.8817296, 10.1109/MARK.1979.8817296]; Castro M, 1999, USENIX ASSOCIATION PROCEEDINGS OF THE THIRD SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDI '99), P173, DOI 10.1145/571637.571640; Christianson B., 1997, Security Protocols. International Workshop Proceedings, P171; Clarke I, 2001, LECT NOTES COMPUTER, P46, DOI [DOI 10.1007/3-540-44702-4_4, DOI 10.1007/3-540-44702-4]; Dainotti A., 2011, P 2011 ACM SIGCOMM C, P1, DOI DOI 10.1145/2068816.2068818; Dingledine R., 2004, DTIC DOCUMENT; Dwork C., 1993, Advances in Cryptology - CRYPTO '92. 12th Annual International Cryptology Conference Proceedings, P139; Ellison C., 2000, Computer Security Journal, V16, P1; Elmer-Dewitt P., 1993, TIME, V142, P62; Fiat A, 2002, SIAM PROC S, P94; Grewal GS, 2013, P IEEE S SECUR PRIV, P367, DOI 10.1109/SP.2013.32; Hunter P, 2008, COMPUT FRAUD SECUR, P10, DOI 10.1016/S1361-3723(08)70065-4; Khalil I, 2010, AD HOC NETW, V8, P148, DOI 10.1016/j.adhoc.2009.06.002; Khiani SR, 2013, IJACR, V3, P374; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Kohno E, 2012, J COMPUT SYST SCI, V78, P1703, DOI 10.1016/j.jcss.2011.10.018; Korzun D, 2013, STRUCTURED PEER TO P; Kshemkalyani A.D., 2011, DISTRIB COMPUT, DOI DOI 10.1017/CBO9780511805318; LAMPORT L, 1982, ACM T PROGR LANG SYS, V4, P382, DOI 10.1145/357172.357176; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Levien R, 2009, HUM-COMPUT INT-SPRIN, P121, DOI 10.1007/978-1-84800-356-9_5; Liu AF, 2012, IEEE T VEH TECHNOL, V61, P3255, DOI 10.1109/TVT.2012.2205284; Lou W, 2006, IEEE T VEH TECHNOL, V55, P1320, DOI 10.1109/TVT.2006.877707; Lua EK, 2005, IEEE COMMUN SURV TUT, V7, P72, DOI 10.1109/COMST.2005.1610546; Mohr LB, 1982, EXPLAINING ORG BEHAV; Nakamoto S., 2008, CONSULTED, V1, P28; Nayak GN, 2010, INT CONF COMP SCI, P491, DOI 10.1109/ICCSIT.2010.5563900; Nickerson JV, 2010, COGSCI, V36; Poulsen K, 2013, WIRED; Qadir J, 2015, IEEE COMMUN SURV TUT, V17, P2176, DOI 10.1109/COMST.2015.2453941; Reiter MK, 1998, IEEE T COMPUT, V47, P1351, DOI 10.1109/12.737682; Richters O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018384; SHAMIR A, 1979, COMMUN ACM, V22, P612, DOI 10.1145/359168.359176; Stellar D., 2015, CONSENSUS PROTOCOL F; Sterbenz JPG, 2010, COMPUT NETW, V54, P1245, DOI 10.1016/j.comnet.2010.03.005; Walker DC, 2012, MASS NOTIFICATION AND CRISIS COMMUNICATIONS: PLANNING, PREPAREDNESS, AND SYSTEMS, P1; Xu XY, 2011, LECT NOTES COMPUT SC, V6579, P133, DOI 10.1007/978-3-642-19260-9_14; Zhang H, 2002, IEEE INFOCOM SER, P1228, DOI 10.1109/INFCOM.2002.1019373; Zimmermann P.R., 1995, OFFICIAL PGP USERS G; Zin SM, 2015, J NETW COMPUT APPL, V55, P123, DOI 10.1016/j.jnca.2015.04.018	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214292	10.1371/journal.pone.0214292	http://dx.doi.org/10.1371/journal.pone.0214292			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943216	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300033
J	Scott, EM; Arnold, C; Dowell, S; Suchodolski, JS				Scott, Erin M.; Arnold, Carolyn; Dowell, Samantha; Suchodolski, Jan S.			Evaluation of the bacterial ocular surface microbiome in clinically normal horses before and after treatment with topical neomycin-polymyxin-bacitracin	PLOS ONE			English	Article							GREENGENES; FLORA	Next generation sequencing (NGS) studies have demonstrated a rich and diverse ocular surface-associated microbiota in people that was previously undetected by traditional culture-based methods. The ocular surface microbiome of horses has yet to be investigated using NGS techniques. This study aimed to determine the bacterial composition of the ocular surface microbiome in healthy horses, and to identify whether there are microbial community changes over time and following topical antibiotic use. One eye of 12 horses was treated 3 times daily for 1 week with neomycin-polymyxin-bacitracin ophthalmic ointment. Contralateral eyes served as untreated controls. The inferior conjunctival fornix of both eyes was sampled at baseline prior to initiating treatment (day 0), after 1 week of treatment (day 7), and 4 weeks after concluding treatment (day 35). Genomic DNA was extracted from ocular surface swabs and sequenced using primers that target the V4 region of bacterial 16S rRNA. At baseline, the most abundant phyla identified were Proteobacteria (46.1%), Firmi-cutes (24.6%), Actinobacteria (12.6%), and Bacteroidetes (11.2%). The most abundant families included Pasteurellaceae (13.7%), Sphingomonadaceae (7.9%), an unclassified Order of Cardiobacteriales (7.7%), and Moraxellaceae (4.8%). Alpha and beta diversity measurements were unchanged in both treatment and control eyes over time. Overall, the major bacterial taxa on the equine ocular surface remained stable over time and following topical antibiotic therapy.	[Scott, Erin M.; Dowell, Samantha; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [Arnold, Carolyn] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Scott, EM (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA.	escott@cvm.tamu.edu		Dowell, Samantha/0000-0002-9808-5115; Scott, Erin/0000-0002-9702-7298				Andrew SE, 2003, VET OPHTHALMOL, V6, P45, DOI 10.1046/j.1463-5224.2003.00265.x; [Anonymous], 2018, PEER J PREPRINTS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doan T, 2016, INVEST OPHTH VIS SCI, V57, P5116, DOI 10.1167/iovs.16-19803; Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939; Gemensky-Metzler AJ, 2005, AM J VET RES, V66, P800, DOI 10.2460/ajvr.2005.66.800; Hampson ECGM, 2018, VET OPHTHALMOL; Huang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.04.008; Johns IC, 2011, VET OPHTHALMOL, V14, P195, DOI 10.1111/j.1463-5224.2010.00867.x; Karacal Humeyra, 2007, International Ophthalmology, V27, P251, DOI 10.1007/s10792-007-9068-3; Kugadas Abirami, 2016, Ocul Surf, V14, P342, DOI 10.1016/j.jtos.2016.04.004; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Leis ML, 2019, VET OPHTHALMOL, V22, P337, DOI 10.1111/vop.12599; Lu Louise J., 2016, Yale Journal of Biology and Medicine, V89, P325; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MOORE CP, 1983, J AM VET MED ASSOC, V182, P600; MOORE CP, 1995, J AM VET MED ASSOC, V207, P928; MOORE CP, 1988, AM J VET RES, V49, P773; Ozkan J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10494-9; Sandmeyer LS, 2017, AM J VET RES, V78, P207, DOI 10.2460/ajvr.78.2.207; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tyler AD, 2014, AM J GASTROENTEROL, V109, P983, DOI 10.1038/ajg.2014.73; Weese SJ, 2015, VET RES, V46, DOI 10.1186/s13567-014-0140-5; Whitley R. D., 1983, Equine Veterinary Journal, P138; WHITLEY RD, 1984, VET CLIN N AM-LARGE, V6, P451; Willcox MDP, 2013, EXP EYE RES, V117, P99, DOI 10.1016/j.exer.2013.06.003; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zegans ME, 2014, AM J OPHTHALMOL, V158, P420, DOI 10.1016/j.ajo.2014.06.014	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214877	10.1371/journal.pone.0214877	http://dx.doi.org/10.1371/journal.pone.0214877			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943258	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300066
J	Hogestol, EA; Nygaard, GO; Alnaes, D; Beyer, MK; Westlye, LT; Harbo, HF				Hogestol, Einar August; Nygaard, Gro Owren; Alnaes, Dag; Beyer, Mona K.; Westlye, Lars T.; Harbo, Hanne Flinstad			Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; COGNITIVE IMPAIRMENT; DYSFUNCTION; ROBUST; SCALE; LINK; SEGMENTATION; DAMAGE	Background Fatigue and depression are frequent and often co-occurring symptoms in multiple sclerosis (MS). Resting-state functional magnetic resonance imaging (rs-fMRI) represents a promising tool for disentangling differential associations between depression and fatigue and brain network function and connectivity. In this study we tested for associations between symptoms of fatigue and depression and DMN connectivity in patients with MS. Materials and methods Seventy-four MS patients were included on average 14 months after diagnosis. They underwent MRI scanning of the brain including rs-fMRI, and symptoms of fatigue and depression were assessed with Fatigue Severity Scale (FSS) and Beck Depression Inventory II (BDI). A principal component analysis (PCA) on FSS and BDI scores was performed, and the component scores were analysed using linear regression models to test for associations with default mode network (DMN) connectivity. Results We observed higher DMN connectivity with higher scores on the primary principal component reflecting common symptom burden for fatigue and depression (Cohen's f(2) = 0.075, t = 2.17, p = 0.03). The secondary principal component reflecting a pattern of low fatigue scores with high scores of depression was associated with lower DMN connectivity (Cohen's f(2) = 0.067, t = -2.1, p = 0.04). Using continuous mean scores of FSS we also observed higher DMN connectivity with higher symptom burden (t = 3.1, p = 0.003), but no significant associations between continuous sum scores of BDI and DMN connectivity (t = 0.8, p = 0.4). Conclusion Multivariate decomposition of FSS and BDI data supported both overlapping and unique manifestation of fatigue and depression in MS patients. Rs-fMRI analyses showed that symptoms of fatigue and depression were reflected in altered DMN connectivity, and that higher DMN activity was seen in MS patients with fatigue even with low depression scores.	[Hogestol, Einar August; Harbo, Hanne Flinstad] Univ Oslo, Inst Clin Med, Dept Neurol, Oslo, Norway; [Nygaard, Gro Owren; Harbo, Hanne Flinstad] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Alnaes, Dag; Westlye, Lars T.] Univ Oslo, NORMENT, Div Mental Hlth & Addict, Oslo Univ Hosp, Oslo, Norway; [Alnaes, Dag; Westlye, Lars T.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Beyer, Mona K.] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway; [Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Hogestol, EA (corresponding author), Univ Oslo, Inst Clin Med, Dept Neurol, Oslo, Norway.	einar.august@gmail.com		Westlye, Lars T./0000-0001-8644-956X; Hogestol, Einar August/0000-0001-8446-2111	Research Council of Norway [240102]; South-Eastern Regional Health Authorities of Norway [2011059/ES563338/Biotek 2021]	Research Council of Norway(Research Council of Norway); South-Eastern Regional Health Authorities of Norway	The project was supported by grants (Principal Investigator for both grants: HFH) from The Research Council of Norway (https://www.forskningsradet.no/en/Home_page/1177315753906) (grant number 240102) and the South-Eastern Regional Health Authorities of Norway (https://www.helse-sorost.no/south-eastern-norway-regional-health-authority) (grant number 2011059/ES563338/Biotek 2021) (Principal Investigator for both grants: HFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Arnett P, 2005, MULT SCLER J, V11, P328, DOI 10.1191/1352458505ms1162oa; Basile B, 2014, MULT SCLER J, V20, P1050, DOI 10.1177/1352458513515082; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bisecco A, 2018, MULT SCLER J, V24, P1696, DOI 10.1177/1352458517730932; Bisecco A, 2016, MULT SCLER J, V22, P1676, DOI 10.1177/1352458516628331; Bonavita S, 2017, EUR J NEUROL, V24, P27, DOI 10.1111/ene.13112; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Gomez AJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077914; Cruz-Gomez AJ, 2014, MULT SCLER J, V20, P338, DOI 10.1177/1352458513495584; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damangir S, 2012, J NEUROL SCI, V322, P211, DOI 10.1016/j.jns.2012.07.064; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; de la Cruz MH, 2018, MULT SCLER J, V24, P1183, DOI 10.1177/1352458517717807; Feinstein A, 2014, NAT REV NEUROL, V10, P507, DOI 10.1038/nrneurol.2014.139; Filippi M, 2019, NEUROIMAGE, V190, P32, DOI 10.1016/j.neuroimage.2017.09.021; Finke C, 2015, MULT SCLER J, V21, P925, DOI 10.1177/1352458514555784; Gobbi C, 2014, MULT SCLER J, V20, P1633, DOI 10.1177/1352458514530022; Goodin DS, 2014, HAND CLINIC, V122, P231, DOI 10.1016/B978-0-444-52001-2.00010-8; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Hampson JP, 2015, NEUROIMAGE-CLIN, V8, P305, DOI 10.1016/j.nicl.2015.04.022; Hanken K, 2016, MULT SCLER RELAT DIS, V6, P81, DOI 10.1016/j.msard.2016.02.005; Janardhan V, 2002, J NEUROL SCI, V205, P51, DOI 10.1016/S0022-510X(02)00312-X; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lerdal A, 2007, EUR J NEUROL, V14, P1338, DOI 10.1111/j.1468-1331.2007.01974.x; Nickerson LD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00115; Nygaard GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135974; Nygaard GO, 2015, MULT SCLER J, V21, P402, DOI 10.1177/1352458514543811; Penner IK, 2017, NAT REV NEUROL, DOI [10.1038/nrneurol.2017.117, DOI 10.1038/NRNEUROL.2017.117]; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Rocca MA, 2014, RADIOLOGY, V273, P511, DOI 10.1148/radiol.14140417; Rocca MA, 2012, NEUROLOGY, V79, P1449, DOI 10.1212/WNL.0b013e31826d5f10; Sbardella E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/212693; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sundgren M, 2013, ARCH CLIN NEUROPSYCH, V28, P144, DOI 10.1093/arclin/acs113	44	12	14	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0210375	10.1371/journal.pone.0210375	http://dx.doi.org/10.1371/journal.pone.0210375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933977	gold, Green Published, Green Submitted			2022-12-27	WOS:000462867000003
J	Cullen, M; Jacob, ME; Cornish, V; VanderSchel, IQ; Cotter, HV; Cubeta, MA; Carbone, I; Gilger, BC				Cullen, Megan; Jacob, Megan E.; Cornish, Vicki; VanderSchel, Ian Q.; Cotter, Henry Van T.; Cubeta, Marc A.; Carbone, Ignazio; Gilger, Brian C.			Multi-locus DNA sequence analysis, antifungal agent susceptibility, and fungal keratitis outcome in horses from Southeastern United States	PLOS ONE			English	Article							EQUINE ULCERATIVE KERATOMYCOSIS; IN-VITRO SUSCEPTIBILITY; ASPERGILLUS-FLAVUS; FUSARIUM KERATITIS; PHYLOGENETIC DIVERSITY; SOUTH-INDIA; BACTERIAL; SNAP; IDENTIFICATION; INFECTIONS	Morphological characterization and multi-locus DNA sequence analysis of fungal isolates obtained from 32 clinical cases of equine fungal keratitis (FK) was performed to identify species and determine associations with antifungal susceptibility, response to therapy and clinical outcome. Two species of Aspergillus (A. flavus and A. fumigatus) and three species of Fusarium (F. falciforme, F. keratoplasticum, and F. proliferatum) were the most common fungi isolated and identified from FK horses. Most (91%) equine FK Fusarium nested within the Fusarium so/anispecies complex (FSSC) with nine genetically diverse strains/lineages, while 83% of equine FK Aspergillus nested within the A. flavus Glade with three genetically diverse lineages. Fungal species and evolutionary lineage were not associated with clinical outcome. However, species of equine FK Fusarium were more likely (p = 0.045) to be associated with stromal keratitis. Species of Aspergillus were more susceptible to voriconazole and terbinafine than species of Fusarium, while species of Fusarium were more susceptible to thiabendazole than species of Aspergillus. At the species level, A. fumigatus and A. flavus were more susceptible to voriconazole and terbinafine than F. falciforme. Natamycin susceptibility was higher for F. falciforme and A. fumigatus compared to A. flavus. Furthermore, F. falciforme was more susceptible to thiabendazole than A. flavus and A. fumigatus. These observed associations of antifungal sensitivity to natamycin, terbinafine, and thiabendazole demonstrate the importance of fungal identification to the species rather than genus level. The results of this study suggest that treatment of equine FK with antifungal agents requires accurate fungal species identification.	[Cullen, Megan; Gilger, Brian C.] NC State Univ, Dept Clin Sci, Raleigh, NC 27695 USA; [Jacob, Megan E.] NC State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Cornish, Vicki; VanderSchel, Ian Q.; Cotter, Henry Van T.; Cubeta, Marc A.; Carbone, Ignazio] NC State Univ, Coll Agr & Life Sci, Ctr Integrated Fungal Res, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Gilger, BC (corresponding author), NC State Univ, Dept Clin Sci, Raleigh, NC 27695 USA.	bgilger@ncsu.edu	Cornish, Vicki/AAW-9370-2020; Gilger, Brian/D-8776-2014	Cornish, Vicki/0000-0001-6253-7266; Gilger, Brian/0000-0002-7771-9166; Cullen, Megan/0000-0003-2651-3798	NC State University College of Agricultural and Life Sciences; NC State University College of Veterinary Medicine; Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (NIFA) [2013-68004-20359]; National Science Foundation (NSF) Genealogy of Life (GoLife) program [DEB-1541418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052080] Funding Source: NIH RePORTER	NC State University College of Agricultural and Life Sciences; NC State University College of Veterinary Medicine; Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (NIFA); National Science Foundation (NSF) Genealogy of Life (GoLife) program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NC State University College of Agricultural and Life Sciences and the College of Veterinary Medicine provided seed funding. This work was partially supported by the Agriculture and Food Research Initiative Competitive Grants Program grant no. 2013-68004-20359 from the USDA National Institute of Food and Agriculture (NIFA) to IC. The development of T-BAS is supported by the National Science Foundation (NSF) Genealogy of Life (GoLife) program to IC (DEB-1541418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew SE, 1998, EQUINE VET J, V30, P109, DOI 10.1111/j.2042-3306.1998.tb04469.x; Andrew SE, 2003, VET OPHTHALMOL, V6, P45, DOI 10.1046/j.1463-5224.2003.00265.x; Ashu EE, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00019-17; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Betbeze CM, 2006, AM J VET RES, V67, P1788, DOI 10.2460/ajvr.67.10.1788; Carbone I, 2017, BIOINFORMATICS, V33, P1160, DOI 10.1093/bioinformatics/btw808; Denis HM, 2004, VET CLIN N AM-EQUINE, V20, P361, DOI 10.1016/j.cveq.2004.04.012; Gajjar DU, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/605308; Geiser DM, 2000, FUNGAL GENET BIOL, V31, P169, DOI 10.1006/fgbi.2000.1215; Gower EW, 2010, OPHTHALMOLOGY, V117, P2263, DOI 10.1016/j.ophtha.2010.03.048; He D, 2011, INVEST OPHTH VIS SCI, V52, P2804, DOI 10.1167/iovs.10-5977; Homa M, 2013, MYCOSES, V56, P501, DOI 10.1111/myc.12062; Hua X, 2010, INVEST OPHTH VIS SCI, V51, P1517, DOI 10.1167/iovs.09-4348; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kredics L, 2015, MYCOSES, V58, P243, DOI 10.1111/myc.12306; KURTZMAN CP, 1986, MYCOLOGIA, V78, P955, DOI 10.2307/3807436; Lalitha P, 2012, CORNEA, V31, P662, DOI 10.1097/ICO.0b013e31823f8ae0; Ledbetter EC, 2017, VET CLIN N AM-EQUINE, V33, P583, DOI 10.1016/j.cveq.2017.08.001; Manikandan P, 2013, MYCOSES, V56, P26, DOI 10.1111/j.1439-0507.2012.02194.x; Mascarenhas J, 2014, AM J OPHTHALMOL, V157, P56, DOI 10.1016/j.ajo.2013.08.032; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Miller MA, 2015, EVOL BIOINFORM, V11, P43, DOI 10.4137/EBO.S21501; Monacell JT, 2014, BIOINFORMATICS, V30, P1488, DOI 10.1093/bioinformatics/btu055; Moore GG, 2017, ECOL EVOL, V7, P9179, DOI 10.1002/ece3.3464; O'Donnell K, 2008, J CLIN MICROBIOL, V46, P2477, DOI 10.1128/JCM.02371-07; O'Donnell K, 2007, J CLIN MICROBIOL, V45, P2235, DOI 10.1128/JCM.00533-07; O'Donnell K, 2016, J CLIN MICROBIOL, V54, P2813, DOI 10.1128/JCM.01607-16; Oechsler RA, 2013, CORNEA, V32, P667, DOI 10.1097/ICO.0b013e318277ac74; Olarte RA, 2012, MOL ECOL, V21, P1453, DOI 10.1111/j.1365-294X.2011.05398.x; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Pearce JW, 2009, VET OPHTHALMOL, V12, P318, DOI 10.1111/j.1463-5224.2009.00721.x; Perez-Nadales E, 2014, FUNGAL GENET BIOL, V70, P42, DOI 10.1016/j.fgb.2014.06.011; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Ramirez-Prado JH, 2008, FUNGAL GENET BIOL, V45, P1292, DOI 10.1016/j.fgb.2008.06.007; Reed Z, 2013, EQUINE VET J, V45, P361, DOI 10.1111/j.2042-3306.2012.00623.x; Rex JH, 2008, M38A2 CLSI, V28, pM38; Roy P, 2017, CLIN EPIDEMIOL GLOB, V5, P40, DOI 10.1016/j.cegh.2016.02.001; Sherman AB, 2017, VET OPHTHALMOL, V20, P140, DOI 10.1111/vop.12381; Sousa ES, 2017, PLANT DIS, V101, P1954, DOI 10.1094/PDIS-05-17-0657-PDN; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tupaki-Sreepurna A, 2017, MYCOSES, V60, P230, DOI 10.1111/myc.12578; Utter ME, 2009, EQUINE VET EDUC, V21, P321, DOI 10.2746/095777309X400270; VILGALYS R, 1990, CURR GENET, V18, P277, DOI 10.1007/BF00318394; Voelter-Ratson K, 2013, EQUINE VET J, V45, P608, DOI 10.1111/evj.12042; Wada S, 2013, VET OPHTHALMOL, V16, P1, DOI 10.1111/j.1463-5224.2012.01004.x; Walther G, 2017, J CLIN MICROBIOL, V55, P2983, DOI 10.1128/JCM.00649-17; Wicklow Donald T., 2002, Mycoscience, V43, P289, DOI 10.1007/s102670200043; Zeiss C, 2013, VET OPHTHALMOL, V16, P341, DOI 10.1111/vop.12004; Zhang N, 2006, J CLIN MICROBIOL, V44, P2186, DOI 10.1128/JCM.00120-06	51	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214214	10.1371/journal.pone.0214214	http://dx.doi.org/10.1371/journal.pone.0214214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921394	gold, Green Submitted, Green Published			2022-12-27	WOS:000462594000042
J	Lee, K; Cho, S				Lee, Kyungmin; Cho, Soohyun			Visuo-spatial (but not verbal) executive working memory capacity modulates susceptibility to non-numerical visual magnitudes during numerosity comparison	PLOS ONE			English	Article							APPROXIMATE NUMBER SYSTEM; INDIVIDUAL-DIFFERENCES; QUANTITY DISCRIMINATION; ACUITY; INHIBITION; TASKS; SENSE; ANS; REPRESENTATIONS; ACHIEVEMENT	The present study tested whether visuo-spatial vs. verbal executive working memory capacity (hereafter EWM) modulates the degree to which non-numerical visual magnitudes influence numerosity comparison using pairs of dot arrays. We hypothesized that visuo-spatial (rather than verbal) EWM capacity would influence one's ability to selectively focus on numerical as opposed to non-numerical visual properties (such as dot size, cumulative area, density) of the dot arrays during numerosity comparison. Participants' performance was better on trials in which non-numerical visual magnitudes were negatively (vs. positively) correlated with numerosity (i.e., reverse congruency effect). The Low visuo-spatial EWM group manifested greater reverse congruency effect compared to the High visuo-spatial EWM group. A trial-based hierarchical regression on the accuracy of each trial using the ratio of (numerical and non-numerical) visual magnitudes as predictors revealed that the ratio of numerical vs. non-numerical visual magnitudes explained the greatest variance in the performance of the High vs. Low visuo-spatial EWM groups, respectively. In contrast, there was no difference between the High vs. Low verbal EWM groups from the same analysis. These results reveal differential susceptibility to numerical vs. non-numerical visual information depending on the capacity of visuo-spatial (but not verbal) EWM. Taken together, numerosity comparison performance measured with the dot comparison paradigm seems to reflect not only one's acuity for numerosity discrimination but also visuo-spatial EWM capacity likely required during integration of visual magnitudes during numerosity comparison.	[Lee, Kyungmin; Cho, Soohyun] Chung Ang Univ, Dept Psychol, Seoul, South Korea	Chung Ang University	Cho, S (corresponding author), Chung Ang Univ, Dept Psychol, Seoul, South Korea.	soohyun@cau.ac.kr		Lee, Kyungmin/0000-0001-5845-6893	National Research Foundation of Korea [NRF2017R1D1A1B03032115]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was funded by a grant (NRF2017R1D1A1B03032115) from the National Research Foundation of Korea (http://www.nrf.re.kr) awarded to S.C.	Agrillo C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015232; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Banks J, 2007, FISC STUD, V28, P143, DOI 10.1111/j.1475-5890.2007.00052.x; Banszegi O, 2016, ANIM COGN, V19, P879, DOI 10.1007/s10071-016-0985-2; Bogale BA, 2011, ANIM BEHAV, V82, P635, DOI 10.1016/j.anbehav.2011.05.025; Bugden S, 2016, DEVELOPMENTAL SCI, V19, P817, DOI 10.1111/desc.12324; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Cappelletti M, 2014, COGNITIVE PSYCHOL, V69, P25, DOI 10.1016/j.cogpsych.2013.11.004; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Clayton S, 2015, ACTA PSYCHOL, V161, P177, DOI 10.1016/j.actpsy.2015.09.007; Clayton S, 2015, ZDM-MATH EDUC, V47, P759, DOI 10.1007/s11858-014-0655-2; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; Dehaene S, 2001, MIND LANG, V16, P16, DOI 10.1111/1468-0017.00154; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dietrich JF, 2017, PSYCHOL RES; Dietrich JF, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00295; Fazio LK, 2014, J EXP CHILD PSYCHOL, V123, P53, DOI 10.1016/j.jecp.2014.01.013; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Foster JL, 2015, MEM COGNITION, V43, P226, DOI 10.3758/s13421-014-0461-7; Friso-van Den Bos I, 2014, LEARN INDIVID DIFFER, V33, P23, DOI 10.1016/j.lindif.2014.05.003; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Gandhi-Lee E., 2017, EUROPEAN J STEM ED, P2; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Gebuis T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025405; Gilmore C, 2016, J COGN PSYCHOL, V28, P923, DOI 10.1080/20445911.2016.1221828; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P1, DOI 10.1007/s10071-010-0337-6; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hanushek E.A., 2010, HIGH COST LOW ED PER; Iacobucci D, 2015, J CONSUM PSYCHOL, V25, P652, DOI 10.1016/j.jcps.2014.12.002; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Leibovich T, 2017, BEHAV BRAIN SCI, V40, P1, DOI 10.1017/S0140525X16000960; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Norris JE, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00999; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Parsons S., 2005, DOES NUMERACY MATTER; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Piffer L, 2012, ANIM COGN, V15, P215, DOI 10.1007/s10071-011-0447-9; Price GR, 2012, ACTA PSYCHOL, V140, P50, DOI 10.1016/j.actpsy.2012.02.008; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Salti M, 2017, BEHAV RES METHODS, V49, P1120, DOI 10.3758/s13428-016-0772-7; Schneider M, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12372; Smets K, 2015, J COGN PSYCHOL, V27, P310, DOI 10.1080/20445911.2014.996568; Soltesz F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-13; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Stancher G, 2015, ANIM COGN, V18, P219, DOI 10.1007/s10071-014-0791-7; Szucs D, 2013, CORTEX, V49, P2674, DOI 10.1016/j.cortex.2013.06.007; Szucs D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00444; Tomonaga M, 2008, ANIM COGN, V11, P43, DOI 10.1007/s10071-007-0089-0; Uller C, 2009, ANIM COGN, V12, P733, DOI 10.1007/s10071-009-0225-0; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x; Vonk J, 2012, ANIM BEHAV, V84, P231, DOI 10.1016/j.anbehav.2012.05.001; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	62	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214270	10.1371/journal.pone.0214270	http://dx.doi.org/10.1371/journal.pone.0214270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917158	Green Published, gold, Green Submitted			2022-12-27	WOS:000462465800059
J	Patil, K; Yelamanchi, S; Kumar, M; Hinduja, I; Prasad, TSK; Gowda, H; Mukherjee, S				Patil, Krutika; Yelamanchi, Soujanya; Kumar, Manish; Hinduja, Indira; Prasad, T. S. Keshava; Gowda, Harsha; Mukherjee, Srabani			Quantitative mass spectrometric analysis to unravel glycoproteomic signature of follicular fluid in women with polycystic ovary syndrome	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GRANULOSA-CELLS; OOCYTE QUALITY; MESSENGER-RNA; PROTEIN; RECEPTOR; NOREPINEPHRINE; METABOLISM; GENERATION; EXPRESSION	Polycystic ovary syndrome (PCOS) is a complex endocrinopathy affecting women of reproductive age, and whose etiology is not well understood yet. In these women, the follicular growth is arrested at preantral stage leading to cyst formation, consequently resulting in anovulatory infertility in these women. As the follicular fluid provides the conducive microenvironment for the growth of oocytes, molecular profiling of the fluid may provide unique information about pathophysiology associated with follicular development in PCOS. Post-translational addition of oligosaccharide residues is one of the many modifications of secreted proteins influencing their functions. These glycoproteins play a significant role in disease pathology. Despite glycoproteins having such essential functions, very limited information is available on their profiling in human reproductive system, and glycoproteomic profile of follicular fluid of women with PCOS is yet unexplored. In the present study, we performed a comparative glycoproteomic analysis of follicular fluid between women with PCOS and controls undergoing in vitro fertilization, by enrichment of glycoproteins using three different lectins viz. concanavalin A, wheat germ agglutinin and Jacalin. Peptides generated by trypsin digestion were labeled with isobaric tags for relative and absolute quantification reagents and analyzed by liquid chromatography tandem mass spectrometry. We identified 10 differentially expressed glycoproteins, in the follicular fluid of women with PCOS compared to controls. Two important differentially expressed proteins- SERPINA1 and ITIH4, were consistently upregulated and downregulated respectively, upon validation by immunoblotting in follicular fluid and real-time polymerase chain reaction in granulosa cells. These proteins play a role in angiogenesis and extracellular matrix stabilization, vital for follicle maturation. In conclusion, a comparative glycoproteomic profiling of follicular fluid from women with PCOS and controls revealed an altered expression of proteins which may contribute to the defects in follicle development in PCOS pathophysiology.	[Patil, Krutika; Mukherjee, Srabani] Indian Council Med Res, Natl Inst Res Reprod Hlth, Dept Mol Endocrinol, Mumbai, Maharashtra, India; [Yelamanchi, Soujanya; Kumar, Manish; Prasad, T. S. Keshava; Gowda, Harsha] Inst Bioinformat, Int Technol Pk, Bangalore, Karnataka, India; [Hinduja, Indira] PD Hinduja Natl Hosp & Med Res Ctr, Mumbai, Maharashtra, India; [Prasad, T. S. Keshava] Yenepoya Deemed Univ, Yenepoya Res Ctr, Ctr Syst Biol & Mol Med, Mangalore, India; [Kumar, Manish] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Yenepoya (Deemed to be University); Harvard University; Harvard T.H. Chan School of Public Health	Mukherjee, S (corresponding author), Indian Council Med Res, Natl Inst Res Reprod Hlth, Dept Mol Endocrinol, Mumbai, Maharashtra, India.	srabanimuk@yahoo.com	Gowda, Harsha/A-8526-2011; Mukherjee, Srabani/AGZ-9170-2022; Prasad, Keshava/F-7631-2010	Gowda, Harsha/0000-0002-4118-6855; Prasad, Keshava/0000-0002-6206-2384; Patil, Krutika/0000-0002-3987-2741; Yelamanchi, Soujanya D./0000-0002-8477-9618	Department of Biotechnology, Government of India [BT/PR16524/MED/97/346/2016]; National Institute for Research in Reproductive Health [RA/692/11-2018]; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute for Research in Reproductive Health; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Grant BT/PR16524/MED/97/346/2016 (to SM) from the Department of Biotechnology, Government of India. We acknowledge necessary support from the National Institute for Research in Reproductive Health (RA/692/11-2018) and Indian Council of Medical Research (ICMR), New Delhi, India. The authors gratefully acknowledge financial assistance from Council of Scientific and Industrial Research (CSIR), India to KP for pursuing her doctoral studies.; The authors thank the study participants. Glycoproteomics experiment was carried out at Institute of Bionformatics, Bangalore 560066. We thank Ministry of Health and Family Welfare, Government of India for supporting with Orbitrap Fusion Tribrid instrument at NIM-HANS-IOB Proteomic and Bioinformatics Laboratory. We also thank Kiran Kumar Mangalaparthi for helping in proteomics analysis. This work was supported by Grant BT/PR16524/MED/97/346/2016 from the Department of Biotechnology, Government of India. We acknowledge necessary support from the National Institute for Research in Reproductive Health (RA/692/11-2018) and Indian Council of Medical Research (ICMR), New Delhi, India. The authors gratefully acknowledge financial assistance from Council of Scientific and Industrial Research (CSIR), India to KP for pursuing her doctoral studies.	Ambekar AS, 2015, J CLIN ENDOCR METAB, V100, P744, DOI 10.1210/jc.2014-2086; Ambekar AS, 2013, J PROTEOMICS, V87, P68, DOI 10.1016/j.jprot.2013.05.017; Amjadi F, 2018, REPROD BIOMED ONLINE, V37, P184, DOI 10.1016/j.rbmo.2018.04.043; Arnold AC, 2017, J CLIN ENDOCR METAB, V102, P10, DOI 10.1210/jc.2016-3274; Atiomo WU, 1998, FERTIL STERIL, V69, P236, DOI 10.1016/S0015-0282(97)00486-X; Barallobre-Barreiro J, 2012, CIRCULATION, V125, P789, DOI 10.1161/CIRCULATIONAHA.111.056952; Benkhalifa M, 2015, EXPERT REV PROTEOMIC, V12, P407, DOI 10.1586/14789450.2015.1056782; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Chander KB, 2014, J PROTEOME RES, V13, P3314, DOI 10.1021/pr500394z; Chandler K, 2013, MOL CELL PROTEOMICS, V12, P836, DOI 10.1074/mcp.R112.026930; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Da Broi MG, 2018, J ASSIST REPROD GEN, V35, P735, DOI 10.1007/s10815-018-1143-3; Di Pietro M, 2018, REPRODUCTION, V155, pR199, DOI 10.1530/REP-17-0597; Drake Richard R, 2018, Curr Protoc Protein Sci, V94, pe68, DOI 10.1002/cpps.68; Escobar-Morreale HF, 2016, DIABETES CARE, V39, P639, DOI 10.2337/dc15-2577; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Fujiwara T, 2000, FERTIL STERIL, V74, P348, DOI 10.1016/S0015-0282(00)00652-X; Gomez R, 2011, J CLIN ENDOCR METAB, V96, P2484, DOI 10.1210/jc.2011-0075; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hess KA, 1999, BIOL REPROD, V61, P436, DOI 10.1095/biolreprod61.2.436; Hunt JM, 2012, CURR MOL MED, V12, P827; Kadariya I, 2015, J STEROID BIOCHEM, V152, P161, DOI 10.1016/j.jsbmb.2015.05.006; Kaur S, 2012, J CLIN ENDOCR METAB, V97, pE2016, DOI 10.1210/jc.2011-3441; Kordestani F, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0662-1; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; LambertMesserlian G, 1997, BIOL REPROD, V57, P1211, DOI 10.1095/biolreprod57.5.1211; Musali N, 2016, GYNECOL ENDOCRINOL, V32, P460, DOI 10.3109/09513590.2015.1130808; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Niu ZH, 2017, CYTOKINE, V91, P180, DOI 10.1016/j.cyto.2016.12.020; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Orio F, 2004, REPROD BIOMED ONLINE, V9, P505, DOI 10.1016/S1472-6483(10)61634-3; Palomba S, 2017, TRENDS ENDOCRIN MET, V28, P186, DOI 10.1016/j.tem.2016.11.008; Pawelczak M, 2014, J PEDIATR ADOL GYNEC, V27, P356, DOI 10.1016/j.jpag.2014.01.104; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Qiao J, 2011, HUM REPROD UPDATE, V17, P17, DOI 10.1093/humupd/dmq032; Roby KF, 1999, BIOL REPROD, V61, P1616, DOI 10.1095/biolreprod61.6.1616; Saller S, 2014, HUM REPROD, V29, P555, DOI 10.1093/humrep/det422; Saller S, 2012, ENDOCRINOLOGY, V153, P1472, DOI 10.1210/en.2011-1769; Scalici E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24976; Son DS, 2004, ENDOCRINOLOGY, V145, P1218, DOI 10.1210/en.2003-0860; Tal R, 2015, SEMIN REPROD MED, V33, P195, DOI 10.1055/s-0035-1552582; Tian Y, 2010, PROTEOM CLIN APPL, V4, P124, DOI 10.1002/prca.200900161; Tillgren V, 2015, J BIOL CHEM, V290, P918, DOI 10.1074/jbc.M114.593541; Wang BJ, 2016, J ASSIST REPROD GEN, V33, P959, DOI 10.1007/s10815-016-0704-6; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Zhou DN, 2017, EUR J OBSTET GYN R B, V218, P106, DOI 10.1016/j.ejogrb.2017.09.017; Zhou L, 2009, J PROTEOME RES, V8, P1992, DOI 10.1021/pr800962q	48	12	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214742	10.1371/journal.pone.0214742	http://dx.doi.org/10.1371/journal.pone.0214742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946770	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500059
J	Ordonez-Gomez, JD; Santillan-Doherty, AM; Hammerschmidt, K				Ordonez-Gomez, Jose D.; Santillan-Doherty, Ana M.; Hammerschmidt, Kurt			Acoustic variation of spider monkey (Ateles geoffroyi) contact calls is related to caller isolation and affects listeners' responses	PLOS ONE			English	Article							COMMUNICATION; SOUND	Group living animals produce vocalizations denominated "contact calls" to maintain contact with out-of-sight group members. These calls have been shown to vary with caller identity and distance to potential listeners. However, it is not clear whether the acoustic variation of contact calls is related to caller social isolation (e.g., inside or outside a subgroup) and listeners' responses that can be helpful to maintain contact. Here, we addressed these questions in spider monkeys (Ateles geoffroyi), a Neotropical primate that exchanges contact calls denominated "whinnies", which show graded variation related to caller immediate behavior and distance between callers. Using 566 whinnies produced by 35 free-ranging adult spider monkeys recorded at <= 20 m from microphones, we first analyzed whether the acoustic variation of spontaneous whinnies (i.e., whinnies that are not responses to previous whinnies) is related to caller social isolation or whether acoustic variation is related to the likelihood of eliciting a response whinny from another individual. Secondly, we assessed whether listeners' responses (i.e., time to respond vocally, acoustic characteristics of response whinnies, orienting behaviors) were related to the acoustic variation of previous whinnies. Our study revealed that callers that were outside a subgroup produced whinnies with a lower fundamental frequency (F0), which travels longer distances, and increases the likelihood of producing a response whinny. Moreover, listeners (i.e., responders) responded faster to lower F0 whinnies. However, the acoustic variation (i.e., F0 variation) in response whinnies was better explained by the separation distance between callers, than by the acoustic variation of the previous whinny. Overall, our results suggest that whinny variation facilitates vocal contact to callers that are outside a subgroup, and that context and whinny variation affect listeners' responses.	[Ordonez-Gomez, Jose D.; Hammerschmidt, Kurt] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Santillan-Doherty, Ana M.] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Neurociencias, Mexico City, DF, Mexico	Deutsches Primatenzentrum (DPZ); Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz	Ordonez-Gomez, JD (corresponding author), German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.	josed_ordonez@hotmail.com		Ordonez Gomez, Jose Domingo/0000-0002-6929-1470	Consejo Nacional de Ciencia y Tecnologia [215506]; program of Estancias Posdoctorales en el Extranjero Vinculadas a la Consolidacion de Grupos de Investigacion y Fortalecimiento del Posgrado Nacional of the Consejo Nacional de Ciencia y Tecnologia (CONACyT)	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); program of Estancias Posdoctorales en el Extranjero Vinculadas a la Consolidacion de Grupos de Investigacion y Fortalecimiento del Posgrado Nacional of the Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	JDOG received financial support by the Consejo Nacional de Ciencia y Tecnologia (https://www.conacyt.gob.mx/), under Grant No. 215506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided by the program of Estancias Posdoctorales en el Extranjero Vinculadas a la Consolidacion de Grupos de Investigacion y Fortalecimiento del Posgrado Nacional of the Consejo Nacional de Ciencia y Tecnologia (CONACyT). We thank B. Hernandez for his invaluable field assistance and the people of the ejido Reforma Agraria for allowing us to conduct this study in their natural reserve. Sofi Blue greatly helped with getting the manuscript in shape, and Julia Fischer provided valuable feed-back. Finally, we thank Jon T. Sakata and two anonymous reviewers for their very helpful suggestions and comments.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; Bouchet H, 2017, ANIM BEHAV, V129, P81, DOI 10.1016/j.anbehav.2017.05.012; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; CHAPMAN CA, 1990, AM J PRIMATOL, V22, P279, DOI 10.1002/ajp.1350220407; Chatterjee S., 2012, REGRESSION ANAL EXAM; Cheney DL, 1996, ANIM BEHAV, V52, P507, DOI 10.1006/anbe.1996.0193; Dittus W., 1988, P31; Fischer J, 2017, NEUROSCI BIOBEHAV R, V82, P22, DOI 10.1016/j.neubiorev.2016.10.014; Fitch WT, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600723; Fox J., 2019, R COMPANION APPL REG, V.; Gomez JD, 2018, AM J PRIMATOL, V80, P1; Liao DNA, 2018, P NATL ACAD SCI USA, V115, P3978, DOI 10.1073/pnas.1722426115; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; Oda R, 1996, INT J PRIMATOL, V17, P191, DOI 10.1007/BF02735447; Ordonez-Gomez JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149671; Ordonez-Gomez JD, 2015, INT J PRIMATOL, V36, P429, DOI 10.1007/s10764-015-9833-5; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Padgham M, 2004, J ACOUST SOC AM, V115, P402, DOI 10.1121/1.1629304; Price T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13220; Ramos-Fernandez G, 2005, INT J PRIMATOL, V26, P1077, DOI 10.1007/s10764-005-6459-z; Ramos-Fernandez G, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0532; Ramos-Fernandez G, 2008, CAM S BIO EVOL ANTHR, V55, P220; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Rivera-Caceres KD, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171791; Santorelli CJ, 2013, INT J PRIMATOL, V34, P1172, DOI 10.1007/s10764-013-9736-2; Schamberg I, 2018, BIOL REV, V93, P2071, DOI 10.1111/brv.12437; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Slocombe KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011473; Sugiura H, 2007, AM J PRIMATOL, V69, P1412, DOI 10.1002/ajp.20447; Takahashi DY, 2013, CURR BIOL, V23, P2162, DOI 10.1016/j.cub.2013.09.005; Teixidor P, 1999, BEHAVIOUR, V136, P279, DOI 10.1163/156853999501333; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Wheeler BC, 2012, EVOL ANTHROPOL, V21, P195, DOI 10.1002/evan.21319; Wilden I., 1998, Bioacoustics, V9, P171	38	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213914	10.1371/journal.pone.0213914	http://dx.doi.org/10.1371/journal.pone.0213914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943237	Green Submitted, gold, Green Published			2022-12-27	WOS:000463194300021
J	Chen, YT; Hsu, HJ; Hsu, CK; Lee, CC; Hsu, KH; Sun, CY; Chen, CY; Chen, YC; Yu, YC; Wu, IW				Chen, Yih-Ting; Hsu, Heng-Jung; Hsu, Cheng-Kai; Lee, Chin-Chan; Hsu, Kuang-Hung; Sun, Chiao-Yin; Chen, Chun-Yu; Chen, Yung-Chang; Yu, Yi-Ching; Wu, I-Wen			Correlation between spot and 24h proteinuria: Derivation and validation of equation to estimate daily proteinuria	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; URINARY PROTEIN/CREATININE RATIO; TO-CREATININE RATIO; EXCRETION RATE; SAMPLES	Daily urine protein (UP) loss is a cumbersome but important measurement to guide diagnosis and treatment of renal disease. Spot urine protein-creatinine ratio (UPCR) can been applied to estimate daily proteinuria. However, the correlations between spot and 24h proteinuria remain controversial. In this cross-sectional study, simultaneous collection of 24h and spot urines were performed from 1,039 (derivation cohort) and 204 CKD patients (validation cohort) of Chang Gung Memorial Hospital, from 2007 to 2017. The correlations between spot UPCR and 24h proteinuria were compared. The mean age of patients of derivation and validation cohort was 63 and 55 years and the mean estimated glomerular filtration rate was 62 +/- 35 and 59 +/- 36 mL/min/m(2), respectively. The correlation coefficient was 0.819 between UPCR and 24hUP. Prediction equation was derived as: Log(10)24hUP (g) = 0.814 x Log(10)UPCR (mg/mg) + 0.110 x Gender-0.004 x Age + 0.004 x Body weight (kg) + 0.002 x CKD stage coefficient-0.018, where CKD stage coefficient: CKD stage G1 = 1, G2 = 2, G3a = 3.1, G3b = 3.2, G4 = 4, G5 = 5. Correlation coefficient between measured and predicted 24hUP among derivation group and validation group is 0.866 and 0.915, respectively. However, the agreement of spot and daily estimates was less pronounced with proteinuria > 3g than lower values in Bland-Altman analysis. Spot UPCR can accurately predict 24hUP in patients with daily proteinuria below 3g. The development of this equation may facilitate estimation of 24hUP in the clinical practice.	[Chen, Yih-Ting; Hsu, Heng-Jung; Hsu, Cheng-Kai; Lee, Chin-Chan; Sun, Chiao-Yin; Chen, Chun-Yu; Chen, Yung-Chang; Wu, I-Wen] Chang Gung Mem Hosp, Dept Nephrol, Keelung, Taiwan; [Hsu, Heng-Jung; Wu, I-Wen] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Yu, Yi-Ching] Chang Gung Mem Hosp, Dept Neurol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Wu, IW (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Keelung, Taiwan.; Wu, IW (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	fliawu@yahoo.com		Hsu, Cheng-Kai/0000-0002-6812-526X; WU, I-WEN/0000-0001-8535-3582	Chang Gung Memorial Hospital [CMRPG260323, CMRPG2C0342, CMRPG2F0072, CIRPG2E0013]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	I.W.W. received grants sponsored by Chang Gung Memorial Hospital (CMRPG260323, CMRPG2C0342, CMRPG2F0072, CIRPG2E0013).	Bhide A, 2015, ACTA OBSTET GYN SCAN, V94, P542, DOI 10.1111/aogs.12624; Chen CF, 2015, AM J MED SCI, V349, P477, DOI 10.1097/MAJ.0000000000000488; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fotheringham J, 2014, AM J KIDNEY DIS, V63, P405, DOI 10.1053/j.ajkd.2013.08.009; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gaspari F, 2006, AM J KIDNEY DIS, V47, P1, DOI 10.1053/j.ajkd.2005.10.014; GINSBERG JM, 1983, NEW ENGL J MED, V309, P1543, DOI 10.1056/NEJM198312223092503; Hogan MC, 2016, KIDNEY INT, V90, P1080, DOI 10.1016/j.kint.2016.06.020; KOOPMAN MG, 1989, NEPHROL DIAL TRANSPL, V4, P9; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Medina-Rosas J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0808-x; Methven S, 2010, NEPHROL DIAL TRANSPL, V25, P2991, DOI 10.1093/ndt/gfq140; Morales JV, 2004, J NEPHROL, V17, P666; Naresh CN, 2013, AM J KIDNEY DIS, V62, P1095, DOI 10.1053/j.ajkd.2013.06.016; Nayak R, 2013, Indian J Nephrol, V23, P428, DOI 10.4103/0971-4065.120340; Price CP, 2005, CLIN CHEM, V51, P1577, DOI 10.1373/clinchem.2005.049742; Rodby RA, 1995, AM J KIDNEY DIS, V26, P904, DOI 10.1016/0272-6386(95)90054-3; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Ruggenenti P, 1998, BRIT MED J, V316, P504, DOI 10.1136/bmj.316.7130.504; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Talreja H, 2014, AM J KIDNEY DIS, V64, P962, DOI 10.1053/j.ajkd.2014.07.027; Teo BW, 2015, INT J NEPHROL, V2015, DOI 10.1155/2015/156484; Ubukata M, 2016, CLIN EXP NEPHROL, V20, P456, DOI 10.1007/s10157-015-1178-z; Wahbeh AM, 2009, SAUDI J KIDNEY DIS T, V20, P443; Wuerzner G, 2014, NEPHROL DIAL TRANSPL, V29, P1475, DOI 10.1093/ndt/gft525; Yang EM, 2017, PEDIATR NEPHROL, V32, P1045, DOI 10.1007/s00467-017-3587-6	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214614	10.1371/journal.pone.0214614	http://dx.doi.org/10.1371/journal.pone.0214614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939176	gold, Green Published, Green Submitted			2022-12-27	WOS:000462993900033
J	Kumpeangkeaw, A; Tan, DG; Fu, LL; Han, BY; Sun, XP; Hu, XW; Ding, ZH; Zhang, JM				Kumpeangkeaw, Anuwat; Tan, Deguan; Fu, Lili; Han, Bingying; Sun, Xuepiao; Hu, Xiaowen; Ding, Zehong; Zhang, Jiaming			Asymmetric birth and death of type I and type II MADS-box gene subfamilies in the rubber tree facilitating laticifer development	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; HOMEOTIC GENE; TRANSCRIPTION FACTOR; ALTERNATIVE SOURCES; FLOWER DEVELOPMENT; EARLY EVOLUTION; ARABIDOPSIS; FAMILY; EXPRESSION; ORIGIN	The rubber tree (Hevea brasiliensis Muell. Arg.) is a rubber producing crop and contains specialized laticifers. MADS-box genes are a family of transcription factor genes that regulate plant development, especially floral organ and gametophyte development. 97 MADS-box genes were identified in the rubber tree through transcriptomes and genome mining. 93.8% of the genes were mapped onto the genome scaffolds in correspondence to the coverage (93.8%) of current version of sequenced genome. Phylogenetic analysis indicates that type II MADS-box genes have been more actively duplicated than their orthologous genes in Arabidopsis and rice, so that most (70, 72.2%) of the MADS-box genes in the rubber tree belong to type II subfamily. This is a high percentage compared to those in Arabidopsis (43.7%) and rice (56.8%). Moreover, 69 out of 70 type II genes in the rubber tree are transcribed, and they are mostly predominantly expressed in flowers, but some genes are predominantly expressed in laticifers, suggesting their roles in both flower and laticifer development. The number of type I genes in the rubber tree is only 27 (27.8%), a much smaller number compared to their orthologous genes in Arabidopsis (56.3%) and rice (43.2%). At the same time, most of the type I genes (55.6%, 15) in the rubber tree are silent and are probably pseudogenes. The high birth rate and low death rate of type II genes and low birth rate and high death rate of type I genes may corresponds to special developmental requirements in the rubber tree, e.g. the development of laticifer system for biosynthesis of cis-poly-isoprene, the rubber. Moreover, atypical MIKC* factors (e.g. HbMADS1 in S-clade, and HbMADS20 in P-clade) are identified. These genes are diverged to typical MIKC* genes in sequences and facilitate functions required in laticifer development and rubber biosynthesis, which is not necessary in Arabidopsis and rice.	[Kumpeangkeaw, Anuwat] Huazhong Agr Univ, Int Coll, Wuhan, Hubei, Peoples R China; [Kumpeangkeaw, Anuwat; Tan, Deguan; Fu, Lili; Han, Bingying; Sun, Xuepiao; Ding, Zehong; Zhang, Jiaming] CATAS, Hainan Bioenergy Ctr, MOA Key Lab Trop Crops Biol & Genet Resources, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China; [Kumpeangkeaw, Anuwat] Minist Agr & Cooperat, Dept Agr, Song Khla Rubber Res Ctr, Hat Yai, Song Khla, Thailand; [Hu, Xiaowen] CATAS, Zhanjiang Expt Stn, Zhanjiang, Guangdong, Peoples R China	Huazhong Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences	Zhang, JM (corresponding author), CATAS, Hainan Bioenergy Ctr, MOA Key Lab Trop Crops Biol & Genet Resources, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China.	zhangjiaming@itbb.org.cn			Natural Science Foundation of China [31471561]; National Key R&D Program of China [2018YFD1000500]; Natural Science Foundation of Hainan Province [318MS091]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Natural Science Foundation of Hainan Province	This study was funded by the Natural Science Foundation of China (31471561), National Key R&D Program of China (2018YFD1000500), and the Natural Science Foundation of Hainan Province (318MS091).	Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bennici A, 2007, RIV BIOL-BIOL FORUM, V100, P55; Bennici Andrea, 2008, Commun Integr Biol, V1, P212; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; De Bodt S, 2003, J MOL EVOL, V56, P573, DOI 10.1007/s00239-002-2426-x; Duan WK, 2015, MOL GENET GENOMICS, V290, P239, DOI 10.1007/s00438-014-0912-7; Friedman WE, 2000, PHILOS T R SOC B, V355, P857, DOI 10.1098/rstb.2000.0620; Fu LL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030283; Garcia-Cruz KV, 2016, ANN BOT-LONDON, V118, P787, DOI 10.1093/aob/mcw126; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gramzow L, 2015, J EXP ZOOL PART B, V324, P353, DOI 10.1002/jez.b.22598; Gramzow L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00214; Gramzow L, 2010, TRENDS GENET, V26, P149, DOI 10.1016/j.tig.2010.01.004; Gu Q, 1998, DEVELOPMENT, V125, P1509; Guo XH, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0544-1; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu LF, 2012, GENOME, V55, P245, DOI [10.1139/G2012-009, 10.1139/g2012-009]; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; Jiang SC, 2014, J INTEGR AGR, V13, P1239, DOI 10.1016/S2095-3119(13)60520-1; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kofuji R, 2003, MOL BIOL EVOL, V20, P1963, DOI 10.1093/molbev/msg216; Kozlowski LP, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0159-9; Kumar G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20695; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwantes M, 2012, MOL BIOL EVOL, V29, P293, DOI 10.1093/molbev/msr200; Li C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fols.2016.01390; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Li HL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01709; Li HL, 2011, MOL BIOL REP, V38, P4045, DOI 10.1007/s11033-010-0523-2; Li QX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0832-2; Lin CS, 2016, PLANT BIOTECHNOL J, V14, P284, DOI 10.1111/pbi.12383; Liu JY, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0031-4; Liu Y, 2013, PLANT CELL, V25, P1288, DOI 10.1105/tpc.113.110049; Ma J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181443; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Mooibroek H, 2000, APPL MICROBIOL BIOT, V53, P355, DOI 10.1007/s002530051627; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; PASSMORE S, 1988, J MOL BIOL, V204, P593, DOI 10.1016/0022-2836(88)90358-0; Pootakham W, 2017, SCI REP-UK, V7, DOI 10.1038/srep41457; Ruelens P, 2017, PLANT CELL, V29, P229, DOI 10.1105/tpc.16.00366; Saha G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1349-z; Sakdapipanich JT, 2007, J BIOSCI BIOENG, V103, P287, DOI 10.1263/jbb.103.287; SCHWARZSOMMER Z, 1992, EMBO J, V11, P251, DOI 10.1002/j.1460-2075.1992.tb05048.x; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; Tan DG, 2019, TREES-STRUCT FUNCT, V33, P193, DOI 10.1007/s00468-018-1768-y; Tan DG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03083-3; Tang CR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.73, 10.1038/nplants.2016.73]; Tapia-Lopez R, 2008, PLANT PHYSIOL, V146, P1182, DOI 10.1104/pp.107.108647; Thangavel G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00510; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/BF02337521; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; van Beilen JB, 2007, CRIT REV BIOTECHNOL, V27, P217, DOI 10.1080/07388550701775927; Verelst W, 2007, PLANT PHYSIOL, V143, P447, DOI 10.1104/pp.106.089805; Verelst W, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r249; Wang YQ, 2010, PLANT J, V64, P177, DOI 10.1111/j.1365-313X.2010.04325.x; Winter KU, 2002, PLANT J, V31, P457, DOI 10.1046/j.1365-313X.2002.01375.x; Yang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051435; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Zhang LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01159-8; Zobell O, 2010, MOL BIOL EVOL, V27, P1201, DOI 10.1093/molbev/msq005	73	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214335	10.1371/journal.pone.0214335	http://dx.doi.org/10.1371/journal.pone.0214335			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934009	Green Published, gold, Green Submitted			2022-12-27	WOS:000462867000014
J	Liu, TW; Ng, SSM				Liu, Tai-Wa; Ng, Shamay S. M.			The reliability and validity of the Survey of Activities and Fear of Falling in the Elderly for assessing fear and activity avoidance among stroke survivors	PLOS ONE			English	Article							BALANCE CONFIDENCE; SENIORS	Introduction Activity restriction due to fear of falling is a common problem after a stroke. It can lead to deteriorated physical condition, restricted social participation and deprived quality of life. The Survey of Activities and Fear of Falling in the Elderly (SAFE) was developed to assess these difficulties, and its utility has been demonstrated among the older adults and older people with Parkinson's disease. This study aimed to expand those demonstrations to community-dwelling chronic stroke survivors using a Chinese translation of the instrument. Methods One hundred and eight elderly individuals with a history of stroke completed the Chinese version of the SAFE (SAFE-C). The internal consistency of their responses was assessed using Cronbach's alpha. Twenty of the same subjects were reassessed after a 1-week interval to assess the instrument's test-retest reliability. Structure validity was examined by exploratory factor analysis. Pearson correlation was used to establish the instrument's convergent validity with respect to the results from the Chinese version of the Activities-specific Balance Confidence Scale (ABC-C) and the Chinese version of the Lawton Instrumental Activities of Daily Living scale (IADL-C). Results The items of the SAFE-C demonstrated excellent internal consistency with a Cronbach's alphas of 0.90. The SAFE-C also had excellent test-retest reliability with an overall intra-class correlaton coefficient of 0.91. A 1-factor structure termed "fear avoidance circumstances" was identified and it was shown to be consistent with the original measure developed among community-living older people. The correlations between the SAFE-C and the ABC-C (r = -0.68) and the IADL-C (r = -0.57) confirmed the convergent validity. Conclusions Fear avoidance behavior is a homogeneous construct applicable to people with stroke-specific impairments alike. The SAFE-C is a reliable and valid instrument for measuring the level of fear avoidance behavior among community-dwelling stroke survivors. Stroke survivors with good functional mobility revealed a low level of fear and avoidance as measured by the SAFE-C.	[Liu, Tai-Wa; Ng, Shamay S. M.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China; [Liu, Tai-Wa] Open Univ Hong Kong, Sch Nursing & Hlth Studies, Ho Man Tin, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Metropolitan University	Ng, SSM (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China.	Shamay.Ng@polyu.edu.hk	NG, Sheung Mei Shamay/E-2731-2016	NG, Sheung Mei Shamay/0000-0003-1660-0548	General Research Fund [15101217]; Research Grants Council, Hong Kong	General Research Fund; Research Grants Council, Hong Kong(Hong Kong Research Grants Council)	This study was supported by the General Research Fund (reference number 15101217) from the Research Grants Council, Hong Kong to Dr. Shamay S. M. Ng and her team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouwer B, 2004, GERONTOLOGY, V50, P135, DOI 10.1159/000076771; Chou KL, 2005, AGING MENT HEALTH, V9, P255, DOI 10.1080/13607860500114035; Chu L. W., 1995, Hong Kong Medical Journal, V1, P207; Field A., 2009, DISCOVERING STAT USI, DOI DOI 10.1080/1057610X.2016.1157408; Fletcher PC, 2004, AGE AGEING, V33, P273, DOI 10.1093/ageing/afh077; Howland J, 1998, GERONTOLOGIST, V38, P549, DOI 10.1093/geront/38.5.549; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kempen GIJM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-170; Kline P., 2000, HDB PSYCHOL TESTING; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lachman ME, 1998, J GERONTOL B-PSYCHOL, V53, pP43, DOI 10.1093/geronb/53B.1.P43; Li FZ, 2003, J GERONTOL B-PSYCHOL, V58, pP283, DOI 10.1093/geronb/58.5.P283; Liu TW, 2015, ARCH PHYS MED REHAB, V96, P1684, DOI 10.1016/j.apmr.2015.05.005; Mak MK, 2007, ARCH PHYS MED REHAB, V88, P496, DOI 10.1016/j.apmr.2007.01.018; Masoumeh Z, 2016, MIDDLE E J REHABIL H, V3; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Ng SSM, 2011, DISABIL REHABIL, V33, P2291, DOI 10.3109/09638288.2011.568667; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Tong AY, OTJR OCCUPATION PART; Ware JE Jr, 1993, SF 36 HLTH SURVEY MA; Wilson MMG, 2005, J GERONTOL A-BIOL, V60, P355, DOI 10.1093/gerona/60.3.355; Zijlstra GAR, 2009, J AM GERIATR SOC, V57, P2020, DOI 10.1111/j.1532-5415.2009.02489.x	22	3	3	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214796	10.1371/journal.pone.0214796	http://dx.doi.org/10.1371/journal.pone.0214796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934022	Green Published, gold			2022-12-27	WOS:000462867000042
J	Sekhar, KR; Wang, J; Freeman, ML; Kirschner, AN				Sekhar, Konjeti R.; Wang, Jian; Freeman, Michael L.; Kirschner, Austin N.			Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway	PLOS ONE			English	Article							ANDROGEN RECEPTOR; CELLS; ATM	Radiation therapy is often combined with androgen deprivation therapy in the treatment of aggressive localized prostate cancer. However, castration-resistant disease may not respond to testosterone deprivation approaches. Enzalutamide is a second-generation antiandrogen with high affinity and activity that is used for the treatment of metastatic disease. Although radiosensitization mechanisms are known to be mediated through androgen receptor activity, this project aims to uncover the detailed DNA damage repair factors influenced by enzalutamide using multiple models of androgen-sensitive (LNCaP) and castration-resistant human prostate cancer (22Rv1 and DU145). Enzalutamide is able to radiosensitize both androgen-dependent and androgen-independent human prostate cancer models in cell culture and xenografts in mice, as well as a treatment-resistant patient-derived xenograft. The enzalutamide-mediated mechanism of radiosensitization includes delay of DNA repair through temporal prolongation of the repair factor complexes and halting the cell cycle, which results in decreased colony survival. Altogether, these findings support the use of enzalutamide concurrently with radiotherapy to enhance the treatment efficacy for prostate cancer.	[Sekhar, Konjeti R.; Wang, Jian; Freeman, Michael L.; Kirschner, Austin N.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University	Kirschner, AN (corresponding author), Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, 221 Kirkland Hall, Nashville, TN 37235 USA.	austin.kirschner@vumg.org	Kirschner, Austin/AAI-8383-2020	Kirschner, Austin/0000-0003-3807-6900; Konjeti, Sekhar/0000-0003-2930-0739	Astellas Pharma Global Development, Inc. [ENZA-15C03]; K12 award from the Vanderbilt Clinical Oncology Research Career Development Program [5K12CA090625-18]; NCI/NIH Cancer Center Support Grant [5P30 CA68485-19]; Vanderbilt Mouse Metabolic Phenotyping Center Grant [5U24DK059637-13]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485, K12CA090625] Funding Source: NIH RePORTER	Astellas Pharma Global Development, Inc.; K12 award from the Vanderbilt Clinical Oncology Research Career Development Program; NCI/NIH Cancer Center Support Grant; Vanderbilt Mouse Metabolic Phenotyping Center Grant; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Astellas Pharma Global Development, Inc. provided enzalutamide and funding for this project (ENZA-15C03 to ANK). ANK is also supported by a K12 award from the Vanderbilt Clinical Oncology Research Career Development Program (5K12CA090625-18). We appreciate the skilled services and assistance from the VUMC Digital Histology Shared Resource, VUMC Flow Cytometry Shared Resource, and the VUMC Translational Pathology Shared Resource supported by NCI/NIH Cancer Center Support Grant 5P30 CA68485-19 and the Vanderbilt Mouse Metabolic Phenotyping Center Grant 5U24DK059637-13. Whole slide imaging and quantification of immunostaining were performed in the Digital Histology Shared Resource at VUMC (www.mc.vanderbilt.edu/dhsr).The VUMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2016, BIOCHEM CELL BIOL, V94, P381, DOI 10.1139/bcb-2016-0017; Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barrado M, 2018, RADIOPOTENTIATION EN, DOI 10.1101/324889; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ghashghaei M, 2018, PROSTATE, V78, P64, DOI 10.1002/pros.23445; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Guerrero J, 2013, PROSTATE, V73, P1291, DOI 10.1002/pros.22674; Hoefer J, 2016, ONCOTARGET, V7, P59781, DOI 10.18632/oncotarget.10926; Hussain M, 2018, NEW ENGL J MED, V378, P2465, DOI 10.1056/NEJMoa1800536; Kirschner AN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju407; Martinez HD, 2008, J BIOL CHEM, V283, P29938, DOI 10.1074/jbc.M800534200; Mohiuddin JJ, 2015, NAT REV UROL, V12, P145, DOI 10.1038/nrurol.2015.25; Ning YMM, 2013, CLIN CANCER RES, V19, P6067, DOI 10.1158/1078-0432.CCR-13-1763; Palacios DA, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-4; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Reddy V, 2015, J BIOL CHEM, V290, P25522, DOI 10.1074/jbc.M115.671404; Rodriguez-Berriguete G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1839-z; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Yan Y, 2008, CANCER RES, V68, P5113, DOI 10.1158/0008-5472.CAN-07-5818	27	19	19	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214670	10.1371/journal.pone.0214670	http://dx.doi.org/10.1371/journal.pone.0214670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933998	gold, Green Submitted, Green Published			2022-12-27	WOS:000462867000034
J	Alsous, M; Jalil, MA; Odeh, M; Al Kurdi, R; Alnan, M				Alsous, Mervat; Jalil, Mariam Abdel; Odeh, Mohanad; Al Kurdi, Rasha; Alnan, Murhaf			Public knowledge, attitudes and practices toward diabetes mellitus: A cross-sectional study from Jordan	PLOS ONE			English	Article							RISK; ASSOCIATION; PREVALENCE; MANAGEMENT; STATEMENT; AWARENESS	Aims To assess the knowledge and practices toward diabetes in the Jordanian community. Methods This study was conducted as a public based cross-sectional study in different cities in Jordan. A previously published validated questionnaire about knowledge, attitudes, and practices (KAP) toward diabetes mellitus (DM) was translated from the Arabic version and used in this study with very minor modification to be suitable for this study of the Jordanian population. Results A total of 1,702 participants were recruited in the present study. About half of the participants (53.3%) had good knowledge scores. The respondents' knowledge scores were significantly correlated with attitudes (p < 0.001). The education level (university or higher) and education related to a field were predictors for good knowledge and positive attitudes. About 46.3% of participants had positive attitudes toward the disease. As for practices, 37.7% of participants did not engage in regular exercise while more than half of the study subjects had never checked their blood glucose level on an annual basis. The factors influencing the practice of checking blood glucose level have been investigated. Conclusion This study has highlighted the need for more educational interventions to address negative attitudes and promote healthy lifestyle practices and regular health checks especially in certain subgroups of patients, such as those not having a degree related to the medical field and not having a first-degree relative with DM.	[Alsous, Mervat] Yarmouk Univ, Dept Pharm Practice, Fac Pharm, Irbid, Jordan; [Jalil, Mariam Abdel; Odeh, Mohanad] Univ Jordan, Dept Biopharmaceut & Clin Pharm, Fac Pharm, Amman, Jordan; [Odeh, Mohanad] Hashemite Univ, Dept Clin Pharm & Pharm Practice, Fac Pharmaceut Sci, Zarqa, Jordan; [Al Kurdi, Rasha; Alnan, Murhaf] Appl Sci Private Univ, Dept Clin Pharm & Therapeut, Fac Pharm, Amman, Jordan	Yarmouk University; University of Jordan; Hashemite University	Alsous, M (corresponding author), Yarmouk Univ, Dept Pharm Practice, Fac Pharm, Irbid, Jordan.	mervat_alsous@yahoo.com	Hamoury, Mariam/Q-8423-2019; Alsous, Mervat/AAF-2470-2019	Hamoury, Mariam/0000-0002-3976-5444; Odeh, Mohanad/0000-0002-6060-8283; Alsous, Mervat/0000-0002-6678-670X				Ajlouni K, 2008, J DIABETES COMPLICAT, V22, P317, DOI 10.1016/j.jdiacomp.2007.01.004; Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; Al-Saeedi M, 2003, East Mediterr Health J, V9, P99; Al-Tamimi S, 1998, INT DENT J, V48, P180, DOI 10.1111/j.1875-595X.1998.tb00475.x; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Dajani R, 2012, J DIABETES COMPLICAT, V26, P175, DOI 10.1016/j.jdiacomp.2012.03.009; Deepa M, 2014, Indian J Endocrinol Metab, V18, P379, DOI 10.4103/2230-8210.131191; Demaio AR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-236; du Monde M, 2011, KNOWLEDGE ATTITUDES; Herath HMM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4459-5; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Kamel N M, 1999, East Mediterr Health J, V5, P967; Khalaf AJ, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-35; Mohan Deepa, 2005, J Assoc Physicians India, V53, P283; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nazer LH, 2017, CAN J HOSP PHARM, V70, P150; Niroomand M, 2016, DIABETES METAB SYND, V10, pS114, DOI 10.1016/j.dsx.2015.10.006; Powers MA, 2017, DIABETES EDUCATOR, V43, P40, DOI 10.1177/0145721716689694; Rani PK, 2008, RURAL REMOTE HEALTH, V8; Saleh F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1112; Salpeter S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub2; Shah VN, 2009, INT J DIABETES DEV C, V29, P118, DOI 10.4103/0973-3930.54288; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Walter FM, 2004, ANN FAM MED, V2, P583, DOI 10.1370/afm.242; Wee H. L., 2002, SMJ Singapore Medical Journal, V43, P128; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	27	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214479	10.1371/journal.pone.0214479	http://dx.doi.org/10.1371/journal.pone.0214479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925187	gold, Green Submitted, Green Published			2022-12-27	WOS:000462732300015
J	Li, H; Li, JL; Zhu, JR				Li, Hao; Li, Jinlin; Zhu, Jingrong			Intervention mechanism of healthcare service goods based on social welfare maximization in China	PLOS ONE			English	Article							SUPPLY CHAIN COORDINATION; INFLUENZA VACCINATION; PUBLIC-HEALTH; DEMAND; SUBSIDIES; MODEL; PRICE; STRATEGIES; DECISIONS; PRODUCTS	In this paper, we aim to establish a mathematical model to design a maximizing social welfare intervention mechanism of healthcare service goods in China. The intervention mechanism is helpful to facilitate the adoption of the healthcare service goods. We consider a research problem that regulates the supply chain system for healthcare service goods by an intervention mechanism, and two intervention strategies composed of demand-growth strategy and subsidy strategy are used to the combination of intervention mechanism. Then this paper presents a new method based on fuzzy set and bilevel programming to design the intervention mechanism. To demonstrate the effectiveness of the proposed model, we conduct a case study for Wudang personalized health package and verify our model by the specific result analysis, the result indicates that our joint intervention mechanism is helpful to achieve the target and increase social welfare.	[Li, Hao; Li, Jinlin; Zhu, Jingrong] Beijing Inst Technol, Dept Management Sci & Engn, Beijing, Peoples R China	Beijing Institute of Technology	Li, H (corresponding author), Beijing Inst Technol, Dept Management Sci & Engn, Beijing, Peoples R China.	lihao999@t.shu.edu.cn		Li, Hao/0000-0001-9149-9457	National Natural Science Foundation of China [71432002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant No. 71432002) to JL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida E, 2013, EUR J OPER RES, V231, P414, DOI 10.1016/j.ejor.2013.05.034; Aghajani S, 2017, ENERGY, V139, P422, DOI 10.1016/j.energy.2017.08.004; Alizadeh SM, 2013, TRANSPORT RES B-METH, V58, P92, DOI 10.1016/j.trb.2013.10.002; Arifoglu K, 2012, MANAGE SCI, V58, P1072, DOI 10.1287/mnsc.1110.1469; Calvete HI, 2014, OMEGA-INT J MANAGE S, V49, P30, DOI 10.1016/j.omega.2014.05.004; Chen SM, 2018, INFORM SCIENCES, V435, P184, DOI 10.1016/j.ins.2017.12.054; Cohen MC, 2016, MANAGE SCI, V62, P1235, DOI 10.1287/mnsc.2015.2173; Colson B., 2005, 4OR-Q J OPER RES, V3, P87, DOI DOI 10.1007/S10288-005-0071-0; Demirci EZ, 2017, OMEGA-INT J MANAGE S, V69, P53, DOI 10.1016/j.omega.2016.08.002; Deng F, 2017, PUBLIC HEALTH, V142, P73, DOI 10.1016/j.puhe.2016.10.007; Ding HP, 2018, EUR J OPER RES, V267, P478, DOI 10.1016/j.ejor.2017.11.057; Doyle JJ, 2017, J HEALTH ECON, V54, P25, DOI 10.1016/j.jhealeco.2017.03.005; Fliege J, 2006, J OPTIMIZ THEORY APP, V131, P209, DOI 10.1007/s10957-006-9136-2; Giri BC, 2017, APPL MATH MODEL, V52, P747, DOI 10.1016/j.apm.2017.05.039; Gu HY, 2017, ENERG POLICY, V109, P579, DOI 10.1016/j.enpol.2017.07.043; Gutjahr WJ, 2016, TRANSPORT RES E-LOG, V85, P1, DOI 10.1016/j.tre.2015.11.001; Hong ZF, 2019, OMEGA-INT J MANAGE S, V83, P155, DOI 10.1016/j.omega.2018.02.010; Huber J, 2018, J ECON BEHAV ORGAN, V148, P171, DOI 10.1016/j.jebo.2018.01.018; Ibuka Y, 2015, JPN WORLD ECON, V36, P56, DOI 10.1016/j.japwor.2015.07.001; Jonathan FB, 1998, PRACTICAL BILEVEL OP; Kerkkamp RBO, 2018, OMEGA-INT J MANAGE S, V76, P137, DOI 10.1016/j.omega.2017.04.005; Kropp JD, 2016, RES INT BUS FINANC, V38, P151, DOI 10.1016/j.ribaf.2016.03.012; Li B, 2018, J CLEAN PROD, V171, P1558, DOI 10.1016/j.jclepro.2017.10.056; Li J, 2017, APPL MATH MODEL, V49, P599, DOI 10.1016/j.apm.2017.04.031; Liu SS, 2018, OMEGA-INT J MANAGE S, V80, P77, DOI 10.1016/j.omega.2017.08.010; Luo CL, 2017, OPER RES LETT, V45, P543, DOI 10.1016/j.orl.2017.08.003; Maiti T, 2017, APPL MATH MODEL, V42, P655, DOI 10.1016/j.apm.2016.10.051; Mamani Hamed, 2012, IIE Transactions on Healthcare Systems Engineering, V2, P78, DOI 10.1080/19488300.2012.666780; Mamani H, 2013, MANAGE SCI, V59, P1650, DOI 10.1287/mnsc.1120.1661; Mochon D, 2017, MANAGE SCI, V63, P58, DOI 10.1287/mnsc.2015.2322; Morcillo JD, 2018, APPL ENERG, V216, P504, DOI 10.1016/j.apenergy.2018.02.104; Muller L, 2011, EXP ECON, V14, P181, DOI 10.1007/s10683-010-9262-4; Qian Q, 2017, EUR J OPER RES, V260, P140, DOI 10.1016/j.ejor.2016.11.048; Raz G, 2015, IEEE T ENG MANAGE, V62, P65, DOI 10.1109/TEM.2014.2380999; Robbins MJ, 2016, EUR J OPER RES, V248, P634, DOI 10.1016/j.ejor.2015.06.075; Shamsi GN, 2018, EUR J OPER RES, V267, P1122, DOI 10.1016/j.ejor.2017.12.013; Shao LL, 2017, EUR J OPER RES, V262, P1181, DOI 10.1016/j.ejor.2017.04.030; Sinha A, 2017, EUR J OPER RES, V257, P395, DOI 10.1016/j.ejor.2016.08.027; Taylor TA, 2014, MANAGE SCI, V60, P2461, DOI 10.1287/mnsc.2014.1910; Teng JT, 2013, APPL MATH MODEL, V37, P7624, DOI 10.1016/j.apm.2013.02.009; Weraikat D, 2016, INT J PROD ECON, V176, P41, DOI 10.1016/j.ijpe.2016.03.003; Wu YN, 2008, INT J PROD ECON, V115, P1, DOI 10.1016/j.ijpe.2008.02.016; Xue CG, 2017, PROCEDIA ENGINEER, V174, P211, DOI 10.1016/j.proeng.2017.01.122; Yamin D, 2013, MANAGE SCI, V59, P2667, DOI 10.1287/mnsc.2013.1725; Ye F, 2018, RESOUR CONSERV RECY, V128, P306, DOI 10.1016/j.resconrec.2016.11.023; Yi YY, 2018, J CLEAN PROD, V181, P675, DOI 10.1016/j.jclepro.2018.01.188; Zheng XY, 2015, SOC SCI J, V52, P449, DOI 10.1016/j.soscij.2014.05.003; Zheng Y, 2016, INFORM SCIENCES, V372, P677, DOI 10.1016/j.ins.2016.08.033; Zhou WH, 2016, EUR J OPER RES, V250, P902, DOI 10.1016/j.ejor.2015.10.024	50	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214655	10.1371/journal.pone.0214655	http://dx.doi.org/10.1371/journal.pone.0214655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9FO	30925169	Green Published, Green Submitted, gold			2022-12-27	WOS:000462732300026
J	Cohen, R; Babushkin, F; Geller, K; Finn, T				Cohen, Regev; Babushkin, Frida; Geller, Keren; Finn, Talya			Characteristics of hospitalized adult patients with laboratory documented Influenza A, B and Respiratory Syncytial Virus - A single center retrospective observational study	PLOS ONE			English	Article							INFECTION; EPIDEMIOLOGY; POPULATION; MORBIDITY; MORTALITY; CHILDREN; SUBTYPE; DISEASE; ILLNESS	Introduction The epidemiology, clinical features and outcomes of hospitalized adult patients with Influenza A (FluA), Influenza B (FluB) and Respiratory Syncytial Virus (RSV) have not been thoroughly compared. The aim of this study was to describe the differences between these viruses during 3 winter seasons. Methods A retrospective observational study was conducted consisting of all the polymerase chain reaction (PCR)-based diagnoses of FluA, FluB and RSV among adults during 2015-2018, in one regional hospital. Epidemiology, clinical symptoms and outcome-related data were comparatively analyzed. Results Between November 2015 and April 2018, 759 patients were diagnosed with FluA, FluB or RSV. Study cohort included 539 adult patients (306 FluA, 148 FluB and 85 RSV). FluB was predominant during the winter of 2017-18. RSV caused 15.7% of hospitalizations with diagnosed viral infection and in comparison to influenza, had distinct epidemiological, clinical features and outcomes, including older age (74.2 vs 66.2, p = 0.001) and higher rates of comorbidities; complications including bacterial pneumonia (31 vs 18%, p = 0.02), mechanical ventilation (20 vs 7%, p = 0.001), and viral-related death (13 vs 6.6%, p = 0.04). FluA and FluB had similar epidemiology, clinical symptoms and outcomes, but vaccinated patients were less prone to be hospitalized with FluB as compared with FluA (3 vs 14%, p = 0.001). Paroxysmal atrial fibrillation and falls were common (8.7 and 8.5% respectively). Conclusions FluA and FluB had similar epidemiological, clinical features and contributed equally to hospitalization burden and complications. RSV had a major impact on hospitalizations, occurring among the more elderly and sick populations and causing significantly worse outcomes, when compared to influenza patients. Vaccination appeared as a protective factor against hospitalizations with FluB as compared with FluA.	[Cohen, Regev; Babushkin, Frida; Geller, Keren; Finn, Talya] Laniado Hosp, Sanz Med Ctr, Infect Dis Unit, Neytanya, Israel; [Cohen, Regev; Finn, Talya] Technion, Ruth & Bruce Rappaport Fac Med, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Cohen, R (corresponding author), Laniado Hosp, Sanz Med Ctr, Infect Dis Unit, Neytanya, Israel.; Cohen, R (corresponding author), Technion, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.	regevco@gmail.com		Cohen, Regev/0000-0001-7773-350X				Adlhoch C, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.13.18-00146; Anderson NW, 2016, DIAGN MICR INFEC DIS, V85, P367, DOI 10.1016/j.diagmicrobio.2016.02.025; [Anonymous], 2018, CONTROL ECFDPA INFLU; [Anonymous], 2018, CONTROL ICFD; Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Beaute J, 2015, EPIDEMIOL INFECT, V143, P2950, DOI 10.1017/S0950268814003422; Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Bennett JE, 2015, MANDELL DOUGLAS BENN, Veighth, DOI DOI 10.1016/B978-1-4557-4801-3.00034-5; Branche AR, 2015, DRUG AGING, V32, P261, DOI 10.1007/s40266-015-0258-9; Caini S, 2018, INFLUENZA OTHER RESP, V12, P780, DOI 10.1111/irv.12575; Caram LB, 2009, J AM GERIATR SOC, V57, P482, DOI 10.1111/j.1532-5415.2008.02153.x; Chagvardieff A, 2018, MED MALADIES INFECT, V48, P180, DOI 10.1016/j.medmal.2017.11.007; Chang TY, 2016, HEART RHYTHM, V13, P1189, DOI 10.1016/j.hrthm.2016.01.026; Cohen JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139431; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Falsey AR, 2005, DRUG AGING, V22, P577, DOI 10.2165/00002512-200522070-00004; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Flannery B, 2019, CLIN INFECT DIS, V68, P1798, DOI 10.1093/cid/ciy775; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Hong KW, 2015, JPN J INFECT DIS, V68, P20, DOI 10.7883/yoken.JJID.2013.466; Irving SA, 2012, INFLUENZA OTHER RESP, V6, P37, DOI 10.1111/j.1750-2659.2011.00263.x; Ivey KS, 2018, J AM COLL CARDIOL, V71, P1574, DOI 10.1016/j.jacc.2018.02.013; Jennings L, 2018, INFLUENZA OTHER RESP, V12, P383, DOI 10.1111/irv.12522; Kestler M, 2018, J HOSP INFECT, V100, P463, DOI 10.1016/j.jhin.2018.03.034; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Lee N, 2013, CLIN INFECT DIS, V57, P1069, DOI 10.1093/cid/cit471; Malosh RE, 2017, J CLIN VIROL, V96, P37, DOI 10.1016/j.jcv.2017.09.001; Moa AM, 2017, INFLUENZA OTHER RESP, V11, P102, DOI 10.1111/irv.12432; Mosnier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136186; Pretorius MA, 2016, J CLIN VIROL, V75, P21, DOI 10.1016/j.jcv.2015.12.004; Puig-Barbera J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100497; Sharabi Sivan, 2018, Oncotarget, V9, P6623, DOI 10.18632/oncotarget.23601; Sharabi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161195; Su S, 2014, CLIN INFECT DIS, V59, P252, DOI 10.1093/cid/ciu269; van de Sandt CE, 2015, FUTURE MICROBIOL, V10, P1447, DOI 10.2217/fmb.15.65; Volling C, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0665-2; Wang D, 2016, J MED VIROL, V88, P1334, DOI 10.1002/jmv.24480; Wie SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062685	39	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214517	10.1371/journal.pone.0214517	http://dx.doi.org/10.1371/journal.pone.0214517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921408	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000080
J	Christman, LM; Dean, LL; Allen, JC; Godinez, SF; Toomer, OT				Christman, Lindsey M.; Dean, Lisa L.; Allen, Jonathan C.; Godinez, Sofia Feng; Toomer, Ondulla T.			Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUCOSE-UPTAKE; GREEN TEA; POLYPHENOLS; CELLS; RESVERATROL; DIGESTION; ENZYMES; MODEL; MICE	Diabetes affects at least 285 million people globally, and this number continues to increase. Clinical complications include impaired glucose metabolism, hyperglycemia, dyslipidemia, atherosclerosis and non-alcoholic fatty liver disease. Evidence has shown that natural phenolics play a protective effect on both the development and management of type 2 diabetes. This study evaluated effects of the extract from peanut skins containing polyphenols on induced-hyperglycemia using in vivo and in vitro methods. A human hepatocellular liver carcinoma cell line (HepG2) was used to investigate the effect of the peanut skin extract on cell viability after exposure to high glucose concentrations. In vivo, the effect of peanut skin extract on an oral glucose tolerance was investigated in human subjects. Fifteen participants aged 21-32 underwent an oral glucose tolerance test with five treatments: 1) 50-gram glucose solution (reference); 2). 50-gram glucose solution, followed by 12 mg of vegi-capsulated maltodextrin; 3) 50-gram glucose solution, followed by 120 mg of vegi-capsulated maltodextrin-encapsulated peanut skin extract; 4). 50-gram glucose solution, followed by 28 grams of unfortified coated peanuts; 5) 50-gram glucose solution, followed by 28 grams of chili lime coated peanuts fortified with encapsulated peanut skin extract. Glucose levels were measured using a continuous monitor. Peanut skin extract was found to attenuate the decrease in cell viability in high glucose treated HepG2 cells, showing a protective effect against hyperglycemia induced cell death. No difference in the glycemic response area under the curve between any treatments using the tolerance test, but the treatment of the peanut skin extract with the glucose reference resulted in a significantly lower peak blood glucose response at 45 minutes, indicating that it was effective at reducing the glycemic response. The present study shows that the phenolic extract of peanut skins has an antidiabetic effect, further confirming their value as a functional food ingredient.	[Christman, Lindsey M.; Allen, Jonathan C.; Godinez, Sofia Feng] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA; [Dean, Lisa L.; Toomer, Ondulla T.] USDA ARS, Market Qual & Handling Res Unit, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA)	Dean, LL (corresponding author), USDA ARS, Market Qual & Handling Res Unit, Raleigh, NC 27695 USA.	Lisa.Dean@ars.usda.gov	Feng, Sofia/AHA-5718-2022; Christman, Lindsey/AAF-1344-2019; Dean, Lisa Louise/B-1463-2015	Feng, Sofia/0000-0002-8250-3618; Dean, Lisa Louise/0000-0002-2407-9548; Toomer, Ondulla/0000-0002-3417-8558				Bahadoran Z, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-43; Bansode RR, 2014, FOOD CHEM, V148, P24, DOI 10.1016/j.foodchem.2013.09.129; Bansode RR, 2012, FOOD CHEM, V135, P1659, DOI 10.1016/j.foodchem.2012.06.034; Brouns F, 2005, NUTR RES REV, V18, P145, DOI 10.1079/NRR2005100; Ceriello A, 2004, AM HEART J, V147, P803, DOI 10.1016/j.ahj.2003.11.020; Chandrasekaran K, 2010, TOXICOL IN VITRO, V24, P387, DOI 10.1016/j.tiv.2009.10.020; Christman LM, 2018, J FOOD SCI, V83, P2571, DOI 10.1111/1750-3841.14323; Coe SA, 2013, NUTR RES, V33, P888, DOI 10.1016/j.nutres.2013.08.002; Constanza KE, 2012, J AGR FOOD CHEM, V60, P10776, DOI 10.1021/jf3035258; Cordero-Herrera I, 2015, MOL NUTR FOOD RES, V59, P597, DOI 10.1002/mnfr.201400492; Cordero-Herrera I, 2014, FOOD CHEM TOXICOL, V64, P10, DOI 10.1016/j.fct.2013.11.014; Ellis PR, 2004, AM J CLIN NUTR, V80, P604; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Francisco MLLD, 2009, J FOOD COMPOS ANAL, V22, P16, DOI 10.1016/j.jfca.2008.05.012; Hardi G., 2004, MED SCI SPORTS EXERC, V36, P28, DOI [10.1249/01.MSS.0000106171.38299.64, DOI 10.1249/01.MSS.0000106171.38299.64]; Josse AR, 2007, METABOLISM, V56, P400, DOI 10.1016/j.metabol.2006.10.024; Kapoor R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041663; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832; Kwon YI, 2008, BIORESOURCE TECHNOL, V99, P2981, DOI 10.1016/j.biortech.2007.06.035; Lavelli V, 2016, J FUNCT FOODS, V4, P391, DOI [10.1939/C6FO00073H, DOI 10.1939/C6FO00073H]; Lewis W. E., 2013, Food and Nutrition Sciences, V4, P22; Lou HX, 2004, PHYTOCHEMISTRY, V65, P2391, DOI 10.1016/j.phytochem.2004.06.026; Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019; Minakawa M, 2011, J CLIN BIOCHEM NUTR, V48, P237, DOI 10.3164/jcbn.10-119; Montonen J, 2004, DIABETES CARE, V27, P362, DOI 10.2337/diacare.27.2.362; Nepote V, 2002, GRASAS ACEITES, V53, P391; Niedowicz DM, 2005, CELL BIOCHEM BIOPHYS, V43, P289, DOI 10.1385/CBB:43:2:289; Reis CEG, 2011, NUTR HOSP, V26; Rosen LAH, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-42; Sanders TH, 2000, J AGR FOOD CHEM, V48, P1243, DOI 10.1021/jf990737b; Shokrzadeh M, 2016, CELL J, V18, P97; Tamura T, 2015, FOOD SCI TECHNOL RES, V21, P111, DOI 10.3136/fstr.21.111; Tang WP, 2013, J FUNCT FOODS, V5, P1784, DOI 10.1016/j.jff.2013.08.007; Urpi-Sarda M, 2009, ANAL BIOANAL CHEM, V394, P1545, DOI 10.1007/s00216-009-2676-1; Vaddiraju Santhisagar, 2010, J Diabetes Sci Technol, V4, P1540; Wolever TMS, 1998, DIABETES CARE, V21, P336, DOI 10.2337/diacare.21.3.336; Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018; Yu JM, 2006, J FOOD COMPOS ANAL, V19, P364, DOI 10.1016/j.jfca.2005.08.003; Yu JM, 2005, FOOD CHEM, V90, P199, DOI 10.1016/j.foodchem.2004.03.048	40	16	17	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214591	10.1371/journal.pone.0214591	http://dx.doi.org/10.1371/journal.pone.0214591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917157	Green Published, Green Submitted, gold			2022-12-27	WOS:000462465800072
J	Valerio, L; Peters, RJ; Zwinderman, AH; Pinto-Sietsma, SJ				Valerio, Luca; Peters, Ron J.; Zwinderman, Aeilko H.; Pinto-Sietsma, Sara-Joan			Sublingual endothelial glycocalyx and atherosclerosis. A cross-sectional study	PLOS ONE			English	Article							SELF-REPORTS; DYSFUNCTION; PREVALENCE; COINCIDES; DISEASE	Background Damage to endothelial glycocalyx is thought to be an early marker of atherosclerosis and measuring reduced glycocalyx size clinically via the Perfused Boundary Region (PBR) may allow early detection of cardiovascular disease. However, the true value of the glycocalyx in estimating cardiovascular risk or detecting cardiovascular disease is uncertain. We therefore investigated whether small glycocalyx size is associated with cardiovascular risk or disease in a large multi-ethnic cohort. Methods In a multi-ethnic community-based sample (N = 6169, 42.4% male, mean age 43.6 +/- 13) we applied multiple imputation for missing data and used logistic regression and odds ratios to cross-sectionally investigate the relationship of small glycocalyx size as estimated by highest quartile of PBR with, on the one hand, classical risk factors for atherosclerosis including age, sex, diastolic and systolic blood pressure, LDL, HDL, triglycerides, BMI, diabetes, smoking status, and antihypertensive and lipid-lowering medication; on the other hand, prevalent cardiovascular disease. Analyses were additionally adjusted for ethnicity. Results With PBR divided in quartiles, the highest PBR quartile (smallest glycocalyx size) as dependent variable was independently associated with female sex (OR for male versus female: 0.61, 95% CI: 0.53, 0.70) and diabetes (OR: 1.28, 95% CI: 1.03-1.59) in a model adjusted for all classical risk factors of atherosclerosis and for ethnicity. With regard to cardiovascular disease, no association was found between the smallest glycocalyx size as independent variable and overall cardiovascular disease, coronary heart disease and revascularization procedures, or stroke. Conclusions Small glycocalyx size as estimated by highest PBR is associated with female sex and diabetes, which do not completely reflect a high cardiovascular risk profile. At the same time, glycocalyx size is not associated with prevalent cardiovascular disease.	[Valerio, Luca] Univ Amsterdam, Amsterdam UMC, Dept Publ Hlth, Amsterdam, Netherlands; [Valerio, Luca; Peters, Ron J.] Univ Amsterdam, Amsterdam UMC, Dept Cardiol, Amsterdam, Netherlands; [Zwinderman, Aeilko H.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands; [Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Amsterdam UMC, Dept Vasc Med, Amsterdam, Netherlands; [Valerio, Luca] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany	University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; Johannes Gutenberg University of Mainz	Valerio, L (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Publ Hlth, Amsterdam, Netherlands.; Valerio, L (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Cardiol, Amsterdam, Netherlands.; Pinto-Sietsma, SJ (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands.; Pinto-Sietsma, SJ (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Vasc Med, Amsterdam, Netherlands.; Valerio, L (corresponding author), Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany.	l.valerio@amc.uva.nl; s.j.pinto@amc.uva.nl	Valerio, Luca/AGX-7211-2022; SJ, Pinto-Sietsma/AAI-3207-2021	Valerio, Luca/0000-0003-4466-0724; 	CTMM, the Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Netherlands Organization for Health Research and Development (ZonMw); European Union (FP-7); European Fund for the Integration of non-EU immigrants (EIF)	CTMM, the Center for Translational Molecular Medicine, project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union (FP-7); European Fund for the Integration of non-EU immigrants (EIF)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104 awarded to Sara-Joan Pinto-Sietsma [SJ-PS]), and supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The HELIUS study is also funded by the Dutch Heart Foundation, the Netherlands Organization for Health Research and Development (ZonMw), the European Union (FP-7), and the European Fund for the Integration of non-EU immigrants (EIF).	Amraoui F, 2014, MICROCIRCULATION, V21, P499, DOI 10.1111/micc.12125; Benedict KF, 2011, MICROCIRCULATION, V18, P63, DOI 10.1111/j.1549-8719.2010.00069.x; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Broekhuizen LN, 2009, CURR OPIN LIPIDOL, V20, P57, DOI 10.1097/MOL.0b013e328321b587; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CASTELLI WP, 1986, AM J MED, V80, P23, DOI 10.1016/0002-9343(86)90157-9; Dane MJC, 2014, CLIN J AM SOC NEPHRO, V9, P698, DOI 10.2215/CJN.08160813; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Donati A, 2013, CRIT CARE RES PRACT, V2013, DOI DOI 10.HTTPS://D0I.0RG/10.1155/2013/; Galenkamp H, 2014, J CLIN EPIDEMIOL, V67, P773, DOI 10.1016/j.jclinepi.2014.02.002; Gorshkov AY, 2018, MICROCIRCULATION, V25, DOI 10.1111/micc.12454; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu YM, 2015, HYPERTENSION, V65, P993, DOI 10.1161/HYPERTENSIONAHA.114.05119; Ikonomidis I, 2018, J CLIN HYPERTENS, V20, P672, DOI 10.1111/jch.13236; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Lee DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096477; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mannan H, 2010, HEART INT, V5, P49, DOI 10.4081/hi.2010.e11; Martens RJH, 2013, CEREBROVASC DIS, V35, P451, DOI 10.1159/000348854; Meuwese MC, 2009, J LIPID RES, V50, P148, DOI 10.1194/jlr.P800025-JLR200; Mulders TA, 2013, INT J CARDIOL, V168, P5026, DOI 10.1016/j.ijcard.2013.07.166; Nieuwdorp M, 2007, DIABETOLOGIA, V50, P1288, DOI 10.1007/s00125-007-0666-4; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Snijder MB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017873; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Valerio L, 2019, REPROD SUBLINGUAL MI; van den Akker M, 2015, EUR J GEN PRACT, V21, P45, DOI 10.3109/13814788.2014.907266	31	14	14	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213097	10.1371/journal.pone.0213097	http://dx.doi.org/10.1371/journal.pone.0213097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917159	Green Submitted, gold, Green Published			2022-12-27	WOS:000462465800020
J	Saito, A; Masugi, Y; Nakagawa, K; Obata, H; Nakazawa, K				Saito, Akira; Masugi, Yohei; Nakagawa, Kento; Obata, Hiroki; Nakazawa, Kimitaka			Repeatability of spinal reflexes of lower limb muscles evoked by transcutaneous spinal cord stimulation	PLOS ONE			English	Article							SOLEUS H-REFLEX; RELIABILITY; MODULATION; ACTIVATION; RESPONSES; DEPRESSION; STROKE	Transcutaneous electrical stimulation is a relatively new technique to evoke spinal reflexes in lower limb muscles. The advantage of this technique is that the spinal reflex responses can be obtained from multiple lower limb muscles simultaneously. However, repeatability of spinal reflexes evoked by transcutaneous spinal cord stimulation between days has not been evaluated. We aimed to examine repeatability of recruitment properties of the spinal reflexes evoked by transcutaneous spinal cord stimulation. Recruitment curves of the spinal reflexes evoked by transcutaneous spinal cord stimulation of 8 lower limb muscles (i.e., foot, lower leg, and thigh muscles) of 20 males were measured on two consecutive days. To confirm that responses were caused by activation of the sensory fiber, a double-pulse stimulation with 50 ms inter-pulse interval was delivered. Peak-to-peak amplitude of the first response was calculated for each muscle when no response was observed in the second response owing to post-activation depression. For comparison with the spinal reflexes evoked by transcutaneous spinal cord stimulation, the recruitment curves of the H-reflex amplitude of the soleus of 9 males were measured. Threshold intensity and maximal slope of the recruitment curves were calculated, and inter-day repeatability of the properties was quantified using intraclass correlation coefficients. For the spinal reflexes evoked by transcutaneous spinal cord stimulation, the intraclass correlation coefficient values of threshold intensity and maximal slope for each muscle ranged from 0.487 to 0.874 and from 0.471 to 0.964, respectively. Regarding the soleus H-reflex, the intraclass correlation coefficients of threshold intensity and maximal slope were 0.936 and 0.751, respectively. The present data showed that repeatability of the recruitment properties of the spinal reflexes evoked by transcutaneous spinal cord stimulation in the lower limb was moderate to high. Measurement of the spinal reflexes evoked by transcutaneous spinal cord stimulation would be useful for longitudinal neurophysiological studies.	[Saito, Akira; Masugi, Yohei; Nakagawa, Kento; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Saito, Akira; Nakagawa, Kento] Japan Soc Promot Sci, Chiyoda Ku, Kojimachi, Tokyo, Japan; [Masugi, Yohei] Tokyo Int Univ, Inst Sports Med & Sci, Kawagoe, Saitama, Japan; [Obata, Hiroki] Kyushu Inst Technol, Inst Liberal Arts, Dept Humanities & Social Sci, Tobata Ku, Kitakyushu, Fukuoka, Japan	University of Tokyo; Japan Society for the Promotion of Science; Kyushu Institute of Technology	Saito, A (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.; Saito, A (corresponding author), Japan Soc Promot Sci, Chiyoda Ku, Kojimachi, Tokyo, Japan.	a-saito@idaten.c.u-tokyo.ac.jp		Nakagawa, Kento/0000-0002-6203-6602; Masugi, Yohei/0000-0001-8156-8586	JSPS KAKENHI [JP17J02997]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI [grant number JP17J02997] to AS.	Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; Andrews JC, 2015, NEUROSCI LETT, V589, P144, DOI 10.1016/j.neulet.2015.01.041; Bakhtiary AH, 2008, CLIN REHABIL, V22, P418, DOI 10.1177/0269215507084008; Bove M, 2003, J PHYSIOL-LONDON, V550, P617, DOI 10.1113/jphysiol.2003.043331; Burke D, 2016, CLIN NEUROPHYS PRACT, V1, P9, DOI 10.1016/j.cnp.2016.02.003; Courtine GG, 2007, J PHYSIOL-LONDON, V582, P1125, DOI 10.1113/jphysiol.2007.128447; Danner SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147479; Danner SM, 2011, ARTIF ORGANS, V35, P257, DOI 10.1111/j.1525-1594.2011.01213.x; Doguet V, 2014, EUR J APPL PHYSIOL, V114, P2509, DOI 10.1007/s00421-014-2969-8; Dy CJ, 2010, J NEUROPHYSIOL, V103, P2808, DOI 10.1152/jn.00316.2009; Freyler K, 2014, GAIT POSTURE, V40, P291, DOI 10.1016/j.gaitpost.2014.04.186; Gerasimenko Y, 2015, ANN PHYS REHABIL MED, V58, P225, DOI 10.1016/j.rehab.2015.05.003; Holtermann A, 2007, EUR J APPL PHYSIOL, V101, P301, DOI 10.1007/s00421-007-0503-y; Jaberzadeh S, 2004, ARCH PHYS MED REHAB, V85, P1168, DOI 10.1016/j.apmr.2003.09.009; Lavrov I, 2006, J NEUROPHYSIOL, V96, P1699, DOI 10.1152/jn.00325.2006; Masugi Y, 2016, NEUROSCI LETT, V627, P100, DOI 10.1016/j.neulet.2016.05.047; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Misiaszek JE, 2003, MUSCLE NERVE, V28, P144, DOI 10.1002/mus.10372; Mynark RG, 2005, CLIN NEUROPHYSIOL, V116, P1400, DOI 10.1016/j.clinph.2005.02.001; Nakagawa K, 2018, NEUROSCI LETT, V668, P55, DOI 10.1016/j.neulet.2018.01.015; Palmieri TM, 2002, INT J NEUROSCI, V112, P841, DOI 10.1080/00207450290025851; Pierrot-Deseilligny E, 2000, NEUROPHYSIOL CLIN, V30, P67, DOI 10.1016/S0987-7053(00)00062-9; Roy FD, 2012, EXP BRAIN RES, V223, P281, DOI 10.1007/s00221-012-3258-6; Sayenko DG, 2015, J APPL PHYSIOL, V118, P1364, DOI 10.1152/japplphysiol.01128.2014; Tokuno CD, 2012, EUR J APPL PHYSIOL, V112, P3259, DOI 10.1007/s00421-011-2302-8; Traversa R, 2000, CLIN NEUROPHYSIOL, V111, P1695, DOI 10.1016/S1388-2457(00)00373-4; Trimble MH, 1998, NEUROSCI LETT, V246, P186, DOI 10.1016/S0304-3940(98)00259-6; Versino M, 2007, MUSCLE NERVE, V36, P39, DOI 10.1002/mus.20775; Vincent W.J., 2012, STAT KINESIOLOGY, V4th ed.; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214818	10.1371/journal.pone.0214818	http://dx.doi.org/10.1371/journal.pone.0214818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947310	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500067
J	Chavez-Zarate, A; Maguina, JL; Quichiz-Lara, AD; Zapata-Fajardo, PE; Mayta-Tristan, P				Chavez-Zarate, Airin; Maguina, Jorge L.; Danciana Quichiz-Lara, Antoinette; Edith Zapata-Fajardo, Patricia; Mayta-Tristan, Percy			Relationship between stunting in children 6 to 36 months of age and maternal employment status in Peru: A sub-analysis of the Peruvian Demographic and Health Survey	PLOS ONE			English	Article							YOUNG-CHILDREN; PRESCHOOL-CHILDREN; PRECONCEPTION CARE; DETERMINANTS; PREVALENCE; OVERWEIGHT; MALNUTRITION	Objectives This study aimed to determine the relationship between stunting in children 6 to 36 months old and maternal employment status in Peru. Methods A secondary data analysis was conducted using information from the Demographic and Health Survey (DHS) in Peru. We used a representative sample of 4637 mother-child binomials to determine the association between stunting in children 6 to 36 months of age and the employment status of their mothers. Results The prevalence of stunting among children was 15.9% (95% CI: 13.9-16.7). The prevalence of working mothers was 63.7%. No association was found between maternal employment status and the presence of stunting in children [prevalence ratio (PR) = 1.04; 95% confidence interval (95% CI): 0.9 to 1.2; p = 0.627). However, on multivariate analysis we found that the prevalence of stunting was significantly higher among children of mothers performing unpaid work (12.4%) (PR = 1.38; 95% CI: 1.2-1.6; p < 0.001) compared with those of paid working mothers. Conclusion No significant association was found between maternal employment status and the presence of stunting in children 6 to 36 months of age. However, children of mothers doing unpaid work are at higher risk of stunting. These findings support the implementation of educational programs and labour policies to reduce the prevalence of stunting among children.	[Chavez-Zarate, Airin; Danciana Quichiz-Lara, Antoinette; Edith Zapata-Fajardo, Patricia] Univ Peruana Ciencias Aplicadas, Escuela Nutr & Dietet, Lima, Peru; [Maguina, Jorge L.; Mayta-Tristan, Percy] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru; [Maguina, Jorge L.] Univ Cient Sur, Fac Ciencias Salud, Lima, Peru; [Mayta-Tristan, Percy] Univ Cient Sur, Direcc Gen Invest Desarrollo & Innovac, Lima, Peru	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Cientifica del Sur (CIENTIFICA); Universidad Cientifica del Sur (CIENTIFICA)	Chavez-Zarate, A (corresponding author), Univ Peruana Ciencias Aplicadas, Escuela Nutr & Dietet, Lima, Peru.; Mayta-Tristan, P (corresponding author), Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru.; Mayta-Tristan, P (corresponding author), Univ Cient Sur, Direcc Gen Invest Desarrollo & Innovac, Lima, Peru.	airinchz1@hotmail.com; p.mayta@cientifica.edu.pe	Maguiña, Jorge L./AGQ-6299-2022; Mayta-Tristan, Percy/D-8587-2011	Maguiña, Jorge L./0000-0002-4136-7795; Mayta-Tristan, Percy/0000-0002-0861-6606; Chavez-Zarate, Airin/0000-0001-8094-8819				Arocena Canazas VM, 2009, FACTORES ASOCIADOS D, P7; Ayazi P, 2010, IRAN J PEDIAT SOC, V2, P37; Beltran A, 2009, CTR INVESTIG U PA S3, V1, P1; Chowdhury R, 2013, INDAN J COMMUNITY HE, V25, P251; Cordova-Villalobos JA, 2008, SALUD PUBLICA MEXICO, V50, P419, DOI 10.1590/s0036-36342008000500015; Delgado Sanchez HD, 2015, THESIS; Deshmukh Pradeep R, 2013, Med J Armed Forces India, V69, P213, DOI 10.1016/j.mjafi.2012.10.004; Diaz A, 2015, REV PANAM SALUD PUBL, V38, P49; Duran Rojas BF, 2009, THESIS; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Forero-Ramirez N, 2014, REV PANAM SALUD PUBL, V35, P163; Gamboa-Delgado Edna M., 2007, Rev. salud pública, V9, P129, DOI 10.1590/S0124-00642007000100013; Grjibovski AM, 2004, CROAT MED J, V45, P757; Grover N, 2015, INDIAN J BASIC AP S1, V5, P657; Institut Nacional de Estadistica e Investigacion, 2012, MAN ANT; Instituto Nacional de Estadistica e Informatica, 2015, PER ENC DEM SAL FAM; Jesmin A, 2011, J HEALTH POPUL NUTR, V29, P494; Joshi N, 2012, MATERN CHILD NUTR, V8, P45, DOI 10.1111/j.1740-8709.2011.00384.x; Keino S, 2014, FOOD NUTR BULL, V35, P167, DOI 10.1177/156482651403500203; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Nakahara S, 2006, AM J HUM BIOL, V18, P169, DOI 10.1002/ajhb.20481; Oficina Tecnica de Difusion del I NEI, 2014, NOT PRENS; Organizacion Panamericana de la Salud Organizacion Mundial de la Salud, 2007, NUEV PATR CREC OMS, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; POWELL CA, 1985, AM J CLIN NUTR, V41, P1322, DOI 10.1093/ajcn/41.6.1322; Ramos CV, 2015, J PEDIAT-BRAZIL, V91, P175, DOI 10.1016/j.jped.2014.07.005; Said-Mohamed R, 2009, ANN HUM BIOL, V36, P146, DOI 10.1080/03014460802660526; Sameena Sultan, 2014, Indian Journal of Basic and Applied Medical Research, V3, P51; Sánchez-Abanto José, 2012, Rev. perú. med. exp. salud publica, V29, P402, DOI 10.1590/s1726-46342012000300018; Seedhom AE., 2014, IPHF, V1, P6; Sivakami M., 1997, HLTH TRANSITION REV, V7, P21, DOI DOI 10.2307/40652231; Sobrino M, 2014, REV PANAM SALUD PUBL, V35, P104; Suarez-Lopez MG, 2013, THESIS; United Nations Children's Fund. Improving child nutrition, 2013, IMPR CHILD NUTR ACH; van der Zee B, 2011, J PUBLIC HEALTH POL, V32, P367, DOI 10.1057/jphp.2011.13; Vieira Viviane Laudelino, 2010, Rev. Bras. Saude Mater. Infant., V10, P199, DOI 10.1590/S1519-38292010000200007; Wildschut H I J, 2006, Ned Tijdschr Geneeskd, V150, P1326; Williams L, 2012, MATERN CHILD HLTH J, V16, P1854, DOI 10.1007/s10995-011-0932-4; Woldemariam G, 2002, DETERMINANTS NUTR ST, P1; World Bank, 2016, TAS POBL ACT MUJ POB; World Health Organization, 2015, ENF TRANSM; World Health Organization, 2008, IND EV PRACT AL LACT; World Health Organization, 2013, PROT LACT MAT PER; Zottarelli L. K., 2007, Eastern Mediterranean Health Journal, V13, P1330	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212164	10.1371/journal.pone.0212164	http://dx.doi.org/10.1371/journal.pone.0212164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943197	gold, Green Published, Green Submitted			2022-12-27	WOS:000463194300003
J	Corcos, D; Cerretti, P; Caruso, V; Mei, M; Falco, M; Marini, L				Corcos, Daria; Cerretti, Pierfilippo; Caruso, Valerio; Mei, Maurizio; Falco, Matteo; Marini, Lorenzo			Impact of urbanization on predator and parasitoid insects at multiple spatial scales	PLOS ONE			English	Article							WASPS HYMENOPTERA ACULEATA; LANDSCAPE CONTEXT; HABITAT FRAGMENTATION; BEE ASSEMBLAGES; URBAN; RESPONSES; EVENNESS; ECOLOGY; PARKS	Landscapes are becoming increasingly urbanized, causing loss and fragmentation of natural habitats, with potentially negative effects on biodiversity. Insects are among the organisms with the largest diversity in urbanized environments. Here, we sampled predator (Ampulicidae, Sphecidae and Crabronidae) and parasitoid (Tachinidae) flower-visiting insects in 36 sites in the city of Rome (Italy). Although the diversity of herbivorous insects in urban areas mostly depends on the availability of flowering plants and nesting sites, predators and parasitoids generally require a larger number of resources during their life cycle, and are expected to be particularly influenced by urbanization. As flower-visitors can easily move between habitat patches, the effect of urbanization was tested at multiple spatial scales (local, landscape and sub-regional). We found that urbanization influenced predator and parasitoid flower-visitors at all three spatial scales. At the local scale, streets and buildings negatively influenced evenness of predators and species richness and abundance of parasitoids probably acting as dispersal barrier. At the landscape scale, higher percentage of urban decreased predator abundance, while increasing their evenness, suggesting an increase in generalist and highly mobile species. Area and compactness (i.e. Contiguity index) of urban green interactively influenced predator communities, whereas evenness of parasitoids increased with increasing Contiguity index. At the sub-regional scale, species richness and abundance of predators increased with increasing distance from the city center. Compared to previous studies testing the effect of urbanization, we found little variation in species richness, abundance and evenness along our urbanization gradient. The current insect fauna has been probably selected for its tolerance to habitat loss and fragmentation, being the result of the intensive anthropogenic alteration occurred in the area in the last centuries. Conservation strategies aimed at predator and parasitoid flying insects have to take in account variables at multiple spatial-scales, as well as the complementarity of resources across the landscape.	[Corcos, Daria; Cerretti, Pierfilippo; Caruso, Valerio; Mei, Maurizio; Falco, Matteo] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Corcos, Daria; Marini, Lorenzo] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy	Sapienza University Rome; University of Padua	Corcos, D (corresponding author), Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.; Corcos, D (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy.	daria.corcos@uniroma1.it	Cerretti, Pierfilippo/L-6504-2016; Marini, Lorenzo/B-1119-2009	Cerretti, Pierfilippo/0000-0002-9204-3352; Marini, Lorenzo/0000-0001-7429-7685; Falco, Matteo/0000-0002-2386-873X				Ahrne K, 2008, CURRENT SCI, V4, pe5574, DOI [10.1371/journal.pone.0005574, DOI 10.1371/JOURNAL.PONE.0005574]; [Anonymous], 2016, WORLD POPULATION REV; Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Bennett AB, 2014, INSECT CONSERV DIVER, V7, P405, DOI 10.1111/icad.12062; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Burkman CE, 2014, BIOL CONTROL, V75, P58, DOI 10.1016/j.biocontrol.2014.02.015; Cerretti P., 2010, TACHINIDI FAUNA ITAL, P912; Cerretti Pierfilippo, 2001, Bollettino dell'Associazione Romana di Entomologia, V56, P63; Cherrill A, 2015, LANDSCAPE RES, V40, P476, DOI 10.1080/01426397.2014.902922; Christie F, 2009, J INSECT CONSERV, V13, P213, DOI 10.1007/s10841-008-9146-5; Clergeau P, 2006, TRENDS ECOL EVOL, V21, P660, DOI 10.1016/j.tree.2006.09.006; Corcos D, 2017, INSECT CONSERV DIVER, V10, P462, DOI 10.1111/icad.12249; Deguines N., 2012, SCIENCE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0045822; Fattorini S, 2014, J INSECT CONSERV, V18, P729, DOI 10.1007/s10841-014-9681-1; Fattorini S, 2011, INSECT CONSERV DIVER, V4, P307, DOI 10.1111/j.1752-4598.2010.00129.x; Geographic Information System (GIS), 2020, GEOGR INF MAN SYST G; Geslin B, 2016, ECOL EVOL, V6, P6599, DOI 10.1002/ece3.2374; Geslin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063421; Heneberg P, 2017, BIODIVERS CONSERV, V26, P843, DOI 10.1007/s10531-016-1275-7; Heneberg P, 2016, ECOL ENG, V93, P187, DOI 10.1016/j.ecoleng.2016.05.026; Inclan DJ, 2014, LANDSCAPE ECOL, V29, P879, DOI 10.1007/s10980-014-0024-0; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; Kindt R., 2005, WORLD; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Koh LP, 2004, ECOL APPL, V14, P1695, DOI 10.1890/03-5269; LAGRO J, 1991, PHOTOGRAMM ENG REM S, V57, P285; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Marini L, 2014, ECOGRAPHY, V37, P544, DOI 10.1111/j.1600-0587.2013.00369.x; Martin EA, 2016, ECOL APPL, V26, P448, DOI 10.1890/15-0856; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Mei Maurizio, 2012, Ampulex, V5, P37; Niinemets U, 2008, TRENDS PLANT SCI, V13, P60, DOI 10.1016/j.tplants.2007.11.009; PAGLIANO G., 2005, HYMENOPTERA SPHECIDA, V40; Pape T, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e4187; R Development Core Team R Foundation for Statistical Computing, 2015, R FDN STAT COMP R LA; Ramalho CE, 2012, TRENDS ECOL EVOL, V27, P179, DOI 10.1016/j.tree.2011.10.008; Sattler T, 2010, LANDSCAPE ECOL, V25, P941, DOI 10.1007/s10980-010-9473-2; Fenoglio MS, 2013, BIOL CONSERV, V164, P82, DOI 10.1016/j.biocon.2013.05.002; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Srba M, 2012, J INSECT CONSERV, V16, P557, DOI 10.1007/s10841-011-9441-4; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Stireman JO, 2006, ANNU REV ENTOMOL, V51, P525, DOI 10.1146/annurev.ento.51.110104.151133; Stireman JO, 2016, CURR OPIN INSECT SCI, V14, P87, DOI 10.1016/j.cois.2016.02.002; Su ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119276; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tscharntke T, 2002, ECOLOGICAL APPL, V21, P2781; Turrini T, 2015, GLOBAL CHANGE BIOL, V21, P1652, DOI 10.1111/gcb.12825; Verboven HAF, 2014, LANDSCAPE URBAN PLAN, V126, P31, DOI 10.1016/j.landurbplan.2014.02.017; Vergnes A, 2014, BIODIVERS CONSERV, V23, P1859, DOI 10.1007/s10531-014-0689-3; Wang XL, 2014, METHODS ECOL EVOL, V5, P634, DOI 10.1111/2041-210X.12198; Westrich P., 1996, The conservation of bees., P1; Zanette LRS, 2005, LANDSCAPE URBAN PLAN, V71, P105, DOI 10.1016/j.landurbplan.2004.02.003; Zapparoli M, 1997, LANDSCAPE URBAN PLAN, V38, P77, DOI 10.1016/S0169-2046(97)00020-0; Zapparoli M., GLI INSETTI DI ROMA	57	26	29	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214068	10.1371/journal.pone.0214068	http://dx.doi.org/10.1371/journal.pone.0214068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943220	Green Submitted, gold, Green Published			2022-12-27	WOS:000463194300030
J	Kim, AY; Jang, EH; Choi, KW; Jeon, HJ; Byun, S; Sim, JY; Choi, JH; Yu, HY				Kim, Ah Young; Jang, Eun Hye; Choi, Kwan Woo; Jeon, Hong Jin; Byun, Sangwon; Sim, Joo Yong; Choi, Jae Hun; Yu, Han Young			Skin conductance responses in Major Depressive Disorder (MDD) under mental arithmetic stress	PLOS ONE			English	Article							ELECTRODERMAL ACTIVITY; BIPOLAR PATIENTS; REACTIVITY; RECOVERY; DISEASE; PERFORMANCE; MECHANISMS	Depressive symptoms are related to abnormalities in the autonomic nervous system (ANS), and physiological signals that can be used to measure and evaluate such abnormalities have previously been used as indicators for diagnosing mental disorder, such as major depressive disorder (MDD). In this study, we investigate the feasibility of developing an objective measure of depressive symptoms that is based on examining physiological abnormalities in individuals when they are experiencing mental stress. To perform this, we recruited 30 patients with MDD and 31 healthy controls. Then, skin conductance (SC) was measured during five 5-min experimental phases, comprising baseline, mental stress, recovery from the stress, relaxation, and recovery from the relaxation, respectively. For each phase, the mean amplitude of the skin conductance level (MSCL), standard deviations of the SCL (SDSCL), slope of the SCL (SSCL), mean amplitude of the non-specific skin conductance responses (MSCR), number of non-specific skin conductance responses (NSCR), and power spectral density (PSD) were evaluated from the SC signals, producing 30 parameters overall (six features for each phase). These features were used as input data for a support vector machine (SVM) algorithm designed to distinguish MDD patients from healthy controls based on their physiological responses. Statistical tests showed that the main effect of task was significant in all SC features, and the main effect of group was significant in MSCL, SDSCL, SSCL, and PSD. In addition, the proposed algorithm achieved 70% accuracy, 70% sensitivity, 71% specificity, 70% positive predictive value, 71% negative predictive value in classifying MDD patients and healthy controls. These results demonstrated that it is possible to extract meaningful features that reflect changes in ANS responses to various stimuli. Using these features, detection of MDD was feasible, suggesting that SC analysis has great potential for future diagnostics and prediction of depression based on objective interpretation of depressive states.	[Kim, Ah Young; Jang, Eun Hye; Sim, Joo Yong; Choi, Jae Hun; Yu, Han Young] ETRI, Biomed IT Convergence Res Dept, Daejeon, South Korea; [Choi, Kwan Woo; Jeon, Hong Jin] Sungkyunkwan Univ, Dept Psychiat, Depress Ctr, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Byun, Sangwon] Incheon Natl Univ, Dept Elect Engn, Incheon, South Korea	Electronics & Telecommunications Research Institute - Korea (ETRI); Sungkyunkwan University (SKKU); Samsung Medical Center; Incheon National University	Kim, AY (corresponding author), ETRI, Biomed IT Convergence Res Dept, Daejeon, South Korea.	aykim@etri.re.kr	Sim, Joo Yong/AAC-8087-2019	Kim, Ah Young/0000-0001-6852-663X; Sim, Joo Yong/0000-0003-3779-7589; Choi, Kwan Woo/0000-0002-0854-3507; Byun, Sangwon/0000-0002-5094-8372	Institute for Information & Communications Technology Promotion (IITP) - Korea government (MSIT) [2015-0-00062, 2017-0-00053]	Institute for Information & Communications Technology Promotion (IITP) - Korea government (MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This work was partly supported by the Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (MSIT) (No. 2015-0-00062 and No. 2017-0-00053). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelink MW, 2001, J AFFECT DISORDERS, V62, P187, DOI 10.1016/S0165-0327(99)00202-5; ARGYLE N, 1991, J NERV MENT DIS, V179, P563, DOI 10.1097/00005053-199109000-00008; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1038/nrdp.2016.65; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brown DK, 2013, ENVIRON SCI TECHNOL, V47, P5562, DOI 10.1021/es305019p; Bylsma LM, 2008, CLIN PSYCHOL REV, V28, P676, DOI 10.1016/j.cpr.2007.10.001; Carney RM, 2000, PSYCHOSOM MED, V62, P639, DOI 10.1097/00006842-200009000-00007; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chizmadzhev YA, 1998, BIOPHYS J, V74, P843, DOI 10.1016/S0006-3495(98)74008-1; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Fuller GD, 1977, BIOFEEDBACK METHODS; Gladwell VF, 2012, EUR J APPL PHYSIOL, V112, P3379, DOI 10.1007/s00421-012-2318-8; Gold PW, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/581976; Goldberg D, 2011, WORLD PSYCHIATRY, V10, P226; Greco A, 2016, IEEE T BIO-MED ENG, V63, P797, DOI 10.1109/TBME.2015.2474131; Greco A, 2014, IEEE J BIOMED HEALTH, V18, P1865, DOI 10.1109/JBHI.2014.2300940; IACONO WG, 1983, ARCH GEN PSYCHIAT, V40, P557; Jacob A, 2013, J NEUROL DISORD, DOI [10.4172/2329-6895.1000122, DOI 10.4172/2329-6895.1000122]; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; LADER MH, 1969, J PSYCHIAT RES, V7, P89, DOI 10.1016/0022-3956(69)90014-4; Liao SC, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061385; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Luppa M, 2007, J AFFECT DISORDERS, V98, P29, DOI 10.1016/j.jad.2006.07.017; Lyubomirsky S, 1999, J PERS SOC PSYCHOL, V77, P1041, DOI 10.1037/0022-3514.77.5.1041; Mahajan R, 2015, INT J BIOMED ENG TEC, V18, P115, DOI 10.1504/IJBET.2015.070033; Mandrick K, 2016, BIOL PSYCHOL, V121, P62, DOI 10.1016/j.biopsycho.2016.10.002; Miller GE, 2005, PSYCHOSOM MED, V67, P679, DOI 10.1097/01.psy.0000174172.82428.ce; MIRKIN AM, 1980, BRIT J PSYCHIAT, V137, P93, DOI 10.1192/bjp.137.1.93; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; MYSLOBODSKY MS, 1978, BIOL PSYCHOL, V6, P111, DOI 10.1016/0301-0511(78)90050-9; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Noteboom JT, 2001, J APPL PHYSIOL, V91, P2093, DOI 10.1152/jappl.2001.91.5.2093; Orzechowska A, 2013, MED SCI MONITOR, V19, P1050, DOI 10.12659/MSM.889778; Phillips ML, 2007, SCHIZOPHRENIA BULL, V33, P893, DOI 10.1093/schbul/sbm060; Posada-Quintero HF, 2016, AM J PHYSIOL-REG I, V311, pR582, DOI 10.1152/ajpregu.00180.2016; Rottenberg J, 2002, EMOTION, V2, P135, DOI 10.1037//1528-3542.2.2.135; Salomon K, 2009, HEALTH PSYCHOL, V28, P157, DOI 10.1037/a0013001; Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141; Segal DL, 2010, DIAGNOSTIC INTERVIEWING, FOURTH EDITION, P1, DOI 10.1007/978-1-4419-1320-3_1; Silk JS, 2007, AM J PSYCHIAT, V164, P1873, DOI 10.1176/appi.ajp.2007.06111816; Sponheim SR, 1995, BEHAV HIGH RISK PARA, P222, DOI [10.1007/978-1-4612-4234-5_8, DOI 10.1007/978-1-4612-4234-5_8]; Sun GH, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00180; THORELL LH, 1987, ARCH GEN PSYCHIAT, V44, P1112; THORELL LH, 1987, ACTA PSYCHIAT SCAND, V76, P693, DOI 10.1111/j.1600-0447.1987.tb02941.x; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Valenza G, 2013, ARTIF INTELL MED, V57, P49, DOI 10.1016/j.artmed.2012.12.001; Widiger T A, 2000, DSM 5 CLASSIFICATION, DOI [10.1037/0033-2909.126.6.946, DOI 10.1037/0033-2909.126.6.946]; WILLIAMS KM, 1985, BIOL PSYCHIAT, V20, P158, DOI 10.1016/0006-3223(85)90075-7; Zarjam P, 2013, COMPUT BIOL MED, V43, P2186, DOI 10.1016/j.compbiomed.2013.08.021	49	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213140	10.1371/journal.pone.0213140	http://dx.doi.org/10.1371/journal.pone.0213140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943195	gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300010
J	Mao, CT; Chen, TH; Tseng, CN; Chen, SW; Hsieh, IC; Hung, MJ; Chu, PH; Wang, CH; Wen, MS; Cherng, WJ; Chen, DY				Mao, Chun-Tai; Chen, Tien-Hsing; Tseng, Chi-Nan; Chen, Shao-Wei; Hsieh, I-Chang; Hung, Ming-Jui; Chu, Pao-Hsien; Wang, Chao-Hung; Wen, Ming-Shien; Cherng, Wen-Jin; Chen, Dong-Yi			Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock	PLOS ONE			English	Article							BARE-METAL STENTS; INSURANCE RESEARCH DATABASE; XIENCE V STENTS; RESOLUTE STENTS; ISCHEMIC-STROKE; RISK; EFFICACY; REVASCULARIZATION; ASSOCIATION; VALIDATION	Objective Whether the cardiovascular (CV) outcomes of second-generation limus-eluting stents (LESs) differ from those of paclitaxel-eluting stents (PESs) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is still unclear. Methods We used the Taiwan National Health Insurance Research Database to analyse data of 516 patients with AMI and CS diagnosed from January 2007 to December 2011. We used propensity score matching to adjust for the imbalance in covariate baseline values between these two groups. We evaluated clinical outcomes by comparing 197 subjects who used second-generation LESs to 319 matched subjects who used PESs. Results The risk of the primary composite outcomes (i.e., myocardial infarction, coronary revascularisation or CV death) was significantly lower in the second-generation LES group than in the PES group [37.3% vs. 51.8%; hazard ratio (HR), 0.73; 95% CI: 0.56-0.95] at the 12-month follow-up. The patients who received second-generation LESs had a lower risk of coronary revascularisation (HR 0.62; 95% CI: 0.41-0.93) than those who used PESs. However, the risks of myocardial infarction (HR 0.56; 95% CI: 0.26-1.24), ischemic stroke (HR 0.73; 95% CI: 0.23-2.35), or CV death (HR 0.90; 95% CI: 0.63-1.28) were not significantly different between the two groups. Conclusions Among patients with CS-complicating AMI, second-generation LES implantation significantly reduced the risk of coronary revascularisation and composite CV events compared to PES implantation at the 12-month follow-up.	[Mao, Chun-Tai; Chen, Tien-Hsing; Hung, Ming-Jui; Wang, Chao-Hung] Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Keelung, Taiwan; [Tseng, Chi-Nan; Chen, Shao-Wei] Chang Gung Mem Hosp Linkou, Dept Thorac & Cardiovasc Surg, Taoyuan, Taiwan; [Hsieh, I-Chang; Chu, Pao-Hsien; Wen, Ming-Shien; Cherng, Wen-Jin; Chen, Dong-Yi] Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, DY (corresponding author), Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan.	dycstudy@gmail.com	Chu, Pao-Hsien/P-5249-2019; Wang, Chao/GXF-8353-2022	Chu, Pao-Hsien/0000-0003-0361-6348; 	Chang Gung Memorial Hospital, Taiwan [CGRPG2F0011, CLRPG2G0081]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from the Chang Gung Memorial Hospital, Taiwan (CGRPG2F0011 and CLRPG2G0081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Champion S, 2016, INT J CARDIOL, V223, P10, DOI 10.1016/j.ijcard.2016.08.059; Chang KH, 2016, ENVIRON INT, V94, P495, DOI 10.1016/j.envint.2016.06.008; Chen DY, 2016, INT J CARDIOL, V215, P98, DOI 10.1016/j.ijcard.2016.04.014; Chen DY, 2016, CIRC J, V80, P363, DOI 10.1253/circj.CJ-15-0778; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chuang YC, 2008, SOC SCI MED, V67, P1321, DOI 10.1016/j.socscimed.2008.06.033; Dangas GD, 2013, JACC-CARDIOVASC INTE, V6, P914, DOI 10.1016/j.jcin.2013.05.005; Hernandez JMD, 2014, REV ESP CARDIOL, V67, P999, DOI 10.1016/j.rec.2014.01.019; Harjola VP, 2015, EUR J HEART FAIL, V17, P501, DOI 10.1002/ejhf.260; Hicks KA, 2010, STANDARDIZED DATA CO; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Jaguszewski M, 2015, J CARDIOVASC MED, V16, P220, DOI 10.2459/JCM.0000000000000106; Kereiakes DJ, 2010, JACC-CARDIOVASC INTE, V3, P1229, DOI 10.1016/j.jcin.2010.09.014; Lee JM, 2014, AM J CARDIOL, V114, P1329, DOI 10.1016/j.amjcard.2014.07.065; LEOR J, 1993, AM J MED, V94, P265, DOI 10.1016/0002-9343(93)90058-W; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Liu YQ, 2015, INT J CARDIOL, V184, P680, DOI 10.1016/j.ijcard.2015.02.002; Mao CT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160070; Mauri L, 2008, NEW ENGL J MED, V359, P1330, DOI 10.1056/NEJMoa0801485; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park KW, 2014, JACC-CARDIOVASC INTE, V7, P471, DOI 10.1016/j.jcin.2013.12.201; Patel BD, 2006, THORAX, V61, P568, DOI 10.1136/thx.2005.053827; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Simsek C, 2013, INT J CARDIOL, V170, P36, DOI 10.1016/j.ijcard.2013.10.006; Sleeper LA, 2010, AM HEART J, V160, P443, DOI 10.1016/j.ahj.2010.06.024; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Valgimigli M, 2014, JACC-CARDIOVASC INTE, V7, P20, DOI 10.1016/j.jcin.2013.09.008; van Diepen S, 2017, CIRCULATION, V136, pE232, DOI 10.1161/CIR.0000000000000525; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214417	10.1371/journal.pone.0214417	http://dx.doi.org/10.1371/journal.pone.0214417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943217	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300036
J	Ushikoshi-Nakayama, R; Ryo, K; Yamazaki, T; Kaneko, M; Sugano, T; Ito, Y; Matsumoto, N; Saito, I				Ushikoshi-Nakayama, Ryoko; Ryo, Koufuchi; Yamazaki, Tomoe; Kaneko, Mie; Sugano, Tomoko; Ito, Yumi; Matsumoto, Naoyuki; Saito, Ichiro			Effect of gummy candy containing ubiquinol on secretion of saliva: A randomized, double- blind, placebo-controlled parallel-group comparative study and an in vitro study	PLOS ONE			English	Article							LIPID-PEROXIDATION; COENZYME Q(10); XEROSTOMIA; SUPPLEMENTATION; TISSUES; GLAND	A randomized, double-blind, placebo-controlled, parallel-group comparative clinical study was conducted to examine the effects of ubiquinol (the reduced form of Coenzyme Q10) on secretion of saliva. This interventional study enrolled 40 subjects aged 65 years or younger who were healthy, but noted slight dryness of the mouth. Subjects were randomized with stratification according to gender and age to ingestion of gummy candy containing 50 mg of ubiquinol or placebo twice daily for 8 weeks. At the end of study, along with a significant increase of the CoQ10 level in saliva (p = 0.025*, d = 0.65), there was a significant increase of the saliva flow rate (p = 0.048*, d = 0.66) in the ubiquinol candy group (n = 18; 47.4 +/- 6.2 years; 6 men and 12 women) compared to the placebo group (n = 20; 52.2 +/- 7.7 years; 4 men and 16 women). The strength of the stomatognathic muscles was not significantly enhanced by ingestion of ubiquinol candy. Compared with baseline, significant improvement of the following four questionnaire items was observed in the ubiquinol group at the end of the study: feeling tired (p = 0.00506, d = -0.726), dryness of the mouth (p = 0.04799, d = -0.648), prone to catching a cold (p = 0.00577, d = -0.963), and diarrhea (p = 0.0166, d = -0.855). There were no serious adverse events. An in vitro study revealed that ubiquinol stimulated a significant and concentration-dependent increase of ATP production by a cell line derived from human salivary gland epithelial cells (p<0.05), while 1 nM ubiquinol significantly suppressed (p = 0.028) generation of malondialdehyde by cells exposed to FeSO4-induced oxidative stress. These findings suggest that ubiquinol increases secretion of saliva by suppressing oxidative stress in the salivary glands and by promoting ATP production.	[Ushikoshi-Nakayama, Ryoko; Ryo, Koufuchi; Yamazaki, Tomoe; Kaneko, Mie; Sugano, Tomoko; Ito, Yumi; Matsumoto, Naoyuki; Saito, Ichiro] Tsurumi Univ, Sch Dent Med, Dept Pathol, Yokohama, Kanagawa, Japan	Tsurumi University	Saito, I (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Pathol, Yokohama, Kanagawa, Japan.	saito-i@tsurumi-u.ac.jp		Ushikoshi, Ryoko/0000-0002-6688-0413	Kaneka Corporation; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1511018]	Kaneka Corporation; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by Kaneka Corporation, including supply of ubiquinol. The funder provided support for this study in the form of a research grant and facilities for LC/MS/MS analysis at Kaneka Techno Research, an affiliated company, but had no involvement in the planning of the study, collection and analysis of the data, decision-making regarding publication, and preparation of the manuscript. This study was partially funded by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1511018).	Abramoff M.D., 2004, BIOPHOTONICS INT; Gil-Montoya JA, 2015, CLIN INTERV AGING, V10, DOI 10.2147/CIA.S54630; Ben Mansour R, 2016, CYTOTECHNOLOGY, V68, P135, DOI 10.1007/s10616-014-9764-6; Bergamini C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033712; BOTSOGLOU NA, 1994, J AGR FOOD CHEM, V42, P1931, DOI 10.1021/jf00045a019; Cacciapuoti F., 2016, J CARDIOVASC MED CAR, V3, P001, DOI [10.17352/2455-2976.000020, DOI 10.17352/2455-2976.000020]; Cacciapuoti F., 2010, TRENDS MED, V10, P191; Cassolato Sandra F, 2003, Gerodontology, V20, P64, DOI 10.1111/j.1741-2358.2003.00064.x; Castro-Marrero J, 2015, ANTIOXID REDOX SIGN, V22, P679, DOI 10.1089/ars.2014.6181; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; Flink Hakan, 2007, Swed Dent J Suppl, P3; FORSMARK P, 1991, FEBS LETT, V285, P39, DOI 10.1016/0014-5793(91)80720-N; Glore RJ, 2009, CLIN OTOLARYNGOL, V34, P358, DOI 10.1111/j.1749-4486.2009.01930.x; Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61, DOI 10.14219/jada.archive.2003.0018; Hagiwara SI, 2007, J AM GERIATR SOC, V55, P1141, DOI 10.1111/j.1532-5415.2007.01209.x; Hibberd J, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-39; Ibrahim WH, 2000, J NUTR, V130, P2343, DOI 10.1093/jn/130.9.2343; Inoue H, 2016, J CLIN BIOCHEM NUTR, V59, P107, DOI 10.3164/jcbn.16-31; Koc D, 2010, EUR J DENT, V4, P223, DOI DOI 10.1016/J.DENTAL.2009.02.009; KOHLER PF, 1985, ARTHRITIS RHEUM-US, V28, P1128, DOI 10.1002/art.1780281008; Kon M, 2007, EXERC IMMUNOL REV, V13, P76; Lenhard W., 2016, COMPUTATION EFFECT S, DOI [10.13140/RG.2.2.17823.92329, DOI 10.13140/RG.2.1.3478.4245, 10.13140/RG.2.1.3478.4245]; Liu B, 2012, OR SURG OR MED OR PA, V114, P52, DOI 10.1016/j.oooo.2011.11.014; Liu XB, 1999, J BIOL CHEM, V274, P25121, DOI 10.1074/jbc.274.35.25121; Locker David, 2003, Spec Care Dentist, V23, P86, DOI 10.1111/j.1754-4505.2003.tb01667.x; Maruoka H, 2014, J PHYS THER SCI, V26, P367, DOI 10.1589/jpts.26.367; Mishra J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.45; Oguchi K., 2000, JPN J REHABIL MED, V37, P375, DOI [10.2490/jjrm1963.37.375, DOI 10.2490/JJRM1963.37.375]; Oguchi K., 2000, JPN J REHAB MED, V38, P383, DOI [10.2490/jjrm1963.37.383, DOI 10.2490/jjrm1963.37.383, DOI 10.2490/JJRM1963.37.383]; Oguma Y., 2016, GLYCATIVE STRESS RES, V3, P177, DOI [10.24659/qsr.3.3_177, DOI 10.24659/GSR.3.3_177]; Ramos-Casals M, 2012, NAT REV RHEUMATOL, V8, P399, DOI 10.1038/nrrheum.2012.53; Ryo K, 2014, J CLIN BIOCHEM NUTR, V55, P168, DOI 10.3164/jcbn.14-49; Ryo K, 2011, CLIN BIOCHEM, V44, P669, DOI 10.1016/j.clinbiochem.2011.03.029; SATO M, 1984, CANCER, V54, P2959, DOI 10.1002/1097-0142(19841215)54:12<2959::AID-CNCR2820541225>3.0.CO;2-5; Schniertshauer D, 2016, PHOTOCHEM PHOTOBIOL, V92, P488, DOI 10.1111/php.12583; Sjogren P, 2016, J AM GERIATR SOC, V64, P2109, DOI 10.1111/jgs.14260; STOYANOVSKY DA, 1995, ARCH BIOCHEM BIOPHYS, V323, P343, DOI 10.1006/abbi.1995.9955; Sugano N, 2013, JAPANESE J CONSERV D, V56, P385, DOI [10.11471/shikahozon.56.385, DOI 10.11471/SHIKAHOZON.56.385]; Takahashi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116008; Thomson W Murray, 2005, Gerodontology, V22, P65, DOI 10.1111/j.1741-2358.2005.00058.x; Topcuoglu A, 2009, CLIN INVEST MED, V32, pE133; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Uchida Y, 2014, JAPANESE J COMPLEMEN, V11, P103; Yagi K, 1998, Methods Mol Biol, V108, P101; Yamada T, 2010, J CLIN BIOCHEM NUTR, V47, P130, DOI 10.3164/jcbn.10-31; Yamamoto Y, 2016, ARCH BIOCHEM BIOPHYS, V595, P132, DOI 10.1016/j.abb.2015.11.026; Yoneda T, 2014, NUTRIENTS, V6, P5756, DOI 10.3390/nu6125756	49	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214495	10.1371/journal.pone.0214495	http://dx.doi.org/10.1371/journal.pone.0214495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943227	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300043
J	Asensio-Martinez, A; Masluk, B; Montero-Marin, J; Olivan-Blazquez, B; Navarro-Gil, MT; Garcia-Campayo, J; Magallon-Botaya, R				Asensio-Martinez, Angela; Masluk, Barbara; Montero-Marin, Jesus; Olivan-Blazquez, Barbara; Teresa Navarro-Gil, Maria; Garcia-Campayo, Javier; Magallon-Botaya, Rosa			Validation of Five Facets Mindfulness Questionnaire - Short form, in Spanish, general health care services patients sample: Prediction of depression through mindfulness scale	PLOS ONE			English	Article							STRESS REDUCTION PROGRAM; QUALITY-OF-LIFE; DIALECTICAL BEHAVIOR-THERAPY; COGNITIVE THERAPY; PSYCHOMETRIC PROPERTIES; EMOTION REGULATION; MEDITATION; ANXIETY; BREAST; IMMUNE	The validation of Five Facets Mindfulness Questionnaire (FFMQ)-short version was performed in a general population of a city in a region of Galicia (Spain), the sample was composed of randomly selected Spanish Health Care patients (N = 845). The results on the goodness of fit of the non-hierarchical, five-dimensional factorial model met the criteria for good and acceptable model adjustment (after eliminating item 18 and despite the correlations detected among the errors included in the model), explaining a 55.5%.of the variance. As the second objective has been analysed the association between the scores obtained in the different facets of the FFMQ-SF and the risk of suffering an episode of depression. (The Odd Ratio, the Hosmer-Lemeshow test and the ROC curve were calculated.) Participants who were currently suffering from an episode of depression were more likely to have low scores in "describing" facet of Mindfulness (adjusted OR = 1.58, 95% CI = 1.04-2.40, linear trend: chi 2 = 3.74, df = 1, p = 0.053) as well as low scores on "acting with awareness" (adjusted OR = 2.19, 95% CI = 1.461-3.30, linear trend: chi 2 = 9.52, df = 1; = 0.002) and "non judging" (adjusted OR = 2.05, 95% CI = 1.36-3.09, linear trend: chi 2 = 143.21, df = 1; p < 0.001). Participants with a previous episode of depression were more likely to have low scores on the subscale "acting with awareness" (adjusted OR = 2.37, 95% CI = 1.43-3.93, linear trend: chi 2 = 9.62, df = 1, p = 0.002) and "non-reactivity" (adjusted OR = 2.14, 95% CI = 1.28-3.56, linear trend: chi 2 = 8.30; df = 1; p = 0.004. Questionnaire FFMQ-SF is an adequate questionnaire for the evaluation of mindfulness in non-clinical multi-occupational population.	[Asensio-Martinez, Angela; Masluk, Barbara; Montero-Marin, Jesus; Olivan-Blazquez, Barbara; Teresa Navarro-Gil, Maria; Garcia-Campayo, Javier; Magallon-Botaya, Rosa] Res Network Prevent Act & Hlth Promot RedIAPP, Barcelona, Spain; [Asensio-Martinez, Angela; Masluk, Barbara; Montero-Marin, Jesus; Olivan-Blazquez, Barbara; Teresa Navarro-Gil, Maria; Garcia-Campayo, Javier; Magallon-Botaya, Rosa] Hlth Res Inst Aragon, Zaragoza, Spain; [Asensio-Martinez, Angela; Masluk, Barbara; Olivan-Blazquez, Barbara; Teresa Navarro-Gil, Maria] Univ Zaragoza, Dept Psychol & Sociol, Zaragoza, Spain; [Garcia-Campayo, Javier; Magallon-Botaya, Rosa] Univ Zaragoza, Dept Med Psychiat & Dermatol, Zaragoza, Spain	University of Zaragoza; University of Zaragoza	Montero-Marin, J (corresponding author), Res Network Prevent Act & Hlth Promot RedIAPP, Barcelona, Spain.; Montero-Marin, J (corresponding author), Hlth Res Inst Aragon, Zaragoza, Spain.	jmonteromarin@hotmail.com	Montero-Marin, Jesus/ABG-8919-2020; Masluk, Barbara/AAD-4499-2021; Masluk, Barbara/AAY-4440-2021; Oliván-Blázquez, Bárbara/AAS-2130-2020; Martínez, Marimar/AAY-5711-2020; ASENSIO-MARTINEZ, ANGELA/Z-3694-2019	Montero-Marin, Jesus/0000-0001-5677-1662; Masluk, Barbara/0000-0001-9887-2250; Oliván-Blázquez, Bárbara/0000-0001-6565-9699; Martínez, Marimar/0000-0002-3006-5353; ASENSIO-MARTINEZ, ANGELA/0000-0001-5208-7556; Garcia-Campayo, Javier/0000-0002-3797-4218	"Aragon Research Group (SM Aragon)" of the Carlos III Health Institute [RedIAPP- RD12 / 005/006]; "Epidem-Galicia" group of the Carlos III Health Institute [RedIAPP- RD12 / 005/006]	"Aragon Research Group (SM Aragon)" of the Carlos III Health Institute; "Epidem-Galicia" group of the Carlos III Health Institute	This study was carried out with the support of the "Aragon Research Group (SM Aragon)" and the "Epidem-Galicia" group, both members of the Research Network on Prevention and Health Promotion Activities in Primary Care (RedIAPP- RD12 / 005/006), of the Carlos III Health Institute.	Aguado J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00404; Anchorena M. N., 2017, ARCH ASSESSMENT PSYC, V7, P29; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2011, ASSESSMENT, V18, P3, DOI 10.1177/1073191110392498; Black David S, 2011, Mindfulness (N Y), V2, P179; Bohlmeijer E, 2011, ASSESSMENT, V18, P308, DOI 10.1177/1073191111408231; Brown DB, 2015, MINDFULNESS, V6, P1021, DOI 10.1007/s12671-014-0349-4; Cabrera E.C, 2017, REV ACTUALIDAD CRIMI, V5, P45; Carlson LE, 2007, BRAIN BEHAV IMMUN, V21, P1038, DOI 10.1016/j.bbi.2007.04.002; Carmody J, 2008, J PSYCHOSOM RES, V64, P393, DOI 10.1016/j.jpsychores.2007.06.015; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Cebolla A, 2012, EUR J PSYCHIAT, V26, P118, DOI 10.4321/S0213-61632012000200005; Chiesa A, 2013, CLIN PSYCHOL REV, V33, P82, DOI 10.1016/j.cpr.2012.10.006; Ferrari AJ, 2010, BURDEN DEPRESSIVE DI; Fjorback LO, 2011, ACTA PSYCHIAT SCAND, V124, P102, DOI 10.1111/j.1600-0447.2011.01704.x; Gabilondo A, 2010, J AFFECT DISORDERS, V120, P76, DOI 10.1016/j.jad.2009.04.016; Galante J, 2013, J RES NURS, V18, P133, DOI 10.1177/1744987112466087; Garcia MA, 2011, ANALISIS CAUSAL CON; Goldenberg DL, 1994, J MUSCULOSKELET PAIN, V2, P53, DOI [10.1300/J094v02n02_05, DOI 10.1300/J094V02N02_05]; Goldman-Mellor S, 2018, SUICIDE LIFE-THREAT, V48, P709, DOI 10.1111/sltb.12390; Gonzalez-Garcia M, 2014, AIDS BEHAV, V18, P676, DOI 10.1007/s10461-013-0612-z; Gross CR, 2010, ALTERN THER HEALTH M, V16, P30; Grossman P, 2011, PSYCHOL ASSESSMENT, V23, P1034, DOI 10.1037/a0022713; Gu J, 2016, PSYCHOL ASSESSMENT, V28, P791, DOI 10.1037/pas0000263; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hou J, 2014, ASSESSMENT, V21, P363, DOI 10.1177/1073191113485121; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; KABATZINN J, 1985, J BEHAV MED, V8, P163, DOI 10.1007/BF00845519; KABATZINN J, 1992, AM J PSYCHIAT, V149, P936; KAPLAN KH, 1993, GEN HOSP PSYCHIAT, V15, P284, DOI 10.1016/0163-8343(93)90020-O; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; KING Gary, 2003, INT STUD PERSPECT, V04, P72, DOI DOI 10.1111/1528-3577.04105; Kristeller J L, 1999, J Health Psychol, V4, P357, DOI 10.1177/135910539900400305; Kumar S, 2008, COGNITIVE THER RES, V32, P734, DOI 10.1007/s10608-008-9190-1; Lang AJ, 2012, BEHAV MODIF, V36, P759, DOI 10.1177/0145445512441200; Lauche R, 2013, J PSYCHOSOM RES, V75, P500, DOI 10.1016/j.jpsychores.2013.10.010; MARDIA KV, 1974, SANKHYA SER B, V36, P115; Monton C, 1993, ATEN PRIM, V12, P9; MUTHEN B, 1992, BRIT J MATH STAT PSY, V45, P19, DOI 10.1111/j.2044-8317.1992.tb00975.x; Omidi A, 2015, EFFECTS MINDFULNESS, P1058, DOI [10.4103/1735-1995.172816, DOI 10.4103/1735-1995.172816]; Orsillo SM, 2005, BEHAV MODIF, V29, P95, DOI 10.1177/0145445504270876; Pbert L, EFFECT MINDFULNESS T, DOI [10.1136/thoraxjnl-2011-200253, DOI 10.1136/THORAXJNL-2011-200253]; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Prazak M, 2012, APPL PSYCHOL-HLTH WE, V4, P91, DOI 10.1111/j.1758-0854.2011.01063.x; Ramel W, 2004, COGNITIVE THER RES, V28, P433, DOI 10.1023/B:COTR.0000045557.15923.96; Raphiphatthana B, 2016, PERS INDIV DIFFER, V93, P104, DOI 10.1016/j.paid.2015.08.005; Reibel DK, 2001, GEN HOSP PSYCHIAT, V23, P183, DOI 10.1016/S0163-8343(01)00149-9; Reiner K, 2013, PAIN MED, V14, P230, DOI 10.1111/pme.12006; Robinson FP, 2003, J ALTERN COMPLEM MED, V9, P683, DOI 10.1089/107555303322524535; Safer DL, 2001, AM J PSYCHIAT, V158, P632, DOI 10.1176/appi.ajp.158.4.632; Salmoirago-Blotcher E, 2013, J EVID-BASED INTEGR, V18, P243, DOI 10.1177/2156587213488600; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Sauer S, 2013, MINDFULNESS, V4, P3, DOI 10.1007/s12671-012-0122-5; Shapiro S. L., 2005, INT J STRESS MANAGE, V12, P164, DOI [10.1037/1072-5245.12.2.164, DOI 10.1037/1072-5245.12.2.164]; Shapiro SL, 2003, J PSYCHOSOM RES, V54, P85, DOI 10.1016/S0022-3999(02)00546-9; Siegel R. D., 2008, CLIN HDB MINDFULNESS, P17; Speca M, 2000, PSYCHOSOM MED, V62, P613, DOI 10.1097/00006842-200009000-00004; Sternberg RJ, 2000, J SOC ISSUES, V56, P11, DOI 10.1111/0022-4537.00149; Strauss C, 2014, MINDFULNESS BASED IN, V9, DOI [10.1371/journal.pone.0096110, DOI 10.1371/JOURNAL.PONE.0096110]; Sugiura Y, 2012, MINDFULNESS, V3, P85, DOI 10.1007/s12671-011-0082-1; Tacon AM, 2004, FAMILIES SYSTEMS HLT, V22, P193, DOI DOI 10.1037/1091-7527.22.2.193; Telch CF, 2001, J CONSULT CLIN PSYCH, V69, P1061, DOI 10.1037//0022-006X.69.6.1061; Teresa Miro M, 2011, REV PSICOPATOLOGIA P, V16, P1, DOI [10.5944/rppc.vol.16.num.1.2011.10347, DOI 10.5944/rppc.vol.16.num.1.2011.10347]; Terry ML, 2013, PERS SOC PSYCHOL B, V39, P911, DOI 10.1177/0146167213488213; Tran US, 2013, J CLIN PSYCHOL, V69, P951, DOI 10.1002/jclp.21996; Van Dam NT, 2012, ASSESSMENT, V19, P198, DOI 10.1177/1073191112438743; Virgili M., 2013, INT COACHING PSYCHOL, V8, P40; Weissbecker I, 2002, J CLIN PSYCHOL MED S, V9, P297, DOI 10.1023/A:1020786917988; Williams MJ, 2014, PSYCHOL ASSESSMENT, V26, P407, DOI 10.1037/a0035566; Wiltink RG, 2010, LIFE SATISFACTION AN, V13, P32, DOI [10.3109/13685530903296698, DOI 10.3109/13685530903296698]; Winton A. S., 2004, CLIN CASE STUD, V3, P275, DOI [DOI 10.1177/1534650103259646, DOI 10.1177/15346]; Witek-Janusek L, 2008, BRAIN BEHAV IMMUN, V22, P969, DOI 10.1016/j.bbi.2008.01.012; Woolhouse H, 2012, EAT DISORD, V20, P321, DOI 10.1080/10640266.2012.691791	74	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214503	10.1371/journal.pone.0214503	http://dx.doi.org/10.1371/journal.pone.0214503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939151	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900028
J	Lauffenburger, JC; Ghazinouri, R; Jan, S; Makanji, S; Ferro, CA; Lewey, J; Wittbrodt, E; Lee, J; Haff, N; Fontanet, CP; Choudhry, NK				Lauffenburger, Julie C.; Ghazinouri, Roya; Jan, Saira; Makanji, Sagar; Ferro, Christina A.; Lewey, Jennifer; Wittbrodt, Eric; Lee, Jessica; Haff, Nancy; Fontanet, Constance P.; Choudhry, Niteesh K.			Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial	PLOS ONE			English	Article							MEDICATION THERAPY MANAGEMENT; IMPROVE ADHERENCE; HEALTH; CARE; PERFORMANCE; PERSISTENCE; INSULIN; METRICS; DESIGN	Background Many factors contribute to suboptimal diabetes control including insufficiently-intensive treatment and non-adherence to medication and lifestyle. Determining which of these is most relevant for individual patients is challenging. Patient engagement techniques may help identify contributors to suboptimal adherence and address barriers (using motivational interviewing) and help facilitate choices among treatment augmentation options (using shared decision-making). These methods have not been used in combination to improve diabetes outcomes. Objective To evaluate the impact of a telephone-based patient-centered intervention on glycosylated hemoglobin (HbA1c) control for individuals with poorly-controlled diabetes. Design Two-arm pragmatic randomized control trial within an explanatory sequential mixed-methods design. Subjects 1,400 participants 18-64 years old with poorly-controlled type 2 diabetes. Intervention The intervention was delivered over the telephone by a clinical pharmacist and consisted of a 2-step process that integrated brief negotiated interviewing and shared decision-making to identify patient goals and options for enhancing diabetes management. Main measures The primary outcome was change in HbA1c. Secondary outcomes were medication adherence measures. Outcomes were evaluated using intention-to-treat principles; multiple imputation was used for missing values in the 12-month follow-up. We used information from pharmacist notes to elicit factors to potentially explain the intervention's effectiveness. Key results Participants had a mean age of 54.7 years (SD:8.3) and baseline HbA1c of 9.4 (SD:1.6). Change in HbA1c from baseline was -0.79 (SD:2.01) in the control arm and-0.75 (SD:1.76) in the intervention arm (difference:+0.04, 95%Cl: -0.22, 0.30). There were no significant differences in adherence. In as-treated analyses, the intervention significantly improved diabetes control (-0.48, 95%CI: -0.91,-0.05). Qualitative findings provided several potential explanations for the findings, including insufficiently addressing patient barriers. Conclusions A novel telephone-based patient-centered intervention did not improve HbA1c among individuals with poorly-controlled diabetes, though as-treated analyses suggest that the intervention was effective for those who received it.	[Lauffenburger, Julie C.; Ghazinouri, Roya; Lee, Jessica; Haff, Nancy; Fontanet, Constance P.; Choudhry, Niteesh K.] Brigham & Womens Hosp, Dept Med, Ctr Healthcare Delivery Sci C4HDS, 75 Francis St, Boston, MA 02115 USA; [Lauffenburger, Julie C.; Ghazinouri, Roya; Lee, Jessica; Haff, Nancy; Fontanet, Constance P.; Choudhry, Niteesh K.] Harvard Med Sch, Boston, MA 02115 USA; [Lauffenburger, Julie C.; Ghazinouri, Roya; Lee, Jessica; Haff, Nancy; Fontanet, Constance P.; Choudhry, Niteesh K.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Jan, Saira] Horizon Blue Cross Blue Shield New Jersey, Newark, NJ USA; [Jan, Saira] Rutgers State Univ, New Brunswick, NJ USA; [Makanji, Sagar; Ferro, Christina A.] Magellan Rx Management, Newport, RI USA; [Lewey, Jennifer] Hosp Univ Penn, Div Cardiovasc Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Wittbrodt, Eric] AstraZeneca, US Med Affairs, Wilmington, DE USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Rutgers State University New Brunswick; University of Pennsylvania; Pennsylvania Medicine; AstraZeneca	Lauffenburger, JC (corresponding author), Brigham & Womens Hosp, Dept Med, Ctr Healthcare Delivery Sci C4HDS, 75 Francis St, Boston, MA 02115 USA.; Lauffenburger, JC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Lauffenburger, JC (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	jlauffenburger@bwh.harvard.edu		Lauffenburger, Julie/0000-0002-4940-4140; Fontanet, Constance/0000-0002-8253-1598	AstraZeneca	AstraZeneca(AstraZeneca)	This research was supported by unrestricted funding from AstraZeneca to Brigham and Women's Hospital (awarded to NKC). The BWH had ultimate decision-making over study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abughosh SM, 2016, J MANAG CARE SPEC PH, V22, P63, DOI 10.18553/jmcp.2016.22.1.63; Adamian MS, 2004, AIDS PATIENT CARE ST, V18, P229, DOI 10.1089/108729104323038900; American Diabetes Association, 2018, Clin Diabetes, V36, P14, DOI 10.2337/cd17-0119; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bergenstal RM, 2013, DIABETES CARE, V36, pE107, DOI 10.2337/dc13-0295; Bernstein SL, 2013, J SUBST ABUSE TREAT, V44, P139, DOI 10.1016/j.jsat.2012.05.005; Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Bryant J, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-109; Bundy C, 2004, J ROY SOC MED, V97, P43; Choudhry NK, 2018, JAMA INTERN MED, V178, P1182, DOI 10.1001/jamainternmed.2018.3189; Choudhry NK, 2017, NEW ENGL J MED, V377, P957, DOI 10.1056/NEJMra1510058; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Cutrona SL, 2010, AM J MANAG CARE, V16, P929; Franklin JM, 2014, STAT MED, V33, P1685, DOI 10.1002/sim.6058; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Hansen RA, 2009, ANN PHARMACOTHER, V43, P413, DOI 10.1345/aph.1L496; Hernan MA, 2017, NEW ENGL J MED, V377, P1391, DOI 10.1056/NEJMsm1605385; Ivankova NV, 2006, FIELD METHOD, V18, P3, DOI 10.1177/1525822X05282260; Kashaf MS, 2017, PATIENT EDUC COUNS, V100, P2159, DOI 10.1016/j.pec.2017.06.030; Lauffenburger JC, 2017, CONTEMP CLIN TRIALS, V59, P57, DOI 10.1016/j.cct.2017.05.014; Lewey J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016551; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; McCambridge J, 2003, DRUG ALCOHOL REV, V22, P391, DOI 10.1080/09595230310001613903; Misono AS, 2010, AM J MANAGED CA SHIT, V16, pSP82; Moczygemba LR, 2008, AM J HEALTH-SYST PH, V65, P1655, DOI 10.2146/ajhp070639; Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x; Newgard CD, 2015, JAMA-J AM MED ASSOC, V314, P940, DOI 10.1001/jama.2015.10516; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735; Pezzi A, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0253-9; */* S  13, 2016, DIABETES CARE S1, V39, pS1, DOI DOI 10.2337/DC16-S005; */* S  73, 2018, DIABETES CARE S1, V41, pS7, DOI DOI 10.2337/DC18-S008; Saitz R, 2014, JAMA-J AM MED ASSOC, V312, P502, DOI 10.1001/jama.2014.7862; Schmittdiel JA, 2015, MED CARE, V53, P332, DOI 10.1097/MLR.0000000000000328; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538; Wei WH, 2014, ENDOCR PRACT, V20, P52, DOI 10.4158/EP13159.OR; Zillich AJ, 2014, HEALTH SERV RES, V49, P1537, DOI 10.1111/1475-6773.12176	38	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214754	10.1371/journal.pone.0214754	http://dx.doi.org/10.1371/journal.pone.0214754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939143	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900039
J	Wamoyi, J; Heise, L; Meiksin, R; Kyegombe, N; Nyato, D; Buller, AM				Wamoyi, Joyce; Heise, Lori; Meiksin, Rebecca; Kyegombe, Nambusi; Nyato, Daniel; Buller, Ana Maria			Is transactional sex exploitative? A social norms perspective, with implications for interventions with adolescent girls and young women in Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; DAR-ES-SALAAM; RISK; HIV; EXCHANGE; VIOLENCE; PEOPLE; ABUSE; MONEY	Although transactional sex is common in many sexual relationships, there has been little research into the degree to which the practice is considered exploitative in the settings in which it is practiced. We describe the social norms that influence transactional sex in two sites in Mwanza, Tanzania, and explore local understandings of whether and under what conditions it is considered exploitative. We then compare these "emic" understandings of exploitation to international definitions and norms around sexual exploitation. This study employed a qualitative research design involving 18 focus group discussions and 43 in-depth interviews with young people aged 14-24 years and parents with children aged 14-24 years in a rural area and an urban center within Mwanza, Tanzania. Thematic analysis was conducted with the aid of NVivo 10. The social norms influencing the practice of transactional sex included: reciprocity as a core cultural value that permeates the way exchange in sexual relationships is judged; gendered expectations that men should provide for women's material needs in sexual relationships and that women should reciprocate by means of sex; and peer pressure to be perceived as "fashionable". Adolescent girls and young women (AGYW) are under strong peer pressure to conform to a "modern lifestyle" as reflected in stylish clothing and other items of modernity such as cellphones. The emic conceptualization of exploitation is defined by circumstances surrounding the relationship or a sexual encounter. Important factors that characterize local notions of when transactional relationships are considered exploitative include: when the encounter or relationship involves an imbalance of power (based on age, male economic power and social status); when a man fails to reciprocate; and when sex is coerced. According to community perspectives, young women's behavior should be considered exploitative of men when they take gifts or money yet refuse sex or when they demand large sums of money. Interventions aimed at reducing AGYW's exploitation through transactional sex need to be cognizant of the variations in the understanding of what constitutes sexual exploitation as well as the social and gender norms influencing the practice of transactional sex. Interventions need to involve communities and families in critical thinking that helps them identify positive alternatives to current gendered social norms that shape the involvement of AGYW and men in transactional sex.	[Wamoyi, Joyce; Nyato, Daniel] Natl Inst Med Res, Dept Sexual & Reprod Hlth, Mwanza, Tanzania; [Heise, Lori] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Meiksin, Rebecca] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England; [Kyegombe, Nambusi; Buller, Ana Maria] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	National Institute of Medical Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Wamoyi, J (corresponding author), Natl Inst Med Res, Dept Sexual & Reprod Hlth, Mwanza, Tanzania.	JWamoyi@gmail.com	Nyato, Daniel/J-1682-2019; Kyegombe, Nambusi/ABC-9970-2020; Wamoyi, Joyce/AAO-6351-2020; Heise, LORI/AAI-6251-2020	Nyato, Daniel/0000-0002-2397-1390; Wamoyi, Joyce/0000-0002-2956-8666; Buller, Ana Maria/0000-0002-3007-9747; Kyegombe, Nambusi/0000-0002-3986-0361	OAK Foundation [OCAY-13-483]	OAK Foundation	The study was funded by OAK Foundation under grand number OCAY-13-483. The funder had no role in the design, analysis and write up of these results.	Buller AM, 2018, REPROD HEALTH MATTER, V26, P38, DOI 10.1080/09688080.2018.1542914; Choudhry V, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27249; Cislaghi B, 2018, HLTH PROMOT INT, DOI 10.1093/heapro/day017/4951539; Cluver L, 2011, JAIDS-J ACQ IMM DEF, V58, P336, DOI 10.1097/QAI.0b013e31822f0d82; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Kabeer N, 1999, DEV CHANGE, V30, P435, DOI 10.1111/1467-7660.00125; Kagesten A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157805; Kaufman CE, 2004, CULT HEALTH SEX, V6, P377, DOI 10.1080/13691050410001680492; Kuate-Defo Bartbelemy, 2004, Afr J Reprod Health, V8, P13, DOI 10.2307/3583175; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Longfield K, 2004, CULT HEALTH SEX, V6, P483, DOI 10.1080/13691050410001701920; Longfield K, 2004, STUD FAMILY PLANN, V35, P125, DOI 10.1111/j.1728-4465.2004.00014.x; Luke N, 2006, ECON DEV CULT CHANGE, V54, P319, DOI 10.1086/497011; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Luke N, 2011, J MARRIAGE FAM, V73, P1048, DOI 10.1111/j.1741-3737.2011.00863.x; Maganja RK, 2007, AIDS CARE, V19, P974, DOI 10.1080/09540120701294286; Mason J., 2006, QUALITATIVE RES; National Working Group for Sexually Exploited Children and Young People, 2008, DEF CHILD SEX EXPL; Norris AH, 2009, SOC SCI MED, V69, P1167, DOI 10.1016/j.socscimed.2009.07.015; Poulin M, 2007, SOC SCI MED, V65, P2383, DOI 10.1016/j.socscimed.2007.05.030; Poverty EvansR., 2002, GENDER DEV, V10, P51, DOI DOI 10.1080/13552070215916; Shannon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028739; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Stoebenau K, 2016, SOC SCI MED, V168, P186, DOI 10.1016/j.socscimed.2016.09.023; The Council of Europe Convention on the Protection of Children against Sexual Exploitation and Sexual Abuse, 2007, RED RISK SEX EXPL CH; UN, 2008, UN COND DISC UN; Wamoyi J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20992; Wamoyi J, 2011, ARCH SEX BEHAV, V40, P5, DOI 10.1007/s10508-010-9646-8; Wamoyi J, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-6; Wight D, 2006, SOC SCI MED, V62, P987, DOI 10.1016/j.socscimed.2005.06.052; Williams TP, 2012, CHILD ABUSE NEGLECT, V36, P354, DOI 10.1016/j.chiabu.2011.11.006; Wojcicki JM, 2002, MED ANTHROPOL Q, V16, P267, DOI 10.1525/maq.2002.16.3.267	34	29	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214366	10.1371/journal.pone.0214366	http://dx.doi.org/10.1371/journal.pone.0214366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939145	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000462993900019
J	Deckx, S; Johnson, DM; Rienks, M; Carai, P; Van Deel, E; Van der Velden, J; Sipido, KR; Heymans, S; Papageorgiou, AP				Deckx, Sophie; Johnson, Daniel M.; Rienks, Marieke; Carai, Paolo; Van Deel, Elza; Van der Velden, Jolanda; Sipido, Karin R.; Heymans, Stephane; Papageorgiou, Anna-Pia			Extracellular SPARC increases cardiomyocyte contraction during health and disease	PLOS ONE			English	Article							VIRAL MYOCARDITIS; OSTEOGLYCIN PREVENTS; CARDIAC DILATATION; DYSFUNCTION; COLLAGEN; EXPRESSION; AKT; ACTIVATION; INFARCTION; APOPTOSIS	Secreted protein acidic and rich in cysteine (SPARC) is a non-structural extracellular matrix protein that regulates interactions between the matrix and neighboring cells. In the cardiovascular system, it is expressed by cardiac fibroblasts, endothelial cells, and at lower levels by ventricular cardiomyocytes. SPARC expression levels are increased upon myocardial injury and also during hypertrophy and fibrosis. We have previously shown that SPARC improves cardiac function after myocardial infarction by regulating post-synthetic procollagen processing, however whether SPARC directly affects cardiomyocyte contraction is still unknown. In this study we demonstrate a novel inotropic function for extracellular SPARC in the healthy heart as well as in the diseased state after myocarditis-induced cardiac dysfunction. We demonstrate SPARC presence on the cardiomyocyte membrane where it is co-localized with the integrin-beta1 and the integrin-linked kinase. Moreover, extracellular SPARC directly increases cardiomyocyte cell shortening ex vivo and cardiac function in vivo, both in healthy myocardium and during coxsackie virus-induced cardiac dysfunction. In conclusion, we demonstrate a novel inotropic function for SPARC in the heart, with a potential therapeutic application when myocyte contractile function is diminished such as that caused by a myocarditis-related cardiac injury.	[Deckx, Sophie; Rienks, Marieke; Carai, Paolo; Heymans, Stephane; Papageorgiou, Anna-Pia] Maastricht Univ, Dept Cardiol, Maastricht, Netherlands; [Deckx, Sophie; Johnson, Daniel M.; Carai, Paolo; Sipido, Karin R.; Heymans, Stephane; Papageorgiou, Anna-Pia] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium; [Johnson, Daniel M.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Rienks, Marieke] Kings Coll London, Kings British Heart Fdn Ctr, London, England; [Van Deel, Elza; Van der Velden, Jolanda] Vrije Univ Amsterdam, Amsterdam UMC, Dept Physiol, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands	Maastricht University; KU Leuven; University of Birmingham; University of London; King's College London; University of Amsterdam; Vrije Universiteit Amsterdam	Papageorgiou, AP (corresponding author), Maastricht Univ, Dept Cardiol, Maastricht, Netherlands.; Papageorgiou, AP (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium.	anna.papageorgiou@maastrichtuniversity.nl	Johnson, Daniel M/A-4654-2010	Johnson, Daniel M/0000-0002-7376-7101; Heymans, Stephane/0000-0001-9477-7803; Carai, Paolo/0000-0003-0718-4773; van der Velden, Jolanda/0000-0001-5224-5788	CARIM; European Commission grant FIBROTARGETS [602904]; European Commission grant MEDIA [261409]; European Commission grant ARENA [CVON2011]; FWO	CARIM; European Commission grant FIBROTARGETS; European Commission grant MEDIA; European Commission grant ARENA [CVON2011]; FWO(FWO)	This work was supported by a CARIM-funded PhD grant, and by the European Commission's grants FIBROTARGETS [602904], MEDIA [261409], and ARENA [CVON2011]. DMJ was funded by a postdoctoral fellowship from the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Chen H, 2004, PHYSIOL GENOMICS, V18, P273, DOI 10.1152/physiolgenomics.00104.2004; Cittadini A, 2006, GENE THER, V13, P8, DOI 10.1038/sj.gt.3302589; Corsten MF, 2012, TRENDS MOL MED, V18, P426, DOI 10.1016/j.molmed.2012.05.005; Deckx S, 2018, MATRIX BIOL, V66, P110, DOI 10.1016/j.matbio.2017.09.002; Harris BS, 2011, AM J PHYSIOL-HEART C, V301, pH841, DOI 10.1152/ajpheart.01247.2010; Hazebroek Mark, 2012, Antiviral Chemistry & Chemotherapy, V22, P249, DOI 10.3851/IMP2047; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kaese S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180029; Kaestner Lars, 2009, J Vis Exp, DOI 10.3791/1433; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Mason JW, 2003, CARDIOVASC RES, V60, P5, DOI 10.1016/S0008-6363(03)00437-1; Mooney A, 1999, AM J PATHOL, V155, P599, DOI 10.1016/S0002-9440(10)65155-3; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Papageorgiou AP, 2012, CARDIOVASC RES, V94, P115, DOI 10.1093/cvr/cvs077; Pollack A, 2015, NAT REV CARDIOL, V12, P670, DOI 10.1038/nrcardio.2015.108; Rienks M, 2018, MATRIX BIOL, V74, P21, DOI 10.1016/j.matbio.2018.04.015; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Sheikh F, 2014, TRENDS CARDIOVAS MED, V24, P133, DOI 10.1016/j.tcm.2013.07.004; Steinke K, 2013, FASEB J, V27, P4108, DOI 10.1096/fj.13-230193; Swinnen M, 2009, CIRCULATION, V120, P1585, DOI 10.1161/CIRCULATIONAHA.109.863266; Terada Y, 2001, KIDNEY INT, V60, P553, DOI 10.1046/j.1523-1755.2001.060002553.x; Van Aelst LNL, 2015, CIRC RES, V116, P425, DOI 10.1161/CIRCRESAHA.116.304599; Vanhoutte D, 2007, CIRCULATION, V115, P475, DOI 10.1161/CIRCULATIONAHA.106.644609; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Wessely R, 1998, J CLIN INVEST, V102, P1444, DOI 10.1172/JCI1972	31	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0209534	10.1371/journal.pone.0209534	http://dx.doi.org/10.1371/journal.pone.0209534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933983	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000462867000001
J	Hussein, H; Fris, ME; Salem, AH; Wiemels, RE; Bastock, RA; Righetti, F; Burke, CA; Narberhaus, F; Carroll, RK; Hassan, NS; Mohamed, SA; Fahmy, AS; Murphy, ER				Hussein, Hebaallaha; Fris, Megan E.; Salem, Ahmed H.; Wiemels, Richard E.; Bastock, Raeven A.; Righetti, Francesco; Burke, Caleb A.; Narberhaus, Franz; Carroll, Ronan K.; Hassan, Nahla S.; Mohamed, Saleh A.; Fahmy, Afaf S.; Murphy, Erin R.			An unconventional RNA-based thermosensor within the 5 ' UTR of Staphylococcus aureus cidA	PLOS ONE			English	Article							METHICILLIN-RESISTANT; VIRULENCE FACTORS; IMMUNE EVASION; MESSENGER-RNA; THERMOMETER; EXPRESSION; TRANSLATION; BACTERIA; FOURU; GENE	Staphylococcus aureus is a Gram-positive bacterial pathogen of global concern and a leading cause of bacterial infections worldwide. Asymptomatic carriage of S. aureus on the skin and in the anterior nares is common and recognized as a predisposing factor to invasive infection. Transition of S. aureus from the carriage state to that of invasive infection is often accompanied by a temperature upshift from approximately 33 degrees C to 37 degrees C. Such a temperature shift is known in other pathogens to influence gene expression, often resulting in increased production of factors that promote survival or virulence within the host. One mechanism by which bacteria modulate gene expression in response to temperature is by the regulatory activity of RNA-based thermosensors, cis-acting riboregulators that control translation efficiency. This study was designed to identify and characterize RNA-based thermosensors in S. aureus. Initially predicted by in silico analyses of the S. aureus USA300 genome, reporter-based gene expression analyses and site-specific mutagenesis were performed to demonstrate the presence of a functional thermosensor within the 5' UTR of cidA, a gene implicated in biofilm formation and survival of the pathogen. The nucleic sequence composing the identified thermosensor are sufficient to confer temperature-dependent post-transcriptional regulation, and activity is predictably altered by the introduction of site-specific mutations designed to stabilize or destabilize the structure within the identified thermosensor. The identified regulator is functional in both the native bacterial host S. aureus and in the distally related species Escherichia coli, suggesting that its regulatory activity is independent of host-specific factors. Interestingly, unlike the majority of bacterial RNA-based thermosensors characterized to date, the cidA thermosensor facilitates increased target gene expression at lower temperatures. In addition to the characterization of the first RNA-based thermosensor in the significant pathogen S. aureus, it highlights the diversity of function within this important class of ribo-regulators.	[Hussein, Hebaallaha; Mohamed, Saleh A.; Fahmy, Afaf S.] Natl Res Ctr, Cairo, Egypt; [Fris, Megan E.; Wiemels, Richard E.; Burke, Caleb A.; Carroll, Ronan K.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Fris, Megan E.; Bastock, Raeven A.; Carroll, Ronan K.; Murphy, Erin R.] Ohio Univ, Infect & Top Dis Inst, Athens, OH 45701 USA; [Salem, Ahmed H.; Hassan, Nahla S.] Ain Shams Univ, Cairo, Egypt; [Bastock, Raeven A.; Carroll, Ronan K.; Murphy, Erin R.] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Righetti, Francesco; Narberhaus, Franz] Ruhr Univ Bochum, Bochum, Germany; [Murphy, Erin R.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University System of Ohio; Ohio University; University System of Ohio; Ohio University; Egyptian Knowledge Bank (EKB); Ain Shams University; University System of Ohio; Ohio University; Ruhr University Bochum; University System of Ohio; Ohio University	Murphy, ER (corresponding author), Ohio Univ, Infect & Top Dis Inst, Athens, OH 45701 USA.; Murphy, ER (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA.; Murphy, ER (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	murphye@ohio.edu	fahmy, afaf/ABC-9033-2020	fahmy, afaf/0000-0002-0196-961X; Hussein, Hebaallaha/0000-0001-6821-2198; Hassan, Nahla/0000-0002-9530-0828; Narberhaus, Franz/0000-0002-8552-5310; Righetti, Francesco/0000-0003-4903-2321; Murphy, Erin/0000-0002-5716-4829	National Institutes of Health [1R03AI135788-01A1]; Ohio University Heritage College of Osteopathic Medicine; Embassy of the Arab Republic of Egypt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI135788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio University Heritage College of Osteopathic Medicine; Embassy of the Arab Republic of Egypt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this work came from National Institutes of Health award 1R03AI135788-01A1, www.nih.gov (ERM and RKC); Ohio University Heritage College of Osteopathic Medicine, www.ohio.edu/medicine (ERM); Embassy of the Arab Republic of Egypt (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTUVIA S, 1989, J MOL BIOL, V210, P265, DOI 10.1016/0022-2836(89)90329-X; Barnwal RP, 2016, NUCLEIC ACIDS RES, V44, P9426, DOI 10.1093/nar/gkw584; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Carroll RK, 2016, MBIO, V7, DOI 10.1128/mBio.01990-15; Carroll RK, 2014, MICROBIOL-SGM, V160, P1737, DOI 10.1099/mic.0.079798-0; Chaudhari SS, 2016, MOL MICROBIOL, V101, P942, DOI 10.1111/mmi.13433; Chen J, 2014, PLASMID, V76, P1, DOI 10.1016/j.plasmid.2014.08.001; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Ellington JK, 2006, J ORTHOP RES, V24, P87, DOI 10.1002/jor.20003; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garzoni C, 2009, AM J TRANSPLANT, V9, pS41, DOI 10.1111/j.1600-6143.2009.02892.x; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Kouse AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063781; Krajewski SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065168; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lam O, 2014, VIRULENCE, V5, P852, DOI 10.4161/21505594.2014.970949; Loh E, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0012-2017; Lorenz WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016178; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Moormeier DE, 2014, MBIO, V5, DOI 10.1128/mBio.01341-14; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Righetti F, 2016, P NATL ACAD SCI USA, V113, P7237, DOI 10.1073/pnas.1523004113; Rinnenthal J, 2010, NUCLEIC ACIDS RES, V38, P3834, DOI 10.1093/nar/gkq124; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Storz G, 1999, GENE DEV, V13, P633, DOI 10.1101/gad.13.6.633; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Grosso-Becerraa MV, 2014, P NATL ACAD SCI USA, V111, P15562, DOI 10.1073/pnas.1402536111; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Waldminghaus T, 2007, MOL MICROBIOL, V65, P413, DOI 10.1111/j.1365-2958.2007.05794.x; Weber GG, 2014, P NATL ACAD SCI USA, V111, P14241, DOI 10.1073/pnas.1411570111; Wei Y, 2016, TEMPERATURE DEPENDEN; Wei YH, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.442; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214521	10.1371/journal.pone.0214521	http://dx.doi.org/10.1371/journal.pone.0214521			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933991	Green Submitted, gold, Green Published			2022-12-27	WOS:000462867000019
J	Loi, F; Berchialla, P; Masu, G; Masala, G; Scaramozzino, P; Carvelli, A; Caligiuri, V; Santi, A; Bona, MC; Maresca, C; Zanoni, MG; Capelli, G; Iannetti, S; Coccollone, A; Cappai, S; Rolesu, S; Piseddu, T				Loi, Federica; Berchialla, Paola; Masu, Gabriella; Masala, Giovanna; Scaramozzino, Paola; Carvelli, Andrea; Caligiuri, Vincenzo; Santi, Annalisa; Bona, Maria Cristina; Maresca, Carmen; Zanoni, Maria Grazia; Capelli, Gioia; Iannetti, Simona; Coccollone, Annamaria; Cappai, Stefano; Rolesu, Sandro; Piseddu, Toni			Prevalence estimation of Italian ovine cystic echinococcosis in slaughterhouses: A retrospective Bayesian data analysis, 2010-2015	PLOS ONE			English	Article							ALVEOLAR ECHINOCOCCOSIS; PARATUBERCULOSIS	Cystic echinococcosis (CE) is a complex zoonosis with domestic and sylvatic life-cycles, involving different intermediate and definitive host species. Many previous studies have highlighted the lack of a surveillance system for CE, its persistence in Italy, and endemicity in several Italian regions. Because of the absence of a uniform surveillance program for both humans and animals, disease occurrence is widely underestimated. This study aimed to estimate the prevalence of ovine CE in Italy. Survey data on the prevalence of Echinococcus granulosus complex infections in Italian sheep farms from 2010 to 2015 were obtained in collaboration with Regional Veterinary Epidemiology Observatories (OEVRs). Bayesian analysis was performed to estimate the true CE farm prevalence. The prior true CE prevalence was estimated using data from Sardinia. Second, Bayesian modelling of the observed prevalence in different regions and the true prevalence estimation from the first step were used to ultimately estimate the prevalence of ovine CE in Italy. We obtained survey data from 10 OEVRs, covering 14 Italian regions. We observed that the risk of CE infection decreased over the years, and it was strictly correlated with the density of susceptible species. Using Sardinia as prior distribution, where the disease farm prevalence was approximately 19% (95% CI, 18.82-20.02), we estimated that the highest endemic CE farm prevalence was in Basilicata with a value of 12% (95% BCI: 7.49-18.9%) and in Piemonte 7.64%(95% BCI: 4.12-13.04%). Our results provide spatially relevant data crucial for guiding CE control in Italy. Precise information on disease occurrence location would aid in the identification of priority areas for disease control implementation by the authorities. The current underestimation of CE occurrence should urge the Italian and European governments to become aware of the public health importance of CE and implement targeted interventions for high-risk areas.	[Loi, Federica; Coccollone, Annamaria; Cappai, Stefano; Rolesu, Sandro] Osservatorio Epidemiol Vet Reg, Cagliari, Italy; [Berchialla, Paola] Univ Torino, Dipartimento Sci Clin & Biol, Turin, Italy; [Masu, Gabriella; Masala, Giovanna; Piseddu, Toni] Ist Zooprofilatt Sperimentale Sardegna G Pegreffi, Sassari, Italy; [Scaramozzino, Paola; Carvelli, Andrea] Ist Zooprofilatt Sperimentale Lazio & Toscana, Rome, Italy; [Caligiuri, Vincenzo] Ist Zooprofilatt Sperimentale Mezzogiorno, Portici, Italy; [Santi, Annalisa; Zanoni, Maria Grazia] Ist Zooprofilatt Sperimentale Lombardia Emilia Ro, Brescia, Italy; [Bona, Maria Cristina] Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy; [Maresca, Carmen] Ist Zooprofilatt Sperimentale Umbria & Marche, Perugia, Italy; [Capelli, Gioia] Ist Zooprofilatt Sperimentale Venezie, Legnaro, Italy; [Iannetti, Simona] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy	University of Turin; IZS Della Sardegna; IZS Lazio e Toscana; IZS del Mezzogiorno; IZS Lombardia e Emilia; IZS Piemonte Liguria e Valle D'aosta; IZS Umbria e Marche; IZS delle Venezie; IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Loi, F (corresponding author), Osservatorio Epidemiol Vet Reg, Cagliari, Italy.	federica.loi@izs-sardegna.it	Iannetti, Simona/AAM-6684-2020; LOI, FEDERICA/AAG-2563-2020; Scaramozzino, Paola/AAS-8717-2020; santi, annalisa/AAX-6603-2021; carvelli, andrea/P-2246-2019; Berchialla, Paola/A-3208-2009	Iannetti, Simona/0000-0001-6380-0898; LOI, FEDERICA/0000-0003-3045-3150; Scaramozzino, Paola/0000-0002-7871-8915; santi, annalisa/0000-0002-7846-8856; carvelli, andrea/0000-0003-1320-9682; Maresca, Carmen/0000-0002-0778-8190; Piseddu, Toni/0000-0002-1024-5250; , Giovanna Masala/0000-0001-5301-2580; Berchialla, Paola/0000-0001-5835-5638	Italian Ministry of Health for the Current Research [IZS SA 05/16 RC]	Italian Ministry of Health for the Current Research	The authors for this work received specific funding from the Italian Ministry of Health for the Current Research IZS SA 05/16 RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Rojas CA, 2014, INT J PARASITOL, V44, P9, DOI 10.1016/j.ijpara.2013.08.008; [Anonymous], EUR UN SUMM REP TREN; [Anonymous], 2009, EFSA J; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bayarri MJ, 2012, ANN STAT, V40, P1550, DOI 10.1214/12-AOS1013; Boelaert F, 2000, VET MICROBIOL, V77, P269, DOI 10.1016/S0378-1135(00)00312-6; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Brundu D, 2014, ACTA TROP, V140, P91, DOI 10.1016/j.actatropica.2014.08.011; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Budke CM, 2006, EMERG INFECT DIS, V12, P296; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Conraths FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005801; Craig P, 2015, VET PARASITOL, V213, P132, DOI 10.1016/j.vetpar.2015.07.028; CRAIG PS, 1992, LANCET, V340, P826, DOI 10.1016/0140-6736(92)92693-A; Deplazes P, 2017, ADV PARASIT, V95, P315, DOI 10.1016/bs.apar.2016.11.001; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eckert J, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P238; Eckert J, 2011, OXFORD TXB ZOONOSES; Garcia-Donato G, 2018, BAYESIAN TESTING VAR, V10, P20; Gardner IA, 2002, AUST VET J, V80, P758, DOI 10.1111/j.1751-0813.2002.tb11347.x; Garippa G., 2006, Parassitologia (Rome), V48, P57; Garippa G, 2009, VET RES COMMUN, V33, pS35, DOI 10.1007/s11259-009-9245-0; Gemmell MA, 2001, WHO OIE MANUAL ONECH; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Heath DD, 1973, RECENT ADV HYDATID D, P7; Hilbe JM, 2011, CAMB CORE; ICD-ICD-9-CM-International Classification of Diseases, ICD 9 CM INT CLASS D; IZS-Sardegna, 1990, SOC IT PAR 16 C ATT; Liu F. J., 1993, Compendium on cystic echinococcosis: with special reference to the Xinjiang Uygur Autonomous Region, The People's Republic of China., P177; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Messam Locksley L. McV., 2008, Animal Health Research Reviews, V9, P1, DOI 10.1017/S1466252307001314; Otero-Abad B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002249; Piseddu T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005771; Possenti A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005114; Schantz PM, 1995, ECHINOCOCCUS HYDATID; Siles-Lucas M, 2017, ADV PARASIT, V96, P159, DOI 10.1016/bs.apar.2016.09.003; Tavornpanich S, 2004, AM J VET RES, V65, P1061, DOI 10.2460/ajvr.2004.65.1061; The Community Summary Report on Trends and Sources of Zoonoses, 2006, EFSA J, V130, P207; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Thompson R. C. A., 1995, P1; Torgerson PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000722; Qian W, 2006, AM J TROP MED HYG, V74, P856, DOI 10.4269/ajtmh.2006.74.856; WHO, 2001, NEGL ZOON DIS MAN EC	44	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214224	10.1371/journal.pone.0214224	http://dx.doi.org/10.1371/journal.pone.0214224			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934010	Green Published, Green Submitted, gold			2022-12-27	WOS:000462867000012
J	Mlynarova, J; Trentin-Sonoda, M; da Silva, FG; Major, JL; Salih, M; Carneiro-Ramos, MS; Tuana, BS				Mlynarova, Jana; Trentin-Sonoda, Mayra; da Silva, Fernanda Gaisler; Major, Jennifer L.; Salih, Maysoon; Carneiro-Ramos, Marcela S.; Tuana, Balwant S.			SLMAP3 isoform modulates cardiac gene expression and function	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED PROTEIN; GENOME-WIDE ASSOCIATION; SARCOLEMMAL-ASSOCIATED PROTEINS; VENTRICULAR-TACHYCARDIA; COMMON VARIANTS; PR INTERVAL; HEART-RATE; CHANNELOPATHIES; BRUGADA; ROLES	The sarcolemmal membrane associated proteins (SLMAPs) belong to the super family of tail anchored membrane proteins which serve diverse roles in biology including cell growth, protein trafficking and ion channel regulation. Mutations in human SLMAP have been linked to Brugada syndrome with putative deficits in trafficking of the sodium channel (Na(v)1.5) to the cell membrane resulting in aberrant electrical activity and heart function. Three main SLMAP isoforms (SLMAP1 (35 kDa), SLMAP2 (45 kDa), and SLMAP3 (91 kDa)) are expressed in myocardium but their precise role remains to be defined. Here we generated transgenic (Tg) mice with cardiac-specific expression of the SLMAP3 isoform during postnatal development which present with a significant decrease (20%) in fractional shortening and (11%) in cardiac output at 5 weeks of age. There was a lack of any notable cardiac remodeling (hypertrophy, fibrosis or fetal gene activation) in Tg hearts but the electrocardiogram indicated a significant increase (14%) in the PR interval and a decrease (43%) in the R amplitude. Western blot analysis indicated a selective and significant decrease (55%) in protein levels of Na(v)1.5 while 45% drop in its transcript levels were detectable by qRT-PCR. Significant decreases in the protein and transcript levels of the calcium transport system of the sarcoplasmic reticulum (SERCA2a/PLN) were also evident in Tg hearts. These data reveal a novel role for SLMAP3 in the selective regulation of important ion transport proteins at the level of gene expression and suggest that it may be a unique target in cardiovascular function and disease.	[Mlynarova, Jana; Trentin-Sonoda, Mayra; da Silva, Fernanda Gaisler; Major, Jennifer L.; Salih, Maysoon; Tuana, Balwant S.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Carneiro-Ramos, Marcela S.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil	University of Ottawa; Universidade Federal do ABC (UFABC)	Tuana, BS (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada.	btuana@uottawa.ca	Sonoda, Mayra Trentin/R-9943-2019; Carneiro-Ramos, Marcela/AAP-6258-2021; Carneiro-Ramos, Marcela Sorelli/I-6191-2017	Sonoda, Mayra Trentin/0000-0003-2446-7783; Carneiro-Ramos, Marcela Sorelli/0000-0003-2666-1280	Canadian Institute of Health Research Project Grant	Canadian Institute of Health Research Project Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Project Grant.	Abriel H, 2015, CIRC RES, V116, P1971, DOI 10.1161/CIRCRESAHA.116.305017; Abriel H, 2013, GENE, V517, P1, DOI 10.1016/j.gene.2012.12.061; Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Adsit GS, 2013, J MOL CELL CARDIOL, V61, P34, DOI 10.1016/j.yjmcc.2013.03.017; Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Behere SP, 2015, ANN PEDIAT CARDIOL, V8, P210, DOI 10.4103/0974-2069.164695; Belevych AE, 2013, CARDIOVASC RES, V98, P240, DOI 10.1093/cvr/cvt024; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bidstrup Signe, 2013, J Atr Fibrillation, V6, P956, DOI 10.4022/jafib.956; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Butler AM, 2012, CIRC-CARDIOVASC GENE, V5, P639, DOI 10.1161/CIRCGENETICS.112.963991; Byers JT, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-48; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chen XL, 2011, EXP DIABETES RES, DOI 10.1155/2011/421982; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dewan A, 2015, CIRC RES, V117; Ding H, 2005, AM J PHYSIOL-HEART C, V289, pH206, DOI 10.1152/ajpheart.00037.2005; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Freyermuth F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11067; Fu V, 2017, CURR OPIN CELL BIOL, V49, P99, DOI 10.1016/j.ceb.2017.12.012; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Goll DE, 1974, SEPARATION SUBCELLUL, P250; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Graham John M, 2002, ScientificWorldJournal, V2, P1638; Grandi E, 2013, CARDIAC ELECTROPHYSI, P319; Guzzo RM, 2005, AM J PHYSIOL-HEART C, V288, pH1810, DOI 10.1152/ajpheart.01015.2004; Guzzo RM, 2004, BIOCHEM J, V381, P599, DOI 10.1042/BJ20031723; Guzzo RM, 2004, J CELL SCI, V117, P2271, DOI 10.1242/jcs.01079; Gwathmey JK, 2011, J MOL CELL CARDIOL, V50, P803, DOI 10.1016/j.yjmcc.2010.11.011; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Ishikawa T, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1098, DOI 10.1161/CIRCEP.111.969972; Kyle John W, 2014, Card Electrophysiol Clin, V6, P797; Lazzerini PE, 2017, NAT REV CARDIOL, V14, P521, DOI 10.1038/nrcardio.2017.61; MEISSNER G, 1975, BIOCHIM BIOPHYS ACTA, V389, P51, DOI 10.1016/0005-2736(75)90385-5; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Nader M, 2012, AM J PHYSIOL-HEART C, V302, pH1138, DOI 10.1152/ajpheart.00872.2011; Napolitano C, 2012, CIRCULATION, V125, P2027, DOI 10.1161/CIRCULATIONAHA.111.055947; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Remme CA, 2010, CARDIOVASC THER, V28, P287, DOI 10.1111/j.1755-5922.2010.00210.x; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Salaun C, 2004, BBA-MOL CELL RES, V1693, P81, DOI 10.1016/j.bbamcr.2004.05.008; Sarquella-Brugada G, 2016, GENET MED, V18, P3, DOI 10.1038/gim.2015.35; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Smith JG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001304; Smith JG, 2009, HEART RHYTHM, V6, P634, DOI 10.1016/j.hrthm.2009.02.022; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Sun XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071876; Teng FYH, 2001, GENOME BIOL, V2; Veerman CC, 2015, GENE, V573, P177, DOI 10.1016/j.gene.2015.08.062; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wielowieyski PA, 2000, J BIOL CHEM, V275, P38474, DOI 10.1074/jbc.M007682200; Wigle JT, 1997, J BIOL CHEM, V272, P32384, DOI 10.1074/jbc.272.51.32384; Zheng YG, 2017, CELL REP, V21, P3612, DOI 10.1016/j.celrep.2017.11.076	60	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214669	10.1371/journal.pone.0214669	http://dx.doi.org/10.1371/journal.pone.0214669			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934005	gold, Green Submitted, Green Published			2022-12-27	WOS:000462867000033
J	Atkinson, MA; Joo, S; Sule, S				Atkinson, Meredith A.; Joo, Sarah; Sule, Sangeeta			Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PULSE-WAVE VELOCITY; CLINICAL-PRACTICE; ANEMIA; IRON; ATHEROSCLEROSIS; OUTCOMES; INFLAMMATION; MANAGEMENT; RISK	Background Cardiovascular disease is common in patients with systemic lupus erythematosis (SLE) and lupus nephritis (LN). Up to 80% of children with SLE develop kidney disease, which is also associated with increased risk for cardiovascular disease and death compared to those without renal involvement. Hepcidin is an iron-regulatory protein which may contribute to atherosclerosis and is elevated in autoimmune disease. Pulse wave velocity (PWV) is a validated indicator of arterial stiffness, an early marker of cardiovascular risk, and is increased in children with SLE versus healthy controls. Our objective was to quantify hepcidin and PWV in children with SLE and investigate if those with biopsy-proven LN have higher hepcidin levels and higher PWV compared to those without kidney disease. Methods Cross-sectional analysis with hepcidin was measured via ELISA assay in 16 children aged 10-21 years with SLE recruited from a single center. Subjects were classified as having LN if histologic evidence of the disease was documented on a clinical renal biopsy. Serum hepcidin was quantified using a validated competitive enzyme-linked immunoassay. Carotid-femoral PWV was measured using applanation tonometry. Wilcoxon rank sum testing was used to compare median levels of hepcidin, PWV, and other continuous variables by nephritis status. Results The cohort (n = 16) was 93.8% female and 68.8% African-American with mean (SD) 16 (3.6) years. 37.5% (n = 6) had LN. Overall median (IQR) hepcidin was 34.4 (18.9, 91.9) ng/ml, and PWV 4.4 (4, 4.6) meters/second. Although significance was limited by small sample size, both hepcidin and PWV were higher in the subjects with LN. Median (IQR) hepcidin in subjects with LN was 71.5 (26.4, 116.4) ng/ml compared to 27.9 (18.7, 59.7) ng/ml in those with SLE(p = 0.19). Similarly, median (IQR) PWV in those with LN was 4.4 (4.4, 4.9) meters/second compared to 3 (3.75, 4.55) meters/second in those with without kidney involvement (p = 0.10). Conclusion PWV and serum hepcidin were higher in subjects with LN compared to those with SLE alone, suggesting that elevated hepcidin levels may be associated with morbid CV changes in children with LN. This association, along with identification of additional predictors of arterial stiffness in patients with LN, warrants further investigation.	[Atkinson, Meredith A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Joo, Sarah] Kaiser San Francisco, San Francisco, CA USA; [Sule, Sangeeta] Childrens Natl Med Ctr, Div Rheumatol, Washington, DC 20010 USA	Johns Hopkins University; Children's National Health System	Atkinson, MA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	matkins3@jhmi.edu			National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K23-DK-084116]	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.A.A. was supported by the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) K23-DK-084116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Khalek MA, 2011, J RHEUMATOL, V38, P2153, DOI 10.3899/jrheum.110339; Askenazi D, 2007, PEDIATR NEPHROL, V22, P981, DOI 10.1007/s00467-007-0447-9; Atkinson MA, 2015, PEDIATR NEPHROL, V30, P635, DOI 10.1007/s00467-014-2991-4; Atkinson MA, 2012, PEDIATR NEPHROL, V27, P33, DOI 10.1007/s00467-011-1832-y; Bjornadal L, 2004, J RHEUMATOL, V31, P713; Cangemi G, 2013, EUR J HAEMATOL, V90, P323, DOI 10.1111/ejh.12081; Demirag MD, 2009, INTERNAL MED, V48, P421, DOI 10.2169/internalmedicine.48.1578; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Hagelberg S, 2002, J RHEUMATOL, V29, P2635; Khoshdel AR, 2007, CLIN MED RES, V5, P45, DOI 10.3121/cmr.2007.708; Koca SS, 2008, INFLAMMATION, V31, P146, DOI 10.1007/s10753-008-9060-8; Lee BS, 2007, PEDIATR NEPHROL, V22, P222, DOI 10.1007/s00467-006-0286-0; Lee TS, 1999, CIRCULATION, V99, P1222, DOI 10.1161/01.CIR.99.9.1222; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Li W, 2006, FASEB J, V20, P2281, DOI 10.1096/fj.06-6114com; Livingston B, 2011, LUPUS, V20, P1345, DOI 10.1177/0961203311416694; Mascitelli L, 2008, INT J CARDIOL, V131, pE20, DOI 10.1016/j.ijcard.2007.07.050; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Quinlan C, 2016, PEDIATR NEPHROL, V31, P861, DOI 10.1007/s00467-015-3202-7; Ren MQ, 2005, FREE RADICAL BIO MED, V38, P1206, DOI 10.1016/j.freeradbiomed.2005.01.008; Reusz GS, 2010, HYPERTENSION, V56, P217, DOI 10.1161/HYPERTENSIONAHA.110.152686; Rianthavorn P, 2015, PEDIATR NEPHROL, V30, P1969, DOI 10.1007/s00467-015-3138-y; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Savant JD, 2017, HYPERTENSION, V69, P863, DOI 10.1161/HYPERTENSIONAHA.116.07653; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Sozeri B, 2013, PEDIATR NEPHROL, V28, P471, DOI 10.1007/s00467-012-2342-2; Sule S, 2011, PEDIATR NEPHROL, V26, P93, DOI 10.1007/s00467-010-1640-9; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Zaritsky J, 2009, CLIN J AM SOC NEPHRO, V4, P1051, DOI 10.2215/CJN.05931108	30	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214248	10.1371/journal.pone.0214248	http://dx.doi.org/10.1371/journal.pone.0214248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925172	gold, Green Submitted, Green Published			2022-12-27	WOS:000462732300011
J	Al-Ghafli, H; Varghese, B; Enani, M; Alrajhi, A; Al Johani, S; Albarrak, A; Althawadi, S; Elkizzi, N; Al Hajoj, S				Al-Ghafli, Hawra; Varghese, Bright; Enani, Mushira; Alrajhi, Abdulrahman; Al Johani, Sameera; Albarrak, Ali; Althawadi, Sahar; Elkizzi, Noura; Al Hajoj, Saha			Demographic risk factors for extra-pulmonary tuberculosis among adolescents and adults in Saudi Arabia	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; GENITAL TUBERCULOSIS; CHILDREN	Despite low infectious potential of extrapulmonary tuberculosis (EPTB), it poses significant clinical challenges in terms of diagnosis and treatment monitoring. Understanding the main demographical risk factors for disease characteristics of EPTB plays a crucial role in speeding up diagnosis process and improving overall clinical experience. The aim of this study was to investigate the main demographical and clinical risk factors for EPTB among adults and adolescents for the first time in Saudi Arabia. A cross-sectional multicenter study was carried out on a collection of 902 extrapulmonary Mycobacterium tuberculosis complex (MTBC) isolates with demographical and clinical data. All isolates were subjected to spoligotyping and 24-loci based MIRU-VNTR typing. The association between two potential variables was assessed using odd ratios (OR) calculations. Independent risk factors for EPTB and diseases characteristics of EPTB were identified using multivariate regression model analyses. Gender was found to be significantly associated with lymph node, gastrointestinal, central nervous system and urogenital TB. Lymph node TB showed statistical association to age group below 25 years, non-Saudis and South East Asian ethnicity. While gastrointestinal TB demonstrated an association with patients above 60 years old, and Saudis. Multivariate analysis showed that gender is an independent risk factor to urogenital TB (p 0.03) and lymph node TB (p 0.005). On the other hands, South Asian (p 0.01) and South East Asian (p 0.03) ethnicities were both identified as independent risk factors significantly associated with EPTB. MTBC lineages, site of infections, gender, HIV and smear positivity showed no significant association. Nationwide qualitative-studies are highly warranted in the future to further understand the main demographic risk factors for disease characteristics of EPTB.	[Al-Ghafli, Hawra; Varghese, Bright; Al Hajoj, Saha] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh, Saudi Arabia; [Enani, Mushira] King Fahad Med City, Med Specialties Dept, Riyadh, Saudi Arabia; [Alrajhi, Abdulrahman] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh, Saudi Arabia; [Al Johani, Sameera] King Abdul Aziz Med City, Dept Microbiol, Riyadh, Saudi Arabia; [Albarrak, Ali] Prince Sultan Mil Med City, Dept Med, Riyadh, Saudi Arabia; [Althawadi, Sahar] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh, Saudi Arabia; [Elkizzi, Noura] Prince Sultan Mil Med City, Dept Microbiol, Riyadh, Saudi Arabia; [Al Hajoj, Saha] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Fahad Medical City; King Faisal Specialist Hospital & Research Center; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Prince Sultan Military Medical City; King Faisal Specialist Hospital & Research Center; Prince Sultan Military Medical City; Alfaisal University	Al Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh, Saudi Arabia.; Al Hajoj, S (corresponding author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.	hajoj@kfshrc.edu.sa	Alrajhi, Abdulrahman A/Q-4359-2019	Al-Ghafli, Hawra/0000-0003-0791-8896; Alrajhi, Abdulrahman/0000-0003-0780-6093	King AbdulAziz City for science and technology [AT-34-103]	King AbdulAziz City for science and technology	This work was supported by King AbdulAziz City for science and technology: Grant code AT-34-103. The funders had no rule in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aktogu S, 1996, EUR RESPIR J, V9, P2031, DOI 10.1183/09031936.96.09102031; Al-Eisa ES, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/642187; Al-Hajoj S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0101667; Al-Hajoj S, 2013, INFECT GENET EVOL, V16, P362, DOI 10.1016/j.meegid.2013.03.019; Alshaikh MK, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/7479357; Arora V. K., 2006, Indian Journal of Tuberculosis, V53, P77; Biadglegne F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137865; Byng-Maddick R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1451-0; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Centre for Diswease Control, 2016, REP TUB US 2015; Chen ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep11084; CHRISTENSEN WI, 1974, MEDICINE, V53, P377, DOI 10.1097/00005792-197409000-00004; Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468; El Mouzan MI, 2008, ANN SAUDI MED, V28, P169, DOI 10.5144/0256-4947.2008.169; el-Hazmi M A, 2000, East Mediterr Health J, V6, P276; Erie H, 2017, IRAN J MICROBIOL, V9, P312; Eum SY, 2008, RESPIRATION, V76, P331, DOI 10.1159/000113932; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Grace GA, 2017, INDIAN J MED RES, V145, P425, DOI 10.4103/ijmr.IJMR_1550_15; Jahromi BN, 2001, INT J GYNECOL OBSTET, V75, P269, DOI 10.1016/S0020-7292(01)00494-5; Khandkar C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132400; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Lin CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063936; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Long NH, 2002, J CLIN EPIDEMIOL, V55, P115, DOI 10.1016/S0895-4356(01)00455-3; Lotfian F, 2017, ARCH PEDIATR INFECT, V5, DOI 10.5812/pedinfect.57253; Memish ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095654; Mert A, 2002, ACTA CHIR BELG, V102, P118; Ministry of Health Saudi Arabia, 2017, STAT YB, V1437; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Nahid P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195392; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448; Pareek M, 2013, THORAX, V68, P221, DOI 10.1136/thoraxjnl-2012-201824; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Phongsamart W, 2009, PEDIATR INFECT DIS J, V28, P416, DOI 10.1097/INF.0b013e3181920d4d; Piergallini TJ, 2018, EXP GERONTOL, V105, P32, DOI 10.1016/j.exger.2017.12.021; Sandgren A, 2013, EUR SURVEILL, V18; Sharma JB, 2015, J OBSTET GYN INDIA, V65, P362, DOI 10.1007/s13224-015-0780-z; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Temple SEL, 2008, CELL IMMUNOL, V251, P69, DOI 10.1016/j.cellimm.2008.04.013; Varghese B, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0966-x; Varghese B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077635; Varghese B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055598; WHO, 2017, GLOB TUB REP 2017; Wiens KE, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1180-x; Winston CA, 2012, PEDIATRICS, V130, pE1425, DOI 10.1542/peds.2012-1057; Yang Dong, 2015, Front Biol (Beijing), V10, P252	49	9	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213846	10.1371/journal.pone.0213846	http://dx.doi.org/10.1371/journal.pone.0213846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917151	gold, Green Published, Green Submitted			2022-12-27	WOS:000462465800042
J	Rentoft, M; Svensson, D; Sjodin, A; Olason, PI; Sjostrom, O; Nylander, C; Osterman, P; Sjogren, R; Netotea, S; Wibom, C; Cederquist, K; Chabes, A; Trygg, J; Melin, BS; Johansson, E				Rentoft, Matilda; Svensson, Daniel; Sjodin, Andreas; Olason, Pall I.; Sjostrom, Olle; Nylander, Carin; Osterman, Pia; Sjogren, Rickard; Netotea, Sergiu; Wibom, Carl; Cederquist, Kristina; Chabes, Andrei; Trygg, Johan; Melin, Beatrice S.; Johansson, Erik			A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis	PLOS ONE			English	Article							COLORECTAL-CANCER; HEREDITARY; DISCOVERY; FRAMEWORK; RISK; LOCI	Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. However, the vast number of genetic variants observed by this method constitutes a challenge when trying to identify the causal variants. This is often handled by restricting disease studies to the most damaging variants, e. g. those found in coding regions, and overlooking the remaining genetic variation. Such a biased approach explains in part why the genetic causes of many families with dominantly inherited diseases, in spite of being included in whole-genome sequencing studies, are left unsolved today. Here we explore the use of a geographically matched control population to minimize the number of candidate disease-causing variants without excluding variants based on assumptions on genomic position or functional predictions. To exemplify the benefit of the geographically matched control population we apply a typical disease variant filtering strategy in a family with an autosomal dominant form of colorectal cancer. With the use of the geographically matched control population we end up with 26 candidate variants genome wide. This is in contrast to the tens of thousands of candidates left when only making use of available public variant datasets. The effect of the local control population is dual, it (1) reduces the total number of candidate variants shared between affected individuals, and more importantly (2) increases the rate by which the number of candidate variants are reduced as additional affected family members are included in the filtering strategy. We demonstrate that the application of a geographically matched control population effectively limits the number of candidate disease-causing variants and may provide the means by which variants suitable for functional studies are identified genome wide.	[Rentoft, Matilda; Osterman, Pia; Chabes, Andrei; Johansson, Erik] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Rentoft, Matilda; Svensson, Daniel; Sjodin, Andreas; Sjogren, Rickard; Netotea, Sergiu; Trygg, Johan] Umea Univ, Dept Chem, Computat Life Sci Cluster, Umea, Sweden; [Sjodin, Andreas] FOI Swedish Def Res Agcy, Div CBRN Secur & Def, Umea, Sweden; [Olason, Pall I.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Sjostrom, Olle; Nylander, Carin; Wibom, Carl; Melin, Beatrice S.] Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden; [Sjostrom, Olle] Unit Res Educ & Dev, Ostersund, Region Jamtland, Sweden; [Netotea, Sergiu] Chalmers Univ Technol, Dept Biol & Biol Engn, Sci Life Lab, Gothenburg, Sweden; [Cederquist, Kristina] Umea Univ, Dept Med Biosci Med & Clin Genet, Umea, Sweden	Umea University; Umea University; FOI - Swedish Defence Research Agency; Uppsala University; Umea University; Chalmers University of Technology; Umea University	Johansson, E (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	erik.tm.johansson@umu.se	Rentoft, Matilda/AAL-2449-2021; Sjödin, Andreas/A-7245-2008	Sjödin, Andreas/0000-0001-5350-4219; Chabes, Andrei/0000-0003-1708-8259; Johansson, Erik/0000-0002-8526-6224; Svensson, Daniel/0000-0002-4476-9255; Osterman, Pia/0000-0001-9360-0782	Knut and Alice Wallenberg Foundation [2011.0042]; Knut and Alice Wallenberg Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was funded by a project grant (2011.0042) from the Knut and Alice Wallenberg Foundation (E.J., B.S.M, J.T., A.C.). http://kaw.wallenberg.org/.; We are grateful to all of the patients and individuals for their participation, and we would also like to thank the clinicians and other hospital staff members, cancer registries, the participants of the VIP cohort of the Northern Sweden Health and Disease Study (NSHDS), the staff at the Department of Biobank Research, Umea University, and the study staff members who contributed to the blood sample and data collection. Illumina sequencing was performed by the National Genomics Infrastructure (NGI), which is hosted by SciLifeLab in Stockholm and Uppsala. The computations were performed using resources provided by the Swedish National Infrastructure for Computing (SNIC) through the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). We acknowledge the support of the National Bioinformatics Infrastructure Sweden (NBIS) and the SciLifeLab Data Centre with help in hosting and sharing the ACpop allele frequency dataset. P. I.O. was supported by a grant from the Knut and Alice Wallenberg Foundation to the Wallenberg Advanced Bioinformatics Infrastructure.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Boomsma DI, 2014, EUR J HUM GENET, V22, P221, DOI 10.1038/ejhg.2013.118; Chubb D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11883; Dashti MJS, 2017, BIOTECHNIQUES, V62, P18, DOI 10.2144/000114492; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dopazo J, 2016, MOL BIOL EVOL, V33, P1205, DOI 10.1093/molbev/msw005; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fernandez-Rozadilla C, 2013, CARCINOGENESIS, V34, P314, DOI 10.1093/carcin/bgs357; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahmood K, 2017, HUM GENOMICS, V11, DOI 10.1186/s40246-017-0104-8; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Mather CA, 2016, GENET MED, V18, P1269, DOI 10.1038/gim.2016.44; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Norberg M, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19166; Norberg M, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.4643; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Rands CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004525; Sjostrom O, 2016, FAM CANCER, V15, P543, DOI 10.1007/s10689-016-9867-7; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Vasen HFA, 2015, NAT REV GASTRO HEPAT, V12, P88, DOI 10.1038/nrgastro.2014.229; Wang HS, 2013, HUM MOL GENET, V22, P5048, DOI 10.1093/hmg/ddt337	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213350	10.1371/journal.pone.0213350	http://dx.doi.org/10.1371/journal.pone.0213350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917156	Green Published, gold, Green Submitted			2022-12-27	WOS:000462465800028
J	Yee, SH; Kyle, V; Blouet, C; Jones, S; Colledge, WH				Yee, Shel-Hwa; Kyle, Victoria; Blouet, Clemence; Jones, Susan; Colledge, William Henry			Mapping neuronal inputs to Kiss1 neurons in the arcuate nucleus of the mouse	PLOS ONE			English	Article							THYROTROPIN-RELEASING-HORMONE; STRESS-INDUCED SUPPRESSION; PARAVENTRICULAR NUCLEUS; KISSPEPTIN NEURONS; SUBFORNICAL ORGAN; SUBSTANCE-P; MEDIAL AMYGDALA; MESSENGER-RNA; RAT; HYPOTHALAMUS	The normal function of the mammalian reproductive axis is strongly influenced by physiological, metabolic and environmental factors. Kisspeptin neuropeptides, encoded by the Kiss1 gene, are potent regulators of the mammalian reproductive axis by stimulating gonadodropin releasing hormone secretion from the hypothalamus. To understand how the reproductive axis is modulated by higher order neuronal inputs we have mapped the afferent circuits into arcuate (ARC) Kiss1 neurons. We used a transgenic mouse that expresses the CRE recombinase in Kiss1 neurons for conditional viral tracing with genetically modified viruses. CRE-mediated activation of these viruses in Kiss1 neurons allows the virus to move transynaptically to label neurons with primary or secondary afferent inputs into the Kiss1 neurons. Several regions of the brain showed synaptic connectivity to arcuate Kiss1 neurons including proopiomelanocortin neurons in the ARC itself, kisspeptin neurons in the anteroventral periventricular nucleus, vasopressin neurons in the supraoptic and suprachiasmatic nuclei, thyrotropin releasing neurons in the paraventricular nucleus and unidentified neurons in other regions including the subfornical organ, amygdala, interpeduncular nucleus, ventral premammilary nucleus, basal nucleus of stria terminalis and the visual, somatosensory and piriform regions of the cortex. These data provide an insight into how the activity of Kiss1 neurons may be regulated by metabolic signals and provide a detailed neuroanatomical map for future functional studies.	[Yee, Shel-Hwa; Kyle, Victoria; Jones, Susan; Colledge, William Henry] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Blouet, Clemence] Univ Cambridge, Metab Res Labs, WT MRC Inst Metab Sci, MRC Metab Dis Unit, Cambridge, England; [Yee, Shel-Hwa] Univ Otago, Dept Physiol, Ctr Neuroendocrinol, Dunedin, New Zealand	University of Cambridge; University of Cambridge; University of Otago	Colledge, WH (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	whc23@cam.ac.uk	Colledge, William/X-4976-2019; Core, Vector/CAF-4832-2022	Colledge, William/0000-0002-9603-4429; Blouet, Clemence/0000-0002-1752-1270	BBSRC [BB/K003178/1]; Ford Physiology Fund; Newton Foundation; British Society for Neuroendocrinology [P40 OD010996]; NIH Virus Center [P40 OD010996]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010996] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ford Physiology Fund; Newton Foundation; British Society for Neuroendocrinology; NIH Virus Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the BBSRC (BB/K003178/1) https://bbsrc.ukri.org/, the Ford Physiology Fund https://www.admin.cam.ac.uk/univ/so/2017/chapter12-section2.html#heading2-184 (WHC, S-H. Y), the Newton Foundation (S-H. Y), and a fellowship from the British Society for Neuroendocrinology, https://www.neuroendo.org.uk/(S-H.Y).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Professor Friedman and Dr Ekstrand (Rockefeller University, USA) for the PRV INTRO vector and Prof Enquist (Princeton University, USA) for supplying us with the PRV Ba2001 (NIH Virus Center Grant No: P40 OD010996).	Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; Adekunbi DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183596; Ahmed AF, 2014, AM J PHYSIOL-REG I, V306, pR363, DOI 10.1152/ajpregu.00462.2013; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; Bilkei-Gorzo A, 2002, J NEUROSCI, V22, P10046; Card JP, 1999, J COMP NEUROL, V407, P438, DOI 10.1002/(SICI)1096-9861(19990510)407:3<438::AID-CNE11>3.0.CO;2-2; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; Cates PS, 1999, J NEUROENDOCRINOL, V11, P677; Cates PS, 2004, STRESS, V7, P113, DOI 10.1080/1025389042000218988; Chachlaki K, 2017, J COMP NEUROL, V525, P3177, DOI 10.1002/cne.24257; Challis C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00043; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clarkson J, 2017, P NATL ACAD SCI USA, V114, pE10216, DOI 10.1073/pnas.1713897114; Comninos AN, 2016, BRAIN STRUCT FUNCT, V221, P2035, DOI 10.1007/s00429-015-1024-9; Coomans CP, 2015, FRONT NEUROENDOCRIN, V37, P29, DOI 10.1016/j.yfrne.2014.11.002; Cournil I, 2000, BRAIN RES, V877, P412, DOI 10.1016/S0006-8993(00)02748-7; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Donato J, 2011, J CLIN INVEST, V121, P355, DOI 10.1172/JCI45106; Driessen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083098; Ducret E, 2010, ENDOCRINOLOGY, V151, P2223, DOI 10.1210/en.2009-1480; Ferguson AV, 1997, CLIN EXP PHARMACOL P, V24, P96, DOI 10.1111/j.1440-1681.1997.tb01790.x; Ghamari-Langroudi M, 2010, MOL ENDOCRINOL, V24, P2366, DOI 10.1210/me.2010-0203; Gottsch ML, 2011, ENDOCRINOLOGY, V152, P4298, DOI 10.1210/en.2011-1521; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Gresham R, 2016, NEUROSCI LETT, V627, P13, DOI 10.1016/j.neulet.2016.05.042; GRUBER K, 1987, NEUROSCI LETT, V75, P1, DOI 10.1016/0304-3940(87)90065-6; Hall JE, 2005, J CLIN ENDOCR METAB, V90, P2050, DOI 10.1210/jc.2004-2033; HAMILL GS, 1984, J COMP NEUROL, V226, P580, DOI 10.1002/cne.902260410; Hrabovszky E, 2005, ENDOCRINOLOGY, V146, P341, DOI 10.1210/en.2004-0856; Kirilov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3492; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Leak RK, 2001, J COMP NEUROL, V433, P312, DOI 10.1002/cne.1142; Lee SK, 2013, NEUROSCI LETT, V556, P160, DOI 10.1016/j.neulet.2013.09.070; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maejima Y, 2014, FEBS LETT, V588, P4404, DOI 10.1016/j.febslet.2014.10.010; Manfredi-Lozano M, 2016, MOL METAB, V5, P844, DOI 10.1016/j.molmet.2016.08.003; McCarthy EA, 2017, EUR J NEUROSCI, V46, P2035, DOI 10.1111/ejn.13636; McKinley MJ, 1998, CLIN EXP PHARMACOL P, V25, pS61, DOI 10.1111/j.1440-1681.1998.tb02303.x; Mimee A, 2013, PHYSIOL BEHAV, V121, P96, DOI 10.1016/j.physbeh.2013.02.012; Nestor CC, 2016, MOL ENDOCRINOL, V30, P630, DOI 10.1210/me.2016-1026; NI L, 1988, J COMP NEUROL, V275, P493, DOI 10.1002/cne.902750403; Padilla SL, 2017, P NATL ACAD SCI USA, V114, P2413, DOI 10.1073/pnas.1621065114; Pineda R, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12342; Pineda R, 2017, NEUROENDOCRINOLOGY, V104, P223, DOI 10.1159/000445895; PLANT TM, 1989, P NATL ACAD SCI USA, V86, P2506, DOI 10.1073/pnas.86.7.2506; Pomeranz LE, 2017, J NEUROSCI, V37, P4128, DOI 10.1523/JNEUROSCI.3193-16.2017; Ratra DV, 2014, J CHEM NEUROANAT, V61-62, P233, DOI 10.1016/j.jchemneu.2014.05.005; Robertson JL, 2009, ENDOCRINOLOGY, V150, P3664, DOI 10.1210/en.2009-0247; Ross RA, 2018, ELIFE, V7, DOI 10.7554/eLife.35960; SAPHIER D, 1987, EXP BRAIN RES, V69, P60; Schafer D, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12660; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; SILVERMAN AJ, 1981, BRAIN RES BULL, V6, P47, DOI 10.1016/S0361-9230(81)80068-8; Simavli S, 2015, ENDOCRINOLOGY, V156, P2313, DOI 10.1210/en.2014-2012; TRIBOLLET E, 1981, NEUROSCIENCE, V6, P1315, DOI 10.1016/0306-4522(81)90190-1; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Umehara H, 2012, NEUROCHEM INT, V61, P942, DOI 10.1016/j.neuint.2012.05.022; Vida B, 2010, J NEUROENDOCRINOL, V22, P1032, DOI 10.1111/j.1365-2826.2010.02045.x; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Yeo SH, 2016, J NEUROENDOCRINOL, V28, P1, DOI 10.1111/jne.12435; Yeo SH, 2011, ENDOCRINOLOGY, V152, P2387, DOI 10.1210/en.2011-0164; Yip SH, 2015, ENDOCRINOLOGY, V156, P2582, DOI 10.1210/en.2015-1131; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhang JC, 2012, AM J PHYSIOL-REG I, V302, pR264, DOI 10.1152/ajpregu.00114.2011	66	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213927	10.1371/journal.pone.0213927	http://dx.doi.org/10.1371/journal.pone.0213927			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917148	Green Published, Green Submitted, gold			2022-12-27	WOS:000462465800044
J	de Santiago, L; Morla, EMS; Ortiz, M; Lopez, E; Usanos, CA; Alonso-Rodriguez, MC; Barea, R; Cavaliere-Ballesta, C; Fernandez, A; Boquete, L				de Santiago, Luis; Sanchez Morla, E. M.; Ortiz, Miguel; Lopez, Elena; Amo Usanos, Carlos; Alonso-Rodriguez, M. C.; Barea, R.; Cavaliere-Ballesta, Carlo; Fernandez, Alfredo; Boquete, Luciano			A computer-aided diagnosis of multiple sclerosis based on mfVEP recordings	PLOS ONE			English	Article							VISUAL-EVOKED POTENTIALS; CLINICALLY ISOLATED SYNDROME; MULTIFOCAL VEP; OPTIC NEURITIS; MRI; SYSTEM; SPECIFICITY; DISABILITY; GUIDELINES; CONVERSION	Introduction The aim of this study is to develop a computer-aided diagnosis system to identify subjects at differing stages of development of multiple sclerosis (MS) using multifocal visual-evoked potentials (mfVEPs). Using an automatic classifier, diagnosis is performed first on the eyes and then on the subjects. Patients MfVEP signals were obtained from patients with Radiologically Isolated Syndrome (RIS) (n = 30 eyes), patients with Clinically Isolated Syndrome (CIS) (n = 62 eyes), patients with definite MS (n = 56 eyes) and 22 control subjects (n = 44 eyes). The CIS and MS groups were divided into two subgroups: those with eyes affected by optic neuritis (ON) and those without (non-ON). Methods For individual eye diagnosis, a feature vector was formed with information about the intensity, latency and singular values of the mfVEP signals. A flat multiclass classifier (FMC) and a hierarchical classifier (HC) were tested and both were implemented using the k-Nearest Neighbour (k-NN) algorithm. The output of the best eye classifier was used to classify the subjects. In the event of divergence, the eye with the best mfVEP recording was selected. Results In the eye classifier, the HC performed better than the FMC (accuracy = 0.74 and extended Matthew Correlation Coefficient (MCC) = 0.68). In the subject classification, accuracy = 0.95 and MCC = 0.93, confirming that it may be a promising tool for MS diagnosis. Conclusion In addition to amplitude (axonal loss) and latency (demyelination), it has shown that the singular values of the mfVEP signals provide discriminatory information that may be used to identify subjects with differing degrees of the disease.	[de Santiago, Luis; Ortiz, Miguel; Lopez, Elena; Amo Usanos, Carlos; Barea, R.; Cavaliere-Ballesta, Carlo; Fernandez, Alfredo; Boquete, Luciano] Univ Alcala, Dept Elect, Grp Ingn Biomed, Alcala De Henares, Spain; [Sanchez Morla, E. M.] Hosp 12 Octubre i 12, Inst Invest, Madrid, Spain; [Sanchez Morla, E. M.] Univ Complutense Madrid, Fac Med, Madrid, Spain; [Alonso-Rodriguez, M. C.] Univ Alcala, Dept Fis & Matemat, Alcala De Henares, Spain; [Boquete, Luciano] RETICS Red Temat Invest Cooperat Sanitaria Enferm, Madrid, Spain	Universidad de Alcala; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Universidad de Alcala	Boquete, L (corresponding author), Univ Alcala, Dept Elect, Grp Ingn Biomed, Alcala De Henares, Spain.; Boquete, L (corresponding author), RETICS Red Temat Invest Cooperat Sanitaria Enferm, Madrid, Spain.	luciano.boquete@uah.es	Boquete, Luciano/GXN-4674-2022; Alonso-Rodriguez, Maria Concepcion/B-9307-2016	Ortiz del Castillo, Miguel/0000-0001-8431-3765; Boquete, Luciano/0000-0001-8591-6103; Sanchez-Morla, Eva Maria/0000-0002-9438-2307; Cavaliere Ballesta, Carlo/0000-0002-2144-6090; Lopez-Guillen, Elena/0000-0002-8145-9045; Alonso-Rodriguez, Maria Concepcion/0000-0003-2175-4162	Agencia Estatal de Investigacion (AEI) European Regional Development Fund (ERDF) grant "Investigacion de la tecnica de potenciales evocados visuales multifocales. Aplicacion en estudios de evolucion de esclerosis multiple y evaluacion de medicamentos" (AEI [DPI2017-88438-R]; RETICS OFTARED (Thematic Networks for Co-operative Research in Health for Ocular Diseases) [RD16/0008/020]	Agencia Estatal de Investigacion (AEI) European Regional Development Fund (ERDF) grant "Investigacion de la tecnica de potenciales evocados visuales multifocales. Aplicacion en estudios de evolucion de esclerosis multiple y evaluacion de medicamentos" (AEI; RETICS OFTARED (Thematic Networks for Co-operative Research in Health for Ocular Diseases)	This work was supported by Agencia Estatal de Investigacion (AEI) European Regional Development Fund (ERDF) grant "Investigacion de la tecnica de potenciales evocados visuales multifocales. Aplicacion en estudios de evolucion de esclerosis multiple y evaluacion de medicamentos" reference: DPI2017-88438-R (AEI/FEDER, UE) to L.B., and RETICS OFTARED (Thematic Networks for Co-operative Research in Health for Ocular Diseases) RD16/0008/020 to L.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi A, 2019, COMPUT METH PROG BIO, V169, P9, DOI 10.1016/j.cmpb.2018.11.006; Alshowaeir D, 2015, CLIN NEUROPHYSIOL, V126, P1617, DOI 10.1016/j.clinph.2014.11.010; Armstrong RA, 2013, OPHTHAL PHYSL OPT, V33, P7, DOI 10.1111/opo.12009; Barbour C, 2017, ANN NEUROL, V82, P795, DOI 10.1002/ana.25083; Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415; Blanco R, 2014, MULT SCLER J, V20, P183, DOI 10.1177/1352458513493683; Bozzo E, 2010, COMPUT MATH APPL, V60, P812, DOI 10.1016/j.camwa.2010.05.028; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; De Santiago L, 2016, CLIN NEUROPHYSIOL, V127, P1574, DOI 10.1016/j.clinph.2015.09.129; de Santiago L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194964; Fernandez A, 2015, COMPUT BIOL MED, V56, P13, DOI 10.1016/j.compbiomed.2014.10.023; Fernandez O, 2010, J NEUROL, V257, P1500, DOI 10.1007/s00415-010-5560-1; Fortune B, 2004, DOC OPHTHALMOL, V109, P87, DOI 10.1007/s10633-004-3300-5; Garcia-Martin E, 2013, ACTA OPHTHALMOL, V91, pE628, DOI 10.1111/aos.12156; Giffroy X, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0608-1; Guven A, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0184-0; Hood DC, 2004, DOC OPHTHALMOL, V109, P189, DOI 10.1007/s10633-004-5512-0; Hood DC, 2003, PROG RETIN EYE RES, V22, P201, DOI 10.1016/S1350-9462(02)00061-7; Hood DC, 2004, DOC OPHTHALMOL, V109, P177, DOI 10.1007/s10633-004-5511-1; Horn FK, 2016, GRAEF ARCH CLIN EXP, V254, P259, DOI 10.1007/s00417-015-3214-9; Hu H, 2017, PEERJ, V5, DOI 10.7717/peerj.3474; Jayaraman M, 2014, INDIAN J OPHTHALMOL, V62, P299, DOI 10.4103/0301-4738.118452; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; Karaca Y, 2017, CNS NEUROL DISORD-DR, V16, P36, DOI 10.2174/1871527315666161024142439; Kaunzner UW, 2017, THER ADV NEUROL DISO, V10, DOI 10.1177/1756285617708911; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2008, DOC OPHTHALMOL, V116, P19, DOI 10.1007/s10633-007-9072-y; Kouchaki S, 2015, IEEE T NEUR SYS REH, V23, P1, DOI 10.1109/TNSRE.2014.2329557; Kuhle J, 2015, MULT SCLER J, V21, P1013, DOI 10.1177/1352458514568827; Lotsch J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33077-8; Maggi P, 2018, ANN NEUROL, V83, P283, DOI 10.1002/ana.25146; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller D, 2005, LANCET NEUROL, V4, P341, DOI 10.1016/S1474-4422(05)70095-8; Mohammadi SM, 2016, J NEUROSCI METH, V273, P96, DOI 10.1016/j.jneumeth.2016.08.008; Mollison D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177727; Moore F, 2009, NEUROLOGY, V73, P1714, DOI 10.1212/WNL.0b013e3181bd69a9; Narayanan D, 2015, OPTOMETRY VISION SCI, V92, P976, DOI 10.1097/OPX.0000000000000684; Nayak DR, 2017, EXPERT SYST APPL, V88, P152, DOI 10.1016/j.eswa.2017.06.038; Okuda DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090509; Perez-Rico C, 2014, INVEST OPHTH VIS SCI, V55, P6127, DOI 10.1167/iovs.14-14807; Pihl-Jensen G, 2017, CLIN NEUROPHYSIOL, V128, P1234, DOI 10.1016/j.clinph.2017.03.047; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Pulido-Valdeolivas I, 2017, EXPERT REV PRECIS ME, V2, P345, DOI 10.1080/23808993.2017.1393315; Qiao ND, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00638; Rasoulzadeh V, 2017, ANN OPER RES, V258, P133, DOI 10.1007/s10479-016-2187-3; Richiardi J, 2012, NEUROIMAGE, V62, P2021, DOI 10.1016/j.neuroimage.2012.05.078; Sastre-Garriga J, 2004, ARCH NEUROL-CHICAGO, V61, P222, DOI 10.1001/archneur.61.2.222; Shen T, 2019, OPHTHALMOLOGY, V126, P445, DOI 10.1016/j.ophtha.2018.06.022; SWANSON JW, 1989, MAYO CLIN PROC, V64, P577, DOI 10.1016/S0025-6196(12)65564-5; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Thie J, 2012, VISION RES, V52, P79, DOI 10.1016/j.visres.2011.11.002; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Torabi A, 2017, AUSTRALAS PHYS ENG S, V40, P785, DOI 10.1007/s13246-017-0584-9; Triplett JD, 2018, ANN CLIN TRANSL NEUR, V5, P1505, DOI 10.1002/acn3.659; Wang SH, 2016, IEEE ACCESS, V4, DOI 10.1109/ACCESS.2016.2620996; Yamamoto D, 2010, COMPUT MED IMAG GRAP, V34, P404, DOI 10.1016/j.compmedimag.2010.02.001; Zhang M, 2004, DOC OPHTHALMOL, V108, P211, DOI 10.1007/s10633-004-5323-3; Zhang Xian, 2002, Documenta Ophthalmologica, V104, P287, DOI 10.1023/A:1015220501743; Zhang YD, 2016, SIMUL-T SOC MOD SIM, V92, P861, DOI 10.1177/0037549716666962; Zurita M, 2018, NEUROIMAGE-CLIN, V20, P724, DOI 10.1016/j.nicl.2018.09.002	60	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214662	10.1371/journal.pone.0214662	http://dx.doi.org/10.1371/journal.pone.0214662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947273	Green Published, gold			2022-12-27	WOS:000463314500050
J	Jeon, MY; Kim, HS; Lim, TS; Han, DH; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Choi, GH; Choi, JS; Han, KH; Kim, SU				Jeon, Mi Young; Kim, Hye Soo; Lim, Tae Seop; Han, Dai Hoon; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Choi, Gi Hong; Choi, Jin Sub; Han, Kwang-Hyub; Kim, Seung Up			Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; MANAGEMENT; SORAFENIB; CRITERIA; OUTCOMES; STAGE	Background/Aims It is important to identify patients who are refractory to transarterial chemoembolization (TACE), which is performed for the treatment of hepatocellular carcinoma (HCC). We investigated the predictors of poor treatment outcomes in patients with recurrent HCC treated who were treated with TACE after curative resection. Methods 428 patients with recurrent HCC after curative resection who were treated with TACE were enrolled. Results The median age of the study population was 59.2 years. On multivariate analysis, >= 2 TACE procedures within 6 months (hazard ratio [HR] = 1.898), and the des-gamma carboxyprothrombin level (HR = 1.000) independently predicted the progression to Barcelona Clinic Liver Cancer (BCLC) stage C in patients with BCLC stage 0-B HCC (both P<0.05). In addition, >= 2 and >= 3 TACE procedures within 6 months independently predicted mortality in the entire study population (HR = 1.863 and 1.620, respectively). The probability of progression to BCLC stage C in patients with BCLC stage 0-B HCC and the mortality rate in the entire study population were significantly higher in patients treated with >= 2 TACE within 6 months than in those who underwent fewer procedures (P= 0.002 and P<0.001, respectively). Conclusions More than 2 TACE procedures within 6 months might be associated with the refractoriness to TACE in patients with recurrent HCC after curative resection.	[Jeon, Mi Young; Kim, Hye Soo; Lim, Tae Seop; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Kim, Seung Up] Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea; [Jeon, Mi Young; Lim, Tae Seop; Han, Dai Hoon; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Choi, Gi Hong; Choi, Jin Sub; Han, Kwang-Hyub; Kim, Seung Up] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea; [Han, Dai Hoon; Choi, Gi Hong; Choi, Jin Sub] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea.; Kim, SU (corresponding author), Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea.	ksukorea@yuhs.ac	Han, Dai Hoon/AAS-3726-2021	Kim, Beom Kyung/0000-0002-5363-2496; Han, Kwang-Hyub/0000-0003-3960-6539; Choi, Gi Hong/0000-0002-1593-3773; Jeon, Mi Young/0000-0002-3980-4503; Ahn, Sang Hoon/0000-0002-3629-4624; Kim, Seung Up/0000-0002-9658-8050; Han, Dai Hoon/0000-0003-2787-7876; Park, Jun Yong/0000-0001-6324-2224; LIM, TAE SEOP/0000-0002-4578-8685	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2016R1A1A1A05005138]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2016R1A1A1A05005138). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Jeon MY, 2018, LIVER INT, V38, P1655, DOI 10.1111/liv.13731; Kim BK, 2015, J HEPATOL, V62, P1304, DOI 10.1016/j.jhep.2015.01.022; Kim BK, 2013, EUR J CANCER, V49, P826, DOI 10.1016/j.ejca.2012.08.022; Kim BK, 2012, LIVER INT, V32, P1120, DOI 10.1111/j.1478-3231.2012.02811.x; Kim HY, 2012, J GASTROEN HEPATOL, V27, P1051, DOI 10.1111/j.1440-1746.2011.06963.x; Kim JY, 2016, CLIN MOL HEPATOL, V22, P250, DOI 10.3350/cmh.2016.0015; Kim JH, 2017, CLIN MOL HEPATOL, V23, P42, DOI 10.3350/cmh.2016.0058; Korean Liver Cancer Study Group and National Cancer Center Korea, 2009, Korean J Hepatol, V15, P391, DOI 10.3350/kjhep.2009.15.3.391; Kudo M, 2014, LIVER CANCER, V3, P458, DOI 10.1159/000343875; Kudo M, 2014, ONCOLOGY-BASEL, V87, P22, DOI 10.1159/000368142; Kudo M, 2012, LIVER CANCER, V1, P62, DOI 10.1159/000342402; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Lee JM, 2016, CLIN MOL HEPATOL, V22, P160, DOI 10.3350/cmh.2016.22.1.160; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Mitchell DG, 2015, HEPATOLOGY, V61, P1056, DOI 10.1002/hep.27304; Park Y, 2016, LIVER INT, V36, P100, DOI 10.1111/liv.12878; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Raoul JL, 2014, LIVER CANCER, V3, P119, DOI 10.1159/000343867; Rosen HR, 2017, HEPATOLOGY, V66, P1020, DOI 10.1002/hep.29361; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Xu XC, 2018, INT J PHARMACEUT, V542, P153, DOI 10.1016/j.ijpharm.2018.03.018; Yamamoto Y, 2015, WORLD J GASTROENTERO, V21, P1207, DOI 10.3748/wjg.v21.i4.1207; Yu SJ, 2016, CLIN MOL HEPATOL, V22, P7, DOI 10.3350/cmh.2016.22.1.7; Yuen MF, 2000, HEPATOLOGY, V31, P330, DOI 10.1002/hep.510310211	29	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214613	10.1371/journal.pone.0214613	http://dx.doi.org/10.1371/journal.pone.0214613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947275	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500045
J	Pinto, OA; Disalvo, EA				Pinto, O. A.; Disalvo, E. A.			A new model for lipid monolayer and bilayers based on thermodynamics of irreversible processes	PLOS ONE			English	Article							AIR-WATER; PHASE-TRANSITIONS; LATERAL DIFFUSION; MEMBRANE; PRESSURE; PERMEABILITY; HYDRATION; TENSION	Lipid monolayers are used as experimental model systems to study the physical chemical properties of biomembranes. With this purpose, surface pressure/area per molecule isotherms provide a way to obtain information on packing and compressibility properties of the lipids. These isotherms have been interpreted considering the monolayer as a two dimensional ideal or van der Waals gas without contact with the water phase. These modelistic approaches do not fit the experimental results. Based on Thermodynamics of Irreversible Processes (TIP), the expansion/compression process is interpreted in terms of coupled phenomena between area changes and water fluxes between a bidimensional solution of hydrated head groups in the monolayer and the bulk solution. The formalism obtained can reproduce satisfactorily the surface pressure/area per lipid isotherms of monolayer in different states and also can explain the area expansion and compression produced in particles enclosed by bilayers during osmotic fluxes. This novel approach gives relevance to the lipid-water interaction in restricted media near the membrane and provides a formalism to understand the thermodynamic and kinetic response of biointerphases to biological effectors.	[Pinto, O. A.] UNSE, CONICET, Inst Bionanotecnol NOA INBIONATEC, Villa El Zanjon, Santiago Del Es, Argentina; [Disalvo, E. A.] UNSE, CONICET, Ctr Invest Biofis Aplicada & Alimentos CIBAAL, Lab Biointerfases & Sistemas Biomimet, Villa El Zanjon, Santiago Del Es, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Disalvo, EA (corresponding author), UNSE, CONICET, Ctr Invest Biofis Aplicada & Alimentos CIBAAL, Lab Biointerfases & Sistemas Biomimet, Villa El Zanjon, Santiago Del Es, Argentina.	disalvoanibal@yahoo.com.ar			ANPCyT [PICT2011-2606, PICT 2015-1111]; PIP CONICET [0484]; CiCyT-UNSE [23/A242]	ANPCyT(ANPCyT); PIP CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CiCyT-UNSE(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT))	E. A. Disalvo and O. A. Pinto are permanent members of the Research Carrier of CONICET. This work was supported with funds from ANPCyT (PICT2011-2606; PICT 2015-1111); PIP CONICET (0484), CiCyT-UNSE (23/A242).	Adamson A. W., 1967, PHYS CHEM SURFACES; Alarcon LM, 2016, EUR PHYS J E, V39, DOI 10.1140/epje/i2016-16094-5; [Anonymous], 2008, THERMAL BIOPHYSICS M; Bouchet AM, 2009, BBA-BIOMEMBRANES, V1788, P918, DOI 10.1016/j.bbamem.2009.02.012; Chen D, 2014, P NATL ACAD SCI USA, V111, P179, DOI 10.1073/pnas.1314993111; Damodaran S, 1998, COLLOID SURFACE B, V11, P231, DOI 10.1016/S0927-7765(98)00040-X; Defay R., 1966, I PRIGOGINE SURFACE; Disalvo EA, 2008, BBA-BIOMEMBRANES, V1778, P2655, DOI 10.1016/j.bbamem.2008.08.025; DISALVO EA, 1983, CHEM PHYS LIPIDS, V32, P39, DOI 10.1016/0009-3084(83)90068-3; Disalvo EA, 2013, BBA-BIOMEMBRANES, V1828, P1834, DOI 10.1016/j.bbamem.2013.03.026; Duncan SL, 2008, BIOPHYS J, V94, P2965, DOI 10.1529/biophysj.107.114215; Dynarowicz-Latka P, 2001, ADV COLLOID INTERFAC, V91, P221, DOI 10.1016/S0001-8686(99)00034-2; Evans E.A., 1980, MECH THERMODYNAMICS; FAHEY PF, 1978, BIOCHEMISTRY-US, V17, P3046, DOI 10.1021/bi00608a016; Feng SS, 1999, LANGMUIR, V15, P998, DOI 10.1021/la980144f; Gong K, 2002, COLLOID SURFACE A, V207, P113, DOI 10.1016/S0927-7757(02)00043-2; JENDRASIAK GL, 1974, BIOCHIM BIOPHYS ACTA, V337, P79, DOI 10.1016/0005-2760(74)90042-3; Jyoti A, 1997, COLLOID SURFACE B, V8, P115, DOI 10.1016/S0927-7765(96)01321-5; Katchalsky A., 1965, NONEQUILIBRIUM THERM; Ladha S, 1996, BIOPHYS J, V71, P1364, DOI 10.1016/S0006-3495(96)79339-6; MACDONALD RC, 1987, P NATL ACAD SCI USA, V84, P4089, DOI 10.1073/pnas.84.12.4089; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; NAGLE JF, 1976, J MEMBRANE BIOL, V27, P233, DOI 10.1007/BF01869138; Nickels Jonathan D, 2015, Subcell Biochem, V71, P45, DOI 10.1007/978-3-319-19060-0_3; PARSEGIAN VA, 1979, P NATL ACAD SCI USA, V76, P2750, DOI 10.1073/pnas.76.6.2750; Pfeiffer Helge, 2015, Subcell Biochem, V71, P69, DOI 10.1007/978-3-319-19060-0_4; Rawicz W, 2008, BIOPHYS J, V94, P4725, DOI 10.1529/biophysj.107.121731; Reddy AS, 2012, BBA-BIOMEMBRANES, V1818, P2271, DOI 10.1016/j.bbamem.2012.05.006; Tristram-Nagle S., 2015, MEMBRANE HYDRATION R, P17; VANZOELEN EJJ, 1978, BIOCHIM BIOPHYS ACTA, V511, P335, DOI 10.1016/0005-2736(78)90271-7; VANZOELEN EJJ, 1978, BIOCHIM BIOPHYS ACTA, V511, P320, DOI 10.1016/0005-2736(78)90270-5	32	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0212269	10.1371/journal.pone.0212269	http://dx.doi.org/10.1371/journal.pone.0212269			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947264	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500008
J	Roberts, AC; Chornak, J; Alzagatiti, JB; Ly, DT; Bill, BR; Trinkeller, J; Pearce, KC; Choe, RC; Campbell, CS; Wong, D; Deutsch, E; Hernandez, S; Glanzman, DL				Roberts, Adam C.; Chornak, Julia; Alzagatiti, Joseph B.; Ly, Duy T.; Bill, Brent R.; Trinkeller, Janie; Pearce, Kaycey C.; Choe, Ronny C.; Campbell, C. S.; Wong, Dustin; Deutsch, Emily; Hernandez, Sarah; Glanzman, David L.			Rapid habituation of a touch-induced escape response in Zebrafish (Danio rerio) Larvae	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MAUTHNER CELL; MUTAGENESIS; NEURONS; MODEL	Zebrafish larvae have several biological features that make them useful for cellular investigations of the mechanisms underlying learning and memory. Of particular interest in this regard is a rapid escape, or startle, reflex possessed by zebrafish larvae; this reflex, the C-start, is mediated by a relatively simple neuronal circuit and exhibits habituation, a non-associative form of learning. Here we demonstrate a rapid form of habituation of the C-start to touch that resembles the previously reported rapid habituation induced by auditory or vibrational stimuli. We also show that touch-induced habituation exhibits input specificity. This work sets the stage for in vivo optical investigations of the cellular sites of plasticity that mediate habituation of the C-start in the larval zebrafish.	[Roberts, Adam C.; Campbell, C. S.; Deutsch, Emily; Hernandez, Sarah] Calif State Univ Fullerton, Dept Psychol, Fullerton, CA 92634 USA; [Chornak, Julia] Univ Calif Los Angeles, Dept Neurosci, Los Angeles, CA USA; [Alzagatiti, Joseph B.; Ly, Duy T.; Trinkeller, Janie; Pearce, Kaycey C.; Choe, Ronny C.; Wong, Dustin; Glanzman, David L.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Bill, Brent R.] Univ Texas Tyler, Dept Biol, Tyler, TX 75799 USA; [Glanzman, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Glanzman, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA	California State University System; California State University Fullerton; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Texas System; University of Texas at Tyler; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Glanzman, DL (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.; Glanzman, DL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.; Glanzman, DL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA.	glanzman@ucla.edu		Chornak, Julia/0000-0002-8008-4325; , Christopher/0000-0002-0569-0712; Roberts, Adam/0000-0001-8596-8552; Ly, Duy/0000-0001-9366-1366; Bill, Brent/0000-0002-3436-1969	National Institutes of Health; National Institute of Neurological Disorders and Stroke [R01 NS029563]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by National Institutes of Health. National Institute of Neurological Disorders and Stroke R01 NS029563. https://www.ninds.nih.gov.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; CASTELLUCCI VF, 1974, P NATL ACAD SCI USA, V71, P5004, DOI 10.1073/pnas.71.12.5004; Del Bene F, 2012, DEV NEUROBIOL, V72, P404, DOI 10.1002/dneu.20914; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; EATON RC, 1977, J NEUROBIOL, V8, P151, DOI 10.1002/neu.480080207; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; Ganser LR, 2013, NEUROBIOL DIS, V60, P139, DOI 10.1016/j.nbd.2013.09.002; Heffer A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189162; Hirata H, 2005, P NATL ACAD SCI USA, V102, P8345, DOI 10.1073/pnas.0500862102; Jain RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026510; KIMMEL CB, 1981, J COMP NEUROL, V198, P101, DOI 10.1002/cne.901980110; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Marsden KC, 2015, CELL REP, V13, P1733, DOI 10.1016/j.celrep.2015.10.060; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Oda Y, 1998, NATURE, V394, P182, DOI 10.1038/28172; ODA Y, 1995, J NEUROPHYSIOL, V74, P1056, DOI 10.1152/jn.1995.74.3.1056; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Roberts AC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00126; Roberts AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029132; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Scott EK, 2009, J NEUROCHEM, V110, P441, DOI 10.1111/j.1471-4159.2009.06161.x; Simmich J, 2012, PROG BRAIN RES, V196, P145, DOI 10.1016/B978-0-444-59426-6.00008-2; Tabor KM, 2014, J NEUROPHYSIOL, V112, P834, DOI 10.1152/jn.00228.2014; Takahashi M, 2002, J NEUROSCI, V22, P3929, DOI 10.1523/JNEUROSCI.22-10-03929.2002; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Wolman MA, 2011, P NATL ACAD SCI USA, V108, P15468, DOI 10.1073/pnas.1107156108; YANG XD, 1991, P NATL ACAD SCI USA, V88, P4299, DOI 10.1073/pnas.88.10.4299; Zada D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004615	33	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214374	10.1371/journal.pone.0214374	http://dx.doi.org/10.1371/journal.pone.0214374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946762	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500030
J	Begg, GA; O'Neill, J; Sohaib, A; McLean, A; Pepper, CB; Graham, LN; Hogarth, AJ; Page, SP; Gillott, RG; Hill, N; Walshaw, J; Schilling, RJ; Kanagaratnam, P; Tayebjee, MH				Begg, Gordon A.; O'Neill, James; Sohaib, Afzal; McLean, Ailsa; Pepper, Chris B.; Graham, Lee N.; Hogarth, Andrew J.; Page, Stephen P.; Gillott, Richard G.; Hill, Nicola; Walshaw, Jacqueline; Schilling, Richard J.; Kanagaratnam, Prapa; Tayebjee, Muzahir H.			Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial)	PLOS ONE			English	Article							AF CATHETER ABLATION; ELECTROPHYSIOLOGY; LESION	Introduction Electrical coupling index (ECI) and contact force (CF) have been developed to aid lesion formation during catheter ablation. ECI measures tissue impedance and capacitance whilst CF measures direct contact. The aim was to determine whether the presence of catheter /tissue interaction information, such as ECI and CF, reduce time to achieve bidirectional cavotricuspid isthmus block during atrial flutter (AFL) ablation. Methods Patients with paroxysmal or persistent AFL were randomised to CF visible (range 5-40g), CF not visible, ECI visible (change of 12%) or ECI not visible. Follow-up occurred at 3 and 6 months and included a 7 day ECG recording. The primary endpoint was time to bidirectional cavotricuspid isthmus block. Results 114 patients were randomised, 16 were excluded. Time to bidirectional block was significantly shorter when ECI was visible (median 30.0 mins (IQR 31) to median 10.5mins (IQR 12) p 0.023) versus ECI not visible. There was a trend towards a shorter time to bidirectional block when CF was visible. Higher force was applied when CF was visible (median 9.03g (IQR 7.4) vs. 11.3g (5.5) p 0.017). There was no difference in the acute recurrence of conduction between groups. The complication rate was 2%, AFL recurrence was 1.1% and at 6 month follow-up, 12% had atrial fibrillation. Conclusion The use of tissue contact information during AFL ablation was associated with reduced time taken to achieve bidirectional block when ECI was visible. Contact force data improved contact when visible with a trend towards a reduction in the procedural endpoint.	[Begg, Gordon A.; O'Neill, James; Pepper, Chris B.; Graham, Lee N.; Hogarth, Andrew J.; Page, Stephen P.; Gillott, Richard G.; Hill, Nicola; Walshaw, Jacqueline; Tayebjee, Muzahir H.] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Dept Cardiol, Leeds, W Yorkshire, England; [Sohaib, Afzal; Kanagaratnam, Prapa] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Cardiol, London, England; [McLean, Ailsa; Schilling, Richard J.] Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Cardiol, London, England	Leeds General Infirmary; University of Leeds; Imperial College London; Barts Health NHS Trust; University of London; Queen Mary University London	Tayebjee, MH (corresponding author), Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Dept Cardiol, Leeds, W Yorkshire, England.	muzahir.tayebjee@nhs.net			Biosense Webster; National Institute for Health Research (NIHR)	Biosense Webster; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This study was funded using a research grant from Biosense Webster. Biosense Webster had no involvement in the trial design, analysis of the results or drafting of the manuscript. Additionally, this work was supported by the National Institute for Health Research (NIHR) with the use of the Leeds Cardiovascular Clinical Research Facility.	Avitall BKA, 2015, HDB CARDIAC ANATOMY, P521; Das M, 2017, EUROPACE, V19, P775, DOI 10.1093/europace/euw105; Deno DC, 2014, IEEE T BIO-MED ENG, V61, P765, DOI 10.1109/TBME.2013.2289328; Gaspar T, 2013, HEART RHYTHM, V10, P176, DOI 10.1016/j.hrthm.2012.10.010; Gepstein L, 1999, CIRCULATION, V100, P419, DOI 10.1161/01.CIR.100.4.419; Holmes D, 2011, J CARDIOVASC ELECTR, V22, P684, DOI 10.1111/j.1540-8167.2010.01963.x; Kautzner J, 2013, EUROPACE, V15; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Lehrmann H, 2012, HEART RHYTHM, V9, P1942, DOI 10.1016/j.hrthm.2012.08.020; Natale A, 2000, J AM COLL CARDIOL, V35, P1898, DOI 10.1016/S0735-1097(00)00635-5; Natale A, 2014, J AM COLL CARDIOL, V64, P647, DOI 10.1016/j.jacc.2014.04.072; Perez FJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P393, DOI 10.1161/CIRCEP.109.871665; Piorkowski C, 2009, J CARDIOVASC ELECTR, V20, P1366, DOI 10.1111/j.1540-8167.2009.01552.x; Sanchez JE, 2003, J INTERV CARD ELECTR, V8, P9, DOI 10.1023/A:1022315308803; Scaglione M, 2004, EUROPACE, V6, P407, DOI 10.1016/j.eupc.2004.05.008; Shurrab M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002476; Thiagalingam A, 2007, J CARDIOVASC ELECTR, V18, P318, DOI 10.1111/j.1540-8167.2006.00745.x; van Es R, 2018, EUROPACE, V20, P149, DOI 10.1093/europace/euw388; Willems S, 2000, J CARDIOVASC ELECTR, V11, P1223, DOI 10.1046/j.1540-8167.2000.01223.x	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212903	10.1371/journal.pone.0212903	http://dx.doi.org/10.1371/journal.pone.0212903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943196	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300008
J	Johnson, AJ; Meyerson, E; de la Parra, J; Savas, TL; Miikkulainen, R; Harper, CB				Johnson, Arielle J.; Meyerson, Elliot; de la Parra, John; Savas, Timothy L.; Miikkulainen, Risto; Harper, Caleb B.			Flavor-cyber-agriculture: Optimization of plant metabolites in an open-source control environment through surrogate modeling	PLOS ONE			English	Article							OCIMUM-BASILICUM L.; ESSENTIAL OIL; UV-B; GROWTH; NUTRITION; CO2	Food production in conventional agriculture faces numerous challenges such as reducing waste, meeting demand, maintaining flavor, and providing nutrition. Contained environments under artificial climate control, or cyber-agriculture, could in principle be used to meet many of these challenges. Through such environments, phenotypic expression of the plant-mass, edible yield, flavor, and nutrients-can be actuated through a "climate recipe," where light, water, nutrients, temperature, and other climate and ecological variables are optimized to achieve a desired result. This paper describes a method for doing this optimization for the desired result of flavor by combining cyber-agriculture, metabolomic phenotype (chemotype) measurements, and machine learning. In a pilot experiment, (1) environmental conditions, i.e. photoperiod and ultraviolet (UV) light (known to affect production of flavor-active molecules in edible plants) were applied under different regimes to basil plants (Ocimum basilicum) growing inside a hydroponic farm with an open-source design; (2) flavoractive volatile molecules were measured in each plant using gas chromatography-mass spectrometry (GC-MS); and (3) symbolic regression was used to construct a surrogate model of this chemistry from the input environmental variables, and this model was used to discover new combinations of photoperiod and UV light to increase this chemistry. These new combinations, or climate recipes, were then implemented in the hydroponic farm, and several of them resulted in a marked increase in volatiles over control. The process also led to two important insights: it demonstrated a "dilution effect", i.e. a negative correlation between weight and desirable chemical species, and it discovered the surprising effect that a 24-hour photoperiod of photosynthetic-active radiation, the equivalent of all-day light, induces the most flavor molecule production in basil. In this manner, surrogate optimization through machine learning can be used to discover effective recipes for cyber-agriculture that would be difficult and time-consuming to find using hand-designed experiments.	[Johnson, Arielle J.; de la Parra, John; Savas, Timothy L.; Harper, Caleb B.] MIT, Media Lab, Cambridge, MA 02139 USA; [Meyerson, Elliot; Miikkulainen, Risto] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Meyerson, Elliot; Miikkulainen, Risto] Cognizant Technol Solut, San Francisco, CA USA; [de la Parra, John] Harvard Univ, Harvard Univ Herbaria, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin; Harvard University	Harper, CB (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	calebh@media.mit.edu			Target Corporation; Lee Kum Kee Health Products Group; Welspun; Sentient Technologies	Target Corporation; Lee Kum Kee Health Products Group; Welspun; Sentient Technologies	CBH, AJJ, and TLS received support in the form of a portion of their salary from commercial funders of this study: Target Corporation, Lee Kum Kee Health Products Group, and Welspun. However, these funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. RM and EM received support from Sentient Technologies (https://www.sentient.ai/) and Technology Solutions (https://cognizant.com/).RM and EM first had an affiliation with commercial funder Sentient Technologies and later with Cognizant Technology Solutions. These funders provided support in the form of salary for RM and EM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams SR, 2005, J HORTIC SCI BIOTECH, V80, P2, DOI 10.1080/14620316.2005.11511882; Banchio E, 2009, J AGR FOOD CHEM, V57, P653, DOI 10.1021/jf8020305; Chang XM, 2008, ENVIRON EXP BOT, V63, P216, DOI 10.1016/j.envexpbot.2007.10.017; Chang XM, 2005, J HORTIC SCI BIOTECH, V80, P593, DOI 10.1080/14620316.2005.11511983; CHERNOFF H, 1959, ANN MATH STAT, V30, P755, DOI 10.1214/aoms/1177706205; Cotrufo MF, 1998, GLOBAL CHANGE BIOL, V4, P43, DOI 10.1046/j.1365-2486.1998.00101.x; Davis DR, 2009, HORTSCIENCE, V44, P15, DOI 10.21273/HORTSCI.44.1.15; Davis DR, 2004, J AM COLL NUTR, V23, P669, DOI 10.1080/07315724.2004.10719409; de la Parra J, 2017, TRENDS BIOTECHNOL, V35, P802, DOI 10.1016/j.tibtech.2017.07.003; Deschamps C, 2006, J ESSENT OIL RES, V18, P618, DOI 10.1080/10412905.2006.9699183; Du Q, 1999, SIAM REV, V41, P637, DOI 10.1137/S0036144599352836; Farnham MW, 2000, J AM SOC HORTIC SCI, V125, P344, DOI 10.21273/JASHS.125.3.344; Ferrer EC, 2017, ARXIV170605104; Folta KM, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.32; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Gonzalez J, 2016, JMLR WORKSH CONF PRO, V51, P648; Harper C., 2016, LED LIGHTING URBAN A, P37, DOI [10.1007/978-981-10-1848-0, DOI 10.1007/978-981-10-1848-0]; Harper C, 2015, IEEE PERVAS COMPUT, V14, P24, DOI 10.1109/MPRV.2015.72; HUGHES M, 1979, HORTSCIENCE, V14, P521; Ioannidis D, 2002, ANN BOT-LONDON, V90, P453, DOI 10.1093/aob/mcf212; JARRELL WM, 1981, ADV AGRON, V34, P197, DOI 10.1016/S0065-2113(08)60887-1; Johnson AJ, 2017, CHEMOSENS PERCEPT, P1; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Khalid K. A., 2006, International Agrophysics, V20, P289; Kim HJ, 2005, J AGR FOOD CHEM, V53, P3696, DOI 10.1021/jf0480804; Koza JR, 1992, GENETIC PROGRAMMING, P237; Koziel S, 2011, STUD COMPUT INTELL, V356, P33; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee SJ, 2005, FOOD CHEM, V91, P131, DOI 10.1016/j.foodchem.2004.05.056; Lehman J., 2013, SCHOLARPEDIA, V8, P30977, DOI DOI 10.4249/SCHOLARPEDIA.30977; Loladze I, 2002, TRENDS ECOL EVOL, V17, P457, DOI 10.1016/S0169-5347(02)02587-9; Meyerson E, 2017, 170405554 ARXIV; Miikkulainen R, 2017, ARXIV PREPRINT ARXIV; Miildulainen R, 2017, PROCEEDINGS OF THE 2017 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE (GECCO'17), P1193, DOI 10.1145/3071178.3071312; Moghe GD, 2015, PLANT PHYSIOL, V169, P1512, DOI 10.1104/pp.15.00994; Nitz GM, 2004, ACTA HORTIC, P375, DOI 10.17660/ActaHortic.2004.659.50; OaAZReilly Una-May, 2013, GENETIC PROGRAMMING, P73; Rodriguez Rafael GD, 2011, P GECCO COMP, P185; Said Al-Ahl H., 2010, J APPL SCI, V3, P97, DOI DOI 10.1002/JPLN.200420516; Schatzker M., 2015, DORITO EFFECT SURPRI; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Shahriari B, 2016, P IEEE, V104, P148, DOI 10.1109/JPROC.2015.2494218; SKRUBIS B, 1976, ECON BOT, V30, P389, DOI 10.1007/BF02904661; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Smits GF, 2005, GENET PROGR SER, V8, P283, DOI 10.1007/0-387-23254-0_17; Snoek J., 2012, ADV NEURAL INF PROCE, V25; Snoek J, 2015, PR MACH LEARN RES, V37, P2171; Srinivas N., 2009, ARXIV09123995; Stijven Sean, 2016, GENETIC PROGRAMMING, P241, DOI [10.1007/978-3-319-34223- 8_14, DOI 10.1007/978-3-319-34223-8_14]; Weng JK, 2014, NEW PHYTOL, V201, P1141, DOI 10.1111/nph.12416; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; YAMAURA T, 1989, PHYTOCHEMISTRY, V28, P741, DOI 10.1016/0031-9422(89)80106-2	54	19	19	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213918	10.1371/journal.pone.0213918	http://dx.doi.org/10.1371/journal.pone.0213918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943244	gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300023
J	Tian, SL; Peng, SX; Kalmbach, M; Gaonkar, KS; Bhagwate, A; Ding, W; Eckel-Passow, J; Yan, HH; Slager, SL				Tian, Shulan; Peng, Shuxia; Kalmbach, Michael; Gaonkar, Krutika S.; Bhagwate, Aditya; Ding, Wei; Eckel-Passow, Jeanette; Yan, Huihuang; Slager, Susan L.			Identification of factors associated with duplicate rate in ChIP-seq data	PLOS ONE			English	Article								Chromatin immunoprecipitation and sequencing (ChIP-seq) has been widely used to map DNA-binding proteins, histone proteins and their modifications. ChIP-seq data contains redundant reads termed duplicates, referring to those mapping to the same genomic location and strand. There are two main sources of duplicates: polymerase chain reaction (PCR) duplicates and natural duplicates. Unlike natural duplicates that represent true signals from sequencing of independent DNA templates, PCR duplicates are artifacts originating from sequencing of identical copies amplified from the same DNA template. In analysis, duplicates are removed from peak calling and signal quantification. Nevertheless, a significant portion of the duplicates is believed to represent true signals. Obviously, removing all duplicates will underestimate the signal level in peaks and impact the identification of signal changes across samples. Therefore, an in-depth evaluation of the impact from duplicate removal is needed. Using eight public ChIP-seq datasets from three narrow-peak and two broad-peak marks, we tried to understand the distribution of duplicates in the genome, the extent by which duplicate removal impacts peak calling and signal estimation, and the factors associated with duplicate level in peaks. The three PCR-free histone H3 lysine 4 tri-methylation (H3K4me3) ChIP-seq data had about 40% duplicates and 97% of them were within peaks. For the other datasets generated with PCR amplification of ChIP DNA, as expected, the narrow-peak marks have a much higher proportion of duplicates than the broad-peak marks. We found that duplicates are enriched in peaks and largely represent true signals, more conspicuous in those with high confidence. Furthermore, duplicate level in peaks is strongly correlated with the target enrichment level estimated using non-redundant reads, which provides the basis to properly allocate duplicates between noise and signal. Our analysis supports the feasibility of retaining the portion of signal duplicates into downstream analysis, thus alleviating the limitation of complete deduplication.	[Tian, Shulan; Peng, Shuxia; Gaonkar, Krutika S.; Bhagwate, Aditya; Eckel-Passow, Jeanette; Yan, Huihuang; Slager, Susan L.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Kalmbach, Michael] Mayo Clin, Dept Informat Technol, Div Res & Educ Support Syst, Rochester, MN USA; [Ding, Wei] Mayo Clin, Div Hematol, Rochester, MN USA; [Peng, Shuxia] Univ Michigan, Sch Publ Hlth 2, Ann Arbor, MI 48109 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan	Yan, HH; Slager, SL (corresponding author), Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN 55905 USA.	yan.huihuang@mayo.edu; Slager.Susan@mayo.edu			National Institutes of Health [CA118444]; Mayo CCaTS grant [UL1TR000135]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo CCaTS grant	This work was supported by National Institutes of Health grant (CA118444) and Mayo CCaTS grant (UL1TR000135) to S. L. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldiri I, 2017, NEURON, V94, P550, DOI 10.1016/j.neuron.2017.04.022; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003326; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bansal V, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1471-9; Benner C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003906; Burriesci MS, 2012, BIOINFORMATICS, V28, P1324, DOI 10.1093/bioinformatics/bts123; Carroll TS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00075; Chen YW, 2012, NAT METHODS, V9, P609, DOI [10.1038/NMETH.1985, 10.1038/nmeth.1985]; Franco HL, 2018, GENOME RES, V28, P159, DOI 10.1101/gr.226019.117; Fu SL, 2018, NUCLEIC ACIDS RES, V46, P11184, DOI 10.1093/nar/gky753; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Klepikova AV, 2017, PEERJ, V5, DOI 10.7717/peerj.3091; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Manconi A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1192-5; Marinov G. K., 2013, G3-GENES GENOM GENET, V4, P209, DOI [10.1534/g3.113.008680, DOI 10.1534/G3.113.008680]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sayols S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1276-2; Smith EN, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0420-4; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Sundaram AYM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3135-y; Venkataraman A, 2018, NAT METHODS, V15, P330, DOI 10.1038/nmeth.4632; Xu HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052249; Yan HH, 2016, EPIGENOMICS-UK, V8, P1239, DOI 10.2217/epi-2016-0053; Yan HH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-280; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	32	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214723	10.1371/journal.pone.0214723	http://dx.doi.org/10.1371/journal.pone.0214723			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943272	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300054
J	Joshi, A; Arora, A; Amadi-Mgbenka, C; Mittal, N; Sharma, S; Malhotra, B; Grover, A; Misra, A; Loomba, M				Joshi, Ashish; Arora, Arushi; Amadi-Mgbenka, Chioma; Mittal, Nidhi; Sharma, Shruti; Malhotra, Bhavya; Grover, Ashoo; Misra, Archa; Loomba, Menka			Burden of household food insecurity in urban slum settings	PLOS ONE			English	Article							PREVALENCE; PREDICTORS; WOMEN; CARE	This study examined the burden of food insecurity in India's un-notified slums, using an SDG framework to identify correlates of food insecurity. A convenience sampling approach was employed in selecting 38 slums from 675 un-notified slums across four geographic zones. Ten percent of the households in each slum site were selected from each zone, and one household member was interviewed, based on their availability and fulfilment of the eligibility criteria. Eligible individuals included those aged 18 years and above, who were resident in the selected slums and provided consent. Individuals with mental or physical challenges were excluded. A total sample of 907 study participants were included. Results showed that 43% (n = 393) of the participants were food insecure. More than half were females (73%, n = 285), who had not completed any schooling (51%, n = 202). One-third (n = 128) resided in the Northern Region of Delhi. SDG-related predictors of food insecurity included: household educational level (SDG 4 Quality education) (p = 0.03), coverage of health service needs (SDG 3 Good health and well-being) (p = 0.0002), electricity needs (SDG 7 affordable and clean energy) (p<0.0001), and employment needs (SDG 8 Decent and economic growth) (p = 0.003). Having healthcare needs that were partially or fully met was equally associated with higher food insecurity: this could be attributed to high healthcare costs and the lack of federal subsidies in un-notified slums, collectively contributing to high out-of-pocket health costs. Failure to fully meet employment needs was also significantly associated with higher food insecurity. However, met needs for electricity, finance, women's safety and satisfactory family relationships, were associated with lower food insecurity. Household predictors of food insecurity included: number of household members, and the presence of physically disabled household members. Necessary interventions should include connecting food insecure households to existing social services such as India's Public Distribution System, and multi-sector partnerships to address the existing challenges.	[Joshi, Ashish; Amadi-Mgbenka, Chioma] CUNY, Dept Epidemiol, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Arora, Arushi; Mittal, Nidhi; Sharma, Shruti; Malhotra, Bhavya; Misra, Archa; Loomba, Menka] Fdn Hlth Care Technol Soc, New Delhi, India; [Arora, Arushi] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Grover, Ashoo] Indian Council Med Res, New Delhi, India	City University of New York (CUNY) System; Columbia University; Indian Council of Medical Research (ICMR)	Joshi, A (corresponding author), CUNY, Dept Epidemiol, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.	ashish.joshi@sph.cuny.edu		Arora, Arushi/0000-0001-8913-3544; Grover, Ashoo/0000-0001-8027-8608				Abraham Tadesse Tantu, 2017, Agriculture and Food Security, V6, DOI 10.1186/s40066-017-0098-4; Anantakrishnan L, 2018, TRANSFORMATION SUSTA, P6; Athreya VB, 2010, REPORT STATE FOOD IN; Aurino E, 2018, WORLD DEV, V111, P211, DOI 10.1016/j.worlddev.2018.07.009; Carman Katherine G, 2016, Int J Food Agric Econ, V4, P1; Chakravarty S, 2010, FOOD INSECURITY INDI; Chaplin SE, INFRASTRUCTURE GENDE; Chinnakali P, 2014, J HEALTH POPUL NUTR, V32, P227; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Dharmaraju Nikitha, 2018, J Family Med Prim Care, V7, P819, DOI 10.4103/jfmpc.jfmpc_185_17; Garikipati S, 2017, J INT DEV, V29, P32, DOI 10.1002/jid.3266; Grebmer K. V., 2018, GLOBAL HUNGER INDEX; Joshi A, 2017, GLOB J HLTH SCI, V9, P153, DOI [10.5539/gjhs.v9n8p153, DOI 10.5539/GJHS.V9N8P153]; Masa R, 2017, ECOL FOOD NUTR, V56, P256, DOI 10.1080/03670244.2017.1311256; McIntyre L, 2014, PUBLIC HEALTH NUTR, V17, P49, DOI 10.1017/S1368980012004053; Meadows G, 2000, SOC PSYCH PSYCH EPID, V35, P427, DOI 10.1007/s001270050260; Nord M., 2014, PREVALENCE US FOOD I; Pal P., 2019, CLIMATE CHANGE FOOD, P133; Parikh P, 2015, WORLD DEV, V66, P468, DOI 10.1016/j.worlddev.2014.09.014; Pellowski JA, 2017, SOC SCI MED, V187, P76, DOI 10.1016/j.socscimed.2017.06.022; Rains E, 2018, URBANIZATION INDIAS; Saunders M.N.K., 2012, PRACTICE QUALITATIVE, P35; Saxena N.C., 2018, POVERTY CHRONIC POVE, P55, DOI 10.1007/978-981-13-0677-8_4; Sonik R, 2016, EXCEPT CHILDREN, V83, P42, DOI 10.1177/0014402916651847; UN-HABITAT, 2013, STAT WORLDS CIT 2012; United Nations, WORLD URB PROSP 2018; United Nations, 2017, SUST DEV KNOWL PLATF; United Nations, 2017, SUST DEV KNOWL PLATF; Weaver L. J., 2018, Food and Nutrition Sciences, V9, P519, DOI 10.4236/fns.2018.95040	29	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214461	10.1371/journal.pone.0214461	http://dx.doi.org/10.1371/journal.pone.0214461			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939157	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900024
J	Harada, H; Hosoda, K; Moriya, H; Mieno, H; Ema, A; Ushiku, H; Washio, M; Nishizawa, N; Ishii, S; Yokota, K; Tanaka, Y; Kaida, T; Soeno, T; Kosaka, Y; Watanabe, M; Yamashita, K				Harada, Hiroki; Hosoda, Kei; Moriya, Hiromitsu; Mieno, Hiroaki; Ema, Akira; Ushiku, Hideki; Washio, Marie; Nishizawa, Nobuyuki; Ishii, Satoru; Yokota, Kazuko; Tanaka, Yoko; Kaida, Takeshi; Soeno, Takafumi; Kosaka, Yoshimasa; Watanabe, Masahiko; Yamashita, Keishi			Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE ACTIVITY; ADJUVANT CHEMOTHERAPY; SURVIVAL; EXPRESSION; IMPACT; S-1; RECEPTOR; MARKERS; CELLS; TRIAL	Background There have been few available prognostic biomarkers in gastric cancer. We rigorously assessed the clinical relevance of promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene, a cancer-specific aberration, in human gastric cancer. Methods Quantitative CDO1 methylation value (TaqMeth V) was initially calculated in 138 gastric cancer patients operated in 2005, and its clinical significance was elucidated. As a subsequent expanded set, 154 gastric cancer patients with pathological stage (pStage) II/III with no postoperative therapy were validated between 2000 and 2010. Results (1) Median TaqMeth V of CDO1 gene methylation of gastric cancer was 25.6, ranging from 0 to 120.9. As pStage progressed, CDO1 TaqMeth V became higher (p < 0.0001). (2) The optimal cut-off value was determined to be 32.6; gastric cancer patients with high CDO1 gene methylation showed a significantly worse prognosis than those with low CDO1 gene methylation (p < 0.0001). (3) A multivariate cox proportional hazards model identified high CDO1 gene methylation (p = 0.033) as an independent prognostic factor. (4) The results were recapitulated in the expanded set in pStage III, where high CDO1 gene methylation group had a significantly worse prognosis than low CDO1 gene methylation group (p = 0.0065). Hematogenous metastasis was unique in pStage III with high CDO1 gene methylation (p = 0.0075). (5) Anchorage independent growth was reduced in several gastric cancer cell lines due to forced expression of the CDO1 gene, suggesting that abnormal CDO1 gene expression may represent distant metastatic ability. Conclusions Promoter DNA hypermethylation of CDO1 gene was rigorously validated as an important prognostic biomarker in primary gastric cancer with specific stage.	[Harada, Hiroki; Hosoda, Kei; Moriya, Hiromitsu; Mieno, Hiroaki; Ema, Akira; Ushiku, Hideki; Washio, Marie; Nishizawa, Nobuyuki; Ishii, Satoru; Yokota, Kazuko; Kaida, Takeshi; Soeno, Takafumi; Watanabe, Masahiko; Yamashita, Keishi] Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan; [Tanaka, Yoko; Kosaka, Yoshimasa] Kitasato Univ, Sch Med, Dept Breast & Endocrine Surg, Minami Ku, Sagamihara, Kanagawa, Japan; [Yamashita, Keishi] Kitasato Univ, Sch Med, Div Adv Surg Oncol, Dept Res & Dev,Ctr New Med Frontiers,Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Kitasato University	Yamashita, K (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan.; Yamashita, K (corresponding author), Kitasato Univ, Sch Med, Div Adv Surg Oncol, Dept Res & Dev,Ctr New Med Frontiers,Minami Ku, Sagamihara, Kanagawa, Japan.	keishi23@med.kitasato-u.ac.jp	Hosoda, Kei/W-8009-2019	Hosoda, Kei/0000-0002-9787-2889; Harada, Hiroki/0000-0002-1983-4692				Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Cheong JH, 2018, LANCET ONCOL, V19, P629, DOI 10.1016/S1470-2045(18)30108-6; Deckers IAG, 2015, CLIN CANCER RES, V21, P3492, DOI 10.1158/1078-0432.CCR-14-2049; Feber A, 2015, CLIN CANCER RES, V21, P1196, DOI 10.1158/1078-0432.CCR-14-1656; Ichikawa W, 2017, GASTRIC CANCER, V20, P263, DOI 10.1007/s10120-016-0600-x; Igarashi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188178; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jeschke J, 2013, CLIN CANCER RES, V19, P3201, DOI 10.1158/1078-0432.CCR-12-3751; Kalmar A, 2015, PATHOL ONCOL RES, V21, P1149, DOI 10.1007/s12253-015-9945-4; Katoh H, 2012, NEOPLASIA, V14, P559, DOI 10.1593/neo.12330; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kojima K, 2017, DIS ESOPHAGUS, V30, DOI 10.1093/dote/dow001; Kojima K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194785; Meller S, 2016, EPIGENETICS-US, V11, P871, DOI 10.1080/15592294.2016.1241931; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; Noh SH, 2014, LANCET ONCOL, V15, P1389, DOI 10.1016/S1470-2045(14)70473-5; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Ooki A, 2017, CLIN CANCER RES, V23, P7141, DOI 10.1158/1078-0432.CCR-17-1222; Ooki A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-122; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Rohrmann S, 2015, INT J CANCER, V136, pE423, DOI 10.1002/ijc.29236; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2015, GASTRIC CANCER, V18, P538, DOI 10.1007/s10120-014-0413-8; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Ushiku H, 2017, GASTRIC CANCER, V20, P784, DOI 10.1007/s10120-017-0697-6; Ushiku Hideki, 2017, Dis Esophagus, V30, P1, DOI 10.1111/dote.12496; Vedeld HM, 2015, INT J CANCER, V136, P844, DOI 10.1002/ijc.29039; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Yamashita K, 2006, CANCER RES, V66, P3921, DOI 10.1158/0008-5472.CAN-05-1511; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2018, CANCER SCI, V109, P3695, DOI 10.1111/cas.13812; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546	35	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214872	10.1371/journal.pone.0214872	http://dx.doi.org/10.1371/journal.pone.0214872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934021	Green Published, Green Submitted, gold			2022-12-27	WOS:000462867000043
J	Meinel, TR; Frey, S; Arnold, M; Kendroud, S; Fischer, U; Kaesmacher, J; Heldner, MR; Jung, S				Meinel, Thomas Raphael; Frey, Sebastien; Arnold, Marcel; Kendroud, Sarah; Fischer, Urs; Kaesmacher, Johannes; Heldner, Mirjam Rachel; Jung, Simon			Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - A systematic review	PLOS ONE			English	Review							NONVALVULAR ATRIAL-FIBRILLATION; DABIGATRAN-TREATED PATIENTS; STROKE PATIENTS; INTRAVENOUS THROMBOLYSIS; PLASMINOGEN-ACTIVATOR; EMBOLISM TRIAL; PLASMA-LEVELS; THERAPY; SEVERITY; RISK	Background Non-vitamin K antagonist oral anticoagulants (NOAC) are equally or potentially superior in terms of effectiveness in the prevention of ischemic stroke and carry a lower associated risk of intracranial hemorrhage compared to Vitamin K antagonists. Nevertheless, ischemic strokes also occur in patients who are being treated with NOAC. In those particular patients, knowledge about the underlying stroke etiology, clinical presentation, acute management, and complication rates is scarce. Objective Systematic literature review to provide a comprehensive clinical overview in terms of presentation, laboratory, imaging parameters and outcomes of patients suffering from acute cerebral ischemic events (i.e. TIA and acute ischemic stroke) while on treatment with a NOAC. Only if available, comparison to VKA is presented which was not the primary focus of this analysis. Data sources PubMed/MEDLINE, Scopus and EMBASE from January 1, 2006, to November 20, 2018. Study eligibility criteria 52 studies providing detailed information on a total of 12247 patients were included. We excluded case reports and case series with less than five patients. Study appraisal and synthesis method We systematically assessed study quality using a bias tool and pooled consistent data. Results Existing data indicates milder stroke severity and smaller infarct size of acute ischemic stroke on treatment with NOAC compared to stroke occurrence on Vitamin K antagonists (VKA). Established risk factors for ischemic events also play a role in stroke while on NOACs, albeit the underlying etiology remains poorly understood. Intravenous thrombolysis and endovascular therapy seem to be safe and effective, but patient selection for recanalization therapies is challenging. Limitations Limited quality of published data, duplicate cases, statistical issues of data pooling, possible incomplete retrieval of identified research and reporting bias might have limited our findings. Conclusions Acute ischemic events despite treatment with NOAC therapy are insufficiently investigated.	[Meinel, Thomas Raphael; Frey, Sebastien; Arnold, Marcel; Fischer, Urs; Heldner, Mirjam Rachel; Jung, Simon] Univ Bern, Dept Neurol, Inselspital, Bern Univ Hosp, Bern, Switzerland; [Kendroud, Sarah] Touro Univ Calif, Dept Neurol, Vallejo, CA USA; [Kaesmacher, Johannes] Univ Bern, Dept Diagnost & Intervent Neuroradiol, Inselspital, Bern Univ Hosp, Bern, Switzerland	University of Bern; University Hospital of Bern; Touro University California; University of Bern; University Hospital of Bern	Meinel, TR (corresponding author), Univ Bern, Dept Neurol, Inselspital, Bern Univ Hosp, Bern, Switzerland.	thomas.meinel@insel.ch	Kaesmacher, Johannes/I-6136-2019	Kaesmacher, Johannes/0000-0002-9177-2289; Fischer, Urs/0000-0003-0521-4051; Meinel, Thomas Raphael/0000-0002-0647-9273; Heldner, Mirjam R/0000-0002-3594-2159				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alberts MJ, 2016, INT J CARDIOL, V215, P11, DOI 10.1016/j.ijcard.2016.03.212; Almutairi AR, 2017, CLIN THER, V39, P1456, DOI 10.1016/j.clinthera.2017.05.358; Altay S, 2017, ANATOL J CARDIOL, V17, P353, DOI 10.14744/AnatolJCardiol.2016.7472; Amarenco P, 2013, CEREBROVASC DIS, V36, P1, DOI 10.1159/000352050; [Anonymous], QUAL ASS TOOL OBS CO; Antoniou T, 2017, CAN MED ASSOC J, V189, pE4, DOI [10.1503/cmaj.160303, 10.1503/cmaj.732638]; Arihiro S, 2016, INT J STROKE, V11, P565, DOI 10.1177/1747493016632239; Bluecher A, 2017, THROMB HAEMOSTASIS, V117, P519, DOI 10.1160/TH16-08-0619; Cappellari M, 2017, J THROMB THROMBOLYS, V43, P248, DOI 10.1007/s11239-016-1430-8; Cavallari I, 2018, INT J CARDIOL, V257, P102, DOI 10.1016/j.ijcard.2018.01.065; Cernik D, 2018, CARDIOVASC INTER RAD, V41, P706, DOI 10.1007/s00270-018-1902-7; Chen ST, 2017, AM J CARDIOL, V120, P1837, DOI 10.1016/j.amjcard.2017.07.095; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; DeFelipe-Mimbrera A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/567026; Elvira-Ruiz G, 2017, EUR HEART J, V38, P967; Endo H, CEREBROVASC DIS; Endres M, S3 LEITLINIE SEKUNDA; Forslund T, 2016, EUR J CLIN PHARMACOL, V72, P329, DOI 10.1007/s00228-015-1983-z; Frol S, 2018, INT J STROKE, V13, P218; Giannandrea D, 2019, J NEUROL NEUROSUR PS, V90, P619, DOI 10.1136/jnnp-2018-318658; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Hankey GJ, 2012, LANCET NEUROL, V11, P315, DOI 10.1016/S1474-4422(12)70042-X; Hayashi T, 2015, INTERNAL MED, V54, P2433, DOI 10.2169/internalmedicine.54.4948; Heidbuchel H, 2015, EUROPACE, V17, P1317, DOI 10.1093/europace/euv124; Hellwig S, 2017, EUROPACE, P1, DOI [10.1093/europace/euw133, DOI 10.1093/EUROPACE/EUW133]; Horstmann S, 2015, CEREBROVASC DIS, V39, P325, DOI 10.1159/000381728; Hoyer C, 2018, J THROMB THROMBOLYS, V45, P529, DOI 10.1007/s11239-018-1634-1; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jackevicius CA, 2017, HEART, V1, P1, DOI [10.1136/heartjnl-2016-301672, DOI 10.1136/HEARTJNL-2016-301672]; Jin C, 2018, STROKE, V49, P2237, DOI 10.1161/STROKEAHA.118.022128; Kamal H, 2015, NEUROLOGY, V84; Kanai Y, 2018, J STROKE CEREBROVASC, V27, P338, DOI 10.1016/j.jstrokecerebrovasdis.2017.09.007; Kate M, 2014, J STROKE CEREBROVASC, V23, P1351, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.013; Kato Y, 2018, J STROKE CEREBROVASC, V27, P1490, DOI 10.1016/j.jstrokecerebrovasdis.2017.12.038; Kepplinger J, 2016, J THROMB THROMBOLYS, V41, P293, DOI 10.1007/s11239-015-1229-z; Kermer P, 2017, INT J STROKE, V12, P383, DOI 10.1177/1747493017701944; Kim BJ, 2015, INT J STROKE, V10, pE68, DOI 10.1111/ijs.12587; Kimura S, 2014, J STROKE CEREBROVASC, V23, pE427, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.015; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Kirchhof P, 2018, J AM COLL CARDIOL, V72, P141, DOI 10.1016/j.jacc.2018.04.058; Krajickova D, 2019, CLIN RADIOL, V74, DOI 10.1016/j.crad.2018.10.009; Kurowski D, 2017, J STROKE CEREBROVASC, V26, P1104, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.027; Liu MS, 2018, J STROKE CEREBROVASC, V27, P2296, DOI 10.1016/j.jstrokecerebrovasdis.2018.04.012; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Nakase T, 2017, NEUROLOGY S, V88; Hristova VN, 2018, EUR J NEUROL, V25, P389; O'Donnell MJ, 2016, AM HEART J, V178, P145, DOI 10.1016/j.ahj.2016.03.019; Oguro H, 2016, INT J PHARM SCI RES, V3, DOI [10.15344/2394-1502/2016/116, DOI 10.15344/2394-1502/2016/116]; OLIVERA P, 2016, BLOOD, V128; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Pfeilschifter W, 2016, CEREBROVASC DIS, V42, P415, DOI 10.1159/000447952; Piccardi B, 2018, EUR STROKE, V3, P469, DOI [10.1177/2396987318770127, DOI 10.1177/2396987318770127]; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Pikija S, 2017, CNS DRUGS, V31, P747, DOI 10.1007/s40263-017-0460-x; Pollack CV, 2016, AM J MED, V129, pS73, DOI 10.1016/j.amjmed.2016.06.008; Purrucker JC, 2018, ACTA NEUROL SCAND, V138, P163, DOI 10.1111/ane.12934; Purrucker JC, 2017, J STROKE, V19, P67, DOI 10.5853/jos.2016.00542; Purrucker JC, 2017, STROKE, V48, P152, DOI 10.1161/STROKEAHA.116.014963; Rebello LC, 2015, STROKE, V46, P3536, DOI 10.1161/STROKEAHA.115.011285; Ruff CT, 2016, JAMA CARDIOL, V1, P999, DOI 10.1001/jamacardio.2016.3311; Rybinnik I, 2013, J STROKE CEREBROVASC, V22, P1312, DOI 10.1016/j.jstrokecerebrovasdis.2012.12.005; Sakamoto Y, 2017, EUR J NEUROL, V24, P1399, DOI 10.1111/ene.13405; Sanak D, 2018, J STROKE CEREBROVASC, V27, P2479, DOI 10.1016/j.jstrokecerebrovasdis.2018.05.004; Sano H., 2016, CLIN NEUROL NEUROSUR, V56, pS342; Seiffge D, 2017, EUR STROKE J, V2, P99, DOI [10.1177/2396987317705242, DOI 10.1177/2396987317705242]; Seiffge DJ, 2018, J NEUROL, V265, P3022, DOI 10.1007/s00415-018-9061-y; Seiffge DJ, 2018, ANN NEUROL, V83, P451, DOI 10.1002/ana.25165; Seiffge DJ, 2017, J STROKE, V19, P347, DOI 10.5853/jos.2017.00395; Seiffge DJ, 2017, J THROMB THROMBOLYS, V43, P112, DOI 10.1007/s11239-016-1431-7; Seiffge DJ, 2015, CIRCULATION, V132, P1261, DOI 10.1161/CIRCULATIONAHA.115.015484; Seki K, 2016, STROKE, V47; Shahjouei S, 2015, J STROKE CEREBROVASC, V24, P2685, DOI 10.1016/j.jstrokecerebrovasdis.2015.07.021; Shibata Y, 2017, STROKE S1, V48; Shin H, 2018, J THROMB THROMBOLYS, V45, P250, DOI 10.1007/s11239-017-1590-1; Shinoda N, 2018, J STROKE CEREBROVASC, V27, P1546, DOI 10.1016/j.jstrokecerebrovasdis.2018.01.002; Steiner T, 2013, CLIN RES CARDIOL, V102, P399, DOI 10.1007/s00392-013-0560-7; Stollberger C, 2014, NEUROL NEUROCHIR POL, V48, P136, DOI 10.1016/j.pjnns.2014.03.001; Suzuki K, 2017, J NEUROL SCI, V379, P207, DOI 10.1016/j.jns.2017.06.004; Tabata E, 2014, INTERNAL MED, V53, P1515, DOI 10.2169/internalmedicine.53.1506; Tomita H, 2015, J STROKE CEREBROVASC, V24, P1430, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.004; Touze E, 2018, EUR J NEUROL, V25, P747, DOI 10.1111/ene.13582; Tse DM, 2018, J NEUROL NEUROSUR PS, V89, P549, DOI 10.1136/jnnp-2017-316449; Tsivgoulis G, 2017, STROKE, V48, P2031, DOI 10.1161/STROKEAHA.117.017206; Valente M, 2018, INT J STROKE, V13, P12; Verma A, 2014, CAN J CARDIOL, V30, P1114, DOI 10.1016/j.cjca.2014.08.001; Volbers B, 2016, J STROKE CEREBROVASC, V25, P877, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.024; Vornicu O, 2017, EXPERT OPIN BIOL TH, V17, P1275, DOI 10.1080/14712598.2017.1349749; Woo HG, 2018, CEREBROVASC DIS, V46, P23; Xian Y, 2017, JAMA-J AM MED ASSOC, V317, P1057, DOI 10.1001/jama.2017.1371; Xian Y, 2017, CIRCULATION, V135, P1024, DOI 10.1161/CIRCULATIONAHA.116.023940; Xiong QM, 2015, EXPERT OPIN DRUG MET, V11, P937, DOI 10.1517/17425255.2015.1027683; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304; Yu HT, 2018, STROKE, V49, P2421, DOI 10.1161/STROKEAHA.118.021387; Zapata-Wainberg G, 2018, J NEUROINTERV SURG, V10, DOI 10.1136/neurintsurg-2017-013504	97	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0213379	10.1371/journal.pone.0213379	http://dx.doi.org/10.1371/journal.pone.0213379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925155	gold, Green Submitted, Green Published			2022-12-27	WOS:000462732300004
J	Bierings, RAJM; Gordijn, MCM; Jansonius, NM				Bierings, Ronald A. J. M.; Gordijn, Marijke C. M.; Jansonius, Nomdo M.			Chronotyping glaucoma patients with the Munich Chrono Type Questionnaire: A case-control study	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; QUALITY-OF-LIFE; PUPILLARY LIGHT REFLEX; HUMAN CIRCADIAN SYSTEM; VISUAL-FIELD LOSS; MORNINGNESS-EVENINGNESS; SLEEP; MELATONIN; RHYTHMS; PERIOD	Purpose The circadian clock is entrained to light by the intrinsically photosensitive retinal ganglion cells. Loss of these cells in glaucoma, an eye disease with loss of retinal ganglion cells as its key feature, might thus result in a change in chronotype. We aimed to compare the chrono-type between glaucoma patients and healthy subjects. Methods We sent the Munich Chrono Type Questionnaire to 221 glaucoma patients (response rate 81%); controls (primary control group) were primarily their spouses. After exclusion of shift workers and participants who woke-up due to an alarm clock on days off, 159 glaucoma patients (88 early, 21 moderate, 23 severe) and 163 controls remained. We calculated chronotype as the mid-sleep on days off, corrected for workweek accumulated sleep debt (MSFsc). We compared means and variances between groups using Welch's tests and F-tests, respectively. A secondary control group was recruited from participants in a citizen-science project (n = 17073) who completed an online questionnaire. A resampling method was applied to enable an age- and gender- matched comparison with the glaucoma patients. Results Compared to the primary control group, glaucoma did not affect the mean MSFsc (controls 3:47; early, moderate, and severe glaucoma 3:40, 3:45, and 3:33, respectively [P = 0.62]). Chrono type variability seemed to increase with increasing disease severity (severe glaucoma versus controls: P = 0.023). The mean MSFsc of the secondary control group was 3:50 (95% confidence interval 3:48 to 3:52); significantly later than that of the glaucoma patients (3:40; P = 0.024). Mean MSFsc did not differ significantly between the control groups (P = 0.42). Conclusions No clear changes were found in the chronotype as determined by sleep phase in patients with glaucoma, especially not in early and moderate glaucoma. In severe glaucoma, chrono-type variability seems to increase, possibly alongside a small advancement.	[Bierings, Ronald A. J. M.; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Gordijn, Marijke C. M.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Chronobiol Unit, Groningen, Netherlands; [Gordijn, Marijke C. M.] Chrono Work BV, Groningen, Netherlands	University of Groningen; University of Groningen	Jansonius, NM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	n.m.jansonius@umcg.nl	Gordijn, Marijke CM/I-5132-2013	Jansonius, Nomdo/0000-0002-6495-6568; Gordijn, Marijke/0000-0001-9521-8085	Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands	Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands(Netherlands Government)	This study was supported by Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands. This funder provided support in the form of part of the salary for author RB. MG is founder/owner of Chrono@WorkBV.MG receives financial support in the form of salary from Chrono@WorkBV.The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Agorastos A, 2013, J NEUROPSYCH CLIN N, V25, P205, DOI 10.1176/appi.neuropsych.12020030; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; Ayaki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25699; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Bierings RAJM, 2018, ACTA OPHTHALMOL, V96, P288, DOI 10.1111/aos.13695; CAMPBELL SS, 1993, SLEEP, V16, P638; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; CHIQUET C, 2004, INVEST OPHTH VIS S2, V45, P3164; Cooper HM, 2008, ARVO ANN M; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; de Zavalia N, 2011, J NEUROCHEM, V117, P904, DOI 10.1111/j.1471-4159.2011.07260.x; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Emens JS, 2009, CHRONOBIOL INT, V26, P474, DOI 10.1080/07420520902821077; Feigl B, 2011, INVEST OPHTH VIS SCI, V52, P4362, DOI 10.1167/iovs.10-7069; Lanzani MF, 2012, CHRONOBIOL INT, V29, P911, DOI 10.3109/07420528.2012.691146; Freeman EE, 2008, OPHTHALMOLOGY, V115, P233, DOI 10.1016/j.ophtha.2007.04.050; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gimenez Marina, 2016, Biology-Basel, V5, DOI 10.3390/biology5010012; Gimenez MC, 2014, CHRONOBIOL INT, V31, P690, DOI 10.3109/07420528.2014.893242; Gracitelli CPB, 2015, OPHTHALMOLOGY, V122, P1139, DOI 10.1016/j.ophtha.2015.02.030; Gracitelli CPB, 2014, INVEST OPHTH VIS SCI, V55, P7997, DOI 10.1167/iovs.14-15146; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Gutierrez P, 1997, ARCH OPHTHALMOL-CHIC, V115, P777, DOI 10.1001/archopht.1997.01100150779014; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Hiddinga AE, 1997, J SLEEP RES, V6, P156, DOI 10.1046/j.1365-2869.1997.00047.x; Hur YM, 1998, PERS INDIV DIFFER, V25, P917, DOI 10.1016/S0191-8869(98)00089-0; Hut RA, 2008, J BIOL RHYTHM, V23, P37, DOI 10.1177/0748730407311851; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jean-Louis Girardin, 2008, J Circadian Rhythms, V6, P1, DOI 10.1186/1740-3391-6-1; Kankipati L, 2011, INVEST OPHTH VIS SCI, V52, P2287, DOI 10.1167/iovs.10-6023; Kantermann T, 2015, J BIOL RHYTHM, V30, P449, DOI 10.1177/0748730415597520; KATZ J, 1991, ARCH OPHTHALMOL-CHIC, V109, P1684, DOI 10.1001/archopht.1991.01080120068028; Kawasaki A, 2007, J NEURO-OPHTHALMOL, V27, P195, DOI 10.1097/WNO.0b013e31814b1df9; Kulkarni KM, 2012, AM J OPHTHALMOL, V154, P445, DOI 10.1016/j.ajo.2012.03.030; Lazar AS, 2013, J SLEEP RES, V22, P155, DOI 10.1111/jsr.12001; Lee JA, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005704; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Middleton B, 1996, J SLEEP RES, V5, P69, DOI 10.1046/j.1365-2869.1996.d01-67.x; Mills RP, 2001, J GLAUCOMA, V10, P192, DOI 10.1097/00061198-200106000-00008; Mongrain V, 2004, J BIOL RHYTHM, V19, P248, DOI 10.1177/0748730404264365; Montolio FGJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151006; Najjar RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085837; Obara EA, 2016, INVEST OPHTH VIS SCI, V57, P4661, DOI 10.1167/iovs.16-19997; Perez-Rico C, 2010, EXP EYE RES, V91, P578, DOI 10.1016/j.exer.2010.07.012; Peters D, 2015, ACTA OPHTHALMOL, V93, P745, DOI 10.1111/aos.12839; Randler C, 2011, INT J PSYCHOL, V46, P91, DOI 10.1080/00207594.2010.518237; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; van Gestel A, 2010, EYE, V24, P1759, DOI 10.1038/eye.2010.133; Wang HZ, 2008, CHINESE MED J-PEKING, V121, P1015, DOI 10.1097/00029330-200806010-00010; Wang HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062841; Wee R, 2004, OPHTHALMOLOGY, V111, P297, DOI 10.1016/j.ophtha.2003.05.014; Woelders T, 2017, J BIOL RHYTHM, V32, P274, DOI 10.1177/0748730417696787; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zavada A, 2005, CHRONOBIOL INT, V22, P267, DOI 10.1081/CBI-200053536; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	64	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214046	10.1371/journal.pone.0214046	http://dx.doi.org/10.1371/journal.pone.0214046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921336	gold, Green Submitted, Green Published			2022-12-27	WOS:000462594000032
J	Kim, CR; Jeon, YJ; Jeong, T				Kim, Chung Reen; Jeon, Young-Jee; Jeong, Taeheum			Risk factors associated with low handgrip strength in the older Korean population	PLOS ONE			English	Article							GRIP STRENGTH; SKELETAL-MUSCLE; ALCOHOL-CONSUMPTION; ELDERLY SUBJECTS; SARCOPENIA; EXERCISE; HEALTH; WOMEN; MASS; MEN	Hand grip strength (HGS) is a means to assess health status and physical abilities indirectly. Various factors are known to be related to HGS, but data on the factors influencing HGS in the Korean population are lacking. Recently, the Korea National Health and Nutrition Examination Survey (KNHANES) conducted by the Korea Centers for Disease Control and Prevention surveyed social status, nutrition, physical status, and other medical history including HGS. This study aimed to investigate the social, physical, and individual health behavior factors associated with low HGS in the elderly Korean population. This population-based cross-sectional study was based on the 2014-2016 KNHANES. Community-dwelling Korean elderly (aged >= 65 years) were included in this survey. The relationship between HGS and socioeconomic status, nutrition, exercise, and other clinical characteristics were analyzed using multivariate logistic regression. The sample size was 3,634 (weighted: 6,006,406). Elderly men and women with low HGS showed lower body mass index, reduced physical activity and lower education level. Among elderly men, excessive carbohydrate and inadequate protein intake were observed in the low HGS group. Meanwhile, older women who did not drink alcohol and had diabetes were at higher risk of low HGS. In conclusion, various physical, nutritional, socioeconomic and comorbidity statuses were seemed to be the factors associated with HGS in Korean elderly. However, further cohort or case-control study will be necessary to determine the causal relationship of those factors and HGS.	[Kim, Chung Reen] Univ Ulsan, Coll Med, Dept Phys Med & Rehabil, Ulsan Univ Hosp, Ulsan, South Korea; [Jeon, Young-Jee; Jeong, Taeheum] Univ Ulsan, Coll Med, Dept Family Med, Ulsan Univ Hosp, Ulsan, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Jeon, YJ (corresponding author), Univ Ulsan, Coll Med, Dept Family Med, Ulsan Univ Hosp, Ulsan, South Korea.	yjjeon@uuh.ulsan.kr		Jeong, Tae Heum/0000-0001-7994-6242; Jeon, Young-Jee/0000-0002-8070-2453				Al-Obaidi S, 2014, J PHYS ACT HEALTH, V11, P1025, DOI 10.1123/jpah.2011-0357; Artaza-Artabe I, 2016, MATURITAS, V93, P89, DOI 10.1016/j.maturitas.2016.04.009; Baek Y, 2015, PUBLIC HLTH WKLY REP, V8, P75; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Cetinus E, 2005, DIABETES RES CLIN PR, V70, P278, DOI 10.1016/j.diabres.2005.03.028; Chang SS, 2000, KOREAN J SOCIOLOGY, V34, P671; Chen LK, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.05.016; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Choi E., 2017, HLTH WELFARE POLICY, V246, P22; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Lima TR, 2017, J BODYW MOV THER, V21, P401, DOI 10.1016/j.jbmt.2016.08.017; Denison HJ, 2015, CLIN INTERV AGING, V10, P859, DOI 10.2147/CIA.S55842; Giglio Bruna M, 2018, Clin Nutr Res, V7, P112, DOI 10.7762/cnr.2018.7.2.112; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Hutton Brian, 2002, J Can Dent Assoc, V68, P182; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Kawamoto R, 2018, INT J GERONTOL, V12, P294, DOI 10.1016/j.ijge.2018.03.005; Kerstetter JE, 2003, J NUTR, V133, p855S, DOI 10.1093/jn/133.3.855S; Kim CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195485; Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kwon YJ, 2017, MENOPAUSE, V24, P1022, DOI 10.1097/GME.0000000000000879; Lee MJ, 1998, KOREAN J SOCIOLOGY, V32, P63; Lee Sun Jae, 2014, INT J SOCIAL SCI HUM, V4, P242; Lenardt MH, 2014, REV ESC ENFERM USP, V48, P1004, DOI 10.1590/S0080-623420140000700007; Lenardt MH, 2016, ESCOLA A NERY, V20; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Ministry of Health and Welfare (KR), 2016, KOR NUTR SOC DIET RE; Ministry of Health and Welfare of Korea Korea Centers for Disease Control and Prevention., 2019, 2017 KOR HLTH STAT; Miyazaki Ryo, 2016, J Clin Med Res, V8, P848; Murakami M, 2015, GERIATR GERONTOL INT, V15, P1007, DOI 10.1111/ggi.12399; Nofuji Y, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.11.003; Quan S, 2013, EPIDEMIOL HEALTH, V35, DOI 10.4178/epih/e2013001; Robert S, 1996, J AGING HEALTH, V8, P359, DOI 10.1177/089826439600800304; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rural Development Administration National Academy of Agricultural Science, 2011, FOOD COMP TABL; Lino VTS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166373; Sayer AA, 2006, AM J EPIDEMIOL, V164, P665, DOI 10.1093/aje/kwj255; Shafiee G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0302-x; Solerte SB, 2008, AM J CARDIOL, V101, p69E, DOI 10.1016/j.amjcard.2008.03.004; Stenholm S, 2012, J AM GERIATR SOC, V60, P77, DOI 10.1111/j.1532-5415.2011.03779.x; Takahashi M, 2018, GERIATR GERONTOL INT, V18, P915, DOI 10.1111/ggi.13279; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V55, pE9, DOI 10.1016/j.archger.2012.06.015; Verreijen AM, 2015, AM J CLIN NUTR, V101, P279, DOI 10.3945/ajcn.114.090290; Yamada M, 2015, J AM MED DIR ASSOC, V16, P654, DOI 10.1016/j.jamda.2015.02.017	49	26	27	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214612	10.1371/journal.pone.0214612	http://dx.doi.org/10.1371/journal.pone.0214612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921399	gold, Green Submitted, Green Published			2022-12-27	WOS:000462594000098
J	Paixao, ES; Campbell, OMR; Rodrigues, LC; Teixeira, MG; Costa, MDN; Brickley, EB; Harron, K				Paixao, Enny S.; Campbell, Oona M. R.; Rodrigues, Laura C.; Teixeira, Maria Gloria; Costa, Maria da Conceicao N.; Brickley, Elizabeth B.; Harron, Katie			Validating linkage of multiple population-based administrative databases in Brazil	PLOS ONE			English	Article							RECORD LINKAGE; SAO-PAULO; ACCURACY; ABORTION; DEATHS	Background Linking routinely-collected data provides an opportunity to measure the effects of exposures that occur before birth on maternal, fetal and infant outcomes. High quality linkage is a prerequisite for producing reliable results, and there are specific challenges in mother-baby linkage. Using population-based administrative databases from Brazil, this study aimed to estimate the accuracy of linkage between maternal deaths and birth outcomes and dengue notifications, and to identify potential sources of bias when assessing the risk of maternal death due to dengue in pregnancy. Methods We identified women with dengue during pregnancy in a previously linked dataset of dengue notifications in women who had experienced a live birth or stillbirth during 2007-2012. We then linked this dataset with maternal death records probabilistically using maternal name, age and municipality. We estimated the accuracy of the linkage, and examined the characteristics of false-matches and missed-matches to identify any sources of bias. Results Of the 10,259 maternal deaths recorded in 2007-2012, 6717 were linked: 5444 to a live birth record, 1306 to a stillbirth record, and 33 to both a live and stillbirth record. After identifying 2620 missed-matches and 124 false-matches, our estimated sensitivity was 72%, specificity was 88%, and positive predictive value was 98%. Linkage errors were associated with maternal education and self-identified race; women with more than 7 years of education or who self-declared as Caucasian were more likely to link. Dengue status was not associated with linkage error. Conclusion Despite not having unique identifiers to link mothers and birth outcomes, we demonstrated a high standard of linkage, with sensitivity and specificity values comparable to previous literature. Although there were no differences in the characteristics of dengue cases missed or included in our linked dataset, linkage error occurred disproportionally by some social demographic characteristics, which should be taken into account in future analyses.	[Paixao, Enny S.; Campbell, Oona M. R.; Rodrigues, Laura C.; Brickley, Elizabeth B.; Harron, Katie] London Sch Hyg & Trop Med, London, England; [Teixeira, Maria Gloria; Costa, Maria da Conceicao N.] Inst Saude Coletiva, Rua Basilio Gama S-N, Salvador, BA, Brazil	University of London; London School of Hygiene & Tropical Medicine	Paixao, ES (corresponding author), London Sch Hyg & Trop Med, London, England.	enny.cruz@lshtm.ac.uk	RODRIGUES, LAURA CUNHA/AAO-4130-2021; Teixeira, Maria Gloria L C/G-4808-2012; Brickley, Elizabeth/U-3625-2017	Teixeira, Maria Gloria L C/0000-0003-3318-3408; Brickley, Elizabeth/0000-0003-0280-2288; Harron, Katie/0000-0002-3418-2856	National Council for Scientific and Technological Development(CNPq-Brazil) [205427/2016-6]; European Union's Horizon 2020 research and innovation program under Zika-PLAN grant [734584]; Wellcome Trust [103975/Z/14/Z]	National Council for Scientific and Technological Development(CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Union's Horizon 2020 research and innovation program under Zika-PLAN grant; Wellcome Trust(Wellcome TrustEuropean Commission)	EP funded by National Council for Scientific and Technological Development(CNPq-Brazil, grant number 205427/2016-6)-http://cnpq.br/bolsas-noexterior1; LCR is partially funded by the European Union's Horizon 2020 research and innovation program under Zika-PLAN grant agreement No. 734584-https://ec.europa.eu/programmes/horizon2020/; KH is funded by the Wellcome Trust (grant number 103975/Z/14/Z)https://wellcome.ac.uk/funding/sirhenry-wellcome-postdoctoral-fellowships.However the funders of this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. There was no additional external funding for this study.	Adams MM, 1997, AM J EPIDEMIOL, V145, P339; Beauchamp A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-42; Brazil, 2013, B EPID OB MAT; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Fusco CLB, 2012, CAD SAUDE PUBLICA, V28, P709, DOI 10.1590/S0102-311X2012000400010; Garbe E, 2011, PHARMACOEPIDEM DR S, V20, P258, DOI 10.1002/pds.2038; Borsari CMG, 2013, REV BRAS GINECOL OBS, V35, P27, DOI 10.1590/S0100-72032013000100006; Gilbert Ruth, 2018, J Public Health (Oxf), V40, P191, DOI 10.1093/pubmed/fdx037; Harron K, GUIDE EVALUATING LIN; Harron K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164667; Homaira N, 2016, EPIDEMIOL INFECT, V144, P1612, DOI 10.1017/S0950268815003015; Vieira MSM, 2016, MATERN CHILD HLTH J, V20, P1634, DOI 10.1007/s10995-016-1962-8; Moore CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103690; Newgard CD, 2006, ACAD EMERG MED, V13, P69, DOI 10.1197/j.aem.2005.07.029; O'Leary CM, 2013, BIRTH DEFECTS RES A, V97, P497, DOI 10.1002/bdra.23142; Paixao ES, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0506-5; Paixao ES, SYMPTOMATIC DENGUE I; Fonseca MGP, 2010, CAD SAUDE PUBLICA, V26, P1431, DOI 10.1590/S0102-311X2010000700022; Reichman NE, 2001, ANN EPIDEMIOL, V11, P186, DOI 10.1016/S1047-2797(00)00209-X; Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495; Swart A, 2015, AUST NZ J PUBL HEAL, V39, P141, DOI 10.1111/1753-6405.12287; William EY., 2005, STAT RES DIV, P3905	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214050	10.1371/journal.pone.0214050	http://dx.doi.org/10.1371/journal.pone.0214050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921353	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000033
J	Pichitpunpong, C; Thongkorn, S; Kanlayaprasit, S; Yuwattana, W; Plaingam, W; Sangsuthum, S; Aizat, WM; Baharum, SN; Tencomnao, T; Hu, VW; Sarachana, T				Pichitpunpong, Chatravee; Thongkorn, Surangrat; Kanlayaprasit, Songphon; Yuwattana, Wasana; Plaingam, Waluga; Sangsuthum, Siriporn; Aizat, Wan Mohd; Baharum, Syarul Nataqain; Tencomnao, Tewin; Hu, Valerie Wailin; Sarachana, Tewarit			Phenotypic subgrouping and multi-omics analyses reveal reduced diazepam-binding inhibitor (DBI) protein levels in autism spectrum disorder with severe language impairment	PLOS ONE			English	Article							GENE-EXPRESSION; PERSONALIZED TREATMENT; PROTEOMIC ANALYSIS; OXIDATIVE STRESS; FETUIN-A; CHILDREN; BRAIN; IDENTIFICATION; DYSFUNCTION; BIOMARKERS	Background The mechanisms underlying autism spectrum disorder (ASD) remain unclear, and clinical biomarkers are not yet available for ASD. Differences in dysregulated proteins in ASD have shown little reproducibility, which is partly due to ASD heterogeneity. Recent studies have demonstrated that subgrouping ASD cases based on clinical phenotypes is useful for identifying candidate genes that are dysregulated in ASD subgroups. However, this strategy has not been employed in proteome profiling analyses to identify ASD biomarker proteins for specific subgroups. Methods We therefore conducted a cluster analysis of the Autism Diagnostic Interview-Revised (ADI-R) scores from 85 individuals with ASD to predict subgroups and subsequently identified dysregulated genes by reanalyzing the transcriptome profiles of individuals with ASD and unaffected individuals. Proteome profiling of lymphoblastoid cell lines from these individuals was performed via 2D-gel electrophoresis, and then mass spectrometry. Disrupted proteins were identified and compared to the dysregulated transcripts and reported dysregulated proteins from previous proteome studies. Biological functions were predicted using the 16 Ingenuity Pathway Analysis (IPA) program. Selected proteins were also analyzed by Western blotting. Results The cluster analysis of ADI-R data revealed four ASD subgroups, including ASD with severe language impairment, and transcriptome profiling identified dysregulated genes in each subgroup. Screening via proteome analysis revealed 82 altered proteins in the ASD subgroup with severe language impairment. Eighteen of these proteins were further identified by nano-LC-MS/MS. Among these proteins, fourteen were predicted by IPA to be associated with neurological functions and inflammation. Among these proteins, diazepam-binding inhibitor (DBI) protein was confirmed by Western blot analysis to be expressed at significantly decreased levels in the ASD subgroup with severe language impairment, and the DBI expression levels were correlated with the scores of several ADI-R items. Conclusions By subgrouping individuals with ASD based on clinical phenotypes, and then performing an integrated transcriptome-proteome analysis, we identified DBI as a novel candidate protein for ASD with severe language impairment. The mechanisms of this protein and its potential use as an ASD biomarker warrant further study.	[Pichitpunpong, Chatravee] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, MSc Program Clin Biochem & Mol Med, Bangkok, Thailand; [Thongkorn, Surangrat; Kanlayaprasit, Songphon] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, PhD Program Clin Biochem & Mol Med, Bangkok, Thailand; [Yuwattana, Wasana] Chulalongkorn Univ, Fac Allied Hlth Sci, BSc Program Med Technol, Bangkok, Thailand; [Plaingam, Waluga] Rangsit Univ, Coll Oriental Med, Pathum Thani, Thailand; [Sangsuthum, Siriporn] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok, Thailand; [Aizat, Wan Mohd; Baharum, Syarul Nataqain] Univ Kebangsaan Malaysia, Inst Syst Biol INBIOSIS, Bangi, Selangor, Malaysia; [Tencomnao, Tewin; Sarachana, Tewarit] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand; [Hu, Valerie Wailin] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC USA	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Rangsit University; Chulalongkorn University; Universiti Kebangsaan Malaysia; Chulalongkorn University; George Washington University	Sarachana, T (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand.	tewarit.sa@chula.ac.th	Baharum, Syarul Nataqain/H-1022-2016; Aizat, Wan Mohd/P-5204-2016	Baharum, Syarul Nataqain/0000-0001-8376-1224; Aizat, Wan Mohd/0000-0001-8115-9774; Tencomnao, Tewin/0000-0003-4177-2165	Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [CU59-004-HR]; 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund) [GCUGR1125601057M 533, GCUGR1125601056M 53-2]; Graduate School, Chulalongkorn University; Faculty of Allied Health Sciences, Chulalongkorn University; Thailand Research Fund [PHD/0029/2561]; 100th Anniversary Chulalongkorn University Fund; NIEHS [R21 ES023061, R21 ES028124]; National Institute of Mental Health [1U24 MH081810]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES028124] Funding Source: NIH RePORTER	Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund); Graduate School, Chulalongkorn University(Chulalongkorn University); Faculty of Allied Health Sciences, Chulalongkorn University(Chulalongkorn University); Thailand Research Fund(Thailand Research Fund (TRF)); 100th Anniversary Chulalongkorn University Fund; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (CU59-004-HR) granted to TS. CP, ST, and SK are graduate students in the M.Sc. and Ph.D. Programs in Clinical Biochemistry and Molecular Medicine, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University. CP and ST were financially supported by the 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund: CP GCUGR1125601057M 53-3; ST GCUGR1125601056M 53-2) and received additional financial support from a "Scholarship from the Graduate School Chulalongkorn University to commemorate the 72nd anniversary of His Majesty King Bhumibala Aduladeja". CP was also financially supported by the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (CU59-004-HR) as a research assistant. ST received "The Overseas Research Experience Scholarship for Graduate Students" from the Graduate School and Faculty of Allied Health Sciences, Chulalongkorn University, and also received the Royal Golden Jubilee Ph.D. Programme Scholarship (Grant No. PHD/0029/2561) by Thailand Research Fund. SK was supported by The 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship. VWH is supported by NIEHS grants R21 ES023061 and R21 ES028124.; We thank Ms. Kanlayaphat Hussem, Mr. Phanuwat Chanasikunphithaya, Ms. Sineemas Naokeaw, Ms. Thanida Tohthong, and Mr. Tiradej Asavachamnan for their help regarding LCL culture. We also thank Ms. Chayanin Tangsuwannasri and Mr. Thanit Saeliw for their help with image analysis. This research was supported by the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (CU59-004-HR) granted to TS. CP, ST, and SK are graduate students in the M.Sc. and Ph.D. Programs in Clinical Biochemistry and Molecular Medicine, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University. CP and ST were financially supported by the 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund: CP GCUGR1125601057M 533; ST GCUGR1125601056M 53-2) and received additional financial support from a "Scholarship from the Graduate School Chulalongkorn University to commemorate the 72nd anniversary of His Majesty King Bhumibala Aduladeja". CP was also financially supported by the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (CU59-004-HR) as a research assistant. ST received "The Overseas Research Experience Scholarship for Graduate Students" from the Graduate School and Faculty of Allied Health Sciences, Chulalongkorn University, and also received the Royal Golden Jubilee Ph.D. Programme Scholarship (Grant No. PHD/0029/2561) by the Thailand Research Fund. SK was supported by the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship. VWH is supported by NIEHS grants R21 ES023061 and R21 ES028124. We also gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium. and the participating AGRE families. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported in part by grant 1U24 MH081810 from the National Institute of Mental Health to ClaraMLajonchere (PI). *The AGRE Consortium: Dan Geschwind, MD, PhD, UCLA, Los Angeles, CA; Maja Bucan, PhD, University of Pennsylvania, Philadelphia, PA; W Ted Brown, MD, PhD, FACMG, NYS Institute for Basic Research in Developmental Disabilities, Long Island, NY; RitaMCantor, PhD, UCLA School of Medicine, Los Angeles, CA; John N Constantino, MD, Washington University School of Medicine, St Louis, MO; T Conrad Gilliam, PhD, University of Chicago, Chicago, IL; Martha Herbert, MD, PhD, Harvard Medical School, Boston, MA; Clara Lajonchere, PhD, Cure Autism Now, Los Angeles, CA; David H Ledbetter, PhD, Emory University, Atlanta, GA; Christa Lese-Martin, PhD, Emory University, Atlanta, GA; Janet Miller, JD, PhD, Cure Autism Now, Los Angeles, CA; Stanley F Nelson, MD, UCLA School of Medicine, Los Angeles, CA; Gerard D Schellenberg, PhD, University of Washington, Seattle, WA; Carol A Samango-Sprouse, EdD, George Washington University, Washington, DC; Sarah Spence, MD, PhD, UCLA, Los Angeles, CA; Matthew State, MD, PhD, Yale University, New Haven, CT; and Rudolph E Tanzi, PhD, Massachusetts General Hospital, Boston, MA.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Akbay EA, 2014, GENE DEV, V28, P479, DOI 10.1101/gad.231233.113; ALHO H, 1988, P NATL ACAD SCI USA, V85, P7018, DOI 10.1073/pnas.85.18.7018; Allen-Brady K, 2009, MOL PSYCHIATR, V14, P590, DOI 10.1038/mp.2008.14; Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Baio J, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6706a1; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bolte S, 2018, CELLULAR MOL LIFE SC, P1; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Broek JAC, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-41; Castagnola M, 2008, J PROTEOME RES, V7, P5327, DOI 10.1021/pr8004088; Chen R, 2011, PEDIATR RES, V69, p63R, DOI 10.1203/PDR.0b013e318212c2b3; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; Cortelazzo A, 2016, PROTEOM CLIN APPL, V10, P1103, DOI 10.1002/prca.201500076; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Elsas J, 2013, DEV NEUROBIOL, V73, P354, DOI 10.1002/dneu.22064; Feng CY, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9138-0; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; Hollis F, 2017, CURR OPIN NEUROBIOL, V45, P178, DOI 10.1016/j.conb.2017.05.018; Hu V. W., 2013, N AM J MED SCI BOSTO, V6; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Hu VW, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-7; Hu VW, 2013, FUTUR NEUROL, V8, P29, DOI 10.2217/FNL.12.83; Hu VW, 2012, DIS MARKERS, V33, P277, DOI [10.1155/2012/835728, 10.3233/DMA-2012-0916]; Hu VW, 2011, PHARMACOGENOMICS, V12, P1235, DOI [10.2217/pgs.11.94, 10.2217/PGS.11.94]; Hu VW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019067; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; Krakowiak P, 2015, BIOL PSYCHIAT; Li QR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00120; Manzi B, 2008, J CHILD NEUROL, V23, P307, DOI 10.1177/0883073807308698; Moosa A, 2018, HORM BEHAV, V101, P13, DOI 10.1016/j.yhbeh.2017.10.003; Mori K, 2011, RECENT PATENTS ENDOC, V5, P124, DOI 10.2174/187221411799015372; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Plaingam Waluga, 2017, J Tradit Complement Med, V7, P538, DOI 10.1016/j.jtcme.2017.01.002; Pramparo T, 2015, JAMA PSYCHIAT, V72, P386, DOI 10.1001/jamapsychiatry.2014.3008; Ramsey JM, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-27; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeliw T, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0213-9; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-39; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Shen C, 2011, J MOL NEUROSCI, V43, P443, DOI 10.1007/s12031-010-9463-5; Shen L, 2017, PROTEOMICS CLIN APPL; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Szoko N, 2017, AUTISM RES, V10, P1460, DOI 10.1002/aur.1803; Talebizadeh Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067569; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Tangsuwansri C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201071; Thongkorn S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39386-w; Ujjainwala AL, 2017, GENES BRAIN BEHAV; van Tilborg E, 2018, GLIA, V66, P78, DOI 10.1002/glia.23216; Vorstman JAS, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.4; Wetie AGN, 2015, J CELL MOL MED, V19, P2664, DOI 10.1111/jcmm.12658; Wetie AGN, 2015, AUTISM RES, V8, P338, DOI 10.1002/aur.1450; Wetie AGN, 2014, ELECTROPHORESIS, V35, P2046, DOI 10.1002/elps.201300370; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Yang L., 2016, J PROTEOM BIOINFORM, VS14, P004, DOI [10.4172/jpb.S14-004, DOI 10.4172/JPB.S14-004]; Zerbo O, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-113; Zoroglu SS, 2004, EUR ARCH PSY CLIN N, V254, P143, DOI 10.1007/s00406-004-0456-7	70	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214198	10.1371/journal.pone.0214198	http://dx.doi.org/10.1371/journal.pone.0214198			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921354	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000039
J	Sun, JC; Cheng, S; Ma, J; Xiong, KW; Su, M; Hu, WD				Sun, Jicheng; Cheng, Shan; Ma, Jin; Xiong, Kaiwen; Su, Miao; Hu, Wendong			Assessment of the static upright balance index and brain blood oxygen levels as parameters to evaluate pilot workload	PLOS ONE			English	Article							FATIGUE ASSESSMENT; POSTURAL CONTROL; PERFORMANCE; ACTIVATION	Objective To investigate the potential for static upright balance function and brain-blood oxygen parameters to evaluate pilot workload. Methods Phase 1: The NASA Task Load Index (NASA-TLX) was used to compare the workloads of real flights with flight simulator simulated flight tasks in 15 pilots (Cohort 1). Phase 2: To determine the effects of workload, 50 cadets were divided equally into simulated flight task load (experimental) and control groups (Cohort 2). The experimental group underwent 2 h of simulated flight tasks, while the control group rested for 2 h. Their static upright balance function was evaluated using balance index-1 (BI-1), before and after the tasks, with balance system posturography equipment and cerebral blood oxygen parameters monitored with near infrared spectroscopy (NIRS) in real time. Sternberg dual-task and reaction time tests were performed in the experimental and control groups before and after the simulated flight tasks. Results (Phase1) There was a significant correlation between the workload caused by real flight and simulated flight tasks (P<0.01), indicating that NASA-TLX scales were also a tool for measuring workloads of the stimulated flight tasks. (Phase 2) For the simulated flight task experiments, the NASA-TLX total scores were significantly different between the two groups (P<0.001) and (pre-to-post) changes of the BI-1 index were greater in the experimental group than in controls (P<0.001). The cerebral blood oxygen saturation levels (rsO(2)) (P<0.01) and Delta Hb reductions (P<0.05) were significantly higher in the experimental, compared to the control group, during the simulated flight task. In contrast to the control group the error rates (P = 0.002) and accuracy (P<0.001) changed significantly in the experimental group after the simulated flight tasks. Conclusions The simulated flight task model could simulate the real flight task load and static balance and NIRS were useful for evaluating pilots' workload/fatigue.	[Sun, Jicheng; Cheng, Shan; Ma, Jin; Xiong, Kaiwen; Su, Miao; Hu, Wendong] Fourth Mil Med Univ, Deparment Aerosp Med, Xian, Shaanxi, Peoples R China	Air Force Military Medical University	Ma, J; Hu, WD (corresponding author), Fourth Mil Med Univ, Deparment Aerosp Med, Xian, Shaanxi, Peoples R China.	doatea@fmmu.com; huwend@fmmu.edu.cn			National Natural Science Foundation of China [U1733101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Grant No. U1733101 to JM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong WJ, 2004, MED SCI SPORTS EX S1, V35; Bennett SA, 2012, AVIAT FOCUS J AERONA, V3; Borghini G, 2014, NEUROSCI BIOBEHAV R, V44, P58, DOI 10.1016/j.neubiorev.2012.10.003; CAANL, 2008, CIV AV AUTH TRANSP W; Caldwell JA, 2009, AVIAT SPACE ENVIR MD, V80, P29, DOI 10.3357/ASEM.2435.2009; Caron RR, 2013, J BIOMECH, V46, P70, DOI 10.1016/j.jbiomech.2012.10.004; Chen S, 2015, PROG MOD BIOMED, V15, P1735; Chen S, 2018, GAIT POSTURE, V63, P97, DOI 10.1016/j.gaitpost.2018.04.037; Cheng S, 2014, PROG MOD BIOMED, V52, P1110; Cheng S, 2018, AEROSP MED HUM PERF, V89, P961, DOI 10.3357/AMHP.5128.2018; Dey A, 2010, ERGONOMICS, V53, P848, DOI 10.1080/00140139.2010.489960; Eoh HJ, 2005, INT J IND ERGONOM, V35, P307, DOI 10.1016/j.ergon.2004.09.006; Estevan I, 2018, MOTOR CONTROL, V22, P425, DOI 10.1123/mc.2017-0063; Fallgatter AJ, 1998, EUR ARCH PSY CLIN N, V248, P245, DOI 10.1007/s004060050045; Gateau T, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00187; Gergelyfi M, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015,00176, 10.3389/fnbeh.2015.00176]; HAGBERG M, 1981, J APPL PHYSIOL, V51, P1; Han J, 2014, CHIN J BIOMED ENG; Han QY, 2014, MED PHYS, V41, DOI 10.1118/1.4896113; Hart SG., 2006, PROC HUM FACTORS ERG, V50, P904, DOI [10.1177/154193120605000909, DOI 10.1177/154193120605000909]; Herath P, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00483; Huang X, 2013, CHIN NURS RES, V15, P2749; Hursh SR, 2004, AVIAT SPACE ENVIR MD, V75, pA44; Jagannath M, 2014, APPL ERGON, V45, P1140, DOI 10.1016/j.apergo.2014.02.001; Jung CM, 2011, J SLEEP RES, V20, P348, DOI 10.1111/j.1365-2869.2010.00877.x; Katerndahl D A, 1993, Fam Pract Res J, V13, P81; Keeley DW, 2014, J SPORT MED PHYS FIT, V54, P118; Keramidas ME, 2018, EUR J APPL PHYSIOL, V118, P1373, DOI 10.1007/s00421-018-3869-0; Li ZY, 2009, EUR J APPL PHYSIOL, V107, P281, DOI 10.1007/s00421-009-1122-6; LIGHT A I, 1989, Current Surgery, V46, P29; Longo A, 2018, EXP BRAIN RES, V236, P1611, DOI 10.1007/s00221-018-5241-3; Ma J, 2009, J INT MED RES, V37, P1311, DOI 10.1177/147323000903700506; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Meeusen R, 2006, SPORTS MED, V36, P881, DOI 10.2165/00007256-200636100-00006; Michielsen HJ, 2003, J PSYCHOSOM RES, V54, P345, DOI 10.1016/S0022-3999(02)00392-6; Monjo F, 2017, HUM MOVEMENT SCI, V54, P1, DOI 10.1016/j.humov.2017.03.001; Morad Y, 2007, AVIAT SPACE ENVIR MD, V78, P859; Ochi G, 2018, NEUROIMAGE, V171, P75, DOI 10.1016/j.neuroimage.2017.12.091; Reid G.B., 1988, ADV PSYCHOL, V52, p185?218, DOI DOI 10.1016/S0166-4115(08)62387-0; Song G, 2015, CHIN J REHABIL THEOR; Takagi S, 2013, ADV EXP MED BIOL, V789, P157, DOI 10.1007/978-1-4614-7411-1_22; Tan W, 2014, 2014 2 INT C SYST IN; Vanicek N, 2013, JOVE-J VIS EXP, DOI 10.3791/51077; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Wang B, 2012, SPACE MED MED ENG, V25; Watson DW, 2001, 2001 PEOPL CONTR 2 I; Williamson A, 2011, ACCIDENT ANAL PREV, V43, P498, DOI 10.1016/j.aap.2009.11.011; Xie X, 2010, SHANDONG MED J, V50, P97	48	1	2	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214277	10.1371/journal.pone.0214277	http://dx.doi.org/10.1371/journal.pone.0214277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921375	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000048
J	Jubilee, M; Park, FJ; Chipango, K; Pule, K; Machinda, A; Taruberekera, N				Jubilee, Makhahliso; Park, Faith Jiyeong; Chipango, Knowledge; Pule, Kenoakae; Machinda, Albert; Taruberekera, Noah			HIV index testing to improve HIV positivity rate and linkage to care and treatment of sexual partners, adolescents and children of PLHIV in Lesotho	PLOS ONE			English	Article							WOMEN	Despite years of HIV testing and other interventions, Lesotho continues to experience an incredibly high HIV burden. Prevalence of HIV among children ages 0-14 years is at 2.1% and 25.6% among adults ages 15-59 years. Among adults living with HIV, 77.2% know their status, 90.2% of those with known HIV positive status are currently receiving ART and 88.3% are virally suppressed. In order to identify adults, adolescents and children at high risk of HIV infection, Population Services International (PSI)/Lesotho with support from the Centers for Disease Control and Prevention (CDC) introduced the HIV Index testing model in 2015. PLHIV recruited for index testing, were accessed through health facilities and community testing at PSI New Start channels in five districts. Consenting index clients received home visits for HIV testing of their biological children and sexual partners with unknown status. Routine monitoring of data gathered between May 2015 and November 2017 was analyzed to assess feasibility of this approach. For HIV index testing, 49.2% of children below 15 years and 37.3% of adolescents ages 15-19 were first time testers while 18.8% of all adults aged 20 years and above tested were testing for the first time. Higher HIV positivity rates among clients tested through the HIV index testing model across all age groups in comparison to other HIV testing models were statistically significant. Among children ages 2-14 years, the HIV positivity rate was 1.4%, adolescents ages 15-19 years had a positivity rate of 2.4% and adults ages 20 years and above had a positivity rate of 17.6%. Linkage rates of 92%, 73% and 72% for children, adolescents and adults, respectively, achieved with the HIV index testing model were higher than linkage rates observed with other HIV testing models. Results indicate that testing of biological children and sexual partners utilizing the HIV index testing model can be viable to identify and link children, adolescents and adults into care and treatment.	[Jubilee, Makhahliso; Chipango, Knowledge; Pule, Kenoakae; Machinda, Albert] Populat Serv Int, Maseru, Lesotho; [Park, Faith Jiyeong; Taruberekera, Noah] Populat Serv Int, Johannesburg, South Africa		Jubilee, M (corresponding author), Populat Serv Int, Maseru, Lesotho.	mjubilee@psi.co.ls		Taruberekera, Noah/0000-0001-6522-7167	Center for Disease and Prevention [5-NU2GGH002005-02-00]	Center for Disease and Prevention	Center for Disease and Prevention funded the implementation of the program under grant 5-NU2GGH002005-02-00. Center for Disease and Prevention Country Director and Activity Manager reviewed and provided comments for decision to publish. Machinda L. received the funding.	[Anonymous], 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093734; Betancourt Theresa S, 2010, J Int AIDS Soc, V13 Suppl 2, pS2, DOI 10.1186/1758-2652-13-S2-S2; Croxford S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192403; DeGennaro V, 2009, GLOB PUBLIC HEALTH, V4, P386, DOI 10.1080/17441690802638725; El-Sadr WM, 2004, INT AIDS C BANGK THA, DOI [10.1056/NEJMoa0800971, DOI 10.1056/NEJMOA0800971]; Kahabuka C, 2017, AIDS BEHAV, V21, P2551, DOI 10.1007/s10461-017-1750-5; Lewis Kulzer Jayne, 2012, J Int AIDS Soc, V15, P8, DOI 10.1186/1758-2652-15-8; Li Li, 2008, Fam Syst Health, V26, P431; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Ministry of Health, 2016, NAT EST PROJ; Rwemisisi J, 2008, HEALTH POLICY PLANN, V23, P36, DOI 10.1093/heapol/czm040; Sheehy M, 2009, FAMILY CTR APPROACH; The Foundation of Professional Development, 2017, HTS MOD; Tonwe-Gold B, 2009, TROP MED INT HEALTH, V14, P204, DOI 10.1111/j.1365-3156.2008.02182.x; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; U. S. Embassy Maseru, 2017, NAT SURV SHOWS LES R; van Rooyen H, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00154; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WILLIAMS RJ, 1991, J COUNS DEV, V69, P423, DOI 10.1002/j.1556-6676.1991.tb01538.x; World Health Organization, 2018, TREATM CAR	20	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0212762	10.1371/journal.pone.0212762	http://dx.doi.org/10.1371/journal.pone.0212762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917167	gold, Green Published, Green Submitted			2022-12-27	WOS:000462465800015
J	Chen, W; Chen, CS; Yang, P; Bi, SY; Liu, J; Xia, MR; Lin, QX; Ma, N; Li, N; He, Y; Zhang, JC; Wang, YW; Wang, WJ				Chen, Wen; Chen, Chuansheng; Yang, Pin; Bi, Suyu; Liu, Jin; Xia, Mingrui; Lin, Qixiang; Ma, Na; Li, Na; He, Yong; Zhang, Jiacai; Wang, Yiwen; Wang, Wenjing			Long-term Chinese calligraphic handwriting reshapes the posterior cingulate cortex: A VBM study	PLOS ONE			English	Article							BRAIN; MINDFULNESS; MEDITATION; INHIBITION; RESPONSES; ABILITY; TASK; FMRI; FDR; CCH	As a special kind of handwriting with a brush, Chinese calligraphic handwriting (CCH) requires a large amount of practice with high levels of concentration and emotion regulation. Previous studies have showed that long-term CCH training has positive effects physically (induced by handwriting activities) and psychologically (induced by the state of relaxation and concentration), the latter of which is similar to the effects of meditation. The aim of this study was to investigate the long-term CCH training effect on anxiety and attention, as well as brain structure. Participants were 32 individuals who had at least five years of CCH experience and 44 controls. Results showed that CCH training benefited individuals' selective and divided attention but did not decrease their anxiety level. Moreover, the VBM analysis showed that long-term CCH training was mainly associated with smaller grey matter volumes (GMV) in the right precuneus/posterior cingulate cortex (PCC). No brain areas showed larger GMV in the CCH group than the control group. Using two sets of regions of interest (ROIs), one related to meditation and the other to handwriting, ROI analysis showed significant differences between the CCH and the control group only at the meditation-related ROIs, not at the handwriting-related ROIs. Finally, for the whole sample, the GMV of both the whole brain and the PCC were negatively correlated with selective attention and divided attention. The present study was cross-sectional and had a relatively small sample size, but its results suggested that CCH training might benefit attention and influence particular brain structure through mental processes such as meditation.	[Chen, Wen] Beijing Normal Univ, Adv Innovat Ctr Future Educ, Beijing, Peoples R China; [Chen, Wen; Liu, Jin; Xia, Mingrui; Lin, Qixiang; Ma, Na; Li, Na; He, Yong; Wang, Wenjing] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Chen, Wen; Liu, Jin; Xia, Mingrui; Lin, Qixiang; He, Yong; Wang, Wenjing] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Chen, Wen; Zhang, Jiacai] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol Sci, Irvine, CA USA; [Yang, Pin] Natl Palace Museum, Conservat Dept, Beijing, Peoples R China; [Bi, Suyu; Wang, Yiwen] Beijing Foreign Studies Univ, Sch Int Journalism & Commun, Beijing, Peoples R China; [Bi, Suyu] Beijing Normal Univ, Sch Arts & Media, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University; University of California System; University of California Irvine; Beijing Foreign Studies University; Beijing Normal University	Wang, WJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Wang, WJ (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Zhang, JC (corresponding author), Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China.; Wang, YW (corresponding author), Beijing Foreign Studies Univ, Sch Int Journalism & Commun, Beijing, Peoples R China.	jiacai.zhang@bnu.edu.cn; wyiw@sina.com; wangwenjing@bnu.edu.cn	Lin, Qixiang/GXG-3598-2022; Wang, Yixuan/GZK-6559-2022; Wang, Yijun/GXW-1763-2022; Wang, Yin/HCI-9352-2022; wang, yixuan/GXW-2866-2022; wang, yi/GVT-8516-2022; He, Yong/Q-5756-2018; Xia, Mingrui/J-3267-2019	Lin, Qixiang/0000-0002-1718-6855; Xia, Mingrui/0000-0003-4615-9132; Chen, Wen/0000-0001-7563-4495; He, Yong/0000-0002-7039-2850; Chen, Chuansheng/0000-0002-8224-1005	Ministry of Education of the People's Republic of China [14YJAZH081]; National Natural Science Foundation of the People's Republic of China [31221003]	Ministry of Education of the People's Republic of China(Ministry of Education, China); National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	This study was supported by the 14YJAZH081 (received by WW) Project of the Ministry of Education of the People's Republic of China (http://en.moe.gov.cn/) and the No. 31221003 (received by YH) Project of the National Natural Science Foundation of the People's Republic of China (http://www.nsfc.gov.cn/).	Azevedo P, 2016, MOVEMENT DISORD, V31, pS360; Chen W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170660; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Compton RJ, 2000, COGNITION EMOTION, V14, P401, DOI 10.1080/026999300378897; Deng Y, 2008, NEUROPSYCHOLOGIA, V46, P1864, DOI 10.1016/j.neuropsychologia.2007.09.010; Doche E, 2017, J NEURORADIOLOGY, V44, P158, DOI 10.1016/j.neurad.2016.10.001; Garrison KA, 2015, COGN AFFECT BEHAV NE, V15, P712, DOI 10.3758/s13415-015-0358-3; Gartenschlager M, 2017, MINDFULNESS, V8, P1009, DOI 10.1007/s12671-017-0677-2; Guo Y, 2010, BRAIN LANG, V115, P113, DOI 10.1016/j.bandl.2010.08.001; Hue MT, 2009, PASTOR CARE EDUC, V27, P63, DOI 10.1080/02643940902733886; Kang DH, 2013, SOC COGN AFFECT NEUR, V8, P27, DOI 10.1093/scan/nss056; Kao H, 2000, INT J PSYCHOL, V35, P302; Kao HSR, 2006, INT J PSYCHOL, V41, P282, DOI 10.1080/00207590544000059; Kao HSR, 2018, NEUROPSYCH DIS TREAT, V14, P407, DOI 10.2147/NDT.S147753; Kao HSR, 2014, PSYCHOL RES BEHAV MA, V7, P47, DOI 10.2147/PRBM.S55743; Kao HSR, 2010, ASIA PAC J COUNS PSY, V1, P55, DOI 10.1080/21507680903570334; KAO HSR, 1992, INT J PSYCHOL, V27, P138; Kao HSR, 2000, VISUAL SPATIAL FEATU; Kao HSR, 1986, MODES HANDWRITING CO; Kao HSR, 1986, EXPLORATORY STUDY EE; Kao HSR, 1989, PSYCHOPHYSIOLOGICAL; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Kuo WJ, 2003, NEUROIMAGE, V18, P720, DOI 10.1016/S1053-8119(03)00015-6; Lee CY, 2004, NEUROIMAGE, V23, P1235, DOI 10.1016/j.neuroimage.2004.07.064; Lou WT, 2016, J ALZHEIMERS DIS, V54, P397, DOI 10.3233/JAD-160201; Lu H, 2014, NEUROSCIENCE, V272, P21, DOI 10.1016/j.neuroscience.2014.04.051; Manuello J, 2016, CONSCIOUS COGN, V40, P67, DOI 10.1016/j.concog.2015.12.005; Matsuo K, 2000, COGNITIVE BRAIN RES, V9, P281, DOI 10.1016/S0926-6410(00)00008-2; Matsuo K, 2001, BRAIN RES BULL, V55, P549, DOI 10.1016/S0361-9230(01)00564-0; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Pacifico MP, 2004, J AM STAT ASSOC, V99, P1002, DOI 10.1198/0162145000001655; Planton S, 2017, CORTEX, V88, P66, DOI 10.1016/j.cortex.2016.11.018; Planton S, 2013, CORTEX, V49, P2772, DOI 10.1016/j.cortex.2013.05.011; Raven JC, 1998, MANUAL RAVENS ADV PR; Rodrigues DBG, 2018, NEUROREPORT, V29, P1463, DOI 10.1097/WNR.0000000000001133; Sanchez-Sandoval Y, 2019, AM J ORTHOPSYCHIAT, V89, P640, DOI 10.1037/ort0000324; SHEK DTL, 1988, J PSYCHOPATHOL BEHAV, V10, P303, DOI 10.1007/BF00960624; Spielberger CD, 1994, USE PSYCHOL TESTING, P292, DOI DOI 10.1002/9780470479216.CORPSY0943; Tang YY, 2015, NAT REV NEUROSCI, V16, P213, DOI 10.1038/nrn3916; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; Taylor TL, 1998, PSYCHON B REV, V5, P625, DOI 10.3758/BF03208839; Taylor VA, 2011, NEUROIMAGE, V57, P1524, DOI 10.1016/j.neuroimage.2011.06.001; Van Droogenbroeck F, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1591-4; Xu M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/975190; Yang JF, 2012, NEUROIMAGE, V60, P979, DOI 10.1016/j.neuroimage.2012.01.036; Yang JF, 2011, BRAIN LANG, V119, P68, DOI 10.1016/j.bandl.2011.03.004; Yang XL, 2010, INT J NURS STUD, V47, P550, DOI 10.1016/j.ijnurstu.2009.10.014; Yu HB, 2011, BRAIN LANG, V119, P60, DOI 10.1016/j.bandl.2010.11.007; Zhao JJ, 2014, CORTEX, V53, P90, DOI 10.1016/j.cortex.2014.01.003; Zhu ZH, 2014, NEUROPSYCH DIS TREAT, V10, P977, DOI 10.2147/NDT.S55016; Zhuang KX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06599-w	52	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214917	10.1371/journal.pone.0214917	http://dx.doi.org/10.1371/journal.pone.0214917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947247	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500085
J	Guidetti, G; Viotti, S; Badagliacca, R; Colombo, L; Converso, D				Guidetti, Gloria; Viotti, Sara; Badagliacca, Rosa; Colombo, Lara; Converso, Daniela			Can mindfulness mitigate the energy-depleting process and increase job resources to prevent burnout? A study on the mindfulness trait in the school context	PLOS ONE			English	Article							WORK ENGAGEMENT; TEACHER STRESS; DEMANDS; INTERVENTION; CONSERVATION; WORKPLACE; MEDIATOR; OUTCOMES	Background Past studies in the teaching context provided evidence of the role of mindfulness-based intervention in improving occupational wellbeing. This study aims to increase the extant knowledge by testing the mechanism that links teachers' mindfulness at work to occupational wellbeing. Rooted in the job demand-resource model, the mindfulness trait is conceptualized as a personal resource that has the ability to impact and interact with job demands and resources, specifically workload stress appraisal and perceived meaningfulness of work, in affecting teachers' burnout. Methods A sample of primary, middle, and secondary school teachers (N = 605) completed a questionnaire that aimed to assess teachers' mindfulness trait and the measures of the quality of occupational life in the school context. Confirmatory factor analysis (CFA) was conducted to test the model fit indices; further analyses were performed to test the hypotheses about mediation and moderation effects. Results The CFA showed good model fit indices. Further analyses highlighted that teachers' mindfulness is negatively associated with workload stress appraisal and that positively influenced work meaning, in turn mediating the relationship between mindfulness and burnout. Finally, mindfulness moderated the effect of workload stress appraisal on burnout. Conclusions Rooted in the job demand-resource model, this study emphasizes an underrepresented personal resource, that is, the mindfulness trait at work, and the links that favor its impact on burnout. Practical and future research implications are also discussed.	[Guidetti, Gloria; Viotti, Sara; Badagliacca, Rosa; Colombo, Lara; Converso, Daniela] Univ Torino, Dipartimento Psicol, Turin, Italy	University of Turin	Viotti, S (corresponding author), Univ Torino, Dipartimento Psicol, Turin, Italy.	sara.viotti@unito.it	viotti, sara/L-2650-2015	viotti, sara/0000-0001-9026-9334; Guidetti, Gloria/0000-0002-7157-658X				Allan BA, 2018, J CAREER ASSESSMENT, V26, P172, DOI 10.1177/1069072716680047; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Bakker A.B., 2008, CAREER DEV INT, V13, P209, DOI [DOI 10.1108/13620430810870476, 10.1108/13620430810870476]; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; Betoret F.D., 2006, EDUC PSYCHOL-UK, V26, P519, DOI [10.1080/01443410500342492, DOI 10.1080/01443410500342492]; BOYLE GJ, 1995, BRIT J EDUC PSYCHOL, V65, P49, DOI 10.1111/j.2044-8279.1995.tb01130.x; Brislin R.W, J CROSS CULT PSYCHOL, V1, DOI [10.1177/1359104570001003011, DOI 10.1177/1359104570001003011]; Byrne B.M., 2013, STRUCTURAL EQUATION, DOI 10.4324/9781410600219; Chalofsky N., 2003, HUMAN RESOURCE DEV I, V6, P69, DOI [10.1080/1367886022000016785, DOI 10.1080/1367886022000016785]; Chaplain RP, 2008, EDUC PSYCHOL-UK, V28, P195, DOI 10.1080/01443410701491858; Chiesa A, 2009, J ALTERN COMPLEM MED, V15, P593, DOI 10.1089/acm.2008.0495; Clausen T, 2011, J MANAGE PSYCHOL, V26, P665, DOI 10.1108/02683941111181761; Clausen T, 2010, SCAND J PUBLIC HEALT, V38, P51, DOI 10.1177/1403494809352105; Dane E, 2014, HUM RELAT, V67, P105, DOI 10.1177/0018726713487753; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demirkasimoglu N, 2015, ANTHROPOLOGIST, V22, P412, DOI 10.1080/09720073.2015.11891894; Emerson LM, 2017, MINDFULNESS, V8, P1136, DOI 10.1007/s12671-017-0691-4; Fairlie P, 2011, ADV DEV HUM RESOUR, V13, P508, DOI 10.1177/1523422311431679; Flook L, 2013, MIND BRAIN EDUC, V7, P256, DOI 10.1111/mbe.12035; Frank JL, 2016, MINDFULNESS, V7, P155, DOI 10.1007/s12671-015-0461-0; Frank JL, 2015, MINDFULNESS, V6, P208, DOI 10.1007/s12671-013-0246-2; Glomb TM, 2011, RES PERS H, V30, P115, DOI 10.1108/S0742-7301(2011)0000030005; Greenglass E.R., 2003, OCCUPATIONAL STRESS, P213, DOI DOI 10.1201/9780203422809; Grover SL, 2017, STRESS HEALTH, V33, P426, DOI 10.1002/smi.2726; Guidetti G, 2015, TURKISH ONLINE J ED, V3, P330; Hakanen JJ, 2006, J SCHOOL PSYCHOL, V43, P495, DOI 10.1016/j.jsp.2005.11.001; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hobfoll SE, 2018, ANNU REV ORGAN PSYCH, V5, P103, DOI 10.1146/annurev-orgpsych-032117-104640; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hulsheger UR, 2018, J OCCUP ORGAN PSYCH, V91, P261, DOI 10.1111/joop.12206; Hulsheger UR, 2013, J APPL PSYCHOL, V98, P310, DOI 10.1037/a0031313; Judge TA, 2001, J APPL PSYCHOL, V86; Kelly AL, 1995, TEACH ED, V11, DOI [10.1016/0742-051x(94)00038-8, DOI 10.1016/0742-051X(94)00038-8]; Klassen RM, 2010, J EDUC RES, V103, P342, DOI 10.1080/00220670903383069; Kline R. B., 2005, PRINCIPALS PRACTICE; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; Kyriacou C, 2001, EDUC REV, V53, P27, DOI 10.1080/00131910120033628; Lazarus RS., 1984, STRESS APPRAISAL COP; Leroy H, 2013, J VOCAT BEHAV, V82, P238, DOI 10.1016/j.jvb.2013.01.012; Loera B, 2013, PSICOLOGIA SALUTE, V1; Loera B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114987; Malinowski P, 2015, MINDFULNESS, V6, P1250, DOI 10.1007/s12671-015-0388-5; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Petitta, 2005, QUESTIONARIO CHECKUP; Roeser RW, 2012, CHILD DEV PERSPECT, V6, P167, DOI 10.1111/j.1750-8606.2012.00238.x; Gomes AR, 2013, WORK STRESS, V27, P351, DOI 10.1080/02678373.2013.840341; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Samios C, 2018, MINDFULNESS, V9, P1088, DOI 10.1007/s12671-017-0844-5; Schaufeli W.B., 2014, BRIDGING OCCUPATIONA, P43; Schlusser DL, 2016, MINDFULNESS, V7, DOI [10.1007/s12671-015-0422-7, DOI 10.1007/S12671-015-0422-7]; Schultz PP, 2015, MINDFULNESS, V6, P971, DOI 10.1007/s12671-014-0338-7; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Taylor C, 2016, MINDFULNESS, V7, P115, DOI 10.1007/s12671-015-0425-4; Van Droogenbroeck F, 2014, TEACH TEACH EDUC, V43, P99, DOI 10.1016/j.tate.2014.07.005; Viotti S, 2016, INT J OCCUP MED ENV, V29, P439, DOI 10.13075/ijomeh.1896.00520; Weinstein N, 2009, J RES PERS, V43, P374, DOI 10.1016/j.jrp.2008.12.008; Wrzesniewski A, 2003, POSITIVE ORG SCHOLAR, P296; Xanthopoulou D., 2007, INT J STRESS MANAGE, V14, P121, DOI [10.1037/1072-5245.14.2.121, DOI 10.1037/10725245.14.2.121, DOI 10.1037/1072-5245.14.2.121]; Youssef CM, 2007, J MANAGE, V33, P774, DOI 10.1177/0149206307305562; Zivnuska S, 2016, CAREER DEV INT, V21, P106, DOI 10.1108/CDI-06-2015-0086	63	22	22	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214935	10.1371/journal.pone.0214935	http://dx.doi.org/10.1371/journal.pone.0214935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947256	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500087
J	Kang, KT; Koh, YG; Nam, JH; Jung, M; Kim, SJ; Kim, SH				Kang, Kyoung-Tak; Koh, Yong-Gon; Nam, Ji-Hoon; Jung, Moonki; Kim, Sung-Jae; Kim, Sung-Hwan			Biomechanical evaluation of the influence of posterolateral corner structures on cruciate ligaments forces during simulated gait and squatting	PLOS ONE			English	Article							IN-SITU FORCES; POPLITEOFIBULAR LIGAMENT; KNEE-JOINT; MULTIBODY DYNAMICS; ACL INJURY; ANATOMY; ELEMENT; MUSCLE; RECONSTRUCTION; INSTABILITY	Posterolateral corner (PLC) structures of the knee joint comprise complex anatomical soft tissues that support static and dynamic functional movements of the knee. Most previous studies analyzed posterolateral stability in vitro under static loading conditions. This study aimed to evaluate the contributions of the lateral (fibular) collateral ligament (LCL), popliteo-fibular ligament (PFL), and popliteus tendon (PT) to cruciate ligament forces under simulated dynamic loading conditions by using selective individual resection. We combined medical imaging and motion capture of healthy subjects (four males and one female) to develop subject-specific knee models that simulated the 12 degrees of freedom of tibiofemoral and patellofemoral joint behaviors. These computational models were validated by comparing electromyographic (EMG) data with muscle activation data and were based on previous experimental studies. A rigid multi-body dynamics simulation using a lower extremity musculoskeletal model was performed to incorporate intact and selective resection of ligaments, based on a novel force-dependent kinematics method, during gait (walking) and squatting. Deficiency of the PLC structures resulted in increased loading on the posterior cruciate ligament and anterior cruciate ligament. Among PLC structures, the PT is the most influential on cruciate ligament forces under dynamic loading conditions.	[Kang, Kyoung-Tak; Nam, Ji-Hoon] Yonsei Univ, Dept Mech Engn, Seoul, South Korea; [Koh, Yong-Gon; Kim, Sung-Jae] Yonsei Sarang Hosp, Dept Orthopaed Surg, Joint Reconstruct Ctr, Seoul, South Korea; [Jung, Moonki] AnyBody Technol AS, Aalborg, Denmark; [Kim, Sung-Hwan] Yonsei Univ, Gangnam Severance Hosp, Arthroscopy & Joint Res Inst, Dept Orthoped Surg,Coll Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System	Kim, SH (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Arthroscopy & Joint Res Inst, Dept Orthoped Surg,Coll Med, Seoul, South Korea.	orthohwanbm@gmail.com		Kim, Sung-Hwan/0000-0001-5743-6241; Jung, Moon Ki/0000-0003-0704-7736				Ali N, 2014, COMPUT METHOD BIOMEC, V17, P1602, DOI 10.1080/10255842.2012.758718; Amis AA, 2003, KNEE, V10, P215, DOI 10.1016/S0968-0160(03)00006-1; Andersen MS, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037100; Association AM, 1968, STAND NOM ATHL INJ; Baldwin JL, 2009, AM J SPORT MED, V37, P2355, DOI 10.1177/0363546509339909; BLANKEVOORT L, 1991, J BIOMECH ENG-T ASME, V113, P263, DOI 10.1115/1.2894883; Bonanzinga T, 2015, KNEE SURG SPORT TR A, V23, P2918, DOI 10.1007/s00167-015-3696-3; Bowman KF, 2010, SPORTS MED ARTHROSC, V18, P222, DOI 10.1097/JSA.0b013e3181f917e2; Chen ZX, 2015, J ORTHOP RES, V33, P1287, DOI 10.1002/jor.22908; Chen ZX, 2014, P I MECH ENG H, V228, P564, DOI 10.1177/0954411914537476; Chun YM, 2008, J ORTHOP RES, V26, P1371, DOI 10.1002/jor.20596; Colwell CW, 2011, CLIN BIOMECH, V26, P52, DOI 10.1016/j.clinbiomech.2010.08.009; Dhaher YY, 2010, J BIOMECH, V43, P3118, DOI 10.1016/j.jbiomech.2010.08.005; Fanelli GC, 2002, ARTHROSCOPY, V18, P1, DOI 10.1053/jars.2002.31779; FANELLI GC, 1993, ARTHROSCOPY, V9, P291, DOI 10.1016/S0749-8063(05)80424-4; FANELLI GC, 1995, ARTHROSCOPY, V11, P526, DOI 10.1016/0749-8063(95)90127-2; Forster E., 2004, PREDICTING MUSCLE FO; Fregly BJ, 2003, J BIOMECH, V36, P1659, DOI 10.1016/S0021-9290(03)00176-3; GOLLEHON DL, 1987, J BONE JOINT SURG AM, V69A, P233, DOI 10.2106/00004623-198769020-00010; GROOD ES, 1988, J BONE JOINT SURG AM, V70A, P88, DOI 10.2106/00004623-198870010-00014; Halloran JP, 2010, J BIOMECH, V43, P2810, DOI 10.1016/j.jbiomech.2010.05.036; Harner CD, 1998, AM J SPORT MED, V26, P669, DOI 10.1177/03635465980260051201; Hoher J, 1998, J ORTHOPAED RES, V16, P675, DOI 10.1002/jor.1100160608; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; Kang KT, 2017, BONE JOINT RES, V6, P31, DOI 10.1302/2046-3758.61.BJR-2016-0184.R1; Kang KT, 2016, BONE JOINT RES, V5, P552, DOI 10.1302/2046-3758.511.BJR-2016-0107.R1; Kang KT, 2018, J ORTHOP RES, V36, P2202, DOI 10.1002/jor.23871; Kim SJ, 2012, J BONE JOINT SURG AM, V94A, P253, DOI 10.2106/JBJS.J.01686; Kim YS, 2015, ARTHROSCOPY, V31, P2380, DOI 10.1016/j.arthro.2015.06.030; Kwon OR, 2014, J ORTHOP RES, V32, P338, DOI 10.1002/jor.22499; LaPrade RF, 2004, AM J SPORT MED, V32, P1695, DOI 10.1177/0363546503262694; LaPrade RF, 2002, AM J SPORT MED, V30, P233, DOI 10.1177/03635465020300021501; LaPrade RF, 1999, AM J SPORT MED, V27, P469, DOI 10.1177/03635465990270041101; LaPrade RF, 2015, KNEE SURG SPORT TR A, V23, P2950, DOI 10.1007/s00167-015-3629-1; Lenhart RL, 2015, ANN BIOMED ENG, V43, P2675, DOI 10.1007/s10439-015-1326-3; Li G, 1999, J BIOMECH ENG-T ASME, V121, P657, DOI 10.1115/1.2800871; Liau JJ, 2002, CLIN BIOMECH, V17, P140, DOI 10.1016/S0268-0033(01)00109-7; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; Marra MA, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029258; Maynard MJ, 1996, AM J SPORT MED, V24, P311, DOI 10.1177/036354659602400311; McCarthy M, 2010, AM J SPORT MED, V38, P1674, DOI 10.1177/0363546510361220; OBRIEN SJ, 1991, J BONE JOINT SURG AM, V73A, P278, DOI 10.2106/00004623-199173020-00016; Ross G, 2004, J BONE JOINT SURG AM, V86A, P2, DOI 10.2106/00004623-200412002-00002; Shahane SA, 1999, J BONE JOINT SURG BR, V81B, P636, DOI 10.1302/0301-620X.81B4.9501; Shelburne KB, 2006, J ORTHOP RES, V24, P1983, DOI 10.1002/jor.20255; Shin CS, 2007, J BIOMECH, V40, P1145, DOI 10.1016/j.jbiomech.2006.05.004; Sugita T, 2001, AM J SPORT MED, V29, P466, DOI 10.1177/03635465010290041501; Terry GC, 1996, AM J SPORT MED, V24, P2, DOI 10.1177/036354659602400102; Terry GC, 1996, AM J SPORT MED, V24, P732, DOI 10.1177/036354659602400606; Thelen DG, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026358; Thompson JA, 2011, J ORTHOP RES, V29, P969, DOI 10.1002/jor.21344; Ullrich K, 2002, KNEE SURG SPORT TR A, V10, P86, DOI 10.1007/s00167-001-0268-5; VELTRI DM, 1995, AM J SPORT MED, V23, P436, DOI 10.1177/036354659502300411; Veltri DM, 1996, AM J SPORT MED, V24, P19, DOI 10.1177/036354659602400105; Vogrin TM, 2000, KNEE SURG SPORT TR A, V8, P93, DOI 10.1007/s001670050193; Zantop T, 2007, ARCH ORTHOP TRAUM SU, V127, P743, DOI 10.1007/s00402-006-0241-3	56	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214496	10.1371/journal.pone.0214496	http://dx.doi.org/10.1371/journal.pone.0214496			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947292	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500036
J	Kim, T; Tafoya, E; Chelliah, MP; Lekwuttikarn, R; Li, J; Sarin, KY; Teng, J				Kim, Taehan; Tafoya, Elidia; Chelliah, Malcolm P.; Lekwuttikarn, Ramrada; Li, Jiang; Sarin, Kavita Y.; Teng, Joyce			Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals with lymphatic malformations	PLOS ONE			English	Article							COMBINATION; MATURATION; SIROLIMUS; GENETICS; THERAPY; CELLS	Lymphatic malformation (LM) is a developmental anomaly of the lymphatic system that may lead to disfigurement, organ dysfunction and recurrent infection. Though several treatment modalities exist, pharmacotherapy is often associated with side effects and recurrence is common following surgical interventions. Moreover, despite the recent discovery of PIK3CA mutations in lymphatic endothelial cells of LM patients, the full spectrum of molecular pathways involved in LM pathogenesis is poorly understood. Here, we performed RNA sequencing on blood samples obtained from ten LM patients and nine healthy subjects and found 421 differentially expressed genes that stratify LM subjects from healthy controls. Using this LM gene signature, we identified novel pathway alterations in LM, such as oxidative phosphorylation, MEK/ERK, bone morphogenetic protein (BMP), and Wnt/beta-catenin pathways, in addition to confirming the known alterations in cell cycle and the PI3K/AKT pathway. Furthermore, we performed computational drug repositioning analysis to predict existing therapies (e.g. sirolimus) and novel classes of drugs for LM. These findings deepen our understanding of LM pathogenesis and may facilitate non-invasive diagnosis, pathway analysis and therapeutic development.	[Kim, Taehan; Tafoya, Elidia; Lekwuttikarn, Ramrada; Li, Jiang; Sarin, Kavita Y.; Teng, Joyce] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Chelliah, Malcolm P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Sarin, KY (corresponding author), Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA.	ksarin@stanford.edu		Sarin, Kavita/0000-0001-5363-3053; Tafoya, Elidia/0000-0001-5094-2117	Stanford Medical Scholars Research Program, School of Medicine, Stanford University [MedScholars 06106913]; NIH [P30 CA124435]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER	Stanford Medical Scholars Research Program, School of Medicine, Stanford University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Stanford Medical Scholars Research Program, School of Medicine, Stanford University (MedScholars 06106913) (TK) (http://med.stanford.edu/medscholars.html) and NIH P30 CA124435 utilizing the following Stanford Cancer Institute Shared Resource, Genetics Bioinformatics Service Center (http://med.stanford.edu/gbsc/community-resources.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3257; Alqahtani A, 1999, J PEDIATR SURG, V34, P1164, DOI 10.1016/S0022-3468(99)90590-0; Balakrishnan K, 2011, LYMPHAT RES BIOL, V9, P205, DOI 10.1089/lrb.2011.0018; Brouillard P, 2014, J CLIN INVEST, V124, P898, DOI 10.1172/JCI71614; Buttler K, 2013, DEV BIOL, V381, P365, DOI 10.1016/j.ydbio.2013.06.028; Elluru RG, 2014, SEMIN PEDIATR SURG, V23, P178, DOI 10.1053/j.sempedsurg.2014.07.002; Elluru Ravindhra G, 2006, Semin Pediatr Surg, V15, P133, DOI 10.1053/j.sempedsurg.2006.02.011; Hammill AM, 2011, PEDIATR BLOOD CANCER, V57, P1018, DOI 10.1002/pbc.23124; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hucthagowder V, 2017, CLIN GENET, V91, P79, DOI 10.1111/cge.12819; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim D, 2015, DERMATOL THER, V28, P218, DOI 10.1111/dth.12208; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Loconte DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123092; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luks VL, 2015, J PEDIATR-US, V166, P1048, DOI 10.1016/j.jpeds.2014.12.069; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Mouta-Bellum C, 2009, DEV DYNAM, V238, P2670, DOI 10.1002/dvdy.22078; Mulligan PR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130392; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Mylonas I, 2012, HISTOPATHOLOGY, V60, P665, DOI 10.1111/j.1365-2559.2011.04103.x; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Osborn AJ, 2015, HUM MOL GENET, V24, P926, DOI 10.1093/hmg/ddu505; Ozeki M, 2013, TOHOKU J EXP MED, V229, P61, DOI 10.1620/tjem.229.61; Palomero J, 2014, BLOOD, V124, P2235, DOI 10.1182/blood-2014-04-569566; Rossler J, 2015, J PEDIAT HEMATOL ONC, V37, pE481, DOI 10.1097/MPH.0000000000000436; Serres M, 1997, EXP CELL RES, V231, P163, DOI 10.1006/excr.1996.3443; Smith Richard J H, 2004, Lymphat Res Biol, V2, P25, DOI 10.1089/1539685041690436; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Swetman GL, 2012, NEW ENGL J MED, V366, P384, DOI 10.1056/NEJMc1112482; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vahidnezhad H, 2016, J INVEST DERMATOL, V136, P15, DOI 10.1038/JID.2015.331; Weisberg E, 2008, BLOOD, V111, P3723, DOI 10.1182/blood-2007-09-114454; WHIMSTER IW, 1976, BRIT J DERMATOL, V94, P473, DOI 10.1111/j.1365-2133.1976.tb05134.x; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zhang YH, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-017-0436-1	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0213872	10.1371/journal.pone.0213872	http://dx.doi.org/10.1371/journal.pone.0213872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947262	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500013
J	Broekhuis, F; Madsen, EK; Keiwua, K; Macdonald, DW				Broekhuis, Femke; Madsen, Emily K.; Keiwua, Kosiom; Macdonald, David W.			Using GPS collars to investigate the frequency and behavioural outcomes of intraspecific interactions among carnivores: A case study of male cheetahs in the Maasai Mara, Kenya	PLOS ONE			English	Article							POPULATION; ECOLOGY; ORGANIZATION; EVOLUTION; HABITAT; SOCIETY	Intraspecific interactions between individuals or groups of individuals of the same species are an important component of population dynamics. Interactions can be static, such as spatial overlap, or dynamic based on the interactions of movements, and can be mediated through communication, such as the deployment of scent marks. Interactions and their behavioural outcomes can be difficult to determine, especially for species that live at low densities. With the use of GPS collars we quantify both static and dynamic interactions between male cheetahs (Acinonyx jubatus) and the behavioural outcomes. The 99% homeranges of males overlapped significantly while there was little overlap of the 50% homeranges. Despite this overlap, male cheetahs rarely came into close proximity of one another, possibly because presence was communicated through frequent visits to marking posts. The minimum distance between individuals in a dyad ranged from 89m to 196m but the average proximity between individuals ranged from 17,145 +/- 6,865m to 26,367 +/- 11,288m. Possible interactions took place more frequently at night than by day and occurred mostly in the 50% home-range of one individual of a dyad or where cores of both individuals overlapped. After a possible encounter male cheetahs stayed in close proximity to each other for up to 6 hours, which could be the result of a territory defence strategy or the presence of a receptive female. We believe that one of the encounters between a singleton and a 5-male coalition resulted in the death of the singleton. Our results give new insights into cheetah interactions, which could help our understanding of ecological processes such as disease transmission.	[Broekhuis, Femke; Keiwua, Kosiom] Kenya Wildlife Trust, Nairobi, Kenya; [Broekhuis, Femke; Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Tubney, England; [Madsen, Emily K.] UCL, Ctr Biodivers & Environm Res, London, England	University of Oxford; University of London; University College London	Broekhuis, F (corresponding author), Kenya Wildlife Trust, Nairobi, Kenya.; Broekhuis, F (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Tubney, England.	femke.broekhuis@gmail.com		Broekhuis, Femke/0000-0002-4216-8819; Madsen, Emily/0000-0003-4108-6608	Banovich Wildscapes Foundation; African Wildlife Foundation; Vidda Foundation; BAND Foundation	Banovich Wildscapes Foundation; African Wildlife Foundation; Vidda Foundation; BAND Foundation	Funding was provided by the Banovich Wildscapes Foundation (www.wildscapesfoundation.org), the African Wildlife Foundation (www.awf.org), Vidda Foundation (www.vidda.org), BAND Foundation (www.bandfdn.org) and donations made through the Kenya Wildlife Trust (www.kenyawildlifetrust.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep27257; Andreassen HP, 2006, ECOLOGY, V87, P88, DOI 10.1890/04-1574; Arnold J, 2011, CAN J ZOOL, V89, P808, DOI 10.1139/Z11-069; Bohm M, 2008, J ANIM ECOL, V77, P735, DOI 10.1111/j.1365-2656.2008.01377.x; Bracis Chloe, 2018, ECOGRAPHY; Broekhuis F, 2018, J ZOOL, V304, P65, DOI 10.1111/jzo.12499; Broekhuis F, 2016, MARA CHEETAH PROJECT; Broekhuis F, 2018, BIODIVER WORL CONS, P447, DOI 10.1016/B978-0-12-804088-1.00032-0; Broekhuis F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153875; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cant MA, 2002, ETHOLOGY, V108, P541, DOI 10.1046/j.1439-0310.2002.00795.x; Carazo P, 2008, ANIM BEHAV, V76, P1953, DOI 10.1016/j.anbehav.2008.08.018; Caro T.M., 1989, Special Publication of the British Ecological Society, P41; Caro T. M., 1994, CHEETAHS SERENGETI G; CARO TM, 1987, ETHOLOGY, V74, P52; CARO TM, 1989, ANIM BEHAV, V38, P309, DOI 10.1016/S0003-3472(89)80092-2; CARO TM, 1987, J ZOOL, V211, P89, DOI 10.1111/j.1469-7998.1987.tb07455.x; Chaber AL, 2017, J WILDLIFE DIS, V53, P170, DOI 10.7589/2015-11-302; Christensen C., 2016, BEHAV ECOLOGY; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Crofoot MC, 2013, AM J PHYS ANTHROPOL, V152, P79, DOI 10.1002/ajpa.22330; Cross PC, 2012, BEHAV ECOL SOCIOBIOL, V66, P1437, DOI 10.1007/s00265-012-1376-6; Devenish-Nelson ES, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0524; Duquette JF, 2017, CAN J ZOOL, V95, P203, DOI 10.1139/cjz-2016-0031; Durant SM, 2007, CONSERV BIOL, V21, P602, DOI 10.1111/j.1523-1739.2007.00702.x; Eaton R.L., 1970, Z TIERPSYCHOL, V27, P481, DOI DOI 10.1111/J.1439-0310.1970.TB01882.X; Elbroch LM, 2017, CURR ZOOL, V63, P357, DOI 10.1093/cz/zow080; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; Gakuya F, 2012, PARASITOLOGY, V139, P1587, DOI 10.1017/S0031182012000935; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gottelli D, 2007, P ROY SOC B-BIOL SCI, V274, P1993, DOI 10.1098/rspb.2007.0502; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Hunter L. T. B., 2003, Transactions of the Royal Society of South Africa, V58, P79; Jordan NR, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2338-9; Kelly MJ, 1998, J ZOOL, V244, P473, DOI 10.1017/S0952836998004014; Kusler A, 2019, AFR J ECOL, V57, P419, DOI 10.1111/aje.12602; LONG J. A., 2014, WILDLIFEDI CALCULATE; Lopez-Bao JV, 2008, MAMM BIOL, V73, P404, DOI 10.1016/j.mambio.2007.10.012; Loveridge AJ, 2001, J ZOOL, V253, P101, DOI 10.1017/S0952836901000097; Lukas D, 2014, SCIENCE, V346, P841, DOI 10.1126/science.1257226; Macdonald DW, 2015, J ZOOL, V295, P75, DOI 10.1111/jzo.12202; Macdonald David W., 2010, P125; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; MacDonald DW., 1980, HDB BIOTELEMETRY RAD, P143; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; Marnewick KA, 2006, S AFR J WILDL RES, V36, P139; Mattisson J, 2013, MAMM BIOL, V78, P304, DOI 10.1016/j.mambio.2012.11.006; Meltzer D., 2006, CHEM PHYS RESTRAINT; Melzheimer J, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2308; Mills G., 2017, KALAHARI CHEETAHS AD; Munson L, 2004, J WILDLIFE DIS, V40, P23, DOI 10.7589/0090-3558-40.1.23; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Oindo BO, 2003, INT J REMOTE SENS, V24, P1053, DOI 10.1080/01431160210144552; Packer C, 1984, INFANTICIDE CARNIVOR; Papastamatiou YP, 2018, OIKOS, V127, P767, DOI 10.1111/oik.04289; R Development Core Team, 2016, R LANG ENV STAT COMP; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Robert K, 2012, J WILDLIFE MANAGE, V76, P1670, DOI 10.1002/jwmg.435; Schwalb-Willmann J., 2019, moveVis: Movement Data Visualization; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; White LA, 2018, P NATL ACAD SCI USA, V115, P7374, DOI 10.1073/pnas.1801383115; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wielgus RB, 2000, BIOL CONSERV, V93, P145, DOI 10.1016/S0006-3207(99)00152-4; Wiley R. H., 1979, SOCIAL BEHAV COMMUNI, P159	65	16	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213910	10.1371/journal.pone.0213910	http://dx.doi.org/10.1371/journal.pone.0213910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943236	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300020
J	Marroig, A; Cukic, I; Robitaille, A; Piccinin, A; Terrera, GM				Marroig, Alejandra; Cukic, Iva; Robitaille, Annie; Piccinin, Andrea; Terrera, Graciela Muniz			Importance of modelling decisions on estimating trajectories of depressive symptoms and co-morbid conditions in older adults: Longitudinal studies from ten European countries	PLOS ONE			English	Article							MULTIMORBIDITY	Background International comparisons of trajectories of depressive symptoms in older adults are scarce and longitudinal associations with co-morbid conditions not fully understood. Objective To compare trajectories of depressive symptoms from participants living in 10 European Countries and identify ages at which the associations of co-morbid conditions with these trajectories become more relevant. Methods Latent growth curve models were fitted to depressive symptoms scores from participants of the Survey of Health and Retirement in Europe (SHARE) initiative (combined n = 21,253) and co-morbid conditions modelled as time varying covariates. To identify the ages at which the association between co-morbid conditions and depressive symptoms was significant the Johnson-Neyman (JN) technique was used. Results The shape of depressive symptoms trajectories varied between countries, and was highly dependent on modelling decisions. The association between the average number of co-morbidities reported over time and depressive symptoms was consistent and positive across countries and ages. Conclusion International differences in ageing-related trajectories of depressive symptoms emerged. The longitudinal association of co-morbid conditions with trajectories of depressive symptoms was found, but the results overall suggest that modelling decisions could greatly influence the outcomes, and should thus be interpreted with caution.	[Marroig, Alejandra] Univ Republ Uruguay, Inst Econ, Montevideo, Uruguay; [Cukic, Iva; Terrera, Graciela Muniz] Univ Edinburgh, Ctr Dementia Prevent, Edinburgh, Midlothian, Scotland; [Robitaille, Annie; Piccinin, Andrea] Univ Victoria, Dept Psychol, Victoria, BC, Canada	Universidad de la Republica, Uruguay; University of Edinburgh; University of Victoria	Terrera, GM (corresponding author), Univ Edinburgh, Ctr Dementia Prevent, Edinburgh, Midlothian, Scotland.	g.muniz@ed.ac.uk	Cukic, Iva/HGE-8252-2022	Marroig, Alejandra/0000-0003-0716-174X; Piccinin, Andrea/0000-0001-5538-7028; Cukic, Iva/0000-0002-2010-1648	National Institute of Health (NIH)/National Institute of Aging (NIA) Program Project Grant [P01AG043362]; Cooperation Funds for Science and Innovation The British Embassy in Montevideo, ANII UK [2015 1 10]; European Commission through FP5 [QLK6-CT-2001-00360]; European Commission through FP6 [SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812]; European Commission through FP7 (SHARE-PREP) [211909]; European Commission through FP7 (SHARE-LEAP) [227822]; European Commission through FP7 (SHARE M4) [261982]; German Ministry of Education and Research; U.S. National Institute on Aging [U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064]; NIH/NIA [P01AG043362]; Grupos I+D de CSIC; UdelaR; NATIONAL INSTITUTE ON AGING [P01AG005842, U01AG009740, P30AG012815, P01AG008291, P01AG043362] Funding Source: NIH RePORTER	National Institute of Health (NIH)/National Institute of Aging (NIA) Program Project Grant; Cooperation Funds for Science and Innovation The British Embassy in Montevideo, ANII UK; European Commission through FP5; European Commission through FP6; European Commission through FP7 (SHARE-PREP); European Commission through FP7 (SHARE-LEAP); European Commission through FP7 (SHARE M4); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grupos I+D de CSIC; UdelaR; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by National Institute of Health (NIH)/National Institute of Aging (NIA) Program Project Grant (P01AG043362; 2013-2018) and Grupos I+D de CSIC, UdelaR and Cooperation Funds for Science and Innovation The British Embassy in Montevideo, ANII UK ID 2015 1 10 have funded the work of GMT and AM, but had no input in the planning or analysing the data for the current paper.; This paper uses data from SHARE Waves 1, 2, 3 (SHARELIFE), 4 and 5, see Borsch-Supan et al. (2013) for methodological details.. The SHARE data collection has been primarily funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812) and FP7 (SHARE-PREP: No 211909, SHARE-LEAP: No 227822, SHARE M4: No 261982). Additional funding from the German Ministry of Education and Research, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064) and from various national funding sources is gratefully acknowledged (see www.share-project.org)."; This work was also funded by NIH/NIA Program Project Grant (P01AG043362; 2013-2018) and Grupos I+D de CSIC, UdelaR and Cooperation Funds for Science and Innovation The British Embassy in Montevideo, ANII UK ID 2015 1 10	Aiken L.S., 1991, MULTIPLE REGRESSION; Ayuso-Mateos JL, 2010, BRIT J PSYCHIAT, V196, P365, DOI 10.1192/bjp.bp.109.071191; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Miller JW, 2013, MULTIVAR BEHAV RES, V48, P267, DOI 10.1080/00273171.2013.763567; Rast P, 2014, GERONTOLOGY, V60, P274, DOI 10.1159/000358757; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; Sliwinski MJ, 2003, PSYCHOL AGING, V18, P658, DOI 10.1037/0882-7974.18.4.658; Stanners MN, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-124; Sutin AR, 2013, JAMA PSYCHIAT, V70, P803, DOI 10.1001/jamapsychiatry.2013.193; World Health Organization, 2008, GLOB BURD DIS	11	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214438	10.1371/journal.pone.0214438	http://dx.doi.org/10.1371/journal.pone.0214438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943221	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300038
J	Borpatragohain, P; Rose, TJ; Liu, L; Raymond, CA; Barkla, BJ; King, GJ				Borpatragohain, Priyakshee; Rose, Terry J.; Liu, Lei; Raymond, Carolyn A.; Barkla, Bronwyn J.; King, Graham J.			Seed glucosinolate yield is maximized by higher rates of sulfur nutrition than required for seed yield in condiment mustard (Brassica juncea L.)	PLOS ONE			English	Article							GENETIC-ANALYSIS; RAPESEED; QUALITY; METABOLISM; PROTEINS; PATHWAY; LINE	Brassica crops require high amounts of inorganic sulfur (S) for optimum yield, and are characterized by the synthesis of S-rich glucosinolates (GSL). Although it is well established that seed and GSL yield can be increased by S fertilizer, the detailed relationship between S supply as primary source and the harvestable sinks of seed GSL and storage proteins is poorly understood. We tested the hypothesis that Brassica juncea mustard seed acts as a secondary S sink, and so require a higher rate of S to achieve maximum seed GSL compared to rates required to attain maximum seed biomass. Our experimental strategy involved comparing responses to available S for seed biomass, GSL, and protein. This was carried out in a protected environment using sand culture for a high-GSL condiment-type homozygous B. juncea genotype. A low-GSL canola-type was used as a control, in order to establish a base-line of response. Significantly more S was required to achieve maximum seed GSL than was required to achieve maximum seed mass. Total seed protein content was not significantly affected by increased S. The high-GSL line appeared to have an efficient mechanism of S supply to the secondary S sink, given the observed increase in seed S with increased S availability. From a practical point of view, increases in seed GSL with S availability suggests that S fertilizer rates should be optimized for maximum seed GSL yield, rather that optimizing for seed yield, as occurs for most other crops.	[Borpatragohain, Priyakshee; Rose, Terry J.; Liu, Lei; Raymond, Carolyn A.; Barkla, Bronwyn J.; King, Graham J.] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia	Southern Cross University	King, GJ (corresponding author), Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia.	graham.king@scu.edu.au	Liu, Lei/AAM-2739-2021; Barkla, Bronwyn J/O-6301-2017; BORPATRAGOHAIN, PRIYAKSHEE/AAM-2080-2020; King, Graham J/AAW-3368-2020; Raymond, Carolyn A/P-4764-2017	Liu, Lei/0000-0002-3710-7042; Barkla, Bronwyn J/0000-0002-4691-8023; BORPATRAGOHAIN, PRIYAKSHEE/0000-0002-9598-5986; King, Graham J/0000-0002-5975-6051; Raymond, Carolyn A/0000-0003-2887-9267; Rose, Terry/0000-0001-5386-6818	Australian Mustard Oil Pty. Ltd, Australia; Department of Biotechnology Center of Assam Agricultural University, India; Southern Cross Plant Science Centre, Southern Cross University, Australia	Australian Mustard Oil Pty. Ltd, Australia; Department of Biotechnology Center of Assam Agricultural University, India; Southern Cross Plant Science Centre, Southern Cross University, Australia	PB received scholarship funding from Australian Mustard Oil Pty. Ltd, Australia, Department of Biotechnology Center of Assam Agricultural University, India and Southern Cross Plant Science Centre, Southern Cross University, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TG, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27740; Anjum NA, 2012, SCI WORLD J, DOI 10.1100/2012/657808; BARROW NJ, 1990, FERT RES, V22, P181, DOI 10.1007/BF01120393; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bellostas N, 2007, GCIRC B; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Borpatragohain P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01735; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng BF, 2001, GENOME, V44, P738, DOI 10.1139/gen-44-4-738; Crocoll Christoph, 2016, Curr Protoc Plant Biol, V1, P385, DOI 10.1002/cppb.20027; CROUCH ML, 1981, PLANTA, V153, P64, DOI 10.1007/BF00385319; Dimov Z, 2012, PLANT BREEDING, V131, P361, DOI 10.1111/j.1439-0523.2012.01951.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Falk KL, 2007, PLANT BIOLOGY, V9, P573, DOI 10.1055/s-2007-965431; Griffiths DW, 1998, J HORTIC SCI BIOTECH, V73, P1; Haskins B, 2009, JUNCEA CANOLA LOW RA; Hassan F, 2007, INT J AGR BIOL PAKIS; Ishida M, 2014, BREEDING SCI, V64, P48, DOI 10.1270/jsbbs.64.48; Jankowski K, 2008, J ELEM, V13, P521; Koprivova A, 2016, J GENET GENOMICS; LAKKINENI KC, 1992, PHYTON-ANN REI BOT A, V32, P75; Li GY, 2002, GENETICS, V162, P1937; Liu Z, 2011, MOL BREEDING, V27, P467, DOI 10.1007/s11032-010-9444-y; LOVE HK, 1990, CAN J PLANT SCI, V70, P419, DOI 10.4141/cjps90-049; Malhi SS, 2007, AGRON J, V99, P570, DOI 10.2134/agronj2006.0269; MONSALVE R, 2001, INT S FOOD ALL; Mugford SG, 2011, PLANT J, V65, P96, DOI 10.1111/j.1365-313X.2010.04410.x; Nesi N, 2008, CR BIOL, V331, P763, DOI 10.1016/j.crvi.2008.07.018; Nishinari K, 2014, FOOD HYDROCOLLOID, V39, P301, DOI 10.1016/j.foodhyd.2014.01.013; Nour-Eldin HH, 2017, NATURE BIOTECHNOLOGY; OHLSON R, 1979, J AM OIL CHEM SOC, V56, P431, DOI 10.1007/BF02671531; Othmane M., 2015, J CHEM, V2015, P6, DOI [10.1155/2015/606142, DOI 10.1155/2015/606142]; Rhee MS, 2003, APPL ENVIRON MICROB, V69, P2959, DOI 10.1128/AEM.69.5.2959-2963.2003; Schatzki J, 2014, THEOR APPL GENET, V127, P1213, DOI 10.1007/s00122-014-2292-0; Sodhi YS, 2002, PLANT BREEDING, V121, P508, DOI 10.1046/j.1439-0523.2002.00747.x; SOSULSKI F, 1979, J AM OIL CHEM SOC, V56, P711, DOI 10.1007/BF02663047; Tian QG, 2005, ANAL BIOCHEM, V343, P93, DOI 10.1016/j.ab.2005.04.045; Wittstock U, 2010, GLUC BREAKD AR MECH; Zhao FJ, 1997, SOIL SCI PLANT NUTR, V43, P1137	39	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213429	10.1371/journal.pone.0213429	http://dx.doi.org/10.1371/journal.pone.0213429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939141	gold, Green Published			2022-12-27	WOS:000462993900005
J	Chang, TC; Goud, S; Torcivia-Rodriguez, J; Hu, Y; Pan, Q; Kahsay, R; Blomberg, J; Mazumder, R				Chang, Ting-Chia; Goud, Santosh; Torcivia-Rodriguez, John; Hu, Yu; Pan, Qing; Kahsay, Robel; Blomberg, Jonas; Mazumder, Raja			Investigation of somatic single nucleotide variations in human endogenous retrovirus elements and their potential association with cancer	PLOS ONE			English	Article							TRANSFER-RNA GENES; NONCODING RNA; EVOLUTIONARY DYNAMICS; REPBASE UPDATE; DATABASE; MUTATIONS; TRANSCRIPTION; EXPRESSION; IDENTIFICATION; ACTIVATION	Human endogenous retroviruses (HERVs) have been investigated for potential links with human cancer. However, the distribution of somatic nucleotide variations in HERV elements has not been explored in detail. This study aims to identify HERV elements with an over-representation of somatic mutations (hot spots) in cancer patients. Four HERV elements with mutation hotspots were identified that overlap with exons of four human protein coding genes. These hotspots were identified based on the significant over-representation (p<8.62e-4) of non-synonymous single-nucleotide variations (nsSNVs). These genes are TNN (HERV-9/LTR12), OR4K15 (HERV-IP10F/LTR10F), ZNF99 (HERV-W/HERV17/LTR17), and KIR2DL1 (MST/MaLR). In an effort to identify mutations that effect survival, all nsSNVs were further evaluated and it was found that kidney cancer patients with mutation C2270G in ZNF99 have a significantly lower survival rate (hazard ratio = 2.6) compared to those without it. Among HERV elements in the human non-protein coding regions, we found 788 HERVs with significantly elevated numbers of somatic single-nucleotide variations (SNVs) (p<1.60e-5). From this category the top three HERV elements with significantly over-represented SNVs are HERV-H/LTR7, HERV-9/LTR12 and HERV-L/MLT2. Majority of the SNVs in these 788 HERV elements are located in three DNA functional groups: long non-coding RNAs (lncRNAs) (60%), introns (22.2%) and transcriptional factor binding sites (TFBS) (14.8%). This study provides a list of mutational hotspots in HERVs, which could potentially be used as biomarkers and therapeutic targets.	[Chang, Ting-Chia; Torcivia-Rodriguez, John; Hu, Yu; Kahsay, Robel; Mazumder, Raja] George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA; [Goud, Santosh] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Pan, Qing] George Washington Univ, Dept Stat, Washington, DC 20052 USA; [Blomberg, Jonas] Uppsala Univ Hosp, Dept Med Sci, Uppsala, Sweden; [Mazumder, Raja] George Washington Univ, McCormick Genom & Prote Ctr, Washington, DC 20037 USA	George Washington University; George Mason University; George Washington University; Uppsala University; Uppsala University Hospital; George Washington University	Mazumder, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA.; Mazumder, R (corresponding author), George Washington Univ, McCormick Genom & Prote Ctr, Washington, DC 20037 USA.	mazumder@gwu.edu	Torcivia, John Paul/AAZ-8456-2020; Hu, Yu/AAI-1837-2020	Torcivia, John Paul/0000-0002-9307-5778; Mazumder, Raja/0000-0001-8823-9945; Hu, Yu/0000-0003-3178-0874	McCormick Genomic and Proteomic Center at George Washington University	McCormick Genomic and Proteomic Center at George Washington University	This work was supported by McCormick Genomic and Proteomic Center at George Washington University. There was no additional external funding received for this study.	Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson ML, 1999, J GEN VIROL, V80, P255, DOI 10.1099/0022-1317-80-1-255; Armbruester V, 2004, J VIROL, V78, P10310, DOI 10.1128/JVI.78.19.10310-10319.2004; Balestrieri E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048831; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Benachenhou F, 2009, GENE, V448, P134, DOI 10.1016/j.gene.2009.07.002; Blomberg J, 2009, GENE, V448, P115, DOI 10.1016/j.gene.2009.06.007; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chiovaro F, 2015, INT J CANCER, V137, P1842, DOI 10.1002/ijc.29565; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; Denne M, 2007, J VIROL, V81, P5607, DOI 10.1128/JVI.02771-06; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Dingerdissen HM, 2018, NUCLEIC ACIDS RES, V46, pD1128, DOI 10.1093/nar/gkx907; Dutta A, 2014, IMMUNOGENETICS, V66, P439, DOI 10.1007/s00251-014-0778-1; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Elfaitouri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024602; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Galli UM, 2005, ONCOGENE, V24, P3223, DOI 10.1038/sj.onc.1208543; George B, 2014, J NUCL CARDIOL, V21, P686, DOI 10.1007/s12350-014-9908-2; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gibb EA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0142-6; Gifford RJ, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0442-1; Gilroy KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154070; Glinsky GV, 2016, CANCER LETT, V381, P176, DOI 10.1016/j.canlet.2016.08.001; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Gustedt J., 2008, J DISCRETE ALGORITHM, V6; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karagiannis Konstantinos, 2013, Genomics Proteomics & Bioinformatics, V11, P122, DOI 10.1016/j.gpb.2012.10.003; Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004; Kuntzer J, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq015; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lehrach Hans, 2013, F1000Prime Rep, V5, P34, DOI 10.12703/P5-34; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029950; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McElroy K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-501; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Miller ML, 2015, CELL SYST, V1, P197, DOI 10.1016/j.cels.2015.08.014; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Onishi A, 2013, ARTHRITIS RHEUM-US, V65, P1913, DOI 10.1002/art.37969; Pan Y, 2014, NUCLEIC ACIDS RES, V42, P11570, DOI 10.1093/nar/gku772; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perron H, 2005, J NEUROVIROL, V11, P23, DOI 10.1080/13550280590901741; Piriyapongsa J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-291; Reimand J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02651; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; Sasani F, 2013, VET PATHOL, V50, P543, DOI 10.1177/0300985812469632; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schmitt K, 2013, J VIROL, V87, P13837, DOI 10.1128/JVI.02388-13; Sin HS, 2006, ARCH VIROL, V151, P1985, DOI 10.1007/s00705-006-0764-5; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; Stauffer Yves, 2004, Cancer Immun, V4, P2; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Vargiu L, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-015-0232-y; Volders PJ, 2015, NUCLEIC ACIDS RES, V43, pD174, DOI 10.1093/nar/gku1060; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wilkinson DA MD, 1994, ENDOGENOUS HUMAN RET; Wu TJ, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav032; Wu TJ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau022; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Yu H, 2014, ONCOGENE, V33, P3947, DOI 10.1038/onc.2013.366; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072	88	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0213770	10.1371/journal.pone.0213770	http://dx.doi.org/10.1371/journal.pone.0213770			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934003	gold, Green Published, Green Submitted			2022-12-27	WOS:000462867000006
J	Silva, FBD; Miguel, DC; Machado, VE; Oliveira, WHC; Goulart, TM; Tosta, CD; Pinheiro, HP; Pinto, MC				da Rocha Silva, Flavia Benini; Miguel, Danilo Ciccone; Machado, Vicente Estevam; Cruz Oliveira, Wanderson Henrique; Goulart, Thais Marchi; Tosta, Christiann Davis; Pinheiro, Hildete Prisco; Pinto, Mara Cristina			Influence of Leishmania (Viannia) braziliensis infection on the attractiveness of BALB/c mice to Nyssomyia neivai (Diptera: Psychodidae)	PLOS ONE			English	Article							PHLEBOTOMINE SAND FLIES; TRIATOMA-INFESTANS; CARBON-DIOXIDE; HUMAN ODOR; IDENTIFICATION; ATTRACTANT; VECTORS; TRANSMISSION; MANIPULATION; BIOMARKERS	Background Phlebotomine sand flies are vectors for several pathogens, with Leishmania being the most important. In Brazil, the main aetiological agent of American cutaneous leishmaniasis (ACL) is Leishmania (Viannia) braziliensis, and Nyssomyia neivai is one of its main vectors in Sao Paulo state and other areas of South America. Similar to other haematophagous insects, sand flies use volatile compounds called kairomones to locate their hosts for blood meals. A possible increase in the attractiveness of hosts infected with Leishmania infantum to their vectors has been demonstrated. In the present study, we aimed to investigate whether L. braziliensis-infected hosts present higher attractiveness to Ny. neivai and to identify differences in the volatile compounds released by infected and uninfected mice. Results Behavioural experiments in which sand fly females directly fed on infected or uninfected mice showed no significant differences in the attractiveness of the mice or the blood volume ingested. Y-tube olfactometer bioassays also revealed no significant differences in the attractiveness of these hosts to Ny. neivai. No differences were observed in the profiles of the volatile compounds released by the two groups of mice. However, PCA and cluster analysis were able to classify the 31 identified compounds into three clusters according to their abundances. This classification showed a possible role for individual variation in the absence of differences in volatile profiles and attractiveness between infected and uninfected mice. Conclusion In this first cross-sectional study with an aetiological agent of ACL, there were no statistically significant differences in the attractiveness of infected hosts to their vector.	[da Rocha Silva, Flavia Benini; Machado, Vicente Estevam; Cruz Oliveira, Wanderson Henrique; Pinto, Mara Cristina] Univ Estadual Paulista UNESP, Fac Ciencias Farmaceut, Dept Ciencias Biol, Campus Araraquara, Araraquara, SP, Brazil; [Miguel, Danilo Ciccone; Goulart, Thais Marchi] Univ Estadual Campinas UNICAMP, Dept Biol Anim, Campinas, SP, Brazil; [Tosta, Christiann Davis] Inst Fed Educ Ciencia & Tecnol Sao Paulo IFSP, Campus Matao, Matao, SP, Brazil; [Pinheiro, Hildete Prisco] Univ Estadual Campinas UNICAMP, Dept Estat, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual de Campinas; Instituto Federal de Sao Paulo (IFSP); Universidade Estadual de Campinas	Pinto, MC (corresponding author), Univ Estadual Paulista UNESP, Fac Ciencias Farmaceut, Dept Ciencias Biol, Campus Araraquara, Araraquara, SP, Brazil.	marap@fcfar.unesp.br	Pinto, Mara C/H-9111-2012; da Rocha Silva, Flávia Benini/AGU-8137-2022; Miguel, Danilo Ciccone/C-1484-2012	Pinto, Mara C/0000-0003-3941-9792; da Rocha Silva, Flávia Benini/0000-0002-3361-0687; Miguel, Danilo Ciccone/0000-0003-0522-6562	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/23832-9, 2015/21100-9]; FAPESP Young Investigator Grant from (FAPESP) [2014/21129-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP Young Investigator Grant from (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - TMG Grant: 2012/23832-9 and FBRS Grant: 2015/21100-9). DCM is supported by a FAPESP Young Investigator Grant from (FAPESP Grant number 2014/21129-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeladhim M, 2014, INFECT GENET EVOL, V28, P691, DOI 10.1016/j.meegid.2014.07.028; Agresti A, 2002, CATEGORICAL DATA ANA, P710, DOI [10.1002/0471249688, DOI 10.1002/0471249688]; Andrade AJ, 2008, MEM I OSWALDO CRUZ, V103, P337, DOI 10.1590/S0074-02762008000400004; Andrade MS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004137; [Anonymous], 2017, LEISHMANIASIS; [Anonymous], [No title captured]; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Batista EPA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-251; Beavers GM, 2004, J AM MOSQUITO CONTR, V20, P130; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Brazil R.P., 2015, ENTOMOLOGY ORNITHOLO, V04, P4, DOI [10.4172/2161, DOI 10.1089/VBZ.2007.0180.V, DOI 10.4172/2161-0983.1000144]; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; Busula AO, 2017, TRENDS PARASITOL, V33, P961, DOI 10.1016/j.pt.2017.08.010; Carregaro V, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-102; Cornet S, 2013, ECOL LETT, V16, P323, DOI 10.1111/ele.12041; de Boer JG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08978-9; De Moraes CM, 2018, P NATL ACAD SCI USA, V115, P5780, DOI 10.1073/pnas.1801512115; De Moraes CM, 2014, P NATL ACAD SCI USA, V111, P11079, DOI 10.1073/pnas.1405617111; de Oliveira CI, 2004, MICROBES INFECT, V6, P977, DOI 10.1016/j.micinf.2004.05.009; Diniz MMCDL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-139; Dormont L, 2013, J EXP BIOL, V216, P2783, DOI 10.1242/jeb.085936; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Emami SN, 2017, SCIENCE, V355, P1076, DOI 10.1126/science.aah4563; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Fleiss JL, 2004, STAT METHODS RATES P, P598, DOI DOI 10.1002/0471445428.CH18; Fontan A, 2002, J MED ENTOMOL, V39, P191, DOI 10.1603/0022-2585-39.1.191; Goulart TM, 2017, ACTA TROP, V174, P102, DOI 10.1016/j.actatropica.2017.07.010; Goulart TM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1035-7; Guerenstein PG, 2001, J EXP BIOL, V204, P585; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Innocent E, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.5701; Kelly M, 2015, MBIO, V6, DOI 10.1128/mBio.00235-15; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2007, PEST MANAG SCI, V63, P647, DOI 10.1002/ps.1408; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Machado VE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0748-y; Maciel C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110551; Magalhaes JT, 2014, ANAL BIOANAL CHEM, V406, P6691, DOI 10.1007/s00216-014-8103-2; Magalhaes JT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-60; Mweresa CK, 2016, J CHEM ECOL, V42, P508, DOI 10.1007/s10886-016-0711-1; Nevatte TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06313-w; O'Shea B, 2002, T ROY SOC TROP MED H, V96, P117, DOI 10.1016/S0035-9203(02)90273-7; Omolo MO, 2004, PHYTOCHEMISTRY, V65, P2797, DOI 10.1016/j.phytochem.2004.08.035; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Perez-Gonzalez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187919; Pinto MC, 2011, J MED ENTOMOL, V48, P39, DOI 10.1603/ME10081; Pinto MC, 2001, MED VET ENTOMOL, V15, P132, DOI 10.1046/j.1365-2915.2001.00294.x; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Robinson A, 2018, P NATL ACAD SCI USA, V115, pE4209, DOI 10.1073/pnas.1721610115; Rock F, 2006, J CHEM ECOL, V32, P1333, DOI 10.1007/s10886-006-9091-2; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; Rogers ME, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00223; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Schaber CL, 2018, J INFECT DIS, V217, P1553, DOI 10.1093/infdis/jiy072; de Freitas TPT, 2012, VECTOR-BORNE ZOONOT, V12, P81, DOI 10.1089/vbz.2010.0268; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Zauli RC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-11; Zhang ZM, 2010, MICROCHEM J, V95, P127, DOI 10.1016/j.microc.2009.12.017	62	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214574	10.1371/journal.pone.0214574	http://dx.doi.org/10.1371/journal.pone.0214574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934013	gold, Green Submitted, Green Published			2022-12-27	WOS:000462867000022
J	Franck, JA; Smeets, RJEM; Seelen, HAM				Franck, Johan Anton; Smeets, Rob Johannes Elise Marie; Seelen, Henk Alexander Maria			Changes in actual arm-hand use in stroke patients during and after clinical rehabilitation involving a well-defined arm-hand rehabilitation program: A prospective cohort study	PLOS ONE			English	Article							UPPER-LIMB ACTIVITY; UPPER EXTREMITY IMPAIRMENT; QUALITY-OF-LIFE; SUBACUTE STROKE; PHYSICAL-ACTIVITY; MOTOR RECOVERY; ACCELEROMETRY; MOVEMENT; PARTICIPATION; ASSOCIATION	Introduction Improvement of arm-hand function and arm-hand skill performance in stroke patients is reported by many authors. However, therapy content often is poorly described, data on actual arm-hand use are scarce, and, as follow-up time often is very short, little information on patients' mid-and long-term progression is available. Also, outcome data mainly stem from either a general patient group, unstratified for the severity of arm-hand impairment, or a very specific patient group. Objectives To investigate to what extent the rate of improvement or deterioration of actual arm-hand use differs between stroke patients with either a severely, moderately or mildly affected arm-hand, during and after rehabilitation involving a well-defined rehabilitation program. Methods Design: single-armed prospective cohort study. Outcome measure: affected arm-hand use during daily tasks (accelerometry), expressed as 'Intensity-of arm-hand-use' and 'Duration-of-arm-hand-use' during waking hours. Measurement dates: at admission, clinical discharge and 3, 6, 9, and 12 months post-discharge. Statistics: Two-way repeated measures ANOVAs. Results Seventy-six patients (63 males); mean age: 57.6 years (sd: 10.6); post-stroke time: 29.8 days (sd: 20.1) participated. Between baseline and 1-year follow-up, Intensity-of-arm-hand-use on the affected side increased by 51%, 114% and 14% (p < .000) in the mildly, moderately and severely affected patients, respectively. Similarly, Duration-of-arm-hand-use increased by 26%, 220% and 161% (p < .000). Regarding bimanual arm-hand use: Intensity-of-arm-hand-use increased by 44%, 74% and 30% (p <.000), whereas Duration-of-arm-hand-use increased by 10%, 22% and 16% (p < .000). Conclusion Stroke survivors with a severely, moderately or mildly affected arm-hand showed different, though (clinically) important, improvements in actual arm-hand use during the rehabilitation phase. Intensity-of-arm-hand-use and Duration-of-arm-hand-use significantly improved in both unimanual and bimanual tasks/skills. These improvements were maintained until at least 1 year post-discharge.	[Franck, Johan Anton] Adelante Rehabil Ctr, Dept Brain Injury Rehabil, Hoensbroek, Netherlands; [Franck, Johan Anton; Seelen, Henk Alexander Maria] Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Smeets, Rob Johannes Elise Marie; Seelen, Henk Alexander Maria] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, Maastricht, Netherlands	Maastricht University	Franck, JA (corresponding author), Adelante Rehabil Ctr, Dept Brain Injury Rehabil, Hoensbroek, Netherlands.; Franck, JA (corresponding author), Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands.	h.franck@adelante-zorggroep.nl	Smeets, Rob JEM/D-1522-2011	Smeets, Rob JEM/0000-0002-9503-366X				[Anonymous], 2003, APPL LONGITUDINAL AN; Bailey RR, 2015, NEUROREHAB NEURAL RE, V29, P969, DOI 10.1177/1545968315583720; Barker RN, 2005, DISABIL REHABIL, V27, P1213, DOI 10.1080/09638280500075717; Block VAJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154335; Boomkamp-Koppen HGM, 2005, CLIN REHABIL, V19, P552, DOI 10.1191/0269215505cr846oa; Buma F, 2013, RESTOR NEUROL NEUROS, V31, P707, DOI 10.3233/RNN-130332; Cambridge_ Neurology_ ltd, 2008, ACT GUID GETT START; Canning CG, 2004, CLIN REHABIL, V18, P300, DOI 10.1191/0269215504cr715oa; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Connell L, 2014, ARCH PHYS MED REHABI, V95; de Niet M, 2007, ARCH PHYS MED REHAB, V88, P1121, DOI 10.1016/j.apmr.2007.06.005; Doman CA, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020891; Franceschini M, 2010, EUR J PHYS REHAB MED, V46, P389; Franck J.A., 2015, OPEN J OCCUP THER, V3, P10, DOI [10.15453/2168-6408.1164, DOI 10.15453/2168-6408.1164]; Frank J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175211; Gebruers N, 2008, CEREBROVASC DIS, V26, P533, DOI 10.1159/000160210; Gebruers N, 2010, ARCH PHYS MED REHAB, V91, P288, DOI 10.1016/j.apmr.2009.10.025; Guidetti S, 2014, J REHABIL MED, V46, P963, DOI 10.2340/16501977-1865; Hardwick DD, 2011, J NEUROL PHYS THER, V35, P18, DOI 10.1097/NPT.0b013e318208efa1; Hayward KS, 2016, BRAIN IMPAIR, P1; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P1706, DOI 10.1016/j.apmr.2004.11.043; Kilbreath SL, 2005, AUSTR J PHYSIOTHERAP, V51; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P56; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P3; Lang CE, 2013, J HAND THER, V26, P104, DOI 10.1016/j.jht.2012.06.005; Lee JY, 2018, PLOS ONE, V13; Lemmens RJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118642; Lemmens RJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096414; Lemmens RJM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-21; Liao WW, 2012, CLIN REHABIL, V26, P111, DOI 10.1177/0269215511416383; Mallinson T, 2010, ARCH PHYS MED REHAB, V91, pS29, DOI 10.1016/j.apmr.2010.04.027; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; Michielsen ME, 2012, ARCH PHYS MED REHAB, V93, P1975, DOI 10.1016/j.apmr.2012.03.016; Mullick AA, 2015, RESTOR NEUROL NEUROS, V33, P389, DOI 10.3233/RNN-150510; Narai E, 2016, J GERIATR PHYS THER, V39, P171, DOI 10.1519/JPT.0000000000000067; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Noorkoiv M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-144; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302; Rand D, 2015, J STROKE CEREBROVASC, V24, P274, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.039; Rand D, 2012, NEUROREHAB NEURAL RE, V26, P76, DOI 10.1177/1545968311408918; Rand D, 2010, AM J OCCUP THER, V64, P877, DOI 10.5014/ajot.2010.09043; Rauch A, 2008, EUR J PHYS REHAB MED, V44, P329; Reenen ETKV, 2009, DISABIL REHABIL, V31, P1338, DOI 10.1080/09638280902846855; Santello M., 2014, HUMAN HAND INSPIRATI, V1; Schaefer SY, 2013, NEUROREHAB NEURAL RE, V27, P602, DOI 10.1177/1545968313481279; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sveen U, 1999, DISABIL REHABIL, V21, P372, DOI 10.1080/096382899297477; Taub E, 2006, Eura Medicophys, V42, P241; Taub E., 2013, NEUROL REHABIL, V19, P161; Thrane G, 2011, J REHABIL MED, V43, P299, DOI 10.2340/16501977-0676; Timmermans AA, 2014, J NEUROENG REHABIL, V31, P11; Tornbom K, 2017, J STROKE CEREBROVASC, V26, P57, DOI 10.1016/j.jstrokecerebrovasdis.2016.08.029; Urbin MA, 2015, ARCH PHYS MED REHAB, V96, P854, DOI 10.1016/j.apmr.2014.11.018; Uswatte G, 2005, ARCH PHYS MED REHAB, V86, P1498, DOI 10.1016/j.apmr.2005.01.010; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Uswatte G, 2006, ARCH PHYS MED REHAB, V87, P1340, DOI 10.1016/j.apmr.2006.06.006; Uswatte G, 2006, NEUROREHABILITATION, V21, P147; van der Pas SC, 2011, ARCH PHYS MED REHAB, V92, P1437, DOI 10.1016/j.apmr.2011.02.021; Vanroy C, PLOS ONE, V9, P1; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Vega-Gonzalez A, 2005, ARCH PHYS MED REHAB, V86, P541, DOI 10.1016/j.apmr.2004.04.049; Waddell KJ, 2017, NEUROREHAB NEURAL RE, V31, P290, DOI 10.1177/1545968316680493; White MJ, 2018, PUBLIC HEALTH NUTR, V21, P2866, DOI 10.1017/S1368980018001751; WHO, 2001, WHO INT CLASS FUNCT; Winters C, 2015, NEUROREHAB NEURAL RE, V29, P614, DOI 10.1177/1545968314562115; Wolf T, 2013, DISABIL REHABIL, V35, P1143, DOI 10.3109/09638288.2012.720635; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120; Wyller TB, 1997, CLIN REHABIL, V11, P139, DOI 10.1177/026921559701100207	70	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214651	10.1371/journal.pone.0214651	http://dx.doi.org/10.1371/journal.pone.0214651			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934015	Green Published, gold, Green Submitted			2022-12-27	WOS:000462867000031
J	Kassem, E; Na'amnih, W; Bdair-Amsha, A; Zahalkah, H; Muhsen, K				Kassem, Eias; Na'amnih, Wasef; Bdair-Amsha, Amna; Zahalkah, Hazar; Muhsen, Khitam			Comparisons between ethnic groups in hospitalizations for respiratory syncytial virus bronchiolitis in Israel	PLOS ONE			English	Article							RISK-FACTORS; PALIVIZUMAB PROPHYLAXIS; YOUNG-CHILDREN; INFANTS; RSV; INFECTION; DISPARITIES; ILLNESS; BURDEN; IMPACT	Background Ethnic disparities have been shown in respiratory syncytial virus (RSV) bronchiolitis. However, it is unclear whether such differences are related to access to care. We compared demographic and clinical characteristics of Arab and Jewish children hospitalized for RSV bronchiolitis in Israel, a country with universal health insurance. Methods We reviewed the medical records of all children (n = 309) aged less than 24 months who were hospitalized with RSV between 2008 and 2011 in one medical center in Israel. Demographic, clinical, laboratory and radiological data were collected. The RSV antigen was identified using immunochromatography. Results The annual incidence of RSV hospitalization was 5.4/1000 and 6.8/1000 among Arab and Jewish children, respectively. Arab patients were significantly younger and had significantly younger parents; most lived in low socioeconomic status towns (93.7% vs. 13.3%; p<0.001) and had more siblings (median 2 vs. 1; p = 0.01) compared to Jewish patients. Disease severity did not differ between the two ethnic groups (p = 0.3). The main predictors of severe illness were having pneumonia (adjusted odds ratio [OR] 3.86; 95% confidence intervals [CI] 1.87-7.97) and history of respiratory diseases (adjusted OR 3.89; 95% CI 1.22-12.38). Conclusions The incidence of hospitalizations for RSV bronchiolitis tended to be higher among Jewish than Arab children, possibly due to differences in health care utilization patterns. Differences between the Jewish and Arab patients in demographic factors likely mirror differences between the groups in the general population. Pneumonia, and not ethnicity, affected the severity of RSV bronchiolitis.	[Kassem, Eias; Zahalkah, Hazar] Hillel Yaffe Med Ctr, Dept Pediat, Hadera, Israel; [Na'amnih, Wasef; Bdair-Amsha, Amna; Muhsen, Khitam] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Muhsen, K (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel.	kmuhsen@post.tau.ac.il		Na'amnih, Wasef/0000-0003-4457-5669				Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; [Anonymous], 2014, HLTH STAT NUTR INF B; [Anonymous], 2013, CHARACTERIZATION CLA, V1530; Ben Natan M, 2016, MIDWIFERY, V34, P173, DOI 10.1016/j.midw.2015.11.013; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Bulkow LR, 2002, PEDIATRICS, V109, P210, DOI 10.1542/peds.109.2.210; DAGAN R, 1993, PEDIATR INFECT DIS J, V12, P381, DOI 10.1097/00006454-199305000-00006; Eidelman AI, 2009, ISR MED ASSOC J, V11, P533; Englund J A, 1999, J Pediatr, V135, P38; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Fitzgerald DA, 2009, PAEDIATR RESPIR REV, V10, P143, DOI 10.1016/j.prrv.2009.06.002; Geskey JM, 2007, BIOL-TARGETS THER, V1, P33; Gilca R, 2006, J INFECT DIS, V193, P54, DOI 10.1086/498526; Goddard NL, 2007, EPIDEMIOL INFECT, V135, P159, DOI 10.1017/S0950268806006601; Grimwood K, 2008, EPIDEMIOL INFECT, V136, P1333, DOI 10.1017/S0950268807000180; Gross I, 2017, NEONATOLOGY, V111, P240, DOI 10.1159/000452196; Halasa N, 2015, VACCINE, V33, P6479, DOI 10.1016/j.vaccine.2015.08.048; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Higgins D, 2016, VACCINE, V34, P2870, DOI 10.1016/j.vaccine.2016.03.109; Holman RC, 2004, PEDIATRICS, V114, pE437, DOI 10.1542/peds.2004-0049; Homaira N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011398; Israel Central Bureau of Statistics, 2012, STAT ABSTRACTS ISR; Iwane MK, 2013, AM J EPIDEMIOL, V177, P656, DOI 10.1093/aje/kws299; Jansson L, 2002, ACTA PAEDIATR, V91, P335, DOI 10.1080/08035250252834021; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Kaaijk P, 2013, HUM VACC IMMUNOTHER, V9, P1263, DOI 10.4161/hv.24096; Law B, 1998, Paediatr Child Health, V3, P402; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Levy A, 1998, EUR J EPIDEMIOL, V14, P179, DOI 10.1023/A:1007439908351; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Modjarrad K, 2016, VACCINE, V34, P190, DOI 10.1016/j.vaccine.2015.05.093; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ohm-Smith MJ, 2004, J CLIN MICROBIOL, V42, P2996, DOI 10.1128/JCM.42.7.2996-2999.2004; Papadopoulos NG, 2004, RESP MED, V98, P879, DOI 10.1016/j.rmed.2004.01.009; Papoff P, 2011, ACTA PAEDIATR, V100, pe17, DOI 10.1111/j.1651-2227.2011.02181.x; Reeve CA, 2006, J PAEDIATR CHILD H, V42, P248, DOI 10.1111/j.1440-1754.2006.00849.x; Sangare L, 2006, J PEDIATR-US, V149, P373, DOI 10.1016/j.jpeds.2006.04.063; Selvarangan R, 2008, DIAGN MICR INFEC DIS, V62, P157, DOI 10.1016/j.diagmicrobio.2008.05.005; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Valet RS, 2013, J PEDIATR-US, V163, P1186, DOI 10.1016/j.jpeds.2013.04.029	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214197	10.1371/journal.pone.0214197	http://dx.doi.org/10.1371/journal.pone.0214197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933992	Green Submitted, Green Published, gold			2022-12-27	WOS:000462867000011
J	Ding, SB; Yuan, CY; Si, BJ; Wang, MR; Da, SY; Bai, LX; Wu, WD				Ding, Shibin; Yuan, Chunyan; Si, Bingjie; Wang, Mengruo; Da, Shuyan; Bai, Lanxin; Wu, Weidong			Combined effects of ambient particulate matter exposure and a high-fat diet on oxidative stress and steatohepatitis in mice	PLOS ONE			English	Article							LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; HEPATIC STEATOSIS; INFLAMMATION; RESPONSES; NAFLD; ATHEROSCLEROSIS; CHOLESTEROL; PROGRESSION	Background Chronic exposure to ambient particulate matter with aerodynamic diameters < 2.5 (PM2.5) induces oxidative injury and liver pathogenesis. The present study assessed the effect and mechanism of long-term, real-world airborne particulate matter (PM) exposure on oxidative stress and hepatic steatosis in the context of a standard chow diet (STD) and a high-fat diet (HFD); the study further explored whether a combination of PM exposure and HFD treatment exacerbates the adverse effects in mice. Methods C57BL/6J mice fed with STD or HFD (41.26% kcal fat) were exposed to PM or filtered air (FA) for 5 months. Lipid metabolism, oxidative stress and liver pathogenesis were evaluated. Real-time PCR and western blotting were performed to determine gene expression and molecular signal transduction in liver. Results Chronic airborne PM exposure impaired oxidative homeostasis, caused inflammation and induced hepatic steatosis in mice. Further investigation found that exposure to real-world PM increased the expression of hepatic Nrf2 and Nrf2-regulated antioxidant enzyme gene. The increased protein expression of the sterol regulatory element binding protein-1c (SREBP-1c) and fatty acid synthase (FAS) in the liver were also observed in PM-exposed groups. Furthermore, the combination of PM exposure and HFD treatment caused a synergistic effect on the changes of lipid accumulation oxidative stress, inflammation in the mouse liver. Conclusions Through in vivo study, we reveal that the combination of real-world ambient PM exposure and HFD treatment aggravates hepatic lipid metabolism disorders, inflammation and oxidative stress. PM exposure may accelerate the progression to non-alcoholic steatohepatitis by regulating SREBP-1c/FAS regulatory axis.	[Ding, Shibin; Yuan, Chunyan; Si, Bingjie; Wang, Mengruo; Da, Shuyan; Bai, Lanxin; Wu, Weidong] Xinxiang Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xinxiang, Henan, Peoples R China; [Ding, Shibin] Xinxiang Med Univ, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Xinxiang, Henan, Peoples R China	Xinxiang Medical University; Xinxiang Medical University	Ding, SB (corresponding author), Xinxiang Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xinxiang, Henan, Peoples R China.; Ding, SB (corresponding author), Xinxiang Med Univ, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Xinxiang, Henan, Peoples R China.	dingshibin@163.com			Peak Subject Project of Public Health in Xinxiang Medical University	Peak Subject Project of Public Health in Xinxiang Medical University	This work was supported by Peak Subject Project of Public Health in Xinxiang Medical University.	Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970; Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003; Bian ZL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00248; Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1; Chen T, 2013, TOXICOL LETT, V223, P146, DOI 10.1016/j.toxlet.2013.09.004; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ding SB, 2018, CHEMOSPHERE, V199, P538, DOI 10.1016/j.chemosphere.2018.02.082; Ding SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183541; Du YX, 2016, J THORAC DIS, V8, pE8, DOI 10.3978/j.issn.2072-1439.2015.11.37; Duvnjak M, 2007, WORLD J GASTROENTERO, V13, P4539, DOI 10.3748/wjg.v13.i34.4539; Foulds C, 2017, NAT REV ENDOCRINOL, V13, P445, DOI 10.1038/nrendo.2017.42; Ge CX, 2017, BIOCHEM BIOPH RES CO, V493, P1402, DOI 10.1016/j.bbrc.2017.09.152; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Laing S, 2010, AM J PHYSIOL-CELL PH, V299, pC736, DOI 10.1152/ajpcell.00529.2009; Lawal AO, 2016, TOXICOL IN VITRO, V32, P92, DOI 10.1016/j.tiv.2015.12.015; Lee MS, 2014, INT J CARDIOL, V176, P166, DOI 10.1016/j.ijcard.2014.07.012; Li JH, 2016, MOL NUTR FOOD RES, V60, P858, DOI 10.1002/mnfr.201500814; Loison C, 2002, BRIT J NUTR, V87, P199, DOI [10.1079/BJNBJN2002521, 10.1079/BJN2002521]; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Moller P, 2014, MUTAT RES-REV MUTAT, V762, P133, DOI 10.1016/j.mrrev.2014.09.001; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Qiu H, 2018, ENVIRON INT, V113, P350, DOI 10.1016/j.envint.2018.01.008; Qiu YN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16490-3; Romero-Gomez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016; Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sookoian S, 2017, CLIN MOL HEPATOL, V23, P1, DOI 10.3350/cmh.2016.0109; Sun Q, 2018, TOXICOL SCI, V164, P240, DOI 10.1093/toxsci/kfy079; Tan HH, 2009, J IMMUNOTOXICOL, V6, P266, DOI [10.3109/15476910903241704, 10.1080/15476910903241704]; Tarantino G, 2015, FUTURE MICROBIOL, V10, P889, DOI [10.2217/FMB.15.13, 10.2217/fmb.15.13]; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3951, DOI 10.3748/wjg.v19.i25.3951; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Videla LA, 2009, WORLD J HEPATOL, V1, P72, DOI 10.4254/wjh.v1.i1.72; Wallwork RS, 2017, AM J EPIDEMIOL, V185, P30, DOI 10.1093/aje/kww157; Win S, 2018, HEPATOLOGY, V67, P2013, DOI 10.1002/hep.29689; Xia SF, 2018, FOOD FUNCT, V9, P906, DOI 10.1039/c7fo01051f; Xu JX, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070787; Xu JQ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030271; Yang BY, 2018, ENVIRON RES, V164, P204, DOI 10.1016/j.envres.2018.02.029; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P2038, DOI 10.1016/j.freeradbiomed.2012.02.042; Zheng Z, 2015, J HEPATOL, V63, P1397, DOI 10.1016/j.jhep.2015.07.020; Zheng Z, 2013, J HEPATOL, V58, P148, DOI 10.1016/j.jhep.2012.08.009	48	19	20	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214680	10.1371/journal.pone.0214680	http://dx.doi.org/10.1371/journal.pone.0214680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921449	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000108
J	Kruk, J; Dziurka, M; Plytycz, B				Kruk, Jerzy; Dziurka, Michal; Plytycz, Barbara			Identification of new fluorophores in coelomic fluid of Eisenia andrei earthworms	PLOS ONE			English	Article							RIBOFLAVIN STORAGE; FLUORESCENCE; AUTOFLUORESCENCE; CELOMOCYTES; ELEOCYTES; FOETIDA	Coelomic fluid of Eisenia andrei contains a number of UV-fluorescent compounds. In the present study we have found that four of these compounds showed identical fluorescence excitation and emission maxima at 310 nm and 364 nm, respectively, suggesting they share the same chromophore. NMR and HR-MS spectroscopy of the most abundant fluorophore reavealed that its molecule is composed of two quinazoline-2,4-dione rings connected by spermine linker. This compound was earlier indentified in Eisenia andrei as SP-8203. Moreover, we have identified the structure of the two other fluorophores, one differing from SP-8203 by the absence of N-acetyl group, the compound not reported in any other organisms before, and the other already found in E. fetida and regarded as species specific. However, our results indicate that this metabolite is also present in E. andrei in significant amounts. The possible origin and function of these new metabolites is discussed.	[Kruk, Jerzy] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Plant Physiol & Biochem, Krakow, Poland; [Dziurka, Michal] Polish Acad Sci, Inst Plant Physiol, Krakow, Poland; [Plytycz, Barbara] Jagiellonian Univ, Fac Biol, Inst Zool & Biochem Res, Dept Evolutionary Immunol, Krakow, Poland	Jagiellonian University; Polish Academy of Sciences; Franciszek Gorski Institute of Plant Physiology Polish Academy of Sciences; Jagiellonian University	Kruk, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Plant Physiol & Biochem, Krakow, Poland.	jerzy.kruk@uj.edu.pl	Dziurka, Michal/H-1228-2016	Dziurka, Michal/0000-0002-8265-6243	Jagiellonian University [K/ZDS/005405]; National Centre of Science [2016/23/B/NZ8/00748]	Jagiellonian University; National Centre of Science	This research was financially supported by the Jagiellonian University (K/ZDS/005405) and the National Centre of Science (2016/23/B/NZ8/00748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani JR, 2003, PHOTOCHEM PHOTOBIOL, V78, P599, DOI 10.1562/0031-8655(2003)078<0599:FFOEFA>2.0.CO;2; Bundy JG, 2002, FEBS LETT, V521, P115, DOI 10.1016/S0014-5793(02)02854-5; Choi YH, 2009, CHROMATOGRAPHIA, V70, P1435, DOI 10.1365/s10337-009-1327-1; Cholewa J, 2006, FOLIA HISTOCHEM CYTO, V44, P65; D'yakonov A. L., 1997, Chemistry of Natural Compounds, V33, P221, DOI 10.1007/BF02234869; Davidson SK, 2013, MOL PHYLOGENET EVOL, V67, P188, DOI 10.1016/j.ympev.2012.12.005; Fior S, 2009, PLANT SCI, V176, P130, DOI 10.1016/j.plantsci.2008.10.001; Griffith CM, 2017, J PROTEOME RES, V16, P3407, DOI 10.1021/acs.jproteome.7b00439; Hadjmohamadi MR, 2008, SPECTROCHIM ACTA A, V70, P358, DOI 10.1016/j.saa.2007.10.029; Kavitha K., 2018, WORLD J PHARM PHARM, V7, P628; Koziol B, 2006, PHOTOCHEM PHOTOBIOL, V82, P570, DOI 10.1562/2005-11-23-RA-738; Lund MB, 2010, ENVIRON MICROBIOL, V12, P2142, DOI 10.1111/j.1462-2920.2009.02084.x; Martinsson S, 2018, EUR J SOIL BIOL, V88, P41, DOI 10.1016/j.ejsobi.2018.06.003; Mazur AI, 2011, PEDOBIOLOGIA, V54, pS37, DOI 10.1016/j.pedobi.2011.09.008; Mazur-Bialy AI, 2015, J PHYSIOL PHARMACOL, V66, P793; Michael JP, 2008, NAT PROD REP, V25, P166, DOI 10.1039/b612168n; MICHMAN M, 1978, ORG PREP PROCED INT, V10, P13, DOI 10.1080/00304947809354998; Noh SJ, 2011, PHARMACOL BIOCHEM BE, V100, P73, DOI 10.1016/j.pbb.2011.07.018; Noh SJ, 2011, PHARMACOL BIOCHEM BE, V98, P150, DOI 10.1016/j.pbb.2010.12.014; Plytycz B, 2016, ISJ-INVERT SURVIV J, V13, P315; Plytycz B, 2011, ISJ-INVERT SURVIV J, V8, P199; Plytycz B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204469; Plytycz B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191711; Plytycz B, 2009, ENVIRON POLLUT, V157, P3042, DOI 10.1016/j.envpol.2009.05.046; Rochfort S, 2017, EUR J SOIL BIOL, V78, P17, DOI 10.1016/j.ejsobi.2016.11.008; Rorat A, 2014, J EXP ZOOL PART A, V321, P28, DOI 10.1002/jez.1834; Santocki M, 2016, FOLIA BIOL-KRAKOW, V64, P121, DOI 10.3409/fb64_2.121; Santocki M, 2016, APPL SOIL ECOL, V104, P163, DOI 10.1016/j.apsoil.2015.08.022	28	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214757	10.1371/journal.pone.0214757	http://dx.doi.org/10.1371/journal.pone.0214757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921437	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000110
J	Amulen, DR; D'Haese, M; D'Haene, E; Acai, JO; Agea, JG; Smagghe, G; Cross, P				Amulen, Deborah Ruth; D'Haese, Marijke; D'Haene, Eline; Acai, James Okwee; Agea, Jacob Godfrey; Smagghe, Guy; Cross, Paul			Estimating the potential of beekeeping to alleviate household poverty in rural Uganda	PLOS ONE			English	Article							ADOPTION; TECHNOLOGY; BEHAVIOR	Robust evidence underpinning the role of beekeeping in poverty alleviation is currently lacking. This study estimated the production potential for beekeepers in Northern Uganda by quantifying current production assets (equipment and knowledge) and impact on rural income streams range of proposed interventions. Intervention scenarios evaluated the economic benefits to be derived from different hive types combined with year-round provision of a nectar source (Calliandra calothyrsus) planted at varying density. Findings show that the type and number of beehive combinations used influenced the amount of revenue streams generated by the beekeepers. Addition of 20 log hives increased incomes 10 times, 20 KTBs increased revenues 16 times and Langstroth 18 times. Adding Calliandra trees as a forage source to the baseline scenario yielded revenues up to 17.6 times higher than the baseline. Implying that good management plus the introduction of a reliable nectar source, to off-set dry season challenges (absconding), could improve beekeeping productivity in Northern Uganda. Further research is required to validate in situ the impact of modelled scenarios on both honey yield and other ecosystem service benefits.	[Amulen, Deborah Ruth; Acai, James Okwee] Makerere Univ, Dept Livestock Ind Resources, Kampala, Uganda; [Amulen, Deborah Ruth; Smagghe, Guy] Univ Ghent, Dept Plants & Crops, Ghent, Belgium; [D'Haese, Marijke; D'Haene, Eline] Univ Ghent, Dept Agr Econ, Ghent, Belgium; [Agea, Jacob Godfrey] Makerere Univ, Dept Extens & Innovat Studies, Kampala, Uganda; [Cross, Paul] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales	Makerere University; Ghent University; Ghent University; Makerere University; Bangor University	Amulen, DR (corresponding author), Makerere Univ, Dept Livestock Ind Resources, Kampala, Uganda.; Amulen, DR (corresponding author), Univ Ghent, Dept Plants & Crops, Ghent, Belgium.	amulendeborah@gmail.com	Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; D'Haene, Eline/0000-0002-6261-4353; D'Haese, Marijke/0000-0002-0544-3420	Erasmus Mundus Action 2-CARIBU grant	Erasmus Mundus Action 2-CARIBU grant	The study was part of a PhD exchange scholarship to Deborah Ruth Amulen covered under Erasmus Mundus Action 2-CARIBU grant (http://www.caribu.be/). The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgaba N, 2014, J ANIM PLANT SCI, V24, P1876; Aemera J., 2014, MONEY IS HONEY, V18; Al-Ghamdi A, 2016, SAUDI J BIOL SCI, V23, P92, DOI 10.1016/j.sjbs.2014.09.020; Amulen DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172820; Arslan A, 2014, AGR ECOSYST ENVIRON, V187, P72, DOI 10.1016/j.agee.2013.08.017; Awotide B. A, 2014, J DEV AGR EC; Bees for Development, 2006, EN SMALL COMM PROD D; Boland DJ, 1996, FOR FARM COMM TREE R, P49; Bradbear N., 2009, NONWOOD FOREST PRODU; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Buyinza Mukadazi, 2007, UGANDA J APPL SCI, V2, P1087; Carroll T, 2013, DEV PRACT, V23, P332, DOI 10.1080/09614524.2013.781123; Centenary Bank, 2014, CENT BANK ANN REP, V8; Chamberlain J.R, 2001, CALLIANDRA CALOTHYRS; Chamberlain JR, 1996, FOR FARM COMM TREE R, P34; Chemurot M., 2013, Bee World, V90, P33; Dafni A, 2005, PRACT POLLINAT BIOL, P274; David S, 2003, AGR ECOSYST ENVIRON, V95, P359, DOI 10.1016/S0167-8809(02)00046-4; Diederen P., 2003, Cahiers d'Economie et Sociologie Rurales, P29; Dubale Bekele Tesfaye, 2015, BEEKEEPING PRACTICES; FEDER G, 1993, TECHNOL FORECAST SOC, V43, P215, DOI 10.1016/0040-1625(93)90053-A; Ghadim AKA, 1999, AGR ECON-BLACKWELL, V21, P145, DOI 10.1016/S0169-5150(99)00023-7; Government of Kenya, 2009, NAT BEEK POL; Gupta RC, 2014, BIOMARKERS IN TOXICOLOGY, P3, DOI 10.1016/B978-0-12-404630-6.00001-4; Hacura A, 2001, EUR PHYS J B, V20, P551, DOI 10.1007/s100510170238; Hernandez-Conrique D, 2007, BIOTROPICA, V39, P459, DOI 10.1111/j.1744-7429.2007.00277.x; Hilmi M, 2011, BEEKEEPING SUSTAINAB, P1; Hope Aldo, 2011, USING MULTIPLE PARTN; Kalanzi F, 2015, INT J RES LAND USE S, V2, P81, DOI DOI 10.13140/RG.2.1.2647.4329; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kumar Mishra P, 2014, INDIA SOURCE MT RES, P27; LAWAL B, 2003, CATEGORICAL DATA ANA; Macqueen D. J., 1992, Commonwealth Forestry Review, V71, P20; Majaliwa JGM, 2010, 2 REFORUM BIENN M 20; Malede Birhan, 2015, ACAD J ENTOMOL, V8, P127; Mwakalalukwa E. E., 2016, APIEXPO AFRICA 2016; Okwee-Acai James, 2010, LIVEST RES RURAL DEV, V22; Platon V, 2014, PROC ECON FINANC, V15, P393, DOI 10.1016/S2212-5671(14)00463-8; Poedianto M., 1980, CALLIANDRA PLANTATIO; Robert Kajobe, 2009, NATL BEEKEEPING CALE; Rodriguez M, 2015, AGR SYST, V135, P122; Saturni FT, 2016, AGR ECOSYST ENVIRON, V235, P1, DOI 10.1016/j.agee.2016.10.008; Simtowe F., 2011, Quarterly Journal of International Agriculture, V50, P325; Simtowe F, 2013, DIFFUSION ADOPTION G, V13, P2; Torne-Noguera A, 2016, BASIC APPL ECOL, V17, P199, DOI 10.1016/j.baae.2015.11.004; TUNADO, 2012, NAT AP MULT PLATF WO; UBOS MAAIF, 2009, NAT LIV CENS REP; Wagner K., 2019, J RURAL STUD; Yildirim I, 2008, ASIAN J ANIM VET ADV, V3, P314, DOI 10.3923/ajava.2008.314.320; Yirga G, 2010, NO ETHIOPIA AGR J, V5, P201; Yirga G, 2010, MOMONA ETHIOP J SCI, V2, P76, DOI 10.4314/mejs.v2i1.49654	51	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214113	10.1371/journal.pone.0214113	http://dx.doi.org/10.1371/journal.pone.0214113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917187	Green Published, gold			2022-12-27	WOS:000462465800052
J	Mutua, MM; Achia, TNO; Manderson, L; Musenge, E				Mutua, Michael M.; Achia, Thomas N. O.; Manderson, Lenore; Musenge, Eustasius			Spatial and socio-economic correlates of effective contraception among women seeking post-abortion care in healthcare facilities in Kenya	PLOS ONE			English	Article							FAMILY-PLANNING-SERVICES; ABORTION SERVICES; PREGNANCY; ATTITUDES	Introduction Information, counseling, availability of contraceptives, and their adoption by post-abortion care (PAC) patients are central to the quality of PAC in healthcare facilities. Effective contraceptive adoption by these patients reduces the risks of unintended pregnancy and repeat abortion. Methods This study uses data from the Incidence and Magnitude of Unsafe Abortion Study of 2012 to assess the level and determinants of highly effective contraception among patients treated with complications from an unsafe abortion in healthcare facilities in Kenya. Highly effective contraception was defined as any method adopted by a PAC patient that reduces pregnancy rate by over 99%. Results Generally, contraceptive counseling was high among all PAC patients (90%). However, only 54% of them received a modern family planning method-45% a short-acting method and 9% a long-acting and permanent method. Adoption of highly effective contraception was determined by patient's previous exposure to unintended pregnancies, induced abortion and modern family planning (FP). Facility level factors associated with the uptake of highly effective contraceptives included: facility ownership, availability of evacuation procedure room, whether the facility had a specialized obstetric-gynecologist, a facility that also had maternity services and the number of FP methods available for PAC patients. Discussion and conclusion For better adoption of highly effective FP, counseling of PAC patients requires an understanding of the patient's past experience with contraception and their future fertility intentions and desires in order to meet their reproductive needs more specifically. Family planning integration with PAC can increase contraceptive uptake and improve the reproductive health of post-abortion care patients.	[Mutua, Michael M.] APHRC, Nairobi, Kenya; [Mutua, Michael M.; Achia, Thomas N. O.; Manderson, Lenore; Musenge, Eustasius] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Achia, Thomas N. O.] Ctr Dis Control & Prevent, Nairobi, Kenya; [Manderson, Lenore] Brown Univ, IBES, Providence, RI 02912 USA	African Population & Health Research Centre; University of Witwatersrand; Brown University	Mutua, MM (corresponding author), APHRC, Nairobi, Kenya.; Mutua, MM (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	mmutua@aphrc.org	Achia, Thomas N. O./I-3674-2013	Achia, Thomas N. O./0000-0002-0700-9468	Consortium for Advanced Research Training in Africa (CARTA); Consortium for Research on Unsafe Abortion in Africa; Wellcome Trust (UK) [087547/Z/08/Z]; Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York [B 8606]; Ford Foundation [1100-0399]; Google. Org [191994]; Sida [54100029]; John D. and Catherine T. MacArthur Foundation [10-95915-000-INP]	Consortium for Advanced Research Training in Africa (CARTA); Consortium for Research on Unsafe Abortion in Africa; Wellcome Trust (UK)(Wellcome Trust); Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York; Ford Foundation; Google. Org; Sida; John D. and Catherine T. MacArthur Foundation	Consortium for Advanced Research Training in Africa (CARTA) The study on which we draw is based on research funded by the Consortium for Research on Unsafe Abortion in Africa and its principal donors, the UK Department for International Development, and the Government of the Netherlands. MM's analysis and writing time was supported through funding from the Consortium for Advanced Research Training in Africa (CARTA), a jointly led consortium by the African Population and Health Research Center and the University of the Witwatersrand and is funded by the Wellcome Trust (UK) [Grant no. 087547/Z/08/Z], the Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE), the Carnegie Corporation of New York [Grant no. B 8606], the Ford Foundation [Grant no. 1100-0399], Google. Org [Grant no. 191994], Sida [grant number 54100029] and John D. and Catherine T. MacArthur Foundation [Grant no. 10-95915-000-INP].	[Anonymous], 2013, BAYESIAN DIS MAPPING; [Anonymous], 2011, FAMILY PLANNING GLOB; Bakibinga P, 2016, J RELIG HEALTH, V55, P192, DOI 10.1007/s10943-015-0030-9; Banerjee S, 2004, BIOMETRICS, V60, P268, DOI 10.1111/j.0006-341X.2004.00032.x; Banerjee S., 2014, HIERARCHICAL MODELIN; Banerjee SK, 2015, STUD FAMILY PLANN, V46, P387, DOI 10.1111/j.1728-4465.2015.00039.x; Basu S., 2016, INT STAT REV, V84, P159; Belitz C., 2015, SOFTWARE BAYESIAN IN; Benson J, 2018, GLOB PUBLIC HEALTH, V13, P35, DOI 10.1080/17441692.2016.1174280; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Biney Adriana A E, 2011, Afr J Reprod Health, V15, P37; Boes S, 2006, ALLGEMEINES STAT ARC, P167, DOI [DOI 10.1007/S10182-006-0228-Y, 10.1007/s10182-006-0228-y]; Borges ALV, 2016, POSTABORTION CONTRAC, P32; Bradley EH, 2002, HEALTH SERV RES, V37, P1221, DOI 10.1111/1475-6773.01053; Center for Reproductive Rights, 2010, HARMS WAY IMP KEN RE; Curtis C, 2010, INT PERSPECT SEX R H, V36, P44, DOI 10.1363/ipsrh.36.044.10; Earnest A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-54; Gemzell-Danielsson K, 2015, WOMENS HEALTH, V11, P779, DOI 10.2217/whe.15.72; HATCHER RA, 2007, CONTRACEPTIVE TECHNO; Juma PA, 2015, AFR HEALTH SCI, V15, P161, DOI 10.4314/ahs.v15i1.22; Keene M, 2015, CONTRACEPTION, V91, P398, DOI 10.1016/j.contraception.2014.10.011; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2014, KEN DEM HLTH SURV; Langer A, 1997, REPROD HEALTH MATTER, V5, P20; Lawson AB, 1977, STAT METHODS SPAT EP, P363; Madden T, 2013, CONTRACEPTION, V88, P243, DOI 10.1016/j.contraception.2012.07.015; Marston C, 2003, INT FAM PLAN PERSPEC, V29, P6, DOI 10.2307/3180995; Mutombo N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004643; Mutua MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204240; Naanyu Violet, 2013, Afr J Reprod Health, V17, P44; National Coordinating Agency for Population and Development (NCAPD) [Kenya] Ministry of Medical Services (MOMS) [Kenya] Ministry of Public Health and Sanitation (MOPHS) [Kenya] Kenya National Bureau of Statistics (KNBS) [Kenya] ICF Macro, 2011, KEN SERV PROV ASS SU; Nguyen MH, 2007, REPROD HEALTH MATTER, V15, P172, DOI 10.1016/S0968-8080(07)29283-3; Nobili MP, 2007, PATIENT ED COUNS; Ohannessian A, 2016, J GYNECOL OBST BIO R, V45, P1568, DOI 10.1016/j.jgyn.2016.09.017; Olenick I, 2000, INT FAM PLAN PERSPEC, V26, P48, DOI 10.2307/2648294; Opollo VSA, 2017, IMP HIV AIDS SCAL UP; Osur J, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19649; Patel R, 2014, AIDS PATIENT CARE ST, V28, P418, DOI 10.1089/apc.2014.0046; Prata N, 2013, AFR J REPROD HLTH, V17; Roberts H, 2010, CONTRACEPTION, V82, P260, DOI 10.1016/j.contraception.2010.03.003; Schreiber CA, 2011, CONTRACEPTION, V84, P230, DOI 10.1016/j.contraception.2011.01.013; Schunmann C, 2006, HUM REPROD, V21, P2296, DOI 10.1093/humrep/del168; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4; Senlet P, 2001, INT FAM PLAN PERSPEC, V27, P90, DOI 10.2307/2673821; Solo J, 1999, STUD FAMILY PLANN, V30, P17, DOI 10.1111/j.1728-4465.1999.00017.x; Thompson KMJ, 2011, CONTRACEPTION, V83, P41, DOI 10.1016/j.contraception.2010.06.008; World Health Organization, 2013, UNS AB GLOB REG EST; World Health Organization, 2005, REP WHO TECHN CONS B; Zhu JL, 2009, EUR J CONTRACEP REPR, V14, P46, DOI 10.1080/13625180802512994	49	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214049	10.1371/journal.pone.0214049	http://dx.doi.org/10.1371/journal.pone.0214049			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917161	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800048
J	Zhang, H; Gordon, R; Li, WQ; Yang, XM; Pattanayak, A; Fowler, G; Zhang, LM; Catalona, WJ; Ding, YZ; Xu, L; Huang, XK; Jovanovic, B; Kelly, DL; Jiang, HW; Bergan, R				Zhang, Hu; Gordon, Ryan; Li, Wenqi; Yang, Ximing; Pattanayak, Abhinandan; Fowler, Graham; Zhang, Limin; Catalona, William J.; Ding, Yongzeng; Xu, Li; Huang, Xiaoke; Jovanovic, Borko; Kelly, David L.; Jiang, Haowen; Bergan, Raymond			Genistein treatment duration effects biomarkers of cell motility in human prostate	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE TYPE-2; CANCER; INVASION; ACTIVATION; EXPRESSION; PROTEIN; RISK; METASTASIS; IMMIGRANTS; ROLES	Background Long term dietary consumption of genistein by Chinese men is associated with decreased PCa metastasis and mortality. Short term treatment of US men with prostate cancer (PCa) with genistein decreases MMP-2 in prostate tissue. MEK4 regulates MMP-2 expression, drives PCa metastasis, and genistein inhibits MEK4, decreases MMP-2 expression and dietary dosing inhibits human PCa metastasis in mice. This study examines short-versus longterm treatment effects of genistein in humans and in vitro. Methods and findings US men with localized PCa were treated on a phase II trial with genistein (N = 14) versus not (N = 14) for one month prior to radical prostatectomy. Prostate epithelial cells were removed from fresh frozen tissue by laser capture microdissection, and the expression of 12,000 genes profiled. Genistein significantly altered the expression of four genes, three had established links to cancer cell motility and metastasis. Of these three, one was a non-coding transcript, and the other two were BASP1 and HCF2. Genistein increased BASP1 expression in humans, and its engineered over expression and knockdown demonstrated that it suppressed cell invasion in all six human prostate cell lines examined. Genistein decreased HCF2 expression in humans, and it was shown to increase cell invasion in all cell lines examined. The expression of MMP-2, MEK4 and BASP1 was then measured in formalin fixed prostate tissue from N = 38 Chinese men living in China and N = 41 US men living in the US, both cohorts with localized PCa. MMP-2 was 52% higher in Chinese compared to US tissue (P < 0.0001), MEK4 was 48% lower (P < 0.0001), and BASP1 was unaltered. Treatment of PC3 human PCa cells in vitro for up to 8 weeks demonstrated that short term genistein treatment decreased MMP-2, while long term treatment increased it, both changes being significant (P<0.05) compared to untreated control cells. Long term genistein-treated cells retained their responsiveness to genistein's anti-motility effect. Conclusions Genistein inhibits pathways in human prostate that drive transformation to a lethal high motility phenotype. Long term treatment induces compensatory changes in biomarkers of efficacy. The current strategy of using such biomarkers after short term intervention as go/ no-go determinants in early phase chemoprevention trials should be carefully examined.	[Zhang, Hu; Gordon, Ryan; Li, Wenqi; Pattanayak, Abhinandan; Fowler, Graham; Zhang, Limin; Bergan, Raymond] Oregon Hlth & Sci Univ, Div Hematol Oncol, Knight Canc Inst, Portland, OR 97201 USA; [Zhang, Hu; Zhang, Limin; Jiang, Haowen] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai, Peoples R China; [Yang, Ximing] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Catalona, William J.] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Ding, Yongzeng; Huang, Xiaoke] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Xu, Li] Xiamen Univ, Xiangan Hosp, Dept Gastroenterol, Xiamen, Fujian, Peoples R China; [Jovanovic, Borko] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Kelly, David L.] Univ Nebraska Med Ctr, Fred & Pamela Buffet Canc Ctr, Omaha, NE USA	Oregon Health & Science University; Fudan University; Northwestern University; Northwestern University; Northwestern University; Xiamen University; Northwestern University; University of Nebraska System; University of Nebraska Medical Center	Bergan, R (corresponding author), Oregon Hlth & Sci Univ, Div Hematol Oncol, Knight Canc Inst, Portland, OR 97201 USA.; Jiang, HW (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai, Peoples R China.	urology_hs@163.com; bergan@ohsu.edu	Pattanayak, Abhinandan/K-8905-2013	Pattanayak, Abhinandan/0000-0001-5822-6430	U.S. Department of Veterans Affairs [IBX002842A]; National Institutes of Health [R01 CA122985]; Prostate SPORE [CA90386, P30 CA069533, 16140903600]; Science and Technology Commission Shanghai Municipality; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate SPORE; Science and Technology Commission Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported with funding to R.B. by the U.S. Department of Veterans Affairs (IBX002842A) and the National Institutes of Health (R01 CA122985, Prostate SPORE CA90386 and P30 CA069533), and to H.J. from grant (16140903600) from Science and Technology Commission Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1993, LANCET, V342, P1209, DOI 10.1016/0140-6736(93)92188-Y; Applegate CC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010040; Breen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072407; Chan PSF, 1999, PROSTATE, V41, P99; Cook LS, 1999, J UROLOGY, V161, P152, DOI 10.1016/S0022-5347(01)62086-X; Craft CS, 2008, MOL PHARMACOL, V73, P235, DOI 10.1124/mol.107.038935; Ding Y, 2006, PROSTATE CANCER P D, V9, P379, DOI 10.1038/sj.pcan.4500888; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; HOFFMAN M, 1991, BIOCHIM BIOPHYS ACTA, V1095, P78, DOI 10.1016/0167-4889(91)90047-2; Huang XK, 2005, CANCER RES, V65, P3470, DOI 10.1158/0008-5472.CAN-04-2807; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; Lee MM, 2003, CANCER EPIDEM BIOMAR, V12, P665; Liu YQ, 2001, PROSTATE CANCER P D, V4, P81, DOI 10.1038/sj.pcan.4500506; Magee JA, 2001, CANCER RES, V61, P5692; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Pavese JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102289; Pavese JM, 2014, AM J CLIN NUTR, V100, p431S, DOI 10.3945/ajcn.113.071290; Reis ST, 2012, INT BRAZ J UROL, V38, P167, DOI 10.1590/S1677-55382012000200004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHIMIZU H, 1991, BRIT J CANCER, V63, P963, DOI 10.1038/bjc.1991.210; Takimoto CH, 2003, CANCER EPIDEM BIOMAR, V12, P1213; Voll EA, 2014, ONCOTARGET, V5, P2648, DOI 10.18632/oncotarget.1917; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Wu YS, 2015, INT UROL NEPHROL, V47, P965, DOI 10.1007/s11255-015-0981-5; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Xu L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04465-5; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Zhang Q, 2017, INT J FOOD SCI NUTR, V68, P28, DOI 10.1080/09637486.2016.1216525	31	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214078	10.1371/journal.pone.0214078	http://dx.doi.org/10.1371/journal.pone.0214078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917169	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800051
J	Akole, A; Warner, JM				Akole, Ajit; Warner, Jason M.			Model of influenza virus acidification	PLOS ONE			English	Article							KINETICS; FUSION; PROTON; PH	Internal acidification of the influenza virus, mediated by the M2 proton channel, is a key step in its life cycle. The interior M1 protein shell dissolves at pH similar to 5.5 to 6.0, allowing the release of vRNA to the cytoplasm upon fusion of the viral envelope with the endosomal membrane. Previous models have described the mechanisms and rate constants of M2-mediated transport but did not describe the kinetics of pH changes inside the virus or consider exterior pH changes due to endosome maturation. Therefore, we developed a mathematical model of M2-mediated virion acidification. We find that similar to 32,000 protons are required to acidify a typically-sized virion. Predicted acidification kinetics were consistent with published in vitro experiments following internal acidification. Finally, we applied the model to the in vivo situation. For all rates of endosomal maturation considered, internal acidification lagged similar to 1 min behind endosomal acidification to pH 6. For slow endosomal maturation requiring several minutes or more, internal and endosomal pH decay together in pseudo-equilibrium to the late endosomal pH similar to 5.0. For fast endosomal maturation (less than or similar to 2 min), a lag of tens of seconds continued toward the late endosomal pH. Recent experiments suggest in vivo maturation is in this "fast" regime where lag is considerable. We predict that internal pH reaches the threshold for M1 shell solvation just before the external pH triggers membrane fusion mediated by the influenza protein hemagglutinin, critical because outward proton diffusion through a single small fusion pore is faster than the collective M2-mediated transport inward.	[Akole, Ajit; Warner, Jason M.] St Lukes Sch, New Canaan, CT 06840 USA		Warner, JM (corresponding author), St Lukes Sch, New Canaan, CT 06840 USA.	warnerj@stlukesct.org		Warner, Jason/0000-0003-4675-3385	St. Luke's School	St. Luke's School	St. Luke's School funded this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batishchev OV, 2016, J VIROL, V90, P575, DOI 10.1128/JVI.01539-15; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Dadonaite B, 2016, J GEN VIROL, V97, P1755, DOI 10.1099/jgv.0.000535; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; HALL JE, 1975, J GEN PHYSIOL, V66, P531, DOI 10.1085/jgp.66.4.531; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Ivanovic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031566; Lagachelt T, 2017, FRONT PHYS, V5, DOI 10.3389/fphy2017DOC25; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13; Lee SH, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3632990; Leiding T, 2010, P NATL ACAD SCI USA, V107, P15409, DOI 10.1073/pnas.1009997107; Li S, 2014, BIOPHYS J, V106, P1447, DOI 10.1016/j.bpj.2014.02.018; MELIKYAN GB, 1993, J GEN PHYSIOL, V102, P1151, DOI 10.1085/jgp.102.6.1151; MELIKYAN GB, 1995, J GEN PHYSIOL, V106, P783, DOI 10.1085/jgp.106.5.783; NCBI, 1998, P NATL ACAD SCI USA, V105, P15382; Pielak RM, 2010, J AM CHEM SOC, V132, P17695, DOI 10.1021/ja108458u; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Schmitt AP, 2005, ADV VIRUS RES, V64, P383, DOI 10.1016/S0065-3527(05)64012-2; Sehgal AA, 2014, CHEM-EUR J, V20, P6332, DOI 10.1002/chem.201304992; Shtykova EV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16986-y; Shtykova EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082431; Sundberg R.J., 2007, ADV ORGANIC CHEM A; Zaraket H, 2013, J VIROL, V87, P4826, DOI 10.1128/JVI.03110-12	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214448	10.1371/journal.pone.0214448	http://dx.doi.org/10.1371/journal.pone.0214448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946753	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500032
J	De Castro, R; Ruiz, D; Lavin, BA; Lamsfus, JA; Vazquez, L; Montalban, C; Marcano, G; Sarabia, R; Paz-Zulueta, M; Blanco, C; Santibanez, M				De Castro, Rocio; Ruiz, David; Lavin, Bernardo-Alio; Angel Lamsfus, Jose; Vazquez, Luis; Montalban, Coral; Marcano, Gilberto; Sarabia, Raquel; Paz-Zulueta, Maria; Blanco, Cristina; Santibanez, Miguel			Cortisol and adrenal androgens as independent predictors of mortality in septic patients	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; DEHYDROEPIANDROSTERONE-SULFATE; CRITICAL ILLNESS; SERUM DEHYDROEPIANDROSTERONE; ANTIINFLAMMATORY THERAPIES; INTENSIVE-CARE; SEPSIS; SHOCK; HORMONES	Objective To determine the prognostic value of cortisol, Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-sulfate (DHEAS), together with their ratios (cortisol/DHEA and cortisol/DHEAS), as independent predictors of mortality in septic patients. Methods Prospective cohort study of 139 consecutive patients with a diagnosis of severe sepsis or septic shock. Adrenal hormones were determined within the first 24 hours of the septic process. To determine and compare the predictive ability of each marker for the risk of unfavorable evolution (in-hospital, 28-day and 90-day mortality), ROC (Receiver Operating Characteristic) curves were constructed and the area under the curve (AUC) was determined. As measures of association, adjusted odds ratios (OR) with their 95% confidence intervals (95%CI) were estimated by unconditional logistic regression. Cortisol, DHEA and DHEAS results were compared to lactate, CRP, SOFA and APACHE II Scores. Results Cortisol showed the best predictive ability, with AUCs of 0.758, 0.759 and 0.705 for in-hospital mortality, and 28-day and 90-day mortality, respectively; whereas AUCs for 28 days mortality for SOFA and APACHE II scores, and other biomarkers studied, such as Lactate or CRP, were 0.644, 0.618, 0.643 and 0.647, respectively. Associations between high cortisol levels (>17.5 pg/dL) and mortality were strong and statistically significant for in-hospital and 28-day mortality: adjusted ORs 10.13 and 9.45 respectively, and lower for long term mortality (90 days): adjusted OR 4.26 (95% CI 1.34-13.56), p trend 0.014. Regarding adrenal androgens, only positive associations were obtained for DHEAS and most of these positive associations did not yield statistical significance. Regarding Cortisol/DHEA and cortisol/DHEAS ratios, they did not improve the predictive ability of cortisol. The only exception was the cortisol/DHEAS ratio, which was the best predictor of mortality at 90 days (AUC 0.737), adjusted OR for highest cortisol/DHEAS ratio values 6.33 (95%CI 1.77-22.60), p trend 0.002. Conclusion Basal cortisol measured within the first 24 hours of the septic process was the best prognostic factor for in-hospital and 28-day mortality, even superior to the Sequential Organ Failure Assessment (SOFA) or Acute Physiology and Chronic Health Evaluation II (APACHE II) scores. The cortisol/DHEAS ratio was an independent predictor of long-term mortality.	[De Castro, Rocio; Angel Lamsfus, Jose; Marcano, Gilberto] Sierrallana Hosp, Anesthesiol Serv, Torrelavega, Spain; [Ruiz, David; Vazquez, Luis; Montalban, Coral] Marques de Valdecilla Univ Hosp, Serv Endocrinol, Santander, Spain; [Lavin, Bernardo-Alio] Marques de Valdecilla Univ Hosp, Clin Anal Serv, Santander, Spain; [Sarabia, Raquel; Paz-Zulueta, Maria; Blanco, Cristina; Santibanez, Miguel] Univ Cantabria, Dept Nursing, IDIVAL, Santander, Spain; [Blanco, Cristina; Santibanez, Miguel] Univ Cantabria, Global Hlth Res Grp, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Universidad de Cantabria	Ruiz, D (corresponding author), Marques de Valdecilla Univ Hosp, Serv Endocrinol, Santander, Spain.	david.ruiz@scsalud.es	Santibanez, Miguel/L-3323-2017	Santibanez, Miguel/0000-0003-2634-615X; Vazquez, Luis Alberto/0000-0003-4929-4479; Ruiz Ochoa, David/0000-0002-9622-6121; Lamsfus-Prieto, Jose-Angel/0000-0002-2241-8198				Ai JT, 2015, CRIT CARE MED, V43, pE490, DOI 10.1097/CCM.0000000000001264; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Arlt W, 2006, J CLIN ENDOCR METAB, V91, P2548, DOI 10.1210/jc.2005-2258; Bendel S, 2008, ANESTH ANALG, V106, P1813, DOI 10.1213/ane.0b013e318172fdba; Bergquist Maria, 2015, Intensive Care Med Exp, V3, P59, DOI 10.1186/s40635-015-0059-9; Boonen E, 2014, J CLIN ENDOCR METAB, V99, P4214, DOI 10.1210/jc.2014-2429; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; Charoensri S, 2017, J CLIN TRANSL ENDOCR, V7, P42, DOI 10.1016/j.jcte.2017.01.001; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dimopoulou I, 2007, INTENS CARE MED, V33, P2116, DOI 10.1007/s00134-007-0790-0; Freeman BD, 2000, EXPERT OPIN INV DRUG, V9, P1651, DOI 10.1517/13543784.9.7.1651; Hazeldine J, 2010, J STEROID BIOCHEM, V120, P127, DOI 10.1016/j.jsbmb.2009.12.016; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Marx C, 2003, CRIT CARE MED, V31, P1382, DOI 10.1097/01.CCM.0000063282.83188.3D; Mueller C., 2014, PLoS ONE, V9, pe99518, DOI 10.1371/journal.pone.0099518; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Venkatesh B, 2015, CRIT CARE MED, V43, P630, DOI 10.1097/CCM.0000000000000750; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Widmer IE, 2005, J CLIN ENDOCR METAB, V90, P4579, DOI 10.1210/jc.2005-0354; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001; Zhang Q, 2014, INTENS CARE MED, V40, P1499, DOI 10.1007/s00134-014-3468-4	26	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e02144312	10.1371/journal.pone.0214312	http://dx.doi.org/10.1371/journal.pone.0214312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946764	Green Published, gold			2022-12-27	WOS:000463314500026
J	Li, WG; Zhang, ZK				Li, Weiguang; Zhang, Zhankuan			Effect of cutting tool with micro-pits texture on wood cutting performance	PLOS ONE			English	Article							FRICTION; CONTACT	A reasonable micro-pits texture has been initially proved that it can improve friction characteristics between wood and cemented carbide surface and reduce surface friction coefficient. In order to study the cutting performance of the micro-texture when it is applied to the cutting tool for cutting wood more effectively, this paper selected micro-pit texture for studying influence of surface micro-texture cutting tool on wood cutting performance and cutting temperature, finding that when micro-pit cemented carbide cutting tool is adopted for turning the northeast China ash (Fraxinus spp.), it can reduce cutting force of turning and surface friction coefficient between rake face and cuttings. Moreover, for type A and type B cutting tools, when the texture parameters are that the diameter of the micro-pit is 80 mu m, the depth of the micro pit is: 10 mu m, area occupancy is 20% and the diameter of the micro-pit is 120 mu m, the depth of the micro-pit is 10 mu m and the area occupancy is 20%, the effect generated is the best. When a texture cutting tool is used for cutting, the decrease of the highest temperature in the cutting area is not very great, but the average temperature in the cutting area changes a lot, which is mainly caused by that micro-texture is processed at a position of the rake face close to the main cutting edge and that the highest temperature of cutting is mainly generated on the contact point between tool tip and wood. A reasonable micro-texture parameter can form a layer of liquid lubricating film on the up and down contact surfaces such that the direct contact between cemented carbide and northeast China ash is changed into indirect contact between lubricating films formed by the liquid so as to reduce the surface friction coefficient.	[Li, Weiguang] Chinese Acad Forestry, Res Inst Forestry New Technol, Beijing, Peoples R China; [Zhang, Zhankuan] Chinese Acad Forestry, Res Inst Wood Ind, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry New Technology, CAF; Chinese Academy of Forestry; Research Institute of Wood Industry, CAF	Li, WG (corresponding author), Chinese Acad Forestry, Res Inst Forestry New Technol, Beijing, Peoples R China.	liwg@caf.ac.cn			Fundamental Research Funds of the Research Institute of Forest New Technology, CAF [CAFYBB2018SZ015]	Fundamental Research Funds of the Research Institute of Forest New Technology, CAF	The authors are very grateful for financial support from the "Fundamental Research Funds of the Research Institute of Forest New Technology, CAF" (CAFYBB2018SZ015 to WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer P, 2005, TRIBOL LETT, V18, P373, DOI 10.1007/s11249-004-2767-2; Beer P, 2007, TRIBOL LETT, V27, P155, DOI 10.1007/s11249-007-9212-2; Cao PX, 1997, CHINA FORESTRY SCI T, V6, P10; Duan R, 2018, INT J ADV MANUF TECH, V95, P973, DOI 10.1007/s00170-017-1285-y; GUAN N, 1983, HOLZ ROH WERKST, V41, P55, DOI 10.1007/BF02612232; Guo XL, 2018, ADV APPL CERAM, V117, P16, DOI 10.1080/17436753.2017.1368946; Kawasegi N, 2009, PRECIS ENG, V33, P248, DOI 10.1016/j.precisioneng.2008.07.005; KLAMECKI BE, 1976, WOOD SCI TECHNOL, V10, P209, DOI 10.1007/BF00355741; Li WeiGuang, 2018, Journal of Forestry Engineering, V3, P103; MCKENZIE WM, 1968, WOOD SCI TECHNOL, V2, P138; MCKENZIE WM, 1991, WOOD SCI TECHNOL, V25, P397, DOI 10.1007/BF00226179; McKenzie WM, 1961, NIPPON NOGEIKAGAKU K, V42, P152; Mcmillin C. W, 1970, FRICTION COEFFICIENT; Murase Y, 1979, MOKUZAI GAKKAISHI, V25, P264; Murase Y., 1980, MOKUZAI GAKKAISHI, V26, P571; Ohtani T, 2016, J WOOD SCI, V62, P377, DOI 10.1007/s10086-016-1560-9; Seki M, 2016, J WOOD SCI, V62, P233, DOI 10.1007/s10086-016-1551-x; Szwajka K, 2018, BIORESOURCES, V13, P8263, DOI 10.15376/biores.13.4.8263-8278	18	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214888	10.1371/journal.pone.0214888	http://dx.doi.org/10.1371/journal.pone.0214888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947288	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500078
J	Mohanty, PS; Bansal, AK; Naaz, F; Arora, M; Gupta, UD; Gupta, P; Sharma, S; Singh, H				Mohanty, Partha Sarathi; Bansal, Avi Kumar; Naaz, Farah; Arora, Mamta; Gupta, Umesh Datta; Gupta, Pushpa; Sharma, Sandeep; Singh, Haribhan			Multiple strain infection of Mycobacterium leprae in a family having 4 patients: A study employing short tandem repeats	PLOS ONE			English	Article							TTC REPEATS; LEPROSY; IDENTIFICATION; TRANSMISSION; DNA	Background Leprosy is a slow, chronic disorder caused by Mycobacterium leprae. India has achieved elimination of leprosy in December 2005 but new cases are being detected and continue to occur in some endemic pockets. The possible ways of transmission of leprosy is not fully understood and is believed that leprosy is transmitted from person to person in long term contact. Studying the transmission dynamics is further complicated by inability to grow M. leprae in culture medium and lack of animal models. More than one family members were found to be affected by leprosy in some highly endemic pockets. This study reported the transmission pattern of leprosy in a family having 4 patients. Methodology/Principal findings We investigated the transmission of leprosy in a single family having 4 patients using microsatellite typing. DNA was isolated from slit skin smear samples taken from the patients and the isolated DNA were amplified using microsatellite loci TA(11)CA(3) . The amplified products were sequenced using Sanger's sequencing methods and the copy number variation in the microsatellite loci between strains were elucidated by multiple sequence alignment. The result showed that all the 4 members of the family acquired infection from 3 different strains of M. leprae from 3 different sources. The elder and middle daughters were infected by same types of strains having the repeat unit TA(13)CA(3) and could have acquired the infection from social contacts of leprosy cases while the father and younger daughter were infected by strains with the repeat unit TA(12)CA(3) and TA(11)CA(3) and could have acquired infection from social contacts . Conclusions/Significance The study suggested that three family members viz, elder daughter, father and younger daughter could be infected by M. leprae from 3 different sources and the history of the disease and genetic analysis showed that the middle daughter acquired infection from her elder sister in due course of contact. This study implies that the transmission of leprosy not only occurred amongst the house hold members but also has been transmitted from social and neighborhood contacts in long term association with the them.	[Mohanty, Partha Sarathi; Bansal, Avi Kumar; Naaz, Farah; Sharma, Sandeep; Singh, Haribhan] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Epidemiol, M Miyazaki Marg, Agra, Uttar Pradesh, India; [Arora, Mamta] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Clin Div, M Miyazaki Marg, Agra, Uttar Pradesh, India; [Gupta, Umesh Datta; Gupta, Pushpa] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Anim Expt, M Miyazaki Marg, Agra, Uttar Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra	Mohanty, PS (corresponding author), Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Epidemiol, M Miyazaki Marg, Agra, Uttar Pradesh, India.	m.sarathipartha@gmail.com	Naaz, Farah/U-2034-2019; Sharma, Sandeep/AAM-2889-2021; Mohanty, Partha/R-8414-2019	Mohanty, Partha/0000-0001-6597-4971	Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Funded by Indian Council of Medical Research. http://www.icmr.nic.in/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON ES, 1956, J CLIN PATHOL, V9, P94, DOI 10.1136/jcp.9.2.94; BLAKE LA, 1987, REV INFECT DIS, V9, P562; Bricker BJ, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-15; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; de Celles MD, 2011, ANTIMICROB AGENTS CH, V55, P5255, DOI 10.1128/AAC.00249-11; Donoghue HD, 2001, J MED MICROBIOL, V50, P177, DOI 10.1099/0022-1317-50-2-177; Gillis T, 2009, LEPROSY REV, V80, P250; Groathouse NA, 2004, J CLIN MICROBIOL, V42, P1666, DOI 10.1128/JCM.42.4.1666-1672.2004; Han XY, 2008, AM J CLIN PATHOL, V130, P856, DOI 10.1309/AJCPP72FJZZRRVMM; Han XY, 2012, J DRUGS DERMATOL, V11, P168; KAZDA J, 1980, INT J LEPROSY, V48, P1; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kimura M, 2009, J CLIN MICROBIOL, V47, P1757, DOI 10.1128/JCM.02019-08; Lahiri R, 2008, LEPROSY REV, V79, P401; Lavania M, 2011, INDIAN J MED RES, V133, P618; Matsuoka M, 2004, J CLIN MICROBIOL, V42, P741, DOI 10.1128/JCM.42.2.741-745.2004; Mohanty PS, 2016, INDIAN J DERMATOL VE, V82, P23, DOI 10.4103/0378-6323.168935; Naaz F., 2016, Indian Journal of Leprosy, V88, P199; Naaz F, 2017, BIOMED BIOTECH RES J, V1, P42, DOI 10.4103/bbrj.bbrj_11_17; Noordeen SK, 1988, CHAPMAN HALL MED MIC, DOI [10.1007/978-1-4615-7511-5_14, DOI 10.1007/978-1-4615-7511-5_14]; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Ravelomanantsoa S, 2016, PEERJ, V4, DOI 10.7717/peerj.1949; Scollard DM, 2016, AM J TROP MED HYG, V95, P500, DOI 10.4269/ajtmh.16-0473; Shin YC, 2000, J CLIN MICROBIOL, V38, P4535, DOI 10.1128/JCM.38.12.4535-4538.2000; Spurgiesz RS, 2003, J CLIN MICROBIOL, V41, P4224, DOI 10.1128/JCM.41.9.4224-4230.2003; Truman R, 2004, J CLIN MICROBIOL, V42, P2558, DOI 10.1128/JCM.42.6.2558-2565.2004; Truman RW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000328; TRUMAN RW, 1986, AM J TROP MED HYG, V35, P588, DOI 10.4269/ajtmh.1986.35.588; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; Webster CA, 2000, J HOSP INFECT, V44, P254, DOI 10.1053/jhin.1999.0703; Weng XM, 2007, J CLIN MICROBIOL, V45, P1728, DOI 10.1128/JCM.00018-07; Young SK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000214; Young SK, 2004, J CLIN MICROBIOL, V42, P4931, DOI 10.1128/JCM.42.11.4931-4936.2004	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214051	10.1371/journal.pone.0214051	http://dx.doi.org/10.1371/journal.pone.0214051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947261	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500015
J	Petrova, A; Reddy, S; Mehta, R				Petrova, Anna; Reddy, Sreenivas; Mehta, Rajeev			Pattern of intracranial findings detected on magnetic resonance imaging in surviving infants born before 29 weeks of gestation	PLOS ONE			English	Article							WHITE-MATTER INJURY; PRETERM INFANTS; NEURODEVELOPMENTAL OUTCOMES; INTRAVENTRICULAR HEMORRHAGE; CRANIAL ULTRASOUND; PREMATURE-INFANT; NATURAL-HISTORY; MRI; TERM; ULTRASONOGRAPHY	Despite the positive survival trend in infants born prematurely, the risk for development of intracranial lesions has remained unchanged. However, there are limitations to our understanding of the pattern of the magnetic resonance imaging (MRI) -detected brain pathology in the preterm infants surviving to discharge. The present study outlines the type of intracranial lesions and factors allied with the neonatal brain hemorrhage (NBH) and white matter injury (WMI) seen on MRI at term-equivalent age or close to discharge in infants born before 29 weeks of gestation. We obtained demographic and clinical data, and reports of serial cranial ultrasound (CUS) performed during first month of life and qualitative MRI at term-equivalent age or close to discharge. Statistical comparison was conducted with respect to the MRI results that were classified as normal, WMI, and NBH using univariate and logistic regression analysis. One hundred and ninety three infants with MRI at term-equivalent age or close to discharge were included in final analysis. They were less mature and had a higher prevalence of pathological findings on CUS as compared with 249 other survivors born with gestational ages less than 29 weeks during the assigned study period. MRI was normal in 72.5% [95% Confidence Interval (95% CI 65.9%-78.4%)], showed WMI in 9.8% (95%CI 6.4%-14.9%) and NBH in 17.6% (95%CI 12.9-23.6) of the studied infants. Intracranial hemorrhages had also been reported in 42.2% of the infants with WMI. Except for moderate agreement with prior CUS results, no other factors were associated with the MRI detected pathological findings. In general, the likelihood for detection of WMI and NBH on MRI at term-equivalent age or close to discharge was reduced by approximately 80% and 70%, respectively if the serial CUS had not shown any abnormalities during the first month of life.	[Petrova, Anna; Mehta, Rajeev] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08903 USA; [Reddy, Sreenivas] Rutgers State Univ, Sch Biomed Sci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Mehta, R (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08903 USA.	mehtara@rwjms.rutgers.edu		Mehta, Rajeev/0000-0003-3075-4498				Adler I, 2010, J CLIN ULTRASOUND, V38, P254, DOI 10.1002/jcu.20683; Allen MC, 2002, MENT RETARD DEV D R, V8, P221, DOI 10.1002/mrdd.10044; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Brouwer MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177128; Depp R, 2002, INT J GYNECOL OBSTET, V79, P181; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Edwards AD, 2018, ARCH DIS CHILD-FETAL, V103, pF15, DOI 10.1136/archdischild-2017-313102; Folkerth RD, 2005, J CHILD NEUROL, V20, P940, DOI 10.1177/08830738050200120301; Gano D, 2015, J PEDIATR-US, V166, P39, DOI 10.1016/j.jpeds.2014.09.009; Haneuse Sebastien, 2016, EGEMS (Wash DC), V4, P1203, DOI 10.13063/2327-9214.1203; Haynes RL, 2005, BRAIN PATHOL, V15, P225; Hinojosa-Rodriguez M, 2017, NEUROIMAGE-CLIN, V16, P355, DOI 10.1016/j.nicl.2017.08.015; Hintz SR, 2015, PEDIATRICS, V135, pE32, DOI 10.1542/peds.2014-0898; Horsch S, 2010, ARCH DIS CHILD-FETAL, V95, pF310, DOI 10.1136/adc.2009.161547; Inder TE, 2003, AM J NEURORADIOL, V24, P805; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Institute of Medicine (US) Committee on Comparative Effectiveness Research Prioritization, 2009, IN NAT PRIOR COMP EF; Jeon TY, 2012, RADIOLOGY, V263, P518, DOI 10.1148/radiol.12111615; Johnson ML, 2009, VALUE HEALTH, V12, P1062, DOI 10.1111/j.1524-4733.2009.00602.x; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Kidokoro H, 2014, PEDIATRICS, V134, pE444, DOI 10.1542/peds.2013-2336; Lekic T, 2015, CURR MED CHEM, V22, P1214, DOI 10.2174/0929867322666150114152421; Martinez-Biarge M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156245; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Ment LR, 2002, NEUROLOGY, V58, P1726, DOI 10.1212/WNL.58.12.1726; Miller SP, 2003, AM J NEURORADIOL, V24, P1661; Mirmiran M, 2004, PEDIATRICS, V114, P992, DOI 10.1542/peds.2003-0772-L; Murphy BP, 2002, ARCH DIS CHILD-FETAL, V87, pF37, DOI 10.1136/fn.87.1.F37; Ortinau CM, 2013, NEOREVIEWS, V14, pe490; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Perlman JM, 2000, ARCH PEDIAT ADOL MED, V154, P822, DOI 10.1001/archpedi.154.8.822; Pierpaoli Carlo, 2010, Top Magn Reson Imaging, V21, P63, DOI 10.1097/RMR.0b013e31821e56f8; Plaisier A, 2015, ARCH DIS CHILD-FETAL, V100, pF293, DOI 10.1136/archdischild-2014-306129; Reid SM, 2014, DEV MED CHILD NEUROL, V56, P222, DOI 10.1111/dmcn.12228; Rutherford MA, HEMORRHAGIC LESION 4; Stoll BJ, 1993, JAMA-J AM MED ASSOC, V314, P1039, DOI DOI 10.1001/JAMA.2015.10244; Tortora D, 2018, EUR RADIOL, V28, P1157, DOI 10.1007/s00330-017-5060-0; van't Hooft J, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0058-7; Volpe J.J., 2008, NEUROLOGY NEWBORN; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Woodward LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051879	42	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214683	10.1371/journal.pone.0214683	http://dx.doi.org/10.1371/journal.pone.0214683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946769	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500054
J	Ahsan, A; Khan, AZ; Javed, H; Mirza, S; Chaudhary, SU; Shahzad-ul-Hussan, S				Ahsan, Asma; Khan, Adnan Zafar; Javed, Hasnain; Mirza, Shaper; Chaudhary, Safee Ullah; Shahzad-ul-Hussan, Syed			Estimation of hepatitis C prevalence in the Punjab province of Pakistan: A retrospective study on general population	PLOS ONE			English	Article							VIRUS-INFECTION; SPONTANEOUS CLEARANCE; VIRAL-HEPATITIS; DRUG-USERS; EPIDEMIOLOGY; POLICY; INDIA; HIV; HCV	Background Hepatitis C virus (HCV) infections are amongst the leading public health concerns in Pakistan with a high disease burden. Despite the availability of effective antiviral treatments in the country the disease burden in general population has not lowered. This could be attributed to the asymptomatic nature of this infection that results in lack of diagnosis until the late symptomatic stage. To better estimate and map HCV infections in the country a population based analysis is necessary for an effective control of the infection. Methods Serologic samples of similar to 66,000 participants from all major cities of the Punjab province were tested for anti-HCV antibodies. The antibody-based seroprevalence was associated with socio-demographic variables including geographical region, age, gender and sex, and occupation. Results Overall serological response to HCV surface antigens was observed in over 17% of the population. Two of the districts were identified with significantly high prevalence in general population. Analysis by occupation showed significantly high prevalence in farmers (over 40%) followed by jobless and retired individuals, laborers and transporters. A significant difference in seroprevalence was observed in different age groups amongst sex and genders (male, female and transgender) with highest response in individuals of over 40 years of age. Moreover, most of the tested IDUs showed positive response for anti-HCV antibody. Conclusion This study represents a retrospective analysis of HCV infections in general population of the most populated province of Pakistan to identify socio-demographic groups at higher risk. Two geographical regions, Faisalabad and Okara districts, and an occupational group, farmers, were identified with significantly high HCV seroprevalence. These socio-demo- graphic groups are the potential focused groups for follow-up studies on factors contributing to the high HCV prevalence in these groups towards orchestrating effective prevention, control-and treatment.	[Ahsan, Asma; Mirza, Shaper; Chaudhary, Safee Ullah; Shahzad-ul-Hussan, Syed] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan; [Khan, Adnan Zafar; Javed, Hasnain] Govt Punjab, Punjab AIDS Control Program, Lahore, Pakistan	Lahore University of Management Sciences	Shahzad-ul-Hussan, S (corresponding author), Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan.	shahazad.hussan@lums.edu.pk	Chaudhary, Safee Ullah/AAY-5013-2020	Chaudhary, Safee Ullah/0000-0002-3758-6581; Javed, Dr. Hasnain/0000-0001-6877-6807; Shahzad-ul-Hussan, Syed/0000-0001-7736-1072				Abdullah MA, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-32; Aisyah DN, 2018, J VIRAL HEPAT, DOI 10.1002/jmv.20103; Ali SA, 2009, INT J INFECT DIS, V13, P9, DOI 10.1016/j.ijid.2008.06.019; Ashraf Sadia, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P190, DOI 10.1016/S2221-1691(15)30004-6; Aslam Zeeshan, 2015, INT J VIROLOGY MOL B, V4, P19; But DYK, 2008, WORLD J GASTROENTERO, V14, P1652, DOI 10.3748/wjg.14.1652; Butt T., 2008, Eastern Mediterranean Health Journal, V14, P791; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Hamid S., 2004, JPMA Journal of the Pakistan Medical Association, V54, P146; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Idrees M, 2008, J DIGEST DIS, V9, P95, DOI 10.1111/j.1751-2980.2008.00329.x; Iqbal Mazhar, 2013, VIROLOGY, V10; Janjua NZ, 2006, PUBLIC HEALTH, V120, P824, DOI 10.1016/j.puhe.2006.05.004; Kandeel A, 2017, LIVER INT, V37, P45, DOI 10.1111/liv.13186; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lehmann M, 2004, J MED VIROL, V73, P387, DOI 10.1002/jmv.20103; Lim AG, 2018, INT J EPIDEMIOL, V47, P550, DOI 10.1093/ije/dyx270; Ming LC, 2016, LANCET, V388, P2601, DOI 10.1016/S0140-6736(16)32222-X; Mirza IA, 2007, JCPSP-J COLL PHYSICI, V17, P114; Panda S, 2014, INT J STD AIDS, V25, P596, DOI 10.1177/0956462413515659; Platt L, 2009, SEX TRANSM INFECT, V85, P17, DOI 10.1136/sti.2008.034090; Raja NS, 2008, J MICROBIOL IMMUNOL, V41, P4; Rehman LU, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-327; Sibley A, 2015, J VIRAL HEPATITIS, V22, P21, DOI 10.1111/jvh.12476; Singh S, 2014, INT J DRUG POLICY, V25, P26, DOI 10.1016/j.drugpo.2013.05.011; Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176; Umer M, 2016, WORLD J GASTROENTERO, V22, P1684, DOI 10.3748/wjg.v22.i4.1684; Waqar M, 2014, EUR J GASTROEN HEPAT, V26, P59, DOI 10.1097/MEG.0b013e328362dc3f; WHO, 2017, NEW HEP DAT HIGHL NE; WHO, PAK TACKL HIGH RAT H; World Health Organization, 2018, HEP C KEY FACTS REP	35	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214435	10.1371/journal.pone.0214435	http://dx.doi.org/10.1371/journal.pone.0214435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943224	Green Submitted, gold, Green Published			2022-12-27	WOS:000463194300037
J	Li, ZW; Guan, YA; Yuan, X; Zheng, P; Zhu, H				Li, Zhongwei; Guan, Yanan; Yuan, Xiang; Zheng, Pan; Zhu, Hu			Prediction of Sphingosine protein-coding regions with a self adaptive spectral rotation method	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; NEURAL P SYSTEMS; TRIPLET PERIODICITY; GENE IDENTIFICATION; DNA-SEQUENCES; CLASSIFICATION; WELAN	Identifying protein coding regions in DNA sequences by computational methods is an active research topic. Welan gum produced by Sphingomonas sp. WG has great application potential in oil recovery and concrete construction industry. Predicting the coding regions in the Sphingomonas sp. WG genome and addressing the mechanism underlying the explanation for the synthesis of Welan gum metabolism is an important issue at present. In this study, we apply a self adaptive spectral rotation (SASR, for short) method, which is based on the investigation of the Triplet Periodicity property, to predict the coding regions of the whole-genome data of Sphingomonas sp. WG without any previous training process, and 1115 suspected gene fragments are obtained. Suspected gene fragments are subjected to a similarity search against the non-redundant protein sequences (nr) database of NCBI with blastx, and 762 suspected gene fragments have been labeled as genes in the nr database.	[Li, Zhongwei; Guan, Yanan; Yuan, Xiang] China Univ Petr, Coll Comp & Commun Engn, Qingdao, Shandong, Peoples R China; [Zheng, Pan] Univ Canterbury, Dept Accounting & Informat Syst, Christchurch, New Zealand; [Zhu, Hu] Fujian Normal Univ, Coll Chem & Mat, Fuzhou, Fujian, Peoples R China	China University of Petroleum; University of Canterbury; Fujian Normal University	Guan, YA (corresponding author), China Univ Petr, Coll Comp & Commun Engn, Qingdao, Shandong, Peoples R China.	guanyanan_gyn@sina.com	Zheng, Pan/A-5435-2009; zhu, hu/GQQ-8365-2022	Zheng, Pan/0000-0002-6067-626X; 	National Natural Science Foundation of China [61873280, 61672033, 61672248]; PetroChina Innovation Foundation [2016D-5007-0305]; Key Research and Development Program of Shandong Province [2017GGX10147]; Natural Science Foundation of Shandong Province [ZR2017MF004]; Fundamental Research Funds for the Central Universities [18CX02152A]; Talent introduction project of China University of Petroleum [2017010054]; AEI/FEDER, Spain-EU [TIN2016-81079-R]; Talento-Comunidad de Madrid [2016-T2/TIC-2024]; MINECO AEI/FEDER, Spain-EU [TIN2016-81079-R]; InGEMICS-CM Project (FSE/FEDER, Comunidad de Madrid-EU) [B2017/BMD-3691]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PetroChina Innovation Foundation; Key Research and Development Program of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Talent introduction project of China University of Petroleum; AEI/FEDER, Spain-EU(Spanish Government); Talento-Comunidad de Madrid; MINECO AEI/FEDER, Spain-EU; InGEMICS-CM Project (FSE/FEDER, Comunidad de Madrid-EU)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 61873280, 61672033, and 61672248), PetroChina Innovation Foundation (2016D-5007-0305), Key Research and Development Program of Shandong Province (No. 2017GGX10147), Natural Science Foundation of Shandong Province (No. ZR2017MF004), Fundamental Research Funds for the Central Universities (No. 18CX02152A), Talent introduction project of China University of Petroleum (No. 2017010054), Research Project TIN2016-81079-R (AEI/FEDER, Spain-EU) and Grant 2016-T2/TIC-2024 from Talento-Comunidad de Madrid, Project TIN2016-81079-R (MINECO AEI/FEDER, Spain-EU), and the InGEMICS-CM Project (B2017/BMD-3691, FSE/FEDER, Comunidad de Madrid-EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal G, 2002, J BIOSCIENCES, V27, P7, DOI 10.1007/BF02703679; Akhtar M, 2007, IEEE INT WORK GENOM, P54; Anastassiou D, 2000, BIOINFORMATICS, V16, P1073, DOI 10.1093/bioinformatics/16.12.1073; Azad RK, 2004, BRIEF BIOINFORM, V5, P118, DOI 10.1093/bib/5.2.118; Birney E, 2001, IBM J RES DEV, V45, P449, DOI 10.1147/rd.453.0449; Borodovsky Mark, 2011, Curr Protoc Bioinformatics, VChapter 4, DOI [10.1002/0471250953.bi0406s35, 10.1002/0471250953.bi0405s35]; Cao Yinhe, 2005, Journal of Bioinformatics and Computational Biology, V3, P677, DOI 10.1142/S0219720005001235; Chen B, 2012, J THEOR BIOL, V296, P95, DOI 10.1016/j.jtbi.2011.12.002; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Do JH, 2006, J MICROBIOL, V44, P137; Durbin  Richard, 1998, BIOL SEQUENCE ANAL P, P549; Farsani Mahsa Saffari, 2016, J Med Signals Sens, V6, P130; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Frenkel FE, 2008, GENE, V421, P52, DOI 10.1016/j.gene.2008.06.012; Frenkel FE, 2008, MOL BIOL+, V42, P629, DOI 10.1134/S0026893308040201; Frenkel FE, 2009, DNA RES, V16, P105, DOI 10.1093/dnares/dsp002; Gao C., 2016, INT J OIL GAS COAL E, V4, P16, DOI [10.11648/j.ogce.20160402.12, DOI 10.11648/J.OGCE.20160402.12]; Gao CH, 2015, J PET EXPLOR PROD TE, V5, P109, DOI 10.1007/s13202-014-0114-1; Guda C, 2014, CURRENT LAB METHODS; Henderson J, 1997, J COMPUT BIOL, V4, P127, DOI 10.1089/cmb.1997.4.127; Issac B, 2002, BIOINFORMATICS, V18, P196, DOI 10.1093/bioinformatics/18.1.196; Korotkov EV, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-131; Kotlar D, 2003, GENOME RES, V13, P1930, DOI 10.1101/gr.1261703; KROGH A, 1994, NUCLEIC ACIDS RES, V22, P4768, DOI 10.1093/nar/22.22.4768; Kulp D, 1996, INT C INT SYST MOL B, V4, P353; Li H, 2011, BIOPROC BIOSYST ENG, V34, P95, DOI 10.1007/s00449-010-0450-6; Liu G, 2019, GENOMICS, V111, P1167, DOI 10.1016/j.ygeno.2018.07.013; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Manavalan B, 2018, ONCOTARGET, V9, P1944, DOI 10.18632/oncotarget.23099; Marhon SA, 2015, NETW MODEL ANAL HLTH, V4, DOI 10.1007/s13721-015-0103-4; Morange M, 2009, RESONANCE, V14, P236, DOI 10.1007/s12045-009-0024-6; Mork S, 2012, BIOINFORMATICS, V28, P636, DOI 10.1093/bioinformatics/btr698; ONEILL MA, 1986, CARBOHYD RES, V147, P295, DOI 10.1016/S0008-6215(00)90638-4; Pang SC, 2018, IEEE ACCESS, V6, P65548, DOI 10.1109/ACCESS.2018.2876364; Putluri S R, 2018, IDENTIFICATION PROTE; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Roy S S, 2015, COMPUTATIONAL ADVANC; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; SANGILL R, 1994, J MAGN RESON SER A, V107, P67, DOI 10.1006/jmra.1994.1048; Sedaaghi MH, 2013, INT J COMPUTER APPL, V67, P25; Sharma S, 2017, INT C COMP IEEE; SNYDER EE, 1993, NUCLEIC ACIDS RES, V21, P607, DOI 10.1093/nar/21.3.607; Song T, 2019, IEEE T NANOBIOSCI, V18, P176, DOI 10.1109/TNB.2019.2896981; Song T, 2018, IEEE T NANOBIOSCI, V17, P474, DOI 10.1109/TNB.2018.2873221; Song T, 2018, IEEE T COGN DEV SYST, V10, P1106, DOI 10.1109/TCDS.2017.2785332; Song T, 2016, IEEE T NANOBIOSCI, V15, P666, DOI 10.1109/TNB.2016.2598879; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Song T, 2014, NEURAL COMPUT APPL, V24, P1833, DOI 10.1007/s00521-013-1397-8; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; STANKOWSKI JD, 1992, CARBOHYD RES, V224, P337, DOI 10.1016/0008-6215(92)84122-9; Suvorova YM, 2012, GENE, V491, P58, DOI 10.1016/j.gene.2011.08.032; THOMAS A, 1994, IMA J MATH APPL MED, V11, P149; Ureta-Vidal A, 2003, NAT REV GENET, V4, P251, DOI 10.1038/nrg1043; Verma S, 2015, PROPAGATION CHARACTE; Wang LY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-550; Wang M, 2003, COLD SPRING HARB SYM, V68, P125, DOI 10.1101/sqb.2003.68.125; Wei LY, 2018, MOL THER-NUCL ACIDS, V12, P635, DOI 10.1016/j.omtn.2018.07.004; Yang H, 2018, J COMPUT BIOL, V25, P1266, DOI 10.1089/cmb.2018.0004; Yin CC, 2007, J THEOR BIOL, V247, P687, DOI 10.1016/j.jtbi.2007.03.038; Yoon BJ, 2009, CURR GENOMICS, V10, P402, DOI 10.2174/138920209789177575	63	2	2	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214442	10.1371/journal.pone.0214442	http://dx.doi.org/10.1371/journal.pone.0214442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943219	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300039
J	Noh, JW; Kim, YM; Lee, LJ; Akram, N; Shahid, F; Kwon, YD; Stekelenburg, J				Noh, Jin-Won; Kim, Young-mi; Lee, Lena J.; Akram, Nabeel; Shahid, Farhana; Kwon, Young Dae; Stekelenburg, Jelle			Factors associated with the use of antenatal care in Sindh province, Pakistan: A population-based study	PLOS ONE			English	Article							UTTAR-PRADESH; PRENATAL-CARE; SERVICES; HEALTH; WOMEN; DETERMINANTS	Background Antenatal care (ANC) is critical to decrease maternal and neonatal mortality. However, little is known about the utilization of ANC services in Pakistan. This study assessed the utilization of ANC in Sindh province, Pakistan, and identified the factors that affect its use. Methods We analysed a subset of data from Maternal and Child Health (MCH) Program Indicator Surveys conducted in Sindh province, Pakistan in 2013 and 2014. Respondents included 10,200 women who had given birth in the past two years. The outcome measure was making at least four ANC visits. Logistic regression models were used to identify demographic, socioeconomic, characteristics of ANC, and informational factors associated with ANC use. Results Most women (83.5%) received one or more ANC, mostly by doctors (95%), but only 57.3% of them made the recommended four or more visits, and just 53.7% received their initial ANC care during the first trimester. Making four or more ANC visits was associated with: fewer household occupants (odds ratio [OR] = 0.98; 95% confidence interval [CI] = [0.97, 0.99]), large city residence (OR = 1.92; 95% CI = [1.57, 2.35]), higher women's education (OR = 1.70; 95% CI = [1.33, 2.15]), greater household wealth (OR = 5.66; 95% CI = [4.22, 7.60]), and receiving MCH information from lady health worker (OR = 1.17; 95% CI = [1.00, 1.37]), mother-in-law (OR = 1.17; 95% CI = [1.01, 1.36]), other relatives/friends (OR = 1.19; 95% CI = [1.03, 1.38]), or nurse/midwife (OR = 1.31; 95% CI = [1.06, 1.61]). Conclusions This study demonstrates that both socioeconomic factors and health information sources are associated with women's use of ANC. Therefore, programs should target socially disadvantaged and vulnerable groups, particularly rural, less educated, and poor women, to improve utilization of ANC. In addition, strategies to increase exposure to MCH information sources should be a priority in Sindh, Pakistan.	[Noh, Jin-Won] Eulji Univ, Dept Healthcare Management, Seongnam, South Korea; [Noh, Jin-Won; Stekelenburg, Jelle] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, Groningen, Netherlands; [Kim, Young-mi; Akram, Nabeel] Johns Hopkins Univ, Jhpiego, Baltimore, MD USA; [Lee, Lena J.] NIH, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Shahid, Farhana] Jhpiego, Karachi, Pakistan; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea; [Stekelenburg, Jelle] Med Ctr Leeuwarden, Dept Obstet & Gynecol, Leeuwarden, Netherlands	Eulji University; University of Groningen; Jhpiego; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Jhpiego; Catholic University of Korea; Catholic University of Korea; Medical Center Leeuwarden	Kwon, YD (corresponding author), Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.; Kwon, YD (corresponding author), Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017; Stekelenburg, Jelle/B-3129-2017	Kwon, Young Dae/0000-0002-8781-6832; Noh, Jin-Won/0000-0001-5172-4023; Stekelenburg, Jelle/0000-0002-2732-6620	US Agency for International Development (USAID) [AID-391-LA-13-00001]; Maternal, Newborn and Child Health Services Project	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); Maternal, Newborn and Child Health Services Project	This publication was made possible through support provided by the US Agency for International Development (USAID), under the terms of Associate Cooperative Agreement No. AID-391-LA-13-00001; Maternal, Newborn and Child Health Services Project. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID.	Abor PA, 2011, INT J SOC ECON, V38, P628, DOI 10.1108/03068291111139258; Acharya Dilaram, 2015, BMC Res Notes, V8, P345, DOI 10.1186/s13104-015-1312-8; Agha S., 2013, MATERNAL CHILD HLTH; Akowuah JA, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/1673517; [Anonymous], 2013, PAK DEM HLTH SURV 20; [Anonymous], 2004, NEPAL POPULATION J; Awasthi MS, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/3467308; Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38; Broadcasting Board of Governors, 2017, CONT MED US PAK; Chama-Chiliba CM, 2013, HLTH POLICY PLANNING, V30, P78, DOI DOI 10.1093/HEAP0L/CZT099; Ciceklioglu M, 2005, INT J QUAL HEALTH C, V17, P533, DOI 10.1093/intqhc/mzi076; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Erci B, 2003, J NURS SCHOLARSHIP, V35, P269, DOI 10.1111/j.1547-5069.2003.00269.x; Gupta R. K., 2015, Tropical Journal of Medical Research, V18, P89; Islam MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204752; Jolliffe I, 2014, PRINCIPAL COMPONENT; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kabir M, 2005, TROP DOCT, V35, P110, DOI 10.1258/0049475054036814; Kuhnt J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017122; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Matsumura M., 2001, ASIA PAC POPULAT J, V16, P23, DOI DOI 10.18356/E8A4C9ED-EN; Mumtaz Z, 2009, SOC SCI MED, V68, P1349, DOI 10.1016/j.socscimed.2009.01.025; Owoyokun K. E., 2010, BENIN J POSTGRADUATE, V12, P3; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Paredes I, 2005, INT J GYNECOL OBSTET, V88, P168, DOI 10.1016/j.ijgo.2004.09.024; Paxton A, 2011, NEW ENGL J MED, V364, P1990, DOI 10.1056/NEJMp1012860; Ram F, 2006, J BIOSOC SCI, V38, P433, DOI 10.1017/S0021932005026453; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Titaley CR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-485; WHO, 2022, WHO RECOMMENDATIONS; World Health Organization (WHO) and United Nations Children's Fund (UNICEF), 2013, ANT CAR DEV COUNTR P	31	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213987	10.1371/journal.pone.0213987	http://dx.doi.org/10.1371/journal.pone.0213987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943243	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300026
J	O'Reilly, AO; Hofmann, G; Mettke-Hofmann, C				O'Reilly, Andrias O.; Hofmann, Gerhard; Mettke-Hofmann, Claudia			Gouldian finches are followers with black-headed females taking the lead	PLOS ONE			English	Article							PERSONALITY-TRAITS; COLOR POLYMORPHISM; REPRODUCTIVE SUCCESS; LEADERSHIP; DOMINANCE; BEHAVIOR; MORPHS; NEST; ELEPHANTS; HABITAT	Colour polymorphism is a widespread phenomenon and often encompasses different behavioural traits and strategies. More recently, it has been shown that morphs can also signal consistent individual differences (personality). An example are Gouldian finches that show discrete head colour morphs in the same population with red-headed birds being more aggressive but less risk-taking and explorative than black-headed birds in the lab. The current study aimed to investigate the link between head colour and behavioural traits in a naturally risky situation in the wild by recording the order of descent at waterholes in relation to hypotheses considering conspicuousness, dominance relationships and experience. Other bird species at the waterholes were also included in the study. Adult Gouldian finches generally preceded juveniles and among the adults the least conspicuous black-headed females descended first to the waterhole. Overall, females descended before the males though this pattern disappeared later in the season likely due to family groups breaking up and releasing males from attending to the juveniles. Finally, Gouldian finches almost always followed other species, particularly Long-tailed finches, to the ground rather than taking the lead. A two-level process of decision-making seems to explain the responses best: on the first level, experience separates adults from juveniles with adults preceding juveniles and on the second level, conspicuousness acts as a factor among the adults with the least conspicuous category taking the lead. Future studies should directly test the link between head colour and personality in the wild, look more into seasonal effects and investigate whether Gouldian finches use Long-tailed finches as an indicator of safety.	[O'Reilly, Andrias O.; Mettke-Hofmann, Claudia] Liverpool John Moores Univ, Sch Nat Sci & Psychol, James Parsons Bldg, Liverpool, Merseyside, England	Liverpool John Moores University	Mettke-Hofmann, C (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, James Parsons Bldg, Liverpool, Merseyside, England.	C.C.Mettke-Hofmann@ljmu.ac.uk	O'Reilly, Andrias/AAC-7628-2022	O'Reilly, Andrias/0000-0003-3449-2368; Mettke-Hofmann, Claudia/0000-0003-3874-5035	German Ornithologists' Society; Society for Tropical Ornithology (GTO); Society of Species Conservation and Aviculture	German Ornithologists' Society; Society for Tropical Ornithology (GTO); Society of Species Conservation and Aviculture	The study was supported by grants from the German Ornithologists' Society, the Society for Tropical Ornithology (GTO) and the Society of Species Conservation and Aviculture (AZ) to CMH. German Ornithologists' Society: http://www.do-g.de/news/?L=1 Society for Tropical Ornithology: https://www.tropenornithologie.de/; Society of Species Conservation and Aviculture: https://www.azvogelzucht.de/content/index.php?sess_az_hp=c9157b82f35d2aeb6783d04ddfc277a6. None of the sponsors played any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amaral PP, 2008, BRAZ J BIOL, V68, P511, DOI 10.1590/S1519-69842008000300007; Aplin LM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1016; BirdLife International, 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22719744A94642482.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22719744A94642482]; Brazill-Boast J, 2013, EVOL ECOL, V27, P1189, DOI 10.1007/s10682-013-9651-1; Brazill-Boast J, 2013, AUSTRAL ECOL, V38, P405, DOI 10.1111/j.1442-9993.2012.02424.x; Brazill-Boast J, 2011, EMU, V111, P304, DOI 10.1071/MU10064; Brazill-Boast J, 2011, J ANIM ECOL, V80, P39, DOI 10.1111/j.1365-2656.2010.01756.x; Brazill-Boast J, 2010, EMU, V110, P170, DOI 10.1071/MU09045; BRUSH AH, 1968, AUK, V85, P416, DOI 10.2307/4083290; Da Silva A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1041, DOI 10.1007/s00265-013-1529-2; Davis JF, 2009, NEUROSCIENCE, V162, P23, DOI 10.1016/j.neuroscience.2009.04.039; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; EPBC, 2018, SPEC PROF THREATS DA; EVANS SM, 1985, IBIS, V127, P348, DOI 10.1111/j.1474-919X.1985.tb05076.x; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Franklin Donald C., 1999, Australian Zoologist, V31, P92; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Ioannou CC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602682; KATZIR G, 1982, BEHAVIOUR, V81, P231, DOI 10.1163/156853982X00157; King AJ, 2015, ANIM BEHAV, V99, P25, DOI 10.1016/j.anbehav.2014.10.016; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Kupper C, 2016, NAT GENET, V48, P79, DOI 10.1038/ng.3443; Langham GM, 2006, BEHAV ECOL, V17, P285, DOI 10.1093/beheco/arj027; Lee PC, 2012, J COMP PSYCHOL, V126, P224, DOI 10.1037/a0026566; Mafli A, 2011, ANIM BEHAV, V81, P859, DOI 10.1016/j.anbehav.2011.01.025; McComb K, 2011, P ROY SOC B-BIOL SCI, V278, P3270, DOI 10.1098/rspb.2011.0168; Mettke-Hofmann C., 2000, International Zoo Yearbook, V37, P244, DOI 10.1111/j.1748-1090.2000.tb00730.x; Mettke-Hofmann C, 2012, ETHOLOGY, V118, P906, DOI 10.1111/j.1439-0310.2012.02079.x; Muniz L, 2010, AM J PRIMATOL, V72, P1118, DOI 10.1002/ajp.20876; Nicolai J., 2001, PRACHTFINKEN AUSTR O; O'Malley C., 2006, NATL RECOVERY PLAN G; Pruitt JN, 2011, P ROY SOC B-BIOL SCI, V278, P1209, DOI 10.1098/rspb.2010.1700; Pryke SR, 2007, BIOLOGY LETT, V3, P494, DOI 10.1098/rsbl.2007.0213; Pryke SR, 2007, BEHAV ECOL, V18, P621, DOI 10.1093/beheco/arm020; Pryke SR, 2009, AM NAT, V174, P455, DOI 10.1086/605376; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Roulin A, 2011, EUR J PHARMACOL, V660, P226, DOI 10.1016/j.ejphar.2011.01.036; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; TIDEMANN SC, 1992, J TROP ECOL, V8, P373, DOI 10.1017/S0266467400006702; Toth Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026605; Williams LJ, 2012, ANIM BEHAV, V84, P159, DOI 10.1016/j.anbehav.2012.04.025; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wright CM, 2015, ANIM BEHAV, V105, P47, DOI 10.1016/j.anbehav.2015.04.001; ZANETTE L, 1994, ANIM BEHAV, V48, P119, DOI 10.1006/anbe.1994.1218	46	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214531	10.1371/journal.pone.0214531	http://dx.doi.org/10.1371/journal.pone.0214531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943239	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000463194300045
J	Freeman-Hildreth, Y; Aron, D; Cola, PA; Wang, YM				Freeman-Hildreth, Yolonda; Aron, David; Cola, Philip A.; Wang, Yunmei			Coping with diabetes: Provider attributes that influence type 2 diabetes adherence	PLOS ONE			English	Article							HEALTH-CARE; COMPASSIONATE CARE; SELF-CARE; MEDICATION; COMMUNICATION; BEHAVIOR; OPTIMISM; HOPE; LIFE; ASSOCIATIONS	Diabetes, a chronic disease affecting over 29 million people in the United States, requires the integration of complex medical tasks into a person's daily life. Patient-centered care and compassion are recognized as essential dimensions of the quality care experience. This research examined provider attributes that influence adherence to type 2 diabetes mellitus (T2DM) regimens and sought to understand the phenomena of provider attributes, treatment adherence, and their relationship to coping ability and treatment outcomes. This quantitative study sampled 474 people with T2DM using a 62-item online survey administered to three different groups. The sample population included people over age 18 diagnosed with T2DM. The first group included 91 persons with T2DM identified through a Facebook group and personal social media connections, the second group included 120 Amazon Mechanical Turk participants with T2DM, and the third group included 263 respondents from a Qualtrics panel who had T2DM. Results indicated that perceived provider compassion (beta = .41, p < .001) and optimism (beta = .48, p < .001) positively affected coping ability. Additionally, full mediation effects for self-management were revealed, with coping ability positively mediating the effect of compassion on self-management and the effects of optimism on self-management. Furthermore, full mediation effects were found for treatment satisfaction, with coping ability positively mediating the effect of compassion on treatment satisfaction and the effects of optimism on treatment satisfaction. This research has implications for patients, healthcare professionals, and leaders suggesting that providers who communicate with optimism and compassion positively affect coping ability. As a result, healthcare providers and professionals have an opportunity to enhance self-management adherence by helping their patients cope with the burdens of diabetes. In addition, this study has implications for developing provider communication tools aimed at assessing patients' coping capacity and increasing compassionate communication.	[Freeman-Hildreth, Yolonda] Univ Detroit Mercy, Coll Hlth Profess, Detroit, MI 48221 USA; [Aron, David] Case Western Reserve Univ, Dept Med, Louis Stokes VA Med Ctr, Cleveland, OH 44106 USA; [Cola, Philip A.] Case Western Reserve Univ, Weatherhead Sch Management, Dept Design & Innovat, Cleveland, OH 44106 USA; [Wang, Yunmei] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA	University of Detroit Mercy; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University	Freeman-Hildreth, Y (corresponding author), Univ Detroit Mercy, Coll Hlth Profess, Detroit, MI 48221 USA.	freemayf@udmercy.edu		Cola, Philip/0000-0003-4131-4180; Freeman-Hildreth, Yolonda/0000-0003-0440-8647				Aikens JE, 2005, DIABETES EDUCATOR, V31, P681, DOI 10.1177/0145721705280829; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; American Diabetes Association, 2018, Clin Diabetes, V36, P14, DOI 10.2337/cd17-0119; American Diabetes Association, 2014, DIABETES CARE, V37, P887, DOI [10.2337/dc14-er03, DOI 10.2337/DC14-ER03]; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; Blanchard J, 2013, ANN EMERG MED, V62, P475, DOI 10.1016/j.annemergmed.2013.04.013; BRADLEY C, 1990, DIABETIC MED, V7, P445, DOI 10.1111/j.1464-5491.1990.tb01421.x; Bradley C, 2002, DIABETES-METAB RES, V18, pS64, DOI 10.1002/dmrr.279; BURGELMAN RA, 1983, MANAGE SCI, V29, P1349, DOI 10.1287/mnsc.29.12.1349; Bussell Jennifer K, 2017, Clin Diabetes, V35, P171, DOI 10.2337/cd016-0029; Capehorn M, 2017, DIABETIC MED, V34, P1100, DOI 10.1111/dme.13357; Cardenas-Valladolid J, 2010, DRUG AGING, V27, P641, DOI 10.2165/11537320-000000000-00000; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chakravarthy B.S., 1982, ACAD MANAGE REV, V7, P35, DOI DOI 10.5465/AMR.1982.4285438; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; de Zulueta PC, 2016, J HEALTHC LEADERSH, V8, P1, DOI 10.2147/JHL.S93724; Edelman SV, 2017, DIABETES CARE, V40, P1425, DOI 10.2337/dc16-1974; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; Feldman DB, 2005, J SOC CLIN PSYCHOL, V24, P401, DOI 10.1521/jscp.24.3.401.65616; Fishbein M., 1979, NEBRASKA S MOTIVATIO, V27; Frankl VE., 1962, MANS SEARCH ULTIMATE; Franklin M, 2017, CHRONIC ILLN; Freeman-Hildreth Y., 2017, MOTIVATING AFR UNPUB; Gabay G, 2015, PATIENT EDUC COUNS, V98, P1550, DOI 10.1016/j.pec.2015.06.019; Gaskin J., 2016, ESTIMAND GASKINATION; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Gray SL, 2001, ANN PHARMACOTHER, V35, P539, DOI 10.1345/aph.10295; Guastello S, 2014, J COMPASSIONATE HLTH, V1, P2; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hester PT, 2014, TOP SAF RISK RELIAB, V26, P1, DOI 10.1007/978-3-319-07629-4; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.21427/D7CF7R, 10.21427/D79B73]; House RJ, 1996, LEADERSHIP QUART, V7, P323, DOI 10.1016/S1048-9843(96)90024-7; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jortberg BT, 2012, CURR DIABETES REP, V12, P721, DOI 10.1007/s11892-012-0316-1; Krass I, 2015, DIABETIC MED, V32, P725, DOI 10.1111/dme.12651; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lown BA, 2015, PATIENT EDUC COUNS, V98, P1005, DOI 10.1016/j.pec.2015.03.019; Lown BA, 2011, HEALTH AFFAIR, V30, P1772, DOI 10.1377/hlthaff.2011.0539; Manteuffel M, 2014, J WOMENS HEALTH, V23, P112, DOI 10.1089/jwh.2012.3972; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; Matthews SM, 2009, PATIENT EDUC COUNS, V76, P31, DOI 10.1016/j.pec.2008.11.022; McClintock HFDV, 2016, BEHAV MED, V42, P63, DOI 10.1080/08964289.2014.904767; MILLER WR, 1975, J ABNORM PSYCHOL, V84, P228, DOI 10.1037/h0076720; Nigg CR, 2002, HEALTH EDUC RES, V17, P670, DOI 10.1093/her/17.5.670; Packer TL, 2018, PATIENT EDUC COUNS, V101, P579, DOI 10.1016/j.pec.2017.10.014; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Park C.L., 1997, REV GEN PSYCHOL, V1, P115, DOI [10.1037/1089-2680.1.2.115, DOI 10.1037/1089-2680.1.2.115, 10.1037//1089-2680.1.2.115, DOI 10.1037//1089-2680.1.2.115]; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Pope JP, 2018, HEALTH COMMUN, V33, P1068, DOI 10.1080/10410236.2017.1331305; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Rasmussen HN, 2009, ANN BEHAV MED, V37, P239, DOI 10.1007/s12160-009-9111-x; Rosenbloom AL, 1999, DIABETES CARE, V22, P345, DOI 10.2337/diacare.22.2.345; Rowley W., 2017, POPUL HLTH MANAG, V20, P6; Moral RR, 2015, PATIENT EDUC COUNS, V98, P977, DOI 10.1016/j.pec.2015.03.008; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138; Schwartz David D, 2017, Clin Diabetes, V35, P35, DOI 10.2337/cd16-0007; Scioli A, 1997, PSYCHOL REP, V81, P723, DOI 10.2466/pr0.1997.81.3.723; Sclar DL, 1999, DIABETES EDUCATOR, V25, P531, DOI 10.1177/014572179902500406; Seppala E.M., 2014, J COMPASSIONATE HLTH, V1, P1, DOI [https://doi.org/10.1186/s40639-014-0005-9, DOI 10.1186/S40639-014-0005-9, 10.1186/s40639-014-0005-9]; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Sinclair S, 2016, J PAIN SYMPTOM MANAG, V51, P193, DOI 10.1016/j.jpainsymman.2015.10.009; Snoek FJ, 2006, MEDICINE, V34, P61, DOI DOI 10.1383/medc.2006.34.2.61; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; SPOSITO VA, 1983, COMMUN STAT-SIMUL C, V12, P265, DOI 10.1080/03610918308812318; Strauss C, 2016, CLIN PSYCHOL REV, V47, P15, DOI 10.1016/j.cpr.2016.05.004; Strecher VJ., 1997, CAMB HDB PSYCHOL HLT, P113; Thomas DM, 2002, COMMUN ASS INF SYST, V8, P9; Thoolen BJ, 2009, PSYCHOL HEALTH, V24, P237, DOI 10.1080/08870440701864504; Tielemans NS, 2014, ARCH PHYS MED REHAB, V95, P670, DOI 10.1016/j.apmr.2013.11.010; Tierney Stephanie., 2017, J COMPASSIONATE HLTH, V4, P1, DOI [10. 1186/s40639-016-0030-y, DOI 10.1186/S40639-016-0030-Y, 10.1186/s40639-016-0030-y]; Trejo BC, 2015, MIL PSYCHOL, V27, P276, DOI 10.1037/mil0000081; Vriticka P., 2017, COMPASSION CONCEPTS, P135, DOI DOI 10.4324/9781315564296-8; Williams JS, 2016, DIABETES TECHNOL THE, V18, P644, DOI 10.1089/dia.2016.0079; Yu YS, 2015, J BEHAV MED, V38, P565, DOI 10.1007/s10865-015-9636-3	81	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214713	10.1371/journal.pone.0214713	http://dx.doi.org/10.1371/journal.pone.0214713			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939144	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900038
J	Kabir, AH; Rahman, MM; Das, U; Sarkar, U; Roy, NC; Abu Reza, M; Talukder, MR; Uddin, MA				Kabir, Ahmad Humayan; Rahman, Md Mosiur; Das, Urmi; Sarkar, Urmi; Roy, Nepal Chandra; Abu Reza, Md; Talukder, Mamunur Rashid; Uddin, Md Alfaz			Reduction of cadmium toxicity in wheat through plasma technology	PLOS ONE			English	Article							SEED-GERMINATION; PLANT-GROWTH; STRESS; COLD; RHIZOSPHERE; TOLERANCE; SEEDLINGS; DROUGHT; LEAVES; YIELD	Cadmium (Cd) contamination in plant-derived food is a big concern. This study examines whether and how Ar/O-2 and Ar/Air plasma techniques lead to Cd detoxification in wheat. Treatment with Ar/O-2 and Ar/Air changed the seed surface and decreased the pH of seeds as well as the cultivation media. Generally, plants subjected to Cd treatment from seeds treated with Ar/O-2 and Ar/Air plasma showed considerable progress in morphology and total chlorophyll synthesis compared to Cd-treated wheat, suggesting that plasma technology is effective for Cd detoxification. Furthermore, Ar/O-2 and Ar/Air plasma treated plants showed a significant decrease in root and shoot Cd concentration, which is consistent with the reduced expression of Cd transporters in the root (TaLCT1 and TaHMA2) compared with the plants not treated with plasma in response to Cd stress. This Cd inhibition is possibly accomplished by the decrease of pH reducing the bioavailability of Cd in the rhizosphere. These observations are in line with maintenance of total soluble protein along with reduced electrolyte leakage and cell death (%) in root and shoot due to Ar/O-2 and Ar/Air treatments. Further, Cd-induced elevated H2O2 or oxidative damage in tissues was mainly diminished through the upregulation of antioxidant enzymes (SOD and CAT) and their corresponding genes (TaSOD and TaCAT) induced by Ar/O-2 and Ar/Air plasma. Grafting results suggest that root originating nitric oxide signal possibly drives the mechanisms of Cd detoxification due to plasma treatment in wheat. These findings provide a novel and eco-friendly use of plasma technology for the mitigation of Cd toxicity in wheat plants.	[Kabir, Ahmad Humayan; Rahman, Md Mosiur; Das, Urmi; Sarkar, Urmi] Univ Rajshahi, Dept Bot, Mol Plant Physiol Lab, Rajshahi, Bangladesh; [Roy, Nepal Chandra; Talukder, Mamunur Rashid] Univ Rajshahi, Dept Appl Phys & Elect Engn, Plasma Sci & Technol Lab, Rajshahi, Bangladesh; [Abu Reza, Md] Univ Rajshahi, Dept Genet Engn & Biotechnol, Mol Biol & Prot Sci Lab, Rajshahi, Bangladesh; [Uddin, Md Alfaz] Univ Rajshahi, Dept Phys, Rajshahi, Bangladesh	University of Rajshahi; University of Rajshahi; University of Rajshahi; University of Rajshahi	Kabir, AH (corresponding author), Univ Rajshahi, Dept Bot, Mol Plant Physiol Lab, Rajshahi, Bangladesh.	ahmad.kabir@ru.ac.bd	Kabir, Ahmad H/B-2738-2017; Talukder, M R/AAX-2018-2020; Abu Reza/ABE-6824-2020; Das, Urmi/AGU-1735-2022	Kabir, Ahmad H/0000-0001-6893-9418; Talukder, M R/0000-0003-2639-2148; Das, Urmi/0000-0002-6350-3049				Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Bari MA, 2019, PLANT PHYSIOL BIOCH, V136, P22, DOI 10.1016/j.plaphy.2019.01.007; Bethke PC, 2001, PLANT J, V25, P19, DOI 10.1046/j.1365-313x.2001.00930.x; Burzynski M, 2007, PHOTOSYNTHETICA, V45, P239, DOI 10.1007/s11099-007-0038-9; Calba H, 2004, PLANT SOIL, V260, P33, DOI 10.1023/B:PLSO.0000030169.75523.52; Dong J, 2007, PLANT SOIL ENVIRON, V53, P193, DOI 10.17221/2205-PSE; Ferrell J. R., 2013, J BIOTECHNOL BIOMATE, V3, P155, DOI [10.4172/2155-952X.1000155, DOI 10.4172/2155-952X.1000155]; Goud PB, 2012, PLANT SIGNAL BEHAV, V7, P1258, DOI 10.4161/psb.21584; Greger M, 2016, ENVIRON POLLUT, V211, P90, DOI 10.1016/j.envpol.2015.12.027; GUY C, 1992, PLANTA, V188, P265, DOI 10.1007/BF00216823; HATCH DJ, 1988, PLANT SOIL, V105, P121, DOI 10.1007/BF02371149; Hinsinger P, 2006, J GEOCHEM EXPLOR, V88, P210, DOI 10.1016/j.gexplo.2005.08.041; Hoagland DR, 1950, CALI AGR EXP STAT, V347; Kabir AH, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01117, 10.3389/fpls.2010.01117]; Lichtenthaler H.K., 1985, BIOL SOC T, V11, P591, DOI DOI 10.1042/BST0110591; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; Ortiz R, 2008, AGR ECOSYST ENVIRON, V126, P46, DOI 10.1016/j.agee.2008.01.019; Park DP, 2013, CURR APPL PHYS, V13, pS19, DOI 10.1016/j.cap.2012.12.019; Prasad MNV, 2013, HEAVY METAL STRESS P; Rahman M, 2016, ECOTOX ENVIRON SAFE, V135, P165; Rahman MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28960-3; Rascio N, 2008, ENVIRON EXP BOT, V62, P267, DOI 10.1016/j.envexpbot.2007.09.002; REDDY CN, 1977, J ENVIRON QUAL, V6, P259, DOI 10.2134/jeq1977.00472425000600030005x; Roy NC, 2018, PLASMA CHEM PLASMA P, V38, P13, DOI 10.1007/s11090-017-9855-1; Sera B, 2008, PLASMA SCI TECHNOL, V10, P506, DOI 10.1088/1009-0630/10/4/22; Sera B, 2013, PLASMA SCI TECHNOL, V15, DOI 10.1088/1009-0630/15/9/19; Sivachandiran L, 2017, RSC ADV, V7, P1822, DOI 10.1039/c6ra24762h; Sreethawong T, 2007, INT J HYDROGEN ENERG, V32, P1067, DOI 10.1016/j.ijhydene.2006.07.013; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Volin JC, 2000, CROP SCI, V40, P1706, DOI 10.2135/cropsci2000.4061706x; Wang YW, 2014, BIOMETALS, V27, P389, DOI 10.1007/s10534-014-9720-0; Wojtyla L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00066; Yu L, 2010, J PHYS CHEM A, V114, P360, DOI 10.1021/jp905082s; Zhao C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13530; Zhao J, 2005, BIOTECHNOL BIOENG, V90, P621, DOI 10.1002/bit.20465; Zhou ZhuWen, 2011, Agricultural Sciences, V2, P23, DOI 10.4236/as.2011.21004	37	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214509	10.1371/journal.pone.0214509	http://dx.doi.org/10.1371/journal.pone.0214509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933989	Green Published, gold, Green Submitted			2022-12-27	WOS:000462867000018
J	Wormwood, JB; Lin, YR; Lynn, SK; Barrett, LF; Quigley, KS				Wormwood, Jolie Baumann; Lin, Yu-Ru; Lynn, Spencer K.; Barrett, Lisa Feldman; Quigley, Karen S.			Psychological impact of mass violence depends on affective tone of media content	PLOS ONE			English	Article							BOSTON MARATHON BOMBINGS; ACUTE STRESS; POLICE OFFICERS; EMOTION; EXPOSURE; FEAR; TERRORISM; CHILDREN; PREDICTIONS; PERCEPTION	Exposure to media coverage of mass violence has been shown to predict poorer mental health symptomology. However, it is unknown whether such media coverage can have ubiquitous effects on average community members, extending to biological and perceptual processes that underlie everyday decision making and behavior. Here, we used a repeated-measures design over the first anniversary of the Boston Marathon bombings to track participants' self-reported distress, their eye blink startle reactivity while viewing images of the bombings, and their ability to perceptually distinguish armed from unarmed individuals in a behavioral shooting task. We leveraged a computational linguistics method in which we sampled news content from the sources our participants most commonly self-reported reading, and then quantified both the extent of news coverage about the marathon and the affective tone of that news coverage. Results revealed that participants experienced greater current distress, greater physiological reactivity to threats, and poorer perceptual sensitivity when recent news coverage of the marathon contained more affectively negative words. This is the first empirical work to examine relationships between the media's affective tone in its coverage of mass violence and individuals' threat perception and physiological threat reactivity.	[Wormwood, Jolie Baumann] Univ New Hampshire, Dept Psychol, Durham, NH 03824 USA; [Lin, Yu-Ru] Univ Pittsburgh, Sch Comp & Informat, Pittsburgh, PA USA; [Lynn, Spencer K.] Charles River Analyt Inc, Cambridge, MA USA; [Lynn, Spencer K.; Barrett, Lisa Feldman; Quigley, Karen S.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Barrett, Lisa Feldman] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Barrett, Lisa Feldman] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Quigley, Karen S.] Edith Nourse Rogers Mem VA Med Ctr, Ctr Healthcare Org & Implementat Res, Bedford, MA USA	University System Of New Hampshire; University of New Hampshire; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northeastern University; Harvard University; Massachusetts General Hospital	Wormwood, JB (corresponding author), Univ New Hampshire, Dept Psychol, Durham, NH 03824 USA.	jolie.wormwood@unh.edu	Barrett, Lisa Feldman/ABC-8157-2020	Barrett, Lisa/0000-0003-4478-2051	National Science Foundation [BCS-1422327, BCS-1426171, BCS-1423697, CMMI-1634944]	National Science Foundation(National Science Foundation (NSF))	This research was funded by grants from the National Science Foundation (BCS-1422327 and BCS-1426171 to K.S.Q. and J.B.W.; BCS-1423697 and CMMI-1634944 to Y.R.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.K.L.'s current affiliation is Charles River Analytics, Inc. During the preparation of this manuscript, Charles River Analytics provided support in the form of salary to S.K.L., but did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075881; Anderson E, 2012, EMOTION, V12, P1210, DOI 10.1037/a0027514; Balzarotti S, 2014, MEDIA PSYCHOL, V17, P357, DOI 10.1080/15213269.2013.826588; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Barrett L. F, 2017, EMOTIONS ARE MADE SE; Barrett LF, 2017, SOC COGN AFFECT NEUR, V12, P1, DOI 10.1093/scan/nsw154; Barrett LF, 2015, NAT REV NEUROSCI, V16, P419, DOI 10.1038/nrn3950; Baumann J, 2010, J PERS SOC PSYCHOL, V99, P595, DOI 10.1037/a0020665; Bisson J, 2005, COCHRANE LIB, V2, P1; Bleich A, 2003, JAMA-J AM MED ASSOC, V290, P612, DOI 10.1001/jama.290.5.612; Browne KD, 2005, LANCET, V365, P702, DOI 10.1016/S0140-6736(05)70938-7; Cantor J, 2000, J ADOLESCENT HEALTH, V27, P30, DOI 10.1016/S1054-139X(00)00129-4; Chanes L, 2016, TRENDS COGN SCI, V20, P96, DOI 10.1016/j.tics.2015.11.005; Correll J, 2002, J PERS SOC PSYCHOL, V83, P1314, DOI 10.1037//0022-3514.83.6.1314; Correll J, 2007, J PERS SOC PSYCHOL, V92, P1006, DOI 10.1037/0022-3514.92.6.1006; Ditton J, 2004, BRIT J CRIMINOL, V44, P595, DOI 10.1093/bjc/azh028; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Fischhoff B, 2005, J EXP PSYCHOL-APPL, V11, P124, DOI [10.1037/1076-898X.11.2.124, 10.1037/a0027959]; Fischhoff B., 2003, J RISK UNCERTAIN, P39, DOI DOI 10.1007/978-1-4757-6787-2_3; FREEDY JR, 1994, J TRAUMA STRESS, V7, P257, DOI 10.1002/jts.2490070207; Garfin DR, 2015, PSYCHOL SCI, V26, P675, DOI 10.1177/0956797614561043; GERBNER G, 1980, J COMMUN, V30, P10, DOI 10.1111/j.1460-2466.1980.tb01987.x; Goodwin R, 2013, J PSYCHIATR RES, V47, P1099, DOI 10.1016/j.jpsychires.2013.04.006; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Hammen C, 2000, J CONSULT CLIN PSYCH, V68, P782, DOI 10.1037/0022-006X.68.5.782; Holman EA, 2008, ARCH GEN PSYCHIAT, V65, P73, DOI 10.1001/archgenpsychiatry.2007.6; Holman EA, 2014, P NATL ACAD SCI USA, V111, P93, DOI 10.1073/pnas.1316265110; Holmes EA, 2007, J BEHAV THER EXP PSY, V38, P474, DOI 10.1016/j.jbtep.2007.10.003; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; Kenny DA, 2003, PSYCHOL METHODS, V8, P115, DOI 10.1037/1082-989X.8.2.115; Kleckner IR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0069; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lang P.J., 2008, A8 U FLOR; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Larson CL, 2000, PSYCHOPHYSIOLOGY, V37, P92, DOI 10.1017/S0048577200981344; Lerner JS, 2003, PSYCHOL SCI, V14, P144, DOI 10.1111/1467-9280.01433; LICHTENSTEIN S, 1978, J EXP PSYCHOL-HUM L, V4, P551, DOI 10.1037/0278-7393.4.6.551; Maas C.J., 2005, METHODOLOGY-EUR, V1, P86, DOI [DOI 10.1027/1614-2241.1.3.86, 10.1027/1614-2241.1.3.86]; McComas KA, 2006, J HEALTH COMMUN, V11, P75, DOI 10.1080/10810730500461091; Merritt A, 2016, CHILD YOUTH CARE FOR, V45, P241, DOI 10.1007/s10566-015-9328-8; Pennebaker J. W., 2015, LINGUISTIC INQUIRY W; Pfefferbaum B, 2001, PSYCHIATRY, V64, P202, DOI 10.1521/psyc.64.3.202.18462; POST RM, 1992, AM J PSYCHIAT, V149, P999; Raudenbush S, 2011, HLM STAT SOFTWARE VE; Raudenbush SW, 2002, HIERARCHICAL LINEAR; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Ruben M.A., 2016, TRANSL ISS PSYCH SCI, V2, P382, DOI [10.1037/tps0000095, DOI 10.1037/TPS0000095]; Seery MD, 2010, J PERS SOC PSYCHOL, V99, P1025, DOI 10.1037/a0021344; Shanahan J, 2002, TELEVISION ITS VIEWE; Shedd OL, 2004, J AM COLL CARDIOL, V44, P1265, DOI 10.1016/j.jacc.2004.04.058; Shenhar-Tsarfaty S, 2015, P NATL ACAD SCI USA, V112, pE467, DOI 10.1073/pnas.1418264112; Siegel EH, PSYCHOL SCI; Silver RC, 2013, PSYCHOL SCI, V24, P1623, DOI 10.1177/0956797612460406; Slovic P., 1980, SOC RISK ASSESSMENT, P181, DOI [10.1007/978-1-4899-0445-4_9, DOI 10.1007/978-1-4899-0445-4_9]; Snijders Tom, 2005, ENCY STAT BEHAV SCI; Sterling P., 2015, PRINCIPLES NEURAL DE; Sterling P, 2012, PHYSIOL BEHAV, V106, P5, DOI 10.1016/j.physbeh.2011.06.004; Thompson RR, 2017, CLIN PSYCHOL SCI A; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Wormwood JB, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01333; Wormwood JB, 2017, J APPL SOC PSYCHOL, V47, P13, DOI 10.1111/jasp.12412; Wormwood JB, 2016, COGNITION EMOTION, V30, P539, DOI 10.1080/02699931.2015.1010487	63	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0213891	10.1371/journal.pone.0213891	http://dx.doi.org/10.1371/journal.pone.0213891			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934012	gold, Green Submitted, Green Published			2022-12-27	WOS:000462867000008
J	van der Velden, PG; Muffels, RJA; Peijen, R; Bosmans, MWG				van der Velden, Peter G.; Muffels, Ruud J. A.; Peijen, Roy; Bosmans, Mark W. G.			Wages and employment security following a major disaster: A 17-year population-based longitudinal comparative study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SOCIOECONOMIC-STATUS; HEALTH; GROWTH; RESILIENCE; WORK; CONSEQUENCES; SURVIVORS; SYMPTOMS; RECOVERY	Objectives The effects of disasters on mental health are well documented, but very little is known about the short to long-term effects of human-made disasters on wage and employment security careers of the affected residents. Methods Residents affected by a major fireworks disaster (May 13, 2000) in a Dutch residential area were all anonymously identified, based on postal codes of the affected area. To gain insight in these effects, data were derived from Statistics Netherlands that records all individual demographic, gross annual wages and employment security data of the entire Dutch population since 1999. A quasi-experimental matched control group design was used by constructing two pair-wise matched groups of non-affected residents of the city of Tilburg and the general Dutch population. Matching was based on nine demographic variables such as gender, age, education level and gross annual wage in 1999 (N-total = 12,648). The effects of the disaster on wage and employment security from 1999 to 2016 among the total group and among those with low wages in 1999, were assessed using fixed-effects panel regression analyses. Results Affected residents had significant lower gross annual wages in the medium and long term than the non-affected groups from the Netherlands, but differences were (very) small. Compared to the Tilburg group the significant differences were trivial in the medium term. Among the low-wage groups, no relevant differences were found between affected and non-affected residents. With respect to employment security, no or trivial differences were found between the total group of affected and matched comparison groups. Among those with low wages in 1999, in 2001 and especially 2002 affected residents worked fewer weeks per year than non-affected from Tilburg. In 2002 the difference with the Tilburg group was above moderate. Conclusions These results speak to the resilience of affected residents, given the mental health problems and PTSD-symptomatology they suffered from, as shown in previous research.	[van der Velden, Peter G.] CentERdata, Tilburg, Netherlands; [van der Velden, Peter G.; Muffels, Ruud J. A.] Tilburg Univ, Network Hlth & Labor NETHLAB, Tilburg, Netherlands; [van der Velden, Peter G.] Tilburg Univ, Intervict, Tilburg, Netherlands; [Muffels, Ruud J. A.] Tilburg Univ, Tilburg Sch Social & Behav Sci, TRANZO, Tilburg, Netherlands; [Muffels, Ruud J. A.; Peijen, Roy] Tilburg Univ, Tilburg Sch Social & Behav Sci, Dept Sociol, Tilburg, Netherlands; [Peijen, Roy] Tilburg Univ, TIG, Tilburg, Netherlands; [Bosmans, Mark W. G.] NIVEL, Utrecht, Netherlands	Tilburg University; Tilburg University; Tilburg University; Tilburg University; Tilburg University; Tilburg University; Netherlands Institute for Health Services Research	van der Velden, PG (corresponding author), CentERdata, Tilburg, Netherlands.; van der Velden, PG (corresponding author), Tilburg Univ, Network Hlth & Labor NETHLAB, Tilburg, Netherlands.; van der Velden, PG (corresponding author), Tilburg Univ, Intervict, Tilburg, Netherlands.	pg.vandervelden@tilburguniversity.edu	Peijen, Roy/AAJ-3676-2020; Muffels, Ruud/E-3644-2013	Peijen, Roy/0000-0002-5556-3340; Muffels, Ruud/0000-0001-8559-7616; Bosmans, Mark/0000-0001-9479-8604; van der Velden, Peter G./0000-0002-0221-6281	Achmea Victim & Society Foundation (SASS), Zeist, the Netherlands	Achmea Victim & Society Foundation (SASS), Zeist, the Netherlands	This study was made possible by a grant of the Achmea Victim & Society Foundation (SASS), Zeist, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2006, ACTA PSYCHIAT SCAND, V420, P38, DOI [10.1111/J.16000047.2004.00329.X, DOI 10.1111/J.16000047.2004.00329.X]; [Anonymous], 2006, MON LABOR REV, V129, P3; [Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Bosmans MWG, 2016, PSYCHOL TRAUMA-US, V8, P241, DOI 10.1037/tra0000088; Bowles SV, 2010, MIL MED, V175, P382, DOI 10.7205/MILMED-D-10-00099; Britt TW, 2016, IND ORGAN PSYCHOL-US, V9, P378, DOI 10.1017/iop.2015.107; COLEMAN JS, 1988, KNOWLEDGE SOCIAL CAP, V94, pS95, DOI DOI 10.1016/B978-0-7506-7222-1.50005-2; De Witte H, 2005, SA J IND PSYCHOL, V31, P1; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Ewing B.T., 2003, ENVIRON HAZARDS-UK, V5, P83, DOI DOI 10.1016/J.HAZARDS.2004.05.002; Faragher EB., 2005, OCCUP ENVIRON MED, V62, P105, DOI [10.1136/oem.2002.006734, DOI 10.1136/oem.2002.006734]; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2008, J TRAUMA STRESS, V21, P357, DOI 10.1002/jts.20355; Gangl M, 2006, AM SOCIOL REV, V71, P986, DOI 10.1177/000312240607100606; Heponiemi T, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-19; Hikichi H, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700426; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Joseph NT, 2014, HEALTH PSYCHOL, V33, P139, DOI 10.1037/a0031661; Kossek EE, 2016, ACAD MANAG ANN, V10, P729, DOI 10.1080/19416520.2016.1159878; Lehmann H, 2011, J HEALTH ECON, V30, P843, DOI 10.1016/j.jhealeco.2011.07.011; Matthews LR, 2005, BEHAV RES THER, V43, P475, DOI 10.1016/j.brat.2004.03.008; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meyerson DA, 2011, CLIN PSYCHOL REV, V31, P949, DOI 10.1016/j.cpr.2011.06.003; Montpetit MA, 2010, PSYCHOL AGING, V25, P631, DOI 10.1037/a0019268; Morina N, 2014, CLIN PSYCHOL REV, V34, P249, DOI 10.1016/j.cpr.2014.03.002; Neria Y., 2009, MENTAL HLTH DISASTER, DOI 10.1017/CBO9780511730030; Norris F.H., 2009, MENTAL HLTH DISASTER, P473, DOI 10.1017/CBO9780511730030.028; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Rasco SS, 2010, J AM ACAD PSYCHIATRY, V38, P80; Rosellini AJ, 2018, PSYCHOL MED, V48, P437, DOI 10.1017/S0033291717001817; RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384; RUHM CJ, 1991, AM ECON REV, V81, P319; Savoca Elizabeth, 2000, J Ment Health Policy Econ, V3, P199, DOI 10.1002/mhp.102; Schubert CF, 2016, CLIN PSYCHOL PSYCHOT, V23, P469, DOI 10.1002/cpp.1985; Searing EAM, 2013, SOC SCI MED, V96, P165, DOI 10.1016/j.socscimed.2013.07.020; Shakespeare-Finch J, 2014, J ANXIETY DISORD, V28, P223, DOI 10.1016/j.janxdis.2013.10.005; Stam K, 2016, WORK EMPLOY SOC, V30, P309, DOI 10.1177/0950017014564602; Stutzer A, 2004, J EUR ECON ASSOC, V2, P696, DOI 10.1162/1542476041423331; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1002/jts.2490090305; van der Noordt M, 2014, OCCUP ENVIRON MED, V71, P730, DOI 10.1136/oemed-2013-101891; van der Velden PG, 2013, PSYCHIAT CLIN NEUROS, V67, P110, DOI 10.1111/pcn.12022; Vogt D, 2017, SOC PSYCH PSYCH EPID, V52, P341, DOI 10.1007/s00127-016-1321-5; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; World Bank, 2003, HDB EST SOC ENV EFF, P109; Yzermans CJ, 2005, INT J EPIDEMIOL, V34, P820, DOI 10.1093/ije/dyi096; Zissimopoulos J, 2010, DEMOGRAPHY, V47, P345	52	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214208	10.1371/journal.pone.0214208	http://dx.doi.org/10.1371/journal.pone.0214208			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9FO	30925173	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300010
J	Kahn-Kirby, AH; Amagata, A; Maeder, CI; Mei, JJ; Sideris, S; Kosaka, Y; Hinman, A; Malone, SA; Bruegger, JJ; Wang, L; Kim, V; Shrader, WD; Hoff, KG; Latham, JC; Ashley, EA; Wheeler, MT; Bertini, E; Carrozzo, R; Martinelli, D; Dionisi-Vici, C; Chapman, KA; Enns, GM; Gahl, W; Wolfe, L; Saneto, RP; Johnson, SC; Trimmer, JK; Klein, MB; Holst, CR				Kahn-Kirby, Amanda H.; Amagata, Akiko; Maeder, Celine I.; Mei, Janet J.; Sideris, Steve; Kosaka, Yuko; Hinman, Andrew; Malone, Stephanie A.; Bruegger, Joel J.; Wang, Leslie; Kim, Virna; Shrader, William D.; Hoff, Kevin G.; Latham, Joey C.; Ashley, Euan A.; Wheeler, Matthew T.; Bertini, Enrico; Carrozzo, Rosalba; Martinelli, Diego; Dionisi-Vici, Carlo; Chapman, Kimberly A.; Enns, Gregory M.; Gahl, William; Wolfe, Lynne; Saneto, Russell P.; Johnson, Simon C.; Trimmer, Jeffrey K.; Klein, Matthew B.; Holst, Charles R.			Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy	PLOS ONE			English	Article							HYPOPLASIA TYPE 6; PONTOCEREBELLAR HYPOPLASIA; CELL-DEATH; UNDIAGNOSED DISEASES; LIPID-PEROXIDATION; OXIDATIVE STRESS; SPONDYLOMETAPHYSEAL DYSPLASIA; SELENOPROTEIN BIOSYNTHESIS; CEREBELLAR HYPOPLASIA; RARS2 MUTATIONS	Background Mitochondrial disease is a family of genetic disorders characterized by defects in the generation and regulation of energy. Epilepsy is a common symptom of mitochondrial disease, and in the vast majority of cases, refractory to commonly used antiepileptic drugs. Ferroptosis is a recently-described form of iron- and lipid-dependent regulated cell death associated with glutathione depletion and production of lipid peroxides by lipoxygenase enzymes. Activation of the ferroptosis pathway has been implicated in a growing number of disorders, including epilepsy. Given that ferroptosis is regulated by balancing the activities of glutathione peroxidase-4 (GPX4) and 15-lipoxygenase (15-LO), targeting these enzymes may provide a rational therapeutic strategy to modulate seizure. The clinical-stage therapeutic vatiquinone (EPI-743, a-tocotrienol quinone) was reported to reduce seizure frequency and associated morbidity in children with the mitochondrial disorder pontocerebellar hypoplasia type 6. We sought to elucidate the molecular mechanism of EPI-743 and explore the potential of targeting 15-LO to treat additional mitochondrial disease-associated epilepsies. Methods Primary fibroblasts and B-lymphocytes derived from patients with mitochondrial disease-associated epilepsy were cultured under standardized conditions. Ferroptosis was induced by treatment with the irreversible GPX4 inhibitor RSL3 or a combination of pharmacological glutathione depletion and excess iron. EPI-743 was co-administered and endpoints, including cell viability and 15-LO-dependent lipid oxidation, were measured. Results EPI-743 potently prevented ferroptosis in patient cells representing five distinct pediatric disease syndromes with associated epilepsy. Cytoprotection was preceded by a dose-dependent decrease in general lipid oxidation and the specific 15-LO product 15-hydroxyeicosatetraenoic acid (15-HETE). Conclusions These findings support the continued clinical evaluation of EPI-743 as a therapeutic agent for PCH6 and other mitochondrial diseases with associated epilepsy.	[Kahn-Kirby, Amanda H.; Amagata, Akiko; Maeder, Celine I.; Mei, Janet J.; Sideris, Steve; Kosaka, Yuko; Hinman, Andrew; Malone, Stephanie A.; Bruegger, Joel J.; Wang, Leslie; Kim, Virna; Shrader, William D.; Hoff, Kevin G.; Latham, Joey C.; Trimmer, Jeffrey K.; Klein, Matthew B.; Holst, Charles R.] BioElectron Technol Corp, Mountain View, CA 94043 USA; [Ashley, Euan A.; Wheeler, Matthew T.] Stanford Univ, Sch Med, Stanford Ctr Undiagnosed Dis, Stanford, CA 94305 USA; [Bertini, Enrico; Carrozzo, Rosalba; Martinelli, Diego] Bambino Gesu Childrens Res Hosp, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy; [Dionisi-Vici, Carlo] Bambino Gesu Pediat Hosp, Clin Div, Rome, Italy; [Dionisi-Vici, Carlo] Bambino Gesu Pediat Hosp, Res Unit Metab Dis, Rome, Italy; [Chapman, Kimberly A.] Childrens Natl Rare Dis Inst, Childrens Natl Hlth Syst, Washington, DC USA; [Enns, Gregory M.] Stanford Univ, Dept Pediat, Div Med Genet, Sch Med, Stanford, CA 94305 USA; [Gahl, William; Wolfe, Lynne] NHGRI, NIH, Undiagnosed Dis Program, Bethesda, MD 20892 USA; [Saneto, Russell P.] Seattle Childrens Hosp, Neurosci Inst, Div Pediat Neurol, Dept Neurol, Seattle, WA USA; [Johnson, Simon C.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Johnson, Simon C.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Stanford University; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; Children's National Health System; Stanford University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Kahn-Kirby, AH (corresponding author), BioElectron Technol Corp, Mountain View, CA 94043 USA.	AKahn-Kirby@BioElectron.com	Bertini, Enrico/ABG-1278-2020; Carrozzo, Rosalba/A-2808-2014; Bertini, Enrico/A-2284-2014; Dionisi-Vici, Carlo/K-2045-2018	Johnson, Simon/0000-0002-1942-3674; Holst, Charles/0000-0001-8010-1677; Carrozzo, Rosalba/0000-0002-3327-4054; Bertini, Enrico/0000-0001-9276-4590; Dionisi-Vici, Carlo/0000-0002-0007-3379; Wheeler, Matthew/0000-0001-8721-3022	BioElectron Technology Corporation, Inc.; National Institutes of Health (NIH) award [1K99GM126147-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM126147] Funding Source: NIH RePORTER	BioElectron Technology Corporation, Inc.; National Institutes of Health (NIH) award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by BioElectron Technology Corporation, Inc. The funder provided support in the form of salaries for authors AA, JJB, AH, KGH, CRH, AHKK, VK, MBK, YK, JCL, CIM, SAM, JJM, WDS, SS, JKT, LWang. In addition, the funding entity had a direct role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. SCJ is supported by National Institutes of Health (NIH) award 1K99GM126147-01.	Abeti R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.111; Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007; Amagata T, 2003, J NAT PROD, V66, P230, DOI 10.1021/np020462l; Anttonen AK, 2015, NEUROLOGY, V85, P306, DOI 10.1212/WNL.0000000000001787; Aygun C, 2012, AM J MED GENET A, V158A, P1400, DOI 10.1002/ajmg.a.35306; Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Cotticelli MG, 2019, J PHARMACOL EXP THER; Cserep C, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0390-17.2018; Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866; Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; English SJ, 2006, AM J MED GENET A, V140A, P1854, DOI 10.1002/ajmg.a.31376; Enns GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100001; Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009; Finsterer J, 2017, EPILEPSY RES, V136, P5, DOI 10.1016/j.eplepsyres.2017.07.003; Fradejas-Villar N, 2018, FREE RADICAL BIO MED, V127, P206, DOI 10.1016/j.freeradbiomed.2018.04.572; Friedmann Angeli JP, 2014, NAT CELL BIOL, V3, P1; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Gahl WA, 2011, JAMA-J AM MED ASSOC, V305, P1904, DOI 10.1001/jama.2011.613; Glamuzina E, 2012, J INHERIT METAB DIS, V35, P459, DOI 10.1007/s10545-011-9413-6; Gulyas AI, 2006, EUR J NEUROSCI, V23, P2581, DOI 10.1111/j.1460-9568.2006.04814.x; Hayhurst H, 2019, BRAIN PATHOL, V29, P97, DOI 10.1111/bpa.12640; Hinman A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201369; Ingold I, 2017, CELL, P1, DOI [10.1016/j.cell.2013.12.010, DOI 10.1016/J.CELL.2013.12.010]; Jaeger B, 2017, JIMD REP; Joseph JT, 2014, J NEUROPATH EXP NEUR, V73, P1009, DOI 10.1097/NEN.0000000000000123; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Kann O, 2014, J CEREBR BLOOD F MET, V34, P1270, DOI 10.1038/jcbfm.2014.104; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737; Kovac S, 2018, MOL NEUROBIOL, P1; Lax NZ, 2015, J NEUROPATH EXP NEUR, V74, P688, DOI 10.1097/NEN.0000000000000209; Lewerenz J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00214; Li ZJ, 2015, J HUM GENET, V60, P363, DOI 10.1038/jhg.2015.31; Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9; Lord LD, 2013, J CEREBR BLOOD F MET, V33, P1347, DOI 10.1038/jcbfm.2013.94; Luhl S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0525-9; Martinc B, 2014, CURR NEUROPHARMACOL, V12, P527, DOI 10.2174/1570159X12666140923205715; Martinelli D., 2013, J INHERIT METAB DIS, V36, pS110; Masaldan S, 2018, REDOX BIOL, V14, P100, DOI 10.1016/j.redox.2017.08.015; Menon B, 2012, SEIZURE-EUR J EPILEP, V21, P780, DOI 10.1016/j.seizure.2012.09.003; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Ngoh A, 2016, EPILEPSIA, V57, pE97, DOI 10.1111/epi.13358; Nishri D, 2016, EUR J PAEDIATR NEURO, V20, P412, DOI 10.1016/j.ejpn.2016.02.012; Pitts MW, 2014, BIOL TRACE ELEM RES, V161, P231, DOI 10.1007/s12011-014-0060-2; Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x; Ramoni RB, 2017, AM J HUM GENET, V100, P185, DOI 10.1016/j.ajhg.2017.01.006; Rankin J, 2010, AM J MED GENET A, V152A, P2079, DOI 10.1002/ajmg.a.33531; Roels F, 2018, ORPHANET J RARE DIS, V13, P1, DOI [10.1186/s13023-017-0741-y, DOI 10.1186/S13023-017-0741-Y]; Sanders LH, 2013, FREE RADICAL BIO MED, V62, P111, DOI 10.1016/j.freeradbiomed.2013.01.003; Saneto RP, 2017, J INBORN ERRORS META, V5, DOI [10.1177/2326409817697399, DOI 10.1177/2326409817697399]; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shah R, 2018, ACS CENTRAL SCI, V4, P387, DOI 10.1021/acscentsci.7b00589; Smith AC, 2014, J MED GENET, V51, P470, DOI 10.1136/jmedgenet-2013-102218; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Turkdogan D, 2002, J CHILD NEUROL, V17, P673, DOI 10.1177/088307380201700904; WASLIDGE NB, 1995, ANAL BIOCHEM, V231, P354, DOI 10.1006/abio.1995.0063; WEBER GF, 1991, LANCET, V337, P1443, DOI 10.1016/0140-6736(91)93130-2; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wirth EK, 2014, BIOL TRACE ELEM RES, V158, P203, DOI 10.1007/s12011-014-9920-z; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9	70	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214250	10.1371/journal.pone.0214250	http://dx.doi.org/10.1371/journal.pone.0214250			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921410	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000047
J	Bagchi, S; Lingaiah, R; Mani, K; Barwad, A; Singh, G; Balooni, V; Bhowmik, D; Agarwal, SK				Bagchi, Soumita; Lingaiah, Raghavendra; Mani, Kalaivani; Barwad, Adarsh; Singh, Geetika; Balooni, Veena; Bhowmik, Dipankar; Agarwal, Sanjay Kumar			Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study	PLOS ONE			English	Article							GLYCOSYLATION; INDIA	Background IgA nephropathy(IgAN) is a common glomerular disease with a higher risk of progression to end stage renal disease (ESRD) in certain ethnic populations. Since galactose deficient IgA1(Gd-IgA1) is a critical molecule in its pathogenesis, it has generated interest as a biomarker for this disease. Methods We measured serum Gd-IgA1 levels using a non-lectin based enzyme linked immunoassay (ELISA) in 136 immunosuppression naive patients with primary IgAN and 110 controls(60non IgA glomerular diseases, 50-healthy volunteers). Results Median serum Gd-IgA1 levels were significantly higher in IgAN patients [13135.6(2723.3, 59603.8) ng/ml] compared to those with non IgA glomerular disease [4954.8(892.9,18256.2) ng/ml] and healthy controls [6299.5(1993.2,19256) ng/ml] and this was observed even after log transformation and adjustment for age and gender(p<0.0001). Considering a cut-off value of serum Gd-IGA1 >= 7982.1ng/ml, the sensitivity for diagnosing IgAN compared to healthy controls was 74.3% and specificity was 72.0% with a positive predictive value of 87.8% and negative predictive value of 50.7%. The serum Gd-IgA1 level did not co-relate with baseline estimated glomerular filtration rate, urine protein creatinine ratio and the M, E, S, T and C scores on renal biopsy. The renal survival (absence of >30% decrease in eGFR, ESRD or death) was lower in patients with higher serum Gd-IgA1 levels(>= 7982ng/ml) than those who had lower levels but it was not statistically significant(p = 0.486). Conclusion Serum Gd-IgA1 level is higher in IgAN patients compared to non-IgA glomerular diseases and healthy controls and has a good positive predictive value for diagnosis. However, it does not correlate with clinical and histological characteristics of disease severity and does not predict disease progression.	[Bagchi, Soumita; Bhowmik, Dipankar; Agarwal, Sanjay Kumar] All India Inst Med Sci, Dept Nephrol, New Delhi, India; [Lingaiah, Raghavendra; Balooni, Veena] All India Inst Med Sci, Dept Lab Med, New Delhi, India; [Mani, Kalaivani] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Barwad, Adarsh; Singh, Geetika] All India Inst Med Sci, Dept Pathol, New Delhi, India; [Lingaiah, Raghavendra] Sanjay Gandhi Post Grad Inst Med Sci, Dept Pathol, Lucknow, Uttar Pradesh, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Bagchi, S (corresponding author), All India Inst Med Sci, Dept Nephrol, New Delhi, India.	soumita_bagchi@yahoo.co.in		Agarwal, Sanjay Kumar/0000-0002-5200-7605	All India Institute of Medical Sciences, New Delhi, India [A-538]	All India Institute of Medical Sciences, New Delhi, India	SB received an intramural grant (Code No A-538) from All India Institute of Medical Sciences, New Delhi, India, for this study. The funding authority did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470; Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862; Bagchi S, 2016, RENAL FAILURE, V38, P431, DOI 10.3109/0886022X.2016.1138817; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chacko B, 2005, NEPHROLOGY, V10, P496, DOI 10.1111/j.1440-1797.2005.00445.x; Chandrika BK, 2009, INDIAN J PATHOL MICR, V52, P14, DOI 10.4103/0377-4929.44954; Coppo R, 2004, KIDNEY INT, V65, P1544, DOI 10.1111/j.1523-1755.2004.05407.x; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Hastings MC, 2010, CLIN J AM SOC NEPHRO, V5, P2069, DOI 10.2215/CJN.03270410; Kim MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148466; Lin XJ, 2009, NEPHROL DIAL TRANSPL, V24, P3372, DOI 10.1093/ndt/gfp294; Mittal N, 2012, POSTGRAD MED J, V88, P15, DOI 10.1136/postgradmedj-2011-130077; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Nguyen C, 2019, CLIN KIDNEY J, V12, P232, DOI 10.1093/ckj/sfy068; Placzek WJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190967; Sanders JT, 2017, INT J NEPHROL, V2017, DOI 10.1155/2017/8210641; Shimozato S, 2008, NEPHROL DIAL TRANSPL, V23, P1931, DOI 10.1093/ndt/gfm913; Sun Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166700; Suzuki H, 2018, KIDNEY INT, V93, P700, DOI 10.1016/j.kint.2017.10.019; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Xu LX, 2005, KIDNEY INT, V68, P167, DOI 10.1111/j.1523-1755.2005.00390.x; Yasutake J, 2015, NEPHROL DIAL TRANSPL, V30, P1315, DOI 10.1093/ndt/gfv221; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214256	10.1371/journal.pone.0214256	http://dx.doi.org/10.1371/journal.pone.0214256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917188	gold, Green Submitted, Green Published			2022-12-27	WOS:000462465800058
J	Liu, J; Hu, TT; Feng, PY; Wang, L; Yang, SH				Liu, Jie; Hu, Tiantian; Feng, Puyu; Wang, Li; Yang, Shuohuan			Tomato yield and water use efficiency change with various soil moisture and potassium levels during different growth stages	PLOS ONE			English	Article							LYCOPERSICON-ESCULENTUM MILL.; BLOSSOM-END ROT; FRUIT-QUALITY; PROCESSING TOMATO; DEFICIT IRRIGATION; DRIP-IRRIGATION; CALCIUM; STRESS; PLANTS; NUTRITION	Faced with the scarcity of water resource and irrational fertilizer use, it is highly important to supply plants with water and fertilizer at desiderated stages to improve yield with high water use efficiency (WUE). A pot experiment was conducted to investigate the effects of growth stage-specific water deficiency and potassium (K) fertilization on tomato yield and WUE. The entire growing season of tomato was divided into 5 stages: vegetative growth stage (VG), flowering and fruit setting stage (FS), early fruit growth stage (FG), fruit development stage (FD) and fruit maturity stage (FM). Three soil moisture (W) and three K fertilization levels were set up. W levels included W1, W2 and W3, indicating that soil water was maintained at 60-70% field capacity, 70-80% field capacity, and 80-90% field capacity, respectively. K levels included K1, K2 and K3, indicating that 0 g K2O per kg soil, 0.46 g K2O per kg soil and 0.92 g K2O per kg soil was applied. All combinations of the three W and three K levels were solely imposed at each of the five growth stages, for other four stages, plants were watered to 80-90% field capacity without K fertilizer (W3K1). The permanent W3K1 over the entire growth stage was taken as control (CK). The results showed that W deficiency imposed at all stages significantly affected tomato yield (P<0.01), except for VG stage in which W deficiency did not cause yield loss. K fertilization level during FS or FM stage had a significant effect on yield (P<0.01). A significant interaction effect of W and K on yield was only observed during FM stage. For WUE, significant effect of W deficiency at FS, FD and FM stages were observed, and a significant effect of K levels at FS, FD and FM stages was observed. Specifically, K fertilization was necessary during specific growth stage of tomato (i.e. FS and FM). During FS stage, even if a sufficient water supply seems necessary, a deficit irrigation with K fertilization could be applied as K fertilization could alleviate the negative effect of soil water deficit, however, excess of K fertilization during FM stage should be avoided to maintain tomato yield and WUE.	[Liu, Jie; Hu, Tiantian; Feng, Puyu; Wang, Li; Yang, Shuohuan] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China; [Liu, Jie; Hu, Tiantian; Feng, Puyu; Wang, Li; Yang, Shuohuan] Northwest A&F Univ, Minist Educ, Key Lab Agr Soil & Water Engn Arid & Semiarid Are, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Hu, TT (corresponding author), Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China.; Hu, TT (corresponding author), Northwest A&F Univ, Minist Educ, Key Lab Agr Soil & Water Engn Arid & Semiarid Are, Yangling, Shaanxi, Peoples R China.	hutiant@nwsuaf.edu.cn			National Natural Science Foundation of China [51279169]; National High Technology Research and Development Program of China [2011AA100504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (51279169), http://www.nsfc.gov.cn/, the National High Technology Research and Development Program of China (2011AA100504).	Abd El-Mageed TA, 2017, ARCH AGRON SOIL SCI, V63, P827, DOI 10.1080/03650340.2016.1240363; Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; Akhtar ME, 2010, PAK J BOT, V42, P1695; Amjad M, 2016, J PLANT NUTR, V39, P1926, DOI 10.1080/01904167.2016.1201107; Amjad M, 2014, TURK J BIOL, V38, P208, DOI 10.3906/biy-1305-54; Amtmann A, 2006, ADV BOT RES, V43, P209, DOI 10.1016/S0065-2296(05)43005-0; Bar-Tal A, 1996, J AM SOC HORTIC SCI, V121, P649, DOI 10.21273/JASHS.121.4.649; Birhanu K., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P2139; Cahn MD, 2001, ACTA HORTIC, P111, DOI 10.17660/ActaHortic.2001.542.13; Chen JL, 2013, AGR WATER MANAGE, V129, P152, DOI 10.1016/j.agwat.2013.07.011; Chen S, 2015, ACTA AGR SCAND B-S P, V65, P460, DOI 10.1080/09064710.2015.1024279; Colpan E, 2013, HORTIC ENVIRON BIOTE, V54, P20, DOI 10.1007/s13580-013-0080-4; DENMEAD OT, 1962, AGRON J, V54, P385, DOI 10.2134/agronj1962.00021962005400050005x; Doorenbos J., 1979, UN FAO PUBLICATION, V33; [杜太生 Du Taisheng], 2011, [水利学报, Journal of Hydraulic Engineering], V42, P245; Gregory PJ, 2000, AGRON J, V92, P814, DOI 10.2134/agronj2000.925814x; Grzebisz W, 2013, J PLANT NUTR SOIL SC, V176, P355, DOI 10.1002/jpln.201200287; Gunter C C, 2005, HORTSCIENCE, V216, P1073; Han QH, 2012, ACTA HORTIC, V944, P45; Harmanto, 2005, AGR WATER MANAGE, V71, P225, DOI 10.1016/j.agwat.2004.09.003; Hartz TK, 2005, HORTSCIENCE, V40, P1862, DOI 10.21273/HORTSCI.40.6.1862; Hartz TK, 1999, J AM SOC HORTIC SCI, V124, P199, DOI 10.21273/JASHS.124.2.199; Hu Y, 2010, J PLANT NUTR SOIL SC, V168, P541; Huang JS, 2009, COMMUN SOIL SCI PLAN, V40, P1937, DOI 10.1080/00103620902896811; HUBER SC, 1984, PLANT PHYSIOL, V76, P424, DOI 10.1104/pp.76.2.424; Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017; Kanai S, 2007, J EXP BOT, V58, P2917, DOI 10.1093/jxb/erm149; Kanai S, 2011, PLANT SCI, V180, P368, DOI 10.1016/j.plantsci.2010.10.011; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Kuscu H, 2014, AGR WATER MANAGE, V133, P92, DOI 10.1016/j.agwat.2013.11.008; Li B.Y., 2007, THESIS; Li J M, 2000, ACTA AGR BOREALI OCC, V4, P71; Liu K, 2011, AGRON J, V103, P1339, DOI 10.2134/agronj2011.0111; Lopez MV, 1996, PLANT SCI, V114, P19, DOI 10.1016/0168-9452(95)04300-4; Marouelli WA, 2007, IRRIGATION SCI, V25, P411, DOI 10.1007/s00271-006-0056-6; Nangare DD, 2016, AGR WATER MANAGE, V171, P73, DOI 10.1016/j.agwat.2016.03.016; Nuruddin MM, 2003, HORTSCIENCE, V38, P1389, DOI 10.21273/HORTSCI.38.7.1389; Padilla FM, 2018, SCI TOTAL ENVIRON, V643, P400, DOI 10.1016/j.scitotenv.2018.06.215; Patane C, 2010, AGR WATER MANAGE, V97, P131, DOI 10.1016/j.agwat.2009.08.021; Patane C, 2011, SCI HORTIC-AMSTERDAM, V129, P590, DOI 10.1016/j.scienta.2011.04.030; Peiter E, 2011, CELL CALCIUM, V50, P120, DOI 10.1016/j.ceca.2011.02.002; Pujos A, 1997, PLANT SOIL, V189, P189, DOI 10.1023/A:1004263304657; Rahmati M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120246; Romheld V, 2007, P 616 INT FERT SOC Y; San-Martin-Hernandez C, 2016, INTERCIENCIA, V41, P60; Sato S, 2010, PLANT CELL ENVIRON, V23, P719; Saure MC, 2001, SCI HORTIC-AMSTERDAM, V90, P193, DOI 10.1016/S0304-4238(01)00227-8; Schilling G, 2016, J PLANT NUTR SOIL SC, V179, P234, DOI 10.1002/jpln.201500407; Serio F, 2007, J HORTIC SCI BIOTECH, V82, P941, DOI 10.1080/14620316.2007.11512330; Stanhill G., 1973, EVAPORATION TRANSPIR; Tuna AL, 2010, J PLANT NUTR, V33, P1276, DOI 10.1080/01904167.2010.484089; Turhan A, 2016, ACTA HORTIC, V1145, P85, DOI 10.17660/ActaHortic.2016.1145.13; Wang F, 2011, AGR WATER MANAGE, V98, P1228, DOI 10.1016/j.agwat.2011.03.004; Wei ZH, 2018, AGR WATER MANAGE, V202, P174, DOI 10.1016/j.agwat.2018.02.027; White PJ, 2013, J PLANT NUTR SOIL SC, V176, P305, DOI 10.1002/jpln.201200121; White PJ, 2010, PLANT CELL MONOGR, V17, P199, DOI 10.1007/978-3-642-10613-2_9; Yang H, 2016, AGR WATER MANAGE, DOI [10.1016/j.agwat.2016.05.010, DOI 10.1016/J.AGWAT.2016.05.010]; Zahoor R, 2017, ENVIRON EXP BOT, V137, P73, DOI 10.1016/j.envexpbot.2017.02.002; Zhang TQ, 2011, SOIL SCI SOC AM J, V75, P738, DOI 10.2136/sssaj2009.0365; Zheng JH, 2013, AGR WATER MANAGE, V129, P181, DOI 10.1016/j.agwat.2013.08.001; Zorb C, 2014, J PLANT PHYSIOL, V171, P656, DOI 10.1016/j.jplph.2013.08.008	61	20	21	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213643	10.1371/journal.pone.0213643	http://dx.doi.org/10.1371/journal.pone.0213643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917147	Green Published, gold, Green Submitted			2022-12-27	WOS:000462465800038
J	Rashid, TA; Abbas, DK; Turel, YK				Rashid, Tarik A.; Abbas, Dosti K.; Turel, Yalin K.			A multi hidden recurrent neural network with a modified grey wolf optimizer	PLOS ONE			English	Article								Identifying university students' weaknesses results in better learning and can function as an early warning system to enable students to improve. However, the satisfaction level of existing systems is not promising. New and dynamic hybrid systems are needed to imitate this mechanism. A hybrid system (a modified Recurrent Neural Network with an adapted Grey Wolf Optimizer) is used to forecast students' outcomes. This proposed system would improve instruction by the faculty and enhance the students' learning experiences. The results show that a modified recurrent neural network with an adapted Grey Wolf Optimizer has the best accuracy when compared with other models.	[Rashid, Tarik A.] Univ Kurdistan Hewler, Comp Sci & Engn Dept, Kurdistan, Iraq; [Rashid, Tarik A.] Salahaddin Univ Erbil, Software & Informat Engn, Kurdistan, Iraq; [Abbas, Dosti K.] Soran Univ, Fac Engn, Kurdistan, Iraq; [Turel, Yalin K.] Firat Univ, Dept Comp Educ & Instruct Technol, Elazig, Turkey	Salahaddin University; Soran University; Firat University	Rashid, TA (corresponding author), Univ Kurdistan Hewler, Comp Sci & Engn Dept, Kurdistan, Iraq.; Rashid, TA (corresponding author), Salahaddin Univ Erbil, Software & Informat Engn, Kurdistan, Iraq.	tarik.ahmed@ukh.edu.krd	Rashid, Tarik A./P-3473-2019; Turel, Yalin K/W-4703-2018	Rashid, Tarik A./0000-0002-8661-258X; Turel, Yalin K/0000-0002-0021-0484; Abbas, dosti/0000-0002-8541-4071	University of Kurdistan Hewler (UKH)	University of Kurdistan Hewler (UKH)	The research and publication fees are part of the funding granted by the University of Kurdistan Hewler (UKH) to TR.	Ahmad H., 2016, J COMPUT SCI-NETH, V12, P255, DOI [10.3844/jcssp.2016.255.264, DOI 10.3844/JCSSP.2016.255.264]; Al-Radaideh Q. A., 2006, INT AR C INF TECHN A; Baker RyanSJD., 2009, J ED DATA MINING, V1, P3; Baradwaj B. K., 2012, ARXIV12013417; Bebis G., 1994, IEEE Potentials, V13, P27, DOI 10.1109/45.329294; Dorffner G., 1996, NEURAL NETWORKS TIME; Dorigo M., 2011, ENCY MACHINE LEARNIN, P36, DOI DOI 10.1002/9780470400531.EORMS0030; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Emary E, 2015, PROCEDIA COMPUT SCI, V65, P623, DOI 10.1016/j.procs.2015.09.006; Guo B, 2015, 2015 INTERNATIONAL SYMPOSIUM ON EDUCATIONAL TECHNOLOGY (ISET 2015), P125, DOI 10.1109/ISET.2015.33; Hagan MT., 1997, NEURAL NETWORK DESIG; Han J, 2012, MOR KAUF D, P1; Iasemidis LD, 2009, INT J NEURAL SYSTEMS, V19; Kennedy J., ENCY MACHINE LEARNIN, P760; Khandelwal A, 2018, ARAB J SCI ENG, V43, P2899, DOI 10.1007/s13369-017-2967-3; Kohonen T, 1998, NEUROCOMPUTING, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; Kovacic Z., EARLY PREDICTION STU; Madhiarasan M., 2016, CIRCUITS SYST, V7, P2975; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Mosavi MR, 2016, NEURAL NETW WORLD, V26, P393, DOI 10.14311/NNW.2016.26.023; PARK J, 1993, NEURAL COMPUT, V5, P305, DOI 10.1162/neco.1993.5.2.305; Pham D. T., 2006, IPROMS, P454, DOI DOI 10.1016/B978-008045157-2/50081-X; Rashid T. A., 2016, ZANCO J PURE APPL SC, V28; Rashid T, 2009, INT J COMPUT SCI NET, V9, P335; Rashid TA, 2016, COMPUT APPL ENG EDUC, V24, P629, DOI 10.1002/cae.21737; Romero C, 2010, IEEE T SYST MAN CY C, V40, P601, DOI 10.1109/TSMCC.2010.2053532; Sikder MF, 2016, 2016 5TH INTERNATIONAL CONFERENCE ON INFORMATICS, ELECTRONICS AND VISION (ICIEV), P524, DOI 10.1109/ICIEV.2016.7760058; Sweidan AH, 2015, INT CONF SOFT COMPUT, P1, DOI 10.1109/SOCPAR.2015.7492777; Tape T.G, 2018, INTERPRETING DIAGNOS; Umamaheswari K, 2013, INT J ADV RES COMPUT, V3, P117; Vosooghifard M, 2015, 2015 5TH INTERNATIONAL CONFERENCE ON COMPUTER AND KNOWLEDGE ENGINEERING (ICCKE), P147, DOI 10.1109/ICCKE.2015.7365818; WIGTON RS, 1986, ARCH INTERN MED, V146, P81, DOI 10.1001/archinte.146.1.81; Yukselturk E, 2014, EUROPEAN J OPEN DIST, P17	34	23	27	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213237	10.1371/journal.pone.0213237	http://dx.doi.org/10.1371/journal.pone.0213237			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917155	Green Published, Green Submitted, gold			2022-12-27	WOS:000462465800024
J	Ali-Saleh, M; Lavie, O; Abramov, Y				Ali-Saleh, Mais; Lavie, Ofer; Abramov, Yoram			Evaluation of blood type as a potential risk factor for early postpartum hemorrhage	PLOS ONE			English	Article							PREGNANCY; ASSOCIATION; COMPLICATIONS; CHILDBIRTH; DELIVERY; IMPACT; WOMEN	Objective Studies have demonstrated an association between ABO blood type and bleeding status. The aim of this analysis was to determine whether O blood type is associated with higher early postpartum hemorrhage (PPH) risk as compared to other blood types. Study design In this retrospective case-control study, data was gathered form 4,516 deliveries occurring at our institution between 2014 and 2016. Cases were categorized into one of two groups according to women's major blood type (O or non-O), and thereafter according to minor blood type (RH positive or negative). The primary outcome was early PPH which was further stratified by clinical severity according to the decrement in hemoglobin concentration after delivery. Categorical variables were compared using the chi 2 test while continuous variables were compared using the student's t-test. All data were further analyzed using a stepwise logistic regression model. Results 1,594 (35.3%) of 4,516 women included in this analysis had O blood type. Early PPH occurred in 44 women (2.7%) with 0 blood type and 65 women (2.22%) with other blood types. O blood type was not associated with an increased risk for early PPH (OR 1.24, 95% CI 0.84-1.82, P = 0.275). This lack of association remained unchanged after stratification by PPH severity. There was also no significant association between Rh blood type and the risk for early PPH (OR 0.97, 95% CI 0.44-1.4, P = 0.422). Conclusions In this cohort, O blood type was not associated with an increased risk for early PPH.	[Ali-Saleh, Mais; Lavie, Ofer; Abramov, Yoram] Technion Univ, Rappaport Fac Med, Lady Davis Carmel Med Ctr, Dept Obstet & Gynecol, Haifa, Israel	Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Ali-Saleh, M (corresponding author), Technion Univ, Rappaport Fac Med, Lady Davis Carmel Med Ctr, Dept Obstet & Gynecol, Haifa, Israel.	Mais_2010@hotmail.com						Abdul-Kadir R, 2014, TRANSFUSION, V54, P1756, DOI 10.1111/trf.12550; Adom Magen David, BLOOD TYPE DISTRIBUT; Aksoy HT, 2013, J THROMB HAEMOST, V11, P2074, DOI 10.1111/jth.12350; [Anonymous], 2017, AM COLL OBSTETRICIAN, V130, P168; Belghiti J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000514; Blustin JM, 2015, MAYO CLIN PROC, V90, P216, DOI 10.1016/j.mayocp.2014.11.013; Borovac-Pinheiro A, 2018, AM J OBSTET GYNECOL, V219, P162, DOI 10.1016/j.ajog.2018.04.013; Clark P, 2008, BRIT J HAEMATOL, V140, P236, DOI 10.1111/j.1365-2141.2007.06902.x; COMBS CA, 1991, OBSTET GYNECOL, V77, P69; Dentali F, 2013, J THROMB HAEMOST, V11, P187, DOI 10.1111/jth.12057; Dentali F, 2013, SEMIN THROMB HEMOST, V39, P72, DOI 10.1055/s-0032-1329550; Drukker L, 2016, J THROMB THROMBOLYS, V42, P340, DOI 10.1007/s11239-016-1360-5; Firmin M, 2019, J GYNECOL OBSTET HUM, V48, P55, DOI 10.1016/j.jogoh.2018.11.006; Franchini M, 2013, J THROMB THROMBOLYS, V36, P358, DOI 10.1007/s11239-012-0855-y; Franchini M, 2012, CRIT REV CL LAB SCI, V49, P137, DOI 10.3109/10408363.2012.708647; Fukami T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208873; Gabbe S, 2012, OBSTET NORMAL PROBLE, P415; Garcia AA, 2006, J THROMB HAEMOST, V4, P1418, DOI 10.1111/j.1538-7836.2006.01962.x; Grotegut CA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.023; Groutz A, 2011, COLORECTAL DIS, V13, pE216, DOI 10.1111/j.1463-1318.2011.02620.x; HALONEN P, 1987, ANN CHIR GYNAECOL FE, V76, P298; IONESCU DA, 1976, LANCET, V1, P278; James AH, 2007, J THROMB HAEMOST, V5, P1165, DOI 10.1111/j.1538-7836.2007.02563.x; JICK H, 1969, LANCET, V1, P539; Kahr MK, 2018, HAEMOPHILIA, V24, pE207, DOI 10.1111/hae.13537; Larsen TB, 2005, J THROMB HAEMOST, V3, P300, DOI 10.1111/j.1538-7836.2005.01195.x; Miller CH, 2003, J THROMB HAEMOST, V1, P2191, DOI 10.1046/j.1538-7836.2003.00367.x; Moeller A, 2001, TRANSFUSION, V41, P56, DOI 10.1046/j.1537-2995.2001.41010056.x; Muraca GM, 2018, BJOG-INT J OBSTET GY, V125, P693, DOI 10.1111/1471-0528.14820; RAMSAHOYE BH, 1994, J CLIN PATHOL, V47, P569, DOI 10.1136/jcp.47.6.569-b; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Sadler JE, 2000, THROMB HAEMOSTASIS, V84, P160; Siboni SM, 2009, HAEMOPHILIA, V15, P1291, DOI 10.1111/j.1365-2516.2009.02072.x; TALBOT S, 1970, LANCET, V1, P1257; The Israeli Association of Obstetrics and Gynecology, 12 ISR ASS OBST GYN; Wheeler TL, 2007, CURR OPIN OBSTET GYN, V19, P474, DOI 10.1097/GCO.0b013e3282ef4142	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214840	10.1371/journal.pone.0214840	http://dx.doi.org/10.1371/journal.pone.0214840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947286	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500070
J	Chatterjee, S; Ghosh, R; Mandal, NC				Chatterjee, Sohini; Ghosh, Ranjan; Mandal, Narayan Chandra			Production of bioactive compounds with bactericidal and antioxidant potential by endophytic fungus Alternaria alternata AE1 isolated from Azadirachta indica A. Juss.	PLOS ONE			English	Article							FERMENTATION; MECHANISM; EXTRACT; SPP.	For combating multidrug-resistant microorganisms, exploration of natural compounds from plant endophytes increases the chance of finding novel compounds. An efficient bioactive metabolites producing endophytic fungal strain AE1 was isolated from leaves of Azadirachta indica A. Juss. The metabolites were found to be thermostable, non-proteinacious and produced prominent zones of inhibition against numbers of Gram positive and Gram negative bacteria. Based on 28S rDNA (D1/D2) sequence homology the isolate AE1 was identified as Alternaria alternata. Malt extract broth was found effective for the maximum production of bioactive metabolites by the isolate and was subjected for solvent extraction. The Ethyl acetate (EA) fraction of AE1 showed MIC values of 300-400 mu g/ml against Gram positive and Gram negative bacteria tested. The cidal mode of action of EA fraction was detected by treating bacterial cultures at mid log phase. Scanning electron microscopic study supported morphological disintegration of bacterial cells. Release of nucleic acid, protein and potassium ions (K+) also suggested lysis of bacterial cells or leakage of cell membrane upon treatment. In addition, reduction of the activity of EMP pathway, TCA cycle and gluconeogenic enzymes in all bacteria suggested the interference of antibacterial principles with central carbohydrate metabolic pathways. Thin layer chromatographic separation followed by GCMS analysis of EA fraction suggested numbers of antimicrobial compound production by AE1. In addition, DPPH free radical as well as superoxide radical scavenging assay also suggested strong antioxidant potential of AE1 with an IC50 value of 38.0 +/- 1.7 mu g/ml and 11.38 +/- 1.2 mu g/ml respectively. On the basis of above facts it can be concluded that the strain AE1 will be a good source of bioactive compounds having medicinal importance.	[Chatterjee, Sohini; Ghosh, Ranjan; Mandal, Narayan Chandra] Visva Bharati, Dept Bot, Mycol & Plant Pathol Lab, Santini Ketan, W Bengal, India	Visva Bharati University	Mandal, NC (corresponding author), Visva Bharati, Dept Bot, Mycol & Plant Pathol Lab, Santini Ketan, W Bengal, India.	mandalnc@rediffmail.com	Mandal, Narayan Chandra/GOP-0560-2022		University Grant Commission-Basic Scientific Research (UGC-BSR) fellowship [F. 25-1/2013-14(BSR)/7-220/2009(BSR)]	University Grant Commission-Basic Scientific Research (UGC-BSR) fellowship	Author who received the fund: Sohini Chatterjee. Funder: University Grant Commission-Basic Scientific Research (UGC-BSR) fellowship. Grant number: [No. F. 25-1/2013-14(BSR)/7-220/2009(BSR)]. URL: https://www.ugc.ac.in/page/Basic-Scientific-Research.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzohairy MA, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7382506; Arivudainambi U. S. Ezhil, 2014, Biological Letters, V51, P7, DOI 10.1515/biolet-2015-0002; Asai EI, 1998, MYCOL RES, V102, P1316, DOI 10.1017/S0953756298006509; Bakshi D, 2006, J PLANT BIOCHEM BIOT, V15, P67, DOI 10.1007/BF03321906; Bandara WMMS, 2006, J BIOSCIENCES, V31, P645, DOI 10.1007/BF02708417; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; Debnath M, 2012, INDIAN J MICROBIOL, V52, P275, DOI 10.1007/s12088-011-0212-4; Fang WanPing, 2013, Journal of Plant Pathology and Microbiology, V4, P169; FERNANDEZGARAYZABAL JF, 1992, APPL ENVIRON MICROB, V58, P434, DOI 10.1128/AEM.58.1.434-438.1992; Fontana M, 2001, BIOCHEM PHARMACOL, V61, P1253, DOI 10.1016/S0006-2952(01)00565-2; Ghosh R, 2016, MICROBIOL RES, V183, P80, DOI 10.1016/j.micres.2015.11.011; Gond SK, 2010, MANAGEMENT OF FUNGAL PLANT PATHOGENS, P183, DOI 10.1079/9781845936037.0183; Govindappa M., 2013, American Journal of Plant Sciences, V4, P1641, DOI 10.4236/ajps.2013.48198; Govindappa M., 2014, INT J BIOL PHARM RES, V5, P527; Hellwig V, 2002, J ANTIBIOT, V55, P881, DOI 10.7164/antibiotics.55.881; Jani C, 2015, J BIOMOL SCREEN, V20, P275, DOI 10.1177/1087057114551334; Kharwar RN, 2008, CURR SCI INDIA, V95, P228; Khiralla A, 2015, ASIAN PAC J TROP MED, V8, P689, DOI 10.1016/j.apjtm.2015.07.032; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071805; Kumar Venugopalan Santhosh, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P505, DOI 10.1016/S2221-1691(13)60105-7; Lee SK, 1998, COMB CHEM HIGH T SCR, V1, P35; Lou JF, 2016, BRAZ J MICROBIOL, V47, P96, DOI 10.1016/j.bjm.2015.11.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANDAL NC, 1993, CURR MICROBIOL, V26, P247, DOI 10.1007/BF01575912; Mukherjee S, 2014, INDIAN J EXP BIOL, V52, P692; Patra JK, 2016, MOLECULES, V21, DOI 10.3390/molecules21030388; Petrini O., 1991, MICROBIAL ECOLOGY LE, V1st ed., P179, DOI [10.1007/978-1-4612-3168-4_9, DOI 10.1007/978-1-4612-3168-4_9]; ROBAK J, 1988, BIOCHEM PHARMACOL, V37, P837, DOI 10.1016/0006-2952(88)90169-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHERRER R, 1971, J BACTERIOL, V107, P718, DOI 10.1128/JB.107.3.718-735.1971; SCHULZ B, 1993, MYCOL RES, V97, P1447, DOI 10.1016/S0953-7562(09)80215-3; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verma VC., 2008, CURR BIOACT COMPD, V4, P36; Fernandes MDV, 2009, BRAZ J PHARM SCI, V45, P677; Wang Y, 2014, FITOTERAPIA, V99, P153, DOI 10.1016/j.fitote.2014.09.015; [杨显志 Yang Xianzhi], 2003, [天然产物研究与开发, Natural Product R & D], V15, P419; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492	40	27	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214744	10.1371/journal.pone.0214744	http://dx.doi.org/10.1371/journal.pone.0214744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946772	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500060
J	Kobayashi, H; Shimoshige, H; Nakajima, Y; Arai, W; Takami, H				Kobayashi, Hideki; Shimoshige, Hirokazu; Nakajima, Yoshikata; Arai, Wataru; Takami, Hideto			An aluminum shield enables the amphipod Hirondellea gigas to inhabit deep-sea environments	PLOS ONE			English	Article							DISSOLVED ALUMINUM; OCEAN; FORAMINIFERA; CRUSTACEANS; OSTRACODA; MARINE	The amphipod Hirondellea gigas inhabits the deepest regions of the oceans in extreme high-pressure conditions. However, the mechanisms by which this amphipod adapts to its high-pressure environment remain unknown. In this study, we investigated the elemental content of the exoskeleton of H. gigas specimens captured from the deepest points of the Mariana Trench. The H. gigas exoskeleton contained aluminum, as well as a major amount of calcium carbonate. Unlike other (accumulated) metals, aluminum was distributed on the surface of the exoskeleton. To investigate how H. gigas obtains aluminum, we conducted a metabolome analysis and found that gluconic acid/gluconolactone was capable of extracting metals from the sediment under the habitat conditions of H. gigas. The extracted aluminum ions are transformed into the gel state of aluminum hydroxide in alkaline seawater, and this gel covers the body to protect the amphipod. This aluminum gel is a good material for adaptation to such high-pressure environments.	[Kobayashi, Hideki; Arai, Wataru; Takami, Hideto] Japan Agcy Marine Earth Sci & Technol JAMSTEC Nat, Yokosuka, Kanagawa, Japan; [Shimoshige, Hirokazu; Nakajima, Yoshikata] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan	Toyo University	Kobayashi, H (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC Nat, Yokosuka, Kanagawa, Japan.	hidekik@jasmtec.go.jp	Nakajima, Yoshikata/Y-8403-2019; Takami, Hideto/D-4200-2012	Nakajima, Yoshikata/0000-0002-0302-7386; Takami, Hideto/0000-0003-3433-7018; Shimoshige, Hirokazu/0000-0002-0583-6160	JSPS KAKENHI [18K05835]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by JSPS KAKENHI (18K05835 to HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn GA, 2004, J COMP PHYSIOL B, V174, P439, DOI 10.1007/s00360-004-0438-0; Alan J., 2015, HADAL ZONE LIFE DEEP, P169; ARMSTRONG J, 1953, J PHARM PHARMACOL, V5, P672, DOI 10.1111/j.2042-7158.1953.tb14033.x; Bobelmann F, 2007, THERMOCHIM ACTA, V463, P65, DOI 10.1016/j.tca.2007.07.018; Boomer I, 1999, MAR MICROPALEONTOL, V37, P131, DOI 10.1016/S0377-8398(99)00015-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLES GP, 1994, PALAEONTOLOGY, V37, P71; Eustace RM, 2013, J CRUSTACEAN BIOL, V33, P793, DOI 10.1163/1937240X-00002193; FERGUSON JW, 1964, ANAL CHEM, V36, P796, DOI 10.1021/ac60210a028; GOLDBERG ED, 1958, GEOCHIM COSMOCHIM AC, V13, P153, DOI 10.1016/0016-7037(58)90046-2; GOON E, 1953, ANAL CHEM, V25, P608, DOI 10.1021/ac60076a019; HESSLER RR, 1978, DEEP-SEA RES, V25, P1029, DOI 10.1016/0146-6291(78)90585-4; Jamieson AJ, 2010, TRENDS ECOL EVOL, V25, P190, DOI 10.1016/j.tree.2009.09.009; Jellinek Thomas, 2006, Senckenbergiana Maritima, V36, P29; Kato Y, 2011, NAT GEOSCI, V4, P535, DOI [10.1038/NGEO1185, 10.1038/ngeo1185]; Kobayashi H, 2018, BIOSCI BIOTECH BIOCH, V82, P1123, DOI 10.1080/09168451.2018.1459178; Kobayashi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042727; Kombo MM, 2005, J OCEANOGR, V61, P591, DOI 10.1007/s10872-005-0067-6; Kramer J, 2004, MAR CHEM, V88, P85, DOI 10.1016/j.marchem.2004.03.009; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; MITCHELL R E, 1970, Annals of the New York Academy of Sciences, V172, P131, DOI 10.1111/j.1749-6632.1970.tb34970.x; Neues F, 2007, CRYSTENGCOMM, V9, P1245, DOI 10.1039/b710789g; ORIANS KJ, 1985, NATURE, V316, P427, DOI 10.1038/316427a0; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Ritchie H, 2015, DEEP-SEA RES PT I, V105, P119, DOI 10.1016/j.dsr.2015.08.014; Sato A, 2011, NAT CHEM BIOL, V7, P197, DOI 10.1038/NCHEMBIO.532; Schmiedl G, 1997, MAR MICROPALEONTOL, V32, P249, DOI 10.1016/S0377-8398(97)00023-6; Seibold E., 1996, SEA FLOOR INTRO MARI; TAYLOR SR, 1964, GEOCHIM COSMOCHIM AC, V28, P1273, DOI 10.1016/0016-7037(64)90129-2; THIEDE J, 1980, EARTH PLANET SC LETT, V47, P416, DOI 10.1016/0012-821X(80)90029-1; Todo Y, 2005, SCIENCE, V307, P689, DOI 10.1126/science.1105407; VIARENGO A, 1989, Reviews in Aquatic Sciences, V1, P295; Wefers K, 1987, OXIDES HYDROXIDES AL, P1; Whatley Robin, 1996, P3; WUST GEORG, 1964, PROGR OCEANOGR, V2, P1, DOI 10.1016/0079-6611(64)90002-3	36	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0206710	10.1371/journal.pone.0206710	http://dx.doi.org/10.1371/journal.pone.0206710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947320	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500004
J	Lee, JC; Chuang, KS; Liu, YWH; Lin, TY; Teng, YC; Wang, LW				Lee, Jia-Cheng; Chuang, Keh-Shih; Liu, Yen-Wan Hsueh; Lin, Tzung-Yi; Teng, Yi-Chiao; Wang, Ling-Wei			A comparison of dose distributions in gross tumor volume between boron neutron capture therapy alone and combined boron neutron capture therapy plus intensity modulation radiation therapy for head and neck cancer	PLOS ONE			English	Article							SIMULTANEOUS INTEGRATED BOOST; TREATMENT PLANNING SYSTEM; LOCALLY RECURRENT HEAD; DISEASE-CONTROL; BNCT; REIRRADIATION; VERIFICATION; EXPERIENCE; TRIAL; IMRT	Nine patients with recurrent head and neck (H&N) cancer received boron neutron capture therapy (BNCT) in one fraction at the Tsing-Hua Open pool reactor (THOR) utilizing the THORplan treatment planning system (TPS). The aims of the present study were to evaluate the use of intensity modulated radiation therapy (IMRT) of 45 Gy in 20 fractions to compensate for the dose heterogeneity in gross tumor volume observed with single-fraction BNCT with mean prescription dose 19 Gy (w), and to evaluate planning quality indices of simulated BNCT+IMRT versus single-fraction BNCT alone. All IMRT plans were generated using the Eclipse TPS which employs the analytical anisotropic algorithm. The conformity index for the gross tumor volume (GTV) was better for the BNCT+IMRT plan than for the BNCT-alone plan (p= 0.003). In addition, the BNCT+IMRT plan provided significantly better homogeneity in the GTV (p = 0.03). The cold spots in inhomogeneous dose distribution in the BNCT plan may be a key factor for H&N cancer recurrence. Our results suggest that single-fraction BNCT combined with compensated multi-fraction IMRT improves treatment homogeneity and conformity than single-fraction BNCT alone, especially for tumor volumes >100 cm(3), and possibly increases local tumor control.	[Lee, Jia-Cheng; Wang, Ling-Wei] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Lee, Jia-Cheng; Chuang, Keh-Shih] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Liu, Yen-Wan Hsueh; Lin, Tzung-Yi; Teng, Yi-Chiao] Natl Tsing Hua Univ, Inst Nucl Engn & Sci, Hsinchu, Taiwan; [Wang, Ling-Wei] Natl Yang Ming Univ, Taipei, Taiwan	Taipei Veterans General Hospital; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University	Wang, LW (corresponding author), Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan.; Wang, LW (corresponding author), Natl Yang Ming Univ, Taipei, Taiwan.	lwwang@vghtpe.gov.tw			Taipei Veterans General Hospital [V106A-016]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The first authors are grateful for financial support provided by grants obtained from Taipei Veterans General Hospital (No: V106A-016, https://www.vghtpe.gov.tw/Index.action).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat P, 2017, REP PRACT ONCOL RADI, V22, P331, DOI 10.1016/j.rpor.2017.05.001; Aly MMOM, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0452-2; Coderre JA, 1999, RADIAT RES, V151, P1, DOI 10.2307/3579742; Department of Health, 2014, TAIW CANC REG ANN RE; Dykstra C, 1996, RADIOTHER ONCOL, V41, P281, DOI 10.1016/S0167-8140(96)01847-6; Fogliata A, 2003, RADIOTHER ONCOL, V69, P267, DOI 10.1016/j.radonc.2003.10.003; ICRU, 1999, 50 ICRU, P62; ICRU I, 1993, 50 ICRU I; Kankaanranta L, 2007, INT J RADIAT ONCOL, V69, P475, DOI 10.1016/j.ijrobp.2007.03.039; Kawabata S, 2011, APPL RADIAT ISOTOPES, V69, P1796, DOI 10.1016/j.apradiso.2011.03.014; KONIJNENBERG MW, 1995, RADIAT RES, V142, P327, DOI 10.2307/3579142; Li HS, 2009, APPL RADIAT ISOTOPES, V67, pS122, DOI 10.1016/j.apradiso.2009.03.029; Lin T.L., 2004, THESIS; Lin TY, 2011, APPL RADIAT ISOTOPES, V69, P1878, DOI 10.1016/j.apradiso.2011.03.025; Liu YWH, 2015, APPL RADIAT ISOTOPES, V106, P121, DOI 10.1016/j.apradiso.2015.08.002; Margalit DN, 2016, ORAL ONCOL, V61, P19, DOI 10.1016/j.oraloncology.2016.07.012; Morgan-Fletcher S, 2001, 62 ICRU, pix+52; SHAW E, 1993, INT J RADIAT ONCOL, V27, P1231, DOI 10.1016/0360-3016(93)90548-A; Sulman EP, 2009, INT J RADIAT ONCOL, V73, P399, DOI 10.1016/j.ijrobp.2008.04.021; Suzuki M, 2006, INT J RADIAT ONCOL, P66; Wang LW, 2011, APPL RADIAT ISOTOPES, V69, P1803, DOI [10.1016/j.apradiso.2011.03.,008, 10.1016/j.apradiso.2011.03.008]; Wang LW, 2016, INT J RADIAT ONCOL, V95, P396, DOI 10.1016/j.ijrobp.2016.02.028; Wang LW, 2014, APPL RADIAT ISOTOPES, V88, P23, DOI 10.1016/j.apradiso.2013.11.134; Yu HT, 2011, APPL RADIAT ISOTOPES, V69, P1907, DOI 10.1016/j.apradiso.2011.02.041	24	5	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0210626	10.1371/journal.pone.0210626	http://dx.doi.org/10.1371/journal.pone.0210626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947267	Green Submitted, gold, Green Published			2022-12-27	WOS:000463314500007
J	Thakur, M; Bhatt, V; Kumar, R				Thakur, Meenakshi; Bhatt, Vinod; Kumar, Rakesh			Effect of shade level and mulch type on growth, yield and essential oil composition of damask rose (Rosa damascena Mill.) under mid hill conditions of Western Himalayas	PLOS ONE			English	Article							PHOTOSYNTHETIC CAPACITY; LIGHT-INTENSITY; LEAF MORPHOLOGY; CHLOROPHYLL; L.	A field experiment was conducted at the experimental farm of CSIR-Institute of Himalayan Bioresource Technology, Palampur, India for two consecutive years (2015-16 and 201617). The aim of the study was to test the hypothesis whether different shade level and mulch type would influence the growth, flower yield and essential oil profile of R. damascena. Yield attributes viz., numbers of flowers plant(-1), fresh flower weight plant(-1), flower yield, and essential oil yield were significantly higher under open sunny conditions as compared to 25% and 50% shade levels. However, plants grown under 50% shade level recorded significantly higher plant height (cm), plant spread (cm) and the lowest numbers of branches as compared to control. Among mulches, black polyethylene mulch recorded significantly higher growth, and yield attributes of damask rose as compared to other mulches. Black polyethylene mulch recorded 74.5 and 39.2% higher fresh flower yield as compared to without mulch, during 2015-16 and 2016-17, respectively. Correlation studies showed a positively significant correlation between quality and quantity traits. A total of twenty-six essential oil compounds were identified which accounted for a total of 88.8 to 95.3%. Plants grown under open sunny conditions along with the applications of black polyethylene mulch produced a higher concentration of citronellol and trans-geraniol. Damask rose planted in open sunny conditions and mulched with black polyethylene sheet recorded significantly higher flower yield.	[Thakur, Meenakshi; Kumar, Rakesh] Acad Sci & Innovat Res, New Delhi, India; [Thakur, Meenakshi; Kumar, Rakesh] Inst Himalayan Bioresource Technol, CSIR, Agrotechnol Med Aromat & Commercially Important P, Palampur, HP, India; [Bhatt, Vinod] Inst Himalayan Bioresource Technol, CSIR, Nat Prod Chem & Proc Dev Div, Palampur, HP, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Kumar, R (corresponding author), Acad Sci & Innovat Res, New Delhi, India.; Kumar, R (corresponding author), Inst Himalayan Bioresource Technol, CSIR, Agrotechnol Med Aromat & Commercially Important P, Palampur, HP, India.	rakeshkumar@ihbt.res.in			Scientific and Engineering Research Board (SERB), department of Science and Technology, GOI, New Delhi, India [SB/S4/AS-134/2013]	Scientific and Engineering Research Board (SERB), department of Science and Technology, GOI, New Delhi, India	The source of funding that supported the work, received from Scientific and Engineering Research Board (SERB), department of Science and Technology, GOI, New Delhi, India. Specific grant numbers: SB/S4/AS-134/2013 Initials of authors who received each award: Rakesh Kumar. Full names of commercial companies that funded the study or authors: No commercial funding was received. Initials of authors who received salary or other funding from commercial companies: No salary was received from commercial funding. URLs to sponsors' websites: http://www.dst.gov.in.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achuthan CR, 2003, PHARM BIOL, V41, P357, DOI 10.1076/phbi.41.5.357.15945; Alizadeh Mohammad Ali, 2017, Journal of Horticultural Research, V25, P19, DOI 10.1515/johr-2017-0002; Bajad A.A., 2017, J PHARMACOGN PHYTOCH, V6, P1321; Baroli I, 2008, PLANT PHYSIOL, V146, P737, DOI 10.1104/pp.107.110924; Bondada BR, 2003, TREE PHYSIOL, V23, P553, DOI 10.1093/treephys/23.8.553; Chawla S. L., 2008, Journal of Ornamental Horticulture, V11, P131; Fadil M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2749-5; Fernandes VF, 2013, REV BRAS FARMACOGN, V23, P419, DOI 10.1590/S0102-695X2013005000041; Gorji-Chakespari A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16050636; Gregoriou K, 2007, PHOTOSYNTHETICA, V45, P172, DOI 10.1007/s11099-007-0029-x; Haque M.M., 2009, ACAD J PLANT SCI, V2, P158; Hatamian M., 2017, Journal of Ornamental Plants, V7, P147; Karami A, 2013, J ESSENT OIL BEAR PL, V16, P489, DOI 10.1080/0972060X.2013.813266; Kumar R, 2014, INT J PLANT PROD, V8, P311; Kumar R, 2014, J ESSENT OIL RES, V26, P1; Kumar R, 2013, J ESSENT OIL RES, V25, P23, DOI 10.1080/10412905.2012.742467; Kumar V, 2014, INT J MULTIDISCIPLIN, V2, P322; Li Q., 2010, EFFECT LIGHT QUALITY; Mamta Bohra, 2015, International Journal of Basic and Applied Agricultural Research, V13, P156; Mattana RS, 2010, SCI AGR, V67, P414, DOI 10.1590/S0103-90162010000400006; Omobolanle Ade-Ademilua E., 2013, J MED ACTIVE PLANTS, V1, P143; Pal PK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00507; Pons TL, 1998, PLANT PHYSL ECOLOGY, DOI [10.1007/978-1-4757-2855-2, DOI 10.1007/978-1-4757-2855-2_6]; Rathinasabapathi B, 2005, HORTSCIENCE, V40, P711, DOI 10.21273/HORTSCI.40.3.711; Rezai S, 2018, HORTIC SCI TECHNOL, V36, P46, DOI 10.12972/kjhst.20180006; Robert Adams P., 1995, IDENTIFICATION ESSEN, P60188; Roozban, 2015, J AGR CROPS PRODUCTI, V17, P1; Shao QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085996; Shrestha A, 2013, J ENV HORTICULTURE, V31, P259; Silva A.D.C., 2014, SCI WORLD J-NIGERIA, V1, P1; Souri MK, 2010, COMMUN SOIL SCI PLAN, V41, P1769, DOI 10.1080/00103624.2010.489139; Stein S.E., 2005, MASS SPECTRAL DATABA; Taiz L., 2006, PLANT PHYSIOL, V4, P764; Wei Sheng-li, 2005, Zhongguo Zhongyao Zazhi, V30, P100	34	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214672	10.1371/journal.pone.0214672	http://dx.doi.org/10.1371/journal.pone.0214672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946775	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500052
J	De Pauw, K; Cherelle, P; Tassignon, B; Van Cutsem, J; Roelands, B; Marulanda, FG; Lefeber, D; Vanderborght, B; Meeusen, R				De Pauw, Kevin; Cherelle, Pierre; Tassignon, Bruno; Van Cutsem, Jeroen; Roelands, Bart; Marulanda, Felipe Gomez; Lefeber, Dirk; Vanderborght, Bram; Meeusen, Romain			Cognitive performance and brain dynamics during walking with a novel bionic foot: A pilot study	PLOS ONE			English	Article							GAIT INITIATION; MOVEMENT; ATTENTION; CORTEX; NETWORK; POSTURE; SINGLE; SPEED; TASK	Objectives The objectives are to determine neural dynamics during gait using electro-encephalography and source localization, and to investigate the attentional demand during walking in able-bodied individuals, and individuals with an amputation. Materials & methods Six able-bodied individuals conducted one experimental trial, and 6 unilateral transtibial and 6 unilateral transfemoral amputees performed 2 experimental trials; the first with the prosthesis currently used by the subjects and the second with a novel powered transtibial prosthesis, i.e. the Ankle Mimicking Prosthetic foot 4.0. Each experimental trial comprised 2 walking tasks; 6 and 2 minutes treadmill walking at normal speed interspersed by 5 minutes of rest. During 6 minutes walking the Sustained Attention to Response (go-no go) Task, which measures reaction time and accuracy, was performed. Electro-encephalographic data were gathered when subjects walked 2 minutes. Motor-related cortical potentials and brain source activity during gait were examined. Normality and (non-) parametric tests were conducted (p<0.05). Results and discussion In contrast to transtibial amputees, transfemoral amputees required more attentional demands during walking with Ankle Mimicking Prosthetic foot 4.0 compared to the current passive prosthetic device and able-bodied individuals (reaction time and accuracy: p <= 0.028). Since risk of falling is associated with altered attentional demands, propulsive forces of the novel device need to be better controlled for transfemoral amputees. No motor-related cortical potentials at Cz were observed in transfemoral amputees walking with the novel prosthesis, whereas motor-related cortical potentials between transtibial amputees and able-bodied individuals during walking at normal speed did not differ. The first positive electro-physiological peak deflection appeared during toe-off phase and showed higher activity within the underlying brain sources in transtibial amputees walking with Ankle Mimicking Prosthetic foot 4.0 compared to able-bodied individuals. The required higher neural input to accomplish the same physical activity compared to able-bodied individuals is possibly due to the limited acclimation period to the novel device and consequently increased afferent sensory feedback for postural control.	[De Pauw, Kevin; Tassignon, Bruno; Van Cutsem, Jeroen; Roelands, Bart; Meeusen, Romain] Vrije Univ Brussel, Res Grp Human Physiol, Fac Phys Educ & Phys Therapy, Brussels, Belgium; [De Pauw, Kevin; Lefeber, Dirk; Vanderborght, Bram; Meeusen, Romain] Vrije Univ Brussel, Strateg Res Program Exercise & Brain Hlth & Dis A, Brussels, Belgium; [Cherelle, Pierre; Lefeber, Dirk; Vanderborght, Bram] Vrije Univ Brussel, Fac Sci Appl, Dept Mech Engn, Brussels, Belgium; [Cherelle, Pierre; Lefeber, Dirk; Vanderborght, Bram] Flanders Make, Brussels, Belgium; [Marulanda, Felipe Gomez] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Artificial Intelligence Lab, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel	Meeusen, R (corresponding author), Vrije Univ Brussel, Res Grp Human Physiol, Fac Phys Educ & Phys Therapy, Brussels, Belgium.; Meeusen, R (corresponding author), Vrije Univ Brussel, Strateg Res Program Exercise & Brain Hlth & Dis A, Brussels, Belgium.	romain.meeusen@vub.be	Roelands, Bart/E-2337-2011; Tassignon, Bruno/M-8793-2017; Van Cutsem, Jeroen/AAZ-6281-2021; De Pauw, Kevin/E-8937-2018; Vanderborght, Bram/A-1599-2008; Van Cutsem, Jeroen/AAZ-7325-2021	Roelands, Bart/0000-0002-2808-044X; Tassignon, Bruno/0000-0003-3216-4045; Vanderborght, Bram/0000-0003-4881-9341; De Pauw, Kevin/0000-0002-6901-7199; Van Cutsem, Jeroen/0000-0001-6122-7629; Lefeber, Dirk/0000-0003-4442-4473				Brunner R, 2013, J CHILD ORTHOP, V7, P367, DOI 10.1007/s11832-013-0508-5; Bulea TC, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00247; Castermans T, 2014, BRAIN SCI, V4, P1, DOI 10.3390/brainsci4010001; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Cherelle P, 2014, ADV MECH ENG, V14, P1; Cherelle P, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0285-8; Cherelle P, 2014, IEEE T NEUR SYS REH, V22, P138, DOI 10.1109/TNSRE.2013.2282416; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; De Pauw K, 2018, PROSTHET ORTHOT INT, V42, P504, DOI 10.1177/0309364618767141; DEECKE L, 1982, EXP BRAIN RES, V48, P144; Deecke L, 1996, COGNITIVE BRAIN RES, V3, P59, DOI 10.1016/0926-6410(95)00046-1; DEECKE L, 1976, BIOL CYBERN, V23, P99, DOI 10.1007/BF00336013; do Nascimento OF, 2005, BEHAV BRAIN RES, V161, P141, DOI 10.1016/j.bbr.2005.02.031; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; Forner-Cordero A, 2006, J BIOMECH, V39, P948, DOI 10.1016/j.jbiomech.2005.01.019; Gramann K, 2014, INT J PSYCHOPHYSIOL, V91, P22, DOI 10.1016/j.ijpsycho.2013.09.003; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; Hargrove L, 2009, P EMBC 2009 ANN INT; Jahanshahi M., 2012, BEREITSCHAFTSPOTENTI; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; Jiang N, 2015, CLIN NEUROPHYSIOL, V126, P154, DOI 10.1016/j.clinph.2014.05.003; Karimi F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00356; Kline JE, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046022; Knaepen K, 2015, NEUROSCI LETT, V599, P75, DOI 10.1016/j.neulet.2015.05.036; Koeneke S, 2009, J MOTOR BEHAV, V41, P347, DOI 10.3200/JMBR.41.4.347-356; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Menant JC, 2014, AGEING RES REV, V16, P83, DOI 10.1016/j.arr.2014.06.001; Morgan SJ, 2016, PROSTHET ORTHOT INT, V40, P490, DOI 10.1177/0309364615596066; O'Connell RG, 2009, J COGNITIVE NEUROSCI, V21, P93, DOI 10.1162/jocn.2009.21008; Penfield W., 1950, CEREBRAL CORTEX MAN; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Robertson CV, 2016, J APPL PHYSIOL, V120, P464, DOI 10.1152/japplphysiol.00363.2015; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sadeghi H, 2000, GAIT POSTURE, V12, P257, DOI 10.1016/S0966-6362(00)00085-0; Snyder KL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00639; Luu TP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188500; Wagner J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00093; Wieser M, 2010, EXP BRAIN RES, V203, P181, DOI 10.1007/s00221-010-2223-5; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wright DJ, 2011, J MOTOR BEHAV, V43, P193, DOI 10.1080/00222895.2011.557751; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	42	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214711	10.1371/journal.pone.0214711	http://dx.doi.org/10.1371/journal.pone.0214711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943265	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300052
J	Kuo, YL; Chen, IJ				Kuo, Ying-Ling; Chen, I-Ju			Facilitating a change model in age-friendly hospital certification: Strategies and effects	PLOS ONE			English	Article							MEDICAL-STUDENTS; ATTITUDES; HEALTH; CARE; KNOWLEDGE; FACTS; MANAGER; PEOPLE	The ageing population is a powerful and transformative demographic force. The World Health Organization (WHO) has encouraged the development of an age-friendly hospital (AFH) network. However, no specific implementation strategies or best practices of AFH standards have been produced. This study sought to apply Kotter's change model to the elements included in a successful AFH certification process and to evaluate the changes in employees' knowledge of ageing and their attitudes toward the elderly. This was an observational study that utilized a pre- and posttest design, before and after an age-friendly hospital certification process was implemented. Participants were 163 hospital employees in Taiwan, who completed both pre- and postquestionnaires. The self-administered online questionnaire consisted of three sections: The Facts on Ageing Quiz, the Geriatric Attitudes Scale, and a demographic questionnaire. Following introduction of the intervention, the change process began, and later Kotter's model was brought in as a descriptive framework. The results showed that Kotter's eight-step framework is a good choice for thinking about how to change practice and make healthcare more age-friendly. Employee knowledge of ageing and their attitudes toward the elderly improved after this certification process. Appointing a chief executive officer, forming a steering committee, obtaining interdepartmental and interdisciplinary cooperation, and "soliciting support" for new policies from all employees, were identified as key factors influencing the success of age-friendly hospital (AFH) certification. This is the first study to apply Kotter's eight-step framework of organizational change to an AFH certification process.	[Kuo, Ying-Ling] Yonghe Cardinal Tien Hosp, Dept Nursing, Taipei, Taiwan; [Kuo, Ying-Ling; Chen, I-Ju] Natl Yang Ming Univ, Dept Nursing, Taipei, Taiwan	National Yang Ming Chiao Tung University	Chen, IJ (corresponding author), Natl Yang Ming Univ, Dept Nursing, Taipei, Taiwan.	ijchen@ym.edu.tw		Chen, I-Ju/0000-0002-9930-8157; KUO, Ying Ling/0000-0003-1181-4707	Yonghe Cardinal Tien Hospital [YCTH-R101-001]	Yonghe Cardinal Tien Hospital	This work was supported by Yonghe Cardinal Tien Hospital (Grant No. YCTH-R101-001 to YLK). The hospital had no input on the content, study design, data selection, decision to publish, or preparation of the manuscript.	Bleijenberg N, 2012, J NURS ED PRACT, V2, P1, DOI DOI 10.5430/JNEP.V2N2P1; Broome K, 2013, TRANSPORT RES A-POL, V53, P68, DOI 10.1016/j.tra.2013.05.003; Caliskan Tugba, 2018, J Family Med Prim Care, V7, P998, DOI 10.4103/jfmpc.jfmpc_277_17; Chiou ST, 2009, ARCH GERONTOL GERIAT, V49, pS3, DOI 10.1016/S0167-4943(09)70004-4; Chiou ST, 2010, AGE FRIENDLY HLTH CA; Christmas C, 2008, J GEN INTERN MED, V23, P1048, DOI 10.1007/s11606-008-0585-1; Cowan DT, 2004, EDUC GERONTOL, V30, P237, DOI 10.1080/03601270490273169; DUERSON MC, 1992, GERONTOLOGIST, V32, P171, DOI 10.1093/geront/32.2.171; Hsiao JL, 2011, J HLTH MANAG, V12, P221; Huang AR, 2011, CAN GERIATR J, V14, P100, DOI [10.5770/cgj.v14i4.8, 10.57700/cgj.v14i4.8]; Kotter J, 2012, 8 STEP PROCESS LEADI; Kotter JR, 2007, HARVARD BUS REV, V85, P96; Lin B.A., 2010, THESIS NATL TAIWAN U; Liu LF., 2003, J LEADER U, V1, P112; McCallin AM, 2010, J NURS MANAGE, V18, P319, DOI 10.1111/j.1365-2834.2010.01067.x; Mellor P, 2007, AUST J ADV NURS, V24, P37; Pachana NA, 2013, AUSTRALAS J AGEING, V32, P117, DOI 10.1111/j.1741-6612.2012.00635.x; PALMORE E, 1977, GERONTOLOGIST, V17, P315, DOI 10.1093/geront/17.4.315; Parke Belinda, 2004, Nurs Leadersh (Tor Ont), V17, P62; Pegram AM, 2014, J NURS MANAGE, V22, P685, DOI 10.1111/jonm.12047; Redick E L, 1999, Dimens Crit Care Nurs, V18, P30, DOI 10.1097/00003465-199911000-00005; REUBEN DB, 1995, J AM GERIATR SOC, V43, P1430, DOI 10.1111/j.1532-5415.1995.tb06626.x; Reuben DB, 1998, J AM GERIATR SOC, V46, P1425, DOI 10.1111/j.1532-5415.1998.tb06012.x; The Health Promotion Administration Ministry of Health and Welfare in Taiwan, 2016, AG FRIENDL HLTH CAR; The International Network of Health Promoting Hospitals and Health Services, 2016, TASK FORC HPH AG FRI; United Nations Department of Economic and Social Affairs, 2015, WORLD POP AG 2015 RE; Unwin BK, 2008, J AM GERIATR SOC, V56, DOI 10.1111/j.1532-5415.2008.01998.x; Wang CC, 2010, INT J NURS STUD, V47, P742, DOI 10.1016/j.ijnurstu.2009.11.009; WHO, 2007, GLOB AG FRIENDL CIT; Wilcox S, 2013, AM J HEALTH PROMOT, V28, P2, DOI 10.4278/ajhp.121116-CIT-564; Wilson MAG, 2018, BMC RES NOTES, V11, P1, DOI [10.1186/s13104-017-3088-5, DOI 10.1186/S13104-017-3088-5]; World Health Organization, 2013, AG FRIENDL ENV PROGR; World Health Organization, 2016, IM TOM REP 2 WHO GLO; World Health Organization, 2002, ACT AG POL FRAM; Wu SW, 2015, CHINESE MED J-PEKING, V128, P2535, DOI 10.4103/0366-6999.164984	35	4	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213496	10.1371/journal.pone.0213496	http://dx.doi.org/10.1371/journal.pone.0213496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943215	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300014
J	Mukhina, KD; Visheratin, AA; Nasonov, D				Mukhina, Ksenia D.; Visheratin, Alexander A.; Nasonov, Denis			Orienteering Problem with Functional Profits for multi-source dynamic path construction	PLOS ONE			English	Article							SOCIAL MEDIA; RECOMMENDATION; ALGORITHM; SEARCH	Orienteering problem (OP) is a routing problem, where the aim is to generate a path through set of nodes, which would maximize total score and would not exceed the budget. In this paper, we present an extension of classic OP-Orienteering Problem with Functional Profits (OPFP), where the score of a specific point depends on its characteristics, position in the route, and other points in the route. For solving OPFP, we developed an open-source framework for solving orienteering problems, which utilizes four core components of OP in its modular architecture. Fully-written in Go programming language our framework can be extended for solving different types of tasks with different algorithms; this was demonstrated by implementation of two popular algorithms for OP solving-Ant Colony Optimization and Recursive Greedy Algorithm. Computational efficiency of the framework was shown through solving four well-known OP types: classic Orienteering Problem (OP), Orienteering Problem with Compulsory Vertices (OPCV), Orienteering Problem with Time Windows (OPTW), and Time Dependent Orienteering Problem (TDOP) along with OPFP. Experiments were conducted on a large multi-source dataset for Saint Petersburg, Russia, containing data from lnstagram, TripAdvisor, Foursquare and official touristic website. Our framework is able to construct touristic paths for different OP types within few seconds using dataset with thousands of points of interest.	[Mukhina, Ksenia D.; Visheratin, Alexander A.; Nasonov, Denis] ITMO Univ, St Petersburg, Russia	ITMO University	Mukhina, KD (corresponding author), ITMO Univ, St Petersburg, Russia.	mukhinaks@gmail.com	Mukhina, Ksenia/A-7911-2015	Mukhina, Ksenia/0000-0002-2926-3037	Russian Scientific Foundation [18-71-00149]	Russian Scientific Foundation(Russian Science Foundation (RSF))	This research is financially supported by The Russian Scientific Foundation, Agreement #18-71-00149 (URL: http://rscf.ru/prjcard/?rid=18-71-00149 [in Russian]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksen D, 2018, OPERAT RES PROCEED, P277, DOI 10.1007/978-3-319-55702-1_37; Anagnostopoulos A, 2017, DATA MIN KNOWL DISC, V31, P1157, DOI 10.1007/s10618-016-0477-7; Baffo I, 2017, TRANSP RES PROC, V22, P297, DOI 10.1016/j.trpro.2017.03.036; Brilhante I, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P757, DOI 10.1145/2505515.2505643; Brilhante IR, 2015, INFORM PROCESS MANAG, V51, P1, DOI 10.1016/j.ipm.2014.10.003; Chekuri C, 2005, ANN IEEE SYMP FOUND, P245, DOI 10.1109/SFCS.2005.9; Chen C, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P1113; Chen C, 2015, IEEE T INTELL TRANSP, V16, P1259, DOI 10.1109/TITS.2014.2357835; Choudhury M. D., 2010, P 21 ACM C HYP HYP T, P35, DOI DOI 10.1145/1810617.1810626; Cohen R, 2008, INFORM PROCESS LETT, V108, P15, DOI 10.1016/j.ipl.2008.03.017; Dredge D, 1999, ANN TOURISM RES, V26, P772, DOI 10.1016/S0160-7383(99)00007-9; Erdogan G, 2013, NETWORKS, V61, P104, DOI 10.1002/net.21496; Fang SH, 2014, IEEE INT CONF MOB DA, P33, DOI 10.1109/MDM.2014.10; Fomin FV, 2002, INFORM PROCESS LETT, V83, P57, DOI 10.1016/S0020-0190(01)00313-1; Freeman NK, 2018, EUR J OPER RES, V266, P354, DOI 10.1016/j.ejor.2017.09.025; Gambardella LM, 2000, INFORMS J COMPUT, V12, P237, DOI 10.1287/ijoc.12.3.237.12636; Gavalas D, 2014, J HEURISTICS, V20, P291, DOI 10.1007/s10732-014-9242-5; Geem ZW, 2005, LECT NOTES COMPUT SC, V3612, P741; Gendreau M, 1998, NETWORKS, V32, P263, DOI 10.1002/(SICI)1097-0037(199812)32:4<263::AID-NET3>3.0.CO;2-Q; GOLDEN BL, 1987, NAV RES LOG, V34, P307, DOI 10.1002/1520-6750(198706)34:3<307::AID-NAV3220340302>3.0.CO;2-D; Gunawan A, 2016, EUR J OPER RES, V255, P315, DOI 10.1016/j.ejor.2016.04.059; Huang HS, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5110195; KANTOR MG, 1992, J OPER RES SOC, V43, P629, DOI 10.1057/jors.1992.88; Kara I, 2016, PROC ECON FINANC, V39, P849, DOI 10.1016/S2212-5671(16)30252-0; Kobeaga G, 2018, COMPUT OPER RES, V90, P42, DOI 10.1016/j.cor.2017.09.003; Korakakis M, 2016, 2016 11TH INTERNATIONAL WORKSHOP ON SEMANTIC AND SOCIAL MEDIA ADAPTATION AND PERSONALIZATION (SMAP), P59, DOI 10.1109/SMAP.2016.7753385; Laestadius Linnea, 2017, SAGE HDB SOCIAL MEDI; Leong KB, 2016, PLOS ONE, V11, P1; Li ZJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189763; Lim KH, 2017, SIGIR'17: PROCEEDINGS OF THE 40TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P325, DOI 10.1145/3077136.3080778; Lu Eric Hsueh-Chan, 2011, 2011 12th IEEE International Conference on Mobile Data Management (MDM 2011), P152, DOI 10.1109/MDM.2011.13; Majid A, 2013, INT J GEOGR INF SCI, V27, P662, DOI 10.1080/13658816.2012.696649; Memon I, 2015, WIRELESS PERS COMMUN, V80, P1347, DOI 10.1007/s11277-014-2082-7; Okuyama K., 2013, TRAVEL PLANNING SYST, DOI 19.1997/978-1-4614-3591-3_54; Pietz J, 2013, NAV RES LOG, V60, P294, DOI 10.1002/nav.21534; Reimann M, 2004, COMPUT OPER RES, V31, P563, DOI 10.1016/S0305-0548(03)00014-5; Schilde Michael, 2009, Swarm Intelligence, V3, P179, DOI 10.1007/s11721-009-0029-5; Silva T. H, 2013, P 2 ACM SIGKDD INT W, V13, P1, DOI [10. 1145/2505821. 2505836, DOI 10.1145/2505821.2505836JULY2014]; TSILIGIRIDES T, 1984, J OPER RES SOC, V35, P797, DOI 10.2307/2582629; Vansteenwegen P, 2011, EUR J OPER RES, V209, P1, DOI 10.1016/j.ejor.2010.03.045; Verbeeck C, 2017, ANN OPER RES, V254, P481, DOI 10.1007/s10479-017-2409-3; Wei X., 2014, INT J U SERV SCI TEC, V7, P159; Yao BZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181275; Yu VF, 2019, COMPUT IND ENG, V127, P213, DOI 10.1016/j.cie.2018.11.044; Zeng BX, 2014, TOUR MANAG PERSPECT, V10, P27, DOI 10.1016/j.tmp.2014.01.001	45	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213777	10.1371/journal.pone.0213777	http://dx.doi.org/10.1371/journal.pone.0213777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939132	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900008
J	Zitouni, S; Laurent, C; Dyke, G; Jalil, NE				Zitouni, Slimane; Laurent, Christian; Dyke, Gareth; Jalil, Nour-Eddine			An abelisaurid (Dinosauria: Theropoda) ilium from the Upper Cretaceous (Cenomanian) of the Kem Kem beds, Morocco	PLOS ONE			English	Article							EVOLUTION	Abelisaurid theropods first appear in the fossil record in the early Jurassic and survived at least until the end of the Mesozoic. They were known to have dominated South America, India and Madagascar but were not so abundant in North America or Asia. Much less is known about their presence in Africa, although there has been several recent discoveries of abelisaurid material in Morocco. Here we add a partially preserved ilium to a growing body of evidence that suggests abelisaurs might also have dominated Africa.	[Zitouni, Slimane; Jalil, Nour-Eddine] Univ Cadi Ayyad, Dept Geol, Marrakech, Morocco; [Zitouni, Slimane] MHNM, Marrakech, Morocco; [Laurent, Christian] Natl Oceanog Ctr, Ocean & Earth Sci, Southampton, Hants, England; [Laurent, Christian; Dyke, Gareth] Babes Bolyai Univ, Dept Geol, Cluj Napoca, Romania; [Dyke, Gareth] Univ Debrecen, Dept Evolutionary Zool, Debrecen, Hungary; [Jalil, Nour-Eddine] Sorbonne Univ, Museum Natl Hist Nat, Paris, France	Cadi Ayyad University of Marrakech; NERC National Oceanography Centre; Babes Bolyai University from Cluj; University of Debrecen; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Laurent, C (corresponding author), Natl Oceanog Ctr, Ocean & Earth Sci, Southampton, Hants, England.; Laurent, C (corresponding author), Babes Bolyai Univ, Dept Geol, Cluj Napoca, Romania.	christian_laurent@live.com		JALIL, Nour-Eddine/0000-0002-7617-7625; Laurent, Christian/0000-0002-2946-9705	UK Natural Environmental Research Council (NERC) [NE/L002531/1]; UK Engineering and Physical Sciences Research Council (EPSRC) [EP/M5081471/1]; Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) Romania [PN-III-P4-ID-PCE-2016-0572]; Enterprise Ireland; University College Dublin	UK Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Enterprise Ireland; University College Dublin	CL was supported by the UK Natural Environmental Research Council (NERC) [grant number NE/L002531/1], https://nerc.ukri.org/and the UK Engineering and Physical Sciences Research Council (EPSRC) [grant number EP/M5081471/1], https://epsrc.ukri.org.CL and GD were supported by the Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) Romania [grant number PN-III-P4-ID-PCE-2016-0572], https://www.uefiscdi.ro/.Fieldwork in Morocco in 2007 was supported by Enterprise Ireland and University College Dublin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2007, J VERTEBR PALEONTOL, V27, P610, DOI 10.1671/0272-4634(2007)27[610:AADTFT]2.0.CO;2; Allain R, 2012, NATURWISSENSCHAFTEN, V99, P369, DOI 10.1007/s00114-012-0911-7; Arden TMS, 2019, CRETACEOUS RES, V93, P275, DOI 10.1016/j.cretres.2018.06.013; Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; Belvedere M, 2013, PALAEOGEOGR PALAEOCL, V383, P52, DOI 10.1016/j.palaeo.2013.04.026; Buffetaut E, 2005, NATURWISSENSCHAFTEN, V92, P477, DOI 10.1007/s00114-005-0022-9; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Chiarenza AA, 2016, PEERJ, V4, DOI 10.7717/peerj.1754; Choubert G., 1948, Vol Jubilaire Soc Sci nat Maroc, P307; Dubar G., 1949, NOTES MEMOIRES SERVI, P60; Dutheil Didier B., 1999, P553; Ettachfini EM, 2004, CRETACEOUS RES, V25, P277, DOI 10.1016/j.cretres.2004.01.001; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Hendrickx C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144695; Ibrahim N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090751; Joly F., 1961, INF GEOGR PERSEE POR, V25, P225, DOI [10.1007/s00114-012-0911-7, DOI 10.1007/S00114-012-0911-7]; Kilian C., 1931, COMPTES RENDUS SOMMA, V9, P109; Longrich NR, 2017, CRETACEOUS RES, V76, P40, DOI 10.1016/j.cretres.2017.03.021; Maganuco S, 2018, PEERJ, V6, DOI 10.7717/peerj.4785; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; McGowan AJ, 2009, GEOLOGY, V37, P843, DOI 10.1130/G30188A.1; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Richter U, 2013, PALAEONTOL Z, V87, P291, DOI 10.1007/s12542-012-0153-1; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Sasso CD, 2005, J VERTEBR PALEONTOL, DOI [10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2]; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Smith JB, 2006, NATURWISSENSCHAFTEN, V93, P242, DOI 10.1007/s00114-006-0092-3; Tortosa T, 2014, ANN PALEONTOL, V100, P63, DOI 10.1016/j.annpal.2013.10.003; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Wenz S., 1981, Annales de Paleontologie Vertebres, V67, P1; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214055	10.1371/journal.pone.0214055	http://dx.doi.org/10.1371/journal.pone.0214055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939139	Green Accepted, Green Published, gold			2022-12-27	WOS:000462993900012
J	Kaihan, AB; Yasuda, Y; Imaizumi, T; Inagaki, K; Ozeki, T; Hishida, M; Katsuno, T; Tsuboi, N; Maruyama, S				Kaihan, Ahmad Baseer; Yasuda, Yoshinari; Imaizumi, Takahiro; Inagaki, Koji; Ozeki, Takaya; Hishida, Manabu; Katsuno, Takayuki; Tsuboi, Naotake; Maruyama, Shoichi			Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients	PLOS ONE			English	Article							OXFORD CLASSIFICATION; HISTOLOGIC CLASSIFICATION; VALIDATION; PROGNOSIS	Predictive values of mesangial proliferation (M), endocapillary proliferation (E), segmental glomerulosclerosis (S), and crescents (C) among 19 validation studies of the Oxford Classification of IgA nephropathy (IgAN) were discrepant, especially in Asian patients. These validation studies indicate that cutoffs of MESC score in the Oxford Classification may not be generalizable. Thus, we aimed to improve the clinical value of MESC scores by modifying the cutoff points. A total of 104 patients with IgAN were diagnosed from 2001 to 2012 vai renal biopsy and retrospectively evaluated at Nagoya University Hospital. The cutoff point for modified (M'E'S'C') was determined using the receiver operating characteristic curve in association with renal outcome in the training cohort. Clinical values of the Oxford MESTC vs M'E'S'C' cutoff points were analyzed using Kaplan-Meier and Cox regression in association with poor renal outcome in the validation and the entire cohort. Of 104 patients, 12.5% reached poor renal outcome over a median of 6.25 [4.16-9.61] years of follow-up. The modified cutoffs were defined as >= 40%, >= 10%, >= 20%, and >= 5% in the glomeruli for M'E'S', and C' respectively. In univariate analysis, E', S', and T were significantly associated with poor renal outcome, whereas Oxford MESC, M', and C' in the training and validation cohort were not associated with poor renal outcome. Using multivariate analysis in the presence of estimated glomerular filtration rate (eGFR), only E' was a significant predictive factor for poor renal outcome. The E' with modified cutoff point of 10% significantly improved predictive value for poor renal outcome in IgAN. Therefore, the clinical value of modified cutoff points for M'E'S'C' scores should be validated with various cohort studies in different regions.	[Kaihan, Ahmad Baseer; Yasuda, Yoshinari; Imaizumi, Takahiro; Inagaki, Koji; Ozeki, Takaya; Hishida, Manabu; Katsuno, Takayuki; Tsuboi, Naotake; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan; [Yasuda, Yoshinari] Nagoya Univ, Grad Sch Med, Dept Nephrol, CKD Initiat, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Yasuda, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan.; Yasuda, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, CKD Initiat, Nagoya, Aichi, Japan.	yyasuda@med.nagoya-u.ac.jp	Tsuboi, Naotake/L-5960-2019	Tsuboi, Naotake/0000-0003-0760-845X	JSPS KAKENHI [15H05291]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The current study was supported by JSPS KAKENHI Grant (15H05291 to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAMARTINE E, 1990, CLIN NEPHROL, V34, P45; Alamartine E, 2011, CLIN J AM SOC NEPHRO, V6, P2384, DOI 10.2215/CJN.01170211; [Anonymous], 1999, J AM SOC NEPHROL, V10, P1772; Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Kaihan AB, 2017, CLIN EXP NEPHROL, V21, P986, DOI 10.1007/s10157-017-1393-x; Kang SH, 2012, NEPHROL DIAL TRANSPL, V27, P252, DOI 10.1093/ndt/gfr295; Katafuchi R, 2011, CLIN J AM SOC NEPHRO, V6, P2806, DOI 10.2215/CJN.02890311; Kawamura T, 2013, J NEPHROL, V26, P350, DOI 10.5301/jn.5000151; Kfoury H, 2014, HK NEPHROPATHOL, V16, P29, DOI DOI 10.1016/J.HKJN.2014.04.001; Le WB, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-158; Lee H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-94; LEE HS, 1987, CLIN NEPHROL, V27, P131; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nasri Hamid, 2012, J Nephropathol, V1, P31, DOI 10.5812/jnp.7; Park KS, 2014, HUM PATHOL, V45, P236, DOI 10.1016/j.humpath.2013.08.019; Peters HPE, IMMUNOSUPPRESSIVE TH, P284; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Shima Y, 2012, PEDIATR NEPHROL, V27, P783, DOI 10.1007/s00467-011-2061-0; Stefan G, 2016, PATHOL INT, V66, P453, DOI 10.1111/pin.12442; Stefan M, 2011, P ROMANIAN ACAD A, V12, P269; Tatematsu M, 2012, CLIN EXP NEPHROL, V16, P883, DOI 10.1007/s10157-012-0644-0; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; Walsh M, 2010, CLIN J AM SOC NEPHRO, V5, P425, DOI 10.2215/CJN.06530909	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214414	10.1371/journal.pone.0214414	http://dx.doi.org/10.1371/journal.pone.0214414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925188	Green Published, Green Submitted, gold			2022-12-27	WOS:000462732300014
J	Kim, YG; Shim, J; Boo, KY; Kim, DY; Oh, SK; Lee, KN; Choi, JI; Kim, YH				Kim, Yun Gi; Shim, Jaemin; Boo, Ki Yung; Kim, Do Young; Oh, Suk-Kyu; Lee, Kwang-No; Choi, Jong-Il; Kim, Young-Hoon			Different influence of cardiac hemodynamics on thromboembolic events in patients with paroxysmal and non-paroxysmal atrial fibrillation	PLOS ONE			English	Article							SPONTANEOUS ECHO CONTRAST; RISK; STROKE; FIBROSIS; PATHOPHYSIOLOGY; ABLATION	Blood stasis in left atrium (LA) or LA appendage (LAA) is thought to be the main cause of thrombus formation and systemic embolism in atrial fibrillation (AF) patients. Paroxysmal and non-paroxysmal AF differ significantly in various aspects. Impact of cardiac hemodynamics on systemic embolism might also differ between the 2 distinct AF entities. This study was performed to evaluate the influence of cardiac hemodynamics on systemic embolism in both paroxysmal and non-paroxysmal AF. Consecutive AF patients undergoing radiofrequency catheter ablation (RFCA) in Korea University Medical Center Anam Hospital between June 1998 and February 2018 were analyzed. Among 2,801 patients who underwent first-time RFCA, a total of 231 patients had either previous ischemic stroke, transient ischemic attack, or arterial embolism. In paroxysmal AF, LA diameter, LA volume (measured with magnetic resonance imaging), left ventricular (LV) ejection fraction, E/e', LAA flow velocity, and prevalence of spontaneous echocontrast (SEC) and dense SEC were significantly different between patients with and without thromboembolic events. However, only E/e' was different between patients with and without thromboembolic events in non-paroxysmal AF. The influence of LA diameter, LA volume, LV EF, LAA flow velocity, and dense SEC on thromboembolic events was significantly moderated by the type of AF. In conclusion, paroxysmal and non-paroxysmal AF might have a different mechanism responsible for thrombus formation and consequent embolic events. Relative contribution of hemodynamic parameters and other factors such as atrial myopathy to thromboembolic events in paroxysmal versus non-paroxysmal AF needs further evaluation.	[Kim, Yun Gi; Shim, Jaemin; Boo, Ki Yung; Kim, Do Young; Oh, Suk-Kyu; Lee, Kwang-No; Choi, Jong-Il; Kim, Young-Hoon] Korea Univ, Med Ctr, Anam Hosp, Arrhythmia Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Shim, J; Kim, YH (corresponding author), Korea Univ, Med Ctr, Anam Hosp, Arrhythmia Ctr, Seoul, South Korea.	jaemins@korea.ac.kr; yhkmd@korea.ac.kr	Kim, Young-Hoon/AAO-5792-2021	Choi, Jong-Il/0000-0001-6617-508X; Kim, Young-Hoon/0000-0002-4254-647X				Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; BLACK IW, 1993, J AM COLL CARDIOL, V21, P451, DOI 10.1016/0735-1097(93)90688-W; Black IW, 2000, ECHOCARDIOGR-J CARD, V17, P373, DOI 10.1111/j.1540-8175.2000.tb01153.x; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Calenda BW, 2016, NAT REV CARDIOL, V13, P549, DOI 10.1038/nrcardio.2016.106; Conway DSG, 2004, J AM COLL CARDIOL, V43, P2075, DOI 10.1016/j.jacc.2003.11.062; Daccarett M, 2011, J AM COLL CARDIOL, V57, P831, DOI 10.1016/j.jacc.2010.09.049; Fiala M, 2010, PACE, V33, P541, DOI 10.1111/j.1540-8159.2009.02646.x; Friberg L, 2016, EUR HEART J, V37, P2478, DOI 10.1093/eurheartj/ehw087; Gaita F, 2011, NAT REV CARDIOL, V8, P307, DOI 10.1038/nrcardio.2011.63; Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638; Hatzinikolaou-Kotsakou E, 2003, J THROMB THROMBOLYS, V16, P155, DOI 10.1023/B:THRO.0000024053.45693.fc; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Karasoy D, 2015, EUR HEART J, V36, P307, DOI 10.1093/eurheartj/ehu421; Khan AA, 2019, CARDIOVASC RES, V115, P31, DOI 10.1093/cvr/cvy272; Kim YG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26212-y; Kostin S, 2002, CARDIOVASC RES, V54, P361, DOI 10.1016/S0008-6363(02)00273-0; Kottkamp H, 2013, EUR HEART J, V34, P2731, DOI 10.1093/eurheartj/eht194; Kottkamp H, 2012, J CARDIOVASC ELECTR, V23, P797, DOI 10.1111/j.1540-8167.2012.02341.x; Lau DH, 2017, HEART LUNG CIRC, V26, P887, DOI 10.1016/j.hlc.2017.05.119; Lau DH, 2016, EUR HEART J, V37, P1573, DOI 10.1093/eurheartj/ehv375; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; PETERSEN P, 1990, STROKE, V21, P4, DOI 10.1161/01.STR.21.1.4; Vazquez-Garza E, 2017, J THROMB THROMBOLYS, V44, P377, DOI 10.1007/s11239-017-1528-7; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6	25	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214743	10.1371/journal.pone.0214743	http://dx.doi.org/10.1371/journal.pone.0214743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925176	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300029
J	Seal, S; Polley, S; Sau, S				Seal, Soham; Polley, Soumitra; Sau, Subrata			A staphylococcal cyclophilin carries a single domain and unfolds via the formation of an intermediate that preserves cyclosporin A binding activity	PLOS ONE			English	Article							X-RAY; LIGAND-BINDING; DENATURATION; STABILITY; PROTEINS; COMPLEX; STABILIZATION; ISOMERASES; AUREUS; MODEL	Cyclophilin (Cyp), a peptidyl-prolyl cis-trans isomerase (PPIase), acts as a virulence factor in many bacteria including Staphylococcus aureus. The enzymatic activity of Cyp is inhibited by cyclosporin A (CsA), an immunosuppressive drug. To precisely determine the unfolding mechanism and the domain structure of Cyp, we have investigated a chimeric S. aureus Cyp (rCyp) using various probes. Our limited proteolysis and the consequent analysis of the proteolytic fragments indicate that rCyp is composed of one domain with a short flexible tail at the C-terminal end. We also show that the urea-induced unfolding of both rCyp and rCyp-CsA is completely reversible and proceeds via the synthesis of at least one stable intermediate. Both the secondary structure and the tertiary structure of each intermediate appears very similar to those of the corresponding native protein. Conversely, the hydrophobic surface areas of the intermediates are comparatively less. Further analyses reveal no loss of CsA binding activity in rCyp intermediate. The thermodynamic stability of rCyp was also significantly increased in the presence of CsA, recommending that this protein could be employed to screen new CsA derivatives in the future.	[Seal, Soham; Polley, Soumitra; Sau, Subrata] Bose Inst, Dept Biochem, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Sau, S (corresponding author), Bose Inst, Dept Biochem, Kolkata, W Bengal, India.	subratasau@gmail.com		Polley, Soumitra/0000-0002-6337-7935				Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Assis LM, 2017, DRUG RESIST UPDATE, V31, P1, DOI 10.1016/j.drup.2017.03.001; Aucamp JP, 2008, BIOTECHNOL BIOENG, V99, P1303, DOI 10.1002/bit.21705; Aucamp JP, 2005, BIOTECHNOL BIOENG, V89, P599, DOI 10.1002/bit.20397; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Barik S, 2018, COMPUT STRUCT BIOTEC, V16, P231, DOI 10.1016/j.csbj.2018.07.001; Bychkova VE, 2018, BIOCHEMISTRY-MOSCOW+, V83, pS33, DOI 10.1134/S0006297918140043; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; CONNELLY PR, 1992, P NATL ACAD SCI USA, V89, P4781, DOI 10.1073/pnas.89.11.4781; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Dawar FU, 2017, J LEUKOCYTE BIOL, V102, P989, DOI 10.1189/jlb.3RU0317-090RR; de Wilde AH, 2018, VIROLOGY, V517, P148, DOI 10.1016/j.virol.2017.11.022; Dimou M, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2330-6; Dunyak BM, 2016, J MED CHEM, V59, P9622, DOI 10.1021/acs.jmedchem.6b00411; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Foster TJ, 2017, FEMS MICROBIOL REV, V41, P430, DOI 10.1093/femsre/fux007; Gaudet M, 2010, PROTEIN SCI, V19, P1544, DOI 10.1002/pro.433; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Harikishore A, 2016, CURR MOL PHARMACOL, V9, P37, DOI 10.2174/1874467208666150519113427; Hiramatsu K, 2014, J INFECT CHEMOTHER, V20, P593, DOI 10.1016/j.jiac.2014.08.001; Hopkins S, 2015, BBA-GEN SUBJECTS, V1850, P2103, DOI 10.1016/j.bbagen.2014.11.011; Jaenicke R, 2000, J BIOTECHNOL, V79, P193, DOI 10.1016/S0168-1656(00)00236-4; Jana B, 2012, BIOCHEMISTRY-US, V51, P1223, DOI 10.1021/bi2015037; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Kahlert V, 2018, ORG BIOMOL CHEM, V16, P4338, DOI 10.1039/c8ob00980e; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; KE HM, 1993, P NATL ACAD SCI USA, V90, P11850, DOI 10.1073/pnas.90.24.11850; Keogh RA, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00379-18; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; Lavin PTM, 2016, CURR MOL PHARMACOL, V9, P148, DOI 10.2174/1874467208666150519115443; Liu CP, 2005, BIOCHIMIE, V87, P1023, DOI 10.1016/j.biochi.2005.03.017; Mahapa A, 2018, PROTEIN J, V37, P103, DOI 10.1007/s10930-018-9762-1; Mahapa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122168; Mahendrarajah K, 2011, ANAL BIOCHEM, V411, P155, DOI 10.1016/j.ab.2010.12.001; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Mandal S, 2018, INT J BIOL MACROMOL, V113, P1221, DOI 10.1016/j.ijbiomac.2018.03.045; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; Mishra P, 2017, J PHYS CHEM B, V121, P9336, DOI 10.1021/acs.jpcb.7b07032; Mitra D, 2006, FEBS LETT, V580, P6846, DOI 10.1016/j.febslet.2006.11.042; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Naoumov NV, 2014, J HEPATOL, V61, P1166, DOI 10.1016/j.jhep.2014.07.008; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Pace CN, 2000, PROTEINS, P1; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Pal A, 2008, J BIOMOL STRUCT DYN, V26, P339, DOI 10.1080/07391102.2008.10507249; Peterson MR, 2000, J MOL BIOL, V298, P123, DOI 10.1006/jmbi.2000.3633; Polley S, 2017, BIOINFORMATION, V13, P78, DOI 10.6026/97320630013078; Polley Soumitra, 2015, Biochim Open, V1, P28, DOI 10.1016/j.biopen.2015.07.001; Polley S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102891; Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514; Rashid F, 2005, PROTEIN J, V24, P283, DOI 10.1007/s10930-005-6749-5; Roy S, 2014, INT J BIOL MACROMOL, V69, P353, DOI 10.1016/j.ijbiomac.2014.05.063; Sambrook J., 2001, MOL CLONING LAB MANU; Sancho J, 2013, ARCH BIOCHEM BIOPHYS, V531, P4, DOI 10.1016/j.abb.2012.10.014; Schiene-Fischer C, 2015, ELS CITABLE REV LIFE; Schon A, 2013, ANAL BIOCHEM, V443, P52, DOI 10.1016/j.ab.2013.08.015; Senisterra G, 2012, ASSAY DRUG DEV TECHN, V10, P128, DOI 10.1089/adt.2011.0390; Shukla VK, 2017, BIOPHYS J, V112, P605, DOI 10.1016/j.bpj.2016.12.020; Singh AR, 2010, EUR BIOPHYS J BIOPHY, V39, P289, DOI 10.1007/s00249-009-0539-5; Sinha D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195416; SPITZFADEN C, 1992, FEBS LETT, V300, P291, DOI 10.1016/0014-5793(92)80866-F; Unal CM, 2014, MICROBIOL MOL BIOL R, V78, P544, DOI 10.1128/MMBR.00015-14; Venugopal V, 2009, ACTA CRYSTALLOGR D, V65, P1187, DOI 10.1107/S0907444909034234; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wiemels RE, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00453-16; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhao XM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00126	72	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0210771	10.1371/journal.pone.0210771	http://dx.doi.org/10.1371/journal.pone.0210771			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925148	Green Submitted, Green Published, gold			2022-12-27	WOS:000462732300001
J	Carstensen-Kirberg, M; Rohrig, K; Niersmann, C; Ouwens, M; Belgardt, BF; Roden, M; Herder, C				Carstensen-Kirberg, Maren; Roehrig, Karin; Niersmann, Corinna; Ouwens, Margriet; Belgardt, Bengt F.; Roden, Michael; Herder, Christian			Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E	PLOS ONE			English	Article							INHIBITION; PROLIFERATION; RESISTANCE	Previous studies reported that secreted frizzled-related protein-5 (Sfrp5) decreases beta cell proliferation and increases fasting insulin levels, but studies on direct effects of Sfrp5 on insulin secretion and its underlying mechanisms are missing. This study examined effects of Sfrp5 on (i) beta cell viability and proliferation, (ii) basal and glucose-stimulated insulin secretion and (iii) canonical and non-canonical Wnt signalling pathways. We incubated rat INS-1E cells with 0.1, 1 or 5 mu g/ml recombinant Sfrp5 for 24h. We measured basal and glucose-stimulated insulin secretion at glucose concentrations of 2.5 and 20 mmol/l. Phosphorylated and total protein content as well as mRNA levels of markers of cell proliferation, canonical and non-canonical Wnt signalling pathways were examined using Western blotting and real-time PCR. Differences between treatments were analysed by repeated measurement one-way ANOVA or Friedman's test followed by correction for multiple testing using the Benjamini-Hochberg procedure. At 5 mu g/ml, Sfrp5 reduced mRNA levels of cyclin -B1 by 25% (p<0.05). At 1 and 5 mu g/ml, Sfrp5 increased glucose-stimulated insulin secretion by 24% and by 34% (both p<0.05), respectively, but had no impact on basal insulin secretion. Sfrp5 reduced the phosphorylation of the splicing forms p46 and p54 of JNK by 39% (p<0.01) and 49% (p<0.05), respectively. In conclusion, Sfrp5 reduced markers of cell proliferation, but increased in parallel dose-dependently glucose-stimulated insulin secretion in INS-1E cells. This effect is likely mediated by reduced JNK activity, an important component of the non-canonical Wnt signalling pathway.	[Carstensen-Kirberg, Maren; Roehrig, Karin; Niersmann, Corinna; Roden, Michael; Herder, Christian] Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, Inst Clin Diabetol, German Diabet Ctr, Dusseldorf, Germany; [Carstensen-Kirberg, Maren; Roehrig, Karin; Niersmann, Corinna; Ouwens, Margriet; Belgardt, Bengt F.; Roden, Michael; Herder, Christian] German Ctr Diabet Res DZD, Partner Dusseldorf, Dusseldorf, Germany; [Ouwens, Margriet] Heinrich Heine Univ Dusseldorf, Inst Clin Biochem & Pathobiochem, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Ouwens, Margriet] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium; [Belgardt, Bengt F.] Heinrich Heine Univ Dusseldorf, Inst Beta Cell Biol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Roden, Michael] Heinrich Heine Univ, Fac Med, Div Endocrinol & Diabetol, Dusseldorf, Germany; [Herder, Christian] Heinrich Heine Univ, Fac Med, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Ghent University; Ghent University Hospital; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Carstensen-Kirberg, M (corresponding author), Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, Inst Clin Diabetol, German Diabet Ctr, Dusseldorf, Germany.; Carstensen-Kirberg, M (corresponding author), German Ctr Diabet Res DZD, Partner Dusseldorf, Dusseldorf, Germany.	maren.carstensen@ddz.de	Roden, Michael/AAD-3843-2019; Ouwens, Margriet/H-2442-2013	Ouwens, Margriet/0000-0001-6709-2702; Belgardt, Bengt-Frederik/0000-0003-4537-9002	German Diabetes Association (Deutsche Diabetes-Gesellschaft, DDG); Ministry of Culture and Science of the State of North Rhine-Westphalia; German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)	German Diabetes Association (Deutsche Diabetes-Gesellschaft, DDG); Ministry of Culture and Science of the State of North Rhine-Westphalia; German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by research grants from the German Diabetes Association (Deutsche Diabetes-Gesellschaft, DDG) to MCK. This work was also supported by the Ministry of Culture and Science of the State of North Rhine-Westphalia and the German Federal Ministry of Health (BMG). This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195850; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Canivell S, 2015, DIABETES-METAB RES, V31, P212, DOI 10.1002/dmrr.2599; Carstensen M, 2013, EUR J CLIN INVEST, V43, P350, DOI 10.1111/eci.12052; Catalan V, 2014, J CLIN ENDOCR METAB, V99, pE1407, DOI 10.1210/jc.2014-1191; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Corlateanu Alexandru, 2017, COPD RES PRACTICE, V3, DOI [DOI 10.1186/S12933-017-0591-X, 10.1186/s40749-017-0025-x, DOI 10.1186/S40749-017-0025-X]; Guan BB, 2016, J ENDOCRINOL, V229, P73, DOI 10.1530/JOE-15-0535; Kim HE, 2008, J ENDOCRINOL, V198, P549, DOI 10.1677/JOE-08-0131; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Nakamura K, 2016, J BIOL CHEM, V291, P2566, DOI 10.1074/jbc.M115.693937; Nowotny B, 2013, DIABETES, V62, P2240, DOI 10.2337/db12-1179; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Ploton M, 2018, J HEPATOL, V69, P1099, DOI 10.1016/j.jhep.2018.06.022; Rebuffat SA, 2013, DIABETOLOGIA, V56, P2446, DOI 10.1007/s00125-013-3030-x; Rulifson IC, 2014, AM J PHYSIOL-ENDOC M, V307, pE1144, DOI 10.1152/ajpendo.00283.2014; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Waasdorp M, 2019, J CELL MOL MED, V23, P1268, DOI 10.1111/jcmm.14028; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	19	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213650	10.1371/journal.pone.0213650	http://dx.doi.org/10.1371/journal.pone.0213650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921355	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000020
J	Valente, D; Palama, A; Malsert, J; Bolens, G; Gentaz, E				Valente, Dannyelle; Palama, Amaya; Malsert, Jennifer; Bolens, Guillemette; Gentaz, Edouard			Adults' visual recognition of actions simulations by finger gestures (ASFGs) produced by sighted and blind individuals	PLOS ONE			English	Article							PICTURE; CHILDREN	The present study examines the visual recognition of action simulations by finger gestures (ASFGs) produced by sighted and blind individuals. In ASFGs, fingers simulate legs to represent actions such as jumping, spinning, climbing, etc. The question is to determine whether the common motor experience of one's own body is sufficient to produce adequate ASFGs or whether the possibility to see gestures from others are also necessary to do it. Three experiments were carried out to address this question. Experiment 1 examined in 74 sighted adults the recognition of 18 types of ASFGs produced by 20 blindfolded sighted adults. Results showed that rates of correct recognition were globally very high, but varied with the type of ASFG. Experiment 2 studied in 91 other sighted adults the recognition of ASFGs produced by 10 early blind and 7 late blind adults. Results also showed a high level of recognition with a similar order of recognizability by type of ASFG. However, ASFGs produced by early blind individuals were more poorly recognized than those produced by late blind individuals. In order to match data of recognition obtained with the form that gestures are produced by individuals, two independant judges evaluated prototypical and atypical attributes of ASFG produced by blindfolded sighted, early blind and late blind individuals in Experiment 3. Results revealed the occurrence of more atypical attributes in ASFG produced by blind individuals: their ASFGs transpose more body movements from a characterviewpoint in less agreement with visual rules. The practical interest of the study relates to the relevance of including ASFGs as a new exploratory procedure in tactile devices which are more apt to convey action concepts to blind users/readers.	[Valente, Dannyelle; Palama, Amaya; Malsert, Jennifer; Gentaz, Edouard] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland; [Valente, Dannyelle] Univ Lumiere Lyon, Dept Dev Psychol, Bron, France; [Bolens, Guillemette] Univ Geneva, Fac Humanities, Geneva, Switzerland	University of Geneva; Universite Lyon 2; University of Geneva	Valente, D (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland.; Valente, D (corresponding author), Univ Lumiere Lyon, Dept Dev Psychol, Bron, France.	dannyelle.valente@univ-lyon2.fr		Palama, Amaya/0000-0002-9251-0520; Gentaz, Edouard/0000-0003-0574-5557; Valente, Dannyelle/0000-0003-2686-4379	Swiss National Science Foundation - SNF [100019_162688]	Swiss National Science Foundation - SNF(Swiss National Science Foundation (SNSF))	This study was supported by Swiss National Science Foundation - SNF (CH), http://www.snf.ch, research grant 100019_162688, awarded by Pr. Edouard Gentaz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bara F, J VISUAL IMPAIRMENT; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; BLASS T, 1974, PERCEPT MOTOR SKILL, V39, P279, DOI 10.2466/pms.1974.39.1.279; Bolens G., 2012, STYLE GESTURES EMBOD; Cuxac, 2000, LANGUE SIGNES FRANCA; Frame MJ, 2000, J VISUAL IMPAIR BLIN, V94, P155, DOI 10.1177/0145482X0009400304; Hainselin M., 2013, REV NEUROPSYCHOL, V5, P129, DOI DOI 10.3917/RNE.052.0129; HELLER MA, 1989, PERCEPTION, V18, P379, DOI 10.1068/p180379; Heller MA, 2014, PSYCHOL TOUCH BLINDN; Hostetter AB, 2008, PSYCHON B REV, V15, P495, DOI 10.3758/PBR.15.3.495; Howell D.C., 2010, STAT METHODS PSYCHOL, V7; Iverson JM, 1997, DEV PSYCHOL, V33, P453, DOI 10.1037/0012-1649.33.3.453; Iverson JM, 2001, DEVELOPMENTAL SCI, V4, P416, DOI 10.1111/1467-7687.00183; Iverson JM, 2000, J NONVERBAL BEHAV, V24, P105, DOI 10.1023/A:1006605912965; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; KLATZKY RL, 1993, PERCEPT PSYCHOPHYS, V54, P170, DOI 10.3758/BF03211752; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; Madan CR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00507; McNeill D, 2016, WHY WE GESTURE: THE SURPRISING ROLE OF HAND MOVEMENTS IN COMMUNICATION, P1, DOI 10.1017/CBO9781316480526; McNeill D, 1992, MIND WHAT GESTURES R; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Sharkey WF, 2000, J VISUAL IMPAIR BLIN, V94, P549, DOI 10.1177/0145482X0009400902; Theurel A, 2013, J EXP PSYCHOL-APPL, V19, P233, DOI 10.1037/a0034255; Theurel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040251; Thompson LJ, 2006, EUR PSYCHOL, V11, P110, DOI 10.1027/1016-9040.11.2.110; Valente D, J EXPT PSYCHOL UNPUB; Valente D, RECONNAISSANCE ILLUS; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214371	10.1371/journal.pone.0214371	http://dx.doi.org/10.1371/journal.pone.0214371			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921397	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000061
J	Ovalle-Bracho, C; Londono-Barbosa, D; Salgado-Almario, J; Gonzalez, C				Ovalle-Bracho, Clemencia; Londono-Barbosa, Diana; Salgado-Almario, Jussep; Gonzalez, Camila			Evaluating the spatial distribution of Leishmania parasites in Colombia from clinical samples and human isolates (1999 to 2016)	PLOS ONE			English	Article							PHLEBOTOMINE SAND FLIES; CUTANEOUS LEISHMANIASIS; CLIMATE-CHANGE; PSYCHODIDAE PHLEBOTOMINAE; GEOGRAPHIC-DISTRIBUTION; BRAZILIENSIS; VIANNIA; LUTZOMYIA; DIPTERA; COAST	In Colombia, nine species of parasites of the genus Leishmania circulate in more than 20 sand fly species, putting at risk of contracting the disease approximately 60% of the population. The Federico Lleras Acosta Dermatological Center, a reference center in Colombia, has been treating patients with cutaneous and mucosal leishmaniasis for more than 15 years, identifying the infecting Leishmania species from different clinical samples, and recording systematically all the epidemiological and geographic information related to each diagnosed patient. With this valuable information, the objective of this work was to perform a long term and large-scale study, aiming to identify the Leishmania species circulating in Colombia from clinical samples from 1999 to 2016, and to assess their current and potential spatial distribution. In all, four Leishmania species were identified in 688 samples from 183 municipalities distributed in 28 of the 32 departments of the country, and 387 records were georeferenced, from 20 departments. The most widespread species was L. (V.) braziliensis, showing new collection records, and the species related to areas with highest leishmaniasis transmission was L. (V.) panamensis. Ecological niche models were built for the three species that had more than 20 georeferenced records, showing a potential distribution for L. (V.) braziliensis on 42% of the national territory mainly in the interandean valleys, and the Orinoquia and Amazon regions. Leishmania (V.) guyanensis potential distribution covers 36% of Colombia continental territory with a spatial distribution similar to that of L. (V.) braziliensis. There was a marked tendency of L. (V.) panamensis to be distributed in the northwest of the country occupying 35% of the national area and mainly in areas of transformed ecosystems. Species were identified in patients from areas where the occurrence of cases was unprecedented, which suggests that the distribution of Leishmania may be greater than currently known. To improve the predictive capacity of the models, we suggest incorporating, in future studies, Leishmania samples from vectors and reservoirs that have a greater dependence on environmental variables. Our results are an important tool for health systems because they allow potential areas of transmission and information gaps to be identified.	[Ovalle-Bracho, Clemencia; Londono-Barbosa, Diana; Salgado-Almario, Jussep] Hosp Univ Ctr Dermatol Federico Lleras Acosta ESE, Bogota, Colombia; [Gonzalez, Camila] Univ Los Andes, Fac Ciencias, Ctr Invest Microbiol & Parasitol Trop CIMPAT, Bogota, Colombia	Universidad de los Andes (Colombia)	Ovalle-Bracho, C (corresponding author), Hosp Univ Ctr Dermatol Federico Lleras Acosta ESE, Bogota, Colombia.	clemovalle@gmail.com	González, Camila/AAW-9144-2021; Ovalle-bracho, Clemencia/O-4004-2018	Salgado-Almario, Jussep/0000-0002-7421-6168; Londono Barbosa, Diana Alexandra/0000-0002-0158-5157; Gonzalez, Camila/0000-0001-8089-4056	Hospital Universitario Centro Dermatologico Federico Lleras Acosta [4000.16.1V]	Hospital Universitario Centro Dermatologico Federico Lleras Acosta	This work was funded by Hospital Universitario Centro Dermatologico Federico Lleras Acosta, Project ID: 4000.16.1V. All the funding or sources of support received during this specific study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Alemayehu B, 2017, HLTH SCI J, V4, P519, DOI DOI 10.21767/1791-809X.1000519; Alexander B, 1998, ACTA TROP, V69, P41, DOI 10.1016/S0001-706X(97)00114-9; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P287; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Bejarano EE, 2002, MEM I OSWALDO CRUZ, V97, P645, DOI 10.1590/S0074-02762002000500010; Boshell, 1985, BIOMEDICA, V5, P95, DOI DOI 10.7705/BIOMEDICA.V5I3-4.1909; Cochero Suljey, 2007, Rev Cubana Med Trop, V59, P0; CORREDOR A, 1990, AM J TROP MED HYG, V42, P206; Ramirez JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28266; Escobar LE, 2018, ECOL EVOL, V8, P4757, DOI 10.1002/ece3.4014; Escobar LE, 2013, REV PANAM SALUD PUBL, V34, P135; Ferro C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139391; Ferro C, 2011, AM J TROP MED HYG, V85, P847, DOI 10.4269/ajtmh.2011.10-0560; González Camila, 2006, Biomed., V26, P64; Gonzalez C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190686; Gonzalez C, 2014, ACTA TROP, V129, P83, DOI 10.1016/j.actatropica.2013.08.014; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Hernandez C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0501-y; Intituto Nacional de Salud, 2016, B EPIDEMIOLOGICO SEM, V52; KREUTZER RD, 1991, AM J TROP MED HYG, V44, P662, DOI 10.4269/ajtmh.1991.44.662; Le Pont F, 1988, CR HEBD ACAD SCI, V307, P276; Alvarez AMM, 2010, T ROY SOC TROP MED H, V104, P364, DOI 10.1016/j.trstmh.2009.12.002; Moreno M, 2015, ACTA TROP, V148, P191, DOI 10.1016/j.actatropica.2015.04.017; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Osorio LE, 1998, AM J TROP MED HYG, V59, P49, DOI 10.4269/ajtmh.1998.59.49; Ovalle Clemencia Elena, 2006, Biomed., V26, P145; Ovalle-Bracho C, 2016, INT J DERMATOL, V55, P531, DOI 10.1111/ijd.12910; Martinez LP, 2010, PARASITOL RES, V106, P647, DOI 10.1007/s00436-009-1712-6; Pardo Raúl H, 2006, Biomed., V26, P95; Patino LH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005876; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2017, INT J PARASITOL, V47, P667, DOI 10.1016/j.ijpara.2017.04.007; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Lopez LP, 2014, REV CES SALUD PUBLIC, V5, P3; ROJAS E, 1995, REV SAUDE PUBL, V29, P1, DOI 10.1590/S0034-89101995000100002; Samy AM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004381; Santaella J, 2011, AM J TROP MED HYG, V84, P674, DOI 10.4269/ajtmh.2011.10-0159; Santamaria E., 1999, Biomedica, V19, P115; Santamaría Erika, 2006, Biomed., V26, P82; SANTRICH C, 1990, AM J TROP MED HYG, V42, P51, DOI 10.4269/ajtmh.1990.42.51; SARAVIA NG, 1985, AM J TROP MED HYG, V34, P714, DOI 10.4269/ajtmh.1985.34.714; Saravia NG, 1998, AM J TROP MED HYG, V59, P86, DOI 10.4269/ajtmh.1998.59.86; Saravia NG, 2002, AM J TROP MED HYG, V66, P738, DOI 10.4269/ajtmh.2002.66.738; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; TRAVI BL, 1988, AM J TROP MED HYG, V39, P261, DOI 10.4269/ajtmh.1988.39.261; Trujillo AV, 2013, MEM I OSWALDO CRUZ, V108, P463, DOI 10.1590/S0074-0276108042013011; Velez I, 2010, AM J TROP MED HYG, V83, P351, DOI 10.4269/ajtmh.2010.10-0060; Velez ID, 2012, AM J TROP MED HYG, V86, P807, DOI 10.4269/ajtmh.2012.11-0408; WARBURG A, 1991, MED VET ENTOMOL, V5, P9, DOI 10.1111/j.1365-2915.1991.tb00514.x; WEIGLE KA, 1986, AM J TROP MED HYG, V35, P722, DOI 10.4269/ajtmh.1986.35.722; WHO, 2010, CONTR LEISHM; YOUNG DG, 1987, J MED ENTOMOL, V24, P587, DOI 10.1093/jmedent/24.5.587	56	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214124	10.1371/journal.pone.0214124	http://dx.doi.org/10.1371/journal.pone.0214124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917177	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800053
J	Arda, K; Akay, S; Erisken, C				Arda, Kemal; Akay, Sinan; Erisken, Cevat			Effect of gadolinium concentration on temperature change under magnetic field	PLOS ONE			English	Article							CONTRAST AGENT; COMPLEXES; KINETICS	Gadolinium based contrast agents (GBCAs) were found to play a role in nephrogenic systemic fibrosis in patients with and without renal impairment. Therefore, preserving the structural stability of GBCAs to reduce their propensity to liberate Gd3+ is of utmost importance. This study evaluates the effect of gadolinium concentration of GBCAs on solution temperature under magnetic fields. It is hypothesized that presence of gadolinium will lead to temperature changes of its solutions under magnetic field, and this change will depend on concentration. In this study, GBCAs were diluted to concentrations of 0.6, 1.2, 1.8, 2.4 mMol/L. A 10mL preparation in pure water, simulated body fluid (SBF), and plasma was scanned at 3T following a soft tissue neck protocol, and their temperatures were measured. Findings revealed that concentration of GBCA had significant effect on temperature change in all dilution media. Type of commercially available GBCA had an effect only in SFB and plasma. Evaluation of correlation between conditional stability constant (K-cond) and temperature difference (Delta T) revealed that in water and SBF there exists a positive correlation between K-cond and temperature variation. Collectively, GBCAs can cause local temperature variations when administered into patients, and can affect dissociation of gadolinium from its chelates, which should be investigated in a further study.	[Arda, Kemal; Akay, Sinan] Hlth Sci Univ, Gulhane Med Fac, Res & Educ Hosp, Dept Radiol, Ankara, Turkey; [Erisken, Cevat] Nazarbayev Univ, Chem & Mat Engn, Astana, Kazakhstan	University of Health Sciences Turkey; Nazarbayev University	Erisken, C (corresponding author), Nazarbayev Univ, Chem & Mat Engn, Astana, Kazakhstan.	cevat.erisken@nu.edu.kz	Erisken, Cevat/P-7850-2014	Erisken, Cevat/0000-0002-6337-8022				Baranyai Z, 2012, CHEM-EUR J, V18, P16426, DOI 10.1002/chem.201202930; BOUSQUET JC, 1988, RADIOLOGY, V166, P693, DOI 10.1148/radiology.166.3.3340763; Bruck E, 2005, J PHYS D APPL PHYS, V38, pR381, DOI 10.1088/0022-3727/38/23/R01; Dams SD, 2010, SKIN RES TECHNOL, V16, P354, DOI 10.1111/j.1600-0846.2010.00441.x; Deka S, 2018, MAT SCI ENG C-MATER, V92, P932, DOI 10.1016/j.msec.2018.07.042; Do C, 2014, AM J PHYSIOL-RENAL, V307, pF844, DOI 10.1152/ajprenal.00379.2014; Gschneidner KA, 2005, REP PROG PHYS, V68, P1479, DOI 10.1088/0034-4885/68/6/R04; Haneder Stefan, 2015, Top Magn Reson Imaging, V24, P57, DOI 10.1097/RMR.0b013e3182a14e79; Hijnen NM, 2013, J THER ULTRASOUND, V1, DOI 10.1186/2050-5736-1-8; Idee JM, 2009, J MAGN RESON IMAGING, V30, P1249, DOI 10.1002/jmri.21967; Port M, 2008, BIOMETALS, V21, P469, DOI 10.1007/s10534-008-9135-x; Rogosnitzky M, 2016, BIOMETALS, V29, P365, DOI 10.1007/s10534-016-9931-7; Russell S, 2012, ANAL CHEM, V84, P8106, DOI 10.1021/ac302136e; Sherry AD, 2009, J MAGN RESON IMAGING, V30, P1240, DOI 10.1002/jmri.21966; SPIKE CG, 1953, J AM CHEM SOC, V75, P3770, DOI 10.1021/ja01111a049; SPIKE CG, 1953, J AM CHEM SOC, V75, P2726, DOI 10.1021/ja01107a053; STAKS T, 1994, INVEST RADIOL, V29, P709, DOI 10.1097/00004424-199407000-00008; VARADARAJAN JA, 1994, INVEST RADIOL, V29, pS18, DOI 10.1097/00004424-199406001-00007; Wang P, 2013, CHEM-ASIAN J, V8, P2943, DOI 10.1002/asia.201300838	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214910	10.1371/journal.pone.0214910	http://dx.doi.org/10.1371/journal.pone.0214910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947239	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500083
J	Braye, K; Foureur, M; de Waal, K; Jones, M; Putt, E; Ferguson, J				Braye, Kathryn; Foureur, Maralyn; de Waal, Koert; Jones, Mark; Putt, Elise; Ferguson, John			Group B streptococcal screening, intrapartum antibiotic prophylaxis, and neonatal early-onset infection rates in an Australian local health district: 2006-2016	PLOS ONE			English	Article							MATERNAL COLONIZATION; UNITED-STATES; DISEASE; PREVENTION; FAILURE; SEPSIS	Background Intrapartum antibiotic prophylaxis (IAP) to reduce the likelihood of neonatal early-onset group B streptococcal infection (EOGBS) has coincided with major reductions in incidence. While the decline has been largely ascribed to IAP following either universal screening or a risk-based approach to identify mothers whose babies may most benefit from IAP, there is lack of high quality evidence to support this view. Aims To describe management of maternal GBS colonisation in one local health district using universal screening and assess rates of EOGBS over time. Methods A retrospective cohort study was undertaken to describe compliance with GBS management, to determine the incidence of EOGBS and association between rates and maternal screening. Linking routinely collected maternity and pathology data, we explored temporal trends using logistic regression and covariates for potential effect modifiers. Results Our cohort included 62,281 women who had 92,055 pregnancies resulting in 93,584 live born babies. Screening occurred in 76% of pregnancies; 69% had a result recorded, 21.5% of those were positive for GBS. Prophylaxis was used by 79% of this group. Eighteen babies developed EOGBS, estimated incidence/1000 live births in 2006 and 2016 was 0.35 (95% CI, 0.07 to 0.63) and 0.1 (95% CI, 0 to 0.2) respectively. Seven of 10 term babies with EOGBS were born to mothers who screened negative. Data were unable to provide evidence of difference in rates of EOGBS between screened and unscreened pregnancies. We estimated the difference in EOGBS incidence from crude and weighted models to be 0 (95% CI, -0. 2 to 0.17) and -0.01 (95% CI, -0.13 to 0.10) /1000 live births respectively. Conclusion No change was detected in rates of EOGBS over time and no difference in EOGBS in babies of screened and unscreened populations. Screening and prophylaxis rates were modest. Limitations of universal screening suggest alternatives be considered.	[Braye, Kathryn; Foureur, Maralyn] Univ Technol, Fac Hlth, Sydney, NSW, Australia; [Braye, Kathryn; Foureur, Maralyn; Putt, Elise; Ferguson, John] Hunter New England Hlth, Newcastle, NSW, Australia; [Foureur, Maralyn] Univ Newcastle, Sch Nursing & Midwifery, Newcastle, NSW, Australia; [de Waal, Koert] John Hunter Hosp, Dept Neonatol, Newcastle, NSW, Australia; [de Waal, Koert; Ferguson, John] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW, Australia; [Jones, Mark] Hunter Med Res Inst, Newcastle, NSW, Australia; [Ferguson, John] New South Wales Hlth Pathol, Newcastle, NSW, Australia	University of Technology Sydney; University of Newcastle; John Hunter Hospital; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Braye, K (corresponding author), Univ Technol, Fac Hlth, Sydney, NSW, Australia.; Braye, K (corresponding author), Hunter New England Hlth, Newcastle, NSW, Australia.	Kathryn.t.braye@student.uts.edu.au	Ferguson, John/AAA-7419-2022; Foureur, Maralyn/ABC-2997-2021; foureur, maralyn/I-9672-2014	Braye, Kathryn/0000-0002-0309-2778; foureur, maralyn/0000-0002-0454-0165; jones, mark/0000-0003-1736-1702				Angstetra D, 2007, AUST NZ J OBSTET GYN, V47, P378, DOI 10.1111/j.1479-828X.2007.00760.x; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 2016, MAT GROUP B STREPT G; Antibiotic expert groups, 2006, THER GUID ANT VERS 1; Antibiotic expert groups, 2010, THER GUID ANT VERS 1; Azad MB, 2016, BJOG-INT J OBSTET GY, V123, P983, DOI 10.1111/1471-0528.13601; Bekker V, 2014, LANCET INFECT DIS, V14, P1083, DOI 10.1016/S1473-3099(14)70919-3; Berardi A, 2017, J MATERN-FETAL NEO M, V30, P1739, DOI 10.1080/14767058.2016.1224832; Berardi A, 2011, J MATERN-FETAL NEO M, V24, P1221, DOI 10.3109/14767058.2011.552652; Braye K, 2018, WOMEN BIRTH, V31, P244, DOI 10.1016/j.wombi.2017.10.012; Butel MJ, 2018, J DEV ORIG HLTH DIS, V9, P590, DOI 10.1017/S2040174418000119; Centers for Disease Control and Prevention, 2010, PREV PER GROUP STREP PREV PER GROUP STREP, V59, P1; Centers for Disease Control and Prevention, 2016, EM INF PROGR NETW GR; Centers for Disease Control and Prevention, 1997, EM INF PROGR NETW GR; Chen JH, 2019, ARTIF INTELL LAW, V27, P73, DOI 10.1007/s10506-018-9229-x; Darlow B., 2013, PAEDIAT CHILD HLTH, V24; Darlow BA, 2016, AUST NZ J OBSTET GYN, V56, P69, DOI 10.1111/ajo.12378; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Fairlie T, 2013, OBSTET GYNECOL, V121, P570, DOI 10.1097/AOG.0b013e318280d4f6; Garland S, 1991, AUST NZ J OBSTET GYN, V31, P110; Gilbert GL, 2002, AUST NZ J OBSTET GYN, V42, P497, DOI 10.1111/j.0004-8666.2002.00497.x; Grimwood K, 2002, J PAEDIATR CHILD H, V38, P272, DOI 10.1046/j.1440-1754.2002.00783.x; Heath PT, 2007, BEST PRACT RES CL OB, V21, P411, DOI 10.1016/j.bpobgyn.2007.01.003; Kurz Ella, 2015, JBI Database System Rev Implement Rep, V13, P206, DOI 10.11124/jbisrir-2015-1876; Kwatra G, 2016, LANCET INFECT DIS, V16, P1076, DOI 10.1016/S1473-3099(16)30055-X; Lin FYC, 2011, PEDIATR INFECT DIS J, V30, P759, DOI 10.1097/INF.0b013e31821dc76f; Miller JE, 2018, INT J EPIDEMIOL, V47, P561, DOI 10.1093/ije/dyx272; National Institute for Health and Care Excellence, 2014, REC RISK FACT INF PR; Neuman H, 2018, FEMS MICROBIOL REV, V42, P489, DOI 10.1093/femsre/fuy018; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ortqvist A, 2019, GUT, V68; Queensland Government department of health, 2015, QUEENSL CLIN GUID EA; Russell NJ, 2017, CLIN INFECT DIS, V65, pS100, DOI 10.1093/cid/cix658; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Schrag SJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2013; Seale AC, 2017, CLIN INFECT DIS, V65, pS125, DOI 10.1093/cid/cix585; Seedat F, 2016, UNIVERSAL ANTENATAL; Seedat F, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l463; Sheehy A, 2013, WOMEN BIRTH, V26, P152, DOI 10.1016/j.wombi.2012.10.004; The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), 2016, MAT GROUP BB STREPT, V19; UK National Screening Committee, 2012, SCREEN GROUP B STREP; Van Dyke MK, 2009, NEW ENGL J MED, V360, P2626, DOI 10.1056/NEJMoa0806820; Verani JR, 2014, OBSTET GYNECOL, V123, P828, DOI 10.1097/AOG.0000000000000163; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Vergnano S, 2010, ARCH DIS CHILD-FETAL, V95, pF72, DOI 10.1136/adc.2009.160333; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2	46	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214295	10.1371/journal.pone.0214295	http://dx.doi.org/10.1371/journal.pone.0214295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946761	Green Published, gold			2022-12-27	WOS:000463314500024
J	Marzorati, C; Monzani, D; Mazzocco, K; Pavan, F; Cozzi, G; De Cobelli, O; Monturano, M; Pravettoni, G				Marzorati, Chiara; Monzani, Dario; Mazzocco, Ketti; Pavan, Francesca; Cozzi, Gabriele; De Cobelli, Ottavio; Monturano, Massimo; Pravettoni, Gabriella			Predicting trajectories of recovery in prostate cancer patients undergone Robot-Assisted Radical Prostatectomy (RARP)	PLOS ONE			English	Article							QUALITY-OF-LIFE; PERSONALIZED MEDICINE; TERM; SURVIVORSHIP; MANAGEMENT; SURGERY; CARE; AGE	Objective To identify trends of patients' urinary and sexual dysfunctions from a clinical and psychological perspective and understand whether sociodemographic and medical predictors could differentiate among patients following different one-year longitudinal trajectories. Methods An Italian sample of 478 prostate cancer patients undergone Robot-Assisted Radical Prostatectomy completed the EPIC-26 survey between July 2015 and July 2016 at the pre-hospitalization (TO), 45 days (T1) and 3 (T2), 6 (T3), 9 (T4), and 12 months (T5) after surgery. Sociodemographic and clinical characteristics (age, BMI, diabetes, nerve-sparing procedure) were also collected. Latent Class Growth Analysis was conducted separately for sexual dysfunction and urinary incontinence EPIC-26 subscales. The association between membership in the two longitudinal trajectories of urinary and sexual dysfunctions was assessed by considering Chi-square test and its related contingency table. Results People who have a high level of urinary incontinence at T1 are likely to have a worse recovery. Age, BMI and pre-surgical continence may affect the level of incontinence at T1 and the recovery trajectories. Patients with low and moderate sexual problems at T1 can face a moderate linear recovery, while people with high level of impotence immediately after surgery may take a longer period to solve sexual dysfunctions. Age and the pre-surgical sexual condition may impact the recovery. Finally, a great proportion of patients reported both steady problems in sexual function and constant high levels of urinary incontinence over time. Conclusions This study highlights different categories of patients at risk who may be important to know in order to develop personalized medical pathways and predictive models in a value-based healthcare.	[Marzorati, Chiara; Monzani, Dario; Mazzocco, Ketti; De Cobelli, Ottavio; Pravettoni, Gabriella] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Marzorati, Chiara; Mazzocco, Ketti; Pravettoni, Gabriella] IRCCS, European Inst Oncol, Appl Res Div Cognit & Psychol Sci, Milan, Italy; [Pavan, Francesca; Monturano, Massimo] IRCCS, European Inst Oncol, Patient Safety & Risk Management Serv, Milan, Italy; [Cozzi, Gabriele; De Cobelli, Ottavio] IRCCS, European Inst Oncol, Div Urol, Milan, Italy	University of Milan; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO)	Marzorati, C (corresponding author), Univ Milan, Dept Oncol & Hematooncol, Milan, Italy.; Marzorati, C (corresponding author), IRCCS, European Inst Oncol, Appl Res Div Cognit & Psychol Sci, Milan, Italy.	chiara.marzorati@ieo.it	Pravettoni, Gabriella/C-6915-2011; Cozzi, Gabriele/AAG-7532-2021; Mazzocco, Ketti/AAP-4509-2020; marzorati, chiara/AAA-9400-2019; Cozzi, Gabriele/ABI-8232-2020; Monzani, Dario/AAP-4501-2020; Pravettoni, Gabriella/AAC-3500-2022; Monzani, Dario/AAR-2609-2021; DE COBELLI, OTTAVIO/O-2315-2017	Pravettoni, Gabriella/0000-0002-4843-4663; Cozzi, Gabriele/0000-0001-6386-7013; Mazzocco, Ketti/0000-0003-1382-6779; Marzorati, Chiara/0000-0001-7761-2804; DE COBELLI, OTTAVIO/0000-0002-0699-8620				Alenizi AM, 2016, CAN J UROL, V23, P8451; [Anonymous], 2012, GLOBOCAN 2012; Bogat GA, 2005, AM J COMMUN PSYCHOL, V36, P49, DOI 10.1007/s10464-005-6232-7; Chambers SK, 2017, PSYCHO-ONCOLOGY, V26, P1576, DOI 10.1002/pon.4342; Chartier-Kastler E, 2008, J SEX MED, V5, P693, DOI 10.1111/j.1743-6109.2007.00743.x; Cutica I, 2014, EUR J INTERN MED, V25, P685, DOI 10.1016/j.ejim.2014.07.002; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; De Sousa A, 2012, PROSTATE CANCER P D, V15, P120, DOI 10.1038/pcan.2011.66; Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630; Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0; Deveci S, 2015, SURVEY PATIENT EXPEC, DOI [10.1111/bju.13398, DOI 10.1111/BJU.13398]; Diallo TMO, 2016, STRUCT EQU MODELING, V23, P507, DOI 10.1080/10705511.2016.1169188; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Downie AS, 2016, PAIN, V157, P225, DOI 10.1097/j.pain.0000000000000351; Dunn LB, 2011, HEALTH PSYCHOL, V30, P683, DOI 10.1037/a0024366; Eisemann N, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0025-6; Garre-Olmo J, 2010, J ALZHEIMERS DIS, V22, P1169, DOI 10.3233/JAD-2010-101215; Goonewardene SS, 2015, TRANSL ANDROL UROL, V4, P413, DOI 10.3978/j.issn.2223-4683.2015.08.04; Gorini A, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.659; Grabbert M, 2018, NEUROUROL URODYNAM, V37, P2263, DOI 10.1002/nau.23557; Hamoen EHJ, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2013.10.005; HAXBY JV, 1992, J CLIN EXP NEUROPSYC, V14, P575, DOI 10.1080/01688639208402846; Heijnsdijk EAM, 2018, INT J CANCER, V142, P741, DOI 10.1002/ijc.31102; Hsiao Chao-Pin, 2007, Cancer Nurs, V30, pE19; Jung T, 2007, INTRO LATENT CLASS G, DOI [10.1111/j.1751-9004.2007.00054.x, DOI 10.1111/J.1751-9004.2007.00054.X]; Knisely MR, 2016, WESTERN J NURS RES, V38, P508, DOI 10.1177/0193945915602856; Kondylakis H, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.400; Kondylakis H, 2012, IEEE INT C BIOINF BI, P535, DOI 10.1109/BIBE.2012.6399770; Lavery HJ, 2017, UROL ONCOL-SEMIN ORI, V35, P40, DOI 10.1016/j.urolonc.2016.11.013; Martin AD, 2011, J UROLOGY, V186, P204, DOI 10.1016/j.juro.2011.02.2698; Marzorati C, 2017, HLTH QUAL LIFE UNPUB; Marzorati C, 2017, J MULTIDISCIP HEALTH, V10, P101, DOI 10.2147/JMDH.S122383; Marzorati C, 2017, J CANCER EDUC, V32, P228, DOI 10.1007/s13187-016-0997-2; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Monzani D, 2018, APPL PSYCHOL-HLTH WE, V10, P434, DOI 10.1111/aphw.12141; Pancani L, 2018, INT J BEHAV MED, V25, P399, DOI 10.1007/s12529-018-9731-2; Porter ME, 2012, VALUE BASED HLTH CAR, P1; Porter ME, 2008, ANN SURG, V248, P503, DOI 10.1097/SLA.0b013e31818a43af; Pravettoni G, 2011, J EVAL CLIN PRACT, V17, P594, DOI 10.1111/j.1365-2753.2011.01709.x; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; Rhebergen D, 2012, PSYCHOL MED, V42, P1383, DOI 10.1017/S0033291711002509; Shao IH, 2018, J INT MED RES, V46, P421, DOI 10.1177/0300060517715396; Singh J, 2010, CLIN INTERV AGING, V5, P187; Skolarus TA, 2014, CA-CANCER J CLIN, V64, P226, DOI 10.3322/caac.21234; Steca P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183905; Steca P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161840; Steentjes L, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12589; Strassberg Donald S, 2017, Curr Urol, V11, P16, DOI 10.1159/000447189; Szymanski KM, 2010, UROLOGY, V76, P1245, DOI 10.1016/j.urology.2010.01.027; Teber D, 2010, J UROLOGY, V183, P1087, DOI 10.1016/j.juro.2009.11.033; von Eye A, 2006, J ADOLESCENCE, V29, P981, DOI 10.1016/j.adolescence.2006.06.007; Wang RH, 2019, QUAL LIFE RES, V28, P481, DOI 10.1007/s11136-018-2013-2; Woo SH, 2014, J ENDOUROL, V28, P172, DOI 10.1089/end.2013.0304; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Zelefsky MJ, 2016, RADIOTHER ONCOL, V118, P85, DOI 10.1016/j.radonc.2015.11.035	55	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214682	10.1371/journal.pone.0214682	http://dx.doi.org/10.1371/journal.pone.0214682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30946773	Green Submitted, gold, Green Published			2022-12-27	WOS:000463314500053
J	Pfeiffenberger, M; Bartsch, J; Hoff, P; Ponomarev, I; Barnewitz, D; Thone-Reineke, C; Buttgereit, F; Gaber, T; Lang, A				Pfeiffenberger, Moritz; Bartsch, Janika; Hoff, Paula; Ponomarev, Igor; Barnewitz, Dirk; Thoene-Reineke, Christa; Buttgereit, Frank; Gaber, Timo; Lang, Annemarie			Hypoxia and mesenchymal stromal cells as key drivers of initial fracture healing in an equine in vitro fracture hematoma model	PLOS ONE			English	Article							STEM-CELLS; THOROUGHBRED RACEHORSES; RACING INJURIES; ADIPOSE-TISSUE; MOUSE MODELS; BONE-MARROW; HORSES; VEGF; THERAPY; REPAIR	Fractures in horses-whether simple fractures with just one clean break, or incomplete greenstick with stress fractures, or complications such as shattered bones can all be either minimal or even catastrophic. Thus, improvement in fracture healing is a hallmark in equine orthopedics. The fracture healing process implements a complex sequence of events including the initial inflammatory phase removing damaged tissue, re-establishment of vessels and mesenchymal stromal cells, a soft and hard callus phase closing the fracture gap as well as the remodeling phase shaping the bone to a scar-free tissue. Detailed knowledge on processes in equine fracture healing in general and on the initial phase in particular is apparently very limited. Therefore, we generated equine in vitro fracture hematoma models (FH models) to study time-dependent changes in cell composition and RNA-expression for the most prominent cells in the FH model (immune cells, mesenchymal stromal cells) under conditions most closely adapted to the in vivo situation (hypoxia) by using flow cytometry and qPCR. In order to analyze the impact of mesenchymal stromal cells in greater detail, we also incubated blood clots without the addition of mesenchymal stromal cells under the same conditions as a control. We observed a superior survival capacity of mesenchymal stromal cells over immune cells within our FH model maintained under hypoxia. Further-more, we demonstrate an upregulation of relevant angiogenic, osteogenic and hypoxia-induced markers within 48 h, a time well-known to be crucial for proper fracture healing.	[Pfeiffenberger, Moritz; Bartsch, Janika; Hoff, Paula; Buttgereit, Frank; Gaber, Timo; Lang, Annemarie] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Pfeiffenberger, Moritz; Bartsch, Janika; Hoff, Paula; Buttgereit, Frank; Gaber, Timo; Lang, Annemarie] Free Univ Berlin, Berlin, Germany; [Pfeiffenberger, Moritz; Bartsch, Janika; Hoff, Paula; Buttgereit, Frank; Gaber, Timo; Lang, Annemarie] Humboldt Univ, Berlin, Germany; [Pfeiffenberger, Moritz; Bartsch, Janika; Hoff, Paula; Buttgereit, Frank; Gaber, Timo; Lang, Annemarie] Berlin Inst Hlth, Berlin, Germany; [Pfeiffenberger, Moritz; Hoff, Paula; Buttgereit, Frank; Gaber, Timo; Lang, Annemarie] German Rheumatism Res Ctr DRFZ Berlin, Berlin, Germany; [Ponomarev, Igor; Barnewitz, Dirk] Res Ctr Med Technol & Biotechnol, Bad Langensalza, Germany; [Thoene-Reineke, Christa] Free Univ Berlin, Dept Vet Med, Inst Anim Welf Anim Behav & Lab Anim Sci, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin	Lang, A (corresponding author), Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany.; Lang, A (corresponding author), Free Univ Berlin, Berlin, Germany.; Lang, A (corresponding author), Humboldt Univ, Berlin, Germany.; Lang, A (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Lang, A (corresponding author), German Rheumatism Res Ctr DRFZ Berlin, Berlin, Germany.	annemarie.lang@charite.de		Buttgereit, Frank/0000-0003-2534-550X; Lang, Annemarie/0000-0002-6539-9476	Bundesministerium fur Bildung und Forschung (BMBF) [031A334]; Deutsche Forschungsgemeinschaft (DFG) [353142848]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the Bundesministerium fur Bildung und Forschung (BMBF) (031A334 to FB). Author TG is funded by the Deutsche Forschungsgemeinschaft (DFG) (353142848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer J.A., 2006, EQUINE SURG, P1000; AUER JA, 1987, EQUINE VET J, V19, P103, DOI 10.1111/j.2042-3306.1987.tb02601.x; Auer JA, 2015, VET J, V206, P5, DOI 10.1016/j.tvjl.2015.06.002; Baddela VS, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-118; Barberini DJ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt414; Berendsen AD, 2014, J HISTOCHEM CYTOCHEM, V62, P103, DOI 10.1369/0022155413516347; Chung R, 2006, J LEUKOCYTE BIOL, V80, P1272, DOI 10.1189/jlb.0606365; Cohen JM, 2012, VET COMP ORTHOPAED, V25, P184, DOI 10.3415/VCOT-11-01-0006; De Miguel MP, 2012, CURR MOL MED, V12, P574; De Schauwer C, 2013, EQUINE VET J, V45, P518, DOI 10.1111/evj.12003; De Schauwer C, 2012, CYTOM PART A, V81A, P312, DOI 10.1002/cyto.a.22026; de Silly RV, 2015, EUR J IMMUNOL, V45, P2263, DOI 10.1002/eji.201445284; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; ENNEKING WF, 1975, J BONE JOINT SURG AM, VA 57, P237, DOI 10.2106/00004623-197557020-00018; Faiella W, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1859567; Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641; Govoni KE, 2015, J ANIM SCI, V93, P871, DOI 10.2527/jas.2014-8516; GROGAARD B, 1990, ARCH ORTHOP TRAUM SU, V109, P268, DOI 10.1007/BF00419942; Hoff P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030583; Hoff P, 2013, CELL MOL IMMUNOL, V10, P151, DOI 10.1038/cmi.2012.56; Holstein JH, 2009, J ORTHOP TRAUMA, V23, pS31, DOI 10.1097/BOT.0b013e31819f27e5; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Jacobs CC, 2017, VET SURG, V46, P242, DOI 10.1111/vsu.12607; Janczarek I, 2017, ANIM SCI J, V88, P953, DOI 10.1111/asj.12800; Kawamoto T, 2014, METHODS MOL BIOL, V1130, P149, DOI 10.1007/978-1-62703-989-5_11; Keramaris NC, 2012, CURR STEM CELL RES T, V7, P293; Klenke S, 2016, N-S ARCH PHARMACOL, V389, P1353, DOI 10.1007/s00210-016-1305-8; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Kobayashi T, 2011, OSTEOPOROSIS INT, V22, P1955, DOI 10.1007/s00198-010-1385-0; Kottstorfer J, 2013, INJURY, V44, P930, DOI 10.1016/j.injury.2013.02.028; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Kovach TK, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/752510; Kovtun A, 2016, EUR CELLS MATER, V32, P152, DOI 10.22203/eCM.v032a10; Liu CH, 2005, CYTOKINE, V32, P270, DOI 10.1016/j.cyto.2005.11.003; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Maeda Yousuke, 2016, Journal of Equine Science, V27, P81, DOI 10.1294/jes.27.81; Maia L, 2013, MICROSC RES TECHNIQ, V76, P618, DOI 10.1002/jemt.22208; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Martini L, 2001, COMPARATIVE MED, V51, P292; McDuffee LA, 2012, VET SURG, V41, P773, DOI 10.1111/j.1532-950X.2012.01024.x; Mejdell CM, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-68; Murphey ED, 2000, J AM VET MED ASSOC, V216, P1949, DOI 10.2460/javma.2000.216.1949; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Ochman S, 2011, J ORTHOP RES, V29, P1093, DOI 10.1002/jor.21340; Onodera S, 2004, HISTOCHEM CELL BIOL, V121, P209, DOI 10.1007/s00418-004-0624-x; Paebst F, 2014, CYTOM PART A, V85A, P678, DOI 10.1002/cyto.a.22491; Pearce AI, 2007, EUR CELLS MATER, V13, P1; PELOSO JG, 1994, J AM VET MED ASSOC, V204, P620; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Radtke CL, 2013, AM J VET RES, V74, P790, DOI 10.2460/ajvr.74.5.790; Ranera B, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-142; Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Rosanowski SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194299; Rosset P, 2014, ORTHOP TRAUMATOL-SUR, V100, pS107, DOI 10.1016/j.otsr.2013.11.010; Schmidt-Bleek K, 2014, J TISSUE ENG REGEN M, V8, P120, DOI 10.1002/term.1505; Schmidt-Bleek K, 2009, J ORTHOP RES, V27, P1147, DOI 10.1002/jor.20901; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; Treonze KM, 2009, VET IMMUNOL IMMUNOP, V130, P79, DOI 10.1016/j.vetimm.2009.01.011; Turek B, 2016, MED WETER, V72, P197; Verheyen KLP, 2004, EQUINE VET J, V36, P167, DOI 10.2746/0425164044868684; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wang CJ, 2011, J SURG RES, V171, P114, DOI 10.1016/j.jss.2010.01.045; Xia WZ, 2015, MOL CELL BIOCHEM, V404, P11, DOI 10.1007/s11010-015-2361-y; Yeo WM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-16	70	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214276	10.1371/journal.pone.0214276	http://dx.doi.org/10.1371/journal.pone.0214276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947253	gold, Green Published, Green Submitted			2022-12-27	WOS:000463314500023
J	Adetunji, AE; Adeniran, KA; Olomu, SC; Odike, AI; Ewah-Odiase, RO; Omoike, IU; Akpede, GO				Adetunji, Adewale Elijah; Adeniran, Kayode Adesoye; Olomu, Sylvia Chinwendu; Odike, Angela Ifeoma; Ewah-Odiase, Rosemary Omonigho; Omoike, Irekpono Ukhueleigbe; Akpede, George Obozokhale			Socio-demographic factors associated with overweight and obesity among primary school children in semi-urban areas of mid-western Nigeria	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; SOCIOECONOMIC-STATUS; NUTRITIONAL-STATUS; BLOOD-PRESSURE; PREVALENCE; ADOLESCENTS; CIRCUMFERENCE; EPIDEMIOLOGY; HYPERTENSION	Background Many developing countries are in a state of nutritional transition from prevalent under-nutrition to the emergent problem of over-nutrition (overweight and obesity), which is associated with increased morbidity and mortality, and whose complications can persist into adulthood with long-term consequences. However, data are limited on the risk factors for overweight and obesity (O&O) among primary school children, particularly those in rural and semiurban areas in these countries. Aim and objectives To determine the socio-demographic factors associated with overweight and obesity among primary school children in semi-urban areas. Subjects and methods 1187 school pupils aged 6-11 years recruited from semi-urban areas using multistage sampling were interviewed for risk factors of overweight and obesity using a structured questionnaire. Nutritional status was assessed using body mass index and this was classified using a standard method. The proportions were compared using Pearson's chi-squared. Multivariate logistic regression analysis was also carried out with overweight and obesity as the dependent variable and socio demographic factors as independent variables. The level of statistical significance was set at p <0.05 in all the statistical analyses. Results Fifty-eight pupils (4.9%) had overweight and obesity while 1129 (95.1%) were either of normal nutritional status (1088, 91.6%) or were thin/severely thin (41, 3.5%). Among those with overweight and obesity, 41 (3.5%) were overweight and 17 (1.4%) obese. A higher prevalence of overweight and obesity was significantly associated (in unadjusted analysis) with female gender [unadjusted Odds Ratio, OR (95% CI) = 2.42 (1.37, 4.28)], attendance at private schools [OR (95% CI) = 3.34 (1.86, 6.00)], higher socio-economic status families [OR (95% CI) = 2.32 (1.65, 5.80)] and presence of a television in the pupil's bedrooms [OR (95% CI) = 2.22 (1.02, 4.82)] on bivariate analyses. However, only gender, school type and family socioeconomic status were independently associated with overweight and obesity on multivariate logistic regression analysis. Conclusion We conclude that overweight and obesity among primary school pupils in semi-urban areas is associated with female gender, attendance at private schools and higher socioeconomic status families. Preventive programmes should accordingly be more directed at children from affluent families; particularly those who are females and those attending private schools.	[Adetunji, Adewale Elijah; Olomu, Sylvia Chinwendu; Odike, Angela Ifeoma; Ewah-Odiase, Rosemary Omonigho; Omoike, Irekpono Ukhueleigbe; Akpede, George Obozokhale] Irrua Specialist Teaching Hosp, Dept Paediat, Irrua, Edo State, Nigeria; [Adeniran, Kayode Adesoye] Fed Med Ctr, Dept Paediat, Asaba, Delta State, Nigeria; [Olomu, Sylvia Chinwendu; Odike, Angela Ifeoma; Ewah-Odiase, Rosemary Omonigho; Akpede, George Obozokhale] Ambrose Alli Univ, Coll Med, Fac Clin Sci, Dept Paediat, Ekpoma, Edo Sate, Nigeria		Adetunji, AE (corresponding author), Irrua Specialist Teaching Hosp, Dept Paediat, Irrua, Edo State, Nigeria.	tunjiwale2007@yahoo.com						Abah S. O., 2012, Journal of Biology, Agriculture and Healthcare, V2, P51; Adebayo A M, 2011, Ann Ib Postgrad Med, V9, P14; Adegoke S A, 2009, West Afr J Med, V28, P216; Adegoke SA, 2009, NIGERIAN ENDOCRINE P, V2, P35; Alhaji, 2015, SAUDI J OBESITY, V3, P59, DOI DOI 10.4103/2347-2618.171959; Ansa V O, 2010, West Afr J Med, V29, P146; Aounallah-Skhiri H, 2008, PUBLIC HEALTH NUTR, V11, P1306, DOI 10.1017/S1368980008002693; Armstrong MEG, 2011, EUR J CLIN NUTR, V65, P835, DOI 10.1038/ejcn.2011.46; Ayoola O, 2009, ANN HUM BIOL, V36, P388, DOI 10.1080/03014460902835606; Ben-Bassey UP, 2007, OBES REV, V8, P475, DOI 10.1111/j.1467-789X.2007.00408.x; Chen JL, 2011, J IMMIGR MINOR HEALT, V13, P268, DOI 10.1007/s10903-009-9288-x; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Crispim P. A. A, RISK FACTORS ASS HIG, DOI [10.5935/abc.20130227, DOI 10.5935/ABC.20130227]; Das JC, 2015, MED CLIN REV, V1, P1, DOI [10.21767/2471-299X.1000001, DOI 10.21767/2471-299X.1000001]; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Ebenizer O O, 2011, J PUBLIC HLTH AFRICA, V2, P45; Ejike CE, HYPERBOLIC RELATIONS; Fetuga M B, 2011, West Afr J Med, V30, P331; Gahagan S., 2011, OVERWEIGHT OBESITY N, P179; GEORGE AB, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI DOI 10.1210/JC.2004-0535; Goran MI, 2001, AM J CLIN NUTR, V73, P158; Han TS, 2006, BMJ-BRIT MED J, V333, P695, DOI 10.1136/bmj.333.7570.695; Hassink S. G, 2009, AM ACAD PEDIAT TXB P; Intiful F. D., 2013, Journal of Biology, Agriculture and Healthcare, V3, P156; Jafar TH, 2008, ARCH DIS CHILD, V93, P373, DOI 10.1136/adc.2007.125641; Janjua NZ, 2012, J OBES, V2012, DOI 10.1155/2012/457173; Kapoor SK, 2002, J EPIDEMIOL COMMUN H, V56, P804, DOI 10.1136/jech.56.11.804; Landry GL, 2007, NELSON TXB PAEDIAT, P18; Longo-Mbenza B, 2007, INT J CARDIOL, V121, P171, DOI 10.1016/j.ijcard.2006.11.004; Lopes HS, 2011, THESIS; Mohammed H, 2012, Ghana Med J, V46, P124; Moselakgomo Violet Kankane, 2012, Rev. paul. pediatr., V30, P562; Musa DI, 2012, TROP MED INT HEALTH, V17, P1369, DOI 10.1111/j.1365-3156.2012.03083.x; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olamoyegun MA, 2016, CARDIOVASC J AFR, V27, P356, DOI 10.5830/CVJA-2016-037; Onokerhoraye AG, 1986, URBAN SYSTEMS PLANNI, P2; Owa JA, 1997, J TROP PEDIATRICS, V43, P13, DOI 10.1093/tropej/43.1.13; OYEDEJI G A, 1985, Nigerian Journal of Paediatrics, V12, P111; Rao G, 2008, AM FAM PHYSICIAN, V78, P56; Robinson TN, 2001, PEDIATR CLIN N AM, V48, P1017, DOI 10.1016/S0031-3955(05)70354-0; Senbanjo IO, 2010, WORLD J PEDIATR, V6, P217, DOI 10.1007/s12519-010-0209-9; Senbanjo IO, 2009, ANN NUTR METAB, V54, P145, DOI 10.1159/000214833; Sidik Sherina Mohd, 2004, Malays J Nutr, V10, P13; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sobal J, 2001, INT J EPIDEMIOL, V30, P1136, DOI 10.1093/ije/30.5.1136; Sorof JM, 2004, PEDIATRICS, V113, P475, DOI 10.1542/peds.113.3.475; Strasburger V. C, 2009, AM ACAD PEDIAT TXB P; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Sweeting HN, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-1; Wamba PCF, 2013, J OBES, V2013, DOI 10.1155/2013/737592; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wang Z.G., 2004, THESIS NE FORESTRY U	52	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214570	10.1371/journal.pone.0214570	http://dx.doi.org/10.1371/journal.pone.0214570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943233	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300047
J	Francis, D; Chanana, B; Fernandez, B; Gordon, B; Mak, T; Palacios, IM				Francis, Deepthy; Chanana, Bhavna; Fernandez, Beatriz; Gordon, Benjamin; Mak, Tiffany; Palacios, Isabel M.			YAP/Yorkie in the germline modulates the age-related decline of germline stem cells and niche cells	PLOS ONE			English	Article							SELF-RENEWAL; DROSOPHILA TESTIS; TUMOR-SUPPRESSOR; HIPPO PATHWAY; PROLIFERATION; TRANSCRIPTION; DOWNSTREAM; CONTRIBUTE; DIVISION; SALVADOR	The properties and behaviour of stem cells rely heavily on signaling from the local microenvironment. At the apical end of Drosophila testis, self-renewal and differentiation of germline stem cells (GSCs) are tightly controlled by distinct somatic cells that comprise a specialised stem cell niche known as the hub. The hub maintains GSC homeostasis through adhesion and cell signaling. The Salvador/Warts/Hippo (SWH) pathway, which suppresses the transcriptional co-activator YAP/Yki via a kinase cascade, is a known regulator of stem cell proliferation and differentiation. Here, we show that increasing YAP/Yki expression in the germline, as well as reducing Warts levels, blocks the decrease of GSC numbers observed in aging flies, with only a small increase on their proliferation. An increased expression of YAP/Yki in the germline or a reduction in Warts levels also stymies an age-related reduction in hub cell number, suggesting a bilateral relationship between GSCs and the hub. Conversely, RNAi-based knockdown of YAP/Yki in the germline leads to a significant drop in hub cell number, further suggesting the existence of such a SC-to-niche relationship. All together, our data implicate the SWH pathway in Drosophila GSC maintenance and raise questions about its role in stem cell homeostasis in aging organisms.	[Francis, Deepthy; Chanana, Bhavna; Gordon, Benjamin; Mak, Tiffany; Palacios, Isabel M.] Univ Cambridge, Cambridge, England; [Fernandez, Beatriz; Palacios, Isabel M.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London, England; [Francis, Deepthy] Cambridge Univ Hosp, IBD BioResource, Cambridge, England; [Chanana, Bhavna] ClearView Healthcare Partners, New York, NY USA; [Gordon, Benjamin] Univ Illinois, Med Scientist Training Program, Chicago, IL USA; [Mak, Tiffany] Francis Crick Inst, London, England	University of Cambridge; University of London; Queen Mary University London; University of Cambridge; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Francis Crick Institute	Palacios, IM (corresponding author), Univ Cambridge, Cambridge, England.; Palacios, IM (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London, England.	i.palacios@qmul.ac.uk	Palacios, Isabel/X-4807-2019	Fernandez, Beatriz F/0000-0002-8612-0251; Palacios, Isabel M/0000-0002-3450-7884; Gordon, Benjamin/0000-0002-3856-0500; Mak, Tiffany/0000-0001-6134-4999	Wellcome Trust [087899]; Biotechnology and Biological Sciences Research Council [BB/L001748/1]; EMBO; Isaac Newton Trust [11.35(af)]; School of Biological and Chemical Sciences (Queen Mary University of London); Meinig Family Cornell National Scholarship; Department of Zoology; University of Cambridge; BBSRC [BB/L001748/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO(European Molecular Biology Organization (EMBO)); Isaac Newton Trust; School of Biological and Chemical Sciences (Queen Mary University of London)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Meinig Family Cornell National Scholarship; Department of Zoology; University of Cambridge(University of Cambridge); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DF and IMP was supported by the Wellcome Trust (087899), and Biotechnology and Biological Sciences Research Council (BB/L001748/1); BC by EMBO, The Isaac Newton Trust (11.35(af)) (Trinity College, University of Cambridge) and the Wellcome Trust (087899); BF by the School of Biological and Chemical Sciences (Queen Mary University of London); BG by the Meinig Family Cornell National Scholarship; IMP by the School of Biological and Chemical Sciences (Queen Mary University of London), Biotechnology and Biological Sciences Research Council (BB/L001748/1), and the Department of Zoology and University of Cambridge.	Amoyel M, 2014, EMBO J, V33, P2295, DOI 10.15252/embj.201387500; Amoyel M, 2013, DEVELOPMENT, V140, P56, DOI 10.1242/dev.086413; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Bonfini A, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0059-8; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Ding R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10510; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Greenspan LJ, 2015, ANNU REV CELL DEV BI, V31, P291, DOI 10.1146/annurev-cellbio-100913-013344; Herrera SC, 2018, ELIFE, V7, DOI 10.7554/eLife.36095; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lee JY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006043; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Michel M, 2012, DEVELOPMENT, V139, P2663, DOI 10.1242/dev.075242; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Resende LPF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068026; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; Sarikaya DP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004962; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Sun SG, 2008, DEV DYNAM, V237, P270, DOI 10.1002/dvdy.21411; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; White-Cooper Helen, 2012, Spermatogenesis, V2, P11; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang XF, 2006, BIOL REPROD, V74, P119, DOI 10.1095/biolreprod.105.045591; Zhao SW, 2013, DEV BIOL, V376, P163, DOI 10.1016/j.ydbio.2013.01.023	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213327	10.1371/journal.pone.0213327	http://dx.doi.org/10.1371/journal.pone.0213327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943201	gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300012
J	Radeloff, D; Stoeber, F; Lempp, T; Kettner, M; Bennefeld-Kersten, K				Radeloff, Daniel; Stoeber, Franziska; Lempp, Thomas; Kettner, Mattias; Bennefeld-Kersten, Katharina			Murderers or thieves at risk? Offence-related suicide rates in adolescent and adult prison populations	PLOS ONE			English	Article							ENGLAND; WALES; DELINQUENCY; BEHAVIORS; COHORT	Purpose Prisoners have a higher risk of suicide compared to non-incarcerated individuals. One aim of suicide prevention for prisoners is to identify risk factors in order to put stronger support mechanisms in place for the more vulnerable detainees. This study investigates the suicide risk (SR) in offence-related sub-populations in a representative German sample and differentiates between SR for adolescent and adult prisoners. Methods Conducting a national study with data from public German records on the entire prison population from 2000 to 2016 and suicide numbers in German prisons in the same period, SR was calculated for the total male prison population as well as for both subgroups, adolescent and adult male prisoners. Results In the study period, male prisoners spent 959.584 life years (LY) in German criminal detention. Among those, 524 prisoners died of suicide. SR was higher for detainees imprisoned for an offence resulting in extensive physical harm for another person, e.g. homicide (suicide rate = 134,8 suicides per 100.000 LY; OR = 2,47; CI95%: 1,98-3,08), bodily injury (suicide rate = 87,3; OR = 1,60; CI95%: 1,29-1,99), and sexual offences (suicide rate = 84,2; OR = 1,54; CI95%: 1,18-2,01) compared with the SR of the total prison population (suicide rate = 54.6). Age differences between offence-related SR were found for theft, with adolescents (suicide rate = 69,3; OR = 1,25; CI95%: 0,85-1,84) showing higher SR than adults (suicide rate = 38,2; OR = 0,7; CI95%: 0,54-0,92). Conclusion The index offence of detainees is associated with SR and age-related differences exist. Suicide prevention in prisons should take both into account to determine populations at risk.	[Radeloff, Daniel; Stoeber, Franziska] Univ Hosp Leipzig, Dept Child & Adolescent Psychiat Psychotherapy &, Leipzig, Germany; [Lempp, Thomas] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany; [Kettner, Mattias] Goethe Univ Frankfurt, Inst Forens Med, Frankfurt, Germany; [Bennefeld-Kersten, Katharina] Inst Suicide Res, Restorf Hoebeck, Germany	Leipzig University; Goethe University Frankfurt; Goethe University Frankfurt	Radeloff, D (corresponding author), Univ Hosp Leipzig, Dept Child & Adolescent Psychiat Psychotherapy &, Leipzig, Germany.	daniel.radeloff@medizin.uni-leipzig.de	Radeloff, Daniel/I-8354-2015	Radeloff, Daniel/0000-0002-8430-8306	German Federal Ministry of Health [BVA/ZMVI-2517FSB134-IRIS-J]	German Federal Ministry of Health	DR recieved funding by the German Federal Ministry of Health (Grant Number: BVA/ZMVI-2517FSB134-IRIS-J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Bjorkenstam E, 2011, INT J EPIDEMIOL, V40, P1585, DOI 10.1093/ije/dyr127; Cipriani C., 2009, CHILDRENS RIGHTS MIN; Dever G. E. A., 1984, EPIDEMIOLOGY HLTH SE; Duthe G, 2013, FORENSIC SCI INT, V233, P273, DOI 10.1016/j.forsciint.2013.09.014; Evans E, 2004, CLIN PSYCHOL REV, V24, P957, DOI 10.1016/j.cpr.2004.04.005; Fazel S, 2005, LANCET, V366, P1301, DOI 10.1016/S0140-6736(05)67325-4; Fazel S, 2008, J CLIN PSYCHIAT, V69, P1721, DOI 10.4088/JCP.v69n1107; Fazel S, 2009, BRIT J PSYCHIAT, V194, P183, DOI 10.1192/bjp.bp.107.046490; Fruehwald S, 2004, BRIT J PSYCHIAT, V185, P494, DOI 10.1192/bjp.185.6.494; Gallagher CA, 2006, SUICIDE LIFE-THREAT, V36, P363, DOI 10.1521/suli.2006.36.3.363; Haglund A, 2014, J CLIN PSYCHIAT, V75, P1047, DOI 10.4088/JCP.13m08967; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Hayes LM, 2012, J CORRECT HEALTH CAR, V18, P233, DOI 10.1177/1078345812445457; Humber N, 2011, PSYCHOL MED, V41, P2275, DOI 10.1017/S0033291711000705; Humber N, 2013, SOC PSYCH PSYCH EPID, V48, P1177, DOI 10.1007/s00127-012-0632-4; IBM Corp, 2015, REL 2015 IBM SPSS ST; Joiner T, 2007, WHY PEOPLE DIE SUICI, DOI DOI 10.2307/J.CTVJGHV2F; King C, 2015, BRIT J PSYCHIAT, V207, P175, DOI 10.1192/bjp.bp.114.154831; Kleiman EM, 2014, COMPR PSYCHIAT, V55, P431, DOI 10.1016/j.comppsych.2013.10.015; MEMORY JM, 1989, DEATH STUD, V13, P455, DOI 10.1080/07481188908252324; Opitz-Welke A, 2013, INT J LAW PSYCHIAT, V36, P386, DOI 10.1016/j.ijlp.2013.06.018; Pompili M, 2016, PSYCHOL MED, V46, P2239, DOI 10.1017/S0033291716000696; Preti A, 2006, MED SCI LAW, V46, P127, DOI 10.1258/rsmmsl.46.2.127; Radeloff D, 2015, EUR CHILD ADOLES PSY, V24, P219, DOI 10.1007/s00787-014-0568-1; Radeloff D, 2016, Z KINDER JUG-PSYCH, V44, P9, DOI 10.1024/1422-4917/a000394; Stenbacka M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-38; TARONE RE, 1985, BIOMETRIKA, V72, P91, DOI 10.1093/biomet/72.1.91; Thompson MP, 2007, J ADOLESCENT HEALTH, V40, P232, DOI 10.1016/j.jadohealth.2006.10.016; Vadini F, 2018, J AFFECT DISORDERS, V225, P273, DOI 10.1016/j.jad.2017.08.030; van Ginneken EFJC, 2017, INT J LAW PSYCHIAT, V50, P76, DOI 10.1016/j.ijlp.2016.05.005; Webb RT, 2013, SOC PSYCH PSYCH EPID, V48, P49, DOI 10.1007/s00127-012-0517-6; Webb RT, 2011, ARCH GEN PSYCHIAT, V68, P591, DOI 10.1001/archgenpsychiatry.2011.7; World Health Organization, 2014, PREV SUIC PREV SUIC; World Health Organization (WHO), 2007, PREV SUIC JAILS PRIS	35	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214936	10.1371/journal.pone.0214936	http://dx.doi.org/10.1371/journal.pone.0214936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943261	gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300073
J	Vupputuri, S; Rubenstein, KB; Derus, AJ; Loftus, BC; Horberg, MA				Vupputuri, Suma; Rubenstein, Kevin B.; Derus, Alphonse J.; Loftus, Bernadette C.; Horberg, Michael A.			Factors contributing to racial disparities in influenza vaccinations	PLOS ONE			English	Article							ETHNIC DISPARITIES; SEASONAL INFLUENZA; UNITED-STATES; POPULATIONS; VACCINES; COVERAGE	Background Racial/ethnic disparities in rates of influenza vaccinations in the US remain an issue even among those with access, no out-of-pocket costs, and after adjusting for confounders. We used an approach called the Oaxaca-Blinder (OB) decomposition method to ascertain the contribution of covariates individually and in aggregate to the racial disparity in influenza vaccination. Methods We included members > = 18 years of age as of 05/01/2014 with continuous enrollment through 04/30/2015. Influenza vaccination was defined by diagnosis, procedure, or medication codes, or documentation in the immunization table. Characteristics were reported by race. Logistic regression models estimated the odds of vaccination associated with: (1) race; and (2) covariates stratified by race. The Oaxaca-Blinder (OB) method calculated the contribution of covariates to the difference or disparity in vaccination between Blacks and Whites. Results We found that among adults, 44% were vaccinated; 55% were Black; and 45% were White. Black members have 42% lower odds of vaccination than White members. The contribution of the differences in the average value of the study covariates between Black and White members (the OB covariate effect) accounted for 29% of the racial disparity. The contributions to the total White-Black disparity in vaccination included: age (16%), neighborhood median income (11%), and registration on the online patient portal (13%). The contribution of the differences in how the covariates impact vaccination (OB coefficient effect) accounted for 71% of the disparity in vaccination between Blacks and Whites. Conclusion In conclusion, equalizing average covariate values in Blacks and Whites could reduce the racial disparity in influenza vaccination by 29%. For health system vaccine campaigns, improving registration on the patient portal may be a target component of an effective system-level strategy to reduce racial disparities in vaccination. Additional information on patient-centered factors could further improve the value of the OB approach.	[Vupputuri, Suma; Rubenstein, Kevin B.; Derus, Alphonse J.; Horberg, Michael A.] Kaiser Permanente Midatlantic States, Midatlantic Permanente Med Grp, Midatlantic Permanente Res Inst, Rockville, MD 20852 USA; [Loftus, Bernadette C.] Kaiser Permanente Midatlantic States, Midatlantic Permanente Med Grp, Rockville, MD USA	Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente; Permanente Medical Groups	Vupputuri, S (corresponding author), Kaiser Permanente Midatlantic States, Midatlantic Permanente Med Grp, Midatlantic Permanente Res Inst, Rockville, MD 20852 USA.	suma.vupputuri@kp.org		Rubenstein, Kevin/0000-0003-3516-5932; Vupputuri, Suma/0000-0001-6848-2649				BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHERNOFF H, 1954, ANN MATH STAT, V25, P579, DOI 10.1214/aoms/1177728726; Cullen KA, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6502a1; Derrick B, 2016, QUANT METH PSYCHOL, V12, P30, DOI 10.20982/tqmp.12.1.p030; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Fiscella K, 2005, HEALTH SERV RES, V40, P539, DOI 10.1111/j.1475-6773.2005.0w372.x; Gasparini R, 2016, J Prev Med Hyg, V57, pE1; Jann B, 2008, STATA J, V8, P453, DOI 10.1177/1536867X0800800401; Link MW, 2006, AM J EPIDEMIOL, V163, P571, DOI 10.1093/aje/kwj086; Lu PJ, 2015, VACCINE, V33, pD83, DOI 10.1016/j.vaccine.2015.09.031; Marin MG, 2002, PREV MED, V34, P235, DOI 10.1006/pmed.2001.0983; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Santibanez T. A. e. a., 2015, FLU VACCINATION COVE; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Wang JL, 2014, RES SOC ADMIN PHARM, V10, P126, DOI 10.1016/j.sapharm.2013.04.011; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yoo BK, 2015, VACCINE, V33, P2997, DOI 10.1016/j.vaccine.2015.03.054; Yun MS, 2004, ECON LETT, V82, P275, DOI 10.1016/j.econlet.2003.09.008	22	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213972	10.1371/journal.pone.0213972	http://dx.doi.org/10.1371/journal.pone.0213972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943242	Green Submitted, gold, Green Published			2022-12-27	WOS:000463194300025
J	Klopfstein, S; Spasojevic, T				Klopfstein, Seraina; Spasojevic, Tamara			Illustrating phylogenetic placement of fossils using RoguePlots: An example from ichneumonid parasitoid wasps (Hymenoptera, Ichneumonidae) and an extensive morphological matrix	PLOS ONE			English	Article							LIKELIHOOD-ESTIMATION; EVOLUTIONARY TREES; DNA-SEQUENCES; CHARACTER; EOCENE; RADIATION; INFERENCE; CLOCKS; ORIGIN; IMPACT	The fossil record constitutes the primary source of information about the evolutionary history of extant and extinct groups, and many analyses of macroevolution rely on fossils that are accurately placed within phylogenies. To avoid misinterpretation of the fossil record, especially by non-palaeontologists, the proper assessment and communication of uncertainty in fossil placement is crucial. We here use Bayesian morphological phylogenetics to evaluate the classifications of fossil parasitoid wasps (Hymenoptera, lchneumonidae) and introduce `RoguePlots' to illustrate placement uncertainty on the phylogeny of extant taxa. Based on an extensive, newly constructed morphological matrix of 222 characters in 24 fossil and 103 extant taxa, we test three different aspects of models of morphological evolution. We find that a model that includes ordered characters, among-character rate variation, and a state space restricted to observed states achieves the highest marginal likelihoods. The individual RoguePlots reveal large differences in confidence in the placement of the different fossils and allow some refinements to their classification: Polyhelictes bipolarus and Ichninsum appendicrassum are moved from an uncertain subfamily placement to Pimplinae, Plectiscidea lanhami is transferred to Allomacrus in Cylloceriinae (Allomacrus lanhami, comb. nov.), Lithotorus cressoni is moved from Diplazontinae to Orthocentrinae, and we note uncertainty in the generic placements of Rhyssella? vera and Xanthopimpla? messelensis. We discuss potential artefacts that might result in biased posterior probabilities in Bayesian morphological phylogenetic analyses, pertaining to character and taxon sampling, fossilization biases, and model misspecification. Finally, we suggest future directions both in ichneumonid palaeontology and in the way RoguePlots can improve both assessment and representation of placement uncertainty, both in fossils and other rogue taxa.	[Klopfstein, Seraina] Nat Hist Museum Basel, Biowissensch, Basel, Switzerland; [Klopfstein, Seraina; Spasojevic, Tamara] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Klopfstein, Seraina; Spasojevic, Tamara] Nat Hist Museum Basel, Dept Invertebrates, Bern, Switzerland	University of Bern	Klopfstein, S (corresponding author), Nat Hist Museum Basel, Biowissensch, Basel, Switzerland.; Klopfstein, S (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.; Klopfstein, S (corresponding author), Nat Hist Museum Basel, Dept Invertebrates, Bern, Switzerland.	seraina.klopfstein@bs.ch		Klopfstein, Seraina/0000-0002-4025-975X; Spasojevic, Tamara/0000-0001-5301-5722	Swiss National Science Foundation [PZ00P3_154791]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (grant PZ00P3_154791 to SK) (www.snf.ch).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Alekseyenko AV, 2008, SYST BIOL, V57, P772, DOI 10.1080/10635150802434394; Antropov AV, 2014, EARTH ENV SCI T R SO, V104, P335, DOI 10.1017/S1755691014000103; Bapst DW, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0237; Beck RMD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1278; Bennett A.M.R., 2015, MEMOIRS AM ENTOMOLOG, V86, P1; Brues Charles T., 1910, Bulletin of the Museum of Comparative Zoology at Harvard College, V54; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Close RA, 2015, CURR BIOL, V25, P2137, DOI 10.1016/j.cub.2015.06.047; Cockerell T. D. A., 1921, Proceedings of the United States National Museum, V59, P29; Cockerell T. D. A., 1920, Proceedings of the United States National Museum, V57; Cockerell TDA, 1941, AM J SCI, V239, P354, DOI 10.2475/ajs.239.5.354; Cockerell TDA, 1919, AM J SCI, V47, P376; Cockerell TDA, 1931, AM NAT, V65, P351, DOI 10.1086/280378; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Estes JA, 2005, PALEOBIOLOGY, V31, P591, DOI 10.1666/04059.1; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gauld ID, 2002, ZOOL J LINN SOC-LOND, V136, P421, DOI 10.1046/j.1096-3642.2002.00031.x; GAULD ID, 1982, SYST ENTOMOL, V7, P73, DOI 10.1111/j.1365-3113.1982.tb00127.x; Goloboff PA, 2018, PALAEONTOLOGY, V61, P625, DOI 10.1111/pala.12353; Gorscak E, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1047; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Kay RF, 2015, MOL PHYLOGENET EVOL, V82, P358, DOI 10.1016/j.ympev.2013.12.002; Khalaim Andrey I., 2008, Alavesia, V2, P101; Klopfstein S, 2018, SYSTEMATIC ENTOMOLOG; Klopfstein S, 2015, SYST BIOL, V64, P1089, DOI 10.1093/sysbio/syv052; Kopylov DS, 2018, ZOOTAXA, V4442, P319, DOI 10.11646/zootaxa.4442.2.8; Kopylov DS, 2012, PALEONTOL J+, V46, P383, DOI 10.1134/S0031030112040041; Kopylov DS, 2012, PALEONTOL J+, V46, P66, DOI 10.1134/S0031030112010078; Kopylov D.S., 2010, Paleontologicheskii Zhurnal, V4, P59; Kopylov D.S., 2009, Paleontologicheskii Zhurnal, V1, P76; Kopylov DS, 2010, AFR INVERTEBR, V51, P423, DOI 10.5733/afin.051.0211; Labandeira CC, 2013, ANNU REV EARTH PL SC, V41, P287, DOI 10.1146/annurev-earth-050212-124139; Lee MSY, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0033; Lee MSY, 2015, CURR BIOL, V25, pR922, DOI 10.1016/j.cub.2015.07.009; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Littlewood D. Timothy J., 2003, Geology Today, V19, P136, DOI 10.1046/j.1365-2451.2003.00406.x; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; MATTHEWS S C, 1973, Palaeontology (Oxford), V16, P713; Mitchell A.A, 2013, EDNA FOSSIL INSECT D; O'Reilly JE, 2018, PALAEONTOLOGY, V61, P631, DOI 10.1111/pala.12361; O'Reilly JE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0081; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pham Nhi Thi, 2011, Zootaxa, V3056, P1; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rust Jes, 1998, Palaeontologische Zeitschrift, V72, P41; Sansom RS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02545; Santos BF, 2017, SYST ENTOMOL, V42, P650, DOI 10.1111/syen.12238; Scudder S.H., 1890, REPORT US GEOLOGICAL, V13, P1, DOI [10.5962/bhl.title.44698, DOI 10.5962/BHL.TITLE.44698, 10.5962/bhl.title.2507]; Slater GJ, 2012, EVOLUTION, V66, P3931, DOI 10.1111/j.1558-5646.2012.01723.x; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; Spasojevic T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197477; Spasojevic T, 2018, PALZ, V92, P35, DOI 10.1007/s12542-017-0365-5; THIELE K, 1993, CLADISTICS, V9, P275, DOI 10.1111/j.1096-0031.1993.tb00226.x; Townes H., 1969, Memoirs of the American Entomological Institute, V11, P1; TOWNES H, 1966, P ENTOMOL SOC WASH, V68, P132; Wagner PJ, 1998, PALEOBIOLOGY, V24, P430, DOI 10.1017/S0094837300020091; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Wills MA, 2001, GEOL J, V36, P187, DOI 10.1002/gj.882; Wortley AH, 2006, SYST BIOL, V55, P677, DOI 10.1080/10635150600899798; Wright AM, 2016, SYST BIOL, V65, P602, DOI 10.1093/sysbio/syv122; Wright DF, 2017, J PALEONTOL, V91, P799, DOI 10.1017/jpa.2016.141; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yu D.S.K., 2016, DATABASE FLASH DRIVE	72	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0212942	10.1371/journal.pone.0212942	http://dx.doi.org/10.1371/journal.pone.0212942			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939174	gold, Green Published, Green Submitted			2022-12-27	WOS:000462993900004
J	Lee, YC; Hu, TH; Hung, CH; Lu, SN; Chen, CH; Wang, JH				Lee, Yu-Chi; Hu, Tsung-Hui; Hung, Chao-Hung; Lu, Sheng-Nan; Chen, Chien-Hung; Wang, Jing-Houng			The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; VIRUS-INFECTION; THERAPY; STEATOSIS	Background and aim Transient elastography and fibrosis-4 index (FIB-4) have been proposed to access hepatic fibrosis and steatosis for patients with chronic liver disease. This study was to determine the changes of liver stiffness (LS), controlled attenuation parameter (CAP) value and FIB-4 and their associated factors for chronic hepatitis C (CHC) patients who underwent direct-acting antivirals (DAAs). Patients and methods Consecutive patients with CHC in advanced fibrosis or compensated cirrhosis undergoing paritaprevir/ritonavir/ombitasvir plus dasabuvir therapy and with LS and CAP before and 12 weeks after treatment were enrolled. The demographics, clinical characteristics and treatment outcomes were reviewed. The changes of LS, FIB-4, CAP and their associated factors were analyzed. Results A total of 213 patients (mean age: 63.7 years) with complete recommended treatment were enrolled. All patients achieved sustained virological response at 12 weeks (SVR12) of follow-up. The mean values of LS, CAP and FIB-4 index before treatment were 18.5kPa, 283dB/m and 5.05 respectively. While there was no significant change in CAP, LS and FIB-4 decreased significantly at the time of SVR12 (p<0.001). Compared with follow-up period, LS and FIB-4 decreased rapidly during DDAs. Multivariate analysis showed that higher baseline LS and FIB-4 were associated with greater reductions at the time of SVR12. Conclusion For CHC patients in advanced fibrosis or compensated cirrhosis, DAAs improved LS and FIB-4 index at SVR12. Higher baseline LS and FIB-4 contributed to greater reductions. However, there was no significant change in CAP value.	[Lee, Yu-Chi; Hu, Tsung-Hui; Hung, Chao-Hung; Lu, Sheng-Nan; Chen, Chien-Hung; Wang, Jing-Houng] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Med Kaohsiung, Kaohsiung, Taiwan; [Lee, Yu-Chi; Hu, Tsung-Hui; Hung, Chao-Hung; Lu, Sheng-Nan; Chen, Chien-Hung; Wang, Jing-Houng] Chang Gung Univ, Kaohsiung, Taiwan; [Hung, Chao-Hung; Lu, Sheng-Nan] Chia Yi Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Med, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Wang, JH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Med Kaohsiung, Kaohsiung, Taiwan.; Wang, JH (corresponding author), Chang Gung Univ, Kaohsiung, Taiwan.	wajing@cgmh.org.tw						[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Axley P, 2018, J CLIN TRANSL HEPATO, V6, P79, DOI 10.14218/JCTH.2017.00067; Bachofner JA, 2017, LIVER INT, V37, P369, DOI 10.1111/liv.13256; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Chekuri S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159413; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Elsharkawy A, 2017, J GASTROEN HEPATOL, V32, P1624, DOI 10.1111/jgh.13758; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Ferraioli G, 2018, ULTRASOUND MED BIOL, V44, P2419, DOI 10.1016/j.ultrasmedbio.2018.07.008; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Hezode C, 2018, LIVER INT, V38, P21, DOI 10.1111/liv.13638; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Kobayashi N, 2018, EUR J GASTROEN HEPAT, V30, P546, DOI [10.1097/MEG.0000000000001106, 10.1097/meg.0000000000001106]; Ogasawara N, 2018, J MED VIROL, V90, P313, DOI 10.1002/jmv.24950; Rubbia-Brandt L, 2001, HISTOPATHOLOGY, V39, P119, DOI 10.1046/j.1365-2559.2001.01208.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Singh S, 2018, CLIN GASTROENTEROL H, V16, P27, DOI 10.1016/j.cgh.2017.04.038; Tada T, 2018, ALIMENT PHARM THER, V47, P1012, DOI 10.1111/apt.14554; Turner BJ, 2017, EUR J GASTROEN HEPAT, V29, P192, DOI 10.1097/MEG.0000000000000766	21	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214323	10.1371/journal.pone.0214323	http://dx.doi.org/10.1371/journal.pone.0214323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939158	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900017
J	Lin, CK; Liu, ST; Chang, CC; Huang, SM				Lin, Chi-Kang; Liu, Shu-Ting; Chang, Cheng-Chang; Huang, Shih-Ming			Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; P21(WAF1/CIP1) GENE; CARDIAC-GLYCOSIDES; P53; CARCINOMA; UBIQUITINATION; DEGRADATION; INHIBITION; EXPRESSION; REDUCTASE	p21, an inhibitor of cyclin-dependent kinase, functions as an oncogene or tumor suppressor depending on the context of a variety of extracellular and intracellular signals. The expression of p21 could be regulated at the transcriptional and/or post-translational levels. The p21 gene is well-known to be regulated in both p53-dependent and -independent manners. However, the detailed regulatory mechanisms of p21 messenger RNA and protein expression via statins remain unknown, and the possible application of statins as anticancer reagents remains to be controversial. Our data showed that the statins-fluvastatin and lovastatin-induced p21 expression as general histone deacetylase inhibitors in a p53-independent manner, which is mediated through various pathways, such as apoptosis, autophagy, cell cycle progression, and DNA damage, to be involved in the function of p21 in HeLa cells. The curative effect repositioning of digoxin, a cardiovascular medication, was combined with fluvastatin and lovastatin, and the results further implied that p21 induction is involved in a p53-dependent and p53-independent manner. Digoxin modified the effects of statins on ATF3, p21, p53, and cyclin D1 expression, while fluvastatin boosted its DNA damage effect and lovastatin impeded its DNA damage effect. Fluvastatin and lovastatin combined with digoxin further support the localization specificity of their interactivity with our subcellular localization data. This study will not only clarify the regulatory mechanisms of p21 induction by statins but will also shed light on the repurposing of widely cardiovascular medications for the treatment of cervical cancer.	[Lin, Chi-Kang; Chang, Cheng-Chang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Liu, Shu-Ting; Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Chang, CC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.; Huang, SM (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	obsgynchang@gmail.com; shihming@ndmctsgh.edu.tw		Lin, Chi-Kang/0000-0001-8608-1320; Chang, Cheng-Chang/0000-0002-7356-446X; Huang, Shih-Ming/0000-0001-9305-921X	Ministry of Science and Technology [MOST 106-2314-B-016-042, 107-2314-B-016-036]; Tri-Service General Hospital [TSGH-C107-083]; Ministry of National Defense-Medical Affairs Bureau, Taiwan, ROC [MAB-107-010]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tri-Service General Hospital; Ministry of National Defense-Medical Affairs Bureau, Taiwan, ROC	This work was supported by grants from the Ministry of Science and Technology [MOST 106-2314-B-016-042 and 107-2314-B-016-036 to C-C Chang], the Tri-Service General Hospital [TSGH-C107-083 to C-C Chang], and the Ministry of National Defense-Medical Affairs Bureau [MAB-107-010 to S-M HUANG], Taiwan, ROC". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Brooks CL, 2004, CELL CYCLE, V3, P895; Chang YH, 2011, ACCIDENT ANAL PREV, V43, P1049, DOI 10.1016/j.aap.2010.12.009; Chang YL, 2017, INT J BIOCHEM CELL B, V92, P155, DOI 10.1016/j.biocel.2017.10.003; Chen JB, 2013, J MED CHEM, V56, P3645, DOI 10.1021/jm400179b; Chen YC, 2013, CELL DEATH DIFFER, V20, P732, DOI 10.1038/cdd.2013.1; Elbaz HA, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Haines BE, 2013, ACCOUNTS CHEM RES, V46, P2416, DOI 10.1021/ar3003267; Hao ZF, 2015, TUMOR BIOL, V36, P1471, DOI 10.1007/s13277-014-2618-1; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Knox JJ, 2005, EUR J CANCER, V41, P523, DOI 10.1016/j.ejca.2004.12.013; Kulikov A, 2007, BBA-BIOMEMBRANES, V1768, P1691, DOI 10.1016/j.bbamem.2007.04.012; Lin YC, 2009, ENERG ENVIRON SCI, V2, P68, DOI 10.1039/b814955k; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; Liu PY, 2008, MOL CANCER RES, V6, P1204, DOI 10.1158/1541-7786.MCR-08-0123; Liu PY, 2011, EXP CELL RES, V317, P2925, DOI 10.1016/j.yexcr.2011.09.018; Lu GY, 2014, BIOCHIMIE, V106, P131, DOI 10.1016/j.biochi.2014.08.013; Menger L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003807; Mo PL, 2010, J BIOL CHEM, V285, P26908, DOI 10.1074/jbc.M110.132597; Nickless A, 2014, NAT MED, V20, P961, DOI 10.1038/nm.3620; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Perne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008292; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Vaklavas C, 2011, PHARMACOL THERAPEUT, V130, P177, DOI 10.1016/j.pharmthera.2011.01.009; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e	34	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214408	10.1371/journal.pone.0214408	http://dx.doi.org/10.1371/journal.pone.0214408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939155	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900021
J	Adair, T; Kippen, R; Naghavi, M; Lopez, AD				Adair, Tim; Kippen, Rebecca; Naghavi, Mohsen; Lopez, Alan D.			The setting of the rising sun? A recent comparative history of life expectancy trends in Japan and Australia	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; CANCER-MORTALITY; DISEASE; TOBACCO	Introduction Adult male and female mortality declines in Japan have been slower than in most high-income countries since the early 1990s. This study compares Japan's recent life expectancy trends with the more favourable trends in Australia, measures the contribution of age groups and causes of death to differences in these trends, and places the findings in the context of the countries' risk factor transitions. Methods The study utilises data on deaths by age, sex and cause in Australia and Japan from 1950-2016 from the Global Burden of Disease Study. A decomposition method measures the contributions of various ages and causes to the male and female life expectancy gap and changes over four distinct phases during this period. Mortality differences by cohort are also assessed. Findings Japan's two-year male life expectancy advantage over Australia in the 1980s closed in the following 20 years. The trend was driven by ages 45-64 and then 65-79 years, and the cohort born in the late 1940s. Over half of Australia's gains were from declines in ischaemic heart disease (IHD) mortality, with lung cancer, chronic respiratory disease and self-harm also contributing substantially. Since 2011 the trend has reversed again, and in 2016 Japan had a slightly higher male life expectancy. The advantage in Japanese female life expectancy widened over the period to 2.3 years in 2016. The 2016 gap was mostly from differential mortality at ages 65 years and over from IHD, chronic respiratory disease and cancers. Conclusions The considerable gains in Australian male life expectancy from declining non-communicable disease mortality are attributable to a range of risk factors, including declining smoking 16 prevalence due to strong public health interventions. A recent reversal in life expectancy trends could continue because Japan has greater scope for further falls in smoking and far lower levels of obesity. Japan's substantial female life expectancy advantage however could diminish in future because it is primarily due to lower mortality at old ages.	[Adair, Tim; Lopez, Alan D.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic, Australia; [Kippen, Rebecca] Monash Univ, Sch Rural Hlth, Clayton, Vic, Australia; [Naghavi, Mohsen] Inst Hlth Metr & Evaluat, Seattle, WA USA	University of Melbourne; Monash University; Institute for Health Metrics & Evaluation	Lopez, AD (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic, Australia.	alan.lopez@unimelb.edu.au	Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022; Adair, Tim/L-1332-2015	Lopez, Alan D/0000-0001-5818-6512; Kippen, Rebecca/0000-0002-4823-5832; Adair, Tim/0000-0002-1562-4452				Adair T, 2012, INT J TUBERC LUNG D, V16, P1699, DOI 10.5588/ijtld.12.0251; Adair T, 2012, EUR J PUBLIC HEALTH, V22, P243, DOI 10.1093/eurpub/ckr048; Adair T, 2011, CANCER CAUSE CONTROL, V22, P1047, DOI 10.1007/s10552-011-9781-0; Adair T, 2011, AUST NZ J PUBL HEAL, V35, P212, DOI 10.1111/j.1753-6405.2011.00700.x; Alperovitch A, 2009, EUR J EPIDEMIOL, V24, P669, DOI 10.1007/s10654-009-9383-2; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Funatogawa I, 2013, B WORLD HEALTH ORGAN, V91, P332, DOI 10.2471/BLT.12.108092; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Jeon SY, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3020-2; Klenk J, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0089-x; Koo J, 2008, CONTEMP ECON POLICY, V26, P162, DOI 10.1111/j.1465-7287.2007.00042.x; Maruo Shinji, 2015, Nihon Koshu Eisei Zasshi, V62, P57, DOI 10.11236/jph.62.2_57; Murray CJL, 2011, LANCET, V378, P1124, DOI 10.1016/S0140-6736(11)61221-X; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Page A, 2007, B WORLD HEALTH ORGAN, V85, P474, DOI 10.2471/BLT.06.036202; Peto R, 1994, MORTALITY SMOKING DE; Pollard JH, 1982, J I ACTUARIES, V109, P225, DOI DOI 10.1017/S0020268100036258; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Preston S, 2001, DEMOGRAPHY MEASURING, P64; Taylor R, 2006, EUR J CARDIOV PREV R, V13, P760, DOI 10.1097/01.hjr.0000220581.42387.d4; Taylor R, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.109538; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 2017, JAP HAS HIGH LIF EXP; World Health Organization, 2018, WHO MORT DAT	29	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214578	10.1371/journal.pone.0214578	http://dx.doi.org/10.1371/journal.pone.0214578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921413	Green Published, gold			2022-12-27	WOS:000462594000089
J	Alem, KD; Arega, DD; Weldegiorgis, ST; Agaje, BG; Tigneh, EG				Alem, Kindie Desta; Arega, Demoze Delelegn; Weldegiorgis, Samson Tesfaye; Agaje, Bekalu Getahun; Tigneh, Emebet Girma			Profile of ocular trauma in patients presenting to the department of ophthalmology at Hawassa University: Retrospective study	PLOS ONE			English	Article							PATTERN	Purpose To assess the pattern, presentation and risk factors of ocular trauma among patients treated at Hawassa University, Referral Hospital, Ophthalmology Department, South Ethiopia, 2014. Methods The medical records of all patients treated for ocular trauma at Hawassa University, Referral Hospital, Ophthalmology Department, during the period January 01, 2012 to July 31, 2014, were retrospectively reviewed. Trained optometrists, ophthalmic nurses and ophthalmic officer collected the data using a pretested data abstraction form. The descriptive and analytic statistics was carried out. Results A total of 773 patients (549 males and 224 females) were included in the study. Closed globe injury was more common in males (P = 0.019) and open globe injury was significantly common in children (P < 0.001). Corneal tear was the most frequently observed finding (39.33%). Surgery, secondary to trauma, was common in open globe injury (P < 0.001). About 98% of the patients presented after 6 hours post trauma. Among 84.61% patients whose visual acuity (VA) was recorded at presentation, 12.23% had VA of 6/6 and 65.90% had VA of <3/60. Conclusion Ocular trauma was more common in males and children. Majority of patients (98%) presented after 6 hours post trauma. Cornea was the most commonly affected ocular structure by trauma.	[Alem, Kindie Desta; Arega, Demoze Delelegn; Agaje, Bekalu Getahun; Tigneh, Emebet Girma] Hawassa Univ, Coll Med & Hlth Sci, Dept Ophthalmol & Optometry, Hawassa, Ethiopia; [Weldegiorgis, Samson Tesfaye] Orbis Int Ethiopia, Addis Ababa, Ethiopia	Hawassa University	Alem, KD (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Dept Ophthalmol & Optometry, Hawassa, Ethiopia.	kindudiaopt@gmail.com	Desta, Kindie/R-4616-2019	Desta, Kindie/0000-0002-3772-1712	Orbis International-Ethiopia	Orbis International-Ethiopia	The research was financially supported by Orbis International-Ethiopia to KDA. Except the one who coauthored here, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addisu Z, 2011, ETHIOP J HEALTH DEV, V25, P150; Alemayehu W, 2015, JOECSA, V18; Babar TF, 2007, JCPSP-J COLL PHYSICI, V17, P148; Dhasmana R, 2012, INDAN J COMMUNITY HE, V24, P297; Ferenc K, 2002, ZDR VESTN, V71, P17; Jahangir T, 2011, PAK J OPHTHALMOL, V27, P96; Khan S, 2012, SAUDI J OPHTHALMOL, V26, P327, DOI 10.1016/j.sjopt.2012.04.004; Khurana A., 2007, COMPREHENSIVE OPHTHA; Kinderan YV, 2012, NEPAL J OPHTHALMOL, V4, P5, DOI 10.3126/nepjoph.v4i1.5843; Lee Ching-Hsing, 2008, Chang Gung Med J, V31, P59; Lewallen S, 2001, BRIT J OPHTHALMOL, V85, P897, DOI 10.1136/bjo.85.8.897; MacEwen CJ, 1999, J ROY COLL SURG EDIN, V44, P317; Omolase Charles Oluwole, 2011, J Ophthalmic Vis Res, V6, P114; Soliman MM, 2008, GRAEF ARCH CLIN EXP, V246, P205, DOI 10.1007/s00417-007-0720-4; Sthapit P R, 2011, Kathmandu Univ Med J (KUMJ), V9, P54; Tejas D, 2013, NHL J MED SCI, V2, P37; Tesfaye A, 2008, East Afr Med J, V85, P593; Titiyal GS, 2013, J INDIAN ACAD FORENS, V35, P116	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213893	10.1371/journal.pone.0213893	http://dx.doi.org/10.1371/journal.pone.0213893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921358	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000027
J	Gunn, KM; Holly, MA; Veith, TL; Buda, AR; Prasad, R; Rotz, CA; Soder, KJ; Stoner, AMK				Gunn, Kpoti M.; Holly, Michael A.; Veith, Tamie L.; Buda, Anthony R.; Prasad, Rishi; Rotz, C. Alan; Soder, Kathy J.; Stoner, Anne M. K.			Projected heat stress challenges and abatement opportunities for US milk production	PLOS ONE			English	Article							CALF BIRTH-WEIGHT; DAIRY-COWS; CLIMATE-CHANGE; LATE-GESTATION; HOLSTEIN COWS; DRY COWS; TEMPERATURE; YIELD; PERFORMANCE; HUMIDITY	Cost-effective heat mitigation strategies are imperative for maintaining milk production and dairy farm profitability in the U.S. with projected climate change. This study investigated the cost-effectiveness of four heat abatement strategies, including Minimal (open barn or shading), Moderate (forced ventilation), High (fans and misting), and Intense (air conditioning). Heat stress and subsequent impacts on milk production per cow were predicted across nine climatic regions in the U.S. for early (2015 to 2034), mid (2045 to 2064) and late (2081 to 2100) 21st century, using downscaled climate projections. Heat abatements were used to adjust predicted milk production losses and illustrate the potential to reduce milk production losses due to heat stress. Economic analysis included a cost-benefit ratio calculation associated with the implementation of each heat abatement. Results showed that milk production losses were expected to accelerate across the U.S. at a mean rate of 174 +/- 7 kg/cow/decade, with the fastest rate in the Southeast region. Relative to Minimal heat abatement, Moderate, High, and Intense heat abatements increased annual milk production per cow by 3%, 4%, and 6% during early-21st century, 3%, 6%, and 11% during mid-21st century, and 3%, 8%, and 21% during late-21st century, respectively. The cost effectiveness of different heat abatement strategies generally increased with subsequently stronger heat abatements. In mid- and late-21st century, mean annual net values of High and Intense heat stress abatement implementation approached -$30 to $190 /cow and -$20 to $590 /cow, respectively, with the largest net annual benefit in late-21st century under Intense abatement. Findings from the study demonstrate the value of using downscaled climate projections to shed light on local and regional strategies to abate heat stress on cattle and mitigate potential milk production losses due to climate change.	[Gunn, Kpoti M.; Holly, Michael A.; Veith, Tamie L.; Buda, Anthony R.; Rotz, C. Alan; Soder, Kathy J.] USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA; [Prasad, Rishi] Auburn Univ, Crop Soil & Environm Sci, Auburn, AL 36849 USA; [Stoner, Anne M. K.] Texas Tech Univ, Climate Sci Ctr, Lubbock, TX 79409 USA	United States Department of Agriculture (USDA); Auburn University System; Auburn University; Texas Tech University System; Texas Tech University	Gunn, KM (corresponding author), USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA.	Stephankpoti.Gunn@ars.usda.gov	Buda, Anthony/ABA-3525-2021	, Stephan Kpoti/0000-0002-8181-7447; Rumery, Holly/0000-0002-9970-1098				Aguilar I, 2010, J DAIRY SCI, V93, P1754, DOI 10.3168/jds.2009-2756; Bennett J, 2010, DEPRECIATION CLASS L; BERMAN A, 1985, J DAIRY SCI, V68, P1488, DOI 10.3168/jds.S0022-0302(85)80987-5; Bohmanova J, 2007, J DAIRY SCI, V90, P1947, DOI 10.3168/jds.2006-513; Bucklin RA, 2009, APPL ENG AGRIC, V25, P727; Carabano MJ, 2016, J DAIRY SCI, V99, P3798, DOI 10.3168/jds.2015-10212; Coffel ED, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaa00e; COLLIER RJ, 1982, J ANIM SCI, V54, P309, DOI 10.2527/jas1982.542309x; Collier RJ, 2006, J DAIRY SCI, V89, P1244, DOI 10.3168/jds.S0022-0302(06)72193-2; COLLIER RJ, 1981, J DAIRY SCI, V64, P844, DOI 10.3168/jds.S0022-0302(81)82656-2; Dahl GE, 2016, J DAIRY SCI, V99, P3193, DOI 10.3168/jds.2015-9990; Das R, 2016, VET WORLD, V9, P260, DOI 10.14202/vetworld.2016.260-268; de Mendiburu F, 2016, AGRICOLAE STAT PROCE; De Rensis F, 2015, THERIOGENOLOGY, V84, P659, DOI 10.1016/j.theriogenology.2015.04.021; Dunn RJH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064006; Federal Reserve, 2018, DISC RAT DAT; Ferrazza RD, 2017, J THERM BIOL, V66, P68, DOI 10.1016/j.jtherbio.2017.03.014; Ferreira FC, 2016, J DAIRY SCI, V99, P9931, DOI 10.3168/jds.2016-11566; FINCH VA, 1984, J AGR SCI-CAMBRIDGE, V102, P141, DOI 10.1017/S0021859600041575; Fournel S, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7050037; Gauly M, 2013, ANIMAL, V7, P843, DOI 10.1017/S1751731112002352; Gooch CA, 2000, ASAE ANN INT; Gooch CA, 2003, 5 INT DAIR HOUS C P, P227; Gould B, 2017, UNDERSTANDING DAIRY; Hahn L, 1970, T ASAE, V12, P448; Harner JP, 1999, SPRINKLER SYSTEMS CO; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; HER E, 1988, J DAIRY SCI, V71, P1085, DOI 10.3168/jds.S0022-0302(88)79656-3; Hill DL, 2015, ANIMAL, V9, P138, DOI 10.1017/S1751731114002456; Holly MA, 2018, J DAIRY SCI, V101, P6632, DOI 10.3168/jds.2017-13819; Hristov AN, 2018, CLIMATIC CHANGE, V146, P33, DOI 10.1007/s10584-017-2023-z; IGONO MO, 1992, INT J BIOMETEOROL, V36, P77, DOI 10.1007/BF01208917; IGONO MO, 1987, J DAIRY SCI, V70, P1069, DOI 10.3168/jds.S0022-0302(87)80113-3; Johnson H D, 1962, RES B MISSOURI AGR E, V79; Jones G.A., 2017, LARGE DAIRY HERD MAN, V3rd, P71; Kadzere CT, 2002, LIVEST PROD SCI, V77, P59, DOI 10.1016/S0301-6226(01)00330-X; Kammel DW, 2015, BUILDING COSTS ESTIM; Karl T.R., 1984, HIST CLIMATOLOGY SER, V4-3; Key N, 2014, AM J AGR ECON, V96, P1136, DOI 10.1093/ajae/aau002; Khongdee S, 2006, INT J BIOMETEOROL, V50, P253, DOI 10.1007/s00484-006-0030-2; Laporta J, 2017, J DAIRY SCI, V100, P2976, DOI 10.3168/jds.2016-11993; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Manning MR, 2010, NAT GEOSCI, V3, P376, DOI 10.1038/ngeo880; Mauger G, 2015, PROF GEOGR, V67, P121, DOI 10.1080/00330124.2014.921017; Monteiro APA, 2016, J DAIRY SCI, V99, P8443, DOI 10.3168/jds.2016-11072; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Nidumolu U, 2014, INT J BIOMETEOROL, V58, P1095, DOI 10.1007/s00484-013-0703-6; OECD (Organisation for Economic Co-operation and Development), 2014, EC OUTL 95 LONG TERM; R Core Team, 2015, R LANGUAGE ENV STAT; Ravagnolo O, 2000, J DAIRY SCI, V83, P2120, DOI 10.3168/jds.S0022-0302(00)75094-6; Romero-Lankao P, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1439; Russo S, 2014, J GEOPHYS RES-ATMOS, V119, P12500, DOI 10.1002/2014JD022098; RYAN DP, 1992, J DAIRY SCI, V75, P1052, DOI 10.3168/jds.S0022-0302(92)77849-7; Schonhart M., 2015, ADV ANIM BIOSCI, V6, P17, DOI DOI 10.1017/S2040470014000430; Segnalini M, 2013, INT J BIOMETEOROL, V57, P451, DOI 10.1007/s00484-012-0571-5; Smith J. R., 2012, Environmental physiology of livestock, P267; Smith TR, 2006, J DAIRY SCI, V89, P3915, DOI 10.3168/jds.S0022-0302(06)72434-1; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Stoner AMK, 2013, INT J CLIMATOL, V33, P2473, DOI 10.1002/joc.3603; Stowell RR, 2001, LIVESTOCK ENV, P29; Tao S, 2013, J DAIRY SCI, V96, P4079, DOI 10.3168/jds.2012-6278; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tucker CB, 2007, APPL ANIM BEHAV SCI, V105, P1, DOI [10.1016/j.applanim.2006.06.009, 10.1016/j.applanim.2007.03.015]; Turner L. W., 1992, Applied Engineering in Agriculture, V8, P251; USDA-NASS, 2014, 2012 CENS AGR COUNT; USEIA, EL DAT; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; West JW, 2003, J DAIRY SCI, V86, P232, DOI 10.3168/jds.S0022-0302(03)73602-9; Wolfe DW, 2008, MITIG ADAPT STRAT GL, V13, P555, DOI 10.1007/s11027-007-9125-2; WOLFENSON D, 1988, J DAIRY SCI, V71, P809, DOI 10.3168/jds.S0022-0302(88)79621-6; Yousef MK, 1985, STRESS PHYSL LIVESTO	72	22	23	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214665	10.1371/journal.pone.0214665	http://dx.doi.org/10.1371/journal.pone.0214665			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921450	gold, Green Submitted, Green Published			2022-12-27	WOS:000462594000106
J	Harry, ML; Acevedo, J; Crea, TM				Harry, Melissa L.; Acevedo, Jose; Crea, Thomas M.			Assessing the factor structure of the Spanish language parent Strengths and Difficulties Questionnaire (SDQ) in Honduras	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; ADOLESCENT MENTAL-HEALTH; MEASUREMENT INVARIANCE; COMMUNITY SAMPLE; PSYCHOMETRIC PROPERTIES; VALIDITY; CHILD; RELIABILITY; VERSION; CONVERGENT	With worldwide prevalence rates between 10% and 20%, mental illness in children and adolescents is an issue for which culturally sensitive screening tools are needed. The Strengths & Difficulties Questionnaire (SDQ) is a commonly used measure that has been translated into numerous languages, although some research suggests issues with cross-cultural validity. Only four other studies have tested the Spanish-language SDQ in Latin America. In this study, we aimed to help fill this gap by assessing the factor structure of the parent or teacher version of the Spanish-language SDQ (for children ages 4-17) with 967 parent or other caregiver respondents of primary school-aged children (ages 4 to 17) in the Department of Intibuca, Honduras. When unable to find a good fitting factor model previously identified in the literature, we conducted split sample exploratory factor analysis (EFA) and confirmatory factor analysis (CFA), along with measurement invariance testing with the best fitting EFA-extracted model based on gender for caregiver respondent and child gender. Results showed that while many EFA models had a good fit, CFI and TLI was < .90 for all extracted models when confirmed in the second sample with CFA. We then modified the best fitting extracted three-factor, 24-item model, which dropped item 15, by allowing select item residuals to correlate, increasing CFI and TLI to > .90 for female child gender. This modified three-factor model was partially invariant for configural and scalar models between child genders. Configural and scalar models would not converge for adult genders. Of note, metric models were not produced in Mplus related to items' cross-loading on more than one factor. These findings suggest that the SDQ Spanish language parent or teacher version may not perform optimally cross-culturally in this area of Honduras. Future research should confirm these findings with other Honduran populations.	[Harry, Melissa L.] Essentia Hlth, Essentia Inst Rural Hlth, Duluth, MN USA; [Acevedo, Jose] Natl Autonomous Univ Honduras, Sch Sociol, Tegucigalpa, Honduras; [Crea, Thomas M.] Boston Coll, Sch Social Work, Chestnut Hill, MA 02167 USA	Universidad Nacional Autonoma de Honduras; Boston College	Crea, TM (corresponding author), Boston Coll, Sch Social Work, Chestnut Hill, MA 02167 USA.	creat@bc.edu		Crea, Thomas/0000-0002-8092-7353; Harry, Melissa/0000-0003-2016-4398				Adams JW, 1999, BRIT J EDUC PSYCHOL, V69, P571, DOI 10.1348/000709999157905; [Anonymous], 2018, R LANG ENV STAT COMP, P2018; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Becker A, 2004, EUR CHILD ADOLES PSY, V13, P11, DOI 10.1007/s00787-004-2003-5; Boe T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152202; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Brown P., 2014, REV PSICOLOGIA, V23, P28, DOI DOI 10.5354/0719-0581.2014.36146; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Bull R, 2016, CHILD CARE HLTH DEV, V42, P109, DOI 10.1111/cch.12288; Byrne B.M., 2012, STRUCTURAL EQUATION; CAMPBELL L, 1978, INT J AM LINGUIST, V44, P330, DOI 10.1086/465560; Caqueo A, 2014, REV CHIL PEDIATR-CHI, V85, P561, DOI 10.4067/S0370-41062014000500006; Clausen Carolyn E, 2018, Tidsskr Nor Laegeforen, V137, DOI 10.4045/tidsskr.17.0639; Cortina MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065041; Croft S, 2015, PEDIATRICS, V135, pE1210, DOI 10.1542/peds.2014-2920; Cullins LM, 2015, CHILD ADOL PSYCH CL, V24, P823, DOI 10.1016/j.chc.2015.06.010; Dahlberg A, 2019, CHILD PSYCHIAT HUM D, V50, P132, DOI 10.1007/s10578-018-0826-4; DeVries JM, 2017, PERS INDIV DIFFER, V119, P1, DOI 10.1016/j.paid.2017.06.026; Di Riso D, 2010, PERS INDIV DIFFER, V49, P570, DOI 10.1016/j.paid.2010.05.005; Dickey WC, 2004, J AM ACAD CHILD PSY, V43, P1159, DOI 10.1097/01.chi.0000132808.36708.a9; Du Yasong, 2008, Child Adolesc Psychiatry Ment Health, V2, P8, DOI 10.1186/1753-2000-2-8; Field A., 2013, DISCOVERING STAT USI; Gadermann A.M., 2012, PRACTICAL ASSESSMENT, V17, P3, DOI DOI 10.7275/N560-J767; Gaete J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191809; Gao Xin, 2013, Shanghai Arch Psychiatry, V25, P364, DOI 10.3969/j.issn.1002-0829.2013.06.005; Gomez R, 2019, ASSESSMENT, V26, P1142, DOI 10.1177/1073191117721743; Gomez R, 2014, ASSESSMENT, V21, P372, DOI 10.1177/1073191112457588; Gomez-Beneyto M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-95; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Goodman R, 2005, SOC PSYCH PSYCH EPID, V40, P11, DOI 10.1007/s00127-005-0851-z; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Gregorcic M, 2009, INNOV EDUC TEACH INT, V46, P357, DOI 10.1080/14703290903301750; Harkness JA, 2013, CROSS CULTURAL SURVE, P35; He JP, 2013, J ABNORM CHILD PSYCH, V41, P583, DOI 10.1007/s10802-012-9696-6; Hill CR, 2007, SCHOOL PSYCHOL QUART, V22, P380, DOI 10.1037/1045-3830.22.3.380; Holzinger KJ, 1937, PSYCHOMETRIKA, V2, P41, DOI 10.1007/BF02287965; Instituto Nacional Estadistica (INE), 2018, CIFR PAIS 2015; Kenny D.A., 2020, MEASURING MODEL FIT; Kersten P, 2016, INT J BEHAV DEV, V40, P64, DOI 10.1177/0165025415570647; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kobor A, 2013, EUR J PSYCHOL ASSESS, V29, P299, DOI 10.1027/1015-5759/a000160; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; McDonald RP, 1999, TEST THEORY UNIFIED; Milfont TL, 2010, INT J PSYCHOL RES, V3, P111; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; Muthen BO., 2017, REMEASUREMENT INVARI; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Muthen L.K., 2015, MPLUS VERSION 7 4; Muthen LK, 2016, REMODEL FIT OUTPUT C; Niclasen J, 2013, J ABNORM CHILD PSYCH, V41, P355, DOI 10.1007/s10802-012-9683-y; Niclasen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032025; Organisation for Economic Co-operation and Development, 2016, PISA DEV CAP BUILD P; Ortuno-Sierra J, 2018, PSYCHIAT RES, V259, P236, DOI 10.1016/j.psychres.2017.10.025; Ortuno-Sierra J, 2015, EUR CHILD ADOLES PSY, V24, P1523, DOI 10.1007/s00787-015-0729-x; Ortuno-Sierra J, 2015, INT J CLIN HLTH PSYC, V15, P265, DOI 10.1016/j.ijchp.2015.05.005; Palmieri PA, 2007, PSYCHOL ASSESSMENT, V19, P189, DOI 10.1037/1040-3590.19.2.189; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Petermann U, 2010, EUR J PSYCHOL ASSESS, V26, P256, DOI 10.1027/1015-5759/a000034; Polit FD, 2010, STAT DATA ANAL NURSI; Raykov T, 1997, APPL PSYCH MEAS, V21, P173, DOI 10.1177/01466216970212006; Raykov T, 2002, STRUCT EQU MODELING, V9, P195, DOI 10.1207/S15328007SEM0902_3; Richter J, 2011, J CHILD PSYCHOL PSYC, V52, P1002, DOI 10.1111/j.1469-7610.2011.02372.x; Samad L, 2005, INT J METH PSYCH RES, V14, P158, DOI 10.1002/mpr.3; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Stevanovic D, 2015, EPIDEMIOL PSYCH SCI, V24, P323, DOI 10.1017/S2045796014000201; Stokes M, 2014, QUAL QUANT, V48, P983, DOI 10.1007/s11135-012-9819-8; Stone LL, 2013, EUR J PSYCHOL ASSESS, V29, P44, DOI 10.1027/1015-5759/a000119; Sveen TH, 2013, J AM ACAD CHILD PSY, V52, P728, DOI 10.1016/j.jaac.2013.04.010; Thabet AA, 2000, INT J SOC PSYCHIATR, V46, P266, DOI 10.1177/002076400004600404; Theunissen MHC, 2013, PEDIATRICS, V131, pE446, DOI 10.1542/peds.2012-0089; Tran T., 2017, DEV CROSS CULTURAL M, V2nd; Universidad Nacional Autonoma de Honduras, 2016, OBS VIOL NO 40; van de Looij-Jansen PM, 2011, BRIT J CLIN PSYCHOL, V50, P127, DOI 10.1348/014466510X498174; Van Leeuwen K, 2006, EUR J PSYCHOL ASSESS, V22, P189, DOI 10.1027/1015-5759.22.3.189; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; Widhiarso W., 2014, REV PSYCHOL, V21, P111, DOI DOI 10.2139/ssrn.1597532; Yu C.-Y., 2002, THESIS; Zumbo BD, 2007, J MOD APPL STAT METH, V6, P21, DOI 10.22237/jmasm/1177992180	82	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214394	10.1371/journal.pone.0214394	http://dx.doi.org/10.1371/journal.pone.0214394			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921369	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000064
J	Hollis-Hansen, K; O'Donnell, SE; Seidman, JS; Brande, SJ; Epstein, LH				Hollis-Hansen, Kelseanna; O'Donnell, Sara E.; Seidman, Jennifer S.; Brande, Spencer J.; Epstein, Leonard H.			Improvements in episodic future thinking methodology: Establishing a standardized episodic thinking control	PLOS ONE			English	Article							INTERTEMPORAL CHOICE; FOOD REINFORCEMENT; ENERGY-INTAKE; IMPULSIVITY; NEVER; EQUIVALENCE; PROSPECTION	Objective Delay discounting (DD) is the choice of a smaller immediate reward over a larger delayed reward, which has been associated with a number of maladaptive behaviors. Episodic future thinking (EFT), the ability to project oneself into the future, is an intervention designed to reduce DD. EFT has reliable effects on DD, but the size of the effect varies, which could be due in part to the use of different control groups. Episodic recent thinking (ERT) serves as a common control for many EFT studies, but the temporal window of "recent" cues ranges from 24 hours ago to 12 days past. Since prior research has shown that retrospection can lead to prospection, it may be important to ensure that EFT controls do not inadvertently lead to prospection for some participants thereby increasing the variability of the control condition. The present study sought to develop a comparison group that standardizes the time frame and experiences that are the basis for the recent thinking control. Methods Participants (n = 53, 18-45) were randomized to one of three conditions: EFT, ERT, or standardized episodic thinking (SET). Participants attended a laboratory appointment where they played mobile application games, created cues, and completed a DD task. Results There was a significant difference between groups (p<0.05), with EFT reducing discounting more than either control (p<0.05), and no differences between ERT and SET (p>0.05). Conclusion This study established that SET provides an alternative control in EFT studies and provides the advantage of standardizing the participant's recent experience without changing the relationship between EFT and recent thinking controls.	[Hollis-Hansen, Kelseanna; O'Donnell, Sara E.; Seidman, Jennifer S.; Brande, Spencer J.; Epstein, Leonard H.] SUNY Buffalo, Dept Pediat, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Hollis-Hansen, Kelseanna] SUNY Buffalo, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hollis-Hansen, K (corresponding author), SUNY Buffalo, Dept Pediat, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14260 USA.; Hollis-Hansen, K (corresponding author), SUNY Buffalo, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA.	kasmith6@buffalo.edu	Epstein, Leonard/AAE-5619-2021	Hollis-Hansen, Kelseanna/0000-0002-0243-2830	Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD080292-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080292] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded in part by a grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) awarded to Leonard H. Epstein (R01HD080292-02; https://www.nichd.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Benoit RG, 2011, J NEUROSCI, V31, P6771, DOI 10.1523/JNEUROSCI.6559-10.2011; Bickel WK, 1999, PSYCHOPHARMACOLOGY, V146, P447, DOI 10.1007/PL00005490; Bjork JM, 2004, ALCOHOL, V34, P133, DOI 10.1016/j.alcohol.2004.06.012; Daniel T, 2013, PSYCHOL SCI, V24; Daniel TO, 2016, J APPL RES MEM COGN, V5, P352; Daniel TO, 2015, EAT BEHAV, V18, P20, DOI 10.1016/j.eatbeh.2015.03.006; Daniel TO, 2013, APPETITE, V71, P120, DOI 10.1016/j.appet.2013.07.010; Dassen FCM, 2016, APPETITE, V96, P327, DOI 10.1016/j.appet.2015.09.032; Epstein LH, 2010, PHYSIOL BEHAV, V100, P438, DOI 10.1016/j.physbeh.2010.04.029; Gage-Bouchard EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089842; Hollis-Hansen K, 2019, APPETITE, V133, P1, DOI 10.1016/j.appet.2018.10.019; Johnson MW, 2007, EXP CLIN PSYCHOPHARM, V15, P187, DOI 10.1037/1064-1297.15.2.187; Kleim B, 2014, CLIN PSYCHOL SCI, V2, P165, DOI 10.1177/2167702613495199; Kwan D, 2015, HIPPOCAMPUS, V25, P432, DOI 10.1002/hipo.22431; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Lin H, 2014, BEHAV NEUROSCI, V128, P12, DOI 10.1037/a0035705; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081717; Mitchell JM, 2005, ALCOHOL CLIN EXP RES, V29, P2158, DOI 10.1097/01.alc.0000191755.63639.4a; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; O'Donnell S, 2019, J BEHAV DECIS MAKING, V32, P231, DOI 10.1002/bdm.2108; O'Donnell S, 2019, BEHAV SCI-BASEL, V9, DOI 10.3390/bs9010001; O'Donnell S, 2017, CONSCIOUS COGN, V51, P10, DOI 10.1016/j.concog.2017.02.014; O'Neill J, 2016, EAT BEHAV, V20, P9, DOI 10.1016/j.eatbeh.2015.10.002; Odum AL, 2011, J EXP ANAL BEHAV, V96, P427, DOI 10.1901/jeab.2011.96-423; Palombo DJ, 2015, HIPPOCAMPUS, V25, P345, DOI 10.1002/hipo.22376; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; Rollins BY, 2010, APPETITE, V55, P420, DOI 10.1016/j.appet.2010.07.014; Rung JM, 2018, J EXP PSYCHOL GEN, V147, P1349, DOI 10.1037/xge0000462; Rung JM, 2018, EXP CLIN PSYCHOPHARM, V26, P77, DOI 10.1037/pha0000171; Sasse LK, 2015, HUM BRAIN MAPP, V36, P4210, DOI 10.1002/hbm.22912; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2017, CURR OPIN BEHAV SCI, V17, P41, DOI 10.1016/j.cobeha.2017.06.002; Snider SE, 2016, ALCOHOL CLIN EXP RES, V40, P1558, DOI 10.1111/acer.13112; Stein JS, 2018, J BEHAV MED, V41, P269, DOI 10.1007/s10865-017-9908-1; Stein JS, 2017, J BEHAV MED, V40, P832, DOI 10.1007/s10865-017-9857-8; Stein JS, 2016, PSYCHOPHARMACOLOGY, V233, P3771, DOI 10.1007/s00213-016-4410-y; Sze YY, 2017, CLIN PSYCHOL SCI, V5, P683, DOI 10.1177/2167702617696511; Weber R, 2012, COMMUN METHODS MEAS, V6, P190, DOI 10.1080/19312458.2012.703834; Wu JQ, 2015, J ANXIETY DISORD, V36, P1, DOI 10.1016/j.janxdis.2015.09.005	42	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214397	10.1371/journal.pone.0214397	http://dx.doi.org/10.1371/journal.pone.0214397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921384	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000065
J	Mohammed, H; McMillan, M; Roberts, CT; Marshall, HS				Mohammed, Hassen; McMillan, Mark; Roberts, Claire T.; Marshall, Helen S.			A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy	PLOS ONE			English	Review							ELECTRONIC HEALTH RECORD; BEST-PRACTICE ALERT; INFLUENZA VACCINATION; PROMOTION PACKAGE; TDAP VACCINATION; YOUNG INFANTS; UNITED-STATES; WOMEN; ATTITUDES; IMMUNIZATION	Background Maternal pertussis vaccination has been introduced in several countries to prevent pertussis morbidity and mortality in infants too young to be vaccinated. Our review aimed to systematically collect and summarize the available evidence on the effectiveness of interventions used to improve pertussis vaccination uptake in pregnant women. Methods We conducted a systematic search of MEDLINE/PubMed, PMC and CINAHL. Before and after studies and those with a concurrent control group were considered for inclusion. Standardized effect sizes were described as the ratio of the odds to be vaccinated in the intervention group compared with the standard care group and absolute benefit increase (ABI) were calculated. Results Six studies were included in the review, of which three were randomized controlled trials (RCTs). Strategies to improve uptake were focused on healthcare providers, pregnant women, or enhancing vaccine access. Healthcare provider interventions included provider reminder, education, feedback and standing orders. Interventions directed at pregnant women focused solely on education. Observational studies showed: (1) the provision of maternal pertussis vaccination by midwives at the place of antenatal care has improved uptake of pertussis vaccine during pregnancy from 20% to 90%; (2) introduction of an automated reminder within the electronic medical record was associated with an improvement in the pertussis immunization rate from 48% to 97%; (3) an increase in prenatal pertussis vaccine uptake from 36% to 61% after strategies to increase provider awareness of recommendations were introduced. In contrast to these findings, interventions in all three RCTs (2 involved education of pregnant women, 1 had multi-component interventions) did not demonstrate improved vaccination uptake. Conclusions Based on the existing research, we recommend incorporating midwife delivered maternal immunization programs at antenatal clinics, use of a provider reminder system to target unvaccinated pregnant women and include maternal pertussis immunization as part of standard antenatal care.	[Mohammed, Hassen; McMillan, Mark; Roberts, Claire T.; Marshall, Helen S.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Mohammed, Hassen; McMillan, Mark; Roberts, Claire T.; Marshall, Helen S.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Mohammed, Hassen; McMillan, Mark; Marshall, Helen S.] Womens & Childrens Hosp, VIRTU, Adelaide, SA, Australia; [Marshall, Helen S.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide	Mohammed, H (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.; Mohammed, H (corresponding author), Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.; Mohammed, H (corresponding author), Womens & Childrens Hosp, VIRTU, Adelaide, SA, Australia.	hassen.mohammed@adelaide.edu.au	McMillan, Mark/N-5941-2019; Mohammed, Hassen/HGB-3057-2022; Mohammed, Hassen/K-1421-2019	McMillan, Mark/0000-0002-6490-7707; Mohammed, Hassen/0000-0003-0189-3739; Roberts, Claire/0000-0002-9250-2192				Akobeng AK, 2005, ARCH DIS CHILD, V90, P840, DOI 10.1136/adc.2004.058222; Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3; [Anonymous], 2015, Weekly Epidemiological Record, V90, P433; Australian Technical Advisory Group on Immunisation, 2018, AUSTR IMM HDB VACC; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Baptista PN, 2010, INT J INFECT DIS, V14, pE111, DOI 10.1016/j.ijid.2009.03.026; Barber A, 2017, MMWR-MORBID MORTAL W, V66, P56, DOI 10.15585/mmwr.mm6602a4; Bisset KA, 2018, VACCINE, V36, P2751, DOI 10.1016/j.vaccine.2018.04.013; Bonville CA, 2015, HUM VACC IMMUNOTHER, V11, P713, DOI 10.1080/21645515.2015.1011999; Boyd CA, 2013, MATERN CHILD HLTH J, V17, P852, DOI 10.1007/s10995-012-1063-2; Briss PA, 2000, AM J PREV MED, V18, P97, DOI 10.1016/S0749-3797(99)00118-X; Broughton DE, 2009, OBSTET GYNECOL, V114, P981, DOI 10.1097/AOG.0b013e3181bd89c2; Chamberlain AT, 2015, VACCINE, V33, P3571, DOI 10.1016/j.vaccine.2015.05.048; Chamberlain AT, 2016, HUM VACC IMMUNOTHER, V12, P2017, DOI 10.1080/21645515.2015.1127489; Cortese MM, 2008, PEDIATRICS, V121, P484, DOI 10.1542/peds.2007-1393; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; Deverall EJ, 2018, NEW ZEAL MED J, V131, P42; Ding H, 2011, AM J OBSTET GYNECOL, V204, pS96, DOI 10.1016/j.ajog.2011.03.003; Fiks AG, 2009, PEDIATRICS, V124, P159, DOI 10.1542/peds.2008-2823; Gall SA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.024; Gauld NJ, 2016, J PRIM HEALTH CARE, V8, P344, DOI 10.1071/HC15049; Healy CM, 2015, VACCINE, V33, P4983, DOI 10.1016/j.vaccine.2015.07.018; Housey M, 2014, MMWR-MORBID MORTAL W, V63, P839; Ishola DA, 2013, J PUBLIC HEALTH-UK, V35, P570, DOI 10.1093/pubmed/fds109; Kharbanda EO, 2011, PREV MED, V52, P75, DOI 10.1016/j.ypmed.2010.10.009; Klatt TE, 2012, OBSTET GYNECOL, V119, P301, DOI 10.1097/AOG.0b013e318242032a; Kriss JL, 2017, VACCINE, V35, P1551, DOI 10.1016/j.vaccine.2017.01.037; Laenen J, 2015, VACCINE, V33, P2125, DOI 10.1016/j.vaccine.2015.03.020; Leddy MA, 2009, OBSTET GYNECOL SURV, V64, P823, DOI 10.1097/OGX.0b013e3181c4bbb7; Ledwich LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1505, DOI 10.1002/art.24873; Link-Gelles R, 2012, MATERN CHILD HLTH J, V16, P1743, DOI 10.1007/s10995-011-0936-0; Llupia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039496; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MacDougall DM, 2016, HUM VACC IMMUNOTHER, V12, P857, DOI 10.1080/21645515.2015.1101524; Mazzoni SE, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.018; Mohammed H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197867; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moniz MH, 2013, OBSTET GYNECOL, V121, P734, DOI 10.1097/AOG.0b013e31828642b1; Mooi FR, 2007, LANCET INFECT DIS, V7, P614, DOI 10.1016/s1473-3099(07)70113-5; Morgan JL, 2015, OBSTET GYNECOL, V126, P333, DOI 10.1097/AOG.0000000000000975; Munoz Flor M, 2006, Semin Pediatr Infect Dis, V17, P14, DOI 10.1053/j.spid.2005.11.005; Payakachat N, 2016, VACCINE, V34, P179, DOI 10.1016/j.vaccine.2015.09.062; Pearce A, 2015, VACCINE, V33, P3377, DOI 10.1016/j.vaccine.2015.04.089; Polus S, 2017, J CLIN EPIDEMIOL, V91, P56, DOI 10.1016/j.jclinepi.2017.07.008; Power ML, 2009, AM J PREV MED, V37, P231, DOI 10.1016/j.amepre.2009.05.019; Quinn HE, 2007, COMMUN DIS INTELL, V31, P205; Quinn HE, 2014, PEDIATRICS, V133, pE513, DOI 10.1542/peds.2013-3181; Robbins SCC, 2011, VACCINE, V29, P5591, DOI 10.1016/j.vaccine.2011.05.049; SA Health, 2012, UND VACC MIDW VACC R; Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131; Shavell VI, 2012, AM J OBSTET GYNECOL, V207, pS67, DOI 10.1016/j.ajog.2012.06.077; Smith C, 2000, EUR J PEDIATR, V159, P898, DOI 10.1007/PL00008365; Tufanaru C., 2020, SYSTEMATIC REV EFFEC, DOI DOI 10.46658/JBIMES-20-04; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Vitek WS, 2011, VACCINE, V29, P2024, DOI 10.1016/j.vaccine.2011.01.026; Wallis DH, 2006, J AM BOARD FAM MED, V19, P345, DOI 10.3122/jabfm.19.4.345; Webb H, 2014, HUM VACC IMMUNOTHER, V10, P1114, DOI 10.4161/hv.27893; Wiley KE, 2013, VACCINE, V31, P618, DOI 10.1016/j.vaccine.2012.11.052; Wiley KE, 2013, MED J AUSTRALIA, V198, P373, DOI 10.5694/mja12.11849; Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046; Wu PS, 2006, SOUTH MED J, V99, P823, DOI 10.1097/01.smj.0000231262.88558.8e	61	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214538	10.1371/journal.pone.0214538	http://dx.doi.org/10.1371/journal.pone.0214538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921421	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000083
J	Wang, S; Li, ZX				Wang, Song; Li, Zhixia			Exploring the mechanism of crashes with automated vehicles using statistical modeling approaches	PLOS ONE			English	Article							INJURY SEVERITY; CLASSIFICATION	Autonomous Vehicles (AV) technology is emerging. Field tests on public roads have been on going in several states in the US as well as in Europe and Asia. During the US public road tests, crashes with AV involved happened, which becomes a concern to the public. Most previous studies on AV safety relied heavily on assessing drivers' performance and behaviors in a simulation environment and developing automated driving system performance in a closed field environment. However, contributing factors and the mechanism of AV-related crashes have not been comprehensively and quantitatively investigated due to the lack of field AV crash data. By harnessing California's Report of Traffic Collision Involving an Autonomous Vehicle Database, which includes the AV crash data from 2014 to 2018, this paper investigates by far the most current and complete AV crash database in the US using statistical modeling approaches that involve both ordinal logistic regression and CART classification tree. The quantitative analysis based on ordinal logistic regression and CART models has successfully explored the mechanism of AV-related crash, via both perspectives of crash severity and collision types. Particularly, the CART model reveals and visualize the hierarchical structure of the AV crash mechanism with knowledge of how these traffic, roadway, and environmental contributing factors can lead to crashes of various serveries and collision types. Statistical analysis results indicate that crash severity significantly increases if the AV is responsible for the crash. The highway is identified as the location where severe injuries are likely to happen. AV collision types are affected by whether the vehicle is on automated driving mode, whether the crashes involve pedestrians/cyclists, as well as the roadway environment. The method used in this research provides a proven approach to statistically analyze and understand AV safety issues. And this benefit is potential be even enhanced with an increasing sample size of AV-related crashes records in the future. The comprehensive knowledge obtained ultimately facilitates assessing and improving safety performance of automated vehicles.	[Wang, Song; Li, Zhixia] Univ Louisville, Ctr Transportat Innovat, Dept Civil & Environm Engn, Louisville, KY 40292 USA	University of Louisville	Li, ZX (corresponding author), Univ Louisville, Ctr Transportat Innovat, Dept Civil & Environm Engn, Louisville, KY 40292 USA.	richard.li@louisville.edu	Li, Zhixia/U-3175-2019; Li, Zhixia/H-6124-2016	Li, Zhixia/0000-0002-7942-4660; Li, Zhixia/0000-0002-7942-4660	Kentucky Transportation Cabinet; University of Louisville EVPRI research grant	Kentucky Transportation Cabinet; University of Louisville EVPRI research grant	This work was funded by Kentucky Transportation Cabinet and University of Louisville EVPRI research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri A.M., 2018, PREDICTING CRASH SEV; [Anonymous], 2019, IEEE ACCESS; [Anonymous], 2018, ASS PRESS; Center of Automotive Research, 2017, AUT VEH IND ACT MICH; Davies A, VERY HUMAN PROBLEM B; de Winter JCF, 2014, TRANSPORT RES F-TRAF, V27, P196, DOI 10.1016/j.trf.2014.06.016; Ding C, 2018, ACCIDENT ANAL PREV, V112, P116, DOI 10.1016/j.aap.2017.12.026; DOT-National Highway Traffic Safety Administration (NHTSA), 2016, OFF DET INV PREL REP; Favaro FM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184952; Federal Highway Administrations (FHWA), KABCO INJ CLASS SCAL; Fleming C, 2016, NTSB SAYS; Fountas G, 2018, ANAL METHODS ACCID R, V18, P57, DOI 10.1016/j.amar.2018.04.003; Ghasemzadeh Ali, 2018, TRANSPORT RES REC; Gibson B., 2017, ANAL AUTONOMOUS VEHI, DOI [10.13023/KTC.RR.2016.25, DOI 10.13023/KTC.RR.2016.25]; Green J., 2018, QUALITATIVE METHODS; Guo YY, 2018, ACCIDENT ANAL PREV, V113, P38, DOI 10.1016/j.aap.2018.01.015; Han J, 2012, MOR KAUF D, P1; Hartwich F., 2018, TRANSPORTATION RES F; Hegedus F, 2017, IFAC PAPERSONLINE, V50, P6958, DOI 10.1016/j.ifacol.2017.08.1336; Hossain M, 2019, ACCIDENT ANAL PREV, V124, P66, DOI 10.1016/j.aap.2018.12.022; Huang HL, 2018, ACCIDENT ANAL PREV, V111, P56, DOI 10.1016/j.aap.2017.11.024; Jeong H, 2018, ACCIDENT ANAL PREV, V120, P250, DOI 10.1016/j.aap.2018.08.025; Kashani AT, 2011, SAFETY SCI, V49, P1314, DOI 10.1016/j.ssci.2011.04.019; Korber M, 2016, TRANSPORT RES F-TRAF, V39, P19, DOI 10.1016/j.trf.2016.03.002; Lassa T., 2012, BEGINNING END DRIVIN; Li XH, 2017, MECH SYST SIGNAL PR, V87, P118, DOI 10.1016/j.ymssp.2015.10.021; Loh WY, 2011, WIRES DATA MIN KNOWL, V1, P14, DOI 10.1002/widm.8; Milton JC, 2008, ACCIDENT ANAL PREV, V40, P260, DOI 10.1016/j.aap.2007.06.006; National Highway Traffic Safety Administration, 2013, PREL STAT POL AUT VE, V1, P14; National Highway Traffic Safety Administration, 2016, FAT MOT VEH CRASH OV; National Transportation Safety Board, PREL REP HIGHW HWY18; National Transportation Safety Board, 2018, PREL REP ISS INV FAT; NCLS, 2020, P NAT C STAT LEG IND; Omidvar A, 2018, TRANSPORT RES REC, V2672, P45, DOI 10.1177/0361198118782798; Osman OA, 2019, ACCIDENT ANAL PREV, V123, P274, DOI 10.1016/j.aap.2018.12.005; SAE, 2021, SAE PUBL; SAE, 2018, TAX DEF TERMS REL ON; Schwarz C, TRANSFER HIGHLY AUTO; State of California Department of Motor Vehicles, DRIV TEST AUT VEH; State of California Department of Motor Vehicles, TEST AUT VEH DRIV; State of Nevada Department of Motor Vehicles, AUT VEH; Sun M, 2019, ACCIDENT ANAL PREV, V124, P50, DOI 10.1016/j.aap.2018.12.016; TESLA, FULL SELF DRIV HARDW; Wakabayashi D, 2018, SELF DRIVING UBER CA; Weng J, 2011, TRANSPORT RES REC, V1, P40; Weng JX, 2011, TRANSPORT RES REC, P40, DOI 10.3141/2257-05; Westreich D, 2010, J CLIN EPIDEMIOL, V63, P826, DOI 10.1016/j.jclinepi.2009.11.020; Yang B, 2019, IEEE ACCESS; Zhu M, 2017, MECH SYST SIGNAL PR, V87, P138, DOI 10.1016/j.ymssp.2016.03.003	49	23	23	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214550	10.1371/journal.pone.0214550	http://dx.doi.org/10.1371/journal.pone.0214550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921396	Green Submitted, gold, Green Published			2022-12-27	WOS:000462594000085
J	Bonora, G; Rubbi, L; Morselli, M; Ma, FY; Chronis, C; Plath, K; Pellegrini, M				Bonora, Giancarlo; Rubbi, Liudmilla; Morselli, Marco; Ma, Feiyang; Chronis, Constantinos; Plath, Kathrin; Pellegrini, Matteo			DNA methylation estimation using methylation-sensitive restriction enzyme bisulfite sequencing (MREBS)	PLOS ONE			English	Article							EPIGENETIC MEMORY; DISCOVERY; SITES	Whole-genome bisulfite sequencing (WGBS) and reduced representation bisulfite sequencing (RRBS) are widely used for measuring DNA methylation levels on a genome-wide scale. Both methods have limitations: WGBS is expensive and prohibitive for most large-scale projects; RRBS only interrogates 6-12% of the CpGs in the human genome. Here, we introduce methylation-sensitive restriction enzyme bisulfite sequencing (MREBS) which has the reduced sequencing requirements of RRBS, but significantly expands the coverage of CpG sites in the genome. We built a multiple regression model that combines the two features of MREBS: the bisulfite conversion ratios of single cytosines (as in WGBS and RRBS) as well as the number of reads that cover each locus (as in MRE-seq). This combined approach allowed us to estimate differential methylation across 60% of the genome using read count data alone, and where counts were sufficiently high in both samples (about 1.5% of the genome), our estimates were significantly improved by the single CpG conversion information. We show that differential DNA methylation values based on MREBS data correlate well with those based on WGBS and RRBS. This newly developed technique combines the sequencing cost of RRBS and DNA methylation estimates on a portion of the genome similar to WGBS, making it ideal for large-scale projects of mammalian genomes.	[Bonora, Giancarlo; Rubbi, Liudmilla; Morselli, Marco; Chronis, Constantinos; Plath, Kathrin; Pellegrini, Matteo] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Bonora, Giancarlo; Plath, Kathrin; Pellegrini, Matteo] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA; [Bonora, Giancarlo; Chronis, Constantinos; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Bonora, Giancarlo; Rubbi, Liudmilla; Morselli, Marco; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Bonora, Giancarlo] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Ma, Feiyang; Plath, Kathrin; Pellegrini, Matteo] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Plath, Kathrin; Pellegrini, Matteo] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Plath, K; Pellegrini, M (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.; Plath, K; Pellegrini, M (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA.; Plath, K (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA.; Pellegrini, M (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.; Plath, K; Pellegrini, M (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Plath, K; Pellegrini, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu; matteop@mcdb.ucla.edu	Ma, Feiyang/GLN-6180-2022; Morselli, Marco/AAF-3182-2019	Morselli, Marco/0000-0003-3351-5791; Plath, Kathrin/0000-0001-7796-3372; chronis, Constantinos/0000-0002-7783-8202; Pellegrini, Matteo/0000-0001-9355-9564	UCLA Philip Whitcome Pre-doctoral Training Fellowship; UCLA Dissertation Year Fellowship; UCLA Quantitative and Computational Biosciences Postdoctoral Fellowship; CIRM Training Grant; Leukemia and Lymphoma Research Visiting Fellowship [10040]; UCLA David Geffen School of Medicine; CIRM; NIH [P01 GM099134]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	UCLA Philip Whitcome Pre-doctoral Training Fellowship; UCLA Dissertation Year Fellowship; UCLA Quantitative and Computational Biosciences Postdoctoral Fellowship; CIRM Training Grant; Leukemia and Lymphoma Research Visiting Fellowship; UCLA David Geffen School of Medicine; CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.B. was supported by a UCLA Philip Whitcome Pre-doctoral Training Fellowship, a UCLA Dissertation Year Fellowship and a UCLA Quantitative and Computational Biosciences Postdoctoral Fellowship; CC by a CIRM Training Grant and a Leukemia and Lymphoma Research Visiting Fellowship (10040); M.M. was supported by a UCLA Philip Whitcome Pre-doctoral Training Fellowship and a UCLA Dissertation Year Fellowship. KP by the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, funds from the UCLA David Geffen School of Medicine, CIRM, and NIH P01 GM099134; and MP from NIH P01 GM099134.	Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Feng SH, 2011, METHODS MOL BIOL, V733, P223, DOI 10.1007/978-1-61779-089-8_16; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6619; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yang Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1572-7; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	28	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214368	10.1371/journal.pone.0214368	http://dx.doi.org/10.1371/journal.pone.0214368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946758	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500029
J	Hata, J; Nakashima, D; Tsuji, O; Fujiyoshi, K; Yasutake, K; Sera, Y; Komaki, Y; Hikishima, K; Nagura, T; Matsumoto, M; Okano, H; Nakamura, M				Hata, Junichi; Nakashima, Daisuke; Tsuji, Osahiko; Fujiyoshi, Kanehiro; Yasutake, Kaori; Sera, Yasushi; Komaki, Yuji; Hikishima, Keigo; Nagura, Takeo; Matsumoto, Morio; Okano, Hideyuki; Nakamura, Masaya			Noninvasive technique to evaluate the muscle fiber characteristics using q-space imaging	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; SKELETAL-MUSCLE; IN-VIVO; ISOFORMS; TIME; AGE; FEASIBILITY; EXPERIENCE; TISSUES; GENDER	Background Skeletal muscles include fast and slow muscle fibers. The tibialis anterior muscle (TA) is mainly composed of fast muscle fibers, whereas the soleus muscle (SOL) is mainly composed of slow muscle fibers. However, a noninvasive approach for appropriately investigating the characteristics of muscles is not available. Monitoring of skeletal muscle characteristics can help in the evaluation of the effects of strength training and diseases on skeletal muscles. Purpose The present study aimed to determine whether q-space imaging can distinguish between TA and SOL in in vivo mice. Methods In vivo magnetic resonance imaging of the right calves of mice (n = 8) was performed using a 7-Tesla magnetic resonance imaging system with a cryogenic probe. TA and SOL were assessed. q-space imaging was performed with a field of view of 10 mm x 10 mm, matrix of 48 x 48, and section thickness of 1000 mu m. There were ten b-values ranging from 0 to 4244 s/mm(2), and each b-value had diffusion encoding in three directions. Magnetic resonance imaging findings were compared with immunohistological findings. Results Full width at half maximum and Kurtosis maps of q-space imaging showed signal intensities consistent with immunohistological findings for both fast (myosin heavy chain II) and slow (myosin heavy chain I) muscle fibers. With regard to quantification, both full width at half maximum and Kurtosis could represent the immunohistological findings that the cell diameter of TA was larger than that of SOL (P < 0.01). Conclusion q-space imaging could clearly differentiate TA from SOL using differences in cell diameters. This technique is a promising method to noninvasively estimate the fiber type ratio in skeletal muscles, and it can be further developed as an indicator of muscle characteristics.	[Hata, Junichi; Komaki, Yuji; Hikishima, Keigo; Okano, Hideyuki] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Hata, Junichi; Okano, Hideyuki] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Hata, Junichi; Komaki, Yuji; Hikishima, Keigo; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo, Japan; [Nakashima, Daisuke; Tsuji, Osahiko; Fujiyoshi, Kanehiro; Yasutake, Kaori; Nagura, Takeo; Matsumoto, Morio; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo, Japan; [Fujiyoshi, Kanehiro] Murayama Med Ctr, Dept Orthopaed Surg, Tokyo, Japan; [Sera, Yasushi] Keio Univ, Sch Med, Inst Integrated Sports Med, Shinjuku Ku, Tokyo, Japan; [Hikishima, Keigo] Okinawa Inst Sci & Technol Grad Univ, Kunigami, Okinawa, Japan; [Nagura, Takeo] Keio Univ, Sch Med, Dept Clin Biomech, Shinjuku Ku, Tokyo, Japan	RIKEN; Keio University; Keio University; Keio University; Okinawa Institute of Science & Technology Graduate University; Keio University	Fujiyoshi, K; Nakamura, M (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo, Japan.; Fujiyoshi, K (corresponding author), Murayama Med Ctr, Dept Orthopaed Surg, Tokyo, Japan.	fujimik@tf7.so-net.ne.jp; masa@keio.jp	Okano, Hideyuki/X-9131-2019; Hikishima, Keigo/AAP-9586-2020; Okano, Hideyuki/I-7584-2019; Tsuji, Osahiko/AHB-2622-2022; Hata, Junichi/AAJ-8826-2020; Nakamura, Masaya/K-4111-2013	Okano, Hideyuki/0000-0001-7482-5935; Hikishima, Keigo/0000-0003-1133-1297; Nakashima, Daisuke/0000-0003-1105-2669; Komaki, Yuji/0000-0002-0250-0354	Japan Society for the Promotion of Science [17K10421]; Japan Agency for Medical Research and Development [JP17lm0203004j0001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was funded by the Japan Society for the Promotion of Science (17K10421) to Mr Junichi Hata and the Japan Agency for Medical Research and Development (JP17lm0203004j0001) to Dr. Masaya Nakamura. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LM, 2006, CELL TISSUE RES, V323, P283, DOI 10.1007/s00441-005-0057-4; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040; Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; Bar-Shir A, 2008, J MAGN RESON, V194, P230, DOI 10.1016/j.jmr.2008.07.009; Bar-Shir A, 2009, NEUROIMAGE, V48, P109, DOI 10.1016/j.neuroimage.2009.06.019; Bosshard SC, 2010, PAIN, V151, P655, DOI 10.1016/j.pain.2010.08.025; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Budzik JF, 2014, RADIOGRAPHICS, V34, pE56, DOI 10.1148/rg.343125062; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; Carroll S, 1999, AM J PHYSIOL-CELL PH, V277, pC1122, DOI 10.1152/ajpcell.1999.277.6.C1122; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Farrell JAD, 2008, MAGN RESON MED, V59, P1079, DOI 10.1002/mrm.21563; Fujiyoshi K, 2016, J NEUROSCI, V36, P2796, DOI 10.1523/JNEUROSCI.1770-15.2016; Galban CJ, 2007, J GERONTOL A-BIOL, V62, P453, DOI 10.1093/gerona/62.4.453; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; Hata J, 2018, JBMR PLUS; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Katsura M, 2014, J MAGN RESON IMAGING, V40, P1208, DOI 10.1002/jmri.24459; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kermarrec E, 2010, AM J ROENTGENOL, V195, pW352, DOI 10.2214/AJR.09.3368; Kern H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00189; Kikuchi N, 2013, INT J SPORT PHYSIOL, V8, P57, DOI 10.1123/ijspp.8.1.57; Kovanen V, 1989, Acta Physiol Scand Suppl, V577, P1; MA TH, 1993, J BIOL CHEM, V268, P22756; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Okamoto Y, 2010, MAGN RESON MED SCI, V9, P111, DOI 10.2463/mrms.9.111; Oudeman J, 2016, J MAGN RESON IMAGING, V43, P773, DOI 10.1002/jmri.25016; Padykula HA, 1967, MORPHOLOGICAL CYTOCH; Peng XG, 2017, J MAGN RESON IMAGING, V46, P61, DOI 10.1002/jmri.25546; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Punkt K, 1999, ACTA HISTOCHEM, V101, P53, DOI 10.1016/S0065-1281(99)80008-7; Punkt K, 1998, ACTA HISTOCHEM, V100, P37, DOI 10.1016/S0065-1281(98)80005-6; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; SCHRODER JM, 1978, ACTA NEUROCHIR, V43, P169; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Smerdu V, 2005, CELLS TISSUES ORGANS, V180, P106, DOI 10.1159/000086751; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stevens L, 1999, AM J PHYSIOL-CELL PH, V277, pC1044, DOI 10.1152/ajpcell.1999.277.6.C1044; Tanikawa M, 2017, J NEUROL SCI, V373, P352, DOI 10.1016/j.jns.2017.01.009; Taylor EN, 2015, BIOPHYS J, V108, P2740, DOI 10.1016/j.bpj.2015.03.061; Trappe T, 2009, APPL PHYSIOL NUTR ME, V34, P459, DOI 10.1139/H09-041; Yamada I, 2016, MAGN RESON MED, V76, P602, DOI 10.1002/mrm.25905; Yamada I, 2015, MAGN RESON MED, V73, P2262, DOI 10.1002/mrm.25334; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214805	10.1371/journal.pone.0214805	http://dx.doi.org/10.1371/journal.pone.0214805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947237	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500064
J	Schelfhout, S; Wille, B; Fonteyne, L; Roels, E; De Fruyt, F; Duyck, W				Schelfhout, Stijn; Wille, Bart; Fonteyne, Lot; Roels, Elisabeth; De Fruyt, Filip; Duyck, Wouter			The effects of vocational interest on study results: Student person - environment fit and program interest diversity	PLOS ONE			English	Article							INTEREST-MAJOR CONGRUENCE; HOLLANDS-THEORY; ACADEMIC-PERFORMANCE; METAANALYSIS; MOTIVATION; PERSONALITIES; PEOPLE; MODELS; CHOICE	The extent to which a good person-environment (PE) interest fit between student and study program leads to better study results in higher education is an ongoing debate wherein the role of the study program environment has remained inadequately studied. Unanswered questions include: how diverse study programs are in the interests of their student populations, and how this program interest diversity influences study results, in comparison to individual PE fit? The present study addressed these questions in students (N = 4,635) enrolled in open-access university education. In such an open access system, students are allowed to make study choices without prior limitations based on previous achievement or high stakes testing. Starting from the homogeneity assumption applied to this open access setting, we propose several hypotheses regarding program interest diversity, motivation, student-program interest fit, and study results. Furthermore, we applied a method of measuring interest diversity based on an existing measure of correlational person-environment fit. Results indicated that interest diversity in an open access study environment was low across study programs. Results also showed the variance present in program interest diversity was linked to autonomous and controlled motivation in the programs' student populations. Finally, program interest diversity better explained study results than individual student fit with their program of choice. Indeed, program interest diversity explained up to 44% of the variance in the average program's study results while individual student-program fit hardly predicted study success at all. Educational policy makers should therefore be aware of the importance of both interest fit and interest diversity during the process of study orientation.	[Schelfhout, Stijn; Roels, Elisabeth; Duyck, Wouter] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Ghent, Belgium; [Wille, Bart] Univ Ghent, Fac Psychol & Educ Sci, Dept Personnel Management Work & Org Psychol, Ghent, Belgium; [Fonteyne, Lot] Univ Ghent, Student Counseling Off, Dept Educ Policy, Campus UFO, Ghent, Belgium; [De Fruyt, Filip] Univ Ghent, Dept Dev Personal & Social Psychol, Fac Psychol & Educ Sci, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Schelfhout, S (corresponding author), Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Ghent, Belgium.	stijn.schelfhout@ugent.be	Schelfhout, Stijn/AAJ-1797-2021	Schelfhout, Stijn/0000-0001-9531-304X; Duyck, Wouter/0000-0003-2114-6212	Ghent University	Ghent University(Ghent University)	The study is part of a larger project called SIMON. This project is funded by Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2010, J COUNS PSYCHOL, V57, P23, DOI 10.1037/a0017267; ASSOULINE M, 1987, J VOCAT BEHAV, V31, P319, DOI 10.1016/0001-8791(87)90046-7; ASTIN AW, 1961, J EDUC PSYCHOL, V52, P308, DOI 10.1037/h0040137; Bradley-Geist JC, 2012, J BUS PSYCHOL, V27, P149, DOI 10.1007/s10869-011-9233-6; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; BROWNE MW, 1992, PSYCHOMETRIKA, V57, P469, DOI 10.1007/BF02294416; Burke MJ, 1999, ORGAN RES METHODS, V2, P49, DOI 10.1177/109442819921004; Burke MJ, 2002, ORGAN RES METHODS, V5, P159, DOI 10.1177/1094428102005002002; Burns ST, 2014, CAREER DEV Q, V62, P114, DOI 10.1002/j.2161-0045.2014.00074.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Donnay DAC, 1997, CAREER DEV Q, V46, P2, DOI 10.1002/j.2161-0045.1997.tb00688.x; Fonteyne L, 2017, INT J EDUC VOCAT GUI, V17, P233, DOI 10.1007/s10775-016-9327-9; Graham S, 2015, J EDUC PSYCHOL, V107, P1, DOI 10.1037/edu0000007; Grassi M, 2010, BEHAV RES METHODS, V42, P55, DOI 10.3758/BRM.42.1.55; Harris K. R., 2003, J EDUC PSYCHOL, V95, P451, DOI [DOI 10.1037/0022-0663.95.3.451, 10.1037/0022-0663.95.3.451]; Holland J.L., 1985, MAKING VOCATIONAL CH; Holland J.L, 1966, PSYCHOL VOCATIONAL C; HOLLAND JL, 1959, J COUNS PSYCHOL, V6, P35, DOI 10.1037/h0040767; HUBERT L, 1987, PSYCHOL BULL, V102, P172, DOI 10.1037/0033-2909.102.1.172; King DD, 2017, J BUS PSYCHOL, V32, P641, DOI 10.1007/s10869-016-9459-4; LENT RW, 1994, J VOCAT BEHAV, V45, P79, DOI 10.1006/jvbe.1994.1027; Linton R, 1945, CULTURAL BACKGROUND; Lubinski D, 1996, PSYCHOL PUBLIC POL L, V2, P363; Nauta MM, 2010, J COUNS PSYCHOL, V57, P11, DOI 10.1037/a0018213; Nye CD, 2012, PERSPECT PSYCHOL SCI, V7, P384, DOI 10.1177/1745691612449021; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Rounds J., 1995, ASSESSING INDIVIDUAL, P177; Rounds J, 2014, CURR DIR PSYCHOL SCI, V23, P98, DOI 10.1177/0963721414522812; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; SCHNEIDER B, 1987, PERS PSYCHOL, V40, P437, DOI 10.1111/j.1744-6570.1987.tb00609.x; Smart John C., 2000, ACAD DISCIPLINES HOL; Spokane AR, 2000, J VOCAT BEHAV, V57, P137, DOI 10.1006/jvbe.2000.1771; Su R, 2009, PSYCHOL BULL, V135, P859, DOI 10.1037/a0017364; SWANSON JL, 1988, J VOCAT BEHAV, V33, P185, DOI 10.1016/0001-8791(88)90055-3; Tinsley HEA, 2000, J VOCAT BEHAV, V56, P147, DOI 10.1006/jvbe.1999.1727; Toomey KD, 2009, J EMPLOYMENT COUNS, V46, P82, DOI 10.1002/j.2161-1920.2009.tb00070.x; Tracey TJG, 2006, J VOCAT BEHAV, V69, P64, DOI 10.1016/j.jvb.2005.11.003; Tracey TJG, 2012, J VOCAT BEHAV, V80, P38, DOI 10.1016/j.jvb.2011.03.005; Tracey TJG, 1997, EDUC PSYCHOL MEAS, V57, P164, DOI 10.1177/0013164497057001012; Tracey TJG, 1996, J VOCAT BEHAV, V48, P3, DOI 10.1006/jvbe.1996.0002; Tsabari O, 2005, J CAREER ASSESSMENT, V13, P216, DOI 10.1177/1069072704273165; Vansteenkiste M, 2009, J EDUC PSYCHOL, V101, P671, DOI 10.1037/a0015083; Wade M., 2009, HDB RES CONT THEORET, P529, DOI [10.4018/978-1-60566-659-4.ch030, DOI 10.4018/978-1-60566-659-4.CH03, 10.4018/978-1-60566-659-4.ch03]; WHITNEY DR, 1969, PERS GUID J, V48, P279, DOI 10.1002/j.2164-4918.1969.tb03318.x	44	9	9	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214618	10.1371/journal.pone.0214618	http://dx.doi.org/10.1371/journal.pone.0214618			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947274	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500046
J	Sorimachi, H; Kurosawa, K; Yoshida, K; Obokata, M; Noguchi, T; Naka, M; Tange, S; Kurabayashi, M; Negishi, K				Sorimachi, Hidemi; Kurosawa, Koji; Yoshida, Kuniko; Obokata, Masaru; Noguchi, Takashi; Naka, Minoru; Tange, Shoichi; Kurabayashi, Masahiko; Negishi, Kazuaki			Sex differences in left ventricular afterload and diastolic function are independent from the aortic size	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; CHRONIC HEART-FAILURE; ARTERIAL STIFFNESS; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; BLOOD-PRESSURE; GENDER; INDEX; AGE; ECHOCARDIOGRAPHY	Background Women have a greater risk of heart failure with preserved ejection fraction (HFPEF) than men do, yet the basis for this disparity remains unclear. Greater arterial stiffness and afterload causes left ventricular (LV) diastolic dysfunction, a central mechanism of HFPEF. Because of smaller body habitus, previous reports have used body surface area as a surrogate of the size of the aorta. We performed a comprehensive hemodynamic evaluation of elderly patients with preserved EF and evaluated sex differences in the associations between LV function and afterload, before and after adjusting for the aortic sizes. Methods and results Four hundred and forty-three patients (mean age: 73 years, 169 women) who underwent clinically indicated echocardiography and computed tomography (CT) were identified. Linear regression analyses were performed to assess the independent contributions of sex to and its interaction with LV function before and after adjusting for CT-derived aortic length and volume. Although blood pressures were similar between the sexes, women had greater arterial elastance, lower arterial compliance, and greater LV ejection fraction (all p<0.001). Sex differences were detected in the associations between LV afterload and relaxation (mitral e') as well as in the left atrial (LA) emptying fraction, but not in LA size. These differences remained significant after adjusting for the aortic length and volume. Sensitivity analyses in an age-matched subgroup (n = 324; 162 of each sex) confirmed the robustness of these sex disparities in LV diastolic function and afterload. Conclusion Women had worse LV relaxation than men did against the same degree of afterload, before and even after adjusting for the aortic sizes.	[Sorimachi, Hidemi; Kurosawa, Koji; Yoshida, Kuniko; Obokata, Masaru; Kurabayashi, Masahiko; Negishi, Kazuaki] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma, Japan; [Noguchi, Takashi; Naka, Minoru] Maebashi Red Cross Hosp, Dept Radiol, Maebashi, Gunma, Japan; [Tange, Shoichi] Maebashi Red Cross Hosp, Dept Cardiovasc Med, Maebashi, Gunma, Japan; [Negishi, Kazuaki] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Negishi, Kazuaki] Univ Sydney, Sydney Med Sch Nepean, Charles Perkins Ctr Nepean, Sydney, NSW, Australia	Gunma University; Maebashi Red Cross Hospital; Maebashi Red Cross Hospital; University of Tasmania; Menzies Institute for Medical Research; University of Sydney	Negishi, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma, Japan.	Kazuaki.Negishi@sydney.edu.au	; Negishi, Kazuaki/J-7242-2014	Kurosawa, Koji/0000-0003-1715-085X; Negishi, Kazuaki/0000-0002-9086-2565; Obokata, Masaru/0000-0002-5473-0688	National Heart Foundation	National Heart Foundation(National Heart Foundation of Australia)	KN is supported by an award from the National Heart Foundation (https://www.heartfoundation.org.au/), which had no role in the preparation of this manuscript.	Borlaug Barry A, 2008, Heart Fail Clin, V4, P23, DOI 10.1016/j.hfc.2007.10.001; Borlaug BA, 2011, CIRCULATION, V123, P2006, DOI 10.1161/CIRCULATIONAHA.110.954388; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Ceia F, 2002, EUR J HEART FAIL, V4, P531, DOI 10.1016/S1388-9842(02)00034-X; Chung AK, 2006, CIRCULATION, V113, P1597, DOI 10.1161/CIRCULATIONAHA.105.574400; Coutinho T, 2013, J AM COLL CARDIOL, V61, P96, DOI 10.1016/j.jacc.2012.08.997; Craiem D, 2016, REV ESP CARDIOL, V69, P827, DOI 10.1016/j.rec.2016.01.031; Dalzell JR, 2014, NEW ENGL J MED, V371, P179, DOI 10.1056/NEJMc1405715; Gerber Y, 2015, JAMA INTERN MED, V175, P996, DOI 10.1001/jamainternmed.2015.0924; Hiratzka Loren F, 2010, Catheter Cardiovasc Interv, V76, pE43; Ho JE, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.003116; KELLY RP, 1992, CIRCULATION, V86, P513, DOI 10.1161/01.CIR.86.2.513; Lam CSP, 2012, CIRC-HEART FAIL, V5, P571, DOI 10.1161/CIRCHEARTFAILURE.112.970061; LANG RM, 1986, CIRCULATION, V74, P1114, DOI 10.1161/01.CIR.74.5.1114; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; Masri A, 2016, CIRCULATION, V134, P1724, DOI 10.1161/CIRCULATIONAHA.116.022995; Mirea O, 2013, J AM SOC ECHOCARDIOG, V26, P419, DOI 10.1016/j.echo.2012.12.013; Mottram PM, 2005, HEART, V91, P1551, DOI 10.1136/hrt.2004.046805; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Negishi K, 2016, AM J HYPERTENS, V29, P1070, DOI 10.1093/ajh/hpw039; Nichols W W, 2001, J Cardiovasc Pharmacol Ther, V6, P5, DOI 10.1177/107424840100600102; Obokata M, 2017, J AM SOC ECHOCARDIOG, V30, P444, DOI 10.1016/j.echo.2016.12.014; Obokata M, 2015, AM HEART J, V169, P523, DOI 10.1016/j.ahj.2015.02.003; Picone DS, 2017, J AM COLL CARDIOL, V70, P572, DOI 10.1016/j.jacc.2017.05.064; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0735-1097(02)02981-9; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Russo C, 2012, HYPERTENSION, V60, P362, DOI 10.1161/HYPERTENSIONAHA.112.191148; Shim CY, 2011, J AM COLL CARDIOL, V57, P1226, DOI 10.1016/j.jacc.2010.09.067; STERGIOPULOS N, 1994, ANN BIOMED ENG, V22, P392, DOI 10.1007/BF02368245; Ujino K, 2006, AM J CARDIOL, V98, P1185, DOI 10.1016/j.amjcard.2006.05.040; Wolak A, 2008, JACC-CARDIOVASC IMAG, V1, P200, DOI 10.1016/j.jcmg.2007.11.005; Yoshida K, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004999; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	34	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214907	10.1371/journal.pone.0214907	http://dx.doi.org/10.1371/journal.pone.0214907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947284	Green Published, gold, Green Accepted			2022-12-27	WOS:000463314500082
J	Andrade, VLC; Flores, BM; Levis, C; Clement, CR; Roberts, P; Schongart, J				Caetano Andrade, Victor L.; Flores, Bernardo M.; Levis, Carolina; Clement, Charles R.; Roberts, Patrick; Schongart, Jochen			Growth rings of Brazil nut trees (Bertholletia excelsa) as a living record of historical human disturbance in Central Amazonia	PLOS ONE			English	Article							SEASONAL TROPICAL FOREST; RAIN-FOREST; DRY FOREST; PATTERNS; DOMESTICATION; DROUGHT; RECRUITMENT; IMPACT; AGE; CONSEQUENCES	The Brazil nut tree (Bertholletia excelsa) is an iconic and economically valuable species that dominates vast swathes of the Amazon Basin. This species seems to have been an important part of human subsistence strategies in the region from at least the Early Holocene, and its current distribution may be a legacy of past human settlement. Because B. excelsa is a long-lived pioneer tree it requires natural or human disturbances to increase light availability in the understory for a successful establishment. However, it remains unclear how the long-term population dynamics of this species have been shaped by pre-colonial and post-colonial human practices. Here, we use tree-ring analyses to look at changes in growing conditions over the past 400 years in a Brazil nut tree population in Central Amazonia. We identify changes in tree recruitment and growth rates associated not only with regional climatic variability, but also major political and socio-economic activities recorded by historical documents in the vicinity of Manaus. We demonstrate that the expansion of a post-colonial political center (Manaus) from the middle of the 18th century onwards coincided with a reduction in recruitment of B. excelsa. We argue that this hiatus suggests the interruption of indigenous management practices, probably due to the collapse of pre-Columbian societies. A second recruitment pulse, and unprecedented cycles of growth release and suppression, aligns with a shift to modern exploitation of the forest into the 20th century. Our findings shed light on how past histories of human-forest interactions can be revealed by the growth rings of trees in Amazonia. Future interdisciplinary analysis of these trees should enable more detailed investigation of how human forest management has changed in this part of the world, through pre-colonial, colonial, and industrial periods of human activity, with potential implications for conservation.	[Caetano Andrade, Victor L.; Levis, Carolina; Clement, Charles R.; Schongart, Jochen] Inst Nacl de Pesquisas da Amazonia, Manaus, AM, Brazil; [Caetano Andrade, Victor L.; Roberts, Patrick] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Thuringen, Germany; [Flores, Bernardo M.] Univ Estadual Campinas, Inst Biol, Dept Biol Vegetal, Campinas, SP, Brazil; [Levis, Carolina] Wageningen Univ & Res, Forest Ecol & Forest Management Grp, Wageningen, Netherlands	Institute Nacional de Pesquisas da Amazonia; Universidade de Sao Paulo; Universidade Estadual de Campinas; Wageningen University & Research	Andrade, VLC (corresponding author), Inst Nacl de Pesquisas da Amazonia, Manaus, AM, Brazil.; Andrade, VLC (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Thuringen, Germany.	caetano_andrade@shh.mpg.de	Clement, Charles Roland/G-6081-2010	Clement, Charles Roland/0000-0002-8421-1029; Schongart, Jochen/0000-0002-7696-9657; Roberts, Patrick/0000-0002-4403-7548; Caetano Andrade, Victor Lery/0000-0002-1333-569X	Dendroecology Laboratory of the Ecology, Monitoring and Sustainable Use of Wetlands Research Group (MAUA) at the National Institute for Amazonian Research; CAPES (Comissao de Aperfeicoamento de Pessoal do Nivel Superior); Sao Paulo Research Foundation [2016/25086-3]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CNPq; Max Planck Society	Dendroecology Laboratory of the Ecology, Monitoring and Sustainable Use of Wetlands Research Group (MAUA) at the National Institute for Amazonian Research; CAPES (Comissao de Aperfeicoamento de Pessoal do Nivel Superior); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Support for this study was provided by the Dendroecology Laboratory of the Ecology, Monitoring and Sustainable Use of Wetlands Research Group (MAUA) at the National Institute for Amazonian Research. Victor L. Caetano Andrade thanks CAPES (Comissao de Aperfeicoamento de Pessoal do Nivel Superior) for a Master's degree scholarship, Bernardo M. Flores is funded by Sao Paulo Research Foundation Grant {2016/25086-3}, Carolina Levis thanks CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) for a doctoral degree scholarship, Charles R. Clement thanks CNPq for a research fellowship, Patrick Roberts and Victor L. Caetano Andrade thank the Max Planck Society for funding and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Almeida JJ, 2016, 6 C INT HIST EC 8 EN, P1; Amoroso MR, 2009, HIST INDIOS BRASIL, P297; Antunes AP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600936; Arroyo-Kalin M., 2010, Diversity, V2, P473; Arroyo-Kalin M, 2012, QUATERN INT, V249, P4, DOI 10.1016/j.quaint.2011.08.004; Baker PJ, 2006, J TROP ECOL, V22, P521, DOI 10.1017/S0266467406003312; Baker PJ, 2005, ECOL MONOGR, V75, P317, DOI 10.1890/04-0488; Baker PJ, 2003, ECOL APPL, V13, P1718, DOI 10.1890/02-5025; Balee W, 2006, ANNU REV ANTHROPOL, V35, P75, DOI 10.1146/annurev.anthro.35.081705.123231; Benchimol S, 1947, GROWTH CITY AMAZON V; Benchimol S, 1977, POUCO ANTES ALEM DEP; Brasil. Projeto Radambrasil, 1973, LEVANTAMENTO RECURSO, P34; Brienen RJW, 2006, J ECOL, V94, P481, DOI 10.1111/j.1365-2745.2005.01080.x; Brienen RJW, 2005, OECOLOGIA, V146, P1, DOI 10.1007/s00442-005-0160-y; Brienen RJW, 2010, GLOBAL CHANGE BIOL, V16, P2001, DOI 10.1111/j.1365-2486.2009.02059.x; Brienen RJW, 2010, OECOLOGIA, V163, P485, DOI 10.1007/s00442-009-1540-5; Burslem DFRP, 2000, J ECOL, V88, P1063, DOI 10.1046/j.1365-2745.2000.00517.x; Caldas YP, 2007, ANAIS DO SETA2007, P1981; Camargo P. B. de, 1994, Scientia Agricola, V51, P389; Cintra BBL, 2013, BIOGEOSCIENCES, V10, P7759, DOI 10.5194/bg-10-7759-2013; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Costa VP, 2013, MURAIDA TRADICAOLITE; CUNHA M. C., POLITICA INDIGENISTA; Dawkins H.C., 1978, LONG TERM SURVEILLAN; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Fauset S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7857; Forline L, 2008, J ECOL ANTHR, V12, P69; Granato-Souza D, 2019, CLIM DYNAM, V52, P1857, DOI 10.1007/s00382-018-4227-y; Guariguata MR, 2017, BIODIVERS CONSERV, V26, P2007, DOI 10.1007/s10531-017-1355-3; Portes MCGD, 2018, ANTHROPOCENE, V24, P61, DOI 10.1016/j.ancene.2018.11.004; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hecht S.B., 2013, SCRAMBLE AMAZON LOST; Heckenberger MJ, 2008, SCIENCE, V321, P1214, DOI 10.1126/science.1159769; Hemming J, 1995, RED GOLD CONQUEST BR; Herraiz AD, 2017, FOREST ECOL MANAG, V406, P46, DOI 10.1016/j.foreco.2017.09.053; Iriarte J, 2007, ENVIRON ARCHAEOL, V12, P115, DOI 10.1179/174963107x226390; Kainer KA, 2006, J TROP ECOL, V22, P147, DOI 10.1017/S0266467405002981; Leite E, 2000, NOTORIOS REBELDES EX, P1; Levis C, 2017, SCIENCE, V355, P925, DOI 10.1126/science.aal0157; Levis C, 2013, ANTES ORELLANA, P305; Levis C, 2018, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00171; Levis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048559; Locosselli GM, 2016, TREES-STRUCT FUNCT, V30, P1127, DOI 10.1007/s00468-015-1351-8; Maezumi SY, 2018, NATURE PLANTS, V23; Marengo JA, 2016, INT J CLIMATOL, V36, P1033, DOI 10.1002/joc.4420; McClenachan L, 2015, BIOSCIENCE, V65, P932, DOI 10.1093/biosci/biv100; McMichael CH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2475; McMichael CNH, 2017, P NATL ACAD SCI USA, V114, P522, DOI 10.1073/pnas.1614577114; Meggers BJ, 1974, ENV CULTURE AMAZONIA, P911; Metcalfe DB, 2010, NEW PHYTOL, V187, P608, DOI 10.1111/j.1469-8137.2010.03319.x; Mori S. A., 1990, Advances in Economic Botany, V8, P130; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Neves EG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P29, DOI 10.1007/1-4020-2597-1_3; Neves EG, 2004, AMAZONIAN DARK EARTHS: EXPLORATIONS IN SPACE AND TIME, P125; Nimuendaj? Curt., 1948, HDB S AM INDIANS, V3, P255; Nowacki GJ, 1997, ECOL MONOGR, V67, P225, DOI 10.1890/0012-9615(1997)067[0225:RGACFR]2.0.CO;2; O'Fallon BD, 2011, P NATL ACAD SCI USA, V108, P20444, DOI 10.1073/pnas.1112563108; Paiva PM, 2011, FOREST ECOL MANAG, V261, P508, DOI 10.1016/j.foreco.2010.11.001; Pequeno ED, 2006, REV ESTUDOS PESQUISA, V3, P133; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Porcher V, 2018, FOREST ECOL MANAG, V427, P52, DOI 10.1016/j.foreco.2018.05.052; Potts MD, 2003, J ECOL, V91, P467, DOI 10.1046/j.1365-2745.2003.00779.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Ribeiro MBN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102187; Roberts P, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.93; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Roosevelt AC, 1996, SCIENCE, V274, P1823; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P115, DOI 10.1007/s00468-010-0478-x; Schongart J, 2015, BIOTROPICA, V47, P550, DOI 10.1111/btp.12243; Scoles R., 2014, B MUS EM LIO GOELDI, V9, P321; Scoles R, 2011, HUM ECOL, V39, P455, DOI 10.1007/s10745-011-9412-0; Scrucca L, 2016, R J, V8, P289; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Silva AG, 2008, ALDEIAS INDIGENAS MU; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Souza M, 2009, HIST DA AMAZONIA; Sternberg H.O.R, 1998, AGUA HOMEM VARZEA CA; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Thomas E, 2015, J BIOGEOGR, V42, P1367, DOI 10.1111/jbi.12540; Vandermeer J, 2000, SCIENCE, V290, P788, DOI 10.1126/science.290.5492.788; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Vlam M, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01984; Worbes M, 1999, IAWA J, V20, P255, DOI 10.1163/22941932-90000689; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018	88	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214128	10.1371/journal.pone.0214128	http://dx.doi.org/10.1371/journal.pone.0214128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943230	gold, Green Submitted, Green Published			2022-12-27	WOS:000463194300032
J	Garcia-Jaramillo, M; Spooner, MH; Lohr, CV; Wong, CP; Zhang, WJ; Jump, DB				Garcia-Jaramillo, Manuel; Spooner, Melinda H.; Lohr, Christiane V.; Wong, Carmen P.; Zhang, Weijian; Jump, Donald B.			Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female LdIr(-/-) mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MASS-SPECTROMETRIC ANALYSIS; HEPATIC STEATOSIS; DOCOSAHEXAENOIC ACID; METABOLIC SYNDROME; AMERICAN ASSOCIATION; PRACTICE GUIDELINE; ARACHIDONIC-ACID; NATURAL-HISTORY; SEX-DIFFERENCES	Background Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, particularly in obese and type 2 diabetic individuals. NAFLD ranges in severity from benign steatosis to nonalcoholic steatohepatitis (NASH); and NASH can progress to cirrhosis, primary hepatocellular carcinoma (HCC) and liver failure. As such, NAFLD has emerged as a major public health concern. Herein, we used a lipidomic and transcriptomic approach to identify lipid markers associated with western diet (WD) induced NASH in female mice. Methods Female mice (low-density lipoprotein receptor null (LdIr(-/-)) were fed a reference or WD diet for 38 and 46 weeks. Transcriptomic and lipidomic approaches, coupled with statistical analyses, were used to identify associations between major NASH markers and transcriptomic & lipidomic markers. Results The WD induced all major hallmarks of NASH in female Ldlr(-/-)r mice, including steatosis (SFA, MUFA, MUFA-containing di- and triacylglycerols), inflammation (TNF alpha), oxidative stress (Ncf2), and fibrosis (Coll A). The WD also increased transcripts associated with membrane remodeling (LpCat), apoptosis & autophagy (Caspl, CtsS), hedgehog (Taz) & notch signaling (Hey1), epithelial-mesenchymal transition (S1004A) and cancer (Gpc3). WD feeding, however, suppressed the expression of the hedgehog inhibitory protein (Hhip), and enzymes involved in triglyceride catabolism (Tgh/Ces3, Ces1 g), as well as the hepatic abundance of C18-22 PUFA-containing phosphoglycerolipids (GpCho, GpEtn, GpSer, Gpins). WD feeding also increased hepatic cyclooxygenase (Cox1 & 2) expression and pro-inflammatory omega 6 PUFA-derived oxylipins (PGE2), as well as lipid markers of oxidative stress 8-iso-PGF2 alpha). The WD suppressed the hepatic abundance of reparative oxylipins (19, 20-DiHDPA) as well as the expression of enzymes involved in fatty epoxide metabolism (Cyp2C, Ephx). Conclusion WD-induced NASH in female LdIr(-/-) mice was characterized by a massive increase in hepatic neutral and membrane lipids containing SFA and MUFA and a loss of C18-22 PUFA-containing membrane lipids. Moreover, the WD increased hepatic pro-inflammatory oxylipins and suppressed the hepatic abundance of reparative oxylipins. Such global changes in the type and abundance of hepatic lipids likely contributes to tissue remodeling and NASH severity.	[Garcia-Jaramillo, Manuel; Spooner, Melinda H.; Wong, Carmen P.; Jump, Donald B.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA; [Garcia-Jaramillo, Manuel; Spooner, Melinda H.; Wong, Carmen P.; Zhang, Weijian; Jump, Donald B.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Garcia-Jaramillo, Manuel] Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA; [Lohr, Christiane V.] Oregon State Univ, Carlson Coll Vet Med, Anat Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Jump, DB (corresponding author), Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA.; Jump, DB (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.	Donald.Jump@oregonstate.edu	Löhr, C. V./AAU-4902-2020	Löhr, C. V./0000-0003-3787-5583; Garcia-Jaramillo, Manuel/0000-0003-2987-2913	National Institutes of Health (NIH) [DK094600, DK112360]; Linus Pauling Institute (LPI) at Oregon State University; National Institutes of Health [NIH 1S10RR022589-01, NIH 1S10RR027878-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112360] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Linus Pauling Institute (LPI) at Oregon State University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by grants from the National Institutes of Health (NIH) to DBJ (DK094600 and DK112360). Additionally, WZ was the recipient of discretionary funds from the Linus Pauling Institute (LPI) at Oregon State University. The Oregon State University Mass Spectrometry Center received the following instrumentation grants from the National Institutes of Health for instruments used in this study: NIH 1S10RR022589-01 [Applied Biosystems 4000 Qtrap] and NIH 1S10RR027878-01 [ABSciex TripleToF 5600]. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Competing interests: The authors have declared	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617; Aukema HM, 2016, LIPIDS, V51, P591, DOI 10.1007/s11745-015-4074-0; Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1; Barupal DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15231-w; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Cajka T, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0929-x; Cajka T, 2014, TRAC-TREND ANAL CHEM, V61, P192, DOI 10.1016/j.trac.2014.04.017; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chalasani NP, 2009, CONTEMP CLIN TRIALS, V30, P88, DOI 10.1016/j.cct.2008.09.003; Chang WH, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0845-y; Chen HY, 2013, CANCER LETT, V336, P204, DOI 10.1016/j.canlet.2013.04.031; Choi J, 2015, J LIPID RES, V56, P1182, DOI 10.1194/jlr.M058941; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Ciccimaro E, 2010, BIOANALYSIS, V2, P311, DOI 10.4155/BIO.09.185; CLARKE SD, 1990, J NUTR, V120, P225, DOI 10.1093/jn/120.2.225; CLARKE SD, 1990, J NUTR, V120, P218, DOI 10.1093/jn/120.2.218; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; Depner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083756; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Depner CM, 2012, J NUTR, V142, P1495, DOI 10.3945/jn.112.158865; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gassaway BM, 2018, P NATL ACAD SCI USA, V115, pE8996, DOI 10.1073/pnas.1804379115; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hernandez C, 2018, J CLIN INVEST, V128, P2436, DOI 10.1172/JCI91786; Housley L, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700665; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Inceoglu B, 2017, PROSTAG OTH LIPID M, V133, P68, DOI 10.1016/j.prostaglandins.2017.08.003; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Jump DB, 2016, P NUTR SOC, V75, P1, DOI 10.1017/S002966511500244X; Jump DB, 2011, BIOCHEM PHARMACOL, V81, P649, DOI 10.1016/j.bcp.2010.12.014; Kanda T, 2018, WORLD J GASTROENTERO, V24, P2661, DOI 10.3748/wjg.v24.i25.2661; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Kim DH, 2016, CELL REP, V17, P1671, DOI 10.1016/j.celrep.2016.10.023; Kirkwood JS, 2012, J BIOL CHEM, V287, P3833, DOI 10.1074/jbc.M111.316018; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Leslie M, 2015, SCIENCE, V347, P1058, DOI 10.1126/science.347.6226.1058; Lian JH, 2012, HEPATOLOGY, V56, P2154, DOI 10.1002/hep.25881; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Liang XR, 2011, BIOANALYSIS, V3, P1923, DOI [10.4155/bio.11.181, 10.4155/BIO.11.181]; Link JC, 2017, ANNU REV NUTR, V37, P225, DOI 10.1146/annurev-nutr-071816-064827; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lytle KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173376; Lytle KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146942; Lytle KA, 2015, J LIPID RES, V56, P1936, DOI 10.1194/jlr.M061275; Machado MV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060857; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Maciejewska D, 2015, PROSTAG OTH LIPID M, V121, P184, DOI 10.1016/j.prostaglandins.2015.09.003; Mater MK, 1999, J LIPID RES, V40, P1045; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; McCullough AJ, 2011, J DIGEST DIS, V12, P333, DOI 10.1111/j.1751-2980.2010.00469.x; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Norheim F, 2017, J LIPID RES, V58, P178, DOI 10.1194/jlr.M071522; Owada S, 2018, ONCOL REP, V39, P1805, DOI 10.3892/or.2018.6279; Pan JJ, 2014, WORLD J HEPATOL, V6, P274, DOI 10.4254/wjh.v6.i5.274; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; Park HG, 2016, BBA-MOL CELL BIOL L, V1861, P91, DOI 10.1016/j.bbalip.2015.11.007; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Peyta L, 2015, BBA-MOL CELL BIOL L, V1851, P1490, DOI 10.1016/j.bbalip.2015.08.008; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prashanth M, 2009, J Assoc Physicians India, V57, P205; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Reue K, 2017, PHYSIOL BEHAV, V176, P174, DOI 10.1016/j.physbeh.2017.02.040; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schuck RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110162; Showalter MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190632; Gasparin FRS, 2018, BBA-MOL BASIS DIS, V1864, P2495, DOI 10.1016/j.bbadis.2018.04.004; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Sparks JD, 2008, J CLIN INVEST, V118, P2012, DOI 10.1172/JCI35693; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; Strazzabosco M, 2012, GASTROENTEROLOGY, V143, P1430, DOI 10.1053/j.gastro.2012.10.025; Sugden MC, 2003, OBES RES, V11, P167, DOI 10.1038/oby.2003.26; Sun CX, 2016, CELL REP, V17, P2015, DOI 10.1016/j.celrep.2016.10.070; Swiderska-Syn M, 2013, HEPATOLOGY, V57, P1814, DOI 10.1002/hep.26230; Tao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071997; Tripathy S, 2014, J LIPID RES, V55, P1448, DOI 10.1194/jlr.M050062; Tripathy S, 2010, J LIPID RES, V51, P2642, DOI 10.1194/jlr.M006080; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wang Y, 2014, J CHROMATOGR A, V1359, P60, DOI 10.1016/j.chroma.2014.07.006; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu XR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623509; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zechner R, 2017, NAT REV MOL CELL BIO, V18, P671, DOI 10.1038/nrm.2017.76; Zhang H, 2013, J LIPID RES, V54, P345, DOI 10.1194/jlr.M028969; Zhang J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011130; Zheng X, 2010, MOL MED REP, V3, P965, DOI 10.3892/mmr.2010.375	109	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214387	10.1371/journal.pone.0214387	http://dx.doi.org/10.1371/journal.pone.0214387			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943218	gold, Green Published, Green Submitted			2022-12-27	WOS:000463194300034
J	Guthrie, JL; Marchand-Austin, A; Cronin, K; Lam, K; Pyskir, D; Kong, C; Jorgensen, D; Rodrigues, M; Roth, D; Tang, P; Cook, VJ; Johnston, J; Jamieson, FB; Gardy, JL				Guthrie, Jennifer L.; Marchand-Austin, Alex; Cronin, Kirby; Lam, Karen; Pyskir, Daria; Kong, Clare; Jorgensen, Danielle; Rodrigues, Mabel; Roth, David; Tang, Patrick; Cook, Victoria J.; Johnston, James; Jamieson, Frances B.; Gardy, Jennifer L.			Universal genotyping reveals province-level differences in the molecular epidemiology of tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BRITISH-COLUMBIA; TRANSMISSION; POPULATION; OUTBREAK; STRAINS; CANADA	Objectives Compare the molecular epidemiology of tuberculosis (TB) between two large Canadian provinces-Ontario and British Columbia (BC)-to identify genotypic clusters within and across both provinces, allowing for an improved understanding of genotype data and providing context to more accurately identify clusters representing local transmission. Design We compared 24-locus Mycobacterial Interspersed Repetitive Units-Variable Number of Tandem Repeats (MIRU-VNTR) genotyping for 3,314 Ontario and 1,602 BC clinical Mycobacterium tuberculosis isolates collected from 2008 through 2014. Laboratory data for each isolate was linked to case-level records to obtain clinical and demographic data. Results The demographic characteristics of persons with TB varied between provinces, most notably in the proportion of persons born outside Canada, which was reflected in the large number of unique genotypes (n = 3,461). The proportion of clustered isolates was significantly higher in BC. Substantial clustering amongst non-Lineage 4 TB strains was observed within and across the provinces. Only two large clusters (>= 10 cases/cluster) representing within province transmission had interprovincial genotype matches. Conclusion We recommend expanding analysis of shared genotypes to include neighbouring jurisdictions, and implementing whole genome sequencing to improve identification of TB transmission, recognize outbreaks, and monitor changing trends in TB epidemiology.	[Guthrie, Jennifer L.; Gardy, Jennifer L.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Guthrie, Jennifer L.; Marchand-Austin, Alex; Cronin, Kirby; Lam, Karen; Pyskir, Daria; Jamieson, Frances B.] Publ Hlth Ontario, Toronto, ON, Canada; [Cronin, Kirby] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Kong, Clare; Jorgensen, Danielle; Rodrigues, Mabel; Tang, Patrick] British Columbia Ctr Dis Control, Publ Hlth Lab, Vancouver, BC, Canada; [Roth, David; Cook, Victoria J.; Johnston, James; Gardy, Jennifer L.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Tang, Patrick] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Cook, Victoria J.; Johnston, James] Univ British Columbia, Resp Med, Vancouver, BC, Canada; [Jamieson, Frances B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of British Columbia; Public Health Agency of Canada; University of British Columbia; University of British Columbia; University of Toronto	Guthrie, JL (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Guthrie, JL (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	jennifer.guthrie@alumni.ubc.ca	Guthrie, Jennifer/ABE-2378-2021	Guthrie, Jennifer/0000-0001-8565-203X; Cronin, Kirby/0000-0002-5124-3446	2008-2009 OPS Innovation Fund (Ontario Ministry of Government and Consumer Services) [08507]; British Columbia Centre for Disease Control Foundation for Population and Public Health; British Columbia Lung Association; University of British Columbia; Canadian Institutes of Health Research; Canada Research Chairs Program; Killam Trusts; Michael Smith Foundation	2008-2009 OPS Innovation Fund (Ontario Ministry of Government and Consumer Services); British Columbia Centre for Disease Control Foundation for Population and Public Health; British Columbia Lung Association; University of British Columbia; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Killam Trusts; Michael Smith Foundation(Michael Smith Foundation for Health Research)	This work was supported in part by the 2008-2009 OPS Innovation Fund (Ontario Ministry of Government and Consumer Services; https://www.ontario.ca/page/ministry-government-and-consumer-services) grant number 08507, and the British Columbia Centre for Disease Control Foundation for Population and Public Health (http://bccdcfoundation.org/), and the British Columbia Lung Association (https://bc.lung.ca/).Financial support was obtained from the University of British Columbia (https://www.ubc.ca/) 4-year doctoral fellowship to J. L. Guthrie, the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) doctoral research award to J. L. Guthrie, Killam Trusts (http://www.killamlaureates.ca/) doctoral scholarship to J. L. Guthrie, the Michael Smith Foundation (https://www.msfhr.org/) scholar awards to J. J. and J. L. Gardy, and the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/) to J. L. Gardy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, INT J TUBERC LUNG D, V14, P1350; Allidina A, 2015, LINKING SERVICES OUT; Aze J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130912; Canada Statistics, 2017, ANN DEM EST CAN PROV; Cheng JM, 2015, EPIDEMIOL INFECT, V143, P3220, DOI 10.1017/S0950268815000825; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Eberle MP, 2001, HOMELESSNESS CAUSES, V2; Fiebig L, 2017, EUROSURVEILLANCE, V22, P15, DOI 10.2807/1560-7917.ES.2017.22.2.30439; FitzGerald JM, 2003, INT J TUBERC LUNG D, V7, P132; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Garzelli C, 2012, INFECT GENET EVOL, V12, P610, DOI 10.1016/j.meegid.2011.10.015; Guthrie JL, 2018, CLIN INFECT DIS, V66, P849, DOI 10.1093/cid/cix906; Guthrie JL, 2017, J AM MED INFORM ASSN, V24, pE136, DOI 10.1093/jamia/ocw130; Hamblion EL, 2016, THORAX, V71, P749, DOI 10.1136/thoraxjnl-2014-206608; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P3795, DOI 10.1128/JCM.01726-14; Jonsson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095159; Lambregts-van Weezenbeek CSB, 2003, INT J TUBERC LUNG D, V7, pS463; Lathan M, 2002, EMERG INFECT DIS, V8, P1249; Mears J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1023; Mehaffy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112928; Menendez MC, 2007, TUBERCULOSIS, V87, P426, DOI 10.1016/j.tube.2007.05.017; Mitruka K, 2014, PUBLIC HEALTH REP, V129, P78, DOI 10.1177/003335491412900112; Montoya Jaime C, 2013, Kekkaku, V88, P543; Murdie RA, 2011, DIVERSITY CONCENTRAT; Palittapongarnpim P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29986-3; Public Health Agency of Canada, 2014, CANADIAN TUBERCULOSI; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Sloot R, 2013, J CLIN MICROBIOL, V51, P2427, DOI 10.1128/JCM.00489-13; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Statistic Canada, 2011, IMM ETHN DIV CAN; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Vachon J, 2018, TUBERCULOSIS CANADA, V44; Wyllie DH, 2018, EBIOMEDICINE, V34, P122, DOI 10.1016/j.ebiom.2018.07.019	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214870	10.1371/journal.pone.0214870	http://dx.doi.org/10.1371/journal.pone.0214870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943250	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300065
J	Yu, WS; Suh, JW; Song, SH; Paik, HC; Kim, SY; Park, MS; Lee, JG				Yu, Woo Sik; Suh, Jee Won; Song, Seung Hwan; Paik, Hyo Chae; Kim, Song Yee; Park, Moo Suk; Lee, Jin Gu			The lung allocation score could evaluate allocation systems in countries that do not use the score	PLOS ONE			English	Article							TRANSPLANTATION; OXYGENATION; EXPERIENCE; SURVIVAL	Background Evaluating allocation system effects on lung transplantation and determining systemic flaws is difficult. The purpose of this study was to assess the Korean urgency-based lung allocation system using the lung allocation score. Methods We reviewed transplantation patients retrospectively. Candidates were classified into groups based on urgency. Status 0 designated hospitalized patients requiring ventilator and/or extracorporeal life support. The lung allocation score was calculated based on the recipient's condition at transplantation. Results One-hundred-twenty-three Status 0, 1, and 2/3 patients (40, 71, and 12, respectively) were enrolled. The median waiting time was 68 days. Nineteen Status 0 patients who received lung transplants deteriorated from non-Status 0 (median, 64 days). The lung allocation score showed a bimodal distribution (peaks around 45 and 90, corresponding with non-Status 0 and Status 0, respectively). Status 0 and the lung allocation score were independent risk factors for poor survival after adjustment for confounders (Status 0, hazard ratio, 2.788, p = 0.001; lung allocation score, hazard ratio, 1.025, p < 0.001). The lung allocation score cut-off for survival was 44. On dividing the non-Status 0 patients into 2 groups using the cutoff values and regrouping into Status 0, non-Status 0 with high lung allocation score (> 44), and non-Status 0 with low lung allocation score (< 44), we observed that non-Status 0 with high lung allocation score patients had better survival than Status 0 patients (p = 0.020) and poorer survival than non-Status 0 with low lung allocation score patients (p = 0.018). Conclusions The LAS demonstrated the characteristics of LTx recipients in Korea and the Korean allocation system needs to be revised to reduce the number of patients receiving LTx in Status 0. The LAS system could be used as a tool to evaluate lung allocation systems in countries that do not use the LAS system.	[Yu, Woo Sik] Ajou Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Suwon, South Korea; [Suh, Jee Won; Song, Seung Hwan; Paik, Hyo Chae; Lee, Jin Gu] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Kim, Song Yee; Park, Moo Suk] Yonsei Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med,Yonsei Univ Hlth Syst, Seoul, South Korea	Ajou University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JG (corresponding author), Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.	csjglee@yuhs.ac		Suh, Jee Won/0000-0003-0287-0651; Yu, Woo Sik/0000-0002-5100-9131; Kim, Song Yee/0000-0001-8627-486X; Song, Seung Hwan/0000-0002-3910-5585; Park, Moo Suk/0000-0003-0820-7615; Paik, Hyo Chae/0000-0001-9309-8235				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boussaud V, 2012, TRANSPLANTATION, V93, P1058, DOI 10.1097/TP.0b013e31824d7079; Egan TM, 2016, J HEART LUNG TRANSPL, V35, P433, DOI 10.1016/j.healun.2016.01.010; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Gottlieb J, 2017, J THORAC DIS, V9, P2670, DOI 10.21037/jtd.2017.07.83; Jeong Yong Ho, 2018, Korean J Thorac Cardiovasc Surg, V51, P22, DOI 10.5090/kjtcs.2018.51.1.22; Kotloff RM, 2011, AM J RESP CRIT CARE, V184, P159, DOI 10.1164/rccm.201101-0134CI; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Lee HJ, 2015, TRANSPL P, V47, P2737, DOI 10.1016/j.transproceed.2015.09.061; Maxwell BG, 2014, AM J TRANSPLANT, V14, P2288, DOI 10.1111/ajt.12903; Maxwelll BG, 2015, AM J RESP CRIT CARE, V191, P302, DOI 10.1164/rccm.201408-1562OC; Orsini B, 2014, EUR J CARDIO-THORAC, V46, pE41, DOI 10.1093/ejcts/ezu259; Riou J, 2017, ERJ OPEN RES, V3; Russo MJ, 2010, CHEST, V137, P651, DOI 10.1378/chest.09-0319; Schuba B, 2018, EUR J CARDIO-THORAC, V54, P328, DOI 10.1093/ejcts/ezy035; Yu WS, 2016, J THORAC DIS, V8, P1712, DOI 10.21037/jtd.2016.06.18; Yuan JD, 2014, CANCER IMMUNOL RES, V2, P127, DOI 10.1158/2326-6066.CIR-13-0163	17	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214853	10.1371/journal.pone.0214853	http://dx.doi.org/10.1371/journal.pone.0214853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943262	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300064
J	Consoli, F; Manganoni, AM; Grisanti, S; Petrelli, F; Venturini, M; Rangoni, G; Guarneri, F; Incardona, P; Vermi, W; Pinton, PGC; Berruti, A				Consoli, Francesca; Manganoni, Ausilia Maria; Grisanti, Salvatore; Petrelli, Fausto; Venturini, Marina; Rangoni, Giovanni; Guarneri, Francesco; Incardona, Paolo; Vermi, William; Pinton, Pier Giacomo Calzavara; Berruti, Alfredo			Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy	PLOS ONE			English	Article							V600-MUTANT METASTATIC MELANOMA; POOLED ANALYSIS; DABRAFENIB; TRAMETINIB; SURVIVAL; VEMURAFENIB; OUTCOMES	Panniculitis and vitiligo-like lesions have been recently identified as rare cutaneous side effects of the combination of BRAF and MEK inhibitors, a standard of care in metastatic and locally advanced BRAF V600 mutated melanoma. An immune-mediated mechanism has been advocated in the pathogenesis of these skin lesions. Herein we retrospectively reviewed our institutional experience with the aim to explore the association between the occurrence of panniculitis and vitiligo-like lesions during combination therapy with dabrafenib (D) and trametinib (T) and outcome of advanced melanoma patients. Among 52 consecutive BRAF V600 mutated melanoma patients submitted to DT in our center, 12 (23%) developed immune related skin lesions (IRSLs): 8 panniculitis and 4 vitiligo. Patients with IRSLs diagnosis obtained a better disease response (83% versus 25%) (p = 0.001) than their counterpart and had a longer progression free survival and overall survival. The association of IRSLs and lower risk of disease progression (HR 0.19; CI 95% 0.04-0.90; p = 0.043) was confirmed after adjusting for major prognostic factors in multivariate analysis. IRSLs might represent an easy predictive surrogate marker for treatment response and favourable outcome in melanoma patients submitted to DT combination therapy.	[Consoli, Francesca; Grisanti, Salvatore; Rangoni, Giovanni; Berruti, Alfredo] Univ Brescia ASST Spedali Civili, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Med Oncol, Brescia, Italy; [Manganoni, Ausilia Maria; Venturini, Marina; Pinton, Pier Giacomo Calzavara] Univ Brescia ASST Spedali Civili, Dept Dermatol, Brescia, Italy; [Petrelli, Fausto] ASST Bergamo Ovest, Oncol Unit, Treviglio, Italy; [Guarneri, Francesco] ASST Spedali Civili, Dept Pharm, Brescia, Italy; [Incardona, Paolo] ASST Spedali Civili, Dept Lab Med, Unit Pathol, Brescia, Italy; [Vermi, William] Univ Brescia ASST Spedali Civili, Sch Med, Sect Pathol, Dept Mol & Translat Med, Brescia, Italy	Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia	Consoli, F (corresponding author), Univ Brescia ASST Spedali Civili, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Med Oncol, Brescia, Italy.	francesca.consoli@icloud.com	calzavara-pinton, piergiacomo/AAH-5597-2021; Berruti, Alfredo/AAC-2069-2019					Ascierto PA, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1468955; Ben-Betzalel G, 2018, EUR J CANCER, V101, P229, DOI 10.1016/j.ejca.2018.06.030; de Golian E, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0434-0; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Galliker NA, 2015, EUR J DERMATOL, V25, P177, DOI 10.1684/ejd.2014.2512; Hauschild A, 2018, JAMA ONCOL, V4, P1382, DOI 10.1001/jamaoncol.2018.2668; Long GV, 2017, ANN ONCOL, V28, P1631, DOI 10.1093/annonc/mdx176; Long GV, 2018, J CLIN ONCOL, V36, P667, DOI 10.1200/JCO.2017.74.1025; Long GV, 2016, LANCET ONCOL, V17, P1743, DOI 10.1016/S1470-2045(16)30578-2; Long GV, 2016, J CLIN ONCOL, V34, P871, DOI 10.1200/JCO.2015.62.9345; Manganoni AM, 2012, GIORN ITAL DERMAT V, V147, P210; Mossner R, 2015, J EUR ACAD DERMATOL, V29, P1797, DOI 10.1111/jdv.13039; Nasca MR, 2016, J DRUGS DERMATOL, V15, P766; Renner K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00248; Ruiz-Villaverde R, 2016, BALK MED J, V33, P115, DOI 10.5152/balkanmedj.2015.15157; Schadendorf D, 2017, EUR J CANCER, V82, P45, DOI 10.1016/j.ejca.2017.05.033; Yan Y, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw379.3	17	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214884	10.1371/journal.pone.0214884	http://dx.doi.org/10.1371/journal.pone.0214884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939167	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900046
J	Sarin, S; Huddart, S; Raizada, N; Parija, D; Kalra, A; Rao, R; Salhotra, VS; Khaparde, SD; Boehme, C; Denkinger, CM; Sohn, H				Sarin, Sanjay; Huddart, Sophie; Raizada, Neeraj; Parija, Debadutta; Kalra, Aakshi; Rao, Raghuram; Salhotra, Virender Singh; Khaparde, Sunil D.; Boehme, Catharina; Denkinger, Claudia M.; Sohn, Hojoon			Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India	PLOS ONE			English	Article								Background Outreach and promotion programs are essential to ensuring uptake of new public health interventions and guidelines. We assessed the costs and operation dynamics of outreach and promotion efforts for up front Xpert MTB/RIF (Xpert) testing for pediatric presumptive tuberculosis (TB) patients in four major Indian cities. Methods Xpert test costs were assessed as weighted average per-test costs based on the daily workload dynamics matched by test volume specific Xpert unit cost at each study site. Costs of outreach programs to recruit health providers to refer pediatric patients for Xpert testing were assessed as cost per referral for each quarter based on total program costs and referral data. All costs were assessed in the health service provider's perspective and expressed in 2015 USD. Results Weighted average per-test costs ranged from $14.71 to $17.81 at the four laboratories assessed. Differences between laboratories were associated with unused testing capacity and/or frequencies of overtime work to cope with increasing demand and same-day testing requirements. Outreach activities generated between 825 and 2,065 Xpert testing referrals on average each quarter across the four study sites, translating into $0.63 to $2.55 per patient referred. Overall outreach costs per referral decreased with time, stabilizing at an average cost of $1.10, and demonstrated a clear association with increased referrals. Conclusions Xpert test and outreach program costs within and across study sites were mainly driven by the dynamics of Xpert testing demand resulting from the combined outreach activities. However, these increases in demand required considerable overtime work resulting in additional costs and operational challenges at the study laboratories. Therefore, careful laboratory operational adjustment should be evaluated at target areas in parallel to the anticipated demand from the Xpert referral outreach program scale-up in other Indian regions.	[Sarin, Sanjay; Raizada, Neeraj; Parija, Debadutta; Kalra, Aakshi] Fdn Innovat New Diagnost, New Delhi, India; [Huddart, Sophie] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Huddart, Sophie] McGill Int TB Ctr, Montreal, PQ, Canada; [Rao, Raghuram; Salhotra, Virender Singh; Khaparde, Sunil D.] Govt India, Cent TB Div, New Delhi, India; [Boehme, Catharina; Denkinger, Claudia M.] Fdn Innovat New Diagnost, Geneva, Switzerland; [Sohn, Hojoon] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Foundation For Innovative New Diagnostics; McGill University; Foundation For Innovative New Diagnostics; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sohn, H (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	hsohn6@jhu.edu	Huddart, Sophie/AAF-8844-2020; Sohn, Hojoon/AAL-2856-2020	Huddart, Sophie/0000-0001-6425-3371; Sohn, Hojoon/0000-0001-5837-3844; Raizada, Neeraj/0000-0003-2116-332X	United States Agency for International Development (USAID) under the Challenge TB project	United States Agency for International Development (USAID) under the Challenge TB project(United States Agency for International Development (USAID))	The FIND/RNTCP pediatric GeneXpert implementation project was funded by United States Agency for International Development (USAID) under the Challenge TB project. FIND was responsible for the implementation, training, coordination, monitoring, data analysis and writing of the report in close coordination with the Central TB Division, Ministry of Health and Family Welfare, Government of India.	[Anonymous], 2009, FINANCIAL MANAGEMENT; Bratt JH, 1999, HEALTH POLICY PLANN, V14, P374, DOI 10.1093/heapol/14.4.374; Central TB Division, 2017, DRAFT NAT STRAT PLAN; Cunnama L, 2016, HEALTH ECON, V25, P53, DOI 10.1002/hec.3295; Edejer T, 2003, MAKING CHOICES HLTH; IPAQT, IN PROM AFF QUAL TB; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Raizada N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193194; Rupert S, 2016, BOTTOM UP TOP DOWN U, V21, P375; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, 2017, GLOB TUB REP	11	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214675	10.1371/journal.pone.0214675	http://dx.doi.org/10.1371/journal.pone.0214675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30933997	gold, Green Published, Green Submitted			2022-12-27	WOS:000462867000035
J	Woldemichael, A; Takian, A; Sari, AA; Olyaeemanesh, A				Woldemichael, Abraha; Takian, Amirhossein; Sari, Ali Akbari; Olyaeemanesh, Alireza			Availability and inequality in accessibility of health centre-based primary healthcare in Ethiopia	PLOS ONE			English	Article							SERVICE DELIVERY; COVERAGE; ACCESS; LESSONS; SYSTEMS	Background Achieving fair access to healthcare and improving population health are crucial in all settings. Properly staffed and fairly distributed primary health care (PHC) facilities are prerequisites to ensure accessible healthcare services. Nevertheless, availability and accessibility issues are common public health concerns, especially in under-resourced countries including Ethiopia. Measuring inequalities in accessibility of healthcare resources guide policy decisions to improve PHC services and ultimately achieving universal health coverage (UHC). Purpose To assess availability and measure magnitude and trend of inequalities in accessibility of health centre-based PHC resources in Ethiopia during 2015 to 2017. Methods We conducted a cross-sectional population-based analysis of district-level data collected from 16th December 2017 until 24th May 2018. Afar, Dire-Dawa, and Tigray regions were purposefully included in the study to represent the four pastoralist/semi-pastoralist, three urban and four agrarian regions in Ethiopia, respectively. We used ratios, different inequality indices and Gini decomposition techniques to characterise the inequalities. Results In 2017, median of health centres (HCs) per 15,000 inhabitants and their Gini indices (GIs) for Afar, Dire-Dawa, and Tigray were 0.781, 0.566, 0.591 vs. 0.237, 0.280, 0.216 respectively. Median overall skilled health workers (SHWs) per 10,000 inhabitants were 5.250, 7.539, and 6.246, respectively. These accounted for 11.80%, 16.94% and 14.04% of the WHO target of 44.5 to achieve SDGs. The corresponding GIs for the regions were 0.347, 0.186 and 0.175. Despite a higher overall SHWs inequality in the urban districts of Tigray (GI = 0.301), only Tigray showed significant inequality reductions in GHE (p < 0.001) and in all categories of SHWs (p < 0.05). Conclusions Our analysis provided a clear picture of availability and inequalities in PHC resources across three regions in Ethiopia. Identifying contributing factors to low densities and high inequalities of SHWs may help improve PHC services nationwide, along with pathway towards UHC.	[Woldemichael, Abraha; Takian, Amirhossein; Sari, Ali Akbari] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran; [Woldemichael, Abraha] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Takian, Amirhossein] Univ Tehran Med Sci, Sch Publ Hlth, Dept Global Hlth & Publ Policy, Tehran, Iran; [Takian, Amirhossein; Olyaeemanesh, Alireza] Univ Tehran Med Sci, HERC, Tehran, Iran; [Olyaeemanesh, Alireza] Natl Inst Hlth Res, Tehran, Iran	Tehran University of Medical Sciences; Mekelle University; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Takian, A (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran.; Takian, A (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Global Hlth & Publ Policy, Tehran, Iran.; Takian, A (corresponding author), Univ Tehran Med Sci, HERC, Tehran, Iran.	takian@tums.ac.ir	Olyaeemanesh, Alireza/ABB-8563-2020; Woldemichael, Abraha/P-2266-2017	Woldemichael, Abraha/0000-0001-6246-9013; nouhi, mojtaba/0000-0002-4466-8403	Tehran University of Medical Sciences [9323476001]; Mekelle University, Ethiopia [CRPO/CHS/PhD/MU-NMBU/019/2010]	Tehran University of Medical Sciences(Tehran University of Medical Sciences); Mekelle University, Ethiopia	AW received a small PhD student research grant from Tehran University of Medical Sciences (grant number: 9323476001) and Mekelle University, Ethiopia (grant number: CRPO/CHS/PhD/MU-NMBU/019/2010).	Balabanova D, 2011, GOOD HLTH LOW COST 2; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Berdine GG, 2017, AM J MED SCI, V354, P445, DOI 10.1016/j.amjms.2017.09.013; Bobo FT, 2018, BMC RES NOTES, V11, P11, DOI [10.1186/s13104-017-3119-2, DOI 10.1186/S13104-017-3119-2]; Brudney D, 2016, THEOR MED BIOETH, V37, P249, DOI 10.1007/s11017-016-9376-6; Chaya N, 2007, RES COMMENT, V2, P1; Chen L, 2006, WORLD HLTH REP; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093267; Costa-Font J, 2007, HEALTH ECON, V16, P291, DOI 10.1002/hec.1154; Das J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1716; De Maio FG, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052969; Dreesch N, 2005, HEALTH POLICY PLANN, V20, P267, DOI 10.1093/heapol/czi036; Durojaye E, 2018, GLOB PUBLIC HEALTH, V13, P1399, DOI 10.1080/17441692.2017.1377745; Epstein M. J., 2011, Innovations: Technology / Governance / Globalisation, V6, P117, DOI 10.1162/INOV_a_00073; Ethiopian Standard Agency, 2012, ES3611 ETH STAND AG; Fisseha G, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2125-3; Gabrani J, 2015, MANAG HLTH, V19, P12; Graham B, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3221-8; Hanlon M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-416; Jenkins SP, 2009, UK STAT US GROUP M, V11; Jin C, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0195-6; King R, 2016, DEV PRACT, V26, P158, DOI 10.1080/09614524.2016.1131244; Lechthaler F, 2018, TROP MED INT HEALTH, V23, P1033, DOI 10.1111/tmi.13120; Liu JX, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0187-2; Lucas K, 2016, TRANSPORTATION, V43, P473, DOI 10.1007/s11116-015-9585-2; Macaia D, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0255-7; Marozzi M, 2018, SOC INDIC RES, V136, P1237, DOI 10.1007/s11205-016-1440-0; Mugisha Frederick, 2010, Cost Eff Resour Alloc, V8, P19, DOI 10.1186/1478-7547-8-19; Mussard S., 2003, EC B, V4, P1; Neutens T, 2010, ENVIRON PLANN A, V42, P1613, DOI 10.1068/a4230; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Obrist B, 2007, PLOS MED, V4, P1584, DOI 10.1371/journal.pmed.0040308; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Pallikadavath S, 2013, HEALTH PLACE, V23, P26, DOI 10.1016/j.healthplace.2013.05.003; Panda B, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1784-9; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Politzer RM, 2001, MED CARE RES REV, V58, P234, DOI 10.1177/107755870105800205; Pozo-Martin F, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0190-7; Ram-Tiktin E, 2012, ETHICAL THEORY MORAL, V15, P337, DOI 10.1007/s10677-011-9322-7; Reich MR, 2016, LANCET, V387, P811, DOI 10.1016/S0140-6736(15)60002-2; Sambo LG, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/s12914-014-0028-5; Schraufnagel AM, 2017, AM J MED SCI, V354, P447, DOI 10.1016/j.amjms.2017.10.001; Shorrocks A, 2005, J ECON GEOGR, V5, P59, DOI 10.1093/jnlecg/lbh054; Tandi TE, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0172-0; Tao Y, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0010-x; van Weel C, 2017, EUR J GEN PRACT, V24, P39, DOI 10.1080/13814788.2017.1397624; Willcox ML, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0073-8; Wiseman V, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0575-1; World Health Organization, 2016, HUM RESOUR HLTH OBS, V17	49	21	21	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0213896	10.1371/journal.pone.0213896	http://dx.doi.org/10.1371/journal.pone.0213896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9FO	30925153	Green Published, Green Submitted, gold			2022-12-27	WOS:000462732300007
J	Gregorio, ER; Medina, JRC; Lomboy, MFTC; Talaga, ADP; Hernandez, PMR; Kodama, M; Kobayashi, J				Gregorio, Ernesto R., Jr.; Medina, John Robert C.; Lomboy, Marian Fe Theresa C.; Talaga, Andre Dominic P.; Hernandez, Paul Michael R.; Kodama, Mitsuya; Kobayashi, Jun			Knowledge, attitudes, and practices of public secondary school teachers on Zika Virus Disease: A basis for the development of evidence-based Zika educational materials for schools in the Philippines	PLOS ONE			English	Article								The Philippines is at risk in developing a Zika Virus (ZIKV) Disease Outbreak. One of the possible interventions is health education because students are potential health advocates and influencers to their communities through the knowledge transfers from their teachers. The competency of Filipino teachers on ZIKV Disease is yet to be described. This study aimed to assess the knowledge, attitudes, and practices of public secondary school teachers on ZIKV Disease. A modified version of the Knowledge, Attitudes, and Practices Survey Tool on Zika Virus Disease from the World Health Organization-Pan American Health Organization (WHO-PAHO) was used to assess the knowledge, attitudes, and practices of teachers of eight public secondary schools in five villages in Quezon City, Philippines. Out of the 609 respondents, 87.3% reported that their main source of information about ZIKV is tri-media, which includes television, print, and radio. Majority of the respondents mentioned that ZIKV is transmitted through a mosquito bite (80.3%). However, only half of the participants identified vector control as a preventive strategy. Moreover, only 54% admitted to have cleaned their water containers or water sources within the last week. Only a few identified mother-to-child (23%) and sexual intercourse (8%) as other means of transmission. Half (49.8%) of the respondents felt that it is possible to acquire ZIKV in their community, while 90% perceived that a private doctor (90%) or a public hospital (88%) can effectively treat the disease. Perceived stigma is high at 50%. This study showed there was good knowledge among teachers on vector transmission of ZIKV but poor knowledge on other aspects of the disease. Also, there was a low level of perceived susceptibility and severity ZIKV which can be explained by the absence of a personal encounter with a Zika patient and the low number of cases in the Philippines. Half of the respondents said that they cleaned the possible mosquito breeding sites within the last week, followed by those who cleaned their water source more than a week ago (19%). None of the socio-demographic characteristics is significantly associated with respondents' knowledge on Zika. Only income and location of residence were found to be significantly associated with attitudes towards Zika. These findings call for a comprehensive training program that includes development of teaching materials for public secondary school teachers on ZIKV Disease based from this study.	[Gregorio, Ernesto R., Jr.; Medina, John Robert C.; Talaga, Andre Dominic P.; Kodama, Mitsuya; Kobayashi, Jun] Univ Philippines Manila, SEAMEO TROPMED Reg Ctr Publ Hlth Hosp Adm & Envir, Coll Publ Hlth, Dept Hlth Promot & Educ, Manila, Philippines; [Lomboy, Marian Fe Theresa C.; Hernandez, Paul Michael R.] Univ Philippines Manila, SEAMEO TROPMED Reg Ctr Publ Hlth Hosp Adm & Envir, Coll Publ Hlth, Dept Environm & Occupat Hlth, Manila, Philippines; [Gregorio, Ernesto R., Jr.; Medina, John Robert C.; Kodama, Mitsuya; Kobayashi, Jun] Univ Ryukyus, Grad Sch Hlth Sci, Dept Global Hlth, Nishihara, Okinawa, Japan; [Kobayashi, Jun] Univ Ryukyus, Japanese Consortium Global Sch Hlth Res, Nishihara, Okinawa, Japan	University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; University of the Ryukyus; University of the Ryukyus	Gregorio, ER (corresponding author), Univ Philippines Manila, SEAMEO TROPMED Reg Ctr Publ Hlth Hosp Adm & Envir, Coll Publ Hlth, Dept Hlth Promot & Educ, Manila, Philippines.; Gregorio, ER (corresponding author), Univ Ryukyus, Grad Sch Hlth Sci, Dept Global Hlth, Nishihara, Okinawa, Japan.	ergregorio@up.edu.ph	Hernandez, Paul Michael/AAP-9266-2021; Medina, John Robert/AGL-6564-2022	Hernandez, Paul Michael/0000-0003-0528-9766; Medina, John Robert/0000-0001-6647-5453; Gregorio, Ernesto Jr/0000-0003-1931-0458	Okinawa Prefecture of Japan	Okinawa Prefecture of Japan	JK received a funding from the Okinawa Prefecture of Japan. http://www.infection.okinawa/.Okinawa Prefecture had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo-Frimpong G, 2017, ANN GLOB HEALTH, V83, P59; Alvarez LS, 2017, OPEN PUBLIC HLTH J, V10; [Anonymous], 2003, BUILD TEACH QUAL WHA; [Anonymous], 2017, ABS CBN NEWS    0203; Arief M., 2017, J PHARM PRACTICE COM, V3, P81, DOI [10.5530/jppcm.2017.2.20, DOI 10.5530/JPPCM.2017.2.20, DOI 10.5530/jppcm.2017.2.20]; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Bonalos P, 2016, CNN PHILIPPINES 0817; Bulario JS, 2018, KNE SOC SCI, V3, P891; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Casapulla SL, 2018, AIMS PUBLIC HEALTH, V5, P49, DOI 10.3934/publichealth.2018.1.49; Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875; Chaw LL, 2018, ASIAN PAC J TROP MED, V11, P638, DOI 10.4103/1995-7645.246340; Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6; Department of Health, DIS SURV 2015 DENG M; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013; Heitzinger Kristen, 2018, Prev Med Rep, V10, P20, DOI 10.1016/j.pmedr.2018.01.002; Huang Y, 2017, JMIR PUBLIC HLTH SUR, V3, DOI DOI 10.1186/S12889-017-4991-3; Jayawardene WP, 2011, J SCHOOL HEALTH, V81, P566, DOI 10.1111/j.1746-1561.2011.00628.x; Katler Quinton, 2017, Infect Dis Obstet Gynecol, V2017, P6350602, DOI 10.1155/2017/6350602; Lohrmann C, 2000, J ADV NURS, V31, P696, DOI 10.1046/j.1365-2648.2000.01326.x; Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367; Mwamwenda TS, MEDITERRANEAN J SOCI, V5, P500; Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050; Philippine Statistics Authority, 2016, 2015 FULL YEAR OFF P; Philippine Statistics Authority (PSA) and ICF, 2018, KEY FIND PHIL NAT DE; Plaster AN, 2018, J COMMUNITY HLTH, P1; Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3; Tun MMN, 2018, AM J TROP MED HYG, V98, P868, DOI 10.4269/ajtmh.17-0708; Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024; Whiteman A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6172-4; World Health Organization, 2016, KNOWL ATT PRACT SURV; World Health Organization [ WHO]/ PAHO, 2016, ZIK STRAT RESP PLAN; World Health Organization [ WHO]/ PAHO, 2016, ZIK STRAT RESP PLAN	36	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214515	10.1371/journal.pone.0214515	http://dx.doi.org/10.1371/journal.pone.0214515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921441	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000079
J	Dinh, KM; Kaspersen, KA; Mikkelsen, S; Pedersen, OB; Petersen, MS; Thorner, LW; Hjalgrim, H; Rostgaard, K; Ullum, H; Erikstrup, C				Khoa Manh Dinh; Kaspersen, Kathrine Agergard; Mikkelsen, Susan; Pedersen, Ole Birger; Petersen, Mikkel Steen; Thorner, Lise Wegner; Hjalgrim, Henrik; Rostgaard, Klaus; Ullum, Henrik; Erikstrup, Christian			Low-grade inflammation is negatively associated with physical Health-Related Quality of Life in healthy individuals: Results from The Danish Blood Donor Study (DBDS)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SELF-RATED HEALTH; CORONARY-HEART-DISEASE; SUBJECTIVE HEALTH; MENTAL-HEALTH; MISSING DATA; WOMEN; RISK; DISTRIBUTIONS; MORTALITY	Background Health-Related Quality of Life (HRQL) represent individuals' subjective assessment of their mental and physical well-being, and is highly predictive of future health. C-reactive protein (CRP) is a well-established marker of inflammation. Low-grade inflammation (LGI), defined as slightly increased CRP levels, is associated with increased risk of several diseases. LGI may reflect subclinical pathology, which could affect individual's subjective health assessment. This study aimed to examine whether LGI has an independent impact on self-reported health or rather is a mediator of a confounder in a large population of healthy individuals. Methods Plasma CRP levels were measured in 17,024 participants from the Danish Blood Donor Study (DBDS). All participants completed a standard questionnaire including smoking status, and the 12-item short-form health survey (SF-12), which is a widely used scale for HRQL. SF-12 is reported as a mental (MCS) and physical (PCS) score. The relationship between LGI (defined as a plasma CRP level between 3 mg/L and 10 mg/L) and MCS or PCS was explored by mediation analysis and adjusted multivariable linear regression analysis. Multiple imputation modelling was used to remedy missing values. The analyses were stratified according to sex and use of combined oral contraception (OC). Results In the study, 1,542 (10.3%) participants had LGI. PCS was associated with LGI in all strata, i.e. women using OC: RC = -0.36 points lower PCS in participants with LGI vs no LGI, CI: -0.94 to -0.19, women not using OC: RC = -0.63, CI: -1.05 to -0.21 and men: RC = -0.76, CI: -1.10 to -0.42. But LGI had no impact on MCS. Predictors of lower PCS included obesity, current smoking, and waist circumference in all strata. Physical activity in leisure time was the only factor positively associated with PCS. Age and physical activity in leisure time was associated with increased MCS in all strata whereas current smoking was the only strong predictor of a reduction in MCS. Only a small effect of smoking on PCS was mediated through LGI. Conclusion In this population of healthy individuals, LGI had independent impact on lower self-rated physical health score in HRQL in both sexes, but was not associated with self-rated mental health score. A small and significant effect of smoking on physical health score was mediated through LGI.	[Khoa Manh Dinh; Kaspersen, Kathrine Agergard; Mikkelsen, Susan; Petersen, Mikkel Steen; Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [Pedersen, Ole Birger] Naestved Hosp, Dept Clin Immunol, Naestved, Denmark; [Thorner, Lise Wegner; Ullum, Henrik] Rigshosp, Copenhagen Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark; [Hjalgrim, Henrik; Rostgaard, Klaus] Statens Serum Inst, Epidemiol Res, Copenhagen, Denmark; [Hjalgrim, Henrik] Rigshosp, Copenhagen Univ Hosp, Dept Haematol, Copenhagen, Denmark	Aarhus University; Naestved Hospital; Rigshospitalet; University of Copenhagen; Statens Serum Institut; Rigshospitalet; University of Copenhagen	Dinh, KM (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark.	khoadinh@rm.dk	Hjalgrim, Henrik/AAG-4973-2021; Pedersen, Ole Birger/W-8679-2019	Pedersen, Ole Birger/0000-0003-2312-5976; Erikstrup, Christian/0000-0001-6551-6647; Kaspersen, Kathrine Agergard/0000-0002-7973-3623; Thorner, Lise Wegner/0000-0003-4391-4956; Ullum, Henrik/0000-0001-7306-9058; Rostgaard, Klaus/0000-0001-6220-9414; Mikkelsen, Susan/0000-0001-7806-1143; Dinh, Khoa Manh/0000-0003-1881-5673				Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Andreasson AN, 2013, J HEALTH PSYCHOL, V18, P311, DOI 10.1177/1359105311435428; Bjorner JB., 2003, DANISH SF 36 MANUAL; Christian LM, 2011, PSYCHONEUROENDOCRINO, V36, P1495, DOI 10.1016/j.psyneuen.2011.04.003; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Fielding R, 2004, BRIT J HEALTH PSYCH, V9, P523, DOI 10.1348/1359107042304533; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gill SC, 2007, PSYCHIAT RES, V152, P63, DOI 10.1016/j.psychres.2006.11.005; Grad E, 2013, BLOOD REV, V27, P23, DOI 10.1016/j.blre.2012.12.001; Grossmann I, 2010, P NATL ACAD SCI USA, V107, P7246, DOI 10.1073/pnas.1001715107; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Haveman-Nies A, 2003, AM J PUBLIC HEALTH, V93, P318, DOI 10.2105/AJPH.93.2.318; Imhof A, 2003, CLIN CHEM, V49, P669, DOI 10.1373/49.4.669; Ishii S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036062; Janszky I, 2005, BRAIN BEHAV IMMUN, V19, P555, DOI 10.1016/j.bbi.2005.01.001; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kaspersen KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164220; Kaspersen KA, 2015, EPIDEMIOLOGY, V26, P580, DOI 10.1097/EDE.0000000000000301; Krauss RM, 2000, STROKE, V31, P2751, DOI 10.1161/01.STR.31.11.2751; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Lee J, 2009, RESP MED, V103, P1286, DOI 10.1016/j.rmed.2009.04.003; Lekander M, 2004, PSYCHOSOM MED, V66, P559, DOI 10.1097/01.psy.0000130491.95823.94; Leshem-Rubinow E, 2015, ISR MED ASSOC J, V17, P213; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Molarius A, 2007, EUR J PUBLIC HEALTH, V17, P125, DOI 10.1093/eurpub/ckl070; Moller L, 1996, J EPIDEMIOL COMMUN H, V50, P423, DOI 10.1136/jech.50.4.423; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P2423, DOI 10.1002/art.20431; Nielsen ABS, 2009, SCAND J PRIM HEALTH, V27, P160, DOI 10.1080/02813430903020446; Pedersen OB, 2012, VOX SANG, V102, P271, DOI 10.1111/j.1423-0410.2011.01553.x; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Perneger TV, 2005, J CLIN EPIDEMIOL, V58, P142, DOI 10.1016/j.jclinepi.2004.06.005; Rifai N, 2003, CLIN CHEM, V49, P666, DOI 10.1373/49.4.666; Rigas AS, 2015, TRANSFUSION, V55, P1752, DOI 10.1111/trf.13085; Rigas AS, 2014, TRANSFUSION, V54, P789, DOI 10.1111/trf.12518; Saarni SI, 2007, J CLIN EPIDEMIOL, V60, P1288, DOI 10.1016/j.jclinepi.2007.03.004; Shanahan L, 2014, BRAIN BEHAV IMMUN, V36, P139, DOI 10.1016/j.bbi.2013.10.020; Sorensen CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088196; Steenstrup T, 2013, TWIN RES HUM GENET, V16, P670, DOI 10.1017/thg.2013.21; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tanno K, 2012, J PSYCHOSOM RES, V73, P225, DOI 10.1016/j.jpsychores.2012.05.013; Thomas ML, 2016, J CLIN PSYCHIAT, V77, pE1019, DOI 10.4088/JCP.16m10671; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; Unden AL, 2007, CLIN SCI, V112, P363, DOI 10.1042/CS20060128; Wang HM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-246; Warnoff C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009440	47	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214468	10.1371/journal.pone.0214468	http://dx.doi.org/10.1371/journal.pone.0214468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921429	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000074
J	Lee, KH; Min, BJ; Kim, JH				Lee, Kye Hwa; Min, Byung Joo; Kim, Ju Han			Personal genome testing on physicians improves attitudes on pharmacogenomic approaches	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; CARE; PERSPECTIVES; INTEGRATION; MEDICINE; GENETICS; OUTCOMES; DESIGN	In this era of clinical genomics, the accumulation of knowledge of pharmacogenomics (PGx) is rising dramatically and attempts to utilize it in clinical practice are also increasing. However, this advanced knowledge and information have not yet been sufficiently utilized in the clinical field due to various barriers including physician factors. This study was conducted to evaluate the attitudes of physicians to PGx services by providing them their own genomic data analysis report focusing on PGx. We also tried to evaluate the clinical applicability of whole exome sequencing (WES)-based functional PGx test. In total 88 physicians participated in the study from September 2015 to August 2016. Physicians who agreed to participate in the study were asked to complete a pre-test survey evaluating their knowledge of and attitude toward clinical genomics including PGx. Only those who completed the pre-test survey proceeded to WES and were provided with a personal PGx analysis report in an offline group meeting. Physicians who received these PGx reports were asked to complete a follow-up survey within two weeks. We then analyzed changes in their knowledge and attitude after reviewing their own PGx analysis results through differences in their pre-test and post-test survey responses. In total, 70 physicians (79.5%) completed the pre-test and post-test surveys and attended an off-line seminar to review their personal PGx reports. After physicians reviewed the report, their perception of and attitude towards the PGx domain and genomics significantly changed. Physician' awareness of the likelihood of occurrence of adverse drug reactions and genetic contribution was also changed significantly. Overall, physicians were very positive about the value and potential of the PGx test but maintained a conservative stance on its actual clinical use. Results revealed that physicians' perception and attitude to the utility of PGx testing was significantly changed after reviewing their own WES results.	[Lee, Kye Hwa] Seoul Natl Univ Hosp, Ctr Precis Med, Seoul, South Korea; [Min, Byung Joo; Kim, Ju Han] Seoul Natl Univ, Coll Med, SNUBI, Seoul, South Korea; [Min, Byung Joo; Kim, Ju Han] Seoul Natl Univ, Coll Med, Syst Biomed Informat Res Ctr, Div Biomed Informat, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, SNUBI, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Syst Biomed Informat Res Ctr, Div Biomed Informat, Seoul, South Korea.	juhan@snu.ac.kr		Lee, Kye Hwa/0000-0002-7593-7020; Kim, Ju Han/0000-0003-1522-9038	Korean Health Technology R&D Project, Ministry of Health and Welfare [H16C11280000]; Ministry of Food and Drug Safety [16183MFDS541]	Korean Health Technology R&D Project, Ministry of Health and Welfare; Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by the grants (H16C11280000) of the Korean Health Technology R&D Project, Ministry of Health and Welfare at http://www.mohw.go.kr/eng/and by the grant (16183MFDS541) from Ministry of Food and Drug Safety at http://www.mfds.go.kr/eng/index.do in 2018. All funders did not play any role in this study. There was no additional external funding received for this study.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Beam AL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42282; Bielinski SJ, 2014, MAYO CLIN PROC, V89, P25, DOI 10.1016/j.mayocp.2013.10.021; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Christensen KD, 2016, CLIN GENET, V89, P228, DOI 10.1111/cge.12626; de Leon J, 2012, J CLIN PSYCHOPHARM, V32, P153, DOI 10.1097/JCP.0b013e3182491383; Dormann H, 2003, DRUG SAFETY, V26, P353, DOI 10.2165/00002018-200326050-00004; Frueh FW, 2008, PHARMACOTHERAPY, V28, P992, DOI 10.1592/phco.28.8.992; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Kim GJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191376; Lee KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162135; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; McKenna AH, 2010, GENOME RES; Mikat-Stevens NA, 2015, GENET MED, V17, P169, DOI 10.1038/gim.2014.101; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Phillips KA, 2001, JAMA-J AM MED ASSOC, V286, P2270, DOI 10.1001/jama.286.18.2270; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; R Core Team, 2018, R FDN STAT COMP, DOI [10.1038/gim.2014.101, DOI 10.1038/GIM.2014.101]; Rasmussen-Torvik LJ, 2014, CLIN PHARMACOL THER, V96, P482, DOI 10.1038/clpt.2014.137; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Sanderson SC, 2015, GENET MED, V17, P866, DOI 10.1038/gim.2014.203; Selkirk CG, 2013, GENET TEST MOL BIOMA, V17, P219, DOI 10.1089/gtmb.2012.0165; Seo H, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0323-4; St Sauver JL, 2016, AM J MED, V129, P1093, DOI 10.1016/j.amjmed.2016.04.009; Tangamornsuksan W, 2013, JAMA DERMATOL, V149, P1025, DOI 10.1001/jamadermatol.2013.4114; Unertl KM, 2015, PERS MED, V12, P339, DOI 10.2217/PME.15.10; US Food and Drug Administration, TABL PHARM BIOM DRUG; Vassy JL, 2015, PERS MED, V12, P23, DOI 10.2217/PME.14.68; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	32	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213860	10.1371/journal.pone.0213860	http://dx.doi.org/10.1371/journal.pone.0213860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921347	Green Submitted, gold, Green Published			2022-12-27	WOS:000462594000025
J	Meikle, WG; Corby-Harris, V; Carroll, MJ; Weiss, M; Snyder, LA; Meador, CAD; Beren, E; Brown, N				Meikle, William G.; Corby-Harris, Vanessa; Carroll, Mark J.; Weiss, Milagra; Snyder, Lucy A.; Meador, Charlotte A. D.; Beren, Eli; Brown, Nicholas			Exposure to sublethal concentrations of methoxyfenozide disrupts honey bee colony activity and thermoregulation	PLOS ONE			English	Article							PESTICIDES; INSECTICIDES; TOXICITY	Methoxyfenozide is an insect growth regulator (IGR) commonly used in agriculture to simultaneously control pests and preserve beneficial insect populations; however, its impact on honey bees in not fully understood. We conducted field and laboratory experiments to investigate bee health in response to field-relevant concentrations of this pesticide. Significant effects were observed in honey bee colony flight activity and thermoregulation after being exposed over 9 weeks to supplemental protein patty containing methoxyfenozide. Compared to bee colonies in the control group, colonies fed pollen patty with 200 ppb methoxyfenozide (as measured by residue analysis) had: 1) a significantly reduced rate of weight loss due to forager departure in the morning; and 2) higher temperature variability during the winter. Colonies in the 100 ppb (as measured by residue analysis) treatment group had values between the 200 ppb group and control for both response variables. The dusk break point, which is the time associated with the end of forager return, differed among all treatment groups but may have been confounded with direction the hives were facing. Bee colony metrics of adult bee mass and brood surface area, and measurements of bee head weight, newly-emerged bee weight, and hypopharyngeal gland size were not significantly affected by methoxyfenozide exposure, suggesting that there may be significant effects on honey bee colony behavior and health in the field that are difficult to detect using standard methods for assessing bee colonies and individuals. The second experiment was continued into the following spring, using the same treatment groups as in the fall. Fewer differences were observed among groups in the spring than the fall, possibly because of abundant spring forage and consequent reduced treatment patty consumption. Residue analyses showed that: 1) observed methoxyfenozide concentrations in treatment patty were about 18-60% lower than the calculated concentrations; 2) no residues were observed in wax in any treatment; and 3) methoxyfenozide was detected in bee bread only in the 200 ppb treatment group, at about 1-2.5% of the observed patty concentration.	[Meikle, William G.; Corby-Harris, Vanessa; Carroll, Mark J.; Weiss, Milagra; Snyder, Lucy A.; Meador, Charlotte A. D.; Beren, Eli; Brown, Nicholas] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA	United States Department of Agriculture (USDA)	Meikle, WG (corresponding author), USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA.	william.meikle@ars.usda.gov	Meikle, William/AAC-2481-2022	Meikle, William/0000-0002-1759-6950				[Anonymous], 2003, 20033 CAL DEP PEST R; Baker NT, 2017, Estimated annual agricultural pesticide use by crop group for states of the conterminous United States, 1992-2014, DOI [10.5066/F7NP22KM, DOI 10.5066/F7NP22KM]; Corby-Harris V, 2018, JOVE-J VIS EXP, DOI 10.3791/58261; Corby-Harris V, 2016, J INSECT PHYSIOL, V85, P65, DOI 10.1016/j.jinsphys.2015.11.016; Curtis B, 2013, BEST MANAGEMENT PRAC, P1; De Smet L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171529; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; du Rand EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11779; Fisher A, 2018, J ECON ENTOMOL, V111, P510, DOI 10.1093/jee/tox347; Fourrier J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132985; Heylen K, 2011, APIDOLOGIE, V42, P103, DOI 10.1051/apido/2010043; Higbee BS, 2012, J ECON ENTOMOL, V105, P1702, DOI 10.1603/EC11389; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P393, DOI 10.1016/S0022-1910(98)00022-5; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Meikle WG, 2016, APIDOLOGIE, V47, P1, DOI 10.1007/s13592-015-0370-1; Meikle WG, 2015, APIDOLOGIE, V46, P10, DOI 10.1007/s13592-014-0298-x; Meikle WG, 2018, APIDOLOGIE, V49, P581, DOI 10.1007/s13592-018-0585-z; Meikle WG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197589; Meikle WG, 2017, JOVE-J VIS EXP, DOI 10.3791/56355; Meikle WG, 2017, APIDOLOGIE, V48, P666, DOI 10.1007/s13592-017-0512-8; Meikle WG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168603; Meikle WG, 2008, APIDOLOGIE, V39, P694, DOI 10.1051/apido:2008055; Muggeo V.M., 2008, R NEWS, V8, P20; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Retnakaran A, 2003, ARCH INSECT BIOCHEM, V54, P187, DOI 10.1002/arch.10116; Ricigliano VA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28732-z; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Smagghe G, 2012, ADV INSECT PHYSIOL, V43, P163, DOI 10.1016/B978-0-12-391500-9.00002-4; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Wood SC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190517; Wood SN, 2001, BIOMETRICS, V57, P240, DOI 10.1111/j.0006-341X.2001.00240.x; Zhu YC, 2015, J ECON ENTOMOL, V108, P2640, DOI 10.1093/jee/tov269	37	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0204635	10.1371/journal.pone.0204635	http://dx.doi.org/10.1371/journal.pone.0204635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921332	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000003
J	Effendy; Pratama, MF; Rauf, RA; Antara, M; Basir-Cyio, M; Mahfudz; Muhardi				Effendy; Pratama, M. Fardhal; Rauf, Rustam Abdul; Antara, Made; Basir-Cyio, Muhammad; Mahfudz; Muhardi			Factors influencing the efficiency of cocoa farms: A study to increase income in rural Indonesia	PLOS ONE			English	Article							TECHNICAL EFFICIENCY; VEGETABLE FARMS; COST EFFICIENCY; DETERMINANTS; PRODUCTIVITY; CROP; INEFFICIENCY; AGRICULTURE; SYSTEMS; HOTELS	Indonesia is the fifth largest cocoa-producing country in the world, and an increase in cocoa farming efficiency can help farmers to increase their per capita income and reduce poverty in rural areas of this country. This research evaluated the efficiency of Indonesian cocoa farms using a non-parametric approach. The results revealed that the majority of cocoa farms are operated relatively inefficiently. The average technical and allocative efficiencies (0.82 and 0.46, respectively) of these cocoa farms demonstrated that there is potential for improvement. The potential cost reductions range from 36 to 76%, with an average of 60%, if farmers practice efficiently. The technical and allocative efficiencies and cocoa farm economies are affected by the use of quality seeds, organic fertilizers, frequency of extension and training of farm managers, access to bank credit and the market, the participation of women, and the farm manager's gender. An increase in the output would increase farmers' income and reduce poverty in rural areas. This research suggests that the availability of extension and training provided to farmers as well as support for women farmer groups should be increased. Credit programs are also important for cocoa farmers, so policymakers should develop programs that make production credit more accessible for farmers, especially through cooperatives and banks.	[Effendy; Pratama, M. Fardhal; Rauf, Rustam Abdul; Antara, Made] Tadulako Univ, Dept Agr Econ, Agr Fac, Palu, Indonesia; [Basir-Cyio, Muhammad; Mahfudz; Muhardi] Tadulako Univ, Dept Agroecotechnol, Agr Fac, Palu, Indonesia	Universitas Tadulako; Universitas Tadulako	Effendy (corresponding author), Tadulako Univ, Dept Agr Econ, Agr Fac, Palu, Indonesia.	effendy_surentu@yahoo.com	rauf, rustam abd/F-8227-2018; , Mahfudz/F-8191-2018	rauf, rustam abd/0000-0002-4012-0395; Effendy, Effendy/0000-0002-0490-3122; , Mahfudz/0000-0001-8161-3287	Kemenristekdikti	Kemenristekdikti(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	The authors would like to thank the reviewers for providing valuable comments and suggestions and to Kemenristekdikti for providing support for this research.	Abu GA, 2011, AFR J AGR RES, V6, P4057; Afriat S.N., 1972, INT ECON REV, V13, P568, DOI [10.2307/2525845, DOI 10.2307/2525845]; ANDERSEN P, 1993, MANAGE SCI, V39, P1261, DOI 10.1287/mnsc.39.10.1261; Antara M., 2009, J AGRISAINS, V10, P1; Assaf A, 2009, J HOSP TOUR RES, V33, P284, DOI 10.1177/1096348009338510; Assaf AG, 2011, TOURISM ECON, V17, P73, DOI 10.5367/te.2011.0027; Ayoola J. B., 2012, Journal of Agricultural Science (Toronto), V4, P215, DOI 10.5539/jas.v4n6p215; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; Bello M., 2012, Sustainable Agriculture Research, V1, P292; Bozoglu M, 2007, AGR SYST, V94, P649, DOI 10.1016/j.agsy.2007.01.007; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Chen Z, 2009, CHINA ECON REV, V20, P153, DOI 10.1016/j.chieco.2009.03.002; Coelli T, 1996, GUIDE DEAP VERSION 2; Coelli T. J., 2005, MEDICINE; Ditjenbun, 2015, TREE CROP EST STAT I; DPDJP, 2009, GER PEN PROD MUT KAK; Effendy, 2013, Journal of Agricultural Science (Toronto), V5, P72; Effendy, 2015, Modern Applied Science, V9, P120; Effendy, 2013, J EC SUSTAIN DEV, V4, P154, DOI [10.14710/agrisocionomics.v3i2.4691, DOI 10.14710/AGRISOCIONOMICS.V3I2.4691]; Effendy Antara M, 2015, AM J APPL SCI, V12, P709; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Ferjani A., 2011, AGR EC REV, V12, P45; Gallego FJ, 2014, INT J APPL EARTH OBS, V29, P22, DOI 10.1016/j.jag.2013.12.013; Gordo G. M., 2013, PHILIPPINE MANAGEMEN, V20, P17; Guinee N, 2014, INT J EDUC DEV, V39, P183, DOI 10.1016/j.ijedudev.2014.07.007; Hu BD, 2005, MATH COMPUT SIMULAT, V68, P475, DOI 10.1016/j.matcom.2005.02.002; Hu JL, 2009, ASIA PAC J TOUR RES, V14, P371, DOI 10.1080/10941660903310060; ICCO, 2018, ICCO Q B COC STAT, VXLIV; Islam T., 2008, J SOCIAL EC DEV, V10, P33; Jahanshahloo GR, 2008, EUR J OPER RES, V184, P814, DOI 10.1016/j.ejor.2006.11.043; Karimov A, 2013, AGRICULTURE-BASEL, V3, P503, DOI 10.3390/agriculture3030503; Krasachat W, 2012, PROC ECON FINANC, V3, P445, DOI 10.1016/S2212-5671(12)00178-5; Ladha JK, 2011, J ENVIRON QUAL, V40, P1756, DOI 10.2134/jeq2011.0064; Leifeld J, 2010, AMBIO, V39, P585, DOI 10.1007/s13280-010-0082-8; Li XiangLian, 2008, Agricultural Sciences in China, V7, P344, DOI 10.1016/S1671-2927(08)60075-9; Liu ZA, 2000, J COMP ECON, V28, P545, DOI 10.1006/jcec.2000.1666; Murshed-E-Jahan K, 2011, AGR SYST, V104, P392, DOI 10.1016/j.agsy.2011.01.003; Nation ML, 2010, AGR HUM VALUES, V27, P163, DOI 10.1007/s10460-009-9207-8; Neilson J., 2008, MASUKAN STRATEGIS DA; Nkang N. M., 2011, Global Journal of Agricultural Sciences, V10, P39; Ogisi OD, 2012, ASIAN J AGR RURAL DE, V2, P149; Olson K, 2009, AGR ECON-BLACKWELL, V40, P587, DOI 10.1111/j.1574-0862.2009.00400.x; Onumah JA, 2013, AGR ECON-CZECH, V59, P271, DOI 10.17221/128/2012-AGRICECON; Quisumbing AR, 2015, AGR HUM VALUES, V32, P705, DOI 10.1007/s10460-015-9587-x; Rahman S, 2009, LAND USE POLICY, V26, P95, DOI 10.1016/j.landusepol.2008.01.003; Rahman S, 2008, J ENVIRON MANAGE, V88, P1495, DOI 10.1016/j.jenvman.2007.07.019; Saputra A., 2015, J PENELITIAN U JAMBI, V17, P1; Shrestha RB, 2016, AGR ECON-CZECH, V62, P181, DOI 10.17221/81/2015-AGRICECON; Suresh A., 2015, Indian Journal of Agricultural Economics, V70, P471; Tao FL, 2005, ECOL MODEL, V183, P385, DOI 10.1016/j.ecolmodel.2004.08.023; Tiwari KR, 2008, INT J AGR SUSTAIN, V6, P289, DOI 10.3763/ijas.2008.0390; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Ullah A, 2014, ENVIRON MANAGE, V54, P288, DOI 10.1007/s00267-014-0300-4; Hoang VN, 2011, J ENVIRON ECON MANAG, V62, P462, DOI 10.1016/j.jeem.2011.05.009	54	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214569	10.1371/journal.pone.0214569	http://dx.doi.org/10.1371/journal.pone.0214569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947276	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500041
J	Kar, B; Patel, P; Free, SJ				Kar, Bibekananda; Patel, Pavan; Free, Stephen J.			Trichophyton rubrum LysM proteins bind to fungal cell wall chitin and to the N-linked oligosaccharides present on human skin glycoproteins	PLOS ONE			English	Article							TRIGGERED IMMUNITY; EFFECTOR ECP6; SUPPRESSION; VIRULENCE	The Trichophyton rubrum genome contains six proteins containing two or more lysin M (LysM) domains. We have characterized two of these proteins, LysM1 and LysM2, and demonstrated that these proteins have the capacity to bind two substrates, chitin and N-linked oligosaccharides associated with human skin glycoproteins. We have characterized the individual LysM domains in LysM1, and shown that the protein contains two functional LysM domains. Each of these domains can bind to chitin, to N-linked oligosaccharides in human skin glycoproteins, and to N-linked oligosaccharides on fungal glycoproteins. We hypothesize that LysM proteins could provide the pathogen with three important functions. First, the T. rubrum LysM proteins could shield host cell wall chitin from the human immune system. Second, the LysM proteins could shield the pathogen's glycoproteins from host degradation and immune surveillance. Third, the LysM proteins could help facilitate pathogen adhesion to human skin.	[Kar, Bibekananda; Patel, Pavan; Free, Stephen J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Free, SJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	free@buffalo.edu	Kar, Bibekananda/AAP-8666-2020	Kar, Bibekananda/0000-0001-8794-1513	UB Foundation; College of Arts and Sciences, SUNY University at Buffalo, Buffalo, NY	UB Foundation; College of Arts and Sciences, SUNY University at Buffalo, Buffalo, NY	SJF received funding from the UB Foundation (no grant number). BK received funding from the College of Arts and Sciences, SUNY University at Buffalo, Buffalo, NY (no grant number). The funders had no role in study design, data collection and analysis, decision to published, or preparation of the manuscript.	Achterman RR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002564; Akcapinar GB, 2015, CURR GENET, V61, P103, DOI 10.1007/s00294-014-0471-9; Ao J, 2017, FUNGAL GENET BIOL, V101, P46, DOI 10.1016/j.fgb.2017.03.002; Arana DM, 2009, MICROB BIOTECHNOL, V2, P308, DOI 10.1111/j.1751-7915.2008.00070.x; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; Doering T. L., 2015, ESSENTIALS GLYCOBIOL, P293; Elieh Ali Komi Daniel, 2018, Clin Rev Allergy Immunol, V54, P213, DOI 10.1007/s12016-017-8600-0; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Gust AA, 2012, TRENDS PLANT SCI, V17, P495, DOI 10.1016/j.tplants.2012.04.003; Hernandez-Chavez MJ, 2017, J FUNGI, V3, DOI 10.3390/jof3040051; JORIS B, 1992, FEMS MICROBIOL LETT, V91, P257; Kelly S, 2017, CURR OPIN PLANT BIOL, V39, P152, DOI 10.1016/j.pbi.2017.06.013; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Koharudin LMI, 2011, STRUCTURE, V19, P662, DOI 10.1016/j.str.2011.03.004; Kombrink A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003769; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Maddi A, 2010, EUKARYOT CELL, V9, P1766, DOI 10.1128/EC.00134-10; Marcos CM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00142; Margolin B.S., 1997, FUNGAL GENET REP, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Martinez DA, 2012, MBIO, V3, DOI 10.1128/mBio.00259-12; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Mesnage S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5269; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Patin EC, 2019, SEMIN CELL DEV BIOL, V89, P24, DOI 10.1016/j.semcdb.2018.03.003; Shinya T, 2015, CURR OPIN PLANT BIOL, V26, P64, DOI 10.1016/j.pbi.2015.05.032; Sukhithasri V, 2013, MICROBIOL RES, V168, P396, DOI 10.1016/j.micres.2013.02.005; Takahara H, 2016, NEW PHYTOL, V211, P1323, DOI 10.1111/nph.13994; White TC, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019802; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108	35	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0215034	10.1371/journal.pone.0215034	http://dx.doi.org/10.1371/journal.pone.0215034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947244	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500097
J	Li, S; Cao, YZ; Li, L; Zhang, HX; Lu, XY; Bo, CR; Kong, XT; Liu, ZJ; Chen, LX; Liu, PF; Jiao, Y; Wang, JJ; Ning, SW; Wang, LH				Li, Shuang; Cao, Yuze; Li, Lei; Zhang, Huixue; Lu, Xiaoyu; Bo, Chunrui; Kong, Xiaotong; Liu, Zhaojun; Chen, Lixia; Liu, Peifang; Jiao, Yang; Wang, Jianjian; Ning, Shangwei; Wang, Lihua			Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis	PLOS ONE			English	Article							NF-KAPPA-B; STEM-CELL TRANSPLANTATION; EXPRESSION; FEATURES; DISEASE; GENES	Myasthenia gravis (MG) is an autoimmune disease. In recent years, considerable evidence has indicated that Gene Ontology (GO) functions, especially GO-biological processes, have important effects on the mechanisms and treatments of different diseases. However, the roles of GO functions in the pathogenesis and treatment of MG have not been well studied. This study aimed to uncover the potential important roles of risk-related GO functions and to screen significant candidate drugs related to GO functions for MG. Based on MG risk genes, 238 risk GO functions and 42 drugs were identified. Through constructing a GO function network, we discovered that positive regulation of NF-kappaB transcription factor activity (GO:0051092) may be one of the most important GO functions in the mechanism of MG. Furthermore, we built a drug-GO function network to help evaluate the latent relationship between drugs and GO functions. According to the drug-GO function network, 5 candidate drugs showing promise for treating MG were identified. Indeed, 2 out of 5 candidate drugs have been investigated to treat MG. Through functional enrichment analysis, we found that the mechanisms between 5 candidate drugs and associated GO functions may involve two vital pathways, specifically hsa05332 (graft-versus-host disease) and hsa04940 (type I diabetes mellitus). More interestingly, most of the processes in these two pathways were consistent. Our study will not only reveal a new perspective on the mechanisms and novel treatment strategies of MG, but also will provide strong support for research on GO functions.	[Li, Shuang; Cao, Yuze; Li, Lei; Zhang, Huixue; Lu, Xiaoyu; Bo, Chunrui; Kong, Xiaotong; Liu, Zhaojun; Chen, Lixia; Liu, Peifang; Jiao, Yang; Wang, Jianjian; Wang, Lihua] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Heilongjiang, Peoples R China; [Cao, Yuze] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China; [Ning, Shangwei] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Harbin Medical University	Wang, JJ; Wang, LH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Heilongjiang, Peoples R China.; Ning, SW (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China.	wangjian_427@163.com; ningsw@ems.hrbmu.edu.cn; wanglh211@163.com	liu, zhao/GXV-6141-2022; lu, xiaoyu/GWU-6357-2022	Bo, Chunrui/0000-0002-6131-4105	National Natural Science Foundation of China [81820108014, 81571166, 81771361, 81701190, 81701155, 81801190]; applied technique research and development project of Harbin [2016RAXYJ067]; Health and Family Planning Commission of Heilongjiang Province [2016-052, 2016-072, 2017-079]; Fundamental Research Funds for the Provincial Universitie [2017LCZX57, 2017LCZX65, 2017LCZX48]; Postdoctoral Foundation of Heilongjiang Province [LBH-Z17138]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); applied technique research and development project of Harbin; Health and Family Planning Commission of Heilongjiang Province; Fundamental Research Funds for the Provincial Universitie; Postdoctoral Foundation of Heilongjiang Province	This work was supported by the National Natural Science Foundation of China (Grant nos. 81820108014 to LW, 81571166 to LW, 81771361 to LW, 81701190 to JW, 81701155 to XL and 81801190 to YC), The applied technique research and development project of Harbin (2016RAXYJ067 to LW), Health and Family Planning Commission of Heilongjiang Province (2016-052 to JW, 2016-072 to HZ and 2017-079 to XL), The Fundamental Research Funds for the Provincial Universitie (2017LCZX57 to JW, 2017LCZX65 to HZ and 2017LCZX48 to XL), The Postdoctoral Foundation of Heilongjiang Province (LBH-Z17138 to HZ).	Amberger Joanna S, 2017, Curr Protoc Bioinformatics, V58, DOI 10.1002/cpbi.27; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Cada Dennis J, 2014, Hosp Pharm, V49, P961, DOI 10.1310/hpj4910-961; Cao YZ, 2017, INT J MOL MED, V39, P268, DOI 10.3892/ijmm.2017.2853; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; Cavalcante P, 2016, IMMUNOBIOLOGY, V221, P516, DOI 10.1016/j.imbio.2015.12.007; Cavalcante P, 2010, ANN NEUROL, V67, P726, DOI 10.1002/ana.21902; Chen CYA, 2016, NUCLEIC ACIDS RES, V44, P3772, DOI 10.1093/nar/gkw205; Chien MW, 2015, J BIOL CHEM, V290, P29329, DOI 10.1074/jbc.M115.674671; Cordiglieri C, 2014, J AUTOIMMUN, V52, P74, DOI 10.1016/j.jaut.2013.12.013; Dennis G, 2003, GENOME BIOL, V4; Denny P, 2018, AUTOPHAGY, V14, P419, DOI 10.1080/15548627.2017.1415189; Di Lena P, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S6; Grauer O, 2010, BRAIN, V133, P2852, DOI 10.1093/brain/awq245; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hu L., 2015, RMC BIOINFORMATICS, V16, P174, DOI DOI 10.1186/S12859-015-0583-3; Jin GX, 2014, DRUG DISCOV TODAY, V19, P637, DOI 10.1016/j.drudis.2013.11.005; Krzewska A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6219730; Kumar N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-96; Lee JS, 2009, NEUROL SCI, V30, P259, DOI 10.1007/s10072-009-0023-0; Lee S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S2; Ma LL, 2002, J BIOL CHEM, V277, P39343, DOI 10.1074/jbc.M204924200; Mamrut S, 2017, J AUTOIMMUN, V82, P62, DOI 10.1016/j.jaut.2017.05.005; Mathur Sachin, 2011, AMIA Annu Symp Proc, V2011, P305; Melzer N, 2016, J NEUROL, V263, P1473, DOI 10.1007/s00415-016-8045-z; Miraghazadeh B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00613; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pohlig F, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1315-6; Porrello A, 2016, CURR GENOMICS, V17, P33, DOI 10.2174/1389202916666151014222603; Sedimbi SK, 2013, CELL MOL LIFE SCI, V70, P4795, DOI 10.1007/s00018-013-1425-y; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Tong LY, 2015, ADV DRUG DELIVER REV, V81, P1, DOI 10.1016/j.addr.2014.09.004; Unal S, 2014, PEDIATR BLOOD CANCER, V61, P928, DOI 10.1002/pbc.24799; Utsugisawa K, 2003, EUR NEUROL, V49, P160, DOI 10.1159/000069079; Uzawa A, 2014, CLIN EXP IMMUNOL, V176, P232, DOI 10.1111/cei.12272; Uzawa A, 2015, J NEUROIMMUNOL, V287, P16, DOI 10.1016/j.jneuroim.2015.07.013; Uzawa A, 2015, J NEUROL NEUROSUR PS, V86, P695, DOI 10.1136/jnnp-2014-309232; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vella D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23672-0; Vitali F, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020055; Wang JJ, 2017, NUCLEIC ACIDS RES, V45, pD902, DOI 10.1093/nar/gkw1038; Wang Z, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01785; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Xie YC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00230; Yang LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104827; Zaja F, 1997, ACTA NEUROL SCAND, V96, P256; Zebda R, 2018, J AM ACAD DERMATOL, V78, pS43, DOI 10.1016/j.jaad.2017.11.056; Zhang M, 2013, J MOL NEUROSCI, V50, P317, DOI 10.1007/s12031-013-9976-9; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zisimopoulou P, 2014, J AUTOIMMUN, V52, P139, DOI 10.1016/j.jaut.2013.12.004	53	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214857	10.1371/journal.pone.0214857	http://dx.doi.org/10.1371/journal.pone.0214857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947317	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500075
J	Mooranian, A; Zamani, N; Takechi, R; Luna, G; Mikov, M; Golocorbin-Kon, S; Elnashar, M; Arfuso, F; Al-Salami, H				Mooranian, Armin; Zamani, Nassim; Takechi, Ryu; Luna, Giuseppe; Mikov, Momir; Golocorbin-Kon, Svetlana; Elnashar, Magdy; Arfuso, Frank; Al-Salami, Hani			An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques	PLOS ONE			English	Article							POTENTIAL ANTIDIABETIC DRUG; BILE-ACID; INSULIN SENSITIVITY; DELIVERY; MICROENCAPSULATION; FORMULATION; MICROCAPSULES; MUSCLES; STRESS	Type 2 diabetes (T2D) is characterised by beta-cell damage and hyperglycaemia. The lipophilic drug, probucol, has shown significant beta-cell protective and potential antidiabetic effects, which were enhanced by hydrophilic bile acid incorporation using taurocholic acid and chenodeoxycholic acid. However, probucol has severe cardiotoxicity and a variable absorption profile, which limit its potential applications in T2D. Accordingly, this study aimed to design multiple formulations to optimise probucol oral delivery in T2D and test their effects on probucol absorption and accumulation in the heart. Adult male mice were given a high fat diet (HFD), and a week later, injected with a single dose of alloxan to accelerate T2D development, and once diabetes confirmed, divided into three groups (six to seven mice each). The groups were gavaged a daily dose of probucol powder, probucol microcapsules, or probucol-bile acid microcapsules for three months, and euthanized; and blood, tissues, and feces collected for blood glucose and probucol concentration analyses. Probucol concentrations in plasma were similar among all the groups. Groups given probucol microcapsules and probucol-bile acid microcapsules showed significant reduction in probucol accumulation in the heart compared with the group given probucol powder (p<0.05). Probucol microencapsulation with or without bile acids reduced its accumulation in heart tissues, without changing plasma concentrations, which may be beneficial in reducing its cardiotoxicity and optimise its potential applications in T2D.	[Mooranian, Armin; Zamani, Nassim; Luna, Giuseppe; Elnashar, Magdy; Al-Salami, Hani] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm & Biomed Sci, Biotechnol & Drug Dev Res Lab, Perth, WA, Australia; [Takechi, Ryu] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Publ Hlth, Perth, WA, Australia; [Mikov, Momir] Univ Novi Sad, Fac Med, Dept Pharmacol Toxicol & Clin Pharmacol, Novi Sad, Serbia; [Golocorbin-Kon, Svetlana] Univ Novi Sad, Dept Pharm, Novi Sad, Serbia; [Arfuso, Frank] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm & Biomed Sci, Stem Cell & Canc Biol Lab, Perth, WA, Australia	Curtin University; Curtin University; University of Novi Sad; University of Novi Sad; Curtin University	Al-Salami, H (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm & Biomed Sci, Biotechnol & Drug Dev Res Lab, Perth, WA, Australia.	hani.al-salami@curtin.edu.au	Elnashar, Magdy Mahmoud/K-3036-2012; Takechi, Ryusuke/D-3692-2012; Al-Salami, Hani/C-3766-2019; Elnashar, Magdy/AAW-3423-2021; Takechi, Ryu/T-9970-2019; Mikov, Momir/AAF-6374-2020; Arfuso, Frank/H-8761-2014	Elnashar, Magdy Mahmoud/0000-0001-9936-3271; Takechi, Ryusuke/0000-0001-6359-3382; Al-Salami, Hani/0000-0003-0049-6969; Takechi, Ryu/0000-0001-6359-3382; Arfuso, Frank/0000-0001-7678-9472; Mooranian, Armin/0000-0001-7103-2067	Australian Postgraduate Award (APA); Curtin Research Scholarship (CRS); Curtin-seeding grant; European Union [690876]	Australian Postgraduate Award (APA)(Australian Government); Curtin Research Scholarship (CRS); Curtin-seeding grant; European Union(European Commission)	This study was funded in part by the Australian Postgraduate Award (APA) and Curtin Research Scholarship (CRS). The authors also acknowledge the Curtin-seeding grant for the support and also acknowledge the use of laboratory equipment, scientific and technical assistance of Microscopy and Microanalysis Facility at Curtin University which has been partially funded by the University, State and Commonwealth Governments. The work is partially supported by the European Union Horizon 2020 MEDLEM research project and innovation program under the Marie Sklodowska-Curie Grant Agreement No 690876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahmood AK, 2006, MALAYS J MED SCI, V13, P37; ASSIMACOPOULOSJEANNET F, 1995, METABOLISM, V44, P228, DOI 10.1016/0026-0495(95)90270-8; BROWNE KF, 1984, AM HEART J, V107, P680, DOI 10.1016/0002-8703(84)90315-6; Kirkpatrick CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011053; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Liang ZY, 2016, J ETHNOPHARMACOL, V191, P341, DOI 10.1016/j.jep.2016.06.054; Mamo JCL, 2018, THER DELIV, V9, P703, DOI 10.4155/tde-2018-0033; Mamo JCL, 2019, DIABETES VASC DIS RE, V16, P87, DOI 10.1177/1479164118795274; Mitri J, 2009, EXPERT OPIN DRUG SAF, V8, P573, DOI 10.1517/14740330903081725; Mooranian A, 2018, DRUG DELIV TRANSL RE; Mooranian A, 2018, ARTIF CELL NANOMED B, V46, pS741, DOI 10.1080/21691401.2018.1511571; Mooranian A, 2018, DRUG DELIV TRANSL RE, V8, P543, DOI 10.1007/s13346-017-0473-5; Mooranian A, 2016, ARTIF CELL NANOMED B, V44, P1642, DOI 10.3109/21691401.2015.1069299; Mooranian A, 2016, ARTIF CELL NANOMED B, V44, P194, DOI 10.3109/21691401.2014.934457; Mooranian A, 2015, J MICROENCAPSUL, V32, P589, DOI 10.3109/02652048.2015.1065922; Mooranian A, 2015, DRUG DELIV TRANSL RE, V5, P511, DOI 10.1007/s13346-015-0248-9; Mooranian A, 2015, J MICROENCAPSUL, V32, P151, DOI 10.3109/02652048.2014.958204; Mooranian A, 2015, AAPS PHARMSCITECH, V16, P45, DOI 10.1208/s12249-014-0205-9; Mooranian A, 2014, DRUG DES DEV THER, V8, P1673, DOI 10.2147/DDDT.S68247; Mooranian A, 2016, DRUG DES DEV THER, V10, P1221, DOI 10.2147/DDDT.S67349; Mooranian A, 2014, DRUG DES DEV THER, V8, P1003, DOI 10.2147/DDDT.S65396; Negrulj R, 2016, ARTIF CELL NANOMED B, V44, P1290, DOI 10.3109/21691401.2015.1024845; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Wali Jibran A, 2013, Cells, V2, P266, DOI 10.3390/cells2020266; Wang XY, 2016, J DIABETES, V8, P24, DOI 10.1111/1753-0407.12323	27	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214984	10.1371/journal.pone.0214984	http://dx.doi.org/10.1371/journal.pone.0214984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947243	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500095
J	Yang, HY				Yang, Hsiao-Yu			Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals	PLOS ONE			English	Article							MESOTHELIN-RELATED PROTEIN; NON-ASBESTIFORM TREMOLITE; CARCINOEMBRYONIC ANTIGEN; MALIGNANT MESOTHELIOMA; OXIDATIVE STRESS; CANCER; CLASSIFICATION; FIBULIN-3; POPULATION; MORTALITY	Workers processing nephrite, antigorite, or talc may be exposed to paragenetic asbestos minerals. An effective screening method for pneumoconiosis in workers exposed to asbestos-contaminated minerals is still lacking. The objective of this study was to assess the diagnostic accuracy of serum and urinary biomarkers for pneumoconiosis in workers exposed to asbestos-contaminated minerals. We conducted a case-control study in a cohort of stone craft workers in Hualien, where asbestos, nephrite, antigorite, and talc are produced. A total of 140 subjects were screened between March 2013 and July 2014. All subjects received a questionnaire survey and a health examination that included a physical examination; chest X-ray; and tests for standard pulmonary function, fractional exhaled nitric oxide, serum soluble mesothelin-related peptide (SMRP), fibulin-3, carcinoembryonic antigen (CEA), and urinary 8-Oxo-2'-deoxyguanosine (8-OHdG)/creatinine. After excluding subjects with uraemia and chronic obstructive pulmonary disease (COPD), we included 48 subjects with pneumoconiosis and 90 control subjects without pneumoconiosis for analysis. In terms of occupational history, 43/48 (90%) case subjects and 68% (61/90) of the control subjects had processed asbestos-contaminated minerals, including nephrite, antigorite, and talc. The case group had decreased pulmonary function in forced vital capacity (FVC), forced expiratory volume in one second, and forced expiratory flow between 25% and 75% of the FVC. The levels of SMRP, fibulin-3, urinary 8-OHdG/creatinine, and CEA were higher in the case group than in the control group. Subjects exposed to nephrite had significantly higher SMRP levels (0.84 +/- 0.52 nM) than subjects exposed to other types of minerals (0.60 +/- 0.30 nM). A dose-response relationship was observed between the SMRP level and the severity of pneumoconiosis. Machine learning algorithms, including variables of sex, age, SMRP, fibulin-3, CEA, and 8-OHdG/creatinine, can predict pneumoconiosis with high accuracy. The areas under the receiver operating characteristic curves ranged from 0.7 to 1.0. We suggest that SMRP and fibulin-3 could be used as biomarkers of pneumoconiosis in workers exposed to asbestos-contaminated minerals.	[Yang, Hsiao-Yu] Natl Taiwan Univ, Coll Publ Hlth, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan; [Yang, Hsiao-Yu] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei, Taiwan; [Yang, Hsiao-Yu] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Yang, HY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan.; Yang, HY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei, Taiwan.; Yang, HY (corresponding author), Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan.	hyang@ntu.edu.tw	Yang, Hsiao-Yu/N-7933-2015	Yang, Hsiao-Yu/0000-0001-5298-2462	Ministry of Science and Technology [MOST 107-2314-B-002-198, MOST 106-2314-B-002-107, NSC 100-2314-B-320-002-MY3, MOST 104-2314-B-303-005, MOST 105-2314-B-002-065]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Ministry of Science and Technology (grant number MOST 107-2314-B-002-198; MOST 106-2314-B-002-107; NSC 100-2314-B-320-002-MY3; MOST 104-2314-B-303-005; and MOST 105-2314-B-002-065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EM, 2015, ANN EPIDEMIOL, V25, P811, DOI 10.1016/j.annepidem.2015.08.003; Amati M, 2008, MUTAT RES-GEN TOX EN, V655, P52, DOI 10.1016/j.mrgentox.2008.06.011; Beyer HL, 2007, CLIN CHEM, V53, P666, DOI 10.1373/clinchem.2006.079327; Brereton RG, 2010, ANALYST, V135, P230, DOI 10.1039/b918972f; Cardile Venera, 2007, Int J Environ Res Public Health, V4, P1, DOI 10.3390/ijerph2007010001; Chang CJ, 2017, CAN RESPIR J, V2017, DOI 10.1155/2017/1270608; Chen TL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/298183; Chong S, 2006, RADIOGRAPHICS, V26, P1811, DOI 10.1148/rg.266065057; Clinkenbeard JP CR, GUIDELINE GEOLOGIC I; Collegium Ramazzini, 2016, Scand J Work Environ Health, V42, P86, DOI 10.5271/sjweh.3541; Cristaudo A, 2007, CLIN CANCER RES, V13, P5076, DOI 10.1158/1078-0432.CCR-07-0629; Demir M, 2016, LUNG, V194, P409, DOI 10.1007/s00408-016-9868-1; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Filiberti R, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0422-6; Finkelstein MM, 2012, AM J IND MED, V55, P863, DOI 10.1002/ajim.22063; Fragkaki AG, 2012, J CHROMATOGR A, V1256, P232, DOI 10.1016/j.chroma.2012.07.064; Joseph NM, 2013, AM J INFECT CONTROL, V41, P471, DOI 10.1016/j.ajic.2012.06.008; Kaya Halide, 2015, Asian Pac J Cancer Prev, V16, P1403; Kiang MY, 2003, DECIS SUPPORT SYST, V35, P441, DOI 10.1016/S0167-9236(02)00110-0; Krittanawong C, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0875-x; Krogh A, 2008, NAT BIOTECHNOL, V26, P195, DOI 10.1038/nbt1386; Leon G., 2013, EPIDEMIOLOGY, V5th; Meng QC, 2017, ONCOTARGETS THER, V10, P4591, DOI 10.2147/OTT.S145708; Middendorf P, 2011, DHHS NIOSH PUBLICATI, P1; Muley T, 2013, J THORAC ONCOL, V8, P947, DOI 10.1097/JTO.0b013e31828f696b; Mustapha IB, 2016, MOLECULES, V21, DOI 10.3390/molecules21080983; Nagai H, 2011, CANCER SCI, V102, P2118, DOI 10.1111/j.1349-7006.2011.02087.x; Park EK, 2008, AM J RESP CRIT CARE, V178, P832, DOI 10.1164/rccm.200802-258OC; Park EK, 2012, SAF HEALTH WORK, V3, P17, DOI 10.5491/SHAW.2012.3.1.17; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Portal JAR, 2009, CANCER EPIDEM BIOMAR, V18, P646, DOI 10.1158/1055-9965.EPI-08-0422; Rapisarda V, 2017, ENVIRON RES, V156, P381, DOI 10.1016/j.envres.2017.03.055; Robinson BWS, 2005, LUNG CANCER, V49, pS109, DOI 10.1016/j.lungcan.2005.03.020; Sajid Khan Mohammad, 2007, J Pak Med Assoc, V57, P595; Sorensen CG, 2016, INT J SURG, V25, P134, DOI 10.1016/j.ijsu.2015.11.065; Soto-Mendez MJ, 2015, AM J CLIN NUTR, V102, P865, DOI 10.3945/ajcn.114.105429; Tamura T, 2015, IND HEALTH, V53, P260, DOI 10.2486/indhealth.2014-0073; The National Institute for Occupational Safety and Health, 2017, DIAGN PNEUM NOV THER; Tsai CH, 2013, J ASIAN EARTH SCI, V63, P218, DOI 10.1016/j.jseaes.2012.09.019; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Williams GJ, 2009, R J, V1, P45; Yang HY, 2016, OCCUP ENVIRON MED, V73, P528, DOI 10.1136/oemed-2016-103586; Yang HY, 2013, OCCUP ENVIRON MED, V70, P852, DOI 10.1136/oemed-2013-101404; Yang HY, 2013, EPIDEMIOLOGY, V24, P143, DOI 10.1097/EDE.0b013e31826b822d; Yang HY, 2010, J FORMOS MED ASSOC, V109, P928, DOI 10.1016/S0929-6646(10)60142-8; Zhang YW, 2010, EXP EYE RES, V90, P374, DOI 10.1016/j.exer.2009.09.018	46	2	3	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214808	10.1371/journal.pone.0214808	http://dx.doi.org/10.1371/journal.pone.0214808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946771	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500065
J	Ye, HL; Lu, CG; Lin, QM				Ye, Hongling; Lu, Changai; Lin, Qimei			Investigation of the spatial heterogeneity of soil microbial biomass carbon and nitrogen under long-term fertilizations in fluvo-aquic soil	PLOS ONE			English	Article							PHYSICAL-PROPERTIES; MANURE APPLICATIONS; ROOT DISTRIBUTION; ORGANIC-MATTER; FOREST SOILS; VARIABILITY; DEPTH; COMMUNITIES; WHEAT; MICROORGANISMS	Soils are heterogeneous and microbial spatial distribution can clearly indicate the spatial characteristics of the soil carbon and nitrogen cycle. However, it is not clear how long-term fertilization affects the spatial distribution of microbial biomass in fluvo-aquic soil. We collected fluvo-aquic soil samples (topsoil 0-7.5 cm and sub-topsoil 7.5-20 cm) using a spatially-explicit design within three 40.5 m(2) plots in each of four fertilization treatments. Fertilization treatments were: cropping without fertilizer inputs (CK); chemical nitrogen, phosphorus, and potassium fertilizer (NPK); chemical fertilizer with straw return (NPKS); and chemical fertilizer with animal manure (NPKM). Variables included soil microbial biomass carbon (MBC) and nitrogen (MBN), and MBC/MBN. For both soil layers, we hypothesized that: microbial biomass was lowest in CK but with the largest spatial heterogeneity; and microbial biomass was highest in NPKM and NPKS but with the lowest spatial heterogeneity. Results showed that: (1) Fertilization significantly increased MBC and MBN more in topsoil than subtopsoil but had no MBC/MBN changes. (2) The coefficient of variation (CV) and Cochran's C showed that variation was largest in CK in topsoil and NPK in sub-topsoil and that variation of topsoil was generally lower than in sub-topsoil. The sample size of the three variables was largest in CK in topsoil but had little variation among the other treatments. (3) The trendsurface model showed that within-plot heterogeneity varied substantially with fertilization (NPKM = NPK > NPKS > CK), but Moran's I and the interpolation map showed that spatial variability with fertilization followed the order NPK > NPKS > CK = NPKM at a fine scale in topsoil. In sub-topsoil, the trend-surface model showed that within-plot heterogeneity followed the order NPKM = CK > NPK > NPKS and that the fine-scale pattern was NPKM>NPK = NPKS>CK. MBC had the highest spatial heterogeneity among the three variables in both soil layers. Our results indicate that the application of organic fertilizer (straw or manure) reduced the variation of MBC and MBN but increased the spatial variability of MBC and MBN. The spatial variation of the three variables was MBC > MBN > MBC/MBN regardless of whether variation was considered at the plot-scale or the fine-scale in both layers.	[Ye, Hongling; Lu, Changai] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China; [Ye, Hongling; Lin, Qimei] China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; China Agricultural University	Lu, CG (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China.	luchangai@caas.cn	LIN, QI/HDO-8145-2022		National Natural Science Foundation of China [41471248]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, http://www.nsfc.gov.cn/, to Li Jianwei, 41471248. Li Jianwei participated in the design of the experiment.	Abiven S, 2011, PLANT SOIL, V343, P369, DOI 10.1007/s11104-011-0725-y; Askin Tayfun, 2007, Agriculturae Conspectus Scientificus, V72, P75; Bai Z, 2016, APPL SOIL ECOL, V98, P65, DOI 10.1016/j.apsoil.2015.09.009; Baldrian P, 2010, APPL SOIL ECOL, V46, P177, DOI 10.1016/j.apsoil.2010.08.013; Baldrian P, 2009, OECOLOGIA, V161, P657, DOI 10.1007/s00442-009-1433-7; Barot Jimenez S., 2016, 5 INT EC EC SYST ENG; Berner D, 2011, PEDOBIOLOGIA, V54, P341, DOI 10.1016/j.pedobi.2011.08.001; Blume E, 2002, APPL SOIL ECOL, V20, P171, DOI 10.1016/S0929-1393(02)00025-2; Boeddinghaus RS, 2015, SOIL BIOL BIOCHEM, V88, P430, DOI 10.1016/j.soilbio.2015.05.026; Bonkowski M, 2000, APPL SOIL ECOL, V14, P37, DOI 10.1016/S0929-1393(99)00047-5; BRODER MW, 1988, SOIL SCI SOC AM J, V52, P112, DOI 10.2136/sssaj1988.03615995005200010020x; Burke IC, 1999, ECOSYSTEMS, V2, P422, DOI 10.1007/s100219900091; Cao CY, 2011, ECOL ENG, V37, P1467, DOI 10.1016/j.ecoleng.2011.03.012; Cao MX, 2015, J GEOCHEM EXPLOR, V153, P1, DOI 10.1016/j.gexplo.2014.11.006; Carron MP, 2015, EUR J SOIL BIOL, V66, P24, DOI 10.1016/j.ejsobi.2014.11.005; Chen GF, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10020363; Chen J., 2007, ANHUI AGR SCI B, V23, P717; Chen Q., 2009, EUR J WOOD PROD, P1; CHEN Y, 1977, SOIL SCI SOC AM J, V41, P352, DOI 10.2136/sssaj1977.03615995004100020037x; Cochran W.G., 2007, SAMPLING TECHNIQUES; COCHRAN WG, 1951, BIOMETRICS, V7, P17, DOI 10.2307/3001601; Cochran WG, 1941, ANN EUGENIC, V11, P47, DOI 10.1111/j.1469-1809.1941.tb02271.x; De Nobili M, 2001, SOIL BIOL BIOCHEM, V33, P1163, DOI 10.1016/S0038-0717(01)00020-7; [董炜华 Dong Weihua], 2016, [土壤, Soils], V48, P211; Doran JW, 2000, APPL SOIL ECOL, V15, P3, DOI 10.1016/S0929-1393(00)00067-6; Doran JW, 1996, ADV AGRON, V56, P1, DOI 10.1016/S0065-2113(08)60178-9; Du ZL, 2009, AUST J SOIL RES, V47, P585, DOI 10.1071/SR09010; Dupuis EM, 2007, CAN J SOIL SCI, V87, P479, DOI 10.4141/CJSS07001; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; Falchini L, 2003, SOIL BIOL BIOCHEM, V35, P775, DOI 10.1016/S0038-0717(03)00105-6; Fan W., 2009, PLANT NUTR FERTILIZE, V15, P936; Fan W, 2018, CHEM ECOL, V34, P355, DOI 10.1080/02757540.2018.1437147; Fang CM, 2005, PLANT SOIL, V268, P243, DOI 10.1007/s11104-004-0278-4; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Frazao LA, 2010, AGR ECOSYST ENVIRON, V135, P161, DOI 10.1016/j.agee.2009.09.003; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Heinze S, 2010, PLANT SOIL, V328, P203, DOI 10.1007/s11104-009-0102-2; Iqbal J, 2005, SOIL SCI SOC AM J, V69, P1338, DOI 10.2136/sssaj2004.0154; Irshad M, 2013, J SOIL SCI PLANT NUT, V13, P115, DOI [10.4067/S0718-95162013005000011, 10.4067/S0718-95162012005000037]; Jiao Y, 2006, GEODERMA, V134, P24, DOI 10.1016/j.geoderma.2005.08.012; Jokubauskaite I., 2015, Eurasian Journal of Soil Science, V4, P137; Kennedy A., 1995, SOIL MICROBIAL DIVER; Kuang EJ, 2014, ACTA AGR SCAND B-S P, V63, P186, DOI 10.1080/09064710.2014.899615; KUCHENBUCH RO, 1987, COMMUN SOIL SCI PLAN, V18, P255, DOI 10.1080/00103628709367816; KUCHENBUCH RO, 1988, PLANT SOIL, V106, P9, DOI 10.1007/BF02371189; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Li CH, 2014, SOIL BIOL BIOCHEM, V75, P264, DOI 10.1016/j.soilbio.2014.04.023; Li JW, 2010, GEODERMA, V156, P60, DOI 10.1016/j.geoderma.2010.01.008; Lim SS, 2018, FOREST ECOL MANAG, V417, P103, DOI 10.1016/j.foreco.2018.02.050; Lin QM, 1999, CHINESE J ECOL, V18, P63; Lin YingHua, 2005, Scientia Agricultura Sinica, V38, P1213; Liu E., 2009, J CHINA AGR U BEIJIN; Liu Y, 2013, SOIL TILL RES, V130, P7, DOI 10.1016/j.still.2013.01.012; Martirosyan V, 2013, PEDOBIOLOGIA, V56, P195, DOI 10.1016/j.pedobi.2013.08.001; MENGEL DB, 1974, AGRON J, V66, P341, DOI 10.2134/agronj1974.00021962006600030002x; Mohammed I., 2011, LONGTERM EFFECTS TRE; Morris SJ, 1999, SOIL BIOL BIOCHEM, V31, P1375, DOI 10.1016/S0038-0717(99)00047-4; MUCINA L, 1982, VEGETATIO, V48, P165, DOI 10.1007/BF00726887; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; PARKIN TB, 1993, J ENVIRON QUAL, V22, P409, DOI 10.2134/jeq1993.00472425002200030004x; PAUL JW, 1994, CAN J SOIL SCI, V74, P147, DOI 10.4141/cjss94-022; Prasad JVNS, 2016, SOIL TILL RES, V156, P131, DOI 10.1016/j.still.2015.10.013; Qiu Haiyuan, 2010, Journal of Agricultural Science (Toronto), V2, P194; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Rogers BF, 2001, SOIL BIOL BIOCHEM, V33, P1389, DOI 10.1016/S0038-0717(01)00044-X; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; Rover M, 1999, SOIL BIOL BIOCHEM, V31, P175, DOI 10.1016/S0038-0717(97)00272-1; Sales MH, 2007, ECOL MODEL, V205, P221, DOI 10.1016/j.ecolmodel.2007.02.033; Schulz S, 2013, BIOGEOSCIENCES, V10, P3983, DOI 10.5194/bg-10-3983-2013; Schutter ME, 2001, BIOL FERT SOILS, V34, P397, DOI 10.1007/s00374-001-0423-7; Shahzad T, 2018, SOIL BIOL BIOCHEM, V124, P150, DOI 10.1016/j.soilbio.2018.06.010; Shaver TM, 2003, GEODERMA, V116, P149, DOI 10.1016/S0016-7061(03)00099-5; Shi W., 2010, AGR ECOLOGICAL SIGNI; [施小清 Shi Xiaoqiang], 2005, [水科学进展, Advances in Water Science], V16, P679; [施小清 Shi Xiaoqing], 2012, [水科学进展, Advances in Water Science], V23, P509; Singh S, 2007, SOIL BIOL BIOCHEM, V39, P76, DOI 10.1016/j.soilbio.2006.06.013; Song JX, 2003, CONTROL CLIN TRIALS, V24, P378, DOI 10.1016/S0197-2456(03)00026-6; Sparling G., 1997, SOIL MICROBIAL BIOMA; Thorup-Kristensen K, 1999, PLANT SOIL, V212, P145, DOI 10.1023/A:1004646522369; Underwood AJ., 2012, EXPT ECOLOGY THEIR L; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; vanGestel M, 1996, SOIL BIOL BIOCHEM, V28, P503, DOI 10.1016/0038-0717(95)00192-1; Wang LiLi, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P1073, DOI 10.3724/SP.J.1011.2013.01073; Wang YG, 2013, ENVIRON EARTH SCI, V70, P3217, DOI 10.1007/s12665-013-2386-z; Wang YF, 2010, MOLECULAR ENVIRONMENTAL SOIL SCIENCE AT THE INTERFACES IN THE EARTH'S CRITICAL ZONE, P320, DOI 10.1007/978-3-642-05297-2_93; Xiang Chang-Guo, 2006, Acta Ecologica Sinica, V26, P1667, DOI 10.1016/S1872-2032(06)60030-9; Xiong Shu-Ping, 2011, Chinese Journal of Plant Ecology, V35, P759, DOI 10.3724/SP.J.1258.2011.00759; Yanai J, 2003, J ENVIRON QUAL, V32, P1965, DOI 10.2134/jeq2003.1965; [袁淑芬 Yuan Shufen], 2015, [土壤通报, Chinese Journal of Soil Science], V46, P916; Zhang JinPing, 2009, Science & Technology Review, P49; Zhang Si-hai, 2014, Yingyong Shengtai Xuebao, V25, P797; Zhao M., 2007, ACTA ECOLOGICA SINIC, V67, P916	93	4	4	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0209635	10.1371/journal.pone.0209635	http://dx.doi.org/10.1371/journal.pone.0209635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947266	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500006
J	Budkaew, J; Chumworathayi, B; Pientong, C; Ekalaksananan, T				Budkaew, Jiratha; Chumworathayi, Bandit; Pientong, Chamsai; Ekalaksananan, Tipaya			Prevalence and factors associated with gonorrhea infection with respect to anatomic distributions among men who have sex with men	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ACID AMPLIFICATION TESTS; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; RISK-FACTORS; PHARYNGEAL; TRANSMISSION; POPULATION; CHALLENGES; SPECIMENS	Introduction Gonorrhea (GC) infection caused by Neisseria gonorrhoeae has been steadily increasing in Thailand over the last decade. Men who have sex with men (MSM) are at high risk for gonorrhea infection. Materials and methods In this study, we determined the prevalence of and risk factors associated with gonococcal infections by three anatomical sites among MSM. We have conducted a cross-sectional analysis of a sexually transmitted disease (STD), gonorrhea among MSM attending two STD clinics in Khon Kaen, Thailand. We included 358 MSM over 18 years of age. Data were collected using self-administered questionnaire. In each participant, an oropharyngeal, anorectal, and endourethral swab were tested with culture and nucleic acid amplification test (NAAT). However, 267 urine samples were tested by both methods. Factors associated with gonorrhea infections were assessed using univariate and multivariate logistic regression. Results One hundred and ninety-five out of 358 (54.47%) MSM tested were found to be positive for gonorrhea using a porA gene targeted NAAT by Real-time PCR with TaqMan probes, but there was no positive result by culture. The gonorrheal prevalence for male genital site, anal, and oropharyngeal, were 34.73% (95% CI 33.07, 45.08), 29.01% (95% CI 24.61, 34.33), and 27.93% (95% CI 23.35, 32.89), respectively, while 5.9% (21/355) were positive for gonococcal infection in all anatomic sites (oropharynx + anus + urethra) of one participant. Previous history of diagnosed STDs was a significant factor associated urethral gonorrhea (odds ratio = 3.52, 95%CI 1.87-6.66, P Value< 0.001). In addition, having more than one partner was increased urethral gonorrhea (adjusted odds ratio = 2.26, 95%CI 1.10-4.68, P Value = 0.026). 100% of condom use was found decreasing urethral infection (adjusted odds ratio = 0.39, 95%CI 0.15-0.99, P Value = 0.046). Conclusions The most common anatomic site of gonorrhea infection was male genital site, and the independent risk factors were having history of diagnosed STDs and having more than one partner in the past 3 months, but 100% condom use was a protective factor of this infection.	[Budkaew, Jiratha] Khon Kaen Ctr Hosp, Dept Social Med, Khon Kaen, Khon Kaen Provi, Thailand; [Chumworathayi, Bandit] Khon Kaen Univ, Dept Obstet & Gynecol, Fac Med, Srinagarind Hosp, Khon Kaen, Thailand; [Pientong, Chamsai] Khon Kaen Univ, Srinagarind Hosp, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Ekalaksananan, Tipaya] Khon Kaen Univ, Srinagarind Hosp, Dept Microbiol, Fac Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University	Chumworathayi, B (corresponding author), Khon Kaen Univ, Dept Obstet & Gynecol, Fac Med, Srinagarind Hosp, Khon Kaen, Thailand.	bchumworathayi@gmail.com	Chumworathayi, Bandit/J-9927-2019	Chumworathayi, Bandit/0000-0003-1214-1962	Royal Golden Jubilee Ph. D Program (RGJPHD) from Thai Government	Royal Golden Jubilee Ph. D Program (RGJPHD) from Thai Government	The authors received fund from The Royal Golden Jubilee Ph. D Program (RGJPHD) to JB from Thai Government.	Alexander S, 2009, SEX TRANSM INFECT, V85, P159, DOI 10.1136/sti.2008.035469; [Anonymous], 2013, ANN REP CLIN CONS HL; Barbee LA, 2013, CLIN INFECT DIS, V56, P1539, DOI 10.1093/cid/cit084; Bergey DH., 1994, BERGEYS MANUAL DETER, pp. 395; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Budkaew Jiratha, 2018, Journal of the Medical Association of Thailand, V101, P323; Budkaew J, 2017, PRAGMAT OBS RES, V8, P167, DOI 10.2147/POR.S137377; Carpenter RJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002775; Centers for Disease Control and Prevention (CDC), 2014, GON CDC FACT SHEET; Centers for Disease Control and Prevention (CDC), MMWR, V55, P1; Charlotte KK, 2005, CLIN INFECT DIS, V41, P67, DOI DOI 10.1086/430704; Chonwattana W, 2013, 7 IAS C HIV PATH TRE; Crotchfelt KA, 1997, J CLIN MICROBIOL, V35, P1536, DOI 10.1128/JCM.35.6.1536-1540.1997; Dallabetta G, 2008, SEXUALLY TRANSMITTED; Detels R, 2011, SEX TRANSM DIS, V38, P503, DOI 10.1097/OLQ.0b013e318206c288; Dosekun O, 2010, CURR OPIN HIV AIDS, V5, P291, DOI 10.1097/COH.0b013e32833a88a3; Dutt K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1971-3; Erbelding EJ, 2003, JAIDS-J ACQ IMM DEF, V33, P247, DOI 10.1097/00126334-200306010-00021; Fenton KA, 2005, J INFECT DIS, V191, pS127, DOI 10.1086/425286; Geral M., 1999, MECH MICROBIAL DIS; Global Forum on MSM and HIV, 2010, OUR OWN WORDS PREF V; Gurung A, 2010, INT AIDS C JUL 18 23; Handsfield HH., 2008, SEXUALLY TRANSMITTED, V16, P627; Hazel A, 2014, EPIDEMIOL INFECT, V142, P2422, DOI 10.1017/S0950268813003488; Hjelmevoll SO, 2006, J MOL DIAGN, V8, P574, DOI 10.2353/jmoldx.2006.060024; Justin LH., 1980, PHARYNGEAL GONOCOCCA, V31, P255; Kohli Ruchika, 2013, BMC Res Notes, V6, P44, DOI 10.1186/1756-0500-6-44; Komisaruk B. R, 2009, ORGASM ANSWER GUIDE, P108; LeFevre ML, 2014, ANN INTERN MED, V161, P894, DOI 10.7326/M14-1965; Martin DH, 2000, J CLIN MICROBIOL, V38, P3544, DOI 10.1128/JCM.38.10.3544-3549.2000; Masek BJ, 2009, J CLIN MICROBIOL, V47, P1663, DOI 10.1128/JCM.02387-08; Michael EW, 1972, J INFECT DIS, V126, P601; Mimiaga MJ, 2009, SEX TRANSM DIS, V36, P507, DOI 10.1097/OLQ.0b013e3181a2ad98; Morris SR, 2006, CLIN INFECT DIS, V43, P1284, DOI 10.1086/508460; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Ng Lai-King, 2005, Can J Infect Dis Med Microbiol, V16, P15; Ojanen TT, 2009, SEX RES SOC POLICY, V6, P4, DOI 10.1525/srsp.2009.6.2.4; Ota KV, 2009, SEX TRANSM INFECT, V85, P182, DOI 10.1136/sti.2008.034140; Podgore JK, 1986, J INFECT DIS, V154; POTTERAT JJ, 1987, SEX TRANSM DIS, V14, P107, DOI 10.1097/00007435-198704000-00010; Rebe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138315; Rieg G, 2008, AIDS PATIENT CARE ST, V22, P947, DOI 10.1089/apc.2007.0240; Sanders EJ, 2010, SEX TRANSM INFECT, V86, P440, DOI 10.1136/sti.2010.043224; Savage E J, 2012, Euro Surveill, V17; Shafer MA, 2002, MIL MED, V167, P496, DOI 10.1093/milmed/167.6.496; Staras SAS, 2009, SEX TRANSM DIS, V36, P232, DOI 10.1097/OLQ.0b013e3181901e32; Stolte IG, 2006, SEX TRANSM DIS, V33, P201, DOI 10.1097/01.olq.0000194596.78637.8e; Stoner BP, 2003, SEX TRANSM INFECT, V79, P197, DOI 10.1136/sti.79.3.197; Templeton DJ, 2008, SEX TRANSM INFECT, V84, P361, DOI 10.1136/sti.2008.032037; Todar K., 2009, TXB MICROBIOLOGY; U.S. Center for Disease Control and Prevention, 2007, THAIL STDS AR SPREAD; US Department of Health and Human Services Centers for Disease Control and Prevention., 2013, ANT RES THREATS US; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; Warner L, 2004, AM J EPIDEMIOL, V159, P242, DOI 10.1093/aje/kwh044; Watcharapol S., 2012, WEEKLY EPIDEMIOLO S1, V43, pS47; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2007, MOD 2 INTR STI S TI, V2nd; Yin YP, 2008, INT J STD AIDS, V19, P381, DOI 10.1258/ijsa.2007.007273; Young H, 2003, SEX TRANSM INFECT, V79, P484, DOI 10.1136/sti.79.6.484	59	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0211682	10.1371/journal.pone.0211682	http://dx.doi.org/10.1371/journal.pone.0211682			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943191	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300002
J	Tejera, B; Lopez, RE; Hidalgo, P; Cardenas, R; Ballesteros, G; Rivillas, L; French, L; Amero, C; Pastor, N; Santiago, A; Groitl, P; Dobner, T; Gonzalez, RA				Tejera, Berto; Lopez, Raul E.; Hidalgo, Paloma; Cardenas, Reinier; Ballesteros, Grisel; Rivillas, Lina; French, Leidys; Amero, Carlos; Pastor, Nina; Santiago, Angel; Groitl, Peter; Dobner, Thomas; Gonzalez, Ramon A.			The human adenovirus type 5 E1B 55kDa protein interacts with RNA promoting timely DNA replication and viral late mRNA metabolism	PLOS ONE			English	Article							55-KILODALTON PROTEIN; NUCLEAR EXPORT; TRANSCRIPTIONAL REPRESSION; TRIPARTITE LEADER; BINDING ACTIVITY; E1B-55K PROTEIN; GENE-EXPRESSION; P53; DEGRADATION; LIGASE	The E1B 55kDa produced by human adenovirus type 5 is a multifunctional protein that participates in the regulation of several steps during the viral replication cycle. Previous studies suggest this protein plays an important role in postranscriptional regulation of viral and cellular gene expression, as it is required for the selective accumulation of maximal levels of viral late mRNA in the cytoplasm of the infected cell; however the molecular mechanisms that are altered or regulated by this protein have not been elucidated. A ribonucleoprotein motif that could implicate the direct interaction of the protein with RNA was initially predicted and tested in vitro, but the interaction with RNA could not be detected in infected cells, suggesting the interaction may be weak or transient. Here it was determined that the E1B 55kDa interacts with RNA in the context of the viral infection in non-transformed human cells, and its contribution to the adenovirus replication cycle was evaluated. Using recombinant adeno-viruses with amino acid substitutions or a deletion in the ribonucleoprotein motif the interaction of E1B 55kDa with RNA was found to correlate with timely and efficient viral DNA replication and viral late mRNA accumulation and splicing.	[Tejera, Berto; Lopez, Raul E.; Hidalgo, Paloma; Cardenas, Reinier; Ballesteros, Grisel; Rivillas, Lina; French, Leidys; Pastor, Nina; Santiago, Angel; Gonzalez, Ramon A.] Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Ctr Invest Dinam Celular, Cuernavaca, Morelos, Mexico; [Lopez, Raul E.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Cardenas, Reinier; French, Leidys; Amero, Carlos] Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Ctr Invest Quim, Lab Bioquim & Resonancia Magnet Nucl, Cuernavaca, Morelos, Mexico; [Groitl, Peter] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany; [Dobner, Thomas] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Heinrich Pette Institute	Gonzalez, RA (corresponding author), Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Ctr Invest Dinam Celular, Cuernavaca, Morelos, Mexico.	rgonzalez@uaem.mx	Amero, Carlos/C-6952-2011; Pastor, Nina/W-4452-2019; Amero, Carlos/AAE-7733-2020; Pacheco, Leidys French/AAE-4987-2020	Amero, Carlos/0000-0001-6300-0241; Pastor, Nina/0000-0001-7755-2936; Tejera-Hernandez, Berto/0000-0002-5418-4955; Cardenas, Reinier Felipe/0000-0001-7213-4081; French-Pacheco, Leidys/0000-0002-4053-5013; Hidalgo, Paloma/0000-0001-5867-0128; Gonzalez, Ramon A./0000-0001-9689-8529; Santiago, Angel/0000-0002-3957-0970	Consejo Nacional de Ciencia y Tecnologia (CONACyT) Scholarship, Mexico [447442, 266820]; CONACyT [CB-2011-01-168497]; Programa para el Desarrollo Profesional Docente-Secretaria de Educacion Publica (PRODEP-SEP); Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG); Research Group Linkage Program of the Alexander von Humboldt Foundation	Consejo Nacional de Ciencia y Tecnologia (CONACyT) Scholarship, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa para el Desarrollo Profesional Docente-Secretaria de Educacion Publica (PRODEP-SEP); Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG); Research Group Linkage Program of the Alexander von Humboldt Foundation	BT received support from Consejo Nacional de Ciencia y Tecnologia (CONACyT) Scholarship 266820, Mexico. https://www.conacyt.gob.mx; PH received support from Consejo Nacional de Ciencia y Tecnologia (CONACyT) Scholarship 447442, Mexico. https://www.conacyt.gob.mx; RAG was supported by grants from CONACyT CB-2011-01-168497 and Programa para el Desarrollo Profesional Docente-Secretaria de Educacion Publica (PRODEP-SEP). http://www.dgesu.ses.sep.gob.mx/prodep.htm; TD and the Heinrich Pette Institute is supported by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit (BMG). https://www.bundesgesundheitsministerium.de/; R.A.G. and T. D. received support from the Research Group Linkage Program of the Alexander von Humboldt Foundation. https://www.humboldt.foundation.de/web/home.html; NO - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07997-w; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; BELTZ GA, 1979, J MOL BIOL, V131, P353, DOI 10.1016/0022-2836(79)90081-0; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; BERKNER KL, 1985, NUCLEIC ACIDS RES, V13, P841, DOI 10.1093/nar/13.3.841; Berscheminski J, 2014, J VIROL, V88, P6076, DOI 10.1128/JVI.00469-14; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Burck C, 2016, J VIROL, V90, P930, DOI 10.1128/JVI.01836-15; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chahal JS, 2013, J VIROL, V87, P4432, DOI 10.1128/JVI.03387-12; Chahal JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002853; Condezo GN, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006320; Dallaire F, 2009, J VIROL, V83, P5329, DOI 10.1128/JVI.00089-09; Dobbelstein M, 1997, EMBO J, V16, P4276, DOI 10.1093/emboj/16.14.4276; Dobner T, 2001, CURR TOP MICROBIOL, V259, P25; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Flint SJ, 2003, CURR TOP MICROBIOL, V272, P287; Gabler S, 1998, J VIROL, V72, P7960, DOI 10.1128/JVI.72.10.7960-7971.1998; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Gonzalez RA, 2002, J VIROL, V76, P4507, DOI 10.1128/JVI.76.9.4507-4519.2002; Groitl Peter, 2007, Methods Mol Med, V130, P29; Gupta A, 2013, ONCOGENE, V32, P5017, DOI 10.1038/onc.2012.534; Hagkarim NC, 2018, J VIROL, V92, DOI 10.1128/JVI.02034-17; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Harada JN, 1999, J VIROL, V73, P5333, DOI 10.1128/JVI.73.7.5333-5344.1999; Hidalgo P, 2016, J VIROL, V90, P3411, DOI 10.1128/JVI.00033-16; Horridge JJ, 1998, J VIROL, V72, P9374, DOI 10.1128/JVI.72.11.9374-9379.1998; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung G, 2017, VIROLOGY, V504, P12, DOI 10.1016/j.virol.2017.01.013; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kallay C, 2011, DALTON T, V40, P9711, DOI 10.1039/c1dt10835b; Kato SEM, 2011, VIROLOGY, V417, P9, DOI 10.1016/j.virol.2011.04.014; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kindsmuller K, 2007, P NATL ACAD SCI USA, V104, P6684, DOI 10.1073/pnas.0702158104; Komatsu T, 2018, J VIROL, V92, DOI 10.1128/JVI.00795-18; Kratzer F, 2000, ONCOGENE, V19, P850, DOI 10.1038/sj.onc.1203395; LEPPARD KN, 1989, EMBO J, V8, P2329, DOI 10.1002/j.1460-2075.1989.tb08360.x; LOGAN J, 1984, P NATL ACAD SCI-BIOL, V81, P3655, DOI 10.1073/pnas.81.12.3655; Lu W, 2004, WORLD J GASTROENTERO, V10, P3634, DOI 10.3748/wjg.v10.i24.3634; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; Menendez-Conejero R, 2017, STRUCTURE, V25, P1562, DOI 10.1016/j.str.2017.08.007; Miller DL, 2009, J VIROL, V83, P3591, DOI 10.1128/JVI.02269-08; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; Orazio NI, 2011, J VIROL, V85, P1887, DOI 10.1128/JVI.02134-10; ORNELLES DA, 1991, J VIROL, V65, P424, DOI 10.1128/JVI.65.1.424-429.1991; Pennella MA, 2010, J VIROL, V84, P12210, DOI 10.1128/JVI.01442-10; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; Rothmann T, 1998, J VIROL, V72, P9470, DOI 10.1128/JVI.72.12.9470-9478.1998; SARNOW P, 1984, J VIROL, V49, P692, DOI 10.1128/JVI.49.3.692-700.1984; Schmid M, 2014, J VIROL, V88, P1404, DOI 10.1128/JVI.02046-13; Schmid M, 2011, J VIROL, V85, P7081, DOI 10.1128/JVI.02368-10; Schreiner S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003775; Schreiner S, 2013, NUCLEIC ACIDS RES, V41, P3532, DOI 10.1093/nar/gkt064; Schreiner S, 2010, J VIROL, V84, P7029, DOI 10.1128/JVI.00074-10; Schwartz RA, 2008, J VIROL, V82, P9043, DOI 10.1128/JVI.00925-08; Sieber T, 2011, VIROLOGY, V418, P133, DOI 10.1016/j.virol.2011.07.012; SIGEL H, 1982, CHEM REV, V82, P385, DOI 10.1021/cr00050a003; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Teodoro JG, 1997, J VIROL, V71, P3620, DOI 10.1128/JVI.71.5.3620-3627.1997; TEODORO JG, 1994, J VIROL, V68, P776, DOI 10.1128/JVI.68.2.776-786.1994; Turnell AS, 1999, J VIROL, V73, P2074, DOI 10.1128/JVI.73.3.2074-2083.1999; WILLIAMS JF, 1973, NATURE, V243, P162, DOI 10.1038/243162a0; Wimmer P, 2013, ONCOGENE, V32, P1626, DOI 10.1038/onc.2012.187; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yatherajam G, 2011, J VIROL, V85, P1429, DOI 10.1128/JVI.02108-10; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012	75	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214882	10.1371/journal.pone.0214882	http://dx.doi.org/10.1371/journal.pone.0214882			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943256	gold, Green Published, Green Submitted			2022-12-27	WOS:000463194300069
J	van Wijngaarden, E; Alma, M; The, AM				van Wijngaarden, Els; Alma, Manna; The, Anne-Mei			'The eyes of others' are what really matters: The experience of living with dementia from an insider perspective	PLOS ONE			English	Article							EARLY-STAGE DEMENTIA; ILLNESS REPRESENTATIONS; PHENOMENOLOGY; EMBODIMENT; CRITIQUE; PEOPLE; HEALTH; DIPEX; SELF; CARE	Introduction This Dutch study is a qualitative interview study. It aims to contribute to our understanding of the day-to-day experiences by providing an idiographic description of what it means existentially to be in the world as a person affected by a form of dementia, taking into account the contextual nature of these embodied experiences. Methods We used a combination of narrative accounts of people from dementia. We first collected 322 recorded messages of 16 diarists who joined the Dutch Dementia Diaries project. This data was supplemented with 37 interview accounts. Our data analysis was inspired by Van Manen's existential phenomenological approach. Results The findings show that living with dementia-from a first-person perspective-can be understood as a severely unsettling experience: the people concerned enter a very uncertain, unpredictable and ambiguous period of life. They have to face all kinds of losses that considerably change and disrupt their relationships with 1) their own body, 2) with others and 3) with the surrounding world. This experience is explicated in the following themes: la) scrutinizing your disrupted body; 1b) trying to control your bodily loss-of-control; 2a) feeling scrutinized by the suspicious gaze of others; 2b) drifting away from significant others; 2c) having difficulties sharing the struggle; 2d) longing to be taken seriously; 2e) engaging in a world of peers; and 3a) sensing disorientation in an alien place; 3b) feeling closed in within a shrinking space; 3c) trying to control a dreaded future; 3d) trying to control a dreaded future by means of euthanasia. Discussion Our study demonstrates how the people with dementia are affected by 'the eyes of others'. They longed for a safe and accepting environment, but quite often felt scrutinized by inquisitive and disapproving looks. The outcomes also reveal a connection between dominant social imaginaries and people's self-understanding of dementia. Much of the suffering stems from living under the shadow of negative imaginaries. Furthermore, our study supports the demand for a socio-relational approach by demonstrating that-from a first-person perspective-dementia can be seen a disorder that is related in particular to questions about self-hood, social relations and social roles. For the people involved, instead of what dementia is, the focus is on what Alzheimer's disease means and does and how it affects daily life.	[van Wijngaarden, Els] Univ Humanist Studies, Res Grp Care Eth, Utrecht, Netherlands; [van Wijngaarden, Els] Res Org Tao Care, Amsterdam, Netherlands; [Alma, Manna] Univ Groningen, Univ Med Ctr Groningen, Appl Hlth Res, Dept Hlth Sci, Groningen, Netherlands; [The, Anne-Mei] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, Netherlands	University of Groningen; University of Amsterdam	van Wijngaarden, E (corresponding author), Univ Humanist Studies, Res Grp Care Eth, Utrecht, Netherlands.; van Wijngaarden, E (corresponding author), Res Org Tao Care, Amsterdam, Netherlands.	e.vanwijngaarden@uvh.nl	van Wijngaarden, Els/AAH-3414-2021; Alma, Manna/G-7987-2011; The, Anne-Mei/AAE-3468-2020	van Wijngaarden, Els/0000-0002-2940-9163; Alma, Manna/0000-0002-8203-2713	Netherlands Organization for Health Research and Development (ZonMw), research program "National Care for the Elderly" [314010301]	Netherlands Organization for Health Research and Development (ZonMw), research program "National Care for the Elderly"	The first and third author received no specific funding for this work. The second author works for the project PratenOverGezondheid. This PratenOverGezondheid study was supported by a grant (314010301) from the Netherlands Organization for Health Research and Development (ZonMw), research program "National Care for the Elderly", appointed by the Ministry of Health (VWS) and the Netherlands Organization for Scientific Research (NWO).	[Anonymous], 2017, THEOLOGICAL ETHICS M; Ashworth A., 2003, J PHENOMENOLOGICAL P, V34, P179, DOI DOI 10.1163/156916203322847137; Carel H, 2012, J MED PHILOS, V37, P96, DOI 10.1093/jmp/jhs008; Cassell EricJ., 1998, LOSS GRIEF CARE, V8, P129, DOI [DOI 10.1300/J132V08N01_18, 10.1300/J132v08n01_18]; Castoriadis C., 1997, IMAGINARY I SOC; Cheston R, 2015, SCI PROGRESS-UK, V98, P416, DOI 10.3184/003685015X14467423210693; Clare L, 2003, SOC SCI MED, V57, P1017, DOI 10.1016/S0277-9536(02)00476-8; Clare L, 2006, INT J GERIATR PSYCH, V21, P761, DOI 10.1002/gps.1558; Clare L, 2008, GERONTOLOGIST, V48, P711, DOI 10.1093/geront/48.6.711; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Dahlberg K., 2008, REFLECTIVE LIFEWORLD, V2nd ed.; Dahlberg K., 2006, INDO-PAC J PHENOMEN, DOI [DOI 10.1080/20797222.2006.11433932, 10.1080/20797222.2006.11433932]; Davis DHJ, 2004, SOC SCI MED, V58, P369, DOI 10.1016/S0277-9536(03)00202-8; de Boer ME, 2007, INT PSYCHOGERIATR, V19, P1021, DOI 10.1017/S1041610207005765; Downs M, 2000, AGEING SOC, V20, P369, DOI 10.1017/S0144686X99007758; Droes RM, 2010, NON PHARM THER DEMEN, V1, P139; Droes RM, 2011, EXPERT REV NEUROTHER, V11, P1769, DOI [10.1586/ern.11.167, 10.1586/ERN.11.167]; Finlay L, 2011, PHENOMENOLOGY FOR THERAPISTS: RESEARCHING THE LIVED WORLD, P1, DOI 10.1002/9781119975144; Giddens A., 1991, MODERNITY SELF IDENT; Gilleard, 2015, RETHINKING OLD AGE T; Gilleard C, 2013, J AGING STUD, V27, P368, DOI 10.1016/j.jaging.2013.08.004; Gilleard C, 2011, J AGING STUD, V25, P135, DOI 10.1016/j.jaging.2010.08.018; Gouras GK, 2014, DEMENTIA REFERENCE M, DOI 10.1016/B978-0-12-801238-3.00159-8; Harman G, 2006, QUAL HEALTH RES, V16, P484, DOI 10.1177/1049732306286851; Hayne Y, 2002, WRITING DARK PHENOME, P179; Herxheimer A, 2000, LANCET, V355, P1540, DOI 10.1016/S0140-6736(00)02174-7; Herxheimer A, 2004, NARRATIVE RES HLTH I, P115; Johnston B, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0250-1; Leventhal H, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P19; Leventhal H., ILLNESS REPRESENTATI; LYMAN KA, 1989, GERONTOLOGIST, V29, P597, DOI 10.1093/geront/29.5.597; Macquarrie CR, 2005, AGING MENT HEALTH, V9, P430, DOI 10.1080/13607860500142853; Martinsen EH, 2011, HEALTH CARE ANAL, V19, P15, DOI 10.1007/s10728-010-0161-9; Matchwick C, 2014, GERONTOLOGIST, V54, P268, DOI 10.1093/geront/gnt014; Onwuteaka-Philipsen B., 2017, 3 EVALUATIE WET TOET; Patton MQ., 2015, QUALITATIVE RES EVAL, V3; Post S.G., 2000, CONCEPTS ALZHEIMERS, P245; Prince M., 2016, WORLD ALZHEIMER REPO; Riessman Catherine Kohler, 2007, NARRATIVE METHODS HU; Sabat, 2006, DEMENTIA MIND MEANIN; Seaman Aaron, 2016, FIGURING FAMILIES CA; Slatman J, 2014, MED HEALTH CARE PHIL, V17, P549, DOI 10.1007/s11019-014-9544-2; Steeman E, 2006, J ADV NURS, V54, P722, DOI 10.1111/j.1365-2648.2006.03874.x; Svenaeus F, 2015, CONT PHILOS REV, V48, P107, DOI 10.1007/s11007-015-9325-5; Svenaeus F, 2009, HUM STUD, V32, P53, DOI 10.1007/s10746-009-9109-1; Taylor Charles, 2004, MODERN SOCIAL IMAGER; Taylor Charles, 1989, SOURCES SELF MAKING; Taylor Janelle S, 2011, ANTHR NOW, V3, P62; The AM, 2017, DAG LEV MET DEM BLIK; Todres, 2013, CARING WELL BEING LI; Todres L, 2007, EMBODIED ENQUIRY: PHENOMENOLOGICAL TOUCHSTONES FOR RESEARCH, PSYCHOTHERAPY AND SPIRITUALITY, P1, DOI 10.1057/9780230598850; Todres Les, 2007, Med Health Care Philos, V10, P53, DOI 10.1007/s11019-006-9012-8; Todres L, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.21421; van Manen M., 1990, RES LIVED EXPERIENCE; Van Manen M., 1984, PHENOMENOLOGY PEDAGO, V2, P36, DOI DOI 10.29173/pandp14931; Van Manen Max., 2014, PHENOMENOLOGY PRACTI, V13; Van Wijngaarden E, 2018, PLOS ONE, V13, P1; van Wijngaarden EJ, BRIDGE GAP AVAILABLE; van Wijngaarden Els, 2017, Tijdschr Gerontol Geriatr, V48, P169, DOI 10.1007/s12439-017-0222-8; van Wijngaarden E, 2017, QUAL HEALTH RES, V27, P1738, DOI 10.1177/1049732317711133; van Wijngaarden E, 2016, MED HEALTH CARE PHIL, V19, P265, DOI 10.1007/s11019-016-9687-4; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	62	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214724	10.1371/journal.pone.0214724	http://dx.doi.org/10.1371/journal.pone.0214724			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943277	Green Published, gold, Green Submitted			2022-12-27	WOS:000463194300055
J	Aikins, AD; Dodoo, F; Awuah, RB; Owusu-Dabo, E; Addo, J; Nicolaou, M; Beune, E; Mockenhaupt, FP; Danquah, I; Bahendeka, S; Meeks, K; Klipstein-Grobusch, K; Afrifa-Anane, E; Smeeth, L; Stronks, K; Agyemang, C				Aikins, Ama de-Graft; Dodoo, Francis; Awuah, Raphael Baffour; Owusu-Dabo, Ellis; Addo, Juliet; Nicolaou, Mary; Beune, Erik; Mockenhaupt, Frank P.; Danquah, Ina; Bahendeka, Silver; Meeks, Karlijn; Klipstein-Grobusch, Kirstin; Afrifa-Anane, Ernest; Smeeth, Liam; Stronks, Karien; Agyemang, Charles			Knowledge and perceptions of type 2 diabetes among Ghanaian migrants in three European countries and Ghanaians in rural and urban Ghana: The RODAM qualitative study	PLOS ONE			English	Article							SOCIAL REPRESENTATIONS; AFRICAN-SURINAMESE; EXPLANATORY MODELS; HEALTH; HYPERTENSION; BELIEFS; ILLNESS	African migrants in Europe and continental Africans are disproportionately affected by type 2 diabetes (T2D). Both groups develop T2D at a younger age, and have higher morbidity and mortality from T2D and complications, compared to European populations. To reduce risk, and avoidable disability and premature deaths, culturally congruent and context specific interventions are required. This study aimed to: (a) assess perceptions and knowledge of T2D among Ghanaian migrants in Europe and their compatriots in Ghana and (b) identify specific perceptions and knowledge gaps that might predispose migrants to higher risk of diabetes. Data was gathered through 26 focus groups with 180 individuals, aged 21 to 70, from Amsterdam, Berlin and London and rural and urban Ashanti Region, Ghana. Thematic analysis of the data was informed by Social Representations Theory, which focuses on the sources, content and functions of social knowledge. Three key insights emerged from analysis. First, there was general awareness, across migrant and non-migrant groups, of T2D as a serious chronic condition with life threatening complications, and some knowledge of biomedical strategies to prevent diabetes (e.g healthy eating) and diabetes complications (e.g medication adherence). However, knowledge of T2D prevention and reduction of diabetes complications was not comprehensive. Secondly, knowledge of biomedical diabetes theories and interventions co-existed with theories about psychosocial and supernatural causes of diabetes and the efficacy of herbal and faith-based treatment of diabetes. Finally, migrants' knowledge was informed by both Ghanaian and European systems of T2D knowledge suggesting enculturation dynamics. We discuss the development of culturally congruent and context-specific T2D interventions for the research communities.	[Aikins, Ama de-Graft; Dodoo, Francis; Awuah, Raphael Baffour; Afrifa-Anane, Ernest] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana; [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res, Kumasi, Ghana; [Addo, Juliet; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Nicolaou, Mary; Beune, Erik; Meeks, Karlijn; Stronks, Karien; Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Mockenhaupt, Frank P.] Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany; [Danquah, Ina] German Inst Human Nutr, Dept Mol Epidemiol, Potsdam, Nuthetal, Germany; [Bahendeka, Silver] Uganda Matyrs Univ, MKPGMS, Kampala, Uganda; [Klipstein-Grobusch, Kirstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands	University of Ghana; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Utrecht University; Utrecht University Medical Center	Aikins, AD (corresponding author), Univ Ghana, Reg Inst Populat Studies, Legon, Ghana.	adaikins@ug.edu.gh	Mockenhaupt, Frank P/U-9824-2017; Klipstein-Grobusch, Kerstin/F-5555-2016; Smeeth, Liam/X-5862-2018	Mockenhaupt, Frank P/0000-0002-8117-5421; Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Danquah, Ina/0000-0003-3222-3498; Meeks, Karlijn/0000-0003-3032-405X; Smeeth, Liam/0000-0002-9168-6022; Stronks, Karien/0000-0002-0921-2232	European Commission [278901]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission under the Framework Programme: Grant Number 278901.	Agyemang C, 2017, ANN NY ACAD SCI, V1391, P54, DOI 10.1111/nyas.13204; Agyemang C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004877; Agyemang C, 2013, EUR J PREV CARDIOL, V20, P938, DOI 10.1177/2047487312451540; Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Aikins AD, 2005, BMJ-BRIT MED J, V331, P737, DOI 10.1136/bmj.331.7519.737; Aikins ADG, 2004, J HEALTH PSYCHOL, V9, P295, DOI 10.1177/1359105304040895; Aikins AD, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-29; [Anonymous], 2002, FORUM QUAL SOC RES, V30, P3; Attride-Stirling J., 2001, QUAL RES, V1, P385, DOI [DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; Awah PK, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-43; Awah PK, 2008, AFRICA, V78, P475, DOI 10.3366/E0001972008000405; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; Beune EJAJ, 2008, J HYPERTENS, V26, P648, DOI 10.1097/HJH.0b013e3282f4d20b; Cole D. C., 2008, HLTH CITY HARVESTS G; Cooper M, 2012, ETHNIC HEALTH, V17, P597, DOI 10.1080/13557858.2012.740003; de Graft Aikins A, 2012, Ghana Med J, V46, P59; de-Graft Aikins A, 2014, ETHN HLTH, V20, P391, DOI [DOI 10.1080/13557858.2014.921896, 10.1080/13557858.2014.921896]; Duveen G, 1998, CULT PSYCHOL, V4, P455, DOI 10.1177/1354067X9800400402; Garro L C, 1995, Soc Sci Med, V40, P37, DOI 10.1016/0277-9536(94)00125-D; Greenhalgh T, 1998, BRIT MED J, V316, P978, DOI 10.1136/bmj.316.7136.978; Hjelm K, 2008, INT NURS REV, V55, P434, DOI 10.1111/j.1466-7657.2008.00665.x; Hjelm K, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-7; Joffe H, 2002, SOC SCI INFORM, V41, P559, DOI 10.1177/0539018402041004004; Joychelovitch S., 2002, PSYCHOL SOC, V5, P121; Kiawi E, 2006, ETHNIC DIS, V16, P503; Kolling M, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-8; Krause K, 2008, J ETHN MIGR STUD, V34, P235, DOI 10.1080/13691830701823863; MOSCOVICI S, 1988, EUR J SOC PSYCHOL, V18, P211, DOI 10.1002/ejsp.2420180303; nternational Diabetes Federation, 2015, DIABETES ATLAS; Parish Jane, 2011, Anthropol Med, V18, P303, DOI 10.1080/13648470.2011.615910; Sabone MB, 2008, J FAM NURS, V14, P363, DOI 10.1177/1074840708323047; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Simao TP, 2016, RELIGIONS, V7, DOI 10.3390/rel7010011; Taylor KD, 2012, ETHNIC HEALTH, V17, P615, DOI 10.1080/13557858.2013.771151; Vickers T., 2012, RES BLACK MINORITY E; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yates-Doerr E, 2016, MED ANTHROPOL, V35, P305, DOI 10.1080/01459740.2015.1030402	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214501	10.1371/journal.pone.0214501	http://dx.doi.org/10.1371/journal.pone.0214501			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939148	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000462993900027
J	Tayler, NM; Boya, CA; Herrera, L; Moy, J; Ng, M; Pineda, L; Almanza, A; Rosero, S; Coronado, LM; Correa, R; Santamaria, R; Caballero, Z; Durant-Archibold, AA; Currency, KJT; Balunas, MJ; Gerwick, WH; Spadafora, A; Gutierrez, M; SpadaforaID, C				Tayler, Nicole M.; Boya, Cristopher A.; Herrera, Liuris; Moy, Jamie; Ng, Michelle; Pineda, Laura; Almanza, Alejandro; Rosero, Sara; Coronado, Lorena M.; Correa, Ricardo; Santamaria, Ricardo; Caballero, Zuleima; Durant-Archibold, Armando A.; Currency, Kevin J. Tidgewell; Balunas, Marcy J.; Gerwick, William H.; Spadafora, Alida; Gutierrez, Marcelino; SpadaforaID, Carmenza			Analysis of the antiparasitic and anticancer activity of the coconut palm (Cocos nucifera L. ARECACEAE) from the natural reserve of Punta Patino, Darien	PLOS ONE			English	Article							IN-VITRO; DRUG; PARASITES	Cocos nucifera (C. nucifera) (the coconut palm tree) has been traditionally used to fight a number of human diseases, but only a few studies have tested its components against parasites such as those that cause malaria. In this study, C. nucifera samples were collected from a private natural reserve in Punta Patino, Darien, Panama. The husk, leaves, pulp, and milk of C. nucifera were extracted and evaluated against the parasites that cause Chagas' disease or American trypanosomiasis (Trypanosoma cruzi), leishmaniasis (Leishmania donovani) and malaria (Plasmodium falciparum), as well as against a line of breast cancer cells. While there was no activity in the rest of the tests, five and fifteen-minute aqueous decoctions of leaves showed antiplasmodial activity at 10% v/v concentration. Removal of some HPLC fractions resulted in loss of activity, pointing to the presence of synergy between the components of the decoction. Chemical molecules were separated and identified using an ultra-performance liquid chromatography (UPLC) approach coupled to tandem mass spectrometry (LC-MS/MS) using atmospheric pressure chemical ionization quadrupole-time of flight mass spectrometry (APCI-Q-TOF-MS) and molecular networking analysis, revealing the presence of compounds including polyphenol, flavone, sterol, fatty acid and chlorophyll families, among others.	[Tayler, Nicole M.; Herrera, Liuris; Ng, Michelle; Pineda, Laura; Almanza, Alejandro; Rosero, Sara; Coronado, Lorena M.; Correa, Ricardo; Caballero, Zuleima; SpadaforaID, Carmenza] Inst Invest Cienti & Serv Alta Tecnol INDICASAT A, Ctr Biol Celular & Mol Enfermedades, Panama City, Panama; [Tayler, Nicole M.; Boya, Cristopher A.; Coronado, Lorena M.; Correa, Ricardo; Gutierrez, Marcelino] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, AP, India; [Boya, Cristopher A.; Santamaria, Ricardo; Durant-Archibold, Armando A.] INDICASAT AIP, Ctr Biodiversidad & Descubrimiento Drogas, Panama City, Panama; [Herrera, Liuris; Moy, Jamie; Ng, Michelle; Pineda, Laura; Almanza, Alejandro; Currency, Kevin J. Tidgewell] Smithsonian Trop Res Inst, Panama City, Panama; [Balunas, Marcy J.] Univ Connecticut, Div Med Chem, Dept Pharmaceut Sci, Storrs, CT USA; [Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Spadafora, Alida] Asociac Nacl Conservac Nat ANCON, Panama City, Panama	Acharya Nagarjuna University; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Smithsonian Institution; Smithsonian Tropical Research Institute; University of Connecticut; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	SpadaforaID, C (corresponding author), Inst Invest Cienti & Serv Alta Tecnol INDICASAT A, Ctr Biol Celular & Mol Enfermedades, Panama City, Panama.	cspadafora@indicasat.org.pa	Spadafora, Carmenza/ABE-8973-2020; Gutiérrez, Marcelino/V-8134-2019	Spadafora, Carmenza/0000-0002-3002-9467; Gutiérrez, Marcelino/0000-0003-1423-3772; Correa, Ricardo/0000-0001-5475-5407; Boya P., Cristopher A./0000-0002-8093-596X; DURANT ARCHIBOLD, ARMANDO/0000-0002-6516-9427; Coronado, Lorena/0000-0001-6755-3118; Tidgewell, Kevin/0000-0002-0501-2604; Tayler, Nicole/0000-0003-4431-6464; Balunas, Marcy/0000-0003-2374-4048	SENACYT, Panama [CCP10-PP013]; NIH (The International Fogarty Center), USA [ICBG TW006634]; FIC International Research Scientist Development Award (IRSDA) [K01 TW008002]; UCSC NIH MHIRT Research Training Grant [5T37MD001480-22]; Panama National System of Investigation (SNI) [SNI 120-2018, SNI 33-2015, SNI 170-2016, SNI 214-2017, SNI 162-2018]; Instituto para la Formacion y Aprovechamiento de los Recursos Humanos-Panama; National Institute on Minority Health and Health Disparities [T37MD001480] Funding Source: NIH RePORTER	SENACYT, Panama; NIH (The International Fogarty Center), USA; FIC International Research Scientist Development Award (IRSDA); UCSC NIH MHIRT Research Training Grant; Panama National System of Investigation (SNI); Instituto para la Formacion y Aprovechamiento de los Recursos Humanos-Panama; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by the following research grants: SENACYT, Panama (CCP10-PP013) to A.S. and C.S.; NIH (The International Fogarty Center), USA (ICBG TW006634) to W.H.G.; FIC International Research Scientist Development Award (IRSDA) (K01 TW008002) to M.J.B.; and UCSC NIH MHIRT Research Training Grant 5T37MD001480-22 supporting J.M., C.S. and M.G. The Panama National System of Investigation (SNI) supported in part the following persons: C.S. (SNI 120-2018), A.A.D.(SNI 33-2015), R.C. (SNI 170-2016), Z.C. (SNI 214-2017) and L.M.C. (SNI 162-2018). SENACYT together with the Instituto para la Formacion y Aprovechamiento de los Recursos Humanos-Panama supported N.T., L.M.C. and R.C. with doctoral scholarships.	Achan J, 2018, EXPERT REV CLIN PHAR, V11, P61, DOI 10.1080/17512433.2018.1387773; Adebayo JO, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/742476; Almanza A., 2011, Current Trends in Biotechnology and Pharmacy, V5, P1130; Bianchi S, 2015, PHYTOCHEMISTRY, V120, P53, DOI 10.1016/j.phytochem.2015.10.006; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Calderon AI, 2006, PHARM BIOL, V44, P487, DOI 10.1080/13880200600878361; Chandrashekaran IR, 2011, ARCH BIOCHEM BIOPHYS, V513, P153, DOI 10.1016/j.abb.2011.07.008; Chang CL, 2011, FOOD CHEM, V126, P710, DOI 10.1016/j.foodchem.2010.11.034; Chithambo B, 2017, J ETHNOPHARMACOL, V199, P91, DOI 10.1016/j.jep.2017.01.051; Corbett Y, 2004, AM J TROP MED HYG, V70, P119, DOI 10.4269/ajtmh.2004.70.119; Fund CEP, MESOAMERICA; Jansen O, 2017, J ETHNOPHARMACOL, V203, P20, DOI 10.1016/j.jep.2017.03.021; Lehane Adele M, 2008, BMC Res Notes, V1, P26, DOI 10.1186/1756-0500-1-26; Manalo RV, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5020017; Mendonca RR, 2004, RES MICROBIOL, V155, P136, DOI 10.1016/j.resmic.2003.12.001; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Romanha AJ, 2010, MEM I OSWALDO CRUZ, V105, P233, DOI 10.1590/S0074-02762010000200022; Roopan SM, 2016, APPL BIOCHEM BIOTECH, V179, P1309, DOI 10.1007/s12010-016-2067-y; Ross IA, 1993, CHEM CONSTITUENTS TR; Schoenen F.J., 2010, PROBE REPORTS NIH MO; Seto R, 1997, BIOSCI BIOTECH BIOCH, V61, P1434, DOI 10.1271/bbb.61.1434; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Thomas R, 2008, CURR PHARM BIOTECHNO, V9, P315, DOI 10.2174/138920108785161505; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; WHO, 2016, WHAT IS CHAG DIS; World Health Organization, 2017, FACT SHEET WORLD MAL	28	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214193	10.1371/journal.pone.0214193	http://dx.doi.org/10.1371/journal.pone.0214193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939131	gold, Green Published, Green Submitted			2022-12-27	WOS:000462993900015
J	Han, S; Jeong, HS; Kim, H; Suh, HS				Han, Sola; Jeong, Hwa Seop; Kim, Hyungtae; Suh, Hae Sun			The treatment pattern and adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65	PLOS ONE			English	Article							WARFARIN; STROKE; PERSISTENCE; DABIGATRAN	Objective In this study, we aimed to assess the utilization pattern (potentially inappropriate dosing and concomitant use of contraindicated drugs) and adherence to direct oral anticoagulants (DOACs), including apixaban, dabigatran, and rivaroxaban, in patients with atrial fibrillation (AF) unsuitable for warfarin. Methods We used nationally representative data, namely Health Insurance Review and Assessment Service-Aged Patient Sample 2014, that included medical and pharmacy claims of approximately 1 million patients aged 65 or older. We included patients who had at least one diagnosis of AF and at least one prescription of DOAC between January 1 and December 31, 2014. In 2014, DOACs were reimbursed only to patients with AF unsuitable for warfarin. Appropriate dosing and contraindicated drugs were determined according to the Summary of Product Characteristics for each DOAC. Multivariate logistic regression was performed to examine the factors contributing to the concomitant use of contraindicated drugs. To assess adherence, we calculated the medication possession ratio (MPR). Results The percentage of inappropriate dosing was 11.8% among 1,234 patients with AF; it was the highest in rivaroxaban users (16.8%). Contraindicated drugs were prescribed to 236 patients (19.1%). Clinics, smaller healthcare institutions, and outpatient visits were significantly related to contraindicated drug use. The mean MPRs were 0.95, 0.93, and 0.91 for apixaban, dabigatran, and rivaroxaban, respectively (P = 0.075). Conclusions Careful monitoring is warranted in patients with AF aged over 65 who were unsuitable for warfarin to reduce the incidence of inappropriate dosing and concomitant use of contraindicated drugs.	[Han, Sola; Jeong, Hwa Seop; Kim, Hyungtae; Suh, Hae Sun] Pusan Natl Univ, Coll Pharm, Busan, South Korea	Pusan National University	Suh, HS (corresponding author), Pusan Natl Univ, Coll Pharm, Busan, South Korea.	haesun.suh@pusan.ac.kr	Han, Sola/ABE-5476-2021	Han, Sola/0000-0002-6269-172X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2016R1C1B1009198]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2016R1C1B1009198).	Barra ME, 2016, AM J MED, V129, P1198, DOI 10.1016/j.amjmed.2016.05.041; Beyer-Westendorf J, 2016, EUROPACE, V18, P1150, DOI 10.1093/europace/euv421; Carter Aleesa A, 2015, Can J Hosp Pharm, V68, P369; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Harper P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020212; Howard M, 2017, J THROMB THROMBOLYS, V43, P149, DOI 10.1007/s11239-016-1435-3; Jung BC, 2015, KOREAN CIRC J, V45, P9, DOI 10.4070/kcj.2015.45.1.9; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Ko YJ, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e163; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Olesen JB, 2015, EUROPACE, V17, P187, DOI 10.1093/europace/euu225; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Sinnaeve PR, 2012, J INTERN MED, V271, P15, DOI 10.1111/j.1365-2796.2011.02464.x; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhou M, 2015, J MANAG CARE SPEC PH, V21, P1054, DOI 10.18553/jmcp.2015.21.11.1054; 고점석, 2011, [The Korean Journal of Medicine, 대한내과학회지], V81, P434	21	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214666	10.1371/journal.pone.0214666	http://dx.doi.org/10.1371/journal.pone.0214666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934004	Green Published, gold, Green Submitted			2022-12-27	WOS:000462867000032
J	Iyer, RG; Rogers, DV; Levine, M; Winchell, CJ; Weisblat, DA				Iyer, Roshni G.; Rogers, D. Valle; Levine, Michelle; Winchell, Christopher J.; Weisblat, David A.			Reproductive differences among species, and between individuals and cohorts, in the leech genus Helobdella (Lophotrochozoa; Annelida; Clitellata; Hirudinida; Glossiphoniidae), with implications for reproductive resource allocation in hermaphrodites	PLOS ONE			English	Article							LIFE-HISTORY; ZEYLANICOBDELLA-ARUGAMENSIS; MARINE LEECH; TRISERIALIS; PHYLOGENY; MORPHOLOGY; SEQUENCE; ACCURACY; BEHAVIOR; ECOLOGY	Leeches and oligochaetes comprise a monophyletic group of annelids, the Clitellata, whose reproduction is characterized by simultaneous hermaphroditism. While most clitellate species reproduce by cross-fertilization, self-fertilization has been described within the speciose genus Helobdella. Here we document the reproductive life histories and reproductive capacities for three other Helobdella species. Under laboratory conditions, both H. robusta and H. octatestisaca exhibit uniparental reproduction, apparently reflecting self-fertility, and suggesting that this trait is ancestral for the genus. However, the third species, H. austinensis, seems incapable of reproduction by self-fertilization, so we inferred its reproductive life history by analyzing reproduction in breeding cohorts. Comparing the reproductive parameters for H. robusta reproducing in isolation and in cohorts revealed that reproduction in cohorts is dramatically delayed with respect to that of isolated individuals, and that cohorts of leeches coordinate their cocoon deposition in a manner that is not predicted from the reproductive parameters of individuals reproducing in isolation. Finally, our comparisons of reproductive capacity for individuals versus cohorts for H. robusta, and between different sizes of cohorts for H. austinensis, reveal differences in resource allocation between male and female reproductive roles that are consistent with evolutionary theory.	[Iyer, Roshni G.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Rogers, D. Valle; Levine, Michelle; Winchell, Christopher J.; Weisblat, David A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Levine, Michelle] Rocky Vista Univ, Coll Osteopath Med, Parker, CO USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Weisblat, DA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	weisblat@berkeley.edu		Weisblat, David/0000-0002-9617-4130; Rogers, Dylan/0000-0001-7674-2199				Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; ASTROW SH, 1989, DEV BIOL, V135, P306, DOI 10.1016/0012-1606(89)90181-4; Bely AE, 2006, EVOL DEV, V8, P491, DOI 10.1111/j.1525-142X.2006.00122.x; Beresic-Perrins RK, 2017, ZOOKEYS, P137, DOI 10.3897/zookeys.661.9728; BLINN DW, 1989, OECOLOGIA, V79, P6, DOI 10.1007/BF00378232; Boore JL, 2000, MOL BIOL EVOL, V17, P87, DOI 10.1093/oxfordjournals.molbev.a026241; Cannarsa E, 2017, CURR ZOOL, V63, P151, DOI 10.1093/cz/zow030; Cho SJ, 2014, MOL BIOL EVOL, V31, P341, DOI 10.1093/molbev/mst201; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAVIES R W, 1982, Freshwater Invertebrate Biology, V1, P40, DOI 10.2307/1467140; DAVIES RW, 1989, OECOLOGIA, V81, P329, DOI 10.1007/BF00377079; Davies RW, 1996, FRESHWATER BIOL, V36, P563, DOI 10.1046/j.1365-2427.1996.00121.x; Deiner K, 2013, MOL ECOL RESOUR, V13, P820, DOI 10.1111/1755-0998.12130; ELSHIMY NA, 1991, HYDROBIOLOGIA, V222, P173, DOI 10.1007/BF00016156; Fischer A, 1999, HYDROBIOLOGIA, V402, P1, DOI 10.1023/A:1003719906378; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Kua BC, 2010, AQUACULTURE, V302, P153, DOI 10.1016/j.aquaculture.2010.02.029; Kuo DH, 2017, DEV BIOL, V427, P230, DOI 10.1016/j.ydbio.2017.01.016; Kutschera U, 2013, ZOOSYST EVOL, V89, P239, DOI 10.1002/zoos.201300010; Lai YT, 2009, ZOOTAXA, P27, DOI 10.11646/zootaxa.2068.1.2; LEARNER MA, 1974, J ANIM ECOL, V43, P199, DOI 10.2307/3167; Lively CM, 2014, J EVOLUTION BIOL, V27, P1292, DOI 10.1111/jeb.12354; MULLER KJ, 1981, NEUROBIOLOGY LEECH; MURPHY PM, 1982, FRESHWATER BIOL, V12, P321, DOI 10.1111/j.1365-2427.1982.tb00626.x; Oceguera-Figueroa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155441; Oceguera-Figueroa A, 2012, MOL PHYLOGENET EVOL, V62, P508, DOI 10.1016/j.ympev.2011.10.020; Oceguera-Figueroa A, 2010, MITOCHONDR DNA, V21, P24, DOI 10.3109/19401736.2010.527965; OOSTHUIZEN JH, 1985, S AFR J WILDL RES, V15, P98; Pamungkas J, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.520.9581; Pfeiffer I, 2004, MOL PHYLOGENET EVOL, V33, P214, DOI 10.1016/j.ympev.2004.04.010; Ravi R, 2017, ASIAN PAC J TROP BIO, V7, P473, DOI 10.1016/j.apjtb.2017.01.018; Reyes-Prieto M, 2014, MITOCHONDR DNA, V25, P387, DOI 10.3109/19401736.2013.809426; Romdhane Y, 2017, INVERTEBR REPROD DEV, V61, P253, DOI 10.1080/07924259.2017.1340354; Saglam N, 2018, ZOOTAXA, V4403, P61, DOI 10.11646/zootaxa.4403.1.3; Salas-Montiel R, 2014, ZOOTAXA, V3900, P77, DOI 10.11646/zootaxa.3900.1.4; SAWYER R.T., 1986, LEECH BIOL BEHAV, VII; Scharer L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0052; Scharer L, 2009, EVOLUTION, V63, P1377, DOI 10.1111/j.1558-5646.2009.00669.x; SHANKLAND M, 1992, CAN J ZOOL, V70, P1258, DOI 10.1139/z92-174; Siddall ME, 2005, CONSERV GENET, V6, P467, DOI 10.1007/s10592-005-4986-y; Siddall ME, 2005, INVERTEBR SYST, V19, P105, DOI 10.1071/IS04034; Siddall ME, 2003, ZOOL SCR, V32, P23, DOI 10.1046/j.1463-6409.2003.00098.x; Siddall ME, 1998, MOL PHYLOGENET EVOL, V9, P156, DOI 10.1006/mpev.1997.0455; Siddall ME, 2001, AM MUS NAT HIST NOVI, P3341; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Tan GN, 2004, J EVOLUTION BIOL, V17, P574, DOI 10.1111/j.1420-9101.2004.00692.x; Tessler M, 2018, MOL PHYLOGENET EVOL, V127, P129, DOI 10.1016/j.ympev.2018.05.001; VANDERLANDE VM, 1976, J ZOOL, V180, P537, DOI 10.1111/j.1469-7998.1976.tb04703.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wedeen C.J., 1990, P145; Weigert A, 2014, MOL BIOL EVOL, V31, P1391, DOI 10.1093/molbev/msu080; WEISBLAT DA, 2009, EMERGING MODEL ORGAN, V1, P245; Weisblat DA, 2014, INT J DEV BIOL, V58, P429, DOI 10.1387/ijdb.140132dw; Whitman C. O., 1878, Q J MICROSC SCI, V18, P215; WILKIALIS J, 1980, J ZOOL, V192, P421; Zattara EE, 2013, J EXP ZOOL PART B, V320, P471, DOI 10.1002/jez.b.22523; Zattara EE, 2011, EVOL DEV, V13, P80, DOI 10.1111/j.1525-142X.2010.00458.x; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	62	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214581	10.1371/journal.pone.0214581	http://dx.doi.org/10.1371/journal.pone.0214581			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934006	Green Submitted, gold, Green Published			2022-12-27	WOS:000462867000023
J	Saeterbakken, AH; Olsen, A; Behm, DG; Bardstu, HB; Andersen, V				Saeterbakken, Atle Hole; Olsen, Alexander; Behm, David George; Bardstu, Hilde Bremseth; Andersen, Vidar			The short- and long-term effects of resistance training with different stability requirements	PLOS ONE			English	Article							ELECTROMYOGRAPHIC ACTIVITY; MUSCLE-ACTIVITY; FORCE OUTPUT; UNSTABLE SURFACES; INSTABILITY; STRENGTH; BALANCE; PERFORMANCE; ACTIVATION; EXERCISES	The aim of this study was to assess the short- and long-term effects of resistance training (RT) with different stability requirements. Fifty-nine men underwent a 3-week familiarization period followed by a 7-week training period. During familiarization, all participants trained four sessions of squats with a Smith machine, free weights and free weights standing on a wobble board. After week-3, participants were randomized into a low (Smith machine), medium (Free-weight) or high (Wobble board) stability RT program, and Control group. All participants were tested pre-, after week-3 and post-intervention. Ten repetition maximum (10RM), rate of force development (RFD), electromyography (EMG) and maximum voluntary isometric contraction (MVIC) were tested in all three squat conditions in addition to countermovement jump (CMJ) on stable and unstable surfaces, and muscle thickness. After familiarization, greater 10RM loads (21.8-27.3%), MVIC (7.4-13.5%), RFD (29.7-43.8%) and CMJ (4.9-8.5%) were observed in all conditions. Between week 3 and 10, the Free-weight and Wobble board groups similarly improved 10RM in all conditions. Smith machine group demonstrated greater improvement in the trained exercise than the medium and high stability exercises. All training groups showed similar improvement in muscle thickness, RFD and MVIC. There was no CMJ improvement on the stable surface, but the Wobble board group demonstrated significantly greater improvement on the unstable surface. In conclusion, low, medium or high stability RT resulted in similar improvements in trained and non-trained testing conditions except for greater CMJ on the unstable surface in the Wobble group. Greater 10RM strength in trained than non-trained exercise was only observed in low stability group. Familiarization was associated with substantial improvements in 10RM and CMJ, with greater improvement associated with higher stability requirements. These findings suggest that high stability can increase strength, muscle thickness and explosive measurements similar to training with lower stability.	[Saeterbakken, Atle Hole; Olsen, Alexander; Bardstu, Hilde Bremseth; Andersen, Vidar] Western Norway Univ, Fac Educ Arts & Sports, Dept Sport Food & Nat Sciens, Sogndal, Sogn Og Fjordan, Norway; [Behm, David George] Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada	Memorial University Newfoundland	Saeterbakken, AH (corresponding author), Western Norway Univ, Fac Educ Arts & Sports, Dept Sport Food & Nat Sciens, Sogndal, Sogn Og Fjordan, Norway.	atle.saeterbakken@hvl.no	Behm, David George/I-6509-2019	Behm, David George/0000-0002-9406-6056				Andersen V, 2018, J STRENGTH COND RES, V32, P587, DOI 10.1519/JSC.0000000000001826; Andersen V, 2015, J STRENGTH COND RES, V29, P2932, DOI 10.1519/JSC.0000000000000950; Anderson K, 2005, CAN J APPL PHYSIOL, V30, P33, DOI 10.1139/h05-103; Anderson K, 2005, SPORTS MED, V35, P43, DOI 10.2165/00007256-200535010-00004; Anderson KG, 2004, J STRENGTH COND RES, V18, P637; Augustsson J, 1998, J ORTHOP SPORT PHYS, V27, P3, DOI 10.2519/jospt.1998.27.1.3; Behm D, 2012, INT J SPORTS PHYS TH, V7, P226; Behm DG, 2006, J STRENGTH COND RES, V20, P716; Behm DG, 2015, SPORTS MED, V45, P1645, DOI 10.1007/s40279-015-0384-x; BEHM DG, 1993, SPORTS MED, V15, P374, DOI 10.2165/00007256-199315060-00003; Behm DG, 2005, J STRENGTH COND RES, V19, P193; Behm DG, 2002, J STRENGTH COND RES, V16, P416; Bloomquist K, 2013, EUR J APPL PHYSIOL, V113, P2133, DOI 10.1007/s00421-013-2642-7; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Chulvi-Medrano I, 2012, INT J SPORTS PHYS TH, V7, P586; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cowley PM, 2007, INT J SPORTS MED, V28, P829, DOI 10.1055/s-2007-964893; Cressey EM, 2007, J STRENGTH COND RES, V21, P561, DOI 10.1519/R-19845.1; Drinkwater EJ, 2007, INT J SPORT PHYSIOL, V2, P400, DOI 10.1123/ijspp.2.4.400; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Kean CO, 2006, J SPORT SCI MED, V5, P138; Kibele A, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-30; Kibele A, 2009, J STRENGTH COND RES, V23, P2443, DOI 10.1519/JSC.0b013e3181bf0489; Marshall PWM, 2011, EUR J APPL PHYSIOL, V111, P3007, DOI 10.1007/s00421-011-1944-x; Mate-Munoz JL, 2014, J SPORT SCI MED, V13, P460; McBride JM, 2006, J STRENGTH COND RES, V20, P915; McBride JM, 2010, INT J SPORT PHYSIOL, V5, P177, DOI 10.1123/ijspp.5.2.177; Norwood JT, 2007, J STRENGTH COND RES, V21, P343, DOI 10.1519/R-17435.1; Prieske O, 2013, EUR J APPL PHYSIOL, V113, P2943, DOI 10.1007/s00421-013-2724-6; Rutherford OM, 1986, J SPORT SCI, V4, P101, DOI 10.1080/02640418608732105; RUTHERFORD OM, 1986, EUR J APPL PHYSIOL O, V55, P100, DOI 10.1007/BF00422902; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P1101, DOI 10.1519/JSC.0b013e3182606d3d; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P130, DOI 10.1519/JSC.0b013e3182541d43; Saeterbakken AH, 2011, J SPORT SCI, V29, P533, DOI 10.1080/02640414.2010.543916; Saeterbakken AH, 2016, EUR J APPL PHYSIOL, V116, P2247, DOI 10.1007/s00421-016-3470-3; SALE D, 1981, Canadian Journal of Applied Sport Sciences, V6, P87; Sparkes R, 2010, J STRENGTH COND RES, V24, P1931, DOI 10.1519/JSC.0b013e3181df7fe4; THORSTENSSON A, 1976, ACTA PHYSIOL SCAND, V96, P392, DOI 10.1111/j.1748-1716.1976.tb10207.x; Wahl MJ, 2008, J STRENGTH COND RES, V22, P1360, DOI 10.1519/JSC.0b013e318175ca3c	40	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214302	10.1371/journal.pone.0214302	http://dx.doi.org/10.1371/journal.pone.0214302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934001	Green Submitted, Green Published, gold			2022-12-27	WOS:000462867000013
J	Walti, MJ; Woolley, DG; Wenderoth, N				Walti, Michel Juhani; Woolley, Daniel Graham; Wenderoth, Nicole			Reinstating verbal memories with virtual contexts: Myth or reality?	PLOS ONE			English	Article							DEPENDENT RECOGNITION MEMORY; ENVIRONMENTAL CONTEXT; FEAR; RETRIEVAL; STIMULI; TESTS; REACTIVATION; EXTINCTION; COLOR	When learning new information, contextual information about the encoding situation is stored in addition to the focal memory content. Later, these strings of extra information can help retrieve the learned content as demonstrated by experiments where contextual cues from an encoding situation facilitate remembering and improve memory performance when reinstated during retrieval. This context-dependent memory effect has been investigated over the course of several decades and has been demonstrated with many different types of contexts. Based on this, the widely held belief is that context-dependent memory is a strong and robust effect, with transferable substance for everyday learning and potential clinical applications. Here we report the results of a multi-study design investigating the influence of reinstated visual contexts on memory performance. Data from 120 participants were included in three studies comprising a variety of visual cues. We show convincingly that even rich, salient and fully surrounding visual contexts provided by virtual reality are not sufficient to induce effects of context-dependency in a free recall memory task. We also investigated contextual modulation of oscillatory brain activity in order to test the effect of reinstated neural contexts, which failed to evoke a robust effect when re-tested in an internal conceptual replication study. Moreover, a Bayesian sequential statistical analysis revealed moderate to strong evidence against the hypothesis that reinstatement of visual contexts benefits free recall memory tasks indicating that effects are small and may not be suitable for transfer into everyday learning.	[Walti, Michel Juhani; Woolley, Daniel Graham; Wenderoth, Nicole] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Walti, Michel Juhani; Wenderoth, Nicole] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Walti, Michel Juhani; Wenderoth, Nicole] Swiss Fed Inst Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Walti, MJ (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.; Walti, MJ (corresponding author), Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland.; Walti, MJ (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	michel.waelti@hest.ethz.ch	Wenderoth, Nicole/D-7262-2015	Wenderoth, Nicole/0000-0002-3246-9386	Swiss National Science Foundation [320030_175616]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (SNSF grant 320030_175616) to NW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, MEMORY; BJORK RA, 1974, COGNITIVE PSYCHOL, V6, P173, DOI 10.1016/0010-0285(74)90009-7; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; BOUTON ME, 1979, J EXP PSYCHOL ANIM B, V5, P368, DOI 10.1037/0097-7403.5.4.368; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; CRAIK FIM, 1983, PHILOS T ROY SOC B, V302, P341, DOI 10.1098/rstb.1983.0059; Dulsky SG, 1935, J EXP PSYCHOL, V18, P725, DOI 10.1037/h0058066; EICH E, 1985, J EXP PSYCHOL LEARN, V11, P764, DOI 10.1037/0278-7393.11.1-4.764; Faller J., 2017, ARXIV170103981, VarXiv, p1701.03981; FERNANDEZ A, 1985, MEM COGNITION, V13, P333, DOI 10.3758/BF03202501; Glenberg AM, 1998, MEM COGNITION, V26, P651, DOI 10.3758/BF03211385; GODDEN D, 1980, BRIT J PSYCHOL, V71, P99, DOI 10.1111/j.2044-8295.1980.tb02735.x; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325, DOI 10.1111/j.2044-8295.1975.tb01468.x; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hockley WE, 2008, J EXP PSYCHOL LEARN, V34, P1412, DOI 10.1037/a0013016; Huff NC, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00075; Isarida T, ADV EXPT PSYCHOL RES, P115; Isarida T, 2007, MEM COGNITION, V35, P1620, DOI 10.3758/BF03193496; JACOBY LL, 1983, J VERB LEARN VERB BE, V22, P485, DOI 10.1016/S0022-5371(83)90301-8; Jafarpour A, 2014, J NEUROSCI, V34, P242, DOI 10.1523/JNEUROSCI.1865-13.2014; Javadi AH, 2017, J NEUROSCI, V37, P9939, DOI 10.1523/JNEUROSCI.0265-17.2017; Jeffreys H., 1939, OXFORD CLASSIC TEXTS; Kishore S, 2014, PRESENCE-TELEOP VIRT, V23, P242, DOI 10.1162/PRES_a_00192; Macken WJ, 2002, J EXP PSYCHOL LEARN, V28, P153, DOI 10.1037//0278-7393.28.1.153; Mania K, 2001, CYBERPSYCHOL BEHAV, V4, P247, DOI 10.1089/109493101300117938; Manning JR, 2011, P NATL ACAD SCI USA, V108, P12893, DOI 10.1073/pnas.1015174108; Marsman M, 2017, EUR J DEV PSYCHOL, V14, P545, DOI 10.1080/17405629.2016.1259614; MURNANE K, 1993, J EXP PSYCHOL LEARN, V19, P882, DOI 10.1037/0278-7393.19.4.882; MURNANE K, 1995, J EXP PSYCHOL LEARN, V21, P158, DOI 10.1037/0278-7393.21.1.158; Murnane K, 1999, J EXP PSYCHOL GEN, V128, P403, DOI 10.1037/0096-3445.128.4.403; MURNANE K, 1994, MEM COGNITION, V22, P584, DOI 10.3758/BF03198397; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; North MM, VIRTUAL REALITY NEUR; Panoz-Brown D, 2016, CURR BIOL, V26, P2821, DOI 10.1016/j.cub.2016.08.023; Parsons TD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7040042; Patrick JR, 1930, J COMP PSYCHOL, V10, P295, DOI 10.1037/h0071189; Pessin J, 1932, J EXP PSYCHOL, V15, P427, DOI 10.1037/h0075537; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pointer SC, 1998, CHEM SENSES, V23, P359, DOI 10.1093/chemse/23.3.359; Polyn SM, 2008, TRENDS COGN SCI, V12, P24, DOI 10.1016/j.tics.2007.10.010; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Proust Marcel, 1992, SEARCH OF LOST TIME; Radvansky GA, 2006, MEM COGNITION, V34, P1150, DOI 10.3758/BF03193261; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Reed HJ, 1931, J EXP PSYCHOL, V14, P632, DOI 10.1037/h0069294; REGAN D, 1977, J OPT SOC AM, V67, P1475, DOI 10.1364/JOSA.67.001475; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Rutherford A, 2004, Q J EXP PSYCHOL-A, V57, P107, DOI 10.1080/02724980343000152; SAUFLEY WH, 1985, MEM COGNITION, V13, P522, DOI 10.3758/BF03198323; Schuemie MJ, 2001, CYBERPSYCHOL BEHAV, V4, P183, DOI 10.1089/109493101300117884; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Smith S.M., 1994, THEORETICAL ASPECTS, P168; SMITH SM, 1978, MEM COGNITION, V6, P342, DOI 10.3758/BF03197465; Smith SM, 2001, PSYCHON B REV, V8, P203, DOI 10.3758/BF03196157; SMITH SM, 1990, AM J PSYCHOL, V103, P229, DOI 10.2307/1423144; Smith SM, ENV CONTEXT DEPENDEN; Smith SM, 2014, MEMORY, V22, P493, DOI 10.1080/09658211.2013.800553; Smith SM, 2010, BEHAV RES METHODS, V42, P292, DOI 10.3758/BRM.42.1.292; Staudigl T, BIORXIV; [Тарноу Юджин Tarnow Eugen], 2015, [Вестник Российского университета дружбы народов. Серия: Психология и педагогика, Vestnik Rossiiskogo universiteta druzhby narodov. Seriya: Psikhologiya i pedagogika], P15; Thompson LA, 2001, HUM FACTORS, V43, P611, DOI 10.1518/001872001775870377; Ucros C. G., 1989, COGNITION EMOTION, V3, P139, DOI [10.1080/02699938908408077, DOI 10.1080/02699938908408077]; van de Schoot R, 2017, PSYCHOL METHODS, V22, P217, DOI 10.1037/met0000100; Vansteenwegen D, 2005, BEHAV RES THER, V43, P323, DOI 10.1016/j.brat.2004.01.001; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Waldhauser GT, 2016, J NEUROSCI, V36, P251, DOI 10.1523/JNEUROSCI.2101-15.2016; Waldhauser GT, 2012, J NEUROSCI, V32, P1953, DOI 10.1523/JNEUROSCI.4201-11.2012; Watson JB, 1907, PSYCHOL MONOGR, V8, P1; WEISS W, 1954, J EXP PSYCHOL, V48, P318, DOI 10.1037/h0060746; Wimber M, 2012, CURR BIOL, V22, P1482, DOI 10.1016/j.cub.2012.05.054	72	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214540	10.1371/journal.pone.0214540	http://dx.doi.org/10.1371/journal.pone.0214540			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9FO	30925185	Green Published, Green Submitted, gold			2022-12-27	WOS:000462732300017
J	Belikov, S; Belkova, N; Butina, T; Chernogor, L; Martynova-Van Kley, A; Nalian, A; Rorex, C; Khanaev, I; Maikova, O; Feranchuk, S				Belikov, Sergei; Belkova, Natalia; Butina, Tatiana; Chernogor, Lubov; Martynova-Van Kley, Alexandra; Nalian, Armen; Rorex, Colin; Khanaev, Igor; Maikova, Olga; Feranchuk, Sergey			Diversity and shifts of the bacterial community associated with Baikal sponge mass mortalities	PLOS ONE			English	Article							FRESH-WATER SPONGE; MICROBIAL DIVERSITY; MARINE SPONGES; LAKE BAIKAL; DISEASE; SYMBIONTS; EPHYDATIA; ABUNDANCE; MICROORGANISMS; IDENTIFICATION	The disease of freshwater sponges was first discovered in 2011, when pink samples were found in the Central Basin of Lake Baikal. Subsequently, the visible signs of the disease have changed, and now sponges appear with various symptoms of damage to the body, such as discoloration, tissue necrosis, the formation of brown patches and dirty-purple bio-films on some branches. These signs of the disease are accompanied by the mass death of sponges. We identified differences in microbiomes by sequencing 16S rRNA genes and found changes in the consortium of microorganisms of freshwater Baikal sponges. We found that the observed imbalance in the studied microbial communities of diseased sponges is caused by several different conditionally pathogenic microorganisms that increase their negative effect by acting together and in concert, which leads to the death of photosynthetic microalgae and sponges. Sponges are an important component of coastal communities, and the massive loss of sponges can obviously affect the structure of benthic communities and the purity of water.	[Belikov, Sergei; Belkova, Natalia; Butina, Tatiana; Chernogor, Lubov; Khanaev, Igor; Maikova, Olga; Feranchuk, Sergey] Russian Acad Sci, Siberian Branch, Limnol Inst, Lab Analyt Bioorgan Chem, Irkutsk, Russia; [Martynova-Van Kley, Alexandra; Nalian, Armen; Rorex, Colin] Stephen F Austin State Univ, Dept Biol, Nacogdoches, TX 75962 USA; [Feranchuk, Sergey] Natl Res Tech Univ, Dept Informat, Irkutsk, Russia	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Irkutsk National Research Technical University (INRTU)	Belikov, S (corresponding author), Russian Acad Sci, Siberian Branch, Limnol Inst, Lab Analyt Bioorgan Chem, Irkutsk, Russia.	sergeibelikov47@gmail.com	Belkova, Natalia/N-6987-2014; Maikova, Olga/AAA-4422-2021; Belikov, Sergei/L-3373-2013	Belkova, Natalia/0000-0001-9720-068X; Maikova, Olga/0000-0001-7263-5767; Khanaev, Igor/0000-0001-6431-2765; Butina, Tatyana/0000-0002-2147-6695; Belikov, Sergei/0000-0001-7206-8299	Federal Agency of Scientific Organizations [0345-2016-0002]; Russian Foundation for Basic Research [16-04-00065, 18-04-00224, 16-54-150007]	Federal Agency of Scientific Organizations; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was supported by Funding by budget project of Federal Agency of Scientific Organizations (no 0345-2016-0002 to SB); Russian Foundation for Basic Research (grants no 16-54-150007 to SB); Russian Foundation for Basic Research (grants no 18-04-00224 to SB); and Russian Foundation for Basic Research (grants no 16-04-00065 to LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127455; Alex A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051834; Angermeier H, 2012, DIS AQUAT ORGAN, V99, P95, DOI 10.3354/dao02460; Angermeier H, 2011, FEMS MICROBIOL ECOL, V75, P218, DOI 10.1111/j.1574-6941.2010.01001.x; [Anonymous], 1941, ECOLOGY, V22, P415, DOI 10.2307/1930719; BAILEY RC, 1995, J GREAT LAKES RES, V21, P42, DOI 10.1016/S0380-1330(95)71019-X; Baldani J.I., 2014, PROKARYOTES, P533, DOI [DOI 10.1007/978-3-642-30197-1_300, 10.1007/978-3-642-30197-1_300]; Barb JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148047; Bell JJ, 2015, CONSERV BIOL, V29, P42, DOI 10.1111/cobi.12447; Belykh O. I., 2011, International Journal on Algae, V13, P149; Blanquer A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00752; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bormotov AE., 2012, SCI 1 HAND, V32, P20; Bourne DG, 2016, ANNU REV MICROBIOL, V70, P317, DOI 10.1146/annurev-micro-102215-095440; Butina T V, 2015, Genetika, V51, P384; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carballo JL, 2013, ECOL EVOL, V3, P872, DOI 10.1002/ece3.452; Cardenas CA, 2014, FEMS MICROBIOL ECOL, V88, P516, DOI 10.1111/1574-6941.12317; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Certner RH, 2018, ENVIRON MICROBIOL, V20, P645, DOI 10.1111/1462-2920.13991; Cervino JM, 2006, MAR ECOL PROG SER, V324, P139, DOI 10.3354/meps324139; Chernogor L, 2013, EUR J PHYCOL, V48, P497, DOI 10.1080/09670262.2013.862306; Choudhury JD, 2015, MAR BIOTECHNOL, V17, P463, DOI 10.1007/s10126-015-9627-y; Correa AMS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00127; Costa R, 2013, MICROB ECOL, V65, P232, DOI 10.1007/s00248-012-0102-2; Cuvelier ML, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00581; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Deignan LK, 2018, MICROB ECOL, V76, P459, DOI 10.1007/s00248-017-1135-3; Della Sala G, 2013, ENV MICROBIOL REP, V5, P809, DOI 10.1111/1758-2229.12081; Denikina NN, 2016, BIOL BULL+, V43, P263, DOI 10.1134/S106235901603002X; Di Camillo CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126689; Dupont S, 2013, FEMS MICROBIOL ECOL, V86, P520, DOI 10.1111/1574-6941.12178; Efremova S.M., 2004, P1261; Fan Lu, 2012, Proc Natl Acad Sci U S A, V109, pE1878, DOI 10.1073/pnas.1203287109; Feranchuk S, 2018, RES MICROBIOL, V169, P254, DOI 10.1016/j.resmic.2018.03.004; GAINO E, 1992, B ZOOL, V59, P79, DOI 10.1080/11250009209386652; Gao ZM, 2015, PEERJ, V3, DOI 10.7717/peerj.890; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gernert C, 2005, MICROB ECOL, V50, P206, DOI 10.1007/s00248-004-0172-x; Gignoux-Wolfsohn SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134416; Gladkikh A S, 2014, Mikrobiologiia, V83, P682; He Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0081-x; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hugerth LW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0834-7; Itskovich V, 2017, INLAND WATERS, V7, P259, DOI 10.1080/20442041.2017.1320507; Jezberova J, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01530-17; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Khanaev IV, 2018, J GREAT LAKES RES, V44, P77, DOI 10.1016/j.jglr.2017.10.004; Kopylova E, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00003-15; KOZHOV M. M, 1972, ESSAYS BAIKAL STUDIE; Kravtsova LS, 2014, J GREAT LAKES RES, V40, P441, DOI 10.1016/j.jglr.2014.02.019; Kulakova NV, 2018, MICROB ECOL, V75, P1024, DOI 10.1007/s00248-017-1097-5; Lebret K, 2016, MAR GENOM, V29, P39, DOI 10.1016/j.margen.2016.09.001; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Luter HM, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix074; Luter HM, 2010, APPL ENVIRON MICROB, V76, P5736, DOI 10.1128/AEM.00653-10; Luter HM, 2017, CLIMATE CHANGE OCEAN, P411, DOI [10.1007/978-3-319-59008-0_9, DOI 10.1007/978-3-319-59008-0_9]; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Manconi R, 2008, HYDROBIOLOGIA, V595, P27, DOI 10.1007/s10750-007-9000-x; Manconi R, 2002, SYSTEMA PORIFERA GUI, P921; Masuda Yoshiki, 2009, V47, P81, DOI 10.1007/978-3-540-88552-8_4; Mats V. D., 2011, GEOSCI FRONT, V2, P349, DOI [10.1016/j.gsf.2011.06.002, DOI 10.1016/J.GSF.2011.06.002]; Mukherjee A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01126-3; Mukherjee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007177; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Olson JB, 2006, DIS AQUAT ORGAN, V71, P163, DOI 10.3354/dao071163; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Perez T, 2014, Mediterranean Sea: Its History and Present Challenges, P577, DOI 10.1007/978-94-007-6704-1_35; Petit C, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001265; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; Pisera A, 2016, PALAEONTOL Z, V90, P673, DOI 10.1007/s12542-016-0328-2; Pita L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02102; PROKSCH P, 1994, TOXICON, V32, P639, DOI 10.1016/0041-0101(94)90334-4; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Raharinirina NA, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00031; Richardson C, 2012, FEMS MICROBIOL ECOL, V81, P407, DOI 10.1111/j.1574-6941.2012.01365.x; RUTZLER K, 1988, DIS AQUAT ORGAN, V5, P143, DOI 10.3354/dao005143; SANDJENSEN K, 1994, LIMNOL OCEANOGR, V39, P551, DOI 10.4319/lo.1994.39.3.0551; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Semiturkina N.A., 2009, P891; Seo EY, 2016, ANN LIMNOL-INT J LIM, V52, P27, DOI 10.1051/limn/2015035; Stabili L, 2012, MICROB ECOL, V64, P802, DOI 10.1007/s00248-012-0068-0; Steinert G, 2016, PEERJ, V4, DOI 10.7717/peerj.1936; Sweet M, 2015, CORAL REEFS, V34, P871, DOI 10.1007/s00338-015-1284-0; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Tan CH, 2014, ISME J, V8, P1186, DOI 10.1038/ismej.2013.240; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Timoshkin OA, 2016, J GREAT LAKES RES, V42, P487, DOI 10.1016/j.jglr.2016.02.011; VACELET J, 1978, J INVERTEBR PATHOL, V31, P246, DOI 10.1016/0022-2011(78)90014-9; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; Vargas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039345; Webster NS, 2008, ENVIRON MICROBIOL, V10, P3366, DOI 10.1111/j.1462-2920.2008.01734.x; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2016, MBIO, V7, DOI 10.1128/mBio.00135-16; Webster NS, 2002, MAR ECOL PROG SER, V232, P305, DOI 10.3354/meps232305; Weigel BL, 2016, APPL ENVIRON MICROB, V82, P650, DOI 10.1128/AEM.02980-15; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; WILKINSON CR, 1980, HYDROBIOLOGIA, V75, P241, DOI 10.1007/BF00006488; WILKINSON CR, 1987, CORAL REEFS, V5, P183, DOI 10.1007/BF00300961; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007; Ziegler M, 2017, J BIOGEOGR, V44, P674, DOI 10.1111/jbi.12913	104	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213926	10.1371/journal.pone.0213926	http://dx.doi.org/10.1371/journal.pone.0213926			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921366	gold, Green Published			2022-12-27	WOS:000462594000029
J	Ciejka, J; Botwina, P; Nowakowska, M; Szczubialka, K; Pyrc, K				Ciejka, Justyna; Botwina, Pawel; Nowakowska, Maria; Szczubialka, Krzysztof; Pyrc, Krzysztof			Synthetic sulfonated derivatives of poly (allylamine hydrochloride) as inhibitors of human metapneumovirus	PLOS ONE			English	Article							ANTIVIRAL ACTIVITY; INFECTION; CARRAGEENAN; CHILDREN; REPLICATION; BINDING; 1-YEAR	Human metapneumovirus (hMPV) is a widely distributed pathogen responsible for acute upper and lower respiratory infections of varying severity. Previously, we reported that Nsulfonated derivatives of poly(allylamine hydrochloride) (NSPAHs) efficiently inhibit replication of the influenza virus in vitro and ex vivo. Here, we show a dose dependent inhibition of hMPV infection by NSPAHs in LLC-MK2 cells. The results showed strong antiviral properties of NSPAHs. While the activity of NSPAHs is comparable to those of carrageenans, they show better physicochemical properties and may be delivered at high concentrations. The functional assays showed that tested polymers block hMPV release from infected cells and, consequently, constrain virus spread. Moreover, further studies on viruses utilizing different egress mechanisms suggest that observed antiviral effect depend on selective inhibition of viruses budding from the cell surface.	[Ciejka, Justyna; Botwina, Pawel; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, Virogenet Lab Virol, Krakow, Poland; [Ciejka, Justyna; Nowakowska, Maria; Szczubialka, Krzysztof] Jagiellonian Univ, Fac Chem, Krakow, Poland; [Botwina, Pawel] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University	Pyrc, K (corresponding author), Jagiellonian Univ, Malopolska Ctr Biotechnol, Virogenet Lab Virol, Krakow, Poland.; Szczubialka, K (corresponding author), Jagiellonian Univ, Fac Chem, Krakow, Poland.	szczubia@chemia.uj.edu.pl; k.a.pyrc@uj.edu.pl	Botwina, Paweł/ABC-9799-2020; Botwina, Paweł/ABI-7838-2020; Szczubiałka, Krzysztof/D-4728-2016; Ciejka, Justyna/AAL-4155-2020	Szczubiałka, Krzysztof/0000-0001-6612-1102; Ciejka, Justyna/0000-0003-2532-3386; Pyrc, Krzysztof/0000-0002-3867-7688	National Science Center [UMO-2012/07/E/NZ6/01712, UMO-2016/21/D/ST5/01661]; National Centre for Research and Development [Lider/27/55/L-2/10/2011]; Foundation for Polish Science - EU European Regional Development Fund [VENTURES/2013-11/1]; COST Action [CM1407]; European Union [POIG.02.01.00-12-064/08]; Ministry of Science and Higher Education of the Republic of Poland	National Science Center(National Science Centre, Poland); National Centre for Research and Development(National Centre for Research & Development, Poland); Foundation for Polish Science - EU European Regional Development Fund; COST Action(European Cooperation in Science and Technology (COST)); European Union(European Commission); Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	This work was supported by grants from the National Science Center (UMO-2012/07/E/NZ6/01712 and UMO-2016/21/D/ST5/01661) (KP and JC, respectively), grant Lider/27/55/L-2/10/2011 (to KP) from the National Centre for Research and Development, Foundation for Polish Science provided funding to JC under grant number VENTURES/2013-11/1 cofinanced by the EU European Regional Development Fund. KP would like to acknowledge networking contribution by the COST Action CM1407 "Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery" from European Cooperation in Science and Technology. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08 - "Molecular biotechnology for health"). Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center supported by the Ministry of Science and Higher Education of the Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin G, 2003, EMERG INFECT DIS, V9, P634; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Camps M, 2008, J MED VIROL, V80, P1452, DOI 10.1002/jmv.21209; Carlucci MJ, 2004, ANTIVIR RES, V64, P137, DOI 10.1016/j.antiviral.2004.07.001; Chang A, 2012, J VIROL, V86, P3230, DOI 10.1128/JVI.06706-11; Ciejka J, 2016, ANTIMICROB AGENTS CH, V60, P1955, DOI 10.1128/AAC.02183-15; Diogo JV, 2015, RES VET SCI, V98, P142, DOI 10.1016/j.rvsc.2014.11.010; Ebihara T, 2003, J MED VIROL, V70, P281, DOI 10.1002/jmv.10391; Eccles R, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0281-8; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Esper F, 2004, J INFECT DIS, V189, P1388, DOI 10.1086/382482; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Fazekas T, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-147; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; Harden EA, 2009, ANTIVIR RES, V83, P282, DOI 10.1016/j.antiviral.2009.06.007; Hopkins P, 2008, AM J RESP CRIT CARE, V178, P876, DOI 10.1164/rccm.200711-1657OC; Klimyte EM, 2016, J VIROL, V90, P9237, DOI 10.1128/JVI.01362-16; Leibbrandt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014320; Luo ZC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140586; LYNCH G, 1994, J LEUKOCYTE BIOL, V56, P266, DOI 10.1002/jlb.56.3.266; Mendes GS, 2014, CARBOHYD POLYM, V101, P313, DOI 10.1016/j.carbpol.2013.09.026; Milewska A, 2018, J VIROL, V92, DOI 10.1128/JVI.01933-17; Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14; Milewska A, 2013, ANTIVIR RES, V97, P112, DOI 10.1016/j.antiviral.2012.11.006; Necas J, 2013, VET MED-CZECH, V58, P187, DOI 10.17221/6758-VETMED; Oliveira DBL, 2009, J MED VIROL, V81, P915, DOI 10.1002/jmv.21436; Orenstein Jan M, 2008, Open Infect Dis J, V2, P52; Pyrc K, 2011, J GEN VIROL, V92, P2324, DOI 10.1099/vir.0.032094-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Talarico LB, 2011, J GEN VIROL, V92, P1332, DOI 10.1099/vir.0.028522-0; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274	33	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214646	10.1371/journal.pone.0214646	http://dx.doi.org/10.1371/journal.pone.0214646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921418	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000102
J	Fareed, MMS; Chun, Q; Ahmed, G; Murtaza, A; Asif, MR; Fareed, MZ				Fareed, Mian Muhammad Sadiq; Chun, Qi; Ahmed, Gulnaz; Murtaza, Adil; Asif, Muhammad Rizwan; Fareed, Muhammad Zeeshan			Salient region detection through salient and non-salient dictionaries	PLOS ONE			English	Article							OBJECT DETECTION; VISUAL SALIENCY; FEATURES	Low-rank representation-based frameworks are becoming popular for the saliency and the object detection because of their easiness and simplicity. These frameworks only need global features to extract the salient objects while the local features are compromised. To deal with this issue, we regularize the low-rank representation through a local graph-regularization and a maximum mean-discrepancy regularization terms. Firstly, we introduce a novel feature space that is extracted by combining the four feature spaces like CIELab, RGB, HOG and LBP. Secondly, we combine a boundary metric, a candidate objectness metric and a candidate distance metric to compute the low-level saliency map. Thirdly, we extract salient and non-salient dictionaries from the low-level saliency. Finally, we regularize the low-rank representation through the Laplacian regularization term that saves the structural and geometrical features and using the mean discrepancy term that reduces the distribution divergence and connections among similar regions. The proposed model is tested against seven latest salient region detection methods using the precision-recall curve, receiver operating characteristics curve, F-measure and mean absolute error. The proposed model remains persistent in all the tests and outperformed against the selected models with higher precision value.	[Fareed, Mian Muhammad Sadiq; Chun, Qi; Asif, Muhammad Rizwan] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Shaanxi, Peoples R China; [Ahmed, Gulnaz; Fareed, Muhammad Zeeshan] Xi An Jiao Tong Univ, Sch Management, Xian, Shaanxi, Peoples R China; [Murtaza, Adil] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Sci, MOE,Key Lab Nonequilibrium Synth & Modulat Conden, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Fareed, MMS; Chun, Q (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Shaanxi, Peoples R China.; Ahmed, G (corresponding author), Xi An Jiao Tong Univ, Sch Management, Xian, Shaanxi, Peoples R China.; Murtaza, A (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Sci, MOE,Key Lab Nonequilibrium Synth & Modulat Conden, Xian, Shaanxi, Peoples R China.	msfareed@mail.xjtu.edu.cn; qichun@mail.xjtu.edu.cn; gulnaz@mail.xjtu.edu.cn; adilmurtaza91@mail.xjtu.edu.cn	Fareed, Muhammad Zeeshan/AAC-8988-2022; Fareed, Mian Muhammad Sadiq/AAE-9299-2020	Fareed, Muhammad Zeeshan/0000-0003-1102-7260; Asif, Muhammad Rizwan/0000-0003-1385-8041	National Natural Science Foundation of China [60972124]; National High-tech Research and Development Program of China [2009AA01Z321]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110201110012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported in part by the National Natural Science Foundation of China (Grant no. 60972124), in part by the National High-tech Research and Development Program of China (Grant no. 2009AA01Z321) and in part of the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant no. 20110201110012). There was no additional external funding received for this study.	Achanta R, 2008, LECT NOTES COMPUT SC, V5008, P66; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Achanta R, 2009, PROC CVPR IEEE, P1597, DOI 10.1109/CVPRW.2009.5206596; Alpert S, 2007, P IEEE C COMP VIS PA, V1, P17; Borji A, 2015, IEEE T IMAGE PROCESS, V24, P5706, DOI 10.1109/TIP.2015.2487833; Borji A, 2012, PROC CVPR IEEE, P478, DOI 10.1109/CVPR.2012.6247711; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Cheng MM, 2015, IEEE T PATTERN ANAL, V37, P569, DOI 10.1109/TPAMI.2014.2345401; Cheng MM, 2011, PROC CVPR IEEE, P409, DOI 10.1109/CVPR.2011.5995344; Duan LJ, 2011, PROC CVPR IEEE, P473, DOI 10.1109/CVPR.2011.5995676; Fan Q, 2016, NEUROCOMPUTING, V175, P81, DOI 10.1016/j.neucom.2015.10.030; Fareed MMS, 2015, J VIS COMMUN IMAGE R, V32, P144, DOI 10.1016/j.jvcir.2015.08.002; Fareed MMS, 2018, COMPUTERS ELECT ENG; Han B., 2011, P 19 ACM INT C MULT, P1117; Hou X., 2007, IEEE C COMP VIS PATT, V1, P1, DOI DOI 10.1109/CVPR.2007.383267; Hou X., 2008, NIPS, P681; Huang F, 2017, IEEE T IMAGE PROCESS, V26, P1911, DOI 10.1109/TIP.2017.2669878; Jia C, 2016, NEUROCOMPUTING, V173, P406, DOI 10.1016/j.neucom.2015.03.122; Lang CY, 2016, IEEE T NEUR NET LEAR, V27, P1190, DOI 10.1109/TNNLS.2015.2513393; Lang CY, 2012, IEEE T IMAGE PROCESS, V21, P1327, DOI 10.1109/TIP.2011.2169274; Li HY, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2440174; Li NY, 2015, PROC CVPR IEEE, P5216, DOI 10.1109/CVPR.2015.7299158; Li S, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2440755; Li X, 2013, IEEE I CONF COMP VIS, P3328, DOI 10.1109/ICCV.2013.413; Li XH, 2013, IEEE I CONF COMP VIS, P2976, DOI 10.1109/ICCV.2013.370; Li Y, 2009, IEEE IMAGE PROC, P3093, DOI 10.1109/ICIP.2009.5414465; Lin MQ, 2015, NEUROCOMPUTING, V159, P1, DOI 10.1016/j.neucom.2015.02.050; Liu Tie, 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383047; Long MS, 2013, PROC CVPR IEEE, P407, DOI 10.1109/CVPR.2013.59; Lu HC, 2016, IEEE T IMAGE PROCESS, V25, DOI 10.1109/TIP.2016.2524198; Ma Y.-F, 2003, P 11 ACM INT C MULTI, P374; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Shen XH, 2012, PROC CVPR IEEE, P853, DOI 10.1109/CVPR.2012.6247758; Sun JG, 2015, IEEE T IMAGE PROCESS, V24, P1639, DOI 10.1109/TIP.2015.2403241; Wang Q, 2013, PATTERN RECOGN LETT, V34, P34, DOI 10.1016/j.patrec.2012.06.002; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Xie YL, 2013, IEEE T IMAGE PROCESS, V22, P1689, DOI 10.1109/TIP.2012.2216276; Yan Q, 2013, PROC CVPR IEEE, P1155, DOI 10.1109/CVPR.2013.153; Yang C, 2013, PROC CVPR IEEE, P3166, DOI 10.1109/CVPR.2013.407; Yang C, 2013, IEEE SIGNAL PROC LET, V20, P637, DOI 10.1109/LSP.2013.2260737; Yang JM, 2012, PROC CVPR IEEE, P2296, DOI 10.1109/CVPR.2012.6247940; Zhang LH, 2015, NEUROCOMPUTING, V155, P1, DOI 10.1016/j.neucom.2014.12.080; Zhang PP, 2017, IEEE I CONF COMP VIS, P202, DOI 10.1109/ICCV.2017.31; Zhang PP, 2017, IEEE I CONF COMP VIS, P212, DOI 10.1109/ICCV.2017.32; Zhu WJ, 2014, PROC CVPR IEEE, P2814, DOI 10.1109/CVPR.2014.360	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213433	10.1371/journal.pone.0213433	http://dx.doi.org/10.1371/journal.pone.0213433			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921343	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000016
J	Koester, KA; Johnson, MO; Wood, T; Fredericksen, R; Neilands, TB; Sauceda, J; Crane, HM; Mugavero, MJ; Christopoulos, KA				Koester, Kimberly A.; Johnson, Mallory O.; Wood, Troy; Fredericksen, Rob; Neilands, Torsten B.; Sauceda, John; Crane, Heidi M.; Mugavero, Michael J.; Christopoulos, Katerina A.			The influence of the 'good' patient ideal on engagement in HIV care	PLOS ONE			English	Article							HEALTH OUTCOMES; RETENTION; ACTIVATION; ADHERENCE; LINKAGE; PHYSICIANS; CONTINUUM; TRUST	Research on patient engagement in health care shows that better health outcomes and lower healthcare costs are observed among highly engaged patients. Similar to other illnesses, high levels of patient engagement in HIV care are considered essential to maintaining optimal health, and patients who are on treatment and retained in HIV care are known to have better health outcomes. In this article, we draw on focus group discussion data with patients living with HIV in order to explain tacit expectations associated with engagement in care. The main objective of our research was to elicit an explanatory model of engagement in HIV care from the patients' perspective. We conducted focus group discussions with a sample of two distinct types of patients: those who regularly attended medical appointments and those who did not. In total, we conducted six focus group discussions (n = 43) across in three cities in the US; these included two focus group discussions with a well-engaged and less-well-engaged group in each location. Both types of patients assigned a moral dimension to engagement in care, in that well-engaged patients were considered to be 'good' patients. Aspiring to become a 'good' patient provided a meaningful goal for some and deepened vulnerabilities among patients that struggled to achieve this status. More vulnerable patients may feel less secure in health care interactions and these feelings may be amplified if patients have an unreasonable impression of what constitutes a 'good' patient; thereby leading to disengagement in care. Our findings can inform the development of patient-centered, tailored messages to better serve patients struggling to stay engaged in HIV care.	[Koester, Kimberly A.; Johnson, Mallory O.; Wood, Troy; Neilands, Torsten B.; Sauceda, John; Christopoulos, Katerina A.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Fredericksen, Rob; Crane, Heidi M.] Univ Washington, Dept Med, Seattle, WA USA; [Mugavero, Michael J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham	Koester, KA (corresponding author), Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	Kimberly.koester@ucsf.edu			National Institutes of Health (NIH) [R01MH102198]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, R01MH102198] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The investigators (MOJ & KAC) have received grant funding (R01MH102198) from the National Institutes of Health (NIH) to conduct this study (Development and Validation of a Multidimensional Index of Engagement in HIV Care). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, DED V7 0 23; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Barello S, J PARTICIP MED, V6, pe9; Barello S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/905934; Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; Campbell C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1139-x; Carman KL, 2013, HEALTH AFFAIR, V32, P223, DOI 10.1377/hlthaff.2012.1133; Castel AD, 2015, JAIDS-J ACQ IMM DEF, V69, pS44, DOI 10.1097/QAI.0000000000000575; Christopoulos KA, 2013, AIDS PATIENT CARE ST, V27, P223, DOI 10.1089/apc.2012.0418; Colasanti J, 2016, CLIN INFECT DIS, V62, P648, DOI 10.1093/cid/civ941; Creswell John W., 1994, RES DESIGN QUALITATI; Dawson-Rose C, 2016, J ASSOC NURSE AIDS C, V27, P574, DOI 10.1016/j.jana.2016.03.001; Dentzer S, 2013, HEALTH AFFAIR, V32, P202, DOI 10.1377/hlthaff.2013.0037; Entwistle V A, 1998, J Health Serv Res Policy, V3, P100; Flickinger TE, 2016, PATIENT EDUC COUNS, V99, P250, DOI 10.1016/j.pec.2015.08.020; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Flores D, 2016, INT J NURS STUD, V62, P126, DOI 10.1016/j.ijnurstu.2016.07.016; Forbat L, 2009, PATIENT EDUC COUNS, V74, P84, DOI 10.1016/j.pec.2008.07.055; Fredericksen RJ, 2015, AIDS CARE, V27, P1255, DOI 10.1080/09540121.2015.1050983; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Graham JL, 2015, AIDS PATIENT CARE ST, V29, P661, DOI 10.1089/apc.2015.0156; Greene J, 2015, HEALTH AFFAIR, V34, P431, DOI 10.1377/hlthaff.2014.0452; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Higgins T, 2017, PATIENT EDUC COUNS, V100, P30, DOI 10.1016/j.pec.2016.09.002; Ibe C, 2017, PATIENT EDUC COUNS, V100, P1258, DOI 10.1016/j.pec.2016.12.016; Johnson MO, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.8520; Johnson MO, 2006, AIDS PATIENT CARE ST, V20, P258, DOI 10.1089/apc.2006.20.258; Kay ES, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0120-0; Lindlof T., 2011, QUALITATIVE COMMUNIC; Marshall R, 2013, J GEN INTERN MED, V28, P668, DOI 10.1007/s11606-012-2307-y; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; McCreaddie M, 2009, INT J NURS STUD, V46, P1079, DOI 10.1016/j.ijnurstu.2009.01.008; Mohta NS, 2016, PATIENT ENGAGEMENT S; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Ondenge K, 2017, SEX TRANSM INFECT, V93, DOI 10.1136/sextrans-2016-052973; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Simon Wand GHJ, 1986, SEXUAL SCRIPTS PERMA, V15; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132	40	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214636	10.1371/journal.pone.0214636	http://dx.doi.org/10.1371/journal.pone.0214636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921440	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000101
J	Maezawa, Y; Nakaminami, H; Takadama, S; Hayashi, M; Wajima, T; Nakase, K; Yamada, T; Ikoshi, H; Noguchi, N				Maezawa, Yuka; Nakaminami, Hidemasa; Takadama, Shunsuke; Hayashi, Minami; Wajima, Takeaki; Nakase, Keisuke; Yamada, Tetsuya; Ikoshi, Hideaki; Noguchi, Norihisa			Tokiinshi, a traditional Japanese medicine (Kampo), suppresses Panton-Valentine leukocidin production in the methicillin-resistant Staphylococcus aureus USA300 clone	PLOS ONE			English	Article							GENE; ANTIBIOTICS; EPIDERMIDIS; MICROBIOTA; PNEUMONIA; STRAIN; HOST	It is necessary to develop agents other than antimicrobials for the treatment of Staphylococcus aureus infections to prevent the emergence of antimicrobial-resistant strains. Particularly, anti-virulence agents against the Panton-Valentine leukocidin (PVL)-positive methicillin-resistant S. aureus (MRSA), USA300 clone, is desired due to its high pathogenicity. Here, we investigated the potential anti-virulence effect of Tokiinshi, which is a traditional Japanese medicine (Kampo) used for skin diseases, against the USA300 clone. A growth inhibition assay showed that a conventional dose (20 mg/ml) of Tokiinshi has bactericidal effects against the clinical USA300 clones. Notably, the growth inhibition effects of Tokiinshi against S. epidermidis strains, which are the major constituents of the skin microbiome, was a bacteriostatic effect. The data suggested that Tokiinshi is unlikely to affect skin flora of S. epidermidis. Furthermore, PVL production and the expression of its gene were significantly suppressed in the USA300 clone by a lower concentration (5 mg/ml) of Tokiinshi. This did not affect the number of viable bacteria. Moreover, Tokiinshi significantly suppressed the expression of the agrA gene, which regulates PVL gene expression. For the first time, our findings strongly suggest that Tokiinshi has the potential to attenuate the virulence of the USA300 clone by suppressing PVL production via agrA gene suppression.	[Maezawa, Yuka; Nakaminami, Hidemasa; Takadama, Shunsuke; Hayashi, Minami; Wajima, Takeaki; Nakase, Keisuke; Noguchi, Norihisa] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Microbiol, Hachioji, Tokyo, Japan; [Yamada, Tetsuya; Ikoshi, Hideaki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Tradit Chinese Med, Hachioji, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences	Nakaminami, H (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Microbiol, Hachioji, Tokyo, Japan.	nakami@toyaku.ac.jp	Nakase, Keisuke/AEP-0804-2022; Nakase, Keisuke/AAQ-2777-2020; Wajma, Takeaki/AAF-4743-2020	Wajma, Takeaki/0000-0001-9506-707X; Nakase, Keisuke/0000-0002-9205-3008; Nakaminami, Hidemasa/0000-0003-2889-8257	Japan Society for the Promotion of Science KAKENHI [JP18H00370]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number JP18H00370 (N.N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen GJM, 2014, BENEF MICROBES, V5, P201, DOI 10.3920/BM2012.0062; Dumitrescu O, 2008, CLIN MICROBIOL INFEC, V14, P384, DOI 10.1111/j.1469-0691.2007.01947.x; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Khodaverdian V, 2013, ANTIMICROB AGENTS CH, V57, P3645, DOI 10.1128/AAC.00269-13; Kong C, 2016, TOXINS, V8, DOI 10.3390/toxins8030072; Laborel-Preneron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141067; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Morgun A, 2015, GUT, V64, P1732, DOI 10.1136/gutjnl-2014-308820; Nakaminami H, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00358-17; Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x; Nose M, 1999, BIOL PHARM BULL, V22, P48, DOI 10.1248/bpb.22.48; Planet PJ, 2015, J INFECT DIS, V212, P1874, DOI 10.1093/infdis/jiv320; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Takadama S, 2018, Clin Microbiol Infect, V24, DOI 10.1016/j.cmi.2018.02.012; Takadama S, 2017, J INFECT CHEMOTHER, V23, P800, DOI 10.1016/j.jiac.2017.04.016; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Villaruz AE, 2009, J INFECT DIS, V200, P724, DOI 10.1086/604728; Wajima T, 2019, PHARMACOLOGY, V103, P221, DOI 10.1159/000496830; Wajima T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167335; Wang LQ, 2015, ACTA PHARM SIN B, V5, P310, DOI [10.1016/j.apsb.2015.05.005, 10.1016//j.apsb.2015.05.005]; Wang YH, 2014, APPL MICROBIOL BIOT, V98, P411, DOI 10.1007/s00253-013-5394-8; Yamada T, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1431-3; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214470	10.1371/journal.pone.0214470	http://dx.doi.org/10.1371/journal.pone.0214470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921402	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000075
J	Otsuka, M; Isaka, T				Otsuka, Mitsuo; Isaka, Tadao			Intra-athlete and inter-group comparisons: Running pace and step characteristics of elite athletes in the 400-m hurdles	PLOS ONE			English	Article							BLOOD LACTATE; SPRINT; 100-M; VELOCITY; LENGTH; 200-M	The aim of this study was to investigate the running pace and step characteristics among various competitive-level 400-m hurdlers through inter-group and intra-athlete comparisons. We analysed spatiotemporal data involving the split time, mean step length (SL) and mean step frequency (SF) for 13 male world-class and 14 male national-level 400-m hurdlers. We analysed 16.5 +/- 3.9 races for each world-class hurdler and 19.8 +/- 6.0 races for each national-level hurdler (the total number of analysed runs was 491) using publicly available television and internet broadcasts. Inter-group comparisons showed that both first- and latter-halves split times of the world-class hurdlers were significantly shorter than those of the national-level hurdlers. In the latter-half phase, no significant differences of SL and SF were observed between the world-class and national level hurdlers. Intra-athlete comparisons showed that no athletes favoured only first-half phase in terms of running speed in short finish times. In contrast, finish times of all hurdlers were sensitive to running speed in the latter half phase. In the latter half of the race, 18 of the 27 hurdlers were identified as being SF reliant during speed enhancements; running speed of the other 9 hurdlers were also sensitive to high SF. In conclusions, important findings regarding high performance in inter-group comparisons do not always corresponded with those in intra-athlete comparisons. All athletes and coaches should first prioritize maintaining high running speeds in the latter half of 400-m hurdles rather than in the first half of the race.	[Otsuka, Mitsuo; Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan	Ritsumeikan University	Otsuka, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan.	otsuka-a@st.ritsumei.ac.jp	Otsuka, Mitsuo/AAB-4120-2019	Otsuka, Mitsuo/0000-0003-1391-4939	Yamaha Motor Foundation	Yamaha Motor Foundation	This work was supported by Yamaha Motor Foundation (http://www.ymfs.jp/project/assist/challenger/otsukam/) to M.O. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAULIEU P, 1995, BRIT J SPORT MED, V29, P80, DOI 10.1136/bjsm.29.2.80; Breizer V, 1990, NEW STUD ATHL, V4, P21; Chow JW, 2011, SPORT BIOMECH, V10, P219, DOI 10.1080/14763141.2011.592212; Ditroilo M, 2001, NEW STUDIES ATHLETIC, V16, P15; Donati A, 1995, NEW STUDIES ATHLETIC, V10, P51; Furusawa K, 1927, P R SOC LOND B-CONTA, V102, P43, DOI 10.1098/rspb.1927.0036; Girard O, 2016, J BIOMECH, V49, P1490, DOI 10.1016/j.jbiomech.2016.03.020; Hanon C, 2011, J SPORT SCI, V29, P905, DOI 10.1080/02640414.2011.562232; Hanon C, 2009, J STRENGTH COND RES, V23, P524, DOI 10.1519/JSC.0b013e318194e071; HIRVONEN J, 1992, CAN J SPORT SCI, V17, P141; Hobara H, 2016, INT J SPORTS MED, V37, P165, DOI 10.1055/s-0035-1564171; Hobara H, 2015, INT J SPORTS MED, V36, P494, DOI 10.1055/s-0034-1387794; Hobara H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163712; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; Ito A, 2006, NEW STUD ATHLET, V21, P35; McDonald C, 2004, HURDLES CONT THEORY, P12; Mero A, 1985, INT J SPORT BIOMECH, V1, P240, DOI [https://doi.org/10.1123/ijsb.1.3.240, DOI 10.1123/IJSB.1.3.240]; Nummela A, 1992, J SPORT SCI, V10, P217, DOI 10.1080/02640419208729920; Otsuka M., 2010, INT J SPORT HLTH SCI, V8, P35, DOI DOI 10.5432/IJSHS.20090027; Otsuka M, 2016, J STRENGTH COND RES, V30, P635, DOI 10.1519/JSC.0000000000001162; Paradisis GP, 2001, J SPORT SCI, V19, P149, DOI 10.1080/026404101300036370; Przednowek K, 2017, J HUM KINET, V60, P175, DOI 10.1515/hukin-2017-0101; Quinn MD, 2010, J APPL BIOMECH, V26, P171, DOI 10.1123/jab.26.2.171; Salo AIT, 2006, SPORT BIOMECH, V5, P155, DOI 10.1080/14763140608522871; Salo AIT, 2011, MED SCI SPORT EXER, V43, P1055, DOI 10.1249/MSS.0b013e318201f6f8; Saraslanidis PJ, 2011, EUR J APPL PHYSIOL, V111, P1579, DOI 10.1007/s00421-010-1772-4; Theodorou AS, 2017, J SPORT SCI, V35, P346, DOI 10.1080/02640414.2016.1164884; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Yasui T, 1996, P 14 INT S BIOM SPOR, P77; Zouhal H, 2010, J STRENGTH COND RES, V24, P2309, DOI 10.1519/JSC.0b013e3181e31287	30	5	5	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0204185	10.1371/journal.pone.0204185	http://dx.doi.org/10.1371/journal.pone.0204185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921329	Green Submitted, Green Published, gold			2022-12-27	WOS:000462594000001
J	Yuan, CL; Sun, QX; Kong, YZ				Yuan, Cuiling; Sun, Quanxi; Kong, Yingzhen			Genome-wide mining seed-specific candidate genes from peanut for promoter cloning	PLOS ONE			English	Article							STORAGE-PROTEIN PROMOTER; ARACHIS-HYPOGAEA L.; BRASSICA-NAPUS; EXPRESSION; ENDOSPERM; RICE; IDENTIFICATION; ELEMENTS; TRANSCRIPTION; BIOSYNTHESIS	Peanut seeds are ideal bioreactors for the production of foreign recombinant proteins and/or nutrient metabolites. Seed-Specific Promoters (SSPs) are important molecular tools for bioreactor research. However, few SSPs have been characterized in peanut seeds. The mining of Seed-Specific Candidate Genes (SSCGs) is a prerequisite for promoter cloning. Here, we described an approach for the genome-wide mining of SSCGs via comparative gene expression between seed and nonseed tissues. Three hundred thirty-seven SSCGs were ultimately identified, and the top 108 SSCGs were characterized. Gene Ontology (GO) analysis revealed that some SSCGs were involved in seed development, allergens, seed storage and fatty acid metabolism. RY REPEAT and GCN4 motifs, which are commonly found in SSPs, were dispersed throughout most of the promoters of SSCGs. Expression pattern analysis revealed that all 108 SSCGs were expressed specifically or preferentially in the seed. These results indicated that the promoters of the 108 SSCGs may perform functions in a seed-specific and/or seed-preferential manner. Moreover, a novel SSP was cloned and characterized from a paralogous gene of SSCG29 from cultivated peanut. Together with the previously characterized SSP of the SSCG5 paralogous gene in cultivated peanut, these results implied that the method for SSCG identification in this study was feasible and accurate. The SSCGs identified in this work could be widely applied to SSP cloning by other researchers. Additionally, this study identified a low-cost, high-throughput approach for exploring tissue-specific genes in other crop species.	[Yuan, Cuiling; Kong, Yingzhen] Chinese Acad Agr Sci, Tobacco Res Inst, Key Lab Tobacco Gene Resources, Qingdao, Shandong, Peoples R China; [Yuan, Cuiling; Sun, Quanxi] Shandong Peanut Res Inst, Qingdao, Shandong, Peoples R China; [Yuan, Cuiling] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Kong, YZ (corresponding author), Chinese Acad Agr Sci, Tobacco Res Inst, Key Lab Tobacco Gene Resources, Qingdao, Shandong, Peoples R China.; Sun, QX (corresponding author), Shandong Peanut Res Inst, Qingdao, Shandong, Peoples R China.	squanxi@163.com; kongyingzhen@caas.cn	kong, yingzhen/AAB-1623-2022		National Natural Science Foundation of China [31601336, 31670302]; National Key Technology RD Program [2015BAD15B03-05]; Elite Youth Program of CAAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Elite Youth Program of CAAS	This work was supported by National Natural Science Foundation of China (31601336 and 31670302), the National Key Technology R&D Program (2015BAD15B03-05), the Elite Youth Program of CAAS (to YK).	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Abid G, 2012, PLANT MOL BIOL REP, V30, P719, DOI 10.1007/s11105-011-0381-7; Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Chang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142952; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Chi XY, 2011, PLANT CELL REP, V30, P1393, DOI 10.1007/s00299-011-1048-4; Clevenger J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01446; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Wilde C, 2000, PLANT MOL BIOL, V43, P347, DOI 10.1023/A:1006464304199; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; Ezura K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180003; Fu GH, 2010, PLANTA, V231, P1049, DOI 10.1007/s00425-010-1111-3; Geng LL, 2014, PLANT CELL PHYSIOL, V55, P1793, DOI 10.1093/pcp/pcu111; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hood EE, 2003, PLANT BIOTECHNOL J, V1, P129, DOI 10.1046/j.1467-7652.2003.00014.x; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang SJ, 2011, PLANT CELL REP, V30, P1135, DOI 10.1007/s00299-011-1022-1; Kang IH, 2007, PLANT PHYSIOL, V144, P836, DOI 10.1104/pp.107.096933; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; Li N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42059; Liu XQ, 2018, PLANT BIOTECHNOL J, V16, P1107, DOI 10.1111/pbi.12883; Liu XQ, 2014, PLANT BIOTECHNOL J, V12, P1286, DOI 10.1111/pbi.12227; Napier JA, 2019, PLANT BIOTECHNOL J, V17, P703, DOI 10.1111/pbi.13045; Naqvi S, 2010, TRENDS PLANT SCI, V15, P48, DOI 10.1016/j.tplants.2009.09.010; Nie DM, 2013, GENE, V530, P236, DOI 10.1016/j.gene.2013.07.088; Onodera Y, 2001, J BIOL CHEM, V276, P14139, DOI 10.1074/jbc.M007405200; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Park JS, 2006, J PLANT BIOL, V49, P133, DOI 10.1007/BF03031009; Pessina S, 2016, PLANT BIOTECHNOL J, V14, P2033, DOI 10.1111/pbi.12562; Stalberg K, 1996, PLANTA, V199, P515, DOI 10.1007/BF00195181; STALBERG K, 1993, PLANT MOL BIOL, V23, P671, DOI 10.1007/BF00021523; Sunkara S, 2014, APPL BIOCHEM BIOTECH, V172, P325, DOI 10.1007/s12010-013-0482-x; Tang GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139213; Washida H, 1999, PLANT MOL BIOL, V40, P1, DOI 10.1023/A:1026459229671; Wei ZY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050624; Xu N, 2016, PLANT CELL, V28, P485, DOI 10.1105/tpc.15.00567; Yang P, 2015, PLANT BIOLOGY, V17, P522, DOI 10.1111/plb.12268; Zhang YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155780; Zhao XB, 2018, MOL BIOL REP, V45, P119, DOI 10.1007/s11033-018-4145-4; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhu QL, 2017, MOL PLANT, V10, P918, DOI 10.1016/j.molp.2017.05.008; ZIMMERMANN CR, 1980, CELL, V21, P709, DOI 10.1016/0092-8674(80)90434-1	48	6	7	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214025	10.1371/journal.pone.0214025	http://dx.doi.org/10.1371/journal.pone.0214025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921362	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000030
J	Zhang, LY; Hemminki, O; Chen, TH; Yu, HY; Zheng, GQ; Chattopadhyay, S; Forsti, A; Sundquist, K; Sundquist, J; Hemminki, K				Zhang, Luyao; Hemminki, Otto; Chen, Tianhui; Yu, Hongyao; Zheng, Guoqiao; Chattopadhyay, Subhayan; Foersti, Asta; Sundquist, Kristina; Sundquist, Jan; Hemminki, Kari			Second cancers and causes of death in patients with testicular cancer in Sweden	PLOS ONE			English	Article							GERM-CELL CANCER; CHILDHOOD-CANCER; ADULT SURVIVORS; SOLID TUMORS; RISK; CHEMOTHERAPY; DIAGNOSIS; LEUKEMIA; LYMPHOMA; REGISTRY	While treatment for testicular cancer (TC) has become standardized after the 1980s with an associated significant improvement in patient survival, this has been accompanied by an increased risk of second primary cancers (SPCs). Patients were identified from the Swedish Cancer Registry spanning the years from 1980 to 2015, including 8788 individuals with primary TC and their SPCs. Relative risks (RRs) for SPC were calculated using the generalized Poisson regression model. SPCs were diagnosed in 9.4% of patients with TC and half of them were late onset cancers not common in the population in their 40s. Overall RR of SPCs (excluding second TC) was 1.30 (95%CI: 1.20-1.40), including high risks for seven solid cancers, non-Hodgkin lymphoma and leukemia. Second TC was the most common SPC and the RR of 17.19 (95%CI: 14.89-19.85) was the highest recorded. Cancers known to be fatal as first primary cancers were also fatal as SPC in TC patients. Survival at 30 years of follow-up was approximately 80% for TC patients without SPC but it decreased to 40% for patients with SPC. The unexpected finding that half of the identified SPCs were typical late onset cancers in the middle-aged population raises concerns that therapy may facilitate premature aging. The risks of SPC are clinically important for the long-term management of TC patients and the high-mortality calls for a future management strategy.	[Zhang, Luyao; Yu, Hongyao; Zheng, Guoqiao; Chattopadhyay, Subhayan; Foersti, Asta; Hemminki, Kari] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Zhang, Luyao; Yu, Hongyao; Zheng, Guoqiao; Chattopadhyay, Subhayan] Heidelberg Univ, Fac Med, Heidelberg, Germany; [Hemminki, Otto] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Hemminki, Otto] Univ Helsinki, Canc Gene Therapy Grp, Fac Med, Helsinki, Finland; [Chen, Tianhui; Hemminki, Kari] Zhejiang Acad Med Sci ZJAMS, Grp Mol Epidemiol & Canc Precis Prevent, Hangzhou, Zhejiang, Peoples R China; [Foersti, Asta; Sundquist, Kristina; Sundquist, Jan] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, Kristina; Sundquist, Jan] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Dept Family Med & Community Hlth, New York, NY 10029 USA; [Sundquist, Kristina; Sundquist, Jan] Shimane Univ, Sch Med, Dept Funct Pathol, Ctr Community Based Healthcare Res & Educ CoHRE, Matsue, Shimane, Japan	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Lund University; Icahn School of Medicine at Mount Sinai; Shimane University	Zhang, LY (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.; Zhang, LY (corresponding author), Heidelberg Univ, Fac Med, Heidelberg, Germany.	luyao.zhang@dkfz-heidelberg.de	Chen, Tianhui/Y-3500-2018	Chen, Tianhui/0000-0003-4677-0361; Chattopadhyay, Subhayan/0000-0002-8599-2971	Deutsche Krebshilfe; Swedish Research Council [2014-2517, 2014-10134, 2016-01176]; ALF from Region Skane	Deutsche Krebshilfe(Deutsche Krebshilfe); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF from Region Skane	This work was supported by Deutsche Krebshilfe, the Swedish Research Council (2014-2517, 2014-10134 and 2016-01176) and ALF funding from Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariffin H, 2017, CANCER-AM CANCER SOC, V123, P4207, DOI 10.1002/cncr.30857; Bray F, 2006, INT J CANCER, V118, P3099, DOI 10.1002/ijc.21747; CenterforEpidemiology, 2010, CANC INC SWED 2009; Chovanec M, 2017, ANN ONCOL, V28, P2670, DOI 10.1093/annonc/mdx360; Eble J, 2003, TUMORS URINARY SYSTE; Frodin JE, 1997, ACTA ONCOL, V36, P465; Fung C, 2018, ADV UROL, V2018, DOI 10.1155/2018/8671832; Fung C, 2013, J CLIN ONCOL, V31, P3807, DOI 10.1200/JCO.2013.50.3409; Groot HJ, 2018, J CLIN ONCOL, V36, P2504, DOI 10.1200/JCO.2017.77.4174; Hanna N, 2014, J CLIN ONCOL, V32, P3085, DOI 10.1200/JCO.2014.56.0896; Hemminki K, 2010, ANN ONCOL, V21, P1546, DOI 10.1093/annonc/mdp562; Hemminki K, 2008, J CLIN ONCOL, V26, P1850, DOI 10.1200/JCO.2007.14.6068; Hemminki K, 2010, INT J CANCER, V126, P2259, DOI 10.1002/ijc.24795; Honecker F, 2018, ANN ONCOL, V29, P1658, DOI 10.1093/annonc/mdy217; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, REV HUMAN CARCINOGEN, V100, P1; International Agency for Research on Cancer (IARC), 2007, CANC INCIDENCE 5 CON, V9; Ji JG, 2012, INT J CANCER, V131, P2085, DOI 10.1002/ijc.27462; Kier MG, 2016, JAMA ONCOL, V2, P1624, DOI 10.1001/jamaoncol.2016.3651; Kvammen O, 2016, CANCER EPIDEM BIOMAR, V25, P773, DOI 10.1158/1055-9965.EPI-15-1153; Le Cornet C, 2014, EUR J CANCER, V50, P831, DOI 10.1016/j.ejca.2013.11.035; Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211; Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268; Prener A, 1996, EPIDEMIOLOGY, V7, P14, DOI 10.1097/00001648-199601000-00004; Pukkala E, 2018, ACTA ONCOL, V57, P440, DOI 10.1080/0284186X.2017.1407039; Pyle LC, 2016, SEMIN ONCOL, V43, P575, DOI 10.1053/j.seminoncol.2016.08.004; Rajpert-De Meyts E, 2016, LANCET, V387, P1762, DOI 10.1016/S0140-6736(15)00991-5; Riihimaki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29765; Skakkebaek NE, 2016, HORM RES PAEDIAT, V86, P240, DOI 10.1159/000443400; Sud A, 2017, J CLIN ONCOL, V35, P1584, DOI 10.1200/JCO.2016.70.9709; Trabert B, 2013, INT J CANCER, V133, P1900, DOI 10.1002/ijc.28207; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1354, DOI 10.1093/jnci/dji278; van den Belt-Dusebout AW, 2007, J CLIN ONCOL, V25, P4370, DOI 10.1200/JCO.2006.10.5296; Verhoeven RHA, 2013, ANN ONCOL, V24, P508, DOI 10.1093/annonc/mds460; Wierecky J, 2005, J CANCER RES CLIN, V131, P255, DOI 10.1007/s00432-004-0628-x; Zequi SD, 2012, BJU INT, V110, P1102, DOI 10.1111/j.1464-410X.2012.11056.x	35	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214410	10.1371/journal.pone.0214410	http://dx.doi.org/10.1371/journal.pone.0214410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921367	gold, Green Submitted, Green Published			2022-12-27	WOS:000462594000066
J	Higashiyama, T; Minamikawa, T; Kakinoki, M; Sawada, O; Ohji, M				Higashiyama, Tomoaki; Minamikawa, Takayuki; Kakinoki, Masashi; Sawada, Osamu; Ohji, Masahito			Decreased orbital fat and enophthalmos due to bimatoprost: Quantitative analysis using magnetic resonance imaging	PLOS ONE			English	Article							UPPER EYELID SULCUS; PROSTAGLANDIN-ASSOCIATED PERIORBITOPATHY; OCULAR HYPERTENSION; MRI MEASUREMENTS; GLAUCOMA; DIFFERENTIATION; 0.03-PERCENT; LATANOPROST; EFFICACY; SAFETY	We quantitatively determined the relation between the decrease in orbital fat and enophthalmos due to bimatoprost using magnetic resonance imaging (MRI). Nine orbits in nine patients were treated unilaterally with bimatoprost for glaucoma or ocular hypertension. The contralateral orbits were used as controls. The volumes of the orbital tissues and the enophthalmos were measured using MRI. The mean volumes on the treated and untreated sides were, respectively, 14.6 +/- 2.1 and 17.0 +/- 4.3 cm(3) for orbital fat (P = 0.04) and 3.4 +/- 0.5 and 3.3 +/- 0.5 cm(3) for total extraocular muscles (P = 0.85). The mean enophthalmos values were 14.7 +/- 2.5 and 16.0 +/- 2.3 mm on the treated and untreated sides, respectively (P = 0.002). The data acquired by quantitatively measuring the volumes of orbital fat and enophthalmos on MRI showed that each might be reduced by bimatoprost administration. The enophthalmos could be caused by the bimatoprost-induced decrease in orbital fat.	[Higashiyama, Tomoaki; Minamikawa, Takayuki; Kakinoki, Masashi; Sawada, Osamu; Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga, Japan	Shiga University of Medical Science	Higashiyama, T (corresponding author), Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga, Japan.	higashi@belle.shiga-med.ac.jp			JSPS KAKENHI Grant [JP17K16966]; Japan Society for the Promotion of Science	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	TH: This work was supported by JSPS KAKENHI Grant Number JP17K16966, Funder: Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2011, JPN J OPHTHALMOL, V55, P600, DOI 10.1007/s10384-011-0075-6; Alm A, 2014, CLIN OPHTHALMOL, V8, P1967, DOI 10.2147/OPTH.S59162; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Brennan N, 2017, INT J OPHTHALMOL-CHI, V10, P1251, DOI 10.18240/ijo.2017.08.11; Ederer F, 2004, OPHTHALMOLOGY, V111, P651, DOI 10.1016/j.ophtha.2003.09.025; Filippopoulos T, 2008, OPHTHAL PLAST RECONS, V24, P302, DOI 10.1097/IOP.0b013e31817d81df; Higashiyama T, 2015, JPN J OPHTHALMOL, V59, P430, DOI 10.1007/s10384-015-0410-4; Inoue K, 2014, CLIN OPHTHALMOL, V8, P1179, DOI 10.2147/OPTH.S60538; Inoue K, 2013, J GLAUCOMA, V22, P626, DOI 10.1097/IJG.0b013e31824d8d7c; Jayaprakasam A, 2010, ORBIT, V29, P357, DOI 10.3109/01676830.2010.527028; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim HW, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0521-4; Kucukevcilioglu M, 2014, CLIN EXP OPHTHALMOL, V42, P126, DOI 10.1111/ceo.12163; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Li TJ, 2016, OPHTHALMOLOGY, V123, P129, DOI 10.1016/j.ophtha.2015.09.005; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Maruyama K, 2013, CLIN OPHTHALMOL, V7, P1441, DOI 10.2147/OPTH.S47783; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; Musch DC, 2011, OPHTHALMOLOGY, V118, P1766, DOI 10.1016/j.ophtha.2011.01.047; Nakakura S, 2015, CLIN OPHTHALMOL, V9, P51, DOI 10.2147/OPTH.S75651; Nishida Y, 2001, GRAEF ARCH CLIN EXP, V239, P824, DOI 10.1007/s004170100352; Rabinowitz MP, 2015, OPHTHAL PLAST RECONS, V31, P373, DOI 10.1097/IOP.0000000000000351; Sakata R, 2014, JPN J OPHTHALMOL, V58, P212, DOI 10.1007/s10384-013-0299-8; Sakata R, 2013, JPN J OPHTHALMOL, V57, P179, DOI 10.1007/s10384-012-0219-3; Serrero G, 1997, BIOCHEM BIOPH RES CO, V233, P200, DOI 10.1006/bbrc.1997.6433; Shrirao N, 2016, INDIAN J OPHTHALMOL, V64, P459, DOI 10.4103/0301-4738.187676; Tian S, 2000, GRAEF ARCH CLIN EXP, V238, P393, DOI 10.1007/s004170050370; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wang KD, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-21; Yang HK, 2009, JPN J OPHTHALMOL, V53, P176, DOI 10.1007/s10384-008-0623-x; Yoshino T, 2013, JPN J OPHTHALMOL, V57, P172, DOI 10.1007/s10384-012-0199-3	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214065	10.1371/journal.pone.0214065	http://dx.doi.org/10.1371/journal.pone.0214065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917168	gold, Green Published, Green Submitted			2022-12-27	WOS:000462465800050
J	Adhikari, L; Ozrazgat-Baslanti, T; Ruppert, M; Madushani, RWMA; Paliwal, S; Hashemighouchani, H; Zheng, F; Tao, M; Lopes, JM; Li, XL; Rashidi, P; Bihorac, A				Adhikari, Lasith; Ozrazgat-Baslanti, Tezcan; Ruppert, Matthew; Madushani, R. W. M. A.; Paliwal, Srajan; Hashemighouchani, Haleh; Zheng, Feng; Tao, Ming; Lopes, Juliano M.; Li, Xiaolin; Rashidi, Parisa; Bihorac, Azra			Improved predictive models for acute kidney injury with IDEA: Intraoperative Data Embedded Analytics	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CONVERTING ENZYME-INHIBITORS; RISK-FACTORS; MORTALITY; SURGERY; MANAGEMENT; PRESSURE; DIALYSIS; BYPASS; COST	Background Acute kidney injury (AKI) is a common complication after surgery that is associated with increased morbidity and mortality. The majority of existing perioperative AKI risk prediction models are limited in their generalizability and do not fully utilize intraoperative physiological time-series data. Thus, there is a need for intelligent, accurate, and robust systems to leverage new information as it becomes available to predict the risk of developing postoperative AKI. Methods A retrospective single-center cohort of 2,911 adults who underwent surgery at the University of Florida Health between 2000 and 2010 was utilized for this study. Machine learning and statistical analysis techniques were used to develop perioperative models to predict the risk of developing AKI during the first three days after surgery, first seven days after surgery, and overall (after surgery during the index hospitalization). The improvement in risk prediction was examined by incorporating intraoperative physiological time-series variables. Our proposed model enriched a preoperative model that produced a probabilistic AKI risk score by integrating intraoperative statistical features through a machine learning stacking approach inside a random forest classifier. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, and Net Reclassification Improvement (NRI). Results The predictive performance of the proposed model is better than the preoperative data only model. The proposed model had an AUC of 0.86 (accuracy of 0.78) for the seven-day AKI outcome, while the preoperative model had an AUC of 0.84 (accuracy of 0.76). Furthermore, by integrating intraoperative features, the algorithm was able to reclassify 40% of the false negative patients from the preoperative model. The NRI for each outcome was AKI at three days (8%), seven days (7%), and overall (4%). Conclusions Postoperative AKI prediction was improved with high sensitivity and specificity through a machine learning approach that dynamically incorporated intraoperative data.	[Adhikari, Lasith; Ozrazgat-Baslanti, Tezcan; Ruppert, Matthew; Madushani, R. W. M. A.; Paliwal, Srajan; Hashemighouchani, Haleh; Tao, Ming; Bihorac, Azra] Univ Florida, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL 32610 USA; [Adhikari, Lasith; Ozrazgat-Baslanti, Tezcan; Ruppert, Matthew; Madushani, R. W. M. A.; Paliwal, Srajan; Hashemighouchani, Haleh; Zheng, Feng; Tao, Ming; Lopes, Juliano M.; Li, Xiaolin; Rashidi, Parisa; Bihorac, Azra] Univ Florida, Precis & Intelligent Syst Med PrismaP, Gainesville, FL 32611 USA; [Zheng, Feng; Li, Xiaolin] Univ Florida, Dept Elect & Comp Engn, Gainesville, FL USA; [Rashidi, Parisa] Univ Florida, Dept Biomed Engn, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bihorac, A (corresponding author), Univ Florida, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL 32610 USA.; Bihorac, A (corresponding author), Univ Florida, Precis & Intelligent Syst Med PrismaP, Gainesville, FL 32611 USA.	abihorac@ufl.edu	Rashidi, Parisa/AAP-7261-2020; Bihorac, Azra/Q-6500-2016; Marcal Lopes, Juliano/E-5827-2015	Rashidi, Parisa/0000-0003-4530-2048; Bihorac, Azra/0000-0002-5745-2863; Adhikari, Lasith/0000-0002-3252-8972; Ruppert, Matthew/0000-0001-9757-4454; Hashemigouchani, Haleh/0000-0002-1995-5072; Marcal Lopes, Juliano/0000-0001-5507-454X	National Institute of General Medical Sciences [R01 GM110240, P50 GM-111152]; Clinical and Translational Science Institute, University of Florida [97071]; University of Florida [127900]; NIH/NCATS Clinical and Translational Sciences Award [UL1 TR000064]; Vision Grant by Society of Critical Care Medicine; I Heermann Anesthesia Foundation, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110240, P50GM111152] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Clinical and Translational Science Institute, University of Florida; University of Florida(University of Florida); NIH/NCATS Clinical and Translational Sciences Award; Vision Grant by Society of Critical Care Medicine; I Heermann Anesthesia Foundation, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences [grant numbers R01 GM110240, P50 GM-111152]; the Clinical and Translational Science Institute, University of Florida [grant number 97071]; the Gatorade grant 127900 from University of Florida; and the NIH/NCATS Clinical and Translational Sciences Award [UL1 TR000064]. Part of the cost for data acquisition for this study was supported by I Heermann Anesthesia Foundation, Inc and Vision Grant by Society of Critical Care Medicine.	Angelo Canty BR, 1997, BOOT FUNCTIONS DATAS; Aronson S, 2013, ANESTHESIOL RES PRAC, V2013, DOI 10.1155/2013/174091; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bihorac A, 2019, ANN SURG, V269, P652, DOI 10.1097/SLA.0000000000002706; Bihorac A, 2018, NAT REV NEPHROL, V14, P8, DOI 10.1038/nrneph.2017.170; Bihorac A, 2013, CRIT CARE MED, V41, P2570, DOI 10.1097/CCM.0b013e31829860fc; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Birnie K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0606-x; Borthwick E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3365; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coca SG, 2013, NEPHROL DIAL TRANSPL, V28, P2787, DOI 10.1093/ndt/gft405; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Flechet M, 2017, INTENS CARE MED, V43, P764, DOI 10.1007/s00134-017-4678-3; Foundation PS, PYTH LANG REF VERS 2; Futier E, 2017, JAMA-J AM MED ASSOC, V318, P1346, DOI 10.1001/jama.2017.14172; Haase M, 2012, NEPHROL DIAL TRANSPL, V27, P153, DOI 10.1093/ndt/gfr275; Hobson C, 2018, J VASC SURG, V68, P916, DOI 10.1016/j.jvs.2018.05.017; Hobson C, 2017, CRIT CARE CLIN, V33, P379, DOI 10.1016/j.ccc.2016.12.008; Hobson C, 2015, CRIT CARE CLIN, V31, P705, DOI 10.1016/j.ccc.2015.06.007; Hobson C, 2015, ANN SURG, V261, P1207, DOI 10.1097/SLA.0000000000000732; Hodgson LE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016591; Holmes J, 2017, KIDNEY INT REP, V2, P342, DOI 10.1016/j.ekir.2016.12.001; Huber M, 2016, JAMA SURG, V151, P441, DOI 10.1001/jamasurg.2015.4526; Huber M, 2016, ANN VASC SURG, V30, P72, DOI 10.1016/j.avsg.2015.04.092; Huen SC, 2012, ANN THORAC SURG, V93, P337, DOI 10.1016/j.athoracsur.2011.09.010; Jones E., 2001, SCIPY OPEN SOURCE SC; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kashani K, 2015, J CARDIOTHOR VASC AN, V29, P1588, DOI 10.1053/j.jvca.2015.04.013; Kertai MD, 2016, ANESTHESIOLOGY, V125, P438, DOI 10.1097/ALN.0000000000001190; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Korenkevych D, 2016, ANN SURG, V263, P1219, DOI 10.1097/SLA.0000000000001362; Koyner JL, 2016, CLIN J AM SOC NEPHRO, V11, P1935, DOI 10.2215/CJN.00280116; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Lysak N, 2017, CURR OPIN ANESTHESIO, V30, P113, DOI 10.1097/ACO.0000000000000422; Mehta RL, 2002, AM J MED, V113, P456, DOI 10.1016/S0002-9343(02)01230-5; Ng SY, 2014, J THORAC CARDIOV SUR, V147, P1875, DOI 10.1016/j.jtcvs.2013.06.049; Oh HJ, 2012, NEPHROL DIAL TRANSPL, V27, P589, DOI 10.1093/ndt/gfr307; Ozrazgat-Baslanti T, 2016, ANN SURG, DOI [10.1097/SLA.000000000000073200000658-201506000-00027, DOI 10.1097/SLA.000000000000073200000658-201506000-00027]; Ozrazgat-Baslanti T, 2016, SURGERY, V160, P463, DOI 10.1016/j.surg.2016.04.013; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Program UNAKI, 2014, AC KIDN INJ AKI ALG; R Development Core Team, 2009, R LANG ENV STAT COMP; Roshanov PS, 2017, ANESTHESIOLOGY, V126, P16, DOI 10.1097/ALN.0000000000001404; Saria S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001304; Shickel B, 2018, ARXIV180210238; Sun LY, 2015, ANESTHESIOLOGY, V123, P515, DOI 10.1097/ALN.0000000000000765; Thottakkara P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155705; United States Census Bureau, 2017, AM FACTFINDER 2010; Roncero LM, 2017, J CLIN ANESTH, V40, P91, DOI 10.1016/j.jclinane.2017.04.018; Wald R, 2006, J VASC SURG, V43, P460, DOI 10.1016/j.jvs.2005.11.053; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	56	27	28	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214904	10.1371/journal.pone.0214904	http://dx.doi.org/10.1371/journal.pone.0214904			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947282	gold, Green Submitted, Green Published			2022-12-27	WOS:000463314500080
J	Burred, JJ; Ponsot, E; Goupil, L; Liuni, M; Aucouturier, JJ				Burred, Juan Jose; Ponsot, Emmanuel; Goupil, Louise; Liuni, Marco; Aucouturier, Jean-Julien			CLEESE: An open-source audio-transformation toolbox for data-driven experiments in speech and music cognition	PLOS ONE			English	Article							PHASE VOCODER; REVERSE-CORRELATION; FACIAL EXPRESSIONS; PERCEPTION; RECOGNITION; INTONATION; PROSODY; TIME; REPRESENTATION; COMMUNICATION	Over the past few years, the field of visual social cognition and face processing has been dramatically impacted by a series of data-driven studies employing computer-graphics tools to synthesize arbitrary meaningful facial expressions. In the auditory modality, reverse correlation is traditionally used to characterize sensory processing at the level of spectral or spectro-temporal stimulus properties, but not higher-level cognitive processing of e.g. words, sentences or music, by lack of tools able to manipulate the stimulus dimensions that are relevant for these processes. Here, we present an open-source audio-transformation toolbox, called CLEESE, able to systematically randomize the prosody/melody of existing speech and music recordings. CLEESE works by cutting recordings in small successive time segments (e.g. every successive 100 milliseconds in a spoken utterance), and applying a random parametric transformation of each segment's pitch, duration or amplitude, using a new Python-language implementation of the phase-vocoder digital audio technique. We present here two applications of the tool to generate stimuli for studying intonation processing of interrogative vs declarative speech, and rhythm processing of sung melodies.	[Ponsot, Emmanuel; Goupil, Louise; Liuni, Marco; Aucouturier, Jean-Julien] Sorbonne Univ, Sci & Technol Music & Sound, UM R9912, IRCAM,CNRS, Paris, France; [Ponsot, Emmanuel] PSL Res Univ, Ecole Normale Super, Lab Syst Perceptifs, CNRS UMR 8248, Paris, France; [Ponsot, Emmanuel] PSL Res Univ, Ecole Normale Super, Dept Etud Cognit, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Aucouturier, JJ (corresponding author), Sorbonne Univ, Sci & Technol Music & Sound, UM R9912, IRCAM,CNRS, Paris, France.	aucouturier@gmail.com	Goupil, Louise/AAJ-9207-2021	Goupil, Louise/0000-0003-4342-9408; Burred, Juan Jose/0000-0001-9755-4162	(European Research Council) [CREAM - 335536]	(European Research Council)(European Research Council (ERC))	The funder (H2020 European Research Council) provided funding for the project to J-J.A (Award Number CREAM - 335536), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author J.J.B., affiliated as Independent Researcher, is registered as a sole-proprietorship company in France dedicated to research and development consulting. Its participation to this study was fully funded by the above-mentioned grant.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0367; AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Arias Pablo, 2018, IEEE T AFFECTIVE COM; Brauneis R, 2009, J COPYRIGHT SOC USA, V56, P335; Brimijoin WO, 2013, J ACOUST SOC AM, V133, pEL118, DOI 10.1121/1.4778264; BURGESS AE, 1988, J OPT SOC AM A, V5, P617, DOI 10.1364/JOSAA.5.000617; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; Doelling KB, 2015, P NATL ACAD SCI USA, V112, pE6233, DOI 10.1073/pnas.1508431112; DOLSON M, 1986, COMPUT MUSIC J, V10, P14, DOI 10.2307/3680093; Dotsch R, 2012, SOC PSYCHOL PERS SCI, V3, P562, DOI 10.1177/1948550611430272; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; GELUYKENS R, 1988, J PRAGMATICS, V12, P467, DOI 10.1016/0378-2166(88)90006-9; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Gosselin F, 2003, PSYCHOL SCI, V14, P505, DOI 10.1111/1467-9280.03452; Gussenhoven C., 2004, PHONOLOGY TONE INTON, DOI [10.1017/CBO9780511616983, DOI 10.1017/CBO9780511616983]; Isnard V, 2016, M AC SOC AM, V140, P3267; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Jiang J, 2015, J AUTISM DEV DISORD, V45, P2067, DOI 10.1007/s10803-015-2370-4; Jiang XM, 2017, SPEECH COMMUN, V88, P106, DOI 10.1016/j.specom.2017.01.011; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kochanski G, 2005, J ACOUST SOC AM, V118, P1038, DOI 10.1121/1.1923349; Kragness HE, 2016, J EXP PSYCHOL HUMAN, V42, P1676, DOI 10.1037/xhp0000245; Laroche J, 1999, IEEE T SPEECH AUDI P, V7, P323, DOI 10.1109/89.759041; Larsen A. B. L., 2015, ARXIV PREPRINT ARXIV; Law LNC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052508; Levitin DJ, 1996, PERCEPT PSYCHOPHYS, V58, P927, DOI 10.3758/BF03205494; Liu F., 2007, 16 INT C PHON SCI; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Liuni M, 2013, MUSICA TECNOL, V7, P73; Mandel MI, 2016, J ACOUST SOC AM, V140, P2542, DOI 10.1121/1.4964102; Mangini MC, 2004, COGNITIVE SCI, V28, P209, DOI 10.1016/j.cogsci.2003.11.004; MARMARELIS PZ, 1972, SCIENCE, V175, P1276, DOI 10.1126/science.175.4027.1276; Mitchell RLC, 2013, NEUROSCI BIOBEHAV R, V37, P471, DOI 10.1016/j.neubiorev.2013.01.027; Murray RF, 2011, J VISION, V11, DOI 10.1167/11.5.2; Neri P, 2010, PSYCHON B REV, V17, P802, DOI 10.3758/PBR.17.6.802; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; PALMER C, 1989, J EXP PSYCHOL HUMAN, V15, P331, DOI 10.1037/0096-1523.15.2.331; Penel A, 2004, PERCEPT PSYCHOPHYS, V66, P545, DOI 10.3758/BF03194900; Pinheiro AP, 2013, PSYCHOL MED, V43, P603, DOI 10.1017/S003329171200133X; Ponsot E, 2018, P NATL ACAD SCI USA; Ponsot E, 2018, J ACOUST SOC AM, V143, pEL19, DOI 10.1121/1.5020989; Ponsot E, 2013, J ACOUST SOC AM, V134, pEL321, DOI [10.1121/1.4830829, 10.1121/1.4830828, 10.1121/1.4819184]; PORTNOFF MR, 1976, IEEE T ACOUST SPEECH, V24, P243, DOI 10.1109/TASSP.1976.1162810; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; REPP BH, 1992, COGNITION, V44, P241, DOI 10.1016/0010-0277(92)90003-Z; Ringach D, 2004, COGNITIVE SCI, V28, P147, DOI 10.1016/j.cogsci.2003.11.003; Roesch EB, 2011, J NONVERBAL BEHAV, V35, P1, DOI 10.1007/s10919-010-0095-9; Rychlowska M, 2017, PSYCHOL SCI, V28, P1259, DOI 10.1177/0956797617706082; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Stivers T, 2010, J PRAGMATICS, V42, P2772, DOI 10.1016/j.pragma.2010.04.011; Tang C, 2017, SCIENCE, V357, P797, DOI 10.1126/science.aam8577; Thoret E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00587; Varnet L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14489; Venezia JH, 2016, J ACOUST SOC AM, V140, P1072, DOI 10.1121/1.4960544; Yu H, 2012, COMPUT GRAPH-UK, V36, P152, DOI 10.1016/j.cag.2011.12.002	59	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0205943	10.1371/journal.pone.0205943	http://dx.doi.org/10.1371/journal.pone.0205943			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947281	gold, Green Published, Green Submitted			2022-12-27	WOS:000463314500003
J	Chevallier, M; Ancel, PY; Torchin, H; Marchand-Martin, L; Lorthe, E; Truffert, P; Jarreau, PH; Roze, JC; Pierrat, V; Marret, S; Baud, O; Benhammou, V; Ego, A; Debillon, T				Chevallier, Marie; Ancel, Pierre-Yves; Torchin, Heloise; Marchand-Martin, Laetitia; Lorthe, Elsa; Truffert, Patrick; Jarreau, Pierre Henri; Roze, Jean Christophe; Pierrat, Veronique; Marret, Stephane; Baud, Olivier; Benhammou, Valerie; Ego, Anne; Debillon, Thierry			Early extubation is not associated with severe intraventricular hemorrhage in preterm infants born before 29 weeks of gestation. Results of an EPIPAGE-2 cohort study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; NEURODEVELOPMENTAL OUTCOMES; CEREBRAL OXYGENATION; RISK-FACTORS; PREDICTORS; MANAGEMENT; MORBIDITY; SUCCESS; GROWTH	Objective To determine whether there is an association between severe intraventricular hemorrhage and early extubation in preterm infants born before 29 weeks of gestational age and intubated at birth. Methods This study included 1587 preterm infants from a nationwide French population cohort (EPIPAGE-2). Secondary data on intubated preterm infants were analyzed. After gestational age and propensity score matching (1:1) we built two comparable groups: an early extubation group and a delayed extubation group. Each neonate in one group was paired with a neonate in the other group having the same propensity score and gestational age. Early extubation was defined as extubation within 48 hours of life. Severe intraventricular hemorrhages were defined as grade III or IV hemorrhages according to the Papile classification. Results After matching, there were 398 neonates in each group. Using a generalized estimating equation model, we found that intraventricular hemorrhage was not associated with early extubation (adjusted OR 0.9, 95%CI 0.6-1.4). This result was supported by sensitivity analyses. Conclusion The practice of early extubation was not associated with an increased proportion of intraventricular hemorrhages. To complete these results, the long-term neurologic outcomes of these infants need to be assessed.	[Chevallier, Marie; Ego, Anne; Debillon, Thierry] Grenoble Alpes Univ, TIMC IMAG, CNRS, UMR 5525 ThEMAS, Grenoble, France; [Chevallier, Marie; Debillon, Thierry] Grenoble Alpes Univ Hosp, Neonatal Intens Care Unit, Grenoble, France; [Ancel, Pierre-Yves; Torchin, Heloise; Marchand-Martin, Laetitia; Lorthe, Elsa; Pierrat, Veronique; Benhammou, Valerie] Paris Descartes Univ, Sorbonne Paris Cite, Obstet Perinatal & Pediat Epidemiol ResearchTeam, INSERM,UMR 1153,Ctr Epidemiol & Biostat, Paris, France; [Ancel, Pierre-Yves] Cochin Hotel Dieu Hosp, AP HP, Risk Pregnancy DHU, Paris, France; [Lorthe, Elsa] Univ Porto, Inst Publ Hlth, EPIUnit, Porto, Portugal; [Truffert, Patrick; Pierrat, Veronique] CHRU Lille, Jeanne de Flandre Hosp, Neonatal Intens Care Unit, Lille, France; [Jarreau, Pierre Henri] Hop Cochin, AP HP, Neonatal Intens Care Unit Port Royal, Paris, France; [Roze, Jean Christophe] CHU Nantes, Dept Neonatal Med, Nantes, France; [Marret, Stephane] CHU Rouen, Dept Neonatal Med & Intens Care, Rouen, France; [Baud, Olivier] CHU Geneva, Div Neonatol & Pediat Intens Care, Geneva, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Universidade do Porto; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; CHU de Rouen; University of Geneva	Chevallier, M (corresponding author), Grenoble Alpes Univ, TIMC IMAG, CNRS, UMR 5525 ThEMAS, Grenoble, France.; Chevallier, M (corresponding author), Grenoble Alpes Univ Hosp, Neonatal Intens Care Unit, Grenoble, France.	mchevallier3@chu-grenoble.fr	Torchin, Héloise/AAM-5170-2020; Lorthe, Elsa/I-9902-2019; Rozé, Jean-Christophe/AAS-1314-2021; EGO, Anne/G-7071-2011	Torchin, Héloise/0000-0003-4699-5384; Lorthe, Elsa/0000-0002-9654-8104; EGO, Anne/0000-0002-1025-910X; Marret, Stephane/0000-0002-2858-148X; Marchand-Martin, Laetitia/0000-0002-8036-8387	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research (INSERM); National Institute of Cancer; National Solidarity Fund for Autonomy (CNSA); National Research Agency through the French EQUIPEX program of investments in the future [ANR-11-EQPX-0038]; PREMUP Foundation	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); National Institute of Cancer; National Solidarity Fund for Autonomy (CNSA); National Research Agency through the French EQUIPEX program of investments in the future; PREMUP Foundation	This project has been funded with support from the following organizations: The French Institute of Public Health Research/Institute of Public Health and its partners: the French Health Ministry, the National Institute of Health and Medical Research (INSERM), the National Institute of Cancer, and the National Solidarity Fund for Autonomy (CNSA); The National Research Agency through the French EQUIPEX program of investments in the future (reference ANR-11-EQPX-0038); the PREMUP Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faleh K, 2011, ANN SAUDI MED, V31, P577, DOI 10.4103/0256-4947.87092; Al-Mandari H, 2015, ARCH DIS CHILD-FETAL, V100, pF428, DOI 10.1136/archdischild-2015-308549; Alderliesten T, 2013, J PEDIATR-US, V162, P698, DOI 10.1016/j.jpeds.2012.09.038; Ambalavanan N, 2006, SEMIN PERINATOL, V30, P192, DOI 10.1053/j.semperi.2006.05.006; Ancel PY, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-97; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Balany J, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00090; Bassan H, 2006, PEDIATR NEUROL, V35, P85, DOI 10.1016/j.pediatrneurol.2006.03.005; Berger J, 2014, AM J PERINAT, V31, P1063, DOI 10.1055/s-0034-1371702; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Calisici E, 2015, J MATERN-FETAL NEO M, V28, P2115, DOI 10.3109/14767058.2014.979783; Chawla S, 2017, J PEDIATR-US, V189, P113, DOI 10.1016/j.jpeds.2017.04.050; Corp Stata, 2013, STATA STAT SOFTW REL; de Vries L S, 2001, Eur J Paediatr Neurol, V5, P139, DOI 10.1053/ejpn.2001.0494; Durrmeyer X, 2017, ARCH DIS CHILD-FETAL, pF1, DOI [10.1161/STROKEAHA.110.597229, DOI 10.1161/STROKEAHA.110.597229]; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Garrido MM, 2014, HEALTH SERV RES, V49, P1701, DOI 10.1111/1475-6773.12182; Jensen EA, 2015, JAMA PEDIATR, V169, P1011, DOI 10.1001/jamapediatrics.2015.2401; Laughon MM, 2011, AM J RESP CRIT CARE, V183, P1715, DOI 10.1164/rccm.201101-0055OC; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Manley BJ, 2016, J PEDIATR-US, V173, P45, DOI 10.1016/j.jpeds.2016.02.016; Miletin J, 2008, ARCH DIS CHILD-FETAL, V93, pF368, DOI 10.1136/adc.2007.129304; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Noori S, 2015, SEMIN FETAL NEONAT M, V20, P232, DOI 10.1016/j.siny.2015.02.004; Noori S, 2009, CLIN PERINATOL, V36, P723, DOI 10.1016/j.clp.2009.07.015; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Shah PS, 2016, J PEDIATR-US, V177, P144, DOI 10.1016/j.jpeds.2016.04.083; Sweet DG, 2010, NEONATOLOGY, V97, P402, DOI 10.1159/000297773; Thome UH, 2009, SEMIN FETAL NEONAT M, V14, P21, DOI 10.1016/j.siny.2008.08.005; Tsai AJ, 2014, J PERINATOL, V34, P399, DOI 10.1038/jp.2014.21; van den Berg E, 2010, ARCH DIS CHILD-FETAL, V95, pF53, DOI 10.1136/adc.2008.156414; VERDER H, 1994, NEW ENGL J MED, V331, P1051, DOI 10.1056/NEJM199410203311603; Verhagen EA, 2010, STROKE, V41, P2901, DOI 10.1161/STROKEAHA.110.597229; Vesoulis ZA, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00064; 2004, PEDIATRICS, V114, P1341, DOI DOI 10.1542/PEDS.2004-1697	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214232	10.1371/journal.pone.0214232	http://dx.doi.org/10.1371/journal.pone.0214232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946750	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500021
J	Prado-Gasco, V; de la Barrera, U; Sancho-Castillo, S; de la Rubia-Orti, JE; Montoya-Castilla, I				Prado-Gasco, Vicente; de la Barrera, Usue; Sancho-Castillo, Sandra; Enrique de la Rubia-Orti, Jose; Montoya-Castilla, Inmaculada			Perceived stress and reference ranges of hair cortisol in healthy adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; SALIVARY CORTISOL; SOCIOECONOMIC-STATUS; PUBERTAL CHANGES; SCALP HAIR; CHILDREN; ASSOCIATION; BIOMARKER; SYMPTOMS	Background Chronic stress during adolescence has usually been evaluated through subjective measures, leaving aside objective measures such as hair cortisol concentrations. Therefore, the aim of this study was to provide reference ranges for hair cortisol concentrations by sex and age and to study the relationship between subjective and objective measures of stress and temporal stability. Methods The participants were 170 adolescents aged between 12 and 14 years (mean = 12.78 years; standard deviation = 0.71 years; 52.40% girls) who completed the Perceived Stress Scale 4 and had their hair sampled. Results The results revealed hair cortisol concentrations ranging from 0.07 pg/mg to 9.54 pg/mg. Subjective and objective measures of stress were not related, nor was there intraindividual stability of the hair cortisol concentrations. Girls had higher hair cortisol concentrations, and there were no age differences. Conclusions This research provides cortisol reference values for adolescents that will allow the early detection of chronic stress. Such detection methods make it possible to prevent problems arising from stress because we can act more quickly and the treatments will be more effective. The study suggests that there is no relationship between perceived and objective stress; while perceived stress remained stable, the levels of hair cortisol were increased at 6 months. Despite the interesting findings of the study, there are some limitations: the sample was not obtained through probabilistic sampling, the age range was narrow, and some demographic, anthropomorphic and clinical factors are missing, which make the generalization of results difficult.	[Prado-Gasco, Vicente] Univ Valencia, Dept Social Psychol, Valencia, Spain; [de la Barrera, Usue; Montoya-Castilla, Inmaculada] Univ Valencia, Dept Personal Assessment & Psychol Treatment, Valencia, Spain; [Sancho-Castillo, Sandra; Enrique de la Rubia-Orti, Jose] Catholic Univ Valencia, Dept Basic Med Sci, Valencia, Spain	University of Valencia; University of Valencia; Universidad Catolica de Valencia San Vicente Martir	Montoya-Castilla, I (corresponding author), Univ Valencia, Dept Personal Assessment & Psychol Treatment, Valencia, Spain.	inmaculada.montoya@uv.es	Montoya-Castilla, Inmaculada/G-8963-2011; PRADO-GASCO, VICENTE/K-7276-2014; de la Rubia Ortí, jose Enrique/ABH-4281-2020	Montoya-Castilla, Inmaculada/0000-0003-2536-2019; PRADO-GASCO, VICENTE/0000-0002-2108-2186; Sancho Castillo, Sandra/0000-0002-3848-3584; De la Barrera Marzal, Usue/0000-0003-1510-9669	Spanish Ministry of Economy and Competitiveness [PSI2013-43943-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was supported by grants from the Spanish Ministry of Economy and Competitiveness (PSI2013-43943-R), http://www.mineco.gob.es/.	Adam EK, 2006, PSYCHONEUROENDOCRINO, V31, P664, DOI 10.1016/j.psyneuen.2006.01.010; Anderson NB, 2011, MONITOR PSYCHOL, V41, P1, DOI [10.1007/s10964-016-0451-0, DOI 10.1007/S10964-016-0451-0]; Bluth K, 2016, J CHILD FAM STUD, V25, P1098, DOI 10.1007/s10826-015-0307-3; Boeckel MG, 2017, COMPR PSYCHIAT, V72, P18, DOI 10.1016/j.comppsych.2016.09.006; Brown BB, 2002, ADOLESCENCE 8 REGION; Burger K, 2017, J YOUTH ADOLESCENCE, V46, P78, DOI 10.1007/s10964-016-0608-x; Burkhart ML, 2017, J CHILD FAM STUD, V26, P1345, DOI 10.1007/s10826-017-0665-0; Cameron CA, 2017, J YOUTH ADOLESCENCE, V46, P104, DOI 10.1007/s10964-016-0548-5; Chen N, 2014, J ABNORM CHILD PSYCH, V42, P1251, DOI 10.1007/s10802-014-9872-y; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; D'Este P, 2016, TECHNOL FORECAST SOC, V113, P280, DOI 10.1016/j.techfore.2015.08.011; Daughters SB, 2013, J ABNORM CHILD PSYCH, V41, P749, DOI 10.1007/s10802-013-9713-4; Debnam KJ, 2018, J YOUTH ADOLESCENCE, V47, P818, DOI 10.1007/s10964-017-0687-3; Duarte JO, 2015, PSYCHOSOM MED, V77, P186, DOI 10.1097/PSY.0000000000000141; Focker M, 2016, EUR EAT DISORD REV, V24, P531, DOI 10.1002/erv.2466; Fuchs A, 2018, PSYCHONEUROENDOCRINO, V90, P52, DOI 10.1016/j.psyneuen.2018.02.003; Gelhaar T, 2007, EUR J DEV PSYCHOL, V4, P129, DOI 10.1080/17405620600831564; Geoffroy MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077603; Gerber M, 2017, PSYCHONEUROENDOCRINO, V76, P1, DOI 10.1016/j.psyneuen.2016.11.008; Gidlow CJ, 2016, PSYCHONEUROENDOCRINO, V63, P163, DOI 10.1016/j.psyneuen.2015.09.022; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Gray NA, 2018, PSYCHONEUROENDOCRINO, V87, P204, DOI 10.1016/j.psyneuen.2017.10.022; Groeneveld MG, 2013, STRESS, V16, P711, DOI 10.3109/10253890.2013.817553; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Herrero J, 2006, COMPUT HUM BEHAV, V22, P830, DOI 10.1016/j.chb.2004.03.007; Kalra S, 2007, CLIN INVEST MED, V30, pE103, DOI 10.25011/cim.v30i2.986; Kamps AWA, 2014, ACTA PAEDIATR, V103, P957, DOI 10.1111/apa.12685; King Shirley L, 2002, Biol Res Nurs, V4, P92, DOI 10.1177/1099800402238334; Kirschbaum C., 2007, ENCY STRESS, V3, P405, DOI DOI 10.1016/B978-012373947-6.00334-2; Lazarus SR, 1984, STRESS APPRAISAL COP; Low NCP, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-116; Lu QY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192901; Lundqvist C, 2010, ACTA PAEDIATR, V99, P1054, DOI 10.1111/j.1651-2227.2010.01727.x; Maldonado EF, 2008, SPAN J PSYCHOL, V11, P3, DOI 10.1017/S1138741600004066; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mayer SE, 2018, PSYCHONEUROENDOCRINO, V92, P57, DOI 10.1016/j.psyneuen.2018.03.020; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; Michels N, 2017, PSYCHOSOM MED, V79, P927, DOI 10.1097/PSY.0000000000000413; Moksnes UK, 2015, QUAL LIFE RES, V24, P2473, DOI 10.1007/s11136-015-0977-8; Moksnes UK, 2010, PERS INDIV DIFFER, V49, P430, DOI 10.1016/j.paid.2010.04.012; Moksnes UK, 2010, SCAND J PSYCHOL, V51, P203, DOI 10.1111/j.1467-9450.2009.00803.x; Noppe G, 2014, CLIN ENDOCRINOL, V81, P820, DOI 10.1111/cen.12551; Noppe G, 2014, HORM RES PAEDIAT, V82, P97, DOI 10.1159/000362519; Oldehinkel AJ, 2011, PSYCHOPHYSIOLOGY, V48, P441, DOI 10.1111/j.1469-8986.2010.01118.x; Olstad DL, 2016, STRESS, V19, P158, DOI 10.3109/10253890.2016.1160282; Papafotiou C, 2017, STRESS, V20, P217, DOI 10.1080/10253890.2017.1303830; Persike M, 2012, J YOUTH ADOLESCENCE, V41, P863, DOI 10.1007/s10964-011-9719-6; Persson R, 2008, CHRONOBIOL INT, V25, P923, DOI 10.1080/07420520802553648; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Puig-Perez S, 2018, PSYCHOL HEALTH, V33, P783, DOI 10.1080/08870446.2017.1408807; Rietschel L, 2016, TWIN RES HUM GENET, V19, P438, DOI 10.1017/thg.2016.50; Rippe RCA, 2016, PSYCHONEUROENDOCRINO, V66, P56, DOI 10.1016/j.psyneuen.2015.12.016; Romeo RD, 2010, DEV PSYCHOBIOL, V52, P244, DOI 10.1002/dev.20437; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Salovey P, 2002, PSYCHOL HEALTH, V17, P611, DOI 10.1080/08870440290025812; Shapero BG, 2017, J YOUTH ADOLESCENCE, V46, P91, DOI 10.1007/s10964-016-0451-0; Simmons JG, 2016, PSYCHONEUROENDOCRINO, V63, P276, DOI 10.1016/j.psyneuen.2015.10.004; Skoluda N, 2012, PSYCHONEUROENDOCRINO, V37, P611, DOI 10.1016/j.psyneuen.2011.09.001; Slominski R, 2015, THER DRUG MONIT, V37, P812, DOI 10.1097/FTD.0000000000000209; Stalder T, 2017, PSYCHONEUROENDOCRINO, V77, P261, DOI 10.1016/j.psyneuen.2016.12.017; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; Steudte S, 2013, BIOL PSYCHIAT, V74, P639, DOI 10.1016/j.biopsych.2013.03.011; Steudte-Schmiedgen S, 2017, J PSYCHIATR RES, V84, P184, DOI 10.1016/j.jpsychires.2016.09.024; Thomson S, 2010, EXP CLIN ENDOCR DIAB, V118, P133, DOI 10.1055/s-0029-1220771; Trueba AF, 2013, BIOL PSYCHOL, V93, P206, DOI 10.1016/j.biopsycho.2013.01.017; Ursache A, 2017, PSYCHONEUROENDOCRINO, V78, P142, DOI 10.1016/j.psyneuen.2017.01.020; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Vanaelst B, 2012, PSYCHOPHYSIOLOGY, V49, P1072, DOI 10.1111/j.1469-8986.2012.01396.x; Veldhorst MAB, 2014, J CLIN ENDOCR METAB, V99, P285, DOI 10.1210/jc.2013-2924; White LO, 2017, J CHILD PSYCHOL PSYC, V58, P998, DOI 10.1111/jcpp.12700; Zhang BS, 2015, SOC INDIC RES, V123, P501, DOI 10.1007/s11205-014-0739-y; Zhang Q, 2017, STEROIDS, V118, P61, DOI 10.1016/j.steroids.2016.12.008	75	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214856	10.1371/journal.pone.0214856	http://dx.doi.org/10.1371/journal.pone.0214856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947316	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500074
J	Zechmann, B				Zechmann, Bernd			Ultrastructure of plastids serves as reliable abiotic and biotic stress marker	PLOS ONE			English	Article							GENE-EXPRESSION; SENESCENCE; LEAVES; CHLOROPLASTS; PLASTOGLOBULES; DEGRADATION; BIOSYNTHESIS; ACCUMULATION; INFECTION; RESPONSES	Plastids perform many essential functions in plant metabolism including photosynthesis, synthesis of metabolites, and stress signaling. The most prominent type in green leaves is the chloroplast which contains thylakoids, plastoglobules, and starch. As these structures are closely linked to the metabolism of chloroplasts, changes during plant growth and development and during environmental stress situations are likely to occur. The aim of this study was to characterize changes in size and ultrastructure of chloroplast on cross-sections of leaves during high light stress, Botrytis infection, and dark induced senescence by quantitative transmission electron microscopy (TEM).The size of chloroplasts on cross sections of leaves decreased significantly when plants were subject to high light (49%), Botrytis infection (58%), and senescence (71%). The number of chloroplasts on cross sections of the palisade cell layer and spongy parenchyma, respectively, decreased significantly in plants exposed to high light conditions (48% and 29%), infected with Botrytis (48% and 46%), and during senescence (78% and 80%). Thylakoids on cross-sections of chloroplasts decreased significantly in plants exposed to high light (22%), inoculated with Botrytis cinerea (36%), and senescence (51%). This correlated with a massive increase in plastoglobules on cross-sections of chloroplasts of 88%, 2,306% and 19,617%, respectively. Starch contents on cross sections of chloroplasts were completely diminished in all three stress scenarios. These results demonstrate that the decrease in the number and size of chloroplasts is a reliable stress marker in plants during abiotic and biotic stress situations which can be easily detected with a light microscope. Further, lack of starch, the occurrence of large plastoglobules and decrease in thylakoids can also be regarded as reliable stress marker in plants which can be detected by TEM.	[Zechmann, Bernd] Baylor Univ, Ctr Microscopy & Imaging, Waco, TX 76798 USA	Baylor University	Zechmann, B (corresponding author), Baylor Univ, Ctr Microscopy & Imaging, Waco, TX 76798 USA.	Bernd_Zechmann@baylor.edu		Zechmann, Bernd/0000-0002-7702-2588				Ambastha V, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.989752; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Brunkard JO, 2018, ESSAYS BIOCHEM, V62, P95, DOI 10.1042/EBC20170011; Chan KX, 2016, ANNU REV PLANT BIOL, V67, P25, DOI 10.1146/annurev-arplant-043015-111854; Chen YY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030654; Dogra V, 2018, PLANT CELL ENVIRON, V41, P1727, DOI 10.1111/pce.13332; Duan QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111165; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Foyer CH, 2018, ENVIRON EXP BOT, V154, P134, DOI 10.1016/j.envexpbot.2018.05.003; Gabara B, 2012, ENVIRON EXP BOT, V77, P33, DOI 10.1016/j.envexpbot.2011.10.010; Ghosh S, 2001, PLANT PHYSIOL BIOCH, V39, P777, DOI 10.1016/S0981-9428(01)01296-7; Gururani MA, 2015, MOL PLANT, V8, P1304, DOI 10.1016/j.molp.2015.05.005; Hernandez JA, 2004, PHYSIOL PLANTARUM, V122, P486, DOI 10.1111/j.1399-3054.2004.00431.x; Itri Rosangela, 2014, Biophys Rev, V6, P47, DOI 10.1007/s12551-013-0128-9; Jajic Ivan, 2015, Plants-Basel, V4, P393, DOI 10.3390/plants4030393; Jensen Poul Erik, 2014, F1000Prime Rep, V6, P40, DOI 10.12703/P6-40; Kim CH, 2008, EMBO REP, V9, P435, DOI 10.1038/embor.2008.57; Lichtenthaler HK, 2007, PHOTOSYNTH RES, V92, P163, DOI 10.1007/s11120-007-9204-y; Liebers M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00023; Luschin-Ebengreuth N, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2150-6; Minamikawa T, 2001, PROTOPLASMA, V218, P144, DOI 10.1007/BF01306604; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Otegui MS, 2018, J EXP BOT, V69, P741, DOI 10.1093/jxb/erx234; Pfannschmidt T, 2009, ANN BOT-LONDON, V103, P599, DOI 10.1093/aob/mcn081; Pourtau N, 2006, PLANTA, V224, P556, DOI 10.1007/s00425-006-0243-y; Pribil M, 2014, J EXP BOT, V65, P1955, DOI 10.1093/jxb/eru090; Rochaix JD, 2018, ESSAYS BIOCHEM, V62, P13, DOI 10.1042/EBC20170048; Rossi FR, 2017, PLANT J, V92, P761, DOI 10.1111/tpj.13718; Rottet S, 2015, BBA-BIOENERGETICS, V1847, P889, DOI 10.1016/j.bbabio.2015.02.002; Shao RX, 2016, PHOTOSYNTHETICA, V54, P74, DOI 10.1007/s11099-015-0158-6; Simon UK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065811; Singh R, 2016, FRONT PLANT SCI, V7, P1, DOI 10.3389/fpls.2016.01299; STEINMULLER D, 1985, PLANTA, V163, P201, DOI 10.1007/BF00393507; Szymanska R, 2017, ENVIRON EXP BOT, V139, P165, DOI 10.1016/j.envexpbot.2017.05.002; TEVINI M, 1985, PLANTA, V163, P91, DOI 10.1007/BF00395902; Thalmann M, 2017, NEW PHYTOL, V214, P943, DOI 10.1111/nph.14491; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; van Wijk KJ, 2017, ANNU REV PLANT BIOL, V68, P253, DOI 10.1146/annurev-arplant-043015-111737; Veloso J, 2018, TRENDS PLANT SCI, V23, P613, DOI 10.1016/j.tplants.2018.03.016; Vidovic M, 2015, PLANT PHYSIOL BIOCH, V93, P44, DOI 10.1016/j.plaphy.2015.01.008; Wada S, 2009, PLANT PHYSIOL, V149, P885, DOI 10.1104/pp.108.130013; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Wojciechowska N, 2018, PLANT BIOLOGY, V20, P167, DOI 10.1111/plb.12672; WRISCHER M, 1975, J CELL SCI, V18, P509; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zechmann B, 2003, ARCH VIROL, V148, P1119, DOI 10.1007/s00705-003-0005-0; Zechmann B, 2007, J STRUCT BIOL, V158, P370, DOI 10.1016/j.jsb.2006.12.003; Zechmann B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00566; Zellnig G, 2004, PROTOPLASMA, V223, P221, DOI 10.1007/s00709-003-0034-2; Zellnig G, 2014, PHYTON-ANN REI BOT A, V54, P343; Zellnig G, 2014, J STRUCT BIOL, V186, P245, DOI 10.1016/j.jsb.2014.03.006; Zellnig G, 2010, PROTOPLASMA, V243, P129, DOI 10.1007/s00709-009-0058-3; Zhao JP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01565	57	16	16	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214811	10.1371/journal.pone.0214811	http://dx.doi.org/10.1371/journal.pone.0214811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946768	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500066
J	Visscher, RMS; Feddermann-Demont, N; Romano, F; Straumann, D; Bertolini, G				Visscher, Rosa M. S.; Feddermann-Demont, Nina; Romano, Fausto; Straumann, Dominik; Bertolini, Giovanni			Artificial intelligence for understanding concussion: Retrospective cluster analysis on the balance and vestibular diagnostic data of concussion patients	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SELF-ORGANIZING MAP; POSTCONCUSSION SYNDROME; CLASSIFICATION	Objectives We propose a bottom-up, machine-learning approach, for the objective vestibular and balance diagnostic data of concussion patients, to provide insight into the differences in patients' phenotypes, independent of existing diagnoses (unsupervised learning). Methods Diagnostic data from a battery of validated balance and vestibular assessments were extracted from the database of the Swiss Concussion Center. The desired number of clusters within the patient database was estimated using Calinski-Harabasz criteria. Complex (self-organizing map, SOM) and standard (k-means) clustering tools were used, and the formed clusters were compared. Results A total of 96 patients (81.3% male, age (median [IQR]): 25.0[10.8]) who were expected to suffer from sports-related concussion or post-concussive syndrome (52[140] days between diagnostic testing and the concussive episode) were included. The cluster evaluation indicated dividing the data into two groups. Only the SOM gave a stable clustering outcome, dividing the patients in group-1 (n = 38) and group-2 (n = 58). A large significant difference was found for the caloric summary score for the maximal speed of the slow phase, where group-1 scored 30.7% lower than group-2 (27.6[18.2] vs. 51.0[31.0]). Group-1 also scored significantly lower on the sensory organisation test composite score (69.0[22.3] vs. 79.0 [10.5]) and higher on the visual acuity (-0.03[0.33] vs. -0.14[0.12]) and dynamic visual acuity (0.38[0.84] vs. 0.20[0.20]) tests. The importance of caloric, SOT and DVA, was supported by the PCA outcomes. Group-1 tended to report headaches, blurred vision and balance problems more frequently than group-2 (>10% difference). Conclusion The SOM divided the data into one group with prominent vestibular disorders and another with no clear vestibular or balance problems, suggesting that artificial intelligence might help improve the diagnostic process.	[Visscher, Rosa M. S.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Visscher, Rosa M. S.; Feddermann-Demont, Nina; Romano, Fausto; Straumann, Dominik; Bertolini, Giovanni] Univ Zurich, Univ Hosp Zurich, Interdisciplinary Ctr Vertigo & Neurol Visual Dis, Dept Neurol, Zurich, Switzerland; [Feddermann-Demont, Nina; Romano, Fausto; Straumann, Dominik; Bertolini, Giovanni] Schulthess Clin, Swiss Concuss Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Schulthess Clinic	Visscher, RMS (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.; Visscher, RMS (corresponding author), Univ Zurich, Univ Hosp Zurich, Interdisciplinary Ctr Vertigo & Neurol Visual Dis, Dept Neurol, Zurich, Switzerland.	rosa.visscher@hest.ethz.ch	Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Visscher, Rosa Maria Sija/0000-0003-2817-9359; Romano, Fausto/0000-0002-6166-7461				Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; [Anonymous], TKK REPORTS INFORM C; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; Ben Slama A, 2016, IEEE IND ELEC, P5165, DOI 10.1109/IECON.2016.7793010; Bohmer A, 1995, J Vestib Res, V5, P35; Borah Diganta, 2007, Indian J Physiol Pharmacol, V51, P395; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Costello AB., 2005, PRACT ASSESS RES EVA, V10, P7; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Ding C, 2004, SIAM PROC S, P497; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Fujimoto C, 2018, CLIN NEUROPHYSIOL, V129, P238, DOI 10.1016/j.clinph.2017.11.006; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Incorporated NM, 2016, NEUROCOM BAL MAN SEN; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Kelly KM, 2018, J HEAD TRAUMA REHAB, DOI [10.1097/HTR, DOI 10.1097/HTR]; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Landry AP, 2019, J NEUROSURG, V131, P1235, DOI 10.3171/2018.6.JNS18607; Lin FR, 2005, ANN OTO RHINOL LARYN, V114, P777, DOI 10.1177/000348940511401007; Liu YG, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003117; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McInnes L, 2018, 180203426 ARXIV; Minaee Shervin, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P1267, DOI 10.1109/EMBC.2018.8512556; Nanetti L, 2009, NEUROIMAGE, V47, P1666, DOI 10.1016/j.neuroimage.2009.06.014; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Oh JH, 2016, METHOD INFORM MED, V55, P431, DOI 10.3414/ME16-01-0035; Park K, 2018, J SPORT REHABIL, V27, P485, DOI 10.1123/jsr.2016-0222; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Peters BT, 2012, J VESTIBUL RES-EQUIL, V22, P145, DOI 10.3233/VES-2012-0440; Polzlbauer G., 2004, WORKSH DAT AN SLIEZS; Randolph C, 2005, CONCUSSION SYMPTOMS; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI [10.1136/BMJSEM-2015-000012, DOI 10.1136/BMJSEM-2015-000012]; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sakai K, 2019, JPN J RADIOL, V37, P34, DOI 10.1007/s11604-018-0794-4; Schmid-Priscoveanu A, 1999, ACTA OTO-LARYNGOL, V119, P750, DOI 10.1080/00016489950180379; Sharp David J, 2015, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Si B, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00606; Si B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198741; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Sun Y, 2000, NEUROCOMPUTING, V34, P169, DOI 10.1016/S0925-2312(00)00292-7; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; van de Berg R, 2018, CURR OPIN NEUROL, V31, P111, DOI 10.1097/WCO.0000000000000526; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; VANEGMOND AAJ, 1954, ACTA OTO-LARYNGOL, V44, P589, DOI 10.3109/00016485409127671; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 2000, SOM TOOLBOX MATLAB 5, V57, P60; Voutilainen A, 2018, GERONTOLOGIST, V58, pE138, DOI 10.1093/geront/gnw251; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Zhao Xinyu, 2018, Front Appl Math Stat, V4, DOI 10.3389/fams.2018.00025; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	68	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214525	10.1371/journal.pone.0214525	http://dx.doi.org/10.1371/journal.pone.0214525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939164	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000462993900031
J	Correa, S; Puertas, S; Gutierrez, L; Asin, L; de la Fuente, JM; Grazu, V; Betancor, L				Correa, Sonali; Puertas, Sara; Gutierrez, Lucia; Asin, Laura; Martinez de la Fuente, Jesus; Grazu, Valeria; Betancor, Lorena			Design of stable magnetic hybrid nanoparticles of Si-entrapped HRP	PLOS ONE			English	Article							HORSERADISH-PEROXIDASE; ENZYME; IMMOBILIZATION; STABILIZATION; ENCAPSULATION; BIOCATALYST; PROTEIN; POLYETHYLENEIMINE	Hybrid and composite nanoparticles represent an attractive material for enzyme integration due to possible synergic advantages of the structural builders in the properties of the nanobiocatalyst. In this study, we report the synthesis of a new stable hybrid nanobiocatalyst formed by biomimetic silica (Si) nanoparticles entrapping both Horseradish Peroxidase (HRP) (EC 1.11.1.7) and magnetic nanoparticles (MNPs). We have demonstrated that tailoring of the synthetic reagents and post immobilization treatments greatly impacted physical and biocatalytic properties such as an unprecedented similar to 280 times increase in the half-life time in thermal stability experiments. The optimized nanohybrid biocatalyst that showed superparamagnetic behaviour, was effective in the batch conversion of indole-3-acetic acid, a prodrug used in Direct Enzyme Prodrug Therapy (DEPT). Our system, that was not cytotoxic per se, showed enhanced cytotoxic activity in the presence of the prodrug towards HCT-116, a colorectal cancer cell line. The strategy developed proved to be effective in obtaining a stabilized nanobiocatalyst combining three different organic/inorganic materials with potential in DEPT and other biotechnological applications.	[Correa, Sonali; Betancor, Lorena] Univ ORT Uruguay, Lab Biotecnol, Montevideo, Uruguay; [Puertas, Sara] Nanoimmunotech SL, Zaragoza, Spain; [Gutierrez, Lucia] Univ Zaragoza, Inst Nanociencia Aragon, Campus Rio Ebro,Edificio I D, Zaragoza, Spain; [Gutierrez, Lucia; Martinez de la Fuente, Jesus; Grazu, Valeria] CSIC, ICMA, Zaragoza, Spain; [Gutierrez, Lucia; Asin, Laura; Martinez de la Fuente, Jesus; Grazu, Valeria] CIBER BBN, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Madrid, Spain	University ORT Uruguay; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Betancor, L (corresponding author), Univ ORT Uruguay, Lab Biotecnol, Montevideo, Uruguay.; Grazu, V (corresponding author), CSIC, ICMA, Zaragoza, Spain.; Grazu, V (corresponding author), CIBER BBN, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Madrid, Spain.	vgrazu@unizar.es; betancor@ort.edu.uy	de la Fuente, Jesus M/L-8361-2016; Betancor, Lorena/AAO-6710-2021; Gutierrez, Lucia/A-4305-2008; ASIN, LAURA/H-7276-2017	de la Fuente, Jesus M/0000-0003-1081-8482; Betancor, Lorena/0000-0002-0569-0499; Gutierrez, Lucia/0000-0003-2366-3598; ASIN, LAURA/0000-0003-0641-3407	ANII [POS_NAC_2015_1_109910]	ANII	SC is funded by ANII (POS_NAC_2015_1_109910).	BAHULEKAR R, 1991, ENZYME MICROB TECH, V13, P858, DOI 10.1016/0141-0229(91)90101-F; Berne C, 2006, BIOMACROMOLECULES, V7, P2631, DOI 10.1021/bm060166d; Betancor L, 2008, TRENDS BIOTECHNOL, V26, P566, DOI 10.1016/j.tibtech.2008.06.009; Betancor L, 2006, CHEM COMMUN, P3640, DOI 10.1039/b604689d; Betancor L, 2010, BIOTECHNOL GENET ENG, V27, P95, DOI 10.1080/02648725.2010.10648146; Bolivar JM, 2013, GREEN PROCESS SYNTH, V2, P541, DOI 10.1515/gps-2013-0091; Cao SL, 2014, J MATER CHEM B, V2, P5522, DOI 10.1039/c4tb00584h; Cazaban D, 2017, CURR ORG CHEM, V21, P96, DOI 10.2174/1385272821666161108103040; Chiu YR, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0829-1; Consolati T, 2018, ACS APPL MATER INTER, V10, P6858, DOI 10.1021/acsami.7b16639; Cui JD, 2015, APPL BIOCHEM BIOTECH, V176, P999, DOI 10.1007/s12010-015-1624-0; Fejerskov B, 2017, ADV DRUG DELIVER REV, V118, P24, DOI 10.1016/j.addr.2017.04.013; Guisan JM, 2013, METHODS MOL BIOL, V1051, P1, DOI 10.1007/978-1-62703-550-7_1; HENLEY JP, 1985, ENZYME MICROB TECH, V7, P50, DOI 10.1016/0141-0229(85)90013-4; Hyde EDER, 2016, IND ENG CHEM RES, V55, P8891, DOI 10.1021/acs.iecr.6b01839; Jackson E, 2016, PROCESS BIOCHEM, DOI [10.1016/j.procbio.2016.03.002, DOI 10.1016/J.PROCBIO.2016.03.002]; Jackson E, 2015, LANGMUIR, V31, P3687, DOI 10.1021/la504978r; Jiang YJ, 2014, ENZYME MICROB TECH, V55, P1, DOI 10.1016/j.enzmictec.2013.11.005; Johnson GR, 2017, METHODS MOL BIOL, V1504, P61, DOI 10.1007/978-1-4939-6499-4_6; Karthikeyan S, 2016, ENVIRON SCI TECHNOL, V50, P11193, DOI 10.1021/acs.est.6b03044; Krainer FW, 2015, APPL MICROBIOL BIOT, V99, P1611, DOI 10.1007/s00253-014-6346-7; Lechner CC, 2015, MAR DRUGS, V13, P5297, DOI 10.3390/md13085297; Liu J, 2015, CHEM COMMUN, V51, P13731, DOI 10.1039/c5cc04590h; Liu RR, 2016, APPL BIOCHEM BIOTECH, V178, P1612, DOI 10.1007/s12010-015-1971-x; Loncar N, 2015, APPL MICROBIOL BIOT, V99, P3351, DOI 10.1007/s00253-015-6512-6; Lopez-Gallego F, 2007, ENZYME MICROB TECH, V40, P278, DOI 10.1016/j.enzmictec.2006.04.021; Lungu CN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040555; Makizumi R, 2008, INT J CLIN EXP MED, V1, P117; Maximov V, 2009, J DRUG DELIV SCI TEC, V19, P311, DOI 10.1016/S1773-2247(09)50066-4; Nanayakkara S, 2014, ACS SUSTAIN CHEM ENG, V2, P1947, DOI 10.1021/sc500392k; Palomo JM, 2013, METHODS MOL BIOL, V1051, P255, DOI 10.1007/978-1-62703-550-7_17; Pavlovic M, 2018, J COLLOID INTERF SCI, V524, P114, DOI 10.1016/j.jcis.2018.04.007; Rakhi RB, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Tapias YAR, 2016, FOOD CHEM, V208, P252, DOI 10.1016/j.foodchem.2016.03.086; Ribeiro LMO, 2019, J POROUS MAT, V26, P77, DOI 10.1007/s10934-018-0615-2; Ritter DW, 2013, ENZYME MICROB TECH, V52, P279, DOI 10.1016/j.enzmictec.2013.01.004; Rodriguez F, 2004, BIOMACROMOLECULES, V5, P261, DOI 10.1021/bm034232c; Romero-Fernandez M, 2018, BIORESOURCE TECHNOL, V266, P249, DOI 10.1016/j.biortech.2018.06.070; Sahare P, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1605-4; Sahare P, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-409; Seo JH, 2007, TRANSDUCERS EUROSENS, DOI [10.1109/SENSOR.2007.4300488, DOI 10.1109/SENSOR.2007.4300488]; Sharma SK, 2017, ANAL BIOCHEM, V535, P1, DOI 10.1016/j.ab.2017.07.019; Sipponen MH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04715-6; Temocin Z, 2018, POLYM BULL, V75, P1843, DOI 10.1007/s00289-017-2129-5; Wang M, 2015, ACS NANO, V9, P10931, DOI 10.1021/acsnano.5b04073; Wu CZ, 2015, SOFT MATTER, V11, P972, DOI 10.1039/c4sm01746c; Zakharova GS, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1391, DOI 10.1134/S0006297911130037; Zamora P, 2009, BIOELECTROCHEMISTRY, V76, P100, DOI 10.1016/j.bioelechem.2009.05.006; Zdarta J, 2018, CATALYSTS, V8, DOI 10.3390/catal8020092	49	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214004	10.1371/journal.pone.0214004	http://dx.doi.org/10.1371/journal.pone.0214004			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933987	Green Published, gold			2022-12-27	WOS:000462867000009
J	Mai, V; Bertoletti, L; Cucherat, M; Jardel, S; Grange, C; Provencher, S; Lega, JC				Mai, Vicky; Bertoletti, Laurent; Cucherat, Michel; Jardel, Sabine; Grange, Claire; Provencher, Steeve; Lega, Jean-Christophe			Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis	PLOS ONE			English	Article							INTENSITY WARFARIN THERAPY; DIRECT ORAL ANTICOAGULANTS; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; 1ST EPISODE; ANTITHROMBOTIC THERAPY; DABIGATRAN ETEXILATE; ATRIAL-FIBRILLATION; SAFETY OUTCOMES; COST-UTILITY	Background Extended treatment is preconized in a significant proportion of patients with unprovoked venous thromboembolism (VTE). However, limited direct/indirect comparisons are available to appropriately weight the benefit/risk ratio of the diverse treatments available. We aimed to compare the rate of symptomatic recurrent VTE and major bleeding (MB), the net clinical benefit (VTE+MB) and death on vitamin-K antagonist (VKA), direct oral anticoagulants (DOAC) and antiplatelet drugs for extended anticoagulation. Methods A systematic literature search through September 2018 identified randomized trials studying these pharmacologic therapies for extended anticoagulation following VTE. Treatment effects were calculated using network meta-analysis with frequentist fixed-effects model. Results 18 trials (18,221 patients) were included in the analysis. All treatments reduced the risk of recurrence compared to placebo/observation. Nonetheless, VKA (RR 0.22; 95% CI 0.13-0.39) and DOAC (RRs ranging from 0.25-0.32; 95% CI ranging from 0.13-0.52) were more effective than aspirin, whereas low-dose VKA was less effective than standard-dose VKA (RR 2.47; 95% CI 1.34-4.55). The efficacy of DOAC was globally comparable to standard-adjusted dose VKA. Low- (RR 3.13; 95% CI 1.37-7.16) and standard-dose (RR 3.23; 95% CI 1.16-8.99) VKA also increased the risk of MB, which was not the case for any DOAC. Low-dose VKA and low-dose DOAC had similar effects on MB compared to standard-doses. Although there was a trend for reduced MB and enhanced net clinical benefit for DOAC compared to VKA, this was not statistically significant. The specific anticoagulant therapies had no significant effects on deaths. Conclusion Standard-dose VKA and low/standard-dose DOAC share similar effects on VTE recurrence and MB, whereas aspirin and low-dose VKA were associated with lower benefit/risk ratio.	[Mai, Vicky; Provencher, Steeve] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Ville De Quebec, PQ, Canada; [Bertoletti, Laurent] CHU St Etienne, Serv Med Vasc & Therapeut, St Etienne, France; [Bertoletti, Laurent; Grange, Claire] Univ Jean Monnet, SAINBIOSE, UMR 1059, St Etienne, France; [Bertoletti, Laurent] INSERM, CIC 1408, St Etienne, France; [Bertoletti, Laurent; Lega, Jean-Christophe] Hosp Civils Lyon, Grp Etud Multidisciplinaire Malad Thrombot GEMMAT, Lyon, France; [Cucherat, Michel; Jardel, Sabine; Grange, Claire; Lega, Jean-Christophe] Univ Lyon, CNRS, UMR 5558, Lab Biometr & Biol Evolut, Villeurbanne, France; [Cucherat, Michel] Hosp Civils Lyon, Serv Pharmacol & Toxicol, Lyon, France; [Jardel, Sabine; Lega, Jean-Christophe] Hosp Civils Lyon, Dept Med Interne & Vasc, Ctr Hosp Lyon Sud, Pierre Benite, France	Laval University; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; CHU Lyon; CHU Lyon	Provencher, S (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Ville De Quebec, PQ, Canada.; Lega, JC (corresponding author), Hosp Civils Lyon, Grp Etud Multidisciplinaire Malad Thrombot GEMMAT, Lyon, France.; Lega, JC (corresponding author), Univ Lyon, CNRS, UMR 5558, Lab Biometr & Biol Evolut, Villeurbanne, France.; Lega, JC (corresponding author), Hosp Civils Lyon, Dept Med Interne & Vasc, Ctr Hosp Lyon Sud, Pierre Benite, France.	steeve.provencher@criucpq.ulaval.ca; jean-christophe.lega@chu-lyon.fr	Bertoletti, Laurent/X-1319-2019; Mainbourg, Sabine/V-1225-2019	Bertoletti, Laurent/0000-0001-8214-3010; Mainbourg, Sabine/0000-0003-4564-2931; Mai, Vicky/0000-0001-6874-7109				Abraham NS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1857; Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Agnelli G, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0071-z; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Andreozzi GM, 2015, CIRCULATION, V132, P1891, DOI 10.1161/CIRCULATIONAHA.115.016930; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Bertoletti L, 2018, BLOOD REV, V32, P272, DOI 10.1016/j.blre.2018.01.002; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller HR, 2007, NEW ENGL J MED, V357, P1105; Castellucci LA, 2014, JAMA-J AM MED ASSOC, V312, P1122, DOI 10.1001/jama.2014.10538; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Chai-Adisaksopha C, 2014, BLOOD, V124, P2450, DOI 10.1182/blood-2014-07-590323; Cohen A, 2014, EUR HEART J, V35, P1064; Cohen AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144856; Couturaud F, 2015, JAMA-J AM MED ASSOC, V314, P31, DOI 10.1001/jama.2015.7046; Diken AI, 2018, PHLEBOLOGY, V33, P53, DOI 10.1177/0268355516688358; Eischer L, 2009, ANN HEMATOL, V88, P485, DOI 10.1007/s00277-008-0626-1; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Gomez-Outes A, 2015, J CARDIOVASC PHARM T, V20, P490, DOI 10.1177/1074248415575154; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2008, COCHRANE BOOK SERIES, Vxxi, DOI [10.1111/j.1365-2885.2004.00580.x, DOI 10.1111/J.1365-2885.2004.00580.X]; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Jugrin AV, 2016, J MED ECON, V19, P1, DOI 10.3111/13696998.2015.1078340; Jugrin AV, 2015, THROMB HAEMOSTASIS, V114, P778, DOI 10.1160/TH14-12-1027; Kaatz S, 2015, J THROMB HAEMOST, V13, P2119, DOI 10.1111/jth.13140; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kearon C, 2014, BLOOD, V123, P1794, DOI 10.1182/blood-2013-12-512681; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Laporte S, 2017, J THROMB HAEMOST, V15, P1547, DOI 10.1111/jth.13740; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Quon P, 2016, J MED ECON, V19, P557, DOI 10.3111/13696998.2016.1141780; Raskob GE, 2018, NEW ENGL J MED, V378, P615, DOI 10.1056/NEJMoa1711948; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Rucker G, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0060-8; Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Sobieraj DM, 2015, THROMB RES, V135, P888, DOI 10.1016/j.thromres.2015.02.032; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Sterne JAC, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21090; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tromeur C, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01202-2017; van Es N, 2014, BLOOD, V124, P1968, DOI [10.1182/blood-2014-04571232, 10.1182/blood-2014-04-571232]; Weitz JI, 2017, NEW ENGL J MED, V376, P1211, DOI 10.1056/NEJMoa1700518; Wells PS, 2018, J MED ECON, V21, P587, DOI 10.1080/13696998.2018.1444615	54	20	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214134	10.1371/journal.pone.0214134	http://dx.doi.org/10.1371/journal.pone.0214134			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933993	Green Submitted, gold, Green Published			2022-12-27	WOS:000462867000010
J	Sanzari, M; Ntouskos, V; Pirri, F				Sanzari, Marta; Ntouskos, Valsamis; Pirri, Fiora			Discovery and recognition of motion primitives in human activities	PLOS ONE			English	Article							AFFINE DIFFERENTIAL GEOMETRY; MOVEMENT PRIMITIVES; REPRESENTATION; MODELS	We present a novel framework for the automatic discovery and recognition of motion primitives in videos of human activities. Given the 3D pose of a human in a video, human motion primitives are discovered by optimizing the 'motion flux', a quantity which captures the motion variation of a group of skeletal joints. A normalization of the primitives is proposed in order to make them invariant with respect to a subject anatomical variations and data sampling rate. The discovered primitives are unknown and unlabeled and are unsupervisedly collected into classes via a hierarchical non-parametric Bayes mixture model. Once classes are determined and labeled they are further analyzed for establishing models for recognizing discovered primitives. Each primitive model is defined by a set of learned parameters. Given new video data and given the estimated pose of the subject appearing on the video, the motion is segmented into primitives, which are recognized with a probability given according to the parameters of the learned models. Using our framework we build a publicly available dataset of human motion primitives, using sequences taken from well-known motion capture datasets. We expect that our framework, by providing an objective way for discovering and categorizing human motion, will be a useful tool in numerous research fields including video analysis, human inspired motion generation, learning by demonstration, intuitive human-robot interaction, and human behavior analysis.	[Sanzari, Marta; Ntouskos, Valsamis; Pirri, Fiora] Univ Rome Sapienza, Alcor LAB, Dipartimento Ingn Informat Automat & Gest, Rome, Italy	Sapienza University Rome	Pirri, F (corresponding author), Univ Rome Sapienza, Alcor LAB, Dipartimento Ingn Informat Automat & Gest, Rome, Italy.	pirri@diag.uniroma1.it		Sanzari, Marta/0000-0002-4640-9122	EU [643950]	EU(European Commission)	This work is supported by the EU H2020 SecondHands project, url: https://secondhands.eu/; research and Innovation programme (call: H2020-ICT-2014-1, RIA) under grant agreement No 643950 (Recipient of funding F.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B., 2013, HUMAN KINETICS, DOI [10.1214/aos/1176342360, DOI 10.1214/AOS/1176342360]; Akhter I, 2015, PROC CVPR IEEE, P1446, DOI 10.1109/CVPR.2015.7298751; Alt H, 2000, HANDBOOK OF COMPUTATIONAL GEOMETRY, P121, DOI 10.1016/B978-044482537-7/50004-8; [Anonymous], 2015, REP; ANTONIAK CE, 1974, ANN STAT, V2, P1152, DOI 10.1214/aos/1176342871; Asfour T, 2006, IEEE-RAS INT C HUMAN, P40, DOI 10.1109/ICHR.2006.321361; Azad P, 2007, IEEE INT CONF ROBOT, P2558, DOI 10.1109/ROBOT.2007.363850; Ben Amor H, 2014, IEEE INT CONF ROBOT, P2831, DOI 10.1109/ICRA.2014.6907265; Ben Mabrouk A, 2018, EXPERT SYST APPL, V91, P480, DOI 10.1016/j.eswa.2017.09.029; Nievas EB, 2011, LECT NOTES COMPUT SC, V6855, P332, DOI 10.1007/978-3-642-23678-5_39; Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; Bizzi Emilio, 1995, P495; Bouchard D, 2007, SEMANTIC SEGMENTATIO, P37; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; Del Vecchio D, 2003, AUTOMATICA, V39, P2085, DOI 10.1016/S0005-1098(03)00250-4; Deniz O, 2014, PROCEEDINGS OF THE 2014 9TH INTERNATIONAL CONFERENCE ON COMPUTER VISION, THEORY AND APPLICATIONS (VISAPP 2014), VOL 2, P478; Endres D, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00068; Fanello SRF, 2010, LECT NOTES COMPUT SC, V6454, P616, DOI 10.1007/978-3-642-17274-8_60; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Fisher R, 2010, ANN OF THE BMVA, V4, P4; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; Flash T, 2007, BIOL CYBERN, V96, P577, DOI 10.1007/s00422-007-0145-5; Flash T, 2013, ROBOT AUTON SYST, V61, P330, DOI 10.1016/j.robot.2012.09.020; Gams A, 2016, ROBOT AUTON SYST, V75, P340, DOI 10.1016/j.robot.2015.09.011; Gao Y, 2016, IMAGE VISION COMPUT, V48-49, P37, DOI 10.1016/j.imavis.2016.01.006; Gates DH, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.015487; Ghanem B., 2017, ARXIV171008011; Gong D, 2014, IEEE T PATTERN ANAL, V36, P1414, DOI 10.1109/TPAMI.2013.244; Hamill J, 2006, BIOMECHANICAL BASIS; Hasan M., 2016, CVPR; Hassner T., 2012, P 2012 IEEE COMPUTER, P1, DOI DOI 10.1109/CVPRW.2012.6239348; Hogan N, 2012, BIOL CYBERN, V106, P727, DOI 10.1007/s00422-012-0527-1; Holte MB, 2010, COMPUT VIS IMAGE UND, V114, P1353, DOI 10.1016/j.cviu.2010.07.012; Ijspeert AJ, 2013, NEURAL COMPUT, V25, P328, DOI 10.1162/NECO_a_00393; Ionescu C, 2014, IEEE T PATTERN ANAL, V36, P1325, DOI 10.1109/TPAMI.2013.248; Jain S, 2004, J COMPUT GRAPH STAT, V13, P158, DOI 10.1198/1061860043001; Kanazawa A, 2018, IEEE C COMP VIS PATT; Kober J., 2009, PROC NEURAL INF PROC, P849; Kooij JFP, 2016, COMPUT VIS IMAGE UND, V144, P106, DOI 10.1016/j.cviu.2015.06.009; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Li Y, 2010, PROC CVPR IEEE, P2630, DOI 10.1109/CVPR.2010.5539977; Lillo I., 2016, CVPR; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Loper M, 2015, ACM T GRAPHIC, V34, DOI 10.1145/2816795.2818013; Loper M, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2661229.2661273; Lu C., 2013, ICCV; Lu CW, 2013, IEEE I CONF COMP VIS, P2720, DOI 10.1109/ICCV.2013.338; Lu JS, 2015, PROC CVPR IEEE, P3762, DOI 10.1109/CVPR.2015.7299000; Luo RK, 2015, IEEE INT C INT ROBOT, P2426, DOI 10.1109/IROS.2015.7353706; MAHADEVAN V, 2010, PROC CVPR IEEE, P1975, DOI DOI 10.1109/CVPR.2010.5539872; Mandery C, 2015, PROCEEDINGS OF THE 17TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS (ICAR), P329, DOI 10.1109/ICAR.2015.7251476; Maoz U, 2014, J NEUROPHYSIOL, V111, P336, DOI 10.1152/jn.01071.2012; MARR D, 1982, PROC R SOC SER B-BIO, V214, P501, DOI 10.1098/rspb.1982.0024; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mohammadi S, 2016, LECT NOTES COMPUT SC, V9911, P3, DOI 10.1007/978-3-319-46478-7_1; Mohammadi S, 2015, 2015 12TH INTERNATIONAL IRANIAN SOCIETY OF CRYPTOLOGY CONFERENCE ON INFORMATION SECURITY AND CRYPTOLOGY (ISCISC), P6, DOI 10.1109/ISCISC.2015.7387890; Moro Federico L, 2012, Front Neurorobot, V6, P10, DOI 10.3389/fnbot.2012.00010; Mousavi H, 2015, IEEE WINT CONF APPL, P148, DOI 10.1109/WACV.2015.27; Natola F, 2015, THESIS; Natola F, 2015, IEEE I CONF COMP VIS, P4606, DOI 10.1109/ICCV.2015.523; Ntouskos Valsamis, 2013, Proceedings of the 2nd International Conference on Pattern Recognition Applications and Methods. ICPRAM 2013, P87; Ntouskos V, 2015, ADV INTELL SYST, V318, P137, DOI 10.1007/978-3-319-12610-4_9; Park DH, 2008, IEEE-RAS INT C HUMAN, P91, DOI 10.1109/ICHR.2008.4755937; Pastor P., 2009, IEEE INT C ROB AUT, P763, DOI DOI 10.1109/ROBOT.2009.5152385; Pirri F, 2011, KNOWING REASONING AC; Platt JC, 2000, ADV NEUR IN, P61; Polyakov F, 2017, BIOL CYBERN, V111, P5, DOI 10.1007/s00422-016-0705-7; Sanzari M, 2016, LECT NOTES COMPUT SC, V9912, P566, DOI 10.1007/978-3-319-46484-8_34; Scholkopf B., 2001, LEARNING KERNELS; Gracia IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120448; Soomro K., 2012, UCF101 ACTION RECOGN; Sultani W., 2018, REAL WORLD ANOMALY D; Tekin B, 2016, PROC CVPR IEEE, pCP8, DOI 10.1109/CVPR.2016.113; Ting LH, 2015, NEURON, V86, P38, DOI 10.1016/j.neuron.2015.02.042; Tome Denis, 2017, CVPR 2017 P, P2500; Turaga P, 2008, IEEE T CIRC SYST VID, V18, P1473, DOI 10.1109/TCSVT.2008.2005594; Ureche ALP, 2015, IEEE T ROBOT; Vapnik V., 2013, NATURE STAT LEARNING; Varol Gul, 2017, 2017 IEEE C COMP VIS; VIVIANI P, 1995, J EXP PSYCHOL HUMAN, V21, P32, DOI 10.1037/0096-1523.21.1.32; Viviani P, 1991, J EXPT PSYCHOL HUMAN, V17; Weinland D, 2006, P IEEE C COMP VIS PA, P1639; West M., 1992, 92A03 ISDS DUK U; Xu L, 2014, INT CONF ACOUST SPEE; Yang Y, 2013, IEEE T PATTERN ANAL, V35, P1635, DOI 10.1109/TPAMI.2012.253; Zhou PP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203668; Zhou X., 2016, CVPR	88	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214499	10.1371/journal.pone.0214499	http://dx.doi.org/10.1371/journal.pone.0214499			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933990	Green Submitted, gold, Green Published			2022-12-27	WOS:000462867000017
J	Schmidt, MJ; Knemeyer, C; Heinsen, H				Schmidt, Martin J.; Knemeyer, Carola; Heinsen, Helmut			Neuroanatomy of the equine brain as revealed by high-field (3Tesla) magnetic-resonance-imaging	PLOS ONE			English	Article							CEREBRAL-CORTEX; HYDROCEPHALUS; MAMMALS; FOAL	In this study, the morphology of the horse brain (Equus caballus) is decribed in detail using high field MRI. The study includes sagittal, dorsal, and transverse T2-weighted images at 0.25 mm resolution at 3 Tesla and 3D models of the brain presenting the external morphology of the brain. Representative gallocyanin stained histological slides of the same brain are presented. The images represent a useful tool for MR image interpretation in horses and may serve as a starting point for further research aiming at in vivo analysis in this species.	[Schmidt, Martin J.; Knemeyer, Carola] Justus Liebig Univ, Small Anim Clin Neurosurg Neuroradiol & Clin Neur, Giessen, Germany; [Heinsen, Helmut] Univ Hosp, Mental Hlth Ctr, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Heinsen, Helmut] Univ Sao Paulo, Dept Pathol, Med Sch, Sao Paulo, Brazil	Justus Liebig University Giessen; University of Wurzburg; Universidade de Sao Paulo	Schmidt, MJ (corresponding author), Justus Liebig Univ, Small Anim Clin Neurosurg Neuroradiol & Clin Neur, Giessen, Germany.	Martin.J.Schmidt@vetmed.uni-giessen.de						Adrian ED, 1943, BRAIN, V66, P89, DOI 10.1093/brain/66.2.89; [Anonymous], 2012, NOM AN VET; Arencibia A, 2001, VET RADIOL ULTRASOUN, V42, P405, DOI 10.1111/j.1740-8261.2001.tb00959.x; Audigie F, 2004, VET RADIOL ULTRASOUN, V45, P210, DOI 10.1111/j.1740-8261.2004.04035.x; Back W., 2013, EQUINE LOCOMOTION, V2nd; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Becht K., 1987, THESIS; Bolk L., 1906, CEREBELLUM SAUGETIER; Bradley O C, 1899, J Anat Physiol, V33, P587; Brauer K, 1970, KATALOG SAUGETIERGEH, V2; Brettschneider H., 1955, Gegenbaurs Jahrbuch, V96, P265; Cavalleri JMV, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-105; Chaffin MK, 1997, VET RADIOL ULTRASOUN, V38, P102, DOI 10.1111/j.1740-8261.1997.tb00823.x; Chukwuezie CI, 2008, THESIS, P49; Constantinescu M, 1992, ILLUSTRATED VET ANAT; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; De Zani D, 2013, EQUINE VET EDUC, V25, P493, DOI 10.1111/eve.12003; DONE JT, 1968, RES VET SCI, V9, P143; Done JT, 1986, LAB ANIM, V2, P207; Dyson PK, 2007, EQUINE VET EDUC, V19, P173, DOI 10.2746/095777307X190771; Edinger T., EVOLUTION HORSE BRAI; Ellenberger W., 1977, HDB VERGLEICHENDEN A, V18; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Ferrell EA, 2002, VET RADIOL ULTRASOUN, V43, P510, DOI 10.1111/j.1740-8261.2002.tb01041.x; Forel A., 1877, ARCH F R PSYCHIATR N, V7, P393, DOI [10.1007/BF02041873, DOI 10.1007/BF02041873]; Heinsen H, 2000, J CHEM NEUROANAT, V20, P49, DOI 10.1016/S0891-0618(00)00067-3; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; Holmes SP, 2014, EQUINE VET EDUC, V26, P605, DOI 10.1111/eve.12039; Hummel G, 1976, Zentralbl Veterinarmed C, V5, P35; Jost K., 1992, THESIS; Kuhlenbeck H., 1927, VORLESUNGEN ZENTRALN; Lassek AM, 1942, J COMP NEUROL, V77, P399, DOI 10.1002/cne.900770205; Manso-Diaz G, 2015, VET RADIOL ULTRASOUN, V56, P176, DOI 10.1111/vru.12210; Maulet BEB, 2008, EQUINE VET EDUC, V20, P74, DOI 10.2746/095777308X273787; McGann JP, 2017, SCIENCE, V356, DOI 10.1126/science.aam7263; Nickel R, 1992, LEHRBUCH ANATOMIE HA, VIV; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Niimi K., 1950, COMP ANATOMICAL STUD; Nitzsche B, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00069; Oey L, 2011, TIERAERZTL PRAX G N, V39, P41; Pillay P, 2007, EUR J NEUROSCI, V25, P2705, DOI 10.1111/j.1460-9568.2007.05524.x; Pongratz MC, 2010, PFERDEHEILKUNDE, V26, P559, DOI 10.21836/PEM20100410; Porter EG, 2014, VET CLIN N AM-EQUINE, V30, P239, DOI 10.1016/j.cveq.2013.11.001; Russo D, 2008, ACTA HISTOCHEM, V110, P245, DOI 10.1016/j.acthis.2007.10.015; Sakamoto K., 1957, REPORTS 2 SECTION AN; Sanders SG, 2001, VET RADIOL ULTRASOUN, V42, P291, DOI 10.1111/j.1740-8261.2001.tb00942.x; Schellenberg K., 1900, THESIS; Schmidt M., 2006, THESIS; Schmidt MJ, 2009, J MORPHOL, V270, P745, DOI 10.1002/jmor.10717; Schmidt MJ, 2011, VET J; Schober W., 1974, Handbuch der Zoologie, V8, P1; SCHULZ L. -C., 1953, ANAT ANZ, V100, P65; Staudacher A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0216-5; STEPHAN H, 1983, NEUROSCI BIOBEHAV R, V7, P367, DOI 10.1016/0149-7634(83)90041-6; Takeuchi Tamaki, 2001, Acta Anatomica Nipponica, V76, P213; Tucker RL, 2001, VET CLIN N AM-EQUINE, V17, P131, DOI 10.1016/S0749-0739(17)30079-2; VOOGD J, 1998, CENTRAL NERVOUS SYST, P1724; WOOLSEY CN, 1946, SURGERY, V19, P684; Yoshikawa T., 1968, ATLAS BRAIN DOMESTIC	59	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0213814	10.1371/journal.pone.0213814	http://dx.doi.org/10.1371/journal.pone.0213814			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933986	Green Submitted, Green Published, gold			2022-12-27	WOS:000462867000007
J	Bhandari, R; Pokhrel, KN; Gabrielle, N; Amatya, A				Bhandari, Rajan; Pokhrel, Khem Narayan; Gabrielle, Nguyen; Amatya, Archana			Long acting reversible contraception use and associated factors among married women of reproductive age in Nepal	PLOS ONE			English	Article								Modern contraceptives are highly effective and proven means of preventing unintended pregnancy and reducing maternal mortality. Social and economic characteristics are some of the key determinants of health and utilization family planning. However, studies examining the factors associated with utilization of long acting reversible contraception (LARC) are limited in Nepal. This study assessed the factors associated with utilization of LARC methods among married women of reproductive age in Nepal. Secondary data analysis was conducted using the 2016 Nepal Demographic and Health Survey (NDHS). A logistic regression model examined the association of socioeconomic, demographic, or fertility related characteristics with the use of LARCs among 9875 ever married women of reproductive age. The overall utilization rate of LARC in this study was 4.7%. Women in the age group of <25 years (AOR: 0.65, 95% CI: 0.45-0.92) and 25-35 years (AOR: 0.70, 95% CI: 0.56-0.89), having husbands with primary education (AOR:0.71; 95%CI: 0.64-0.84) and no education (AOR: 0.54; 95%CI: 0.38-0.73), belonging to Janajatis (AOR: 0.55; 95%CI: 0.42-0.71) and Newars (AOR: 0.29; 95%CI: 0.19-42), poor wealth quintile (AOR: 0.60; 95% CI: 0.45-0.86) had negative association with LARC use. On the other hand, women having their husband as a skilled worker (AOR: 1.49; 95%CI: 1.10-2), having two or less than two children (AOR: 1.46; 95% CI: 1.15-1.186), and having desire for children in future (AOR: 3.24; 95% CI: 2.29-4.57) had positive association with the use of LARC. In this study, younger women's age, low or no husband's education, from indigenous community such as Janajati and Newer, being in lowest wealth quintile negatively influenced the use of LARC. Conversely, women having her husband as skilled worker, parity less than two, and desire of having future children, positively influenced the use of LARC. The study highlights the need to reach women who were in the lower socioeconomic background to improve LARC use.	[Bhandari, Rajan] GHAN, Kathmandu, Nepal; [Pokhrel, Khem Narayan] Georgetown Univ, Inst Reprod Hlth, Airport Gate Area, Kathmandu, Nepal; [Gabrielle, Nguyen] Save Children, Washington, DC USA; [Amatya, Archana] Tribhuvan Univ, Dept Community Med & Publ Hlth, Inst Med, Kathmandu, Nepal	Save the Children; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Bhandari, R (corresponding author), GHAN, Kathmandu, Nepal.	rjbhandari11@gmail.com	pokhrel, khem/AAT-6102-2021	pokhrel, khem/0000-0001-6956-1672				Abdisa B, 2017, ANAT PHYSL, V07, P2, DOI [10.4172/2161-0940.1000254, DOI 10.4172/2161-0940.1000254]; ACOG Committee, 2018, OBS GYNECOL, V131, P130; Azmoude E, 2017, WOOMENS HLTH B, V4; Bagade O., 2014, WORLD J PHARM PHARM, V3, P364; Baldwin MK, 2013, J ADOLESCENT HEALTH, V52, pS47, DOI 10.1016/j.jadohealth.2012.10.278; Biza N, 2017, LONG ACTING REVERSIB, V4, P469; Budihastuti UR, 2014, E JAVA APPL SOCIAL C, V1172, P313; Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1; Dempsey AR, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.014; Desta SA., 2017, SCIENCE, V5, P428, DOI [10.11648/j.sjph.20170506.14, DOI 10.11648/J.SJPH.20170506.14]; Dockalova BLK, 2016, SUSTAINABLE DEV GOAL; Earsido A., 2015, J PREG CHILD HLTH, V2, P165; Frost JJ, 2008, PERSPECT SEX REPRO H, V40, P94, DOI 10.1363/4009408; Getinet S., 2014, GREENER J EPIDEMIOL, V2, P23, DOI [10.15580/GJEPH.2014.1.070514294, DOI 10.15580/GJEPH.2014.1.070514294]; Gudaynhe SW, 2014, GLOB J MED RES, V14; Gultie T, 2016, QUAL PRIM CARE, V24, P17; ICF International, 2012, MEASURE DHS, P41; Johnson OE, 2017, AFR J REPROD HEALTH, V21, P89, DOI 10.29063/ajrh2017/v21i3.8; Lotke PS, 2015, OBSTET GYN CLIN N AM, V42, P557, DOI 10.1016/j.ogc.2015.07.008; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Ministry of Health and Population, 2015, NAT FAM PLANN COST I, V39, P90; Ministry of Health and Population (MoHP), 2015, NEP HLTH SECT STRAT, P75; Ministry of Health Nepal; New ERA; and ICF, 2017, NEP DEM HLTH SURV 20; Ministry of Health (Nepal) New Era Macro International, 1996, NEP DEM HLTH SURV; Mishra MK, 2011, ETHNIC DISPARITIES C, V6, P14; Mustafa R, 2008, JCPSP-J COLL PHYSICI, V18, P542, DOI 09.2008/JCPSP.542545; Rose SB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.06.102; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Sharma SK, 2011, DEMOGR RES, V25, P837, DOI 10.4054/DemRes.2011.25.27; Melka AS, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.246.5835; Tamang L, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-017-0040-y; Tekelab T., 2015, FAM MED MED SCI RES, V4, P2, DOI [10.4172/2327-4972.1000158, DOI 10.4172/2327-4972.1000158]; Tibaijuka L, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0382-2; Townsend JW, 2007, CONTRACEPTION, V75, pS35, DOI 10.1016/j.contraception.2007.01.023; Wasti S P, 2017, Kathmandu Univ Med J (KUMJ), V15, P222; World Health Organisation, 2007, REP WHO TECHN CONS B, P34; World Health Organization, 2018, INT SOC BEH CHANG CO; Yalew Saleamlak Adbaru, 2015, BMC Res Notes, V8, P29, DOI 10.1186/s13104-015-0974-6	38	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214590	10.1371/journal.pone.0214590	http://dx.doi.org/10.1371/journal.pone.0214590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921403	gold, Green Published, Green Submitted			2022-12-27	WOS:000462594000092
J	Zhou, D; Eliasy, A; Abass, A; Markov, P; Whitford, C; Boote, C; Movchan, A; Movchan, N; Elsheikh, A				Zhou, Dong; Eliasy, Ashkan; Abass, Ahmed; Markov, Petar; Whitford, Charles; Boote, Craig; Movchan, Alexander; Movchan, Natalia; Elsheikh, Ahmed			Analysis of X-ray scattering microstructure data for implementation in numerical simulations of ocular biomechanical behaviour	PLOS ONE			English	Article							HUMAN CORNEAL STROMA; COLLAGEN ORIENTATION; MODEL; ORGANIZATION; DIFFRACTION; ANISOTROPY; FIBRILS	This study aimed to analyse microstructure data on the density and orientation of collagen fibrils in whole eye globes and to propose an effective method for the preparation of data for use in numerical simulations of the eye's biomechanical performance. Wide-angle X-ray scattering was applied to seven healthy ex-vivo human eyes. Each eye was dissected into an anterior and a posterior cup, and radial incisions were used to flatten the tissue before microstructure characterisation. A method was developed to use the microstructure data obtained for the dissected tissue to build realistic 3D maps of fibril density and orientation covering the whole eye globe. At the central cornea, 61.5 +/- 2.3% of fibrils were aligned within 45 degrees sectors surrounding the two orthogonal directions. In contrast, more than one-third of the total fibril content was concentrated along the circumferential direction at the limbus (37.0 +/- 2.4%) and around the optic nerve head (34.8 +/- 2.1%). The insertion locations of the four recti muscles exhibited a preference in the meridional direction near the equator (38.6 +/- 3.9%). There was also a significant difference in fibril density between the limbus and other regions (ratio = 1.91 +/- 0.45, p < 0.01 at the central cornea and ratio = 0.80 +/- 0.21, p < 0.01 at the posterior pole). Characterisation of collagen fibril density and orientation across the whole ocular surface has been possible but required the use of a technique that involved tissue dissection and hence caused tissue damage. The method presented in this paper aimed to minimise the effect of dissection on the quality of obtained data and was successful in identifying fibril distribution trends that were compatible with earlier studies, which concentrated on localised areas of the ocular globe.	[Zhou, Dong; Eliasy, Ashkan; Abass, Ahmed; Elsheikh, Ahmed] Univ Liverpool, Sch Engn, Liverpool, Merseyside, England; [Markov, Petar; Boote, Craig] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Whitford, Charles] Mfg Technol Ctr, Liverpool, Merseyside, England; [Movchan, Alexander; Movchan, Natalia] Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England; [Elsheikh, Ahmed] Moorfields Eye Hosp Natl Hlth Serv Fdn Trust, Biomed Res Ctr Ophthalmol, Natl Inst Hlth Res, London, England; [Elsheikh, Ahmed] UCL, Inst Ophthalmol, London, England; [Elsheikh, Ahmed] Beihang Univ, Sch Biol Sci & Biomed Engn, Beijing, Peoples R China	University of Liverpool; Cardiff University; University of Liverpool; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Beihang University	Zhou, D (corresponding author), Univ Liverpool, Sch Engn, Liverpool, Merseyside, England.	sgdzhou3@student.liverpool.ac.uk	Elsheikh, Ahmed/AAT-1476-2020; Eliasy, Ashkan/AAF-4941-2019; Abass, Ahmed/S-3107-2019	Elsheikh, Ahmed/0000-0001-7456-1749; Eliasy, Ashkan/0000-0002-4473-1900; Abass, Ahmed/0000-0002-8622-4632; Markov, Petar/0000-0002-0306-5868	Engineering and Physical Sciences Research Council (EPSRC); EPSRC [1805086, EP/N014499/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was partly supported by the UK's Science and Technology Facilities Council (STFC) who provided beam times at the Diamond Research Centre and the Engineering and Physical Sciences Research Council (EPSRC) which provided a PhD studentship for Petar Markov at Cardiff University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abahussin M, 2009, INVEST OPHTH VIS SCI, V50, P5159, DOI 10.1167/iovs.09-3669; Abass A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0717; Aghamohammadzadeh H, 2004, STRUCTURE, V12, P249, DOI 10.1016/j.str.2004.01.002; [Anonymous], 2006, J BIOMECHANICAL ENG, V128, P150; Benoit A, 2016, J MECH BEHAV BIOMED, V60, P93, DOI 10.1016/j.jmbbm.2015.12.031; Bjorck A., 1996, NUMERICAL METHODS LE; Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Boote C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068166; Bryant MR, 1996, J BIOMECH ENG-T ASME, V118, P473, DOI 10.1115/1.2796033; Daxer A, 1997, INVEST OPHTH VIS SCI, V38, P121; Elsheikh A, 2010, EYE VIS RES DEV, P1; Elsheikh A, 2008, J REFRACT SURG, V24, P178, DOI 10.3928/1081597X-20080201-09; Elsheikh Ahmed, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P85, DOI 10.1080/10255840600976013; Everitt B. S., 2006, CAMBRIDGE DICT STAT; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113682; Grytz R, 2014, J MECH BEHAV BIOMED, V29, P602, DOI 10.1016/j.jmbbm.2013.03.027; Grytz R, 2011, BIOMECH MODEL MECHAN, V10, P371, DOI 10.1007/s10237-010-0240-8; Grytz R, 2010, BIOMECH MODEL MECHAN, V9, P225, DOI 10.1007/s10237-009-0173-2; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Jogi R., 2016, BASIC OPHTHALMOLOGY; Mashige KP, 2013, AFR VIS EYE HEALTH J, V72, P185; Meek K. M., 2008, P359, DOI 10.1007/978-0-387-73906-9_13; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; Meek KM, 2001, MICRON, V32, P261, DOI 10.1016/S0968-4328(00)00041-X; Meek KM, 2005, INVEST OPHTH VIS SCI, V46, P1948, DOI 10.1167/iovs.04-1253; MEEK KM, 1987, CURR EYE RES, V6, P841, DOI 10.3109/02713688709034853; Nejad TM, 2014, ARQ BRAS OFTALMOL, V77, P60, DOI 10.5935/0004-2749.20140016; Pandolfi A, 2006, BIOMECH MODEL MECHAN, V5, P237, DOI 10.1007/s10237-005-0014-x; Pandolfi A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2982251; Pijanka JK, 2012, INVEST OPHTH VIS SCI, V53, P5258, DOI 10.1167/iovs.12-9705; Pijanka JK, 2013, J APPL CRYSTALLOGR, V46, P1481, DOI 10.1107/S0021889813022358; Pinsky PM, 2005, J CATARACT REFR SURG, V31, P136, DOI 10.1016/j.jcrs.2004.10.048; Pinsky PM, 1991, J BIOMECH, V24; Shen J, 1997, INTELLIGENT SYSTEMS; SHENG YL, 1994, J OPT SOC AM A, V11, P1748, DOI 10.1364/JOSAA.11.001748; Smith G., 1997, EYE VISUAL OPTICAL I; Smith M., 2020, ABAQUSSTANDARD USERS; Studer H, 2010, J BIOMECH, V43, P836, DOI 10.1016/j.jbiomech.2009.11.021; Whitford C, 2014, CHINESE J OPTOMETRY, V16, P257; Whitford C, 2015, J MECH BEHAV BIOMED, V42, P76, DOI 10.1016/j.jmbbm.2014.11.006; Zernike F, 1934, PHYSICA, V1, P689	45	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214770	10.1371/journal.pone.0214770	http://dx.doi.org/10.1371/journal.pone.0214770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934028	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000462867000040
J	Bosu, WK; Reilly, ST; Aheto, JMK; Zucchelli, E				Bosu, William Kofi; Reilly, Siobhan Theresa; Aheto, Justice Moses Kwaku; Zucchelli, Eugenio			Hypertension in older adults in Africa: A systematic review and meta-analysis	PLOS ONE			English	Review							SUB-SAHARAN AFRICA; RISK-FACTORS; BLOOD-PRESSURE; AGED 50; PREVALENCE; AWARENESS; PEOPLE; HEALTH; DEMENTIA; URBAN	Background Hypertension is the leading driver of cardiovascular disease deaths in Africa. Its prevalence is highest in older populations. Yet, this group has received little attention in many African countries. We conducted a systematic review and meta-analysis (PROSPERO registration: CRD42017056474) to estimate the prevalence of hypertension in older adults living in Africa. Methods We searched grey literature and major electronic databases including PubMed and Embase for population-based studies and published between 1 January 1980 to 28 May 2018 reporting the prevalence of hypertension for adults aged >= 50 years living in Africa. We employed a random effects model to estimate the pooled prevalence across included studies. Findings We screened 10,719 articles and retrieved 103 full-text articles to evaluate for inclusion in the review. Thirty-four unique studies providing 37 data points on 43,025 individuals in 15 African countries were analyzed. The prevalence of hypertension ranged from 22.3% to 90.0% from the individual studies while the overall pooled prevalence was 57.0% (95% CI 52%-61%). The prevalence was not statistically significantly different by sex, residence, or African sub-region. In individual studies, older age and overweight/obesity were independently associated with hypertension. Twenty-nine (78%) data points were deemed to be of low-or moderate-risk of bias. Eliminating high-risk bias studies made little difference to the pooled estimate of hypertension. Sensitivity analyses, omitting one study at a time, identified three studies with significant but relatively small impact on the pooled estimate. We observed substantial heterogeneity (I-2 = 98.9%) across the studies which was further explored by meta-regression analyses. Overall, the GRADE assessment suggested moderate quality evidence in the results. Conclusion The persistent high prevalence of hypertension among older adults in Africa, even in rural populations warrants more attention to the cardiovascular health of this group by public health authorities.	[Bosu, William Kofi] West African Hlth Org, Dept Publ Hlth & Res, Bobo Dioulasso, Burkina Faso; [Bosu, William Kofi; Reilly, Siobhan Theresa; Zucchelli, Eugenio] Univ Lancaster, Fac Hlth & Med, Div Hlth Res, Lancaster, England; [Aheto, Justice Moses Kwaku] Univ Ghana, Sch Publ Hlth, Dept Biostat, Legon, Accra, Ghana	Lancaster University; University of Ghana	Bosu, WK (corresponding author), West African Hlth Org, Dept Publ Hlth & Res, Bobo Dioulasso, Burkina Faso.; Bosu, WK (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Hlth Res, Lancaster, England.	billybosu@gmail.com	Aheto, Justice Moses K./H-8890-2019; Zucchelli, Eugenio/Z-4871-2019	Aheto, Justice Moses K./0000-0003-1384-2461; Zucchelli, Eugenio/0000-0003-3883-5006; Reilly, Siobhan Theresa/0000-0003-4372-4415				Abegunde KA, 2013, ANN AFR MED, V12, P90, DOI 10.4103/1596-3519.112398; Aboderin I, 2010, PUBLIC HEALTH REV, V32, P357, DOI 10.1007/BF03391607; Aboyade OM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1378-4; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Addo J, 2006, ETHNIC DIS, V16, P894; Adeloye D, 2015, J HYPERTENS, V33, P230, DOI 10.1097/HJH.0000000000000413; Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300; Akinyemi RO, 2019, BRAIN RES BULL, V145, P97, DOI 10.1016/j.brainresbull.2018.05.018; Amugsi DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26991-4; Amugsi DA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017344; [Anonymous], 2002, Aging Male, V5, P1; Apt NA, 2012, AGEING INT, V37, P93, DOI 10.1007/s12126-011-9138-8; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Awuah RB, 2014, J HYPERTENS, V32, P1203, DOI 10.1097/HJH.0000000000000165; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Boateng GO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186947; Bosu WK, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0585-5; Bosu WK, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/3192149; Bosu WK, 2015, P NUTR SOC, V74, P466, DOI 10.1017/S0029665114001669; Bosu WK, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26227; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Callender T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001699; Chami MA, 2015, MED MALADIES METABOL, V9, P210, DOI [10.1016/S1957-2557%2815%2930046-8, DOI 10.1016/S1957-2557%2815%2930046-8]; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Debpuur C, 2010, GLOBAL HEALTH ACTION, V3, P54, DOI 10.3402/gha.v3i0.2151; Dewhurst MJ, 2013, J HUM HYPERTENS, V27, P374, DOI 10.1038/jhh.2012.59; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Duboz P, 2015, Bull Soc Pathol Exot, V108, P25, DOI 10.1007/s13149-014-0397-y; Duda RB, 2011, J CROSS-CULT GERONTO, V26, P299, DOI 10.1007/s10823-011-9148-8; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El Tallawy HN, 2012, NEUROEPIDEMIOLOGY, V38, P130, DOI 10.1159/000335655; El-Tallawy HN, 2013, CLIN NEUROL NEUROSUR, V115, P1792, DOI 10.1016/j.clineuro.2013.04.014; Etyang AO, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19090; Ezejimofor M, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010420; Fajemilehin BR, 2005, AFR J NURS MIDWIFERY, V7, P17; Gray WK, 2016, ARCH GERONTOL GERIAT, V62, P36, DOI 10.1016/j.archger.2015.10.008; Guerchet M, 2012, J ALZHEIMERS DIS, V29, P15, DOI 10.3233/JAD-2011-111364; Hammami S, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-65; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Hien H, 2014, TROP MED INT HEALTH, V19, P1328, DOI 10.1111/tmi.12377; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Ice GH, 2008, J CROSS-CULT GERONTO, V23, P111, DOI 10.1007/s10823-008-9063-9; Iorio A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h870; Iribhogbe I, 2013, INT J COMMUNITY RES, V2, P22; Ivy A, 2015, J CLIN HYPERTENS, V17, P389, DOI 10.1111/jch.12501; Kamoun M, 2006, REV GERIATR, V31, P477; Kaze AD, 2017, J HYPERTENS, V35, P1345, DOI 10.1097/HJH.0000000000001345; Kinyanda E, 2016, AIDS CARE, V28, P1516, DOI 10.1080/09540121.2016.1191601; Koopman JJE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046855; Laouani Kechrid Chadia, 2004, Tunis Med, V82, P1001; Lasisi AO, 2010, OTOLARYNG HEAD NECK, V143, P510, DOI 10.1016/j.otohns.2010.06.817; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lloyd-Sherlock P, 2017, EUR J DEV RES, V29, P827, DOI 10.1057/s41287-016-0063-2; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Macia E, 2012, CARDIOVASC J AFR, V23, P265, DOI 10.5830/CVJA-2011-039; Macia E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161544; Mathenge W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-569; MDS Project Team, 2002, PROP WORK DEF OLD PE; Minicuci N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.21292; Mkhize XN, 2011, SITUATION ANAL FREE; Mkhize X, 2013, HEALTH SA GESONDHEID, V18, DOI 10.4102/hsag.v18i1.656; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Mugisha JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078394; Ndabarora E, 2018, KIBOGORA POLYTECHNIC, V1, P11; Nuertey Benjamin D, 2017, BMC Obes, V4, P26, DOI 10.1186/s40608-017-0162-4; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Ochayi B, 2006, AGING MENT HEALTH, V10, P616, DOI 10.1080/13607860600736182; Ogunniyi A, 2011, ACTA NEUROL SCAND, V124, P396, DOI 10.1111/j.1600-0404.2011.01491.x; Okeahialam B N, 2012, West Afr J Med, V31, P14; Okpechi IG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073403; Osman A-Q, 2017, THESIS; Paddick SM, 2015, AM J GERIAT PSYCHIAT, V23, P950, DOI 10.1016/j.jagp.2014.12.005; Peltzer K, 2013, CARDIOVASC J AFR, V24, P66, DOI 10.5830/CVJA-2013-002; Phaswana-Mafuya N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20680; Pilleron S, 2017, J AM SOC HYPERTENS, V11, P449, DOI 10.1016/j.jash.2017.04.013; Putnam HWI, 2018, J CLIN HYPERTENS, V20, P217, DOI 10.1111/jch.13187; Raji Yemi Raheem, 2017, Pan Afr Med J, V27, P190, DOI 10.11604/pamj.2017.27.190.11682; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Scholten F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-886; Schutte AE, 2017, J HUM HYPERTENS, V31, P491, DOI 10.1038/jhh.2017.18; StataCorp, 2015, STAT SOFTW REL 14; Tianyi FL, 2018, HEALTH SCI REP-US, V1, DOI 10.1002/hsr2.44; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Tyrovolas S, 2015, ATHEROSCLEROSIS, V238, P240, DOI 10.1016/j.atherosclerosis.2014.11.029; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Veritas Health Innovation, 2018, COV SYST REV SOFTW; Villareal DT, 2006, AM J CLIN NUTR, V84, P1317, DOI 10.1093/ajcn/84.6.1317; WHO, 2016, WHO STEPS SURV MANUA; World Health Organization, 2016, A6939 WHO; Yerly P, 2013, CARDIOVASC J AFR, V24, P17, DOI 10.5830/CVJA-2012-070; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	96	49	49	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2019	14	4							e0214934	10.1371/journal.pone.0214934	http://dx.doi.org/10.1371/journal.pone.0214934			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR9NM	30951534	Green Published, gold, Green Submitted			2022-12-27	WOS:000463487500021
J	Llewellyn-Beardsley, J; Rennick-Egglestone, S; Callard, F; Crawford, P; Farkas, M; Hui, A; Manley, D; McGranahan, R; Pollock, K; Ramsay, A; Saelor, KT; Wright, N; Slade, M				Llewellyn-Beardsley, Joy; Rennick-Egglestone, Stefan; Callard, Felicity; Crawford, Paul; Farkas, Marianne; Hui, Ada; Manley, David; McGranahan, Rose; Pollock, Kristian; Ramsay, Amy; Saelor, Knut Tore; Wright, Nicola; Slade, Mike			Characteristics of mental health recovery narratives: Systematic review and narrative synthesis	PLOS ONE			English	Review							POSTTRAUMATIC GROWTH; ANOREXIA-NERVOSA; IDENTITY; SELF; PEOPLE; SCHIZOPHRENIA; STORIES; LIFE; INTERVENTIONS; INDIVIDUALS	Background Narratives of recovery from mental health distress have played a central role in the establishment of the recovery paradigm within mental health policy and practice. As use of recovery narratives increases within services, it is critical to understand how they have been characterised, and what may be missing from their characterisation thus far. The aim of this review was to synthesise published typologies in order to develop a conceptual framework characterising mental health recovery narratives. Method A systematic review was conducted of published literature on the characteristics of mental health recovery narratives. Narrative synthesis involved identifying characteristics and organising them into dimensions and types; and subgroup analysis based on study quality, narrator involvement in analysis, diagnosis of psychosis and experience of trauma. The synthesis was informed by consultation with a Lived Experience Advisory Panel and an academic panel. The review protocol was pre-registered (Prospero CRD42018090188). Results 8951 titles, 366 abstracts and 121 full-text articles published January 2000-July 2018 were screened, of which 45 studies analysing 629 recovery narratives were included. A conceptual framework of mental health recovery narratives was developed, comprising nine dimensions (Genre; Positioning; Emotional Tone; Relationship with Recovery; Trajectory; Use of Turning Points; Narrative Sequence; Protagonists; and Use of Metaphors), each containing between two and six types. Subgroup analysis indicated all dimensions were present across most subgroups, with Turning Points particularly evident in trauma-related studies. Conclusions Recovery narratives are diverse and multidimensional. They may be non-linear and reject coherence. To a greater extent than illness narratives, they incorporate social, political and rights aspects. Approaches to supporting development of recovery narratives should expand rather than reduce available choices. Research into the narratives of more diverse populations is needed. The review supports trauma-informed approaches, and highlights the need to understand and support post-traumatic growth for people experiencing mental health issues.	[Llewellyn-Beardsley, Joy; Rennick-Egglestone, Stefan; Crawford, Paul; Hui, Ada; Wright, Nicola; Slade, Mike] Univ Nottingham, Inst Mental Hlth, Sch Hlth Sci, Nottingham, England; [Callard, Felicity] Birkbeck Univ, Dept Psychosocial Studies, London, England; [Farkas, Marianne] Boston Univ, Coll Hlth & Rehabil Sci, Boston, MA 02215 USA; [Manley, David] Nottinghamshire Healthcare NHS Fdn Trust, Nottingham, England; [McGranahan, Rose] Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, Blizard Inst, London, England; [Pollock, Kristian] Univ Nottingham, Sch Hlth Sci, Nottingham, England; [Ramsay, Amy] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England; [Saelor, Knut Tore] Univ South Eastern Norway, Fac Hlth & Social Sci, Dept Hlth Social & Welf Studies, Ctr Mental Hlth & Subst Abuse, Kongsberg, Norway	University of Nottingham; University of London; Birkbeck University London; Boston University; University of London; Queen Mary University London; University of Nottingham; University of London; King's College London; University College of Southeast Norway	Llewellyn-Beardsley, J (corresponding author), Univ Nottingham, Inst Mental Hlth, Sch Hlth Sci, Nottingham, England.	joy.llewellyn-beardsley@nottingham.ac.uk	Pollock, Kristian/B-9734-2008; Callard, Felicity/AEP-9676-2022	Pollock, Kristian/0000-0002-6836-8595; Callard, Felicity/0000-0002-5350-1963; Rennick-Egglestone, Stefan/0000-0003-4187-011X; Llewellyn-Beardsley, Joy/0000-0003-0525-6358; Wright, Nicola/0000-0002-0747-8977	NIHR under its Programme Grants for Applied Research Programme [RP-PG-0615-20016]; Center for Mental Health and Substance Abuse, University of South-Eastern Norway; NIHR Nottingham Biomedical Research Centre; ESRC [ES/S002588/1] Funding Source: UKRI	NIHR under its Programme Grants for Applied Research Programme; Center for Mental Health and Substance Abuse, University of South-Eastern Norway; NIHR Nottingham Biomedical Research Centre; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This article is independent research funded by the NIHR under its Programme Grants for Applied Research Programme (Personal experience as a recovery resource in psychosis: Narrative Experiences ONline (NEON) Programme, RP-PG-0615-20016). Mike Slade acknowledges the support of Center for Mental Health and Substance Abuse, University of South-Eastern Norway and the NIHR Nottingham Biomedical Research Centre. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Adame AL., 2006, THESIS; Adame AL, 2008, J HUMANIST PSYCHOL, V48, P142, DOI 10.1177/0022167807305544; Adame AL, 2007, NARRAT INQ, V17, P157, DOI 10.1075/ni.17.2.02ada; Adichie ChimamandaNgozi, 2009, DANGER SINGLE STORY; Anderson BA., 2010, THESIS; Anderson KM, 2007, FAM SOC, V88, P637, DOI 10.1606/1044-3894.3686; [Anonymous], 2006, HUMANIST PSYCHOL, DOI [DOI 10.1207/S15473333THP3402_3, 10.1207/s15473333thp3402_3]; Anthony W. A., 1993, PSYCHOSOC REHABIL J, V16, P11, DOI DOI 10.1037/H0095655; Bal M., 2009, NARRATOLOGY INTRO TH; Baldwin C, 2005, AUST NZ J PSYCHIAT, V39, P1022, DOI 10.1111/j.1440-1614.2005.01721.x; Bamberg M, 2008, TEXT TALK, V28, P377, DOI 10.1515/TEXT.2008.018; Banyard VL, 2007, CHILD ABUSE NEGLECT, V31, P275, DOI 10.1016/j.chiabu.2006.02.016; Barnett H., 2006, JOURNEYS DESPAIR JOU; Basset Thurstine, 2005, Ment Health Today, P16; Beiza G, 2015, RES PSYCHOTHERAPY PS, V18; Bluffield S., 2006, THESIS; Brawn P., 2015, J NEW WRITING HLTH S, V2, P30; Brown W., 2007, REPORT NARRATIVE INV; Brown W, 2008, SOC ALTERN, V27, P42; Buhagiar JPM., 2013, THESIS; Butler A, 2016, WORLDV EVID-BASED NU, V13, P241, DOI 10.1111/wvn.12134; Calhoun L.G., 2014, HDB POSTTRAUMATIC GR, DOI [10.4324/9781315805597, DOI 10.4324/9781315805597]; Carless D., 2008, QUALITATIVE RES PSYC, V5, P233, DOI DOI 10.1080/14780880701826101; Carless D, 2008, PSYCHOL SPORT EXERC, V9, P576, DOI 10.1016/j.psychsport.2007.08.002; Cohen BMZ, 2008, MENTAL HEALTH USER NARRATIVES: NEW PERSPECTIVES ON ILLNESS AND RECOVERY, P1, DOI 10.1057/9780230593961; Cooke A, 2014, UNDERSTANDING PSYCHO; Crawford R., 2004, STORYTELLING THERAPY; Cronise R, 2016, PSYCHIATR REHABIL J, V39, P211, DOI 10.1037/prj0000222; Crossley M.L., 2000, INTRO NARRATIVE PSYC; Daley A., 2013, MAD MATTERS CRITICAL, P298; Davidson Larry, 2011, ROOTS RECOVERY MOVEM; de Jager A, 2016, QUAL HEALTH RES, V26, P1409, DOI 10.1177/1049732315581602; Deegan P, 1996, PSYCHIATR REHABIL J, V19, P91, DOI 10.1037/h0101301; Deegan P.E., 1988, PSYCHOSOC REHABIL, V11, P11, DOI [10.1037/h0099565, DOI 10.1037/H0099565]; Department of Health, 2014, CLOS GAP PRIOR ESS C; DiClemente CC, 1998, APPL CLIN PSYCHOL TR; Eli K, 2016, ANTHROPOL MED, V23, P71, DOI 10.1080/13648470.2015.1135786; Ezzy D, 2000, SOC SCI MED, V50, P605, DOI 10.1016/S0277-9536(99)00306-8; Fisher P, 2016, HEALTH-LONDON, V20, P599, DOI 10.1177/1363459315600774; Forrest R., 2014, MENT HLTH PRACT, V17, P29; Frank AW., 2010, LETTING STORIES BREA; Frank AW., 2013, WOUNDED STORYTELLER; Frazier P, 2009, PSYCHOL SCI, V20, P912, DOI 10.1111/j.1467-9280.2009.02381.x; Galderisi S, 2015, WORLD PSYCHIATRY, V14, P231, DOI 10.1002/wps.20231; Garrett CJ, 1996, SOC SCI MED, V43, P1489, DOI 10.1016/0277-9536(96)00088-3; Garrett CJ, 1997, INT J EAT DISORDER, V21, P261, DOI 10.1002/(SICI)1098-108X(199704)21:3<261::AID-EAT6>3.3.CO;2-X; Georgaca E., 2017, ANN REV CRITICAL PSY, V13, P1; GERGEN KJ, 1990, J MIND BEHAV, V11, P353; Goffman E., 1959, PRESENTATION SELF EV; Grant A, 2015, J PSYCHIATR MENT HLT, V22, P278, DOI 10.1111/jpm.12188; Grinter DJ, 2012, THESIS; Grover A, A65255 UN GEN ASS, P32; Hall JM, 2011, QUAL HEALTH RES, V21, P3, DOI 10.1177/1049732310377181; Haroz EE, 2017, SOC SCI MED, V183, P151, DOI 10.1016/j.socscimed.2016.12.030; Harvey MR, 2000, NARRAT INQ, V10, P291, DOI 10.1075/ni.10.2.02har; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Howard J, 2006, SOC PSYCHOL QUART, V69, P307, DOI 10.1177/019027250606900402; Ibarra H, 2010, ACAD MANAGE REV, V35, P135, DOI 10.5465/AMR.2010.45577925; Jabareen Y, 2009, INT J QUAL METH, V8, P49, DOI DOI 10.1177/160940690900800406; Jacobson N, 2001, PSYCHIATR REHABIL J, V24, P248, DOI 10.1037/h0095087; Jayawickreme E, 2014, EUR J PERSONALITY, V28, P312, DOI 10.1002/per.1963; Jennings H, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1794-8; Johnstone L., 2018, POWER THREAT MEANING; Kirkpatrick H, 2009, J PSYCHIATR MENT HLT, V16, P68, DOI 10.1111/j.1365-2850.2008.01331.x; Kleinman A., 1988, ILLNESS NARRATIVES; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Kumagai AK, 2009, ADV HEALTH SCI EDUC, V14, P315, DOI 10.1007/s10459-008-9123-5; LaMarre A, 2014, THESIS; Lapsley H., 2002, KIA MAURI TAU NARRAT; Leamy M, 2011, BRIT J PSYCHIAT, V199, P445, DOI 10.1192/bjp.bp.110.083733; Longden E, 2016, EPIDEMIOL PSYCH SCI, V25, P349, DOI 10.1017/S204579601500044X; Lysaker P.H., 2017, RECOVERY MEANING MAK; Lysaker P, 2009, PSYCHOSIS, V1, P113, DOI 10.1080/17522430902948175; Lysaker PH, 2001, PSYCHOTHERAPY, V38, P252, DOI 10.1037/0033-3204.38.3.252; Lysaker PH, 2002, THEOR PSYCHOL, V12, P207, DOI 10.1177/0959354302012002630; Manley DS., 2015, THESIS; Matusek JA, 2009, QUAL HEALTH RES, V19, P697, DOI 10.1177/1049732309334077; McAdams D.P., 2001, TURNS ROAD NARRATIVE, P3, DOI [10.1037/10410-001, DOI 10.1037/10410-000]; McAdams D. P., 2013, REDEMPTIVE SELF STOR; McCarthy C, 2014, THESIS; McEvoy PM, 2009, J COGN PSYCHOTHER, V23, P20, DOI 10.1891/0889-8391.23.1.20; McKeown J, 2006, J ADV NURS, V55, P237, DOI 10.1111/j.1365-2648.2006.03897.x; McLeod J., 1997, NARRATIVE PSYCHOTHER, DOI DOI 10.4135/9781849209489; McNamee Sheila, 1992, THERAPY SOCIAL CONST; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moran GS, 2012, QUAL HEALTH RES, V22, P304, DOI 10.1177/1049732311420578; Morrison Linda J., 2013, TALKING BACK PSYCHIA; Moulding NT, 2016, AFFILIA J WOM SOC WO, V31, P70, DOI 10.1177/0886109915576519; Nurser KP, 2018, MENT HEALTH REV J, V23, P25, DOI 10.1108/MHRJ-08-2017-0034; O'Brien K, 2014, THESIS; O'Connor C, 2018, SOC SCI MED, V212, P94, DOI 10.1016/j.socscimed.2018.07.011; Onken SJ, 2007, PSYCHIATR REHABIL J, V31, P9, DOI 10.2975/31.1.2007.9.22; Pals JL, 2004, PSYCHOL INQ, V15, P65; Petticrew M, 2013, J CLIN EPIDEMIOL, V66, P1230, DOI 10.1016/j.jclinepi.2013.06.005; Phare J., 2003, NARRATIVES PEOPLES E; Plummer K., 2002, TELLING SEXUAL STORI; Pluye P., 2011, PROPOSAL MIXED METHO; Polkinghorne D.E., 1988, NARRATIVE KNOWING HU; Popay J., 2006, PRODUCT ESRC METHODS, DOI DOI 10.13140/2.1.1018.4643; Rennick-Egglestone S, 2019, CANADIAN J PSYCHIAT; Repper J., 2003, SOCIAL INCLUSION REC; Rhodes P, 2014, CLIN PSYCHOL-UK, V18, P99, DOI 10.1111/cp.12021; Ridgway P, 2001, PSYCHIATR REHABIL J, V24, P335, DOI 10.1037/h0095071; Riessman CK, 2015, SOCIOL HEALTH ILL, V37, P1055, DOI 10.1111/1467-9566.12281; Riessman Catherine Kohler, 2007, NARRATIVE METHODS HU; Ross LE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201437; Russo J., 2016, SEARCHING ROSE GARDE; Saavedra J, 2009, QUAL HEALTH RES, V19, P1548, DOI 10.1177/1049732309351110; SAMHSA, SHAR YOUR STOR GUID; Saxena S, 2015, COMPREHENSIVE MENTAL; Schrank B, 2012, SOC SCI MED, V74, P554, DOI 10.1016/j.socscimed.2011.11.008; Shohet M, 2007, ETHOS, V35, P344, DOI 10.1525/ETH.2007.35.3.344; Shohet M, 2018, TRANSCULT PSYCHIATRY, V55, P495, DOI 10.1177/1363461517722467; Slade M, 2018, PERSONAL GROWTH PSYC; Slade M, 2019, WORLD PSYCHIATRY, V18, P29, DOI 10.1002/wps.20585; Slade M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0678-4; Slade M, 2014, WORLD PSYCHIATRY, V13, P12, DOI 10.1002/wps.20084; Smith B, 2009, PSYCHOL SPORT EXERC, V10, P1, DOI 10.1016/j.psychsport.2008.01.004; Smith-Merry J, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-11; Spector-Mersel G, 2018, J MENT HEALTH, V27, P298, DOI 10.1080/09638237.2017.1340607; Stone B, 2004, AUTOBIOGRAPHY, V12, P16, DOI [10.1191/0967550704ab002oa, DOI 10.1191/0967550704AB002OA]; Stott A, 2018, ADV DUAL DIAGN, V11, P16, DOI 10.1108/ADD-08-2017-0012; Sullivan PW, 2017, J PSYCHOSOCIAL REHAB, V4, P221, DOI DOI 10.1007/S40737-017-0097-6; Sutton-Brown CA, 2014, PHOTOGR CULT, V7, P169, DOI 10.2752/175145214X13999922103165; Swift TL, 2005, PATIENT EDUC COUNS, V57, P115, DOI 10.1016/j.pec.2004.05.004; Taylor S., 2014, INT PRACTICE DEV J, V4, P1, DOI DOI 10.19043/IPDJ.41.005; Thomas SP, 2008, QUAL HEALTH RES, V18, P149, DOI 10.1177/1049732307312201; Thompson RB, 2003, THESIS; Thorne A, 2003, AUTOBIOGRAPHICAL MEMORY AND THE CONSTRUCTION OF A NARRATIVE SELF: DEVELOPMENTAL AND CULTURAL PERSPECTIVES, P169; Thornhill Hermione, 2004, Anthropol Med, V11, P181, DOI 10.1080/13648470410001678677; Toth C., 2014, J COMP RES ANTHR SOC, V5, P153; Vander Kooij C., 2009, CAN J MUSIC THER, V15, P37; White M., 1990, NARRATIVE MEANS THER; Williams CC, 2015, BRIT J SOC WORK, V45, P9, DOI 10.1093/bjsw/bcv100; Woods A, 2011, MED HUMANIT, V37, P73, DOI 10.1136/medhum-2011-010045; Yael Elran-Barak RL, 2012, TREATMENT RECOVERY E; Zussman R, 2000, QUALITATIVE SOCIOLOG, V23, P5, DOI DOI 10.1023/A:1005447331522	137	75	76	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214678	10.1371/journal.pone.0214678	http://dx.doi.org/10.1371/journal.pone.0214678			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921432	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000462594000107
J	Zeiberg, D; Prahlad, T; Nallamothu, BK; Iwashyna, TJ; Wiens, J; Sjoding, MW				Zeiberg, Daniel; Prahlad, Tejas; Nallamothu, Brahmajee K.; Iwashyna, Theodore J.; Wiens, Jenna; Sjoding, Michael W.			Machine learning for patient risk stratification for acute respiratory distress syndrome	PLOS ONE			English	Article							INJURY PREDICTION SCORE	Background Existing prediction models for acute respiratory distress syndrome (ARDS) require manual chart abstraction and have only fair performance-limiting their suitability for driving clinical interventions. We sought to develop a machine learning approach for the prediction of ARDS that (a) leverages electronic health record (EHR) data, (b) is fully automated, and (c) can be applied at clinically relevant time points throughout a patient's stay. Methods and Findings We trained a risk stratification model for ARDS using a cohort of 1,621 patients with moderate hypoxia from a single center in 2016, of which 51 patients developed ARDS. We tested the model in a temporally distinct cohort of 1,122 patients from 2017, of which 27 patients developed ARDS. Gold standard diagnosis of ARDS was made by intensive care trained physicians during retrospective chart review. We considered both linear and non-linear approaches to learning the model. The best model used L2-logistic regression with 984 features extracted from the EHR. For patients observed in the hospital at least six hours who then developed moderate hypoxia, the model achieved an area under the receiver operating characteristics curve (AUROC) of 0.81 (95% CI: 0.73-0.88). Selecting a threshold based on the 85th percentile of risk, the model had a sensitivity of 56% (95% CI: 35%, 74%), specificity of 86% (95% CI: 85%, 87%) and positive predictive value of 9% (95% CI: 5%, 14%), identifying a population at four times higher risk for ARDS than other patients with moderate hypoxia and 17 times the risk of hospitalized adults. Conclusions We developed an ARDS prediction model based on EHR data with good discriminative performance. Our results demonstrate the feasibility of a machine learning approach to risk stratifying patients for ARDS solely from data extracted automatically from the EHR.	[Zeiberg, Daniel; Prahlad, Tejas; Wiens, Jenna] Univ Michigan, Comp Sci & Engn, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Iwashyna, Theodore J.; Sjoding, Michael W.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Iwashyna, Theodore J.; Sjoding, Michael W.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Iwashyna, Theodore J.] US Dept Vet Affairs, VA Ctr Clin Management Res, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.; Iwashyna, Theodore J.; Wiens, Jenna; Sjoding, Michael W.] Univ Michigan, Michigan Integrated Ctr Hlth Analyt & Med Predict, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Sjoding, Michael W.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sjoding, MW (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Sjoding, MW (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.; Sjoding, MW (corresponding author), Univ Michigan, Michigan Integrated Ctr Hlth Analyt & Med Predict, Ann Arbor, MI 48109 USA.; Sjoding, MW (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	msjoding@umich.edu		Zeiberg, Daniel/0000-0002-6919-7572	NHLBI [K01HL136687]; VA HSRD IIR [17-045]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL136687] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA HSRD IIR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to Dr. Sjoding from the NHLBI K01HL136687 and Dr. Nallamothu from the Michigan Institute for Data Science (http://midas.umich.edu/).Additional funding from VA HSR&D IIR 17-045 to Brahmajee K. Nallamothu and Theodore J. Iwashyna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Brown SM, 2017, CRIT CARE MED, V45, P1317, DOI 10.1097/CCM.0000000000002514; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; de Haro C, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-11; Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC; Guestrin, 2016, P 22 ACM SIGKDD INT; Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306; Herasevich V, 2009, INTENS CARE MED, V35, P1018, DOI 10.1007/s00134-009-1460-1; Janz DR, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0086-3; Kor DJ, 2016, JAMA-J AM MED ASSOC, V315, P2406, DOI 10.1001/jama.2016.6330; Levitt JE, 2013, CRIT CARE MED, V41, P1929, DOI 10.1097/CCM.0b013e31828a3d99; Oh J, 2018, INFECT CONT HOSP EP, V39, P425, DOI 10.1017/ice.2018.16; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Sjoding MW, 2018, CHEST, V153, P361, DOI 10.1016/j.chest.2017.11.037; Sjoding MW, 2016, CRIT CARE MED, V44, P1611, DOI 10.1097/CCM.0000000000001771; Soto GJ, 2016, CRIT CARE MED, V44, P2182, DOI 10.1097/CCM.0000000000002001; Summers C, 2016, THORAX, V71, P1050, DOI 10.1136/thoraxjnl-2016-208402; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Wang JX, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2417, DOI 10.1145/3219819.3220070; Weiss CH, 2016, CRIT CARE MED, V44, P1515, DOI 10.1097/CCM.0000000000001710; Wetzel R., 2017, LEARNING DIAGNOSE LS; Yadav H, 2017, AM J RESP CRIT CARE, V195, P725, DOI 10.1164/rccm.201609-1767CI; Yadav H, 2015, AM J PHYSIOL-LUNG C, V309, pL915, DOI 10.1152/ajplung.00266.2015	24	32	32	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214465	10.1371/journal.pone.0214465	http://dx.doi.org/10.1371/journal.pone.0214465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921400	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000073
J	Muktar, M; Roba, KT; Mengistie, B; Gebremichael, B; Tessema, AB; Kebede, MW				Muktar, Muzemil; Roba, Kedir Teji; Mengistie, Bezatu; Gebremichael, Berhe; Tessema, Adamu Belay; Kebede, Meseret Woldeyohannes			Goiter and its associated factors among primary school children aged 6-12 years in Anchar district, Eastern Ethiopia	PLOS ONE			English	Article							IODINE DEFICIENCY; PREVALENCE	Background Goiter is a major public health problem in Ethiopia. Even though there were studies done on goiter in Ethiopia, there was little evidence in the eastern part of the country. Therefore, the aim of this study was to assess the prevalence of goiter and its associated factors among school-age children in Anchar district of Eastern Ethiopia. Methods A school based cross-sectional study was conducted from February 13 to 30, 2017. Multistage sampling method was used to select 418 children aged 6-12 years. Data were collected using a questionnaire. Children were examined for the presence or absence of goiter based on the criteria of the World Health Organization (WHO). Salt samples were tested using a rapid test kit. Data were entered to EpiData version 3.1 and exported to SPSS version 22.0 for analysis. Bivariate and multivariate logistic regression models were fitted; Crude Odds Ratio (COR) and Adjusted Odds Ratio (AOR) with 95% Confidence Interval (CI) were computed. Level of significance was determined at p-value less than 0.05. Results The total goiter prevalence rate was 51.8% (CI: 46.9%, 56.8%). Father's education (AOR = 1.87, CI: 1.06, 3.30), type of salt used (AOR = 2.09, CI: 1.13, 3.88), iodine level of salt (AOR = 2.77, CI: 1.11, 6.89), frequency of milk consumption (AOR = 3.65, CI: 1.63, 8.20), frequency of cabbage consumption (AOR = 7.74, CI: 4.48, 13.39), eating status of eggs (AOR = 3.16, CI: 1.54, 6.50), and eating status of dark green vegetables/fruits (AOR = 2.14, CI: 1.17, 3.93) were factors associated with goiter among school-age children. CONCLUSION The total goiter prevalence rate was very high. Therefore, the health and education sectors of the study area should work hand in hand to improve the awareness of the community about goiter, iodized salt and iodine rich foods.	[Muktar, Muzemil] West Hararge Zone Hlth Off, Chiro, Ethiopia; [Roba, Kedir Teji] Haramaya Univ, Sch Nursing & Midwifery, Harar, Ethiopia; [Mengistie, Bezatu] Haramaya Univ, Dept Environm Hlth Sci, Harar, Ethiopia; [Gebremichael, Berhe] Haramaya Univ, Sch Publ Hlth, Harar, Ethiopia; [Tessema, Adamu Belay; Kebede, Meseret Woldeyohannes] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia	Haramaya University; Haramaya University; Haramaya University	Gebremichael, B (corresponding author), Haramaya Univ, Sch Publ Hlth, Harar, Ethiopia.	berhegere09@gmail.com	Gebremichael, Berhe/W-2874-2019	Gebremichael, Berhe/0000-0002-0669-8521; ROBA, KEDIR TEJI/0000-0001-6227-9594				Abebe Z, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3914-z; Abuye C, 2007, FOOD NUTR BULL, V28, P391, DOI 10.1177/156482650702800403; Andersson M, 2004, IODINE STATUS WORLDW; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 1989, STORY IODINE DEFICIE; Assey VD, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-319; Bailey RL, 2015, ANN NUTR METAB, V66, P22, DOI 10.1159/000371618; Chandra AK., 2016, BLDE U J HLTH SCI, V1, P33, DOI [10.4103/2456-1975.183283, DOI 10.4103/2456-1975]; Deresse Legesse Kebede, 2015, Journal of Nutrition and Food Sciences, V5, P368; Elnour A, 2000, AM J CLIN NUTR, V71, P59; Enyew HD, 2015, INT J NUTR FOOD SCI, V4, P381, DOI DOI 10.11648/J.IJNFS.20150403.26; EPHI, 2016, ETH NAT MICR SURV RE; Federal Democratic Republic of Ethiopia. Central Statistical Agency (CSA); ICF, 2017, ETH DEM HLTH SURV 20; Gebriel TW., 2014, J PREG CHILD HLTH, V1, P2; Hemchandra L., 2015, INT J MED HLTH SCI, V4; Hibstu D. T., 2017, CURR PEDIAT RES, V21, P620; Jacob K., 2015, J COMMUNITY HLTH, V27; Jahangir M, 2015, ACTA ENDOCRINOL-BUCH, V11, P337, DOI 10.4183/aeb.2015.337; Kebede A., 2014, AFRICAN J FOOD AGR N, V14; Khan SMS, 2017, ANN MED HEALTH SCI R, V7, P102; Kibatu G., 2012, ETHIOP J HLTH SCI, V23; Mesele M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-130; Mezgebu Y., 2012, PREVALENCE SEVERITY; Misra S, 2007, INDIAN J MED RES, V126, P475; Pearce EN, 2013, THYROID, V23, P523, DOI 10.1089/thy.2013.0128; Sadou H., 2011, OPEN NUTR J, V8, P8; Shawel D, 2010, J HEALTH POPUL NUTR, V28, P238; Singh Madhu B., 2010, Journal of Human Ecology, V32, P79; Tigabu E, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017055; Urvashi Mehlawat, 2015, World Journal of Pharmaceutical Research, V4, P1281; WHO, 2013, GLOB DAT IOD DEF DIS; WHO. UNICEF. and ICCIDD, 2001, ASS IOD DEF DIS MON; WHO/UNICEF/ICCIDD, 2007, ASS IOD DEF DIS MON; Wolka E, 2014, FOOD NUTR BULL, V35, P20, DOI 10.1177/156482651403500103; Zali MRMK., 1994, IRANIAN J MED ASS, V13, P113; Zimmermann MB, 2003, AM J CLIN NUTR, V77, P1453, DOI 10.1093/ajcn/77.6.1453; Zimmermann MB, 2013, ENDOCR PRACT, V19, P839, DOI 10.4158/EP13180.RA; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	38	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214927	10.1371/journal.pone.0214927	http://dx.doi.org/10.1371/journal.pone.0214927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30947246	Green Published, gold, Green Submitted			2022-12-27	WOS:000463314500086
J	Zhang, Y; Chen, JN; Wang, Y; Wang, DH; Cong, WH; Lai, BS; Zhao, Y				Zhang, Yang; Chen, Jiannan; Wang, Yu; Wang, Dehua; Cong, Weihui; Lai, Bo Shiun; Zhao, Yi			Multilayer network analysis of miRNA and protein expression profiles in breast cancer patients	PLOS ONE			English	Article							CELL-PROLIFERATION; INVASION; OVEREXPRESSION; PROGRESSION; INVASIVENESS; SIGNATURES; REGULATOR; MIGRATION; PATHWAYS; TARGETS	MiRNAs and proteins play important roles in different stages of breast tumor development and serve as biomarkers for the early diagnosis of breast cancer. A new algorithm that combines machine learning algorithms and multilayer complex network analysis is hereby proposed to explore the potential diagnostic values of miRNAs and proteins. XGBoost and random forest algorithms were employed to screen the most important miRNAs and proteins. Maximal information coefficient was applied to assess intralayer and interlayer connection. A multilayer complex network was constructed to identify miRNAs and proteins that could serve as biomarkers for breast cancer. Proteins and miRNAs that are nodes in the network were subsequently categorized into two network layers considering their distinct functions. The betweenness centrality was used as the first measurement of the importance of the nodes within each single layer. The degree of the nodes was chosen as the second measurement to map their signalling pathways. By combining these two measurements into one score and comparing the difference of the same candidate between normal tissue and cancer tissue, this novel multilayer network analysis could be applied to successfully identify molecules associated with breast cancer.	[Zhang, Yang; Chen, Jiannan; Wang, Yu; Wang, Dehua; Cong, Weihui; Zhao, Yi] Harbin Inst Technol Shenzhen, Shenzhen, Guangdong, Peoples R China; [Lai, Bo Shiun] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Harbin Institute of Technology; Johns Hopkins University	Zhao, Y (corresponding author), Harbin Inst Technol Shenzhen, Shenzhen, Guangdong, Peoples R China.	zhao.yi@hit.edu.cn	Zhang, Yang/AAK-8021-2021; Zhao, Yi/AAX-3232-2020	Zhang, Yang/0000-0002-3503-5161; chen, jiannan/0000-0002-6816-7056	National Natural Nature Science Foundation of China [61573119]; Fundamental Research Project of Shenzhen [JCYJ20170307150444573, JCYJ20180306172131515, JCYJ201703071513122153, JCYJ20150625142543468]	National Natural Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Project of Shenzhen	The project is supported by the National Natural Nature Science Foundation of China under Project No. 61573119 to Y Zhao and a Fundamental Research Project of Shenzhen under Project Nos. JCYJ20170307150444573 to Y Zhang, JCYJ20180306172131515 to Y Zhang, JCYJ201703071513122153 to Y Zhao, and JCYJ20150625142543468 to Y Zhao.	Azoulay-Alfaguter I, 2015, ONCOGENE, V34, P4613, DOI 10.1038/onc.2014.390; Biau G, 2016, TEST-SPAIN, V25, P197, DOI 10.1007/s11749-016-0481-7; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Bosch A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4442; Boulay PL, 2016, CANCER RES, V76, P2662, DOI 10.1158/0008-5472.CAN-15-2782; Cai J, 2013, J CLIN INVEST, V123, DOI [10.1007/s10549-011-1604-1, DOI 10.1007/S10549-011-1604-1]; Cantini L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17386; Chang CH, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0257-3; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chu A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv808; De Domenico M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7868; Escudero-Esparza A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-43; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gasparini P, 2014, P NATL ACAD SCI USA, V111, P4536, DOI 10.1073/pnas.1402604111; Hardy SD, INVESTIGATING ROLE S; Hong YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep37421; Hsieh TH, 2012, FASEB J, V26, P778, DOI 10.1096/fj.11-191742; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Joly MM, 2016, CANCER RES, V76, P4752, DOI 10.1158/0008-5472.CAN-15-3393; Karousou E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/606458; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Kholoussi NM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249372; Kinoshita T, 2013, BRIT J CANCER, V109, P2636, DOI 10.1038/bjc.2013.607; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Knezevic J, 2015, ONCOGENE, V34, P5997, DOI 10.1038/onc.2015.48; Krishnan K, 2013, RNA, V19, P1767, DOI 10.1261/rna.042143.113; Lee JH, 2010, CANCER RES; Leung MKK, 2016, P IEEE, V104, P176, DOI 10.1109/JPROC.2015.2494198; Li M, 2015, INT J ONCOL, V47, P296, DOI 10.3892/ijo.2015.3015; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Lin WH, 2016, BIOMED PHARMACOTHER, V83, P177, DOI 10.1016/j.biopha.2016.06.011; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Macedo T, 2017, ONCOL LETT, V14, P1054, DOI 10.3892/ol.2017.6265; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Rai A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41676; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Ricketts CJ, 2018, CELL REP, V23, P313, DOI [10.1016/j.celrep.2018.03.075, 10.1016/j.celrep.2018.06.032]; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Taipaleenmaki H, 2015, CANCER RES, V75, P1433, DOI 10.1158/0008-5472.CAN-14-1026; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Viera AJ, 2005, FAM MED, V37, P360; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang J., 2016, SCI REP-UK, V6, P1, DOI [DOI 10.1038/SREP27327, 10.1038/s41598-016-0001-8]; Wisniewski JR, 2011, J PROTEOME RES, V10, P3040, DOI 10.1021/pr200019m; Wu BL, 2003, BIOINFORMATICS, V19, P1636, DOI 10.1093/bioinformatics/btg210; Xie FY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185565; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Zhang JG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08087	58	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0202311	10.1371/journal.pone.0202311	http://dx.doi.org/10.1371/journal.pone.0202311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946749	Green Submitted, Green Published, gold			2022-12-27	WOS:000463314500001
J	Gordon, DG; Zelaya, A; Arganda-Carreras, I; Arganda, S; Traniello, JFA				Gordon, Darcy Greer; Zelaya, Alejandra; Arganda-Carreras, Ignacio; Arganda, Sara; Traniello, James F. A.			Division of labor and brain evolution in insect societies: Neurobiology of extreme specialization in the turtle ant Cephalotes varians	PLOS ONE			English	Article							MUSHROOM BODY CALYX; SYNAPTIC ORGANIZATION; ZACRYPTOCERUS-VARIANS; VISUAL EXPERIENCE; CASTE DIFFERENCES; PLASTICITY; BODIES; HONEYBEE; PERFORMANCE; MORPHOLOGY	Strongly polyphenic social insects provide excellent models to examine the neurobiological basis of division of labor. Turtle ants, Cephalotes varians, have distinct minor worker, soldier, and reproductive (gyne/queen) morphologies associated with their behavioral profiles: small-bodied task-generalist minors lack the phragmotic shield-shaped heads of soldiers, which are specialized to block and guard the nest entrance. Gynes found new colonies and during early stages of colony growth overlap behaviorally with soldiers. Here we describe patterns of brain structure and synaptic organization associated with division of labor in C. varians minor workers, soldiers, and gynes. We quantified brain volumes, determined scaling relationships among brain regions, and quantified the density and size of microglomeruli, synaptic complexes in the mushroom body calyxes important to higher-order processing abilities that may underpin behavioral performance. We found that brain volume was significantly larger in gynes; minor workers and soldiers had similar brain sizes. Consistent with their larger behavioral repertoire, minors had disproportionately larger mushroom bodies than soldiers and gynes. Soldiers and gynes had larger optic lobes, which may be important for flight and navigation in gynes, but serve different functions in soldiers. Microglomeruli were larger and less dense in minor workers; soldiers and gynes did not differ. Correspondence in brain structure despite differences in soldiers and gyne behavior may reflect developmental integration, suggesting that neurobiological metrics not only advance our understanding of brain evolution in social insects, but may also help resolve questions of the origin of novel castes.	[Gordon, Darcy Greer; Zelaya, Alejandra; Arganda, Sara; Traniello, James F. A.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Arganda-Carreras, Ignacio] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Arganda-Carreras, Ignacio] Univ Basque Country, Dept Comp Sci & Artificial Intelligence, San Sebastian, Spain; [Arganda-Carreras, Ignacio] DIPC, San Sebastian, Spain; [Arganda, Sara] Univ Rey Juan Carlos, Dept Biol & Geologia Fis & Quim Inorgan, Area Biodiversidad & Conservac, Madrid, Spain; [Traniello, James F. A.] Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA	Boston University; Basque Foundation for Science; University of Basque Country; Universidad Rey Juan Carlos; Boston University	Gordon, DG (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	dggordon@bu.edu	Carreras, Sara Arganda/B-2200-2017; Arganda-Carreras, Ignacio/L-4605-2014	Carreras, Sara Arganda/0000-0002-9875-2379; Arganda-Carreras, Ignacio/0000-0003-0229-5722	National Science Foundation [IOS 1354291]; Marie Sklodowska-Curie Individual Fellowship; European Union [660976]	National Science Foundation(National Science Foundation (NSF)); Marie Sklodowska-Curie Individual Fellowship; European Union(European Commission)	This research was supported by grant IOS 1354291 from the National Science Foundation to JFAT, a Marie Sklodowska-Curie Individual Fellowship to SA (funded by the European Union's Horizon 2020 research and innovation program under grant agreement No BrainiAnts-Project 660976), and participation of AZ in the Undergraduate Research Opportunities Program at Boston University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2017, I S BIOMED IMAGING, P429, DOI 10.1109/ISBI.2017.7950553; Arganda-Carreras I, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00013; Avants B, 2004, INSIGHT IN IMAGES: PRINCIPLES AND PRACTICE FOR SEGMENTATION REGISTRATION AND IMAGE ANALYSIS, P307; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Chessel D, 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; COLE BJ, 1980, INSECT SOC, V27, P265, DOI 10.1007/BF02223668; Fahrbach SE, 2016, CURR OPIN INSECT SCI, V18, P27, DOI 10.1016/j.cois.2016.08.009; Falibene A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00073; Falibene A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00084; Frambach I, 2004, J COMP NEUROL, V475, P303, DOI 10.1002/cne.20165; Giraldo YM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2603; Gordon DG, 2018, INSECT SOC, V65, P431, DOI 10.1007/s00040-018-0629-4; Gordon DG, 2018, NEUROSCI LETT, V676, P46, DOI 10.1016/j.neulet.2018.04.001; Gordon DG, 2018, NEUROSCI LETT, V662, P110, DOI 10.1016/j.neulet.2017.10.009; Gordon DG, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2396-z; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh C, 2008, ARTHROPOD STRUCT DEV, V37, P459, DOI 10.1016/j.asd.2008.04.001; Groh C, 2006, BRAIN BEHAV EVOLUT, V68, P1, DOI 10.1159/000092309; Groh C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0432; Groh C, 2012, J COMP NEUROL, V520, P3509, DOI 10.1002/cne.23102; Groh C, 2011, ARTHROPOD STRUCT DEV, V40, P358, DOI 10.1016/j.asd.2010.12.002; HASEGAWA E, 1993, INSECT SOC, V40, P261, DOI 10.1007/BF01242362; Holekamp KE, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0350; Holldobler B., 1990, pi; Hourcade B, 2010, J NEUROSCI, V30, P6461, DOI 10.1523/JNEUROSCI.0841-10.2010; Huang MH, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.0101; Ilies I, 2015, BRAIN BEHAV EVOLUT, V85, P63, DOI 10.1159/000370100; Julian GE, 2002, BRAIN BEHAV EVOLUT, V60, P152, DOI 10.1159/000065936; Kamhi JF, 2017, DEV NEUROBIOL, V77, P1072, DOI 10.1002/dneu.22496; Kamhi JF, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1949; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Krofczik S, 2008, DEV NEUROBIOL, V68, P1007, DOI 10.1002/dneu.20640; Liao WB, 2015, J EVOLUTION BIOL, V28, P1986, DOI 10.1111/jeb.12714; Lillico-Ouachour A, 2017, CURR OPIN INSECT SCI, V19, P43, DOI 10.1016/j.cois.2016.11.003; Londe S, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0031-5; Mares S, 2005, BRAIN BEHAV EVOLUT, V66, P50, DOI 10.1159/000085047; Molet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084929; Molet M, 2012, AM NAT, V180, P328, DOI 10.1086/667368; Muenz TS, 2015, DEV NEUROBIOL, V75, P1368, DOI 10.1002/dneu.22290; Muscedere ML, 2016, BEHAV ECOL, V27, P271, DOI 10.1093/beheco/arv152; Muscedere ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031618; Muscedere ML, 2009, ANIM BEHAV, V77, P911, DOI 10.1016/j.anbehav.2008.12.018; O'Donnell S, 2018, BMC ZOOL, V3, DOI 10.1186/s40850-018-0028-3; O'Donnell S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0791; O'Donnell S, 2014, BEHAV ECOL SOCIOBIOL, V68, P529, DOI 10.1007/s00265-013-1667-6; O'Donnell S, 2011, P NATL ACAD SCI USA, V108, P7107, DOI 10.1073/pnas.1017566108; Ott SR, 2008, J NEUROSCI METH, V172, P220, DOI 10.1016/j.jneumeth.2008.04.031; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; Peeters C, 2013, ARTHROPOD STRUCT DEV, V42, P257, DOI 10.1016/j.asd.2013.02.003; Powell BJ, 2012, BRAIN BEHAV EVOLUT, V80, P170, DOI 10.1159/000341161; Powell S, 2009, J EVOLUTION BIOL, V22, P1004, DOI 10.1111/j.1420-9101.2009.01710.x; Powell S, 2006, FUNCT ECOL, V20, P1105, DOI 10.1111/j.1365-2435.2006.01184.x; Powell S, 2016, BEHAV ECOL SOCIOBIOL, V70, P1075, DOI 10.1007/s00265-016-2080-8; Rajakumar R, 2018, NATURE, V562, P574, DOI 10.1038/s41586-018-0613-1; Rajakumar R, 2012, SCIENCE, V335, P79, DOI 10.1126/science.1211451; Riccomagno MM, 2015, ANNU REV CELL DEV BI, V31, P779, DOI 10.1146/annurev-cellbio-100913-013038; Scholl C, 2014, DEV NEUROBIOL, V74, P1141, DOI 10.1002/dneu.22195; Schurmann FW, 2016, ARTHROPOD STRUCT DEV, V45, P399, DOI 10.1016/j.asd.2016.08.005; Seid MA, 2005, J COMP NEUROL, V488, P269, DOI 10.1002/cne.20545; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Stieb SM, 2012, DEV NEUROBIOL, V72, P729, DOI 10.1002/dneu.20982; Stieb SM, 2010, DEV NEUROBIOL, V70, P408, DOI 10.1002/dneu.20785; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Trible W, 2017, J EXP BIOL, V220, P53, DOI 10.1242/jeb.145292; Tsuboi M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-39; Urbani CB, 1998, INSECT SOC, V45, P315, DOI 10.1007/s000400050091; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Waxman HK, 2017, BRAIN BEHAV EVOLUT, V89, P195, DOI 10.1159/000470899; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; WILSON E O, 1974, Psyche (Cambridge), V81, P182, DOI 10.1155/1974/17428; WILSON EO, 1976, ANIM BEHAV, V24, P354, DOI 10.1016/S0003-3472(76)80043-7; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Yilmaz A, 2016, DEV NEUROBIOL, V76, P1041, DOI 10.1002/dneu.22374	74	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213618	10.1371/journal.pone.0213618	http://dx.doi.org/10.1371/journal.pone.0213618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917163	Green Published, Green Submitted, gold			2022-12-27	WOS:000462465800036
J	Willson, NL; Van, TTH; Bhattarai, SP; Courtice, JM; McIntyre, JR; Prasai, TP; Moore, RJ; Walsh, K; Stanley, D				Willson, Nicky-Lee; Van, Thi T. H.; Bhattarai, Surya P.; Courtice, Jodi M.; McIntyre, Joshua R.; Prasai, Tanka P.; Moore, Robert J.; Walsh, Kerry; Stanley, Dragana			Feed supplementation with biochar may reduce poultry pathogens, including Campylobacter hepaticus, the causative agent of Spotty Liver Disease	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; GROWTH PROMOTERS; CHARCOAL; CHICKENS; DATABASE; SEARCH; UPDATE	Increased global regulation and restrictions on the non-therapeutic use of antibiotics in the poultry industry means that there is a need to identify alternatives that prevent infection while still conveying the growth and performance benefits afforded by their use. Biochars are produced by the incomplete pyrolysis of organic materials, with reports of use as a feed supplement and activity against pathogenic bacteria. In the current study the dose-dependent effects of biochar dietary inclusion in layer diets at 1%, 2% and 4% w/w were investigated to determine a) the efficacy of biochar as an anti-pathogenic additive on the intestinal microbiota and b) the optimal inclusion level. Biochar inclusion for anti-pathogenic effects was found to be most beneficial at 2% w/w. Poultry pathogens such as Gallibacterium anatis and campylobacters, including Campylobacter hepaticus, were found to be significantly lower in biochar fed birds. A shift in microbiota was also associated with the incorporation of 2% w/w biochar in the feed in two large scale trials on two commercial layer farms. Biochar inclusion for anti-pathogenic effects was found to be most beneficial at 2% w/w. Differential effects of the timing of biochar administration (supplementation beginning at hatch or at point of lay) were also evident, with greater impact on community microbial structure at 48 weeks of age when birds were fed from hatch rather than supplemented at point of lay.	[Willson, Nicky-Lee; Bhattarai, Surya P.; McIntyre, Joshua R.; Prasai, Tanka P.; Walsh, Kerry; Stanley, Dragana] Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia; [Willson, Nicky-Lee] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Van, Thi T. H.; Moore, Robert J.] RMIT Univ, Sch Sci, Bundoora, Vic, Australia; [Courtice, Jodi M.] Univ Southern Queensland, Toowoomba, Qld, Australia; [Prasai, Tanka P.] Govt Nepal, Minist Agr Land Management & Cooperat, Dept Livestock Serv, Hariharbhawan, Lalitpur, Nepal	Central Queensland University; University of Adelaide; Royal Melbourne Institute of Technology (RMIT); University of Southern Queensland	Stanley, D (corresponding author), Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia.	D.Stanley@cqu.edu.au	Willson, Nicky-Lee/ABF-4475-2021; Stanley, Dragana/AAC-2596-2020; Moore, Robert J/D-8352-2011	Stanley, Dragana/0000-0001-7019-4726; Moore, Robert J/0000-0002-0776-5861; Willson, Nicky-Lee/0000-0002-3851-8548; Van, Thi Thu Hao/0000-0002-1559-568X; McIntyre, Joshua/0000-0002-6443-5367; walsh, kerry/0000-0002-3033-8622				Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Blake JP, 2014, J APPL POULTRY RES, V23, P101, DOI 10.3382/japr.2013-00838; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Flint S, 2017, INT DAIRY J, V65, P38, DOI 10.1016/j.idairyj.2016.10.002; Food and Agriculture Organization (FAO), 2016, FAO ACT PLAN ANT RES; Foster JA, 2017, NEUROBIOL STRESS, V7, P124, DOI 10.1016/j.ynstr.2017.03.001; Gerlach H., 2012, ITHAKA J, V2012, P262; Hagemann N, 2018, WATER-SUI, V10, DOI 10.3390/w10020182; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jiya E. Z., 2013, British Journal of Applied Science & Technology, V3, P268; Kana JR, 2011, TROP ANIM HEALTH PRO, V43, P51, DOI 10.1007/s11250-010-9653-8; Kutlu HR, 2001, ANIM FEED SCI TECH, V90, P213, DOI 10.1016/S0377-8401(01)00205-X; Lehman J., 2015, BIOCHAR ENV MANAGEME; Lehmann J., 2009, SCI TECHNOL HUM VAL, DOI 10.4324/9781849770552; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Prasai TP, 2018, ANIM PROD SCI, V58, P1632, DOI [10.1071/AN16290, 10.1071/an16290]; Prasai TP, 2017, MICROBIOL RES, V195, P24, DOI 10.1016/j.micres.2016.11.006; Prasai TP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154061; Schokker D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1646-6; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Singh S. V., 2016, Journal of Veterinary Science and Technology, V7, P324; Stanley D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0388-6; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Van TTH, 2017, VET MICROBIOL, V207, P226, DOI 10.1016/j.vetmic.2017.06.022; Van TTH, 2016, INT J SYST EVOL MICR, V66, P4518, DOI 10.1099/ijsem.0.001383; Toth JD, 2016, SSSA SPEC PUBL, V63, P199, DOI 10.2136/sssaspecpub63.2014.0043.5; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Watarai S, 2005, POULTRY SCI, V84, P515, DOI 10.1093/ps/84.4.515; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725	40	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214471	10.1371/journal.pone.0214471	http://dx.doi.org/10.1371/journal.pone.0214471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943226	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300040
J	Miftahussurur, M; Cruz, M; Doohan, D; Subsomwong, P; Abreu, JAJ; Hosking, C; Waskito, LA; Yamaoka, Y				Miftahussurur, Muhammad; Cruz, Modesto; Doohan, Dalla; Subsomwong, Phawinee; Abreu, Jose A. Jimenez; Hosking, Celso; Waskito, Langgeng Agung; Yamaoka, Yoshio			Five alternative Helicobacter pylori antibiotics to counter high levofloxacin and metronidazole resistance in the Dominican Republic	PLOS ONE			English	Article							RIFAXIMIN-BASED REGIMENS; TRIPLE THERAPY; RPOB MUTATIONS; CROSS-RESISTANCE; RESCUE THERAPY; RIFABUTIN; SITAFLOXACIN; ERADICATION; AMOXICILLIN; RIFAMPICIN	The prevalence of Helicobacter pylori resistance to levofloxacin and metronidazole was high in the Dominican Republic. We used two-fold agar dilution method to determine the minimum inhibitory concentration of five alternative antibiotics in 63 Dominican strains. We also assessed the genetic mutations associated with the antibiotic resistance using next-generation sequencing. We revealed that all 63 strains were sensitive towards sitafloxacin, furazolidone, and rifabutin. In contrast, the prevalence of rifaximin and garenoxacin resistance were high (82.5% and 34.9%, respectively). Patients more than or equal to 60 years old had the highest risk of double-antibiotic resistance (7/9, 77.8%, OR = 31.5, P = 0.009) and garenoxacin resistances (8/9, 88.9%, OR = 45.33, P = 0.002) with an increasing risk simultaneously by age (P = 0.004, r = 0.357). Almost all rifaximin resistant strains possessed multiple mutations with more than three mutations within rpoB including the most frequent novel mutations of S352L, I2726L, and V2465A. There was a significant association between vacA genotype and rifaximin resistance (P = 0.042). Among 23 levofloxacin-resistant strains, 82.6% (19/23, P < 0.001) were also resistant to garenoxacin, and 39.1% (9/23) had a high minimal inhibitory concentration. 8 mu g/mL with positive trend correlation (P = < 0.001, r = 0.84). Among 19 garenoxacin resistant strains, 16 (84.2%) contained mutations at D91 and N87 of gyrA. In conclusion, sitafloxacin, rifabutin, and furazolidone might be considered as alternative antibiotics to be included in H. pylori eradication regimen in regions with high prevalence of levofloxacin and metronidazole resistance, such as the Dominican Republic.	[Miftahussurur, Muhammad] Univ Airlangga, Fac Med, Gastroenterohepatol Div, Dept Internal Med,Inst Tropical Dis, Surabaya, Indonesia; [Miftahussurur, Muhammad; Doohan, Dalla; Waskito, Langgeng Agung] Univ Airlangga, Inst Trop Dis, Surabaya, Indonesia; [Cruz, Modesto] Autonomous Univ Santo Domingo, Inst Microbiol & Parasitol, Fac Sci, Santo Domingo, Dominican Rep; [Cruz, Modesto; Hosking, Celso] Natl Inst Med & Diagnost Imaging, Dept Biomed Res, Santo Domingo, Dominican Rep; [Doohan, Dalla; Subsomwong, Phawinee; Waskito, Langgeng Agung; Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan; [Abreu, Jose A. Jimenez] Dr Luis E Aybar Hlth & Hyg City, Dominican Japanese Digest Dis Ctr, Santo Domingo, Dominican Rep; [Yamaoka, Yoshio] Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA; [Yamaoka, Yoshio] Univ Airlangga, Fac Med, Surabaya, Indonesia	Airlangga University; Airlangga University; Universidad Autonoma de Santo Domingo; Oita University; Baylor College of Medicine; Airlangga University	Yamaoka, Y (corresponding author), Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan.; Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA.; Yamaoka, Y (corresponding author), Univ Airlangga, Fac Med, Surabaya, Indonesia.	yyamaoka@oita-u.ac.jp	Miftahussurur, Muhammad/AAB-6151-2021; Cruz, Modesto/AGM-1113-2022	Miftahussurur, Muhammad/0000-0003-1415-6033; Yamaoka, Yoshio/0000-0002-1222-5819; Doohan, Dalla/0000-0003-3076-571X; Cruz, Modesto/0000-0003-0917-5555	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [26640114, 221S0002, 16H06279, 15H02657, 16H05191]; Japan Society for the Promotion of Science Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology Agency (JST); Ministry of Research [123.4/D2.3/KP/2018]; Ministry of Technology [123.4/D2.3/KP/2018]; Ministry of Higher Education of Indonesia for World Class Professor Program [123.4/D2.3/KP/2018]; Japanese Government (MEXT); National Fund for Innovation and Development of Science and Technology (FONDOCYT) from the Ministry of Higher Education Science and Technology (MESCyT) of the Dominican Republic [2012-2013-2A1-65, 2015-3A1-182]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Institutional Program for Young Researcher Overseas Visits(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Funds for the Promotion of Science and Technology Agency (JST); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Ministry of Technology; Ministry of Higher Education of Indonesia for World Class Professor Program; Japanese Government (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Fund for Innovation and Development of Science and Technology (FONDOCYT) from the Ministry of Higher Education Science and Technology (MESCyT) of the Dominican Republic	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (YY), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (26640114, 221S0002, 16H06279, 15H02657 and 16H05191) (YY). This work was also supported by the Japan Society for the Promotion of Science Institutional Program for Young Researcher Overseas Visits and the Strategic Funds for the Promotion of Science and Technology Agency (JST) for YY and The Ministries of Research, Technology and Higher Education of Indonesia for World Class Professor Program (no. 123.4/D2.3/KP/2018) to MIL and MM. LAW and DD are PhD students supported by the Japanese Government (MEXT) scholarship program for 2015, 2016, and 2017, respectively. In addition, it was supported in part by a grant from The National Fund for Innovation and Development of Science and Technology (FONDOCYT) from the Ministry of Higher Education Science and Technology (MESCyT) of the Dominican Republic (2012-2013-2A1-65 and 2015-3A1-182) (MC).	Adachi JA, 2006, CLIN INFECT DIS, V42, P541, DOI 10.1086/499950; Borody TJ, 2006, ALIMENT PHARM THER, V23, P481, DOI 10.1111/j.1365-2036.2006.02793.x; Buowari Y.D, 2017, J AGING RES HEALTHC, V1, P1, DOI [10.14302/issn.2474-7785.jarh-16-1396, DOI 10.14302/ISSN.2474-7785.JARH-16-1396]; Camargo MC, 2014, AM J GASTROENTEROL, V109, P485, DOI 10.1038/ajg.2014.24; Cheng H, 2009, WORLD J GASTROENTERO, V15, P860, DOI 10.3748/wjg.15.860; Coelho LGV, 2000, AM J GASTROENTEROL, V95, P2688, DOI 10.1111/j.1572-0241.2000.03174.x; Corral JE, 2017, WORLD J GASTRO ONCOL, V9, P184, DOI 10.4251/wjgo.v9.i4.184; De Giorgio R, 1997, Eur Rev Med Pharmacol Sci, V1, P105; ElMaraachli W, 2015, INT J TUBERC LUNG D, V19, P1222, DOI 10.5588/ijtld.14.0936; Furuta T, 2014, J GASTROEN HEPATOL, V29, P487, DOI 10.1111/jgh.12442; Gasbarrini A, 2006, DIGESTION, V73, P129, DOI 10.1159/000089788; Gasbarrini A, 2006, DIGEST DIS, V24, P195, DOI 10.1159/000090330; Gisbert JP, 2012, ALIMENT PHARM THER, V35, P209, DOI 10.1111/j.1365-2036.2011.04937.x; Glocker E, 2007, J ANTIMICROB CHEMOTH, V59, P874, DOI 10.1093/jac/dkm039; Graham D.Y., 2016, HELICOBACTER PYLORI, P417; Hays C, 2018, HELICOBACTER, V23, DOI 10.1111/hel.12451; Heep M, 1999, ANTIMICROB AGENTS CH, V43, P1497, DOI 10.1128/AAC.43.6.1497; Heep M, 2000, ANTIMICROB AGENTS CH, V44, P1075, DOI 10.1128/AAC.44.4.1075-1077.2000; Hirata Y, 2012, INT J ANTIMICROB AG, V39, P352, DOI 10.1016/j.ijantimicag.2011.12.002; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Hunt RH, 2011, J GASTROINTEST LIVER, V20, P299, DOI 10.1097/MCG.0b013e31820fb8f6; JABES D, 1994, ANTIMICROB AGENTS CH, V38, P2346, DOI 10.1128/AAC.38.10.2346; Kothary V, 2013, ANTIMICROB AGENTS CH, V57, P811, DOI 10.1128/AAC.02163-12; Kunin CM, 1996, CLIN INFECT DIS, V22, pS3, DOI 10.1093/clinids/22.Supplement_1.S3; Lim HC, 2014, HELICOBACTER, V19, P455, DOI 10.1111/hel.12147; Malfertheiner P, 2017, GUT, V66, P6, DOI 10.1136/gutjnl-2016-312288; Miftahussurur M, 2017, AM J TROP MED HYG, V96, P1050, DOI 10.4269/ajtmh.16-0729; Mori H, 2016, UNITED EUR GASTROENT, V4, P380, DOI 10.1177/2050640615618043; Murakami K, 2009, ANTIMICROB AGENTS CH, V53, P3097, DOI 10.1128/AAC.01552-08; Nishizawa T, 2011, ANTIMICROB AGENTS CH, V55, P5374, DOI 10.1128/AAC.05437-11; Nizhevich A A, 2011, Eksp Klin Gastroenterol, P85; Nizhevich A A, 2009, Eksp Klin Gastroenterol, P98; O'Connor JR, 2008, ANTIMICROB AGENTS CH, V52, P2813, DOI 10.1128/AAC.00342-08; Ogata SK, 2014, BRAZ J MICROBIOL, V45, P1439, DOI 10.1590/S1517-83822014000400039; Segura AM, 1997, ALIMENT PHARM THERAP, V11, P529, DOI 10.1046/j.1365-2036.1997.00172.x; Shiota S, 2014, J MED MICROBIOL, V63, P1189, DOI 10.1099/jmm.0.075275-0; Sousa M, 2008, J ANTIMICROB CHEMOTH, V62, P872, DOI 10.1093/jac/dkn330; Sugimoto M, 2015, ALIMENT PHARM THER, V42, P477, DOI 10.1111/apt.13280; Suzuki H, 2009, ANTIMICROB AGENTS CH, V53, P1720, DOI 10.1128/AAC.00049-09; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Yang B, 1998, J ANTIMICROB CHEMOTH, V42, P621, DOI 10.1093/jac/42.5.621	42	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213868	10.1371/journal.pone.0213868	http://dx.doi.org/10.1371/journal.pone.0213868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917150	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000462465800043
J	Rector, JL; Tay, L; Wiese, CW; Friedman, EM				Rector, Jerrald L.; Tay, Louis; Wiese, Christopher W.; Friedman, Elliot M.			Relative sensitivity of cortisol indices to psychosocial and physical health factors	PLOS ONE			English	Article							AWAKENING RESPONSE; SALIVARY CORTISOL; POSITIVE AFFECT; DEPRESSION; STRESS; HAPPINESS; ANXIETY; HYPOCORTISOLISM; ASSOCIATIONS; SAMPLE	Objective Regulation of cortisol under resting conditions is widely used to assess physical and psychological status, but due to the diversity of possible assessments (e.g., cumulative levels; diurnal patterns), considering one or a few at a time hampers understanding and interpretation. Moreover, most studies of cortisol regulation focus on negatively-valanced experiences. This study examined the inter-correlations among cortisol indices and their relative contribution to the explained variance in diverse psychosocial and health factors, including positive functioning. Methods Data are from midlife and older adults (N = 513; 47.2% male). Cortisol was assessed in urine (overnight) and saliva (at rest and over 4 consecutive days). Positive and negative psychosocial and health factors were assessed by self-report. In addition to examining associations among cortisol indices, relative weight analysis was used to determine which indices were most robustly linked to specific psychosocial factors. Results Inter-correlations among indices were weak-to-moderate, suggesting that they measure different aspects of hypothalamic-pituitary-axis activity. Overall variance in psychosocial and health factors (R-2) explained by the cortisol indices ranged from 0.01 to 0.07. Of this explained variance, relative weight analysis showed that waking cortisol contributed most to the variance in hedonic well-being (32.1%-38.2%), bedtime cortisol to depression-related factors (32.1%-46.9%), the cortisol awakening response to eudaimonic well-being (35.8%-50.5%), cortisol slope to perceived stress (29.2%), and urinary cortisol to physical factors (38.5% and 62.7%). Conclusions Positive and negative factors were related to largely non-overlapping cortisol indices. This study illuminates nuanced associations among cortisol indices and diverse aspects of 16 mental and physical health, facilitating thoughtful examination of the complex role of hypothalamic-pituitary-axis activity in health.	[Rector, Jerrald L.; Friedman, Elliot M.] Purdue Univ, Dept Human Dev & Family Studies, W Lafayette, IN 47907 USA; [Tay, Louis] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [Wiese, Christopher W.] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Georgia; Georgia Institute of Technology	Rector, JL (corresponding author), Purdue Univ, Dept Human Dev & Family Studies, W Lafayette, IN 47907 USA.	jerraldrector@hotmail.com	Rector, Jerrald L/T-6533-2018; Tay, Louis/AAW-1457-2020; Friedman, Elliot M/AAT-2585-2020	Rector, Jerrald L/0000-0001-9838-6375; Wiese, Christopher/0000-0002-3932-4008	National Institute on Aging [R01-AG041750, P01AG020166]; John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; General Clinical Research Centers Program [M01-RR023942, M01-RR00865]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041750] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant to EMF (R01-AG041750) from the National Institute on Aging. The MIDUS 1 study (Midlife in the U. S.) was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development. The MIDUS 2 research was supported by the National Institute on Aging (P01AG020166). The research was further supported by the following grants M01-RR023942 (Georgetown), M01-RR00865 (UCLA) from the General Clinical Research Centers Program and UL1TR000427 (UW) from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2006, P NATL ACAD SCI USA, V103, P17058, DOI 10.1073/pnas.0605053103; Adam EK, 2017, PSYCHONEUROENDOCRINO, V83, P25, DOI 10.1016/j.psyneuen.2017.05.018; Adam EK, 2009, PSYCHONEUROENDOCRINO, V34, P1423, DOI 10.1016/j.psyneuen.2009.06.011; Boehm JK, 2012, PSYCHOL BULL, V138, P655, DOI 10.1037/a0027448; Boggero IA, 2017, BIOL PSYCHOL, V129, P207, DOI 10.1016/j.biopsycho.2017.08.058; Champaneri S, 2013, OBESITY, V21, pE56, DOI 10.1002/oby.20047; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Dedovic K, 2015, NEUROPSYCH DIS TREAT, V11, P1181, DOI 10.2147/NDT.S62289; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Gaab J, 2006, PSYCHONEUROENDOCRINO, V31, P428, DOI 10.1016/j.psyneuen.2005.10.005; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Golden SH, 2013, PSYCHONEUROENDOCRINO, V38, P2720, DOI 10.1016/j.psyneuen.2013.06.032; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Herbert J, 2013, PSYCHOL MED, V43, P449, DOI 10.1017/S0033291712000955; Jarcho MR, 2013, BIOL PSYCHOL, V93, P150, DOI 10.1016/j.biopsycho.2013.01.018; Johnson JW, 2004, ORGAN RES METHODS, V7, P238, DOI 10.1177/1094428104266510; Johnson JW, 2000, MULTIVAR BEHAV RES, V35, P1, DOI 10.1207/S15327906MBR3501_1; Karlamangla AS, 2013, PSYCHONEUROENDOCRINO, V38, P2585, DOI 10.1016/j.psyneuen.2013.06.010; Kudielka BM, 2003, PSYCHONEUROENDOCRINO, V28, P35, DOI 10.1016/S0306-4530(02)00008-2; Law R, 2015, STRESS, V18, P616, DOI 10.3109/10253890.2015.1076789; Maripuu M, 2016, J AFFECT DISORDERS, V204, P187, DOI 10.1016/j.jad.2016.06.024; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Piazza JR, 2013, PSYCHOL AGING, V28, P47, DOI 10.1037/a0029983; Powers SI, 2016, PSYCHONEUROENDOCRINO, V69, P172, DOI 10.1016/j.psyneuen.2016.04.007; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richman LS, 2005, HEALTH PSYCHOL, V24, P422, DOI 10.1037/0278-6133.24.4.422; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; Ross KM, 2014, PSYCHONEUROENDOCRINO, V39, P184, DOI 10.1016/j.psyneuen.2013.09.016; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Ryff CD, 2006, PSYCHOTHER PSYCHOSOM, V75, P85, DOI 10.1159/000090892; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; RYFF CD, 1989, PSYCHOL AGING, V4, P195, DOI 10.1037/0882-7974.4.2.195; Ryff CD, 2004, PHILOS T R SOC B, V359, P1383, DOI 10.1098/rstb.2004.1521; Saxbe D. E., 2008, HLTH PSYCHOL REV, V2, P163, DOI DOI 10.1080/17437190802530812; Short SJ, 2016, PSYCHONEUROENDOCRINO, V71, P12, DOI 10.1016/j.psyneuen.2016.05.007; Sin NL, 2017, PSYCHONEUROENDOCRINO, V83, P91, DOI 10.1016/j.psyneuen.2017.06.001; Sjogren E, 2006, INT J BEHAV MED, V13, P193, DOI 10.1207/s15327558ijbm1303_2; Stalder T, 2016, PSYCHONEUROENDOCRINO, V63, P414, DOI 10.1016/j.psyneuen.2015.10.010; Stawski RS, 2013, PSYCHONEUROENDOCRINO, V38, P2654, DOI 10.1016/j.psyneuen.2013.06.023; Steptoe A, 2005, NEUROBIOL AGING, V26, pS108, DOI 10.1016/j.neurobiolaging.2005.08.016; Steptoe A., 2019, ANN REV PUBLIC HLTH; Steptoe A, 2007, PSYCHONEUROENDOCRINO, V32, P56, DOI 10.1016/j.psyneuen.2006.10.001; Steptoe A, 2009, J PERS, V77, P1747, DOI 10.1111/j.1467-6494.2009.00599.x; Tonidandel S, 2011, J BUS PSYCHOL, V26, P1, DOI 10.1007/s10869-010-9204-3; Vedhara K, 2003, BIOL PSYCHOL, V62, P89, DOI 10.1016/S0301-0511(02)00128-X; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; WATERMAN AS, 1993, J PERS SOC PSYCHOL, V64, P678, DOI 10.1037/0022-3514.64.4.678; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; Wong JD, 2016, J AGING HEALTH; Yehuda R, 2003, LIFE SCI, V73, P349, DOI 10.1016/S0024-3205(03)00286-8; Zautra AJ, 2002, COGNITION EMOTION, V16, P309, DOI 10.1080/02699930143000257; Zilioli S, 2015, PSYCHONEUROENDOCRINO, V60, P91, DOI 10.1016/j.psyneuen.2015.06.010	60	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213513	10.1371/journal.pone.0213513	http://dx.doi.org/10.1371/journal.pone.0213513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943214	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300015
J	Somann, JP; Wasilczuk, KM; Neihouser, KV; Sturgis, J; Albors, GO; Robinson, JP; Powley, TL; Irazoqui, PP				Somann, Jesse P.; Wasilczuk, Kelsey M.; Neihouser, Kaitlyn V.; Sturgis, Jennifer; Albors, Gabriel O.; Robinson, J. Paul; Powley, Terry L.; Irazoqui, Pedro P.			Characterization of plasma cytokine response to intraperitoneally administered LPS & subdiaphragmatic branch vagus nerve stimulation in rat model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; VAGAL INNERVATION; TNF-ALPHA; ENDOTOXIN; CORTICOSTERONE; INTERLEUKIN-6; LETHALITY; RECEPTOR; RELEASE	Vagus nerve stimulation (VNS) has been on the forefront of inflammatory disorder research and has yielded many promising results. Questions remain, however, about the biological mechanisms of such treatments and the inconsistencies in the methods used in research efforts. Here, we aimed to clarify the inflammatory response to intraperitoneal (IP) injections of lipopolysaccharide (LPS) in rats, while analyzing corresponding effects of electrical stimulation to subdiaphragmatic branches (anterior gastric, accessory celiac, and hepatic) of the left vagus nerve. We accomplished an in-depth characterization of the time-varying cytokine cascade response in the serum of 58 rats to an acute IP LPS challenge over a 330-minute period by utilizing curve-fitting and starting point-alignment methods. We then explored the post-LPS neuromodulation effects of electrically stimulating individually cuffed subdiaphragmatic branches. Through our analysis, we found there to be a consistent order of IP LPS cytokine response (IL-10, TNF-alpha, GM-CSF, IL-17F, IL-6, IL-22, INF-gamma). Apart from IL-10, the IP cytokine cascade was more variable in starting time and occurred later than in previously recorded intravenous (IV) challenges. We also found distinct regulatory effects on multiple cytokine levels by each of the three subdiaphragmatic stimulation subsets. While the time variability of IP LPS use in rats complicates its utility, we have shown it to be a practical, arguably more physiologically relevant method than IV in rats when our methods are used. More importantly, we have shown that selective subdiaphragmatic neurostimulation can be utilized to selectively induce specific effects on inflammation in the body.	[Somann, Jesse P.; Irazoqui, Pedro P.] Purdue Univ, Dept Elect & Comp Engn, W Lafayette, IN 47907 USA; [Somann, Jesse P.; Wasilczuk, Kelsey M.; Neihouser, Kaitlyn V.; Albors, Gabriel O.; Irazoqui, Pedro P.] Purdue Univ, CID, W Lafayette, IN 47907 USA; [Wasilczuk, Kelsey M.; Neihouser, Kaitlyn V.; Albors, Gabriel O.; Robinson, J. Paul; Irazoqui, Pedro P.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Sturgis, Jennifer; Robinson, J. Paul] Purdue Univ, Purdue Cytometry Labs, W Lafayette, IN 47907 USA; [Powley, Terry L.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Somann, JP (corresponding author), Purdue Univ, Dept Elect & Comp Engn, W Lafayette, IN 47907 USA.; Somann, JP (corresponding author), Purdue Univ, CID, W Lafayette, IN 47907 USA.	jsomann@purdue.edu	Robinson, Joseph/AAA-1001-2020	Robinson, Joseph/0000-0001-8383-3240; Somann, Jesse/0000-0001-9022-6051	Defense Advanced Research Projects Agency (DARPA) ElectRx program [N66001-15-2-4056]	Defense Advanced Research Projects Agency (DARPA) ElectRx program	Research by all authors is supported by the Defense Advanced Research Projects Agency (DARPA) ElectRx program under the auspices of Dr. Douglas Weber, Grant No. N66001-15-2-4056. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of DARPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mousawi AM, 2010, SHOCK, V34, P261, DOI 10.1097/SHK.0b013e3181d8e2a6; [Anonymous], 2007, SURG PROC FEM CANN R; Asari Y, 1996, SHOCK, V5, P208, DOI 10.1097/00024382-199603000-00007; BELLINGER DL, 1993, BRAIN BEHAV IMMUN, V7, P191, DOI 10.1006/brbi.1993.1021; Berthoud HR, 1996, MICROSC RES TECHNIQ, V35, P80, DOI 10.1002/(SICI)1097-0029(19960901)35:1<80::AID-JEMT7>3.0.CO;2-W; BERTHOUD HR, 1993, J AUTONOM NERV SYST, V42, P153, DOI 10.1016/0165-1838(93)90046-W; BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bratton BO, 2012, EXP PHYSIOL, V97, P1180, DOI 10.1113/expphysiol.2011.061531; Chapleau MW, 2016, AM J PHYSIOL-HEART C, V311, pH276, DOI 10.1152/ajpheart.00043.2016; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; Fleshner M, 1998, J NEUROIMMUNOL, V86, P134, DOI 10.1016/S0165-5728(98)00026-5; GIVALOIS L, 1994, AM J PHYSIOL, V267, pR164, DOI 10.1152/ajpregu.1994.267.1.R164; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Grimonprez A, 2015, NEUROSCI BIOBEHAV R, V56, P26, DOI 10.1016/j.neubiorev.2015.06.019; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Huston JM, 2008, J IMMUNOL, V181, P3535, DOI 10.4049/jimmunol.181.5.3535; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Jarry KV, 2017, THESIS; Kakizaki Y, 1999, ENDOCR J, V46, P487, DOI 10.1507/endocrj.46.487; Komegae EN, 2018, BRAIN BEHAV IMMUNITY; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Kraaij MD, 2014, CYTOKINE, V67, P7, DOI 10.1016/j.cyto.2014.02.001; Laemle Lois B., 2012, NOBACKS HUMAN NERVOU; Lenczowski MJP, 1997, AM J PHYSIOL-REG I, V273, pR1870, DOI 10.1152/ajpregu.1997.273.6.R1870; Lenczowski MJP, 1998, ANN NY ACAD SCI, V856, P139, DOI 10.1111/j.1749-6632.1998.tb08322.x; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Matteoli G, 2013, GUT; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; NORGREN R, 1988, J COMP NEUROL, V273, P207, DOI 10.1002/cne.902730206; Panescu D, 2005, IEEE ENG MED BIOL, V24, P68, DOI 10.1109/MEMB.2005.1549737; Patel YA, 2017, SCI REP-UK, V7, DOI 10.1038/srep39810; Peters S, 2000, CURR SEPARATIONS, V18, P140; PRECHTL JC, 1990, ANAT EMBRYOL, V181, P101; REDL H, 1991, J INFECT DIS, V164, P383, DOI 10.1093/infdis/164.2.383; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Somann JP, 2017, J NEURAL ENG; Stakenborg N, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13075; Steven S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102176; STREETER AM, 1974, AM J SURG, V128, P340, DOI 10.1016/0002-9610(74)90169-X; SUFFREDINI AF, 1995, J IMMUNOL, V155, P5038; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; VANDERPOLL T, 1994, J EXP MED, V180, P1985, DOI 10.1084/jem.180.5.1985; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wasilczuk KM, 2019, ULTRASOUND MED BIOL, V45, P481, DOI 10.1016/j.ultrasmedbio.2018.09.005	48	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214317	10.1371/journal.pone.0214317	http://dx.doi.org/10.1371/journal.pone.0214317			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921373	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000054
J	Moncel, MH; Fernandes, P; Willmes, M; James, H; Grun, R				Moncel, Marie-Helene; Fernandes, Paul; Willmes, Malte; James, Hannah; Grun, Rainer			Rocks, teeth, and tools: New insights into early Neanderthal mobility strategies in South-Eastern France from lithic reconstructions and strontium isotope analysis	PLOS ONE			English	Article							MIDDLE PALEOLITHIC SITE; QUARTZITE ARTIFACTS; PECHEURS ARDECHE; FLINT ARTIFACTS; CENTRAL-EUROPE; PAYRE ARDECHE; RATIOS; PATTERNS; SR; TERRITORIES	Neanderthals had complex land use patterns, adapting to diversified landscapes and climates. Over the past decade, considerable progress has been made in reconstructing the chronology, land use and subsistence patterns, and occupation types of sites in the Rhone Valley, southeast France. In this study, Neanderthal mobility at the site of Payre is investigated by combining information from lithic procurement analysis ("chaine evolutive" and "chaine operatoire" concepts) and strontium isotope analysis of teeth (childhood foraging area), from two units (F and G). Both units date to the transition from Marine Isotope Stage (MIS) 8 to MIS 7, and show similar environmental conditions, but represent contrasting occupation durations. Level Gb (unit G) represents a long-term year-round use, in contrast to short-term seasonal use of the cave in level Fb (unit F). For both levels, lithic material and food were generally collected from a local to semi-local region. However, in level Gb, lithic materials were mainly collected from colluviums and food collected in the valley, whereas in level Fb, lithic procurement focused primarily on alluvial deposits and food was collected from higher elevation plateaus. These procurement or exchange patterns might be related to flint availability, knapping advantages of alluvial flint or occupation duration. The site of Payre is located in a flint rich circulation corridor and the movement of groups or exchanges between groups were organized along a north-south axis on the plateaus or towards the east following the river. The ridges were widely used as they are rich in flint, whereas the Rhone Valley is not an important source of lithic raw materials. Compared to other western European Middle Palaeolithic sites, these results indicate that procurement strategies have a moderate link with occupation types and duration, and with lithic technology. The Sr isotope ratios broadly match the proposed foraging areas, with the Rhone Valley being predominantly used in unit G and the ridges and limestone plateaus in unit F. While lithic reconstructions and childhood foraging are not directly related this suggests that the three analysed Neanderthals spend their childhood in the same general area and supports the idea of mobile Neanderthals in the Rhone Valley and neighbouring higher elevation plateaus. The combination of reconstructing lithic raw material sources, provisioning strategies, and strontium isotope analyses provides new details on how Neanderthals at Payre practised land use and mobility in the Early Middle Palaeolithic.	[Moncel, Marie-Helene] Natl Museum Nat Hist, UMR 7194, CNRS, Inst Paleontol Humaine, 1 Rue Rene Panhard, Paris, France; [Fernandes, Paul] SARL Paleotime, Villard De Lans, France; [Fernandes, Paul] Univ Bordeaux, UMR PACEA, CNRS, CS, Pessac, France; [Fernandes, Paul] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Willmes, Malte] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [James, Hannah] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Grun, Rainer] Griffith Univ, Res Ctr Human Evolut, Nathan, Qld, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Max Planck Society; University of California System; University of California Davis; Australian National University; Griffith University	Moncel, MH (corresponding author), Natl Museum Nat Hist, UMR 7194, CNRS, Inst Paleontol Humaine, 1 Rue Rene Panhard, Paris, France.	marie-helene.moncel@mnhn.fr	Fernandes, Paul/H-2972-2013; Willmes, Malte/J-3710-2015	Fernandes, Paul/0000-0003-4135-115X; Willmes, Malte/0000-0001-8734-5324; James, Hannah F/0000-0001-7953-5240; Moncel, Marie-helene/0000-0002-0398-2316	Ministry of Culture; Service regional de l'Archeologie Auvergne Rhone-Alpes; Center for the Study of Law and Culture, Columbia University (US); Ministry of Culture, Service regional de l'Archeologie Auvergne Rhone-Alpes; Research Centre for Human Evolution, Environmental Futures Research Institute, Griffith University, Gold Coast, Queensland, Australia; Project Origins Region Aquitaine	Ministry of Culture; Service regional de l'Archeologie Auvergne Rhone-Alpes; Center for the Study of Law and Culture, Columbia University (US); Ministry of Culture, Service regional de l'Archeologie Auvergne Rhone-Alpes; Research Centre for Human Evolution, Environmental Futures Research Institute, Griffith University, Gold Coast, Queensland, Australia; Project Origins Region Aquitaine	Funded by MHM: Ministry of Culture. Service regional de l'Archeologie Auvergne Rhone-Alpes (Fieldworks) (Permit 1990-2002); Center for the Study of Law and Culture, Columbia University (US) (Permit 2009-2016). MHM, PF: Ministry of Culture, Service regional de l'Archeologie Auvergne Rhone-Alpes (Collective projects on Neanderthal and flint origins) (Permit 2005-2018) MW, HJ, RG: Research Centre for Human Evolution, Environmental Futures Research Institute, Griffith University, Gold Coast, Queensland 4222, Australia (strontium isotopes) PF: Project Origins Region Aquitaine (Permit 2000-2005) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, THESIS; AUBRY MP, 1975, CR ACAD SCI D NAT, V280, P1509; Baena J, 2017, QUATERN INT, V436, P212, DOI 10.1016/j.quaint.2014.08.031; Baena J, 2012, QUATERN INT, V247, P199, DOI 10.1016/j.quaint.2011.07.031; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bernard-Guell S., 2014, TRANSITION RUPTURES, V2, P229; Bernard-Guelle S, 2005, ANTHROPOLOGIE, V109, P799, DOI 10.1016/j.anthro.2005.10.008; Bernard-Guelle S, 2006, BULL SOC PREHIST FR, V103, P9, DOI 10.3406/bspf.2006.13392; Bernard-Guelle S, 2011, BULL SOC PREHIST FR, V108, P671, DOI 10.3406/bspf.2011.14066; Besancon J., 1982, CMO, V12, P21; Binford L.R., 1982, J ANTHROPOL ARCHAEOL, V1, P5, DOI DOI 10.1016/0278-4165(82)90006-X; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Binford LR, 1983, PURSUIT; Binford LR., 1984, FAUNAL REMAINS KLASI; Bocherens H, 2016, QUATERNARY SCI REV, V154, P226, DOI 10.1016/j.quascirev.2016.11.004; Boeda E., 1993, BULL SOC PREHIST FR, V90, P392, DOI DOI 10.3406/BSPF.1993.9669; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Boeda E, 1994, MONOGRAPHIES DU CRA, V9; Bordes F, 1972, A TALE OF 2 CAVES; Bordes F, 1972, QUATERNARIA, V16, P15; Brenet M, 2017, QUATERN INT, V428, P151, DOI 10.1016/j.quaint.2015.12.052; Britton K, 2011, J HUM EVOL, V61, P176, DOI 10.1016/j.jhevol.2011.03.004; Burke A, 2006, J ANTHROPOL ARCHAEOL, V25, P510, DOI 10.1016/j.jaa.2006.03.003; Burke A, 2012, QUATERN INT, V247, P230, DOI 10.1016/j.quaint.2010.10.029; Burroni D, 2002, J ARCHAEOL SCI, V29, P1277, DOI 10.1006/jasc.2001.0771; Bustos-Perez G, 2017, J ARCHAEOL SCI-REP, V12, P658, DOI 10.1016/j.jasrep.2017.02.021; Callow P., 1986, COTTE ST BRELADE 196; Capo RC, 1998, GEODERMA, V82, P197, DOI 10.1016/S0016-7061(97)00102-X; Carmignani L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178550; Combier J., 1967, MEMOIRE, V4; Conard MJ, 2000, INT J OSTEOARCHAEOL, V10, P286, DOI 10.1002/1099-1212(200009/10)10:5<286::AID-OA557>3.0.CO;2-8; Conard NJ, 2012, QUATERN INT, V247, P236, DOI 10.1016/j.quaint.2011.05.043; Conard NJ, 2001, SETTLEMENT DYNAMICS, P7; Costamagno S, 2006, J ANTHROPOL ARCHAEOL, V25, P466, DOI 10.1016/j.jaa.2006.03.008; Cregut-Bonnoure E., 2002, OVIBOVINI CAPRINI MA; Daujeard C., 2011, HALTES CHASSE PREHIS, P77; Daujeard C, 2016, QUATERN INT, V411, P179, DOI 10.1016/j.quaint.2016.02.009; Daujeard C, 2012, QUATERN INT, V252, P32, DOI 10.1016/j.quaint.2011.01.047; Daujeard C, 2010, J ANTHROPOL ARCHAEOL, V29, P368, DOI 10.1016/j.jaa.2010.05.002; Defleur A, 2015, ANTHROPOLOGIE, V119, P170, DOI 10.1016/j.anthro.2015.04.002; Delagnes A., 2010, SYSTEME TECHNIQUES S; Delagnes A, 2011, J ARCHAEOL SCI, V38, P1771, DOI 10.1016/j.jas.2011.04.007; Deschamps M, 2017, QUATERN INT, V433, P33, DOI 10.1016/j.quaint.2016.01.043; Di Modica K, 2016, QUATERN INT, V411, P77, DOI 10.1016/j.quaint.2015.12.072; Di Modica K., 2010, CONTRAINTES NATURELL, P307; Garralda MD, 2014, J HUM EVOL, V75, P1, DOI 10.1016/j.jhevol.2014.02.019; Domingo R, 2017, QUATERN INT, V435, P129, DOI 10.1016/j.quaint.2015.09.088; Doronichev V, 2016, QUATERN INT, V409, P222, DOI 10.1016/j.quaint.2015.05.063; Ecker M, 2013, J HUM EVOL, V65, P363, DOI 10.1016/j.jhevol.2013.06.013; Embry A.F., 1971, B CAN PETROL GEOL, V19, P730, DOI DOI 10.35767/GSCPGBULL.19.4.730; Evans JA, 2010, J GEOL SOC LONDON, V167, P1, DOI 10.1144/0016-76492009-090; Faure G., 2005, ISOTOPES PRINCIPLES, VThird; FEBLOTAUGUSTINS J, 1993, J ANTHROPOL ARCHAEOL, V12, P211, DOI 10.1006/jaar.1993.1007; Fernandes P., 2010, RIV SCI PREISTORICHE, VLVII, P31; Fernandes P, 2012, THESIS; Fernandes P., 2006, MEMOIRE DIPLOME EHES; Fernandes P, 2008, J ARCHAEOL SCI, V35, P2357, DOI 10.1016/j.jas.2008.02.012; Fernandes P, 2007, CR PALEVOL, V6, P557, DOI 10.1016/j.crpv.2007.09.015; Fernandes P, 2006, CR PALEVOL, V5, P981, DOI 10.1016/j.crpv.2006.09.009; Fernandes P, 2006, CR PALEVOL, V5, P829, DOI 10.1016/j.crpv.2006.04.002; Frei R, 2013, APPL GEOCHEM, V38, P147, DOI 10.1016/j.apgeochem.2013.09.007; Gamble C, 1998, WORLD ARCHAEOL, V29, P426, DOI 10.1080/00438243.1998.9980389; Gaudzinski S, 2000, J HUM EVOL, V38, P497, DOI 10.1006/jhev.1999.0359; Geneste J.-M., 1999, BISON GIBIER MOYEN S, P185; Geneste J.-M., 1988, ETUDES RECHERCHES AR, V35, P61; Geneste J-M., 1997, PALEO REV ARCHEOL PR, V9, P101; Goyal E., 2012, PEUPLEMENTS NEANDERT; Graetsch HA, 2012, ARCHAEOMETRY, V54, P18, DOI 10.1111/j.1475-4754.2011.00610.x; Grayson DK, 2002, J ARCHAEOL SCI, V29, P1439, DOI 10.1006/jasc.2002.0806; Grove M, 2009, J ANTHROPOL ARCHAEOL, V28, P222, DOI 10.1016/j.jaa.2009.01.003; Hans U, 2013, EARTH PLANET SC LETT, V374, P204, DOI 10.1016/j.epsl.2013.05.029; Hardaker T, 2012, P GEOLOGIST ASSOC, V123, P692, DOI 10.1016/j.pgeola.2012.05.009; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Khun S., 1995, MOUSTERIAN LITHIC TE; Koehler H, 2016, BULL SOC PREHIST FR, V113, P429; Kowalewski SA, 2008, J ARCHAEOL RES, V16, P225, DOI 10.1007/s10814-008-9020-8; Kozlowski JK, 2014, QUATERN INT, V326, P344, DOI 10.1016/j.quaint.2013.08.020; KUHN SL, 1992, J ANTHROPOL RES, V48, P185, DOI 10.1086/jar.48.3.3630634; Lavin L., 1992, N AM ARCHAEOL, V13, P97, DOI DOI 10.2190/WFXT-26NX-XBP6-X09D; Le Ribault L., 1975, EXOSCOPIE METHODE AP; Lugli F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09007-5; Machado J, 2013, J ARCHAEOL SCI, V40, P2254, DOI 10.1016/j.jas.2013.01.002; Lopez-Garcia JM, 2012, QUATERNARY SCI REV, V43, P33, DOI 10.1016/j.quascirev.2012.04.008; Masaoudi H., 1994, QUATERNAIRE, V5, P79; Masson A., 1981, THESIS, P1035; Maurer AF, 2012, SCI TOTAL ENVIRON, V433, P216, DOI 10.1016/j.scitotenv.2012.06.046; MCARTHUR JM, 1994, TERRA NOVA, V6, P331, DOI 10.1111/j.1365-3121.1994.tb00507.x; Moncel M.-H., 2007, ANTHROPOLOGIE BRNO, VXLV, P7; Moncel M -H, 2002, TABLE RONDE INT MATI, P227; Moncel M -H, 2003, BAR IS, V1184; Moncel M-H, 1997, BSPF, V94, P68; Moncel MH, 2008, CR PALEVOL, V7, P441, DOI 10.1016/j.crpv.2008.07.004; Moncel MH, 2008, J ANTHROPOL ARCHAEOL, V27, P382, DOI 10.1016/j.jaa.2008.03.005; Moncel MH, 2007, ANTHROPOLOGIE, V111, P211, DOI 10.1016/j.anthro.2007.05.001; Moncel MH, 2015, QUATERN INT, V378, P22, DOI 10.1016/j.quaint.2013.12.009; Moncel MH, 2014, QUATERN INT, V350, P180, DOI 10.1016/j.quaint.2014.05.013; Moncel MH, 2011, J ANTHROPOL RES, V67, P47, DOI 10.3998/jar.0521004.0067.104; Moncel MH, 2011, VERTEBR PALEOBIOL PA, P261, DOI 10.1007/978-94-007-0415-2_22; Moncel MH, 2012, QUATERN INT, V247, P103, DOI 10.1016/j.quaint.2010.10.030; Moncel MH, 2009, J ARCHAEOL SCI, V36, P1892, DOI 10.1016/j.jas.2009.04.018; Moncel MH, 1996, CR ACAD SCI II A, V322, P251; Moncel MH, 2014, TRANSITIONS RUPTURES, V2, P43; Moncel MH, 2002, B SOC PREHISTORIQUE, V99, P249, DOI DOI 10.3406/bspf.2002.12656; Moncel MH, 2008, MEMOIRE SOC PREHISTO, V46; Montgomery J, 2007, APPL GEOCHEM, V22, P1502, DOI 10.1016/j.apgeochem.2007.02.009; MOORE LJ, 1982, J RES NAT BUR STAND, V87, P1, DOI 10.6028/jres.087.001; Neruda P, 2017, QUATERN INT, V435, P58, DOI 10.1016/j.quaint.2015.10.028; Niven L, 2012, J HUM EVOL, V63, P624, DOI 10.1016/j.jhevol.2012.07.002; Nowell GM, 2009, J ARCHAEOL SCI, V36, P1334, DOI 10.1016/j.jas.2009.01.019; Pedergnana A, 2018, ARCHAEOL ANTHROP SCI, V10, P369, DOI 10.1007/s12520-016-0368-2; Peresani M, 2012, QUATERN INT, V247, P125, DOI 10.1016/j.quaint.2011.02.006; Picin A, 2016, CR PALEVOL, V15, P581, DOI 10.1016/j.crpv.2015.09.012; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Purdy B.A., 1987, ADV ARCHAEOLOGICAL M, V11, P211; Raynal J. -P., 2012, BAR INT SERIES, V2400, P53; Raynal J -P, 2008, BAR IINT SERIES S, V1725, P141; Raynal Jean-Paul, 2013, Quartaer, V60, P29; Richards M, 2008, J ARCHAEOL SCI, V35, P1251, DOI 10.1016/j.jas.2007.08.018; Richards M, 2009, J ARCHAEOL SCI, V36, P1657, DOI 10.1016/j.jas.2009.03.009; Richter Juergen, 2006, P51; Rios-Garaizar J, 2015, CR PALEVOL, V14, P233, DOI 10.1016/j.crpv.2014.11.006; Rivals F, 2009, J ARCHAEOL SCI, V36, P1070, DOI 10.1016/j.jas.2008.12.009; Roebroeks W., 1999, MIDDLE PALAEOLITHIC, P121; Roebroeks W., 1988, ANALECTA PRAEHISTORI, V21; Rolland N., 2001, SETTLEMENT DYNAMICS, P545; Rosell J, 2010, QUATERNAIRE, V21, P139; Rufa A, 2016, QUATERN INT, V421, P46, DOI 10.1016/j.quaint.2015.05.016; Sanchez-Hernandez C, 2014, J ARCHAEOL SCI, V49, P317, DOI 10.1016/j.jas.2014.06.002; Seronie-Vivien M, 1987, B SOC LINNEENNE BORD, V15; Shea J., 1997, CURR ANTHROPOL, V39, P45; Slovak NM, 2012, HDB ENV ISOTOPE GEOC; Smith TM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau9483; Texier P, 1998, EC PREHISTORIQUE COM, P325; Texier P.-J., 2005, TERRITOIRES DEPLACEM, V16, P115; Thiebaut C, 2009, BULL SOC PREHIST FR, V106, P239, DOI 10.3406/bspf.2009.13847; Thiebaut C, 2012, QUATERN INT, V247, P182, DOI 10.1016/j.quaint.2011.05.028; THIRLWALL MF, 1991, CHEM GEOL, V94, P85, DOI 10.1016/0168-9622(91)90002-E; Thiry M, 2014, EARTH-SCI REV, V136, P141, DOI 10.1016/j.earscirev.2014.05.008; Turq A., 1990, CHASSEURS AUROCHS BO, P69, DOI [10.4000/books.editionsmsh.36013, DOI 10.4000/BOOKS.EDITIONSMSH.36013]; Turq A, 2017, QUATERN INT, V433, P88, DOI 10.1016/j.quaint.2016.02.062; Valladas H, 2008, QUAT GEOCHRONOL, V3, P377, DOI 10.1016/j.quageo.2008.01.001; Vaquero M, 2018, J ARCHAEOL METHOD TH, V25, P334, DOI 10.1007/s10816-017-9339-x; Vaquero M, 2012, QUATERN INT, V247, P162, DOI 10.1016/j.quaint.2010.12.015; Willmes M, 2016, J ARCHAEOL SCI, V70, P102, DOI 10.1016/j.jas.2016.04.017; Willmes M, 2014, EARTH SYST SCI DATA, V6, P117, DOI 10.5194/essd-6-117-2014; Willmes M, 2018, APPL GEOCHEM, V90, P75, DOI 10.1016/j.apgeochem.2017.12.025; Wilson L, 2014, J HUM EVOL, V75, P28, DOI 10.1016/j.jhevol.2013.12.018	148	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214925	10.1371/journal.pone.0214925	http://dx.doi.org/10.1371/journal.pone.0214925			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943255	Green Submitted, Green Published, gold			2022-12-27	WOS:000463194300071
J	Pau, MC; Pantaleo, A; Tsamesidis, I; Hoang, H; Tran, AT; Nguyen, TLH; Phan, THG; Nu, PAT; Ngo, TMC; Marchetti, G; Schwarzer, E; Fiori, PL; Low, PS; Huynh, CD; Turrini, FM				Pau, Maria Carmina; Pantaleo, Antonella; Tsamesidis, Ioannis; Ha Hoang; Anh Tuan Tran; Thi Lien Hanh Nguyen; Thi Hang Giang Phan; Phuong Anh Ton Nu; Thi Minh Chau Ngo; Marchetti, Giuseppe; Schwarzer, Evelin; Fiori, Pier Luigi; Low, Philip S.; Chien Dinh Huynh; Turrini, Francesco Michelangelo			Clinical impact of the two ART resistance markers, K13 gene mutations and DPC3 in Vietnam	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; EMERGING ARTEMISININ RESISTANCE; DIHYDROARTEMISININ-PIPERAQUINE; PARASITE CLEARANCE; MULTIDRUG-RESISTANCE; WESTERN CAMBODIA; MYANMAR BORDER; SPREAD; PROPELLER; PROVINCE	Background In Vietnam, a rapid decline of P. falciparum malaria cases has been documented in the past years, the number of Plasmodium falciparum malaria cases has rapidly decreased passing from 19.638 in 2012 to 4.073 cases in 2016. Concomitantly, the spread of artemisinin resistance markers is raising concern on the future efficacy of the ACTs. An evaluation of the clinical impact of the artemisinin resistance markers is therefore of interest. Methods The clinical effectiveness of dihydroartemisinin-piperaquine therapy (DHA-PPQ) has been evaluated in three districts characterized by different rates of ART resistance markers: K13 (C580Y) mutation and delayed parasite clearance on day 3 (DPC3). Patients were stratified in 3 groups a) no markers, b) one marker (suspected resistance), c) co-presence of both markers (confirmed resistance). In the studied areas, the clinical effectiveness of DHA-PPQ has been estimated as malaria recrudescence within 60 days. Results The rate of K13(C580Y) ranged from 75.8% in Krong Pa to 1.2% in Huong Hoa district. DPC3 prevalence was higher in Krong Pa than in Huong Hoa (86.2% vs 39.3%). In the two districts, the prevalence of confirmed resistance was found in 69.0% and 1.2% of patients, respectively. In Thuan Bac district, we found intermediate prevalence of confirmed resistance. Treatment failure was not evidenced in any district. PPQ resistance was not evidenced. Confirmed resistance was associated to the persistence of parasites on day 28 and to 3.4-fold higher parasite density at diagnosis. The effectiveness of malaria control strategies was very high in the studied districts. Conclusion No treatment failure has been observed in presence of high prevalence of ART resistance and in absence of PPQ resistance. K13(C580Y) was strongly associated to higher parasitemia at admission, on days 3 and 28. Slower parasite clearance was also observed in younger patients.	[Pau, Maria Carmina; Pantaleo, Antonella; Tsamesidis, Ioannis; Marchetti, Giuseppe; Fiori, Pier Luigi] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Ha Hoang] Duy Tan Univ, Danang, Vietnam; [Anh Tuan Tran] Huong Hoa Dist Hlth Ctr, Quang Tri, Vietnam; [Thi Lien Hanh Nguyen] Quy Nhon Inst Malaria Parasitol & Entomol, Quy Nhon, Vietnam; [Thi Hang Giang Phan] Hue Univ, Dept Immunol & Pathophysiol, Hue City, Vietnam; [Phuong Anh Ton Nu; Thi Minh Chau Ngo] Hue Univ, Dept Parasitol, Hue City, Vietnam; [Schwarzer, Evelin; Turrini, Francesco Michelangelo] Univ Turin, Dept Oncol, Turin, Italy; [Low, Philip S.] Purdue Univ, Purdue Ctr Drug Discovery, W Lafayette, IN 47907 USA; [Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Chien Dinh Huynh] VINMEC Heath Care Syst, Hanoi, Vietnam	University of Sassari; Duy Tan University; Hue University; Hue University; University of Turin; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pantaleo, A (corresponding author), Univ Sassari, Dept Biomed Sci, Sassari, Italy.	apantaleo@uniss.it	Tran, Anh Tuan/GZB-0391-2022; Pantaleo, Antonella/ABA-5190-2020; TSAMESIDIS, IOANNIS/AAL-7655-2021; Fiori, Pier Luigi/GVU-9300-2022	Fiori, Pier Luigi/0000-0001-6190-612X; Ngo, Thi Minh Chau/0000-0001-9016-4436; Phan, Thi Hang Giang/0000-0002-2247-8043; Tsamesidis, Ioannis/0000-0002-1439-3920	Legge Regionale 7 Agosto 2007, N 7: "Promozione della ricerca scientifica ed innovazione tecnologica in Sardegna"; Hulow Company (USA)	Legge Regionale 7 Agosto 2007, N 7: "Promozione della ricerca scientifica ed innovazione tecnologica in Sardegna"; Hulow Company (USA)	This study was supported by grants from Legge Regionale 7 Agosto 2007, N 7: "Promozione della ricerca scientifica ed innovazione tecnologica in Sardegna" and (in part) by research funding by a grant from Hulow Company (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ataide R, 2017, P NATL ACAD SCI USA, V114, P3515, DOI 10.1073/pnas.1615875114; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Phuc BQ, 2017, EMERG INFECT DIS, V23, P715, DOI 10.3201/eid2304.161872; Chookajorn T, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006923; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duru V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0539-5; Hanboonkunupakarn B, 2016, TRAVEL MED INFECT DI, V14, P548, DOI 10.1016/j.tmaid.2016.11.016; Hastings IM, 2015, ANTIMICROB AGENTS CH, V59, P6428, DOI 10.1128/AAC.00481-15; Huang F, 2015, J INFECT DIS, V212, P1629, DOI 10.1093/infdis/jiv249; Imwong M, 2017, LANCET INFECT DIS, V17, P1022, DOI 10.1016/S1473-3099(17)30524-8; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/s1473-3099(17)30048-8, 10.1016/S1473-3099(17)30048-8]; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Lamikanra AA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-201; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Matsuoka H, 2007, ACTA MED OKAYAMA, V61, P213; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ministry of Health Portal VietNam, 2009, GUID MAL DIAGN TREAT; Mintel Mintel's Traditional Toys and Games US, 2016, REP; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Myint MK, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1775-2; Na-Bangchang K, 2013, EXPERT REV CLIN PHAR, V6, P307, DOI [10.1586/ecp.13.17, 10.1586/ECP.13.17]; Thanh NV, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1680-8; Nguyen TH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-152; Nguyen TN, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01578-16, 10.1128/AAC.01578-16]; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nyunt MH, 2015, CLIN INFECT DIS, V60, P1208, DOI 10.1093/cid/ciu1160; Pantaleo A, 2015, J INFECT DEV COUNTR, V9, P597, DOI 10.3855/jidc.7015; Phyo AP, 2016, CLIN INFECT DIS, V63, P784, DOI 10.1093/cid/ciw388; Scott N, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2418-y; Spring MD, 2015, LANCET INFECT DIS, V15, P683, DOI 10.1016/S1473-3099(15)70049-6; Thriemer K, 2014, ANTIMICROB AGENTS CH, V58, P7049, DOI 10.1128/AAC.02746-14; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Tun KM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1240-7; Wang ZL, 2015, ANTIMICROB AGENTS CH, V59, P6952, DOI 10.1128/AAC.01255-15; WHO, 2018, ART RES ART BAS COMB; WHO, 2015, STAT REP ART ACI RES; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI [10.1016/S1473-3099(16)30415-7, 10.1016/s1473-3099(16)30415-7]; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2012, UPD ART RES APR; World Health Organization, 2017, STAT REP ART ACT RES; World Health Organization, 2014, STAT REP ART RES SEP; World Health Organization, 2011, UPD ART RES SEPT; World Health Organization, 2018, STAT REP ART RES ACT; World Health Organization, 2014, STAT REP ART RES JAN	49	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214667	10.1371/journal.pone.0214667	http://dx.doi.org/10.1371/journal.pone.0214667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939179	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900034
J	Lekamge, S; Miranda, AF; Ball, AS; Shukla, R; Nugegoda, D				Lekamge, Sam; Miranda, Ana F.; Ball, Andrew S.; Shukla, Ravi; Nugegoda, Dayanthi			The toxicity of coated silver nanoparticles to Daphnia carinata and trophic transfer from alga Raphidocelis subcapitata	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; ZINC-OXIDE; GOLD NANOPARTICLES; PSEUDOKIRCHNERIELLA-SUBCAPITATA; CHLAMYDOMONAS-REINHARDTII; ENGINEERED NANOPARTICLES; AGGREGATION KINETICS; OXIDATIVE STRESS; SURFACE-CHARGE; FOOD-CHAIN	Nanoparticles (NPs) are causing threats to the environment. Silver NPs (AgNPs) are increasingly used in commercial products and may end up in freshwater ecosystems. The freshwater organisms are vulnerable due to water-borne and dietary exposure to AgNPs. Surface properties play an important role in the fate and behavior of AgNPs in the aquatic environment and their effects on organisms. However, effects of surface properties of AgNPs on organisms are poorly understood. In this study, we explored the effects of AgNPs coated with three different ligands; Tyrosine (T-AgNP), Epigallocatechin gallate (E-AgNP) and Curcumin (C-AgNP) in relation to the toxicity to a key aquatic organism; Daphnia carinata. The study focused on how coatings determine fate of NPs in the medium, mortality, feeding behaviour, bioaccumulation and trophic transfer from the freshwater alga, Raphidocelis subcapitata to daphnids. NP stability tests indicated that T-AgNPs were least stable in the ASTM daphnia medium while C-AgNPs were most stable. 48 h EC50 values of AgNPs to D. carinata were in the order of E-AgNP (19.37 mu g L-1) > C-AgNP (21.37 mu g L-1) > T-AgNP (49.74 g L-1) while the 48 h EC50 value of Ag+ ions was 1.21 mu g L-1. AgNP contaminated algae significantly decreased the feeding rates of daphnids. However, no significant differences were observed in feeding rates between algae contaminated with differently coated AgNPs. Trophic transfer studies showed that AgNPs were transferred from algae to daphnids. The bioacumulation of AgNPs in algae and the diet-borne bioaccumulation of AgNPs in daphnids varied for differently coated AgNPs. Bioaccumulation of C-AgNPs in algae was 1.5 time higher than T-AgNPs. However, the accumulation of T-AgNPs in daphnids via trophic transfer was 2.6 times higher than T-AgNPs. The knowledge generated from this study enhances the understanding of surface property dependent toxicity, bioaccumulation and trophic transfer of AgNPs in aquatic environments.	[Lekamge, Sam; Miranda, Ana F.; Nugegoda, Dayanthi] RMIT Univ, Sch Sci, Ecotoxicol Res Grp, Bundoora, Vic, Australia; [Lekamge, Sam; Ball, Andrew S.; Nugegoda, Dayanthi] RMIT Univ, Sch Sci, Ctr Environm Sustainabil & Remediat, Bundoora, Vic, Australia; [Shukla, Ravi] RMIT Univ, Sch Sci, Nanobiotechnol Res Lab NBRL, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Lekamge, S (corresponding author), RMIT Univ, Sch Sci, Ecotoxicol Res Grp, Bundoora, Vic, Australia.	samlekamge@gmail.com	Miranda, Ana F/AAI-6109-2020; Lekamge, Sam/S-6055-2019	Miranda, Ana F/0000-0003-3941-975X; Lekamge, Sam/0000-0001-5546-3668; Shukla, Ravi/0000-0002-1537-9637; Ball, Andrew/0000-0003-2387-968X; Nugegoda, Dayanthi/0000-0002-6327-4581				Abramenko NB, 2018, J HAZARD MATER, V347, P89, DOI 10.1016/j.jhazmat.2017.12.060; Ahmad N, 2010, COLLOID SURFACE B, V81, P81, DOI 10.1016/j.colsurfb.2010.06.029; Allen HJ, 2010, ENVIRON TOXICOL CHEM, V29, P2742, DOI 10.1002/etc.329; ALLEN Y, 1995, ENVIRON TOXICOL CHEM, V14, P1625, DOI 10.1002/etc.5620140923; Artells E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071260; Asghari S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-14; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Barry MJ, 2000, CHEMOSPHERE, V41, P1669, DOI 10.1016/S0045-6535(00)00091-6; Baumann J, 2014, SCI TOTAL ENVIRON, V484, P176, DOI 10.1016/j.scitotenv.2014.03.023; Becaro AA., 2015, ENV NANOTECHNOL MONI, V3, P22, DOI DOI 10.1016/J.ENMM.2014.11.002; Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002; Behra R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0396; Bhuvaneshwari M, 2018, ENVIRON RES, V164, P395, DOI 10.1016/j.envres.2018.03.015; Bhuvaneshwari M, 2017, AQUAT TOXICOL, V183, P63, DOI 10.1016/j.aquatox.2016.12.013; Bianchini A, 2003, ENVIRON TOXICOL CHEM, V22, P1361, DOI [10.1002/etc.5620220624, 10.1897/1551-5028(2003)022&lt;1361:MOASTI&gt;2.0.CO;2]; Blinova I, 2013, ENVIRON SCI POLLUT R, V20, P3456, DOI 10.1007/s11356-012-1290-5; Bolch CJS, 1996, J APPL PHYCOL, V8, P5, DOI 10.1007/BF02186215; Bouldin JL, 2008, ENVIRON TOXICOL CHEM, V27, P1958, DOI 10.1897/07-637.1; Brant J, 2005, J NANOPART RES, V7, P545, DOI 10.1007/s11051-005-4884-8; Bundschuh M, 2016, FRESHWATER BIOL; Cecchin I, 2017, INT BIODETER BIODEGR, V119, P419, DOI 10.1016/j.ibiod.2016.09.027; Chae Y, 2016, AQUAT TOXICOL, V173, P94, DOI 10.1016/j.aquatox.2016.01.011; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Cruz D, 2010, COLLOID SURFACE B, V81, P67, DOI 10.1016/j.colsurfb.2010.06.025; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; Daima HK, 2014, NANOSCALE, V6, P758, DOI 10.1039/c3nr03806h; Djurisic AB, 2015, SMALL, V11, P26, DOI 10.1002/smll.201303947; Dominguez GA, 2015, AQUAT TOXICOL, V162, P1, DOI 10.1016/j.aquatox.2015.02.015; Dubey K, 2015, AMINO ACIDS, V47, P2551, DOI 10.1007/s00726-015-2046-6; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; El Badawy AM, 2010, ENVIRON SCI TECHNOL, V44, P1260, DOI 10.1021/es902240k; El Khoury E, 2015, COLLOID SURFACE B, V127, P274, DOI 10.1016/j.colsurfb.2015.01.050; Elimelech M., 1995, PARTICLE DEPOSITION, DOI [10.1016/B978-0-7506-7024-1.X5000-6, DOI 10.1016/B978-0-7506-7024-1.X5000-6]; Erbis S, 2016, REV RES TRENDS METHO; Freitas EC, 2011, ARCH ENVIRON CON TOX, V60, P241, DOI 10.1007/s00244-010-9541-2; Gardea-Torresdey JL, 2014, ENVIRON SCI TECHNOL, V48, P2526, DOI 10.1021/es4050665; Gillis PL, 2005, AQUAT TOXICOL, V71, P143, DOI 10.1016/j.aquatox.2004.10.016; Grintzalis K, 2017, ECOTOX ENVIRON SAFE, V139, P352, DOI 10.1016/j.ecoenv.2017.02.002; Hamers RJ, 2017, ACCOUNTS CHEM RES, V50, P633, DOI 10.1021/acs.accounts.6b00634; Hanazato T, 2001, ENVIRON POLLUT, V112, P1, DOI 10.1016/S0269-7491(00)00110-X; Hoheisel SM, 2012, ENVIRON TOXICOL CHEM, V31, P2557, DOI 10.1002/etc.1978; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Huynh KA, 2011, ENVIRON SCI TECHNOL, V45, P5564, DOI 10.1021/es200157h; Jak RG, 1996, WATER RES, V30, P1215, DOI 10.1016/0043-1354(95)00272-3; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; JONES M, 1991, FRESHWATER BIOL, V26, P35, DOI 10.1111/j.1365-2427.1991.tb00506.x; Kalman J, 2015, ENVIRON CHEM, V12, P662, DOI 10.1071/EN15035; Karimi M, 2018, TRENDS FOOD SCI TECH; Keller AA, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1692-4; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; KIERDASZUK B, 1995, PHOTOCHEM PHOTOBIOL, V61, P319, DOI 10.1111/j.1751-1097.1995.tb08615.x; Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p; Klaine SJ, 2012, ENVIRON TOXICOL CHEM, V31, P3, DOI 10.1002/etc.733; Koser J, 2017, ENVIRON SCI-NANO, V4, P1470, DOI [10.1039/c7en00026j, 10.1039/C7EN00026J]; Larguinho M, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2549-1; Lee WM, 2015, ENVIRON POLLUT, V201, P10, DOI 10.1016/j.envpol.2015.02.021; Levard C, 2013, ENVIRON SCI TECHNOL, V47, P5738, DOI 10.1021/es400396f; Li LZ, 2015, ECOTOX ENVIRON SAFE, V119, P66, DOI 10.1016/j.ecoenv.2015.05.005; Li Y, 2017, ARCH TOXICOL, V91, P509, DOI 10.1007/s00204-016-1730-y; Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Lopes S, 2014, ENVIRON TOXICOL CHEM, V33, P190, DOI 10.1002/etc.2413; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e; Lu GH, 2017, WATER AIR SOIL POLL, V228, DOI 10.1007/s11270-016-3206-3; Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s; McTeer J, 2014, NANOTOXICOLOGY, V8, P305, DOI 10.3109/17435390.2013.778346; Mendonca E, 2011, J HAZARD MATER, V186, P265, DOI 10.1016/j.jhazmat.2010.10.115; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Miao AJ, 2010, ENVIRON TOXICOL CHEM, V29, P2814, DOI 10.1002/etc.340; MOORE M, 1993, TRENDS ECOL EVOL, V8, P178, DOI 10.1016/0169-5347(93)90144-E; Newton KM, 2013, ENVIRON TOXICOL CHEM, V32, P2356, DOI 10.1002/etc.2300; Nowack B, 2011, ENVIRON SCI TECHNOL, V45, P1177, DOI 10.1021/es103316q; OECD, 2011, TEST 201 FRESHW ALG, DOI [10.1787/9789264069923-en., DOI 10.1787/9789264069923-EN.]; OECD, 2004, OECD GUIDELINES TEST, DOI [10.1787/9789264069947-en, DOI 10.1787/9789264069947-EN]; Petersen EJ, 2009, ENVIRON SCI TECHNOL, V43, P2969, DOI 10.1021/es8029363; Piccapietra F, 2012, ENVIRON SCI TECHNOL, V46, P7390, DOI 10.1021/es300734m; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Ribeiro F, 2017, SCI TOTAL ENVIRON, V574, P1633, DOI 10.1016/j.scitotenv.2016.08.204; Ribeiro F, 2014, SCI TOTAL ENVIRON, V466, P232, DOI 10.1016/j.scitotenv.2013.06.101; Rodrigues M.A., 2012, AM J CHEM, V2, P157, DOI DOI 10.5923/j.chemistry.20120203.10; Rodriguez-Leon E, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-318; Romer I, 2011, J CHROMATOGR A, V1218, P4226, DOI 10.1016/j.chroma.2011.03.034; Sager TM, 2007, NANOTOXICOLOGY, V1, P118, DOI 10.1080/17435390701381596; Sakamoto M, 2015, ARCH ENVIRON CON TOX, V68, P500, DOI 10.1007/s00244-014-0091-x; Schluesener JK, 2013, ARCH TOXICOL, V87, P569, DOI 10.1007/s00204-012-1007-z; Seitz F, 2015, ECOTOX ENVIRON SAFE, V111, P263, DOI 10.1016/j.ecoenv.2014.09.031; Selvakannan PR, 2004, LANGMUIR, V20, P7825, DOI 10.1021/la049258j; Seo J, 2014, B ENVIRON CONTAM TOX, V93, P257, DOI 10.1007/s00128-014-1337-z; Shen MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09674; Shukla R, 2012, P NATL ACAD SCI USA, V109, P12426, DOI 10.1073/pnas.1121174109; Silva LP, 2017, NANO STR MED, P577, DOI 10.1016/B978-0-323-46152-8.00026-3; Silva T, 2014, SCI TOTAL ENVIRON, V468, P968, DOI 10.1016/j.scitotenv.2013.09.006; Skjolding LM, 2014, AQUAT TOXICOL, V157, P101, DOI 10.1016/j.aquatox.2014.10.005; Snitsarev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079834; Stebounova LV, 2011, J NANOPART RES, V13, P233, DOI 10.1007/s11051-010-0022-3; Taylor G, 1998, ENVIRON TOXICOL CHEM, V17, P412, DOI 10.1002/etc.5620170310; Tejamaya M, 2012, ENVIRON SCI TECHNOL, V46, P7011, DOI 10.1021/es2038596; Van Hoecke K, 2008, ENVIRON TOXICOL CHEM, V27, P1948, DOI 10.1897/07-634.1; Vance ME, 2015, BEILSTEIN J NANOTECH, V6, P1769, DOI 10.3762/bjnano.6.181; Varaprasad K, 2011, J APPL POLYM SCI, V121, P784, DOI 10.1002/app.33508; Wong SWY, 2010, ANAL BIOANAL CHEM, V396, P609, DOI 10.1007/s00216-009-3249-z; Wu F, 2017, AQUAT TOXICOL, V190, P78, DOI 10.1016/j.aquatox.2017.06.021; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Yeo MK, 2013, ENVIRON POLLUT, V178, P166, DOI 10.1016/j.envpol.2013.03.040; Zhang W, 2011, ENVIRON SCI TECHNOL, V45, P4422, DOI 10.1021/es104205a; Zhao CM, 2012, ENVIRON SCI TECHNOL, V46, P11345, DOI 10.1021/es3014375; Zhao CM, 2012, NANOTOXICOLOGY, V6, P361, DOI 10.3109/17435390.2011.579632; Zhao CM, 2011, ENVIRON TOXICOL CHEM, V30, P885, DOI 10.1002/etc.451; Zhao CM, 2010, ENVIRON SCI TECHNOL, V44, P7699, DOI 10.1021/es101484s; Zhou DX, 2010, WATER RES, V44, P2948, DOI 10.1016/j.watres.2010.02.025; Zhu XS, 2010, CHEMOSPHERE, V79, P928, DOI 10.1016/j.chemosphere.2010.03.022; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013	116	19	19	17	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214398	10.1371/journal.pone.0214398	http://dx.doi.org/10.1371/journal.pone.0214398			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943225	Green Published, Green Submitted, gold			2022-12-27	WOS:000463194300035
J	Ponnan, SM; Pattabiram, S; Thiruvengadam, K; Goyal, R; Singla, N; Mukherjee, J; Chatrath, S; Bergin, P; Kopycinski, JT; Gilmour, J; Kumar, S; Muthu, M; Subramaniam, S; Swaminathan, S; Tripathy, SP; Luke, HE				Ponnan, Sivasankaran Munusamy; Pattabiram, Sathyamurthy; Thiruvengadam, Kannan; Goyal, Rajat; Singla, Nikhil; Mukherjee, Joyeeta; Chatrath, Shweta; Bergin, Philip; Kopycinski, Jakub T.; Gilmour, Jill; Kumar, Sriram; Muthu, Malathy; Subramaniam, Sudha; Swaminathan, Soumya; Tripathy, Srikanth Prasad; Luke, Hanna Elizabeth			Induction and maintenance of bi-functional (IFN-gamma(+) IL-2(+) and IL-2(+) TNF-alpha(+))T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India	PLOS ONE			English	Article							CD8(+) T-CELLS; IMMUNE-RESPONSES; HIV; IMMUNIZATION; IMMUNOGENICITY; PROTECTION; VIREMIA; BROAD; ADENOVIRUS; SAFETY	Effective vaccine design relies on accurate knowledge of protection against a pathogen, so as to be able to induce relevant and effective protective responses against it. An ideal Human Immunodeficiency virus (HIV) vaccine should induce humoral as well as cellular immune responses to prevent initial infection of host cells or limit early events of viral dissemination. A Phase I HIV-1 prophylactic vaccine trial sponsored by the International AIDS Vaccine Initiative (IAVI) was conducted in India in 2009.The trial tested a HIV-1 subtype C vaccine in a primeboost regimen, comprising of a DNA prime (ADVAX) and Modified Vaccine Ankara (MVA) (TBC-M4) boost. The trial reported that the vaccine regimen was safe, well tolerated, and resulted in enhancement of HIV-specific immune responses. However, preliminary immunological studies were limited to vaccine-induced IFN-gamma responses against the Env and Gag peptides. The present study is a retrospective study to characterize in detail the nature of the vaccine-induced cell mediated immune responses among volunteers, using Peripheral Blood Mononuclear Cells (PBMC) that were archived during the trial. ELISpot was used to measure IFN-gamma responses and polyfunctional T cells were analyzed by intracellular multicolor flow cytometry. It was observed that DNA priming and MVA boosting induced Env and Gag specific bi-functional and multi-functional CD4(+) and CD8(+) T cells expressing IFN-gamma, TNF-alpha and IL-2. The heterologous prime-boost regimen appeared to be slightly superior to the homologous prime-boost regimen in inducing favorable cell mediated immune responses. These results suggest that an in-depth analysis of vaccine-induced cellular immune response can aid in the identification of correlates of an effective immunogenic response, and inform future design of HIV vaccines.	[Ponnan, Sivasankaran Munusamy; Pattabiram, Sathyamurthy; Thiruvengadam, Kannan; Kumar, Sriram; Muthu, Malathy; Subramaniam, Sudha; Swaminathan, Soumya; Tripathy, Srikanth Prasad; Luke, Hanna Elizabeth] Indian Council Med Res, Natl Inst Res TB, Dept HIV, Chennai, Tamil Nadu, India; [Goyal, Rajat; Singla, Nikhil; Mukherjee, Joyeeta; Chatrath, Shweta] Int AIDS Vaccine Initiat, New Delhi, India; [Bergin, Philip; Kopycinski, Jakub T.; Gilmour, Jill] Imperial Coll, IAVI Human Immunol Lab, London, England; [Luke, Hanna Elizabeth] Natl Inst Res TB, Dept HIV AIDS, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Luke, HE (corresponding author), Indian Council Med Res, Natl Inst Res TB, Dept HIV, Chennai, Tamil Nadu, India.; Luke, HE (corresponding author), Natl Inst Res TB, Dept HIV AIDS, Chennai, Tamil Nadu, India.	hanna@nirt.res.in	Thiruvengadam, Kannan/AAQ-8532-2021	Thiruvengadam, Kannan/0000-0002-3758-1094; Tripathy, Srikanth/0000-0002-8363-2606	International AIDS Vaccine Initiative (IAVI); Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; The World Bank; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); USAID; United States Agency for International Development (USAID) [2233]	International AIDS Vaccine Initiative (IAVI); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; The World Bank; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); USAID(United States Agency for International Development (USAID)); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The vaccine trial and the present study were supported and coordinated by the International AIDS Vaccine Initiative (IAVI). IAVI's work is made possible by generous support from many donors including the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan in partnership with The World Bank, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation (NORAD), the United Kingdom Department for International Development (DFID), and the USAID. The full list of IAVI donors is available at www.iavi.org.This study was made possible by the generous support of the American people through funding from United States Agency for International Development (USAID; Grant ID: 2233). The contents are the responsibility of the authors does not necessarily reflect the views of USAID or the United States Government.	Bailey JR, 2009, J VIROL, V83, P88, DOI 10.1128/JVI.01958-08; Bakari M, 2011, VACCINE, V29, P8417, DOI 10.1016/j.vaccine.2011.08.001; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Bolhassani Azam, 2009, Avicenna Journal of Medical Biotechnology, V1, P71; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Boyd A, 2015, PLOS ONE, V10; Burgers WA, 2009, J GEN VIROL, V90, P468, DOI 10.1099/vir.0.004614-0; Buseyne F, 2002, J INFECT DIS, V186, P1589, DOI 10.1086/345482; Cebere I, 2006, VACCINE, V24, P417, DOI 10.1016/j.vaccine.2005.08.041; Cosma A, 2003, VACCINE, V22, P21, DOI 10.1016/S0264-410X(03)00538-3; Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Demers KR, 2013, IMMUNOL REV, V254, P190, DOI 10.1111/imr.12069; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Dyer WB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-112; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Fraser KA, 2013, IMMUNITY, V39, P171, DOI 10.1016/j.immuni.2013.07.003; Friedrich TC, 2008, CURR OPIN HIV AIDS, V3, P393, DOI 10.1097/COH.0b013e3282faa461; Ganusov VV, 2016, J IMMUNOL S, V196; Gaspari D, 2011, FORMATEX, P422; Gill DK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014330; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Graw F, 2014, J VIROL; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Hayes P, 2013, CLIN VACCINE IMMUNOL; Hayes PJ, 2016, AIDS, V30, P1703, DOI 10.1097/QAD.0000000000001122; Huang TX, 2008, JAIDS-J ACQ IMM DEF, V47, P403, DOI 10.1097/QAI.0b013e3181651b9d; Jones RB, 2016, J CLIN INVEST, V126, P455, DOI 10.1172/JCI80566; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Koopman G, 2008, J GEN VIROL, V89, P540, DOI 10.1099/vir.0.83384-0; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Koup RA, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007252; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Lee SH, 2015, HUM VACC IMMUNOTHER, V11, P1889, DOI 10.1080/21645515.2015.1035502; Leroux-Roels G, 2014, CLIN VACCINE IMMUNOL; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; McKinnon LR, 2008, JAIDS-J ACQ IMM DEF, V49, P123, DOI 10.1097/QAI.0b013e3181869a88; Mehendale S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055831; MOSS PAH, 1995, P NATL ACAD SCI USA, V92, P5773, DOI 10.1073/pnas.92.13.5773; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Papagno L, 2011, AIDS, V25, P27, DOI 10.1097/QAD.0b013e328340fe55; Paris RM, 2010, EXPERT REV VACCINES, V9, P1055, DOI 10.1586/ERV.10.106; Petrovas C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2285; Ponnan SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203037; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Rosa DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016921; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Stiles T, 2011, QUALITY SYSTEM LAB T, P1; Tritel M, 2003, J IMMUNOL, V171, P2538, DOI 10.4049/jimmunol.171.5.2538; Tung FY, 2016, VACCINE, V34, P2225, DOI 10.1016/j.vaccine.2016.03.021; Valor L, 2008, VACCINE, V26, P2738, DOI 10.1016/j.vaccine.2008.03.019; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008617; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11; Winstone N, 2009, EUR J IMMUNOL, V39, P975, DOI 10.1002/eji.200839167; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	71	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213911	10.1371/journal.pone.0213911	http://dx.doi.org/10.1371/journal.pone.0213911			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921340	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000462594000028
J	Jakubik, J; Randakova, A; El-Fakahany, EE; Dolezal, V				Jakubik, Jan; Randakova, Alena; El-Fakahany, Esam E.; Dolezal, Vladimir			Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators	PLOS ONE			English	Article							MOLECULAR-MECHANISM; LIGAND-BINDING; RECEPTOR; SITE; ACETYLCHOLINE; A(1)	Allosteric ligands bind to receptors at sites that are distinct from those endogenous agonists and orthosteric pharmacological agents interact with. Both an allosteric and orthosteric ligand bind simultaneously to the receptor to form a ternary complex, where each ligand influences binding affinity of the other to the receptor, either positively or negatively. Allosteric modulators are an intensively studied group of receptor ligands because of their potentially greater selectivity over orthosteric ligands, with the possibility of fine tuning of the effects of endogenous neurotransmitters and hormones. The affinity of an unlabelled allosteric ligand is commonly estimated by measuring its effects on binding of a radio-labelled orthosteric tracer. This scenario is complicated by many folds when one studies the kinetics of interactions of two allosteric agents, added simultaneously, on binding of an orthosteric tracer. In this paper, we provide, for the first time, theoretical basis for analysis of such complex interactions. We have expanded our analysis to include the possibility of having two allosteric modulators interact with the same or different sites on the receptor. An added value of our analysis is to provide a tool to distinguish between the two situations. Finally, we also modelled binding of two molecules of one allosteric modulator to one receptor.	[Jakubik, Jan; Randakova, Alena; Dolezal, Vladimir] CAS, Inst Physiol, Dept Neurochem, Prague, Czech Republic; [El-Fakahany, Esam E.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of Minnesota System; University of Minnesota Twin Cities	Jakubik, J (corresponding author), CAS, Inst Physiol, Dept Neurochem, Prague, Czech Republic.	jan.jakubik@fgu.cas.cz	Jakubik, Jan/B-7461-2012; Dolezal, Vladimir/A-8732-2008; Randáková, Alena/K-3445-2017	Jakubik, Jan/0000-0002-1737-1487; Dolezal, Vladimir/0000-0003-3412-256X; Randáková, Alena/0000-0002-8403-6494	Czech Academy of Sciences [RVO:67985823]; Grant Agency of the Czech Republic [P304/10/G069, 19-05318S]	Czech Academy of Sciences(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by the Czech Academy of Sciences institutional support [RVO:67985823] and the Grant Agency of the Czech Republic grant [P304/10/G069] and [19-05318S]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doornbos MLJ, 2016, BRIT J PHARMACOL, V173, P588, DOI 10.1111/bph.13390; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Guo D, 2014, BRIT J PHARMACOL, V171, P5295, DOI 10.1111/bph.12836; Hansen KB, 2018, J GEN PHYSIOL, V150, P1081, DOI 10.1085/jgp.201812032; Hill SJ, 2014, BRIT J PHARMACOL, V171, P1102, DOI 10.1111/bph.12345; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Jakubik J, 1997, MOL PHARMACOL, V52, P172, DOI 10.1124/mol.52.1.172; Jakubik J, 2016, NEUROMETHODS, V107, P95, DOI 10.1007/978-1-4939-2858-3_6; Jakubik J, 2014, MOL PHARMACOL, V86, P180, DOI 10.1124/mol.114.093310; Lazareno S, 2002, MOL PHARMACOL, V62, P1492, DOI 10.1124/mol.62.6.1492; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Lysikova M, 1999, BRIT J PHARMACOL, V127, P1240, DOI 10.1038/sj.bjp.0702646; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Noetzel MJ, 2013, MOL PHARMACOL, V83, P835, DOI 10.1124/mol.112.082891; Redka DS, 2008, MOL PHARMACOL, V74, P834, DOI 10.1124/mol.108.048074; Rovati GE, 1998, TRENDS PHARMACOL SCI, V19, P365; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Stoddart LA, 2016, BRIT J PHARMACOL, V173, P3028, DOI 10.1111/bph.13316; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; Uddin R, 2018, METHODS, V147, P213, DOI 10.1016/j.ymeth.2018.02.018	22	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214255	10.1371/journal.pone.0214255	http://dx.doi.org/10.1371/journal.pone.0214255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917186	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800057
J	Nomoto, S; Kinno, R; Ochiai, H; Kubota, S; Mori, Y; Futamura, A; Sugimoto, A; Kuroda, T; Yano, S; Murakami, H; Shirasawa, T; Yoshimoto, T; Minoura, A; Kokaze, A; Ono, K				Nomoto, Shohei; Kinno, Ryuta; Ochiai, Hirotaka; Kubota, Satomi; Mori, Yukiko; Futamura, Akinori; Sugimoto, Azusa; Kuroda, Takeshi; Yano, Satoshi; Murakami, Hidetomo; Shirasawa, Takako; Yoshimoto, Takahiko; Minoura, Akira; Kokaze, Akatsuki; Ono, Kenjiro			The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer's disease	PLOS ONE			English	Article							STIMULATING HORMONE; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DEMENTIA; RISK; SPECT; RECOMMENDATIONS; HYPOTHYROIDISM; QUANTIFICATION	The thyroid hormones have been reported to be associated with cognitive decline and Alzheimer's disease. The relationship between thyroid function within the normal range and cerebral blood flow in Alzheimer's disease patients has been shown in a recent study. Mild cognitive impairment is often the first stage of Alzheimer's disease; thus, early diagnosis is important. The present study investigated the relationship between thyroid function and regional cerebral blood flow in patients with mild cognitive impairment and Alzheimer's disease. A total of 122 memory clinic outpatients who underwent thyroid function testing and single photon emission computed tomography were divided into mild cognitive impairment, Alzheimer's disease, and Normal groups. Regional cerebral blood flow was calculated using a three-dimensional stereotactic region of interest template in an automated cerebral perfusion single photon emission computed tomography analysis system. Multiple regression analysis adjusted for age and sex was conducted to examine the relationships between thyroid hormones and regional cerebral blood flow. Thyroid stimulating hormone was significantly associated with regional cerebral blood flow in the bilateral temporal, bilateral pericallosal, and bilateral hippocampal regions in the mild cognitive impairment group. In the Alzheimer's disease group, free triiodothyronine was significantly associated with regional cerebral blood flow in the bilateral parietal, right temporal, and bilateral pericallosal regions. The present study showed the association of thyroid stimulating hormone with regional cerebral blood flow in the mild cognitive impairment group and the association of free triiodothyronine with regional cerebral blood flow in the Alzheimer's disease group. These study findings could contribute to the early diagnosis of mild cognitive impairment at general memory clinics and the prevention of subsequent progression to Alzheimer's disease.	[Nomoto, Shohei; Kinno, Ryuta; Kubota, Satomi; Mori, Yukiko; Futamura, Akinori; Sugimoto, Azusa; Kuroda, Takeshi; Yano, Satoshi; Murakami, Hidetomo; Ono, Kenjiro] Showa Univ, Sch Med, Dept Med, Div Neurol, Tokyo, Japan; [Nomoto, Shohei; Ochiai, Hirotaka; Shirasawa, Takako; Yoshimoto, Takahiko; Minoura, Akira; Kokaze, Akatsuki] Showa Univ, Sch Med, Dept Hyg Publ Hlth & Prevent Med, Tokyo, Japan	Showa University; Showa University	Ono, K (corresponding author), Showa Univ, Sch Med, Dept Med, Div Neurol, Tokyo, Japan.	onoken@med.showa-u.ac.jp	Minoura, Akira/AAM-4103-2021	Minoura, Akira/0000-0002-9805-508X				Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Annerbo Sylvia, 2006, Am J Alzheimers Dis Other Demen, V21, P182, DOI 10.1177/1533317506289282; Chiaravalloti A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06138-7; Davis Jennifer Duncan, 2008, Curr Aging Sci, V1, P175; de Jong FJ, 2009, NEUROBIOL AGING, V30, P600, DOI 10.1016/j.neurobiolaging.2007.07.019; Devanand DP, 2010, AM J GERIAT PSYCHIAT, V18, P959, DOI 10.1097/JGP.0b013e3181ec8696; Edman A, 2011, DEMENT GER COGN D EX, V1, P228, DOI 10.1159/000329447; Etgen T, 2011, DTSCH ARZTEBL INT, V108, P743, DOI 10.3238/arztebl.2011.0743; Forti P, 2012, GERONTOLOGY, V58, P41, DOI 10.1159/000324522; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gan EH, 2012, J CLIN ENDOCR METAB, V97, P3438, DOI 10.1210/jc.2012-2284; Haji M, 2015, DEMENT GERIATR COGN, V39, P360, DOI 10.1159/000375298; Ito K, 2014, INT J GERIATR PSYCH, V29, P1079, DOI 10.1002/gps.4102; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kimura N, 2011, ALZ DIS ASSOC DIS, V25, P138, DOI 10.1097/WAD.0b013e3181f9aff2; Kobayashi S, 2008, J NEUROL SCI, V264, P27, DOI 10.1016/j.jns.2007.07.015; Li YH, 2013, J INVEST MED, V61, P578, DOI [10.231/JIM.0b013e318280aafb, 10.2310/JIM.0b013e318280aafb]; Luo LG, 2002, J ALZHEIMERS DIS, V4, P97, DOI 10.3233/JAD-2002-4204; Marangell LB, 1997, AM J PSYCHIAT, V154, P224; MATSUDA H, 1995, EUR J NUCL MED, V22, P633, DOI 10.1007/BF01254564; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Nitrini R, 2000, ACTA NEUROL SCAND, V101, P172, DOI 10.1034/j.1600-0404.2000.101003172.x; Ojala AK, 2016, AGE AGEING, V45, P155, DOI 10.1093/ageing/afv160; Parsaik AK, 2014, JAMA NEUROL, V71, P201, DOI 10.1001/jamaneurol.2013.5402; Pasqualetti G, 2015, J CLIN ENDOCR METAB, V100, P4240, DOI 10.1210/jc.2015-2046; Prinz PN, 1999, J GERONTOL A-BIOL, V54, pM111, DOI 10.1093/gerona/54.3.M111; SCHEINBERG P, 1950, J CLIN INVEST, V29, P1139, DOI 10.1172/JCI102351; SENSENBACH W, 1954, J CLIN INVEST, V33, P1434, DOI 10.1172/JCI103021; Takeuchi R, 2003, NEUROL MED-CHIR, V43, P153, DOI 10.2176/nmc.43.153; Takeuchi Ryo, 2003, Nihon Hoshasen Gijutsu Gakkai Zasshi, V59, P1462; THOMAS DR, 1987, ACTA PSYCHIAT SCAND, V76, P158, DOI 10.1111/j.1600-0447.1987.tb02879.x; van Osch LADM, 2004, NEUROLOGY, V62, P1967, DOI 10.1212/01.WNL.0000128134.84230.9F; Winkler A, 2016, J ALZHEIMERS DIS, V49, P797, DOI 10.3233/JAD-150561	34	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214676	10.1371/journal.pone.0214676	http://dx.doi.org/10.1371/journal.pone.0214676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943231	gold, Green Published, Green Submitted			2022-12-27	WOS:000463194300051
J	Ocimati, W; Bouwmeester, H; Groot, JCJ; Tittonell, P; Brown, D; Blomme, G				Ocimati, Walter; Bouwmeester, Hein; Groot, Jeroen C. J.; Tittonell, Pablo; Brown, David; Blomme, Guy			The risk posed by Xanthomonas wilt disease of banana: Mapping of disease hotspots, fronts and vulnerable landscapes	PLOS ONE			English	Article							CAMPESTRIS-PV.-MUSACEARUM; BACTERIAL WILT; EAST; INFECTION; SPREAD; SPACE; TIME	Banana production landscapes in the African Great Lakes Region (AGLR) have been under immense pressure from Xanthomonas wilt (XW) disease over the past two decades. XW, first reported on banana in central Uganda and eastern DR Congo in 2001, has since spread to the entire AGLR. XW is currently spreading westwards from hot spots in eastern DR Congo highlands, putting the plantain (Musa AAB genome) belt of central and west Africa at risk. In-depth understanding of the key variables responsible for disease spread, current hotspots, and vulnerable landscapes is crucial for disease early warning and management. We mapped aggregated disease distribution and hotspots in the AGLR and identified vulnerable landscapes across African banana production zones. Available data on disease prevalence collected over 11 years was regressed against environmental and expert developed covariates to develop the AGLR XW hotspots map. For the Africa-wide risk map, precipitation, distance to hotspots, degree of trade in fresh banana products, production zone interconnectedness and banana genotype composition were used as covariates. In the AGLR, XW was mainly correlated to precipitation and disease/banana management. Altitude and temperature had unexpectedly low effects, possibly due to an overriding impact of tool-mediated spread which is part of the management covariate. In the AGLR, the eastern part of DR Congo was a large hotspot with highest vulnerability. Apart from endemic zones in the AGLR and Ethiopia, northern Mozambique was perceived as a moderate risk zone mainly due to the predominance of ' Bluggoe' (Musa ABB type) which is highly susceptible to insect-vectored transmission. Presence of XW hotspots (e.g. eastern DR Congo) and vulnerable areas with low (e.g. north-western Tanzania) or no disease (e.g. Congo basin, western DR Congo and northern Mozambique) pressure suggest key areas where proactive measures e.g. quarantines and information sharing on XW diagnosis, epidemiology, and control could be beneficial.	[Ocimati, Walter] Biovers Int, Kampala, Uganda; [Ocimati, Walter; Groot, Jeroen C. J.] Wageningen Univ & Res, Farming Syst Ecol, Wageningen, Netherlands; [Bouwmeester, Hein] GeoSpace, Ede, Netherlands; [Tittonell, Pablo] INTA CONICET, Agroecol Environm & Syst Grp, Inst Invest Forestales & Agr Bariloche IFAB, San Carlos De Bariloche, Rio Negro, Argentina; [Tittonell, Pablo] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Brown, David] Biovers Int, Turrialba, Cartago, Costa Rica; [Blomme, Guy] Biovers Int, Addis Ababa, Ethiopia	Alliance; Bioversity International; Wageningen University & Research; Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Groningen; Alliance; Bioversity International; Alliance; Bioversity International	Ocimati, W (corresponding author), Biovers Int, Kampala, Uganda.; Ocimati, W (corresponding author), Wageningen Univ & Res, Farming Syst Ecol, Wageningen, Netherlands.	w.ocimati@cgiar.org	Brown, David/AAV-1842-2021	Brown, David/0000-0003-2859-1618; Ocimati, Walter/0000-0001-6177-7073; Tittonell, Pablo/0000-0002-0284-2514	RTB Program Management Unit	RTB Program Management Unit	The fieldwork of this study was conducted within the framework of the CGIAR Research Program on Roots, Tubers and Bananas (RTB) and was led by Bioversity International. This study was supported by the CGIAR Fund Donors (https://www.cgiar.org/funders/) with support through the RTB Program Management Unit (https://www.cgiar.org/research/program-platform/roots-tubers-and-bananas/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele S, 2007, J CROP IMPROV, V19, P173, DOI 10.1300/J411v19n01_09; Abele S., 2007, FOOD SECURITY E AFRI, P110; Agrios G., 2005, PLANT PATHOL, DOI [10.1016/C2009-0-02037-6, DOI 10.1016/C2009-0-02037-6]; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 1966, TROPICAL AGR SERIES; Aung K, 2018, PLANT J, V93, P771, DOI 10.1111/tpj.13795; Bioversity International, 2017, XANTH WILT BAN S KIV, P103; Biruma M, 2007, AFR J BIOTECHNOL, V6, P953; Blomme G, 2013, ANN APPL BIOL, V162, P4, DOI 10.1111/aab.12002; Blomme G., 2005, P AFR CROP SCI C, V7, P317; Blomme G, 2017, EUR J PLANT PATHOL, V149, P385, DOI 10.1007/s10658-017-1189-6; Blomme G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01290; Blomme G, 2014, EUR J PLANT PATHOL, V139, P265, DOI 10.1007/s10658-014-0402-0; Bouwmeester H, 2016, EUR J AGRON, V74, P173, DOI 10.1016/j.eja.2015.12.013; Carter BA, 2010, PLANT PATHOL, V59, P403, DOI 10.1111/j.1365-3059.2009.02124.x; Desktop ESRI ArcGIS, 2014, REL 10 2 2 REDL; Eden-Green S., 2004, Infomusa, V13, P38; Edmeades S, 2007, IFPRI RES REPORT, V155, P49; Goovaerts P., 1997, GEOSTATISTICS NATURA, P137; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2017, GEOGRAPHIC DATA ANAL, V2, P15; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Hosmer D. W., 2000, APPL LOGISTIC REGRES, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Jarvis A, 2008, HOLE FILLED SEAMLESS; Kalyebara M. R., 2006, African Crop Science Journal, V14, P93; Kang WS, 2010, PLANT PATHOLOGY J, V26, P17, DOI 10.5423/PPJ.2010.26.1.017; Kubiriba J., 2012, Journal of Development and Agricultural Economics, V4, P125; Markham R., 2008, DIAGNOSTIC MANAGEMEN; Meki Shehabu, 2010, Tree and Forestry Science and Biotechnology, V4, P63; Mina U., 2008, ENV NEWS, V14, P6; Nakato G. V., 2013, J CROP PROT, V2, P151; Nakato GV, 2015, CAN J PLANT PATHOL, V36, P418; Ndungo V, 2006, PLANT PATHOL, V55, P294, DOI 10.1111/j.1365-3059.2005.01258.x; Ndungo V., 2008, Journal of Applied Biosciences, V1, P1; Nkuba J., 2015, African Journal of Plant Science, V9, P279; Ochola D, 2015, PLANT PATHOL, V64, P552, DOI 10.1111/ppa.12281; Ochola D., 2014, African Journal of Agricultural Research, V9, P2727; Ocimati W, 2015, PLANT PATHOL, V64, P81, DOI 10.1111/ppa.12233; Ocimati W, 2013, ACTA HORTIC, V986, P103; Ocimati W, 2013, PLANT PATHOL, V62, P777, DOI 10.1111/j.1365-3059.2012.02697.x; Ocimati W, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01471; Okech SHO, 2004, UGANDA J AGR SCI, V9, P437; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Reeder RH, 2007, PLANT PATHOL, V56, P1038, DOI 10.1111/j.1365-3059.2007.01640.x; Rutikanga A., 2015, Proceedings of the 7th Congress on Plant Protection "Integrated Plant Protection - a Knowledge-Based Step Towards Sustainable Agriculture, Forestry and Landscape Architecture". November 24-28, 2014, Zlatibor, Serbia, P139; Rutikanga A, 2016, J PHYTOPATHOL, V164, P659, DOI 10.1111/jph.12489; SADDLER GS, 2005, BERGEYS MANUAL SYSTE, V2, P63, DOI DOI 10.1007/0-387-28022-7_3; Shimelash D., 2008, African Crop Science Journal, V16, P75; Shimwela MM, 2017, PLANT PATHOL, V66, P1003, DOI 10.1111/ppa.12637; Simmonds NW., 1995, BOT J LINN SOC, V55, P302, DOI [10.1111/j.1095-8339.1955.tb00015.x, DOI 10.1111/J.1095-8339.1955.TB00015.X]; Ssekiwoko F, 2006, AFR CROP SCI J, V14; Taketani RG, 2017, MICROB ECOL, V73, P153, DOI 10.1007/s00248-016-0835-4; Tinzaara W., 2006, African Crop Science Journal, V14, P105; Tinzaara W., 2013, Acta Horticulturae, P157; Tripathi L, 2009, PLANT DIS, V93, P440, DOI 10.1094/PDIS-93-5-0440; Tushemereirwe W, 2004, PLANT PATHOL, V53, P802, DOI 10.1111/j.1365-3059.2004.01090.x; Tushemereiwe W. K., 2006, African Crop Science Journal, V14, P73; Wang CC, 2005, PLANTA, V222, P947, DOI 10.1007/s00425-005-0036-8; Webster R., 2007, STAT PRACTICE; Xin XF, 2016, NATURE, V539, P524, DOI 10.1038/nature20166; Yirgou D., 1974, East African Agricultural and Forestry Journal, V40, P111; You L., 2017, SPATIAL PRODUCTION A	62	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213691	10.1371/journal.pone.0213691	http://dx.doi.org/10.1371/journal.pone.0213691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939129	Green Submitted, Green Published, gold			2022-12-27	WOS:000462993900007
J	Schindler, C; Collinson, A; Matthews, C; Pointon, A; Jenkinson, L; Minter, RR; Vaughan, TJ; Tigue, NJ				Schindler, Christina; Collinson, Andie; Matthews, Carl; Pointon, Amy; Jenkinson, Lesley; Minter, Ralph R.; Vaughan, Tristan J.; Tigue, Natalie J.			Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency	PLOS ONE			English	Article							THERAPEUTIC INDEX; DRUG-DELIVERY; EXTRACELLULAR VESICLES; LIPOSOMAL FORMULATION; BREAST; DNA; BIODISTRIBUTION; CARDIOTOXICITY; MECHANISMS; TOXICITY	Doxorubicin is a chemotherapeutic agent that is commonly used to treat a broad range of cancers. However, significant cardiotoxicity, associated with prolonged exposure to doxorubicin, limits its continued therapeutic use. One strategy to prevent the uptake of doxorubicin into cardiac cells is the encapsulation of the drug to prevent non-specific uptake and also to improve the drugs' pharmacokinetic properties. Although encapsulated forms of doxorubicin limit the cardiotoxicity observed, they are not without their own liabilities as an increased amount of drug is deposited in the skin where liposomal doxorubicin can cause palmar-plantar erythrodysesthesia. Exosomes are small endogenous extracellular vesicles, that transfer bioactive material from one cell to another, and are considered attractive drug delivery vehicles due to their natural origin. In this study, we generated doxorubicin-loaded exosomes and demonstrate their rapid cellular uptake and re-distribution of doxorubicin from endosomes to the cytoplasm and nucleus resulting in enhanced potency in a number of cultured and primary cell lines when compared to free doxorubicin and liposomal formulations of doxorubicin. In contrast to other delivery methods for doxorubicin, exosomes do not accumulate in the heart, thereby providing potential for limiting the cardiac side effects and improved therapeutic index.	[Schindler, Christina; Collinson, Andie; Matthews, Carl; Jenkinson, Lesley; Minter, Ralph R.; Vaughan, Tristan J.; Tigue, Natalie J.] MedImmune Ltd, Dept Antibody Discovery & Prot Engn, Cambridge, England; [Pointon, Amy] AstraZeneca, IMED Biotech Unit, Mech Safety & ADME Sci, Drug Safety & Metab, Cambridge, England	AstraZeneca; Medimmune; AstraZeneca	Tigue, NJ (corresponding author), MedImmune Ltd, Dept Antibody Discovery & Prot Engn, Cambridge, England.	tiguen@medimmune.com		Tigue, Natalie/0000-0001-9916-0255	MedImmune Ltd, a subsidiary of AstraZeneca PLC; AstraZeneca PLC	MedImmune Ltd, a subsidiary of AstraZeneca PLC; AstraZeneca PLC(AstraZeneca)	This study was funded solely by MedImmune Ltd which is a subsidiary of AstraZeneca PLC and AstraZeneca PLC. Support was provided in the form of salaries to all authors (CS, AC, CM, AP, LJ, RRM, TJV, NJT) and procurement of materials but funders did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SA, 2005, METHOD ENZYMOL, V391, P71, DOI 10.1016/S0076-6879(05)91004-5; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059; BALLY MB, 1988, CHEM PHYS LIPIDS, V47, P97, DOI 10.1016/0009-3084(88)90078-3; Box VGS, 2007, J MOL GRAPH MODEL, V26, P14, DOI 10.1016/j.jmgm.2006.09.005; Carvalho FS, 2014, MED RES REV, V34, P106, DOI 10.1002/med.21280; Cen H, 2008, FASEB J, V22, P2243, DOI 10.1096/fj.07-099234; Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006; Chavez K. J., 2011, BREAST DIS, V32, P35; Chen L, 2016, FEBS LETT, V590, P4263, DOI 10.1002/1873-3468.12448; Clark Amy S, 2004, Support Cancer Ther, V1, P213, DOI 10.3816/SCT.2004.n.013; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Furedia A, 2017, J CONTROL RELEASE, V261, P287, DOI 10.1016/j.jconrel.2017.07.010; Gorini Stefania, 2018, Oxid Med Cell Longev, V2018, P7582730, DOI 10.1155/2018/7582730; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Hadla M, 2016, NANOMEDICINE-UK, V11, P2431, DOI 10.2217/nnm-2016-0154; Kim MS, 2016, NANOMED-NANOTECHNOL, V12, P655, DOI 10.1016/j.nano.2015.10.012; Kooijmans SAA, 2016, PHARMACOL RES, V111, P487, DOI 10.1016/j.phrs.2016.07.006; Kooijmans SAA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31053; Longatti A, 2018, NANOSCALE, V10, P14230, DOI 10.1039/c8nr03970d; Lorusso D, 2007, ANN ONCOL, V18, P1159, DOI 10.1093/annonc/mdl477; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Montaigne D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951539; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Ohno S-i, 2012, MOL THERAPY, DOI [10.10238/MT.2012.180, DOI 10.10238/MT.2012.180]; Reynolds JG, 2012, TOXICOL APPL PHARM, V262, P1, DOI 10.1016/j.taap.2012.04.008; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; SEIFERT CF, 1994, ANN PHARMACOTHER, V28, P1063, DOI 10.1177/106002809402800912; Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Smyth T, 2014, BIOCONJUGATE CHEM, V25, P1777, DOI 10.1021/bc500291r; Soininen SK, 2016, MOL PHARMACEUT, V13, P1358, DOI 10.1021/acs.molpharmaceut.6b00008; Speelmans G, 1996, BBA-BIOMEMBRANES, V1284, P240, DOI 10.1016/S0005-2736(96)00137-X; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Tahover E, 2015, ANTI-CANCER DRUG, V26, P241, DOI 10.1097/CAD.0000000000000182; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Tian T, 2013, J CELL PHYSIOL, V228, P1487, DOI 10.1002/jcp.24304; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Toffoli G, 2015, NANOMEDICINE-UK, V10, P2963, DOI 10.2217/nnm.15.118; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Wiklander OPB, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26316; Yang ZG, 2016, J CONTROL RELEASE, V243, P160, DOI 10.1016/j.jconrel.2016.10.008; Zhao LQ, 2017, PSYCHOGERIATRICS, V17, P3, DOI 10.1111/psyg.12180; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	52	74	76	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214545	10.1371/journal.pone.0214545	http://dx.doi.org/10.1371/journal.pone.0214545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925190	Green Published, Green Submitted, gold			2022-12-27	WOS:000462732300018
J	Montel, L; Sotiropoulos, A; Henon, S				Montel, Lorraine; Sotiropoulos, Athanassia; Henon, Sylvie			The nature and intensity of mechanical stimulation drive different dynamics of MRTF-A nuclear redistribution after actin remodeling in myoblasts	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTIONAL COACTIVATOR; RPEL MOTIFS; FACTOR SRF; MYOCARDIN; ACTIVATION; CELLS; REORGANIZATION; NETWORK; LIFEACT	Serum response factor and its cofactor myocardin-related transcription factor (MRTF) are key elements of muscle-mass adaptation to workload. The transcription of target genes is activated when MRTF is present in the nucleus. The localization of MRTF is controlled by its binding to G-actin. Thus, the pathway can be mechanically activated through the mechano-sensitivity of the actin cytoskeleton. The pathway has been widely investigated from a biochemical point of view, but its mechanical activation and the timescales involved are poorly understood. Here, we applied local and global mechanical cues to myoblasts through two custom-built set-ups, magnetic tweezers and stretchable substrates. Both induced nuclear accumulation of MRTF-A. However, the dynamics of the response varied with the nature and level of mechanical stimulation and correlated with the polymerization of different actin sub-structures. Local repeated force induced local actin polymerization and nuclear accumulation of MRTF-A by 30 minutes, whereas a global static strain induced both rapid (minutes) transient nuclear accumulation, associated with the polymerization of an actin cap above the nucleus, and long-term accumulation, with a global increase in polymerized actin. Conversely, high strain induced actin depolymerization at intermediate times, associated with cytoplasmic MRTF accumulation.	[Montel, Lorraine; Henon, Sylvie] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR 7057,Matiere & Syst Complexes, Paris, France; [Sotiropoulos, Athanassia] Univ Paris 05, Sorbonne Paris Cite, CNRS, UMR 8104,Inst Cochin,INSERM,U1016, Paris, France; [Montel, Lorraine] PSL Univ, Sorbonne Univ, CNRS, Inst Pierre Gilles Gennes Microfluid, Paris, France; [Montel, Lorraine] PSL Univ, Sorbonne Univ, CNRS, PASTEUR,Dept Chim,Ecole Normale Super, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Henon, S (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR 7057,Matiere & Syst Complexes, Paris, France.	sylvie.henon@univ-paris-diderot.fr		Sotiropoulos, Athanassia/0000-0002-7265-1473; HENON, SYLVIE/0000-0002-4633-3957	Agence Nationale de la Recherche [ANR-13-BSV1-0005]; Universite Sorbonne Paris Cite (Appel a projets de recherche USPC); Labex WhoAmI? transition post-doc program	Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite Sorbonne Paris Cite (Appel a projets de recherche USPC); Labex WhoAmI? transition post-doc program	This research was funded by Agence Nationale de la Recherche (ANR-13-BSV1-0005 to AS and SH), Universite Sorbonne Paris Cite (Appel a projets de recherche USPC 2012 to AS and SH), and Labex WhoAmI? transition post-doc program, LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed WW, 2010, BIOMATERIALS, V31, P250, DOI 10.1016/j.biomaterials.2009.09.047; Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Ben-Ari Y, 2010, J CELL SCI, V123, P1761, DOI 10.1242/jcs.062638; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chambliss AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01087; Chan MWC, 2010, J BIOL CHEM, V285, P9273, DOI 10.1074/jbc.M109.075218; Charrier EE, 2018, BIOL CELL, V110, P77, DOI 10.1111/boc.201700040; Collard L, 2014, J CELL SCI, V127, P5157, DOI 10.1242/jcs.155911; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Courtemanche N, 2016, NAT CELL BIOL, V18, P676, DOI 10.1038/ncb3351; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Gerber A, 2013, CELL, V152, P492, DOI 10.1016/j.cell.2012.12.027; Gomez EW, 2010, J CELLULAR BIOCH; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hirano H, 2011, BIOCHEM BIOPH RES CO, V414, P373, DOI 10.1016/j.bbrc.2011.09.079; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Icard-Arcizet D, 2008, BIOPHYS J, V94, P2906, DOI 10.1529/biophysj.107.118265; Iyer KV, 2012, BIOPHYS J, V103, P1416, DOI 10.1016/j.bpj.2012.08.041; Janmey PA, 2013, DIFFERENTIATION, V86, P112, DOI 10.1016/j.diff.2013.07.004; Janostiak R, 2014, EUR J CELL BIOL, V93, P445, DOI 10.1016/j.ejcb.2014.07.002; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kalita K, 2012, INT J BIOCHEM CELL B, V44, P1444, DOI 10.1016/j.biocel.2012.05.008; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kuwahara K, 2010, MOL CELL BIOL, V30, P4134, DOI 10.1128/MCB.00154-10; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Lundquist MR, 2014, CELL, V156, P563, DOI 10.1016/j.cell.2013.12.035; Mendez MG, 2012, INT J BIOCHEM CELL B, V44, P728, DOI 10.1016/j.biocel.2012.02.003; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Randrianarison-Huetz V, 2018, J CELL BIOL, V217, P685, DOI 10.1083/jcb.201705130; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Staus DP, 2007, ARTERIOSCL THROM VAS, V27, P478, DOI 10.1161/01.ATV.0000255559.77687.c1; Strale PO, 2015, J CELL BIOL, V210, P333, DOI 10.1083/jcb.201410111; van der Honing HS, 2011, CYTOSKELETON, V68, P578, DOI 10.1002/cm.20534; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	48	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214385	10.1371/journal.pone.0214385	http://dx.doi.org/10.1371/journal.pone.0214385			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921405	Green Published, gold, Green Submitted			2022-12-27	WOS:000462594000063
J	Pons, BJ; Bezine, E; Hanique, M; Guillet, V; Mourey, L; Chicher, J; Frisan, T; Vignard, J; Mirey, G				Pons, Benoit J.; Bezine, Elisabeth; Hanique, Melissa; Guillet, Valerie; Mourey, Lionel; Chicher, Johana; Frisan, Teresa; Vignard, Julien; Mirey, Gladys			Cell transfection of purified cytolethal distending toxin B subunits allows comparing their nuclease activity while plasmid degradation assay does not	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; DNA-DAMAGE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTERIAL GENOTOXIN; HELICOBACTER-HEPATICUS; DEOXYRIBONUCLEASE I; CYCLE PROGRESSION; APOPTOTIC DEATH; G(2) ARREST	The Cytolethal Distending Toxin (CDT) is produced by many pathogenic bacteria. CDT is known to induce genomic DNA damage to host eukaryotic cells through its catalytic subunit, CdtB. CdtB is structurally homologous to DNase I and has a nuclease activity, dependent on several key residues. Yet some differences between various CdtB subunit activities, and discrepancies between biochemical and cellular data, have been observed. To better characterise the role of CdtB in the induction of DNA damage, we affinity-purified wild-type and mutants of CdtB, issued from E. coli and H. ducreyi, under native and denaturing conditions. We then compared their nuclease activity by a classic in vitro assay using plasmid DNA, and two different eukaryotic assays-the first assay where host cells were transfected with a plasmid encoding CdtB, the second assay where host cells were directly transfected with purified CdtB. We show here that in vitro nuclease activities are difficult to quantify, whereas CdtB activities in host cells can be easily interpreted and confirmed the loss of function of the catalytic mutant. Our results highlight the importance of performing multiple assays while studying the effects of bacterial genotoxins, and indicate that the classic in vitro assay should be complemented with cellular assays.	[Pons, Benoit J.; Bezine, Elisabeth; Hanique, Melissa; Vignard, Julien; Mirey, Gladys] INRA, Toxalim, Res Ctr Food Toxicol, UMR1331, Toulouse, France; [Pons, Benoit J.; Guillet, Valerie; Mourey, Lionel; Mirey, Gladys] Univ Toulouse III Paul Sabatier UPS, Toulouse, France; [Bezine, Elisabeth] Inst Natl Polytech Toulouse, Toulouse, France; [Guillet, Valerie; Mourey, Lionel] CNRS, IPBS, Toulouse, France; [Chicher, Johana] IBMC, Plateforme Prote Strasbourg Esplande, FRC1589, Strasbourg, France; [Frisan, Teresa] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Karolinska Institutet	Vignard, J; Mirey, G (corresponding author), INRA, Toxalim, Res Ctr Food Toxicol, UMR1331, Toulouse, France.; Mirey, G (corresponding author), Univ Toulouse III Paul Sabatier UPS, Toulouse, France.	julien.vignard@toulouse.inra.fr; gladys.mirey@toulouse.inra.fr	Frisan, Teresa/H-8444-2019; PONS, Benoît/AAA-6340-2020; Mirey, Gladys/H-5676-2019	Frisan, Teresa/0000-0002-1209-0942; PONS, Benoît/0000-0002-9137-1047; Mirey, Gladys/0000-0002-0095-1864; Chicher, Johana/0000-0002-4403-7484; Mourey, Lionel/0000-0002-8259-1259	ANR [ANR-10-CESA-011]; Institut National de la Recherche Agronomique (INRA); Toxalim internal program; French Ministry of Research; COLiveTox IDEXToulouse University fellowship	ANR(French National Research Agency (ANR)); Institut National de la Recherche Agronomique (INRA); Toxalim internal program; French Ministry of Research(Ministry of Research, FranceEuropean Commission); COLiveTox IDEXToulouse University fellowship	This work was supported by the ANR Grant No ANR-10-CESA-011 to GM, the Institut National de la Recherche Agronomique (INRA) and the Toxalim internal program to JV. E. Bezine was supported by a Ph.D. fellowship of the French Ministry of Research, B, Pons by the COLiveTox IDEXToulouse University fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenaud P, 2004, BIOCHEM BIOPH RES CO, V318, P739, DOI 10.1016/j.bbrc.2004.04.089; Baranovskii AG, 2004, BIOCHEMISTRY-MOSCOW+, V69, P587, DOI 10.1023/B:BIRY.0000033731.50496.01; Bezine E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36022; Bielaszewska M, 2005, INFECT IMMUN, V73, P552, DOI 10.1128/IAI.73.1.552-562.2005; Blazkova H, 2010, J CELL MOL MED, V14, P357, DOI 10.1111/j.1582-4934.2009.00862.x; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Dassanayake RP, 2005, FEMS MICROBIOL LETT, V251, P219, DOI 10.1016/j.femsle.2005.08.005; DiRienzo JM, 2014, TOXINS, V6, P3098, DOI 10.3390/toxins6113098; DiRienzo JM, 2009, FEMS MICROBIOL LETT, V291, P222, DOI 10.1111/j.1574-6968.2008.01457.x; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Fahrer J, 2014, DNA REPAIR, V18, P31, DOI 10.1016/j.dnarep.2014.03.002; Fedor Y, 2013, CELL MICROBIOL, V15, P1, DOI 10.1111/cmi.12028; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Gelfanova V, 1999, INFECT IMMUN, V67, P6394; Graillot V, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00034; Grasso F, 2015, BIOMOLECULES, V5, P1762, DOI 10.3390/biom5031762; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hassane DC, 2003, INFECT IMMUN, V71, P541, DOI 10.1128/IAI.71.1.541-545.2003; He Z, 2019, GUT, V68, P289, DOI 10.1136/gutjnl-2018-317200; Hu X, 2005, BIOORGAN MED CHEM, V13, P1101, DOI 10.1016/j.bmc.2004.11.026; Hu X, 2006, PROTEINS, V65, P843, DOI 10.1002/prot.21167; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; JOHNSON WM, 1987, FEMS MICROBIOL LETT, V43, P19, DOI 10.1111/j.1574-6968.1987.tb02091.x; Kanno F, 2005, J PERIODONTOL, V76, P1189, DOI 10.1902/jop.2005.76.7.1189; Kim HS, 2017, J BIOL CHEM, V292, P2795, DOI 10.1074/jbc.M116.758235; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; Liyanage NPM, 2013, HELICOBACTER, V18, P433, DOI 10.1111/hel.12084; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; Nalbant A, 2003, ORAL MICROBIOL IMMUN, V18, P339, DOI 10.1046/j.0902-0055.2003.00082.x; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Obradovic D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159231; Pan CQ, 1997, BIOCHEMISTRY-US, V36, P6624, DOI 10.1021/bi962960x; Pan CQ, 1998, PROTEIN SCI, V7, P628, DOI 10.1002/pro.5560070312; PICKETT CL, 1994, INFECT IMMUN, V62, P1046, DOI 10.1128/IAI.62.3.1046-1051.1994; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; SEKI S, 1991, BIOCHIM BIOPHYS ACTA, V1079, P57, DOI 10.1016/0167-4838(91)90024-T; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Shenker BJ, 2016, CELL MICROBIOL, V18, P223, DOI 10.1111/cmi.12497; Solier S, 2014, CELL MOL LIFE SCI, V71, P2289, DOI 10.1007/s00018-013-1555-2; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; Taieb F, 2006, CELL MICROBIOL, V8, P1910, DOI 10.1111/j.1462-5822.2006.00757.x; Yamamoto K, 2004, EUR J ORAL SCI, V112, P445, DOI 10.1111/j.1600-0722.2004.00157.x; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214313	10.1371/journal.pone.0214313	http://dx.doi.org/10.1371/journal.pone.0214313			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921382	Green Published, Green Submitted, gold			2022-12-27	WOS:000462594000053
J	Mokhele, I; Nattey, C; Jinga, N; Mongwenyana, C; Fox, MP; Onoya, D				Mokhele, Idah; Nattey, Cornelius; Jinga, Nelly; Mongwenyana, Constance; Fox, Matthew P.; Onoya, Dorina			Prevalence and predictors of postpartum depression by HIV status and timing of HIV diagnosis in Gauteng, South Africa	PLOS ONE			English	Article							POSTNATAL DEPRESSION; RISK-FACTORS; SOCIAL SUPPORT; PRIMARY-CARE; WOMEN; SYMPTOMS; MORTALITY; PREGNANCY; HEALTH; TRANSMISSION	Background Postpartum depression (PPD) is a common mental health condition that can compromise the quality of life and functional capacity of mothers and cause health and developmental problems in children born to affected mothers. Objectives We set out to measure the prevalence of PPD comparing postpartum HIV-1 infected women with pre-pregnancy HIV care experience, newly diagnosed (in latest pregnancy) HIV-1 infected women and HIV negative women, and to identify predictors of major PPD among these women in a peri-urban clinic in South Africa. Methods We conducted a cross-sectional survey of 1151 adult (>= 18 years) postpartum HIV-1 infected (690) and HIV negative (461) women who delivered up to 30 days before study enrolment, interviewed after their first post-natal visit (3-6 days post- delivery) at Midwife Obstetric Units in Gauteng, South Africa. PPD was categorised into no depression (CES-D 10 total score <5), low to medium depression (CES-D 10 total score >= 5 and <10) and major depressive symptoms (CES-D 10 total score >= 10). We used ordered logistic regression to identify predictors of postpartum depression and report adjusted odds ratio (aOR) and 95% confidence intervals (CIs). Results Overall 288 (25.0%) women screened positive for postpartum depression, a total of 168 (14.6%) women had low to medium PPD and 120 (10.4%) had major PPD. A higher proportion of HIV negative women experienced PPD, 129/461 (28.0%) among HIV negative vs. 159/690 (23.0%) among HIV-1 infected. Among HIV positive women, there was no meaningful difference in PPD between newly HIV diagnosed and those diagnosed before the most recent pregnancy (aOR 1.3, 95% confidence interval (CI): 0.9-1.8). Predictors of PPD among HIV positive women were living with friends/in a house-share (aOR 0.5 for house share vs. own home, 95% CI: 0.3-0.9), and attending antenatal care (ANC) for the most recent pregnancy (aOR 0.2 for ANC attendance vs. no ANC attendance, 95% CI: 0.0-0.5). Living with friends/in a house-share was also a predictor of PPD among HIV negative women (aOR 0.4 for house-share vs. own home, 95% CI: 0.2-0.8). Conclusions and recommendations Targeted symptom screening based on identified risk factors should be considered for postpartum women to increase PPD case-finding and referral to specialised social support services.	[Mokhele, Idah; Nattey, Cornelius; Jinga, Nelly; Mongwenyana, Constance; Fox, Matthew P.; Onoya, Dorina] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Witwatersrand; Boston University; Boston University	Onoya, D (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa.	donoya@heroza.org	Onoya, Dorina/AAW-2839-2020	Onoya, Dorina/0000-0002-2664-7342; Mokhele, Idah/0000-0002-8054-0116	President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID) [AID-674-A-12-00029, 72067419CA00004]; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) [2016/353-ONO]; South African National Research Foundation (NRF) [TTK 150708124222]	President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Collaborative Initiative for Paediatric HIV Education and Research (CIPHER); South African National Research Foundation (NRF)(National Research Foundation - South Africa)	This study has been made possible by the generous support of the American People and the President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID) under the terms of Cooperative Agreements AID-674-A-12-00029 and 72067419CA00004 to the Health Economics and Epidemiology Research Office. Additional support for this study came from the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) funding award 2016/353-ONO, and the South African National Research Foundation (NRF) funding award TTK 150708124222. The contents are the responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, the United States, CIPHER or the NRF.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318; Appleby L, 2003, J AFFECT DISORDERS, V77, P261, DOI 10.1016/S0165-0327(02)00145-3; Baron EC, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1178-x; Barron P, 2013, B WORLD HEALTH ORGAN, V91, P70, DOI 10.2471/BLT.12.106807; Benvenuti P, 2006, CLIN NEUROPSYCHIATR, V3, P39; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Castle J., 2008, J LANCASTER GEN HOSP, V2009, P4; Chen YH, 2011, PSYCHOL MED, V41, P2287, DOI 10.1017/S0033291711000584; Chibanda D, 2010, J WOMENS HEALTH, V19, P2071, DOI 10.1089/jwh.2010.2012; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dennis C.-L, 2013, PSYCHOSOCIAL PSYCHOL; ENGLAND SJ, 1994, EUR J PSYCHIAT, V8, P93; Evagorou O, 2016, PSYCHIAT QUART, V87, P129, DOI 10.1007/s11126-015-9367-1; Field T, 2007, INFANT MENT HEALTH J, V28, P314, DOI 10.1002/imhj.20138; Holt C, 2017, ARCHAEOLOGY TIME TRA, P1; Hugo CJ, 2003, SOC PSYCH PSYCH EPID, V38, P715, DOI 10.1007/s00127-003-0695-3; Hutton HE, 2004, AM J PSYCHIAT, V161, P912, DOI 10.1176/appi.ajp.161.5.912; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Joint United Nations Programme on HIV/ AIDS, 2013, PROGR REP GLOB PLAN; Kathree T, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0140-7; Kwalombota M, 2002, AIDS CARE, V14, P431, DOI 10.1080/09540120220123829; Madlala S, 2017, S AFRICAN J CLIN NUT, P1; Mokwena K, 2014, AFR J PHYS HLTH REC, V20, P116; Mosack V, 2006, J COMMUN HEALTH NURS, V23, P37, DOI 10.1207/s15327655jchn2301_4; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Natamba BK, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0303-y; National Collaborating Centre for Mental Health, 2014, ANT POSTN MENT HLTH, DOI [10.1016/j.wombi.2016.05.008, DOI 10.1016/J.WOMBI.2016.05.008]; Paris R, 2009, ARCH WOMEN MENT HLTH, V12, P309, DOI 10.1007/s00737-009-0105-2; Peltzer K, 2011, S AFR J HIV MED, P24; Peltzer K, 2018, AIDS CARE, P1; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Ramchandani PG, 2009, J AFFECT DISORDERS, V113, P279, DOI 10.1016/j.jad.2008.05.007; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Rochat TJ, 2013, ARCH WOMEN MENT HLTH, V16, P401, DOI 10.1007/s00737-013-0353-z; Rubin LH, 2011, J WOMENS HEALTH, V20, P1287, DOI 10.1089/jwh.2010.2485; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Seedat S, 2008, SOC PSYCH PSYCH EPID, V43, P889, DOI 10.1007/s00127-008-0399-9; Stellenberg EL, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.874; Stewart D.E., 2003, U HLTH NETWORK WOMEN; Stocky A, 2000, BEST PRACT RES CL OB, V14, P73, DOI 10.1053/beog.1999.0064; Surkan PJ, 2011, B WORLD HEALTH ORGAN, V89, P607, DOI 10.2471/BLT.11.088187; Taylor AL, 2012, SOCIAL SUPPORT PREDI; Turner R E, 2016, SAMJ, S. Afr. med. j., V106, P1164, DOI 10.7196/SAMJ.2016.VL06IL2.12129; Uwakwe R, 2003, ACTA PSYCHIAT SCAND, V107, P251, DOI 10.1034/j.1600-0447.2003.02477.x; Verreault N, 2014, J PSYCHOSOM OBST GYN, V35, P84, DOI 10.3109/0167482X.2014.947953; Wachs TD, 2009, CHILD DEV PERSPECT, V3, P51, DOI 10.1111/j.1750-8606.2008.00077.x; Weinberg MK, 2001, AM J ORTHOPSYCHIAT, V71, P87, DOI 10.1037/0002-9432.71.1.87; Weobong B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006509; Woolhouse H, 2016, WOMEN BIRTH, V29, P381, DOI 10.1016/j.wombi.2016.05.008; World Federation for Mental health, 2010, DEPR GLOB CRIS, P140; Yator O, 2016, AIDS CARE, V28, P884, DOI 10.1080/09540121.2016.1160026; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040793	54	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214849	10.1371/journal.pone.0214849	http://dx.doi.org/10.1371/journal.pone.0214849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR7EH	30947293	Green Published, Green Submitted, gold			2022-12-27	WOS:000463314500072
J	Dahood, A; Watters, GM; de Mutsert, K				Dahood, Adrian; Watters, George M.; de Mutsert, Kim			Using sea-ice to calibrate a dynamic trophic model for the Western Antarctic Peninsula	PLOS ONE			English	Article							SOUTH SHETLAND ISLANDS; KRILL EUPHAUSIA-SUPERBA; CHINSTRAP PENGUINS; CLIMATE-CHANGE; POPULATION-CHANGES; MARINE ECOSYSTEM; ELEPHANT ISLAND; SCOTIA SEA; FOOD-WEB; BIOMASS	The pelagic ecosystems of the Western Antarctic Peninsula are dynamic and changing rapidly in the face of sustained warming. There is already evidence that warming may be impacting the food web. Antarctic krill, Euphausia superba, is an ice-associated species that is both an important prey item and the target of the only commercial fishery operating in the region. The goal of this study is to develop a dynamic trophic model for the region that includes the impact of the sea-ice regime on krill and krill predators. Such a model may be helpful to fisheries managers as they develop new management strategies in the face of continued sea-ice loss. A mass balanced food-web model (Ecopath) and time dynamic simulations (Ecosim) were created. The Ecopath model includes eight currently monitored species as single species to facilitate its future development into a model that could be used for marine protected area planning in the region. The Ecosim model is calibrated for the years 1996-2012. The successful calibration represents an improvement over existing Ecopath models for the region. Simulations indicate that the role of sea ice is both central and complex. The simulations are only able to recreate observed biomass trends for the monitored species when metrics describing the sea-ice regime are used to force key predator-prey interactions, and to drive the biomasses of Antarctic krill and the fish species Gobionotothen gibberifrons. This model is ready to be used for exploring results from sea-ice scenarios or to be developed into a spatial model that informs discussions regarding the design of marine protected areas in the region.	[Dahood, Adrian; de Mutsert, Kim] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Dahood, Adrian; Watters, George M.] NOAA, Antarctic Ecosyst Res Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Dahood, Adrian] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	George Mason University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz	Dahood, A (corresponding author), George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA.; Dahood, A (corresponding author), NOAA, Antarctic Ecosyst Res Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA.; Dahood, A (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.	adahood@gmail.com	de Mutsert, Kim/AAV-1035-2020	de Mutsert, Kim/0000-0002-7902-3787; Dahood, Adrian/0000-0001-5346-8537	Pew Charitable Trusts [31815]; Environmental Science and Policy Department at George Mason University	Pew Charitable Trusts; Environmental Science and Policy Department at George Mason University	This work was supported by funding from the Pew Charitable Trusts, contract ID#31815. A.D. was a graduate student during model development and benefitted from funding from the Environmental Science and Policy Department at George Mason University. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The Pew Charitable Trusts required publication in a peer reviewed journal, but did not influence the decision on where to submit.	Acker J.G., 2007, EOS T AM GEOPHYS UN, V88, P14, DOI [DOI 10.1029/2007EO020003, 10.1029/2007EO020003]; Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Ballerini T, 2014, PROG OCEANOGR, V122, P10, DOI 10.1016/j.pocean.2013.11.007; BANSE K, 1980, ECOL MONOGR, V50, P355, DOI 10.2307/2937256; Barrera-Oro ER, 2000, CCAMLR SCI, V7, P43; Branch T. A., 2011, Journal of Cetacean Research and Management, P53; Candy SG, 2006, MAR ECOL PROG SER, V306, P17, DOI 10.3354/meps306017; Casaux R, 2009, POLAR BIOL, V32, P833, DOI 10.1007/s00300-009-0583-8; Casaux R, 2009, POLAR BIOL, V32, P307, DOI 10.1007/s00300-008-0567-0; CCAMLR, 2011, COBS MEAS 91 04 GEN; CCAMLR, 2017, 36 M COMM HOB TASM; CCAMLR, 2011, WORKSH MAR PROT AR A; CCAMLR (Commission for the Conservation of Antarctic Marine Living Resources), 2018, CCAMLR STAT B, V30; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V, 2014, ECOSYSTEMS, V17, P1397, DOI 10.1007/s10021-014-9803-3; Constable AJ, 2002, CCAMLR SCI, V9, P233; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Constable AJ, 2011, FISH FISH, V12, P138, DOI 10.1111/j.1467-2979.2011.00410.x; Cooper APR, 2013, SCAR ANTARCTIC DIGIT; Cornejo-Donoso J, 2008, ECOL MODEL, V218, P1, DOI 10.1016/j.ecolmodel.2008.06.011; Daly KL, 2004, DEEP-SEA RES PT II, V51, P2139, DOI 10.1016/j.dsr2.2004.07.010; Ducklow HW, 2008, DEEP-SEA RES PT II, V55, P2118, DOI 10.1016/j.dsr2.2008.04.028; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Ducklow HW, 2013, OCEANOGRAPHY, V26, P190, DOI 10.5670/oceanog.2013.62; Erfran, 2005, FISHERIES CTR RES RE, V13, P5; Everson I, 2000, KRILL BIOL ECOLOGY F; Flores H, 2004, POLAR BIOL, V27, P119, DOI 10.1007/s00300-003-0570-4; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Goebel M.E., 2014, WGEMM1439; Hewitt RP, 2004, DEEP-SEA RES PT II, V51, P1215, DOI 10.1016/j.dsr2.2004.06.011; Heymans JJ, 2016, ECOL MODEL, V331, P173, DOI 10.1016/j.ecolmodel.2015.12.007; Hill SL, 2007, CCAMLR SCI, V14, P1; Hill SL, 2012, DEEP-SEA RES PT II, V59, P237, DOI 10.1016/j.dsr2.2011.09.001; Hinke JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170132; Hinke JT, 2014, POLAR BIOL, V37, P1797, DOI 10.1007/s00300-014-1562-2; Hinke JT, 2007, OECOLOGIA, V153, P845, DOI 10.1007/s00442-007-0781-4; Hoover C., 2012, FROM TROPICS POLES E, P108; Hucke-Gaete R, 2004, POLAR BIOL, V27, P304, DOI 10.1007/s00300-003-0587-8; [Information Manager PAL Palmer Station Antarctica LTER], 2018, BAS W ANT PEN SURV G, DOI [10.6073/pasta/fc528df1b8b8971a4fd28754101f5d6b, DOI 10.6073/PASTA/FC528DF1B8B8971A4FD28754101F5D6B]; IPCC, 2018, SUMMARY POLICYMAKERS; Iverson I, 1998, CCAMLR SCI, V5, P245; Kinzey D, 2013, CCAMLR SCI, V20, P81; Klein ES, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191011; Kock KH, 2005, REV FISH SCI, V13, P75, DOI 10.1080/10641260590953900; Kock KH, 2012, 2012WGFSA120 CCAMLR; Loeb VJ, 2012, PROG OCEANOGR, V96, P93, DOI 10.1016/j.pocean.2011.11.001; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lynnes AS, 2004, POLAR BIOL, V27, P544, DOI 10.1007/s00300-004-0617-1; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Miller AK, 2010, CONDOR, V112, P683, DOI 10.1525/cond.2010.090221; Miller DGM, 2002, CCAMLR SCI, V9, P175; Mori M, 2006, CCAMLR SCI, V13, P217; Murphy EJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07205-9; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Pakhomov EA, 2004, DEEP-SEA RES PT II, V51, P2645, DOI 10.1016/j.dsr2.2001.03.001; Pastene LA, 2016, WGEMM1626; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Ramm DC, 2015, CCAMLR STAT AR BOUND; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Reiss CS, 2017, MAR ECOL PROG SER, V568, P1, DOI 10.3354/meps12099; Reiss CS, 2016, ADV POL ECO, P101, DOI 10.1007/978-3-319-29279-3_3; Ribic CA, 2011, DEEP-SEA RES PT II, V58, P1695, DOI 10.1016/j.dsr2.2009.09.017; ROSENBERG AA, 1986, NATURE, V324, P152, DOI 10.1038/324152a0; Santora JA, 2013, MAR BIOL, V160, P1383, DOI 10.1007/s00227-013-2190-z; Santora JA, 2009, FISH OCEANOGR, V18, P20, DOI 10.1111/j.1365-2419.2008.00490.x; Schofield O., 2020, ENV DATA INITIATIVE, Vv7, DOI [10.6073/pasta/1201-43cf21718c300db9777f89e09f8, DOI 10.6073/PASTA/1201-43CF21718C300DB9777F89E09F8]; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; Stammerjohn S.E., 2013, AVERAGE MONTHLY SEA; Stammerjohn S, 2011, DEEP-SEA RES PT II, V58, P999, DOI 10.1016/j.dsr2.2010.10.026; Steele JH, 2011, J MARINE SYST, V87, P227, DOI 10.1016/j.jmarsys.2011.04.005; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Stroeve J., 2018, Sea Ice Trends and Climatologies From SMMR and SSM/ISSMIS, Version 3.1, DOI 10.5067/IJ0T7HFHB9Y6; Suprenand PM, 2017, MAR ECOL PROG SER, V569, P37, DOI 10.3354/meps12100; Taki K, 2006, FISHERIES SCI, V72, P221, DOI 10.1111/j.1444-2906.2006.01142.x; Townsend C. R., 2003, ESSENTIALS ECOLOGY; Trathan PN, 2016, ADV POL ECO, P321, DOI 10.1007/978-3-319-29279-3_9; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; VEIT RR, 1993, J ANIM ECOL, V62, P551, DOI 10.2307/5204; Zeng C, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122075	85	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214814	10.1371/journal.pone.0214814	http://dx.doi.org/10.1371/journal.pone.0214814			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939156	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900041
J	Cavedon, V; Sandri, M; Pirlo, M; Petrone, N; Zancanaro, C; Milanese, C				Cavedon, Valentina; Sandri, Marco; Pirlo, Mariola; Petrone, Nicola; Zancanaro, Carlo; Milanese, Chiara			Anthropometry-driven block setting improves starting block performance in sprinters	PLOS ONE			English	Article							FORCE APPLICATION; KINEMATICS; VELOCITY; PHASE; ELITE; POWER; MOVEMENT	This study tested the effect of two block setting conditions i.e., the usual block setting [US] and an anthropometry-driven block setting [AS] on the kinematic and kinetic parameters of the sprint start. Furthermore, we verified whether this effect is influenced by the relative lengths of the sprinter's trunk and lower limbs i.e., the Cormic Index by subdividing sprinters into brachycormic, metricormic and macrocormic groups. Forty-two sprinters performed 6 maximal-effort 10 m sprints using the US and AS conditions. Dynamometric starting blocks measured forces generated by the sprinters. The times at 5 m and 10 m in the sprint trials were measured with photocells. Results showed that the anteroposterior block distances were significantly different between the two conditions (P< 0.001). Across the sample, the horizontal block velocity, the rear peak force, the rear force impulse, the total force impulse, the horizontal block power, the ratio of horizontal to resultant impulse in the rear block, the first and second step lengths and the times at 5m and 10 mimproved in AS vs. US (P values from 0.05 to 0.001). Considering the interaction between the block setting condition and the Cormic Index, the rear peak force and the rear force impulse were significantly increased in the metricormic and brachycormic groups (P <= 0.001) and the metricormic group (P< 0.001), respectively. Kinetic variables in the rear block and the difference (Delta) in the front block/starting line distance between US and AS were related with each other (Adjusted R-2 values from 0.07 to 0.36). In conclusion, AS was associated with improvement in the kinematic and kinetic parameters of the sprint start performance vs. US; however, AS is apparently best suited for metricormic sprinters. Further work is needed to verify how the sprint start kinetic and kinematic parameters are related to the front block/starting line distance and whether a block setting driven by the sprinter's Cormic Index is able to improve sprint start performance.	[Cavedon, Valentina; Sandri, Marco; Zancanaro, Carlo; Milanese, Chiara] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Pirlo, Mariola] OMR Automot, Brescia, Italy; [Petrone, Nicola] Univ Padua, Dept Ind Engn, Padua, Italy	University of Verona; University of Padua	Milanese, C (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	chiara.milanese@univr.it	Sandri, Marco/L-2875-2013; Cavedon, Valentina/AAL-3002-2020	Sandri, Marco/0000-0002-1422-5695; Cavedon, Valentina/0000-0002-2464-1019; PETRONE, NICOLA/0000-0002-6638-484X; Milanese, Chiara/0000-0002-8011-4379	University of Verona	University of Verona	This work was supported in part by Departmental intramural funds (Joint Projects 2009) to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. The funding organization (OMR Automotive) did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for an author [PM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; The authors thank all the participants for kind cooperation. This study was supported by a grant from the University of Verona (Joint Projects 2009) to CM.	Bartlett RM, 2007, INTRO SPORTS BIOMECH, P126; Bezodis NE, 2018, J SPORTS SCI, V11, P1; Bezodis NE, 2010, SPORT BIOMECH, V9, P258, DOI 10.1080/14763141.2010.538713; Bezodis NE, 2015, EUR J SPORT SCI, V15, P118, DOI 10.1080/17461391.2014.928915; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bradshaw EJ, 2007, SPORT BIOMECH, V6, P246, DOI 10.1080/14763140701489660; Brazil A, 2018, J SPORT SCI, V36, P1656, DOI 10.1080/02640414.2017.1409608; Brazil A, 2017, J SPORT SCI, V35, P1629, DOI 10.1080/02640414.2016.1227465; Cagnazzo F, 2009, VALUTAZIONE ANTROPOM, P65; Chamari K, 2008, J STRENGTH COND RES, V22, P944, DOI 10.1519/JSC.0b013e31816a57c6; Ciacci S, 2017, J SPORT SCI, V35, P1270, DOI 10.1080/02640414.2016.1221519; Coh M, 2017, J HUM KINET, V56, P29, DOI 10.1515/hukin-2017-0020; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Debaere S, 2013, J SPORT SCI, V31, P137, DOI 10.1080/02640414.2012.722225; Dickinson A.D., 1934, RES QUART, V5, P12, DOI [https://doi.org/10.1080/23267402.1934.10761653, DOI 10.1080/23267402.1934.10761653]; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleisig Glenn, 2003, Sports Biomech, V2, P51, DOI 10.1080/14763140308522807; Fortier S, 2005, J SPORT SCI MED, V4, P134; Frossard L, 2005, INT COUNCIL SPORT SC; GUISSARD N, 1992, MED SCI SPORT EXER, V24, P1257; Harland MJ, 1997, SPORTS MED, V23, P11, DOI 10.2165/00007256-199723010-00002; Henry FM, 1952, RES QUART, V23, P301, DOI 10.1080/10671188.1952.10624871; Kraan GA, 2001, J BIOMECH, V34, P211, DOI 10.1016/S0021-9290(00)00178-0; LEMAIRE ED, 1990, CAN J SPORT SCI, V15, P149; Lohman T.G., 1992, MANUALE RIFERIMENTO; Massidda M, 2013, COLL ANTROPOL; Mero A, 2006, J SPORT SCI, V24, P165, DOI 10.1080/02640410500131753; MERO A, 1988, RES Q EXERCISE SPORT, V59, P94, DOI 10.1080/02701367.1988.10605484; Mero A., 1983, SCANDINAVIAM J SPORT, V5, P20; Milanese C, 2014, BIOL SPORT, V31, P209, DOI 10.5604/20831862.1111848; Milanese C, 2014, 19 ANN C EUR COLL SP, P283; Morin JB, 2011, MED SCI SPORT EXER, V43, P1680, DOI 10.1249/MSS.0b013e318216ea37; oh M., 1998, GYMNICA, V28, P33; oh M., 2006, NEW STUDIES ATHLETIC, V21, P23; Otsuka M, 2014, J APPL BIOMECH, V30, P390, DOI 10.1123/jab.2013-0017; Payne AH, 1971, BIOMECHANICS 2, VII, P225; Reinschmidt C, 1997, J BIOMECH, V30, P729, DOI 10.1016/S0021-9290(97)00001-8; SCHOT PK, 1992, RES Q EXERCISE SPORT, V63, P137, DOI 10.1080/02701367.1992.10607573; Schrodter E, 2017, INT J SPORT PHYSIOL, V12, P448, DOI 10.1123/ijspp.2015-0512; SIGERSETH PO, 1962, RES QUART, V33, P599, DOI 10.1080/10671188.1962.10762113; Slawinski J, 2012, INT J SPORTS MED, V33, P555, DOI 10.1055/s-0032-1304587; Slawinski J, 2013, J SPORT SCI, V31, P256, DOI 10.1080/02640414.2012.729076; Slawinski J, 2010, J STRENGTH COND RES, V24, P896, DOI 10.1519/JSC.0b013e3181ad3448; STOCK M, 1962, RES QUART, V33, P607, DOI 10.1080/10671188.1962.10762114; Ukwuma M., 2009, INTERNET J BIOL ANTH, V4, P1, DOI [10.5580/2971, DOI 10.5580/2971]; van Coppenolle H., 1989, ATHL COACH, V23, P82; Vucetic V, 2008, COLLEGIUM ANTROPOL, V32, P863; Willwacher S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166219; Willwacher S, 2013, PROCEDIA ENGINEER, V60, P124, DOI 10.1016/j.proeng.2013.07.073	49	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213979	10.1371/journal.pone.0213979	http://dx.doi.org/10.1371/journal.pone.0213979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917173	Green Submitted, Green Published, gold			2022-12-27	WOS:000462465800045
J	Al-Ani, AK; Anbar, M; Manickam, S; Al-Ani, A				Al-Ani, Ahmed K.; Anbar, Mohammed; Manickam, Selvakumar; Al-Ani, Ayman			DAD-match; Security technique to prevent denial of service attack on duplicate address detection process in IPv6 link-local network	PLOS ONE			English	Article								An efficiently unlimited address space is provided by Internet Protocol version 6 (IPv6). It aims to accommodate thousands of hundreds of unique devices on a similar link. This can be achieved through the Duplicate Address Detection (DAD) process. It is considered one of the core IPv6 network's functions. It is implemented to make sure that IP addresses do not conflict with each other on the same link. However, IPv6 design's functions are exposed to security threats like the DAD process, which is vulnerable to Denial of Service (DoS) attack. Such a threat prevents the host from configuring its IP address by responding to each Neighbor Solicitation (NS) through fake Neighbor Advertisement (NA). Various mechanisms have been proposed to secure the IPv6 DAD procedure. The proposed mechanisms, however, suffer from complexity, high processing time, and the consumption of more resources. The experiments-based findings revealed that all the existing mechanisms had failed to secure the IPv6 DAD process. Therefore, DAD-match security technique is proposed in this study to efficiently secure the DAD process consuming less processing time. DAD-match is built based on SHA-3 to hide the exchange tentative IP among hosts throughout the process of DAD in an IPv6 link-local network. The obtained experimental results demonstrated that the DAD-match security technique achieved less processing time compared with the existing mechanisms as it can resist a range of different threats like collision and brute-force attacks. The findings concluded that the DAD-match technique effectively prevents the DoS attack during the DAD process. The DAD-match technique is implemented on a small area IPv6 network; hence, the author future work is to implement and test the DAD-match technique on a large area IPv6 network.	[Al-Ani, Ahmed K.; Anbar, Mohammed; Manickam, Selvakumar; Al-Ani, Ayman] USM, Natl Adv IPv6 Ctr NAv6, Gelugor, Penang, Malaysia	Universiti Sains Malaysia	Anbar, M (corresponding author), USM, Natl Adv IPv6 Ctr NAv6, Gelugor, Penang, Malaysia.	anbar@nav6.usm.my	Al-Ani, Ahmed K./AAC-9187-2020; Manickam, Selvakumar/AGD-8568-2022; Anbar, Mohammed/S-9296-2019	Manickam, Selvakumar/0000-0003-4378-1954; Anbar, Mohammed/0000-0002-7026-6408; Khallel, Ayman/0000-0001-8391-5887	National Advanced IPv6 Center, USM of Malaysia	National Advanced IPv6 Center, USM of Malaysia	This work was supported by the National Advanced IPv6 Center, USM of Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AS, 2017, IEEE ACCESS; Al-Ani A.K., 2017, PROPOSED DAD MATCH S; Al-Ani AK, 2019, ARAB J SCI ENG, V44, P3745, DOI 10.1007/s13369-018-3643-y; Al-Ani AK, 2018, LECT NOTES ELECTR EN, V488, P108, DOI 10.1007/978-981-10-8276-4_11; Al-Ani AK, 2018, J COMMUN, V13, P317, DOI DOI 10.12720/JCM.13.6.317-324; AlSadeh A., 2013, THEORY PRACTICE CRYP, P178; Anbar M, 2017, ADV SCI LETT; Anbar M, 2018, COGN COMPUT, V10, P201, DOI 10.1007/s12559-017-9519-8; Arkko J., 2005, SECURE NEIGHBOR DISC, P1; Aurora V., 2017, LIFETIMES CRYPTOGRAP; Bapat AC, 2016, 2016 INT C WIR COMM; Biondi P., 2014, SCAPY PACKET MANIPUL; Center CIT, 2014, UN INS THREATS SOC E; Cho C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170566; Cordasco J, 2008, ELECTRON NOTES THEOR, V197, P131, DOI 10.1016/j.entcs.2007.12.022; Deering S., 2017, INTERNET PROTOCOL VE; Dunham K., 2013, ISSA J; Elejla OE, 2017, IETE TECH REV, V34, P390, DOI 10.1080/02564602.2016.1192964; Gagneja K, 2016, J DISCRET MATH SCI C, V19, P39, DOI 10.1080/09720529.2015.1085730; Gu K, 2017, 2017 13 INT C NAT CO; Guo J, 2011, LECT NOTES COMPUT SC, V6841, P222, DOI 10.1007/978-3-642-22792-9_13; Hollick M, 2017, COMPUT COMMUN REV; Ksimi A El CL, 2018, NEW ALGORITHM OPTIMI; Lazarevic A, 2005, MASSIVE COMP, V5, P19, DOI 10.1007/0-387-24230-9_2; Narten T., 2007, PRIVACY EXTENSIONS S; Narten T., 2007, 4861 RFC; Praptodiyono Supriyanto, 2016, INT J SIMULATION SYS, V17; Rehman S. Ul, 2015, 4 IEEE INT C REL INF, P1; Rehman SU, 2015, INDIAN J SCI TECHNOL, V8; Simpson W., 2007, NEIGHBOR DISCOVERY I, P1; Stallings W., 2002, INTERNET PROTOCOL J, V3; Tayal P., 2014, INT J ENG COMPUT SCI, V3, P4; Turner S., 2011, UPDATED SECURITY CON; Ul Rehman S, 2017, INT J ADV COMPUT SC, V8, P63; Van Hauser T. H. C., 2006, ATTACKING IPV6 PROTO; Vijayakumar P., 2015, INVESTIGATIONS HYPER; Wang D, 2018, WIREL COMMUN MOB COM, DOI 10.1155/2018/7849065	37	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214518	10.1371/journal.pone.0214518	http://dx.doi.org/10.1371/journal.pone.0214518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939154	Green Published, gold, Green Submitted			2022-12-27	WOS:000462993900030
J	Li, T; Zhou, WJ; Li, YM; Gan, YQ; Peng, YL; Xiao, Q; Ouyang, CL; Wu, AQ; Zhang, S; Liu, JQ; Fan, LL; Han, D; Wei, Y; Shu, G; Yin, G				Li, Tong; Zhou, Wenjuan; Li, Yimin; Gan, Yaqi; Peng, Yulong; Xiao, Qing; Ouyang, Chunli; Wu, Anqi; Zhang, Sai; Liu, Jiaqi; Fan, Lili; Han, Duo; Wei, Yu; Shu, Guang; Yin, Gang			MiR-4524b-5p/WTX/beta-catenin axis functions as a regulator of metastasis in cervical cancer	PLOS ONE			English	Article							WTX; EXPRESSION; MICRORNAS; PROLIFERATION; PROGRESSION; SUPPRESSES; INVASION; PATHWAY; TARGETS; GENE	Cervical cancer is the second most deadly gynecological tumor worldwide. MicroRNAs (miRNAs) play very important roles in tumor oncogenesis and progression. The mechanism of post-transcription regulation of WTX gene is still unknown. A series of differential miRNAs were discovered by microarray analysis comparing three pairs of primary cervical cancer specimens and their relapsed tumors from three patients. Quantitative reverse transcriptase PCR (qRT-PCR), Western Blot (WB) and lmmunohistochemistry (IHC) was used to detect the expression of miR-4524b-5p and WTX in cervical cell lines and tissues. The biological function of miR-4524b-5p and WTX was investigated through knockdown and overexpression with inhibitor/siRNA and mimic/plasmid in vitro and in vivo. In this study, we found that miR-4524b-5p is highly expressed in relapsed cervical cancer specimens. Combined in vitro and in vivo experiments, showed that miR-4524b-5p could regulate the migration and invasion ability of cervical cancer. Furthermore, we also found that miR-4524b-5p could regulate the migration and invasion of cervical cancer by targeting WTX and that WTX could regulate the expression of beta-catenin. Taken together, our data identified a miR-4524b-5p/WTX/beta-catenin regulatory axis for cervical cancer, and miR-4524b-5p may be a potential target for cervical cancer therapy.	[Li, Tong; Li, Yimin; Gan, Yaqi; Peng, Yulong; Xiao, Qing; Ouyang, Chunli; Wu, Anqi; Zhang, Sai; Liu, Jiaqi; Fan, Lili; Shu, Guang; Yin, Gang] Cent S Univ, Sch Basic Med Sci, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China; [Zhou, Wenjuan] Cent S Univ, Xiangya Sch Nursing, Changsha, Hunan, Peoples R China; [Han, Duo] Cent S Univ, Dept Gen Surg, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Wei, Yu] Inner Mongolia Univ, Sch Life Sci, Hohhot, Inner Mongolia, Peoples R China	Central South University; Central South University; Central South University; Inner Mongolia University	Yin, G (corresponding author), Cent S Univ, Sch Basic Med Sci, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China.	gangyin@csu.edu.cn		Gan, Yaqi/0000-0001-8097-4603	National Natural Science Foundation of China [81572900]; National Key R&D Program of China, Stem Cell and Translation Research [2016YFA0102000]; Key Project of Hunan Province 2016 [2016JC2036]; Fundamental Research Funds for the Central Universities of Central South University [1053320171187]; Hunan Provincial Natural Science Foundation of China [2017JJ3513]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China, Stem Cell and Translation Research; Key Project of Hunan Province 2016; Fundamental Research Funds for the Central Universities of Central South University; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This study was supported by grants from the National Natural Science Foundation of China (no. 81572900), the National Key R&D Program of China, Stem Cell and Translation Research (no. 2016YFA0102000), the Key Project of Hunan Province 2016 (no. 2016JC2036), the Fundamental Research Funds for the Central Universities of Central South University (no. 1053320171187), and the Hunan Provincial Natural Science Foundation of China (no. 2017JJ3513).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chandeying N, 2017, J OBSTET GYNAECOL, V37, P347, DOI 10.1080/01443615.2016.1245279; Choong ES, 2016, BRACHYTHERAPY, V15, P40, DOI 10.1016/j.brachy.2015.09.002; Du K, 2014, ASIAN PAC J CANCER P, V15, P8793, DOI 10.7314/APJCP.2014.15.20.8793; Gao JK, 2019, MOL THER-ONCOLYTICS, V12, P214, DOI 10.1016/j.omto.2019.01.006; Golubovic M, 2017, VOJNOSANIT PREGL, V74, P24, DOI 10.2298/VSP150205143G; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hou T, 2014, BRIT J CANCER, V110, P1260, DOI 10.1038/bjc.2013.829; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kilic S, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.18; Li G, 2019, J CELL BIOCHEM, V120, P10587, DOI 10.1002/jcb.28345; Li N, 2019, ONCOL LETT, V17, P2631, DOI 10.3892/ol.2019.9923; Li X, 2016, WORLD J GASTROENTERO, V22, P5317, DOI 10.3748/wjg.v22.i23.5317; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Liu Xia, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P318; Luo ST, 2017, EXP THER MED, V14, P1227, DOI 10.3892/etm.2017.4586; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; Rennie D, 2015, AUST FAM PHYSICIAN, V44, P515; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Rothschild SI, 2012, ONCOGENE, V31, P4221, DOI 10.1038/onc.2011.578; Seppa K, 2016, BJOG-INT J OBSTET GY, V123, P772, DOI 10.1111/1471-0528.13754; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang W, 2018, ONCOL LETT, V15, P6131, DOI 10.3892/ol.2018.8110; Yao GD, 2018, ONCOL LETT, V15, P991, DOI 10.3892/ol.2017.7381; Yeung CLA, 2011, ONCOGENE, V30, P2401, DOI 10.1038/onc.2010.613; Yin MZ, 2012, J SURG ONCOL, V105, P206, DOI 10.1002/jso.22052; Zhang YY, 2017, PATHOL ONCOL RES, V23, P439, DOI 10.1007/s12253-016-0168-0; Zuo XL, 2018, AM J CANCER RES, V8, P662	33	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214822	10.1371/journal.pone.0214822	http://dx.doi.org/10.1371/journal.pone.0214822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939162	Green Published, Green Submitted, gold			2022-12-27	WOS:000462993900044
J	Ahrens, A; Lund, KD; Marschall, M; Dau, T				Ahrens, Axel; Lund, Kasper Duemose; Marschall, Marton; Dau, Torsten			Sound source localization with varying amount of visual information in virtual reality	PLOS ONE			English	Article							DIFFERENCE THRESHOLDS; SPECTRAL CUES; VISION	To achieve accurate spatial auditory perception, subjects typically require personal head-related transfer functions (HRTFs) and the freedom for head movements. Loudspeaker-based virtual sound environments allow for realism without individualized measurements. To study audio-visual perception in realistic environments, the combination of spatially tracked head mounted displays (HMDs), also known as virtual reality glasses, and virtual sound environments may be valuable. However, HMDs were recently shown to affect the subjects' HRTFs and thus might influence sound localization performance. Furthermore, due to limitations of the reproduction of visual information on the HMD, audio-visual perception might be influenced. Here, a sound localization experiment was conducted both with and without an HMD and with a varying amount of visual information provided to the subjects. Furthermore, interaural time and level difference errors (ITDs and ILDs) as well as spectral perturbations induced by the HMD were analyzed and compared to the perceptual localization data. The results showed a reduction of the localization accuracy when the subjects were wearing an HMD and when they were blindfolded. The HMD-induced error in azimuth localization was found to be larger in the left than in the right hemisphere. When visual information of the limited set of source locations was provided, the localization error induced by the HMD was found to be negligible. Presenting visual information of hand-location and room dimensions showed better sound localization performance compared to the condition with no visual information. The addition of possible source locations further improved the localization accuracy. Also adding pointing feedback in form of a virtual laser pointer improved the accuracy of elevation perception but not of azimuth perception.	[Ahrens, Axel; Lund, Kasper Duemose; Marschall, Marton; Dau, Torsten] Tech Univ Denmark, Hearing Syst Sect, Dept Hlth Technol, Lyngby, Denmark	Technical University of Denmark	Ahrens, A (corresponding author), Tech Univ Denmark, Hearing Syst Sect, Dept Hlth Technol, Lyngby, Denmark.	aahr@dtu.dk	Ahrens, Axel/ABB-3395-2020; Dau, Torsten/AAJ-3709-2020	Ahrens, Axel/0000-0001-8800-2497; Dau, Torsten/0000-0001-8110-4343	Oticon Centre of Excellence for Hearing and Speech Sciences - Centre for Applied Hearing Research	Oticon Centre of Excellence for Hearing and Speech Sciences - Centre for Applied Hearing Research	The authors AA and KDL were funded by the Oticon Centre of Excellence for Hearing and Speech Sciences. MM was funded by the Centre for Applied Hearing Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner R, 2014, J ACOUST SOC AM, V136, P791, DOI 10.1121/1.4887447; Blauert J., 1997, SPATIAL HEARING PSYC; Borrego A, 2018, GAMES HEALTH J, V7, P151, DOI 10.1089/g4h.2017.0114; Carlile S, 1997, HEARING RES, V114, P179, DOI 10.1016/S0378-5955(97)00161-5; Dobreva MS, 2011, J NEUROPHYSIOL, V105, P2471, DOI 10.1152/jn.00951.2010; Dufour A, 2002, VIS COGN, V9, P741, DOI 10.1080/13506280042000250; Ege R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34512-6; Genovese A, 2018, AES INT C AUD VIRT A; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Gupta R., 2018, AES INT C AUD VIRT A, pP8; HAFTER ER, 1975, J ACOUST SOC AM, V57, P181, DOI 10.1121/1.380412; HAFTER ER, 1977, J ACOUST SOC AM, V61, P829, DOI 10.1121/1.381372; HEBRANK J, 1974, J ACOUST SOC AM, V56, P1829, DOI 10.1121/1.1903520; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Kuznetsova A, 2015, FOOD QUAL PREFER, V40, P31, DOI 10.1016/j.foodqual.2014.08.004; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Macpherson EA, 2013, HEARING RES, V306, P76, DOI 10.1016/j.heares.2013.09.007; Maddox RK, 2014, CURR BIOL, V24, P748, DOI 10.1016/j.cub.2014.02.021; Majdak P, 2010, ATTEN PERCEPT PSYCHO, V72, P454, DOI 10.3758/APP.72.2.454; MAKOUS JC, 1990, J ACOUST SOC AM, V87, P2188, DOI 10.1121/1.399186; Middlebrooks JC, 1999, J ACOUST SOC AM, V106, P1493, DOI 10.1121/1.427147; MILLS AW, 1960, J ACOUST SOC AM, V32, P132, DOI 10.1121/1.1907864; Muller S, 2001, J AUDIO ENG SOC, V49, P443; MUSICANT AD, 1984, J ACOUST SOC AM, V75, P1195, DOI 10.1121/1.390770; Nam J, 2008, AUDIO ENG SOC CONV, V125; Niehorster DC, 2017, I-PERCEPTION, V8, DOI 10.1177/2041669517708205; OLDFIELD SR, 1984, PERCEPTION, V13, P581, DOI 10.1068/p130581; Perrett S, 1997, J ACOUST SOC AM, V102, P2325, DOI 10.1121/1.419642; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; SHELTON BR, 1980, PERCEPT PSYCHOPHYS, V28, P589, DOI 10.3758/BF03198830; Shinn-Cunningham BG, 1998, J ACOUST SOC AM, V103, P3667, DOI 10.1121/1.423107; Shinn-Cunningham BG, 1998, J ACOUST SOC AM, V103, P3656, DOI 10.1121/1.423088; Sondergaard P., 2013, TECHNOLOGY BINAURAL, P33, DOI 10.1007/978-3-642-37762-4_2; Strutt J., 1907, PHILOS MAG, V13, P214, DOI [DOI 10.1080/14786440709463595, 10.1080/14786440709463595]; Tabry V, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00932; van Beers RJ, 1999, EXP BRAIN RES, V125, P43, DOI 10.1007/s002210050656; Van Opstal AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174185	38	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214603	10.1371/journal.pone.0214603	http://dx.doi.org/10.1371/journal.pone.0214603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925174	gold, Green Published, Green Submitted			2022-12-27	WOS:000462732300024
J	Jiang, Y; Chen, L; Zhang, H; Xiao, X				Jiang, Yun; Chen, Li; Zhang, Hai; Xiao, Xiao			Breast cancer histopathological image classification using convolutional neural networks with small SE-ResNet module	PLOS ONE			English	Article								Although successful detection of malignant tumors from histopathological images largely depends on the long-term experience of radiologists, experts sometimes disagree with their decisions. Computer-aided diagnosis provides a second option for image diagnosis, which can improve the reliability of experts' decision-making. Automatic and precision classification for breast cancer histopathological image is of great importance in clinical application for identifying malignant tumors from histopathological images. Advanced convolution neural network technology has achieved great success in natural image classification, and it has been used widely in biomedical image processing. In this paper, we design a novel convolutional neural network, which includes a convolutional layer, small SE-ResNet module, and fully connected layer. We propose a small SE-ResNet module which is an improvement on the combination of residual module and Squeeze-and-Excitation block, and achieves the similar performance with fewer parameters. In addition, we propose a new learning rate scheduler which can get excellent performance without complicatedly fine-tuning the learning rate. We use our model for the automatic classification of breast cancer histology images (BreakHis dataset) into benign and malignant and eight subtypes. The results show that our model achieves the accuracy between 98.87% and 99.34% for the binary classification and achieve the accuracy between 90.66% and 93.81% for the multi-class classification.	[Jiang, Yun; Chen, Li; Zhang, Hai; Xiao, Xiao] Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou 730070, Gansu, Peoples R China	Northwest Normal University - China	Chen, L (corresponding author), Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou 730070, Gansu, Peoples R China.	fightinggirllichen@163.com			National Natural Science Foundation of China [61163036]; 2016 Gansu Provincial Science and Technology Plan Funded Natural Science Fund Project [1606RJZA047]; 2012 Gansu Provincial University Basic Research Business Expenses Special Fund Project; Gansu Provincial University Graduate Tutor Project [1201-16]; Northwest Normal University knowledge and innovation engineering research backbone project [nwnu-kjcxgc-03-67]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 2016 Gansu Provincial Science and Technology Plan Funded Natural Science Fund Project; 2012 Gansu Provincial University Basic Research Business Expenses Special Fund Project; Gansu Provincial University Graduate Tutor Project; Northwest Normal University knowledge and innovation engineering research backbone project	This work was supported by National Natural Science Foundation of China (61163036), 2016 Gansu Provincial Science and Technology Plan Funded Natural Science Fund Project (1606RJZA047), 2012 Gansu Provincial University Basic Research Business Expenses Special Fund Project, Gansu Provincial University Graduate Tutor Project (1201-16), The third phase of the Northwest Normal University knowledge and innovation engineering research backbone project (nwnu-kjcxgc-03-67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar S, 2018, COMPUTER METHODBIO, P1; AlRahhal MM., 2018, BREAST CANC, V9; Araujo T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177544; Bardou D, IEEE ACCESS, P1; Chan A, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160558; Chang SH, 2011, IEEE T COMMUN, V59, P2939, DOI 10.1109/TCOMM.2011.072011.100049; Chollet F., 2015, KERAS; Das K, 2018, I S BIOMED IMAGING, P578; DeVries Terrance, 2017, ARXIV170804552; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Guo Y., 2018, INT C IM AN REC, P827, DOI [DOI 10.1007/978-3-319-93000-8_94, 10.1007/978-3-319-93000-8_94]; Han ZY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04075-z; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Horvat JV, 2019, RADIOGRAPHICS; Hu J., 2017, SQUEEZE AND EXCITATI; Huang YL, 2019, ARXIV190109407; IOFFE S, 2015, ARXIV 1502 03167, V1502, P3167, DOI DOI 10.1007/S13398-014-0173-7.2; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; Kahya MA., 2017, J APPL MATH BIOINFOR, V7, P49; Karthiga R, 2018, 2018 2 INT C EL COMM, P274, DOI DOI 10.1109/ICECA.2018.8474739; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krizhevsky A., 2009, HDB SYSTEMIC AUTOIMM; Krizhevsky A., P 25 INT C NEUR INF, P1097; Kumar K., 2018, 2018 4 INT C RECENT, P1; Lim CN, 2019, RECENT ADV BREAST CA; Loshchilov Ilya, 2016, ARXIV160803983; Nahid AA, 2018, INFORMATION, V9, DOI 10.3390/info9010019; Nair V, 2010, PROC 27 TH INT C MAC, P807; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pratiher S, 2018, ARXIV180606876; Ruder S., 2016, ARXIV; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Spanhol FA, 2017, IEEE SYS MAN CYBERN, P1868; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; Wang J, 2018, ENVIRON TECHNOL, V39, P3055, DOI 10.1080/09593330.2017.1371797; Wang Zheng-peng, 2012, Computer Engineering, V38, P38, DOI 10.3969/j.issn.1000-3428.2012.10.010; Wei BZ, 2017, 2017 2ND IEEE INTERNATIONAL CONFERENCE ON CLOUD COMPUTING AND BIG DATA ANALYSIS (ICCCBDA 2017), P348, DOI 10.1109/ICCCBDA.2017.7951937	41	91	92	8	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214587	10.1371/journal.pone.0214587	http://dx.doi.org/10.1371/journal.pone.0214587			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925170	Green Published, gold, Green Submitted			2022-12-27	WOS:000462732300022
J	Bluhm, SL; Eitzinger, B; Ferlian, O; Bluhm, C; Schroter, K; Pena, R; Maraun, M; Scheu, S				Bluhm, Sarah L.; Eitzinger, Bernhard; Ferlian, Olga; Bluhm, Christian; Schroeter, Kristina; Pena, Rodica; Maraun, Mark; Scheu, Stefan			Deprivation of root-derived resources affects microbial biomass but not community structure in litter and soil	PLOS ONE			English	Article							CARBON STOCKS; TEMPERATE FORESTS; FAGUS-SYLVATICA; MINERAL SOIL; DOUGLAS-FIR; FATTY-ACIDS; FOOD-WEB; NITROGEN; PLANT; INPUT	The input of plant leaf litter has been assumed to be the most important resource for soil organisms of forest ecosystems, but there is increasing evidence that root-derived resources may be more important. By trenching roots of trees in deciduous and coniferous forests, we cut-off the input of root-derived resources and investigated the response of microorganisms using substrate-induced respiration and phospholipid fatty acid (PLFA) analysis. After one and three years, root trenching strongly decreased microbial biomass and concentrations of PLFAs by about 20%, but the microbial community structure was little affected and the effects were similar in deciduous and coniferous forests. However, the reduction in microbial biomass varied between regions and was more pronounced in forests on limestone soils (Hainich) than in those on sandy soils (Schorfheide). Trenching also reduced microbial biomass in the litter layer but only in the Hainich after one year, whereas fungal and bacterial marker PLFAs as well as the fungal-to-plant marker ratio in litter were reduced in the Schorfheide both after one and three years. The pronounced differences between forests of the two regions suggest that root-derived resources are more important in fueling soil microorganisms of base-rich forests characterized by mull humus than in forests poor in base cations characterized by moder soils. The reduction in microbial biomass and changes in microbial community characteristics in the litter layer suggests that litter microorganisms do not exclusively rely on resources from decomposing litter but also from roots, i.e. from resources based on labile recently fixed carbon. Our results suggest that both bacteria and fungi heavily depend on root-derived resources with both suffering to a similar extent to deprivation of these resources. Further, the results indicate that the community structure of microorganisms is remarkably resistant to changes in resource supply and adapts quickly to new conditions irrespective of tree species composition and forest management.	[Bluhm, Sarah L.; Eitzinger, Bernhard; Ferlian, Olga; Bluhm, Christian; Maraun, Mark; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Anim Ecol, Untere Karspule 2, Gottingen, Germany; [Schroeter, Kristina; Pena, Rodica] Univ Gottingen, Busgen Inst, Forest Bot & Tree Physiol, Busgenweg 2, Gottingen, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany; [Eitzinger, Bernhard] Univ Freiburg, Chair Nat Conservat & Landscape Ecol, Freiburg, Germany; [Eitzinger, Bernhard] Philipps Univ Marburg, Conservat Ecol, Karl von Frisch Str 8, Marburg, Germany; [Ferlian, Olga] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, Leipzig, Germany; [Ferlian, Olga] Univ Leipzig, Inst Biol, Deutsch Pl 5e, Leipzig, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Freiburg; Philipps University Marburg; Leipzig University	Bluhm, SL (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Anim Ecol, Untere Karspule 2, Gottingen, Germany.	szieger@gwdg.de	Eitzinger, Bernhard/M-5104-2015	Eitzinger, Bernhard/0000-0001-5903-4887; Bluhm, Sarah L./0000-0001-7314-7415	German Research Foundation (DFG) [SCHE 376/22-3]	German Research Foundation (DFG)(German Research Foundation (DFG))	This project was funded by the German Research Foundation (DFG; SCHE 376/22-3 to S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Averill C, 2016, ECOL LETT, V19, P937, DOI 10.1111/ele.12631; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bakker MR, 2008, J FOREST RES-JPN, V13, P176, DOI 10.1007/s10310-008-0068-6; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Brant JB, 2006, OECOLOGIA, V148, P650, DOI 10.1007/s00442-006-0402-7; Claus A, 2005, CAN J FOREST RES, V35, P1617, DOI 10.1139/x05-079; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cremer M, 2016, FOREST ECOL MANAG, V367, P30, DOI 10.1016/j.foreco.2016.02.020; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; De Vos B, 2015, GEODERMA, V251, P33, DOI 10.1016/j.geoderma.2015.03.008; de Vries FT, 2016, SOIL BIOL BIOCHEM, V102, P4, DOI 10.1016/j.soilbio.2016.06.023; Diaz-Pines E, 2010, EUR J FOREST RES, V129, P101, DOI 10.1007/s10342-008-0250-6; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Eisenhauer N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44641; Felsmann K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122539; Finer L, 2007, PLANT BIOSYST, V141, P394, DOI 10.1080/11263500701625897; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Goldmann K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01300; Griffiths BS, 1999, SOIL BIOL BIOCHEM, V31, P145, DOI 10.1016/S0038-0717(98)00117-5; GUCKERT JB, 1986, APPL ENVIRON MICROB, V52, P794, DOI 10.1128/AEM.52.4.794-801.1986; Hart SC, 1998, CAN J FOREST RES, V28, P1261, DOI 10.1139/cjfr-28-8-1261; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Jagodzinski AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148668; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Janssens IA, 2003, SCIENCE, V300, P1538, DOI 10.1126/science.1083592; Joergensen RG, 1999, PEDOBIOLOGIA, V43, P134; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kaiser C, 2010, SOIL BIOL BIOCHEM, V42, P1650, DOI 10.1016/j.soilbio.2010.05.019; Kaiser K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33696; Klarner B, 2014, OIKOS, V123, P1173, DOI 10.1111/j.1600-0706.2013.00939.x; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lang C, 2011, MYCORRHIZA, V21, P297, DOI 10.1007/s00572-010-0338-y; Lemanski K, 2014, SOIL BIOL BIOCHEM, V69, P38, DOI 10.1016/j.soilbio.2013.10.034; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Meinen C, 2009, OECOLOGIA, V161, P99, DOI 10.1007/s00442-009-1352-7; MIKOLA PEITSA, 1966, ANN BOT FENN, V3, P406; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; Oksanen J., 2022, R PACKAGE VERSION; Orwin KH, 2018, SOIL BIOL BIOCHEM, V117, P27, DOI 10.1016/j.soilbio.2017.10.036; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Pausch J, 2018, GLOBAL CHANGE BIOL, V24, P1, DOI 10.1111/gcb.13850; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Pollierer MM, 2015, SOIL BIOL BIOCHEM, V91, P248, DOI 10.1016/j.soilbio.2015.08.035; Preece C, 2018, TREE PHYSIOL, V38, P690, DOI 10.1093/treephys/tpx163; Preece C, 2016, PLANT SOIL, V409, P1, DOI 10.1007/s11104-016-3090-z; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Rosling A, 2003, NEW PHYTOL, V159, P775, DOI 10.1046/j.1469-8137.2003.00829.x; Rousk J, 2015, FUNCT ECOL, V29, P285, DOI 10.1111/1365-2435.12377; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Samaniego L, 2018, NAT CLIM CHANGE, V8, P421, DOI 10.1038/s41558-018-0138-5; SCHEU S, 1992, SOIL BIOL BIOCHEM, V24, P1113, DOI 10.1016/0038-0717(92)90061-2; Scheunemann N, 2015, OECOLOGIA, V179, P1135, DOI 10.1007/s00442-015-3415-2; Schulp CJE, 2008, FOREST ECOL MANAG, V256, P482, DOI 10.1016/j.foreco.2008.05.007; Siira-Pietikainen A, 2003, BIOL FERT SOILS, V37, P163, DOI 10.1007/s00374-002-0571-4; Sokol NW, 2019, NAT GEOSCI, V12, P46, DOI 10.1038/s41561-018-0258-6; Solly E, 2013, BIOGEOSCIENCES, V10, P4833, DOI 10.5194/bg-10-4833-2013; Vesterdal L, 2008, FOREST ECOL MANAG, V255, P35, DOI 10.1016/j.foreco.2007.08.015; Vesterdal L, 2013, FOREST ECOL MANAG, V309, P4, DOI 10.1016/j.foreco.2013.01.017; Zieger SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189502	70	5	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214233	10.1371/journal.pone.0214233	http://dx.doi.org/10.1371/journal.pone.0214233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921392	Green Published, gold			2022-12-27	WOS:000462594000044
